activity_comment	activity_id	assay_chembl_id	assay_description	assay_type	canonical_smiles	data_validity_comment	molecule_chembl_id	relation	standard_type	standard_units	standard_value	target_chembl_id	target_organism	type	units	value
	1504915	CHEMBL827045	Inhibition of Aurora kinase A	B	CC(C)(C)c1ccc(C(=O)Nc2[nH]nc3c2CN(C(=O)Cc2ccsc2)C3)cc1		CHEMBL192928	=	IC50	nM	5.0	CHEMBL4722	Homo sapiens	IC50	uM	0.005
	1504915	CHEMBL827045	Inhibition of Aurora kinase A	B	CC(C)(C)c1ccc(C(=O)Nc2[nH]nc3c2CN(C(=O)Cc2ccsc2)C3)cc1		CHEMBL192928	=	IC50	nM	5.0	CHEMBL4722	Homo sapiens	IC50	uM	0.005
	1504917	CHEMBL827045	Inhibition of Aurora kinase A	B	CC(C)(C)c1ccc(C(=O)Nc2n[nH]c3c2CN(C(=O)c2ccco2)C3)cc1		CHEMBL191816	=	IC50	nM	41.0	CHEMBL4722	Homo sapiens	IC50	uM	0.041
	1504919	CHEMBL827045	Inhibition of Aurora kinase A	B	CC(C)(C)c1ccc(C(=O)Nc2n[nH]c3c2CN(C(=O)Cc2ccccc2)C3)cc1		CHEMBL192575	=	IC50	nM	130.0	CHEMBL4722	Homo sapiens	IC50	uM	0.13
	1504921	CHEMBL827045	Inhibition of Aurora kinase A	B	CCc1cccc(CC)c1NC(=O)N1Cc2[nH]nc(NC(=O)c3ccc(C(C)(C)C)cc3)c2C1		CHEMBL191402	=	IC50	nM	100.0	CHEMBL4722	Homo sapiens	IC50	uM	0.1
	1504923	CHEMBL827045	Inhibition of Aurora kinase A	B	CN1CCN(c2ccc(C(=O)Nc3[nH]nc4c3CN(C(=O)Cc3ccsc3)C4)cc2)CC1		CHEMBL363857	=	IC50	nM	65.0	CHEMBL4722	Homo sapiens	IC50	uM	0.065
	1504925	CHEMBL827045	Inhibition of Aurora kinase A	B	CN1CCN(c2ccc(C(=O)Nc3n[nH]c4c3CN(C(=O)c3ccco3)C4)cc2)CC1		CHEMBL427170	=	IC50	nM	160.0	CHEMBL4722	Homo sapiens	IC50	uM	0.16
	1504927	CHEMBL827045	Inhibition of Aurora kinase A	B	CN1CCN(c2ccc(C(=O)Nc3n[nH]c4c3CN(C(=O)Cc3ccccc3)C4)cc2)CC1		CHEMBL190252	=	IC50	nM	140.0	CHEMBL4722	Homo sapiens	IC50	uM	0.14
	1504929	CHEMBL827045	Inhibition of Aurora kinase A	B	CCc1cccc(CC)c1NC(=O)N1Cc2[nH]nc(NC(=O)c3ccc(N4CCN(C)CC4)cc3)c2C1		CHEMBL363160	=	IC50	nM	27.0	CHEMBL4722	Homo sapiens	IC50	uM	0.027
	1504939	CHEMBL831065	Inhibitory activity against Aurora kinase A	B	CCc1cccc(CC)c1NC(=O)N1Cc2[nH]nc(NC(=O)c3ccc(N4CCN(C)CC4)cc3)c2C1		CHEMBL363160	=	IC50	nM	27.0	CHEMBL4722	Homo sapiens	IC50	nM	27.0
	1507327	CHEMBL827052	Inhibition of Aurora kinase A (Aur1)	B	CC(CN(C)C)Oc1ccc(Cl)cc1NC(=O)Nc1cnc(C#N)cn1		CHEMBL425904	=	IC50	nM	3229.0	CHEMBL4722	Homo sapiens	IC50	nM	3229.0
	1507343	CHEMBL827052	Inhibition of Aurora kinase A (Aur1)	B	CC1(COc2ccc(Cl)cc2NC(=O)Nc2cnc(C#N)cn2)COC1		CHEMBL192161	>	IC50	nM	10000.0	CHEMBL4722	Homo sapiens	IC50	nM	10000.0
Not Active	1650900	CHEMBL859641	Average Binding Constant for Aurora2; NA=Not Active at 10 uM	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554		Kd			CHEMBL4722	Homo sapiens	Kd		
Not Active	1650901	CHEMBL859641	Average Binding Constant for Aurora2; NA=Not Active at 10 uM	B	CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL607707		Kd			CHEMBL4722	Homo sapiens	Kd		
Not Active	1650902	CHEMBL859641	Average Binding Constant for Aurora2; NA=Not Active at 10 uM	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253		Kd			CHEMBL4722	Homo sapiens	Kd		
	1650903	CHEMBL859641	Average Binding Constant for Aurora2; NA=Not Active at 10 uM	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Kd	nM	6600.0	CHEMBL4722	Homo sapiens	Kd	uM	6.6
Not Active	1650904	CHEMBL859641	Average Binding Constant for Aurora2; NA=Not Active at 10 uM	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660		Kd			CHEMBL4722	Homo sapiens	Kd		
Not Active	1650905	CHEMBL859641	Average Binding Constant for Aurora2; NA=Not Active at 10 uM	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829		Kd			CHEMBL4722	Homo sapiens	Kd		
Not Active	1650906	CHEMBL859641	Average Binding Constant for Aurora2; NA=Not Active at 10 uM	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336		Kd			CHEMBL4722	Homo sapiens	Kd		
Not Active	1650907	CHEMBL859641	Average Binding Constant for Aurora2; NA=Not Active at 10 uM	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762		Kd			CHEMBL4722	Homo sapiens	Kd		
Not Active	1650908	CHEMBL859641	Average Binding Constant for Aurora2; NA=Not Active at 10 uM	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690		Kd			CHEMBL4722	Homo sapiens	Kd		
	1651731	CHEMBL859641	Average Binding Constant for Aurora2; NA=Not Active at 10 uM	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Kd	nM	16.0	CHEMBL4722	Homo sapiens	Kd	uM	0.016
Not Active	1651732	CHEMBL859641	Average Binding Constant for Aurora2; NA=Not Active at 10 uM	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041		Kd			CHEMBL4722	Homo sapiens	Kd		
Not Active	1651733	CHEMBL859641	Average Binding Constant for Aurora2; NA=Not Active at 10 uM	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10		Kd			CHEMBL4722	Homo sapiens	Kd		
Not Active	1651734	CHEMBL859641	Average Binding Constant for Aurora2; NA=Not Active at 10 uM	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385		Kd			CHEMBL4722	Homo sapiens	Kd		
Not Active	1651735	CHEMBL859641	Average Binding Constant for Aurora2; NA=Not Active at 10 uM	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667		Kd			CHEMBL4722	Homo sapiens	Kd		
	1651736	CHEMBL859641	Average Binding Constant for Aurora2; NA=Not Active at 10 uM	B	Oc1c2ccccc2c2c3c(cccc13)N=N2		CHEMBL1725279	=	Kd	nM	980.0	CHEMBL4722	Homo sapiens	Kd	uM	0.98
Not Active	1651737	CHEMBL859641	Average Binding Constant for Aurora2; NA=Not Active at 10 uM	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941		Kd			CHEMBL4722	Homo sapiens	Kd		
Not Active	1651738	CHEMBL859641	Average Binding Constant for Aurora2; NA=Not Active at 10 uM	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939		Kd			CHEMBL4722	Homo sapiens	Kd		
	1651739	CHEMBL859641	Average Binding Constant for Aurora2; NA=Not Active at 10 uM	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	=	Kd	nM	3800.0	CHEMBL4722	Homo sapiens	Kd	uM	3.8
Not Active	1651740	CHEMBL859641	Average Binding Constant for Aurora2; NA=Not Active at 10 uM	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828		Kd			CHEMBL4722	Homo sapiens	Kd		
Not Active	1651741	CHEMBL859641	Average Binding Constant for Aurora2; NA=Not Active at 10 uM	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965		Kd			CHEMBL4722	Homo sapiens	Kd		
	1659070	CHEMBL868729	Inhibitory activity against Aurora A kinase	B	Cc1ccc(C(=O)Nc2ncc(Nc3ncnc4c3NCc3ccccc3O4)cn2)cc1		CHEMBL202926	=	IC50	nM	3700.0	CHEMBL4722	Homo sapiens	IC50	uM	3.7
	1659071	CHEMBL868729	Inhibitory activity against Aurora A kinase	B	COc1ccc2c(c1)CNc1c(Nc3cnc(NC(=O)c4ccc(C)cc4)nc3)ncnc1O2		CHEMBL200535	=	IC50	nM	3500.0	CHEMBL4722	Homo sapiens	IC50	uM	3.5
	1659072	CHEMBL868729	Inhibitory activity against Aurora A kinase	B	COc1cc2c(cc1OC)Oc1ncnc(Nc3cnc(NC(=O)c4ccc(C)cc4)nc3)c1NC2		CHEMBL199950	=	IC50	nM	1200.0	CHEMBL4722	Homo sapiens	IC50	uM	1.2
	1659073	CHEMBL868729	Inhibitory activity against Aurora A kinase	B	COc1ccc2c(c1)CNc1c(Nc3cnc(NC(=O)c4cccc(F)c4)nc3)ncnc1O2		CHEMBL381649	=	IC50	nM	1100.0	CHEMBL4722	Homo sapiens	IC50	uM	1.1
	1659074	CHEMBL868729	Inhibitory activity against Aurora A kinase	B	COc1ccc2c(c1)Oc1ncnc(Nc3cnc(NC(=O)c4cccc(F)c4)nc3)c1NC2		CHEMBL371270	=	IC50	nM	320.0	CHEMBL4722	Homo sapiens	IC50	uM	0.32
	1659075	CHEMBL868729	Inhibitory activity against Aurora A kinase	B	COc1cc2c(cc1OC)Oc1ncnc(Nc3cnc(NC(=O)c4cccc(F)c4)nc3)c1NC2		CHEMBL371937	=	IC50	nM	1100.0	CHEMBL4722	Homo sapiens	IC50	uM	1.1
	1659076	CHEMBL868729	Inhibitory activity against Aurora A kinase	B	COc1ccc2c(c1)Oc1ncnc(Nc3cnc(NC(=O)c4ccc(F)cc4)nc3)c1NC2		CHEMBL199765	=	IC50	nM	330.0	CHEMBL4722	Homo sapiens	IC50	uM	0.33
	1661554	CHEMBL868729	Inhibitory activity against Aurora A kinase	B	O=C(Nc1ncc(Nc2ncnc3c2NCc2ccccc2O3)cn1)c1ccccc1		CHEMBL199476	=	IC50	nM	1900.0	CHEMBL4722	Homo sapiens	IC50	uM	1.9
	1661736	CHEMBL868729	Inhibitory activity against Aurora A kinase	B	CCN(CC)c1ccc2c(c1)Oc1ncnc(Nc3cnc(NC(=O)c4ccccc4)nc3)c1NC2		CHEMBL200395	=	IC50	nM	5000.0	CHEMBL4722	Homo sapiens	IC50	uM	5.0
	1661737	CHEMBL868729	Inhibitory activity against Aurora A kinase	B	COc1cc2c(cc1OC)Oc1ncnc(Nc3cnc(NC(=O)c4ccccc4)nc3)c1NC2		CHEMBL439512	=	IC50	nM	470.0	CHEMBL4722	Homo sapiens	IC50	uM	0.47
	1661738	CHEMBL868729	Inhibitory activity against Aurora A kinase	B	COc1cccc2c1Oc1ncnc(Nc3cnc(NC(=O)c4ccccc4)nc3)c1NC2		CHEMBL371458	>	IC50	nM	10000.0	CHEMBL4722	Homo sapiens	IC50	uM	10.0
	1661739	CHEMBL868729	Inhibitory activity against Aurora A kinase	B	COc1ccc2c(c1)Oc1ncnc(Nc3cnc(NC(=O)c4ccccc4)nc3)c1NC2		CHEMBL200525	=	IC50	nM	600.0	CHEMBL4722	Homo sapiens	IC50	uM	0.6
	1661740	CHEMBL868729	Inhibitory activity against Aurora A kinase	B	COc1ccc2c(c1)CNc1c(Nc3cnc(NC(=O)c4ccccc4)nc3)ncnc1O2		CHEMBL199547	=	IC50	nM	970.0	CHEMBL4722	Homo sapiens	IC50	uM	0.97
	1661741	CHEMBL868729	Inhibitory activity against Aurora A kinase	B	COc1cccc2c1CNc1c(Nc3cnc(NC(=O)c4ccccc4)nc3)ncnc1O2		CHEMBL381661	=	IC50	nM	2200.0	CHEMBL4722	Homo sapiens	IC50	uM	2.2
	1678089	CHEMBL861926	Inhibition of Aurora A kinase activity	B	COc1cc2c(Nc3ncc(C)s3)ncnc2cc1OCCCN1CCOCC1		CHEMBL201654	=	IC50	nM	43.0	CHEMBL4722	Homo sapiens	IC50	uM	0.043
	1678092	CHEMBL861926	Inhibition of Aurora A kinase activity	B	COc1cc2c(Nc3ncc(CC(=O)Nc4cccc(F)c4)s3)ncnc2cc1OCCN1CCC(CCO)CC1		CHEMBL202593	<	IC50	nM	1.0	CHEMBL4722	Homo sapiens	IC50	uM	0.001
	1678093	CHEMBL861926	Inhibition of Aurora A kinase activity	B	COc1cc2c(Nc3ncc(CC(=O)Nc4cccc(F)c4)s3)ncnc2cc1OCCCN1CCC(CO)CC1		CHEMBL201307	<	IC50	nM	1.0	CHEMBL4722	Homo sapiens	IC50	uM	0.001
	1678094	CHEMBL861926	Inhibition of Aurora A kinase activity	B	COc1cc2c(Nc3ncc(CC(=O)Nc4cccc(F)c4)s3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL381721	<	IC50	nM	1.0	CHEMBL4722	Homo sapiens	IC50	uM	0.001
	1678095	CHEMBL861926	Inhibition of Aurora A kinase activity	B	C#CCN(CCO)CCCOc1cc2ncnc(Nc3ncc(CC(=O)Nc4cccc(F)c4)s3)c2cc1OC		CHEMBL377289	<	IC50	nM	1.0	CHEMBL4722	Homo sapiens	IC50	uM	0.001
	1678096	CHEMBL861926	Inhibition of Aurora A kinase activity	B	CCN(CCO)CCCOc1cc2ncnc(Nc3ncc(CC(=O)Nc4cccc(F)c4)s3)c2cc1OC		CHEMBL202198	<	IC50	nM	1.0	CHEMBL4722	Homo sapiens	IC50	uM	0.001
	1678097	CHEMBL861926	Inhibition of Aurora A kinase activity	B	COc1cc2c(Nc3ncc(CC(=O)Nc4cccc(F)c4)s3)ncnc2cc1OCCCNCCO		CHEMBL373013	=	IC50	nM	5.0	CHEMBL4722	Homo sapiens	IC50	uM	0.005
	1678098	CHEMBL861926	Inhibition of Aurora A kinase activity	B	COCCOc1cc2ncnc(Nc3ncc(CC(=O)Nc4cccc(F)c4)s3)c2cc1OC		CHEMBL201297	=	IC50	nM	1.0	CHEMBL4722	Homo sapiens	IC50	uM	0.001
	1678099	CHEMBL861926	Inhibition of Aurora A kinase activity	B	COc1cc2c(Nc3ncc(CC(=O)Nc4ccccc4C(N)=O)s3)ncnc2cc1OCCCN1CCC[C@H]1CO		CHEMBL203039	=	IC50	nM	452.0	CHEMBL4722	Homo sapiens	IC50	uM	0.452
	1678100	CHEMBL861926	Inhibition of Aurora A kinase activity	B	COc1cc2c(Nc3ncc(CC(=O)Nc4cccc(N(C)C)c4)s3)ncnc2cc1OCCCN1CCC[C@H]1CO		CHEMBL203422	=	IC50	nM	483.0	CHEMBL4722	Homo sapiens	IC50	uM	0.483
	1678101	CHEMBL861926	Inhibition of Aurora A kinase activity	B	COc1cccc(NC(=O)Cc2cnc(Nc3ncnc4cc(OCCCN5CCC[C@H]5CO)c(OC)cc34)s2)c1		CHEMBL383448	=	IC50	nM	106.0	CHEMBL4722	Homo sapiens	IC50	uM	0.106
	1678102	CHEMBL861926	Inhibition of Aurora A kinase activity	B	COc1cc2c(Nc3ncc(CC(=O)Nc4cccc(F)c4F)s3)ncnc2cc1OCCCN1CCC[C@H]1CO		CHEMBL201197	=	IC50	nM	2.0	CHEMBL4722	Homo sapiens	IC50	uM	0.002
	1678103	CHEMBL861926	Inhibition of Aurora A kinase activity	B	COc1cc2c(Nc3ncc(CC(=O)Nc4cccc(F)c4)s3)ncnc2cc1OCCCN1CCC[C@H]1CO		CHEMBL380478	<	IC50	nM	1.0	CHEMBL4722	Homo sapiens	IC50	uM	0.001
	1678104	CHEMBL861926	Inhibition of Aurora A kinase activity	B	COc1cc2c(Nc3ncc(CNS(=O)(=O)c4cccc(F)c4)s3)ncnc2cc1OCCCN1CCC(CO)CC1		CHEMBL382054	=	IC50	nM	12.0	CHEMBL4722	Homo sapiens	IC50	uM	0.012
	1678105	CHEMBL861926	Inhibition of Aurora A kinase activity	B	COc1cc2c(Nc3ncc(CNC(=O)c4cccc(F)c4)s3)ncnc2cc1OCCCN1CCC(CO)CC1		CHEMBL201263	=	IC50	nM	111.0	CHEMBL4722	Homo sapiens	IC50	uM	0.111
	1678106	CHEMBL861926	Inhibition of Aurora A kinase activity	B	COc1cc2c(Nc3ncc(SCc4cccc(F)c4)s3)ncnc2cc1OCCCN1CCC(CO)CC1		CHEMBL201953	<	IC50	nM	1.0	CHEMBL4722	Homo sapiens	IC50	uM	0.001
	1678107	CHEMBL861926	Inhibition of Aurora A kinase activity	B	COc1cc2c(Nc3ncc(CC(=O)NCCC(C)C)s3)ncnc2cc1OCCCN1CCOCC1		CHEMBL424850	=	IC50	nM	158.0	CHEMBL4722	Homo sapiens	IC50	uM	0.158
	1678108	CHEMBL861926	Inhibition of Aurora A kinase activity	B	CCN(C(=O)Cc1cnc(Nc2ncnc3cc(OCCCN4CCOCC4)c(OC)cc23)s1)c1ccccc1		CHEMBL202026	=	IC50	nM	55.0	CHEMBL4722	Homo sapiens	IC50	uM	0.055
	1678109	CHEMBL861926	Inhibition of Aurora A kinase activity	B	COc1cc2c(Nc3ncc(CC(=O)Nc4cccc(F)c4)o3)ncnc2cc1OCCCN1CCOCC1		CHEMBL202502	=	IC50	nM	472.0	CHEMBL4722	Homo sapiens	IC50	uM	0.472
	1678110	CHEMBL861926	Inhibition of Aurora A kinase activity	B	COc1cc2c(Nc3nc(C(=O)Nc4ccc(F)cc4)c[nH]3)ncnc2cc1OCCCN1CCOCC1		CHEMBL202370	>	IC50	nM	1000.0	CHEMBL4722	Homo sapiens	IC50	uM	1.0
	1678111	CHEMBL861926	Inhibition of Aurora A kinase activity	B	COc1cc2c(Nc3ncc(CC(=O)Nc4cccc(F)c4)s3)ncnc2cc1OCCCN1CCOCC1		CHEMBL202241	<	IC50	nM	1.0	CHEMBL4722	Homo sapiens	IC50	uM	0.001
	1678112	CHEMBL861926	Inhibition of Aurora A kinase activity	B	COc1cc2c(Nc3nc(CC(=O)Nc4cccc(F)c4)cs3)ncnc2cc1OCCCN1CCOCC1		CHEMBL382804	=	IC50	nM	578.0	CHEMBL4722	Homo sapiens	IC50	uM	0.578
	1678113	CHEMBL861926	Inhibition of Aurora A kinase activity	B	COc1cc2c(Nc3ncc(C(=O)Nc4ccc(F)cc4)s3)ncnc2cc1OCCCN1CCOCC1		CHEMBL202567	=	IC50	nM	1.0	CHEMBL4722	Homo sapiens	IC50	uM	0.001
	1678114	CHEMBL861926	Inhibition of Aurora A kinase activity	B	CCCCc1cnc(Nc2ncnc3cc(OCCCN4CCOCC4)c(OC)cc23)s1		CHEMBL201655	=	IC50	nM	6.0	CHEMBL4722	Homo sapiens	IC50	uM	0.006
	1684484	CHEMBL867069	Inhibitory activity against Aurora A kinase	B	CCCCNC(=O)N1Cc2n[nH]c(NC(=O)[C@@H](C)c3ccc4ccccc4c3)c2C1		CHEMBL380946	>	IC50	nM	10000.0	CHEMBL4722	Homo sapiens	IC50	uM	10.0
	1684726	CHEMBL867069	Inhibitory activity against Aurora A kinase	B	CC(=O)N1Cc2n[nH]c(NC(=O)c3ccccc3)c2C1		CHEMBL204090	=	IC50	nM	3110.0	CHEMBL4722	Homo sapiens	IC50	uM	3.11
	1684727	CHEMBL867069	Inhibitory activity against Aurora A kinase	B	CCCCNC(=O)N1Cc2n[nH]c(NC(=O)Cc3ccc(N4CCCC4=O)cc3)c2C1		CHEMBL381565	>	IC50	nM	10000.0	CHEMBL4722	Homo sapiens	IC50	uM	10.0
	1684728	CHEMBL867069	Inhibitory activity against Aurora A kinase	B	CCCCNC(=O)N1Cc2n[nH]c(NC(=O)Cc3ccc4ccccc4c3)c2C1		CHEMBL381823	>	IC50	nM	10000.0	CHEMBL4722	Homo sapiens	IC50	uM	10.0
	1684729	CHEMBL867069	Inhibitory activity against Aurora A kinase	B	CCCCNC(=O)N1Cc2n[nH]c(NC(=O)Cc3ccc(N4CCCC4)cc3)c2C1		CHEMBL383104	=	IC50	nM	4200.0	CHEMBL4722	Homo sapiens	IC50	uM	4.2
	1684730	CHEMBL867069	Inhibitory activity against Aurora A kinase	B	CCCCNC(=O)N1Cc2n[nH]c(NC(=O)Cc3ccccc3F)c2C1		CHEMBL204294	>	IC50	nM	10000.0	CHEMBL4722	Homo sapiens	IC50	uM	10.0
	1684731	CHEMBL867069	Inhibitory activity against Aurora A kinase	B	NC(=O)N1Cc2n[nH]c(NC(=O)Cc3ccccc3)c2C1		CHEMBL378584	>	IC50	nM	10000.0	CHEMBL4722	Homo sapiens	IC50	uM	10.0
	1684732	CHEMBL867069	Inhibitory activity against Aurora A kinase	B	O=C(Cc1ccccc1)Nc1[nH]nc2c1CN(C(=O)Nc1ccccc1)C2		CHEMBL203707	>	IC50	nM	10000.0	CHEMBL4722	Homo sapiens	IC50	uM	10.0
	1684733	CHEMBL867069	Inhibitory activity against Aurora A kinase	B	CC(=O)N1Cc2n[nH]c(NC(=O)Cc3ccccc3)c2C1		CHEMBL205167	=	IC50	nM	2310.0	CHEMBL4722	Homo sapiens	IC50	uM	2.31
	1684734	CHEMBL867069	Inhibitory activity against Aurora A kinase	B	CC(C)NC(=O)N1Cc2n[nH]c(NC(=O)c3ccc4c(c3)OCO4)c2C1		CHEMBL439514	=	IC50	nM	390.0	CHEMBL4722	Homo sapiens	IC50	uM	0.39
	1684735	CHEMBL867069	Inhibitory activity against Aurora A kinase	B	CC(C)C(=O)N1Cc2n[nH]c(NC(=O)c3ccc4c(c3)OCO4)c2C1		CHEMBL204087	=	IC50	nM	160.0	CHEMBL4722	Homo sapiens	IC50	uM	0.16
	1684736	CHEMBL867069	Inhibitory activity against Aurora A kinase	B	Cc1ccc(C(=O)Nc2[nH]nc3c2CN(C(=O)c2cccc4cccnc24)C3)cc1		CHEMBL204555	=	IC50	nM	440.0	CHEMBL4722	Homo sapiens	IC50	uM	0.44
	1684737	CHEMBL867069	Inhibitory activity against Aurora A kinase	B	CC(=O)N1Cc2n[nH]c(NC(=O)c3ccc4c(c3)OCO4)c2C1		CHEMBL204610	>	IC50	nM	10000.0	CHEMBL4722	Homo sapiens	IC50	uM	10.0
	1684738	CHEMBL867069	Inhibitory activity against Aurora A kinase	B	CC(=O)N1Cc2n[nH]c(NC(=O)c3cccc(F)c3)c2C1		CHEMBL203714	=	IC50	nM	4850.0	CHEMBL4722	Homo sapiens	IC50	uM	4.85
	1684739	CHEMBL867069	Inhibitory activity against Aurora A kinase	B	CC(=O)N1Cc2n[nH]c(NC(=O)c3ccc(C#N)cc3)c2C1		CHEMBL202793	=	IC50	nM	8500.0	CHEMBL4722	Homo sapiens	IC50	uM	8.5
	1684740	CHEMBL867069	Inhibitory activity against Aurora A kinase	B	COc1ccc(C(=O)Nc2[nH]nc3c2CN(C(C)=O)C3)cc1		CHEMBL204383	=	IC50	nM	660.0	CHEMBL4722	Homo sapiens	IC50	uM	0.66
	1684741	CHEMBL867069	Inhibitory activity against Aurora A kinase	B	CC(=O)N1Cc2n[nH]c(NC(=O)c3ccc(F)cc3)c2C1		CHEMBL383652	>	IC50	nM	10000.0	CHEMBL4722	Homo sapiens	IC50	uM	10.0
	1684742	CHEMBL867069	Inhibitory activity against Aurora A kinase	B	CC(=O)N1Cc2n[nH]c(NC(=O)c3ccc(C)cc3)c2C1		CHEMBL382416	=	IC50	nM	2140.0	CHEMBL4722	Homo sapiens	IC50	uM	2.14
	1693028	CHEMBL859289	Inhibitory activity against Aurora A	B	COc1cc2ncnc(Nc3ccc(NC(=O)c4ccccc4)cc3)c2cc1OC		CHEMBL382590	=	IC50	nM	393.0	CHEMBL4722	Homo sapiens	IC50	nM	393.0
	1693031	CHEMBL859289	Inhibitory activity against Aurora A	B	CCCCC(=O)Nc1ncc(Nc2ncnc3cc(OCCCN4CCOCC4)c(OC)cc23)cn1		CHEMBL204318	=	IC50	nM	17.0	CHEMBL4722	Homo sapiens	IC50	nM	17.0
	1693032	CHEMBL859289	Inhibitory activity against Aurora A	B	COc1cc2c(Nc3cnc(NC(=O)c4ccncc4)nc3)ncnc2cc1OCCCN1CCOCC1		CHEMBL203507	=	IC50	nM	690.0	CHEMBL4722	Homo sapiens	IC50	nM	690.0
	1693033	CHEMBL859289	Inhibitory activity against Aurora A	B	CCCN(CCC)S(=O)(=O)c1ccc(C(=O)Nc2ncc(Nc3ncnc4cc(OCCCN5CCOCC5)c(OC)cc34)cn2)cc1		CHEMBL206374	=	IC50	nM	3900.0	CHEMBL4722	Homo sapiens	IC50	nM	3900.0
	1693034	CHEMBL859289	Inhibitory activity against Aurora A	B	CCc1ccc(C(=O)Nc2ncc(Nc3ncnc4cc(OCCCN5CCOCC5)c(OC)cc34)cn2)cc1		CHEMBL204217	=	IC50	nM	85.0	CHEMBL4722	Homo sapiens	IC50	nM	85.0
	1693035	CHEMBL859289	Inhibitory activity against Aurora A	B	COc1cc2c(Nc3cnc(NC(=O)c4ccc(C)c(Br)c4)nc3)ncnc2cc1OCCCN1CCOCC1		CHEMBL203007	=	IC50	nM	70.0	CHEMBL4722	Homo sapiens	IC50	nM	70.0
	1693036	CHEMBL859289	Inhibitory activity against Aurora A	B	COc1cc2c(Nc3cnc(NC(=O)c4ccc(F)c(Cl)c4)nc3)ncnc2cc1OCCCN1CCOCC1		CHEMBL382667	=	IC50	nM	0.15	CHEMBL4722	Homo sapiens	IC50	nM	0.15
	1693037	CHEMBL859289	Inhibitory activity against Aurora A	B	COc1cc2c(Nc3cnc(NC(=O)c4cccc(Cl)c4)nc3)ncnc2cc1OCCCN1CCOCC1		CHEMBL205877	<	IC50	nM	0.1	CHEMBL4722	Homo sapiens	IC50	nM	0.1
	1693038	CHEMBL859289	Inhibitory activity against Aurora A	B	COc1cc2c(Nc3ncc(NC(=O)c4ccccc4)cn3)ncnc2cc1OCCCN1CCOCC1		CHEMBL206266	=	IC50	nM	629.0	CHEMBL4722	Homo sapiens	IC50	nM	629.0
	1693039	CHEMBL859289	Inhibitory activity against Aurora A	B	COc1cc2c(Nc3cnc(NC(=O)c4ccccc4)nc3)ncnc2cc1OCCCN1CCOCC1		CHEMBL381724	=	IC50	nM	3.0	CHEMBL4722	Homo sapiens	IC50	nM	3.0
	1693040	CHEMBL859289	Inhibitory activity against Aurora A	B	COc1cc2c(Nc3ccc(NC(=O)c4ccccc4)cc3)ncnc2cc1OCCCN1CCOCC1		CHEMBL202721	=	IC50	nM	110.0	CHEMBL4722	Homo sapiens	IC50	nM	110.0
	1693048	CHEMBL859289	Inhibitory activity against Aurora A	B	COc1cc2c(Nc3cnc(NC(=O)c4cccc(Cl)c4)nc3)ncnc2cc1OCCCN1CCCCC1		CHEMBL203945	=	IC50	nM	0.8	CHEMBL4722	Homo sapiens	IC50	nM	0.8
	1722955	CHEMBL860192	Inhibition of Aurora1	B	CCOc1nc(NC(C)=O)cc(N)c1C#N		CHEMBL208637	>	Ki	nM	6900.0	CHEMBL4722	Homo sapiens	Ki	nM	6900.0
	1722962	CHEMBL860192	Inhibition of Aurora1	B	CCOc1nc(NC(=O)Cc2cc(OC)c(S(C)(=O)=O)cc2OC)cc(N)c1Cl		CHEMBL210928	>	Ki	nM	6900.0	CHEMBL4722	Homo sapiens	Ki	nM	6900.0
	1722963	CHEMBL860192	Inhibition of Aurora1	B	CC(=O)Nc1cc(N)c(C#N)c(-c2ccccc2)n1		CHEMBL210032	>	Ki	nM	6900.0	CHEMBL4722	Homo sapiens	Ki	nM	6900.0
	1722964	CHEMBL860192	Inhibition of Aurora1	B	COc1cc(S(C)(=O)=O)c(OC)cc1CC(=O)Nc1cc(N)c(C#N)c(OC(C)C)n1		CHEMBL378627	>	Ki	nM	6900.0	CHEMBL4722	Homo sapiens	Ki	nM	6900.0
	1722965	CHEMBL860192	Inhibition of Aurora1	B	CCOc1nc(NC(=O)Cc2cc(OC)c(S(C)(=O)=O)cc2OC)cc(N)c1C#N		CHEMBL210963	>	Ki	nM	6900.0	CHEMBL4722	Homo sapiens	Ki	nM	6900.0
	1722966	CHEMBL860192	Inhibition of Aurora1	B	CCOc1nc(NC(=O)Cc2cc(OC)ccc2OC)cc(N)c1C#N		CHEMBL210618	>	Ki	nM	6900.0	CHEMBL4722	Homo sapiens	Ki	nM	6900.0
	1734235	CHEMBL871594	Residual activity at human Aurora A at 10 uM in presence of 10 uM ATP relative to control	B	O=C1NC(=O)/C(=C/c2ccc(-c3ccc(F)cc3O)o2)S1		CHEMBL379156	=	Activity	%	85.0	CHEMBL4722	Homo sapiens	Activity	%	85.0
	1744517	CHEMBL867288	Inhibition of Aurora1	B	CCOc1nc(C(=O)NCc2ccc(S(C)(=O)=O)cc2)cc(N)c1Cl		CHEMBL377383	>	Ki	nM	6900.0	CHEMBL4722	Homo sapiens	Ki	uM	6.9
	1765517	CHEMBL871547	Inhibition of Aurora1 by HTRF kinase assay	B	CNc1ncc2cc(-c3cc(C(=O)Nc4cc(C(F)(F)F)ccc4OC4CCN(C)CC4)ccc3C)ccc2n1		CHEMBL386661	>	IC50	nM	5000.0	CHEMBL4722	Homo sapiens	IC50	uM	5.0
	1765529	CHEMBL871547	Inhibition of Aurora1 by HTRF kinase assay	B	Cc1ccc(C(=O)Nc2cccc(C(F)(F)F)c2)cc1-c1ccc2nc(NCCN3CCOCC3)ncc2c1		CHEMBL215943	>	IC50	nM	5000.0	CHEMBL4722	Homo sapiens	IC50	uM	5.0
	1769378	CHEMBL910898	Inhibition of Aurora-A	B	C[C@@H]1C[C@H]2CN1CCn1nc3c(cccc3c1O)-c1nc3c(cccc3nc1O)O2		CHEMBL215803	>	IC50	nM	1000.0	CHEMBL4722	Homo sapiens	IC50	uM	1.0
	1781947	CHEMBL911831	Inhibition of Aurora A kinase	B	CN1CCN(c2ccc(C(=O)Nc3n[nH]c4c3CN(C(=O)Cc3ccccc3)C4)cc2)CC1		CHEMBL190252	=	IC50	nM	130.0	CHEMBL4722	Homo sapiens	IC50	nM	130.0
	1781948	CHEMBL911831	Inhibition of Aurora A kinase	B	CO[C@H](C(=O)N1Cc2[nH]nc(NC(=O)c3ccc(N4CCN(C)CC4)cc3)c2C1)c1ccccc1		CHEMBL384575	=	IC50	nM	354.0	CHEMBL4722	Homo sapiens	IC50	nM	354.0
	1781949	CHEMBL911831	Inhibition of Aurora A kinase	B	C[C@H](C(=O)N1Cc2[nH]nc(NC(=O)c3ccc(N4CCN(C)CC4)cc3)c2C1)c1ccccc1		CHEMBL217748	=	IC50	nM	452.0	CHEMBL4722	Homo sapiens	IC50	nM	452.0
	1781950	CHEMBL911831	Inhibition of Aurora A kinase	B	CO[C@@H](C(=O)N1Cc2n[nH]c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)c2C1)c1ccccc1		CHEMBL402548	=	IC50	nM	13.0	CHEMBL4722	Homo sapiens	IC50	uM	0.013
	1781951	CHEMBL911831	Inhibition of Aurora A kinase	B	C[C@@H](C(=O)N1Cc2[nH]nc(NC(=O)c3ccc(N4CCN(C)CC4)cc3)c2C1)c1ccccc1		CHEMBL427787	=	IC50	nM	24.0	CHEMBL4722	Homo sapiens	IC50	nM	24.0
	1781952	CHEMBL911831	Inhibition of Aurora A kinase	B	CN1CCN(c2ccc(C(=O)Nc3n[nH]c4c3CN(C(=O)[C@H](O)c3ccccc3)C4)cc2)CC1		CHEMBL385872	=	IC50	nM	6.0	CHEMBL4722	Homo sapiens	IC50	nM	6.0
	1781953	CHEMBL911831	Inhibition of Aurora A kinase	B	CN1CCN(c2ccc(C(=O)Nc3n[nH]c4c3CN(C(=O)[C@H](F)c3ccccc3)C4)cc2)CC1		CHEMBL385266	=	IC50	nM	9.0	CHEMBL4722	Homo sapiens	IC50	nM	9.0
	1782000	CHEMBL911831	Inhibition of Aurora A kinase	B	CO[C@@H](C(=O)N1Cc2n[nH]c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)c2C1)c1ccccc1		CHEMBL402548	=	Ki	nM	2.5	CHEMBL4722	Homo sapiens	Ki	nM	2.5
	1790065	CHEMBL855326	Percentage activity of human Aurora-A in the presence of 10 uM of compound and 10 uM of ATP in comparison with control	B	O=C(NCc1ccc(S(=O)(=O)N2CCC(n3nnc4ccccc43)CC2)s1)c1ccc(Cl)cc1		CHEMBL383955	=	Activity	%	79.0	CHEMBL4722	Homo sapiens	Activity	%	79.0
	1790088	CHEMBL873731	In vitro inhibition constant for Aurora-A	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	Ki	nM	0.6	CHEMBL4722	Homo sapiens	Ki	umol	0.0006
	1790092	CHEMBL873735	Inhibition of in vitro Aurora-A kinase activity	B	COc1cc2c(Nc3ccc(NC(=O)c4ccccc4)cc3)ncnc2cc1OCCCN1CCOCC1		CHEMBL202721	=	IC50	nM	100.0	CHEMBL4722	Homo sapiens	IC50	umol	0.1
	1790096	CHEMBL912713	Inhibition of Aurora A	B	COc1cc2ncnc(Nc3ccc(NC(=O)c4ccccc4)cc3)c2cc1OC		CHEMBL382590	=	IC50	nM	393.0	CHEMBL4722	Homo sapiens	IC50	uM	0.393
	1790097	CHEMBL912713	Inhibition of Aurora A	B	COc1cc2c(Nc3cnc(NC(=O)c4ccccc4)nc3)ncnc2cc1OCCCN1CCOCC1		CHEMBL381724	=	IC50	nM	3.0	CHEMBL4722	Homo sapiens	IC50	uM	0.003
	1790098	CHEMBL912713	Inhibition of Aurora A	B	COc1cc2c(Nc3ncc(NC(=O)c4ccccc4)cn3)ncnc2cc1OCCCN1CCOCC1		CHEMBL206266	=	IC50	nM	629.0	CHEMBL4722	Homo sapiens	IC50	uM	0.629
	1790099	CHEMBL912713	Inhibition of Aurora A	B	COc1cc2c(Nc3cnc(NC(=O)c4ccncc4)nc3)ncnc2cc1OCCCN1CCOCC1		CHEMBL203507	=	IC50	nM	690.0	CHEMBL4722	Homo sapiens	IC50	uM	0.69
	1790100	CHEMBL912713	Inhibition of Aurora A	B	COc1cc2c(Nc3cnc(NC(=O)c4ccc(F)c(Cl)c4)nc3)ncnc2cc1OCCCN1CCOCC1		CHEMBL382667	=	IC50	nM	0.15	CHEMBL4722	Homo sapiens	IC50	uM	0.00015
	1790101	CHEMBL912713	Inhibition of Aurora A	B	COc1cc2c(Nc3cnc(NC(=O)c4ccc(Cc5ccccc5)c(Br)c4)nc3)ncnc2cc1OCCCN1CCOCC1		CHEMBL264903	=	IC50	nM	70.0	CHEMBL4722	Homo sapiens	IC50	uM	0.07
	1790102	CHEMBL912713	Inhibition of Aurora A	B	COc1cc2c(Nc3ccc(NC(=O)c4ccccc4)cc3)ncnc2cc1OCCCN1CCOCC1		CHEMBL202721	=	IC50	nM	110.0	CHEMBL4722	Homo sapiens	IC50	uM	0.11
	1790103	CHEMBL912713	Inhibition of Aurora A	B	COc1cc2c(Nc3cnc(NC(=O)c4ccccc4)nc3)ncnc2cc1OC[C@@H](O)CN1CCCCC1		CHEMBL427212	=	IC50	nM	0.8	CHEMBL4722	Homo sapiens	IC50	uM	0.0008
	1790104	CHEMBL912713	Inhibition of Aurora A	B	COc1cc2c(Nc3cnc(NC(=O)c4cccc(Cl)c4)nc3)ncnc2cc1OCCCN1CCCCC1		CHEMBL203945	=	IC50	nM	0.8	CHEMBL4722	Homo sapiens	IC50	uM	0.0008
	1790105	CHEMBL912713	Inhibition of Aurora A	B	COc1cc2c(Nc3cnc(NC(=O)c4cccc(Cl)c4)nc3)ncnc2cc1OCCCN1CCOCC1		CHEMBL205877	<	IC50	nM	0.1	CHEMBL4722	Homo sapiens	IC50	uM	0.0001
	1790106	CHEMBL912713	Inhibition of Aurora A	B	CCc1ccc(C(=O)Nc2ncc(Nc3ncnc4cc(OCCCN5CCOCC5)c(OC)cc34)cn2)cc1		CHEMBL204217	=	IC50	nM	85.0	CHEMBL4722	Homo sapiens	IC50	uM	0.085
	1790107	CHEMBL912713	Inhibition of Aurora A	B	CCCCC(=O)Nc1ncc(Nc2ncnc3cc(OCCCN4CCOCC4)c(OC)cc23)cn1		CHEMBL204318	=	IC50	nM	17.0	CHEMBL4722	Homo sapiens	IC50	uM	0.017
	1790108	CHEMBL912713	Inhibition of Aurora A	B	CCCN(CCC)S(=O)(=O)c1ncc(C(=O)Nc2ncc(Nc3ncnc4cc(OCCCN5CCOCC5)c(OC)cc34)cn2)cn1		CHEMBL214755	=	IC50	nM	3900.0	CHEMBL4722	Homo sapiens	IC50	uM	3.9
	1790116	CHEMBL873744	Inhibition of Aurora	B	CC(CO)NC(=N)c1c(O)nsc1Nc1ccc(Nc2ccccc2)cc1		CHEMBL253116	=	IC50	nM	265.0	CHEMBL4722	Homo sapiens	IC50	nM	265.0
	1790286	CHEMBL873744	Inhibition of Aurora	B	CC(CO)/N=C(\N)c1c(O)nsc1Nc1ccc(Oc2ccccc2)cc1		CHEMBL437331	=	IC50	nM	260.0	CHEMBL4722	Homo sapiens	IC50	nM	260.0
	1790292	CHEMBL873750	Inhibition of histone H3 phosphorylation by murine Aurora A kinase	F	c1cc(N2CCOCC2)ccc1Nc1ncc2ccn(C3CCCCC3)c2n1		CHEMBL385744	=	IC50	nM	49.0	CHEMBL4722	Homo sapiens	IC50	uM	0.049
	1790294	CHEMBL873750	Inhibition of histone H3 phosphorylation by murine Aurora A kinase	F	COCCN1CCN(c2ccc(Nc3ncc4ccn(C5CCCCC5)c4n3)cc2)CC1		CHEMBL214913	=	IC50	nM	6.0	CHEMBL4722	Homo sapiens	IC50	uM	0.006
	1790296	CHEMBL873750	Inhibition of histone H3 phosphorylation by murine Aurora A kinase	F	O=C(O)Cc1cccc(Nc2ncc3ccn(C4CCCCC4)c3n2)c1		CHEMBL215116	=	IC50	nM	0.6	CHEMBL4722	Homo sapiens	IC50	uM	0.0006
	1790298	CHEMBL873750	Inhibition of histone H3 phosphorylation by murine Aurora A kinase	F	O=S1(=O)CCN(c2ccc(Nc3ncc4ccn(C5CCCCC5)c4n3)cc2)CC1		CHEMBL215117	=	IC50	nM	12.0	CHEMBL4722	Homo sapiens	IC50	uM	0.012
	1790300	CHEMBL873750	Inhibition of histone H3 phosphorylation by murine Aurora A kinase	F	CN1CCN(c2ccc(Nc3ncc4ccn(C5CC6CCC5C6)c4n3)cc2)CC1		CHEMBL214609	=	IC50	nM	39.0	CHEMBL4722	Homo sapiens	IC50	uM	0.039
	1790302	CHEMBL873750	Inhibition of histone H3 phosphorylation by murine Aurora A kinase	F	COc1cccc(-n2ccc3cnc(Nc4ccc(N5CCN(C)CC5)cc4)nc32)c1		CHEMBL385013	=	IC50	nM	18.0	CHEMBL4722	Homo sapiens	IC50	uM	0.018
	1790304	CHEMBL873750	Inhibition of histone H3 phosphorylation by murine Aurora A kinase	F	CN1CCN(c2ccc(Nc3ncc4ccn(-c5cccnc5)c4n3)cc2)CC1		CHEMBL213770	=	IC50	nM	13.0	CHEMBL4722	Homo sapiens	IC50	uM	0.013
	1790311	CHEMBL873756	Inhibition of Aurora-A	B	CN1CCN(c2ccc(Nc3ncc4ccn(C5CCCCC5)c4n3)cc2)CC1		CHEMBL214329	=	IC50	nM	47.0	CHEMBL4722	Homo sapiens	IC50	uM	0.047
	1790312	CHEMBL873750	Inhibition of histone H3 phosphorylation by murine Aurora A kinase	F	CN1CCN(c2ccc(Nc3ncc4ccn(C5CCCCC5)c4n3)cc2)CC1		CHEMBL214329	=	IC50	nM	47.0	CHEMBL4722	Homo sapiens	IC50	uM	0.047
	1790317	CHEMBL873750	Inhibition of histone H3 phosphorylation by murine Aurora A kinase	F	CN1CCN(c2ccc(Nc3ncc4ccn(-c5cccc(S(C)(=O)=O)c5)c4n3)cc2)CC1		CHEMBL385945	=	IC50	nM	9.0	CHEMBL4722	Homo sapiens	IC50	uM	0.009
	1790319	CHEMBL873750	Inhibition of histone H3 phosphorylation by murine Aurora A kinase	F	CN1CCN(c2ccc(Nc3ncc4ccn(C5Cc6ccccc6C5)c4n3)cc2)CC1		CHEMBL387267	=	IC50	nM	18.0	CHEMBL4722	Homo sapiens	IC50	uM	0.018
	1790444	CHEMBL912732	Inhibition of human Aurora-A	B	COc1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)cc(OC)c1OC		CHEMBL201511	=	IC50	nM	9900.0	CHEMBL4722	Homo sapiens	IC50	M	0.0000099
	1790449	CHEMBL856401	Inhibition of Aurora-A	B	O=C(Nc1cccc(Nc2nccc(Nc3cccc(C(F)(F)F)c3)n2)c1)C1CC1		CHEMBL383899	=	IC50	nM	42.0	CHEMBL4722	Homo sapiens	IC50	nM	42.0
	1790451	CHEMBL856401	Inhibition of Aurora-A	B	O=C(Nc1cccc(Nc2ccnc(Nc3cccc(C(F)(F)F)c3)n2)c1)C1CC1		CHEMBL216260	=	IC50	nM	931.0	CHEMBL4722	Homo sapiens	IC50	nM	931.0
	1790453	CHEMBL856401	Inhibition of Aurora-A	B	O=C(Nc1cccc(Nc2cc(Nc3cccc(C(F)(F)F)c3)ncn2)c1)C1CC1		CHEMBL387187	>	IC50	nM	10000.0	CHEMBL4722	Homo sapiens	IC50	nM	10000.0
	1790454	CHEMBL856402	Inhibition of human recombinant Aurora A	B	COc1cc2c(Nc3cc(CC(=O)Nc4cccc(F)c4F)[nH]n3)ncnc2cc1OCCCN1CCC(CO)CC1		CHEMBL263067	=	Ki	nM	2.0	CHEMBL4722	Homo sapiens	Ki	uM	0.002
	1790455	CHEMBL856402	Inhibition of human recombinant Aurora A	B	COc1cc2c(Nc3cc(CC(=O)Nc4cccc(F)c4F)[nH]n3)ncnc2cc1OCCCN1CCC(CO)CC1		CHEMBL263067	=	Ki	nM	410.0	CHEMBL4722	Homo sapiens	Ki	uM	0.41
	1790457	CHEMBL856402	Inhibition of human recombinant Aurora A	B	COc1cc2c(Nc3cc(CC(=O)Nc4cc(F)cc(F)c4)[nH]n3)ncnc2cc1OCCCN1CCC(CO)CC1		CHEMBL262434	=	Ki	nM	1.0	CHEMBL4722	Homo sapiens	Ki	uM	0.001
	1790458	CHEMBL856402	Inhibition of human recombinant Aurora A	B	COc1cc2c(Nc3cc(CC(=O)Nc4cc(F)cc(F)c4)[nH]n3)ncnc2cc1OCCCN1CCC(CO)CC1		CHEMBL262434	=	Ki	nM	230.0	CHEMBL4722	Homo sapiens	Ki	uM	0.23
	1790460	CHEMBL856402	Inhibition of human recombinant Aurora A	B	COc1cc2c(Nc3cc(CC(=O)Nc4cccc(Cl)c4)[nH]n3)ncnc2cc1OCCCN1CCC(CO)CC1		CHEMBL215636	=	Ki	nM	8.0	CHEMBL4722	Homo sapiens	Ki	uM	0.008
	1790461	CHEMBL856402	Inhibition of human recombinant Aurora A	B	COc1cc2c(Nc3cc(CC(=O)Nc4cccc(Cl)c4)[nH]n3)ncnc2cc1OCCCN1CCC(CO)CC1		CHEMBL215636	=	Ki	nM	450.0	CHEMBL4722	Homo sapiens	Ki	uM	0.45
	1790463	CHEMBL856402	Inhibition of human recombinant Aurora A	B	COc1cc2c(Nc3cc(CC(=O)Nc4cccc(C#N)c4)[nH]n3)ncnc2cc1OCCCN1CCC(CO)CC1		CHEMBL217037	=	Ki	nM	83.0	CHEMBL4722	Homo sapiens	Ki	uM	0.083
	1790464	CHEMBL856402	Inhibition of human recombinant Aurora A	B	COc1cc2c(Nc3cc(CC(=O)Nc4cccc(C#N)c4)[nH]n3)ncnc2cc1OCCCN1CCC(CO)CC1		CHEMBL217037	=	Ki	nM	2600.0	CHEMBL4722	Homo sapiens	Ki	uM	2.6
	1790466	CHEMBL856402	Inhibition of human recombinant Aurora A	B	COc1cc2c(Nc3cc(CC(=O)Nc4cccc([N+](=O)[O-])c4)[nH]n3)ncnc2cc1OCCCN1CCC(CO)CC1		CHEMBL268345	=	Ki	nM	39.0	CHEMBL4722	Homo sapiens	Ki	uM	0.039
	1790467	CHEMBL856402	Inhibition of human recombinant Aurora A	B	COc1cc2c(Nc3cc(CC(=O)Nc4cccc([N+](=O)[O-])c4)[nH]n3)ncnc2cc1OCCCN1CCC(CO)CC1		CHEMBL268345	=	Ki	nM	890.0	CHEMBL4722	Homo sapiens	Ki	uM	0.89
	1790469	CHEMBL856402	Inhibition of human recombinant Aurora A	B	COc1cc2c(Nc3cc(CC(=O)Nc4cccc(O)c4)[nH]n3)ncnc2cc1OCCCN1CCC(CO)CC1		CHEMBL214648	=	Ki	nM	140.0	CHEMBL4722	Homo sapiens	Ki	uM	0.14
	1790470	CHEMBL856402	Inhibition of human recombinant Aurora A	B	COc1cc2c(Nc3cc(CC(=O)Nc4cccc(O)c4)[nH]n3)ncnc2cc1OCCCN1CCC(CO)CC1		CHEMBL214648	=	Ki	nM	4000.0	CHEMBL4722	Homo sapiens	Ki	uM	4.0
	1790472	CHEMBL856402	Inhibition of human recombinant Aurora A	B	COc1cccc(NC(=O)Cc2cc(Nc3ncnc4cc(OCCCN5CCC(CO)CC5)c(OC)cc34)[nH]n2)c1		CHEMBL385597	=	Ki	nM	9.0	CHEMBL4722	Homo sapiens	Ki	uM	0.009
	1790473	CHEMBL856402	Inhibition of human recombinant Aurora A	B	COc1cccc(NC(=O)Cc2cc(Nc3ncnc4cc(OCCCN5CCC(CO)CC5)c(OC)cc34)[nH]n2)c1		CHEMBL385597	=	Ki	nM	1900.0	CHEMBL4722	Homo sapiens	Ki	uM	1.9
	1790475	CHEMBL856402	Inhibition of human recombinant Aurora A	B	COc1cc2c(Nc3cc(CC(=O)Nc4cccc(C(F)(F)F)c4)[nH]n3)ncnc2cc1OCCCN1CCC(CO)CC1		CHEMBL405120	=	Ki	nM	13.0	CHEMBL4722	Homo sapiens	Ki	uM	0.013
	1790480	CHEMBL856402	Inhibition of human recombinant Aurora A	B	COc1cc2c(Nc3cc(CC(=O)Nc4cccc(F)c4F)[nH]n3)ncnc2cc1OCCCN1CCC[C@@H]1CO		CHEMBL385049	=	Ki	nM	94.0	CHEMBL4722	Homo sapiens	Ki	uM	0.094
	1790488	CHEMBL856402	Inhibition of human recombinant Aurora A	B	COc1cc2c(Nc3cc(CC(=O)Nc4cccc(F)c4F)[nH]n3)ncnc2cc1OCCCN1CCC[C@H]1CO		CHEMBL214940	=	Ki	nM	39.0	CHEMBL4722	Homo sapiens	Ki	uM	0.039
	1790491	CHEMBL856402	Inhibition of human recombinant Aurora A	B	COc1cc2c(Nc3cc(CC(=O)Nc4cccc(F)c4F)[nH]n3)ncnc2cc1OCCCN1CCN(CCO)CC1		CHEMBL386310	=	Ki	nM	55.0	CHEMBL4722	Homo sapiens	Ki	uM	0.055
	1790494	CHEMBL856402	Inhibition of human recombinant Aurora A	B	COc1cc2c(Nc3cc(CC(=O)Nc4cccc(F)c4F)[nH]n3)ncnc2cc1OCCCN1CCC(O)CC1		CHEMBL214842	=	Ki	nM	220.0	CHEMBL4722	Homo sapiens	Ki	uM	0.22
	1790497	CHEMBL856402	Inhibition of human recombinant Aurora A	B	COc1cc2c(Nc3cc(CC(=O)Nc4cccc(F)c4F)[nH]n3)ncnc2cc1OCCCN1CCC(CCO)CC1		CHEMBL384054	=	Ki	nM	280.0	CHEMBL4722	Homo sapiens	Ki	uM	0.28
	1790500	CHEMBL856402	Inhibition of human recombinant Aurora A	B	COc1cc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2cc1OCCCN1CCC[C@@H]1CO		CHEMBL424899	=	Ki	nM	110.0	CHEMBL4722	Homo sapiens	Ki	uM	0.11
	1790504	CHEMBL856402	Inhibition of human recombinant Aurora A	B	COc1cc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2cc1OCCCNCCO		CHEMBL386253	=	Ki	nM	690.0	CHEMBL4722	Homo sapiens	Ki	uM	0.69
	1790507	CHEMBL856402	Inhibition of human recombinant Aurora A	B	COc1cc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2cc1OCCCN(C)CCO		CHEMBL214601	=	Ki	nM	65.0	CHEMBL4722	Homo sapiens	Ki	uM	0.065
	1790510	CHEMBL856402	Inhibition of human recombinant Aurora A	B	CCN(CCO)CCCOc1cc2ncnc(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)c2cc1OC		CHEMBL215275	=	Ki	nM	190.0	CHEMBL4722	Homo sapiens	Ki	uM	0.19
	1790515	CHEMBL856402	Inhibition of human recombinant Aurora A	B	CCCN(CCO)CCCOc1cc2ncnc(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)c2cc1OC		CHEMBL217804	=	Ki	nM	220.0	CHEMBL4722	Homo sapiens	Ki	uM	0.22
	1790518	CHEMBL856402	Inhibition of human recombinant Aurora A	B	CCN(CCO)CCCOc1cc2ncnc(Nc3cc(CC(=O)Nc4cccc(F)c4F)[nH]n3)c2cc1OC		CHEMBL214848	=	Ki	nM	360.0	CHEMBL4722	Homo sapiens	Ki	uM	0.36
	1790525	CHEMBL856402	Inhibition of human recombinant Aurora A	B	CCCN(CCO)CCCOc1cc2ncnc(Nc3cc(CC(=O)Nc4cccc(F)c4F)[nH]n3)c2cc1OC		CHEMBL214849	=	Ki	nM	87.0	CHEMBL4722	Homo sapiens	Ki	uM	0.087
	1790535	CHEMBL856402	Inhibition of human recombinant Aurora A	B	COc1cc2c(Nc3cc(CC(=O)Nc4cccc(F)c4F)[nH]n3)ncnc2cc1OCCCN(CCO)CC(C)C		CHEMBL216053	=	Ki	nM	18.0	CHEMBL4722	Homo sapiens	Ki	uM	0.018
	1790540	CHEMBL856402	Inhibition of human recombinant Aurora A	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4F)[nH]n3)ncnc2c1		CHEMBL215322	=	Ki	nM	160.0	CHEMBL4722	Homo sapiens	Ki	uM	0.16
	1790543	CHEMBL856402	Inhibition of human recombinant Aurora A	B	CCCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4F)[nH]n3)ncnc2c1		CHEMBL214637	=	Ki	nM	350.0	CHEMBL4722	Homo sapiens	Ki	uM	0.35
	1790547	CHEMBL856402	Inhibition of human recombinant Aurora A	B	O=C(Cc1cc(Nc2ncnc3cc(OCCCN4CCC[C@@H]4CO)ccc23)n[nH]1)Nc1cccc(F)c1F		CHEMBL215022	=	Ki	nM	950.0	CHEMBL4722	Homo sapiens	Ki	uM	0.95
	1790572	CHEMBL856402	Inhibition of human recombinant Aurora A	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	=	Ki	nM	1400.0	CHEMBL4722	Homo sapiens	Ki	uM	1.4
	1790583	CHEMBL856402	Inhibition of human recombinant Aurora A	B	CCCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215495	=	Ki	nM	980.0	CHEMBL4722	Homo sapiens	Ki	uM	0.98
	1790586	CHEMBL856402	Inhibition of human recombinant Aurora A	B	O=C(Cc1cc(Nc2ncnc3cc(OCCCN4CCC[C@@H]4CO)ccc23)n[nH]1)Nc1cccc(F)c1		CHEMBL215203	=	Ki	nM	1400.0	CHEMBL4722	Homo sapiens	Ki	uM	1.4
	1790597	CHEMBL856402	Inhibition of human recombinant Aurora A	B	COc1cc2c(Nc3cc(CC(=O)Nc4ccccc4)[nH]n3)ncnc2cc1OCCCN1CCC(CO)CC1		CHEMBL387190	=	Ki	nM	18.0	CHEMBL4722	Homo sapiens	Ki	uM	0.018
	1790598	CHEMBL856402	Inhibition of human recombinant Aurora A	B	COc1cc2c(Nc3cc(CC(=O)Nc4ccccc4)[nH]n3)ncnc2cc1OCCCN1CCC(CO)CC1		CHEMBL387190	=	Ki	nM	1600.0	CHEMBL4722	Homo sapiens	Ki	uM	1.6
	1790599	CHEMBL856402	Inhibition of human recombinant Aurora A	B	COc1cc2c(Nc3cc(CC(=O)Nc4ccccc4)[nH]n3)ncnc2cc1OCCCN1CCC(CO)CC1		CHEMBL387190	=	Ki	nM	1200.0	CHEMBL4722	Homo sapiens	Ki	uM	1.2
	1790600	CHEMBL856402	Inhibition of human recombinant Aurora A	B	COc1cc2c(Nc3cc(CC(=O)Nc4ccccc4F)[nH]n3)ncnc2cc1OCCCN1CCC(CO)CC1		CHEMBL425280	=	Ki	nM	14.0	CHEMBL4722	Homo sapiens	Ki	uM	0.014
	1790601	CHEMBL856402	Inhibition of human recombinant Aurora A	B	COc1cc2c(Nc3cc(CC(=O)Nc4ccccc4F)[nH]n3)ncnc2cc1OCCCN1CCC(CO)CC1		CHEMBL425280	=	Ki	nM	1400.0	CHEMBL4722	Homo sapiens	Ki	uM	1.4
	1790602	CHEMBL856402	Inhibition of human recombinant Aurora A	B	COc1cc2c(Nc3cc(CC(=O)Nc4ccccc4F)[nH]n3)ncnc2cc1OCCCN1CCC(CO)CC1		CHEMBL425280	=	Ki	nM	470.0	CHEMBL4722	Homo sapiens	Ki	uM	0.47
	1790603	CHEMBL856402	Inhibition of human recombinant Aurora A	B	COc1cc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2cc1OCCCN1CCC(CO)CC1		CHEMBL216769	=	Ki	nM	2.0	CHEMBL4722	Homo sapiens	Ki	uM	0.002
	1790604	CHEMBL856402	Inhibition of human recombinant Aurora A	B	COc1cc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2cc1OCCCN1CCC(CO)CC1		CHEMBL216769	=	Ki	nM	450.0	CHEMBL4722	Homo sapiens	Ki	uM	0.45
	1790608	CHEMBL856402	Inhibition of human recombinant Aurora A	B	COc1cc2c(Nc3cc(CC(=O)Nc4ccc(F)cc4)[nH]n3)ncnc2cc1OCCCN1CCC(CO)CC1		CHEMBL216388	=	Ki	nM	30.0	CHEMBL4722	Homo sapiens	Ki	uM	0.03
	1790609	CHEMBL856402	Inhibition of human recombinant Aurora A	B	COc1cc2c(Nc3cc(CC(=O)Nc4ccc(F)cc4)[nH]n3)ncnc2cc1OCCCN1CCC(CO)CC1		CHEMBL216388	=	Ki	nM	2000.0	CHEMBL4722	Homo sapiens	Ki	uM	2.0
	1815216	CHEMBL910142	Inhibition of AurA	B	CNc1ncnc(-c2cccnc2Oc2ccc(F)c(C(=O)Nc3cc(C(F)(F)F)ccc3N(C)CCCN(C)C)c2)n1		CHEMBL373882	=	IC50	nM	25000.0	CHEMBL4722	Homo sapiens	IC50	nM	25000.0
	1820466	CHEMBL917088	Inhibition of AURA kinase	B	O=C(N[C@H](CO)c1ccc(F)c(Cl)c1)c1cc(-c2n[nH]cc2-c2cccc(Cl)c2)c[nH]1		CHEMBL387385	>	Ki	nM	4000.0	CHEMBL4722	Homo sapiens	Ki	uM	4.0
	1824467	CHEMBL913838	Inhibition of Aurora 1	B	CS(=O)(=O)Nc1cc2c(cc1Cl)NC(=O)Nc1cnc(C#N)c(n1)OCCCCCO2		CHEMBL223460	>	Ki	nM	10000.0	CHEMBL4722	Homo sapiens	Ki	uM	10.0
	1824615	CHEMBL913838	Inhibition of Aurora 1	B	N#Cc1ncc2nc1OCCCCCOc1cc(CCCO)c(Cl)cc1NC(=O)N2		CHEMBL223367	>	Ki	nM	10000.0	CHEMBL4722	Homo sapiens	Ki	uM	10.0
	1824693	CHEMBL913838	Inhibition of Aurora 1	B	N#Cc1ncc2nc1OCCCCCOc1cc(OCCCO)c(Cl)cc1NC(=O)N2		CHEMBL373598	>	Ki	nM	10000.0	CHEMBL4722	Homo sapiens	Ki	uM	10.0
	1914920	CHEMBL894337	Inhibition of human recombinant aurora A kinase	B	CO/N=C1\C(c2c(O)[nH]c3ccccc23)=Nc2ccccc21		CHEMBL211243	=	IC50	nM	4300.0	CHEMBL4722	Homo sapiens	IC50	uM	4.3
	1914922	CHEMBL894337	Inhibition of human recombinant aurora A kinase	B	O=Nc1c(-c2c(O)[nH]c3ccccc23)[nH]c2ccccc12		CHEMBL126077	=	IC50	nM	4000.0	CHEMBL4722	Homo sapiens	IC50	uM	4.0
	1914923	CHEMBL894337	Inhibition of human recombinant aurora A kinase	B	O=C1Nc2cc(Br)ccc2/C1=C1/Nc2ccccc2/C1=N\O		CHEMBL409450	=	IC50	nM	600.0	CHEMBL4722	Homo sapiens	IC50	uM	0.6
	1914924	CHEMBL894337	Inhibition of human recombinant aurora A kinase	B	CC(=O)O/N=C1\C(c2c(O)[nH]c3ccccc23)=Nc2ccccc21		CHEMBL209849	=	IC50	nM	2300.0	CHEMBL4722	Homo sapiens	IC50	uM	2.3
	1914925	CHEMBL894337	Inhibition of human recombinant aurora A kinase	B	O=Nc1c(-c2c(O)[nH]c3c(Br)cccc23)[nH]c2ccccc12		CHEMBL373834	=	IC50	nM	100000.0	CHEMBL4722	Homo sapiens	IC50	uM	100.0
	1914936	CHEMBL894337	Inhibition of human recombinant aurora A kinase	B	CO/N=C1C(=C2\C(=O)Nc3c(Br)cccc32)\Nc2ccccc2\1		CHEMBL243556	>	IC50	nM	100000.0	CHEMBL4722	Homo sapiens	IC50	uM	100.0
	1914958	CHEMBL894337	Inhibition of human recombinant aurora A kinase	B	O=C1C(c2c(O)[nH]c3c(Cl)cccc23)=Nc2ccccc21		CHEMBL378191	>	IC50	nM	100000.0	CHEMBL4722	Homo sapiens	IC50	uM	100.0
	1914959	CHEMBL894337	Inhibition of human recombinant aurora A kinase	B	CC(=O)O/N=C1C(=C2\C(=O)Nc3c(Cl)cccc32)\Nc2ccccc2\1		CHEMBL397719	>	IC50	nM	100000.0	CHEMBL4722	Homo sapiens	IC50	uM	100.0
	1914960	CHEMBL894337	Inhibition of human recombinant aurora A kinase	B	CO/N=C1C(=C2\C(=O)Nc3c(Cl)cccc32)\Nc2ccccc2\1		CHEMBL243776	>	IC50	nM	100000.0	CHEMBL4722	Homo sapiens	IC50	uM	100.0
	1914961	CHEMBL894337	Inhibition of human recombinant aurora A kinase	B	O=Nc1c(-c2c(O)[nH]c3c(Cl)cccc23)[nH]c2ccccc12		CHEMBL213650	>	IC50	nM	100000.0	CHEMBL4722	Homo sapiens	IC50	uM	100.0
	1914962	CHEMBL894337	Inhibition of human recombinant aurora A kinase	B	O=C1C(c2c(O)[nH]c3c(Br)cccc23)=Nc2ccccc21		CHEMBL214173	>	IC50	nM	100000.0	CHEMBL4722	Homo sapiens	IC50	uM	100.0
	1914963	CHEMBL894337	Inhibition of human recombinant aurora A kinase	B	CC(=O)O/N=C1C(=C2\C(=O)Nc3c(Br)cccc32)\Nc2ccccc2\1		CHEMBL395766	>	IC50	nM	100000.0	CHEMBL4722	Homo sapiens	IC50	uM	100.0
	1914964	CHEMBL894337	Inhibition of human recombinant aurora A kinase	B	O=Nc1c(-c2c(O)[nH]c3c(F)cccc23)[nH]c2ccccc12		CHEMBL212174	=	IC50	nM	2000.0	CHEMBL4722	Homo sapiens	IC50	uM	2.0
	1914965	CHEMBL894337	Inhibition of human recombinant aurora A kinase	B	CO/N=C1C(=C2\C(=O)Nc3c(F)cccc32)\Nc2ccccc2\1		CHEMBL397720	>	IC50	nM	100000.0	CHEMBL4722	Homo sapiens	IC50	uM	100.0
	1914966	CHEMBL894337	Inhibition of human recombinant aurora A kinase	B	CC(=O)O/N=C1C(=C2\C(=O)Nc3c(F)cccc32)\Nc2ccccc2\1		CHEMBL243985	=	IC50	nM	20000.0	CHEMBL4722	Homo sapiens	IC50	uM	20.0
	1914967	CHEMBL894337	Inhibition of human recombinant aurora A kinase	B	O=C1C(c2c(O)[nH]c3c(F)cccc23)=Nc2ccccc21		CHEMBL210446	>	IC50	nM	100000.0	CHEMBL4722	Homo sapiens	IC50	uM	100.0
	1914968	CHEMBL894337	Inhibition of human recombinant aurora A kinase	B	O=C1C(c2c(O)[nH]c3c(I)cccc23)=Nc2ccccc21		CHEMBL379160	>	IC50	nM	100000.0	CHEMBL4722	Homo sapiens	IC50	uM	100.0
	1914969	CHEMBL894337	Inhibition of human recombinant aurora A kinase	B	CC(=O)O/N=C1C(=C2\C(=O)Nc3c(I)cccc32)\Nc2ccccc2\1		CHEMBL395077	>	IC50	nM	100000.0	CHEMBL4722	Homo sapiens	IC50	uM	100.0
	1914970	CHEMBL894337	Inhibition of human recombinant aurora A kinase	B	CO/N=C1C(=C2\C(=O)Nc3c(I)cccc32)\Nc2ccccc2\1		CHEMBL244191	>	IC50	nM	100000.0	CHEMBL4722	Homo sapiens	IC50	uM	100.0
	1914971	CHEMBL894337	Inhibition of human recombinant aurora A kinase	B	O=Nc1c(-c2c(O)[nH]c3c(I)cccc23)[nH]c2ccccc12		CHEMBL209648	>	IC50	nM	100000.0	CHEMBL4722	Homo sapiens	IC50	uM	100.0
Not Determined	1944452	CHEMBL891242	Inhibition of Aur1 by radiometric assay	B	O=C(NCc1ccncc1)c1ccc2c(c1)Cc1c(-c3ccc(-c4ccc(O)cc4)cc3)n[nH]c1-2		CHEMBL242753		IC50			CHEMBL4722	Homo sapiens	IC50		
	1944454	CHEMBL891242	Inhibition of Aur1 by radiometric assay	B	O=C(N[C@H]1CC[C@H](O)CC1)c1ccc2c(c1)Cc1c(-c3ccc(-c4ccc(O)cc4)cc3)n[nH]c1-2		CHEMBL438485	=	IC50	nM	8090.0	CHEMBL4722	Homo sapiens	IC50	nM	8090.0
	1989393	CHEMBL899105	Inhibition of Aurora A	B	CC(C)NCc1ccc(Nc2cc(-c3ccc(-c4ccc(O)cc4O)cc3)[nH]n2)cc1		CHEMBL398606	=	IC50	nM	10050.0	CHEMBL4722	Homo sapiens	IC50	uM	10.05
	1997481	CHEMBL899962	Inhibition of aurora A kinase	B	CN(C)c1ccc(-c2nc3c(N4CCN(CC(=O)Nc5nccs5)CC4)c(Cl)cnc3[nH]2)cc1		CHEMBL392525	=	IC50	nM	42.0	CHEMBL4722	Homo sapiens	IC50	uM	0.042
	1997482	CHEMBL899962	Inhibition of aurora A kinase	B	CN(C)c1ccc(-c2nc3c(N4CCN(CC(=O)Nc5nccs5)CC4)ccnc3[nH]2)cc1		CHEMBL412173	=	IC50	nM	870.0	CHEMBL4722	Homo sapiens	IC50	uM	0.87
	1997483	CHEMBL899962	Inhibition of aurora A kinase	B	CN(C)c1ccc(-c2nc3c(Cl)ccnc3[nH]2)cc1		CHEMBL237369	=	IC50	nM	2400.0	CHEMBL4722	Homo sapiens	IC50	uM	2.4
	1997484	CHEMBL899962	Inhibition of aurora A kinase	B	Cc1ccnc2[nH]c(-c3ccc(N(C)C)cc3)nc12		CHEMBL391394	=	IC50	nM	7000.0	CHEMBL4722	Homo sapiens	IC50	uM	7.0
	1997485	CHEMBL899962	Inhibition of aurora A kinase	B	CN(C)c1ccc(-c2nc3c(Cl)c(Cl)cnc3[nH]2)cc1		CHEMBL237573	=	IC50	nM	250.0	CHEMBL4722	Homo sapiens	IC50	uM	0.25
	1997486	CHEMBL899962	Inhibition of aurora A kinase	B	CC(=O)c1cccc(-c2cnc3[nH]c(-c4ccc(N(C)C)cc4)nc3c2)c1		CHEMBL394674	=	IC50	nM	9000.0	CHEMBL4722	Homo sapiens	IC50	uM	9.0
	1997487	CHEMBL899962	Inhibition of aurora A kinase	B	COc1ccc(-c2cnc3[nH]c(-c4ccc(N(C)C)cc4)nc3c2)cc1		CHEMBL395839	=	IC50	nM	20000.0	CHEMBL4722	Homo sapiens	IC50	uM	20.0
	1997488	CHEMBL899962	Inhibition of aurora A kinase	B	Cc1cnc2[nH]c(-c3ccc(N(C)C)cc3)nc2c1		CHEMBL237145	=	IC50	nM	6900.0	CHEMBL4722	Homo sapiens	IC50	uM	6.9
	1997489	CHEMBL899962	Inhibition of aurora A kinase	B	CN(C)c1ccc(-c2nc3cc(C(F)(F)F)cnc3[nH]2)cc1		CHEMBL237144	=	IC50	nM	740.0	CHEMBL4722	Homo sapiens	IC50	uM	0.74
	1997490	CHEMBL899962	Inhibition of aurora A kinase	B	CN(C)c1ccc(-c2nc3cc(Br)cnc3[nH]2)cc1		CHEMBL395601	=	IC50	nM	490.0	CHEMBL4722	Homo sapiens	IC50	uM	0.49
	1997491	CHEMBL899962	Inhibition of aurora A kinase	B	c1cnc2[nH]c(-c3ccc(C4CCCCN4)cc3)nc2c1		CHEMBL237142	=	IC50	nM	4400.0	CHEMBL4722	Homo sapiens	IC50	uM	4.4
	1997492	CHEMBL899962	Inhibition of aurora A kinase	B	c1cnc2[nH]c(-c3ccc(N4CCCC4)cc3)nc2c1		CHEMBL236938	=	IC50	nM	4600.0	CHEMBL4722	Homo sapiens	IC50	uM	4.6
	1997493	CHEMBL899962	Inhibition of aurora A kinase	B	COc1ccccc1-c1nc2ccc[nH]c-2n1		CHEMBL236937	=	IC50	nM	29000.0	CHEMBL4722	Homo sapiens	IC50	uM	29.0
	1997494	CHEMBL899962	Inhibition of aurora A kinase	B	COc1cccc(-c2nc3cccnc3[nH]2)c1		CHEMBL235452	=	IC50	nM	16000.0	CHEMBL4722	Homo sapiens	IC50	uM	16.0
	1997495	CHEMBL899962	Inhibition of aurora A kinase	B	COc1ccc(-c2nc3cccnc3[nH]2)cc1		CHEMBL235451	=	IC50	nM	6600.0	CHEMBL4722	Homo sapiens	IC50	uM	6.6
	1997496	CHEMBL899962	Inhibition of aurora A kinase	B	CN(C)c1cccc(-c2nc3cccnc3[nH]2)c1		CHEMBL235450	=	IC50	nM	10000.0	CHEMBL4722	Homo sapiens	IC50	uM	10.0
	1997497	CHEMBL899962	Inhibition of aurora A kinase	B	CN(C)c1ccc(-c2nc3cccnc3[nH]2)cc1		CHEMBL235232	=	IC50	nM	4300.0	CHEMBL4722	Homo sapiens	IC50	uM	4.3
	1997498	CHEMBL899962	Inhibition of aurora A kinase	B	CN(C)c1ccc(-c2nc3cc(Cl)cnc3[nH]2)cc1		CHEMBL236694	=	IC50	nM	570.0	CHEMBL4722	Homo sapiens	IC50	uM	0.57
	1997499	CHEMBL899962	Inhibition of aurora A kinase	B	COc1cc2ncnc(N3CCN(Cc4cccc5ccccc45)CC3)c2cc1OC		CHEMBL399390	=	IC50	nM	9600.0	CHEMBL4722	Homo sapiens	IC50	uM	9.6
	1997500	CHEMBL899962	Inhibition of aurora A kinase	B	COc1cc2ncnc(N3CCN(C(C)c4ccccc4)CC3)c2cc1OC		CHEMBL236693	=	IC50	nM	25000.0	CHEMBL4722	Homo sapiens	IC50	uM	25.0
	1997501	CHEMBL899962	Inhibition of aurora A kinase	B	COc1cc2ncnc(N3CCN(CCOc4ccccc4)CC3)c2cc1OC		CHEMBL236691	=	IC50	nM	35000.0	CHEMBL4722	Homo sapiens	IC50	uM	35.0
	1997502	CHEMBL899962	Inhibition of aurora A kinase	B	COc1cc2ncnc(N3CCN(Cc4ccc(F)cc4)CC3)c2cc1OC		CHEMBL236487	=	IC50	nM	40000.0	CHEMBL4722	Homo sapiens	IC50	uM	40.0
	1997503	CHEMBL899962	Inhibition of aurora A kinase	B	COc1cc2ncnc(N3CCN(CC(=O)Nc4nccs4)CC3)c2cc1OC		CHEMBL394223	=	IC50	nM	5900.0	CHEMBL4722	Homo sapiens	IC50	uM	5.9
	1997504	CHEMBL899962	Inhibition of aurora A kinase	B	COc1cc2ncnc(N3CCN(CC(=O)N(C)c4ccccc4)CC3)c2cc1OC		CHEMBL236485	=	IC50	nM	16500.0	CHEMBL4722	Homo sapiens	IC50	uM	16.5
	1997505	CHEMBL899962	Inhibition of aurora A kinase	B	COc1cc2ncnc(N3CCN(CC(=O)N4CCCC4)CC3)c2cc1OC		CHEMBL236279	=	IC50	nM	98000.0	CHEMBL4722	Homo sapiens	IC50	uM	98.0
	1997506	CHEMBL899962	Inhibition of aurora A kinase	B	COc1cc2ncnc(N3CCN(CCc4ccccc4)CC3)c2cc1OC		CHEMBL236277	=	IC50	nM	76000.0	CHEMBL4722	Homo sapiens	IC50	uM	76.0
Not Active	1997507	CHEMBL899963	Inhibition of aurora A kinase at 100 uM	B	COc1cc2ncnc(N3CCN(c4ncccn4)CC3)c2cc1OC		CHEMBL396810		Activity			CHEMBL4722	Homo sapiens	Activity		
Not Active	1997508	CHEMBL899963	Inhibition of aurora A kinase at 100 uM	B	COc1cc2ncnc(N3CCN(CCn4ccnc4)CC3)c2cc1OC		CHEMBL236692		Activity			CHEMBL4722	Homo sapiens	Activity		
Not Active	1997509	CHEMBL899963	Inhibition of aurora A kinase at 100 uM	B	COc1cc2ncnc(N3CCN(c4cnccn4)CC3)c2cc1OC		CHEMBL236278		Activity			CHEMBL4722	Homo sapiens	Activity		
Not Active	1997510	CHEMBL899963	Inhibition of aurora A kinase at 100 uM	B	COc1cc2ncnc(N3CCN(CC(=O)OC(C)(C)C)CC3)c2cc1OC		CHEMBL236486		Activity			CHEMBL4722	Homo sapiens	Activity		
	1997511	CHEMBL899962	Inhibition of aurora A kinase	B	CN(C)c1ccc(-c2nc3cc[nH]cc-3n2)cc1		CHEMBL355818	=	IC50	nM	12500.0	CHEMBL4722	Homo sapiens	IC50	uM	12.5
	1997512	CHEMBL899961	Inhibition of aurora A kinase at 10 uM	B	CN(C)c1ccc(-c2nc3cc[nH]cc-3n2)cc1		CHEMBL355818	=	Inhibition	%	35.0	CHEMBL4722	Homo sapiens	Inhibition	%	35.0
	1997513	CHEMBL899961	Inhibition of aurora A kinase at 10 uM	B	CN(C)c1ccc(-c2nc3cc(-c4cccs4)cnc3[nH]2)cc1		CHEMBL237363	=	Inhibition	%	34.0	CHEMBL4722	Homo sapiens	Inhibition	%	34.0
	1997514	CHEMBL899961	Inhibition of aurora A kinase at 10 uM	B	CN(C)c1ccc(-c2nc3cc(-c4cccnc4)cnc3[nH]2)cc1		CHEMBL237362	=	Inhibition	%	28.0	CHEMBL4722	Homo sapiens	Inhibition	%	28.0
	1997515	CHEMBL899961	Inhibition of aurora A kinase at 10 uM	B	CN(C)c1ccc(-c2nc3cc(-c4cccc(O)c4)cnc3[nH]2)cc1		CHEMBL237361	=	Inhibition	%	31.0	CHEMBL4722	Homo sapiens	Inhibition	%	31.0
	1997516	CHEMBL899961	Inhibition of aurora A kinase at 10 uM	B	N#Cc1ccc(-c2nc3cccnc3[nH]2)cc1		CHEMBL237143	=	Inhibition	%	38.0	CHEMBL4722	Homo sapiens	Inhibition	%	38.0
	1997517	CHEMBL899963	Inhibition of aurora A kinase at 100 uM	B	CN(C)c1ccc(-c2nc3cc(-c4ccc5c(c4)OCO5)cnc3[nH]2)cc1		CHEMBL237360	=	Inhibition	%	33.0	CHEMBL4722	Homo sapiens	Inhibition	%	33.0
	1997518	CHEMBL899962	Inhibition of aurora A kinase	B	CN(C)c1ccc(-c2nc3cc(-c4cccc(O)c4)cnc3[nH]2)cc1		CHEMBL237361	=	IC50	nM	18000.0	CHEMBL4722	Homo sapiens	IC50	uM	18.0
	1997519	CHEMBL899961	Inhibition of aurora A kinase at 10 uM	B	CN(C)c1ccccc1-c1nc2cccnc2[nH]1		CHEMBL394314	=	Inhibition	%	20.0	CHEMBL4722	Homo sapiens	Inhibition	%	20.0
	1997520	CHEMBL899963	Inhibition of aurora A kinase at 100 uM	B	CN(C)c1ccc(-c2nc3ccccc3[nH]2)cc1		CHEMBL209544	=	Inhibition	%	8.0	CHEMBL4722	Homo sapiens	Inhibition	%	8.0
	1997521	CHEMBL899963	Inhibition of aurora A kinase at 100 uM	B	CCn1c(-c2ccc(N(C)C)cc2)nc2cccnc21		CHEMBL235449	=	Inhibition	%	26.0	CHEMBL4722	Homo sapiens	Inhibition	%	26.0
	2025115	CHEMBL886940	Inhibition of human Aurora A at 1 uM relative to control	B	CN(C)c1cc2cc(n1)CCCn1cc(c3ccccc31)C1=C(C(=O)NC1=O)c1cn(c3ccccc13)CCC2		CHEMBL247067	=	Inhibition	%	111.0	CHEMBL4722	Homo sapiens	Inhibition	%	111.0
	2025234	CHEMBL886940	Inhibition of human Aurora A at 1 uM relative to control	B	CN(C)c1nc2ccc1CCCn1cc(c3ccccc31)C1=C(C(=O)NC1=O)c1cn(c3ccccc13)CC2		CHEMBL1162963	=	Inhibition	%	109.0	CHEMBL4722	Homo sapiens	Inhibition	%	109.0
	2025235	CHEMBL886940	Inhibition of human Aurora A at 1 uM relative to control	B	O=C1NC(=O)C2=C1c1cn(c3ccccc13)CCCc1ccc(c(N3CCCC3)n1)CCCn1cc2c2ccccc21		CHEMBL396327	=	Inhibition	%	106.0	CHEMBL4722	Homo sapiens	Inhibition	%	106.0
	2025236	CHEMBL886940	Inhibition of human Aurora A at 1 uM relative to control	B	O=C1NC(=O)C2=C1c1cn(c3ccccc13)CCCc1cc(nc(N3CCCC3)c1)CCCn1cc2c2ccccc21		CHEMBL397771	=	Inhibition	%	111.0	CHEMBL4722	Homo sapiens	Inhibition	%	111.0
	2029838	CHEMBL886305	Inhibition of aurora A at 10 uM	B	O=C1Cc2cnn(-c3ccccc3)c2-c2ccccc2N1		CHEMBL250583	<=	Inhibition	%	40.0	CHEMBL4722	Homo sapiens	Inhibition	%	40.0
	2029964	CHEMBL886305	Inhibition of aurora A at 10 uM	B	O=C1Cc2cnn(-c3ccc([N+](=O)[O-])cc3)c2-c2ccccc2N1		CHEMBL400310	<=	Inhibition	%	40.0	CHEMBL4722	Homo sapiens	Inhibition	%	40.0
	2029965	CHEMBL886305	Inhibition of aurora A at 10 uM	B	O=C1Cc2cnn(-c3ccc(F)cc3F)c2-c2ccccc2N1		CHEMBL248954	<=	Inhibition	%	40.0	CHEMBL4722	Homo sapiens	Inhibition	%	40.0
	2029966	CHEMBL886305	Inhibition of aurora A at 10 uM	B	O=C1Cc2cnn(-c3ccccc3Br)c2-c2ccccc2N1		CHEMBL400113	<=	Inhibition	%	40.0	CHEMBL4722	Homo sapiens	Inhibition	%	40.0
	2029967	CHEMBL886305	Inhibition of aurora A at 10 uM	B	O=C1Cc2cnn(-c3ccccc3F)c2-c2ccccc2N1		CHEMBL399076	<=	Inhibition	%	40.0	CHEMBL4722	Homo sapiens	Inhibition	%	40.0
	2029968	CHEMBL886305	Inhibition of aurora A at 10 uM	B	O=C1Cc2cnn(-c3cccc(Cl)c3)c2-c2ccccc2N1		CHEMBL248760	<=	Inhibition	%	40.0	CHEMBL4722	Homo sapiens	Inhibition	%	40.0
	2029969	CHEMBL886305	Inhibition of aurora A at 10 uM	B	O=C1Cc2cnn(-c3ccccc3Cl)c2-c2ccccc2N1		CHEMBL248759	<=	Inhibition	%	40.0	CHEMBL4722	Homo sapiens	Inhibition	%	40.0
	2029970	CHEMBL886305	Inhibition of aurora A at 10 uM	B	CC(C)(C)c1ccc(-n2ncc3c2-c2ccccc2NC(=O)C3)cc1		CHEMBL398877	<=	Inhibition	%	40.0	CHEMBL4722	Homo sapiens	Inhibition	%	40.0
	2029971	CHEMBL886305	Inhibition of aurora A at 10 uM	B	O=C1Cc2cnn(-c3cc(Cl)cc(Cl)c3)c2-c2ccccc2N1		CHEMBL248758	<=	Inhibition	%	40.0	CHEMBL4722	Homo sapiens	Inhibition	%	40.0
	2029972	CHEMBL886305	Inhibition of aurora A at 10 uM	B	O=C1Cc2cnn(-c3ccc(C(F)(F)F)cc3)c2-c2ccccc2N1		CHEMBL398876	<=	Inhibition	%	40.0	CHEMBL4722	Homo sapiens	Inhibition	%	40.0
	2029973	CHEMBL886305	Inhibition of aurora A at 10 uM	B	Cc1ccc(-n2ncc3c2-c2ccccc2NC(=O)C3)cc1		CHEMBL400898	<=	Inhibition	%	40.0	CHEMBL4722	Homo sapiens	Inhibition	%	40.0
	2029974	CHEMBL886305	Inhibition of aurora A at 10 uM	B	COc1ccc(-n2ncc3c2-c2ccccc2NC(=O)C3)cc1		CHEMBL248558	<=	Inhibition	%	40.0	CHEMBL4722	Homo sapiens	Inhibition	%	40.0
	2029975	CHEMBL886305	Inhibition of aurora A at 10 uM	B	Cc1ccccc1-n1ncc2c1-c1ccccc1NC(=O)C2		CHEMBL400897	<=	Inhibition	%	40.0	CHEMBL4722	Homo sapiens	Inhibition	%	40.0
	2029976	CHEMBL886305	Inhibition of aurora A at 10 uM	B	O=C1Cc2cnn(-c3ccc(Cl)cc3)c2-c2ccccc2N1		CHEMBL248557	<=	Inhibition	%	40.0	CHEMBL4722	Homo sapiens	Inhibition	%	40.0
	2029977	CHEMBL886305	Inhibition of aurora A at 10 uM	B	O=C1Cc2cnn(-c3ccc(Br)cc3)c2-c2ccccc2N1		CHEMBL398288	<=	Inhibition	%	40.0	CHEMBL4722	Homo sapiens	Inhibition	%	40.0
	2036544	CHEMBL922909	Inhibition of aurora-A	B	COc1ccc2nc(-c3n[nH]cc3/C=C/c3cccnc3)[nH]c2c1		CHEMBL428225	=	IC50	nM	510.0	CHEMBL4722	Homo sapiens	IC50	uM	0.51
	2036586	CHEMBL922909	Inhibition of aurora-A	B	CCNCc1cncc(/C=C/c2c[nH]nc2-c2nc(C(F)(F)F)c[nH]2)c1		CHEMBL245376	>	IC50	nM	10000.0	CHEMBL4722	Homo sapiens	IC50	uM	10.0
	2036587	CHEMBL922909	Inhibition of aurora-A	B	FC(F)(F)c1c[nH]c(-c2n[nH]cc2/C=C/c2cncc3ccccc23)n1		CHEMBL246167	=	IC50	nM	300.0	CHEMBL4722	Homo sapiens	IC50	uM	0.3
	2036588	CHEMBL922909	Inhibition of aurora-A	B	N#Cc1c[nH]c(-c2n[nH]cc2/C=C/c2cccnc2)n1		CHEMBL394466	>	IC50	nM	10000.0	CHEMBL4722	Homo sapiens	IC50	uM	10.0
	2036589	CHEMBL922909	Inhibition of aurora-A	B	FC(F)(F)c1c[nH]c(-c2n[nH]cc2/C=C/c2cccnc2)n1		CHEMBL246165	=	IC50	nM	120.0	CHEMBL4722	Homo sapiens	IC50	uM	0.12
	2036590	CHEMBL922909	Inhibition of aurora-A	B	CN1CCN(c2ccc3nc(-c4n[nH]cc4/C=C/c4cccnc4)[nH]c3c2)CC1		CHEMBL394465	>	IC50	nM	10000.0	CHEMBL4722	Homo sapiens	IC50	uM	10.0
	2036591	CHEMBL922909	Inhibition of aurora-A	B	CCNCc1cncc(/C=C/c2c[nH]nc2-c2nc3ccc(OC)cc3[nH]2)c1		CHEMBL245967	=	IC50	nM	590.0	CHEMBL4722	Homo sapiens	IC50	uM	0.59
	2036592	CHEMBL922909	Inhibition of aurora-A	B	CCNC(=O)c1cncc(/C=C/c2c[nH]nc2-c2nc3ccc(OC)cc3[nH]2)c1		CHEMBL245966	>	IC50	nM	100000.0	CHEMBL4722	Homo sapiens	IC50	uM	100.0
	2036593	CHEMBL922909	Inhibition of aurora-A	B	COC(=O)c1cncc(/C=C/c2c[nH]nc2-c2nc3ccc(OC)cc3[nH]2)c1		CHEMBL397549	>	IC50	nM	100000.0	CHEMBL4722	Homo sapiens	IC50	uM	100.0
	2036594	CHEMBL922909	Inhibition of aurora-A	B	COc1cncc(/C=C/c2c[nH]nc2-c2nc3ccc(OC)cc3[nH]2)c1		CHEMBL245770	=	IC50	nM	400.0	CHEMBL4722	Homo sapiens	IC50	uM	0.4
	2036595	CHEMBL922909	Inhibition of aurora-A	B	COc1ccc2nc(-c3n[nH]cc3/C=C/c3cncc(C#N)c3)[nH]c2c1		CHEMBL395393	=	IC50	nM	4200.0	CHEMBL4722	Homo sapiens	IC50	uM	4.2
	2036596	CHEMBL922909	Inhibition of aurora-A	B	COc1ccc2nc(-c3n[nH]cc3/C=C/c3cncc4ccccc34)[nH]c2c1		CHEMBL395392	=	IC50	nM	530.0	CHEMBL4722	Homo sapiens	IC50	uM	0.53
	2036597	CHEMBL922909	Inhibition of aurora-A	B	COc1ccc2nc(-c3n[nH]cc3/C=C/c3cnccc3C)[nH]c2c1		CHEMBL245574	=	IC50	nM	550.0	CHEMBL4722	Homo sapiens	IC50	uM	0.55
	2081459	CHEMBL928667	Inhibition of Aurora A kinase	B	COc1cc2c(Nc3cnn(CC(=O)Nc4cccc(F)c4F)c3)nncc2cc1OCCCN1CCC[C@@H]1CO		CHEMBL254974	=	Ki	nM	340.0	CHEMBL4722	Homo sapiens	Ki	uM	0.34
	2081463	CHEMBL928667	Inhibition of Aurora A kinase	B	O=C(Cn1cc(Nc2nncc3cc(OCCCN4CCC[C@@H]4CO)ccc23)cn1)Nc1cccc(F)c1		CHEMBL253967	=	Ki	nM	3000.0	CHEMBL4722	Homo sapiens	Ki	uM	3.0
	2081464	CHEMBL928667	Inhibition of Aurora A kinase	B	CCN(CCO)CCCOc1cc2cnnc(Nc3cnn(CC(=O)Nc4cccc(F)c4)c3)c2cc1OC		CHEMBL401656	=	Ki	nM	1100.0	CHEMBL4722	Homo sapiens	Ki	uM	1.1
	2081465	CHEMBL928667	Inhibition of Aurora A kinase	B	COc1cc2c(Nc3cnn(CC(=O)Nc4cccc(F)c4)c3)nncc2cc1OCCCN1CCC[C@@H]1CO		CHEMBL429126	=	Ki	nM	1300.0	CHEMBL4722	Homo sapiens	Ki	uM	1.3
	2081466	CHEMBL928667	Inhibition of Aurora A kinase	B	CCN(CCO)CCCOc1cc2cnnc(Nc3cnn(CC(=O)Nc4cccc(F)c4F)c3)c2cc1OC		CHEMBL404742	=	Ki	nM	540.0	CHEMBL4722	Homo sapiens	Ki	uM	0.54
Active	2100671	CHEMBL933053	Activation of human AURA mediated histone H3 phosphorylation by phosphoimager analyzer	B	C=CC/C=C\C/C=C\CCCCCCCc1cccc(O)c1C(=O)O		CHEMBL455368		Activity			CHEMBL4722	Homo sapiens	Activity		
Dose-dependent effect	2100672	CHEMBL933054	Activation of human AURA assessed as histone H3 phosphorylation	B	C=CC/C=C\C/C=C\CCCCCCCc1cccc(O)c1C(=O)O		CHEMBL455368		Activity			CHEMBL4722	Homo sapiens	Activity		
Active	2100673	CHEMBL931972	Activation of human AURA activity expressed in baculovirus cells by time course assay	B	C=CC/C=C\C/C=C\CCCCCCCc1cccc(O)c1C(=O)O		CHEMBL455368		Activity			CHEMBL4722	Homo sapiens	Activity		
Active	2100674	CHEMBL931973	Activation of human AURA autophosphorylation activity	B	C=CC/C=C\C/C=C\CCCCCCCc1cccc(O)c1C(=O)O		CHEMBL455368		Activity			CHEMBL4722	Homo sapiens	Activity		
	2100676	CHEMBL933055	Binding affinity to human AURA expressed in baculovirus	B	C=CC/C=C\C/C=C\CCCCCCCc1cccc(O)c1C(=O)O		CHEMBL455368	=	Ka	/uM	5.2	CHEMBL4722	Homo sapiens	Ka	/uM	5.2
	2100677	CHEMBL931969	Binding affinity to human AURA expressed in baculovirus in presence of ATP	B	C=CC/C=C\C/C=C\CCCCCCCc1cccc(O)c1C(=O)O		CHEMBL455368	=	Ka	/uM	10.1	CHEMBL4722	Homo sapiens	Ka	/uM	10.1
	2100678	CHEMBL933055	Binding affinity to human AURA expressed in baculovirus	B	Nc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)O)[C@@H](O)[C@H]1O		CHEMBL14249	=	Ka	/uM	5.7	CHEMBL4722	Homo sapiens	Ka	/uM	5.7
	2100679	CHEMBL931970	Binding affinity to human AURA expressed in baculovirus in presence of anacardic acid	B	Nc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)O)[C@@H](O)[C@H]1O		CHEMBL14249	=	Ka	/nM	27.5	CHEMBL4722	Homo sapiens	Ka	/nM	27.5
	2100680	CHEMBL931971	Activity of human AURA expressed in baculovirus at 50 uM by phosphorimager analyzer	B	C=CC/C=C\C/C=C\CCCCCCCc1cccc(O)c1C(=O)O		CHEMBL455368	=	Vmax	mmol/min/mg	62.5	CHEMBL4722	Homo sapiens	Vmax	mmol/min/mg	62.5
	2100681	CHEMBL931971	Activity of human AURA expressed in baculovirus at 50 uM by phosphorimager analyzer	B	C=CC/C=C\C/C=C\CCCCCCCc1cccc(O)c1C(=O)O		CHEMBL455368	=	Km	nM	40250000.0	CHEMBL4722	Homo sapiens	Km	mM	40.25
	2100682	CHEMBL931971	Activity of human AURA expressed in baculovirus at 50 uM by phosphorimager analyzer	B	C=CC/C=C\C/C=C\CCCCCCCc1cccc(O)c1C(=O)O		CHEMBL455368	=	Kcat	/s	281.5	CHEMBL4722	Homo sapiens	Kcat	/s	281.5
	2100683	CHEMBL931975	Ratio of Kcat for human AURA to Km for human AURA	B	C=CC/C=C\C/C=C\CCCCCCCc1cccc(O)c1C(=O)O		CHEMBL455368	=	Kcat/Km	/s/mM	6.99	CHEMBL4722	Homo sapiens	Kcat/Km	/s/mM	6.99
	2104525	CHEMBL931994	Inhibition of Aurora A kinase at 50 uM	B	O=C1c2nc3cc(-c4ccco4)nn3c(O)c2CN1Cc1ccccc1		CHEMBL1589017	=	Inhibition	%	90.2	CHEMBL4722	Homo sapiens	Inhibition	%	90.2
	2104526	CHEMBL931995	Inhibition of Aurora A kinase at 10 uM	B	O=C1c2nc3cc(-c4ccco4)nn3c(O)c2CN1Cc1ccccc1		CHEMBL1589017	=	Inhibition	%	35.6	CHEMBL4722	Homo sapiens	Inhibition	%	35.6
	2104527	CHEMBL931994	Inhibition of Aurora A kinase at 50 uM	B	O=C1c2[nH]c3cc(-c4ccco4)nn3c(=O)c2CN1CCN1CCOCC1		CHEMBL404055	=	Inhibition	%	10.7	CHEMBL4722	Homo sapiens	Inhibition	%	10.7
	2104528	CHEMBL931994	Inhibition of Aurora A kinase at 50 uM	B	CC(=O)Nc1cccc(CN2Cc3c([nH]c4cc(-c5ccco5)nn4c3=O)C2=O)c1		CHEMBL255808	=	Inhibition	%	87.8	CHEMBL4722	Homo sapiens	Inhibition	%	87.8
	2104529	CHEMBL931994	Inhibition of Aurora A kinase at 50 uM	B	O=C1c2[nH]c3cc(-c4ccco4)nn3c(=O)c2CN1Cc1ccc(F)cc1		CHEMBL255810	=	Inhibition	%	89.8	CHEMBL4722	Homo sapiens	Inhibition	%	89.8
	2104530	CHEMBL931994	Inhibition of Aurora A kinase at 50 uM	B	O=C1c2[nH]c3cc(-c4ccco4)nn3c(=O)c2CN1Cc1ccc2c(c1)OCO2		CHEMBL437603	=	Inhibition	%	75.2	CHEMBL4722	Homo sapiens	Inhibition	%	75.2
	2104531	CHEMBL931994	Inhibition of Aurora A kinase at 50 uM	B	COc1ccc(CN2Cc3c([nH]c4cc(-c5ccco5)nn4c3=O)C2=O)cc1OC		CHEMBL404656	=	Inhibition	%	70.8	CHEMBL4722	Homo sapiens	Inhibition	%	70.8
	2104532	CHEMBL931994	Inhibition of Aurora A kinase at 50 uM	B	COc1cc(CN2Cc3c([nH]c4cc(-c5ccco5)nn4c3=O)C2=O)cc(OC)c1		CHEMBL256186	=	Inhibition	%	75.3	CHEMBL4722	Homo sapiens	Inhibition	%	75.3
	2104533	CHEMBL931994	Inhibition of Aurora A kinase at 50 uM	B	COc1ccccc1CN1Cc2c([nH]c3cc(-c4ccco4)nn3c2=O)C1=O		CHEMBL402349	=	Inhibition	%	95.1	CHEMBL4722	Homo sapiens	Inhibition	%	95.1
	2104534	CHEMBL931994	Inhibition of Aurora A kinase at 50 uM	B	COc1cccc(CN2Cc3c([nH]c4cc(-c5ccco5)nn4c3=O)C2=O)c1		CHEMBL439417	=	Inhibition	%	90.0	CHEMBL4722	Homo sapiens	Inhibition	%	90.0
	2104535	CHEMBL931994	Inhibition of Aurora A kinase at 50 uM	B	COc1ccc(CN2Cc3c([nH]c4cc(-c5ccco5)nn4c3=O)C2=O)cc1		CHEMBL271894	=	Inhibition	%	88.2	CHEMBL4722	Homo sapiens	Inhibition	%	88.2
	2104536	CHEMBL931994	Inhibition of Aurora A kinase at 50 uM	B	O=C1c2[nH]c3cc(-c4ccco4)nn3c(=O)c2CN1Cc1cccc2ccccc12		CHEMBL404695	=	Inhibition	%	79.9	CHEMBL4722	Homo sapiens	Inhibition	%	79.9
	2104537	CHEMBL931994	Inhibition of Aurora A kinase at 50 uM	B	O=C1c2[nH]c3cc(-c4ccco4)nn3c(=O)c2CN1Cc1ccccn1		CHEMBL272762	=	Inhibition	%	79.2	CHEMBL4722	Homo sapiens	Inhibition	%	79.2
	2104538	CHEMBL931994	Inhibition of Aurora A kinase at 50 uM	B	O=C1c2[nH]c3cc(-c4ccco4)nn3c(=O)c2CN1CCCc1ccccc1		CHEMBL272764	=	Inhibition	%	84.4	CHEMBL4722	Homo sapiens	Inhibition	%	84.4
	2104539	CHEMBL931994	Inhibition of Aurora A kinase at 50 uM	B	O=C1c2[nH]c3cc(-c4ccco4)nn3c(=O)c2CN1CCc1ccccc1		CHEMBL272728	=	Inhibition	%	83.9	CHEMBL4722	Homo sapiens	Inhibition	%	83.9
	2104540	CHEMBL931994	Inhibition of Aurora A kinase at 50 uM	B	O=C1c2[nH]c3cc(-c4ccco4)nn3c(=O)c2CN1c1ccccc1		CHEMBL272727	=	Inhibition	%	73.7	CHEMBL4722	Homo sapiens	Inhibition	%	73.7
	2104541	CHEMBL931994	Inhibition of Aurora A kinase at 50 uM	B	O=C1c2c(c(=O)n3nc(-c4ccco4)cc3n2CCN2CCOCC2)CN1Cc1ccccc1		CHEMBL272729	=	Inhibition	%	1.1	CHEMBL4722	Homo sapiens	Inhibition	%	1.1
	2104542	CHEMBL931994	Inhibition of Aurora A kinase at 50 uM	B	Cn1c2c(c(=O)n3nc(-c4ccco4)cc13)CN(Cc1ccccc1)C2=O		CHEMBL256433	=	Inhibition	%	3.4	CHEMBL4722	Homo sapiens	Inhibition	%	3.4
	2104543	CHEMBL931994	Inhibition of Aurora A kinase at 50 uM	B	O=C1c2[nH]c3ccnn3c(=O)c2CN1Cc1ccccc1		CHEMBL403609	=	Inhibition	%	14.5	CHEMBL4722	Homo sapiens	Inhibition	%	14.5
	2104544	CHEMBL931994	Inhibition of Aurora A kinase at 50 uM	B	Cc1cc2[nH]c3c(c(=O)n2n1)CN(Cc1ccccc1)C3=O		CHEMBL256037	=	Inhibition	%	20.8	CHEMBL4722	Homo sapiens	Inhibition	%	20.8
	2104545	CHEMBL931994	Inhibition of Aurora A kinase at 50 uM	B	O=C1c2nc3cc(-c4ccccc4)nn3c(O)c2CN1Cc1ccccc1		CHEMBL1535014	=	Inhibition	%	47.2	CHEMBL4722	Homo sapiens	Inhibition	%	47.2
	2104546	CHEMBL931994	Inhibition of Aurora A kinase at 50 uM	B	O=C1c2[nH]c3cc(-c4cccs4)nn3c(=O)c2CN1Cc1ccccc1		CHEMBL402547	=	Inhibition	%	72.3	CHEMBL4722	Homo sapiens	Inhibition	%	72.3
	2104547	CHEMBL931995	Inhibition of Aurora A kinase at 10 uM	B	O=C1c2[nH]c3cc(-c4ccco4)nn3c(=O)c2CN1CCN1CCOCC1		CHEMBL404055	=	Inhibition	%	0.9	CHEMBL4722	Homo sapiens	Inhibition	%	0.9
	2104548	CHEMBL931995	Inhibition of Aurora A kinase at 10 uM	B	CC(=O)Nc1cccc(CN2Cc3c([nH]c4cc(-c5ccco5)nn4c3=O)C2=O)c1		CHEMBL255808	=	Inhibition	%	35.8	CHEMBL4722	Homo sapiens	Inhibition	%	35.8
	2104549	CHEMBL931995	Inhibition of Aurora A kinase at 10 uM	B	O=C1c2[nH]c3cc(-c4ccco4)nn3c(=O)c2CN1Cc1ccc(F)cc1		CHEMBL255810	=	Inhibition	%	24.0	CHEMBL4722	Homo sapiens	Inhibition	%	24.0
	2104550	CHEMBL931995	Inhibition of Aurora A kinase at 10 uM	B	O=C1c2[nH]c3cc(-c4ccco4)nn3c(=O)c2CN1Cc1ccc2c(c1)OCO2		CHEMBL437603	=	Inhibition	%	12.3	CHEMBL4722	Homo sapiens	Inhibition	%	12.3
	2104551	CHEMBL931995	Inhibition of Aurora A kinase at 10 uM	B	COc1ccc(CN2Cc3c([nH]c4cc(-c5ccco5)nn4c3=O)C2=O)cc1OC		CHEMBL404656	=	Inhibition	%	7.8	CHEMBL4722	Homo sapiens	Inhibition	%	7.8
	2104552	CHEMBL931995	Inhibition of Aurora A kinase at 10 uM	B	COc1cc(CN2Cc3c([nH]c4cc(-c5ccco5)nn4c3=O)C2=O)cc(OC)c1		CHEMBL256186	=	Inhibition	%	10.1	CHEMBL4722	Homo sapiens	Inhibition	%	10.1
	2104553	CHEMBL931995	Inhibition of Aurora A kinase at 10 uM	B	COc1ccccc1CN1Cc2c([nH]c3cc(-c4ccco4)nn3c2=O)C1=O		CHEMBL402349	=	Inhibition	%	51.6	CHEMBL4722	Homo sapiens	Inhibition	%	51.6
	2104554	CHEMBL931995	Inhibition of Aurora A kinase at 10 uM	B	COc1cccc(CN2Cc3c([nH]c4cc(-c5ccco5)nn4c3=O)C2=O)c1		CHEMBL439417	=	Inhibition	%	29.3	CHEMBL4722	Homo sapiens	Inhibition	%	29.3
	2104555	CHEMBL931995	Inhibition of Aurora A kinase at 10 uM	B	COc1ccc(CN2Cc3c([nH]c4cc(-c5ccco5)nn4c3=O)C2=O)cc1		CHEMBL271894	=	Inhibition	%	42.4	CHEMBL4722	Homo sapiens	Inhibition	%	42.4
	2104556	CHEMBL931995	Inhibition of Aurora A kinase at 10 uM	B	O=C1c2[nH]c3cc(-c4ccco4)nn3c(=O)c2CN1Cc1cccc2ccccc12		CHEMBL404695	=	Inhibition	%	30.4	CHEMBL4722	Homo sapiens	Inhibition	%	30.4
	2104557	CHEMBL931995	Inhibition of Aurora A kinase at 10 uM	B	O=C1c2[nH]c3cc(-c4ccco4)nn3c(=O)c2CN1Cc1ccccn1		CHEMBL272762	=	Inhibition	%	21.6	CHEMBL4722	Homo sapiens	Inhibition	%	21.6
	2104558	CHEMBL931995	Inhibition of Aurora A kinase at 10 uM	B	O=C1c2[nH]c3cc(-c4ccco4)nn3c(=O)c2CN1CCCc1ccccc1		CHEMBL272764	=	Inhibition	%	16.4	CHEMBL4722	Homo sapiens	Inhibition	%	16.4
	2104559	CHEMBL931995	Inhibition of Aurora A kinase at 10 uM	B	O=C1c2[nH]c3cc(-c4ccco4)nn3c(=O)c2CN1CCc1ccccc1		CHEMBL272728	=	Inhibition	%	19.6	CHEMBL4722	Homo sapiens	Inhibition	%	19.6
	2104560	CHEMBL931995	Inhibition of Aurora A kinase at 10 uM	B	O=C1c2[nH]c3cc(-c4ccco4)nn3c(=O)c2CN1c1ccccc1		CHEMBL272727	=	Inhibition	%	7.6	CHEMBL4722	Homo sapiens	Inhibition	%	7.6
	2104561	CHEMBL931995	Inhibition of Aurora A kinase at 10 uM	B	O=C1c2c(c(=O)n3nc(-c4ccco4)cc3n2CCN2CCOCC2)CN1Cc1ccccc1		CHEMBL272729	=	Inhibition	%	0.0	CHEMBL4722	Homo sapiens	Inhibition	%	0.0
	2104562	CHEMBL931995	Inhibition of Aurora A kinase at 10 uM	B	Cn1c2c(c(=O)n3nc(-c4ccco4)cc13)CN(Cc1ccccc1)C2=O		CHEMBL256433	=	Inhibition	%	2.3	CHEMBL4722	Homo sapiens	Inhibition	%	2.3
	2104563	CHEMBL931995	Inhibition of Aurora A kinase at 10 uM	B	O=C1c2[nH]c3ccnn3c(=O)c2CN1Cc1ccccc1		CHEMBL403609	=	Inhibition	%	1.6	CHEMBL4722	Homo sapiens	Inhibition	%	1.6
	2104564	CHEMBL931995	Inhibition of Aurora A kinase at 10 uM	B	Cc1cc2[nH]c3c(c(=O)n2n1)CN(Cc1ccccc1)C3=O		CHEMBL256037	=	Inhibition	%	1.8	CHEMBL4722	Homo sapiens	Inhibition	%	1.8
	2104565	CHEMBL931995	Inhibition of Aurora A kinase at 10 uM	B	O=C1c2nc3cc(-c4ccccc4)nn3c(O)c2CN1Cc1ccccc1		CHEMBL1535014	=	Inhibition	%	25.9	CHEMBL4722	Homo sapiens	Inhibition	%	25.9
	2104566	CHEMBL931995	Inhibition of Aurora A kinase at 10 uM	B	O=C1c2[nH]c3cc(-c4cccs4)nn3c(=O)c2CN1Cc1ccccc1		CHEMBL402547	=	Inhibition	%	29.4	CHEMBL4722	Homo sapiens	Inhibition	%	29.4
	2104567	CHEMBL931996	Inhibition of Aurora A kinase	B	O=C1c2nc3cc(-c4ccco4)nn3c(O)c2CN1Cc1ccccc1		CHEMBL1589017	=	IC50	nM	15100.0	CHEMBL4722	Homo sapiens	IC50	uM	15.1
	2104568	CHEMBL931996	Inhibition of Aurora A kinase	B	CC(=O)Nc1cccc(CN2Cc3c([nH]c4cc(-c5ccco5)nn4c3=O)C2=O)c1		CHEMBL255808	=	IC50	nM	18300.0	CHEMBL4722	Homo sapiens	IC50	uM	18.3
	2104569	CHEMBL931996	Inhibition of Aurora A kinase	B	COc1ccccc1CN1Cc2c([nH]c3cc(-c4ccco4)nn3c2=O)C1=O		CHEMBL402349	=	IC50	nM	5600.0	CHEMBL4722	Homo sapiens	IC50	uM	5.6
	2104570	CHEMBL931996	Inhibition of Aurora A kinase	B	COc1cccc(CN2Cc3c([nH]c4cc(-c5ccco5)nn4c3=O)C2=O)c1		CHEMBL439417	=	IC50	nM	15200.0	CHEMBL4722	Homo sapiens	IC50	uM	15.2
	2104571	CHEMBL931996	Inhibition of Aurora A kinase	B	COc1ccc(CN2Cc3c([nH]c4cc(-c5ccco5)nn4c3=O)C2=O)cc1		CHEMBL271894	=	IC50	nM	8000.0	CHEMBL4722	Homo sapiens	IC50	uM	8.0
	2104572	CHEMBL931996	Inhibition of Aurora A kinase	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	Ki	nM	0.6	CHEMBL4722	Homo sapiens	Ki	nM	0.6
	2104575	CHEMBL931996	Inhibition of Aurora A kinase	B	CO[C@@H](C(=O)N1Cc2n[nH]c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)c2C1)c1ccccc1		CHEMBL402548	=	Ki	nM	13.0	CHEMBL4722	Homo sapiens	Ki	nM	13.0
	2120680	CHEMBL951284	Inhibition of Aurora A	B	COc1cc2nccc(Oc3ccc4c(C(=O)Nc5ccc(Cl)cc5)cccc4c3)c2cc1OC		CHEMBL429743	=	IC50	nM	371.0	CHEMBL4722	Homo sapiens	IC50	nM	371.0
	2120695	CHEMBL951284	Inhibition of Aurora A	B	COc1cc2nccc(Oc3ccc4c(C(N)=O)cccc4c3)c2cc1C(N)=O		CHEMBL260532	=	IC50	nM	6800.0	CHEMBL4722	Homo sapiens	IC50	nM	6800.0
	2120696	CHEMBL951284	Inhibition of Aurora A	B	COCCNC(=O)c1cccc2cc(Oc3ccnc4cc(OC)c(C(N)=O)cc34)ccc12		CHEMBL260531	=	IC50	nM	8300.0	CHEMBL4722	Homo sapiens	IC50	nM	8300.0
	2120697	CHEMBL951284	Inhibition of Aurora A	B	COc1cc2nccc(Oc3ccc4c(C(=O)NC5CC5)cccc4c3)c2cc1C(N)=O		CHEMBL272250	=	IC50	nM	4400.0	CHEMBL4722	Homo sapiens	IC50	nM	4400.0
	2120698	CHEMBL951284	Inhibition of Aurora A	B	COc1ccc2c(Oc3ccc4c(C(N)=O)cccc4c3)ccnc2c1		CHEMBL272252	=	IC50	nM	8300.0	CHEMBL4722	Homo sapiens	IC50	nM	8300.0
	2120699	CHEMBL951284	Inhibition of Aurora A	B	COCCNC(=O)c1cccc2cc(Oc3ccnc4cc(OC)ccc34)ccc12		CHEMBL272251	=	IC50	nM	8300.0	CHEMBL4722	Homo sapiens	IC50	nM	8300.0
	2120700	CHEMBL951284	Inhibition of Aurora A	B	COc1ccc2c(Oc3ccc4c(C(=O)NC5CC5)cccc4c3)ccnc2c1		CHEMBL270342	=	IC50	nM	8300.0	CHEMBL4722	Homo sapiens	IC50	nM	8300.0
	2120701	CHEMBL951284	Inhibition of Aurora A	B	COc1cc2ncnc(Oc3ccc4c(C(N)=O)cccc4c3)c2cc1OC		CHEMBL270556	=	IC50	nM	8300.0	CHEMBL4722	Homo sapiens	IC50	nM	8300.0
	2120702	CHEMBL951284	Inhibition of Aurora A	B	COCCNC(=O)c1cccc2cc(Oc3ncnc4cc(OC)c(OC)cc34)ccc12		CHEMBL412278	=	IC50	nM	25000.0	CHEMBL4722	Homo sapiens	IC50	nM	25000.0
	2120703	CHEMBL951284	Inhibition of Aurora A	B	COc1cc2ncnc(Oc3ccc4c(C(=O)NC5CC5)cccc4c3)c2cc1OC		CHEMBL411284	=	IC50	nM	8300.0	CHEMBL4722	Homo sapiens	IC50	nM	8300.0
	2120704	CHEMBL951284	Inhibition of Aurora A	B	COc1cc2nccc(Oc3ccc4c(C(N)=O)cccc4c3)c2cc1OC		CHEMBL271984	=	IC50	nM	5000.0	CHEMBL4722	Homo sapiens	IC50	nM	5000.0
	2120705	CHEMBL951284	Inhibition of Aurora A	B	COCCCNC(=O)c1cccc2cc(Oc3ccnc4cc(OC)c(OC)cc34)ccc12		CHEMBL271189	=	IC50	nM	3500.0	CHEMBL4722	Homo sapiens	IC50	nM	3500.0
	2120706	CHEMBL951284	Inhibition of Aurora A	B	COCCNC(=O)c1cccc2cc(Oc3ccnc4cc(OC)c(OC)cc34)ccc12		CHEMBL271188	=	IC50	nM	7200.0	CHEMBL4722	Homo sapiens	IC50	nM	7200.0
	2120707	CHEMBL951284	Inhibition of Aurora A	B	COc1cc2nccc(Oc3ccc4c(C(=O)NCC(F)(F)F)cccc4c3)c2cc1OC		CHEMBL410840	=	IC50	nM	930.0	CHEMBL4722	Homo sapiens	IC50	nM	930.0
	2120708	CHEMBL951284	Inhibition of Aurora A	B	COc1cc2nccc(Oc3ccc4c(C(=O)NC(C)(C)C)cccc4c3)c2cc1OC		CHEMBL406914	=	IC50	nM	3700.0	CHEMBL4722	Homo sapiens	IC50	nM	3700.0
	2120709	CHEMBL951284	Inhibition of Aurora A	B	COc1cc2nccc(Oc3ccc4c(C(=O)NC(C)C)cccc4c3)c2cc1OC		CHEMBL408211	=	IC50	nM	3600.0	CHEMBL4722	Homo sapiens	IC50	nM	3600.0
	2120710	CHEMBL951284	Inhibition of Aurora A	B	CCCNC(=O)c1cccc2cc(Oc3ccnc4cc(OC)c(OC)cc34)ccc12		CHEMBL409103	=	IC50	nM	1700.0	CHEMBL4722	Homo sapiens	IC50	nM	1700.0
	2120711	CHEMBL951284	Inhibition of Aurora A	B	CCNC(=O)c1cccc2cc(Oc3ccnc4cc(OC)c(OC)cc34)ccc12		CHEMBL269871	=	IC50	nM	1500.0	CHEMBL4722	Homo sapiens	IC50	nM	1500.0
	2120712	CHEMBL951284	Inhibition of Aurora A	B	CNC(=O)c1cccc2cc(Oc3ccnc4cc(OC)c(OC)cc34)ccc12		CHEMBL270754	=	IC50	nM	3600.0	CHEMBL4722	Homo sapiens	IC50	nM	3600.0
	2120713	CHEMBL951284	Inhibition of Aurora A	B	COc1cc2nccc(Oc3ccc4c(C(=O)NCC5CC5)cccc4c3)c2cc1OC		CHEMBL270755	=	IC50	nM	840.0	CHEMBL4722	Homo sapiens	IC50	nM	840.0
	2120714	CHEMBL951284	Inhibition of Aurora A	B	COc1cc2nccc(Oc3ccc4c(C(=O)NC5(C)CC5)cccc4c3)c2cc1OC		CHEMBL428961	=	IC50	nM	560.0	CHEMBL4722	Homo sapiens	IC50	nM	560.0
	2120715	CHEMBL951284	Inhibition of Aurora A	B	COc1cc2nccc(Oc3ccc4c(C(=O)NC5CCCC5)cccc4c3)c2cc1OC		CHEMBL410903	=	IC50	nM	620.0	CHEMBL4722	Homo sapiens	IC50	nM	620.0
	2120716	CHEMBL951284	Inhibition of Aurora A	B	COc1cc2nccc(Oc3ccc4c(C(=O)NC5CCC5)cccc4c3)c2cc1OC		CHEMBL259252	=	IC50	nM	440.0	CHEMBL4722	Homo sapiens	IC50	nM	440.0
	2120717	CHEMBL951284	Inhibition of Aurora A	B	COc1cc2nccc(Oc3ccc4c(C(=O)NC5CC5)cccc4c3)c2cc1OC		CHEMBL272198	=	IC50	nM	2000.0	CHEMBL4722	Homo sapiens	IC50	nM	2000.0
	2132674	CHEMBL939030	Inhibition of AuroraA	B	Nc1nccn2c1c(-c1ccc3ccc(-c4ccccc4)nc3c1)nc2[C@H]1C[C@@H](CN2CCC2)C1		CHEMBL410659	>	IC50	nM	10000.0	CHEMBL4722	Homo sapiens	IC50	uM	10.0
	2136751	CHEMBL921714	Inhibition of Aurora kinase A	B	COc1cc2ncnc(Nc3ccc(NC(=O)c4ccccc4)cc3)c2cc1OC		CHEMBL382590	=	IC50	nM	310.0	CHEMBL4722	Homo sapiens	IC50	nM	310.0
	2136868	CHEMBL921714	Inhibition of Aurora kinase A	B	O=C(Nc1cccc(Nc2nccc(Nc3cccc(C(F)(F)F)c3)n2)c1)C1CC1		CHEMBL383899	=	IC50	nM	42.0	CHEMBL4722	Homo sapiens	IC50	nM	42.0
	2137091	CHEMBL921714	Inhibition of Aurora kinase A	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(O)c1c(F)cccc1F		CHEMBL259605	=	IC50	nM	11.0	CHEMBL4722	Homo sapiens	IC50	nM	11.0
Active	2147111	CHEMBL922648	Inhibition of Aurora A Thr288 autophosphorylation in human HCT116 cells at 0.25 uM after 24 hrs	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084		Activity			CHEMBL4722	Homo sapiens	Activity		
Active	2147112	CHEMBL922649	Inhibition of Aurora A Thr288 autophosphorylation in human HCT116 cells at 1 uM after 24 hrs	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084		Activity			CHEMBL4722	Homo sapiens	Activity		
Active	2147113	CHEMBL922650	Inhibition of Aurora A Thr288 autophosphorylation in human HCT116 cells at 4 uM after 24 hrs	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084		Activity			CHEMBL4722	Homo sapiens	Activity		
	2147114	CHEMBL922651	Inhibition of Aurora A Thr288 autophosphorylation in human HeLa cells after 1 hr	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	=	IC50	nM	34.0	CHEMBL4722	Homo sapiens	IC50	uM	0.034
Active	2147161	CHEMBL931561	Inhibition of Aurora A in human HCT116 cells assessed as formation of abnormal mitotic spindles with deffective chromosome alignment at 0.25 uM	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084		Activity			CHEMBL4722	Homo sapiens	Activity		
Active	2147162	CHEMBL931562	Inhibition of Aurora A in human HCT116 cells assessed as formation of abnormal mitotic spindles with deffective chromosome alignment at 1 uM	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084		Activity			CHEMBL4722	Homo sapiens	Activity		
	2147194	CHEMBL927938	Activity of human Aurora A kinase at 1 uM	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	=	Activity	%	0.0	CHEMBL4722	Homo sapiens	Activity	%	0.0
Active	2147424	CHEMBL922287	Inhibition of Aurora A in human HCT116 cells xenografted in mouse assessed as decrease in pT88 staining at 30 mg/kg, po after 24 hrs	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084		Activity			CHEMBL4722	Homo sapiens	Activity		
Not Active	2172617	CHEMBL921635	Inhibition of human recombinant Aurora A kinase at 10 uM	B	Cc1ccc(N2CCN(CCCNC(=O)c3nc(-c4cccnc4)no3)CC2)cc1C		CHEMBL427726		Activity			CHEMBL4722	Homo sapiens	Activity		
Not Active	2172625	CHEMBL921635	Inhibition of human recombinant Aurora A kinase at 10 uM	B	Cc1cccc(N2CCN(CCCNC(=O)c3nc(-c4cccnc4)no3)C(C)C2)c1		CHEMBL254582		Activity			CHEMBL4722	Homo sapiens	Activity		
Not Active	2172626	CHEMBL921635	Inhibition of human recombinant Aurora A kinase at 10 uM	B	COc1ccccc1N1CCN(CCCNC(=O)c2nc(-c3cccnc3)no2)CC1		CHEMBL402228		Activity			CHEMBL4722	Homo sapiens	Activity		
Not Determined	2172938	CHEMBL928212	Inhibition of Aurora A	B	O=[N+]([O-])c1cnc(Nc2ccccc2)nc1Nc1ccccc1		CHEMBL256366		IC50			CHEMBL4722	Homo sapiens	IC50		
Not Determined	2172939	CHEMBL928212	Inhibition of Aurora A	B	O=C(O)COc1ccc(Nc2ncc3nnn(C45CC6CC(CC(O)(C6)C4)C5)c3n2)cc1		CHEMBL254350		IC50			CHEMBL4722	Homo sapiens	IC50		
Not Determined	2172940	CHEMBL928212	Inhibition of Aurora A	B	O=C(O)CCc1ccc(Nc2ncc([N+](=O)[O-])c(NC34CC5CC(CC(C5)C3)C4)n2)cc1		CHEMBL404175		IC50			CHEMBL4722	Homo sapiens	IC50		
Not Determined	2172941	CHEMBL928212	Inhibition of Aurora A	B	O=C(O)c1ccc(Nc2ncc3nnn(C45CC6CC(CC(O)(C6)C4)C5)c3n2)cc1		CHEMBL257575		IC50			CHEMBL4722	Homo sapiens	IC50		
Not Determined	2172942	CHEMBL928212	Inhibition of Aurora A	B	COC(=O)COc1ccc(Nc2ncc3nnn(-c4ccccc4)c3n2)cc1		CHEMBL404242		IC50			CHEMBL4722	Homo sapiens	IC50		
Not Determined	2172943	CHEMBL928212	Inhibition of Aurora A	B	COC(=O)COc1ccc(Nc2ncc([N+](=O)[O-])c(Nc3ccccc3)n2)cc1		CHEMBL253958		IC50			CHEMBL4722	Homo sapiens	IC50		
Not Determined	2172944	CHEMBL928212	Inhibition of Aurora A	B	O=[N+]([O-])c1cnc(N[C@H]2CC[C@H](O)CC2)nc1Nc1ccccc1		CHEMBL256517		IC50			CHEMBL4722	Homo sapiens	IC50		
Not Determined	2172945	CHEMBL928212	Inhibition of Aurora A	B	c1ccc(Nc2ncc3nnn(-c4ccccc4)c3n2)cc1		CHEMBL256518		IC50			CHEMBL4722	Homo sapiens	IC50		
	2172946	CHEMBL928212	Inhibition of Aurora A	B	O=C(O)c1ccc(Nc2ncc3nnn(-c4ccccc4)c3n2)cc1		CHEMBL402932	=	IC50	nM	292.0	CHEMBL4722	Homo sapiens	IC50	nM	292.0
	2172947	CHEMBL928212	Inhibition of Aurora A	B	O=C(O)c1ccc(Nc2ncc([N+](=O)[O-])c(Nc3ccccc3)n2)cc1		CHEMBL257188	=	IC50	nM	346.0	CHEMBL4722	Homo sapiens	IC50	nM	346.0
Not Determined	2172948	CHEMBL928212	Inhibition of Aurora A	B	OC12CC3CC(C1)CC(Nc1nc(N[C@H]4CC[C@H](O)CC4)ncc1F)(C3)C2		CHEMBL254587		IC50			CHEMBL4722	Homo sapiens	IC50		
	2172949	CHEMBL928212	Inhibition of Aurora A	B	O=C(O)c1ccc(Nc2ncc([N+](=O)[O-])c(NC34CC5CC(CC(O)(C5)C3)C4)n2)cc1		CHEMBL402902	=	IC50	nM	156.0	CHEMBL4722	Homo sapiens	IC50	nM	156.0
	2172950	CHEMBL928212	Inhibition of Aurora A	B	O=C(O)c1ccc(Nc2ncc3nnn(C45CC6CC(CC(C6)C4)C5)c3n2)cc1		CHEMBL257577	=	IC50	nM	910.0	CHEMBL4722	Homo sapiens	IC50	nM	910.0
Not Determined	2172951	CHEMBL928212	Inhibition of Aurora A	B	O=C(O)c1ccc(Nc2ncc([N+](=O)[O-])c(NC34CC5CC(CC(C5)C3)C4)n2)cc1		CHEMBL253748		IC50			CHEMBL4722	Homo sapiens	IC50		
	2172952	CHEMBL928212	Inhibition of Aurora A	B	O=C1OC(Nc2ncc3nnn(-c4ccccc4)c3n2)c2ccccc21		CHEMBL253956	=	IC50	nM	7300.0	CHEMBL4722	Homo sapiens	IC50	nM	7300.0
	2172953	CHEMBL928212	Inhibition of Aurora A	B	O=C(O)COc1ccc(Nc2ncc3nnn(-c4ccccc4)c3n2)cc1		CHEMBL402541	=	IC50	nM	128.0	CHEMBL4722	Homo sapiens	IC50	nM	128.0
	2172954	CHEMBL928212	Inhibition of Aurora A	B	O=C(O)COc1ccc(Nc2ncc([N+](=O)[O-])c(Nc3ccccc3)n2)cc1		CHEMBL402969	=	IC50	nM	85.0	CHEMBL4722	Homo sapiens	IC50	nM	85.0
	2172955	CHEMBL928212	Inhibition of Aurora A	B	O=C(O)/C=C\c1ccc(Nc2ncc3nnn(-c4ccccc4)c3n2)cc1		CHEMBL255735	=	IC50	nM	112.0	CHEMBL4722	Homo sapiens	IC50	nM	112.0
	2172956	CHEMBL928212	Inhibition of Aurora A	B	O=C(O)CCc1ccc(Nc2ncc3nnn(-c4ccccc4)c3n2)cc1		CHEMBL404565	=	IC50	nM	375.0	CHEMBL4722	Homo sapiens	IC50	nM	375.0
	2172957	CHEMBL928213	Inhibition of Aurora A at 10 uM	B	O[C@H]1CC[C@H](Nc2ncc3nnn(-c4ccccc4)c3n2)CC1		CHEMBL255948	=	Inhibition	%	25.0	CHEMBL4722	Homo sapiens	Inhibition	%	25.0
	2172958	CHEMBL928213	Inhibition of Aurora A at 10 uM	B	OC12CC3CC(C1)CC(Nc1nc(N[C@H]4CC[C@H](O)CC4)ncc1Cl)(C3)C2		CHEMBL257370	=	Inhibition	%	65.0	CHEMBL4722	Homo sapiens	Inhibition	%	65.0
	2172959	CHEMBL928213	Inhibition of Aurora A at 10 uM	B	OC12CC3CC(C1)CC(Nc1nc(N[C@H]4CC[C@H](O)CC4)ncc1Br)(C3)C2		CHEMBL403385	=	Inhibition	%	69.0	CHEMBL4722	Homo sapiens	Inhibition	%	69.0
	2172960	CHEMBL928213	Inhibition of Aurora A at 10 uM	B	OC12CC3CC(C1)CC(Nc1nc(N[C@H]4CC[C@H](O)CC4)ncc1C(F)(F)F)(C3)C2		CHEMBL255905	=	Inhibition	%	45.0	CHEMBL4722	Homo sapiens	Inhibition	%	45.0
	2172961	CHEMBL928213	Inhibition of Aurora A at 10 uM	B	OC12CC3CC(C1)CC(n1nnc4cnc(N[C@H]5CC[C@H](O)CC5)nc41)(C3)C2		CHEMBL254155	=	Inhibition	%	23.0	CHEMBL4722	Homo sapiens	Inhibition	%	23.0
	2172962	CHEMBL928213	Inhibition of Aurora A at 10 uM	B	O=[N+]([O-])c1cnc(N[C@H]2CC[C@H](O)CC2)nc1NC12CC3CC(CC(O)(C3)C1)C2		CHEMBL404174	=	Inhibition	%	33.0	CHEMBL4722	Homo sapiens	Inhibition	%	33.0
	2182835	CHEMBL941461	Inhibition of STK6 at 5 uM	B	O=c1cc(N2CCOCC2)nc2c3ccccc3ccn12		CHEMBL179242	=	Inhibition	%	44.0	CHEMBL4722	Homo sapiens	INH	%	44.0
	2232195	CHEMBL973638	Inhibition of aurora 2 kinase	B	COc1cc2nccc(Oc3ccc4c(NC(=O)c5cccc(C(F)(F)F)c5)nn(C)c4c3)c2cc1OC		CHEMBL462168	=	IC50	nM	764.0	CHEMBL4722	Homo sapiens	IC50	uM	0.764
	2239226	CHEMBL971645	Inhibition of Aurora A at 100 uM	B	Nc1ncnc(Nc2ccc(OCc3ccccc3)c(Cl)c2)c1C=O		CHEMBL461311	=	Inhibition	%	30.0	CHEMBL4722	Homo sapiens	INH	%	30.0
	2239991	CHEMBL971644	Inhibition of Aurora A	B	Nc1ncnc(Nc2ccc(OCc3ccccc3)c(Cl)c2)c1C(=O)Nc1ccccc1		CHEMBL461114	>	IC50	nM	100000.0	CHEMBL4722	Homo sapiens	IC50	uM	100.0
	2239994	CHEMBL971644	Inhibition of Aurora A	B	Nc1ncnc(Nc2ccc(OCc3ccccc3)c(Cl)c2)c1-c1nnc(CCN2CCOCC2)o1		CHEMBL472545	>	IC50	nM	100000.0	CHEMBL4722	Homo sapiens	IC50	uM	100.0
	2239995	CHEMBL971644	Inhibition of Aurora A	B	Nc1ncnc(Nc2ccc(OCc3ccccc3)c(Cl)c2)c1C(=O)NNC(=O)CCN1CCOCC1		CHEMBL472544	>	IC50	nM	100000.0	CHEMBL4722	Homo sapiens	IC50	uM	100.0
	2239996	CHEMBL971644	Inhibition of Aurora A	B	NNC(=O)c1c(N)ncnc1Nc1ccc(OCc2ccccc2)c(Cl)c1		CHEMBL511478	>	IC50	nM	10000.0	CHEMBL4722	Homo sapiens	IC50	uM	10.0
	2239997	CHEMBL971644	Inhibition of Aurora A	B	COc1ccc(NC(=O)c2c(N)ncnc2Nc2ccc(OCc3ccccc3)c(Cl)c2)cc1		CHEMBL472383	>	IC50	nM	10000.0	CHEMBL4722	Homo sapiens	IC50	uM	10.0
	2239998	CHEMBL971644	Inhibition of Aurora A	B	Nc1ncnc(Nc2ccc(OCc3ccccc3)c(Cl)c2)c1C(=O)OCc1cccc(F)c1		CHEMBL472382	>	IC50	nM	100000.0	CHEMBL4722	Homo sapiens	IC50	uM	100.0
	2239999	CHEMBL971644	Inhibition of Aurora A	B	CCN(CC)C(=O)c1c(N)ncnc1Nc1ccc(OCc2ccccc2)c(Cl)c1		CHEMBL452727	>	IC50	nM	100000.0	CHEMBL4722	Homo sapiens	IC50	uM	100.0
	2240000	CHEMBL971644	Inhibition of Aurora A	B	COCCNC(=O)c1c(N)ncnc1Nc1ccc(OCc2ccccc2)c(Cl)c1		CHEMBL517745	>	IC50	nM	100000.0	CHEMBL4722	Homo sapiens	IC50	uM	100.0
	2240001	CHEMBL971644	Inhibition of Aurora A	B	COc1ccc(CCNC(=O)c2c(N)ncnc2Nc2ccc(OCc3ccccc3)c(Cl)c2)cc1		CHEMBL461115	>	IC50	nM	100000.0	CHEMBL4722	Homo sapiens	IC50	uM	100.0
	2240002	CHEMBL971644	Inhibition of Aurora A	B	Nc1ncnc(Nc2ccc(OCc3ccccc3)c(Cl)c2)c1C(=O)NCCN1CCOCC1		CHEMBL518646	>	IC50	nM	100000.0	CHEMBL4722	Homo sapiens	IC50	uM	100.0
	2240003	CHEMBL971644	Inhibition of Aurora A	B	Nc1ncnc(Nc2ccc(OCc3ccccc3)c(Cl)c2)c1C(=O)NCCN1CCCCC1		CHEMBL462343	=	IC50	nM	100000.0	CHEMBL4722	Homo sapiens	IC50	uM	100.0
	2240026	CHEMBL971645	Inhibition of Aurora A at 100 uM	B	Nc1ncnc(Nc2ccc(OCc3ccccc3)c(Cl)c2)c1C(=O)OCCN1CCOCC1		CHEMBL461113	=	Inhibition	%	55.0	CHEMBL4722	Homo sapiens	INH	%	55.0
	2240027	CHEMBL971645	Inhibition of Aurora A at 100 uM	B	COC(=O)c1c(N)ncnc1Nc1ccc(OCc2ccccc2)c(Cl)c1		CHEMBL516487	=	Inhibition	%	50.0	CHEMBL4722	Homo sapiens	INH	%	50.0
	2240028	CHEMBL971645	Inhibition of Aurora A at 100 uM	B	Nc1ncnc(Nc2ccc(OCc3ccccc3)c(Cl)c2)c1C(=O)O		CHEMBL512391	=	Inhibition	%	73.0	CHEMBL4722	Homo sapiens	INH	%	73.0
	2240033	CHEMBL971645	Inhibition of Aurora A at 100 uM	B	N#Cc1c(N)ncnc1Nc1ccc(OCc2ccccc2)c(Cl)c1		CHEMBL500591	=	Inhibition	%	33.0	CHEMBL4722	Homo sapiens	INH	%	33.0
	2240184	CHEMBL972583	Inhibition of Aurora A by radiometric assay	B	O=C(Nc1ccc(CCNc2ncnc3ccsc23)cc1)c1cccc(C(F)(F)F)c1		CHEMBL459888	=	IC50	nM	3200.0	CHEMBL4722	Homo sapiens	IC50	nM	3200.0
	2240185	CHEMBL972583	Inhibition of Aurora A by radiometric assay	B	O=C(Nc1cccc(CCN2CCC2)c1)Nc1ncc(CCNc2ncnc3ccsc23)s1		CHEMBL519728	=	IC50	nM	53.0	CHEMBL4722	Homo sapiens	IC50	nM	53.0
	2240186	CHEMBL972583	Inhibition of Aurora A by radiometric assay	B	O=C(Nc1cc(CN2CCCC2)cc(C(F)(F)F)c1)Nc1ncc(CCNc2ncnc3ccsc23)s1		CHEMBL486850	=	IC50	nM	4.0	CHEMBL4722	Homo sapiens	IC50	nM	4.0
	2240187	CHEMBL972583	Inhibition of Aurora A by radiometric assay	B	O=C(Nc1ncc(CCNc2ncnc3ccsc23)s1)NC1CCCCC1		CHEMBL487892	=	IC50	nM	270.0	CHEMBL4722	Homo sapiens	IC50	nM	270.0
	2240188	CHEMBL972583	Inhibition of Aurora A by radiometric assay	B	O=C(Nc1ncc(CCNc2ncnc3ccsc23)s1)Nc1cccc2cc[nH]c12		CHEMBL486877	=	IC50	nM	30.0	CHEMBL4722	Homo sapiens	IC50	nM	30.0
	2240189	CHEMBL972583	Inhibition of Aurora A by radiometric assay	B	O=C(Nc1ccc(F)c(Cl)c1)Nc1ncc(CCNc2ncnc3ccsc23)s1		CHEMBL520053	=	IC50	nM	11.0	CHEMBL4722	Homo sapiens	IC50	nM	11.0
	2240190	CHEMBL972583	Inhibition of Aurora A by radiometric assay	B	O=C(Nc1ccc(Cl)c(Cl)c1)Nc1ncc(CCNc2ncnc3ccsc23)s1		CHEMBL505037	=	IC50	nM	96.0	CHEMBL4722	Homo sapiens	IC50	nM	96.0
	2240191	CHEMBL972583	Inhibition of Aurora A by radiometric assay	B	O=C(Nc1ncc(CCNc2ncnc3ccsc23)s1)Nc1ccccc1Cl		CHEMBL472546	=	IC50	nM	280.0	CHEMBL4722	Homo sapiens	IC50	nM	280.0
	2240192	CHEMBL972583	Inhibition of Aurora A by radiometric assay	B	O=C(Nc1ccc(Cl)cc1)Nc1ncc(CCNc2ncnc3ccsc23)s1		CHEMBL472377	=	IC50	nM	39.0	CHEMBL4722	Homo sapiens	IC50	nM	39.0
	2240193	CHEMBL972583	Inhibition of Aurora A by radiometric assay	B	CS(=O)(=O)O.O=C(Nc1cccc(Cl)c1)Nc1ncc(CCN=c2[nH]cnc3ccsc23)s1		CHEMBL518051	=	IC50	nM	9.0	CHEMBL4722	Homo sapiens	IC50	nM	9.0
	2240194	CHEMBL972583	Inhibition of Aurora A by radiometric assay	B	O=C(Nc1cccc(F)c1)Nc1ncc(CCNc2ncnc3ccsc23)s1		CHEMBL512184	=	IC50	nM	23.0	CHEMBL4722	Homo sapiens	IC50	nM	23.0
	2240195	CHEMBL972583	Inhibition of Aurora A by radiometric assay	B	C#Cc1cccc(NC(=O)Nc2ncc(CCNc3ncnc4ccsc34)s2)c1		CHEMBL471337	=	IC50	nM	41.0	CHEMBL4722	Homo sapiens	IC50	nM	41.0
	2240196	CHEMBL972583	Inhibition of Aurora A by radiometric assay	B	COc1cccc(NC(=O)Nc2ncc(CCNc3ncnc4ccsc34)s2)c1		CHEMBL470119	=	IC50	nM	50.0	CHEMBL4722	Homo sapiens	IC50	nM	50.0
	2240197	CHEMBL972583	Inhibition of Aurora A by radiometric assay	B	Cc1cccc(NC(=O)Nc2ncc(CCNc3ncnc4ccsc34)s2)c1		CHEMBL513078	=	IC50	nM	9.0	CHEMBL4722	Homo sapiens	IC50	nM	9.0
	2240198	CHEMBL972583	Inhibition of Aurora A by radiometric assay	B	CN(C(=O)Nc1ncc(CCNc2ncnc3ccsc23)s1)c1ccccc1		CHEMBL472203	=	IC50	nM	7200.0	CHEMBL4722	Homo sapiens	IC50	nM	7200.0
	2240199	CHEMBL972583	Inhibition of Aurora A by radiometric assay	B	O=C(Nc1ccccc1)Nc1ncc(CCNc2ncnc3ccsc23)s1		CHEMBL472202	=	IC50	nM	52.0	CHEMBL4722	Homo sapiens	IC50	nM	52.0
	2240200	CHEMBL972583	Inhibition of Aurora A by radiometric assay	B	O=C(Cc1ncc(CCNc2ncnc3ccsc23)s1)Nc1cccc(C(F)(F)F)c1		CHEMBL471511	=	IC50	nM	4900.0	CHEMBL4722	Homo sapiens	IC50	nM	4900.0
	2240201	CHEMBL972583	Inhibition of Aurora A by radiometric assay	B	O=C(Cc1cccc(C(F)(F)F)c1)Nc1ncc(CCNc2ncnc3ccsc23)s1		CHEMBL471169	>	IC50	nM	10000.0	CHEMBL4722	Homo sapiens	IC50	nM	10000.0
	2240202	CHEMBL972583	Inhibition of Aurora A by radiometric assay	B	O=C(Nc1ncc(CCNc2ncnc3ccsc23)s1)c1cccc(C(F)(F)F)c1		CHEMBL472194	=	IC50	nM	2500.0	CHEMBL4722	Homo sapiens	IC50	nM	2500.0
	2240203	CHEMBL972583	Inhibition of Aurora A by radiometric assay	B	O=C(Nc1cccc(C(F)(F)F)c1)Nc1nc(CCNc2ncnc3ccsc23)cs1		CHEMBL513076	>	IC50	nM	20000.0	CHEMBL4722	Homo sapiens	IC50	nM	20000.0
	2240204	CHEMBL972583	Inhibition of Aurora A by radiometric assay	B	O=C(Nc1cccc(C(F)(F)F)c1)Nc1ncc(CCNc2ncnc3ccsc23)s1		CHEMBL472193	=	IC50	nM	22.0	CHEMBL4722	Homo sapiens	IC50	nM	22.0
	2240205	CHEMBL972583	Inhibition of Aurora A by radiometric assay	B	O=C(Nc1cccc(C(F)(F)F)c1)Nc1cn(CCNc2ncnc3ccsc23)nn1		CHEMBL518666	=	IC50	nM	250.0	CHEMBL4722	Homo sapiens	IC50	nM	250.0
	2240206	CHEMBL972583	Inhibition of Aurora A by radiometric assay	B	O=C(Nc1cccc(C(F)(F)F)c1)Nc1cn(CCNc2ncnc3ccsc23)cn1		CHEMBL462354	=	IC50	nM	1200.0	CHEMBL4722	Homo sapiens	IC50	nM	1200.0
	2240207	CHEMBL972583	Inhibition of Aurora A by radiometric assay	B	O=C(Nc1cccc(CCNc2ncnc3ccsc23)c1)Nc1cccc(C(F)(F)F)c1		CHEMBL462000	>	IC50	nM	20000.0	CHEMBL4722	Homo sapiens	IC50	nM	20000.0
	2240208	CHEMBL972583	Inhibition of Aurora A by radiometric assay	B	O=C(Nc1ccc(CCNc2ncnc3ccsc23)cc1)Nc1cccc(C(F)(F)F)c1		CHEMBL461999	=	IC50	nM	1200.0	CHEMBL4722	Homo sapiens	IC50	nM	1200.0
	2240209	CHEMBL972583	Inhibition of Aurora A by radiometric assay	B	O=C(Nc1cccc(C(F)(F)F)c1)c1ccc(CCNc2ncnc3ccsc23)cc1		CHEMBL461995	>	IC50	nM	20000.0	CHEMBL4722	Homo sapiens	IC50	nM	20000.0
	2248187	CHEMBL1012670	Inhibition of AurA at 5 uM	B	O=C1NC(=O)/C(=C/c2cccc(C(F)(F)F)c2)S1		CHEMBL183906	=	Inhibition	%	6.0	CHEMBL4722	Homo sapiens	INH	%	6.0
	2248217	CHEMBL1012670	Inhibition of AurA at 5 uM	B	CCCOc1ccc(/C=C2\SC(=O)NC2=O)cc1		CHEMBL84558	=	Inhibition	%	4.0	CHEMBL4722	Homo sapiens	INH	%	4.0
	2250931	CHEMBL1022476	Inhibition of AUR2	B	Nc1nccc(-c2cc3c([nH]2)[C@@H](CCF)CNC3=O)n1		CHEMBL524266	>	IC50	nM	4000.0	CHEMBL4722	Homo sapiens	IC50	uM	4.0
	2250973	CHEMBL1022475	Inhibition of AUR1	B	Nc1nccc(-c2cc3c([nH]2)[C@@H](CCF)CNC3=O)n1		CHEMBL524266	>	IC50	nM	4000.0	CHEMBL4722	Homo sapiens	IC50	uM	4.0
	2251032	CHEMBL1011056	Inhibition of Aurora A at 100 nM relative to control	B	N=C(N)NCCC[C@@H](NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)CCCCCNC(=O)[C@@H](CCCCN)NC(=O)CCCCCNC(=O)[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1O)C(N)=O		CHEMBL525385	=	Inhibition	%	10.0	CHEMBL4722	Homo sapiens	INH	%	10.0
	2251196	CHEMBL1009894	Inhibition of Aurora A at 3.0 nM	B	O=C(Nc1c[nH]nc1-c1nc2ccc(CN3CCOCC3)cc2[nH]1)NC1CC1		CHEMBL495727	=	Inhibition	%	52.0	CHEMBL4722	Homo sapiens	INH	%	52.0
	2251229	CHEMBL1009880	Inhibition of Aurora A	B	c1ccc2[nH]c(-c3cc[nH]n3)nc2c1		CHEMBL495758	=	IC50	nM	910.0	CHEMBL4722	Homo sapiens	IC50	uM	0.91
	2251230	CHEMBL1009880	Inhibition of Aurora A	B	CC(=O)Nc1c[nH]nc1-c1nc2ccccc2[nH]1		CHEMBL504155	=	IC50	nM	70.0	CHEMBL4722	Homo sapiens	IC50	uM	0.07
	2251231	CHEMBL1009880	Inhibition of Aurora A	B	O=C(Nc1c[nH]nc1-c1nc2ccccc2[nH]1)c1ccccc1		CHEMBL522891	=	IC50	nM	5.9	CHEMBL4722	Homo sapiens	IC50	uM	0.0059
	2251232	CHEMBL1009880	Inhibition of Aurora A	B	O=C(Nc1c[nH]nc1-c1nc2cc(CN3CCOCC3)ccc2[nH]1)c1ccccc1		CHEMBL496569	=	IC50	nM	3.5	CHEMBL4722	Homo sapiens	IC50	uM	0.0035
	2251233	CHEMBL1009880	Inhibition of Aurora A	B	O=C(Nc1c[nH]nc1-c1nc2ccc(CN3CCOCC3)cc2[nH]1)c1ccc(F)cc1		CHEMBL522563	=	IC50	nM	10.0	CHEMBL4722	Homo sapiens	IC50	uM	0.01
	2251234	CHEMBL1009880	Inhibition of Aurora A	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	IC50	nM	1.4	CHEMBL4722	Homo sapiens	IC50	uM	0.0014
	2251235	CHEMBL1009880	Inhibition of Aurora A	B	O=C(Nc1ccccc1)Nc1c[nH]nc1-c1nc2cc(CN3CCOCC3)ccc2[nH]1		CHEMBL458420	=	IC50	nM	12.0	CHEMBL4722	Homo sapiens	IC50	uM	0.012
	2251236	CHEMBL1009880	Inhibition of Aurora A	B	O=C(Nc1ccccc1F)Nc1c[nH]nc1-c1nc2cc(CN3CCOCC3)ccc2[nH]1		CHEMBL516003	=	IC50	nM	2.8	CHEMBL4722	Homo sapiens	IC50	uM	0.0028
	2251237	CHEMBL1009880	Inhibition of Aurora A	B	O=C(Nc1c[nH]nc1-c1nc2cc(CN3CCOCC3)ccc2[nH]1)Nc1c(F)cccc1F		CHEMBL458421	=	IC50	nM	1.5	CHEMBL4722	Homo sapiens	IC50	uM	0.0015
	2251238	CHEMBL1009880	Inhibition of Aurora A	B	O=C(Nc1c[nH]nc1-c1nc2cc(CN3CCOCC3)ccc2[nH]1)NC1CCCCC1		CHEMBL496754	=	IC50	nM	5.7	CHEMBL4722	Homo sapiens	IC50	uM	0.0057
	2251239	CHEMBL1009880	Inhibition of Aurora A	B	O=C(Nc1cccnc1)Nc1c[nH]nc1-c1nc2cc(CN3CCOCC3)ccc2[nH]1		CHEMBL523923	=	IC50	nM	13.0	CHEMBL4722	Homo sapiens	IC50	uM	0.013
	2251240	CHEMBL1009880	Inhibition of Aurora A	B	O=C(Nc1c[nH]nc1-c1nc2cc(CN3CCOCC3)ccc2[nH]1)NC1CCOCC1		CHEMBL522214	=	IC50	nM	26.0	CHEMBL4722	Homo sapiens	IC50	uM	0.026
	2264703	CHEMBL1011757	Binding affinity to Aurora A at 10 uM	B	O=C(NOCCO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F		CHEMBL244488	=	Inhibition	%	11.0	CHEMBL4722	Homo sapiens	INH	%	11.0
	2264704	CHEMBL1011757	Binding affinity to Aurora A at 10 uM	B	O=C(NOCCO)c1cc(COCCO)c(F)c(F)c1Nc1ccc(I)cc1F		CHEMBL464238	=	Inhibition	%	2.0	CHEMBL4722	Homo sapiens	INH	%	2.0
	2264705	CHEMBL1011757	Binding affinity to Aurora A at 10 uM	B	O=C(NOCCO)c1cc(/C=N/OCCO)c(F)c(F)c1Nc1ccc(I)cc1F		CHEMBL464239	=	Inhibition	%	5.0	CHEMBL4722	Homo sapiens	INH	%	5.0
	2264706	CHEMBL1011757	Binding affinity to Aurora A at 10 uM	B	COCCCNC(=O)N/N=C/c1cc(C(=O)NOCCO)c(Nc2ccc(I)cc2F)c(F)c1F		CHEMBL518248	=	Inhibition	%	0.0	CHEMBL4722	Homo sapiens	INH	%	0.0
	2264707	CHEMBL1011757	Binding affinity to Aurora A at 10 uM	B	O=C(O)CCCO/N=C/c1cc(C(=O)NOCCO)c(Nc2ccc(I)cc2F)c(F)c1F		CHEMBL464257	=	Inhibition	%	29.0	CHEMBL4722	Homo sapiens	INH	%	29.0
	2264708	CHEMBL1011757	Binding affinity to Aurora A at 10 uM	B	O=C(O)c1ccc(CO/N=C/c2cc(C(=O)NOCCO)c(Nc3ccc(I)cc3F)c(F)c2F)o1		CHEMBL464258	=	Inhibition	%	21.0	CHEMBL4722	Homo sapiens	INH	%	21.0
	2264741	CHEMBL963871	Binding affinity to Aurora A	B	CS(=O)(=O)c1ccc(CNCc2cc(C(=O)O)c(Nc3ccc(I)cc3F)c(F)c2F)cc1		CHEMBL465465	=	IC50	nM	1000.0	CHEMBL4722	Homo sapiens	IC50	uM	1.0
	2264742	CHEMBL963871	Binding affinity to Aurora A	B	NC(=O)C[C@H](N)C(=O)NCc1cc(C(=O)O)c(Nc2ccc(I)cc2F)c(F)c1F		CHEMBL517647	=	IC50	nM	2000.0	CHEMBL4722	Homo sapiens	IC50	uM	2.0
	2264743	CHEMBL963871	Binding affinity to Aurora A	B	O=C(N/N=C/c1cc(C(=O)O)c(Nc2ccc(I)cc2F)c(F)c1F)c1ccc(CO)o1		CHEMBL481968	=	IC50	nM	3000.0	CHEMBL4722	Homo sapiens	IC50	uM	3.0
	2264744	CHEMBL963871	Binding affinity to Aurora A	B	O=C(CS(=O)(=O)c1ccc(Cl)cc1)N/N=C/c1cc(C(=O)O)c(Nc2ccc(I)cc2F)c(F)c1F		CHEMBL481969	=	IC50	nM	4000.0	CHEMBL4722	Homo sapiens	IC50	uM	4.0
	2268427	CHEMBL960831	Inhibition of Aurora A at 10 uM	B	Clc1cccc(-n2cc(-c3ccccc3NCc3ccncc3)nn2)c1		CHEMBL522629	<	Inhibition	%	30.0	CHEMBL4722	Homo sapiens	INH	%	30.0
	2268819	CHEMBL960831	Inhibition of Aurora A at 10 uM	B	Clc1cccc(-n2cc(-c3ccccc3NCc3c[nH]cn3)nn2)c1		CHEMBL464619	<	Inhibition	%	30.0	CHEMBL4722	Homo sapiens	INH	%	30.0
	2268820	CHEMBL960831	Inhibition of Aurora A at 10 uM	B	FC(F)(F)c1cccc(-n2cc(-c3ccccc3NCc3ccnc4ccccc34)nn2)c1		CHEMBL517021	<	Inhibition	%	30.0	CHEMBL4722	Homo sapiens	INH	%	30.0
	2268821	CHEMBL960831	Inhibition of Aurora A at 10 uM	B	Clc1cccc(-n2cc(-c3ccccc3NCc3ccnc4ccccc34)nn2)c1		CHEMBL516635	<	Inhibition	%	30.0	CHEMBL4722	Homo sapiens	INH	%	30.0
	2268822	CHEMBL960831	Inhibition of Aurora A at 10 uM	B	FC(F)(F)c1cccc(-n2cc(-c3ccccc3NCc3ccc4c(c3)OCO4)nn2)c1		CHEMBL460959	<	Inhibition	%	30.0	CHEMBL4722	Homo sapiens	INH	%	30.0
	2268823	CHEMBL960831	Inhibition of Aurora A at 10 uM	B	Clc1cccc(-n2cc(-c3ccccc3NCc3ccc4c(c3)OCO4)nn2)c1		CHEMBL460958	<	Inhibition	%	30.0	CHEMBL4722	Homo sapiens	INH	%	30.0
	2268824	CHEMBL960831	Inhibition of Aurora A at 10 uM	B	Fc1ccc(CNc2ccccc2-c2cn(-c3cccc(Cl)c3)nn2)cc1F		CHEMBL460751	<	Inhibition	%	30.0	CHEMBL4722	Homo sapiens	INH	%	30.0
	2268825	CHEMBL960831	Inhibition of Aurora A at 10 uM	B	Cc1cc(-n2cc(-c3ccccc3NCc3ccncc3)nn2)ccc1C(F)(F)F		CHEMBL454403	<	Inhibition	%	30.0	CHEMBL4722	Homo sapiens	INH	%	30.0
	2268826	CHEMBL960831	Inhibition of Aurora A at 10 uM	B	Cc1ccc(-n2cc(-c3ccccc3NCc3ccncc3)nn2)cc1C(F)(F)F		CHEMBL523320	<	Inhibition	%	30.0	CHEMBL4722	Homo sapiens	INH	%	30.0
	2268827	CHEMBL960831	Inhibition of Aurora A at 10 uM	B	Clc1ccc(-n2cc(-c3ccccc3NCc3ccncc3)nn2)cc1Cl		CHEMBL491872	<	Inhibition	%	30.0	CHEMBL4722	Homo sapiens	INH	%	30.0
	2268828	CHEMBL960831	Inhibition of Aurora A at 10 uM	B	FC(F)(F)c1ccc(-n2cc(-c3ccccc3NCc3ccncc3)nn2)cc1Cl		CHEMBL491871	<	Inhibition	%	30.0	CHEMBL4722	Homo sapiens	INH	%	30.0
	2268829	CHEMBL960831	Inhibition of Aurora A at 10 uM	B	FC(F)(F)c1cc(-n2cc(-c3ccccc3NCc3ccncc3)nn2)ccc1Cl		CHEMBL522133	<	Inhibition	%	30.0	CHEMBL4722	Homo sapiens	INH	%	30.0
	2268830	CHEMBL960831	Inhibition of Aurora A at 10 uM	B	c1ccc(-c2cn(-c3ccc4[nH]ncc4c3)nn2)c(NCc2ccncc2)c1		CHEMBL516645	<	Inhibition	%	30.0	CHEMBL4722	Homo sapiens	INH	%	30.0
	2268831	CHEMBL960831	Inhibition of Aurora A at 10 uM	B	c1ccc(-c2cn(-c3ccc4ccccc4n3)nn2)c(NCc2ccncc2)c1		CHEMBL461605	<	Inhibition	%	30.0	CHEMBL4722	Homo sapiens	INH	%	30.0
	2268832	CHEMBL960831	Inhibition of Aurora A at 10 uM	B	CC(C)(C)c1ccc(-n2cc(-c3ccccc3NCc3ccncc3)nn2)cc1		CHEMBL461392	<	Inhibition	%	30.0	CHEMBL4722	Homo sapiens	INH	%	30.0
	2268833	CHEMBL960831	Inhibition of Aurora A at 10 uM	B	CC(C)(C)c1cccc(-n2cc(-c3ccccc3NCc3ccncc3)nn2)c1		CHEMBL461391	<	Inhibition	%	30.0	CHEMBL4722	Homo sapiens	INH	%	30.0
	2268834	CHEMBL960831	Inhibition of Aurora A at 10 uM	B	CC(C)c1cccc(-n2cc(-c3ccccc3NCc3ccncc3)nn2)c1		CHEMBL518652	<	Inhibition	%	30.0	CHEMBL4722	Homo sapiens	INH	%	30.0
	2268835	CHEMBL960831	Inhibition of Aurora A at 10 uM	B	FC(F)(F)Oc1ccc(-n2cc(-c3ccccc3NCc3ccncc3)nn2)cc1		CHEMBL491681	<	Inhibition	%	30.0	CHEMBL4722	Homo sapiens	INH	%	30.0
	2268836	CHEMBL960831	Inhibition of Aurora A at 10 uM	B	FC(F)(F)c1ccc(-n2cc(-c3ccccc3NCc3ccncc3)nn2)cc1		CHEMBL522304	<	Inhibition	%	30.0	CHEMBL4722	Homo sapiens	INH	%	30.0
	2268837	CHEMBL960831	Inhibition of Aurora A at 10 uM	B	Clc1ccc(-n2cc(-c3ccccc3NCc3ccncc3)nn2)cc1		CHEMBL491680	<	Inhibition	%	30.0	CHEMBL4722	Homo sapiens	INH	%	30.0
	2268838	CHEMBL960831	Inhibition of Aurora A at 10 uM	B	FC(F)(F)Oc1cccc(-n2cc(-c3ccccc3NCc3ccncc3)nn2)c1		CHEMBL491502	<	Inhibition	%	30.0	CHEMBL4722	Homo sapiens	INH	%	30.0
	2268839	CHEMBL960831	Inhibition of Aurora A at 10 uM	B	FC(F)(F)c1cccc(-n2cc(-c3ccccc3NCc3ccccn3)nn2)c1		CHEMBL523133	<	Inhibition	%	30.0	CHEMBL4722	Homo sapiens	INH	%	30.0
	2268840	CHEMBL960831	Inhibition of Aurora A at 10 uM	B	FC(F)(F)c1cccc(-n2cc(-c3ccccc3NCc3cccnc3)nn2)c1		CHEMBL490969	<	Inhibition	%	30.0	CHEMBL4722	Homo sapiens	INH	%	30.0
	2268841	CHEMBL960831	Inhibition of Aurora A at 10 uM	B	FC(F)(F)c1cccc(-n2cc(-c3ccccc3NCc3ccncc3)nn2)c1		CHEMBL490968	<	Inhibition	%	30.0	CHEMBL4722	Homo sapiens	INH	%	30.0
	2268842	CHEMBL960831	Inhibition of Aurora A at 10 uM	B	Clc1cccc(-n2cc(-c3ccccc3NCc3ccccn3)nn2)c1		CHEMBL523301	<	Inhibition	%	30.0	CHEMBL4722	Homo sapiens	INH	%	30.0
	2268843	CHEMBL960831	Inhibition of Aurora A at 10 uM	B	Clc1cccc(-n2cc(-c3ccccc3NCc3cccnc3)nn2)c1		CHEMBL489329	<	Inhibition	%	30.0	CHEMBL4722	Homo sapiens	INH	%	30.0
	2270282	CHEMBL960142	Inhibition of Aurora A by virtual HTS assay	B	c1cc(Nc2ncnc3[nH]cnc23)cc(-c2nc3ccccc3s2)c1		CHEMBL443906	>	IC50	nM	10000.0	CHEMBL4722	Homo sapiens	IC50	uM	10.0
	2270283	CHEMBL960142	Inhibition of Aurora A by virtual HTS assay	B	c1cc(Nc2ncnc3[nH]ccc23)cc(-c2nc3ccccc3s2)c1		CHEMBL490555	>	IC50	nM	10000.0	CHEMBL4722	Homo sapiens	IC50	uM	10.0
	2270284	CHEMBL960142	Inhibition of Aurora A by virtual HTS assay	B	CNc1nc(Nc2ccc(-c3nc4ccccc4s3)cc2)c2cc(OC)c(OC)cc2n1		CHEMBL514941	>	IC50	nM	10000.0	CHEMBL4722	Homo sapiens	IC50	uM	10.0
	2270285	CHEMBL960142	Inhibition of Aurora A by virtual HTS assay	B	COc1cc2ncnc(Nc3ccc(-c4nc5ccccc5s4)c(OC)c3)c2cc1OC		CHEMBL473553	>	IC50	nM	10000.0	CHEMBL4722	Homo sapiens	IC50	uM	10.0
	2270286	CHEMBL960142	Inhibition of Aurora A by virtual HTS assay	B	COc1cc2ncnc(Nc3ccc(-c4nc5ccccc5s4)c(O)c3)c2cc1OC		CHEMBL473351	>	IC50	nM	10000.0	CHEMBL4722	Homo sapiens	IC50	uM	10.0
	2270287	CHEMBL960142	Inhibition of Aurora A by virtual HTS assay	B	Clc1ccc2c(Nc3ccc(-c4nc5ccccc5s4)c(Cl)c3)ncnc2c1		CHEMBL514016	>	IC50	nM	10000.0	CHEMBL4722	Homo sapiens	IC50	uM	10.0
	2270288	CHEMBL960142	Inhibition of Aurora A by virtual HTS assay	B	Fc1cc(-c2nc3ccccc3s2)ccc1Nc1ncnc2cc(Cl)ccc12		CHEMBL473557	>	IC50	nM	10000.0	CHEMBL4722	Homo sapiens	IC50	uM	10.0
	2270289	CHEMBL960142	Inhibition of Aurora A by virtual HTS assay	B	COc1cc(Nc2ccnc3cc(Cl)ccc23)ccc1-c1nc2ccccc2s1		CHEMBL474544	>	IC50	nM	10000.0	CHEMBL4722	Homo sapiens	IC50	uM	10.0
	2270290	CHEMBL960142	Inhibition of Aurora A by virtual HTS assay	B	Clc1cc(Nc2ncnc3ccsc23)ccc1-c1nc2ccccc2s1		CHEMBL474346	>	IC50	nM	10000.0	CHEMBL4722	Homo sapiens	IC50	uM	10.0
	2270291	CHEMBL960142	Inhibition of Aurora A by virtual HTS assay	B	COc1cc(Nc2ncnc3ccsc23)ccc1-c1nc2ccccc2s1		CHEMBL514929	>	IC50	nM	10000.0	CHEMBL4722	Homo sapiens	IC50	uM	10.0
	2270292	CHEMBL960142	Inhibition of Aurora A by virtual HTS assay	B	c1ccc2sc(-c3ccc(Nc4ncnc5[nH]cnc45)cc3)nc2c1		CHEMBL515598	>	IC50	nM	10000.0	CHEMBL4722	Homo sapiens	IC50	uM	10.0
	2270293	CHEMBL960142	Inhibition of Aurora A by virtual HTS assay	B	COc1nc(Nc2ccc(-c3nc4ccccc4s3)c(OC)c2)c2cc[nH]c2n1		CHEMBL475351	>	IC50	nM	10000.0	CHEMBL4722	Homo sapiens	IC50	uM	10.0
	2270294	CHEMBL960142	Inhibition of Aurora A by virtual HTS assay	B	COc1nc(Nc2ccc(-c3nc4ccccc4s3)cc2)c2cc[nH]c2n1		CHEMBL462338	>	IC50	nM	10000.0	CHEMBL4722	Homo sapiens	IC50	uM	10.0
	2270295	CHEMBL960142	Inhibition of Aurora A by virtual HTS assay	B	COc1cc(Nc2ncnc3[nH]ccc23)ccc1-c1nc2ccccc2s1		CHEMBL462162	>	IC50	nM	10000.0	CHEMBL4722	Homo sapiens	IC50	uM	10.0
	2270296	CHEMBL960142	Inhibition of Aurora A by virtual HTS assay	B	CN(C)c1ccnc(Nc2ccc(-c3nc4ccccc4s3)cc2)n1		CHEMBL462161	>	IC50	nM	10000.0	CHEMBL4722	Homo sapiens	IC50	uM	10.0
	2270297	CHEMBL960142	Inhibition of Aurora A by virtual HTS assay	B	CNc1nccc(Nc2ccc(-c3nc4ccccc4s3)cc2)n1		CHEMBL512933	>	IC50	nM	10000.0	CHEMBL4722	Homo sapiens	IC50	uM	10.0
	2270298	CHEMBL960142	Inhibition of Aurora A by virtual HTS assay	B	CNC(=O)c1cc(Nc2ccc(-c3nc4ccccc4s3)cc2)ccn1		CHEMBL464210	>	IC50	nM	10000.0	CHEMBL4722	Homo sapiens	IC50	uM	10.0
	2270299	CHEMBL960142	Inhibition of Aurora A by virtual HTS assay	B	CNc1cc(Nc2ccc(-c3nc4ccccc4s3)cc2)ccn1		CHEMBL464014	>	IC50	nM	10000.0	CHEMBL4722	Homo sapiens	IC50	uM	10.0
	2270439	CHEMBL960142	Inhibition of Aurora A by virtual HTS assay	B	c1ccc2sc(-c3ccc(Nc4ncnc5[nH]ccc45)cc3)nc2c1		CHEMBL518803	=	IC50	nM	8000.0	CHEMBL4722	Homo sapiens	IC50	uM	8.0
	2270454	CHEMBL960142	Inhibition of Aurora A by virtual HTS assay	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OC		CHEMBL301018	=	IC50	nM	6500.0	CHEMBL4722	Homo sapiens	IC50	uM	6.5
	2270458	CHEMBL960142	Inhibition of Aurora A by virtual HTS assay	B	COc1cc2nc(Nc3cc(C)[nH]n3)nc(Nc3ccc(-c4nc5ccccc5s4)cc3)c2cc1OC		CHEMBL473761	=	IC50	nM	6000.0	CHEMBL4722	Homo sapiens	IC50	uM	6.0
	2270460	CHEMBL960142	Inhibition of Aurora A by virtual HTS assay	B	COc1cc(Nc2ncnc3[nH]cnc23)ccc1-c1nc2ccccc2s1		CHEMBL475352	=	IC50	nM	5800.0	CHEMBL4722	Homo sapiens	IC50	uM	5.8
	2270461	CHEMBL960142	Inhibition of Aurora A by virtual HTS assay	B	Clc1ccc2c(Nc3ccc(-c4nc5ccccc5s4)cc3)ccnc2c1		CHEMBL474543	=	IC50	nM	5700.0	CHEMBL4722	Homo sapiens	IC50	uM	5.7
	2270462	CHEMBL960142	Inhibition of Aurora A by virtual HTS assay	B	COc1cc2nc(Nc3cc(C)[nH]n3)nc(Nc3cccc(-c4nc5ccccc5s4)c3)c2cc1OC		CHEMBL522785	=	IC50	nM	5500.0	CHEMBL4722	Homo sapiens	IC50	uM	5.5
	2270463	CHEMBL960142	Inhibition of Aurora A by virtual HTS assay	B	COc1cc2ncnc(Nc3ccc(N4Cc5ccccc5C4)cc3)c2cc1OC		CHEMBL491677	=	IC50	nM	5300.0	CHEMBL4722	Homo sapiens	IC50	uM	5.3
	2270467	CHEMBL960142	Inhibition of Aurora A by virtual HTS assay	B	COc1cc2ncnc(Nc3ccc(-c4nc5ccccc5s4)cc3C)c2cc1OC		CHEMBL514942	=	IC50	nM	4400.0	CHEMBL4722	Homo sapiens	IC50	uM	4.4
	2270473	CHEMBL960142	Inhibition of Aurora A by virtual HTS assay	B	Fc1cc(-c2nc3ccccc3s2)ccc1Nc1ncnc2ccsc12		CHEMBL474347	=	IC50	nM	4000.0	CHEMBL4722	Homo sapiens	IC50	uM	4.0
	2270489	CHEMBL960142	Inhibition of Aurora A by virtual HTS assay	B	c1ccc2sc(-c3ccc(Nc4ncnc5ccsc45)cc3)nc2c1		CHEMBL472946	=	IC50	nM	2800.0	CHEMBL4722	Homo sapiens	IC50	uM	2.8
	2270490	CHEMBL960142	Inhibition of Aurora A by virtual HTS assay	B	Cc1cc2c(Nc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1Cl		CHEMBL473354	=	IC50	nM	2700.0	CHEMBL4722	Homo sapiens	IC50	uM	2.7
	2270513	CHEMBL960142	Inhibition of Aurora A by virtual HTS assay	B	CNc1ccnc(Nc2ccc(-c3nc4ccccc4s3)cc2)n1		CHEMBL462160	=	IC50	nM	1500.0	CHEMBL4722	Homo sapiens	IC50	uM	1.5
	2270518	CHEMBL960142	Inhibition of Aurora A by virtual HTS assay	B	Cc1cc(Nc2cc(Nc3ccc(-c4nc5ccccc5s4)cc3)ccn2)n[nH]1		CHEMBL461991	=	IC50	nM	1300.0	CHEMBL4722	Homo sapiens	IC50	uM	1.3
	2270541	CHEMBL960142	Inhibition of Aurora A by virtual HTS assay	B	CN1CCN(c2ccnc(Nc3ccc(-c4nc5ccccc5s4)cc3)n2)CC1		CHEMBL459886	=	IC50	nM	840.0	CHEMBL4722	Homo sapiens	IC50	uM	0.84
	2270564	CHEMBL960142	Inhibition of Aurora A by virtual HTS assay	B	Cc1cc(Nc2ccnc(Nc3ccc(-c4nc5ccccc5s4)cc3)n2)n[nH]1		CHEMBL461109	=	IC50	nM	370.0	CHEMBL4722	Homo sapiens	IC50	uM	0.37
	2270565	CHEMBL960142	Inhibition of Aurora A by virtual HTS assay	B	COc1cc2ncnc(Nc3ccc(-c4nc5ccccc5s4)cc3)c2cc1OC		CHEMBL473556	=	IC50	nM	350.0	CHEMBL4722	Homo sapiens	IC50	uM	0.35
	2270566	CHEMBL960142	Inhibition of Aurora A by virtual HTS assay	B	COc1cc(Nc2nccc(Nc3cc(C)[nH]n3)n2)ccc1-c1nc2ccccc2s1		CHEMBL461110	=	IC50	nM	320.0	CHEMBL4722	Homo sapiens	IC50	uM	0.32
	2270574	CHEMBL960142	Inhibition of Aurora A by virtual HTS assay	B	Cc1cc(Nc2ccnc(Nc3cccc(-c4nc5ccccc5s4)c3)n2)n[nH]1		CHEMBL491686	=	IC50	nM	160.0	CHEMBL4722	Homo sapiens	IC50	uM	0.16
	2270715	CHEMBL954377	Inhibition of Aurora A at 100 nM	B	CCn1cnc(-c2cc3nccc(Oc4ccc(NC(=O)N5CCN(c6ccc(F)cc6)C5=O)cc4F)c3s2)c1		CHEMBL464211	=	Inhibition	%	9.0	CHEMBL4722	Homo sapiens	INH	%	9.0
Not Active	2301929	CHEMBL949869	Inhibition of Aurora A up to 100 uM	B	CN(C)c1ncnc2c1ncn2CC(=O)c1c[nH]c2ccccc12		CHEMBL519977		Inhibition	%		CHEMBL4722	Homo sapiens	INH		
Not Active	2301954	CHEMBL949869	Inhibition of Aurora A up to 100 uM	B	COc1ncnc2ncn(CC(=O)c3ccccc3)c12		CHEMBL483271		Inhibition	%		CHEMBL4722	Homo sapiens	INH		
Not Active	2301977	CHEMBL949869	Inhibition of Aurora A up to 100 uM	B	COc1ncnc2c1ncn2CC(=O)c1ccccc1		CHEMBL519976		Inhibition	%		CHEMBL4722	Homo sapiens	INH		
Not Active	2302001	CHEMBL949869	Inhibition of Aurora A up to 100 uM	B	Nc1ncnc2c1ncn2CC(=O)c1cccnc1		CHEMBL501256		Inhibition	%		CHEMBL4722	Homo sapiens	INH		
Not Active	2302025	CHEMBL949869	Inhibition of Aurora A up to 100 uM	B	Nc1ncnc2c1ncn2CC(=O)c1ccccn1		CHEMBL504135		Inhibition	%		CHEMBL4722	Homo sapiens	INH		
Not Active	2302049	CHEMBL949869	Inhibition of Aurora A up to 100 uM	B	Nc1ncnc2ncn(CC(=O)c3ccccc3)c12		CHEMBL485444		Inhibition	%		CHEMBL4722	Homo sapiens	INH		
Not Active	2302073	CHEMBL949869	Inhibition of Aurora A up to 100 uM	B	Nc1ncnc2c1ncn2CC(=O)c1ccccc1		CHEMBL520515		Inhibition	%		CHEMBL4722	Homo sapiens	INH		
Not Active	2302097	CHEMBL949869	Inhibition of Aurora A up to 100 uM	B	Nc1ncnc2ncn(CC(=O)c3c[nH]c4ccccc34)c12		CHEMBL485246		Inhibition	%		CHEMBL4722	Homo sapiens	INH		
Not Active	2302121	CHEMBL949869	Inhibition of Aurora A up to 100 uM	B	Nc1ncnc2c1ncn2CC(=O)c1c[nH]c2ccccc12		CHEMBL521155		Inhibition	%		CHEMBL4722	Homo sapiens	INH		
	2356974	CHEMBL958270	Inhibition of AurA at 1 uM relative to control	B	Cc1ccn(-c2ccc(-c3ncco3)cc2)c(=O)c1-c1ccc2nc(N)ncc2c1		CHEMBL525893	>	Inhibition	%	50.0	CHEMBL4722	Homo sapiens	INH	%	50.0
	2361191	CHEMBL970666	Inhibition of Aurora2	B	COc1cc2c(Oc3ccc(-c4cnc(Cc5ccccc5)n(C)c4=O)cc3F)ccnc2cc1OCCCN1CCOCC1		CHEMBL505896	=	IC50	nM	116.0	CHEMBL4722	Homo sapiens	IC50	nM	116.0
	2361213	CHEMBL970666	Inhibition of Aurora2	B	COc1cc2c(Oc3ccc(-c4cnc(Nc5ccc(F)cc5)n(C)c4=O)cc3F)ccnc2cc1OCCCN1CCOCC1		CHEMBL453737	>	IC50	nM	200.0	CHEMBL4722	Homo sapiens	IC50	nM	200.0
	2361236	CHEMBL970666	Inhibition of Aurora2	B	COc1cc2c(Oc3ccc(-c4cnc(Nc5ccc(F)cc5)n(C)c4=O)nc3)ccnc2cc1OCCCN1CCOCC1		CHEMBL447602	=	IC50	nM	426.0	CHEMBL4722	Homo sapiens	IC50	nM	426.0
	2369773	CHEMBL981691	Inhibition of Aurora A at 100 uM	B	CN1Cc2cccc(-c3ccc[nH]3)c2C1=O		CHEMBL523308	=	Inhibition	%	37.0	CHEMBL4722	Homo sapiens	INH	%	37.0
	2369779	CHEMBL981688	Inhibition of Aurora A	B	O=C(O)c1cccc2c1C(=O)NC2		CHEMBL505379	>	IC50	nM	100000.0	CHEMBL4722	Homo sapiens	IC50	uM	100.0
	2369780	CHEMBL981688	Inhibition of Aurora A	B	COC(=O)c1cccc2c1C(=O)NC2		CHEMBL473040	>	IC50	nM	100000.0	CHEMBL4722	Homo sapiens	IC50	uM	100.0
	2369781	CHEMBL981688	Inhibition of Aurora A	B	NC(=O)c1cccc2c1C(=O)NC2		CHEMBL505167	=	IC50	nM	14340.0	CHEMBL4722	Homo sapiens	IC50	uM	14.34
	2369782	CHEMBL981688	Inhibition of Aurora A	B	COc1ccc2[nH]c(-c3cccc4c3C(=O)NC4)nc2c1		CHEMBL507927	=	IC50	nM	205.0	CHEMBL4722	Homo sapiens	IC50	uM	0.205
	2369783	CHEMBL981691	Inhibition of Aurora A at 100 uM	B	COc1ccc(NC(=O)c2cccc3c2C(=O)NC3)cc1		CHEMBL484677	=	Inhibition	%	45.0	CHEMBL4722	Homo sapiens	INH	%	45.0
	2369784	CHEMBL981691	Inhibition of Aurora A at 100 uM	B	COc1ccc2[nH]c(-c3cccc4c3C(=O)NC4=O)cc2c1		CHEMBL483045	=	Inhibition	%	30.0	CHEMBL4722	Homo sapiens	INH	%	30.0
	2369785	CHEMBL981691	Inhibition of Aurora A at 100 uM	B	O=C1NCc2cccc(-c3c[nH]c4ccccc34)c21		CHEMBL451586	=	Inhibition	%	60.0	CHEMBL4722	Homo sapiens	INH	%	60.0
Active	2369788	CHEMBL981694	Inhibition of Aurora A-mediated histone H3 (Ser10) phosphorylation in human HeLa cells at 2.5 uM after 8 hrs in presence of nocodazole	B	O=C1NCc2cccc(-c3cc4cc(OCCN5CCCCC5)ccc4[nH]3)c21		CHEMBL484876		Activity			CHEMBL4722	Homo sapiens	Activity		
	2373124	CHEMBL981688	Inhibition of Aurora A	B	O=C1NCc2cccc(-c3ccc[nH]3)c21		CHEMBL491045	=	IC50	nM	338.0	CHEMBL4722	Homo sapiens	IC50	uM	0.338
	2373137	CHEMBL981688	Inhibition of Aurora A	B	O=C1NCc2cccc(-c3cc4cc(OCc5ccccc5)ccc4[nH]3)c21		CHEMBL484678	=	IC50	nM	21230.0	CHEMBL4722	Homo sapiens	IC50	uM	21.23
	2373138	CHEMBL981688	Inhibition of Aurora A	B	O=C1NCc2cccc(-c3cc4ccccc4[nH]3)c21		CHEMBL482621	=	IC50	nM	100.0	CHEMBL4722	Homo sapiens	IC50	uM	0.1
	2373139	CHEMBL981688	Inhibition of Aurora A	B	O=C1NCc2cccc(-c3cc4cc(O)ccc4[nH]3)c21		CHEMBL443338	=	IC50	nM	90.0	CHEMBL4722	Homo sapiens	IC50	uM	0.09
	2373140	CHEMBL981688	Inhibition of Aurora A	B	COc1ccc2[nH]c(-c3cccc4c3C(=O)NC4)cc2c1		CHEMBL520975	=	IC50	nM	338.0	CHEMBL4722	Homo sapiens	IC50	uM	0.338
	2373141	CHEMBL981688	Inhibition of Aurora A	B	O=C1NCc2cccc(-c3cc4cc(OCCN5CCOCC5)ccc4[nH]3)c21		CHEMBL483451	=	IC50	nM	135.0	CHEMBL4722	Homo sapiens	IC50	uM	0.135
	2373142	CHEMBL981688	Inhibition of Aurora A	B	O=C1NCc2cccc(-c3cc4cc(OCCCN5CCCCC5)ccc4[nH]3)c21		CHEMBL485081	=	IC50	nM	179.0	CHEMBL4722	Homo sapiens	IC50	uM	0.179
	2373143	CHEMBL981688	Inhibition of Aurora A	B	O=C1NCc2cccc(-c3cc4cc(OCCN5CCCCC5)ccc4[nH]3)c21		CHEMBL484876	=	IC50	nM	200.0	CHEMBL4722	Homo sapiens	IC50	uM	0.2
	2373144	CHEMBL981688	Inhibition of Aurora A	B	O=C1NCc2cccc(-c3cc4cc(OCCCO)ccc4[nH]3)c21		CHEMBL449663	=	IC50	nM	100.0	CHEMBL4722	Homo sapiens	IC50	uM	0.1
	2373145	CHEMBL981688	Inhibition of Aurora A	B	O=C1NCc2cccc(-c3cc4cc(OCCCN5CCC(O)CC5)ccc4[nH]3)c21		CHEMBL522601	=	IC50	nM	61.0	CHEMBL4722	Homo sapiens	IC50	uM	0.061
	2373146	CHEMBL981688	Inhibition of Aurora A	B	CCN1CCN(CCCOc2ccc3[nH]c(-c4cccc5c4C(=O)NC5)cc3c2)CC1		CHEMBL489820	=	IC50	nM	44.0	CHEMBL4722	Homo sapiens	IC50	uM	0.044
	2373147	CHEMBL981688	Inhibition of Aurora A	B	CN1Cc2cccc(-c3cccn3C(=O)OC(C)(C)C)c2C1=O		CHEMBL491243	>	IC50	nM	100000.0	CHEMBL4722	Homo sapiens	IC50	uM	100.0
	2373162	CHEMBL981691	Inhibition of Aurora A at 100 uM	B	CC(C)(C)OC(=O)n1cccc1-c1cccc2c1C(=O)NC2		CHEMBL521779	=	Inhibition	%	25.0	CHEMBL4722	Homo sapiens	INH	%	25.0
	2395370	CHEMBL1006293	Inhibition of Aurora kinase A T288D mutant expressed in Escherichia coli BL21 DE3 at 10 uM	B	CCOC(=O)c1c(C)n[nH]c1N/N=C/c1ccc(OC)cc1		CHEMBL455177	=	Inhibition	%	33.9	CHEMBL4722	Homo sapiens	INH	%	33.9
	2395371	CHEMBL1006293	Inhibition of Aurora kinase A T288D mutant expressed in Escherichia coli BL21 DE3 at 10 uM	B	CCOC(=O)c1c(C)n[nH]c1N/N=C/c1ccccc1		CHEMBL455178	=	Inhibition	%	16.4	CHEMBL4722	Homo sapiens	INH	%	16.4
	2395372	CHEMBL1006293	Inhibition of Aurora kinase A T288D mutant expressed in Escherichia coli BL21 DE3 at 10 uM	B	CCOC(=O)c1c(C)n[nH]c1N/N=C/Cc1ccccc1		CHEMBL454387	=	Inhibition	%	3.6	CHEMBL4722	Homo sapiens	INH	%	3.6
	2395373	CHEMBL1006293	Inhibition of Aurora kinase A T288D mutant expressed in Escherichia coli BL21 DE3 at 10 uM	B	CCOC(=O)c1c(C)n[nH]c1N/N=C/c1ccc(F)cc1		CHEMBL454388	=	Inhibition	%	36.5	CHEMBL4722	Homo sapiens	INH	%	36.5
	2395374	CHEMBL1006293	Inhibition of Aurora kinase A T288D mutant expressed in Escherichia coli BL21 DE3 at 10 uM	B	CCOC(=O)c1c(C)n[nH]c1N/N=C/c1ccc(-c2ccccc2)cc1		CHEMBL510397	=	Inhibition	%	27.5	CHEMBL4722	Homo sapiens	INH	%	27.5
	2395375	CHEMBL1006293	Inhibition of Aurora kinase A T288D mutant expressed in Escherichia coli BL21 DE3 at 10 uM	B	CCOC(=O)c1c(C)n[nH]c1N/N=C/c1ccc(N2CCN(C)CC2)cc1		CHEMBL454389	=	Inhibition	%	41.0	CHEMBL4722	Homo sapiens	INH	%	41.0
	2395376	CHEMBL1006293	Inhibition of Aurora kinase A T288D mutant expressed in Escherichia coli BL21 DE3 at 10 uM	B	CCOC(=O)c1c(C)n[nH]c1N/N=C/c1ccc2[nH]ccc2c1		CHEMBL454390	=	Inhibition	%	50.0	CHEMBL4722	Homo sapiens	INH	%	50.0
	2395377	CHEMBL1006293	Inhibition of Aurora kinase A T288D mutant expressed in Escherichia coli BL21 DE3 at 10 uM	B	CCOC(=O)c1c(C)n[nH]c1N/N=C/c1cccc2[nH]ccc12		CHEMBL455180	=	Inhibition	%	50.3	CHEMBL4722	Homo sapiens	INH	%	50.3
	2395378	CHEMBL1006293	Inhibition of Aurora kinase A T288D mutant expressed in Escherichia coli BL21 DE3 at 10 uM	B	CCOC(=O)c1c(C)n[nH]c1N/N=C(\C)c1ccc(OC)cc1		CHEMBL511185	=	Inhibition	%	18.2	CHEMBL4722	Homo sapiens	INH	%	18.2
	2395379	CHEMBL1006294	Inhibition of Aurora kinase A T288D mutant expressed in Escherichia coli BL21 DE3	B	CCOC(=O)c1c(C)n[nH]c1N/N=C/c1ccc(OC)cc1		CHEMBL455177	=	IC50	nM	15140.0	CHEMBL4722	Homo sapiens	IC50	uM	15.14
	2395380	CHEMBL1006294	Inhibition of Aurora kinase A T288D mutant expressed in Escherichia coli BL21 DE3	B	CCOC(=O)c1c(C)n[nH]c1N/N=C/c1ccc2[nH]ccc2c1		CHEMBL454390	=	IC50	nM	11505.0	CHEMBL4722	Homo sapiens	IC50	uM	11.505
	2395381	CHEMBL1006294	Inhibition of Aurora kinase A T288D mutant expressed in Escherichia coli BL21 DE3	B	CCOC(=O)c1c(C)n[nH]c1N/N=C/c1cccc2[nH]ccc12		CHEMBL455180	=	IC50	nM	13740.0	CHEMBL4722	Homo sapiens	IC50	uM	13.74
	2395382	CHEMBL1006294	Inhibition of Aurora kinase A T288D mutant expressed in Escherichia coli BL21 DE3	B	COc1ccc(/C=N/Nc2[nH]nc(C)c2C(=O)OCc2ccccc2)cc1		CHEMBL517571	=	IC50	nM	5250.0	CHEMBL4722	Homo sapiens	IC50	uM	5.25
	2395383	CHEMBL1006294	Inhibition of Aurora kinase A T288D mutant expressed in Escherichia coli BL21 DE3	B	COc1ccc(/C=N/Nc2[nH]nc(C)c2C(=O)NCc2ccccc2)cc1		CHEMBL460720	=	IC50	nM	1580.0	CHEMBL4722	Homo sapiens	IC50	uM	1.58
	2395384	CHEMBL1006294	Inhibition of Aurora kinase A T288D mutant expressed in Escherichia coli BL21 DE3	B	COc1ccc(/C=N/Nc2[nH]nc(C)c2C(=O)NCCc2ccccc2)cc1		CHEMBL461599	=	IC50	nM	1350.0	CHEMBL4722	Homo sapiens	IC50	uM	1.35
	2395385	CHEMBL1006294	Inhibition of Aurora kinase A T288D mutant expressed in Escherichia coli BL21 DE3	B	COc1ccc(/C=N/Nc2[nH]nc(C)c2C(=O)NCCCc2ccccc2)cc1		CHEMBL461972	=	IC50	nM	1942.0	CHEMBL4722	Homo sapiens	IC50	uM	1.942
	2395386	CHEMBL1006294	Inhibition of Aurora kinase A T288D mutant expressed in Escherichia coli BL21 DE3	B	COc1ccc(/C=N/Nc2[nH]nc(C)c2C(=O)Nc2ccccc2)cc1		CHEMBL461954	=	IC50	nM	804.0	CHEMBL4722	Homo sapiens	IC50	uM	0.804
	2395387	CHEMBL1006294	Inhibition of Aurora kinase A T288D mutant expressed in Escherichia coli BL21 DE3	B	COc1ccc(/C=N/Nc2[nH]nc(C)c2C(=O)N(C)c2ccccc2)cc1		CHEMBL461955	>	IC50	nM	50000.0	CHEMBL4722	Homo sapiens	IC50	uM	50.0
	2395388	CHEMBL1006294	Inhibition of Aurora kinase A T288D mutant expressed in Escherichia coli BL21 DE3	B	COc1ccc(/C=N/Nc2[nH]nc(C)c2C(=O)N(C)Cc2ccccc2)cc1		CHEMBL451034	>	IC50	nM	50000.0	CHEMBL4722	Homo sapiens	IC50	uM	50.0
	2395389	CHEMBL1006294	Inhibition of Aurora kinase A T288D mutant expressed in Escherichia coli BL21 DE3	B	COc1ccc(/C=N/Nc2[nH]nc(C)c2C(=O)NCCc2cccnc2)cc1		CHEMBL517573	=	IC50	nM	1484.0	CHEMBL4722	Homo sapiens	IC50	uM	1.484
	2395390	CHEMBL1006294	Inhibition of Aurora kinase A T288D mutant expressed in Escherichia coli BL21 DE3	B	COc1ccc(/C=N/Nc2[nH]nc(C)c2C(=O)NCCc2c[nH]cn2)cc1		CHEMBL460728	=	IC50	nM	1937.0	CHEMBL4722	Homo sapiens	IC50	uM	1.937
	2395391	CHEMBL1006294	Inhibition of Aurora kinase A T288D mutant expressed in Escherichia coli BL21 DE3	B	COc1ccc(/C=N/Nc2[nH]nc(C)c2C(=O)NCCc2c[nH]c3ccccc23)cc1		CHEMBL518032	=	IC50	nM	1071.0	CHEMBL4722	Homo sapiens	IC50	uM	1.071
	2395392	CHEMBL1006294	Inhibition of Aurora kinase A T288D mutant expressed in Escherichia coli BL21 DE3	B	COc1ccc(/C=N/Nc2[nH]nc(C)c2C(=O)NCc2ccc(OC)cc2)cc1		CHEMBL461784	=	IC50	nM	1623.0	CHEMBL4722	Homo sapiens	IC50	uM	1.623
	2395393	CHEMBL1006294	Inhibition of Aurora kinase A T288D mutant expressed in Escherichia coli BL21 DE3	B	COc1ccc(/C=N/Nc2[nH]nc(C)c2C(=O)NCc2cccc(OC)c2)cc1		CHEMBL461785	=	IC50	nM	838.0	CHEMBL4722	Homo sapiens	IC50	uM	0.838
	2395394	CHEMBL1006294	Inhibition of Aurora kinase A T288D mutant expressed in Escherichia coli BL21 DE3	B	COc1ccc(/C=N/Nc2[nH]nc(C)c2C(=O)NCc2cccc(NC(C)=O)c2)cc1		CHEMBL460905	=	IC50	nM	1746.0	CHEMBL4722	Homo sapiens	IC50	uM	1.746
	2395395	CHEMBL1006294	Inhibition of Aurora kinase A T288D mutant expressed in Escherichia coli BL21 DE3	B	COc1ccc(/C=N/Nc2[nH]nc(C)c2C(=O)NCCc2ccc(OC)cc2)cc1		CHEMBL514951	=	IC50	nM	1580.0	CHEMBL4722	Homo sapiens	IC50	uM	1.58
	2395396	CHEMBL1006294	Inhibition of Aurora kinase A T288D mutant expressed in Escherichia coli BL21 DE3	B	COc1ccc(/C=N/Nc2[nH]nc(C)c2C(=O)NCCc2cccc(OC)c2)cc1		CHEMBL473948	=	IC50	nM	2895.0	CHEMBL4722	Homo sapiens	IC50	uM	2.895
	2395397	CHEMBL1006294	Inhibition of Aurora kinase A T288D mutant expressed in Escherichia coli BL21 DE3	B	COc1ccc(/C=N/Nc2[nH]nc(C)c2C(=O)Nc2ccc(OC)cc2)cc1		CHEMBL515112	=	IC50	nM	460.0	CHEMBL4722	Homo sapiens	IC50	uM	0.46
	2395398	CHEMBL1006294	Inhibition of Aurora kinase A T288D mutant expressed in Escherichia coli BL21 DE3	B	COc1ccc(/C=N/Nc2[nH]nc(C)c2C(=O)Nc2cccc(OC)c2)cc1		CHEMBL474344	=	IC50	nM	449.0	CHEMBL4722	Homo sapiens	IC50	uM	0.449
	2395399	CHEMBL1006294	Inhibition of Aurora kinase A T288D mutant expressed in Escherichia coli BL21 DE3	B	COc1ccc(/C=N/Nc2[nH]nc(C)c2C(=O)Nc2ccccc2OC)cc1		CHEMBL474540	=	IC50	nM	1087.0	CHEMBL4722	Homo sapiens	IC50	uM	1.087
	2395400	CHEMBL1006294	Inhibition of Aurora kinase A T288D mutant expressed in Escherichia coli BL21 DE3	B	COc1ccc(/C=N/Nc2[nH]nc(C)c2C(=O)Nc2ccc(OC)c(OC)c2)cc1		CHEMBL473131	=	IC50	nM	960.0	CHEMBL4722	Homo sapiens	IC50	uM	0.96
	2395401	CHEMBL1006294	Inhibition of Aurora kinase A T288D mutant expressed in Escherichia coli BL21 DE3	B	COc1ccc(/C=N/Nc2[nH]nc(C)c2C(=O)Nc2ccc(N(C)C)cc2)cc1		CHEMBL516353	=	IC50	nM	1568.0	CHEMBL4722	Homo sapiens	IC50	uM	1.568
	2395402	CHEMBL1006294	Inhibition of Aurora kinase A T288D mutant expressed in Escherichia coli BL21 DE3	B	COc1ccc(/C=N/Nc2[nH]nc(C)c2C(=O)Nc2ccc(F)cc2)cc1		CHEMBL473333	=	IC50	nM	1447.0	CHEMBL4722	Homo sapiens	IC50	uM	1.447
	2396056	CHEMBL1006294	Inhibition of Aurora kinase A T288D mutant expressed in Escherichia coli BL21 DE3	B	COc1ccc(/C=N/Nc2[nH]nc(C)c2C(=O)Nc2ccc(NC(C)=O)cc2)cc1		CHEMBL473334	=	IC50	nM	719.0	CHEMBL4722	Homo sapiens	IC50	uM	0.719
	2396057	CHEMBL1006294	Inhibition of Aurora kinase A T288D mutant expressed in Escherichia coli BL21 DE3	B	COc1ccc(/C=N/Nc2[nH]nc(C)c2C(=O)Nc2cccc(NC(C)=O)c2)cc1		CHEMBL515560	=	IC50	nM	33.0	CHEMBL4722	Homo sapiens	IC50	uM	0.033
	2396062	CHEMBL1006301	Inhibition of AURKA at 1 uM relative to control	B	COc1ccc(/C=N/Nc2[nH]nc(C)c2C(=O)Nc2cccc(NC(C)=O)c2)cc1		CHEMBL515560	=	Inhibition	%	91.0	CHEMBL4722	Homo sapiens	INH	%	91.0
Dose-dependent effect	2396089	CHEMBL1006295	Inhibition of Aurora kinase A Thr288 autophosphorylation in human HCT116 cells by Western blot	B	COc1ccc(/C=N/Nc2[nH]nc(C)c2C(=O)Nc2cccc(NC(C)=O)c2)cc1		CHEMBL515560		Activity			CHEMBL4722	Homo sapiens	Activity		
	2419154	CHEMBL1019642	Inhibition of STK6 at 1 uM	B	C[C@H]1O[C@@H]2CC(=O)O[C@@H]2C2=C1C(=O)c1c(ccc([C@H]3C[C@@H](N(C)C)[C@H](O)[C@@H](C)O3)c1O)C2=O		CHEMBL2216825	=	Inhibition	%	17.0	CHEMBL4722	Homo sapiens	INH	%	17.0
	2452358	CHEMBL983040	Inhibition of Aurora kinase A	B	CCCCNC(=O)c1cccc(NC(=O)CCCCCCNc2cc(N)ncn2)c1		CHEMBL481522	=	IC50	nM	17000.0	CHEMBL4722	Homo sapiens	IC50	uM	17.0
	2452359	CHEMBL983040	Inhibition of Aurora kinase A	B	CCCCCCNc1ncnc2[nH]cnc12		CHEMBL449217	>	IC50	nM	100000.0	CHEMBL4722	Homo sapiens	IC50	uM	100.0
	2452360	CHEMBL983040	Inhibition of Aurora kinase A	B	CCCCNC(=O)c1cccc(NC(=O)CCCCCNc2ncnc3[nH]cnc23)c1		CHEMBL521105	=	IC50	nM	2900.0	CHEMBL4722	Homo sapiens	IC50	uM	2.9
	2460276	CHEMBL958737	Inhibition of aurora kinase A	B	COc1cc2[nH]c3ncnc(Cl)c3c2cc1OC		CHEMBL482663	=	IC50	nM	3000.0	CHEMBL4722	Homo sapiens	IC50	uM	3.0
	2460277	CHEMBL958737	Inhibition of aurora kinase A	B	COc1cc2[nH]c3ncnc(N4CCN(C(=S)Nc5ccc(S(=O)(=O)Nc6ncccn6)cc5)CC4)c3c2cc1OC		CHEMBL456689	=	IC50	nM	94.0	CHEMBL4722	Homo sapiens	IC50	uM	0.094
	2460278	CHEMBL958737	Inhibition of aurora kinase A	B	Nc1ccc(S(=O)(=O)Nc2ncccn2)cc1		CHEMBL439	=	IC50	nM	21000.0	CHEMBL4722	Homo sapiens	IC50	uM	21.0
	2461676	CHEMBL966176	Inhibition of recombinant Aurora A	B	Cc1cc(O)cc2oc(=O)c3c(O)cc(O)cc3c12		CHEMBL519982	=	IC50	ug.mL-1	0.73	CHEMBL4722	Homo sapiens	IC50	10'-7g/ml	7.3
	2461702	CHEMBL966176	Inhibition of recombinant Aurora A	B	O=C1C[C@H](O)[C@@H]2c3c(ccc(O)c31)-c1ccc(O)c3c1[C@@]2(O)CCC3=O		CHEMBL521470	=	IC50	ug.mL-1	1.7	CHEMBL4722	Homo sapiens	IC50	10'-6g/ml	1.7
	2461703	CHEMBL966176	Inhibition of recombinant Aurora A	B	COc1cc(O)c(C(=O)O)c(C2=C(C)C[C@@H](O)C2=O)c1		CHEMBL519395	=	IC50	ug.mL-1	4.4	CHEMBL4722	Homo sapiens	IC50	10'-6g/ml	4.4
	2461704	CHEMBL966176	Inhibition of recombinant Aurora A	B	COc1cc(O)c2c(c1)C1(OC2=O)C(C)=CC(=O)C1O		CHEMBL408995	>	IC50	ug.mL-1	10.0	CHEMBL4722	Homo sapiens	IC50	10'-5g/ml	1.0
	2461705	CHEMBL966176	Inhibition of recombinant Aurora A	B	COc1cc(O)c2c(c1)-c1cc(O)c(O)cc1COC2=O		CHEMBL507058	>	IC50	ug.mL-1	10.0	CHEMBL4722	Homo sapiens	IC50	10'-5g/ml	1.0
	2461706	CHEMBL966176	Inhibition of recombinant Aurora A	B	Cc1cc(O)c(O)cc1-c1cc(O)cc(O)c1C(=O)O		CHEMBL483532	=	IC50	ug.mL-1	2.7	CHEMBL4722	Homo sapiens	IC50	10'-6g/ml	2.7
	2461707	CHEMBL966176	Inhibition of recombinant Aurora A	B	COc1cc(O)c(C(=O)O)c(-c2cc(O)c(O)cc2C)c1		CHEMBL483531	=	IC50	ug.mL-1	1.8	CHEMBL4722	Homo sapiens	IC50	10'-6g/ml	1.8
	2461708	CHEMBL966176	Inhibition of recombinant Aurora A	B	COc1cc(O)c2c(=O)oc3c(O)c(O)cc(C)c3c2c1		CHEMBL520144	=	IC50	ug.mL-1	1.5	CHEMBL4722	Homo sapiens	IC50	10'-6g/ml	1.5
	2461709	CHEMBL966176	Inhibition of recombinant Aurora A	B	COc1cc(O)c2c(=O)oc3cc(O)cc(C)c3c2c1		CHEMBL483526	=	IC50	ug.mL-1	5.0	CHEMBL4722	Homo sapiens	IC50	10'-6g/ml	5.0
	2461710	CHEMBL966176	Inhibition of recombinant Aurora A	B	Cc1cc(O)cc2oc(=O)c3c(O)cc(OS(=O)(=O)O)cc3c12		CHEMBL483525	=	IC50	ug.mL-1	0.39	CHEMBL4722	Homo sapiens	IC50	10'-7g/ml	3.9
	2464990	CHEMBL962087	Inhibition of human recombinant Aurora A	B	COc1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)cc(OC)c1OC		CHEMBL201511	=	IC50	nM	5400.0	CHEMBL4722	Homo sapiens	IC50	uM	5.4
	2465014	CHEMBL962087	Inhibition of human recombinant Aurora A	B	COc1ccc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2)cc1		CHEMBL452812	=	IC50	nM	16000.0	CHEMBL4722	Homo sapiens	IC50	uM	16.0
	2465015	CHEMBL962087	Inhibition of human recombinant Aurora A	B	COc1cc(C2=C(c3cn(C)c4ccccc34)C(=O)NC2)cc(OC)c1OC		CHEMBL509435	=	IC50	nM	3200.0	CHEMBL4722	Homo sapiens	IC50	uM	3.2
	2465016	CHEMBL962087	Inhibition of human recombinant Aurora A	B	COc1cc(C2=C(c3cn(CC(O)CO)c4ccccc34)CNC2=O)cc(OC)c1OC		CHEMBL453593	=	IC50	nM	47000.0	CHEMBL4722	Homo sapiens	IC50	uM	47.0
	2465017	CHEMBL962087	Inhibition of human recombinant Aurora A	B	COc1cc(C2=C(c3cn(COc4ccccc4)c4ccccc34)CNC2=O)cc(OC)c1OC		CHEMBL488811	=	IC50	nM	6500.0	CHEMBL4722	Homo sapiens	IC50	uM	6.5
	2465018	CHEMBL962087	Inhibition of human recombinant Aurora A	B	COc1cc(C2=C(c3cn(COC(C)(C)C)c4ccccc34)CNC2=O)cc(OC)c1OC		CHEMBL488646	=	IC50	nM	30000.0	CHEMBL4722	Homo sapiens	IC50	uM	30.0
	2465019	CHEMBL962087	Inhibition of human recombinant Aurora A	B	COc1cc(C2=C(c3cn(COC(C)C)c4ccccc34)CNC2=O)cc(OC)c1OC		CHEMBL488645	=	IC50	nM	33000.0	CHEMBL4722	Homo sapiens	IC50	uM	33.0
	2465020	CHEMBL962087	Inhibition of human recombinant Aurora A	B	CCOCn1cc(C2=C(c3cc(OC)c(OC)c(OC)c3)C(=O)NC2)c2ccccc21		CHEMBL529217	=	IC50	nM	29000.0	CHEMBL4722	Homo sapiens	IC50	uM	29.0
	2465021	CHEMBL962087	Inhibition of human recombinant Aurora A	B	COc1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2)cc(OC)c1OC		CHEMBL521201	=	IC50	nM	3200.0	CHEMBL4722	Homo sapiens	IC50	uM	3.2
	2465022	CHEMBL962087	Inhibition of human recombinant Aurora A	B	COc1cc(C2=C(c3c[nH]c4ccccc34)CNC2=O)cc(OC)c1OC		CHEMBL529663	=	IC50	nM	16000.0	CHEMBL4722	Homo sapiens	IC50	uM	16.0
	2470111	CHEMBL1032254	Inhibition of AURKA at 3 uM	B	CN(C)CCOc1cc(-c2cn[nH]c2)ccc1NC(=O)C1COc2ccccc2O1		CHEMBL521179	<	Inhibition	%	10.0	CHEMBL4722	Homo sapiens	INH	%	10.0
Not Evaluated	2476735	CHEMBL982763	Binding affinity to human AURA at 10 uM relative to control	B	NC(=O)c1ccc(-c2cc(C(N)=O)c(N)c(-c3ccc(S(N)(=O)=O)cc3)c2)cc1		CHEMBL514582		Activity			CHEMBL4722	Homo sapiens	Activity		
Not Evaluated	2478574	CHEMBL982763	Binding affinity to human AURA at 10 uM relative to control	B	N#Cc1c(NC(=O)c2ccccc2)sc2c1CCCC2		CHEMBL233000		Activity			CHEMBL4722	Homo sapiens	Activity		
	2478777	CHEMBL982763	Binding affinity to human AURA at 10 uM relative to control	B	O=C1Nc2ccccc2/C1=C/c1ccc[nH]1		CHEMBL86755	=	Activity	%	9.1	CHEMBL4722	Homo sapiens	Activity	%	9.1
	2479579	CHEMBL1025765	Inhibition of AURA	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	Ki	nM	0.6	CHEMBL4722	Homo sapiens	Ki	nM	0.6
Not Evaluated	2479632	CHEMBL982763	Binding affinity to human AURA at 10 uM relative to control	B	N#Cc1ccc(-c2cnc3[nH]cc(NC(=O)c4cccnc4)c3c2)cc1		CHEMBL516312		Activity			CHEMBL4722	Homo sapiens	Activity		
	2479835	CHEMBL982763	Binding affinity to human AURA at 10 uM relative to control	B	NC(=O)Nc1sc(-c2ccc(F)cc2)cc1C(N)=O		CHEMBL257167	=	Activity	%	13.2	CHEMBL4722	Homo sapiens	Activity	%	13.2
Active	2480632	CHEMBL982763	Binding affinity to human AURA at 10 uM relative to control	B	CCS(=O)(=O)Nc1ccc2c(c1)/C(=C(/Nc1ccc(CN3CCCCC3)cc1)c1ccccc1)C(=O)N2		CHEMBL514409		Activity			CHEMBL4722	Homo sapiens	Activity		
Active	2480834	CHEMBL982763	Binding affinity to human AURA at 10 uM relative to control	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878		Activity			CHEMBL4722	Homo sapiens	Activity		
	2488264	CHEMBL946776	Inhibition of Aurora A	B	CCc1cc(Nc2nccc(-c3c(-c4ccc(OC)c(C(=O)Nc5c(F)cccc5F)c4)nc4ccccn34)n2)c(OC)cc1N1CCC(N2CCN(S(C)(=O)=O)CC2)CC1		CHEMBL466397	>	IC50	nM	1500.0	CHEMBL4722	Homo sapiens	IC50	nM	1500.0
	2488265	CHEMBL946776	Inhibition of Aurora A	B	COc1cc(N2CCC(N3CCN(S(C)(=O)=O)CC3)CC2)ccc1Nc1nccc(-c2c(-c3cccc(C(=O)Nc4c(F)cccc4F)c3)nc3ccccn23)n1		CHEMBL507714	=	IC50	nM	1600.0	CHEMBL4722	Homo sapiens	IC50	nM	1600.0
	2488271	CHEMBL946776	Inhibition of Aurora A	B	CCc1cc(Nc2nccc(-c3c(-c4cccc(C(=O)Nc5c(F)cccc5F)c4)nc4ccccn34)n2)c(OC)cc1N1CCC(N2CCN(S(C)(=O)=O)CC2)CC1		CHEMBL448929	>	IC50	nM	9500.0	CHEMBL4722	Homo sapiens	IC50	nM	9500.0
	2505610	CHEMBL941569	Inhibition of Aurora A	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(N)=O)s3)c2cc1OC		CHEMBL514499	=	IC50	nM	4800.0	CHEMBL4722	Homo sapiens	IC50	nM	4800.0
	2506927	CHEMBL942603	Inhibition of Aurora A at 10 uM	B	COc1cc(O)ccc1-c1ccc2c(-c3nc4c(N5CCN(C)CC5)cccc4[nH]3)n[nH]c2c1		CHEMBL474619	<	Inhibition	%	50.0	CHEMBL4722	Homo sapiens	INH	%	50.0
	2506928	CHEMBL942603	Inhibition of Aurora A at 10 uM	B	CN1CCN(c2cccc3nc(-c4n[nH]c5cc(-c6ccc(N)cc6)ccc45)[nH]c23)CC1		CHEMBL480391	<	Inhibition	%	50.0	CHEMBL4722	Homo sapiens	INH	%	50.0
	2511564	CHEMBL972523	Inhibition of Aurora-A	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	22.0	CHEMBL4722	Homo sapiens	IC50	uM	0.022
	2511913	CHEMBL966955	Inhibition of N-terminal flag-tagged Aurora A expressed in Escherichia coli BL21-DE3 by ELISA	B	CC(C)NC(=O)c1ccc(Nc2nc(Nc3ccc(O)cc3)ncc2F)cc1		CHEMBL523463	=	IC50	nM	51.0	CHEMBL4722	Homo sapiens	IC50	uM	0.051
	2511914	CHEMBL966955	Inhibition of N-terminal flag-tagged Aurora A expressed in Escherichia coli BL21-DE3 by ELISA	B	CCCNC(=O)c1ccc(Nc2nc(Nc3ccc(O)cc3)ncc2F)cc1		CHEMBL504355	=	IC50	nM	49.0	CHEMBL4722	Homo sapiens	IC50	uM	0.049
	2511915	CHEMBL966955	Inhibition of N-terminal flag-tagged Aurora A expressed in Escherichia coli BL21-DE3 by ELISA	B	CN(C)C(=O)c1ccc(Nc2nc(Nc3ccc(O)cc3)ncc2F)cc1		CHEMBL522644	=	IC50	nM	640.0	CHEMBL4722	Homo sapiens	IC50	uM	0.64
	2511916	CHEMBL966955	Inhibition of N-terminal flag-tagged Aurora A expressed in Escherichia coli BL21-DE3 by ELISA	B	NC(=O)c1ccc(Nc2nc(Nc3ccc(O)cc3)ncc2F)cc1		CHEMBL491975	=	IC50	nM	160.0	CHEMBL4722	Homo sapiens	IC50	uM	0.16
	2511917	CHEMBL966955	Inhibition of N-terminal flag-tagged Aurora A expressed in Escherichia coli BL21-DE3 by ELISA	B	Cc1ccc(Nc2nc(Nc3ccc(O)cc3)ncc2F)cc1		CHEMBL491306	=	IC50	nM	75.0	CHEMBL4722	Homo sapiens	IC50	uM	0.075
	2511918	CHEMBL966955	Inhibition of N-terminal flag-tagged Aurora A expressed in Escherichia coli BL21-DE3 by ELISA	B	Cc1cccc(Nc2nc(Nc3ccc(O)cc3)ncc2F)c1		CHEMBL491305	=	IC50	nM	180.0	CHEMBL4722	Homo sapiens	IC50	uM	0.18
	2511919	CHEMBL966955	Inhibition of N-terminal flag-tagged Aurora A expressed in Escherichia coli BL21-DE3 by ELISA	B	Cc1ccccc1Nc1nc(Nc2ccc(O)cc2)ncc1F		CHEMBL492139	=	IC50	nM	67.0	CHEMBL4722	Homo sapiens	IC50	uM	0.067
	2511920	CHEMBL966955	Inhibition of N-terminal flag-tagged Aurora A expressed in Escherichia coli BL21-DE3 by ELISA	B	COc1ccc(Nc2nc(Nc3ccc(O)cc3)ncc2F)cc1		CHEMBL523490	=	IC50	nM	78.0	CHEMBL4722	Homo sapiens	IC50	uM	0.078
	2511921	CHEMBL966955	Inhibition of N-terminal flag-tagged Aurora A expressed in Escherichia coli BL21-DE3 by ELISA	B	COc1cccc(Nc2nc(Nc3ccc(O)cc3)ncc2F)c1		CHEMBL504824	=	IC50	nM	260.0	CHEMBL4722	Homo sapiens	IC50	uM	0.26
	2511922	CHEMBL966955	Inhibition of N-terminal flag-tagged Aurora A expressed in Escherichia coli BL21-DE3 by ELISA	B	COc1ccccc1Nc1nc(Nc2ccc(O)cc2)ncc1F		CHEMBL522476	=	IC50	nM	20.0	CHEMBL4722	Homo sapiens	IC50	uM	0.02
	2511923	CHEMBL966955	Inhibition of N-terminal flag-tagged Aurora A expressed in Escherichia coli BL21-DE3 by ELISA	B	CCCc1cnc(Nc2ccc(O)cc2)nc1Nc1ccc(O)cc1		CHEMBL491962	=	IC50	nM	11000.0	CHEMBL4722	Homo sapiens	IC50	uM	11.0
	2511924	CHEMBL966955	Inhibition of N-terminal flag-tagged Aurora A expressed in Escherichia coli BL21-DE3 by ELISA	B	CCc1cnc(Nc2ccc(O)cc2)nc1Nc1ccc(O)cc1		CHEMBL492125	=	IC50	nM	150.0	CHEMBL4722	Homo sapiens	IC50	uM	0.15
	2511925	CHEMBL966955	Inhibition of N-terminal flag-tagged Aurora A expressed in Escherichia coli BL21-DE3 by ELISA	B	N#Cc1cnc(Nc2ccc(O)cc2)nc1Nc1ccc(O)cc1		CHEMBL491956	=	IC50	nM	23.0	CHEMBL4722	Homo sapiens	IC50	uM	0.023
	2511926	CHEMBL966955	Inhibition of N-terminal flag-tagged Aurora A expressed in Escherichia coli BL21-DE3 by ELISA	B	Cc1cnc(Nc2ccc(O)cc2)nc1Nc1ccc(O)cc1		CHEMBL492124	=	IC50	nM	34.0	CHEMBL4722	Homo sapiens	IC50	uM	0.034
	2511927	CHEMBL966955	Inhibition of N-terminal flag-tagged Aurora A expressed in Escherichia coli BL21-DE3 by ELISA	B	Oc1ccc(Nc2ncc(C(F)(F)F)c(Nc3ccc(O)cc3)n2)cc1		CHEMBL491774	=	IC50	nM	14.0	CHEMBL4722	Homo sapiens	IC50	uM	0.014
	2511928	CHEMBL966955	Inhibition of N-terminal flag-tagged Aurora A expressed in Escherichia coli BL21-DE3 by ELISA	B	Oc1ccc(Nc2ncc(Cl)c(Nc3ccc(O)cc3)n2)cc1		CHEMBL491773	=	IC50	nM	8.0	CHEMBL4722	Homo sapiens	IC50	uM	0.008
	2511929	CHEMBL966955	Inhibition of N-terminal flag-tagged Aurora A expressed in Escherichia coli BL21-DE3 by ELISA	B	Oc1ccc(Nc2ccnc(Nc3ccc(O)cc3)n2)cc1		CHEMBL489915	=	IC50	nM	490.0	CHEMBL4722	Homo sapiens	IC50	uM	0.49
	2511930	CHEMBL966955	Inhibition of N-terminal flag-tagged Aurora A expressed in Escherichia coli BL21-DE3 by ELISA	B	Cc1cc(Nc2ccc(O)cc2)nc(Nc2ccc(O)cc2)n1		CHEMBL522599	>	IC50	nM	17000.0	CHEMBL4722	Homo sapiens	IC50	uM	17.0
	2511931	CHEMBL966955	Inhibition of N-terminal flag-tagged Aurora A expressed in Escherichia coli BL21-DE3 by ELISA	B	Cc1nc(Nc2ccc(O)cc2)nc(Nc2ccc(O)cc2)c1C		CHEMBL501636	>	IC50	nM	17000.0	CHEMBL4722	Homo sapiens	IC50	uM	17.0
	2511932	CHEMBL966955	Inhibition of N-terminal flag-tagged Aurora A expressed in Escherichia coli BL21-DE3 by ELISA	B	Oc1ccc(Nc2cc(Cl)nc(Nc3ccc(O)cc3)n2)cc1		CHEMBL492108	>	IC50	nM	17000.0	CHEMBL4722	Homo sapiens	IC50	uM	17.0
	2511933	CHEMBL966955	Inhibition of N-terminal flag-tagged Aurora A expressed in Escherichia coli BL21-DE3 by ELISA	B	Oc1ccc(Nc2ncc(F)c(Nc3ccc(O)cc3)n2)cc1		CHEMBL489736	=	IC50	nM	30.0	CHEMBL4722	Homo sapiens	IC50	uM	0.03
	2511934	CHEMBL966955	Inhibition of N-terminal flag-tagged Aurora A expressed in Escherichia coli BL21-DE3 by ELISA	B	Fc1ccc(Nc2ncc(F)c(Nc3ccc(F)cc3)n2)cc1		CHEMBL491759	=	IC50	nM	200.0	CHEMBL4722	Homo sapiens	IC50	uM	0.2
	2511935	CHEMBL966955	Inhibition of N-terminal flag-tagged Aurora A expressed in Escherichia coli BL21-DE3 by ELISA	B	Fc1cnc(Nc2ccccc2)nc1Nc1ccccc1		CHEMBL491758	=	IC50	nM	80.0	CHEMBL4722	Homo sapiens	IC50	uM	0.08
	2511936	CHEMBL966955	Inhibition of N-terminal flag-tagged Aurora A expressed in Escherichia coli BL21-DE3 by ELISA	B	COc1ccc(Nc2ncc(F)c(Nc3ccc(OC)cc3)n2)cc1		CHEMBL523818	=	IC50	nM	130.0	CHEMBL4722	Homo sapiens	IC50	uM	0.13
	2511937	CHEMBL966955	Inhibition of N-terminal flag-tagged Aurora A expressed in Escherichia coli BL21-DE3 by ELISA	B	Cc1cccc(Nc2ncc(F)c(Nc3cccc(C)c3)n2)c1		CHEMBL524321	=	IC50	nM	680.0	CHEMBL4722	Homo sapiens	IC50	uM	0.68
	2511965	CHEMBL969665	Inhibition of human Aurora A at 1 uM assessed as residual enzyme activity	B	O=C(Nc1ccccc1Cl)c1ccc(Nc2nc(Nc3ccc(O)cc3)ncc2F)cc1		CHEMBL521949	=	Activity	%	1.0	CHEMBL4722	Homo sapiens	Activity	%	1.0
	2512032	CHEMBL970563	Inhibition of Aurora A at 1 uM	B	CC(=O)N1CCN(C(=O)Cc2ccc(Nc3ncc(F)c(Nc4ccc(C(=O)Nc5ccccc5Cl)cc4)n3)cc2)CC1		CHEMBL508307	=	Inhibition	%	103.0	CHEMBL4722	Homo sapiens	INH	%	103.0
	2512040	CHEMBL973506	Inhibition of N-terminal flag-tagged Aurora A T217E mutant expressed in Escherichia coli BL21-DE3	B	CCN1CCN(C(=O)Cc2ccc(Nc3ncc(F)c(Nc4ccc(C(=O)Nc5ccccc5Cl)cc4)n3)cc2)CC1		CHEMBL502124	=	IC50	nM	2000.0	CHEMBL4722	Homo sapiens	IC50	uM	2.0
	2512042	CHEMBL973506	Inhibition of N-terminal flag-tagged Aurora A T217E mutant expressed in Escherichia coli BL21-DE3	B	CC(=O)N1CCN(C(=O)Cc2ccc(Nc3ncc(F)c(Nc4ccc(C(=O)Nc5ccccc5Cl)cc4)n3)cc2)CC1		CHEMBL508307	=	IC50	nM	2800.0	CHEMBL4722	Homo sapiens	IC50	uM	2.8
	2512043	CHEMBL973510	Inhibition of GST-fused full length wild type Aurora A expressed in Escherichia coli BL21-DE3 relative to Aurora A kinase domain	B	O=C(NC1CC1)c1ccc(Nc2nc(Nc3ccc(O)cc3)ncc2F)cc1		CHEMBL507170	=	Ratio IC50		0.36	CHEMBL4722	Homo sapiens	Ratio IC50		0.36
	2512044	CHEMBL973510	Inhibition of GST-fused full length wild type Aurora A expressed in Escherichia coli BL21-DE3 relative to Aurora A kinase domain	B	O=C(Nc1ccccc1Cl)c1ccc(Nc2nc(Nc3ccc(O)cc3)ncc2F)cc1		CHEMBL521949	=	Ratio IC50		0.32	CHEMBL4722	Homo sapiens	Ratio IC50		0.32
	2512045	CHEMBL973510	Inhibition of GST-fused full length wild type Aurora A expressed in Escherichia coli BL21-DE3 relative to Aurora A kinase domain	B	CCN1CCN(C(=O)Cc2ccc(Nc3ncc(F)c(Nc4ccc(C(=O)Nc5ccccc5Cl)cc4)n3)cc2)CC1		CHEMBL502124	=	Ratio IC50		0.35	CHEMBL4722	Homo sapiens	Ratio IC50		0.35
	2512046	CHEMBL973510	Inhibition of GST-fused full length wild type Aurora A expressed in Escherichia coli BL21-DE3 relative to Aurora A kinase domain	B	CC(=O)N1CCN(C(=O)Cc2ccc(Nc3ncc(F)c(Nc4ccc(C(=O)Nc5ccccc5Cl)cc4)n3)cc2)CC1		CHEMBL508307	=	Ratio IC50		0.31	CHEMBL4722	Homo sapiens	Ratio IC50		0.31
	2512047	CHEMBL973510	Inhibition of GST-fused full length wild type Aurora A expressed in Escherichia coli BL21-DE3 relative to Aurora A kinase domain	B	O=C(Nc1ccc(Nc2nc(Nc3ccc(O)cc3)ncc2F)cc1)c1ccccc1Cl		CHEMBL523991	=	Ratio IC50		0.4	CHEMBL4722	Homo sapiens	Ratio IC50		0.4
	2512059	CHEMBL966955	Inhibition of N-terminal flag-tagged Aurora A expressed in Escherichia coli BL21-DE3 by ELISA	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	=	IC50	nM	1.0	CHEMBL4722	Homo sapiens	IC50	uM	0.001
	2512060	CHEMBL966955	Inhibition of N-terminal flag-tagged Aurora A expressed in Escherichia coli BL21-DE3 by ELISA	B	O=C(Nc1ccc(Nc2nc(Nc3ccc(O)cc3)ncc2F)cc1)c1ccccc1Cl		CHEMBL523991	=	IC50	nM	6.0	CHEMBL4722	Homo sapiens	IC50	uM	0.006
	2512061	CHEMBL966955	Inhibition of N-terminal flag-tagged Aurora A expressed in Escherichia coli BL21-DE3 by ELISA	B	O=C(Nc1ccccc1Cl)c1ccc(Nc2nc(Nc3ccc(O)cc3)ncc2F)cc1		CHEMBL521949	=	IC50	nM	10.0	CHEMBL4722	Homo sapiens	IC50	uM	0.01
	2512062	CHEMBL966955	Inhibition of N-terminal flag-tagged Aurora A expressed in Escherichia coli BL21-DE3 by ELISA	B	O=C(NC1CC1)c1ccc(Nc2nc(Nc3ccc(O)cc3)ncc2F)cc1		CHEMBL507170	=	IC50	nM	54.0	CHEMBL4722	Homo sapiens	IC50	uM	0.054
	2512063	CHEMBL966955	Inhibition of N-terminal flag-tagged Aurora A expressed in Escherichia coli BL21-DE3 by ELISA	B	CC(=O)N1CCN(C(=O)Cc2ccc(Nc3ncc(F)c(Nc4ccc(C(=O)Nc5ccccc5Cl)cc4)n3)cc2)CC1		CHEMBL508307	=	IC50	nM	4.3	CHEMBL4722	Homo sapiens	IC50	uM	0.0043
	2512064	CHEMBL966955	Inhibition of N-terminal flag-tagged Aurora A expressed in Escherichia coli BL21-DE3 by ELISA	B	CCN1CCN(C(=O)Cc2ccc(Nc3ncc(F)c(Nc4ccc(C(=O)Nc5ccccc5Cl)cc4)n3)cc2)CC1		CHEMBL502124	=	IC50	nM	3.4	CHEMBL4722	Homo sapiens	IC50	uM	0.0034
	2512086	CHEMBL973502	Inhibition of Aurora A in human HCT116 cells assessed as complete failure of centrosome seperation by immunofluorescence assay	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	=	IC50	nM	160.0	CHEMBL4722	Homo sapiens	IC50	uM	0.16
	2512087	CHEMBL973502	Inhibition of Aurora A in human HCT116 cells assessed as complete failure of centrosome seperation by immunofluorescence assay	B	O=C(Nc1ccc(Nc2nc(Nc3ccc(O)cc3)ncc2F)cc1)c1ccccc1Cl		CHEMBL523991	=	IC50	nM	1600.0	CHEMBL4722	Homo sapiens	IC50	uM	1.6
	2512088	CHEMBL973502	Inhibition of Aurora A in human HCT116 cells assessed as complete failure of centrosome seperation by immunofluorescence assay	B	O=C(Nc1ccccc1Cl)c1ccc(Nc2nc(Nc3ccc(O)cc3)ncc2F)cc1		CHEMBL521949	=	IC50	nM	1600.0	CHEMBL4722	Homo sapiens	IC50	uM	1.6
	2512089	CHEMBL973502	Inhibition of Aurora A in human HCT116 cells assessed as complete failure of centrosome seperation by immunofluorescence assay	B	O=C(NC1CC1)c1ccc(Nc2nc(Nc3ccc(O)cc3)ncc2F)cc1		CHEMBL507170	=	IC50	nM	6300.0	CHEMBL4722	Homo sapiens	IC50	uM	6.3
	2512090	CHEMBL973502	Inhibition of Aurora A in human HCT116 cells assessed as complete failure of centrosome seperation by immunofluorescence assay	B	CC(=O)N1CCN(C(=O)Cc2ccc(Nc3ncc(F)c(Nc4ccc(C(=O)Nc5ccccc5Cl)cc4)n3)cc2)CC1		CHEMBL508307	=	IC50	nM	1600.0	CHEMBL4722	Homo sapiens	IC50	uM	1.6
	2512091	CHEMBL973502	Inhibition of Aurora A in human HCT116 cells assessed as complete failure of centrosome seperation by immunofluorescence assay	B	CCN1CCN(C(=O)Cc2ccc(Nc3ncc(F)c(Nc4ccc(C(=O)Nc5ccccc5Cl)cc4)n3)cc2)CC1		CHEMBL502124	=	IC50	nM	390.0	CHEMBL4722	Homo sapiens	IC50	uM	0.39
	2512092	CHEMBL973503	Inhibition of Aurora A in human HCT116 cells assessed as complete loss of phospho-Aurora A staining in centrosomes by immunofluorescence assay	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	=	IC50	nM	310.0	CHEMBL4722	Homo sapiens	IC50	uM	0.31
	2512093	CHEMBL973503	Inhibition of Aurora A in human HCT116 cells assessed as complete loss of phospho-Aurora A staining in centrosomes by immunofluorescence assay	B	O=C(Nc1ccccc1Cl)c1ccc(Nc2nc(Nc3ccc(O)cc3)ncc2F)cc1		CHEMBL521949	=	IC50	nM	5000.0	CHEMBL4722	Homo sapiens	IC50	uM	5.0
	2512094	CHEMBL973503	Inhibition of Aurora A in human HCT116 cells assessed as complete loss of phospho-Aurora A staining in centrosomes by immunofluorescence assay	B	CC(=O)N1CCN(C(=O)Cc2ccc(Nc3ncc(F)c(Nc4ccc(C(=O)Nc5ccccc5Cl)cc4)n3)cc2)CC1		CHEMBL508307	=	IC50	nM	2500.0	CHEMBL4722	Homo sapiens	IC50	uM	2.5
	2512095	CHEMBL973503	Inhibition of Aurora A in human HCT116 cells assessed as complete loss of phospho-Aurora A staining in centrosomes by immunofluorescence assay	B	CCN1CCN(C(=O)Cc2ccc(Nc3ncc(F)c(Nc4ccc(C(=O)Nc5ccccc5Cl)cc4)n3)cc2)CC1		CHEMBL502124	=	IC50	nM	2500.0	CHEMBL4722	Homo sapiens	IC50	uM	2.5
	2512107	CHEMBL966955	Inhibition of N-terminal flag-tagged Aurora A expressed in Escherichia coli BL21-DE3 by ELISA	B	O=C(Nc1ccccc1)c1ccc(Nc2nc(Nc3ccc(O)cc3)ncc2F)cc1		CHEMBL490711	=	IC50	nM	19.0	CHEMBL4722	Homo sapiens	IC50	uM	0.019
	2512108	CHEMBL966955	Inhibition of N-terminal flag-tagged Aurora A expressed in Escherichia coli BL21-DE3 by ELISA	B	COc1ccccc1NC(=O)c1ccc(Nc2nc(Nc3ccc(O)cc3)ncc2F)cc1		CHEMBL490712	=	IC50	nM	78.0	CHEMBL4722	Homo sapiens	IC50	uM	0.078
	2512109	CHEMBL966955	Inhibition of N-terminal flag-tagged Aurora A expressed in Escherichia coli BL21-DE3 by ELISA	B	COc1cccc(NC(=O)c2ccc(Nc3nc(Nc4ccc(O)cc4)ncc3F)cc2)c1		CHEMBL491574	=	IC50	nM	36.0	CHEMBL4722	Homo sapiens	IC50	uM	0.036
	2512110	CHEMBL966955	Inhibition of N-terminal flag-tagged Aurora A expressed in Escherichia coli BL21-DE3 by ELISA	B	COc1ccc(NC(=O)c2ccc(Nc3nc(Nc4ccc(O)cc4)ncc3F)cc2)cc1		CHEMBL491575	=	IC50	nM	14.0	CHEMBL4722	Homo sapiens	IC50	uM	0.014
	2512111	CHEMBL966955	Inhibition of N-terminal flag-tagged Aurora A expressed in Escherichia coli BL21-DE3 by ELISA	B	Cc1ccccc1NC(=O)c1ccc(Nc2nc(Nc3ccc(O)cc3)ncc2F)cc1		CHEMBL491739	=	IC50	nM	20.0	CHEMBL4722	Homo sapiens	IC50	uM	0.02
	2512112	CHEMBL966955	Inhibition of N-terminal flag-tagged Aurora A expressed in Escherichia coli BL21-DE3 by ELISA	B	Cc1cccc(NC(=O)c2ccc(Nc3nc(Nc4ccc(O)cc4)ncc3F)cc2)c1		CHEMBL490738	=	IC50	nM	50.0	CHEMBL4722	Homo sapiens	IC50	uM	0.05
	2512113	CHEMBL966955	Inhibition of N-terminal flag-tagged Aurora A expressed in Escherichia coli BL21-DE3 by ELISA	B	Cc1ccc(NC(=O)c2ccc(Nc3nc(Nc4ccc(O)cc4)ncc3F)cc2)cc1		CHEMBL489912	=	IC50	nM	180.0	CHEMBL4722	Homo sapiens	IC50	uM	0.18
	2512114	CHEMBL966955	Inhibition of N-terminal flag-tagged Aurora A expressed in Escherichia coli BL21-DE3 by ELISA	B	O=C(Nc1ccccc1O)c1ccc(Nc2nc(Nc3ccc(O)cc3)ncc2F)cc1		CHEMBL522598	=	IC50	nM	28.0	CHEMBL4722	Homo sapiens	IC50	uM	0.028
	2512115	CHEMBL966955	Inhibition of N-terminal flag-tagged Aurora A expressed in Escherichia coli BL21-DE3 by ELISA	B	O=C(Nc1cccc(O)c1)c1ccc(Nc2nc(Nc3ccc(O)cc3)ncc2F)cc1		CHEMBL489913	=	IC50	nM	19.0	CHEMBL4722	Homo sapiens	IC50	uM	0.019
	2512116	CHEMBL966955	Inhibition of N-terminal flag-tagged Aurora A expressed in Escherichia coli BL21-DE3 by ELISA	B	O=C(Nc1ccc(O)cc1)c1ccc(Nc2nc(Nc3ccc(O)cc3)ncc2F)cc1		CHEMBL489914	=	IC50	nM	13.0	CHEMBL4722	Homo sapiens	IC50	uM	0.013
	2512117	CHEMBL966955	Inhibition of N-terminal flag-tagged Aurora A expressed in Escherichia coli BL21-DE3 by ELISA	B	O=C(Nc1ccccc1F)c1ccc(Nc2nc(Nc3ccc(O)cc3)ncc2F)cc1		CHEMBL522941	=	IC50	nM	9.0	CHEMBL4722	Homo sapiens	IC50	uM	0.009
	2512118	CHEMBL966955	Inhibition of N-terminal flag-tagged Aurora A expressed in Escherichia coli BL21-DE3 by ELISA	B	O=C(Nc1cccc(F)c1)c1ccc(Nc2nc(Nc3ccc(O)cc3)ncc2F)cc1		CHEMBL490944	=	IC50	nM	59.0	CHEMBL4722	Homo sapiens	IC50	uM	0.059
	2512119	CHEMBL966955	Inhibition of N-terminal flag-tagged Aurora A expressed in Escherichia coli BL21-DE3 by ELISA	B	O=C(Nc1ccc(F)cc1)c1ccc(Nc2nc(Nc3ccc(O)cc3)ncc2F)cc1		CHEMBL522791	=	IC50	nM	25.0	CHEMBL4722	Homo sapiens	IC50	uM	0.025
	2512120	CHEMBL966955	Inhibition of N-terminal flag-tagged Aurora A expressed in Escherichia coli BL21-DE3 by ELISA	B	O=C(Nc1cccc(Cl)c1)c1ccc(Nc2nc(Nc3ccc(O)cc3)ncc2F)cc1		CHEMBL491124	=	IC50	nM	140.0	CHEMBL4722	Homo sapiens	IC50	uM	0.14
	2512121	CHEMBL966955	Inhibition of N-terminal flag-tagged Aurora A expressed in Escherichia coli BL21-DE3 by ELISA	B	O=C(Nc1ccc(Cl)cc1)c1ccc(Nc2nc(Nc3ccc(O)cc3)ncc2F)cc1		CHEMBL492409	=	IC50	nM	64.0	CHEMBL4722	Homo sapiens	IC50	uM	0.064
	2512122	CHEMBL966955	Inhibition of N-terminal flag-tagged Aurora A expressed in Escherichia coli BL21-DE3 by ELISA	B	O=C(Nc1ccc(Nc2nc(Nc3ccc(O)cc3)ncc2F)cc1)c1ccccc1		CHEMBL492410	=	IC50	nM	18.0	CHEMBL4722	Homo sapiens	IC50	uM	0.018
	2512123	CHEMBL966955	Inhibition of N-terminal flag-tagged Aurora A expressed in Escherichia coli BL21-DE3 by ELISA	B	O=C(Nc1ccc(Nc2nc(Nc3ccc(O)cc3)ncc2F)cc1)c1ccccc1F		CHEMBL523713	=	IC50	nM	14.0	CHEMBL4722	Homo sapiens	IC50	uM	0.014
Not Determined	2512125	CHEMBL973503	Inhibition of Aurora A in human HCT116 cells assessed as complete loss of phospho-Aurora A staining in centrosomes by immunofluorescence assay	B	O=C(NC1CC1)c1ccc(Nc2nc(Nc3ccc(O)cc3)ncc2F)cc1		CHEMBL507170		IC50			CHEMBL4722	Homo sapiens	IC50		
Not Determined	2512126	CHEMBL973503	Inhibition of Aurora A in human HCT116 cells assessed as complete loss of phospho-Aurora A staining in centrosomes by immunofluorescence assay	B	O=C(Nc1ccc(Nc2nc(Nc3ccc(O)cc3)ncc2F)cc1)c1ccccc1Cl		CHEMBL523991		IC50			CHEMBL4722	Homo sapiens	IC50		
	2526264	CHEMBL993738	Inhibition of aurora A kinase	B	COc1cc2c(Nc3ccc(NC(=O)c4ccccc4)cc3)ncnc2cc1OCCCN1CCOCC1		CHEMBL202721	=	IC50	nM	110.0	CHEMBL4722	Homo sapiens	IC50	nM	110.0
	2526265	CHEMBL993738	Inhibition of aurora A kinase	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	Ki	nM	0.6	CHEMBL4722	Homo sapiens	Ki	nM	0.6
	2526266	CHEMBL993738	Inhibition of aurora A kinase	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	=	IC50	nM	4.0	CHEMBL4722	Homo sapiens	IC50	nM	4.0
	2526267	CHEMBL993738	Inhibition of aurora A kinase	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4F)[nH]n3)ncnc2c1		CHEMBL215322	=	IC50	nM	800.0	CHEMBL4722	Homo sapiens	IC50	nM	800.0
	2526268	CHEMBL993738	Inhibition of aurora A kinase	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	=	IC50	nM	1400.0	CHEMBL4722	Homo sapiens	IC50	uM	1.4
	2526269	CHEMBL993738	Inhibition of aurora A kinase	B	COc1cc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2OC)=NC3)ccc1C(=O)O		CHEMBL483158	=	IC50	nM	1.0	CHEMBL4722	Homo sapiens	IC50	nM	1.0
	2526270	CHEMBL993738	Inhibition of aurora A kinase	B	O=C(Nc1c[nH]nc1-c1nc2ccc(CN3CCOCC3)cc2[nH]1)NC1CC1		CHEMBL495727	=	IC50	nM	3.0	CHEMBL4722	Homo sapiens	IC50	nM	3.0
	2526271	CHEMBL993738	Inhibition of aurora A kinase	B	Cc1nc(N)sc1-c1ccnc(Nc2ccc(N3CCOCC3)cc2)n1		CHEMBL482967	=	IC50	nM	44.0	CHEMBL4722	Homo sapiens	IC50	nM	44.0
	2526272	CHEMBL993738	Inhibition of aurora A kinase	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(/C=C/c3ccccc3)n2)n[nH]1		CHEMBL482968	=	IC50	nM	14.0	CHEMBL4722	Homo sapiens	IC50	nM	14.0
	2526273	CHEMBL993738	Inhibition of aurora A kinase	B	Cc1cc(Nc2nc(-c3ccccc3)nc3ccccc23)n[nH]1		CHEMBL359482	=	Ki	nM	58.0	CHEMBL4722	Homo sapiens	Ki	nM	58.0
	2526274	CHEMBL993738	Inhibition of aurora A kinase	B	CC(=O)Nc1ccc(Sc2nc(Nc3cc(C)n[nH]3)c3ccccc3n2)cc1		CHEMBL484950	=	Ki	nM	4.0	CHEMBL4722	Homo sapiens	Ki	nM	4.0
	2526275	CHEMBL993738	Inhibition of aurora A kinase	B	CCC(=O)Nc1ccc(Sc2nc(Nc3cc(C)[nH]n3)cc(N3CCCCC3)n2)cc1		CHEMBL484951	=	IC50	nM	1.6	CHEMBL4722	Homo sapiens	IC50	nM	1.6
	2526276	CHEMBL993738	Inhibition of aurora A kinase	B	CCC(=O)Nc1ccc(Sc2nc(Nc3cc(C)[nH]n3)cc(N3CCOCC3)n2)cc1		CHEMBL482778	=	IC50	nM	1.7	CHEMBL4722	Homo sapiens	IC50	nM	1.7
	2526277	CHEMBL993738	Inhibition of aurora A kinase	B	CCC(=O)Nc1ccc(Sc2nc(Nc3cc(C)[nH]n3)cc(N3CCNCC3)n2)cc1		CHEMBL482779	=	IC50	nM	3.7	CHEMBL4722	Homo sapiens	IC50	nM	3.7
	2526278	CHEMBL993738	Inhibition of aurora A kinase	B	CCC(=O)Nc1ccc(Sc2nc(Nc3cc(C)[nH]n3)cc(N3CCN(C)CC3)n2)cc1		CHEMBL484609	=	IC50	nM	1.6	CHEMBL4722	Homo sapiens	IC50	nM	1.6
	2526279	CHEMBL993738	Inhibition of aurora A kinase	B	CCC(=O)Nc1ccc(Sc2nc(Nc3cc(C)[nH]n3)cc(N3CCN(CC)CC3)n2)cc1		CHEMBL485351	<	IC50	nM	1.0	CHEMBL4722	Homo sapiens	IC50	nM	1.0
	2526280	CHEMBL993738	Inhibition of aurora A kinase	B	CCC(=O)Nc1ccc(Sc2nc(Nc3cc(C)[nH]n3)cc(N3CCN(C4CC4)CC3)n2)cc1		CHEMBL485186	<	IC50	nM	1.0	CHEMBL4722	Homo sapiens	IC50	nM	1.0
	2526281	CHEMBL993738	Inhibition of aurora A kinase	B	CCC(=O)Nc1ccc(Sc2nc(Nc3cc(C)[nH]n3)cc(N3CCN(C(C)(C)C)CC3)n2)cc1		CHEMBL484006	=	IC50	nM	1.3	CHEMBL4722	Homo sapiens	IC50	nM	1.3
	2526282	CHEMBL993738	Inhibition of aurora A kinase	B	CC(C)(C)c1ccc(C(=O)Nc2n[nH]c3c2CN(C(=O)Cc2cccs2)C3)cc1		CHEMBL484007	=	IC50	nM	5.0	CHEMBL4722	Homo sapiens	IC50	nM	5.0
	2526283	CHEMBL993738	Inhibition of aurora A kinase	B	CC(C)(C)c1ccc(C(=O)Nc2n[nH]c3c2CN(C(=O)c2ccco2)C3)cc1		CHEMBL191816	=	IC50	nM	41.0	CHEMBL4722	Homo sapiens	IC50	nM	41.0
	2526284	CHEMBL993738	Inhibition of aurora A kinase	B	CC(C)(C)c1ccc(C(=O)Nc2n[nH]c3c2CN(C(=O)Cc2ccccc2)C3)cc1		CHEMBL192575	=	IC50	nM	130.0	CHEMBL4722	Homo sapiens	IC50	nM	130.0
	2526285	CHEMBL993738	Inhibition of aurora A kinase	B	CCc1cccc(CC)c1NC(=O)N1Cc2[nH]nc(NC(=O)c3ccc(C(C)(C)C)cc3)c2C1		CHEMBL191402	=	IC50	nM	100.0	CHEMBL4722	Homo sapiens	IC50	nM	100.0
	2526286	CHEMBL993738	Inhibition of aurora A kinase	B	CN1CCN(c2ccc(C(=O)Nc3n[nH]c4c3CN(C(=O)Cc3cccs3)C4)cc2)CC1		CHEMBL516110	=	IC50	nM	65.0	CHEMBL4722	Homo sapiens	IC50	nM	65.0
	2526287	CHEMBL993738	Inhibition of aurora A kinase	B	CN1CCN(c2ccc(C(=O)Nc3n[nH]c4c3CN(C(=O)c3ccco3)C4)cc2)CC1		CHEMBL427170	=	IC50	nM	160.0	CHEMBL4722	Homo sapiens	IC50	nM	160.0
	2526288	CHEMBL993738	Inhibition of aurora A kinase	B	CN1CCN(c2ccc(C(=O)Nc3n[nH]c4c3CN(C(=O)Cc3ccccc3)C4)cc2)CC1		CHEMBL190252	=	IC50	nM	130.0	CHEMBL4722	Homo sapiens	IC50	nM	130.0
	2526289	CHEMBL993738	Inhibition of aurora A kinase	B	CCc1cccc(CC)c1NC(=O)N1Cc2[nH]nc(NC(=O)c3ccc(N4CCN(C)CC4)cc3)c2C1		CHEMBL363160	=	IC50	nM	27.0	CHEMBL4722	Homo sapiens	IC50	nM	27.0
	2526290	CHEMBL993738	Inhibition of aurora A kinase	B	CN1CCN(c2ccc(C(=O)Nc3n[nH]c4c3CN(C(=O)[C@H](F)c3ccccc3)C4)cc2)CC1		CHEMBL385266	=	IC50	nM	9.0	CHEMBL4722	Homo sapiens	IC50	nM	9.0
	2526291	CHEMBL993738	Inhibition of aurora A kinase	B	CN1CCN(c2ccc(C(=O)Nc3n[nH]c4c3CN(C(=O)[C@H](O)c3ccccc3)C4)cc2)CC1		CHEMBL385872	=	IC50	nM	6.0	CHEMBL4722	Homo sapiens	IC50	nM	6.0
	2526292	CHEMBL993738	Inhibition of aurora A kinase	B	C[C@@H](C(=O)N1Cc2[nH]nc(NC(=O)c3ccc(N4CCN(C)CC4)cc3)c2C1)c1ccccc1		CHEMBL427787	=	IC50	nM	24.0	CHEMBL4722	Homo sapiens	IC50	nM	24.0
	2526293	CHEMBL993738	Inhibition of aurora A kinase	B	C[C@H](C(=O)N1Cc2[nH]nc(NC(=O)c3ccc(N4CCN(C)CC4)cc3)c2C1)c1ccccc1		CHEMBL217748	=	IC50	nM	452.0	CHEMBL4722	Homo sapiens	IC50	nM	452.0
	2526294	CHEMBL993738	Inhibition of aurora A kinase	B	CO[C@H](C(=O)N1Cc2[nH]nc(NC(=O)c3ccc(N4CCN(C)CC4)cc3)c2C1)c1ccccc1		CHEMBL384575	=	IC50	nM	354.0	CHEMBL4722	Homo sapiens	IC50	nM	354.0
	2526295	CHEMBL993738	Inhibition of aurora A kinase	B	COc1cc2c(Nc3cnc(NC(=O)c4ccccc4)nc3)ncnc2cc1OCCCN1CCOCC1		CHEMBL381724	=	IC50	nM	3.0	CHEMBL4722	Homo sapiens	IC50	uM	0.003
	2526296	CHEMBL993738	Inhibition of aurora A kinase	B	COc1cc2c(Nc3nc(C(=O)Nc4ccccc4)cs3)ncnc2cc1OCCCN1CCOCC1		CHEMBL484601	=	IC50	nM	182.0	CHEMBL4722	Homo sapiens	IC50	uM	0.182
	2526297	CHEMBL993738	Inhibition of aurora A kinase	B	COc1cc2c(Nc3ccc(C(=O)Nc4ccccc4)s3)ncnc2cc1OCCCN1CCOCC1		CHEMBL485337	=	IC50	nM	11.0	CHEMBL4722	Homo sapiens	IC50	uM	0.011
	2526298	CHEMBL993738	Inhibition of aurora A kinase	B	COc1cc2c(Nc3ncc(C(=O)Nc4ccccc4)s3)ncnc2cc1OCCCN1CCOCC1		CHEMBL482774	=	IC50	nM	4.0	CHEMBL4722	Homo sapiens	IC50	uM	0.004
	2526299	CHEMBL993738	Inhibition of aurora A kinase	B	COc1cc2c(Nc3ncc(CC(=O)Nc4ccccc4)s3)ncnc2cc1OCCCN1CCOCC1		CHEMBL518981	<	IC50	nM	1.0	CHEMBL4722	Homo sapiens	IC50	uM	0.001
	2526300	CHEMBL993738	Inhibition of aurora A kinase	B	COc1cc2c(Nc3ncc(CC(=O)Nc4cccc(F)c4)s3)ncnc2cc1OCCCN1CCC(CO)CC1		CHEMBL201307	<	IC50	nM	1.0	CHEMBL4722	Homo sapiens	IC50	uM	0.001
	2526301	CHEMBL993738	Inhibition of aurora A kinase	B	COc1cc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2cc1OCCCN1CCC(CO)CC1		CHEMBL216769	=	IC50	nM	450.0	CHEMBL4722	Homo sapiens	IC50	uM	0.45
	2526302	CHEMBL993738	Inhibition of aurora A kinase	B	CCN(CCO)CCCOc1cc2ncnc(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)c2cc1OC		CHEMBL215275	=	IC50	nM	190.0	CHEMBL4722	Homo sapiens	IC50	uM	0.19
	2526303	CHEMBL993738	Inhibition of aurora A kinase	B	CCCN(CCO)CCCOc1cc2ncnc(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)c2cc1OC		CHEMBL217804	=	IC50	nM	220.0	CHEMBL4722	Homo sapiens	IC50	uM	0.22
	2526304	CHEMBL993738	Inhibition of aurora A kinase	B	CCN(CCO)CCCOc1cc2ncnc(Nc3cc(CC(=O)Nc4cccc(F)c4F)[nH]n3)c2cc1OC		CHEMBL214848	=	IC50	nM	360.0	CHEMBL4722	Homo sapiens	IC50	uM	0.36
	2526305	CHEMBL993738	Inhibition of aurora A kinase	B	CCCN(CCO)CCCOc1cc2ncnc(Nc3cc(CC(=O)Nc4cccc(F)c4F)[nH]n3)c2cc1OC		CHEMBL214849	=	IC50	nM	87.0	CHEMBL4722	Homo sapiens	IC50	uM	0.087
	2526306	CHEMBL993738	Inhibition of aurora A kinase	B	COc1cc2c(Nc3cc(CC(=O)Nc4cccc(F)c4F)[nH]n3)ncnc2cc1OCCCN(CCO)CC(C)C		CHEMBL216053	=	IC50	nM	18.0	CHEMBL4722	Homo sapiens	IC50	uM	0.018
	2526307	CHEMBL993738	Inhibition of aurora A kinase	B	O=C(Nc1ccc(CCNc2ncnc3ccsc23)cc1)c1cccc(C(F)(F)F)c1		CHEMBL459888	=	IC50	nM	3200.0	CHEMBL4722	Homo sapiens	IC50	nM	3200.0
	2526308	CHEMBL993738	Inhibition of aurora A kinase	B	O=C(Nc1cccc(C(F)(F)F)c1)c1ccc(CCNc2ncnc3ccsc23)cc1		CHEMBL461995	>	IC50	nM	20000.0	CHEMBL4722	Homo sapiens	IC50	nM	20000.0
	2526309	CHEMBL993738	Inhibition of aurora A kinase	B	O=C(Nc1ccc(CCNc2ncnc3ccsc23)cc1)Nc1cccc(C(F)(F)F)c1		CHEMBL461999	=	IC50	nM	1200.0	CHEMBL4722	Homo sapiens	IC50	nM	1200.0
	2526310	CHEMBL993738	Inhibition of aurora A kinase	B	O=C(Nc1cccc(C(F)(F)F)c1)Nc1cn(CCNc2ncnc3ccsc23)nn1		CHEMBL518666	=	IC50	nM	250.0	CHEMBL4722	Homo sapiens	IC50	nM	250.0
	2526311	CHEMBL993738	Inhibition of aurora A kinase	B	O=C(Nc1cccc(C(F)(F)F)c1)Nc1ncc(CCNc2ncnc3ccsc23)s1		CHEMBL472193	=	IC50	nM	22.0	CHEMBL4722	Homo sapiens	IC50	nM	22.0
	2526312	CHEMBL993738	Inhibition of aurora A kinase	B	O=C(Nc1cccc(C(F)(F)F)c1)Nc1nc(CCNc2ncnc3ccsc23)cs1		CHEMBL513076	>	IC50	nM	20000.0	CHEMBL4722	Homo sapiens	IC50	nM	20000.0
	2526313	CHEMBL993738	Inhibition of aurora A kinase	B	O=C(Nc1ccccc1)Nc1ncc(CCNc2ncnc3ccsc23)s1		CHEMBL472202	=	IC50	nM	52.0	CHEMBL4722	Homo sapiens	IC50	nM	52.0
	2526452	CHEMBL993740	Inhibition of aurora A autophosphorylation in human HCT116 cells by immunofluorescence method	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	=	IC50	nM	34.0	CHEMBL4722	Homo sapiens	IC50	nM	34.0
	2567135	CHEMBL970765	Inhibition of Aurora A	B	Cc1cc(-c2nc3cc4c(cc3[nH]2)C(C)(C)C(=O)N4)n[nH]1		CHEMBL452478	=	IC50	nM	180.0	CHEMBL4722	Homo sapiens	IC50	uM	0.18
	2567136	CHEMBL970765	Inhibition of Aurora A	B	Cc1[nH]nc2c1CCCc1c-2[nH]c2cc3c(cc12)C(C)(C)C(=O)N3		CHEMBL469206	=	IC50	nM	72.0	CHEMBL4722	Homo sapiens	IC50	uM	0.072
	2567137	CHEMBL970765	Inhibition of Aurora A	B	Cc1[nH]nc2c1CCCc1c-2[nH]c2cc3c(cc12)NC(=O)C3(C)C		CHEMBL469205	=	IC50	nM	2.0	CHEMBL4722	Homo sapiens	IC50	uM	0.002
	2567138	CHEMBL970765	Inhibition of Aurora A	B	Cc1[nH]nc2c1CCCC1c3ccccc3NC21		CHEMBL512833	=	IC50	nM	42.0	CHEMBL4722	Homo sapiens	IC50	uM	0.042
	2567139	CHEMBL970765	Inhibition of Aurora A	B	Cc1[nH]nc2c1Cc1c-2[nH]c2ccccc12		CHEMBL469204	=	IC50	nM	870.0	CHEMBL4722	Homo sapiens	IC50	uM	0.87
	2567140	CHEMBL970765	Inhibition of Aurora A	B	Cc1cc(-c2cc3ccccc3[nH]2)n[nH]1		CHEMBL454457	=	IC50	nM	1100.0	CHEMBL4722	Homo sapiens	IC50	uM	1.1
	2567141	CHEMBL970765	Inhibition of Aurora A	B	OCc1[nH]nc2c1CCc1c-2[nH]c2ccccc12		CHEMBL511947	=	IC50	nM	340.0	CHEMBL4722	Homo sapiens	IC50	uM	0.34
	2567142	CHEMBL970765	Inhibition of Aurora A	B	CCOC(=O)c1[nH]nc2c1CCc1c-2[nH]c2ccccc12		CHEMBL502692	=	IC50	nM	5700.0	CHEMBL4722	Homo sapiens	IC50	uM	5.7
	2567143	CHEMBL970765	Inhibition of Aurora A	B	c1ccc2c3c([nH]c2c1)-c1n[nH]c(C2CC2)c1CC3		CHEMBL499229	=	IC50	nM	110.0	CHEMBL4722	Homo sapiens	IC50	uM	0.11
	2567144	CHEMBL970765	Inhibition of Aurora A	B	Cc1[nH]nc2c1CCc1c-2[nH]c2ccccc12		CHEMBL510472	=	IC50	nM	51.0	CHEMBL4722	Homo sapiens	IC50	uM	0.051
	2567145	CHEMBL970765	Inhibition of Aurora A	B	c1ccc2c3c([nH]c2c1)-c1n[nH]cc1CC3		CHEMBL512649	=	IC50	nM	300.0	CHEMBL4722	Homo sapiens	IC50	uM	0.3
	2567146	CHEMBL970765	Inhibition of Aurora A	B	CCN1C(=O)C(C)(C)c2cc3[nH]c(-c4cc(C)[nH]n4)nc3cc21		CHEMBL469197	=	IC50	nM	69.0	CHEMBL4722	Homo sapiens	IC50	uM	0.069
	2567170	CHEMBL970765	Inhibition of Aurora A	B	CCN1C(=O)C(C)(C)c2cc3[nH]c4c(c3cc21)CCCc1c(C)n[nH]c1-4		CHEMBL223147	=	IC50	nM	4.0	CHEMBL4722	Homo sapiens	IC50	uM	0.004
	2567179	CHEMBL970773	Inhibition of Aurora A in human HCT cells assessed as loss of autophosphorylation of Aurora A	B	CCN1C(=O)C(C)(C)c2cc3[nH]c4c(c3cc21)CCCc1c(C)n[nH]c1-4		CHEMBL223147	=	IC50	nM	160.0	CHEMBL4722	Homo sapiens	IC50	uM	0.16
	2567180	CHEMBL970774	Inhibition of Aurora A assessed as separation of centrosomes in human HCT cells	B	CCN1C(=O)C(C)(C)c2cc3[nH]c4c(c3cc21)CCCc1c(C)n[nH]c1-4		CHEMBL223147	=	IC50	nM	80.0	CHEMBL4722	Homo sapiens	IC50	uM	0.08
	2567183	CHEMBL970765	Inhibition of Aurora A	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	IC50	nM	6.0	CHEMBL4722	Homo sapiens	IC50	uM	0.006
	2567189	CHEMBL970773	Inhibition of Aurora A in human HCT cells assessed as loss of autophosphorylation of Aurora A	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	IC50	nM	310.0	CHEMBL4722	Homo sapiens	IC50	uM	0.31
	2567190	CHEMBL970774	Inhibition of Aurora A assessed as separation of centrosomes in human HCT cells	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	IC50	nM	310.0	CHEMBL4722	Homo sapiens	IC50	uM	0.31
	2568939	CHEMBL971702	Inhibition of Aurora A by radiometric assay	B	O=C(NC1CCNCC1)c1n[nH]cc1NC(=O)c1c(Cl)cccc1Cl		CHEMBL445813	>	IC50	nM	10000.0	CHEMBL4722	Homo sapiens	IC50	nM	10000.0
Not Evaluated	2577253	CHEMBL982763	Binding affinity to human AURA at 10 uM relative to control	B	CC(=O)c1c(-c2ccncc2)[nH]c(-c2ccncc2)c1C		CHEMBL526901		Activity			CHEMBL4722	Homo sapiens	Activity		
Not Evaluated	2577456	CHEMBL982763	Binding affinity to human AURA at 10 uM relative to control	B	NC(=O)c1ccc(Nc2cc(-c3ccc(F)cc3)[nH]n2)cc1		CHEMBL511337		Activity			CHEMBL4722	Homo sapiens	Activity		
	2584868	CHEMBL955778	Inhibition of Aurora A	B	O=c1[nH]cnc2[nH]c(-c3ccnc(/C=C/c4ccc(CN5CCOCC5)cc4)c3)cc12		CHEMBL461139	=	IC50	nM	93.0	CHEMBL4722	Homo sapiens	IC50	uM	0.093
	2584896	CHEMBL955778	Inhibition of Aurora A	B	CN(C)CCOc1ccc(/C=C/c2cc(-c3cc4c(=O)[nH]cnc4[nH]3)ccn2)cc1		CHEMBL461140	=	IC50	nM	280.0	CHEMBL4722	Homo sapiens	IC50	uM	0.28
	2593661	CHEMBL982763	Binding affinity to human AURA at 10 uM relative to control	B	Cc1ccc(O)cc1Nc1ccnc(Nc2cccc(C(N)=O)c2)n1		CHEMBL249097	=	Activity	%	8.7	CHEMBL4722	Homo sapiens	Activity	%	8.7
Not Evaluated	2593927	CHEMBL982763	Binding affinity to human AURA at 10 uM relative to control	B	Nc1ncnc2c1c(-c1cccc(O)c1)cn2C1CCNCC1		CHEMBL450519		Activity			CHEMBL4722	Homo sapiens	Activity		
Not Evaluated	2594130	CHEMBL982763	Binding affinity to human AURA at 10 uM relative to control	B	Cc1ccc(C(=O)Nc2cccc(C(C)(C)C)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL515466		Activity			CHEMBL4722	Homo sapiens	Activity		
Not Evaluated	2594870	CHEMBL982763	Binding affinity to human AURA at 10 uM relative to control	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL478649		Activity			CHEMBL4722	Homo sapiens	Activity		
Not Evaluated	2595073	CHEMBL982763	Binding affinity to human AURA at 10 uM relative to control	B	Cc1ccc(NC(=O)c2cccc(N3CCCCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL1964275		Activity			CHEMBL4722	Homo sapiens	Activity		
	2596270	CHEMBL982763	Binding affinity to human AURA at 10 uM relative to control	B	CN(C)c1ccc(-c2cc3ncccc3c(NCCCCN)n2)cc1		CHEMBL282342	=	Activity	%	32.7	CHEMBL4722	Homo sapiens	Activity	%	32.7
Not Evaluated	2596473	CHEMBL982763	Binding affinity to human AURA at 10 uM relative to control	B	O=C(Nc1n[nH]c2nc(-c3cccc(O)c3)ccc12)C1CC1		CHEMBL408019		Activity			CHEMBL4722	Homo sapiens	Activity		
Not Evaluated	2597742	CHEMBL982763	Binding affinity to human AURA at 10 uM relative to control	B	c1ccc(-c2n[nH]cc2-c2ccnc3ccccc23)nc1		CHEMBL261454		Activity			CHEMBL4722	Homo sapiens	Activity		
	2602486	CHEMBL1034908	Inhibition of Aurora A at 10 uM by HTRF assay	B	O=C(Nc1cccc(C(F)(F)F)c1)c1nscc1NCc1ccncc1		CHEMBL515880	<	Inhibition	%	30.0	CHEMBL4722	Homo sapiens	INH	%	30.0
	2602896	CHEMBL1034908	Inhibition of Aurora A at 10 uM by HTRF assay	B	O=C(Nc1cccc(Br)c1)c1nscc1NCc1ccc2ccccc2n1		CHEMBL458532	<	Inhibition	%	30.0	CHEMBL4722	Homo sapiens	INH	%	30.0
	2602897	CHEMBL1034908	Inhibition of Aurora A at 10 uM by HTRF assay	B	O=C(Nc1cccc(Br)c1)c1nscc1NCc1cnoc1		CHEMBL512380	<	Inhibition	%	30.0	CHEMBL4722	Homo sapiens	INH	%	30.0
	2602898	CHEMBL1034908	Inhibition of Aurora A at 10 uM by HTRF assay	B	O=C(Nc1cccc(C(F)(F)F)c1)c1nscc1NCc1ccnc2ccccc12		CHEMBL458531	<	Inhibition	%	30.0	CHEMBL4722	Homo sapiens	INH	%	30.0
	2602899	CHEMBL1034908	Inhibition of Aurora A at 10 uM by HTRF assay	B	O=C(Nc1cccc(Br)c1)c1nscc1NCc1ccnc2ccccc12		CHEMBL517399	<	Inhibition	%	30.0	CHEMBL4722	Homo sapiens	INH	%	30.0
	2602900	CHEMBL1034908	Inhibition of Aurora A at 10 uM by HTRF assay	B	O=C(Nc1cccc(Br)c1)c1nscc1NCCc1ccc2c(c1)OCO2		CHEMBL462528	<	Inhibition	%	30.0	CHEMBL4722	Homo sapiens	INH	%	30.0
	2602901	CHEMBL1034908	Inhibition of Aurora A at 10 uM by HTRF assay	B	O=C(Nc1cccc(C(F)(F)F)c1)c1nscc1NCCc1ccc2c(c1)OCO2		CHEMBL462527	<	Inhibition	%	30.0	CHEMBL4722	Homo sapiens	INH	%	30.0
	2602902	CHEMBL1034908	Inhibition of Aurora A at 10 uM by HTRF assay	B	O=C(Nc1cccc(C(F)(F)F)c1)c1nscc1NCc1ccc(F)c(F)c1		CHEMBL518204	<	Inhibition	%	30.0	CHEMBL4722	Homo sapiens	INH	%	30.0
	2602903	CHEMBL1034908	Inhibition of Aurora A at 10 uM by HTRF assay	B	O=C(NCc1ccc2c(c1)OCO2)c1nscc1NCc1ccncc1		CHEMBL462315	<	Inhibition	%	30.0	CHEMBL4722	Homo sapiens	INH	%	30.0
	2602904	CHEMBL1034908	Inhibition of Aurora A at 10 uM by HTRF assay	B	Cc1ccc(NC(=O)c2nscc2NCc2ccncc2)c(F)c1		CHEMBL460191	<	Inhibition	%	30.0	CHEMBL4722	Homo sapiens	INH	%	30.0
	2602905	CHEMBL1034908	Inhibition of Aurora A at 10 uM by HTRF assay	B	Cc1cc(NC(=O)c2nscc2NCc2ccncc2)ccc1C(F)(F)F		CHEMBL512863	<	Inhibition	%	30.0	CHEMBL4722	Homo sapiens	INH	%	30.0
	2602906	CHEMBL1034908	Inhibition of Aurora A at 10 uM by HTRF assay	B	Cc1ccc(NC(=O)c2nscc2NCc2ccncc2)cc1C(F)(F)F		CHEMBL470441	<	Inhibition	%	30.0	CHEMBL4722	Homo sapiens	INH	%	30.0
	2602907	CHEMBL1034908	Inhibition of Aurora A at 10 uM by HTRF assay	B	O=C(Nc1ccc(Cl)c(Cl)c1)c1nscc1NCc1ccncc1		CHEMBL470440	<	Inhibition	%	30.0	CHEMBL4722	Homo sapiens	INH	%	30.0
	2602908	CHEMBL1034908	Inhibition of Aurora A at 10 uM by HTRF assay	B	O=C(Nc1ccc(C(F)(F)F)c(Cl)c1)c1nscc1NCc1ccncc1		CHEMBL512862	<	Inhibition	%	30.0	CHEMBL4722	Homo sapiens	INH	%	30.0
	2602909	CHEMBL1034908	Inhibition of Aurora A at 10 uM by HTRF assay	B	O=C(Nc1ccc(Cl)c(C(F)(F)F)c1)c1nscc1NCc1ccncc1		CHEMBL473268	<	Inhibition	%	30.0	CHEMBL4722	Homo sapiens	INH	%	30.0
	2602910	CHEMBL1034908	Inhibition of Aurora A at 10 uM by HTRF assay	B	O=C(NC1=CC2C=NNC2C=C1)c1nscc1NCc1ccncc1		CHEMBL443921	<	Inhibition	%	30.0	CHEMBL4722	Homo sapiens	INH	%	30.0
	2602911	CHEMBL1034908	Inhibition of Aurora A at 10 uM by HTRF assay	B	O=C(Nc1ccc2ccccc2n1)c1nscc1NCc1ccncc1		CHEMBL474709	<	Inhibition	%	30.0	CHEMBL4722	Homo sapiens	INH	%	30.0
	2602912	CHEMBL1034908	Inhibition of Aurora A at 10 uM by HTRF assay	B	O=C(Nc1ccccc1Br)c1nscc1NCc1ccncc1		CHEMBL509737	<	Inhibition	%	30.0	CHEMBL4722	Homo sapiens	INH	%	30.0
	2602913	CHEMBL1034908	Inhibition of Aurora A at 10 uM by HTRF assay	B	O=C(Nc1ccc(Br)cc1)c1nscc1NCc1ccncc1		CHEMBL473288	<	Inhibition	%	30.0	CHEMBL4722	Homo sapiens	INH	%	30.0
	2602914	CHEMBL1034908	Inhibition of Aurora A at 10 uM by HTRF assay	B	O=C(Nc1cccc(Br)c1)c1nscc1NCc1ccncc1		CHEMBL473287	<	Inhibition	%	30.0	CHEMBL4722	Homo sapiens	INH	%	30.0
	2602915	CHEMBL1034908	Inhibition of Aurora A at 10 uM by HTRF assay	B	O=C(Nc1ccc(Cl)cc1)c1nscc1NCc1ccncc1		CHEMBL475709	<	Inhibition	%	30.0	CHEMBL4722	Homo sapiens	INH	%	30.0
	2602916	CHEMBL1034908	Inhibition of Aurora A at 10 uM by HTRF assay	B	CC(C)(C)c1ccc(NC(=O)c2nscc2NCc2ccncc2)cc1		CHEMBL475708	<	Inhibition	%	30.0	CHEMBL4722	Homo sapiens	INH	%	30.0
	2602917	CHEMBL1034908	Inhibition of Aurora A at 10 uM by HTRF assay	B	CC(C)(C)c1cccc(NC(=O)c2nscc2NCc2ccncc2)c1		CHEMBL475510	<	Inhibition	%	30.0	CHEMBL4722	Homo sapiens	INH	%	30.0
	2602918	CHEMBL1034908	Inhibition of Aurora A at 10 uM by HTRF assay	B	O=C(Nc1ccc(OC(F)(F)F)cc1)c1nscc1NCc1ccncc1		CHEMBL516243	<	Inhibition	%	30.0	CHEMBL4722	Homo sapiens	INH	%	30.0
	2602919	CHEMBL1034908	Inhibition of Aurora A at 10 uM by HTRF assay	B	O=C(Nc1cccc(OC(F)(F)F)c1)c1nscc1NCc1ccncc1		CHEMBL475509	<	Inhibition	%	30.0	CHEMBL4722	Homo sapiens	INH	%	30.0
	2602920	CHEMBL1034908	Inhibition of Aurora A at 10 uM by HTRF assay	B	O=C(Nc1ccc(C(F)(F)F)cc1)c1nscc1NCc1ccccn1		CHEMBL474494	<	Inhibition	%	30.0	CHEMBL4722	Homo sapiens	INH	%	30.0
	2602921	CHEMBL1034908	Inhibition of Aurora A at 10 uM by HTRF assay	B	O=C(Nc1ccc(C(F)(F)F)cc1)c1nscc1NCc1cccnc1		CHEMBL474293	<	Inhibition	%	30.0	CHEMBL4722	Homo sapiens	INH	%	30.0
	2602922	CHEMBL1034908	Inhibition of Aurora A at 10 uM by HTRF assay	B	O=C(Nc1ccc(C(F)(F)F)cc1)c1nscc1NCc1ccncc1		CHEMBL475704	<	Inhibition	%	30.0	CHEMBL4722	Homo sapiens	INH	%	30.0
	2602923	CHEMBL1034908	Inhibition of Aurora A at 10 uM by HTRF assay	B	O=C(Nc1cccc(C(F)(F)F)c1)c1nscc1NCc1ccccn1		CHEMBL475703	<	Inhibition	%	30.0	CHEMBL4722	Homo sapiens	INH	%	30.0
	2602924	CHEMBL1034908	Inhibition of Aurora A at 10 uM by HTRF assay	B	O=C(Nc1cccc(C(F)(F)F)c1)c1nscc1NCc1cccnc1		CHEMBL514986	<	Inhibition	%	30.0	CHEMBL4722	Homo sapiens	INH	%	30.0
	2604774	CHEMBL1034041	Activity of Aurora A	B	CC(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CSCc1ccc2c(S(=O)(=O)N(C)C)ccc(O)c2n1)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(N)=O		CHEMBL450359	=	Km	nM	297800.0	CHEMBL4722	Homo sapiens	Km	uM	297.8
	2604775	CHEMBL1034041	Activity of Aurora A	B	CC(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CSCc1ccc2c(S(=O)(=O)N(C)C)ccc(O)c2n1)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(N)=O		CHEMBL450359	=	Vmax	umol/min/mg	1.7	CHEMBL4722	Homo sapiens	Vmax	umol/min/mg	1.7
	2604776	CHEMBL1034042	Ratio of Kcat to Km for Aurora A	B	CC(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CSCc1ccc2c(S(=O)(=O)N(C)C)ccc(O)c2n1)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(N)=O		CHEMBL450359	=	Kcat/Km	/uM/min	1.0	CHEMBL4722	Homo sapiens	Kcat/Km	/uM/min	1.0
	2604777	CHEMBL1034042	Ratio of Kcat to Km for Aurora A	B	CC(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CSCc1ccc2c(S(=O)(=O)N(C)C)ccc(O)c2n1)C(=O)N[C@H](C)C(=O)N[C@@H](C)C(N)=O		CHEMBL510984	=	Kcat/Km	/uM/min	5.0	CHEMBL4722	Homo sapiens	Kcat/Km	/uM/min	5.0
	2604778	CHEMBL1034042	Ratio of Kcat to Km for Aurora A	B	CC(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CSCc1ccc2c(S(=O)(=O)N(C)C)ccc(O)c2n1)C(=O)NCC(=O)N[C@@H](C)C(N)=O		CHEMBL445231	=	Kcat/Km	/uM/min	7.0	CHEMBL4722	Homo sapiens	Kcat/Km	/uM/min	7.0
	2604779	CHEMBL1034042	Ratio of Kcat to Km for Aurora A	B	CC(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CSCc1ccc2c(S(=O)(=O)N(C)C)ccc(O)c2n1)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(N)=O		CHEMBL449629	=	Kcat/Km	/uM/min	3.0	CHEMBL4722	Homo sapiens	Kcat/Km	/uM/min	3.0
	2604780	CHEMBL1034041	Activity of Aurora A	B	CC(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CSCc1ccc2c(S(=O)(=O)N(C)C)ccc(O)c2n1)C(=O)N[C@H](C)C(=O)N[C@@H](C)C(N)=O		CHEMBL510984	=	Km	nM	65000.0	CHEMBL4722	Homo sapiens	Km	uM	65.0
	2604781	CHEMBL1034041	Activity of Aurora A	B	CC(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CSCc1ccc2c(S(=O)(=O)N(C)C)ccc(O)c2n1)C(=O)N[C@H](C)C(=O)N[C@@H](C)C(N)=O		CHEMBL510984	=	Vmax	umol/min/mg	1.8	CHEMBL4722	Homo sapiens	Vmax	umol/min/mg	1.8
	2604782	CHEMBL1034041	Activity of Aurora A	B	CC(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CSCc1ccc2c(S(=O)(=O)N(C)C)ccc(O)c2n1)C(=O)NCC(=O)N[C@@H](C)C(N)=O		CHEMBL445231	=	Km	nM	57100.0	CHEMBL4722	Homo sapiens	Km	uM	57.1
	2604783	CHEMBL1034041	Activity of Aurora A	B	CC(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CSCc1ccc2c(S(=O)(=O)N(C)C)ccc(O)c2n1)C(=O)NCC(=O)N[C@@H](C)C(N)=O		CHEMBL445231	=	Vmax	umol/min/mg	2.2	CHEMBL4722	Homo sapiens	Vmax	umol/min/mg	2.2
	2604784	CHEMBL1034041	Activity of Aurora A	B	CC(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CSCc1ccc2c(S(=O)(=O)N(C)C)ccc(O)c2n1)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(N)=O		CHEMBL449629	=	Km	nM	152300.0	CHEMBL4722	Homo sapiens	Km	uM	152.3
	2604785	CHEMBL1034041	Activity of Aurora A	B	CC(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CSCc1ccc2c(S(=O)(=O)N(C)C)ccc(O)c2n1)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(N)=O		CHEMBL449629	=	Vmax	umol/min/mg	2.6	CHEMBL4722	Homo sapiens	Vmax	umol/min/mg	2.6
	2616309	CHEMBL1029843	Inhibition of Aurora A	B	CNc1nccc(-c2cccnc2Oc2c(C)cc(Nc3nc4ccccc4[nH]3)c3ccccc23)n1		CHEMBL458023	=	IC50	nM	28.0	CHEMBL4722	Homo sapiens	IC50	nM	28.0
	2616313	CHEMBL1029843	Inhibition of Aurora A	B	CNc1nccc(-c2cccnc2Oc2ccc(Nc3nc4ccccc4[nH]3)c3ccccc23)n1		CHEMBL465793	=	IC50	nM	19.0	CHEMBL4722	Homo sapiens	IC50	nM	19.0
	2626899	CHEMBL999783	Binding affinity to human Aurora A at 5 uM	B	Cc1cccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(Nc3ncnc4ccc(N)cc34)cc2)c1		CHEMBL497033	=	Activity	%	100.0	CHEMBL4722	Homo sapiens	Activity	%	100.0
	2626926	CHEMBL999783	Binding affinity to human Aurora A at 5 uM	B	Cc1cccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2cccc(Nc3ncnc4ccc(N)cc34)c2)c1		CHEMBL497615	=	Activity	%	90.0	CHEMBL4722	Homo sapiens	Activity	%	90.0
Not Determined	2639193	CHEMBL1022927	Inhibition of Aurora 2	B	O[C@H]1CC[C@H](Nc2ccc3nnc(-c4cccc(C(F)(F)F)c4)n3n2)CC1		CHEMBL494221		Ki			CHEMBL4722	Homo sapiens	Ki		
	2639194	CHEMBL1022927	Inhibition of Aurora 2	B	FC(F)(F)c1cccc(-c2nnc3ccc(NC4CCNCC4)nn23)c1		CHEMBL493169	=	Ki	nM	800.0	CHEMBL4722	Homo sapiens	Ki	nM	800.0
	2644567	CHEMBL1031294	Inhibition of Aurora-A by coupled assay	B	Cc1cc(Nc2nc(-c3ccncc3)nc3ccccc23)n[nH]1		CHEMBL549536	=	Ki	nM	81.0	CHEMBL4722	Homo sapiens	Ki	nM	81.0
	2658067	CHEMBL1031294	Inhibition of Aurora-A by coupled assay	B	Cc1cc(Nc2nc(-c3ccccc3)nc3ccccc23)n[nH]1		CHEMBL359482	=	Ki	nM	58.0	CHEMBL4722	Homo sapiens	Ki	nM	58.0
	2658068	CHEMBL1031294	Inhibition of Aurora-A by coupled assay	B	Cc1cc(Nc2nc(Nc3ccccc3)nc3ccccc23)n[nH]1		CHEMBL552038	=	Ki	nM	24.0	CHEMBL4722	Homo sapiens	Ki	nM	24.0
	2658069	CHEMBL1031294	Inhibition of Aurora-A by coupled assay	B	Cc1cc(Nc2nc(N(C)c3ccccc3)nc3ccccc23)n[nH]1		CHEMBL550825	=	Ki	nM	17.0	CHEMBL4722	Homo sapiens	Ki	nM	17.0
	2658070	CHEMBL1031294	Inhibition of Aurora-A by coupled assay	B	Cc1cc(Nc2nc(Oc3ccccc3)nc3ccccc23)n[nH]1		CHEMBL565205	=	Ki	nM	36.0	CHEMBL4722	Homo sapiens	Ki	nM	36.0
	2658071	CHEMBL1031294	Inhibition of Aurora-A by coupled assay	B	Cc1cc(Nc2nc(Sc3ccccc3)nc3ccccc23)n[nH]1		CHEMBL549322	=	Ki	nM	20.0	CHEMBL4722	Homo sapiens	Ki	nM	20.0
	2658072	CHEMBL1031294	Inhibition of Aurora-A by coupled assay	B	Cc1cc(Nc2nc(Sc3ccccc3Cl)nc3ccccc23)n[nH]1		CHEMBL562415	=	Ki	nM	5.0	CHEMBL4722	Homo sapiens	Ki	nM	5.0
	2658073	CHEMBL1031294	Inhibition of Aurora-A by coupled assay	B	Cc1cc(Nc2nc(Sc3cccc(Cl)c3)nc3ccccc23)n[nH]1		CHEMBL562416	=	Ki	nM	4.0	CHEMBL4722	Homo sapiens	Ki	nM	4.0
	2658074	CHEMBL1031294	Inhibition of Aurora-A by coupled assay	B	Cc1cc(Nc2nc(Sc3ccc(Cl)cc3)nc3ccccc23)n[nH]1		CHEMBL562157	=	Ki	nM	6.0	CHEMBL4722	Homo sapiens	Ki	nM	6.0
	2658075	CHEMBL1031294	Inhibition of Aurora-A by coupled assay	B	Cc1cc(Nc2nc(Sc3cccc(Cl)c3Cl)nc3ccccc23)n[nH]1		CHEMBL564459	=	Ki	nM	3.0	CHEMBL4722	Homo sapiens	Ki	nM	3.0
	2658076	CHEMBL1031294	Inhibition of Aurora-A by coupled assay	B	Cc1cc(Nc2nc(Sc3ccc(Cl)cc3Cl)nc3ccccc23)n[nH]1		CHEMBL551633	=	Ki	nM	2.0	CHEMBL4722	Homo sapiens	Ki	nM	2.0
	2658077	CHEMBL1031294	Inhibition of Aurora-A by coupled assay	B	Cc1cc(Nc2nc(Sc3c(Cl)cccc3Cl)nc3ccccc23)n[nH]1		CHEMBL561834	=	Ki	nM	5.0	CHEMBL4722	Homo sapiens	Ki	nM	5.0
	2658078	CHEMBL1031294	Inhibition of Aurora-A by coupled assay	B	Cc1cc(Nc2nc(Sc3ccc(Cl)c(Cl)c3)nc3ccccc23)n[nH]1		CHEMBL552385	=	Ki	nM	2.0	CHEMBL4722	Homo sapiens	Ki	nM	2.0
	2658079	CHEMBL1031294	Inhibition of Aurora-A by coupled assay	B	COc1ccccc1Sc1nc(Nc2cc(C)[nH]n2)c2ccccc2n1		CHEMBL551634	=	Ki	nM	24.0	CHEMBL4722	Homo sapiens	Ki	nM	24.0
	2658080	CHEMBL1031294	Inhibition of Aurora-A by coupled assay	B	COc1ccc(Sc2nc(Nc3cc(C)[nH]n3)c3ccccc3n2)cc1		CHEMBL552500	=	Ki	nM	9.0	CHEMBL4722	Homo sapiens	Ki	nM	9.0
	2658081	CHEMBL1031294	Inhibition of Aurora-A by coupled assay	B	COc1ccc(Sc2nc(Nc3cc(C)[nH]n3)c3ccccc3n2)cc1OC		CHEMBL564290	=	Ki	nM	17.0	CHEMBL4722	Homo sapiens	Ki	nM	17.0
	2658082	CHEMBL1031294	Inhibition of Aurora-A by coupled assay	B	Cc1cc(Nc2nc(Sc3ccc4ccccc4c3)nc3ccccc23)n[nH]1		CHEMBL559900	=	Ki	nM	1.0	CHEMBL4722	Homo sapiens	Ki	nM	1.0
	2658083	CHEMBL1031294	Inhibition of Aurora-A by coupled assay	B	Cc1cc(Nc2nc(Sc3ccc(NS(C)(=O)=O)cc3)nc3ccccc23)n[nH]1		CHEMBL552033	=	Ki	nM	2.0	CHEMBL4722	Homo sapiens	Ki	nM	2.0
	2658084	CHEMBL1031294	Inhibition of Aurora-A by coupled assay	B	Cc1cc(Nc2nc(Sc3ccc(NC(=O)OC(C)(C)C)cc3)nc3ccccc23)n[nH]1		CHEMBL556460	=	Ki	nM	9.0	CHEMBL4722	Homo sapiens	Ki	nM	9.0
	2658085	CHEMBL1031294	Inhibition of Aurora-A by coupled assay	B	CC(=O)Nc1ccc(Sc2nc(Nc3cc(C)n[nH]3)c3ccccc3n2)cc1		CHEMBL484950	=	Ki	nM	4.0	CHEMBL4722	Homo sapiens	Ki	nM	4.0
	2658086	CHEMBL1031294	Inhibition of Aurora-A by coupled assay	B	CC(=O)N(C)c1ccc(Sc2nc(Nc3cc(C)[nH]n3)c3ccccc3n2)cc1		CHEMBL549668	<	Ki	nM	1.0	CHEMBL4722	Homo sapiens	Ki	nM	1.0
	2658087	CHEMBL1031294	Inhibition of Aurora-A by coupled assay	B	CCC(=O)Nc1ccc(Sc2nc(Nc3cc(C)[nH]n3)c3ccccc3n2)cc1		CHEMBL564941	=	Ki	nM	1.0	CHEMBL4722	Homo sapiens	Ki	nM	1.0
	2658088	CHEMBL1031294	Inhibition of Aurora-A by coupled assay	B	Cc1cc(Nc2nc(Sc3ccc(NC(=O)C4CC4)cc3)nc3ccccc23)n[nH]1		CHEMBL564449	<	Ki	nM	1.0	CHEMBL4722	Homo sapiens	Ki	nM	1.0
	2658089	CHEMBL1031294	Inhibition of Aurora-A by coupled assay	B	CC(=O)Nc1ccc(Sc2nc(Nc3cc[nH]n3)c3ccccc3n2)cc1		CHEMBL560158	=	Ki	nM	24.0	CHEMBL4722	Homo sapiens	Ki	nM	24.0
	2658090	CHEMBL1031294	Inhibition of Aurora-A by coupled assay	B	CC(=O)Nc1ccc(Sc2nc(Nc3cc(C4CC4)[nH]n3)c3ccccc3n2)cc1		CHEMBL561421	<	Ki	nM	1.0	CHEMBL4722	Homo sapiens	Ki	nM	1.0
	2658091	CHEMBL1031294	Inhibition of Aurora-A by coupled assay	B	CC(=O)Nc1ccc(Sc2nccc(Nc3cc(C)[nH]n3)n2)cc1		CHEMBL549469	=	Ki	nM	86.0	CHEMBL4722	Homo sapiens	Ki	nM	86.0
	2658092	CHEMBL1031294	Inhibition of Aurora-A by coupled assay	B	CC(=O)Nc1ccc(Sc2nc(C)cc(Nc3cc(C)[nH]n3)n2)cc1		CHEMBL562497	=	Ki	nM	18.0	CHEMBL4722	Homo sapiens	Ki	nM	18.0
	2658093	CHEMBL1031294	Inhibition of Aurora-A by coupled assay	B	CC(=O)Nc1ccc(Sc2nc(Nc3cc(C)[nH]n3)cc(-c3ccccc3)n2)cc1		CHEMBL557279	=	Ki	nM	2.4	CHEMBL4722	Homo sapiens	Ki	nM	2.4
	2658094	CHEMBL1031294	Inhibition of Aurora-A by coupled assay	B	CCC(=O)Nc1ccc(Sc2nc(C)cc(Nc3cc(C)[nH]n3)n2)cc1		CHEMBL560556	=	Ki	nM	5.1	CHEMBL4722	Homo sapiens	Ki	nM	5.1
	2658095	CHEMBL1031294	Inhibition of Aurora-A by coupled assay	B	CCC(=O)Nc1ccc(Sc2nc(Nc3cc(C)[nH]n3)cc(C3CC3)n2)cc1		CHEMBL561617	=	Ki	nM	3.9	CHEMBL4722	Homo sapiens	Ki	nM	3.9
	2658096	CHEMBL1031294	Inhibition of Aurora-A by coupled assay	B	CCC(=O)Nc1ccc(Sc2nc(Nc3cc(C)[nH]n3)cc(C(C)(C)C)n2)cc1		CHEMBL565183	=	Ki	nM	10.0	CHEMBL4722	Homo sapiens	Ki	nM	10.0
	2658097	CHEMBL1031294	Inhibition of Aurora-A by coupled assay	B	CCC(=O)Nc1ccc(Sc2nc(Nc3cc(C)[nH]n3)cc(-c3ccccc3)n2)cc1		CHEMBL554941	<	Ki	nM	1.0	CHEMBL4722	Homo sapiens	Ki	nM	1.0
	2658098	CHEMBL1031294	Inhibition of Aurora-A by coupled assay	B	CCC(=O)Nc1ccc(Sc2nc(Nc3cc(C)[nH]n3)cc(-c3cccnc3)n2)cc1		CHEMBL557682	=	Ki	nM	3.9	CHEMBL4722	Homo sapiens	Ki	nM	3.9
	2658099	CHEMBL1031294	Inhibition of Aurora-A by coupled assay	B	CCC(=O)Nc1ccc(Sc2nc(Nc3cc(C)[nH]n3)cc(-c3ccncc3)n2)cc1		CHEMBL560630	<	Ki	nM	3.0	CHEMBL4722	Homo sapiens	Ki	nM	3.0
	2658100	CHEMBL1031294	Inhibition of Aurora-A by coupled assay	B	CCC(=O)Nc1ccc(Sc2nc(Nc3cc(C)[nH]n3)cc(N3CCC3)n2)cc1		CHEMBL563682	=	Ki	nM	2.4	CHEMBL4722	Homo sapiens	Ki	nM	2.4
	2658101	CHEMBL1031294	Inhibition of Aurora-A by coupled assay	B	CCC(=O)Nc1ccc(Sc2nc(Nc3cc(C)[nH]n3)cc(N3CCCCC3)n2)cc1		CHEMBL484951	=	Ki	nM	1.6	CHEMBL4722	Homo sapiens	Ki	nM	1.6
	2658102	CHEMBL1031294	Inhibition of Aurora-A by coupled assay	B	CCC(=O)Nc1ccc(Sc2nc(Nc3cc(C)[nH]n3)cc(N3CCOCC3)n2)cc1		CHEMBL482778	=	Ki	nM	1.7	CHEMBL4722	Homo sapiens	Ki	nM	1.7
	2658103	CHEMBL1031294	Inhibition of Aurora-A by coupled assay	B	CCC(=O)Nc1ccc(Sc2nc(Nc3cc(C)[nH]n3)cc(N3CCNCC3)n2)cc1		CHEMBL482779	=	Ki	nM	3.7	CHEMBL4722	Homo sapiens	Ki	nM	3.7
	2658104	CHEMBL1031294	Inhibition of Aurora-A by coupled assay	B	CCC(=O)Nc1ccc(Sc2nc(Nc3cc(C)[nH]n3)cc(N3CCN(C)CC3)n2)cc1		CHEMBL484609	=	Ki	nM	1.6	CHEMBL4722	Homo sapiens	Ki	nM	1.6
	2658105	CHEMBL1031294	Inhibition of Aurora-A by coupled assay	B	CCC(=O)Nc1ccc(Sc2nc(Nc3cc(C)[nH]n3)cc(N3CCN(CC)CC3)n2)cc1		CHEMBL485351	<	Ki	nM	1.0	CHEMBL4722	Homo sapiens	Ki	nM	1.0
	2658106	CHEMBL1031294	Inhibition of Aurora-A by coupled assay	B	CCC(=O)Nc1ccc(Sc2nc(Nc3cc(C)[nH]n3)cc(N3CCN(C4CC4)CC3)n2)cc1		CHEMBL485186	<	Ki	nM	1.0	CHEMBL4722	Homo sapiens	Ki	nM	1.0
	2658107	CHEMBL1031294	Inhibition of Aurora-A by coupled assay	B	CCC(=O)Nc1ccc(Sc2nc(Nc3cc(C)[nH]n3)cc(N3CCN(C(C)(C)C)CC3)n2)cc1		CHEMBL484006	=	Ki	nM	1.3	CHEMBL4722	Homo sapiens	Ki	nM	1.3
	2658108	CHEMBL1031294	Inhibition of Aurora-A by coupled assay	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	Ki	nM	0.6	CHEMBL4722	Homo sapiens	Ki	nM	0.6
	2661261	CHEMBL1063937	Inhibition of Aurora A	B	CN1CCN(c2cccc(Nc3ncc4c(n3)-c3c(c(C(N)=O)nn3C)CC4)c2)CC1		CHEMBL559513	=	IC50	nM	30.0	CHEMBL4722	Homo sapiens	IC50	uM	0.03
	2661270	CHEMBL1063937	Inhibition of Aurora A	B	Cn1nc(C(N)=O)c2c1-c1nc(Nc3ccccc3)ncc1CC2		CHEMBL559845	=	IC50	nM	50.0	CHEMBL4722	Homo sapiens	IC50	uM	0.05
	2661272	CHEMBL1063937	Inhibition of Aurora A	B	Cn1nc(C(N)=O)c2c1-c1nc(Nc3ccc(N4CCOCC4)cc3)ncc1CC2		CHEMBL556881	=	IC50	nM	51.0	CHEMBL4722	Homo sapiens	IC50	uM	0.051
	2661273	CHEMBL1063937	Inhibition of Aurora A	B	CN1CCN(c2ccc(Nc3ncc4c(n3)-c3c(c(C(N)=O)nn3C)CC4)cc2)CC1		CHEMBL560817	=	IC50	nM	53.0	CHEMBL4722	Homo sapiens	IC50	uM	0.053
	2661289	CHEMBL1063937	Inhibition of Aurora A	B	CNC(=O)c1nn(C)c2c1CCc1cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc1-2		CHEMBL559844	=	IC50	nM	175.0	CHEMBL4722	Homo sapiens	IC50	uM	0.175
	2661292	CHEMBL1063937	Inhibition of Aurora A	B	Cn1nc(C(=O)NC2CC2)c2c1-c1nc(Nc3ccccc3)ncc1CC2		CHEMBL559639	=	IC50	nM	213.0	CHEMBL4722	Homo sapiens	IC50	uM	0.213
	2661297	CHEMBL1063937	Inhibition of Aurora A	B	CNC(=O)c1nn(C)c2c1CCc1cnc(Nc3ccccc3)nc1-2		CHEMBL562104	=	IC50	nM	312.0	CHEMBL4722	Homo sapiens	IC50	uM	0.312
	2661300	CHEMBL1063937	Inhibition of Aurora A	B	Cn1nc(C(=O)NCCO)c2c1-c1nc(Nc3ccccc3)ncc1CC2		CHEMBL538195	=	IC50	nM	364.0	CHEMBL4722	Homo sapiens	IC50	uM	0.364
	2661302	CHEMBL1063937	Inhibition of Aurora A	B	Cn1nc(C(=O)NCc2ccccc2)c2c1-c1nc(Nc3ccccc3)ncc1CC2		CHEMBL562030	=	IC50	nM	374.0	CHEMBL4722	Homo sapiens	IC50	uM	0.374
	2661309	CHEMBL1063937	Inhibition of Aurora A	B	CNC(=O)c1nn(C)c2c1C(C)(C)Cc1cnc(Nc3ccc(CN4CCOCC4)cc3)nc1-2		CHEMBL550959	=	IC50	nM	535.0	CHEMBL4722	Homo sapiens	IC50	uM	0.535
	2661313	CHEMBL1063937	Inhibition of Aurora A	B	CN1CCN(c2ccc(Nc3ncc4c(n3)-c3c(c(C(N)=O)nn3C)C(C)(C)C4)cc2)CC1		CHEMBL563641	=	IC50	nM	582.0	CHEMBL4722	Homo sapiens	IC50	uM	0.582
	2661314	CHEMBL1063937	Inhibition of Aurora A	B	CNC(=O)c1nn(C)c2c1C(C)(C)Cc1cnc(Nc3cccc(N4CCOCC4)c3)nc1-2		CHEMBL560839	=	IC50	nM	625.0	CHEMBL4722	Homo sapiens	IC50	uM	0.625
	2661315	CHEMBL1063937	Inhibition of Aurora A	B	CNC(=O)c1nn(C)c2c1C(C)(C)Cc1cnc(Nc3cccc(CN4CCOCC4)c3)nc1-2		CHEMBL565160	=	IC50	nM	638.0	CHEMBL4722	Homo sapiens	IC50	uM	0.638
	2661316	CHEMBL1063937	Inhibition of Aurora A	B	CNC(=O)c1nn(C)c2c1C(C)(C)Cc1cnc(Nc3ccc(N4CCOCC4)cc3)nc1-2		CHEMBL565211	=	IC50	nM	649.0	CHEMBL4722	Homo sapiens	IC50	uM	0.649
	2661318	CHEMBL1063937	Inhibition of Aurora A	B	CNC(=O)c1nn(C)c2c1C(C)(C)Cc1cnc(Nc3ccc(N(C)C)cc3)nc1-2		CHEMBL560301	=	IC50	nM	855.0	CHEMBL4722	Homo sapiens	IC50	uM	0.855
	2661320	CHEMBL1063937	Inhibition of Aurora A	B	CNC(=O)c1nn(C)c2c1C(C)(C)Cc1cnc(Nc3cccc(N4CCN(C)CC4)c3)nc1-2		CHEMBL564884	=	IC50	nM	1000.0	CHEMBL4722	Homo sapiens	IC50	uM	1.0
	2661321	CHEMBL1063937	Inhibition of Aurora A	B	CNC(=O)c1nn(C)c2c1C(C)(C)Cc1cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc1-2		CHEMBL564829	=	IC50	nM	1051.0	CHEMBL4722	Homo sapiens	IC50	uM	1.051
	2661323	CHEMBL1063937	Inhibition of Aurora A	B	CNC(=O)c1nn(C)c2c1C(C)(C)Cc1cnc(Nc3cccc(CN4CCN(C)CC4)c3)nc1-2		CHEMBL564470	=	IC50	nM	1184.0	CHEMBL4722	Homo sapiens	IC50	uM	1.184
	2661324	CHEMBL1063937	Inhibition of Aurora A	B	CNC(=O)c1nn(C)c2c1C(C)(C)Cc1cnc(Nc3ccc(OC4CCN(C)CC4)cc3)nc1-2		CHEMBL565137	=	IC50	nM	1343.0	CHEMBL4722	Homo sapiens	IC50	uM	1.343
	2661325	CHEMBL1063937	Inhibition of Aurora A	B	CNC(=O)c1nn(C)c2c1C(C)(C)Cc1cnc(Nc3cccc(N(C)C)c3)nc1-2		CHEMBL563366	=	IC50	nM	1437.0	CHEMBL4722	Homo sapiens	IC50	uM	1.437
	2661326	CHEMBL1063937	Inhibition of Aurora A	B	CNC(=O)c1nn(C)c2c1C(C)(C)Cc1cnc(Nc3cccc(OC4CCN(C)CC4)c3)nc1-2		CHEMBL560102	=	IC50	nM	1584.0	CHEMBL4722	Homo sapiens	IC50	uM	1.584
	2661327	CHEMBL1063937	Inhibition of Aurora A	B	CNC(=O)c1nn(C)c2c1C(C)(C)Cc1cnc(Nc3ccc(CN4CCN(C)CC4)cc3)nc1-2		CHEMBL549675	=	IC50	nM	1615.0	CHEMBL4722	Homo sapiens	IC50	uM	1.615
	2661330	CHEMBL1063937	Inhibition of Aurora A	B	CNC(=O)c1nn(C)c2c1C(C)(C)Cc1cnc(Nc3cccc(CN(C)C)c3)nc1-2		CHEMBL550964	=	IC50	nM	2940.0	CHEMBL4722	Homo sapiens	IC50	uM	2.94
	2661334	CHEMBL1063937	Inhibition of Aurora A	B	Cn1nc(C(=O)NC2CCCC2)c2c1-c1nc(Nc3ccccc3)ncc1CC2		CHEMBL563028	>	IC50	nM	10000.0	CHEMBL4722	Homo sapiens	IC50	uM	10.0
	2661335	CHEMBL1063937	Inhibition of Aurora A	B	Cn1nc(C(=O)Nc2ccccc2)c2c1-c1nc(Nc3ccccc3)ncc1CC2		CHEMBL563150	>	IC50	nM	10000.0	CHEMBL4722	Homo sapiens	IC50	uM	10.0
	2661336	CHEMBL1063937	Inhibition of Aurora A	B	Cn1nc(C(N)=O)c2c1-c1nc(Nc3ccccc3)ncc1CC2(C)C		CHEMBL560818	>	IC50	nM	10000.0	CHEMBL4722	Homo sapiens	IC50	uM	10.0
	2661339	CHEMBL1063937	Inhibition of Aurora A	B	CNC(=O)c1nn(C)c2c1C(C)(C)Cc1cnc(Nc3ccc(CN(C)C)cc3)nc1-2		CHEMBL561440	>	IC50	nM	5000.0	CHEMBL4722	Homo sapiens	IC50	uM	5.0
	2672279	CHEMBL1026220	Inhibition of recombinant Aurora A	B	COc1cc(O)c2c(c1)C(=O)c1cc(C)c(O)c(O)c1C2=O		CHEMBL556684	=	IC50	ug.mL-1	3.0	CHEMBL4722	Homo sapiens	IC50	ug ml-1	3.0
	2672281	CHEMBL1026220	Inhibition of recombinant Aurora A	B	COc1cc2c(c(O)c1-c1c(OC)cc(O)c3c1C(=O)C1=C(C3=O)[C@H](O)[C@@H](O)[C@@](C)(O)[C@@H]1O)C(=O)c1cc(O)c(C)cc1C2=O		CHEMBL554993	=	IC50	ug.mL-1	2.8	CHEMBL4722	Homo sapiens	IC50	ug ml-1	2.8
	2672293	CHEMBL1026220	Inhibition of recombinant Aurora A	B	COc1cc(O)c2c(c1)C(=O)c1cc(C)c(O)cc1C2=O		CHEMBL463054	=	IC50	ug.mL-1	1.9	CHEMBL4722	Homo sapiens	IC50	ug ml-1	1.9
	2672301	CHEMBL1026220	Inhibition of recombinant Aurora A	B	COc1cc(O)c2c(c1)C(=O)C1=C(C2=O)[C@H](O)[C@@H](O)[C@@](C)(O)[C@@H]1O		CHEMBL512054	=	IC50	ug.mL-1	1.3	CHEMBL4722	Homo sapiens	IC50	ug ml-1	1.3
	2696407	CHEMBL1064037	Inhibition of recombinant Aurora A expressed in Escherichia coli	B	Cn1cc(C2=C(c3cn(CCCN4CCOCC4)c4ccccc34)C(=O)NC2=O)c2ncccc21		CHEMBL552265	>	IC50	nM	40000.0	CHEMBL4722	Homo sapiens	IC50	uM	40.0
	2696408	CHEMBL1064037	Inhibition of recombinant Aurora A expressed in Escherichia coli	B	O=C1NC(=O)C(n2ccc3ncccc32)=C1c1cn(CCCn2ccnc2)c2ccc(Br)cc12		CHEMBL561066	>	IC50	nM	40000.0	CHEMBL4722	Homo sapiens	IC50	uM	40.0
	2696409	CHEMBL1064037	Inhibition of recombinant Aurora A expressed in Escherichia coli	B	O=C1NC(=O)C(n2ccc3ncccc32)=C1c1cn(CCn2ccnc2)c2ccccc12		CHEMBL558512	>	IC50	nM	40000.0	CHEMBL4722	Homo sapiens	IC50	uM	40.0
	2696437	CHEMBL1064037	Inhibition of recombinant Aurora A expressed in Escherichia coli	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	18.0	CHEMBL4722	Homo sapiens	IC50	uM	0.018
	2704619	CHEMBL1054854	Inhibition of Aurora-A at 10 uM by HotSpot assay relative to control	B	Cc1cc(O)cc(-c2nn(CC#N)cc2-c2cc(NC[C@H](C)O)nc(-c3cccnc3)n2)c1		CHEMBL560733	=	Inhibition	%	21.75	CHEMBL4722	Homo sapiens	INH	%	21.75
	2721553	CHEMBL1060961	Inhibition of Aurora A at 1 uM	B	C[C@@H](Oc1cc(-c2cnc3ccccn23)sc1C(N)=O)c1ccc(CNC(C)(C)C)cc1OC(F)F		CHEMBL551079	<	Inhibition	%	50.0	CHEMBL4722	Homo sapiens	INH	%	50.0
	2892446	CHEMBL1051356	Selectivity for AURKA as proportion of 290 kinases in screen with similar potency; non-selective = 1 highly selective = 0	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	=	Selectivity		0.0104	CHEMBL4722	Homo sapiens	Selectivity		0.0104
	2892447	CHEMBL1051356	Selectivity for AURKA as proportion of 290 kinases in screen with similar potency; non-selective = 1 highly selective = 0	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	Selectivity		0.0314	CHEMBL4722	Homo sapiens	Selectivity		0.0314
	2898997	CHEMBL1062833	Binding constant for AURKA kinase domain	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	=	Kd	nM	1600.0	CHEMBL4722	Homo sapiens	Kd	nM	1600.0
	2898998	CHEMBL1062833	Binding constant for AURKA kinase domain	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	>	Kd	nM	10000.0	CHEMBL4722	Homo sapiens	Kd	uM	10.0
	2898999	CHEMBL1062833	Binding constant for AURKA kinase domain	B	CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(Oc4cc(NC)ncn4)cc3)cc2C(F)(F)F)CC1		CHEMBL574738	>	Kd	nM	10000.0	CHEMBL4722	Homo sapiens	Kd	uM	10.0
	2899000	CHEMBL1062833	Binding constant for AURKA kinase domain	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	=	Kd	nM	590.0	CHEMBL4722	Homo sapiens	Kd	nM	590.0
	2899001	CHEMBL1062833	Binding constant for AURKA kinase domain	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	>	Kd	nM	10000.0	CHEMBL4722	Homo sapiens	Kd	uM	10.0
	2899002	CHEMBL1062833	Binding constant for AURKA kinase domain	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	=	Kd	nM	7400.0	CHEMBL4722	Homo sapiens	Kd	nM	7400.0
	2899003	CHEMBL1062833	Binding constant for AURKA kinase domain	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	>	Kd	nM	10000.0	CHEMBL4722	Homo sapiens	Kd	uM	10.0
	2899004	CHEMBL1062833	Binding constant for AURKA kinase domain	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	>	Kd	nM	10000.0	CHEMBL4722	Homo sapiens	Kd	uM	10.0
	2899005	CHEMBL1062833	Binding constant for AURKA kinase domain	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	>	Kd	nM	10000.0	CHEMBL4722	Homo sapiens	Kd	uM	10.0
	2899006	CHEMBL1062833	Binding constant for AURKA kinase domain	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	Kd	nM	10000.0	CHEMBL4722	Homo sapiens	Kd	uM	10.0
	2899007	CHEMBL1062833	Binding constant for AURKA kinase domain	B	COCC(=O)NC/C=C/c1ccc2ncnc(Nc3ccc(Oc4ccc(C)nc4)c(C)c3)c2c1		CHEMBL483321	>	Kd	nM	10000.0	CHEMBL4722	Homo sapiens	Kd	uM	10.0
	2899008	CHEMBL1062833	Binding constant for AURKA kinase domain	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	>	Kd	nM	10000.0	CHEMBL4722	Homo sapiens	Kd	uM	10.0
	2899009	CHEMBL1062833	Binding constant for AURKA kinase domain	B	CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL607707	>	Kd	nM	10000.0	CHEMBL4722	Homo sapiens	Kd	uM	10.0
	2899010	CHEMBL1062833	Binding constant for AURKA kinase domain	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	=	Kd	nM	2200.0	CHEMBL4722	Homo sapiens	Kd	nM	2200.0
	2899011	CHEMBL1062833	Binding constant for AURKA kinase domain	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	>	Kd	nM	10000.0	CHEMBL4722	Homo sapiens	Kd	uM	10.0
	2899012	CHEMBL1062833	Binding constant for AURKA kinase domain	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	>	Kd	nM	10000.0	CHEMBL4722	Homo sapiens	Kd	uM	10.0
	2899013	CHEMBL1062833	Binding constant for AURKA kinase domain	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	>	Kd	nM	10000.0	CHEMBL4722	Homo sapiens	Kd	uM	10.0
	2899014	CHEMBL1062833	Binding constant for AURKA kinase domain	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	=	Kd	nM	7100.0	CHEMBL4722	Homo sapiens	Kd	nM	7100.0
	2899015	CHEMBL1062833	Binding constant for AURKA kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	Kd	nM	10000.0	CHEMBL4722	Homo sapiens	Kd	uM	10.0
	2899016	CHEMBL1062833	Binding constant for AURKA kinase domain	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	=	Kd	nM	250.0	CHEMBL4722	Homo sapiens	Kd	nM	250.0
	2899017	CHEMBL1062833	Binding constant for AURKA kinase domain	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	10000.0	CHEMBL4722	Homo sapiens	Kd	uM	10.0
	2899018	CHEMBL1062833	Binding constant for AURKA kinase domain	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	>	Kd	nM	10000.0	CHEMBL4722	Homo sapiens	Kd	uM	10.0
	2899019	CHEMBL1062833	Binding constant for AURKA kinase domain	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL4722	Homo sapiens	Kd	uM	10.0
	2899020	CHEMBL1062833	Binding constant for AURKA kinase domain	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	=	Kd	nM	6.5	CHEMBL4722	Homo sapiens	Kd	nM	6.5
	2899021	CHEMBL1062833	Binding constant for AURKA kinase domain	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	>	Kd	nM	10000.0	CHEMBL4722	Homo sapiens	Kd	uM	10.0
	2899022	CHEMBL1062833	Binding constant for AURKA kinase domain	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Kd	nM	120.0	CHEMBL4722	Homo sapiens	Kd	nM	120.0
	2899807	CHEMBL1062833	Binding constant for AURKA kinase domain	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	>	Kd	nM	10000.0	CHEMBL4722	Homo sapiens	Kd	uM	10.0
	2899808	CHEMBL1062833	Binding constant for AURKA kinase domain	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762	>	Kd	nM	10000.0	CHEMBL4722	Homo sapiens	Kd	uM	10.0
	2899809	CHEMBL1062833	Binding constant for AURKA kinase domain	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	>	Kd	nM	10000.0	CHEMBL4722	Homo sapiens	Kd	uM	10.0
	2899810	CHEMBL1062833	Binding constant for AURKA kinase domain	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	>	Kd	nM	10000.0	CHEMBL4722	Homo sapiens	Kd	uM	10.0
	2899811	CHEMBL1062833	Binding constant for AURKA kinase domain	B	NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL440084	>	Kd	nM	10000.0	CHEMBL4722	Homo sapiens	Kd	uM	10.0
	2899812	CHEMBL1062833	Binding constant for AURKA kinase domain	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	10000.0	CHEMBL4722	Homo sapiens	Kd	uM	10.0
	2899813	CHEMBL1062833	Binding constant for AURKA kinase domain	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Kd	nM	110.0	CHEMBL4722	Homo sapiens	Kd	nM	110.0
	2899814	CHEMBL1062833	Binding constant for AURKA kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	>	Kd	nM	10000.0	CHEMBL4722	Homo sapiens	Kd	uM	10.0
	2899815	CHEMBL1062833	Binding constant for AURKA kinase domain	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Kd	nM	1700.0	CHEMBL4722	Homo sapiens	Kd	nM	1700.0
	2899816	CHEMBL1062833	Binding constant for AURKA kinase domain	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	Kd	nM	4.1	CHEMBL4722	Homo sapiens	Kd	nM	4.1
	2899817	CHEMBL1062833	Binding constant for AURKA kinase domain	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	>	Kd	nM	10000.0	CHEMBL4722	Homo sapiens	Kd	uM	10.0
	2899818	CHEMBL1062833	Binding constant for AURKA kinase domain	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	>	Kd	nM	10000.0	CHEMBL4722	Homo sapiens	Kd	uM	10.0
	2921436	CHEMBL1059261	Inhibition of AURKA assessed as enzyme activity at 1 uM relative to untreated control	B	Cc1ccc2c(Nc3ccc(Cl)cc3)nccc2c1Nc1ncccc1-c1ncnc2[nH]cnc12.Cl.Cl.Cl		CHEMBL3215582	=	Activity	%	100.0	CHEMBL4722	Homo sapiens	Activity	%	100.0
	2938295	CHEMBL1044907	Inhibition of AURA	B	Cc1cnc(Nc2ccccc2)nc1-c1c[nH]c(C(=O)N[C@H](CO)c2ccccc2)c1		CHEMBL565459	=	Ki	nM	15.0	CHEMBL4722	Homo sapiens	Ki	nM	15.0
	2938539	CHEMBL1044907	Inhibition of AURA	B	Cc1cnc(Nc2ccccc2Cl)nc1-c1c[nH]c(C(=O)N[C@H](CO)c2ccccc2)c1		CHEMBL571038	=	Ki	nM	1550.0	CHEMBL4722	Homo sapiens	Ki	nM	1550.0
	2938540	CHEMBL1044907	Inhibition of AURA	B	Cc1ccccc1Nc1ncc(C)c(-c2c[nH]c(C(=O)N[C@H](CO)c3ccccc3)c2)n1		CHEMBL584754	=	Ki	nM	860.0	CHEMBL4722	Homo sapiens	Ki	nM	860.0
	2938541	CHEMBL1044907	Inhibition of AURA	B	CCc1ccccc1Nc1ncc(C)c(-c2c[nH]c(C(=O)N[C@H](CO)c3ccccc3)c2)n1		CHEMBL572361	=	Ki	nM	1430.0	CHEMBL4722	Homo sapiens	Ki	nM	1430.0
	2938542	CHEMBL1044907	Inhibition of AURA	B	Cc1cnc(Nc2ccccc2F)nc1-c1c[nH]c(C(=O)N[C@H](CO)c2ccccc2)c1		CHEMBL572162	=	Ki	nM	160.0	CHEMBL4722	Homo sapiens	Ki	nM	160.0
	2938543	CHEMBL1044907	Inhibition of AURA	B	Cc1cnc(Nc2ccccc2C(F)(F)F)nc1-c1c[nH]c(C(=O)N[C@H](CO)c2ccccc2)c1		CHEMBL571030	>	Ki	nM	800.0	CHEMBL4722	Homo sapiens	Ki	nM	800.0
	2938544	CHEMBL1044907	Inhibition of AURA	B	Cc1cnc(Nc2ccccc2O)nc1-c1c[nH]c(C(=O)N[C@H](CO)c2ccccc2)c1		CHEMBL570366	=	Ki	nM	99.0	CHEMBL4722	Homo sapiens	Ki	nM	99.0
	2938545	CHEMBL1044907	Inhibition of AURA	B	Cc1cnc(Nc2ccccc2)nc1-c1c[nH]c(C(=O)N[C@@H](CO)c2ccccc2)c1		CHEMBL570367	=	Ki	nM	270.0	CHEMBL4722	Homo sapiens	Ki	nM	270.0
Not Active	2938599	CHEMBL1040612	Inhibition of AurA at 10 uM	B	O=C1OC(/C=C/c2ccccc2)=N/C1=C\c1cccnc1		CHEMBL565286		Inhibition	%		CHEMBL4722	Homo sapiens	INH		
	2939211	CHEMBL1044907	Inhibition of AURA	B	Cc1cnc(Nc2ccccc2)nc1-c1c[nH]c(C(=O)N[C@H](CO)c2cccc(Cl)c2)c1		CHEMBL577193	=	Ki	nM	19.0	CHEMBL4722	Homo sapiens	Ki	nM	19.0
	2939212	CHEMBL1044907	Inhibition of AURA	B	Cc1cccc([C@@H](CO)NC(=O)c2cc(-c3nc(Nc4ccccc4)ncc3C)c[nH]2)c1		CHEMBL565460	=	Ki	nM	45.0	CHEMBL4722	Homo sapiens	Ki	nM	45.0
	2939213	CHEMBL1044907	Inhibition of AURA	B	Cc1ccccc1Nc1ncc(C)c(-c2c[nH]c(C(=O)N[C@H](CO)c3cccc(Cl)c3)c2)n1		CHEMBL571031	=	Ki	nM	400.0	CHEMBL4722	Homo sapiens	Ki	nM	400.0
	2939214	CHEMBL1044907	Inhibition of AURA	B	Cc1cnc(Nc2cccc(C)c2C)nc1-c1c[nH]c(C(=O)N[C@H](CO)c2cccc(Cl)c2)c1		CHEMBL572157	=	Ki	nM	440.0	CHEMBL4722	Homo sapiens	Ki	nM	440.0
	2939215	CHEMBL1044907	Inhibition of AURA	B	Cc1cnc(Nc2cccc(F)c2C)nc1-c1c[nH]c(C(=O)N[C@H](CO)c2cccc(Cl)c2)c1		CHEMBL582829	=	Ki	nM	410.0	CHEMBL4722	Homo sapiens	Ki	nM	410.0
	2939216	CHEMBL1044907	Inhibition of AURA	B	Cc1cc(Cl)ccc1Nc1ncc(C)c(-c2c[nH]c(C(=O)N[C@H](CO)c3cccc(Cl)c3)c2)n1		CHEMBL568483	=	Ki	nM	410.0	CHEMBL4722	Homo sapiens	Ki	nM	410.0
	2939217	CHEMBL1044907	Inhibition of AURA	B	Cc1cnc(Nc2ccc(F)cc2Cl)nc1-c1c[nH]c(C(=O)N[C@H](CO)c2cccc(Cl)c2)c1		CHEMBL583042	=	Ki	nM	540.0	CHEMBL4722	Homo sapiens	Ki	nM	540.0
	2939218	CHEMBL1044907	Inhibition of AURA	B	Cc1cnc(Nc2ccc(Cl)cc2F)nc1-c1c[nH]c(C(=O)N[C@H](CO)c2cccc(Cl)c2)c1		CHEMBL576048	=	Ki	nM	540.0	CHEMBL4722	Homo sapiens	Ki	nM	540.0
	2939219	CHEMBL1044907	Inhibition of AURA	B	CCc1ccccc1Nc1ncc(C)c(-c2c[nH]c(C(=O)N[C@H](CO)c3cccc(Cl)c3)c2)n1		CHEMBL571056	=	Ki	nM	720.0	CHEMBL4722	Homo sapiens	Ki	nM	720.0
	2939220	CHEMBL1044907	Inhibition of AURA	B	Cc1cnc(Nc2cccc3c2CCC3)nc1-c1c[nH]c(C(=O)N[C@H](CO)c2cccc(Cl)c2)c1		CHEMBL568937	=	Ki	nM	550.0	CHEMBL4722	Homo sapiens	Ki	nM	550.0
	2939221	CHEMBL1044907	Inhibition of AURA	B	Cc1cnc(Nc2cccc3c2CCCC3)nc1-c1c[nH]c(C(=O)N[C@H](CO)c2cccc(Cl)c2)c1		CHEMBL570111	=	Ki	nM	280.0	CHEMBL4722	Homo sapiens	Ki	nM	280.0
	2939222	CHEMBL1044907	Inhibition of AURA	B	Cc1cnc(Nc2cccc3c2OCO3)nc1-c1c[nH]c(C(=O)N[C@H](CO)c2cccc(Cl)c2)c1		CHEMBL571484	=	Ki	nM	15.0	CHEMBL4722	Homo sapiens	Ki	nM	15.0
	2939223	CHEMBL1044907	Inhibition of AURA	B	Cc1cnc(Nc2cccc3c2OC(F)(F)O3)nc1-c1c[nH]c(C(=O)N[C@H](CO)c2cccc(Cl)c2)c1		CHEMBL576683	>	Ki	nM	800.0	CHEMBL4722	Homo sapiens	Ki	nM	800.0
	2939224	CHEMBL1044907	Inhibition of AURA	B	Cc1cnc(Nc2cccc3c2OCCO3)nc1-c1c[nH]c(C(=O)N[C@H](CO)c2cccc(Cl)c2)c1		CHEMBL571722	=	Ki	nM	11.0	CHEMBL4722	Homo sapiens	Ki	nM	11.0
	2939225	CHEMBL1044907	Inhibition of AURA	B	COc1cccc(Nc2ncc(C)c(-c3c[nH]c(C(=O)N[C@H](CO)c4cccc(Cl)c4)c3)n2)c1OC		CHEMBL569181	>	Ki	nM	200.0	CHEMBL4722	Homo sapiens	Ki	nM	200.0
Not Determined	2939238	CHEMBL1044907	Inhibition of AURA	B	Cc1cnc(Nc2ccccc2)nc1-c1c[nH]c(C(=O)N[C@H](CO)c2cccc(F)c2)c1		CHEMBL569869		Ki			CHEMBL4722	Homo sapiens	Ki		
	2945999	CHEMBL1054428	Inhibition of AuroraA at 2 uM	B	c1ccc2c(c1)CC(Nc1nc(Nc3ccncc3)nc(N3CCNCC3)n1)C2		CHEMBL575741	<	Inhibition	%	50.0	CHEMBL4722	Homo sapiens	INH	%	50.0
	2947557	CHEMBL1047347	Inhibition of Aurora A at 100 uM	B	COc1cc2nccc(Oc3ccc(NC(=O)N4CCN(c5ccccc5)C4=O)cc3F)c2cc1OC		CHEMBL573761	=	Inhibition	%	0.0	CHEMBL4722	Homo sapiens	INH	%	0.0
	2989957	CHEMBL1039184	Inhibition of Aurora A at 100 nM by radiometric protein kinase assay	B	CCn1cnc(-c2cc3nccc(Oc4ccc(NC(=O)C5(C(=O)Nc6ccccc6)CC5)cc4F)c3s2)c1		CHEMBL565807	=	Inhibition	%	96.0	CHEMBL4722	Homo sapiens	INH	%	96.0
	2992198	CHEMBL1044501	Inhibition of human Aurora A at 20 uM by FRET assay	B	C#Cn1c(C#CCCO)nc(-c2ccc(F)cc2)c1-c1ccncc1		CHEMBL576620	=	Inhibition	%	7.0	CHEMBL4722	Homo sapiens	INH	%	7.0
	3052529	CHEMBL1047780	Residual activity of Aurora-A at 1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3F)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL604483	=	Residual activity	%	28.0	CHEMBL4722	Homo sapiens	Residual activity	%	28.0
	3052781	CHEMBL1047807	Residual activity of Aurora-A at 10 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3F)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL604483	=	Residual activity	%	4.0	CHEMBL4722	Homo sapiens	Residual activity	%	4.0
	3054090	CHEMBL1066608	Residual activity of Aurora-A at 0.1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL595143	=	Residual activity	%	52.0	CHEMBL4722	Homo sapiens	Residual activity	%	52.0
	3055377	CHEMBL1047780	Residual activity of Aurora-A at 1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL595143	=	Residual activity	%	22.0	CHEMBL4722	Homo sapiens	Residual activity	%	22.0
	3055629	CHEMBL1047807	Residual activity of Aurora-A at 10 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL595143	=	Residual activity	%	5.0	CHEMBL4722	Homo sapiens	Residual activity	%	5.0
	3056934	CHEMBL1066608	Residual activity of Aurora-A at 0.1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCCC1		CHEMBL595373	=	Residual activity	%	68.0	CHEMBL4722	Homo sapiens	Residual activity	%	68.0
	3058254	CHEMBL1047780	Residual activity of Aurora-A at 1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCCC1		CHEMBL595373	=	Residual activity	%	25.0	CHEMBL4722	Homo sapiens	Residual activity	%	25.0
	3058506	CHEMBL1047807	Residual activity of Aurora-A at 10 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCCC1		CHEMBL595373	=	Residual activity	%	4.0	CHEMBL4722	Homo sapiens	Residual activity	%	4.0
	3062441	CHEMBL1048634	Binding affinity to human aurora kinase A at 200 nM by cell-based competition binding assay relative to control in presence of DTT	B	CO[C@@H]1[C@H](N(C)C(=O)CCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)N[C@H]2CSSC[C@@H](C(=O)NCC(N)=O)NC(=O)CNC(=O)[C@H](Cc3ccccc3)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc3ccccc3)NC(=O)[C@H](C(C)C)NC2=O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL595545	=	Activity	%	19.0	CHEMBL4722	Homo sapiens	Activity	%	19.0
	3063576	CHEMBL1045162	Binding affinity to human aurora kinase A at 500 nM by cell-based competition binding assay relative to control in presence of DTT	B	CO[C@@H]1[C@H](N(C)C(=O)CCC(=O)NCCC(=O)NCCC(=O)NCCC(N)=O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL595546	=	Activity	%	4.2	CHEMBL4722	Homo sapiens	Activity	%	4.2
	3063666	CHEMBL1038877	Binding affinity to human aurora kinase A at 50 nM by cell-based competition binding assay relative to control in presence of DTT	B	CO[C@@H]1[C@H](N(C)C(=O)CCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)N[C@H]2CNC(=O)C[C@@H](C(N)=O)NC(=O)CNC(=O)[C@H](Cc3ccccc3)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc3ccccc3)NC(=O)[C@H](C(C)C)NC2=O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL609010	=	Activity	%	63.0	CHEMBL4722	Homo sapiens	Activity	%	63.0
	3065847	CHEMBL1068653	Inhibition of AURKA at 10 uM	B	CN1C(=O)/C(=C2/C(=O)Nc3ccccc32)c2ccccc21		CHEMBL607535	=	Inhibition	%	0.0	CHEMBL4722	Homo sapiens	INH	%	0.0
	3066913	CHEMBL1068653	Inhibition of AURKA at 10 uM	B	O=C1Nc2ccccc2/C1=C1\C(=O)N(CCCc2ccccc2)c2ccccc21		CHEMBL607196	=	Inhibition	%	16.0	CHEMBL4722	Homo sapiens	INH	%	16.0
	3071579	CHEMBL1073376	Inhibition of Aurora-A by microplate scintillation counting	B	COc1cc2ncnc(Nc3ccc(-c4nc5ccccc5s4)cc3)c2cc1OC		CHEMBL473556	=	IC50	nM	350.0	CHEMBL4722	Homo sapiens	IC50	uM	0.35
	3071580	CHEMBL1073376	Inhibition of Aurora-A by microplate scintillation counting	B	COc1cc2ncnc(Nc3ccc(-c4nc5ccccc5s4)cc3C)c2cc1OC		CHEMBL514942	=	IC50	nM	4400.0	CHEMBL4722	Homo sapiens	IC50	uM	4.4
	3071581	CHEMBL1073376	Inhibition of Aurora-A by microplate scintillation counting	B	COc1cc2ncnc(Nc3ccc(-c4nc5ccccc5s4)cc3O)c2cc1OC		CHEMBL593293	>	IC50	nM	10000.0	CHEMBL4722	Homo sapiens	IC50	uM	10.0
	3071582	CHEMBL1073376	Inhibition of Aurora-A by microplate scintillation counting	B	COc1cc(-c2nc3ccccc3s2)ccc1Nc1ncnc2cc(OC)c(OC)cc12		CHEMBL596059	>	IC50	nM	10000.0	CHEMBL4722	Homo sapiens	IC50	uM	10.0
	3071583	CHEMBL1073376	Inhibition of Aurora-A by microplate scintillation counting	B	COc1cc2c(Nc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL595615	=	IC50	nM	14.0	CHEMBL4722	Homo sapiens	IC50	uM	0.014
	3071584	CHEMBL1073376	Inhibition of Aurora-A by microplate scintillation counting	B	COc1cc2c(Nc3ccc(-c4nc5ccccc5s4)cc3C)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL595406	=	IC50	nM	340.0	CHEMBL4722	Homo sapiens	IC50	uM	0.34
	3071585	CHEMBL1073376	Inhibition of Aurora-A by microplate scintillation counting	B	COc1cc2c(Nc3ccc(-c4nc5ccccc5s4)cc3O)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL595142	=	IC50	nM	230.0	CHEMBL4722	Homo sapiens	IC50	uM	0.23
	3071586	CHEMBL1073376	Inhibition of Aurora-A by microplate scintillation counting	B	COc1cc(-c2nc3ccccc3s2)ccc1Nc1ncnc2cc(OCCCN3CCN(C)CC3)c(OC)cc12		CHEMBL593221	=	IC50	nM	65.0	CHEMBL4722	Homo sapiens	IC50	uM	0.065
	3071587	CHEMBL1073376	Inhibition of Aurora-A by microplate scintillation counting	B	COc1cc2c(Nc3ccc(-c4nc5ccccc5s4)cc3OC(F)(F)F)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL593245	=	IC50	nM	290.0	CHEMBL4722	Homo sapiens	IC50	uM	0.29
	3071588	CHEMBL1073376	Inhibition of Aurora-A by microplate scintillation counting	B	COc1cc2c(Nc3ccc(-c4nc5ccccc5s4)cc3F)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL594228	=	IC50	nM	26.0	CHEMBL4722	Homo sapiens	IC50	uM	0.026
	3071589	CHEMBL1073376	Inhibition of Aurora-A by microplate scintillation counting	B	COc1cc2c(Nc3ccc(-c4nc5ccccc5s4)c(C)c3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL596087	=	IC50	nM	230.0	CHEMBL4722	Homo sapiens	IC50	uM	0.23
	3071590	CHEMBL1073376	Inhibition of Aurora-A by microplate scintillation counting	B	COc1cc2c(Nc3ccc(-c4nc5ccccc5s4)c(O)c3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL606466	=	IC50	nM	91.0	CHEMBL4722	Homo sapiens	IC50	uM	0.091
	3071591	CHEMBL1073376	Inhibition of Aurora-A by microplate scintillation counting	B	COc1cc2c(Nc3ccc(-c4nc5ccccc5s4)c(OC)c3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL593860	=	IC50	nM	120.0	CHEMBL4722	Homo sapiens	IC50	uM	0.12
	3071592	CHEMBL1073376	Inhibition of Aurora-A by microplate scintillation counting	B	COc1cc2c(Nc3ccc(-c4nc5ccccc5s4)c(F)c3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL593987	=	IC50	nM	9.0	CHEMBL4722	Homo sapiens	IC50	uM	0.009
	3071593	CHEMBL1073376	Inhibition of Aurora-A by microplate scintillation counting	B	COc1cc2c(Nc3ccc(-c4nc5ccccc5s4)c(Cl)c3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL593274	=	IC50	nM	27.0	CHEMBL4722	Homo sapiens	IC50	uM	0.027
	3071594	CHEMBL1073376	Inhibition of Aurora-A by microplate scintillation counting	B	COc1ccc2nc(-c3ccc(Nc4ncnc5cc(OCCCN6CCN(C)CC6)c(OC)cc45)cc3)sc2c1		CHEMBL593306	=	IC50	nM	62.0	CHEMBL4722	Homo sapiens	IC50	uM	0.062
	3071595	CHEMBL1073376	Inhibition of Aurora-A by microplate scintillation counting	B	COc1cc2c(Nc3ccc(-c4nc5ccc(F)cc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL604992	=	IC50	nM	26.0	CHEMBL4722	Homo sapiens	IC50	uM	0.026
	3071596	CHEMBL1073376	Inhibition of Aurora-A by microplate scintillation counting	B	COc1cc2c(Nc3ccc(-c4nc5ccc(Cl)cc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL593275	=	IC50	nM	54.0	CHEMBL4722	Homo sapiens	IC50	uM	0.054
	3071597	CHEMBL1073376	Inhibition of Aurora-A by microplate scintillation counting	B	COc1cc2c(Nc3ccc(-c4nc5cc(Cl)ccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL596292	=	IC50	nM	24.0	CHEMBL4722	Homo sapiens	IC50	uM	0.024
	3071598	CHEMBL1073376	Inhibition of Aurora-A by microplate scintillation counting	B	COc1cc2c(Nc3ccc(-c4nc5cc(C(F)(F)F)ccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL593908	=	IC50	nM	60.0	CHEMBL4722	Homo sapiens	IC50	uM	0.06
	3071599	CHEMBL1073376	Inhibition of Aurora-A by microplate scintillation counting	B	COc1cc2c(Nc3ccc(-c4nc5ccc(Cl)cc5s4)cc3F)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL593909	=	IC50	nM	85.0	CHEMBL4722	Homo sapiens	IC50	uM	0.085
	3072610	CHEMBL1073376	Inhibition of Aurora-A by microplate scintillation counting	B	COc1cc2c(N(C)c3ccc(-c4nc5ccccc5s4)c(OC)c3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL593770	=	IC50	nM	3300.0	CHEMBL4722	Homo sapiens	IC50	uM	3.3
	3072611	CHEMBL1073376	Inhibition of Aurora-A by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3F)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL604483	=	IC50	nM	220.0	CHEMBL4722	Homo sapiens	IC50	uM	0.22
	3072612	CHEMBL1073376	Inhibition of Aurora-A by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL595143	=	IC50	nM	82.0	CHEMBL4722	Homo sapiens	IC50	uM	0.082
	3072613	CHEMBL1073376	Inhibition of Aurora-A by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCCC1		CHEMBL595373	=	IC50	nM	170.0	CHEMBL4722	Homo sapiens	IC50	uM	0.17
	3072773	CHEMBL1073376	Inhibition of Aurora-A by microplate scintillation counting	B	COc1cc2ncnc(Nc3ccc(-c4nc5ccccc5s4)cc3)c2cc1OCCCN1CCN(C)CC1		CHEMBL593292	=	IC50	nM	110.0	CHEMBL4722	Homo sapiens	IC50	uM	0.11
	3072774	CHEMBL1073376	Inhibition of Aurora-A by microplate scintillation counting	B	COc1cc2ncnc(Nc3ccc(-c4nc5ccccc5s4)cc3C)c2cc1OCCCN1CCN(C)CC1		CHEMBL595374	=	IC50	nM	9400.0	CHEMBL4722	Homo sapiens	IC50	uM	9.4
	3072775	CHEMBL1073376	Inhibition of Aurora-A by microplate scintillation counting	B	COc1cc2ncnc(Nc3ccc(-c4nc5ccccc5s4)cc3O)c2cc1OCCCN1CCN(C)CC1		CHEMBL593294	=	IC50	nM	800.0	CHEMBL4722	Homo sapiens	IC50	uM	0.8
	3072776	CHEMBL1073376	Inhibition of Aurora-A by microplate scintillation counting	B	COc1cc(-c2nc3ccccc3s2)ccc1Nc1ncnc2cc(OC)c(OCCCN3CCN(C)CC3)cc12		CHEMBL593910	=	IC50	nM	1300.0	CHEMBL4722	Homo sapiens	IC50	uM	1.3
	3072777	CHEMBL1073376	Inhibition of Aurora-A by microplate scintillation counting	B	COc1cc2ncnc(Nc3ccc(-c4nc5ccccc5s4)cc3F)c2cc1OCCCN1CCN(C)CC1		CHEMBL594661	=	IC50	nM	390.0	CHEMBL4722	Homo sapiens	IC50	uM	0.39
	3072778	CHEMBL1073376	Inhibition of Aurora-A by microplate scintillation counting	B	COc1cc2ncnc(Nc3ccc(-c4nc5ccccc5s4)c(O)c3)c2cc1OCCCN1CCN(C)CC1		CHEMBL604485	=	IC50	nM	300.0	CHEMBL4722	Homo sapiens	IC50	uM	0.3
	3072779	CHEMBL1073376	Inhibition of Aurora-A by microplate scintillation counting	B	COc1cc2ncnc(Nc3ccc(-c4nc5ccccc5s4)c(OC)c3)c2cc1OCCCN1CCN(C)CC1		CHEMBL593911	=	IC50	nM	1600.0	CHEMBL4722	Homo sapiens	IC50	uM	1.6
	3072780	CHEMBL1073376	Inhibition of Aurora-A by microplate scintillation counting	B	COc1cc2ncnc(Nc3ccc(-c4nc5ccccc5s4)c(F)c3)c2cc1OCCCN1CCN(C)CC1		CHEMBL593760	=	IC50	nM	200.0	CHEMBL4722	Homo sapiens	IC50	uM	0.2
	3072781	CHEMBL1073376	Inhibition of Aurora-A by microplate scintillation counting	B	COc1cc2ncnc(Nc3ccc(-c4nc5ccccc5s4)c(Cl)c3)c2cc1OCCCN1CCN(C)CC1		CHEMBL604893	=	IC50	nM	690.0	CHEMBL4722	Homo sapiens	IC50	uM	0.69
	3072782	CHEMBL1073376	Inhibition of Aurora-A by microplate scintillation counting	B	COc1cc2ncnc(Nc3ccc(-c4nc5cc(Cl)ccc5s4)cc3)c2cc1OCCCN1CCN(C)CC1		CHEMBL593971	=	IC50	nM	400.0	CHEMBL4722	Homo sapiens	IC50	uM	0.4
	3072783	CHEMBL1073376	Inhibition of Aurora-A by microplate scintillation counting	B	COc1cc2ncnc(Nc3ccc(-c4nc5cc(C(F)(F)F)ccc5s4)cc3)c2cc1OCCCN1CCN(C)CC1		CHEMBL593905	=	IC50	nM	1200.0	CHEMBL4722	Homo sapiens	IC50	uM	1.2
	3072852	CHEMBL1066608	Residual activity of Aurora-A at 0.1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3F)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL604483	=	Residual activity	%	65.0	CHEMBL4722	Homo sapiens	Residual activity	%	65.0
	3084402	CHEMBL1072681	Inhibition of Aurora A	B	NCCn1cc(-c2cc(-c3cc4ccccc4s3)c3[nH]ncc3c2)c2nc(N)ncc21		CHEMBL590109	=	IC50	nM	1100.0	CHEMBL4722	Homo sapiens	IC50	uM	1.1
	3091553	CHEMBL1067151	Inhibition of AUR2	B	O=C1Nc2cc3c(O)cccc3c3c4c(cc1c23)OCO4		CHEMBL609040	=	IC50	nM	2140.0	CHEMBL4722	Homo sapiens	IC50	nM	2140.0
	3091554	CHEMBL1067151	Inhibition of AUR2	B	COc1c(O)cc2c3c(cc4ccc(O)cc4c13)NC2=O		CHEMBL388956	=	IC50	nM	5000.0	CHEMBL4722	Homo sapiens	IC50	nM	5000.0
	3091555	CHEMBL1067151	Inhibition of AUR2	B	COc1ccc2nc3[nH]nc(C)c3c(OC)c2c1		CHEMBL603097	=	IC50	nM	3500.0	CHEMBL4722	Homo sapiens	IC50	nM	3500.0
	3094786	CHEMBL1068404	Inhibition of AurA at 1 uM by microfluidic substrate phosphorylation assay	B	NCCNC(=O)c1cc(-c2scc3c2OCCO3)cnc1N		CHEMBL599171	=	Inhibition	%	8.0	CHEMBL4722	Homo sapiens	INH	%	8.0
	3094807	CHEMBL1068404	Inhibition of AurA at 1 uM by microfluidic substrate phosphorylation assay	B	NCCNC(=O)c1cc(-c2ccsc2)cnc1N		CHEMBL610226	=	Inhibition	%	22.0	CHEMBL4722	Homo sapiens	INH	%	22.0
	3094816	CHEMBL1068404	Inhibition of AurA at 1 uM by microfluidic substrate phosphorylation assay	B	NC(=O)c1ccc(-c2cc(-c3cccc4c3OCO4)cnc2N)cc1		CHEMBL590335	=	Inhibition	%	31.0	CHEMBL4722	Homo sapiens	INH	%	31.0
	3094826	CHEMBL1068404	Inhibition of AurA at 1 uM by microfluidic substrate phosphorylation assay	B	NC(=O)c1ccc(-c2cc(-c3scc4c3OCCO4)cnc2N)cc1		CHEMBL602931	=	Inhibition	%	51.0	CHEMBL4722	Homo sapiens	INH	%	51.0
Not Active	3098418	CHEMBL1067041	Inhibition of human Aurora A	B	O=C(CC(Nc1ccc(Oc2cc(NC(=O)N3CCCC3)ncn2)c(F)c1)C(F)(F)F)Nc1ccccc1		CHEMBL612137		Inhibition	%		CHEMBL4722	Homo sapiens	INH		
	3104136	CHEMBL1066412	Inhibition of recombinant Aurora A by IMAP assay	B	C[C@@H](Oc1ccc2ncccc2c1)c1c(Cl)ccc(F)c1Cl		CHEMBL600795	>	IC50	nM	50000.0	CHEMBL4722	Homo sapiens	IC50	uM	50.0
	3104183	CHEMBL1066412	Inhibition of recombinant Aurora A by IMAP assay	B	C[C@@H](Oc1ccc2ncc(C3CC3C(N)=O)cc2c1)c1c(Cl)ccc(F)c1Cl		CHEMBL602472	=	IC50	nM	22000.0	CHEMBL4722	Homo sapiens	IC50	uM	22.0
	3104228	CHEMBL1066412	Inhibition of recombinant Aurora A by IMAP assay	B	C[C@@H](Oc1ccc2ncc(/C=C/C(N)=O)cc2c1)c1c(Cl)ccc(F)c1Cl		CHEMBL602471	=	IC50	nM	6400.0	CHEMBL4722	Homo sapiens	IC50	uM	6.4
	3117089	CHEMBL1072179	Inhibition of Aurora A	B	NC(=O)c1nn(-c2ccc(S(N)(=O)=O)cc2)c2c1CCc1cnc(NC3CCCC3)nc1-2		CHEMBL606000	=	IC50	nM	442.0	CHEMBL4722	Homo sapiens	IC50	uM	0.442
	3117094	CHEMBL1072179	Inhibition of Aurora A	B	Cn1nc(C(N)=O)c2c1-c1nc(NC3CCN(C(=O)c4ccccc4)CC3)ncc1CC2		CHEMBL599428	=	IC50	nM	670.0	CHEMBL4722	Homo sapiens	IC50	uM	0.67
	3117095	CHEMBL1072179	Inhibition of Aurora A	B	CC(=O)Nc1ccc(CNc2ncc3c(n2)-c2c(c(C(N)=O)nn2C)CC3)cc1		CHEMBL598986	=	IC50	nM	672.0	CHEMBL4722	Homo sapiens	IC50	uM	0.672
	3117098	CHEMBL1072179	Inhibition of Aurora A	B	Cn1nc(C(N)=O)c2c1-c1nc(NCc3ccc(S(C)(=O)=O)cc3)ncc1CC2		CHEMBL598987	=	IC50	nM	890.0	CHEMBL4722	Homo sapiens	IC50	uM	0.89
	3117114	CHEMBL1072179	Inhibition of Aurora A	B	Cn1nc(C(N)=O)c2c1-c1nc(NCc3ccccc3)ncc1CC2		CHEMBL599629	=	IC50	nM	1004.0	CHEMBL4722	Homo sapiens	IC50	uM	1.004
	3117116	CHEMBL1072179	Inhibition of Aurora A	B	COc1cccc(CNc2ncc3c(n2)-c2c(c(C(N)=O)nn2C)CC3)c1		CHEMBL599630	=	IC50	nM	1144.0	CHEMBL4722	Homo sapiens	IC50	uM	1.144
	3117117	CHEMBL1072179	Inhibition of Aurora A	B	Cn1nc(C(N)=O)c2c1-c1nc(NC3CCN(C(=O)C4CCN(S(C)(=O)=O)CC4)CC3)ncc1CC2		CHEMBL597753	=	IC50	nM	1237.0	CHEMBL4722	Homo sapiens	IC50	uM	1.237
	3117119	CHEMBL1072179	Inhibition of Aurora A	B	CN1CCN(c2ccc(CNc3ncc4c(n3)-c3c(c(C(N)=O)nn3C)CC4)cc2)CC1		CHEMBL598988	=	IC50	nM	1287.0	CHEMBL4722	Homo sapiens	IC50	uM	1.287
	3117120	CHEMBL1072179	Inhibition of Aurora A	B	Cn1nc(C(N)=O)c2c1-c1nc(NC3CCN(C(=O)C4CCN(S(=O)(=O)c5ccccc5)CC4)CC3)ncc1CC2		CHEMBL592256	=	IC50	nM	1288.0	CHEMBL4722	Homo sapiens	IC50	uM	1.288
	3117122	CHEMBL1072179	Inhibition of Aurora A	B	CCOC(=O)N1CCC(C(=O)N2CCC(Nc3ncc4c(n3)-c3c(c(C(N)=O)nn3C)CC4)CC2)CC1		CHEMBL598401	=	IC50	nM	1308.0	CHEMBL4722	Homo sapiens	IC50	uM	1.308
	3117125	CHEMBL1072179	Inhibition of Aurora A	B	COc1ccc(CNc2ncc3c(n2)-c2c(c(C(N)=O)nn2C)CC3)cc1		CHEMBL599631	=	IC50	nM	1447.0	CHEMBL4722	Homo sapiens	IC50	uM	1.447
	3117128	CHEMBL1072179	Inhibition of Aurora A	B	Cn1nc(C(N)=O)c2c1-c1nc(NCc3ccc(Br)cc3)ncc1CC2		CHEMBL610218	=	IC50	nM	1688.0	CHEMBL4722	Homo sapiens	IC50	uM	1.688
	3117130	CHEMBL1072179	Inhibition of Aurora A	B	Cn1nc(C(N)=O)c2c1-c1nc(NCc3ccncc3)ncc1CC2		CHEMBL591230	=	IC50	nM	1923.0	CHEMBL4722	Homo sapiens	IC50	uM	1.923
	3117131	CHEMBL1072179	Inhibition of Aurora A	B	CC(=O)N1CCC(n2nc(C(N)=O)c3c2-c2nc(NC4CCCC4)ncc2CC3)CC1		CHEMBL603079	=	IC50	nM	1970.0	CHEMBL4722	Homo sapiens	IC50	uM	1.97
	3117134	CHEMBL1072179	Inhibition of Aurora A	B	CN1CCN(c2cccc(CNc3ncc4c(n3)-c3c(c(C(N)=O)nn3C)CC4)c2)CC1		CHEMBL605350	=	IC50	nM	2136.0	CHEMBL4722	Homo sapiens	IC50	uM	2.136
	3117137	CHEMBL1072179	Inhibition of Aurora A	B	Cn1nc(C(N)=O)c2c1-c1nc(NCc3cccnc3)ncc1CC2		CHEMBL597352	=	IC50	nM	2306.0	CHEMBL4722	Homo sapiens	IC50	uM	2.306
	3117138	CHEMBL1072179	Inhibition of Aurora A	B	COc1ccc(-n2nc(C(N)=O)c3c2-c2nc(NC4CCCC4)ncc2CC3)cc1		CHEMBL605153	=	IC50	nM	2312.0	CHEMBL4722	Homo sapiens	IC50	uM	2.312
	3117143	CHEMBL1072179	Inhibition of Aurora A	B	CN(O)C(=O)c1nn(C)c2c1CCc1cnc(NC3CCCC3)nc1-2		CHEMBL599824	=	IC50	nM	3057.0	CHEMBL4722	Homo sapiens	IC50	uM	3.057
	3117144	CHEMBL1072179	Inhibition of Aurora A	B	CNC(=O)c1nn(C)c2c1CCc1cnc(NC3CCN(C(=O)C4CCN(S(=O)(=O)c5ccccc5)CC4)CC3)nc1-2		CHEMBL592272	=	IC50	nM	3112.0	CHEMBL4722	Homo sapiens	IC50	uM	3.112
	3117145	CHEMBL1072179	Inhibition of Aurora A	B	CNC(=O)c1nn(C)c2c1CCc1cnc(NC3CCN(C(=O)C4CCN(S(C)(=O)=O)CC4)CC3)nc1-2		CHEMBL597754	=	IC50	nM	3500.0	CHEMBL4722	Homo sapiens	IC50	uM	3.5
	3117146	CHEMBL1072179	Inhibition of Aurora A	B	Cn1nc(C(=O)N(O)C2CCCCC2)c2c1-c1nc(NC3CCCC3)ncc1CC2		CHEMBL605781	=	IC50	nM	3839.0	CHEMBL4722	Homo sapiens	IC50	uM	3.839
	3117148	CHEMBL1072179	Inhibition of Aurora A	B	NC(=O)c1nn(-c2ccccc2)c2c1CCc1cnc(NC3CCCC3)nc1-2		CHEMBL599210	=	IC50	nM	4050.0	CHEMBL4722	Homo sapiens	IC50	uM	4.05
	3117152	CHEMBL1072179	Inhibition of Aurora A	B	Cn1nc(C(=O)N(O)Cc2ccccc2)c2c1-c1nc(NC3CCCC3)ncc1CC2		CHEMBL605774	=	IC50	nM	4564.0	CHEMBL4722	Homo sapiens	IC50	uM	4.564
	3117154	CHEMBL1072179	Inhibition of Aurora A	B	Cn1nc(C(N)=O)c2c1-c1nc(NCCO)ncc1CC2		CHEMBL597353	=	IC50	nM	4597.0	CHEMBL4722	Homo sapiens	IC50	uM	4.597
	3117155	CHEMBL1072179	Inhibition of Aurora A	B	Cn1nc(C(N)=O)c2c1-c1nc(NCc3ccccn3)ncc1CC2		CHEMBL607852	=	IC50	nM	4643.0	CHEMBL4722	Homo sapiens	IC50	uM	4.643
	3117156	CHEMBL1072179	Inhibition of Aurora A	B	CN1CCN(C(=O)N2CCC(Nc3ncc4c(n3)-c3c(c(C(N)=O)nn3C)CC4)CC2)CC1		CHEMBL598185	=	IC50	nM	4708.0	CHEMBL4722	Homo sapiens	IC50	uM	4.708
	3117161	CHEMBL1072179	Inhibition of Aurora A	B	NC(=O)c1nn(CCO)c2c1CCc1cnc(NC3CCCC3)nc1-2		CHEMBL600876	=	IC50	nM	6040.0	CHEMBL4722	Homo sapiens	IC50	uM	6.04
	3117200	CHEMBL1072179	Inhibition of Aurora A	B	Cn1nc(C(N)=O)c2c1-c1nc(N)ncc1CC2		CHEMBL603313	>	IC50	nM	10000.0	CHEMBL4722	Homo sapiens	IC50	uM	10.0
	3117202	CHEMBL1072179	Inhibition of Aurora A	B	Cn1nc(C(N)=O)c2c1-c1nc(NCCN3CCOCC3)ncc1CC2		CHEMBL605208	>	IC50	nM	10000.0	CHEMBL4722	Homo sapiens	IC50	uM	10.0
	3117203	CHEMBL1072179	Inhibition of Aurora A	B	Cn1nc(C(N)=O)c2c1-c1nc(NCCN3CCCCC3)ncc1CC2		CHEMBL608444	>	IC50	nM	10000.0	CHEMBL4722	Homo sapiens	IC50	uM	10.0
	3117204	CHEMBL1072179	Inhibition of Aurora A	B	Cn1nc(C(N)=O)c2c1-c1nc(NC3CCCCC3)ncc1CC2		CHEMBL591467	>	IC50	nM	10000.0	CHEMBL4722	Homo sapiens	IC50	uM	10.0
	3117205	CHEMBL1072179	Inhibition of Aurora A	B	CCN1CCC(Nc2ncc3c(n2)-c2c(c(C(N)=O)nn2C)CC3)CC1		CHEMBL599401	>	IC50	nM	10000.0	CHEMBL4722	Homo sapiens	IC50	uM	10.0
	3117206	CHEMBL1072179	Inhibition of Aurora A	B	Cn1nc(C(N)=O)c2c1-c1nc(NC3CCCC3)ncc1CC2		CHEMBL599607	>	IC50	nM	10000.0	CHEMBL4722	Homo sapiens	IC50	uM	10.0
	3117208	CHEMBL1072179	Inhibition of Aurora A	B	CNC(=O)c1nn(C)c2c1CCc1cnc(NC3CCCC3)nc1-2		CHEMBL598382	>	IC50	nM	10000.0	CHEMBL4722	Homo sapiens	IC50	uM	10.0
	3117210	CHEMBL1072179	Inhibition of Aurora A	B	CC(CN(C)C)NC(=O)c1nn(C)c2c1CCc1cnc(NC3CCCC3)nc1-2		CHEMBL597361	>	IC50	nM	10000.0	CHEMBL4722	Homo sapiens	IC50	uM	10.0
	3117212	CHEMBL1072179	Inhibition of Aurora A	B	CN(C)CCN(C)C(=O)c1nn(C)c2c1CCc1cnc(NC3CCCC3)nc1-2		CHEMBL597362	>	IC50	nM	10000.0	CHEMBL4722	Homo sapiens	IC50	uM	10.0
	3117214	CHEMBL1072179	Inhibition of Aurora A	B	CN1CCN(C(=O)c2nn(C)c3c2CCc2cnc(NC4CCCC4)nc2-3)CC1		CHEMBL604092	>	IC50	nM	10000.0	CHEMBL4722	Homo sapiens	IC50	uM	10.0
	3117215	CHEMBL1072179	Inhibition of Aurora A	B	NC(=O)c1nn(Cc2ccccc2)c2c1CCc1cnc(NC3CCCC3)nc1-2		CHEMBL607187	>	IC50	nM	10000.0	CHEMBL4722	Homo sapiens	IC50	uM	10.0
	3117216	CHEMBL1072179	Inhibition of Aurora A	B	NC(=O)c1nn(-c2ccccn2)c2c1CCc1cnc(NC3CCCC3)nc1-2		CHEMBL597977	>	IC50	nM	10000.0	CHEMBL4722	Homo sapiens	IC50	uM	10.0
	3117217	CHEMBL1072179	Inhibition of Aurora A	B	NC(=O)c1nn(CC(F)(F)F)c2c1CCc1cnc(NC3CCCC3)nc1-2		CHEMBL602904	>	IC50	nM	10000.0	CHEMBL4722	Homo sapiens	IC50	uM	10.0
	3117218	CHEMBL1072179	Inhibition of Aurora A	B	CN1CCC(n2nc(C(N)=O)c3c2-c2nc(NC4CCCC4)ncc2CC3)CC1		CHEMBL603108	>	IC50	nM	10000.0	CHEMBL4722	Homo sapiens	IC50	uM	10.0
	3117219	CHEMBL1072179	Inhibition of Aurora A	B	CNC(=O)c1nn(C2CCN(C)CC2)c2c1CCc1cnc(NC3CCCC3)nc1-2		CHEMBL600394	>	IC50	nM	10000.0	CHEMBL4722	Homo sapiens	IC50	uM	10.0
	3117220	CHEMBL1072179	Inhibition of Aurora A	B	CNC(=O)c1nn(C)c2c1CCc1cnc(NC3CCCCC3)nc1-2		CHEMBL591463	>	IC50	nM	10000.0	CHEMBL4722	Homo sapiens	IC50	uM	10.0
	3117221	CHEMBL1072179	Inhibition of Aurora A	B	CN1CCC(Nc2ncc3c(n2)-c2c(c(C(N)=O)nn2C)CC3)CC1		CHEMBL603080	>	IC50	nM	10000.0	CHEMBL4722	Homo sapiens	IC50	uM	10.0
	3117223	CHEMBL1072179	Inhibition of Aurora A	B	CNC(=O)c1nn(C)c2c1CCc1cnc(NC3CCN(C)CC3)nc1-2		CHEMBL606428	>	IC50	nM	10000.0	CHEMBL4722	Homo sapiens	IC50	uM	10.0
	3117224	CHEMBL1072179	Inhibition of Aurora A	B	CC(=O)N1CCC(Nc2ncc3c(n2)-c2c(c(C(N)=O)nn2C)CC3)CC1		CHEMBL599224	>	IC50	nM	10000.0	CHEMBL4722	Homo sapiens	IC50	uM	10.0
	3117226	CHEMBL1072179	Inhibition of Aurora A	B	CNC(=O)c1nn(C)c2c1CCc1cnc(NC3CCN(C(C)=O)CC3)nc1-2		CHEMBL599427	>	IC50	nM	10000.0	CHEMBL4722	Homo sapiens	IC50	uM	10.0
	3117227	CHEMBL1072179	Inhibition of Aurora A	B	CNC(=O)c1nn(C)c2c1CCc1cnc(NC3CCN(C(=O)c4ccccc4)CC3)nc1-2		CHEMBL606409	>	IC50	nM	10000.0	CHEMBL4722	Homo sapiens	IC50	uM	10.0
	3117899	CHEMBL1072179	Inhibition of Aurora A	B	CNC(=O)c1nn(C)c2c1CCc1cnc(NC3CCN(C(=O)N4CCN(C)CC4)CC3)nc1-2		CHEMBL598186	>	IC50	nM	10000.0	CHEMBL4722	Homo sapiens	IC50	uM	10.0
	3117901	CHEMBL1072179	Inhibition of Aurora A	B	CCOC(=O)N1CCC(C(=O)N2CCC(Nc3ncc4c(n3)-c3c(c(C(=O)NC)nn3C)CC4)CC2)CC1		CHEMBL597379	>	IC50	nM	10000.0	CHEMBL4722	Homo sapiens	IC50	uM	10.0
	3127437	CHEMBL1074430	Inhibition of Aurora A by scintillation proximity assay	B	CC(C)CC(=O)Nc1n[nH]c2c1CN(C(=O)C1CCN(C)CC1)C2(C)C		CHEMBL1230607	>	IC50	nM	10000.0	CHEMBL4722	Homo sapiens	IC50	uM	10.0
	3127471	CHEMBL1074430	Inhibition of Aurora A by scintillation proximity assay	B	CC(C)(C)C(=O)N1Cc2c(NC(=O)c3cc(F)cc(F)c3)n[nH]c2C1(C)C		CHEMBL604712	>	IC50	nM	10000.0	CHEMBL4722	Homo sapiens	IC50	uM	10.0
	3185743	CHEMBL1106062	Inhibition of Aurora A by HTRF assay	B	O=C1Nc2ccc(F)cc2/C1=C1/Nc2ccccc2/C1=N\O		CHEMBL1077291	=	IC50	nM	1270.0	CHEMBL4722	Homo sapiens	IC50	uM	1.27
	3186446	CHEMBL1113293	Inhibition of Aurora A at 20 uM	B	CCCC(=O)Nc1n[nH]c2cc(Cl)c(-c3ccccc3)cc12		CHEMBL1095040	=	Inhibition	%	34.0	CHEMBL4722	Homo sapiens	INH	%	34.0
	3198605	CHEMBL1103325	Inhibition of Aurora A kinase	B	Cc1nc(N)ncc1-c1nc(N2CCOCC2)c2sc(C(C)(C)O)cc2n1		CHEMBL1085178	>	IC50	nM	1000.0	CHEMBL4722	Homo sapiens	IC50	uM	1.0
	3198608	CHEMBL1103325	Inhibition of Aurora A kinase	B	CC(C)(O)c1cc2nc(-c3cnc(N)nc3)nc(N3CCOCC3)c2s1		CHEMBL1084926	>	IC50	nM	10000.0	CHEMBL4722	Homo sapiens	IC50	uM	10.0
	3201820	CHEMBL1101659	Inhibition of human Aurora A assessed as remaining enzyme activity at 10 uM	B	CCCCc1nc2c(-c3ccc(Cl)cc3)n[nH]c2c(=O)n1NC(=O)c1ccccc1		CHEMBL1080920	=	Inhibition	%	16.0	CHEMBL4722	Homo sapiens	INH	%	16.0
	3201823	CHEMBL1101660	Inhibition of human Aurora A at 10 uM	B	O=C(Cc1ccccc1)Nn1c(CC2CCCCC2)nc2c(-c3ccc(Cl)cc3)n[nH]c2c1=O		CHEMBL1088576	=	Inhibition	%	74.0	CHEMBL4722	Homo sapiens	INH	%	74.0
	3201824	CHEMBL1101659	Inhibition of human Aurora A assessed as remaining enzyme activity at 10 uM	B	CCCCCc1nc2c(-c3ccc(Cl)cc3)n[nH]c2c(=O)n1NC(=O)c1ccccc1		CHEMBL1080921	=	Inhibition	%	9.0	CHEMBL4722	Homo sapiens	INH	%	9.0
	3201827	CHEMBL1101659	Inhibition of human Aurora A assessed as remaining enzyme activity at 10 uM	B	O=C(Cc1ccccc1)Nn1c(CC2CCCCC2)nc2c(-c3ccc(Cl)cc3)n[nH]c2c1=O		CHEMBL1088576	=	Inhibition	%	26.0	CHEMBL4722	Homo sapiens	INH	%	26.0
	3201830	CHEMBL1101660	Inhibition of human Aurora A at 10 uM	B	CCCCCc1nc2c(-c3ccc(Cl)cc3)n[nH]c2c(=O)n1NC(=O)c1ccccc1		CHEMBL1080921	=	Inhibition	%	74.0	CHEMBL4722	Homo sapiens	INH	%	74.0
	3201831	CHEMBL1101659	Inhibition of human Aurora A assessed as remaining enzyme activity at 10 uM	B	CCCCCc1nc2c(-c3ccc(Cl)cc3)n[nH]c2c(=O)n1NC(=O)c1cccc(C)c1		CHEMBL1087759	=	Inhibition	%	7.0	CHEMBL4722	Homo sapiens	INH	%	7.0
	3201834	CHEMBL1101659	Inhibition of human Aurora A assessed as remaining enzyme activity at 10 uM	B	Cc1cccc(C(=O)Nn2c(CC3CCCCC3)nc3c(-c4ccc(Cl)cc4)n[nH]c3c2=O)c1		CHEMBL1087760	=	Inhibition	%	18.0	CHEMBL4722	Homo sapiens	INH	%	18.0
	3201837	CHEMBL1101660	Inhibition of human Aurora A at 10 uM	B	CCCCc1nc2c(-c3ccc(Cl)cc3)n[nH]c2c(=O)n1NC(=O)c1ccccc1		CHEMBL1080920	=	Inhibition	%	74.0	CHEMBL4722	Homo sapiens	INH	%	74.0
	3201839	CHEMBL1101660	Inhibition of human Aurora A at 10 uM	B	CCCCCc1nc2c(-c3ccc(Cl)cc3)n[nH]c2c(=O)n1NC(=O)c1cccc(C)c1		CHEMBL1087759	=	Inhibition	%	74.0	CHEMBL4722	Homo sapiens	INH	%	74.0
	3201840	CHEMBL1101660	Inhibition of human Aurora A at 10 uM	B	Cc1cccc(C(=O)Nn2c(CC3CCCCC3)nc3c(-c4ccc(Cl)cc4)n[nH]c3c2=O)c1		CHEMBL1087760	=	Inhibition	%	74.0	CHEMBL4722	Homo sapiens	INH	%	74.0
	3203234	CHEMBL1101130	Inhibition of AURKA	B	Cn1cc(C2=C(c3cccc(NCC(O)CO)c3)C(=O)NC2=O)c2cc(F)ccc21		CHEMBL1082152	=	Kd	nM	40000.0	CHEMBL4722	Homo sapiens	Kd	uM	40.0
Not Active	3211302	CHEMBL1116882	Inhibition of Aurora A at 100 uM by IMAP fluorescence polarization assay	B	CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)N)C(=O)N[C@@H](CCC(=O)O)C(=O)NCC(=O)NCC(=O)NCC(=O)NCC(=O)NCC(=O)NCC(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O		CHEMBL1076985		Inhibition	%		CHEMBL4722	Homo sapiens	INH		
	3211303	CHEMBL1116882	Inhibition of Aurora A at 100 uM by IMAP fluorescence polarization assay	B	CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)N)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)O)[C@@H](C)CC		CHEMBL1076928	=	Inhibition	%	20.0	CHEMBL4722	Homo sapiens	INH	%	20.0
Not Active	3211304	CHEMBL1116882	Inhibition of Aurora A at 100 uM by IMAP fluorescence polarization assay	B	CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)N)C(=O)N[C@@H](CCC(=O)O)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)O)C(C)C)C(C)C		CHEMBL1076943		Inhibition	%		CHEMBL4722	Homo sapiens	INH		
	3211305	CHEMBL1116882	Inhibition of Aurora A at 100 uM by IMAP fluorescence polarization assay	B	CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)N)C(=O)N[C@@H](CCC(=O)O)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)O)C(C)C)C(C)C)C(C)C		CHEMBL1076958	=	Inhibition	%	35.0	CHEMBL4722	Homo sapiens	INH	%	35.0
	3211306	CHEMBL1116882	Inhibition of Aurora A at 100 uM by IMAP fluorescence polarization assay	B	CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)N)C(=O)N[C@@H](CCC(=O)O)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)O)C(C)C		CHEMBL1076954	=	Inhibition	%	17.0	CHEMBL4722	Homo sapiens	INH	%	17.0
Not Active	3211307	CHEMBL1116882	Inhibition of Aurora A at 100 uM by IMAP fluorescence polarization assay	B	CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)N)C(=O)N[C@@H](CCC(=O)O)C(=O)NCC(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)O)C(C)C)C(C)C		CHEMBL1076974		Inhibition	%		CHEMBL4722	Homo sapiens	INH		
	3211308	CHEMBL1116883	Inhibition of Aurora A at 10 uM by IMAP fluorescence polarization assay	B	CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)N)C(=O)N[C@@H](CCC(=O)O)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(N)=O)C(C)C)C(C)C)C(C)C		CHEMBL1077000	=	Inhibition	%	42.0	CHEMBL4722	Homo sapiens	INH	%	42.0
Not Active	3211309	CHEMBL1116882	Inhibition of Aurora A at 100 uM by IMAP fluorescence polarization assay	B	CC(C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CN)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(=O)O)C(N)=O)C(C)C)C(C)C		CHEMBL1076990		Inhibition	%		CHEMBL4722	Homo sapiens	INH		
Active	3211310	CHEMBL1116881	Binding affinity to GST-tagged Aurora A after 1 hr by ELISA	B	CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)N)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)O)[C@@H](C)CC		CHEMBL1076928		Activity			CHEMBL4722	Homo sapiens	Activity		
Active	3211311	CHEMBL1116881	Binding affinity to GST-tagged Aurora A after 1 hr by ELISA	B	CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](C)N)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)O		CHEMBL2368728		Activity			CHEMBL4722	Homo sapiens	Activity		
Active	3211312	CHEMBL1116881	Binding affinity to GST-tagged Aurora A after 1 hr by ELISA	B	CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)N)C(=O)N[C@@H](CCC(=O)O)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)O)C(C)C)C(C)C		CHEMBL1076943		Activity			CHEMBL4722	Homo sapiens	Activity		
Active	3211313	CHEMBL1116881	Binding affinity to GST-tagged Aurora A after 1 hr by ELISA	B	CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)N)C(=O)N[C@@H](CCC(=O)O)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)O)C(C)C		CHEMBL1076944		Activity			CHEMBL4722	Homo sapiens	Activity		
Active	3211314	CHEMBL1116881	Binding affinity to GST-tagged Aurora A after 1 hr by ELISA	B	CSCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](C)N)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)O)C(C)C		CHEMBL1076941		Activity			CHEMBL4722	Homo sapiens	Activity		
Active	3211315	CHEMBL1116881	Binding affinity to GST-tagged Aurora A after 1 hr by ELISA	B	CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CO)NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](C)N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)O		CHEMBL1076940		Activity			CHEMBL4722	Homo sapiens	Activity		
Active	3211316	CHEMBL1116881	Binding affinity to GST-tagged Aurora A after 1 hr by ELISA	B	CSCC[C@H](NC(=O)[C@@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)N)[C@@H](C)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)O		CHEMBL1076947		Activity			CHEMBL4722	Homo sapiens	Activity		
Active	3211317	CHEMBL1116881	Binding affinity to GST-tagged Aurora A after 1 hr by ELISA	B	CSCC[C@H](NC(=O)[C@@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)N)C(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)O		CHEMBL1076946		Activity			CHEMBL4722	Homo sapiens	Activity		
Active	3211318	CHEMBL1116881	Binding affinity to GST-tagged Aurora A after 1 hr by ELISA	B	CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)CNC(=O)[C@H](CCSC)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)N)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)O		CHEMBL1076945		Activity			CHEMBL4722	Homo sapiens	Activity		
Active	3211319	CHEMBL1116881	Binding affinity to GST-tagged Aurora A after 1 hr by ELISA	B	CSCC[C@H](NC(=O)CNC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)O		CHEMBL1076952		Activity			CHEMBL4722	Homo sapiens	Activity		
Active	3211320	CHEMBL1116881	Binding affinity to GST-tagged Aurora A after 1 hr by ELISA	B	CC[C@H](C)[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)O)C(C)C		CHEMBL1076950		Activity			CHEMBL4722	Homo sapiens	Activity		
Active	3211321	CHEMBL1116881	Binding affinity to GST-tagged Aurora A after 1 hr by ELISA	B	CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCSC)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)N)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)O		CHEMBL1076951		Activity			CHEMBL4722	Homo sapiens	Activity		
Active	3211322	CHEMBL1116881	Binding affinity to GST-tagged Aurora A after 1 hr by ELISA	B	CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)N)C(=O)N[C@@H](CCC(=O)O)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CC(C)C)C(=O)N[C@H](C)C(=O)N[C@H](C)C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](C)C(=O)O		CHEMBL1075633		Activity			CHEMBL4722	Homo sapiens	Activity		
Active	3211323	CHEMBL1116881	Binding affinity to GST-tagged Aurora A after 1 hr by ELISA	B	CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](C)N)C(=O)N[C@@H](CCC(=O)O)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(=O)O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)O)C(C)C)C(C)C)[C@H](C)O		CHEMBL1076948		Activity			CHEMBL4722	Homo sapiens	Activity		
Active	3211324	CHEMBL1116881	Binding affinity to GST-tagged Aurora A after 1 hr by ELISA	B	CSCC[C@H](NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)N)C(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)O)C(C)C		CHEMBL1076949		Activity			CHEMBL4722	Homo sapiens	Activity		
Active	3211325	CHEMBL1116881	Binding affinity to GST-tagged Aurora A after 1 hr by ELISA	B	CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](C)N)C(=O)N[C@@H](CCC(=O)O)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)O		CHEMBL1076959		Activity			CHEMBL4722	Homo sapiens	Activity		
Active	3211326	CHEMBL1116881	Binding affinity to GST-tagged Aurora A after 1 hr by ELISA	B	CC[C@H](C)[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CCSC)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)N)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)O		CHEMBL1076960		Activity			CHEMBL4722	Homo sapiens	Activity		
Active	3211327	CHEMBL1116881	Binding affinity to GST-tagged Aurora A after 1 hr by ELISA	B	CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCSC)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)N)C(C)C)[C@@H](C)O)C(=O)N[C@@H](CCSC)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)O		CHEMBL1076962		Activity			CHEMBL4722	Homo sapiens	Activity		
Active	3211328	CHEMBL1116881	Binding affinity to GST-tagged Aurora A after 1 hr by ELISA	B	CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)N)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)O)C(C)C)[C@@H](C)CC		CHEMBL1076961		Activity			CHEMBL4722	Homo sapiens	Activity		
Active	3211329	CHEMBL1116881	Binding affinity to GST-tagged Aurora A after 1 hr by ELISA	B	CSCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCC(N)=O)NC(=O)[C@@H]1CCCN1C(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](C)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)O		CHEMBL1076955		Activity			CHEMBL4722	Homo sapiens	Activity		
Active	3211330	CHEMBL1116881	Binding affinity to GST-tagged Aurora A after 1 hr by ELISA	B	CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)N)C(=O)N[C@@H](CCC(=O)O)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)O)C(C)C)C(C)C)C(C)C		CHEMBL1076958		Activity			CHEMBL4722	Homo sapiens	Activity		
Active	3211331	CHEMBL1116881	Binding affinity to GST-tagged Aurora A after 1 hr by ELISA	B	CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)N)C(=O)N[C@@H](CCC(=O)O)C(=O)NCC(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)O)C(C)C		CHEMBL1076956		Activity			CHEMBL4722	Homo sapiens	Activity		
Active	3211332	CHEMBL1116881	Binding affinity to GST-tagged Aurora A after 1 hr by ELISA	B	CSCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)N)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)O		CHEMBL1076957		Activity			CHEMBL4722	Homo sapiens	Activity		
Active	3211333	CHEMBL1116881	Binding affinity to GST-tagged Aurora A after 1 hr by ELISA	B	CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)N)C(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)O		CHEMBL1076953		Activity			CHEMBL4722	Homo sapiens	Activity		
Active	3211334	CHEMBL1116881	Binding affinity to GST-tagged Aurora A after 1 hr by ELISA	B	CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)N)C(=O)N[C@@H](CCC(=O)O)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)O)C(C)C		CHEMBL1076954		Activity			CHEMBL4722	Homo sapiens	Activity		
Active	3211335	CHEMBL1116881	Binding affinity to GST-tagged Aurora A after 1 hr by ELISA	B	CC(C)C[C@H](NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)N)C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)O		CHEMBL1076963		Activity			CHEMBL4722	Homo sapiens	Activity		
Active	3211336	CHEMBL1116881	Binding affinity to GST-tagged Aurora A after 1 hr by ELISA	B	CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)N)C(=O)N[C@@H](CCC(=O)O)C(=O)NCC(=O)NCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)O)[C@@H](C)O)C(C)C		CHEMBL1076964		Activity			CHEMBL4722	Homo sapiens	Activity		
Active	3211337	CHEMBL1116881	Binding affinity to GST-tagged Aurora A after 1 hr by ELISA	B	CSCC[C@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)N)C(C)C)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)O)[C@@H](C)O		CHEMBL1076965		Activity			CHEMBL4722	Homo sapiens	Activity		
Active	3211338	CHEMBL1116881	Binding affinity to GST-tagged Aurora A after 1 hr by ELISA	B	CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)N)C(=O)N[C@@H](CCC(=O)O)C(=O)NCC(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)O)C(C)C)[C@@H](C)O)C(C)C)[C@@H](C)O		CHEMBL1076968		Activity			CHEMBL4722	Homo sapiens	Activity		
Active	3211339	CHEMBL1116881	Binding affinity to GST-tagged Aurora A after 1 hr by ELISA	B	CSCC[C@H](NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@@H]1CCCN1C(=O)[C@H](C)NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)N)C(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)O)[C@@H](C)O)[C@@H](C)O		CHEMBL1076969		Activity			CHEMBL4722	Homo sapiens	Activity		
Active	3211340	CHEMBL1116881	Binding affinity to GST-tagged Aurora A after 1 hr by ELISA	B	CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCSC)NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)N)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)O)[C@@H](C)CC		CHEMBL1076970		Activity			CHEMBL4722	Homo sapiens	Activity		
Active	3211341	CHEMBL1116881	Binding affinity to GST-tagged Aurora A after 1 hr by ELISA	B	CSCC[C@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)O		CHEMBL1076971		Activity			CHEMBL4722	Homo sapiens	Activity		
Active	3211342	CHEMBL1116881	Binding affinity to GST-tagged Aurora A after 1 hr by ELISA	B	CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)N)C(=O)N[C@@H](CCC(=O)O)C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)O)C(C)C)C(C)C)C(C)C		CHEMBL1076967		Activity			CHEMBL4722	Homo sapiens	Activity		
Active	3211343	CHEMBL1116881	Binding affinity to GST-tagged Aurora A after 1 hr by ELISA	B	CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)N)C(=O)N[C@@H](CCC(=O)O)C(=O)NCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)O		CHEMBL1076966		Activity			CHEMBL4722	Homo sapiens	Activity		
Active	3211344	CHEMBL1116881	Binding affinity to GST-tagged Aurora A after 1 hr by ELISA	B	CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)N)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)O		CHEMBL1076977		Activity			CHEMBL4722	Homo sapiens	Activity		
Active	3211345	CHEMBL1116881	Binding affinity to GST-tagged Aurora A after 1 hr by ELISA	B	CC[C@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CNC(=O)[C@H](CCSC)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)CNC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)N)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)O		CHEMBL1076976		Activity			CHEMBL4722	Homo sapiens	Activity		
Active	3211346	CHEMBL1116881	Binding affinity to GST-tagged Aurora A after 1 hr by ELISA	B	CSCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCC(=O)O)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)O		CHEMBL1076975		Activity			CHEMBL4722	Homo sapiens	Activity		
Active	3211347	CHEMBL1116881	Binding affinity to GST-tagged Aurora A after 1 hr by ELISA	B	CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)N)C(=O)N[C@@H](CCC(=O)O)C(=O)NCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)O)C(C)C)C(C)C)C(C)C		CHEMBL1076979		Activity			CHEMBL4722	Homo sapiens	Activity		
Active	3211348	CHEMBL1116881	Binding affinity to GST-tagged Aurora A after 1 hr by ELISA	B	CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)N)C(=O)N[C@@H](CCC(=O)O)C(=O)NCC(=O)NCC(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)O		CHEMBL1076978		Activity			CHEMBL4722	Homo sapiens	Activity		
Active	3211349	CHEMBL1116881	Binding affinity to GST-tagged Aurora A after 1 hr by ELISA	B	CSCC[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)CNC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)N)[C@@H](C)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)O)C(C)C		CHEMBL1076972		Activity			CHEMBL4722	Homo sapiens	Activity		
Active	3211350	CHEMBL1116881	Binding affinity to GST-tagged Aurora A after 1 hr by ELISA	B	CSCC[C@H](NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)N)C(C)C)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)O)C(C)C		CHEMBL1076973		Activity			CHEMBL4722	Homo sapiens	Activity		
Active	3211351	CHEMBL1116881	Binding affinity to GST-tagged Aurora A after 1 hr by ELISA	B	CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)N)C(=O)N[C@@H](CCC(=O)O)C(=O)NCC(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)O)C(C)C)C(C)C		CHEMBL1076974		Activity			CHEMBL4722	Homo sapiens	Activity		
Active	3211352	CHEMBL1116881	Binding affinity to GST-tagged Aurora A after 1 hr by ELISA	B	CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)N)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)O		CHEMBL1076988		Activity			CHEMBL4722	Homo sapiens	Activity		
Active	3211353	CHEMBL1116881	Binding affinity to GST-tagged Aurora A after 1 hr by ELISA	B	CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCSC)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)N)[C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)O		CHEMBL1076983		Activity			CHEMBL4722	Homo sapiens	Activity		
Active	3211354	CHEMBL1116881	Binding affinity to GST-tagged Aurora A after 1 hr by ELISA	B	CSCC[C@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)N)[C@@H](C)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)O		CHEMBL1076980		Activity			CHEMBL4722	Homo sapiens	Activity		
Active	3211355	CHEMBL1116881	Binding affinity to GST-tagged Aurora A after 1 hr by ELISA	B	CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)N)C(=O)N[C@@H](CCC(=O)O)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)O		CHEMBL1076981		Activity			CHEMBL4722	Homo sapiens	Activity		
Active	3211356	CHEMBL1116881	Binding affinity to GST-tagged Aurora A after 1 hr by ELISA	B	CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)N)C(=O)N[C@@H](CCC(=O)O)C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)O)[C@@H](C)O)C(C)C		CHEMBL1076986		Activity			CHEMBL4722	Homo sapiens	Activity		
Active	3211357	CHEMBL1116881	Binding affinity to GST-tagged Aurora A after 1 hr by ELISA	B	CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)N)C(=O)N[C@@H](CCC(=O)O)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)O)C(C)C		CHEMBL1076987		Activity			CHEMBL4722	Homo sapiens	Activity		
Active	3211358	CHEMBL1116881	Binding affinity to GST-tagged Aurora A after 1 hr by ELISA	B	CC(C)C[C@H](NC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccccc1)NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)O)C(C)C		CHEMBL1076982		Activity			CHEMBL4722	Homo sapiens	Activity		
Active	3211359	CHEMBL1116881	Binding affinity to GST-tagged Aurora A after 1 hr by ELISA	B	CC(C)C[C@H](NC(=O)CNC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)N)C(C)C)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)O		CHEMBL1076984		Activity			CHEMBL4722	Homo sapiens	Activity		
Not Active	3211360	CHEMBL1116881	Binding affinity to GST-tagged Aurora A after 1 hr by ELISA	B	CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)N)C(=O)N[C@@H](CCC(=O)O)C(=O)NCC(=O)NCC(=O)NCC(=O)NCC(=O)NCC(=O)NCC(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O		CHEMBL1076985		Activity			CHEMBL4722	Homo sapiens	Activity		
	3214065	CHEMBL1105941	Inhibition of Aurora A at 5 uM	B	O=C(Nc1ccccc1Cl)c1cnc2ccc(C3CCNCC3)cn12.O=C(O)C(=O)O		CHEMBL1077739	=	Inhibition	%	-2.0	CHEMBL4722	Homo sapiens	INH	%	-2.0
	3219664	CHEMBL1110415	Inhibition of Aurora A at 100 nM relative to control	B	N=C(N)NCCC[C@@H](NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)CCCCCNC(=O)[C@@H](CCCCN)NC(=O)CCCCCNC(=O)c1ccc(-c2ccnc(N)n2)s1)C(N)=O		CHEMBL1077375	=	Inhibition	%	46.0	CHEMBL4722	Homo sapiens	INH	%	46.0
	3224743	CHEMBL1102600	Inhibition of Aurora A at 10 uM	B	Cc1cc(OCc2ccc(F)cc2F)c(Br)c(=O)n1-c1cnc(CO)cn1		CHEMBL1081678	<	Inhibition	%	50.0	CHEMBL4722	Homo sapiens	INH	%	50.0
	3225008	CHEMBL1102600	Inhibition of Aurora A at 10 uM	B	Cc1cc(OCc2ccc(F)cc2F)c(Br)c(=O)n1Cc1ccc(CN(C)C)cc1		CHEMBL1078665	<	Inhibition	%	50.0	CHEMBL4722	Homo sapiens	INH	%	50.0
Not Determined	3225999	CHEMBL1112280	Inhibition of Aurora A after 60 mins	B	FC(F)(F)c1cccc(Nc2nc3ccc(CCNc4ncnc5ccsc45)cc3[nH]2)c1		CHEMBL1080981		IC50			CHEMBL4722	Homo sapiens	IC50		
Not Determined	3226000	CHEMBL1112280	Inhibition of Aurora A after 60 mins	B	c1ccc(-c2c[nH]c(Nc3ccc(CCNc4ncnc5ccsc45)cc3)n2)cc1		CHEMBL1080980		IC50			CHEMBL4722	Homo sapiens	IC50		
Not Determined	3226001	CHEMBL1112280	Inhibition of Aurora A after 60 mins	B	Cc1nc(Nc2ccc(CCNc3ncnc4ccsc34)cc2)[nH]c1C		CHEMBL1080080		IC50			CHEMBL4722	Homo sapiens	IC50		
	3226002	CHEMBL1112280	Inhibition of Aurora A after 60 mins	B	Clc1cnc2[nH]c(Nc3ccc(CCNc4ncnc5ccsc45)cc3)nc2c1		CHEMBL1079713	=	IC50	nM	20.0	CHEMBL4722	Homo sapiens	IC50	nM	20.0
	3226003	CHEMBL1112280	Inhibition of Aurora A after 60 mins	B	FC(F)(F)c1cnc2[nH]c(Nc3ccc(CCNc4ncnc5ccsc45)cc3)nc2c1		CHEMBL1079538	=	IC50	nM	17.0	CHEMBL4722	Homo sapiens	IC50	nM	17.0
Not Determined	3226004	CHEMBL1112280	Inhibition of Aurora A after 60 mins	B	FC(F)(F)c1ccc2[nH]c(Nc3ccc(CCNc4ncnc5ccsc45)cn3)nc2c1		CHEMBL1081881		IC50			CHEMBL4722	Homo sapiens	IC50		
Not Determined	3226005	CHEMBL1112280	Inhibition of Aurora A after 60 mins	B	FC(F)(F)c1ccc2[nH]c(Nc3ccc(CCNc4ncnc5ccsc45)nc3)nc2c1		CHEMBL1081880		IC50			CHEMBL4722	Homo sapiens	IC50		
	3226006	CHEMBL1112280	Inhibition of Aurora A after 60 mins	B	Fc1cc(CCNc2ncnc3ccsc23)ccc1Nc1nc2cc(C(F)(F)F)ccc2[nH]1		CHEMBL1078061	=	IC50	nM	64.0	CHEMBL4722	Homo sapiens	IC50	nM	64.0
	3226007	CHEMBL1112280	Inhibition of Aurora A after 60 mins	B	Clc1ccc2[nH]c(Nc3ccc(CCNc4ncnc5ccsc45)cc3)nc2c1		CHEMBL1078060	=	IC50	nM	28.0	CHEMBL4722	Homo sapiens	IC50	nM	28.0
	3226008	CHEMBL1112280	Inhibition of Aurora A after 60 mins	B	FC(F)(F)c1ccc2[nH]c(Nc3ccc(CCNc4ncnc5ccsc45)cc3)nc2c1		CHEMBL1077729	=	IC50	nM	40.0	CHEMBL4722	Homo sapiens	IC50	nM	40.0
Not Determined	3226009	CHEMBL1112280	Inhibition of Aurora A after 60 mins	B	c1ccc2sc(Nc3ccc(CCNc4ncnc5ccsc45)cc3)nc2c1		CHEMBL1079271		IC50			CHEMBL4722	Homo sapiens	IC50		
Not Determined	3226010	CHEMBL1112280	Inhibition of Aurora A after 60 mins	B	c1ccc2oc(Nc3ccc(CCNc4ncnc5ccsc45)cc3)nc2c1		CHEMBL1079150		IC50			CHEMBL4722	Homo sapiens	IC50		
Not Determined	3226011	CHEMBL1112280	Inhibition of Aurora A after 60 mins	B	Cn1c(Nc2ccc(CCNc3ncnc4ccsc34)cc2)nc2ccccc21		CHEMBL1079052		IC50			CHEMBL4722	Homo sapiens	IC50		
Not Determined	3226012	CHEMBL1112280	Inhibition of Aurora A after 60 mins	B	c1cc2nc(Nc3ccc(CCNc4ncnc5ccsc45)cc3)[nH]c2cn1		CHEMBL1079051		IC50			CHEMBL4722	Homo sapiens	IC50		
Not Determined	3226013	CHEMBL1112280	Inhibition of Aurora A after 60 mins	B	c1cnc2[nH]c(Nc3ccc(CCNc4ncnc5ccsc45)cc3)nc2c1		CHEMBL1077955		IC50			CHEMBL4722	Homo sapiens	IC50		
	3226014	CHEMBL1112280	Inhibition of Aurora A after 60 mins	B	c1ccc2[nH]c(Nc3ccc(CCNc4ncnc5ccsc45)cc3)nc2c1		CHEMBL1078906	=	IC50	nM	28.0	CHEMBL4722	Homo sapiens	IC50	nM	28.0
Not Determined	3226015	CHEMBL1112280	Inhibition of Aurora A after 60 mins	B	c1ccc2[nH]c(Nc3ccc(CNc4ncnc5ccsc45)cc3)nc2c1		CHEMBL1078327		IC50			CHEMBL4722	Homo sapiens	IC50		
Not Determined	3226016	CHEMBL1112280	Inhibition of Aurora A after 60 mins	B	c1cc(CCNc2ncnc3ccsc23)cc(Nc2nc3ccccc3[nH]2)c1		CHEMBL1078927		IC50			CHEMBL4722	Homo sapiens	IC50		
Not Determined	3226017	CHEMBL1112280	Inhibition of Aurora A after 60 mins	B	c1cc(CNc2ncnc3ccsc23)cc(Nc2nc3ccccc3[nH]2)c1		CHEMBL1078926		IC50			CHEMBL4722	Homo sapiens	IC50		
	3226018	CHEMBL1112280	Inhibition of Aurora A after 60 mins	B	FC(F)(F)c1ccc2nc(Nc3ncc(CCNc4ncnc5ccsc45)s3)[nH]c2c1		CHEMBL1078828	=	IC50	nM	490.0	CHEMBL4722	Homo sapiens	IC50	nM	490.0
	3226019	CHEMBL1112280	Inhibition of Aurora A after 60 mins	B	c1ccc2[nH]c(Nc3ncc(CCNc4ncnc5ccsc45)s3)nc2c1		CHEMBL1078827	=	IC50	nM	1400.0	CHEMBL4722	Homo sapiens	IC50	nM	1400.0
	3226020	CHEMBL1112280	Inhibition of Aurora A after 60 mins	B	CS(=O)(=O)O.O=C(Nc1cccc(Cl)c1)Nc1ncc(CCN=c2[nH]cnc3ccsc23)s1		CHEMBL518051	=	IC50	nM	9.0	CHEMBL4722	Homo sapiens	IC50	nM	9.0
	3226021	CHEMBL1112280	Inhibition of Aurora A after 60 mins	B	O=C(Nc1cccc(C(F)(F)F)c1)Nc1ncc(CCNc2ncnc3ccsc23)s1		CHEMBL472193	=	IC50	nM	22.0	CHEMBL4722	Homo sapiens	IC50	nM	22.0
	3226022	CHEMBL1112280	Inhibition of Aurora A after 60 mins	B	O=C(Nc1ccccc1)Nc1ncc(CCNc2ncnc3ccsc23)s1		CHEMBL472202	=	IC50	nM	52.0	CHEMBL4722	Homo sapiens	IC50	nM	52.0
	3239921	CHEMBL1113415	Inhibition of hexahistidine tagged recombinant Aurora A expressed in Hi-5 cells assessed as ATP remaining after 2 hrs by bioluminescence	B	Cc1cc(N)cc(-c2ccc3[nH]nc(/C=C/c4cccc(CN5CCN(C)CC5)c4)c3c2C)c1		CHEMBL1093821	=	IC50	nM	350.0	CHEMBL4722	Homo sapiens	IC50	uM	0.35
	3239922	CHEMBL1113415	Inhibition of hexahistidine tagged recombinant Aurora A expressed in Hi-5 cells assessed as ATP remaining after 2 hrs by bioluminescence	B	Cc1c(C#N)ccc2[nH]nc(/C=C/c3cccc(CN4CCN(C)CC4)c3)c12		CHEMBL1093515	=	IC50	nM	280.0	CHEMBL4722	Homo sapiens	IC50	uM	0.28
	3239923	CHEMBL1113415	Inhibition of hexahistidine tagged recombinant Aurora A expressed in Hi-5 cells assessed as ATP remaining after 2 hrs by bioluminescence	B	O=S(=O)(Cc1ccccc1)Nc1ccc2[nH]nc(/C=C/c3ccccc3)c2c1		CHEMBL1093514	=	IC50	nM	35.0	CHEMBL4722	Homo sapiens	IC50	uM	0.035
	3239924	CHEMBL1113415	Inhibition of hexahistidine tagged recombinant Aurora A expressed in Hi-5 cells assessed as ATP remaining after 2 hrs by bioluminescence	B	COc1ccc(OC)c(CC(=O)Nc2cc3c(/C=C/c4ccccc4)n[nH]c3cc2C)c1		CHEMBL1091617	=	IC50	nM	42.0	CHEMBL4722	Homo sapiens	IC50	uM	0.042
	3239925	CHEMBL1113415	Inhibition of hexahistidine tagged recombinant Aurora A expressed in Hi-5 cells assessed as ATP remaining after 2 hrs by bioluminescence	B	Cc1c(NC(=O)Cc2cccs2)ccc2[nH]nc(/C=C/c3cccc(CN4CCN(C)CC4)c3)c12		CHEMBL1091233	=	IC50	nM	1900.0	CHEMBL4722	Homo sapiens	IC50	uM	1.9
	3239926	CHEMBL1113415	Inhibition of hexahistidine tagged recombinant Aurora A expressed in Hi-5 cells assessed as ATP remaining after 2 hrs by bioluminescence	B	CN1CCN(Cc2cccc(/C=C/c3n[nH]c4ccc(NC(=O)Cc5cccs5)cc34)c2)CC1		CHEMBL1091232	=	IC50	nM	35.0	CHEMBL4722	Homo sapiens	IC50	uM	0.035
	3239927	CHEMBL1113415	Inhibition of hexahistidine tagged recombinant Aurora A expressed in Hi-5 cells assessed as ATP remaining after 2 hrs by bioluminescence	B	Cc1cc2[nH]nc(/C=C/c3cccc(CN4CCN(C)CC4)c3)c2cc1NC(=O)Cc1cccs1		CHEMBL1091231	=	IC50	nM	79.0	CHEMBL4722	Homo sapiens	IC50	uM	0.079
	3239928	CHEMBL1113415	Inhibition of hexahistidine tagged recombinant Aurora A expressed in Hi-5 cells assessed as ATP remaining after 2 hrs by bioluminescence	B	Cc1cc2[nH]nc(/C=C/c3cccc(NC(=O)N4CCN(C)CC4)c3)c2cc1NC(=O)Cc1cccs1		CHEMBL1093265	=	IC50	nM	13.0	CHEMBL4722	Homo sapiens	IC50	uM	0.013
	3239929	CHEMBL1113415	Inhibition of hexahistidine tagged recombinant Aurora A expressed in Hi-5 cells assessed as ATP remaining after 2 hrs by bioluminescence	B	O=C(Cc1cccs1)Nc1cc2c(/C=C/c3ccccc3)n[nH]c2cc1N1CCCC1		CHEMBL1090237	=	IC50	nM	91.0	CHEMBL4722	Homo sapiens	IC50	uM	0.091
	3239930	CHEMBL1113415	Inhibition of hexahistidine tagged recombinant Aurora A expressed in Hi-5 cells assessed as ATP remaining after 2 hrs by bioluminescence	B	CN1CCN(C(=O)Nc2cccc(/C=C/c3n[nH]c4cc(N5CCCC5)c(NS(C)(=O)=O)cc34)c2)CC1		CHEMBL1093854	=	IC50	nM	140.0	CHEMBL4722	Homo sapiens	IC50	uM	0.14
	3239931	CHEMBL1113415	Inhibition of hexahistidine tagged recombinant Aurora A expressed in Hi-5 cells assessed as ATP remaining after 2 hrs by bioluminescence	B	Nc1cc2c(/C=C/c3ccccc3)n[nH]c2cc1N1CCCC1		CHEMBL1091975	=	IC50	nM	200.0	CHEMBL4722	Homo sapiens	IC50	uM	0.2
	3239932	CHEMBL1113415	Inhibition of hexahistidine tagged recombinant Aurora A expressed in Hi-5 cells assessed as ATP remaining after 2 hrs by bioluminescence	B	O=[N+]([O-])c1cc2c(/C=C/c3ccccc3)n[nH]c2cc1N1CCCC1		CHEMBL1091974	=	IC50	nM	240.0	CHEMBL4722	Homo sapiens	IC50	uM	0.24
	3239933	CHEMBL1113415	Inhibition of hexahistidine tagged recombinant Aurora A expressed in Hi-5 cells assessed as ATP remaining after 2 hrs by bioluminescence	B	C(=C/c1n[nH]c2cc(N3CCCC3)c(NCc3ccccn3)cc12)\c1ccccc1		CHEMBL1093879	=	IC50	nM	620.0	CHEMBL4722	Homo sapiens	IC50	uM	0.62
	3239934	CHEMBL1113415	Inhibition of hexahistidine tagged recombinant Aurora A expressed in Hi-5 cells assessed as ATP remaining after 2 hrs by bioluminescence	B	CN1CCN(c2cc3[nH]nc(/C=C/c4ccccc4)c3cc2NCc2ccccn2)CC1		CHEMBL1093878	>	IC50	nM	10000.0	CHEMBL4722	Homo sapiens	IC50	uM	10.0
	3239935	CHEMBL1113415	Inhibition of hexahistidine tagged recombinant Aurora A expressed in Hi-5 cells assessed as ATP remaining after 2 hrs by bioluminescence	B	C(=C/c1n[nH]c2cc(N3CCCC3)c(-c3ccncc3)cc12)\c1ccccc1		CHEMBL1090679	=	IC50	nM	160.0	CHEMBL4722	Homo sapiens	IC50	uM	0.16
	3239936	CHEMBL1113415	Inhibition of hexahistidine tagged recombinant Aurora A expressed in Hi-5 cells assessed as ATP remaining after 2 hrs by bioluminescence	B	Cc1cc2[nH]nc(C#Cc3ccccc3)c2cc1NC(=O)Cc1cccs1		CHEMBL1093877	=	IC50	nM	240.0	CHEMBL4722	Homo sapiens	IC50	uM	0.24
	3239937	CHEMBL1113415	Inhibition of hexahistidine tagged recombinant Aurora A expressed in Hi-5 cells assessed as ATP remaining after 2 hrs by bioluminescence	B	Cc1cc2[nH]nc(/C=C/c3ccccc3)c2cc1NC(=O)Cc1cccs1		CHEMBL1090568	=	IC50	nM	17.0	CHEMBL4722	Homo sapiens	IC50	uM	0.017
	3239938	CHEMBL1113415	Inhibition of hexahistidine tagged recombinant Aurora A expressed in Hi-5 cells assessed as ATP remaining after 2 hrs by bioluminescence	B	Cc1cc2[nH]nc(/C=C/c3ccccc3)c2cc1NC(=O)Cc1ccccc1		CHEMBL1091643	=	IC50	nM	19.0	CHEMBL4722	Homo sapiens	IC50	uM	0.019
	3239939	CHEMBL1113415	Inhibition of hexahistidine tagged recombinant Aurora A expressed in Hi-5 cells assessed as ATP remaining after 2 hrs by bioluminescence	B	O=C(Cc1ccccc1)Nc1ccc2[nH]nc(/C=C/c3ccccc3)c2c1		CHEMBL1090912	=	IC50	nM	22.0	CHEMBL4722	Homo sapiens	IC50	uM	0.022
	3239940	CHEMBL1113415	Inhibition of hexahistidine tagged recombinant Aurora A expressed in Hi-5 cells assessed as ATP remaining after 2 hrs by bioluminescence	B	O=C(Cc1ccccc1)Nc1ccc2[nH]nc(C3CC3c3ccccc3)c2c1		CHEMBL1090911	=	IC50	nM	640.0	CHEMBL4722	Homo sapiens	IC50	uM	0.64
	3239941	CHEMBL1113415	Inhibition of hexahistidine tagged recombinant Aurora A expressed in Hi-5 cells assessed as ATP remaining after 2 hrs by bioluminescence	B	O=C(Cc1ccccc1)Nc1ccc2[nH]nc(CCc3ccccc3)c2c1		CHEMBL1090910	=	IC50	nM	1700.0	CHEMBL4722	Homo sapiens	IC50	uM	1.7
	3240789	CHEMBL1109652	Inhibition of Aurora1	B	O=C(Cc1ccccc1)Nc1cccc(-c2nc3sccn3c2-c2ccnc(Nc3cccc(N4CCOCC4)c3)n2)c1		CHEMBL1090360	=	IC50	nM	65.0	CHEMBL4722	Homo sapiens	IC50	uM	0.065
	3260035	CHEMBL1104353	Inhibition of Aurora A at 10 uM assessed as residual activity by [33P]ATP radioactive filter binding assay relative to control	B	CN(C)CCCC(=O)Nc1ccc2nccc(Nc3cccc(Br)c3)c2c1		CHEMBL1089524	=	Activity	%	88.0	CHEMBL4722	Homo sapiens	Activity	%	88.0
	3261152	CHEMBL1112578	Inhibition of Aurora A at 10 uM	B	O=C1OC(c2ccccc2)=N/C1=C\c1cccnc1		CHEMBL579387	=	Inhibition	%	6.0	CHEMBL4722	Homo sapiens	INH	%	6.0
	3261153	CHEMBL1112578	Inhibition of Aurora A at 10 uM	B	Cc1cccc(C2=N/C(=C\c3cccnc3)C(=O)O2)c1		CHEMBL1091786	=	Inhibition	%	3.0	CHEMBL4722	Homo sapiens	INH	%	3.0
	3261154	CHEMBL1112578	Inhibition of Aurora A at 10 uM	B	O=C1OC(c2ccc(Cl)cc2)=N/C1=C\c1cccnc1		CHEMBL1091787	=	Inhibition	%	15.0	CHEMBL4722	Homo sapiens	INH	%	15.0
	3261155	CHEMBL1112578	Inhibition of Aurora A at 10 uM	B	O=C1OC(/C=C/c2ccccc2)=N/C1=C\c1cccnc1		CHEMBL565286	=	Inhibition	%	14.0	CHEMBL4722	Homo sapiens	INH	%	14.0
	3261156	CHEMBL1112578	Inhibition of Aurora A at 10 uM	B	O=C1OC(c2ccc(F)c(F)c2)=N/C1=C\c1cccnc1		CHEMBL1091764	=	Inhibition	%	8.0	CHEMBL4722	Homo sapiens	INH	%	8.0
	3261157	CHEMBL1112578	Inhibition of Aurora A at 10 uM	B	Cc1cc(C2=N/C(=C\c3cccnc3)C(=O)O2)ccc1Br		CHEMBL1091766	=	Inhibition	%	16.0	CHEMBL4722	Homo sapiens	INH	%	16.0
	3261435	CHEMBL1104353	Inhibition of Aurora A at 10 uM assessed as residual activity by [33P]ATP radioactive filter binding assay relative to control	B	CN(C)CCCC(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1		CHEMBL1088901	=	Activity	%	66.0	CHEMBL4722	Homo sapiens	Activity	%	66.0
	3262024	CHEMBL1114558	Inhibition of aurora 1	B	O=C(N[C@H]1CC[C@H](O)CC1)c1ccc2c(c1)Cc1c(-c3ccc(-c4ccc(O)cc4)cc3)n[nH]c1-2		CHEMBL438485	=	IC50	nM	8090.0	CHEMBL4722	Homo sapiens	IC50	uM	8.09
Not Active	3271748	CHEMBL1112899	Inhibition of Aurora A	B	COc1cc(OC)c(C=C2C(=O)Nc3ccccc32)c(OC)c1		CHEMBL576349		Inhibition	%		CHEMBL4722	Homo sapiens	INH		
Not Active	3271749	CHEMBL1112899	Inhibition of Aurora A	B	COc1ccccc1/C=C1/C(=O)Nc2ccccc21		CHEMBL444673		Inhibition	%		CHEMBL4722	Homo sapiens	INH		
Not Active	3271750	CHEMBL1112899	Inhibition of Aurora A	B	O=C1Nc2ccc(Cl)cc2/C1=C\c1ccccc1F		CHEMBL1088391		Inhibition	%		CHEMBL4722	Homo sapiens	INH		
Not Active	3271751	CHEMBL1112899	Inhibition of Aurora A	B	O=C1Nc2ccc(Cl)cc2/C1=C\c1ccccc1[N+](=O)[O-]		CHEMBL1088392		Inhibition	%		CHEMBL4722	Homo sapiens	INH		
Not Active	3271752	CHEMBL1112899	Inhibition of Aurora A	B	O=C1Nc2ccc(Cl)cc2/C1=C\c1ccccc1S(=O)(=O)O		CHEMBL1088529		Inhibition	%		CHEMBL4722	Homo sapiens	INH		
Not Active	3271753	CHEMBL1112899	Inhibition of Aurora A	B	O=C1Nc2ccc(Cl)cc2/C1=C\c1ccc2c(c1)OCO2		CHEMBL1086669		Inhibition	%		CHEMBL4722	Homo sapiens	INH		
Not Active	3271754	CHEMBL1112899	Inhibition of Aurora A	B	O=C1Nc2ccc(Cl)cc2/C1=C\c1cc(F)cc(F)c1		CHEMBL1086670		Inhibition	%		CHEMBL4722	Homo sapiens	INH		
Not Active	3271755	CHEMBL1112899	Inhibition of Aurora A	B	NC(=O)Cc1ccc(/C=C2/C(=O)Nc3ccc(Cl)cc32)cc1		CHEMBL1086795		Inhibition	%		CHEMBL4722	Homo sapiens	INH		
Not Active	3271756	CHEMBL1112899	Inhibition of Aurora A	B	COc1ccc(/C=C2/C(=O)Nc3ccc(Cl)cc32)c(OC)c1OC		CHEMBL1086796		Inhibition	%		CHEMBL4722	Homo sapiens	INH		
Not Active	3271757	CHEMBL1112899	Inhibition of Aurora A	B	COc1cc(/C=C2/C(=O)Nc3ccc(Cl)cc32)cc(OC)c1OC		CHEMBL383871		Inhibition	%		CHEMBL4722	Homo sapiens	INH		
	3271758	CHEMBL1112899	Inhibition of Aurora A	B	COc1cc(OC)c(/C=C2/C(=O)Nc3ccc(Cl)cc32)c(OC)c1		CHEMBL1086939	<	Inhibition	%	20.0	CHEMBL4722	Homo sapiens	INH	%	20.0
Not Active	3271759	CHEMBL1112899	Inhibition of Aurora A	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535		Inhibition	%		CHEMBL4722	Homo sapiens	INH		
	3273883	CHEMBL1106490	Inhibition of recombinant auroraA preincubated for 15 mins by HTRF assay	B	O=C1Nc2ccc([N+](=O)[O-])cc2/C1=C1/Nc2ccc(O)cc2/C1=N/O		CHEMBL1088704	=	IC50	nM	1000.0	CHEMBL4722	Homo sapiens	IC50	uM	1.0
Not Active	3273894	CHEMBL1107392	Inhibition of recombinant auroraA at 10 uM preincubated for 15 mins by HTRF assay	B	O=C1Nc2ccc([N+](=O)[O-])cc2/C1=C1/Nc2ccc(Cl)cc2/C1=N/O		CHEMBL1086811		Inhibition	%		CHEMBL4722	Homo sapiens	INH		
	3291435	CHEMBL1109146	Inhibition of Aurora A assessed as [33P]gamma-ATP incorporation into substrate after 60 mins by gamma counting	B	COc1ccc(N2CCN(C)CC2)cc1Nc1ncc2c(n1)-c1c(c(C(N)=O)nn1C)CC2		CHEMBL1094408	>	IC50	nM	10000.0	CHEMBL4722	Homo sapiens	IC50	uM	10.0
	3291664	CHEMBL1109146	Inhibition of Aurora A assessed as [33P]gamma-ATP incorporation into substrate after 60 mins by gamma counting	B	NC(=O)c1nn(CC(F)(F)F)c2c1CCc1cnc(Nc3ccccc3)nc1-2		CHEMBL1095709	=	IC50	nM	42.0	CHEMBL4722	Homo sapiens	IC50	uM	0.042
	3291667	CHEMBL1109146	Inhibition of Aurora A assessed as [33P]gamma-ATP incorporation into substrate after 60 mins by gamma counting	B	Cn1nc(C(N)=O)c2c1-c1nc(Nc3ccccc3)ncc1CC2		CHEMBL559845	=	IC50	nM	50.0	CHEMBL4722	Homo sapiens	IC50	uM	0.05
	3291672	CHEMBL1109146	Inhibition of Aurora A assessed as [33P]gamma-ATP incorporation into substrate after 60 mins by gamma counting	B	NC(=O)c1n[nH]c2c1CCc1cnc(Nc3ccccc3)nc1-2		CHEMBL1094401	=	IC50	nM	92.0	CHEMBL4722	Homo sapiens	IC50	uM	0.092
	3291676	CHEMBL1109146	Inhibition of Aurora A assessed as [33P]gamma-ATP incorporation into substrate after 60 mins by gamma counting	B	CC(=O)c1ccc(Nc2ncc3c(n2)-c2c(c(C(N)=O)nn2C)CC3)cc1		CHEMBL1099106	=	IC50	nM	116.0	CHEMBL4722	Homo sapiens	IC50	uM	0.116
	3291678	CHEMBL1109146	Inhibition of Aurora A assessed as [33P]gamma-ATP incorporation into substrate after 60 mins by gamma counting	B	COc1ccc(Nc2ncc3c(n2)-c2c(c(C(N)=O)nn2C)CC3)cc1		CHEMBL1094322	=	IC50	nM	128.0	CHEMBL4722	Homo sapiens	IC50	uM	0.128
	3291681	CHEMBL1109146	Inhibition of Aurora A assessed as [33P]gamma-ATP incorporation into substrate after 60 mins by gamma counting	B	COc1cccc(Nc2ncc3c(n2)-c2c(c(C(N)=O)nn2C)CC3)c1		CHEMBL1095448	=	IC50	nM	158.0	CHEMBL4722	Homo sapiens	IC50	uM	0.158
	3291682	CHEMBL1109146	Inhibition of Aurora A assessed as [33P]gamma-ATP incorporation into substrate after 60 mins by gamma counting	B	NC(=O)c1nn(C2CCCCC2)c2c1CCc1cnc(Nc3ccccc3)nc1-2		CHEMBL1094402	=	IC50	nM	169.0	CHEMBL4722	Homo sapiens	IC50	uM	0.169
	3291683	CHEMBL1109146	Inhibition of Aurora A assessed as [33P]gamma-ATP incorporation into substrate after 60 mins by gamma counting	B	CC(=O)c1cccc(Nc2ncc3c(n2)-c2c(c(C(N)=O)nn2C)CC3)c1		CHEMBL1099105	=	IC50	nM	176.0	CHEMBL4722	Homo sapiens	IC50	uM	0.176
	3291689	CHEMBL1109146	Inhibition of Aurora A assessed as [33P]gamma-ATP incorporation into substrate after 60 mins by gamma counting	B	Cn1nc(C(N)=O)c2c1-c1nc(Nc3ccc(C(F)(F)F)cc3)ncc1CC2		CHEMBL1097429	=	IC50	nM	270.0	CHEMBL4722	Homo sapiens	IC50	uM	0.27
	3291702	CHEMBL1109146	Inhibition of Aurora A assessed as [33P]gamma-ATP incorporation into substrate after 60 mins by gamma counting	B	COc1ccccc1Nc1ncc2c(n1)-c1c(c(C(N)=O)nn1C)CC2		CHEMBL1094135	=	IC50	nM	607.0	CHEMBL4722	Homo sapiens	IC50	uM	0.607
	3291711	CHEMBL1109146	Inhibition of Aurora A assessed as [33P]gamma-ATP incorporation into substrate after 60 mins by gamma counting	B	CC(C)n1nc(C(N)=O)c2c1-c1nc(Nc3ccccc3)ncc1CC2		CHEMBL1094735	=	IC50	nM	1392.0	CHEMBL4722	Homo sapiens	IC50	uM	1.392
	3291716	CHEMBL1109146	Inhibition of Aurora A assessed as [33P]gamma-ATP incorporation into substrate after 60 mins by gamma counting	B	NC(=O)c1nn(-c2ccccc2)c2c1CCc1cnc(Nc3ccccc3)nc1-2		CHEMBL1094400	=	IC50	nM	2360.0	CHEMBL4722	Homo sapiens	IC50	uM	2.36
	3291718	CHEMBL1109146	Inhibition of Aurora A assessed as [33P]gamma-ATP incorporation into substrate after 60 mins by gamma counting	B	NC(=O)c1nn(CCN2CCCCC2)c2c1CCc1cnc(Nc3ccccc3)nc1-2		CHEMBL1098058	=	IC50	nM	2848.0	CHEMBL4722	Homo sapiens	IC50	uM	2.848
	3291725	CHEMBL1109146	Inhibition of Aurora A assessed as [33P]gamma-ATP incorporation into substrate after 60 mins by gamma counting	B	CN1CCC(n2nc(C(N)=O)c3c2-c2nc(Nc4ccccc4)ncc2CC3)CC1		CHEMBL1098057	>	IC50	nM	10000.0	CHEMBL4722	Homo sapiens	IC50	uM	10.0
	3291730	CHEMBL1109146	Inhibition of Aurora A assessed as [33P]gamma-ATP incorporation into substrate after 60 mins by gamma counting	B	Cn1nc(C(N)=O)c2c1-c1nc(Nc3ccccc3C(F)(F)F)ncc1CC2		CHEMBL1097071	>	IC50	nM	10000.0	CHEMBL4722	Homo sapiens	IC50	uM	10.0
	3291732	CHEMBL1109146	Inhibition of Aurora A assessed as [33P]gamma-ATP incorporation into substrate after 60 mins by gamma counting	B	Cn1nc(C(N)=O)c2c1-c1nc(Nc3cccc(C(F)(F)F)c3)ncc1CC2		CHEMBL1097424	>	IC50	nM	10000.0	CHEMBL4722	Homo sapiens	IC50	uM	10.0
	3291733	CHEMBL1109146	Inhibition of Aurora A assessed as [33P]gamma-ATP incorporation into substrate after 60 mins by gamma counting	B	CC(=O)c1ccccc1Nc1ncc2c(n1)-c1c(c(C(N)=O)nn1C)CC2		CHEMBL1099104	>	IC50	nM	10000.0	CHEMBL4722	Homo sapiens	IC50	uM	10.0
	3291735	CHEMBL1109146	Inhibition of Aurora A assessed as [33P]gamma-ATP incorporation into substrate after 60 mins by gamma counting	B	Cn1nc(C(N)=O)c2c1-c1nc(Nc3ccccc3[N+](=O)[O-])ncc1CC2		CHEMBL1094810	>	IC50	nM	10000.0	CHEMBL4722	Homo sapiens	IC50	uM	10.0
	3291737	CHEMBL1109146	Inhibition of Aurora A assessed as [33P]gamma-ATP incorporation into substrate after 60 mins by gamma counting	B	Cn1nc(C(N)=O)c2c1-c1nc(Nc3cccc([N+](=O)[O-])c3)ncc1CC2		CHEMBL1094811	>	IC50	nM	10000.0	CHEMBL4722	Homo sapiens	IC50	uM	10.0
	3291739	CHEMBL1109146	Inhibition of Aurora A assessed as [33P]gamma-ATP incorporation into substrate after 60 mins by gamma counting	B	Cn1nc(C(N)=O)c2c1-c1nc(Nc3ccc([N+](=O)[O-])cc3)ncc1CC2		CHEMBL1095132	>	IC50	nM	10000.0	CHEMBL4722	Homo sapiens	IC50	uM	10.0
	3291761	CHEMBL1109146	Inhibition of Aurora A assessed as [33P]gamma-ATP incorporation into substrate after 60 mins by gamma counting	B	Cn1nc(C(=O)O)c2c1-c1nc(Nc3ccccc3)ncc1CC2		CHEMBL1098060	=	IC50	nM	16.0	CHEMBL4722	Homo sapiens	IC50	uM	0.016
	3292691	CHEMBL1109146	Inhibition of Aurora A assessed as [33P]gamma-ATP incorporation into substrate after 60 mins by gamma counting	B	Cn1nc(C(=O)NC2CC2)c2c1-c1nc(Nc3ccccc3)ncc1CC2		CHEMBL559639	=	IC50	nM	213.0	CHEMBL4722	Homo sapiens	IC50	uM	0.213
	3292694	CHEMBL1109146	Inhibition of Aurora A assessed as [33P]gamma-ATP incorporation into substrate after 60 mins by gamma counting	B	CNC(=O)c1nn(C)c2c1CCc1cnc(Nc3ccccc3)nc1-2		CHEMBL562104	=	IC50	nM	312.0	CHEMBL4722	Homo sapiens	IC50	uM	0.312
	3292702	CHEMBL1109146	Inhibition of Aurora A assessed as [33P]gamma-ATP incorporation into substrate after 60 mins by gamma counting	B	Cc1ccccc1Nc1ncc2c(n1)-c1c(c(C(N)=O)nn1C)CC2		CHEMBL1094477	=	IC50	nM	605.0	CHEMBL4722	Homo sapiens	IC50	uM	0.605
	3292712	CHEMBL1109146	Inhibition of Aurora A assessed as [33P]gamma-ATP incorporation into substrate after 60 mins by gamma counting	B	Cn1nc(C(N)=O)c2c1-c1nc(Nc3ccccc3F)ncc1CC2		CHEMBL1095771	=	IC50	nM	1181.0	CHEMBL4722	Homo sapiens	IC50	uM	1.181
	3292726	CHEMBL1109146	Inhibition of Aurora A assessed as [33P]gamma-ATP incorporation into substrate after 60 mins by gamma counting	B	Cn1nc(C(N)=O)c2c1-c1nc(Nc3ccccc3N)ncc1CC2		CHEMBL1097022	=	IC50	nM	2497.0	CHEMBL4722	Homo sapiens	IC50	uM	2.497
	3292733	CHEMBL1109146	Inhibition of Aurora A assessed as [33P]gamma-ATP incorporation into substrate after 60 mins by gamma counting	B	CNc1ccccc1Nc1ncc2c(n1)-c1c(c(C(N)=O)nn1C)CC2		CHEMBL1095457	=	IC50	nM	2900.0	CHEMBL4722	Homo sapiens	IC50	uM	2.9
	3292762	CHEMBL1109146	Inhibition of Aurora A assessed as [33P]gamma-ATP incorporation into substrate after 60 mins by gamma counting	B	CCOC(=O)c1nn(C)c2c1CCc1cnc(Nc3ccccc3)nc1-2		CHEMBL1098059	>	IC50	nM	10000.0	CHEMBL4722	Homo sapiens	IC50	uM	10.0
	3292765	CHEMBL1109146	Inhibition of Aurora A assessed as [33P]gamma-ATP incorporation into substrate after 60 mins by gamma counting	B	Cn1nc(C(=O)NC2CCCC2)c2c1-c1nc(Nc3ccccc3)ncc1CC2		CHEMBL563028	>	IC50	nM	10000.0	CHEMBL4722	Homo sapiens	IC50	uM	10.0
	3292768	CHEMBL1109146	Inhibition of Aurora A assessed as [33P]gamma-ATP incorporation into substrate after 60 mins by gamma counting	B	Cn1nc(C(=O)Nc2ccccc2)c2c1-c1nc(Nc3ccccc3)ncc1CC2		CHEMBL563150	>	IC50	nM	10000.0	CHEMBL4722	Homo sapiens	IC50	uM	10.0
	3292770	CHEMBL1109146	Inhibition of Aurora A assessed as [33P]gamma-ATP incorporation into substrate after 60 mins by gamma counting	B	CSc1ccccc1Nc1ncc2c(n1)-c1c(c(C(N)=O)nn1C)CC2		CHEMBL1094478	>	IC50	nM	10000.0	CHEMBL4722	Homo sapiens	IC50	uM	10.0
	3292771	CHEMBL1109146	Inhibition of Aurora A assessed as [33P]gamma-ATP incorporation into substrate after 60 mins by gamma counting	B	CC(C)c1ccccc1Nc1ncc2c(n1)-c1c(c(C(N)=O)nn1C)CC2		CHEMBL1095772	>	IC50	nM	10000.0	CHEMBL4722	Homo sapiens	IC50	uM	10.0
	3292773	CHEMBL1109146	Inhibition of Aurora A assessed as [33P]gamma-ATP incorporation into substrate after 60 mins by gamma counting	B	COC(=O)c1ccccc1Nc1ncc2c(n1)-c1c(c(C(N)=O)nn1C)CC2		CHEMBL1094484	>	IC50	nM	10000.0	CHEMBL4722	Homo sapiens	IC50	uM	10.0
	3292775	CHEMBL1109146	Inhibition of Aurora A assessed as [33P]gamma-ATP incorporation into substrate after 60 mins by gamma counting	B	Cn1nc(C(N)=O)c2c1-c1nc(Nc3ccccc3C(N)=O)ncc1CC2		CHEMBL1094815	>	IC50	nM	10000.0	CHEMBL4722	Homo sapiens	IC50	uM	10.0
	3292777	CHEMBL1109146	Inhibition of Aurora A assessed as [33P]gamma-ATP incorporation into substrate after 60 mins by gamma counting	B	Cn1nc(C(N)=O)c2c1-c1nc(Nc3ccccc3S(N)(=O)=O)ncc1CC2		CHEMBL1094816	>	IC50	nM	10000.0	CHEMBL4722	Homo sapiens	IC50	uM	10.0
	3292778	CHEMBL1109146	Inhibition of Aurora A assessed as [33P]gamma-ATP incorporation into substrate after 60 mins by gamma counting	B	Cn1nc(C(N)=O)c2c1-c1nc(Nc3ccccc3-c3ccccc3)ncc1CC2		CHEMBL1094817	>	IC50	nM	10000.0	CHEMBL4722	Homo sapiens	IC50	uM	10.0
	3292780	CHEMBL1109146	Inhibition of Aurora A assessed as [33P]gamma-ATP incorporation into substrate after 60 mins by gamma counting	B	Cn1nc(C(N)=O)c2c1-c1nc(Nc3ccccc3Oc3ccccc3)ncc1CC2		CHEMBL1096095	>	IC50	nM	10000.0	CHEMBL4722	Homo sapiens	IC50	uM	10.0
	3292782	CHEMBL1109146	Inhibition of Aurora A assessed as [33P]gamma-ATP incorporation into substrate after 60 mins by gamma counting	B	Cn1nc(C(N)=O)c2c1-c1nc(Nc3ccccc3Cc3ccccc3)ncc1CC2		CHEMBL1094488	>	IC50	nM	10000.0	CHEMBL4722	Homo sapiens	IC50	uM	10.0
	3292784	CHEMBL1109146	Inhibition of Aurora A assessed as [33P]gamma-ATP incorporation into substrate after 60 mins by gamma counting	B	Cn1nc(C(N)=O)c2c1-c1nc(Nc3ccccc3Nc3ccccc3)ncc1CC2		CHEMBL1094820	>	IC50	nM	10000.0	CHEMBL4722	Homo sapiens	IC50	uM	10.0
	3292786	CHEMBL1109146	Inhibition of Aurora A assessed as [33P]gamma-ATP incorporation into substrate after 60 mins by gamma counting	B	Cn1nc(C(N)=O)c2c1-c1nc(Nc3ccccc3C(=O)c3ccccc3)ncc1CC2		CHEMBL1094821	>	IC50	nM	10000.0	CHEMBL4722	Homo sapiens	IC50	uM	10.0
	3292789	CHEMBL1109146	Inhibition of Aurora A assessed as [33P]gamma-ATP incorporation into substrate after 60 mins by gamma counting	B	Cn1nc(C(N)=O)c2c1-c1nc(Nc3ccccc3Sc3ccccc3)ncc1CC2		CHEMBL1094822	>	IC50	nM	10000.0	CHEMBL4722	Homo sapiens	IC50	uM	10.0
	3292791	CHEMBL1109146	Inhibition of Aurora A assessed as [33P]gamma-ATP incorporation into substrate after 60 mins by gamma counting	B	CC(=O)Nc1ccccc1Nc1ncc2c(n1)-c1c(c(C(N)=O)nn1C)CC2		CHEMBL1097373	>	IC50	nM	10000.0	CHEMBL4722	Homo sapiens	IC50	uM	10.0
	3292794	CHEMBL1109146	Inhibition of Aurora A assessed as [33P]gamma-ATP incorporation into substrate after 60 mins by gamma counting	B	CC(=O)c1c(Nc2ncc3c(n2)-c2c(c(C(N)=O)nn2C)CC3)cccc1N1CCN(C)CC1		CHEMBL1097374	>	IC50	nM	10000.0	CHEMBL4722	Homo sapiens	IC50	uM	10.0
	3292798	CHEMBL1109146	Inhibition of Aurora A assessed as [33P]gamma-ATP incorporation into substrate after 60 mins by gamma counting	B	CC(=O)c1cc(N2CCN(C)CC2)ccc1Nc1ncc2c(n1)-c1c(c(C(N)=O)nn1C)CC2		CHEMBL1096028	>	IC50	nM	10000.0	CHEMBL4722	Homo sapiens	IC50	uM	10.0
	3292803	CHEMBL1109146	Inhibition of Aurora A assessed as [33P]gamma-ATP incorporation into substrate after 60 mins by gamma counting	B	CC(=O)c1ccc(N2CCN(C)CC2)cc1Nc1ncc2c(n1)-c1c(c(C(N)=O)nn1C)CC2		CHEMBL1095716	>	IC50	nM	10000.0	CHEMBL4722	Homo sapiens	IC50	uM	10.0
	3292804	CHEMBL1109146	Inhibition of Aurora A assessed as [33P]gamma-ATP incorporation into substrate after 60 mins by gamma counting	B	COc1cc(N2CCN(C)CC2)ccc1Nc1ncc2c(n1)-c1c(c(C(N)=O)nn1C)CC2		CHEMBL1095717	>	IC50	nM	10000.0	CHEMBL4722	Homo sapiens	IC50	uM	10.0
	3294175	CHEMBL1104795	Inhibition of Aurora A	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	Ki	nM	0.6	CHEMBL4722	Homo sapiens	Ki	nM	0.6
	3294178	CHEMBL1104795	Inhibition of Aurora A	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	=	IC50	nM	4.0	CHEMBL4722	Homo sapiens	IC50	nM	4.0
	3294179	CHEMBL1104795	Inhibition of Aurora A	B	CCN(CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1)CCOP(=O)(O)O		CHEMBL415049	=	IC50	nM	1400.0	CHEMBL4722	Homo sapiens	IC50	nM	1400.0
	3294183	CHEMBL1104795	Inhibition of Aurora A	B	CCn1cc(-c2ccnc3[nH]c(-c4cccc(CN(C)C)c4)cc23)c(-c2ccc(NC(=O)N(C)C)cc2)n1		CHEMBL1090479	=	Ki	nM	492.0	CHEMBL4722	Homo sapiens	Ki	nM	492.0
	3294232	CHEMBL1108258	Competitive inhibition of human Aurora A ATP binding site	B	CCn1cc(-c2ccnc3[nH]c(-c4cccc(CN(C)C)c4)cc23)c(-c2ccc(NC(=O)N(C)C)cc2)n1		CHEMBL1090479	=	Ki	nM	490.0	CHEMBL4722	Homo sapiens	Ki	nM	490.0
	3294240	CHEMBL1104791	Inhibition of human Aurora A	B	CCn1cc(-c2ccnc3[nH]c(-c4cccc(CN(C)C)c4)cc23)c(-c2ccc(NC(=O)N(C)C)cc2)n1		CHEMBL1090479	=	IC50	nM	1259.0	CHEMBL4722	Homo sapiens	IC50	nM	1259.0
	3294306	CHEMBL1104791	Inhibition of human Aurora A	B	O=C(Nc1ccccc1)Nc1ccc(-c2n[nH]cc2-c2ccnc3[nH]ccc23)cc1		CHEMBL1095192	=	IC50	nM	3848.0	CHEMBL4722	Homo sapiens	IC50	nM	3848.0
	3294307	CHEMBL1104791	Inhibition of human Aurora A	B	CCn1ncc(-c2ccnc3[nH]ccc23)c1-c1ccc(NC(=O)Nc2ccccc2)cc1		CHEMBL1095828	=	IC50	nM	5600.0	CHEMBL4722	Homo sapiens	IC50	nM	5600.0
	3294308	CHEMBL1104791	Inhibition of human Aurora A	B	CCn1cc(-c2ccnc3[nH]ccc23)c(-c2ccc(NC(=O)Nc3ccccc3)cc2)n1		CHEMBL1089116	=	IC50	nM	631.0	CHEMBL4722	Homo sapiens	IC50	nM	631.0
	3294309	CHEMBL1104791	Inhibition of human Aurora A	B	CC(C)(C)n1ncc(-c2ccnc3[nH]ccc23)c1-c1ccc(NC(=O)Nc2ccccc2)cc1		CHEMBL1098666	=	IC50	nM	5770.0	CHEMBL4722	Homo sapiens	IC50	nM	5770.0
	3294310	CHEMBL1104791	Inhibition of human Aurora A	B	CC(C)(C)n1cc(-c2ccnc3[nH]ccc23)c(-c2ccc(NC(=O)Nc3ccccc3)cc2)n1		CHEMBL1095498	=	IC50	nM	8156.0	CHEMBL4722	Homo sapiens	IC50	nM	8156.0
	3294311	CHEMBL1104791	Inhibition of human Aurora A	B	O=C(Nc1ccccc1)Nc1ccc(-c2nn(CC(F)(F)F)cc2-c2ccnc3[nH]ccc23)cc1		CHEMBL1095817	=	IC50	nM	2150.0	CHEMBL4722	Homo sapiens	IC50	nM	2150.0
	3294312	CHEMBL1104791	Inhibition of human Aurora A	B	O=C(Nc1ccccc1)Nc1ccc(-c2nn(CCO)cc2-c2ccnc3[nH]ccc23)cc1		CHEMBL1099010	=	IC50	nM	792.0	CHEMBL4722	Homo sapiens	IC50	nM	792.0
	3294313	CHEMBL1104791	Inhibition of human Aurora A	B	O=C(Nc1ccccc1)Nc1ccc(-c2nn(CC(O)CO)cc2-c2ccnc3[nH]ccc23)cc1		CHEMBL1097106	=	IC50	nM	377.0	CHEMBL4722	Homo sapiens	IC50	nM	377.0
	3294314	CHEMBL1104791	Inhibition of human Aurora A	B	O=C(Nc1ccccc1)Nc1ccc(-c2nn(CCCO)cc2-c2ccnc3[nH]ccc23)cc1		CHEMBL1097454	=	IC50	nM	969.0	CHEMBL4722	Homo sapiens	IC50	nM	969.0
	3294315	CHEMBL1104791	Inhibition of human Aurora A	B	O=C(Nc1ccccc1)Nc1ccc(-c2nn(CC3CCCO3)cc2-c2ccnc3[nH]ccc23)cc1		CHEMBL1964276	=	IC50	nM	6195.0	CHEMBL4722	Homo sapiens	IC50	nM	6195.0
	3294316	CHEMBL1104791	Inhibition of human Aurora A	B	NC(=O)Cn1cc(-c2ccnc3[nH]ccc23)c(-c2ccc(NC(=O)Nc3ccccc3)cc2)n1		CHEMBL1094505	=	IC50	nM	5676.0	CHEMBL4722	Homo sapiens	IC50	nM	5676.0
	3294317	CHEMBL1104791	Inhibition of human Aurora A	B	CCNC(=O)Cn1cc(-c2ccnc3[nH]ccc23)c(-c2ccc(NC(=O)Nc3ccccc3)cc2)n1		CHEMBL1094506	=	IC50	nM	3392.0	CHEMBL4722	Homo sapiens	IC50	nM	3392.0
	3294318	CHEMBL1104791	Inhibition of human Aurora A	B	O=C(Nc1ccccc1)Nc1ccc(-c2nn(CC(=O)N3CCOCC3)cc2-c2ccnc3[nH]ccc23)cc1		CHEMBL1094507	=	IC50	nM	6810.0	CHEMBL4722	Homo sapiens	IC50	nM	6810.0
	3294319	CHEMBL1104791	Inhibition of human Aurora A	B	CCn1cc(-c2ccnc3[nH]ccc23)c(-c2ccc(NC(=O)N(C)C)cc2)n1		CHEMBL1090156	>	IC50	nM	10000.0	CHEMBL4722	Homo sapiens	IC50	nM	10000.0
	3294320	CHEMBL1104791	Inhibition of human Aurora A	B	CCn1cc(-c2ccnc3[nH]c(-c4cccc(NC(C)=O)c4)cc23)c(-c2ccc(NC(=O)Nc3ccccc3)cc2)n1		CHEMBL1099343	=	IC50	nM	126.0	CHEMBL4722	Homo sapiens	IC50	nM	126.0
	3294321	CHEMBL1104791	Inhibition of human Aurora A	B	CCn1cc(-c2ccnc3[nH]c(-c4ccc(NC(C)=O)cc4)cc23)c(-c2ccc(NC(=O)Nc3ccccc3)cc2)n1		CHEMBL1099344	=	IC50	nM	62.0	CHEMBL4722	Homo sapiens	IC50	nM	62.0
	3294322	CHEMBL1104791	Inhibition of human Aurora A	B	CCn1cc(-c2ccnc3[nH]c(-c4cccc(CN(C)C)c4)cc23)c(-c2ccc(NC(=O)Nc3ccccc3)cc2)n1		CHEMBL1099345	=	IC50	nM	53.0	CHEMBL4722	Homo sapiens	IC50	nM	53.0
	3294323	CHEMBL1104791	Inhibition of human Aurora A	B	CCn1cc(-c2ccnc3[nH]c(-c4cc(CN(C)C)ccc4C)cc23)c(-c2ccc(NC(=O)Nc3ccccc3)cc2)n1		CHEMBL1099346	=	IC50	nM	113.0	CHEMBL4722	Homo sapiens	IC50	nM	113.0
	3294324	CHEMBL1104791	Inhibition of human Aurora A	B	CCn1cc(-c2ccnc3[nH]c(-c4ccc(CN(C)C)cc4)cc23)c(-c2ccc(NC(=O)Nc3ccccc3)cc2)n1		CHEMBL1099347	=	IC50	nM	45.0	CHEMBL4722	Homo sapiens	IC50	nM	45.0
	3294325	CHEMBL1104791	Inhibition of human Aurora A	B	CCn1cc(-c2ccnc3[nH]c(-c4ccc(CN(C)C)cc4C)cc23)c(-c2ccc(NC(=O)Nc3ccccc3)cc2)n1		CHEMBL1099348	=	IC50	nM	42.0	CHEMBL4722	Homo sapiens	IC50	nM	42.0
	3294326	CHEMBL1104791	Inhibition of human Aurora A	B	CCn1cc(-c2ccnc3[nH]c(-c4cccc(CN5CCCC5)c4)cc23)c(-c2ccc(NC(=O)Nc3ccccc3)cc2)n1		CHEMBL1099349	=	IC50	nM	22.0	CHEMBL4722	Homo sapiens	IC50	nM	22.0
	3294327	CHEMBL1104791	Inhibition of human Aurora A	B	CCn1cc(-c2ccnc3[nH]c(-c4cccc(CN5CCOCC5)c4)cc23)c(-c2ccc(NC(=O)Nc3ccccc3)cc2)n1		CHEMBL1099350	=	IC50	nM	94.0	CHEMBL4722	Homo sapiens	IC50	nM	94.0
	3294328	CHEMBL1104791	Inhibition of human Aurora A	B	CCn1cc(-c2ccnc3[nH]c(-c4ccc(CN5CCOCC5)cc4)cc23)c(-c2ccc(NC(=O)Nc3ccccc3)cc2)n1		CHEMBL1099351	=	IC50	nM	59.0	CHEMBL4722	Homo sapiens	IC50	nM	59.0
	3294329	CHEMBL1104791	Inhibition of human Aurora A	B	CCNC(=O)Nc1ccc(-c2nn(CC)cc2-c2ccnc3[nH]c(-c4cccc(CN(C)C)c4)cc23)cc1		CHEMBL1095157	=	IC50	nM	128.0	CHEMBL4722	Homo sapiens	IC50	nM	128.0
	3294330	CHEMBL1104791	Inhibition of human Aurora A	B	CCNC(=O)Nc1ccc(-c2nn(CC)cc2-c2ccnc3[nH]c(-c4ccc(CN(C)C)cc4)cc23)cc1		CHEMBL1094838	=	IC50	nM	39.0	CHEMBL4722	Homo sapiens	IC50	nM	39.0
	3294331	CHEMBL1104791	Inhibition of human Aurora A	B	CCn1cc(-c2ccnc3[nH]c(-c4ccc(CN(C)C)cc4)cc23)c(-c2ccc(NC(=O)N(C)C)cc2)n1		CHEMBL1095149	=	IC50	nM	514.0	CHEMBL4722	Homo sapiens	IC50	nM	514.0
	3294332	CHEMBL1104791	Inhibition of human Aurora A	B	CCNC(=O)Nc1ccc(-c2nn(CC)cc2-c2ccnc3[nH]c(-c4cccc(CN5CCCC5)c4)cc23)cc1		CHEMBL1095475	=	IC50	nM	58.0	CHEMBL4722	Homo sapiens	IC50	nM	58.0
	3294333	CHEMBL1104791	Inhibition of human Aurora A	B	CCn1cc(-c2ccnc3[nH]c(-c4cccc(CN5CCCC5)c4)cc23)c(-c2ccc(NC(=O)N(C)C)cc2)n1		CHEMBL1095788	=	IC50	nM	366.0	CHEMBL4722	Homo sapiens	IC50	nM	366.0
	3294334	CHEMBL1104791	Inhibition of human Aurora A	B	CCNC(=O)Nc1ccc(-c2nn(CC)cc2-c2ccnc3[nH]c(-c4ccc(CN5CCCC5)cc4)cc23)cc1		CHEMBL1097191	=	IC50	nM	42.0	CHEMBL4722	Homo sapiens	IC50	nM	42.0
	3294335	CHEMBL1104791	Inhibition of human Aurora A	B	CCn1cc(-c2ccnc3[nH]c(-c4ccc(CN5CCCC5)cc4)cc23)c(-c2ccc(NC(=O)N(C)C)cc2)n1		CHEMBL1097521	=	IC50	nM	414.0	CHEMBL4722	Homo sapiens	IC50	nM	414.0
	3294336	CHEMBL1104791	Inhibition of human Aurora A	B	CCNC(=O)Nc1ccc(-c2nn(CC)cc2-c2ccnc3[nH]c(-c4cccc(CN5CCOCC5)c4)cc23)cc1		CHEMBL1094700	=	IC50	nM	70.0	CHEMBL4722	Homo sapiens	IC50	nM	70.0
	3294337	CHEMBL1104791	Inhibition of human Aurora A	B	CCn1cc(-c2ccnc3[nH]c(-c4cccc(CN5CCOCC5)c4)cc23)c(-c2ccc(NC(=O)N(C)C)cc2)n1		CHEMBL1094701	=	IC50	nM	495.0	CHEMBL4722	Homo sapiens	IC50	nM	495.0
	3294338	CHEMBL1104791	Inhibition of human Aurora A	B	CCNC(=O)Nc1ccc(-c2nn(CC)cc2-c2ccnc3[nH]c(-c4ccc(CN5CCOCC5)cc4)cc23)cc1		CHEMBL1094702	=	IC50	nM	23.0	CHEMBL4722	Homo sapiens	IC50	nM	23.0
	3294339	CHEMBL1104791	Inhibition of human Aurora A	B	CCn1cc(-c2ccnc3[nH]c(-c4ccc(CN5CCOCC5)cc4)cc23)c(-c2ccc(NC(=O)N(C)C)cc2)n1		CHEMBL1094703	=	IC50	nM	250.0	CHEMBL4722	Homo sapiens	IC50	nM	250.0
	3294340	CHEMBL1104791	Inhibition of human Aurora A	B	CCn1cc(-c2ccnc3[nH]c(C(=O)NCCN4CCOCC4)cc23)c(-c2ccc(NC(=O)Nc3ccccc3)cc2)n1		CHEMBL1094704	=	IC50	nM	197.0	CHEMBL4722	Homo sapiens	IC50	nM	197.0
	3294341	CHEMBL1104791	Inhibition of human Aurora A	B	CCn1cc(-c2ccnc3[nH]c(C(=O)NCCCN4CCN(C)CC4)cc23)c(-c2ccc(NC(=O)Nc3ccccc3)cc2)n1		CHEMBL1094705	=	IC50	nM	228.0	CHEMBL4722	Homo sapiens	IC50	nM	228.0
	3294342	CHEMBL1104791	Inhibition of human Aurora A	B	CCn1cc(-c2ccnc3[nH]c(C(=O)NCCN4CCN(C)CC4)cc23)c(-c2ccc(NC(=O)Nc3ccccc3)cc2)n1		CHEMBL1094706	=	IC50	nM	203.0	CHEMBL4722	Homo sapiens	IC50	nM	203.0
	3294343	CHEMBL1104791	Inhibition of human Aurora A	B	CCn1cc(-c2ccnc3[nH]c(CN(C)C)cc23)c(-c2ccc(NC(=O)Nc3ccccc3)cc2)n1		CHEMBL1097839	=	IC50	nM	1701.0	CHEMBL4722	Homo sapiens	IC50	nM	1701.0
	3294344	CHEMBL1104791	Inhibition of human Aurora A	B	CCn1cc(-c2ccnc3[nH]c(CNCCO)cc23)c(-c2ccc(NC(=O)Nc3ccccc3)cc2)n1		CHEMBL1094904	=	IC50	nM	2819.0	CHEMBL4722	Homo sapiens	IC50	nM	2819.0
	3294345	CHEMBL1104791	Inhibition of human Aurora A	B	CCn1cc(-c2ccnc3[nH]c(CNCCN(C)C)cc23)c(-c2ccc(NC(=O)Nc3ccccc3)cc2)n1		CHEMBL1096491	=	IC50	nM	5477.0	CHEMBL4722	Homo sapiens	IC50	nM	5477.0
	3294346	CHEMBL1104791	Inhibition of human Aurora A	B	CCn1cc(-c2ccnc3[nH]c(CNCCS(C)(=O)=O)cc23)c(-c2ccc(NC(=O)Nc3ccccc3)cc2)n1		CHEMBL1096492	=	IC50	nM	579.0	CHEMBL4722	Homo sapiens	IC50	nM	579.0
	3294347	CHEMBL1104791	Inhibition of human Aurora A	B	CCn1cc(-c2ccnc3[nH]c(CNCCN4CCOCC4)cc23)c(-c2ccc(NC(=O)Nc3ccccc3)cc2)n1		CHEMBL1095988	=	IC50	nM	2445.0	CHEMBL4722	Homo sapiens	IC50	nM	2445.0
	3294348	CHEMBL1104791	Inhibition of human Aurora A	B	CCn1cc(-c2ccnc3[nH]c(CNCCCN4CCN(C)CC4)cc23)c(-c2ccc(NC(=O)Nc3ccccc3)cc2)n1		CHEMBL1095989	=	IC50	nM	5111.0	CHEMBL4722	Homo sapiens	IC50	nM	5111.0
	3301897	CHEMBL1119040	Inhibition of human recombinant Aurora A expressed in baculovirus system	B	COc1ccc(-c2nc3c(N4CCN(CC(=O)Nc5nccs5)CC4)c(C4CC4)cnc3[nH]2)cc1		CHEMBL1085357	=	IC50	nM	53.0	CHEMBL4722	Homo sapiens	IC50	uM	0.053
	3301899	CHEMBL1119040	Inhibition of human recombinant Aurora A expressed in baculovirus system	B	CN(C)c1ccc(-c2nc3c(N4CCN(CC(=O)Nc5nccs5)CC4)c(C#N)cnc3[nH]2)cc1		CHEMBL1085356	=	IC50	nM	50.0	CHEMBL4722	Homo sapiens	IC50	uM	0.05
	3301901	CHEMBL1119040	Inhibition of human recombinant Aurora A expressed in baculovirus system	B	CN(C)c1ccc(-c2nc3c(N4CCN(CC(=O)Nc5nccs5)CC4)c(Br)cnc3[nH]2)cc1		CHEMBL1086309	=	IC50	nM	55.0	CHEMBL4722	Homo sapiens	IC50	uM	0.055
	3301903	CHEMBL1119040	Inhibition of human recombinant Aurora A expressed in baculovirus system	B	CN(C)c1ccc(-c2nc3c(N4CCN(CC(=O)Nc5nccs5)CC4)c(Cl)cnc3[nH]2)cc1		CHEMBL392525	=	IC50	nM	42.0	CHEMBL4722	Homo sapiens	IC50	uM	0.042
	3301904	CHEMBL1119040	Inhibition of human recombinant Aurora A expressed in baculovirus system	B	O=C(CN1CCN(c2c(Br)cnc3[nH]cnc23)CC1)Nc1nccs1		CHEMBL1086219	=	IC50	nM	517.0	CHEMBL4722	Homo sapiens	IC50	uM	0.517
	3301905	CHEMBL1119040	Inhibition of human recombinant Aurora A expressed in baculovirus system	B	CN(C)Cc1ccc(-c2nc3c(N4CCN(CC(=O)Nc5nccs5)CC4)c(Br)cnc3[nH]2)cc1		CHEMBL1082507	=	IC50	nM	16.0	CHEMBL4722	Homo sapiens	IC50	uM	0.016
	3301906	CHEMBL1119040	Inhibition of human recombinant Aurora A expressed in baculovirus system	B	O=C(CN1CCN(c2c(Br)cnc3[nH]c(-c4ccccc4)nc23)CC1)Nc1nccs1		CHEMBL1082830	=	IC50	nM	81.0	CHEMBL4722	Homo sapiens	IC50	uM	0.081
	3301907	CHEMBL1119040	Inhibition of human recombinant Aurora A expressed in baculovirus system	B	COc1ccc(-c2nc3c(N4CCN(CC(=O)Nc5nccs5)CC4)c(Cl)cnc3[nH]2)cc1		CHEMBL1082831	=	IC50	nM	52.0	CHEMBL4722	Homo sapiens	IC50	uM	0.052
	3301908	CHEMBL1119040	Inhibition of human recombinant Aurora A expressed in baculovirus system	B	O=C(CN1CCN(c2c(Cl)cnc3[nH]c(-c4ccc(CN5CCOCC5)cc4)nc23)CC1)Nc1nccs1		CHEMBL1085848	=	IC50	nM	3.0	CHEMBL4722	Homo sapiens	IC50	uM	0.003
	3301909	CHEMBL1119040	Inhibition of human recombinant Aurora A expressed in baculovirus system	B	CN(C)c1ccc(-c2nc3c(N4CCNCC4)c(Br)cnc3[nH]2)cc1		CHEMBL1086444	=	IC50	nM	365.0	CHEMBL4722	Homo sapiens	IC50	uM	0.365
	3301910	CHEMBL1119040	Inhibition of human recombinant Aurora A expressed in baculovirus system	B	CN(C)c1ccc(-c2nc3c(N4CCN(CC(=O)Nc5ccccc5)CC4)c(Cl)cnc3[nH]2)cc1		CHEMBL1083771	=	IC50	nM	115.0	CHEMBL4722	Homo sapiens	IC50	uM	0.115
	3301911	CHEMBL1119040	Inhibition of human recombinant Aurora A expressed in baculovirus system	B	CN(C)c1ccc(-c2nc3c(N4CCN(CC(=O)Nc5cccnc5)CC4)c(Br)cnc3[nH]2)cc1		CHEMBL1086556	=	IC50	nM	118.0	CHEMBL4722	Homo sapiens	IC50	uM	0.118
	3301912	CHEMBL1119040	Inhibition of human recombinant Aurora A expressed in baculovirus system	B	CN(C)c1ccc(-c2nc3c(N4CCN(CC(=O)Nc5cccc(Cl)c5)CC4)c(Cl)cnc3[nH]2)cc1		CHEMBL1086557	=	IC50	nM	75.0	CHEMBL4722	Homo sapiens	IC50	uM	0.075
	3301913	CHEMBL1119040	Inhibition of human recombinant Aurora A expressed in baculovirus system	B	CN(C)c1ccc(-c2nc3c(N4CCN(C(=O)Nc5ccccc5)CC4)c(Br)cnc3[nH]2)cc1		CHEMBL1085133	=	IC50	nM	277.0	CHEMBL4722	Homo sapiens	IC50	uM	0.277
	3301914	CHEMBL1119040	Inhibition of human recombinant Aurora A expressed in baculovirus system	B	CN(C)c1ccc(-c2nc3c(N4CCN(S(=O)(=O)c5ccccc5)CC4)c(Br)cnc3[nH]2)cc1		CHEMBL1085134	=	IC50	nM	178.0	CHEMBL4722	Homo sapiens	IC50	uM	0.178
	3301915	CHEMBL1119040	Inhibition of human recombinant Aurora A expressed in baculovirus system	B	CN(C)c1ccc(-c2nc3c(N4CCN(c5ccccc5)CC4)c(Br)cnc3[nH]2)cc1		CHEMBL1085135	=	IC50	nM	258.0	CHEMBL4722	Homo sapiens	IC50	uM	0.258
	3301916	CHEMBL1119040	Inhibition of human recombinant Aurora A expressed in baculovirus system	B	CC(C)CN1CCN(c2c(Br)cnc3[nH]c(-c4ccc(N(C)C)cc4)nc23)CC1		CHEMBL1085136	=	IC50	nM	210.0	CHEMBL4722	Homo sapiens	IC50	uM	0.21
	3301917	CHEMBL1119040	Inhibition of human recombinant Aurora A expressed in baculovirus system	B	CC(c1ccncc1)N1CCN(c2c(Br)cnc3[nH]c(-c4ccc(N(C)C)cc4)nc23)CC1		CHEMBL1086581	=	IC50	nM	85.0	CHEMBL4722	Homo sapiens	IC50	uM	0.085
	3301918	CHEMBL1119040	Inhibition of human recombinant Aurora A expressed in baculovirus system	B	CC(c1ccccc1)N1CCN(c2c(Cl)cnc3[nH]c(-c4ccc(N(C)C)cc4)nc23)CC1		CHEMBL1083490	=	IC50	nM	79.0	CHEMBL4722	Homo sapiens	IC50	uM	0.079
	3301919	CHEMBL1119040	Inhibition of human recombinant Aurora A expressed in baculovirus system	B	CN(C)c1ccc(-c2nc3c(N4CCN(Cc5ccncc5)CC4)c(Br)cnc3[nH]2)cc1		CHEMBL1083491	=	IC50	nM	55.0	CHEMBL4722	Homo sapiens	IC50	uM	0.055
	3301920	CHEMBL1119040	Inhibition of human recombinant Aurora A expressed in baculovirus system	B	COc1ccc(-c2nc3c(N4CCN(Cc5cccnc5)CC4)c(Br)cnc3[nH]2)cc1		CHEMBL1083801	=	IC50	nM	9.0	CHEMBL4722	Homo sapiens	IC50	uM	0.009
	3301921	CHEMBL1119040	Inhibition of human recombinant Aurora A expressed in baculovirus system	B	Brc1cnc2[nH]c(-c3ccc(CN4CCOCC4)cc3)nc2c1N1CCN(Cc2cccnc2)CC1		CHEMBL1084858	=	IC50	nM	5.0	CHEMBL4722	Homo sapiens	IC50	uM	0.005
	3301922	CHEMBL1119040	Inhibition of human recombinant Aurora A expressed in baculovirus system	B	COc1ccc(-c2nc3c(N4CCN(Cc5cncnc5)CC4)c(Br)cnc3[nH]2)cc1		CHEMBL1084859	=	IC50	nM	8.0	CHEMBL4722	Homo sapiens	IC50	uM	0.008
	3301923	CHEMBL1119040	Inhibition of human recombinant Aurora A expressed in baculovirus system	B	Brc1cnc2[nH]c(-c3ccc(CN4CCOCC4)cc3)nc2c1N1CCN(Cc2cncnc2)CC1		CHEMBL1084860	=	IC50	nM	6.0	CHEMBL4722	Homo sapiens	IC50	uM	0.006
	3301924	CHEMBL1119040	Inhibition of human recombinant Aurora A expressed in baculovirus system	B	COc1ccc(-c2nc3c(N4CCN(Cc5ccc(Cl)cc5)CC4)c(Br)cnc3[nH]2)cc1		CHEMBL1084067	=	IC50	nM	40.0	CHEMBL4722	Homo sapiens	IC50	uM	0.04
	3301925	CHEMBL1119040	Inhibition of human recombinant Aurora A expressed in baculovirus system	B	Clc1ccc(CN2CCN(c3c(Br)cnc4[nH]c(-c5ccc(CN6CCOCC6)cc5)nc34)CC2)cc1		CHEMBL1083772	=	IC50	nM	12.0	CHEMBL4722	Homo sapiens	IC50	uM	0.012
	3301926	CHEMBL1119040	Inhibition of human recombinant Aurora A expressed in baculovirus system	B	COc1ccc(-c2nc3c(N4CCN(CC5CC5)CC4)c(Br)cnc3[nH]2)cc1		CHEMBL1083773	=	IC50	nM	650.0	CHEMBL4722	Homo sapiens	IC50	uM	0.65
	3301927	CHEMBL1119040	Inhibition of human recombinant Aurora A expressed in baculovirus system	B	COc1ccc(-c2nc3c(N4CCN(Cc5cc(C)on5)CC4)c(Br)cnc3[nH]2)cc1		CHEMBL1083774	=	IC50	nM	17.0	CHEMBL4722	Homo sapiens	IC50	uM	0.017
	3301928	CHEMBL1119040	Inhibition of human recombinant Aurora A expressed in baculovirus system	B	Cc1cc(CN2CCN(c3c(Br)cnc4[nH]c(-c5ccc(CN6CCOCC6)cc5)nc34)CC2)no1		CHEMBL1084079	=	IC50	nM	2.0	CHEMBL4722	Homo sapiens	IC50	uM	0.002
	3301929	CHEMBL1119040	Inhibition of human recombinant Aurora A expressed in baculovirus system	B	CC(C)c1nc(CN2CCN(c3c(Br)cnc4[nH]c(-c5ccc(CN6CCOCC6)cc5)nc34)CC2)co1		CHEMBL1084887	=	IC50	nM	81.0	CHEMBL4722	Homo sapiens	IC50	uM	0.081
	3301930	CHEMBL1119040	Inhibition of human recombinant Aurora A expressed in baculovirus system	B	COc1ccc(-c2nc3c(N4CCN(Cc5nccn5C)CC4)c(Br)cnc3[nH]2)cc1		CHEMBL1084888	=	IC50	nM	32.0	CHEMBL4722	Homo sapiens	IC50	uM	0.032
	3301931	CHEMBL1119040	Inhibition of human recombinant Aurora A expressed in baculovirus system	B	Cn1ccnc1CN1CCN(c2c(Br)cnc3[nH]c(-c4ccc(CN5CCOCC5)cc4)nc23)CC1		CHEMBL1084889	=	IC50	nM	30.0	CHEMBL4722	Homo sapiens	IC50	uM	0.03
	3301932	CHEMBL1119040	Inhibition of human recombinant Aurora A expressed in baculovirus system	B	COc1ccc(-c2nc3c(N4CCN(Cc5cscn5)CC4)c(Br)cnc3[nH]2)cc1		CHEMBL1082291	=	IC50	nM	4.0	CHEMBL4722	Homo sapiens	IC50	uM	0.004
	3301933	CHEMBL1119040	Inhibition of human recombinant Aurora A expressed in baculovirus system	B	Brc1cnc2[nH]c(-c3ccc(CN4CCOCC4)cc3)nc2c1N1CCN(Cc2cscn2)CC1		CHEMBL1082492	=	IC50	nM	6.0	CHEMBL4722	Homo sapiens	IC50	uM	0.006
	3301934	CHEMBL1119040	Inhibition of human recombinant Aurora A expressed in baculovirus system	B	Cc1cc(CN2CCN(c3c(Br)cnc4[nH]c(-c5ccc(CN6CCNCC6)cc5)nc34)CC2)no1		CHEMBL1085607	=	IC50	nM	10.0	CHEMBL4722	Homo sapiens	IC50	uM	0.01
	3301935	CHEMBL1119040	Inhibition of human recombinant Aurora A expressed in baculovirus system	B	Cc1cc(CN2CCN(c3c(Br)cnc4[nH]c(-c5ccc(CN(C)C)cc5)nc34)CC2)no1		CHEMBL1085833	=	IC50	nM	14.0	CHEMBL4722	Homo sapiens	IC50	uM	0.014
	3301936	CHEMBL1119040	Inhibition of human recombinant Aurora A expressed in baculovirus system	B	Cc1cc(CN2CCN(c3c(Br)cnc4[nH]c(-c5ccc(CN)cc5)nc34)CC2)no1		CHEMBL1082597	=	IC50	nM	10.0	CHEMBL4722	Homo sapiens	IC50	uM	0.01
	3301937	CHEMBL1119040	Inhibition of human recombinant Aurora A expressed in baculovirus system	B	Cc1cc(CN2CCN(c3c(Cl)cnc4[nH]c(-c5ccc(CN)cc5)nc34)CC2)no1		CHEMBL1085131	=	IC50	nM	55.0	CHEMBL4722	Homo sapiens	IC50	uM	0.055
	3301938	CHEMBL1119040	Inhibition of human recombinant Aurora A expressed in baculovirus system	B	Cc1cc(CN2CCN(c3c(Br)cnc4[nH]c(-c5ccc(OCCO)cc5)nc34)CC2)no1		CHEMBL1085132	=	IC50	nM	30.0	CHEMBL4722	Homo sapiens	IC50	uM	0.03
	3301939	CHEMBL1119040	Inhibition of human recombinant Aurora A expressed in baculovirus system	B	Cc1cc(CN2CCN(c3c(Cl)cnc4[nH]c(-c5ccc(OCCO)cc5)nc34)CC2)no1		CHEMBL1085387	=	IC50	nM	20.0	CHEMBL4722	Homo sapiens	IC50	uM	0.02
	3301940	CHEMBL1119040	Inhibition of human recombinant Aurora A expressed in baculovirus system	B	Cc1cc(CN2CCN(c3c(Br)cnc4[nH]c(N5CCNCC5)nc34)CC2)no1		CHEMBL1084636	=	IC50	nM	10.0	CHEMBL4722	Homo sapiens	IC50	uM	0.01
	3301941	CHEMBL1119040	Inhibition of human recombinant Aurora A expressed in baculovirus system	B	Cc1cc(CN2CCN(c3c(Br)cnc4[nH]c(N5CCN(C)CC5)nc34)CC2)no1		CHEMBL1086579	=	IC50	nM	15.0	CHEMBL4722	Homo sapiens	IC50	uM	0.015
	3301942	CHEMBL1119040	Inhibition of human recombinant Aurora A expressed in baculovirus system	B	Cc1cc(CN2CCN(c3c(Cl)cnc4[nH]c(N5CCN(C)CC5)nc34)CC2)no1		CHEMBL1086582	=	IC50	nM	10.0	CHEMBL4722	Homo sapiens	IC50	uM	0.01
	3301943	CHEMBL1119040	Inhibition of human recombinant Aurora A expressed in baculovirus system	B	Cc1cc(CN2CCN(c3c(Br)cnc4[nH]c(N5CCN(Cn6cccn6)CC5)nc34)CC2)no1		CHEMBL1086583	=	IC50	nM	3.0	CHEMBL4722	Homo sapiens	IC50	uM	0.003
	3301944	CHEMBL1119040	Inhibition of human recombinant Aurora A expressed in baculovirus system	B	Cc1cc(CN2CCN(c3c(Cl)cnc4[nH]c(N5CCN(Cn6cccn6)CC5)nc34)CC2)no1		CHEMBL1086584	=	IC50	nM	10.0	CHEMBL4722	Homo sapiens	IC50	uM	0.01
	3301997	CHEMBL1118604	Inhibition of Aurora A at 1 uM	B	Clc1ccc(CN2CCN(c3c(Br)cnc4[nH]c(-c5ccc(CN6CCOCC6)cc5)nc34)CC2)cc1		CHEMBL1083772	=	Inhibition	%	98.0	CHEMBL4722	Homo sapiens	INH	%	98.0
	3302025	CHEMBL1118604	Inhibition of Aurora A at 1 uM	B	Cc1cc(CN2CCN(c3c(Br)cnc4[nH]c(N5CCN(C)CC5)nc34)CC2)no1		CHEMBL1086579	=	Inhibition	%	80.0	CHEMBL4722	Homo sapiens	INH	%	80.0
	3302664	CHEMBL1120722	Inhibition of Aurora A	B	CCN1CCC(CNc2nccc(-c3cccnc3Oc3ccc(Nc4nc5ccccc5[nH]4)c4ccccc34)n2)CC1		CHEMBL1084451	=	IC50	nM	332.0	CHEMBL4722	Homo sapiens	IC50	uM	0.332
	3302673	CHEMBL1120722	Inhibition of Aurora A	B	CN1CCCC1CCNc1nccc(-c2cccnc2Oc2ccc(Nc3nc4ccccc4[nH]3)c3ccccc23)n1		CHEMBL1084452	=	IC50	nM	327.0	CHEMBL4722	Homo sapiens	IC50	uM	0.327
	3302682	CHEMBL1120722	Inhibition of Aurora A	B	CNc1nccc(-c2cccnc2Oc2c(C)cc(Nc3nc4ccccc4[nH]3)c3ccccc23)n1		CHEMBL458023	=	IC50	nM	29.0	CHEMBL4722	Homo sapiens	IC50	uM	0.029
	3302691	CHEMBL1120722	Inhibition of Aurora A	B	CN(C)CC(C)(C)CNc1nccc(-c2cccnc2Oc2ccc(Nc3nc4ccccc4[nH]3)c3ccccc23)n1		CHEMBL1084453	=	IC50	nM	1658.0	CHEMBL4722	Homo sapiens	IC50	uM	1.658
	3302700	CHEMBL1120722	Inhibition of Aurora A	B	CNc1nccc(-c2cccnc2Oc2ccc(Nc3nc4ccccc4[nH]3)c3ccccc23)n1		CHEMBL465793	=	IC50	nM	19.0	CHEMBL4722	Homo sapiens	IC50	uM	0.019
	3302709	CHEMBL1120722	Inhibition of Aurora A	B	CNc1nccc(-c2cccnc2Oc2ccc(Nc3nc4ccncc4[nH]3)c3ccccc23)n1		CHEMBL1086334	=	IC50	nM	1067.0	CHEMBL4722	Homo sapiens	IC50	uM	1.067
	3302718	CHEMBL1120722	Inhibition of Aurora A	B	CNc1nccc(-c2cccnc2Oc2ccc(NC(=O)Nc3ccccc3)c3ccccc23)n1		CHEMBL457099	=	IC50	nM	52.0	CHEMBL4722	Homo sapiens	IC50	uM	0.052
	3302727	CHEMBL1120722	Inhibition of Aurora A	B	CNc1nccc(-c2cccnc2Oc2ccc(Nc3nc4ccccc4o3)c3ccccc23)n1		CHEMBL456463	=	IC50	nM	141.0	CHEMBL4722	Homo sapiens	IC50	uM	0.141
	3302736	CHEMBL1120722	Inhibition of Aurora A	B	CNc1nccc(-c2cccnc2Oc2ccc(Nc3nc4ccccc4s3)c3ccccc23)n1		CHEMBL456683	=	IC50	nM	380.0	CHEMBL4722	Homo sapiens	IC50	uM	0.38
	3302745	CHEMBL1120722	Inhibition of Aurora A	B	CNc1nccc(-c2cccnc2Oc2ccc(Nc3nc4ccc(C(F)(F)F)cc4[nH]3)c3ccccc23)n1		CHEMBL463323	=	IC50	nM	16.0	CHEMBL4722	Homo sapiens	IC50	uM	0.016
	3302754	CHEMBL1120722	Inhibition of Aurora A	B	CNc1nccc(-c2cccnc2Oc2ccc(NC(=O)NC(C)(C)C)c3ccccc23)n1		CHEMBL1084633	=	IC50	nM	225.0	CHEMBL4722	Homo sapiens	IC50	uM	0.225
	3302763	CHEMBL1120722	Inhibition of Aurora A	B	CCNC(=O)Nc1ccc(Oc2ncccc2-c2ccnc(NC)n2)c2ccccc12		CHEMBL1084634	=	IC50	nM	534.0	CHEMBL4722	Homo sapiens	IC50	uM	0.534
	3302783	CHEMBL1120730	Inhibition of Aurora A at 1 uM relative to control	B	CCN1CCC(CNc2nccc(-c3cccnc3Oc3ccc(Nc4nc5ccccc5[nH]4)c4ccccc34)n2)CC1		CHEMBL1084451	=	Inhibition	%	25.0	CHEMBL4722	Homo sapiens	INH	%	25.0
	3302784	CHEMBL1120730	Inhibition of Aurora A at 1 uM relative to control	B	CN1CCCC1CCNc1nccc(-c2cccnc2Oc2ccc(Nc3nc4ccccc4[nH]3)c3ccccc23)n1		CHEMBL1084452	=	Inhibition	%	25.0	CHEMBL4722	Homo sapiens	INH	%	25.0
	3302785	CHEMBL1120730	Inhibition of Aurora A at 1 uM relative to control	B	CNc1nccc(-c2cccnc2Oc2c(C)cc(Nc3nc4ccccc4[nH]3)c3ccccc23)n1		CHEMBL458023	=	Inhibition	%	3.0	CHEMBL4722	Homo sapiens	INH	%	3.0
	3302786	CHEMBL1120730	Inhibition of Aurora A at 1 uM relative to control	B	CN(C)CC(C)(C)CNc1nccc(-c2cccnc2Oc2ccc(Nc3nc4ccccc4[nH]3)c3ccccc23)n1		CHEMBL1084453	=	Inhibition	%	62.0	CHEMBL4722	Homo sapiens	INH	%	62.0
	3302787	CHEMBL1120730	Inhibition of Aurora A at 1 uM relative to control	B	CNc1nccc(-c2cccnc2Oc2ccc(Nc3nc4ccccc4[nH]3)c3ccccc23)n1		CHEMBL465793	=	Inhibition	%	2.0	CHEMBL4722	Homo sapiens	INH	%	2.0
	3302788	CHEMBL1120730	Inhibition of Aurora A at 1 uM relative to control	B	CNc1nccc(-c2cccnc2Oc2ccc(Nc3nc4ccncc4[nH]3)c3ccccc23)n1		CHEMBL1086334	=	Inhibition	%	52.0	CHEMBL4722	Homo sapiens	INH	%	52.0
	3302789	CHEMBL1120730	Inhibition of Aurora A at 1 uM relative to control	B	CNc1nccc(-c2cccnc2Oc2ccc(NC(=O)Nc3ccccc3)c3ccccc23)n1		CHEMBL457099	=	Inhibition	%	5.0	CHEMBL4722	Homo sapiens	INH	%	5.0
	3302790	CHEMBL1120730	Inhibition of Aurora A at 1 uM relative to control	B	CNc1nccc(-c2cccnc2Oc2ccc(Nc3nc4ccccc4o3)c3ccccc23)n1		CHEMBL456463	=	Inhibition	%	12.0	CHEMBL4722	Homo sapiens	INH	%	12.0
	3302791	CHEMBL1120730	Inhibition of Aurora A at 1 uM relative to control	B	CNc1nccc(-c2cccnc2Oc2ccc(Nc3nc4ccccc4s3)c3ccccc23)n1		CHEMBL456683	=	Inhibition	%	28.0	CHEMBL4722	Homo sapiens	INH	%	28.0
	3302792	CHEMBL1120730	Inhibition of Aurora A at 1 uM relative to control	B	CNc1nccc(-c2cccnc2Oc2ccc(Nc3nc4ccc(C(F)(F)F)cc4[nH]3)c3ccccc23)n1		CHEMBL463323	=	Inhibition	%	2.0	CHEMBL4722	Homo sapiens	INH	%	2.0
	3302793	CHEMBL1120730	Inhibition of Aurora A at 1 uM relative to control	B	CNc1nccc(-c2cccnc2Oc2ccc(NC(=O)NC(C)(C)C)c3ccccc23)n1		CHEMBL1084633	=	Inhibition	%	18.0	CHEMBL4722	Homo sapiens	INH	%	18.0
	3302794	CHEMBL1120730	Inhibition of Aurora A at 1 uM relative to control	B	CCNC(=O)Nc1ccc(Oc2ncccc2-c2ccnc(NC)n2)c2ccccc12		CHEMBL1084634	=	Inhibition	%	35.0	CHEMBL4722	Homo sapiens	INH	%	35.0
	3305017	CHEMBL1119479	Selectivity for Aurora A over Aurora B	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	=	Selectivity ratio		40.0	CHEMBL4722	Homo sapiens	Selectivity ratio		40.0
	3305034	CHEMBL1119477	Inhibition of human recombinant Aurora A after 30 mins	B	Cc1nc(N)sc1-c1ccnc(Nc2ccc(N3CCOCC3)cc2)n1		CHEMBL482967	=	Ki	nM	8.0	CHEMBL4722	Homo sapiens	Ki	nM	8.0
	3305035	CHEMBL1119477	Inhibition of human recombinant Aurora A after 30 mins	B	Cc1nc(C)c(-c2ccnc(Nc3ccc(N4CCN(S(C)(=O)=O)CC4)cc3)n2)s1		CHEMBL1083484	=	Ki	nM	9.2	CHEMBL4722	Homo sapiens	Ki	nM	9.2
	3305036	CHEMBL1119477	Inhibition of human recombinant Aurora A after 30 mins	B	CC(=O)N1CCN(c2ccc(Nc3nccc(-c4sc(C)nc4C)n3)cc2)CC1		CHEMBL1083786	=	Ki	nM	8.2	CHEMBL4722	Homo sapiens	Ki	nM	8.2
	3305037	CHEMBL1119477	Inhibition of human recombinant Aurora A after 30 mins	B	CNc1nc(C)c(-c2ccnc(Nc3ccc(N4CCN(C(C)=O)CC4)cc3)n2)s1		CHEMBL1083785	=	Ki	nM	12.0	CHEMBL4722	Homo sapiens	Ki	nM	12.0
	3305038	CHEMBL1119477	Inhibition of human recombinant Aurora A after 30 mins	B	CC(=O)N1CCN(c2ccc(Nc3nccc(-c4sc(N)nc4C)n3)cc2)CC1		CHEMBL1084969	=	Ki	nM	7.6	CHEMBL4722	Homo sapiens	Ki	nM	7.6
	3305039	CHEMBL1119477	Inhibition of human recombinant Aurora A after 30 mins	B	CCNc1nc(C)c(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)s1		CHEMBL1084630	=	Ki	nM	14.0	CHEMBL4722	Homo sapiens	Ki	nM	14.0
	3305040	CHEMBL1119477	Inhibition of human recombinant Aurora A after 30 mins	B	CNc1nc(C)c(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)s1		CHEMBL1084629	=	Ki	nM	19.0	CHEMBL4722	Homo sapiens	Ki	nM	19.0
	3305041	CHEMBL1119477	Inhibition of human recombinant Aurora A after 30 mins	B	Cc1nc(C)c(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)s1		CHEMBL1085626	=	Ki	nM	4.0	CHEMBL4722	Homo sapiens	Ki	nM	4.0
	3305042	CHEMBL1119477	Inhibition of human recombinant Aurora A after 30 mins	B	CCNc1nc(C)c(-c2ccnc(Nc3ccc(CNC(C)=O)cc3)n2)s1		CHEMBL1084715	=	Ki	nM	5.0	CHEMBL4722	Homo sapiens	Ki	nM	5.0
	3305043	CHEMBL1119477	Inhibition of human recombinant Aurora A after 30 mins	B	CCNc1nc(C)c(-c2ccnc(Nc3cc(OC)c(OC)c(OC)c3)n2)s1		CHEMBL1086088	=	Ki	nM	3.0	CHEMBL4722	Homo sapiens	Ki	nM	3.0
	3305044	CHEMBL1119477	Inhibition of human recombinant Aurora A after 30 mins	B	CNc1nc(C)c(-c2ccnc(Nc3cc(OC)c(OC)c(OC)c3)n2)s1		CHEMBL1083152	=	Ki	nM	1.0	CHEMBL4722	Homo sapiens	Ki	nM	1.0
	3305045	CHEMBL1119477	Inhibition of human recombinant Aurora A after 30 mins	B	COc1cc(Nc2nccc(-c3sc(C)nc3C)n2)cc(OC)c1OC		CHEMBL1083151	=	Ki	nM	0.4	CHEMBL4722	Homo sapiens	Ki	nM	0.4
	3305046	CHEMBL1119477	Inhibition of human recombinant Aurora A after 30 mins	B	Cc1nc(C)c(-c2ccnc(Nc3ccc(N)cc3)n2)s1		CHEMBL1084454	=	Ki	nM	31.0	CHEMBL4722	Homo sapiens	Ki	nM	31.0
	3305047	CHEMBL1119477	Inhibition of human recombinant Aurora A after 30 mins	B	CNc1ccc(Nc2nccc(-c3sc(C)nc3C)n2)cc1		CHEMBL1083150	=	Ki	nM	18.0	CHEMBL4722	Homo sapiens	Ki	nM	18.0
	3305048	CHEMBL1119477	Inhibition of human recombinant Aurora A after 30 mins	B	Cc1nc(C)c(-c2ccnc(Nc3ccc(N(C)C)cc3)n2)s1		CHEMBL46817	=	Ki	nM	6.9	CHEMBL4722	Homo sapiens	Ki	nM	6.9
	3305049	CHEMBL1119477	Inhibition of human recombinant Aurora A after 30 mins	B	Cc1nc(N)sc1-c1ccnc(Nc2cccc([N+](=O)[O-])c2)n1		CHEMBL298445	=	Ki	nM	73.0	CHEMBL4722	Homo sapiens	Ki	nM	73.0
Active	3305781	CHEMBL1120452	Inhibition of Aurora A phosphorylation in human A549 cells at 0.15 to 5 uM after 1 hr by Western blot analysis in presence of nocodazole and proteasome inhibitor MG132	B	Cc1nc(N)sc1-c1ccnc(Nc2ccc(N3CCOCC3)cc2)n1		CHEMBL482967		Inhibition	%		CHEMBL4722	Homo sapiens	INH		
	3307893	CHEMBL1119348	Inhibition of human aurora A	B	Cc1cn(-c2cc(NC(=O)Nc3ccc(-c4nc5[nH]ncc5[nH]4)c(C)c3)cc(C(F)(F)F)c2)cn1		CHEMBL1084036	=	Inhibition	%	10.0	CHEMBL4722	Homo sapiens	INH	%	10.0
	3316768	CHEMBL1120193	Inhibition of Aurora A at 1 uM	B	O=C(Nc1cccc(-n2ccc3c(NC(=O)c4ccccc4)nccc32)c1)c1ccc(N2CCOCC2)c(C(F)(F)F)c1		CHEMBL1084450	=	Inhibition	%	21.0	CHEMBL4722	Homo sapiens	INH	%	21.0
	3327261	CHEMBL1168265	Inhibition of Aurora A at 10 uM by HotSpot assay	B	CC(=O)Nc1cccc(-c2ccc(-c3ccnc(NC(=O)Nc4cc(C(F)(F)F)cc(C(F)(F)F)c4)n3)cn2)c1.Cl		CHEMBL1164847	=	Inhibition	%	60.0	CHEMBL4722	Homo sapiens	INH	%	60.0
	3331832	CHEMBL1168791	Inhibition of AURKA at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(F)ccc3F)CCN4)cn2)CC1		CHEMBL1165499	<	Inhibition	%	50.0	CHEMBL4722	Homo sapiens	INH	%	50.0
	3333247	CHEMBL1168791	Inhibition of AURKA at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)cn2)CC1		CHEMBL1164180	<	Inhibition	%	50.0	CHEMBL4722	Homo sapiens	INH	%	50.0
	3334652	CHEMBL1168791	Inhibition of AURKA at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3Cl)CCN4)cn2)CC1		CHEMBL1164181	<	Inhibition	%	50.0	CHEMBL4722	Homo sapiens	INH	%	50.0
	3336072	CHEMBL1168791	Inhibition of AURKA at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3c(F)ccc(F)c3Cl)CCN4)cn2)CC1		CHEMBL1164265	<	Inhibition	%	50.0	CHEMBL4722	Homo sapiens	INH	%	50.0
	3337455	CHEMBL1168791	Inhibition of AURKA at 1 uM	B	O=C(O)c1ccc(-c2cnc3c(c2)N(Cc2cc(Cl)ccc2C(F)(F)F)CCN3)cc1		CHEMBL1163510	=	Inhibition	%	80.2	CHEMBL4722	Homo sapiens	INH	%	80.2
	3337703	CHEMBL1168791	Inhibition of AURKA at 1 uM	B	O=C(c1ccc(-c2cnc3c(c2)N(Cc2cc(Cl)ccc2C(F)(F)F)CCN3)cc1)N1CCCCC1		CHEMBL1163518	<	Inhibition	%	50.0	CHEMBL4722	Homo sapiens	INH	%	50.0
	3339035	CHEMBL1168791	Inhibition of AURKA at 1 uM	B	COC1CCN(C(=O)c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)cc2)CC1		CHEMBL1163567	<	Inhibition	%	50.0	CHEMBL4722	Homo sapiens	INH	%	50.0
	3339291	CHEMBL1168791	Inhibition of AURKA at 1 uM	B	O=C(c1ccc(-c2cnc3c(c2)N(Cc2cc(Cl)ccc2C(F)(F)F)CCN3)cc1)N1CCC(N2CCCC2)CC1		CHEMBL1163559	=	Inhibition	%	69.5	CHEMBL4722	Homo sapiens	INH	%	69.5
	3340600	CHEMBL1168791	Inhibition of AURKA at 1 uM	B	FC(F)(F)c1ccc(Cl)cc1CN1CCNc2ncc(-c3ccnc(N4CCNCC4)c3)cc21		CHEMBL1163566	=	Inhibition	%	68.0	CHEMBL4722	Homo sapiens	INH	%	68.0
	3342016	CHEMBL1168791	Inhibition of AURKA at 1 uM	B	CC(=O)N1CCN(c2cc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)ccn2)CC1		CHEMBL1163565	=	Inhibition	%	68.0	CHEMBL4722	Homo sapiens	INH	%	68.0
	3344657	CHEMBL1168347	Inhibition of Aurora A assessed as residual activity at 10 uM after 80 mins by microplate scintillation counting	B	CN1CCN(c2ccc(NC(=O)c3ccc4c(c3)/C(=C3/Nc5ccccc5C3=O)C(=O)N4)cc2)CC1		CHEMBL1164526	=	Activity	%	63.0	CHEMBL4722	Homo sapiens	Activity	%	63.0
	3344658	CHEMBL1167717	Inhibition of Aurora A assessed as residual activity at 1 uM after 80 mins by microplate scintillation counting	B	CN1CCN(c2ccc(NC(=O)c3ccc4c(c3)/C(=C3/Nc5ccccc5C3=O)C(=O)N4)cc2)CC1		CHEMBL1164526	=	Activity	%	86.0	CHEMBL4722	Homo sapiens	Activity	%	86.0
Active	3345446	CHEMBL1166286	Inhibition of GST-tagged human recombinant Aurora A kinase at 20 uM	B	O=C(OCCCCCCCOC(=O)c1cc(O)c(O)c(O)c1)c1cc(O)c(O)c(O)c1		CHEMBL1165533		Inhibition	%		CHEMBL4722	Homo sapiens	INH		
Active	3345448	CHEMBL1166286	Inhibition of GST-tagged human recombinant Aurora A kinase at 20 uM	B	O=C(OCCCCCCOC(=O)c1cc(O)c(O)c(O)c1)c1cc(O)c(O)c(O)c1		CHEMBL1164468		Inhibition	%		CHEMBL4722	Homo sapiens	INH		
Active	3345450	CHEMBL1166286	Inhibition of GST-tagged human recombinant Aurora A kinase at 20 uM	B	O=C(OCCCCCCCOC(=O)c1ccc(O)c(O)c1)c1ccc(O)c(O)c1		CHEMBL1165527		Inhibition	%		CHEMBL4722	Homo sapiens	INH		
Active	3345452	CHEMBL1166286	Inhibition of GST-tagged human recombinant Aurora A kinase at 20 uM	B	O=C(OCCCCCCOC(=O)c1ccc(O)c(O)c1)c1ccc(O)c(O)c1		CHEMBL1164100		Inhibition	%		CHEMBL4722	Homo sapiens	INH		
	3345496	CHEMBL1166286	Inhibition of GST-tagged human recombinant Aurora A kinase at 20 uM	B	COc1cc(C(=O)OCCCCCCOC(=O)c2ccc(O)c(OC)c2)ccc1O		CHEMBL1164563	>	Inhibition	%	50.0	CHEMBL4722	Homo sapiens	INH	%	50.0
Active	3352640	CHEMBL1175612	Inhibition of aurora A at 40 uM	B	Cc1cc(CNC(=O)c2nn(CCCN)c3c2CCc2cnc(Nc4cccc(CC(=O)N(C)C)c4)nc2-3)ccn1		CHEMBL1172241		Inhibition	%		CHEMBL4722	Homo sapiens	INH		
	3354261	CHEMBL1173979	Inhibition of Aur A at 10 uM by mobility shift assay	B	O=S(=O)(NCCNC/C=C/c1ccc(Br)cc1)c1cccc2cnccc12		CHEMBL104264	=	Inhibition	%	75.0	CHEMBL4722	Homo sapiens	INH	%	75.0
	3354296	CHEMBL1173979	Inhibition of Aur A at 10 uM by mobility shift assay	B	c1ccc(-c2cnc3cnc(-c4cc[nH]n4)cn23)cc1		CHEMBL1170750	=	Inhibition	%	41.0	CHEMBL4722	Homo sapiens	INH	%	41.0
	3354297	CHEMBL1173979	Inhibition of Aur A at 10 uM by mobility shift assay	B	c1ccc(-c2cnc3cnc(-c4cn[nH]c4)cn23)cc1		CHEMBL1172464	=	Inhibition	%	47.0	CHEMBL4722	Homo sapiens	INH	%	47.0
	3354298	CHEMBL1173979	Inhibition of Aur A at 10 uM by mobility shift assay	B	c1ccc(-c2cnc3cnc(-c4ccncc4)cn23)cc1		CHEMBL1170317	=	Inhibition	%	21.0	CHEMBL4722	Homo sapiens	INH	%	21.0
	3354299	CHEMBL1173979	Inhibition of Aur A at 10 uM by mobility shift assay	B	c1n[nH]cc1-c1cnc2ncc(-c3cn[nH]c3)n2c1		CHEMBL1171532	=	Inhibition	%	86.0	CHEMBL4722	Homo sapiens	INH	%	86.0
	3354300	CHEMBL1173979	Inhibition of Aur A at 10 uM by mobility shift assay	B	Cn1cc(-c2cnc3ncc(-c4cn[nH]c4)cn23)cn1		CHEMBL1171533	=	Inhibition	%	62.0	CHEMBL4722	Homo sapiens	INH	%	62.0
	3354301	CHEMBL1173979	Inhibition of Aur A at 10 uM by mobility shift assay	B	c1cc(-c2cnc3ncc(-c4cn[nH]c4)cn23)n[nH]1		CHEMBL1171534	=	Inhibition	%	95.0	CHEMBL4722	Homo sapiens	INH	%	95.0
	3354302	CHEMBL1173979	Inhibition of Aur A at 10 uM by mobility shift assay	B	OCc1cccc(-c2cnc3ncc(-c4cn[nH]c4)cn23)c1		CHEMBL1171699	=	Inhibition	%	45.0	CHEMBL4722	Homo sapiens	INH	%	45.0
	3354303	CHEMBL1173979	Inhibition of Aur A at 10 uM by mobility shift assay	B	c1ccc2c(-c3cnc4cnc(-c5cn[nH]c5)cn34)c[nH]c2c1		CHEMBL1170126	=	Inhibition	%	87.0	CHEMBL4722	Homo sapiens	INH	%	87.0
	3354304	CHEMBL1173979	Inhibition of Aur A at 10 uM by mobility shift assay	B	NCc1ccc(-c2cn3c(-c4cn[nH]c4)cnc3cn2)cc1		CHEMBL1170747	=	Inhibition	%	73.0	CHEMBL4722	Homo sapiens	INH	%	73.0
	3354305	CHEMBL1173979	Inhibition of Aur A at 10 uM by mobility shift assay	B	OCc1cccc(-c2cn3c(-c4cn[nH]c4)cnc3cn2)c1		CHEMBL1170748	=	Inhibition	%	45.0	CHEMBL4722	Homo sapiens	INH	%	45.0
	3354306	CHEMBL1173979	Inhibition of Aur A at 10 uM by mobility shift assay	B	OCc1ccc(-c2cn3c(-c4cn[nH]c4)cnc3cn2)cc1		CHEMBL1170749	=	Inhibition	%	89.0	CHEMBL4722	Homo sapiens	INH	%	89.0
	3358459	CHEMBL1174073	Inhibition of AURKA at 10 uM	B	CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(C#Cc4cccnc4)c3)cc2C(F)(F)F)CC1		CHEMBL1171523	=	Inhibition	%	100.0	CHEMBL4722	Homo sapiens	INH	%	100.0
	3358901	CHEMBL1174073	Inhibition of AURKA at 10 uM	B	CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(C#Cc4cnc5[nH]ccc5c4)c3)cc2C(F)(F)F)CC1		CHEMBL1170139	=	Inhibition	%	97.0	CHEMBL4722	Homo sapiens	INH	%	97.0
	3365173	CHEMBL1175882	Inhibition of Aurora A	B	OCCNc1ncnc2oc(-c3ccccc3)c(-c3ccccc3)c12		CHEMBL189434	=	IC50	nM	309.0	CHEMBL4722	Homo sapiens	IC50	nM	309.0
	3365174	CHEMBL1175882	Inhibition of Aurora A	B	c1ccc(-c2oc3ncnc(NCCCn4ccnc4)c3c2-c2ccccc2)cc1		CHEMBL1173823	=	IC50	nM	3311.0	CHEMBL4722	Homo sapiens	IC50	nM	3311.0
	3365175	CHEMBL1175882	Inhibition of Aurora A	B	OC1CCN(c2ncnc3oc(-c4ccccc4)c(-c4ccccc4)c23)CC1		CHEMBL1173824	=	IC50	nM	807.0	CHEMBL4722	Homo sapiens	IC50	nM	807.0
	3365176	CHEMBL1175882	Inhibition of Aurora A	B	c1ccc(-c2oc3ncnc(NCCN4CCOCC4)c3c2-c2ccccc2)cc1		CHEMBL1173522	=	IC50	nM	1766.0	CHEMBL4722	Homo sapiens	IC50	nM	1766.0
	3365177	CHEMBL1175882	Inhibition of Aurora A	B	c1ccc(-c2oc3ncnc(NCCc4c[nH]cn4)c3c2-c2ccccc2)cc1		CHEMBL1173585	=	IC50	nM	296.0	CHEMBL4722	Homo sapiens	IC50	nM	296.0
	3365178	CHEMBL1175882	Inhibition of Aurora A	B	CCOC(=O)CCNc1ncnc2oc(-c3ccccc3)c(-c3ccccc3)c12		CHEMBL1173586	=	IC50	nM	796.0	CHEMBL4722	Homo sapiens	IC50	nM	796.0
	3365179	CHEMBL1175882	Inhibition of Aurora A	B	Nc1ccc(CCNc2ncnc3oc(-c4ccccc4)c(-c4ccccc4)c23)cc1		CHEMBL1173151	=	IC50	nM	640.0	CHEMBL4722	Homo sapiens	IC50	nM	640.0
	3365180	CHEMBL1175882	Inhibition of Aurora A	B	C[C@@H](CO)Nc1ncnc2oc(-c3ccccc3)c(-c3ccccc3)c12		CHEMBL1173152	=	IC50	nM	792.0	CHEMBL4722	Homo sapiens	IC50	nM	792.0
	3365181	CHEMBL1175882	Inhibition of Aurora A	B	OCCOCCNc1ncnc2oc(-c3ccccc3)c(-c3ccccc3)c12		CHEMBL1172831	=	IC50	nM	760.0	CHEMBL4722	Homo sapiens	IC50	nM	760.0
	3365182	CHEMBL1175882	Inhibition of Aurora A	B	c1ccc(-c2oc3ncnc(NCCc4ccccn4)c3c2-c2ccccc2)cc1		CHEMBL1172832	=	IC50	nM	535.0	CHEMBL4722	Homo sapiens	IC50	nM	535.0
	3365183	CHEMBL1175882	Inhibition of Aurora A	B	COC1C=CC(CNc2ncnc3oc(-c4ccccc4)c(-c4ccccc4)c23)(OC)O1		CHEMBL1173544	=	IC50	nM	827.0	CHEMBL4722	Homo sapiens	IC50	nM	827.0
	3365184	CHEMBL1175882	Inhibition of Aurora A	B	CC1CN(c2ncnc3oc(-c4ccccc4)c(-c4ccccc4)c23)CC(C)N1		CHEMBL1173545	=	IC50	nM	334.0	CHEMBL4722	Homo sapiens	IC50	nM	334.0
	3365185	CHEMBL1175882	Inhibition of Aurora A	B	Oc1ccc(CCNc2ncnc3oc(-c4ccccc4)c(-c4ccccc4)c23)cc1		CHEMBL1173116	=	IC50	nM	640.0	CHEMBL4722	Homo sapiens	IC50	nM	640.0
	3365186	CHEMBL1175882	Inhibition of Aurora A	B	C[C@@H](O)CNc1ncnc2oc(-c3ccccc3)c(-c3ccccc3)c12		CHEMBL1172716	=	IC50	nM	973.0	CHEMBL4722	Homo sapiens	IC50	nM	973.0
	3365187	CHEMBL1175882	Inhibition of Aurora A	B	Nc1ccc(CNc2ncnc3oc(-c4ccccc4)c(-c4ccccc4)c23)cc1		CHEMBL1172780	=	IC50	nM	945.0	CHEMBL4722	Homo sapiens	IC50	nM	945.0
	3365188	CHEMBL1175883	Inhibition of Aurora A at 10 uM	B	OCCNc1ncnc2oc(-c3ccccc3)c(-c3ccccc3)c12		CHEMBL189434	=	Inhibition	%	98.2	CHEMBL4722	Homo sapiens	INH	%	98.2
	3365189	CHEMBL1175883	Inhibition of Aurora A at 10 uM	B	c1ccc(-c2oc3ncnc(NCCCn4ccnc4)c3c2-c2ccccc2)cc1		CHEMBL1173823	=	Inhibition	%	73.8	CHEMBL4722	Homo sapiens	INH	%	73.8
	3365190	CHEMBL1175883	Inhibition of Aurora A at 10 uM	B	OC1CCN(c2ncnc3oc(-c4ccccc4)c(-c4ccccc4)c23)CC1		CHEMBL1173824	=	Inhibition	%	85.8	CHEMBL4722	Homo sapiens	INH	%	85.8
	3365191	CHEMBL1175883	Inhibition of Aurora A at 10 uM	B	c1ccc(-c2oc3ncnc(NCCN4CCOCC4)c3c2-c2ccccc2)cc1		CHEMBL1173522	=	Inhibition	%	81.7	CHEMBL4722	Homo sapiens	INH	%	81.7
	3365192	CHEMBL1175883	Inhibition of Aurora A at 10 uM	B	c1ccc(-c2oc3ncnc(NCCc4c[nH]cn4)c3c2-c2ccccc2)cc1		CHEMBL1173585	=	Inhibition	%	91.4	CHEMBL4722	Homo sapiens	INH	%	91.4
Active	3365196	CHEMBL1176120	Inhibition of Aurora A phosphorylation in human HCT116 cells assessed as phosphorylated Aurora A protein level by Western blotting	B	OC[C@@H](Nc1ncnc2oc(-c3ccccc3)c(-c3ccccc3)c12)c1ccccc1		CHEMBL1172781		Activity			CHEMBL4722	Homo sapiens	Activity		
	3365198	CHEMBL1175882	Inhibition of Aurora A	B	O=C(Nc1ccccc1)Nc1ccc(CCNc2ncnc3oc(-c4ccccc4)c(-c4ccccc4)c23)cc1		CHEMBL1173731	=	IC50	nM	43.0	CHEMBL4722	Homo sapiens	IC50	nM	43.0
	3365199	CHEMBL1175882	Inhibition of Aurora A	B	O=C(Nc1ccc(CCNc2ncnc3oc(-c4ccccc4)c(-c4ccccc4)c23)cc1)c1ccccc1		CHEMBL1173801	=	IC50	nM	304.0	CHEMBL4722	Homo sapiens	IC50	nM	304.0
	3365200	CHEMBL1175882	Inhibition of Aurora A	B	O=S(=O)(Nc1ccc(CCNc2ncnc3oc(-c4ccccc4)c(-c4ccccc4)c23)cc1)c1ccccc1		CHEMBL1173465	=	IC50	nM	5831.0	CHEMBL4722	Homo sapiens	IC50	nM	5831.0
	3365201	CHEMBL1175882	Inhibition of Aurora A	B	O=C(CCNc1ncnc2oc(-c3ccccc3)c(-c3ccccc3)c12)Nc1ccccc1		CHEMBL1173178	>	IC50	nM	10000.0	CHEMBL4722	Homo sapiens	IC50	nM	10000.0
	3365202	CHEMBL1175882	Inhibition of Aurora A	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	IC50	nM	20.0	CHEMBL4722	Homo sapiens	IC50	nM	20.0
	3370112	CHEMBL1176697	Inhibition of Aurora A at 10 uM	B	COc1ccc(NC(=O)Nc2ccc3c(c2)NC(=O)/C3=C\c2[nH]cc(C(=O)O)c2C)cc1		CHEMBL1173411	=	Inhibition	%	97.2	CHEMBL4722	Homo sapiens	INH	%	97.2
	3370113	CHEMBL1176696	Inhibition of Aurora A	B	COc1ccc(NC(=O)Nc2ccc3c(c2)NC(=O)/C3=C\c2[nH]cc(C(=O)O)c2C)cc1		CHEMBL1173411	=	IC50	nM	2.09	CHEMBL4722	Homo sapiens	IC50	nM	2.09
	3396959	CHEMBL1218396	Inhibition of Aurora A ATP-binding site	B	Cc1cc(Nc2cc(N3CCN(CC(=O)O)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL1213077	=	Ki	nM	20.0	CHEMBL4722	Homo sapiens	Ki	nM	20.0
	3396960	CHEMBL1218396	Inhibition of Aurora A ATP-binding site	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	Ki	nM	1.0	CHEMBL4722	Homo sapiens	Ki	nM	1.0
	3396965	CHEMBL1218394	Inhibition of Aurora A ATP-binding site assessed as inhibition of [gamma-33P]ATP incorporation into substrate by scintillation counting	B	CCCCN(C)c1nc(NCCc2ccccc2OC)nc(NC(Cc2c[nH]c3ncccc23)C(N)=O)n1		CHEMBL1213108	=	IC50	nM	3.8	CHEMBL4722	Homo sapiens	IC50	nM	3.8
	3396966	CHEMBL1218394	Inhibition of Aurora A ATP-binding site assessed as inhibition of [gamma-33P]ATP incorporation into substrate by scintillation counting	B	CCCCN(C)c1nc(NCCc2ccccc2OC)nc(NCCc2c[nH]c3ncccc23)n1		CHEMBL1213109	=	IC50	nM	1.2	CHEMBL4722	Homo sapiens	IC50	nM	1.2
	3396967	CHEMBL1218394	Inhibition of Aurora A ATP-binding site assessed as inhibition of [gamma-33P]ATP incorporation into substrate by scintillation counting	B	COc1ccccc1CCNc1nc(NC(Cc2c[nH]c3ncccc23)C(N)=O)nc(N(C)[C@@H](C)c2ccccc2)n1		CHEMBL1213110	=	IC50	nM	6.3	CHEMBL4722	Homo sapiens	IC50	nM	6.3
	3396968	CHEMBL1218394	Inhibition of Aurora A ATP-binding site assessed as inhibition of [gamma-33P]ATP incorporation into substrate by scintillation counting	B	COc1ccccc1CCNc1nc(Nc2ccc3ncccc3c2)nc(NC(Cc2c[nH]c3ncccc23)C(N)=O)n1		CHEMBL1213111	=	IC50	nM	3.7	CHEMBL4722	Homo sapiens	IC50	nM	3.7
	3396969	CHEMBL1218394	Inhibition of Aurora A ATP-binding site assessed as inhibition of [gamma-33P]ATP incorporation into substrate by scintillation counting	B	COc1ccc(Nc2nc(NCCc3ccccc3F)nc(Nc3ccc4ncccc4c3)n2)cc1OC		CHEMBL1213151	=	IC50	nM	2.1	CHEMBL4722	Homo sapiens	IC50	nM	2.1
	3396970	CHEMBL1218394	Inhibition of Aurora A ATP-binding site assessed as inhibition of [gamma-33P]ATP incorporation into substrate by scintillation counting	B	COc1ccc(Nc2nc(Nc3ccc4ncccc4c3)nc(NC(Cc3c[nH]c4ncccc34)C(N)=O)n2)cc1OC	Potential transcription error	CHEMBL1213152	=	IC50	nM	0.27	CHEMBL4722	Homo sapiens	IC50	nM	0.27
	3396971	CHEMBL1218394	Inhibition of Aurora A ATP-binding site assessed as inhibition of [gamma-33P]ATP incorporation into substrate by scintillation counting	B	CNc1nc(NCCc2ccccc2OC)nc(Nc2ccc3ncccc3c2)n1		CHEMBL1213153	=	IC50	nM	5.1	CHEMBL4722	Homo sapiens	IC50	nM	5.1
	3400006	CHEMBL1217203	Inhibition of human Aurora A at 10 uM	B	Cc1ccc(Nc2ncc3c(n2)N(C)C(=O)N(c2cc(NC(=O)c4cccc(C(F)(F)F)c4)ccc2C)C3)cn1		CHEMBL1214141	=	Inhibition	%	31.0	CHEMBL4722	Homo sapiens	INH	%	31.0
	3407561	CHEMBL1219720	Inhibition of recombinant aurora A	B	CC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1CCC(=O)O		CHEMBL1214853	=	IC50	nM	362.0	CHEMBL4722	Homo sapiens	IC50	uM	0.362
	3407562	CHEMBL1219720	Inhibition of recombinant aurora A	B	O=C(O)CCc1c(/C=C2\C(=O)Nc3ccc(Br)cc32)[nH]c2c1C(=O)CCC2		CHEMBL1214854	=	IC50	nM	210.0	CHEMBL4722	Homo sapiens	IC50	uM	0.21
	3407563	CHEMBL1219720	Inhibition of recombinant aurora A	B	O=C(O)CCc1c(/C=C2\C(=O)Nc3ccc([N+](=O)[O-])cc32)[nH]c2c1C(=O)CCC2		CHEMBL1214855	=	IC50	nM	724.0	CHEMBL4722	Homo sapiens	IC50	uM	0.724
	3407564	CHEMBL1219720	Inhibition of recombinant aurora A	B	COc1cc(-c2ccc3c(c2)/C(=C/c2[nH]c4c(c2CCC(=O)O)C(=O)CCC4)C(=O)N3)ccc1O		CHEMBL1214856	=	IC50	nM	357.0	CHEMBL4722	Homo sapiens	IC50	uM	0.357
	3407565	CHEMBL1219720	Inhibition of recombinant aurora A	B	COc1ccc(-c2ccc3c(c2)/C(=C/c2[nH]c4c(c2CCC(=O)O)C(=O)CCC4)C(=O)N3)cc1OC		CHEMBL1214925	=	IC50	nM	560.0	CHEMBL4722	Homo sapiens	IC50	uM	0.56
	3407566	CHEMBL1219720	Inhibition of recombinant aurora A	B	CC(=O)Nc1ccc2c(c1)/C(=C/c1[nH]c3c(c1CCC(=O)O)C(=O)CCC3)C(=O)N2		CHEMBL1214926	=	IC50	nM	252.0	CHEMBL4722	Homo sapiens	IC50	uM	0.252
	3407567	CHEMBL1219720	Inhibition of recombinant aurora A	B	O=C(O)CCc1c(/C=C2\C(=O)Nc3ccc(NC(=O)c4ccccc4)cc32)[nH]c2c1C(=O)CCC2		CHEMBL1214927	=	IC50	nM	720.0	CHEMBL4722	Homo sapiens	IC50	uM	0.72
	3407568	CHEMBL1219720	Inhibition of recombinant aurora A	B	CCS(=O)(=O)c1ccc2c(c1)/C(=C/c1[nH]c3c(c1CCC(=O)O)C(=O)CCC3)C(=O)N2		CHEMBL1214928	=	IC50	nM	57.0	CHEMBL4722	Homo sapiens	IC50	uM	0.057
	3407569	CHEMBL1219720	Inhibition of recombinant aurora A	B	C=CCS(=O)(=O)c1ccc2c(c1)/C(=C/c1[nH]c3c(c1CCC(=O)O)C(=O)CCC3)C(=O)N2		CHEMBL1214994	=	IC50	nM	39.0	CHEMBL4722	Homo sapiens	IC50	uM	0.039
	3407570	CHEMBL1219720	Inhibition of recombinant aurora A	B	O=C(O)CCc1c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4ccccc4)cc32)[nH]c2c1C(=O)CCC2		CHEMBL1214995	=	IC50	nM	271.0	CHEMBL4722	Homo sapiens	IC50	uM	0.271
	3407571	CHEMBL1219720	Inhibition of recombinant aurora A	B	O=C(O)CCc1c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4ccc(F)cc4)cc32)[nH]c2c1C(=O)CCC2		CHEMBL1214996	=	IC50	nM	443.0	CHEMBL4722	Homo sapiens	IC50	uM	0.443
	3407572	CHEMBL1219720	Inhibition of recombinant aurora A	B	NS(=O)(=O)c1ccc2c(c1)/C(=C/c1[nH]c3c(c1CCC(=O)O)C(=O)CCC3)C(=O)N2		CHEMBL1214997	=	IC50	nM	61.0	CHEMBL4722	Homo sapiens	IC50	uM	0.061
	3407573	CHEMBL1219720	Inhibition of recombinant aurora A	B	CNS(=O)(=O)c1ccc2c(c1)/C(=C/c1[nH]c3c(c1CCC(=O)O)C(=O)CCC3)C(=O)N2		CHEMBL1215070	=	IC50	nM	31.0	CHEMBL4722	Homo sapiens	IC50	uM	0.031
	3407574	CHEMBL1219720	Inhibition of recombinant aurora A	B	CN(C)S(=O)(=O)c1ccc2c(c1)/C(=C/c1[nH]c3c(c1CCC(=O)O)C(=O)CCC3)C(=O)N2		CHEMBL1215071	=	IC50	nM	21.0	CHEMBL4722	Homo sapiens	IC50	uM	0.021
	3407575	CHEMBL1219720	Inhibition of recombinant aurora A	B	O=C(O)CCc1c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)N4CCCC4)cc32)[nH]c2c1C(=O)CCC2		CHEMBL1215072	=	IC50	nM	7.0	CHEMBL4722	Homo sapiens	IC50	uM	0.007
	3407576	CHEMBL1219720	Inhibition of recombinant aurora A	B	O=C(O)CCc1c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)N4CCCCC4)cc32)[nH]c2c1C(=O)CCC2		CHEMBL1215073	=	IC50	nM	14.0	CHEMBL4722	Homo sapiens	IC50	uM	0.014
	3407577	CHEMBL1219720	Inhibition of recombinant aurora A	B	O=C(O)CCc1c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)N4CCOCC4)cc32)[nH]c2c1C(=O)CCC2		CHEMBL1215145	=	IC50	nM	29.0	CHEMBL4722	Homo sapiens	IC50	uM	0.029
	3407578	CHEMBL1219720	Inhibition of recombinant aurora A	B	O=C(O)CCc1c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)N4CCc5ccccc54)cc32)[nH]c2c1C(=O)CCC2		CHEMBL1215146	=	IC50	nM	8.0	CHEMBL4722	Homo sapiens	IC50	uM	0.008
	3407579	CHEMBL1219720	Inhibition of recombinant aurora A	B	CCS(=O)(=O)Nc1ccc2c(c1)/C(=C/c1[nH]c3c(c1CCC(=O)O)C(=O)CCC3)C(=O)N2		CHEMBL1215147	=	IC50	nM	34.0	CHEMBL4722	Homo sapiens	IC50	uM	0.034
	3407580	CHEMBL1219720	Inhibition of recombinant aurora A	B	O=C(O)CCc1c(/C=C2\C(=O)Nc3ccc(NS(=O)(=O)c4ccccc4)cc32)[nH]c2c1C(=O)CCC2		CHEMBL1215148	=	IC50	nM	12.0	CHEMBL4722	Homo sapiens	IC50	uM	0.012
	3407581	CHEMBL1219720	Inhibition of recombinant aurora A	B	O=C(O)CCc1c(/C=C2\C(=O)Nc3ccc(NS(=O)(=O)Cc4ccccc4)cc32)[nH]c2c1C(=O)CCC2		CHEMBL1215216	=	IC50	nM	63.0	CHEMBL4722	Homo sapiens	IC50	uM	0.063
	3407582	CHEMBL1219720	Inhibition of recombinant aurora A	B	CCOC(=O)CCc1c(/C=C2\C(=O)Nc3ccc(NS(=O)(=O)c4ccccc4)cc32)[nH]c2c1C(=O)CCC2		CHEMBL1215218	=	IC50	nM	84.0	CHEMBL4722	Homo sapiens	IC50	uM	0.084
	3407583	CHEMBL1219720	Inhibition of recombinant aurora A	B	O=C1Nc2ccc(NS(=O)(=O)c3ccccc3)cc2/C1=C/c1[nH]c2c(c1CCC(=O)N1CCCC1)C(=O)CCC2		CHEMBL1215280	=	IC50	nM	218.0	CHEMBL4722	Homo sapiens	IC50	uM	0.218
	3407584	CHEMBL1219720	Inhibition of recombinant aurora A	B	O=C1Nc2ccc(NS(=O)(=O)c3ccccc3)cc2/C1=C/c1[nH]c2c(c1CCC(=O)N1CCOCC1)C(=O)CCC2		CHEMBL1215281	=	IC50	nM	281.0	CHEMBL4722	Homo sapiens	IC50	uM	0.281
	3407585	CHEMBL1219720	Inhibition of recombinant aurora A	B	CNC(=O)CCc1c(/C=C2\C(=O)Nc3ccc(NS(=O)(=O)c4ccccc4)cc32)[nH]c2c1C(=O)CCC2		CHEMBL1215282	=	IC50	nM	117.0	CHEMBL4722	Homo sapiens	IC50	uM	0.117
	3407586	CHEMBL1219720	Inhibition of recombinant aurora A	B	O=C1Nc2ccc(S(=O)(=O)N3CCc4ccccc43)cc2/C1=C/c1[nH]c2c(c1CCC(=O)N1CCOCC1)C(=O)CCC2		CHEMBL1215283	=	IC50	nM	563.0	CHEMBL4722	Homo sapiens	IC50	uM	0.563
	3407587	CHEMBL1219720	Inhibition of recombinant aurora A	B	O=C1Nc2ccc(NS(=O)(=O)c3ccccc3)cc2/C1=C/c1[nH]c2c(c1CCCN1CCCC1)C(=O)CCC2		CHEMBL1215284	=	IC50	nM	2170.0	CHEMBL4722	Homo sapiens	IC50	uM	2.17
	3407588	CHEMBL1219720	Inhibition of recombinant aurora A	B	CN(C)CCCc1c(/C=C2\C(=O)Nc3ccc(NS(=O)(=O)c4ccccc4)cc32)[nH]c2c1C(=O)CCC2		CHEMBL1215346	=	IC50	nM	2190.0	CHEMBL4722	Homo sapiens	IC50	uM	2.19
	3407589	CHEMBL1219720	Inhibition of recombinant aurora A	B	CCN(CC)CCCc1c(/C=C2\C(=O)Nc3ccc(NS(=O)(=O)c4ccccc4)cc32)[nH]c2c1C(=O)CCC2		CHEMBL1215347	=	IC50	nM	2450.0	CHEMBL4722	Homo sapiens	IC50	uM	2.45
	3407590	CHEMBL1219720	Inhibition of recombinant aurora A	B	CN(C)CCCc1c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)N4CCc5ccccc54)cc32)[nH]c2c1C(=O)CCC2		CHEMBL1215348	=	IC50	nM	2270.0	CHEMBL4722	Homo sapiens	IC50	uM	2.27
	3407591	CHEMBL1219720	Inhibition of recombinant aurora A	B	CCN(CC)CCCc1c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)N4CCc5ccccc54)cc32)[nH]c2c1C(=O)CCC2		CHEMBL1215349	=	IC50	nM	2340.0	CHEMBL4722	Homo sapiens	IC50	uM	2.34
	3407592	CHEMBL1219720	Inhibition of recombinant aurora A	B	CCOC(=O)CCc1c(/C=C2\C(=O)Nc3ccccc32)[nH]c2c1C(=O)CCC2		CHEMBL1214708	=	IC50	nM	1780.0	CHEMBL4722	Homo sapiens	IC50	uM	1.78
	3407593	CHEMBL1219720	Inhibition of recombinant aurora A	B	CCOC(=O)CCc1c(/C=C2\C(=O)Nc3ccc(F)cc32)[nH]c2c1C(=O)CCC2		CHEMBL1214781	=	IC50	nM	1980.0	CHEMBL4722	Homo sapiens	IC50	uM	1.98
	3407594	CHEMBL1219720	Inhibition of recombinant aurora A	B	O=C(O)CCc1c(/C=C2\C(=O)Nc3ccccc32)[nH]c2c1C(=O)CCC2		CHEMBL1214782	=	IC50	nM	208.0	CHEMBL4722	Homo sapiens	IC50	uM	0.208
	3407595	CHEMBL1219720	Inhibition of recombinant aurora A	B	O=C(O)CCc1c(/C=C2\C(=O)Nc3ccc(F)cc32)[nH]c2c1C(=O)CCC2		CHEMBL1214783	=	IC50	nM	178.0	CHEMBL4722	Homo sapiens	IC50	uM	0.178
	3407596	CHEMBL1219720	Inhibition of recombinant aurora A	B	CC1(C)CC(=O)c2c([nH]c(/C=C3\C(=O)Nc4ccc(F)cc43)c2CCC(=O)O)C1		CHEMBL1214784	=	IC50	nM	456.0	CHEMBL4722	Homo sapiens	IC50	uM	0.456
	3407597	CHEMBL1219721	Inhibition of recombinant aurora A at 1 uM	B	O=C(O)CCc1c(/C=C2\C(=O)Nc3ccc(NS(=O)(=O)c4ccc5ccccc5c4)cc32)[nH]c2c1C(=O)CCC2		CHEMBL1215217	=	Inhibition	%	40.6	CHEMBL4722	Homo sapiens	INH	%	40.6
	3407598	CHEMBL1219721	Inhibition of recombinant aurora A at 1 uM	B	O=C(O)CCc1c(/C=C2\C(=O)Nc3ccc(F)cc32)[nH]c2c1C(=O)CCCC2		CHEMBL1214785	=	Inhibition	%	45.5	CHEMBL4722	Homo sapiens	INH	%	45.5
Active	3407670	CHEMBL1219728	Inhibition of aurora A in human HCT116 cells assessed as reduction of phosphorylated histone H3 at ser10 level measured at 1.25 to 40 uM after 3 hrs by Western blot analysis	B	CCOC(=O)CCc1c(/C=C2\C(=O)Nc3ccc(NS(=O)(=O)c4ccccc4)cc32)[nH]c2c1C(=O)CCC2		CHEMBL1215218		Inhibition	%		CHEMBL4722	Homo sapiens	INH		
Active	3407671	CHEMBL1219728	Inhibition of aurora A in human HCT116 cells assessed as reduction of phosphorylated histone H3 at ser10 level measured at 1.25 to 40 uM after 3 hrs by Western blot analysis	B	CN(C)CCCc1c(/C=C2\C(=O)Nc3ccc(NS(=O)(=O)c4ccccc4)cc32)[nH]c2c1C(=O)CCC2		CHEMBL1215346		Inhibition	%		CHEMBL4722	Homo sapiens	INH		
Active	3407672	CHEMBL1219729	Inhibition of aurora A in human HCT116 cells assessed as reduction of phosphorylated aurora A at Thr288 level measured at 1.25 to 40 uM after 3 hrs by Western blot analysis	B	CCOC(=O)CCc1c(/C=C2\C(=O)Nc3ccc(NS(=O)(=O)c4ccccc4)cc32)[nH]c2c1C(=O)CCC2		CHEMBL1215218		Inhibition	%		CHEMBL4722	Homo sapiens	INH		
Not Active	3407673	CHEMBL1219729	Inhibition of aurora A in human HCT116 cells assessed as reduction of phosphorylated aurora A at Thr288 level measured at 1.25 to 40 uM after 3 hrs by Western blot analysis	B	CN(C)CCCc1c(/C=C2\C(=O)Nc3ccc(NS(=O)(=O)c4ccccc4)cc32)[nH]c2c1C(=O)CCC2		CHEMBL1215346		Inhibition	%		CHEMBL4722	Homo sapiens	INH		
Active	3407674	CHEMBL1219730	Inhibition of aurora A in human HCT116 cells assessed as reduction of phosphorylated histone H3 at ser10 level measured at 10 uM after 3 hrs by Western blot analysis	B	CCOC(=O)CCc1c(/C=C2\C(=O)Nc3ccc(NS(=O)(=O)c4ccccc4)cc32)[nH]c2c1C(=O)CCC2		CHEMBL1215218		Inhibition	%		CHEMBL4722	Homo sapiens	INH		
Active	3407675	CHEMBL1219730	Inhibition of aurora A in human HCT116 cells assessed as reduction of phosphorylated histone H3 at ser10 level measured at 10 uM after 3 hrs by Western blot analysis	B	CN(C)CCCc1c(/C=C2\C(=O)Nc3ccc(NS(=O)(=O)c4ccccc4)cc32)[nH]c2c1C(=O)CCC2		CHEMBL1215346		Inhibition	%		CHEMBL4722	Homo sapiens	INH		
	3419151	CHEMBL1228781	Inhibition of Aurora A	B	NC(=O)c1sc2c([N+](=O)[O-])cc(C(F)(F)F)cc2[n+]1[O-]		CHEMBL476124	>	IC50	nM	100000.0	CHEMBL4722	Homo sapiens	IC50	uM	100.0
	3419168	CHEMBL1228781	Inhibition of Aurora A	B	NC(=O)c1sc2c([N+](=O)[O-])cc(SC(F)(F)F)cc2[n+]1[O-]		CHEMBL1222044	>	IC50	nM	100000.0	CHEMBL4722	Homo sapiens	IC50	uM	100.0
	3420228	CHEMBL1226924	Inhibition of Aurora-A	B	O=C1NCCc2[nH]c(-c3ccncc3)cc21		CHEMBL225519	>	IC50	nM	10000.0	CHEMBL4722	Homo sapiens	IC50	nM	10000.0
	3423091	CHEMBL1227381	Inhibition of recombinant aurora A after 1 hr	B	O=C(CCc1cn(Cc2ccc(Cl)cc2)c2ccccc12)Nc1ccc([N+](=O)[O-])cc1		CHEMBL1221633	>	IC50	nM	100000.0	CHEMBL4722	Homo sapiens	IC50	uM	100.0
	3423092	CHEMBL1227381	Inhibition of recombinant aurora A after 1 hr	B	O=C(CCc1cn(Cc2ccc(Cl)cc2)c2ccccc12)Nc1ccncc1		CHEMBL185140	>	IC50	nM	100000.0	CHEMBL4722	Homo sapiens	IC50	uM	100.0
Active	3439170	CHEMBL1247992	Inhibition of aurora A autophosphorylation in human HeLa cells at 0.313 uM after 24 hrs by Western blotting	B	CNc1nccc(-c2cccnc2Oc2ccc(Nc3nnc(-c4ccc(F)cc4)c4ccccc34)cc2)n1		CHEMBL1243326		Activity			CHEMBL4722	Homo sapiens	Activity		
Active	3439172	CHEMBL1247994	Inhibition of aurora A autophosphorylation in human HeLa cells at 0.5 uM after 24 hrs by Western blotting	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084		Activity			CHEMBL4722	Homo sapiens	Activity		
	3443320	CHEMBL1244303	Inhibition of STK6 at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc3ncccc3c2)c2c(N)ncnc21		CHEMBL1233882	=	Inhibition	%	2.0	CHEMBL4722	Homo sapiens	INH	%	2.0
	3443537	CHEMBL1244303	Inhibition of STK6 at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc(Br)c(O)c2)c2c(N)ncnc21		CHEMBL1241578	=	Inhibition	%	24.0	CHEMBL4722	Homo sapiens	INH	%	24.0
	3445033	CHEMBL1244729	Binding affinity to AURKA	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	=	Kd	nM	16.0	CHEMBL4722	Homo sapiens	Kd	nM	16.0
	3445316	CHEMBL1244303	Inhibition of STK6 at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	Nc1ncnc2c1c(-c1cnc3[nH]ccc3c1)nn2C1CCCC1		CHEMBL1081312	=	Inhibition	%	11.0	CHEMBL4722	Homo sapiens	INH	%	11.0
	3445533	CHEMBL1244303	Inhibition of STK6 at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	COc1ccc(-c2nn(C3CCC3)c3ncnc(N)c23)cc1OC		CHEMBL1233881	=	Inhibition	%	2.0	CHEMBL4722	Homo sapiens	INH	%	2.0
	3445750	CHEMBL1244303	Inhibition of STK6 at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2cc3cc(O)ccc3[nH]2)c2c(N)ncnc21		CHEMBL1241674	=	Inhibition	%	31.0	CHEMBL4722	Homo sapiens	INH	%	31.0
	3445940	CHEMBL1244303	Inhibition of STK6 at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2cccc(O)c2)c2c(N)ncnc21		CHEMBL1230790	=	Inhibition	%	16.0	CHEMBL4722	Homo sapiens	INH	%	16.0
	3446130	CHEMBL1244303	Inhibition of STK6 at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	Cn1nc(-c2ccc3ccccc3c2)c2c(N)ncnc21		CHEMBL1234815	=	Inhibition	%	15.0	CHEMBL4722	Homo sapiens	INH	%	15.0
	3447185	CHEMBL1249641	Inhibition of Aurora A kinase	B	COc1cc2c(Nc3ncc(CC(=O)Nc4cccc(F)c4)s3)ncnc2cc1OCCCN1CCC(CO)CC1		CHEMBL201307	<	IC50	nM	1.0	CHEMBL4722	Homo sapiens	IC50	uM	0.001
	3448049	CHEMBL1249677	Inhibition of human aurora-A activity at 10 uM by radiometric assay	B	NC(=O)c1cccc(-c2cc(Nc3ccc(OC(F)(F)F)cc3)ncn2)c1		CHEMBL483847	=	Inhibition	%	19.0	CHEMBL4722	Homo sapiens	INH	%	19.0
	3448125	CHEMBL1249677	Inhibition of human aurora-A activity at 10 uM by radiometric assay	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	=	Inhibition	%	16.0	CHEMBL4722	Homo sapiens	INH	%	16.0
	3448882	CHEMBL1244729	Binding affinity to AURKA	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Kd	nM	120.0	CHEMBL4722	Homo sapiens	Kd	nM	120.0
	3449393	CHEMBL1244729	Binding affinity to AURKA	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Kd	nM	1700.0	CHEMBL4722	Homo sapiens	Kd	nM	1700.0
	3449565	CHEMBL1244729	Binding affinity to AURKA	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	>	Kd	nM	10000.0	CHEMBL4722	Homo sapiens	Kd	uM	10.0
	3449990	CHEMBL1244729	Binding affinity to AURKA	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL4722	Homo sapiens	Kd	uM	10.0
	3450918	CHEMBL1244729	Binding affinity to AURKA	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)N[C@H]4O		CHEMBL1240703	>	Kd	nM	10000.0	CHEMBL4722	Homo sapiens	Kd	uM	10.0
	3451209	CHEMBL1244729	Binding affinity to AURKA	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	10000.0	CHEMBL4722	Homo sapiens	Kd	uM	10.0
	3463174	CHEMBL1251634	Inhibition of AURKB at 1 uM in presence of 10 uM ATP by Select Screen kinase assay relative to untreated control	B	Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4c[nH]c5ccccc45)c3)cc12		CHEMBL379300	=	Inhibition	%	9.0	CHEMBL4722	Homo sapiens	INH	%	9.0
	3463370	CHEMBL1251703	Inhibition of STK6 at 1 uM in presence of 10 uM ATP by Select Screen kinase assay relative to untreated control	B	Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4c[nH]c5ccccc45)c3)cc12		CHEMBL379300	=	Inhibition	%	16.0	CHEMBL4722	Homo sapiens	INH	%	16.0
	3463393	CHEMBL1251634	Inhibition of AURKB at 1 uM in presence of 10 uM ATP by Select Screen kinase assay relative to untreated control	B	COc1ccccc1N1CCN(c2ncnc3[nH]nc(Br)c23)CC1		CHEMBL1254209	=	Inhibition	%	20.0	CHEMBL4722	Homo sapiens	INH	%	20.0
	3463914	CHEMBL1251703	Inhibition of STK6 at 1 uM in presence of 10 uM ATP by Select Screen kinase assay relative to untreated control	B	COc1ccccc1N1CCN(c2ncnc3[nH]nc(Br)c23)CC1		CHEMBL1254209	=	Inhibition	%	22.0	CHEMBL4722	Homo sapiens	INH	%	22.0
	3463937	CHEMBL1251634	Inhibition of AURKB at 1 uM in presence of 10 uM ATP by Select Screen kinase assay relative to untreated control	B	O=C(NCCCNc1nc(Nc2cccc(NC(=O)N3CCCC3)c2)ncc1I)c1cccs1		CHEMBL577784	=	Inhibition	%	103.0	CHEMBL4722	Homo sapiens	INH	%	103.0
	3464133	CHEMBL1251703	Inhibition of STK6 at 1 uM in presence of 10 uM ATP by Select Screen kinase assay relative to untreated control	B	O=C(NCCCNc1nc(Nc2cccc(NC(=O)N3CCCC3)c2)ncc1I)c1cccs1		CHEMBL577784	=	Inhibition	%	97.0	CHEMBL4722	Homo sapiens	INH	%	97.0
	3471619	CHEMBL1250660	Inhibition of aurora A	B	Cn1ccc2ncnc(Oc3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)c(F)c3)c21		CHEMBL1254007	=	IC50	nM	1050.0	CHEMBL4722	Homo sapiens	IC50	nM	1050.0
Not Active	3499116	CHEMBL1259860	Inhibition of aurora A at 10 uM relative to control	B	CCNC(=O)NCc1ccccc1-c1cc(-c2cnc(NC(C)C)s2)nc(NCCN(C)C)n1		CHEMBL1230171		Inhibition	%		CHEMBL4722	Homo sapiens	INH		
	3504281	CHEMBL1260146	Inhibition of AurA	B	CN1CCN(c2ccc(C(=O)Nc3n[nH]c4cc(C(=O)Nc5ccccc5)sc34)cc2)CC1		CHEMBL1258460	=	IC50	nM	105.0	CHEMBL4722	Homo sapiens	IC50	uM	0.105
	3504282	CHEMBL1260146	Inhibition of AurA	B	C[C@H](NC(=O)c1cc2[nH]nc(NC(=O)c3ccc(N4CCOCC4)cc3)c2s1)c1ccccc1		CHEMBL1257995	=	IC50	nM	83.0	CHEMBL4722	Homo sapiens	IC50	uM	0.083
	3504283	CHEMBL1260146	Inhibition of AurA	B	C[C@H](NC(=O)c1cc2[nH]nc(NC(=O)c3ccc(N4CCN(C)CC4)cc3)c2s1)c1ccccc1		CHEMBL1258115	=	IC50	nM	66.0	CHEMBL4722	Homo sapiens	IC50	uM	0.066
	3504284	CHEMBL1260146	Inhibition of AurA	B	CC(C)NC(=O)c1cc2[nH]nc(NC(=O)c3ccc(N4CCN(C)CC4)cc3)c2s1		CHEMBL1258347	=	IC50	nM	59.0	CHEMBL4722	Homo sapiens	IC50	uM	0.059
	3504285	CHEMBL1260146	Inhibition of AurA	B	CN1CCN(c2ccc(C(=O)Nc3n[nH]c4cc(C(=O)NC5CCc6ccccc65)sc34)cc2)CC1		CHEMBL1258229	=	IC50	nM	52.0	CHEMBL4722	Homo sapiens	IC50	uM	0.052
	3504286	CHEMBL1260146	Inhibition of AurA	B	CN1CCN(c2ccc(C(=O)Nc3n[nH]c4cc(C(=O)NC(c5ccccc5)c5ccccc5)sc34)cc2)CC1		CHEMBL1257884	=	IC50	nM	48.0	CHEMBL4722	Homo sapiens	IC50	uM	0.048
	3504287	CHEMBL1260146	Inhibition of AurA	B	CCNC(=O)c1cc2[nH]nc(NC(=O)c3ccc(N4CCN(C)CC4)cc3)c2s1		CHEMBL1258114	=	IC50	nM	48.0	CHEMBL4722	Homo sapiens	IC50	uM	0.048
	3504288	CHEMBL1260146	Inhibition of AurA	B	CN1CCN(c2ccc(C(=O)Nc3n[nH]c4cc(C(=O)NC5CCCc6ccccc65)sc34)cc2)CC1		CHEMBL1258230	=	IC50	nM	45.0	CHEMBL4722	Homo sapiens	IC50	uM	0.045
	3504289	CHEMBL1260146	Inhibition of AurA	B	CN1CCN(c2ccc(C(=O)Nc3n[nH]c4cc(C(=O)NC(C)(C)c5ccccc5)sc34)cc2)CC1		CHEMBL1258569	=	IC50	nM	44.0	CHEMBL4722	Homo sapiens	IC50	uM	0.044
	3504290	CHEMBL1260146	Inhibition of AurA	B	CN1CCN(c2ccc(C(=O)Nc3n[nH]c4cc(C(=O)NCc5ccccc5)sc34)cc2)CC1		CHEMBL1258568	=	IC50	nM	32.0	CHEMBL4722	Homo sapiens	IC50	uM	0.032
	3504291	CHEMBL1260146	Inhibition of AurA	B	CC[C@H](NC(=O)c1cc2[nH]nc(NC(=O)c3ccc(N4CCN(C)CC4)cc3)c2s1)c1ccccc1		CHEMBL1258459	=	IC50	nM	31.0	CHEMBL4722	Homo sapiens	IC50	uM	0.031
	3504292	CHEMBL1260146	Inhibition of AurA	B	CN1CCN(c2ccc(C(=O)Nc3n[nH]c4cc(C(=O)N[C@H](CN5CCCC5)c5ccccc5)sc34)cc2)CC1		CHEMBL1258346	=	IC50	nM	27.0	CHEMBL4722	Homo sapiens	IC50	uM	0.027
	3504293	CHEMBL1260146	Inhibition of AurA	B	O=C(Nc1n[nH]c2cc(C(=O)N[C@H](CN3CCOCC3)c3ccccc3)sc12)c1ccc(N2CCOCC2)cc1		CHEMBL1258680	=	IC50	nM	25.0	CHEMBL4722	Homo sapiens	IC50	uM	0.025
	3504294	CHEMBL1260146	Inhibition of AurA	B	O=C(Nc1n[nH]c2cc(C(=O)N[C@H](CN3CCCC3)c3ccccc3)sc12)c1ccc(N2CCOCC2)cc1		CHEMBL1258913	=	IC50	nM	18.0	CHEMBL4722	Homo sapiens	IC50	uM	0.018
	3504295	CHEMBL1260146	Inhibition of AurA	B	CN1CCN(c2ccc(C(=O)Nc3n[nH]c4cc(C(=O)N[C@H](CN5CCOCC5)c5ccccc5)sc34)cc2)CC1		CHEMBL1258793	=	IC50	nM	18.0	CHEMBL4722	Homo sapiens	IC50	uM	0.018
	3504296	CHEMBL1260146	Inhibition of AurA	B	CC(NC(=O)c1cc2[nH]nc(NC(=O)c3ccc(N4CCN(C)CC4)cc3)c2s1)c1ccccc1		CHEMBL1257179	=	IC50	nM	13.0	CHEMBL4722	Homo sapiens	IC50	uM	0.013
	3504297	CHEMBL1260146	Inhibition of AurA	B	O=C(Nc1n[nH]c2cc(C(=O)NCc3ccccc3)sc12)c1ccc(N2CCOCC2)cc1		CHEMBL1258794	=	IC50	nM	11.0	CHEMBL4722	Homo sapiens	IC50	uM	0.011
	3504298	CHEMBL1260146	Inhibition of AurA	B	CCC(NC(=O)c1cc2[nH]nc(NC(=O)c3ccc(N4CCN(C)CC4)cc3)c2s1)c1ccccc1		CHEMBL1257180	=	IC50	nM	10.0	CHEMBL4722	Homo sapiens	IC50	uM	0.01
	3504299	CHEMBL1260146	Inhibition of AurA	B	CC[C@@H](NC(=O)c1cc2[nH]nc(NC(=O)c3ccc(N4CCN(C)CC4)cc3)c2s1)c1ccccc1		CHEMBL1230201	=	IC50	nM	9.0	CHEMBL4722	Homo sapiens	IC50	uM	0.009
	3504300	CHEMBL1260146	Inhibition of AurA	B	C[C@@H](NC(=O)c1cc2[nH]nc(NC(=O)c3ccc(N4CCN(C)CC4)cc3)c2s1)c1ccccc1		CHEMBL1257296	=	IC50	nM	6.0	CHEMBL4722	Homo sapiens	IC50	uM	0.006
	3504301	CHEMBL1260146	Inhibition of AurA	B	C[C@@H](NC(=O)c1cc2[nH]nc(NC(=O)c3ccc(N4CCOCC4)cc3)c2s1)c1ccccc1		CHEMBL1258912	=	IC50	nM	5.0	CHEMBL4722	Homo sapiens	IC50	uM	0.005
	3505229	CHEMBL1261371	Inhibition of human aurora A	B	c1ccc(Nc2nc(-c3cccnc3)cn3ccnc23)cc1		CHEMBL1257210	=	IC50	nM	6700.0	CHEMBL4722	Homo sapiens	IC50	uM	6.7
	3505230	CHEMBL1261371	Inhibition of human aurora A	B	c1cncc(-c2cn3ccnc3c(Nc3ccc(N4CCOCC4)cc3)n2)c1		CHEMBL1257211	=	IC50	nM	2120.0	CHEMBL4722	Homo sapiens	IC50	uM	2.12
	3505231	CHEMBL1261371	Inhibition of human aurora A	B	COc1ccc(Nc2nc(-c3cccnc3)cn3ccnc23)cc1		CHEMBL1257331	=	IC50	nM	2900.0	CHEMBL4722	Homo sapiens	IC50	uM	2.9
	3505232	CHEMBL1261371	Inhibition of human aurora A	B	Clc1ccc(Nc2nc(-c3cccnc3)cn3ccnc23)cc1		CHEMBL1257332	=	IC50	nM	5500.0	CHEMBL4722	Homo sapiens	IC50	uM	5.5
	3505233	CHEMBL1261371	Inhibition of human aurora A	B	CC(=O)Nc1ccc(Nc2nc(-c3cccnc3)cn3ccnc23)cc1		CHEMBL1257333	=	IC50	nM	2500.0	CHEMBL4722	Homo sapiens	IC50	uM	2.5
	3505234	CHEMBL1261371	Inhibition of human aurora A	B	O=C(Nc1ccc(Nc2nc(-c3cccnc3)cn3ccnc23)cc1)c1ccccc1		CHEMBL1257445	=	IC50	nM	3750.0	CHEMBL4722	Homo sapiens	IC50	uM	3.75
	3505235	CHEMBL1261371	Inhibition of human aurora A	B	COc1ccc(Nc2nc(-c3ccn(C)n3)cn3ccnc23)cc1		CHEMBL1257923	=	IC50	nM	9700.0	CHEMBL4722	Homo sapiens	IC50	uM	9.7
	3505236	CHEMBL1261371	Inhibition of human aurora A	B	COc1ccc(Nc2nc(-c3cccc(N)c3)cn3ccnc23)cc1		CHEMBL1258033	=	IC50	nM	5480.0	CHEMBL4722	Homo sapiens	IC50	uM	5.48
	3505237	CHEMBL1261371	Inhibition of human aurora A	B	COCC(=O)Nc1cccc(-c2cn3ccnc3c(Nc3ccc(OC)cc3)n2)c1		CHEMBL1258151	=	IC50	nM	7310.0	CHEMBL4722	Homo sapiens	IC50	uM	7.31
	3505238	CHEMBL1261371	Inhibition of human aurora A	B	COc1ccc(Nc2nc(-c3cccc(NC(=O)Nc4ccccc4)c3)cn3ccnc23)cc1		CHEMBL1258266	=	IC50	nM	7200.0	CHEMBL4722	Homo sapiens	IC50	uM	7.2
	3505239	CHEMBL1261371	Inhibition of human aurora A	B	COc1ccc(NC(=O)Nc2cccc(-c3cn4ccnc4c(Nc4ccc(OC)cc4)n3)c2)cc1		CHEMBL1258267	=	IC50	nM	7900.0	CHEMBL4722	Homo sapiens	IC50	uM	7.9
	3505240	CHEMBL1261371	Inhibition of human aurora A	B	COc1ccc(Nc2nc(-c3cccc(NS(=O)(=O)c4ccc(OC)cc4)c3)cn3ccnc23)cc1		CHEMBL1258378	=	IC50	nM	6700.0	CHEMBL4722	Homo sapiens	IC50	uM	6.7
	3505241	CHEMBL1261371	Inhibition of human aurora A	B	COc1ccc(Nc2nc(-c3cccc(NS(=O)(=O)c4cccnc4)c3)cn3ccnc23)cc1		CHEMBL1258379	=	IC50	nM	4500.0	CHEMBL4722	Homo sapiens	IC50	uM	4.5
	3505242	CHEMBL1261371	Inhibition of human aurora A	B	Cc1cnc2c(Nc3ccc(N4CCOCC4)cc3)nc(-c3cccnc3)cn12		CHEMBL1258490	=	IC50	nM	208.0	CHEMBL4722	Homo sapiens	IC50	uM	0.208
	3505243	CHEMBL1261371	Inhibition of human aurora A	B	Brc1cnc2c(Nc3ccc(N4CCOCC4)cc3)nc(-c3cccnc3)cn12		CHEMBL1258491	=	IC50	nM	152.0	CHEMBL4722	Homo sapiens	IC50	uM	0.152
	3505244	CHEMBL1261371	Inhibition of human aurora A	B	c1cncc(-c2cn3c(-c4cccnc4)cnc3c(Nc3ccc(N4CCOCC4)cc3)n2)c1		CHEMBL1258604	=	IC50	nM	4200.0	CHEMBL4722	Homo sapiens	IC50	uM	4.2
	3505245	CHEMBL1261371	Inhibition of human aurora A	B	Clc1cnc2c(Nc3ccc(N4CCOCC4)cc3)nc(-c3cccnc3)cn12		CHEMBL1231066	=	IC50	nM	190.0	CHEMBL4722	Homo sapiens	IC50	uM	0.19
	3505246	CHEMBL1261372	Inhibition of human aurora A at 10 uM	B	c1cncc(-c2cn3ccnc3c(NCc3ccc(N4CCOCC4)cc3)n2)c1		CHEMBL1257446	=	Inhibition	%	41.0	CHEMBL4722	Homo sapiens	INH	%	41.0
	3505247	CHEMBL1261372	Inhibition of human aurora A at 10 uM	B	COc1ccc(Nc2nc(-c3cccc(NC(=O)COc4ccccc4)c3)cn3ccnc23)cc1		CHEMBL1258152	=	Inhibition	%	22.0	CHEMBL4722	Homo sapiens	INH	%	22.0
	3505248	CHEMBL1261372	Inhibition of human aurora A at 10 uM	B	COc1ccc(Nc2nc(-c3cccc(Cl)c3)cn3ccnc23)cc1		CHEMBL1258032	=	Inhibition	%	46.0	CHEMBL4722	Homo sapiens	INH	%	46.0
	3505249	CHEMBL1261372	Inhibition of human aurora A at 10 uM	B	COc1ccc(Nc2nc(-c3cnn(Cc4ccccc4)c3)cn3ccnc23)cc1		CHEMBL1257924	=	Inhibition	%	38.0	CHEMBL4722	Homo sapiens	INH	%	38.0
	3505250	CHEMBL1261372	Inhibition of human aurora A at 10 uM	B	COc1ccc(Nc2nc(-c3ccc(F)nc3)cn3ccnc23)cc1		CHEMBL1257807	=	Inhibition	%	32.0	CHEMBL4722	Homo sapiens	INH	%	32.0
	3505251	CHEMBL1261372	Inhibition of human aurora A at 10 uM	B	COc1ccc(Nc2nc(-c3ccc(Cl)nc3)cn3ccnc23)cc1		CHEMBL1257806	=	Inhibition	%	28.0	CHEMBL4722	Homo sapiens	INH	%	28.0
	3505252	CHEMBL1261372	Inhibition of human aurora A at 10 uM	B	COc1ccc(Nc2nc(-c3ccc(OC)nc3)cn3ccnc23)cc1		CHEMBL1257685	=	Inhibition	%	30.0	CHEMBL4722	Homo sapiens	INH	%	30.0
	3505253	CHEMBL1261372	Inhibition of human aurora A at 10 uM	B	OC1CCC(Nc2nc(-c3cccnc3)cn3ccnc23)CC1		CHEMBL1257684	=	Inhibition	%	32.0	CHEMBL4722	Homo sapiens	INH	%	32.0
	3505254	CHEMBL1261372	Inhibition of human aurora A at 10 uM	B	c1cncc(-c2cn3ccnc3c(NCCN3CCOCC3)n2)c1		CHEMBL1257564	=	Inhibition	%	33.0	CHEMBL4722	Homo sapiens	INH	%	33.0
	3505255	CHEMBL1261372	Inhibition of human aurora A at 10 uM	B	c1cncc(-c2cn3ccnc3c(NCc3ccc4c(c3)OCCO4)n2)c1		CHEMBL1257563	=	Inhibition	%	35.0	CHEMBL4722	Homo sapiens	INH	%	35.0
	3505270	CHEMBL1261372	Inhibition of human aurora A at 10 uM	B	CN(c1ccccc1)c1nc(-c2cccnc2)cn2ccnc12		CHEMBL1258832	=	Inhibition	%	27.0	CHEMBL4722	Homo sapiens	INH	%	27.0
	3521129	CHEMBL1272503	Inhibition of Aurora A	B	CSc1cn2c(-c3cn[nH]c3)cnc2c(Nc2cc(C)ns2)n1		CHEMBL1270795	<=	IC50	nM	4.0	CHEMBL4722	Homo sapiens	IC50	nM	4.0
	3521130	CHEMBL1272503	Inhibition of Aurora A	B	Cc1cc(Nc2nc(C)cn3c(-c4cn[nH]c4)cnc23)sn1		CHEMBL1270796	<=	IC50	nM	4.0	CHEMBL4722	Homo sapiens	IC50	nM	4.0
	3521131	CHEMBL1272503	Inhibition of Aurora A	B	CCN(Cc1cc(Nc2nc(C)cn3c(-c4cn[nH]c4)cnc23)sn1)C(C)(C)CO		CHEMBL1232515	<=	IC50	nM	4.0	CHEMBL4722	Homo sapiens	IC50	nM	4.0
	3521132	CHEMBL1272503	Inhibition of Aurora A	B	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2cc(CN3CCOCC3(C)C)ns2)n1		CHEMBL1270897	<=	IC50	nM	4.0	CHEMBL4722	Homo sapiens	IC50	nM	4.0
	3521133	CHEMBL1272503	Inhibition of Aurora A	B	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2cc(CN3CCCCC3(C)C)ns2)n1		CHEMBL1270996	<=	IC50	nM	4.0	CHEMBL4722	Homo sapiens	IC50	nM	4.0
	3521200	CHEMBL1272503	Inhibition of Aurora A	B	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2cc(CN3CCN(C)CC3)ns2)n1		CHEMBL1270997	<=	IC50	nM	4.0	CHEMBL4722	Homo sapiens	IC50	nM	4.0
	3521201	CHEMBL1272503	Inhibition of Aurora A	B	CCOC(=O)N1CCN(Cc2cc(Nc3nc(C)cn4c(-c5cn[nH]c5)cnc34)sn2)CC1		CHEMBL1271103	<=	IC50	nM	4.0	CHEMBL4722	Homo sapiens	IC50	nM	4.0
	3521202	CHEMBL1272503	Inhibition of Aurora A	B	CC(=O)N1CCN(Cc2cc(Nc3nc(C)cn4c(-c5cn[nH]c5)cnc34)sn2)CC1		CHEMBL1271104	<=	IC50	nM	4.0	CHEMBL4722	Homo sapiens	IC50	nM	4.0
	3521203	CHEMBL1272503	Inhibition of Aurora A	B	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2cc(CN3CCN(S(C)(=O)=O)CC3)ns2)n1		CHEMBL1271203	<=	IC50	nM	4.0	CHEMBL4722	Homo sapiens	IC50	nM	4.0
	3521204	CHEMBL1272503	Inhibition of Aurora A	B	CCNC(=O)N1CCN(Cc2cc(Nc3nc(C)cn4c(-c5cn[nH]c5)cnc34)sn2)CC1		CHEMBL1271204	<=	IC50	nM	4.0	CHEMBL4722	Homo sapiens	IC50	nM	4.0
	3521205	CHEMBL1272503	Inhibition of Aurora A	B	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2cc(CN3CCN(CCO)CC3)ns2)n1		CHEMBL1271306	<=	IC50	nM	4.0	CHEMBL4722	Homo sapiens	IC50	nM	4.0
	3521206	CHEMBL1272503	Inhibition of Aurora A	B	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2cc(CN3CCN(C)CC3=O)ns2)n1		CHEMBL1271307	<=	IC50	nM	4.0	CHEMBL4722	Homo sapiens	IC50	nM	4.0
	3521207	CHEMBL1272503	Inhibition of Aurora A	B	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2cc(CN3CCN(C)C(=O)C3)ns2)n1		CHEMBL1271413	<=	IC50	nM	4.0	CHEMBL4722	Homo sapiens	IC50	nM	4.0
	3521208	CHEMBL1272503	Inhibition of Aurora A	B	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2cc(CN3CCOC[C@@H]3CO)ns2)n1		CHEMBL1271414	<=	IC50	nM	4.0	CHEMBL4722	Homo sapiens	IC50	nM	4.0
	3521209	CHEMBL1272503	Inhibition of Aurora A	B	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2cc(CN3CCOCC34CCC4)ns2)n1		CHEMBL1269880	<=	IC50	nM	4.0	CHEMBL4722	Homo sapiens	IC50	nM	4.0
	3521210	CHEMBL1272503	Inhibition of Aurora A	B	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2cc(CN3C[C@H](C)O[C@H](C)C3)ns2)n1		CHEMBL1269881	<=	IC50	nM	4.0	CHEMBL4722	Homo sapiens	IC50	nM	4.0
	3521211	CHEMBL1272503	Inhibition of Aurora A	B	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2cc(CN3C[C@@H]4CC[C@H](C3)O4)ns2)n1		CHEMBL1269988	<=	IC50	nM	4.0	CHEMBL4722	Homo sapiens	IC50	nM	4.0
	3521212	CHEMBL1272503	Inhibition of Aurora A	B	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2cc(CN3C[C@H](C)OC[C@@H]3C)ns2)n1		CHEMBL1269989	<=	IC50	nM	4.0	CHEMBL4722	Homo sapiens	IC50	nM	4.0
	3521213	CHEMBL1272503	Inhibition of Aurora A	B	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2cc(CN3CCOC(C)(C)C3)ns2)n1		CHEMBL1270096	<=	IC50	nM	4.0	CHEMBL4722	Homo sapiens	IC50	nM	4.0
	3521214	CHEMBL1272503	Inhibition of Aurora A	B	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2cc(C(C)N3CCOCC3)ns2)n1		CHEMBL1270097	<=	IC50	nM	4.0	CHEMBL4722	Homo sapiens	IC50	nM	4.0
	3521215	CHEMBL1272503	Inhibition of Aurora A	B	CCC(c1cc(Nc2nc(C)cn3c(-c4cn[nH]c4)cnc23)sn1)N1CCOCC1		CHEMBL1270205	<=	IC50	nM	4.0	CHEMBL4722	Homo sapiens	IC50	nM	4.0
	3521216	CHEMBL1272503	Inhibition of Aurora A	B	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2cc(C(c3ccccn3)N3CCOCC3)ns2)n1		CHEMBL1270206	<=	IC50	nM	4.0	CHEMBL4722	Homo sapiens	IC50	nM	4.0
	3521217	CHEMBL1272503	Inhibition of Aurora A	B	COCC(c1cc(Nc2nc(C)cn3c(-c4cn[nH]c4)cnc23)sn1)N1CCOCC1		CHEMBL1270299	<=	IC50	nM	4.0	CHEMBL4722	Homo sapiens	IC50	nM	4.0
	3521218	CHEMBL1272503	Inhibition of Aurora A	B	CCOCC(c1cc(Nc2nc(C)cn3c(-c4cn[nH]c4)cnc23)sn1)N1CCOCC1		CHEMBL1270300	<=	IC50	nM	4.0	CHEMBL4722	Homo sapiens	IC50	nM	4.0
	3521219	CHEMBL1272503	Inhibition of Aurora A	B	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2cc(C3(N4C[C@H](C)O[C@H](C)C4)CC3)ns2)n1		CHEMBL1270398	=	IC50	nM	45.0	CHEMBL4722	Homo sapiens	IC50	nM	45.0
	3521220	CHEMBL1272503	Inhibition of Aurora A	B	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2cc([C@@H](C)N3C[C@H](C)O[C@H](C)C3)ns2)n1		CHEMBL1270399	<=	IC50	nM	4.0	CHEMBL4722	Homo sapiens	IC50	nM	4.0
	3521221	CHEMBL1272503	Inhibition of Aurora A	B	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2cc(C(C)N3CCOC(C)(C)C3)ns2)n1		CHEMBL1270491	<=	IC50	nM	4.0	CHEMBL4722	Homo sapiens	IC50	nM	4.0
	3521222	CHEMBL1272503	Inhibition of Aurora A	B	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2cc(C(C)N3C[C@H](C)O[C@H](C)C3)ns2)n1		CHEMBL1270492	<=	IC50	nM	4.0	CHEMBL4722	Homo sapiens	IC50	nM	4.0
	3526996	CHEMBL1275115	Inhibition of AUR1	B	NC(=O)c1cc(-c2ccnc(N)n2)[nH]c1-c1ccccc1		CHEMBL1270230	>	IC50	nM	10000.0	CHEMBL4722	Homo sapiens	IC50	uM	10.0
	3556541	CHEMBL1285570	Inhibition of AURKA at 1 uM	B	CN1C[C@@H]2C[C@H]1CN2c1cc(F)c(-c2ccnc3c(-c4cccc5[nH]ncc45)c(-c4ccncc4)nn23)c(F)c1		CHEMBL1276179	=	Inhibition	%	7.0	CHEMBL4722	Homo sapiens	INH	%	7.0
	3559085	CHEMBL1286524	Inhibition of human purified recombinant aurora-A kinase	B	CC1=C(C(=O)Nc2ccc(C(F)(F)F)cc2)C(c2ccco2)n2c(nc3ccccc32)N1		CHEMBL1277382	=	IC50	nM	1320.0	CHEMBL4722	Homo sapiens	IC50	uM	1.32
	3559092	CHEMBL1286524	Inhibition of human purified recombinant aurora-A kinase	B	CC1=C(C(=O)Nc2ccc([N+](=O)[O-])cc2)C(c2ccco2)n2c(nc3ccccc32)N1		CHEMBL1277294	=	IC50	nM	3000.0	CHEMBL4722	Homo sapiens	IC50	uM	3.0
	3559099	CHEMBL1286524	Inhibition of human purified recombinant aurora-A kinase	B	CN(C)c1ccc(-c2nc3cc(Cl)cnc3[nH]2)cc1		CHEMBL236694	=	IC50	nM	4970.0	CHEMBL4722	Homo sapiens	IC50	uM	4.97
	3559104	CHEMBL1286524	Inhibition of human purified recombinant aurora-A kinase	B	CC1=C(C(=O)Nc2ccc(F)c(Cl)c2)C(c2ccco2)n2c(nc3ccccc32)N1		CHEMBL1277383	=	IC50	nM	5730.0	CHEMBL4722	Homo sapiens	IC50	uM	5.73
	3559106	CHEMBL1286524	Inhibition of human purified recombinant aurora-A kinase	B	CC1=C(C(=O)Nc2ccc(F)cc2)C(c2ccco2)n2c(nc3ccccc32)N1		CHEMBL1277473	=	IC50	nM	6150.0	CHEMBL4722	Homo sapiens	IC50	uM	6.15
	3559108	CHEMBL1286524	Inhibition of human purified recombinant aurora-A kinase	B	COc1ccc(NC(=O)C2=C(C)Nc3nc4ccccc4n3C2c2ccco2)cc1		CHEMBL1277293	=	IC50	nM	7580.0	CHEMBL4722	Homo sapiens	IC50	uM	7.58
	3559109	CHEMBL1286524	Inhibition of human purified recombinant aurora-A kinase	B	CC1=C(C(=O)Nc2ccc(F)cc2)C(c2ccco2)c2c[nH]nc2N1		CHEMBL1277199	=	IC50	nM	8100.0	CHEMBL4722	Homo sapiens	IC50	uM	8.1
	3559111	CHEMBL1286524	Inhibition of human purified recombinant aurora-A kinase	B	COc1ccc(NC(=O)C2=C(C)Nc3n[nH]cc3C2c2ccco2)cc1		CHEMBL1277017	=	IC50	nM	9250.0	CHEMBL4722	Homo sapiens	IC50	uM	9.25
	3559120	CHEMBL1286524	Inhibition of human purified recombinant aurora-A kinase	B	CC1=C(C(=O)Nc2ccc(F)c(Cl)c2)C(c2ccco2)c2c[nH]nc2N1		CHEMBL1277198	=	IC50	nM	15000.0	CHEMBL4722	Homo sapiens	IC50	uM	15.0
	3559131	CHEMBL1286524	Inhibition of human purified recombinant aurora-A kinase	B	CC1=C(C(=O)Nc2ccc(Cl)cc2)C(c2ccccc2)C2=C(CC(C)(C)CC2=O)N1		CHEMBL1277474	=	IC50	nM	40340.0	CHEMBL4722	Homo sapiens	IC50	uM	40.34
	3559135	CHEMBL1286524	Inhibition of human purified recombinant aurora-A kinase	B	COc1ccc(NC(=O)C2=C(C)Nc3n[nH]cc3C2c2ccccc2)cc1		CHEMBL1278096	>	IC50	nM	50000.0	CHEMBL4722	Homo sapiens	IC50	uM	50.0
	3559136	CHEMBL1286524	Inhibition of human purified recombinant aurora-A kinase	B	CC1=C(C(=O)Nc2ccc([N+](=O)[O-])cc2)C(c2ccccc2)c2c[nH]nc2N1		CHEMBL1278186	>	IC50	nM	50000.0	CHEMBL4722	Homo sapiens	IC50	uM	50.0
	3559137	CHEMBL1286524	Inhibition of human purified recombinant aurora-A kinase	B	CC1=C(C(=O)Nc2ccc(C(F)(F)F)cc2)C(c2ccccc2)c2c[nH]nc2N1		CHEMBL1278187	>	IC50	nM	50000.0	CHEMBL4722	Homo sapiens	IC50	uM	50.0
	3559138	CHEMBL1286524	Inhibition of human purified recombinant aurora-A kinase	B	CC1=C(C(=O)Nc2ccc(F)c(Cl)c2)C(c2ccccc2)c2c[nH]nc2N1		CHEMBL1276844	>	IC50	nM	50000.0	CHEMBL4722	Homo sapiens	IC50	uM	50.0
	3559139	CHEMBL1286524	Inhibition of human purified recombinant aurora-A kinase	B	CC1=C(C(=O)Nc2ccc(F)cc2)C(c2ccccc2)c2c[nH]nc2N1		CHEMBL1276845	>	IC50	nM	50000.0	CHEMBL4722	Homo sapiens	IC50	uM	50.0
	3559140	CHEMBL1286524	Inhibition of human purified recombinant aurora-A kinase	B	COc1ccc(NC(=O)C2=C(C)Nc3n[nH]cc3C2c2cccs2)cc1		CHEMBL1276930	>	IC50	nM	50000.0	CHEMBL4722	Homo sapiens	IC50	uM	50.0
	3559141	CHEMBL1286524	Inhibition of human purified recombinant aurora-A kinase	B	CC1=C(C(=O)Nc2ccc([N+](=O)[O-])cc2)C(c2cccs2)c2c[nH]nc2N1		CHEMBL1276931	>	IC50	nM	50000.0	CHEMBL4722	Homo sapiens	IC50	uM	50.0
	3559142	CHEMBL1286524	Inhibition of human purified recombinant aurora-A kinase	B	CC1=C(C(=O)Nc2ccc(C(F)(F)F)cc2)C(c2cccs2)c2c[nH]nc2N1		CHEMBL1277016	>	IC50	nM	50000.0	CHEMBL4722	Homo sapiens	IC50	uM	50.0
	3559143	CHEMBL1286524	Inhibition of human purified recombinant aurora-A kinase	B	CC1=C(C(=O)Nc2ccc(F)c(Cl)c2)C(c2cccs2)c2c[nH]nc2N1		CHEMBL1278004	>	IC50	nM	50000.0	CHEMBL4722	Homo sapiens	IC50	uM	50.0
	3559144	CHEMBL1286524	Inhibition of human purified recombinant aurora-A kinase	B	CC1=C(C(=O)Nc2ccc([N+](=O)[O-])cc2)C(c2ccco2)c2c[nH]nc2N1		CHEMBL1277110	>	IC50	nM	50000.0	CHEMBL4722	Homo sapiens	IC50	uM	50.0
	3559145	CHEMBL1286524	Inhibition of human purified recombinant aurora-A kinase	B	CC1=C(C(=O)Nc2ccc(C(F)(F)F)cc2)C(c2ccco2)c2c[nH]nc2N1		CHEMBL1277111	>	IC50	nM	50000.0	CHEMBL4722	Homo sapiens	IC50	uM	50.0
	3559146	CHEMBL1286524	Inhibition of human purified recombinant aurora-A kinase	B	CCOC(=O)C1=C(C)NC(=S)NC1c1cccc(O)c1		CHEMBL236789	>	IC50	nM	50000.0	CHEMBL4722	Homo sapiens	IC50	uM	50.0
	3559147	CHEMBL1286524	Inhibition of human purified recombinant aurora-A kinase	B	CCC(c1nc2cc(Cl)ccc2c(=O)n1Cc1ccccc1)N(CCCN(C)C)C(=O)c1ccc(Br)cc1		CHEMBL1164552	>	IC50	nM	50000.0	CHEMBL4722	Homo sapiens	IC50	uM	50.0
Active	3564127	CHEMBL1285297	Inhibition of aurora A at 0.1 uM	B	NC(=O)c1cccc(CNC(=O)c2cc3c(c4c2[nH]c2ccccc24)C(=O)NC3=O)c1		CHEMBL1278026		Inhibition	%		CHEMBL4722	Homo sapiens	INH		
	3590780	CHEMBL1292143	Inhibition of human Aurora A	B	COc1ccc(CNc2ccnc3oc4ccccc4c23)cc1	Outside typical range	CHEMBL1290072	>	Ki	nM	1000000.0	CHEMBL4722	Homo sapiens	Ki	uM	1000.0
	3601419	CHEMBL1292327	Inhibition of Aurora A	B	COc1ccc2cc(-c3n[nH]c4cccnc34)[nH]c2c1		CHEMBL1288582	=	IC50	nM	190.0	CHEMBL4722	Homo sapiens	IC50	uM	0.19
	3603132	CHEMBL1291229	Inhibition of AURKA at 10 uM	B	O=C(Cc1cccc2cnccc12)Nc1scnc1-c1cscn1		CHEMBL1288160	=	Inihibition	%	27.0	CHEMBL4722	Homo sapiens	Inihibition	%	27.0
	5120064	CHEMBL1648790	Inhibition of Aurora A at 10 uM after 60 mins by TR-FRET assay	B	O=c1n(Cc2ccccn2)nc(-c2ccnc(NC3CCOCC3)c2)n1-c1ccc2ccccc2c1		CHEMBL1644615	=	Inhibition	%	2.0	CHEMBL4722	Homo sapiens	INH	%	2.0
	5120153	CHEMBL1648790	Inhibition of Aurora A at 10 uM after 60 mins by TR-FRET assay	B	O=c1[nH]nc(-c2ccnc(NC3CCCOC3)c2)n1-c1ccc2ccccc2c1		CHEMBL1644619	=	Inhibition	%	10.0	CHEMBL4722	Homo sapiens	INH	%	10.0
	5120190	CHEMBL1648790	Inhibition of Aurora A at 10 uM after 60 mins by TR-FRET assay	B	O=c1[nH]nc(-c2ccnc(NC3CCCCC3)c2)n1-c1ccc2ccccc2c1		CHEMBL1644618	=	Inhibition	%	17.0	CHEMBL4722	Homo sapiens	INH	%	17.0
	5120214	CHEMBL1648790	Inhibition of Aurora A at 10 uM after 60 mins by TR-FRET assay	B	O=c1[nH]nc(-c2ccnc(NC3CCOCC3)c2)n1-c1ccc2ccccc2c1		CHEMBL1644620	=	Inhibition	%	30.0	CHEMBL4722	Homo sapiens	INH	%	30.0
	5120305	CHEMBL1648177	Inhibition of human Aurora-A at 10 uM after 60 mins by TR-FRET assay	B	S=c1[nH]nc(-c2ccncc2)n1-c1ccc2ccccc2c1		CHEMBL1644616	=	Inhibition	%	99.0	CHEMBL4722	Homo sapiens	INH	%	99.0
	5120827	CHEMBL1646811	Inhibition of aurora A at 10 uM	B	CC(C)(C)c1cc(C(=O)O)c(NC(=O)Nc2ccc3[nH]ncc3c2)s1		CHEMBL1641799	=	Inhibition	%	0.0	CHEMBL4722	Homo sapiens	INH	%	0.0
	5123786	CHEMBL1649026	Inhibition of AURKA at 1 uM	B	CCN1C(=O)CCC(C)(C)c2ccc(Nc3ncc(Cl)c(Nc4c(F)cccc4C(=O)NC)n3)cc21		CHEMBL1644812	=	Inhibition	%	97.0	CHEMBL4722	Homo sapiens	INH	%	97.0
	5128726	CHEMBL1647308	Inhibition of human recombinant His-tagged Aurora A kinase expressed in insect cells	B	COc1ccc(-c2cc(C(=O)Nc3ccc(C)cc3C)c3c(-c4ccccc4)[nH]nc3n2)cc1OC		CHEMBL1643137	>	IC50	nM	100000.0	CHEMBL4722	Homo sapiens	IC50	uM	100.0
Not Active	5128727	CHEMBL1647308	Inhibition of human recombinant His-tagged Aurora A kinase expressed in insect cells	B	COc1ccc(N(CC(=O)Nc2cc(Cl)ccc2C)S(=O)(=O)c2c(C)n[nH]c2C)cc1		CHEMBL1464421		IC50			CHEMBL4722	Homo sapiens	IC50		
Not Active	5128728	CHEMBL1647308	Inhibition of human recombinant His-tagged Aurora A kinase expressed in insect cells	B	Cc1ccc(Nc2cc(Nc3ccc(NS(=O)(=O)c4ccccc4F)cc3)nc(C)n2)cc1		CHEMBL1643140		IC50			CHEMBL4722	Homo sapiens	IC50		
	5128729	CHEMBL1647308	Inhibition of human recombinant His-tagged Aurora A kinase expressed in insect cells	B	CC(=O)Nc1cccc(NC(=O)C(=O)NCCc2sc(-c3ccc(Cl)cc3)nc2C)c1		CHEMBL1643141	>	IC50	nM	100000.0	CHEMBL4722	Homo sapiens	IC50	uM	100.0
	5128730	CHEMBL1647308	Inhibition of human recombinant His-tagged Aurora A kinase expressed in insect cells	B	COc1ccc2cc(C(=O)C3CCC(C(C)C(=O)NCCC4=CCCCC4)CC3)[nH]c2c1		CHEMBL1643142	=	IC50	nM	86150.0	CHEMBL4722	Homo sapiens	IC50	uM	86.15
	5128731	CHEMBL1647308	Inhibition of human recombinant His-tagged Aurora A kinase expressed in insect cells	B	COc1ccc(OCC(O)Cn2c(N/N=C/c3ccccc3O)nc3c2c(=O)[nH]c(=O)n3C)cc1		CHEMBL1643143	=	IC50	nM	18400.0	CHEMBL4722	Homo sapiens	IC50	uM	18.4
	5128732	CHEMBL1647308	Inhibition of human recombinant His-tagged Aurora A kinase expressed in insect cells	B	CCOc1ccc2nc(Nc3nc(O)c4ccccc4n3)nc(C)c2c1		CHEMBL1643144	=	IC50	nM	16720.0	CHEMBL4722	Homo sapiens	IC50	uM	16.72
	5128733	CHEMBL1647308	Inhibition of human recombinant His-tagged Aurora A kinase expressed in insect cells	B	Cc1ccc(NC(=O)C(Cc2ccc(O)cc2)NC(=O)c2ccccc2N)cc1		CHEMBL1643145	=	IC50	nM	11940.0	CHEMBL4722	Homo sapiens	IC50	uM	11.94
Not Active	5128734	CHEMBL1647308	Inhibition of human recombinant His-tagged Aurora A kinase expressed in insect cells	B	CCOc1ccc2nc(NC3=NC(=O)CC(c4ccc(OC)cc4)N3)nc(C)c2c1		CHEMBL1576310		IC50			CHEMBL4722	Homo sapiens	IC50		
	5128735	CHEMBL1647308	Inhibition of human recombinant His-tagged Aurora A kinase expressed in insect cells	B	CCOc1ccc(NC(=O)Cn2c(Nc3ccc(OCC)cc3)nc3c2c(=O)[nH]c(=O)n3C)cc1		CHEMBL1643146	=	IC50	nM	98700.0	CHEMBL4722	Homo sapiens	IC50	uM	98.7
	5128736	CHEMBL1647308	Inhibition of human recombinant His-tagged Aurora A kinase expressed in insect cells	B	COc1ccc(C(=O)Nc2ccccc2C(=O)NC(Cc2ccc(O)cc2)C(=O)Nc2ccc(C)cc2C)cc1		CHEMBL1643147	=	IC50	nM	5090.0	CHEMBL4722	Homo sapiens	IC50	uM	5.09
	5128737	CHEMBL1647308	Inhibition of human recombinant His-tagged Aurora A kinase expressed in insect cells	B	COc1ccc2sc(SCC(=O)Nc3ncc(Br)s3)nc2c1		CHEMBL1643148	>	IC50	nM	100000.0	CHEMBL4722	Homo sapiens	IC50	uM	100.0
Not Active	5128738	CHEMBL1647308	Inhibition of human recombinant His-tagged Aurora A kinase expressed in insect cells	B	CCOc1ccc(NC(=S)N(CCN(CC)CC)Cc2cc3cc4c(cc3[nH]c2=O)OCCO4)cc1		CHEMBL1643149		IC50			CHEMBL4722	Homo sapiens	IC50		
Not Active	5128739	CHEMBL1647308	Inhibition of human recombinant His-tagged Aurora A kinase expressed in insect cells	B	CCOc1ccc2cc(CNc3cc(OC)cc(OC)c3)c(=O)[nH]c2c1		CHEMBL1643150		IC50			CHEMBL4722	Homo sapiens	IC50		
Not Active	5128740	CHEMBL1647308	Inhibition of human recombinant His-tagged Aurora A kinase expressed in insect cells	B	CCCOc1ccc(CNC(=O)c2[nH]c3cc(C)ccc3c2Sc2ccccc2)cc1		CHEMBL1643151		IC50			CHEMBL4722	Homo sapiens	IC50		
	5128741	CHEMBL1647308	Inhibition of human recombinant His-tagged Aurora A kinase expressed in insect cells	B	O=C(c1cccc(Cl)c1Cl)N1CCN(Cc2cccc(Nc3nccs3)c2)CC1		CHEMBL1643135	=	IC50	nM	0.5	CHEMBL4722	Homo sapiens	IC50	uM	0.0005
	5128742	CHEMBL1647308	Inhibition of human recombinant His-tagged Aurora A kinase expressed in insect cells	B	O=C(O)c1cccc(Nc2ncc3ccn(C4CCCCC4)c3n2)c1		CHEMBL1643136	=	IC50	nM	0.6	CHEMBL4722	Homo sapiens	IC50	uM	0.0006
	5128743	CHEMBL1647308	Inhibition of human recombinant His-tagged Aurora A kinase expressed in insect cells	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	IC50	nM	0.7	CHEMBL4722	Homo sapiens	IC50	uM	0.0007
	5128744	CHEMBL1647308	Inhibition of human recombinant His-tagged Aurora A kinase expressed in insect cells	B	O=C(c1cccc(C(F)(F)F)c1F)N1CCN(Cc2cccc(Nc3cc[nH]n3)n2)CC1		CHEMBL1643138	=	IC50	nM	0.9	CHEMBL4722	Homo sapiens	IC50	uM	0.0009
	5128745	CHEMBL1647308	Inhibition of human recombinant His-tagged Aurora A kinase expressed in insect cells	B	CC(C)(C)c1ccc(C(=O)Nc2n[nH]c3c2CN(C(=O)Cc2cccs2)C3)cc1		CHEMBL484007	=	IC50	nM	5.0	CHEMBL4722	Homo sapiens	IC50	uM	0.005
	5128746	CHEMBL1647308	Inhibition of human recombinant His-tagged Aurora A kinase expressed in insect cells	B	Cc1ccc(-c2nnc(Nc3ccc(Oc4ncccc4-c4c[nH]nc4N)cc3)c3ccccc23)cc1		CHEMBL1643139	=	IC50	nM	60.0	CHEMBL4722	Homo sapiens	IC50	uM	0.06
	5133676	CHEMBL1648736	Inhibition of aurora A assessed as residual activity at 10 uM	B	CN(C)C/C=C/C(=O)Nc1ccc2c(C#N)cnc(Nc3cccc(Br)c3)c2c1		CHEMBL1641990	=	Activity	%	79.0	CHEMBL4722	Homo sapiens	Activity	%	79.0
	5133771	CHEMBL1648736	Inhibition of aurora A assessed as residual activity at 10 uM	B	CN(C)CCCC(=O)Nc1ccc2c(C#N)cnc(Nc3cccc(Br)c3)c2c1		CHEMBL1641989	=	Activity	%	94.0	CHEMBL4722	Homo sapiens	Activity	%	94.0
	5133900	CHEMBL1648736	Inhibition of aurora A assessed as residual activity at 10 uM	B	CN1CCN(CCC(=O)Nc2ccc3c(C#N)cnc(Nc4cccc(Br)c4)c3c2)CC1		CHEMBL1641992	=	Activity	%	80.0	CHEMBL4722	Homo sapiens	Activity	%	80.0
	5139737	CHEMBL1648790	Inhibition of Aurora A at 10 uM after 60 mins by TR-FRET assay	B	O=c1n(Cc2ccncc2)nc(-c2ccnc(NC3CCCCC3)c2)n1-c1ccc2ccccc2c1		CHEMBL1644642	=	Inhibition	%	-5.0	CHEMBL4722	Homo sapiens	INH	%	-5.0
	5139768	CHEMBL1648790	Inhibition of Aurora A at 10 uM after 60 mins by TR-FRET assay	B	O=c1n(C2CCOCC2)nc(-c2ccnc(NC3CCCCC3)c2)n1-c1ccc2ccccc2c1		CHEMBL1644639	=	Inhibition	%	0.0	CHEMBL4722	Homo sapiens	INH	%	0.0
	5140519	CHEMBL1646075	Inhibition of aurora A at 1 uM	B	CC(C)(C)c1cc(C(=O)O)c(NC(=O)Nc2ccc3[nH]ncc3c2)s1		CHEMBL1641799	=	Inhibition	%	0.0	CHEMBL4722	Homo sapiens	INH	%	0.0
	5142671	CHEMBL1656569	Inhibition of Aurora A	B	CCN(Cc1cc(Nc2nc(C)cn3c(-c4cn[nH]c4)cnc23)sn1)C(C)(C)CO.Cl		CHEMBL1650533	<=	IC50	nM	4.0	CHEMBL4722	Homo sapiens	IC50	nM	4.0
	5142672	CHEMBL1656569	Inhibition of Aurora A	B	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2cc(CN(CC(F)F)C(C)(C)CO)ns2)n1.Cl		CHEMBL1650534	<=	IC50	nM	4.0	CHEMBL4722	Homo sapiens	IC50	nM	4.0
	5142673	CHEMBL1656569	Inhibition of Aurora A	B	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2cc(CN(CC(F)(F)F)C(C)(C)CO)ns2)n1.Cl		CHEMBL1650535	<=	IC50	nM	4.0	CHEMBL4722	Homo sapiens	IC50	nM	4.0
	5142674	CHEMBL1656569	Inhibition of Aurora A	B	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2cc(CN3CCCCC3)ns2)n1.Cl		CHEMBL1650536	<=	IC50	nM	4.0	CHEMBL4722	Homo sapiens	IC50	nM	4.0
	5142675	CHEMBL1656569	Inhibition of Aurora A	B	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2cc(CN3CCC(F)CC3)ns2)n1.Cl		CHEMBL1650537	<=	IC50	nM	4.0	CHEMBL4722	Homo sapiens	IC50	nM	4.0
	5142676	CHEMBL1656569	Inhibition of Aurora A	B	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2cc(CN3CCC(F)(F)CC3)ns2)n1.Cl		CHEMBL1650538	<=	IC50	nM	4.0	CHEMBL4722	Homo sapiens	IC50	nM	4.0
	5142677	CHEMBL1656569	Inhibition of Aurora A	B	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2cc(CN3CCCC(F)C3)ns2)n1.Cl		CHEMBL1650539	<=	IC50	nM	4.0	CHEMBL4722	Homo sapiens	IC50	nM	4.0
	5142678	CHEMBL1656569	Inhibition of Aurora A	B	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2cc(CN3CCCC(F)(F)C3)ns2)n1.Cl		CHEMBL1650540	<=	IC50	nM	4.0	CHEMBL4722	Homo sapiens	IC50	nM	4.0
	5142679	CHEMBL1656569	Inhibition of Aurora A	B	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2cc(CN3CCC(C(F)(F)F)CC3)ns2)n1.Cl		CHEMBL1650541	<=	IC50	nM	4.0	CHEMBL4722	Homo sapiens	IC50	nM	4.0
	5142680	CHEMBL1656569	Inhibition of Aurora A	B	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2cc(CN3CCCC3)ns2)n1.Cl		CHEMBL1650542	<=	IC50	nM	4.0	CHEMBL4722	Homo sapiens	IC50	nM	4.0
	5142681	CHEMBL1656569	Inhibition of Aurora A	B	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2cc(CN3CC[C@H](F)C3)ns2)n1.Cl		CHEMBL1650543	<=	IC50	nM	4.0	CHEMBL4722	Homo sapiens	IC50	nM	4.0
	5142682	CHEMBL1656569	Inhibition of Aurora A	B	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2cc(CN3CC[C@@H](F)C3)ns2)n1.Cl		CHEMBL1650544	<=	IC50	nM	4.0	CHEMBL4722	Homo sapiens	IC50	nM	4.0
	5142683	CHEMBL1656569	Inhibition of Aurora A	B	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2cc(CN3CCC(F)(F)C3)ns2)n1.Cl		CHEMBL1650545	<=	IC50	nM	4.0	CHEMBL4722	Homo sapiens	IC50	nM	4.0
	5142684	CHEMBL1656569	Inhibition of Aurora A	B	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2cc(CN3CC(F)(F)C(F)(F)C3)ns2)n1.Cl		CHEMBL1650546	<=	IC50	nM	4.0	CHEMBL4722	Homo sapiens	IC50	nM	4.0
	5142685	CHEMBL1656569	Inhibition of Aurora A	B	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2cc(CN3CC(F)C3)ns2)n1.O=C(O)C(F)(F)F		CHEMBL1650547	<=	IC50	nM	4.0	CHEMBL4722	Homo sapiens	IC50	nM	4.0
	5142686	CHEMBL1656569	Inhibition of Aurora A	B	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2cc(CN3CC(F)(F)C3)ns2)n1.O=C(O)C(F)(F)F		CHEMBL1650548	<=	IC50	nM	4.0	CHEMBL4722	Homo sapiens	IC50	nM	4.0
	5142687	CHEMBL1656569	Inhibition of Aurora A	B	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2cc(CNCCC(F)(F)F)ns2)n1.Cl		CHEMBL1650549	<=	IC50	nM	4.0	CHEMBL4722	Homo sapiens	IC50	nM	4.0
	5142688	CHEMBL1656569	Inhibition of Aurora A	B	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2cc(CNCC(F)(F)C(F)(F)F)ns2)n1.Cl		CHEMBL1650550	<=	IC50	nM	4.0	CHEMBL4722	Homo sapiens	IC50	nM	4.0
	5143781	CHEMBL1656569	Inhibition of Aurora A	B	Cl.[2H]C([2H])(c1cc(Nc2nc(C)cn3c(-c4cn[nH]c4)cnc23)sn1)N1CCC(F)(F)C1		CHEMBL1650551	<=	IC50	nM	4.0	CHEMBL4722	Homo sapiens	IC50	nM	4.0
	5150965	CHEMBL1656337	Inhibition of Aurora A by ELISA	B	Cc1cc(Nc2nn(Cc3ccc(F)cc3)c(=O)c3ccccc23)n[nH]1		CHEMBL1651476	=	IC50	nM	14.0	CHEMBL4722	Homo sapiens	IC50	uM	0.014
	5150966	CHEMBL1656337	Inhibition of Aurora A by ELISA	B	Cc1cc(Nc2nn(Cc3cccnc3)c(=O)c3ccccc23)n[nH]1		CHEMBL1651482	=	IC50	nM	17.0	CHEMBL4722	Homo sapiens	IC50	uM	0.017
	5150967	CHEMBL1656337	Inhibition of Aurora A by ELISA	B	Cc1ccc(-n2nc(Nc3cc(C)[nH]n3)c3ccccc3c2=O)cc1		CHEMBL1651470	=	IC50	nM	23.0	CHEMBL4722	Homo sapiens	IC50	uM	0.023
	5150968	CHEMBL1656337	Inhibition of Aurora A by ELISA	B	Cc1cccc(-n2nc(Nc3cc(C)[nH]n3)c3ccccc3c2=O)c1		CHEMBL1651471	=	IC50	nM	24.0	CHEMBL4722	Homo sapiens	IC50	uM	0.024
	5150969	CHEMBL1656337	Inhibition of Aurora A by ELISA	B	Cc1cc(Nc2nn(Cc3cc(F)ccc3F)c(=O)c3ccccc23)n[nH]1		CHEMBL516231	=	IC50	nM	25.0	CHEMBL4722	Homo sapiens	IC50	uM	0.025
	5150970	CHEMBL1656337	Inhibition of Aurora A by ELISA	B	COc1ccc(-n2nc(Nc3cc(C)[nH]n3)c3ccccc3c2=O)cc1		CHEMBL1651469	=	IC50	nM	29.0	CHEMBL4722	Homo sapiens	IC50	uM	0.029
	5150971	CHEMBL1656337	Inhibition of Aurora A by ELISA	B	Cc1cc(Nc2nn(-c3ccccc3)c(=O)c3ccccc23)n[nH]1		CHEMBL1615165	=	IC50	nM	31.0	CHEMBL4722	Homo sapiens	IC50	uM	0.031
	5150972	CHEMBL1656337	Inhibition of Aurora A by ELISA	B	COc1ccc(Cn2nc(Nc3cc(C)[nH]n3)c3ccccc3c2=O)cc1		CHEMBL1651478	=	IC50	nM	32.0	CHEMBL4722	Homo sapiens	IC50	uM	0.032
	5150973	CHEMBL1656337	Inhibition of Aurora A by ELISA	B	Cc1cc(Nc2nn(C(C)C)c(=O)c3ccccc23)n[nH]1		CHEMBL1651489	=	IC50	nM	35.0	CHEMBL4722	Homo sapiens	IC50	uM	0.035
	5150974	CHEMBL1656337	Inhibition of Aurora A by ELISA	B	COc1cccc(Cn2nc(Nc3cc(C)[nH]n3)c3ccccc3c2=O)c1		CHEMBL1651479	=	IC50	nM	36.0	CHEMBL4722	Homo sapiens	IC50	uM	0.036
	5150975	CHEMBL1656337	Inhibition of Aurora A by ELISA	B	Cc1cc(Nc2nn(-c3ccc(F)cc3)c(=O)c3ccccc23)n[nH]1		CHEMBL1651473	=	IC50	nM	37.0	CHEMBL4722	Homo sapiens	IC50	uM	0.037
	5150976	CHEMBL1656337	Inhibition of Aurora A by ELISA	B	Cc1cc(Nc2nn(Cc3cc(F)cc(F)c3)c(=O)c3ccccc23)n[nH]1		CHEMBL1651462	=	IC50	nM	49.0	CHEMBL4722	Homo sapiens	IC50	uM	0.049
	5150977	CHEMBL1656337	Inhibition of Aurora A by ELISA	B	Cc1cc(Nc2nn(Cc3ccc(S(C)(=O)=O)cc3)c(=O)c3ccccc23)n[nH]1		CHEMBL1651477	=	IC50	nM	56.0	CHEMBL4722	Homo sapiens	IC50	uM	0.056
	5150979	CHEMBL1656337	Inhibition of Aurora A by ELISA	B	Cc1cc(Nc2nn(Cc3ccccc3)c(=O)c3ccccc23)n[nH]1		CHEMBL1651461	=	IC50	nM	65.0	CHEMBL4722	Homo sapiens	IC50	uM	0.065
	5150980	CHEMBL1656337	Inhibition of Aurora A by ELISA	B	Cc1cc(Nc2nn(CC(F)(F)F)c(=O)c3ccccc23)n[nH]1		CHEMBL470718	=	IC50	nM	66.0	CHEMBL4722	Homo sapiens	IC50	uM	0.066
	5150981	CHEMBL1656337	Inhibition of Aurora A by ELISA	B	COc1ccc(C(=O)Cn2nc(Nc3cc(C)[nH]n3)c3ccccc3c2=O)cc1		CHEMBL1651484	=	IC50	nM	67.0	CHEMBL4722	Homo sapiens	IC50	uM	0.067
	5150982	CHEMBL1656337	Inhibition of Aurora A by ELISA	B	Cc1cc(Nc2nn(CC(=O)c3ccccc3)c(=O)c3ccccc23)n[nH]1		CHEMBL474651	=	IC50	nM	71.0	CHEMBL4722	Homo sapiens	IC50	uM	0.071
	5150983	CHEMBL1656337	Inhibition of Aurora A by ELISA	B	Cc1cc(Nc2nn(-c3ccc(Cl)cc3)c(=O)c3ccccc23)n[nH]1		CHEMBL452355	=	IC50	nM	93.0	CHEMBL4722	Homo sapiens	IC50	uM	0.093
	5150984	CHEMBL1656337	Inhibition of Aurora A by ELISA	B	CC(=O)Nc1ccc(Cn2nc(Nc3cc(C)[nH]n3)c3ccccc3c2=O)cc1		CHEMBL1651480	=	IC50	nM	93.0	CHEMBL4722	Homo sapiens	IC50	uM	0.093
	5150985	CHEMBL1656337	Inhibition of Aurora A by ELISA	B	COc1cccc(C(=O)Cn2nc(Nc3cc(C)[nH]n3)c3ccccc3c2=O)c1		CHEMBL1651485	=	IC50	nM	100.0	CHEMBL4722	Homo sapiens	IC50	uM	0.1
	5150986	CHEMBL1656337	Inhibition of Aurora A by ELISA	B	Cc1cc(Nc2nn(Cc3ccc([N+](=O)[O-])cc3)c(=O)c3ccccc23)n[nH]1		CHEMBL1651483	=	IC50	nM	109.0	CHEMBL4722	Homo sapiens	IC50	uM	0.109
	5150987	CHEMBL1656337	Inhibition of Aurora A by ELISA	B	Cc1cc(Nc2nn(CC(C)C)c(=O)c3ccccc23)n[nH]1		CHEMBL1651490	=	IC50	nM	115.0	CHEMBL4722	Homo sapiens	IC50	uM	0.115
	5150988	CHEMBL1656337	Inhibition of Aurora A by ELISA	B	Cc1cc(Nc2nn(Cc3csc(C)n3)c(=O)c3ccccc23)n[nH]1		CHEMBL1651487	=	IC50	nM	120.0	CHEMBL4722	Homo sapiens	IC50	uM	0.12
	5150990	CHEMBL1656337	Inhibition of Aurora A by ELISA	B	Cc1cc(Nc2nn(-c3ccc(C(C)(C)C)cc3)c(=O)c3ccccc23)n[nH]1		CHEMBL1651472	=	IC50	nM	240.0	CHEMBL4722	Homo sapiens	IC50	uM	0.24
	5150991	CHEMBL1656337	Inhibition of Aurora A by ELISA	B	Cc1cc(Nc2nn(Cc3ccncc3)c(=O)c3ccccc23)n[nH]1		CHEMBL1651481	=	IC50	nM	270.0	CHEMBL4722	Homo sapiens	IC50	uM	0.27
	5150992	CHEMBL1656337	Inhibition of Aurora A by ELISA	B	Cc1cc(Nc2nn(C)c(=O)c3ccccc23)n[nH]1		CHEMBL1651488	=	IC50	nM	270.0	CHEMBL4722	Homo sapiens	IC50	uM	0.27
	5150995	CHEMBL1656337	Inhibition of Aurora A by ELISA	B	CC(=O)Nc1ccc(Cn2nc(Nc3cc[nH]n3)c3ccccc3c2=O)cc1		CHEMBL1651491	=	IC50	nM	550.0	CHEMBL4722	Homo sapiens	IC50	uM	0.55
	5150997	CHEMBL1656337	Inhibition of Aurora A by ELISA	B	Cc1cc(Nc2n[nH]c(=O)c3ccccc23)n[nH]1		CHEMBL1651468	=	IC50	nM	650.0	CHEMBL4722	Homo sapiens	IC50	uM	0.65
	5151000	CHEMBL1656337	Inhibition of Aurora A by ELISA	B	Cc1cc(Nc2nn(CC(=O)c3ccc(C(F)(F)F)cc3)c(=O)c3ccccc23)n[nH]1		CHEMBL1651486	=	IC50	nM	720.0	CHEMBL4722	Homo sapiens	IC50	uM	0.72
	5151005	CHEMBL1656337	Inhibition of Aurora A by ELISA	B	Cc1ccc(-n2nc(Nc3cc[nH]n3)c3ccccc3c2=O)cc1		CHEMBL1651474	=	IC50	nM	1000.0	CHEMBL4722	Homo sapiens	IC50	uM	1.0
	5151049	CHEMBL1656337	Inhibition of Aurora A by ELISA	B	O=c1c2ccccc2c(Nc2n[nH]c3ccccc23)nn1-c1ccccc1		CHEMBL1651475	=	IC50	nM	14000.0	CHEMBL4722	Homo sapiens	IC50	uM	14.0
	5152472	CHEMBL1656383	Inhibition of Aurora A kinase by Caliper mobility shift assay	B	COc1cc(O)c2c(c1)CCC[C@H](O)[C@H](O)C(=O)/C=C\C[C@H](C)OC2=O		CHEMBL2012519	>	IC50	nM	10000.0	CHEMBL4722	Homo sapiens	IC50	uM	10.0
	5152497	CHEMBL1656383	Inhibition of Aurora A kinase by Caliper mobility shift assay	B	COc1cc(O)c2c(c1)CCC[C@H](O)CC(=O)/C=C\C[C@H](C)OC2=O		CHEMBL1651521	>	IC50	nM	10000.0	CHEMBL4722	Homo sapiens	IC50	uM	10.0
	5179827	CHEMBL1664805	Inhibition of Aurora A	B	O=C(CN1CCN(c2c(Br)cnc3[nH]cnc23)CC1)Nc1nccs1		CHEMBL1086219	=	IC50	nM	81.0	CHEMBL4722	Homo sapiens	IC50	uM	0.081
	5179828	CHEMBL1664805	Inhibition of Aurora A	B	CN(C)c1ccc(-c2nc3c(N4CCN(CC(=O)Nc5nccs5)CC4)c(Br)cnc3[nH]2)cc1		CHEMBL1086309	=	IC50	nM	55.0	CHEMBL4722	Homo sapiens	IC50	uM	0.055
	5179829	CHEMBL1664805	Inhibition of Aurora A	B	CN(C)c1ccc(-c2nc3c(N4CCN(CC(=O)Nc5nccs5)CC4)c(C#N)cnc3[nH]2)cc1		CHEMBL1085356	=	IC50	nM	50.0	CHEMBL4722	Homo sapiens	IC50	uM	0.05
	5179830	CHEMBL1664805	Inhibition of Aurora A	B	COc1ccc(-c2nc3c(N4CCN(CC(=O)Nc5nccs5)CC4)c(C4CC4)cnc3[nH]2)cc1		CHEMBL1085357	=	IC50	nM	53.0	CHEMBL4722	Homo sapiens	IC50	uM	0.053
	5179831	CHEMBL1664805	Inhibition of Aurora A	B	CN(C)c1ccc(-c2nc3c(N4CCN(CC(=O)Nc5nccs5)CC4)c(Cl)cnc3[nH]2)cc1		CHEMBL392525	=	IC50	nM	42.0	CHEMBL4722	Homo sapiens	IC50	uM	0.042
	5179832	CHEMBL1664805	Inhibition of Aurora A	B	CN(C)Cc1ccc(-c2nc3c(N4CCN(CC(=O)Nc5nccs5)CC4)c(Br)cnc3[nH]2)cc1		CHEMBL1082507	=	IC50	nM	16.0	CHEMBL4722	Homo sapiens	IC50	uM	0.016
	5179833	CHEMBL1664805	Inhibition of Aurora A	B	COc1ccc(-c2nc3c(N4CCN(CC(=O)Nc5nccs5)CC4)c(Cl)cnc3[nH]2)cc1		CHEMBL1082831	=	IC50	nM	52.0	CHEMBL4722	Homo sapiens	IC50	uM	0.052
	5179834	CHEMBL1664805	Inhibition of Aurora A	B	O=C(CN1CCN(c2c(Cl)cnc3[nH]c(-c4ccc(CN5CCOCC5)cc4)nc23)CC1)Nc1nccs1		CHEMBL1085848	=	IC50	nM	3.0	CHEMBL4722	Homo sapiens	IC50	uM	0.003
	5179835	CHEMBL1664805	Inhibition of Aurora A	B	CN(C)c1ccc(-c2nc3c(N4CCN(CC(=O)Nc5ccccc5)CC4)c(Cl)cnc3[nH]2)cc1		CHEMBL1083771	=	IC50	nM	115.0	CHEMBL4722	Homo sapiens	IC50	uM	0.115
	5179836	CHEMBL1664805	Inhibition of Aurora A	B	CN(C)c1ccc(-c2nc3c(N4CCN(CC(=O)Nc5cccnc5)CC4)c(Br)cnc3[nH]2)cc1		CHEMBL1086556	=	IC50	nM	118.0	CHEMBL4722	Homo sapiens	IC50	uM	0.118
	5179837	CHEMBL1664805	Inhibition of Aurora A	B	CN(C)c1ccc(-c2nc3c(N4CCN(CC(=O)Nc5cccc(Cl)c5)CC4)c(Cl)cnc3[nH]2)cc1		CHEMBL1086557	=	IC50	nM	75.0	CHEMBL4722	Homo sapiens	IC50	uM	0.075
	5179838	CHEMBL1664805	Inhibition of Aurora A	B	CN(C)c1ccc(-c2nc3c(N4CCN(CC(=O)Nc5ccccc5)CC4)c(Br)cnc3[nH]2)cc1		CHEMBL1651450	=	IC50	nM	277.0	CHEMBL4722	Homo sapiens	IC50	uM	0.277
	5179839	CHEMBL1664805	Inhibition of Aurora A	B	CN(C)c1ccc(-c2nc3c(N4CCN(S(=O)(=O)c5ccccc5)CC4)c(Br)cnc3[nH]2)cc1		CHEMBL1085134	=	IC50	nM	178.0	CHEMBL4722	Homo sapiens	IC50	uM	0.178
	5179840	CHEMBL1664805	Inhibition of Aurora A	B	CN(C)c1ccc(-c2nc3c(N4CCN(c5ccccc5)CC4)c(Br)cnc3[nH]2)cc1		CHEMBL1085135	=	IC50	nM	258.0	CHEMBL4722	Homo sapiens	IC50	uM	0.258
	5179841	CHEMBL1664805	Inhibition of Aurora A	B	CC(C)CN1CCN(c2c(Br)cnc3[nH]c(-c4ccc(N(C)C)cc4)nc23)CC1		CHEMBL1085136	=	IC50	nM	210.0	CHEMBL4722	Homo sapiens	IC50	uM	0.21
	5179842	CHEMBL1664805	Inhibition of Aurora A	B	CC(c1ccncc1)N1CCN(c2c(Br)cnc3[nH]c(-c4ccc(N(C)C)cc4)nc23)CC1		CHEMBL1086581	=	IC50	nM	55.0	CHEMBL4722	Homo sapiens	IC50	uM	0.055
	5179843	CHEMBL1664805	Inhibition of Aurora A	B	CC(c1ccccc1)N1CCN(c2c(Cl)cnc3[nH]c(-c4ccc(N(C)C)cc4)nc23)CC1		CHEMBL1083490	=	IC50	nM	79.0	CHEMBL4722	Homo sapiens	IC50	uM	0.079
	5179844	CHEMBL1664805	Inhibition of Aurora A	B	COc1ccc(-c2nc3c(N4CCN(Cc5ccncc5)CC4)c(Br)cnc3[nH]2)cc1		CHEMBL1651451	=	IC50	nM	9.0	CHEMBL4722	Homo sapiens	IC50	uM	0.009
	5179845	CHEMBL1664805	Inhibition of Aurora A	B	COc1ccc(-c2nc3c(N4CCN(Cc5cncnc5)CC4)c(Br)cnc3[nH]2)cc1		CHEMBL1084859	=	IC50	nM	8.0	CHEMBL4722	Homo sapiens	IC50	uM	0.008
	5179846	CHEMBL1664805	Inhibition of Aurora A	B	COc1ccc(-c2nc3c(N4CCN(Cc5ccc(Cl)cc5)CC4)c(Br)cnc3[nH]2)cc1		CHEMBL1084067	=	IC50	nM	40.0	CHEMBL4722	Homo sapiens	IC50	uM	0.04
	5179847	CHEMBL1664805	Inhibition of Aurora A	B	COc1ccc(-c2nc3c(N4CCN(CC5CC5)CC4)c(Br)cnc3[nH]2)cc1		CHEMBL1083773	=	IC50	nM	650.0	CHEMBL4722	Homo sapiens	IC50	uM	0.65
	5179848	CHEMBL1664805	Inhibition of Aurora A	B	COc1ccc(-c2nc3c(N4CCN(Cc5cc(C)on5)CC4)c(Br)cnc3[nH]2)cc1		CHEMBL1083774	=	IC50	nM	17.0	CHEMBL4722	Homo sapiens	IC50	uM	0.017
	5179849	CHEMBL1664805	Inhibition of Aurora A	B	COc1ccc(-c2nc3c(N4CCN(Cc5coc(C(C)C)n5)CC4)c(Br)cnc3[nH]2)cc1		CHEMBL1651452	=	IC50	nM	81.0	CHEMBL4722	Homo sapiens	IC50	uM	0.081
	5179850	CHEMBL1664805	Inhibition of Aurora A	B	COc1ccc(-c2nc3c(N4CCN(Cc5nccn5C)CC4)c(Br)cnc3[nH]2)cc1		CHEMBL1084888	=	IC50	nM	32.0	CHEMBL4722	Homo sapiens	IC50	uM	0.032
	5179851	CHEMBL1664805	Inhibition of Aurora A	B	Brc1cnc2[nH]c(-c3ccc(CN4CCOCC4)cc3)nc2c1N1CCN(Cc2ccncc2)CC1		CHEMBL1651453	=	IC50	nM	5.0	CHEMBL4722	Homo sapiens	IC50	uM	0.005
	5179852	CHEMBL1664805	Inhibition of Aurora A	B	Brc1cnc2[nH]c(-c3ccc(CN4CCOCC4)cc3)nc2c1N1CCN(Cc2cncnc2)CC1		CHEMBL1084860	=	IC50	nM	6.0	CHEMBL4722	Homo sapiens	IC50	uM	0.006
	5179853	CHEMBL1664805	Inhibition of Aurora A	B	Clc1ccc(CN2CCN(c3c(Br)cnc4[nH]c(-c5ccc(CN6CCOCC6)cc5)nc34)CC2)cc1		CHEMBL1083772	=	IC50	nM	12.0	CHEMBL4722	Homo sapiens	IC50	uM	0.012
	5179854	CHEMBL1664805	Inhibition of Aurora A	B	Cc1cc(CN2CCN(c3c(Br)cnc4[nH]c(-c5ccc(CN6CCOCC6)cc5)nc34)CC2)no1		CHEMBL1084079	=	IC50	nM	2.0	CHEMBL4722	Homo sapiens	IC50	uM	0.002
	5179855	CHEMBL1664805	Inhibition of Aurora A	B	Cn1ccnc1CN1CCN(c2c(Br)cnc3[nH]c(-c4ccc(CN5CCOCC5)cc4)nc23)CC1		CHEMBL1084889	=	IC50	nM	30.0	CHEMBL4722	Homo sapiens	IC50	uM	0.03
	5179856	CHEMBL1664805	Inhibition of Aurora A	B	Brc1cnc2[nH]c(-c3ccc(CN4CCOCC4)cc3)nc2c1N1CCN(Cc2cscn2)CC1		CHEMBL1082492	=	IC50	nM	6.0	CHEMBL4722	Homo sapiens	IC50	uM	0.006
	5179857	CHEMBL1664805	Inhibition of Aurora A	B	Cc1cc(CN2CCN(c3c(Br)cnc4[nH]c(-c5ccc(CN6CCNCC6)cc5)nc34)CC2)no1		CHEMBL1085607	=	IC50	nM	10.0	CHEMBL4722	Homo sapiens	IC50	uM	0.01
	5179858	CHEMBL1664805	Inhibition of Aurora A	B	CC(=O)c1cccc(-c2ccc(-c3nc4c(N5CCN(Cc6cc(C)on6)CC5)c(Br)cnc4[nH]3)cc2)c1		CHEMBL1651454	=	IC50	nM	14.0	CHEMBL4722	Homo sapiens	IC50	uM	0.014
	5179859	CHEMBL1664805	Inhibition of Aurora A	B	Cc1cc(CN2CCN(c3c(Br)cnc4[nH]c(-c5ccc(CN)cc5)nc34)CC2)no1		CHEMBL1082597	=	IC50	nM	10.0	CHEMBL4722	Homo sapiens	IC50	uM	0.01
	5179860	CHEMBL1664805	Inhibition of Aurora A	B	Cc1cc(CN2CCN(c3c(Cl)cnc4[nH]c(-c5ccc(CN)cc5)nc34)CC2)no1		CHEMBL1085131	=	IC50	nM	55.0	CHEMBL4722	Homo sapiens	IC50	uM	0.055
	5179861	CHEMBL1664805	Inhibition of Aurora A	B	Cc1cc(CN2CCN(c3c(Br)cnc4[nH]c(-c5ccc(OCCO)cc5)nc34)CC2)no1		CHEMBL1085132	=	IC50	nM	30.0	CHEMBL4722	Homo sapiens	IC50	uM	0.03
	5179862	CHEMBL1664805	Inhibition of Aurora A	B	Cc1cc(CN2CCN(c3c(Cl)cnc4[nH]c(-c5ccc(OCCO)cc5)nc34)CC2)no1		CHEMBL1085387	=	IC50	nM	29.0	CHEMBL4722	Homo sapiens	IC50	uM	0.029
	5179863	CHEMBL1664805	Inhibition of Aurora A	B	Cc1cc(CN2CCN(c3c(Br)cnc4[nH]c(-c5ccc(N6CCNCC6)cc5)nc34)CC2)no1		CHEMBL1651455	=	IC50	nM	10.0	CHEMBL4722	Homo sapiens	IC50	uM	0.01
	5179864	CHEMBL1664805	Inhibition of Aurora A	B	Cc1cc(CN2CCN(c3c(Br)cnc4nc(-c5ccc(N6CCN(C)CC6)cc5)[nH]c34)CC2)no1		CHEMBL1236904	=	IC50	nM	15.0	CHEMBL4722	Homo sapiens	IC50	uM	0.015
	5179865	CHEMBL1664805	Inhibition of Aurora A	B	Cc1cc(CN2CCN(c3c(Cl)cnc4[nH]c(-c5ccc(N6CCN(C)CC6)cc5)nc34)CC2)no1		CHEMBL1651456	=	IC50	nM	10.0	CHEMBL4722	Homo sapiens	IC50	uM	0.01
	5179866	CHEMBL1664805	Inhibition of Aurora A	B	Cc1cc(CN2CCN(c3c(Br)cnc4[nH]c(-c5ccc(Cn6cccn6)cc5)nc34)CC2)no1		CHEMBL1651457	=	IC50	nM	10.0	CHEMBL4722	Homo sapiens	IC50	uM	0.01
	5179867	CHEMBL1664805	Inhibition of Aurora A	B	Cc1cc(CN2CCN(c3c(Cl)cnc4[nH]c(-c5ccc(Cn6cccn6)cc5)nc34)CC2)no1		CHEMBL1651458	=	IC50	nM	3.0	CHEMBL4722	Homo sapiens	IC50	uM	0.003
	5179868	CHEMBL1664805	Inhibition of Aurora A	B	CN(C)c1ccc(-c2nc3cccnc3[nH]2)cc1		CHEMBL235232	=	IC50	nM	4300.0	CHEMBL4722	Homo sapiens	IC50	uM	4.3
	5179869	CHEMBL1664805	Inhibition of Aurora A	B	CN(C)c1cccc(-c2nc3cccnc3[nH]2)c1		CHEMBL235450	=	IC50	nM	10000.0	CHEMBL4722	Homo sapiens	IC50	uM	10.0
	5179870	CHEMBL1664805	Inhibition of Aurora A	B	COc1ccc(-c2nc3cccnc3[nH]2)cc1		CHEMBL235451	=	IC50	nM	6600.0	CHEMBL4722	Homo sapiens	IC50	uM	6.6
	5179871	CHEMBL1664805	Inhibition of Aurora A	B	COc1cccc(-c2nc3cccnc3[nH]2)c1		CHEMBL235452	=	IC50	nM	16000.0	CHEMBL4722	Homo sapiens	IC50	uM	16.0
	5179872	CHEMBL1664805	Inhibition of Aurora A	B	COc1ccccc1-c1nc2ccc[nH]c-2n1		CHEMBL236937	=	IC50	nM	29000.0	CHEMBL4722	Homo sapiens	IC50	uM	29.0
	5179873	CHEMBL1664805	Inhibition of Aurora A	B	c1cnc2[nH]c(-c3ccc(N4CCCC4)cc3)nc2c1		CHEMBL236938	=	IC50	nM	4600.0	CHEMBL4722	Homo sapiens	IC50	uM	4.6
	5179874	CHEMBL1664805	Inhibition of Aurora A	B	c1ccc(-c2ccc(-c3nc4cccnc4[nH]3)cc2)nc1		CHEMBL1651459	=	IC50	nM	4400.0	CHEMBL4722	Homo sapiens	IC50	uM	4.4
	5179875	CHEMBL1664805	Inhibition of Aurora A	B	CN(C)c1ccc(-c2nc3cc(Cl)cnc3[nH]2)cc1		CHEMBL236694	=	IC50	nM	570.0	CHEMBL4722	Homo sapiens	IC50	uM	0.57
	5179876	CHEMBL1664805	Inhibition of Aurora A	B	CN(C)c1ccc(-c2nc3cc(Br)cnc3[nH]2)cc1		CHEMBL395601	=	IC50	nM	490.0	CHEMBL4722	Homo sapiens	IC50	uM	0.49
	5179877	CHEMBL1664805	Inhibition of Aurora A	B	Cc1cnc2[nH]c(-c3ccc(N(C)C)cc3)nc2c1		CHEMBL237145	=	IC50	nM	6900.0	CHEMBL4722	Homo sapiens	IC50	uM	6.9
	5179878	CHEMBL1664805	Inhibition of Aurora A	B	COc1ccc(-c2cnc3[nH]c(-c4ccc(N(C)C)cc4)nc3c2)cc1		CHEMBL395839	=	IC50	nM	20000.0	CHEMBL4722	Homo sapiens	IC50	uM	20.0
	5179879	CHEMBL1664805	Inhibition of Aurora A	B	CC(=O)c1cccc(-c2cnc3[nH]c(-c4ccc(N(C)C)cc4)nc3c2)c1		CHEMBL394674	=	IC50	nM	9000.0	CHEMBL4722	Homo sapiens	IC50	uM	9.0
	5179880	CHEMBL1664805	Inhibition of Aurora A	B	CN(C)c1ccc(-c2nc3c(Cl)c(Cl)cnc3[nH]2)cc1		CHEMBL237573	=	IC50	nM	250.0	CHEMBL4722	Homo sapiens	IC50	uM	0.25
	5179881	CHEMBL1664805	Inhibition of Aurora A	B	Cc1ccnc2[nH]c(-c3ccc(N(C)C)cc3)nc12		CHEMBL391394	=	IC50	nM	7000.0	CHEMBL4722	Homo sapiens	IC50	uM	7.0
	5179882	CHEMBL1664805	Inhibition of Aurora A	B	CN(C)c1ccc(-c2nc3c(Cl)ccnc3[nH]2)cc1		CHEMBL237369	=	IC50	nM	2400.0	CHEMBL4722	Homo sapiens	IC50	uM	2.4
	5179883	CHEMBL1664805	Inhibition of Aurora A	B	CN(C)c1ccc(-c2nc3c(N4CCN(CC(=O)Nc5nccs5)CC4)ccnc3[nH]2)cc1		CHEMBL412173	=	IC50	nM	870.0	CHEMBL4722	Homo sapiens	IC50	uM	0.87
	5179884	CHEMBL1664805	Inhibition of Aurora A	B	O=C(CN1CCN(c2c(Br)cnc3[nH]c(-c4ccccc4)nc23)CC1)Nc1nccs1		CHEMBL1082830	=	IC50	nM	81.0	CHEMBL4722	Homo sapiens	IC50	uM	0.081
	5242944	CHEMBL1685638	Inhibition of aurora-A at 0.1 uM	B	Cc1ccc2cc(-c3n[nH]c4ccc(NC5CCN(Cc6ccccc6)CC5)cc34)[nH]c2c1		CHEMBL1684543	=	Inhibition	%	34.0	CHEMBL4722	Homo sapiens	INH	%	34.0
	5243783	CHEMBL1685887	Inhibition of aurora-A at 1 uM	B	Cc1ccc2cc(-c3n[nH]c4ccc(NC5CCN(Cc6ccccc6)CC5)cc34)[nH]c2c1		CHEMBL1684543	=	Inhibition	%	-7.0	CHEMBL4722	Homo sapiens	INH	%	-7.0
	5243896	CHEMBL1685638	Inhibition of aurora-A at 0.1 uM	B	Cc1ccc2cc(-c3n[nH]c4ccc(NC5CCNC5)cc34)[nH]c2c1		CHEMBL1684654	=	Inhibition	%	5.0	CHEMBL4722	Homo sapiens	INH	%	5.0
	5244004	CHEMBL1685887	Inhibition of aurora-A at 1 uM	B	Cc1ccc2cc(-c3n[nH]c4ccc(NC5CCNC5)cc34)[nH]c2c1		CHEMBL1684654	=	Inhibition	%	0.0	CHEMBL4722	Homo sapiens	INH	%	0.0
	5244877	CHEMBL1685638	Inhibition of aurora-A at 0.1 uM	B	O=C(Cc1ccc2cc(-c3n[nH]c4cccnc34)[nH]c2c1)c1ccccc1		CHEMBL1684662	=	Inhibition	%	20.0	CHEMBL4722	Homo sapiens	INH	%	20.0
	5244985	CHEMBL1685887	Inhibition of aurora-A at 1 uM	B	O=C(Cc1ccc2cc(-c3n[nH]c4cccnc34)[nH]c2c1)c1ccccc1		CHEMBL1684662	=	Inhibition	%	2.0	CHEMBL4722	Homo sapiens	INH	%	2.0
	5245136	CHEMBL1685638	Inhibition of aurora-A at 0.1 uM	B	Cc1ccc2cc(-c3n[nH]c4ccc(NS(=O)(=O)c5ncn(C)c5C)cc34)[nH]c2c1		CHEMBL1684525	=	Inhibition	%	24.0	CHEMBL4722	Homo sapiens	INH	%	24.0
	5245966	CHEMBL1685887	Inhibition of aurora-A at 1 uM	B	Cc1ccc2cc(-c3n[nH]c4ccc(NS(=O)(=O)c5ncn(C)c5C)cc34)[nH]c2c1		CHEMBL1684525	=	Inhibition	%	15.0	CHEMBL4722	Homo sapiens	INH	%	15.0
	5249420	CHEMBL1686773	Inhibition of Aurora A at 10 uM	B	O=C(Cc1cccc2cnccc12)Nc1scc(Cl)c1-c1ncn[nH]1		CHEMBL1682017	=	Inhibition	%	31.0	CHEMBL4722	Homo sapiens	INH	%	31.0
	5249798	CHEMBL1687327	Inhibition of Aurora A kinase at 10 uM	B	COc1ccc(Cn2ncc(NC(=O)c3cc(NC(=O)Nc4ccc(Cl)c(C(F)(F)F)c4)ccc3C)c2N)cc1		CHEMBL1684800	=	Inhibition	%	0.0	CHEMBL4722	Homo sapiens	INH	%	0.0
	5249808	CHEMBL1687354	Inhibition of Aurora A kinase	B	COc1ccc(Cn2ncc(NC(=O)c3cc(NC(=O)Nc4ccc(Cl)c(C(F)(F)F)c4)ccc3C)c2N)cc1		CHEMBL1684800	<	IC50	nM	1.0	CHEMBL4722	Homo sapiens	IC50	nM	1.0
	5293779	CHEMBL1696298	Inhibition of Aurora A	B	Nc1nccc(-c2ccc3c(N)n[nH]c3c2)n1		CHEMBL1688215	=	IC50	nM	390.0	CHEMBL4722	Homo sapiens	IC50	uM	0.39
	5293872	CHEMBL1697110	Inhibition of Aurora-A after 60 mins by radiometric assay	B	O=C(Nc1ccc([N+](=O)[O-])cc1Cl)c1cc(Cl)ccc1O		CHEMBL1448	=	IC50	nM	54100.0	CHEMBL4722	Homo sapiens	IC50	uM	54.1
Active	5294118	CHEMBL1695259	Inhibition of Aurora A kinase	B	c1ccc(-c2nnc(Nc3ccc4c(c3)OCCO4)o2)c(NCc2ccncc2)c1		CHEMBL1087218		Inhibition	%		CHEMBL4722	Homo sapiens	INH		
Active	5294119	CHEMBL1695259	Inhibition of Aurora A kinase	B	c1cnc(NCc2ccc3ncccc3c2)c(-c2nnc(Nc3ccc4c(c3)OCCO4)o2)c1		CHEMBL1688352		Inhibition	%		CHEMBL4722	Homo sapiens	INH		
	5312992	CHEMBL1694381	Inhibition of recombinant human Aurora A kinase assessed as residual activity at 10 uM in presence of 100 uM ATP	B	Cc1ccc(-c2csc3ncnc(SCCC(=O)O)c23)cc1		CHEMBL1689369	=	Activity	%	23.0	CHEMBL4722	Homo sapiens	Activity	%	23.0
	5313000	CHEMBL1694381	Inhibition of recombinant human Aurora A kinase assessed as residual activity at 10 uM in presence of 100 uM ATP	B	CCOc1ccc(-c2csc3ncnc(SCCC(=O)O)c23)cc1		CHEMBL1689372	=	Activity	%	48.0	CHEMBL4722	Homo sapiens	Activity	%	48.0
	6154990	CHEMBL1763104	Inhibition of Aurora A	B	O=C1C(c2ccc(O)cc2O)=CC(=O)c2c(O)cccc21		CHEMBL1762116	=	IC50	nM	12000.0	CHEMBL4722	Homo sapiens	IC50	uM	12.0
	6154991	CHEMBL1763104	Inhibition of Aurora A	B	O=C1C=C(c2ccc(O)c(O)c2O)C(=O)c2c(O)ccc(O)c21		CHEMBL1762119	=	IC50	nM	6200.0	CHEMBL4722	Homo sapiens	IC50	uM	6.2
	6154992	CHEMBL1763104	Inhibition of Aurora A	B	O=C1C=C(c2ccc(O)c(O)c2O)C(=O)c2c1cccc2[N+](=O)[O-]		CHEMBL1762123	=	IC50	nM	4800.0	CHEMBL4722	Homo sapiens	IC50	uM	4.8
	6157878	CHEMBL1764779	Inhibition of Aurora A	B	COc1cc(Nc2nccc(Nc3cnc4ccccc4c3)n2)cc(OC)c1OC		CHEMBL1760035	>	IC50	nM	5000.0	CHEMBL4722	Homo sapiens	IC50	uM	5.0
	6157879	CHEMBL1764779	Inhibition of Aurora A	B	c1ccc2ncc(Nc3ccnc(Nc4ccc(OCCCN5CCCCC5)cc4)n3)cc2c1		CHEMBL1760057	>	IC50	nM	5000.0	CHEMBL4722	Homo sapiens	IC50	uM	5.0
	6161912	CHEMBL1764219	Inhibition of Aurora A kinase	B	CCCS(=O)(=O)N1CCC(c2c[nH]c3c(C(N)=O)cc(-c4ccccc4)cc23)CC1		CHEMBL1761512	=	IC50	nM	1258.93	CHEMBL4722	Homo sapiens	pIC50		5.9
	6167002	CHEMBL1768888	Inhibition of AURORA A	B	CNc1cncc(-c2c[nH]c(=O)c(NC(=O)c3ccc(N4CCC[C@H]4CN4CCCC4)cc3)c2)n1		CHEMBL1765781	>	Ki	nM	1000.0	CHEMBL4722	Homo sapiens	Ki	uM	1.0
	6168341	CHEMBL1768779	Inhibition of aurora A	B	C[C@@H]1COCCN1c1cc(-c2ccc3c(N)[nH]nc3c2)nc(N)n1		CHEMBL1614773	=	IC50	nM	12589.25	CHEMBL4722	Homo sapiens	pIC50		4.9
	6168342	CHEMBL1768779	Inhibition of aurora A	B	C[C@H]1COCCN1c1cc(-c2ccc3c(N)n[nH]c3c2)nc(N)n1		CHEMBL1765727	<	IC50	nM	10000.0	CHEMBL4722	Homo sapiens	pIC50		5.0
	6168343	CHEMBL1768779	Inhibition of aurora A	B	CC[C@@H]1COCCN1c1cc(-c2ccc3c(N)n[nH]c3c2)nc(N)n1		CHEMBL1765728	=	IC50	nM	5011.87	CHEMBL4722	Homo sapiens	pIC50		5.3
	6168344	CHEMBL1768779	Inhibition of aurora A	B	CC(C)[C@@H]1COCCN1c1cc(-c2ccc3c(N)n[nH]c3c2)nc(N)n1		CHEMBL1765729	=	IC50	nM	12589.25	CHEMBL4722	Homo sapiens	pIC50		4.9
	6168345	CHEMBL1768779	Inhibition of aurora A	B	C[C@@H]1CCCCN1c1cc(-c2ccc3c(N)n[nH]c3c2)nc(N)n1		CHEMBL1765730	<	IC50	nM	10000.0	CHEMBL4722	Homo sapiens	pIC50		5.0
	6168346	CHEMBL1768779	Inhibition of aurora A	B	Nc1nc(-c2ccc3c(N)[nH]nc3c2)cc(N2CCO[C@H](C(=O)Nc3ccccc3)C2)n1		CHEMBL1614774	=	IC50	nM	1258.93	CHEMBL4722	Homo sapiens	pIC50		5.9
	6168347	CHEMBL1768779	Inhibition of aurora A	B	Nc1nc(-c2ccc3c(N)n[nH]c3c2)cc(N2CCO[C@@H](C(=O)Nc3ccccc3)C2)n1		CHEMBL1765731	<	IC50	nM	10000.0	CHEMBL4722	Homo sapiens	pIC50		5.0
	6168348	CHEMBL1768779	Inhibition of aurora A	B	Nc1nc(-c2ccc3c(N)n[nH]c3c2)cc(N2CCC[C@H](C(=O)Nc3ccccc3)C2)n1		CHEMBL1765732	=	IC50	nM	7943.28	CHEMBL4722	Homo sapiens	pIC50		5.1
	6168349	CHEMBL1768779	Inhibition of aurora A	B	Nc1nc(-c2ccc3c(N)n[nH]c3c2)cc(N2CCC[C@@H](C(=O)Nc3ccccc3)C2)n1		CHEMBL1765733	=	IC50	nM	7943.28	CHEMBL4722	Homo sapiens	pIC50		5.1
	6168350	CHEMBL1768779	Inhibition of aurora A	B	Nc1nc(-c2ccc3c(N)n[nH]c3c2)cc(N2CCC[C@H](C(=O)NC3CCCCC3)C2)n1		CHEMBL1765734	<	IC50	nM	10000.0	CHEMBL4722	Homo sapiens	pIC50		5.0
	6168351	CHEMBL1768779	Inhibition of aurora A	B	Nc1nc(-c2ccc3c(N)n[nH]c3c2)cc(N2CCC[C@H](C(=O)NC3CCCC3)C2)n1		CHEMBL1765735	<	IC50	nM	10000.0	CHEMBL4722	Homo sapiens	pIC50		5.0
	6168352	CHEMBL1768779	Inhibition of aurora A	B	C[C@@H]1CC[C@H](C(=O)Nc2ccccc2)CN1c1cc(-c2ccc3c(N)[nH]nc3c2)nc(N)n1		CHEMBL1614775	=	IC50	nM	1258.93	CHEMBL4722	Homo sapiens	pIC50		5.9
	6168353	CHEMBL1768779	Inhibition of aurora A	B	C[C@H]1CC[C@@H](C(=O)Nc2ccccc2)CN1c1cc(-c2ccc3c(N)n[nH]c3c2)nc(N)n1		CHEMBL1765736	<	IC50	nM	10000.0	CHEMBL4722	Homo sapiens	pIC50		5.0
	6168354	CHEMBL1768779	Inhibition of aurora A	B	C[C@@H]1CC[C@@H](C(=O)Nc2ccccc2)CN1c1cc(-c2ccc3c(N)n[nH]c3c2)nc(N)n1		CHEMBL1765737	<	IC50	nM	10000.0	CHEMBL4722	Homo sapiens	pIC50		5.0
	6168355	CHEMBL1768779	Inhibition of aurora A	B	CNc1nc(-c2ccc3c(N)n[nH]c3c2)cc(N2C[C@@H](C(=O)Nc3ccccc3)CC[C@H]2C)n1		CHEMBL1765738	<	IC50	nM	10000.0	CHEMBL4722	Homo sapiens	pIC50		5.0
	6168356	CHEMBL1768779	Inhibition of aurora A	B	C[C@@H]1CC[C@H](C(=O)NC2CCCCC2)CN1c1cc(-c2ccc3c(N)n[nH]c3c2)nc(N)n1		CHEMBL1765739	=	IC50	nM	5011.87	CHEMBL4722	Homo sapiens	pIC50		5.3
	6168357	CHEMBL1768779	Inhibition of aurora A	B	CNc1nc(-c2ccc3c(N)n[nH]c3c2)cc(N2C[C@@H](C(=O)NC3CCCCC3)CC[C@H]2C)n1		CHEMBL1765740	<	IC50	nM	10000.0	CHEMBL4722	Homo sapiens	pIC50		5.0
	6168358	CHEMBL1768779	Inhibition of aurora A	B	C[C@@H]1CO[C@H](C(=O)Nc2ccccc2)CN1c1cc(-c2ccc3c(N)n[nH]c3c2)nc(N)n1		CHEMBL1765741	=	IC50	nM	199.53	CHEMBL4722	Homo sapiens	pIC50		6.7
	6168359	CHEMBL1768779	Inhibition of aurora A	B	CC[C@@H]1CO[C@H](C(=O)Nc2ccccc2)CN1c1cc(-c2ccc3c(N)n[nH]c3c2)nc(NC)n1		CHEMBL1765742	=	IC50	nM	7943.28	CHEMBL4722	Homo sapiens	pIC50		5.1
	6168360	CHEMBL1768779	Inhibition of aurora A	B	CNc1nc(-c2ccc3c(N)n[nH]c3c2)cc(N2C[C@@H](C(=O)NC3CCCCC3)OC[C@H]2C)n1		CHEMBL1765743	<	IC50	nM	10000.0	CHEMBL4722	Homo sapiens	pIC50		5.0
	6168361	CHEMBL1768779	Inhibition of aurora A	B	CC[C@@H]1CO[C@H](C(=O)NC2CCCCC2)CN1c1cc(-c2ccc3c(N)n[nH]c3c2)nc(NC)n1		CHEMBL1765744	<	IC50	nM	10000.0	CHEMBL4722	Homo sapiens	pIC50		5.0
	6168362	CHEMBL1768779	Inhibition of aurora A	B	Nc1nc(-c2ccc3c(N)n[nH]c3c2)cc(N2CCCC(NC(=O)c3ccccc3)C2)n1		CHEMBL1765745	=	IC50	nM	1258.93	CHEMBL4722	Homo sapiens	pIC50		5.9
	6168363	CHEMBL1768779	Inhibition of aurora A	B	CC(C)(C)OC(=O)NC1CCCN(c2cc(-c3ccc4c(N)n[nH]c4c3)nc(N)n2)C1		CHEMBL1765746	=	IC50	nM	1258.93	CHEMBL4722	Homo sapiens	pIC50		5.9
	6168364	CHEMBL1768779	Inhibition of aurora A	B	CC(C)(C)OC(=O)N[C@H]1CCCN(c2cc(-c3ccc4c(N)n[nH]c4c3)nc(N)n2)C1		CHEMBL1765747	=	IC50	nM	6309.57	CHEMBL4722	Homo sapiens	pIC50		5.2
	6168365	CHEMBL1768779	Inhibition of aurora A	B	CC(C)(C)OC(=O)N[C@@H]1CCCN(c2cc(-c3ccc4c(N)n[nH]c4c3)nc(N)n2)C1		CHEMBL1765748	=	IC50	nM	1584.89	CHEMBL4722	Homo sapiens	pIC50		5.8
	6168366	CHEMBL1768779	Inhibition of aurora A	B	C[C@H]1CC[C@@H](NC(=O)OC(C)(C)C)CN1c1cc(-c2ccc3c(N)[nH]nc3c2)nc(N)n1		CHEMBL1614776	=	IC50	nM	794.33	CHEMBL4722	Homo sapiens	pIC50		6.1
	6168367	CHEMBL1768779	Inhibition of aurora A	B	C[C@@H]1CC[C@H](NC(=O)OC(C)(C)C)CN1c1cc(-c2ccc3c(N)n[nH]c3c2)nc(N)n1		CHEMBL1765749	=	IC50	nM	1995.26	CHEMBL4722	Homo sapiens	pIC50		5.7
	6168368	CHEMBL1768779	Inhibition of aurora A	B	C[C@H]1CC[C@@H](NC(=O)OC(C)(C)C)CN1c1cc(-c2ccc3c(N)[nH]nc3c2)nc(N)n1		CHEMBL1614776	=	IC50	nM	501.19	CHEMBL4722	Homo sapiens	pIC50		6.3
	6168369	CHEMBL1768779	Inhibition of aurora A	B	C[C@@H]1C[C@@H](NC(=O)OC(C)(C)C)CN(c2cc(-c3ccc4c(N)[nH]nc4c3)nc(N)n2)C1		CHEMBL1614777	=	IC50	nM	398.11	CHEMBL4722	Homo sapiens	pIC50		6.4
	6168370	CHEMBL1768779	Inhibition of aurora A	B	CNc1nc(-c2ccc3c(N)n[nH]c3c2)cc(N2C[C@H](C)C[C@@H](N(C)C(=O)OC(C)(C)C)C2)n1		CHEMBL1765750	=	IC50	nM	125.89	CHEMBL4722	Homo sapiens	pIC50		6.9
	6168371	CHEMBL1768779	Inhibition of aurora A	B	C[C@@H]1C[C@@H](N(C)C(=O)CC(C)(C)C)CN(c2cc(-c3ccc4c(N)n[nH]c4c3)nc(N)n2)C1		CHEMBL1765751	=	IC50	nM	63.1	CHEMBL4722	Homo sapiens	pIC50		7.2
	6168372	CHEMBL1768779	Inhibition of aurora A	B	Nc1nccc(-c2ccc3c(N)n[nH]c3c2)n1		CHEMBL1688215	=	IC50	nM	398.11	CHEMBL4722	Homo sapiens	pIC50		6.4
	6168373	CHEMBL1768779	Inhibition of aurora A	B	Cc1cc(-c2ccc3c(N)n[nH]c3c2)nc(N)n1		CHEMBL1765756	=	IC50	nM	3981.07	CHEMBL4722	Homo sapiens	pIC50		5.4
	6168374	CHEMBL1768779	Inhibition of aurora A	B	CC(C)c1cc(-c2ccc3c(N)n[nH]c3c2)nc(N)n1		CHEMBL1765757	=	IC50	nM	3162.28	CHEMBL4722	Homo sapiens	pIC50		5.5
	6168375	CHEMBL1768779	Inhibition of aurora A	B	Nc1nc(-c2ccccc2)cc(-c2ccc3c(N)n[nH]c3c2)n1		CHEMBL1765758	=	IC50	nM	1584.89	CHEMBL4722	Homo sapiens	pIC50		5.8
	6168376	CHEMBL1768779	Inhibition of aurora A	B	COc1cc(-c2ccc3c(N)n[nH]c3c2)nc(N)n1		CHEMBL1765759	=	IC50	nM	6309.57	CHEMBL4722	Homo sapiens	pIC50		5.2
	6168377	CHEMBL1768779	Inhibition of aurora A	B	CNc1cc(-c2ccc3c(N)n[nH]c3c2)nc(N)n1		CHEMBL1765760	=	IC50	nM	3162.28	CHEMBL4722	Homo sapiens	pIC50		5.5
	6168378	CHEMBL1768779	Inhibition of aurora A	B	CCNc1cc(-c2ccc3c(N)[nH]nc3c2)nc(N)n1		CHEMBL1614771	=	IC50	nM	2511.89	CHEMBL4722	Homo sapiens	pIC50		5.6
	6168379	CHEMBL1768779	Inhibition of aurora A	B	CC(C)Nc1cc(-c2ccc3c(N)n[nH]c3c2)nc(N)n1		CHEMBL1765761	=	IC50	nM	1995.26	CHEMBL4722	Homo sapiens	pIC50		5.7
	6168380	CHEMBL1768779	Inhibition of aurora A	B	Nc1nc(NC2CCCC2)cc(-c2ccc3c(N)n[nH]c3c2)n1		CHEMBL1765762	=	IC50	nM	2511.89	CHEMBL4722	Homo sapiens	pIC50		5.6
	6168381	CHEMBL1768779	Inhibition of aurora A	B	Nc1nc(Nc2ccccc2)cc(-c2ccc3c(N)n[nH]c3c2)n1		CHEMBL1765876	=	IC50	nM	199.53	CHEMBL4722	Homo sapiens	pIC50		6.7
	6168382	CHEMBL1768779	Inhibition of aurora A	B	CN(C)c1cc(-c2ccc3c(N)n[nH]c3c2)nc(N)n1		CHEMBL1765877	<	IC50	nM	10000.0	CHEMBL4722	Homo sapiens	pIC50		5.0
	6168383	CHEMBL1768779	Inhibition of aurora A	B	Nc1nc(-c2ccc3c(N)[nH]nc3c2)cc(N2CCOCC2)n1		CHEMBL1614772	<	IC50	nM	10000.0	CHEMBL4722	Homo sapiens	pIC50		5.0
	6168384	CHEMBL1768779	Inhibition of aurora A	B	Nc1nc(-c2ccc3c(N)n[nH]c3c2)cc(N2CCCC2)n1		CHEMBL1765878	<	IC50	nM	10000.0	CHEMBL4722	Homo sapiens	pIC50		5.0
	6168385	CHEMBL1768779	Inhibition of aurora A	B	Nc1nc(-c2ccc3c(N)n[nH]c3c2)cc(N2CCCCC2)n1		CHEMBL1765879	<	IC50	nM	10000.0	CHEMBL4722	Homo sapiens	pIC50		5.0
	6169239	CHEMBL1768779	Inhibition of aurora A	B	CNc1nc(-c2ccc3c(N)n[nH]c3c2)cc(N2C[C@@H](C(=O)NC3CCCCC3)CC[C@H]2C)n1		CHEMBL1765740	=	IC50	nM	39810.0	CHEMBL4722	Homo sapiens	IC50	nM	39810.0
	6172476	CHEMBL1767756	Inhibition of Aurora A assessed as residual activity at 25 uM after 20 mins using kemptide as a substrate for [gamma-33P]ATP incorporation by liquid scintillation counting	B	CCOC(=O)c1c(O)nc2cccc3c2c1-c1ccccc1C3=O		CHEMBL1345690	=	Activity	%	79.0	CHEMBL4722	Homo sapiens	Activity	%	79.0
	6173413	CHEMBL1768217	Inhibition of AURK A at 25 uM by TR-FRET assay	B	NC(=O)c1ccsc1NC(=O)Cc1csc2ccccc12		CHEMBL1767254	=	Inhibition	%	0.0	CHEMBL4722	Homo sapiens	INH	%	0.0
	6198103	CHEMBL1776514	Inhibition of Aur-A assessed as [33P]gamma-ATP incorporation into substrate after 60 mins by gamma counting	B	CN1CCN(c2ccc(OC(F)(F)F)c(Nc3ncc4c(n3)-c3c(c(C(N)=O)nn3CCO)CC4)c2)CC1		CHEMBL1738758	>	IC50	nM	10000.0	CHEMBL4722	Homo sapiens	IC50	uM	10.0
	6201880	CHEMBL1781779	Inhibition of aurora A assessed as FLC-LRRASLG peptide phosphorylation by fluorescence polarization assay	B	CC1(C)c2cc(C3CCN(C4COC4)CC3)ccc2C(=O)c2c1[nH]c1cc(C#N)ccc21		CHEMBL1779202	>	IC50	nM	50000.0	CHEMBL4722	Homo sapiens	IC50	uM	50.0
	6204384	CHEMBL1781278	Inhibition of phosphotransferase activity of recombinant aurora A expressed in HeLa cells	B	Cc1cc(Nc2cc(-c3ccccc3)c(C#N)c(Sc3ccc(NC(=O)C(C)C)cc3)n2)n[nH]1		CHEMBL1780256	=	Ki	nM	310.0	CHEMBL4722	Homo sapiens	Ki	nM	310.0
	6204385	CHEMBL1781278	Inhibition of phosphotransferase activity of recombinant aurora A expressed in HeLa cells	B	CC(=O)Nc1ccc(Sc2nc(Nc3cc(C)[nH]n3)cc(C)c2C#N)cc1		CHEMBL1780257	=	Ki	nM	5.3	CHEMBL4722	Homo sapiens	Ki	nM	5.3
	6204386	CHEMBL1781278	Inhibition of phosphotransferase activity of recombinant aurora A expressed in HeLa cells	B	Cc1cc(Nc2cc(C)c(C#N)c(NC(C)CCCC(C)(C)O)n2)n[nH]1.Cl		CHEMBL1778662	=	Ki	nM	1.2	CHEMBL4722	Homo sapiens	Ki	nM	1.2
	6204387	CHEMBL1781278	Inhibition of phosphotransferase activity of recombinant aurora A expressed in HeLa cells	B	Cc1cc(Nc2cc(C)c(C#N)c(N[C@@H](C)CCCC(C)(C)O)n2)n[nH]1		CHEMBL1778663	=	Ki	nM	0.59	CHEMBL4722	Homo sapiens	Ki	nM	0.59
	6204388	CHEMBL1781278	Inhibition of phosphotransferase activity of recombinant aurora A expressed in HeLa cells	B	Cc1cc(Nc2cc(C)c(C#N)c(N[C@H](C)CCCC(C)(C)O)n2)n[nH]1		CHEMBL1778664	=	Ki	nM	66.0	CHEMBL4722	Homo sapiens	Ki	nM	66.0
	6204401	CHEMBL1781288	Inhibition of aurora A	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	Ki	nM	0.6	CHEMBL4722	Homo sapiens	Ki	nM	0.6
	6204402	CHEMBL1781288	Inhibition of aurora A	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(/C=C/c3ccccc3)n2)n[nH]1		CHEMBL482968	=	IC50	nM	14.0	CHEMBL4722	Homo sapiens	IC50	nM	14.0
	6204412	CHEMBL1781278	Inhibition of phosphotransferase activity of recombinant aurora A expressed in HeLa cells	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	Ki	nM	2.0	CHEMBL4722	Homo sapiens	Ki	nM	2.0
	6204413	CHEMBL1781278	Inhibition of phosphotransferase activity of recombinant aurora A expressed in HeLa cells	B	CCCCCCSc1nc(Nc2cc(C)[nH]n2)cc(C)c1C#N		CHEMBL1780258	=	Ki	nM	3.8	CHEMBL4722	Homo sapiens	Ki	nM	3.8
	6204414	CHEMBL1781278	Inhibition of phosphotransferase activity of recombinant aurora A expressed in HeLa cells	B	Cc1cc(Nc2cc(C)c(C#N)c(SCCCCCCO)n2)n[nH]1		CHEMBL1777841	=	Ki	nM	8.5	CHEMBL4722	Homo sapiens	Ki	nM	8.5
	6204415	CHEMBL1781278	Inhibition of phosphotransferase activity of recombinant aurora A expressed in HeLa cells	B	Cc1cc(Nc2cc(C)c(C#N)c(SCCCCCCN)n2)n[nH]1		CHEMBL1777842	=	Ki	nM	28.0	CHEMBL4722	Homo sapiens	Ki	nM	28.0
	6204416	CHEMBL1781278	Inhibition of phosphotransferase activity of recombinant aurora A expressed in HeLa cells	B	Cc1cc(Nc2cc(C)c(C#N)c(NCCO)n2)n[nH]1		CHEMBL1777839	=	Ki	nM	20.0	CHEMBL4722	Homo sapiens	Ki	nM	20.0
	6204417	CHEMBL1781278	Inhibition of phosphotransferase activity of recombinant aurora A expressed in HeLa cells	B	Cc1cc(Nc2cc(C)c(C#N)c(NCCCCCCO)n2)n[nH]1		CHEMBL1777840	=	Ki	nM	4.5	CHEMBL4722	Homo sapiens	Ki	nM	4.5
	6204418	CHEMBL1781278	Inhibition of phosphotransferase activity of recombinant aurora A expressed in HeLa cells	B	Cc1cc(Nc2cc(C)c(C#N)c(SCCCCCC(C)(C)O)n2)n[nH]1		CHEMBL1778660	=	Ki	nM	9.7	CHEMBL4722	Homo sapiens	Ki	nM	9.7
	6204419	CHEMBL1781278	Inhibition of phosphotransferase activity of recombinant aurora A expressed in HeLa cells	B	Cc1cc(Nc2cc(C)c(C#N)c(NCCCCCC(C)(C)O)n2)n[nH]1		CHEMBL1778661	=	Ki	nM	2.3	CHEMBL4722	Homo sapiens	Ki	nM	2.3
	6219881	CHEMBL1785569	Inhibition of human Aurora A using H-LRRASLG peptide substrate by Hotspot assay	B	CNC(=O)c1ncc(C#Cc2cc(C(=O)Nc3ccc(CN4CCN(CCO)CC4)c(C(F)(F)F)c3)ccc2C)n1C		CHEMBL1784637	>	IC50	nM	3000.0	CHEMBL4722	Homo sapiens	IC50	nM	3000.0
	6221237	CHEMBL1785351	Inhibition of AURKA at 10 uM	B	S=c1[nH]nc(-c2ccncc2)n1-c1ccc2ccccc2c1		CHEMBL1644616	=	Inhibition	%	103.0	CHEMBL4722	Homo sapiens	INH	%	103.0
	6262754	CHEMBL1798623	Inhibition of AURKA	B	Cc1ccc(C(=O)NCCO)cc1-n1cnc(OCc2ccc(F)cc2F)c(Cl)c1=O		CHEMBL1738710	>	IC50	nM	10000.0	CHEMBL4722	Homo sapiens	IC50	uM	10.0
	6264909	CHEMBL1799792	Inhibition of AURKA at 1 uM	B	COCCN1CCc2cc(Nc3ncc(Cl)c(N[C@@H]4CCCC[C@H]4NS(C)(=O)=O)n3)c(OC)cc2CC1		CHEMBL1796254	<	Inhibition	%	65.0	CHEMBL4722	Homo sapiens	INH	%	65.0
	6265633	CHEMBL1799792	Inhibition of AURKA at 1 uM	B	COCCN1CCc2cc(Nc3ncc(Cl)c(N[C@@H]4CCCC[C@H]4N(C)S(C)(=O)=O)n3)c(OC)cc2CC1		CHEMBL1796257	<	Inhibition	%	65.0	CHEMBL4722	Homo sapiens	INH	%	65.0
	6267495	CHEMBL1799020	Inhibition of AURKA at 10 uM	B	O=c1c(Cl)c(OCc2ccc(F)cc2F)cc(CO)n1-c1c(F)cccc1F		CHEMBL1797211	<	Inhibition	%	50.0	CHEMBL4722	Homo sapiens	INH	%	50.0
	6267496	CHEMBL1799020	Inhibition of AURKA at 10 uM	B	Cc1cc(OCc2ccc(F)cc2F)c(Br)c(=O)n1-c1cccc(C(N)=O)c1		CHEMBL1797224	<	Inhibition	%	50.0	CHEMBL4722	Homo sapiens	INH	%	50.0
	6268090	CHEMBL1805334	Inhibition of aurora A kinase using 5TAMRA-GRTGRRNSICOOH as substrate by fluorescent assay	B	Cc1cc(Nc2nccn3c(-c4cnn(C)c4)cnc23)sn1		CHEMBL1801100	=	IC50	nM	570.0	CHEMBL4722	Homo sapiens	IC50	uM	0.57
	6268091	CHEMBL1805334	Inhibition of aurora A kinase using 5TAMRA-GRTGRRNSICOOH as substrate by fluorescent assay	B	CC(C)c1cc(Nc2nccn3c(-c4cnn(C)c4)cnc23)sn1		CHEMBL1801101	=	IC50	nM	640.0	CHEMBL4722	Homo sapiens	IC50	uM	0.64
	6268092	CHEMBL1805334	Inhibition of aurora A kinase using 5TAMRA-GRTGRRNSICOOH as substrate by fluorescent assay	B	Cn1cc(-c2cnc3c(Nc4cc(C5CCNCC5)ns4)nccn23)cn1		CHEMBL1801102	=	IC50	nM	1600.0	CHEMBL4722	Homo sapiens	IC50	uM	1.6
	6268093	CHEMBL1805334	Inhibition of aurora A kinase using 5TAMRA-GRTGRRNSICOOH as substrate by fluorescent assay	B	Cn1cc(-c2cnc3c(Nc4cc(C5CCN(S(C)(=O)=O)CC5)ns4)nccn23)cn1		CHEMBL1801103	=	IC50	nM	170.0	CHEMBL4722	Homo sapiens	IC50	uM	0.17
	6268094	CHEMBL1805334	Inhibition of aurora A kinase using 5TAMRA-GRTGRRNSICOOH as substrate by fluorescent assay	B	Cc1nsc(Nc2nccn3c(-c4cnn(C)c4)cnc23)n1		CHEMBL1801104	>	IC50	nM	10000.0	CHEMBL4722	Homo sapiens	IC50	uM	10.0
	6268095	CHEMBL1805334	Inhibition of aurora A kinase using 5TAMRA-GRTGRRNSICOOH as substrate by fluorescent assay	B	Cc1csc(Nc2nccn3c(-c4cnn(C)c4)cnc23)n1		CHEMBL1801105	>	IC50	nM	10000.0	CHEMBL4722	Homo sapiens	IC50	uM	10.0
	6268096	CHEMBL1805334	Inhibition of aurora A kinase using 5TAMRA-GRTGRRNSICOOH as substrate by fluorescent assay	B	Cc1csc(Nc2nccn3c(-c4cnn(C)c4)cnc23)c1		CHEMBL1801106	=	IC50	nM	2500.0	CHEMBL4722	Homo sapiens	IC50	uM	2.5
	6268097	CHEMBL1805334	Inhibition of aurora A kinase using 5TAMRA-GRTGRRNSICOOH as substrate by fluorescent assay	B	CN(C)c1cccc(Nc2nccn3c(-c4cnn(C)c4)cnc23)c1		CHEMBL1801107	>	IC50	nM	10000.0	CHEMBL4722	Homo sapiens	IC50	uM	10.0
	6268098	CHEMBL1805334	Inhibition of aurora A kinase using 5TAMRA-GRTGRRNSICOOH as substrate by fluorescent assay	B	CN(C)S(=O)(=O)c1ccc(Nc2nccn3c(-c4cnn(C)c4)cnc23)cc1		CHEMBL1801108	=	IC50	nM	3700.0	CHEMBL4722	Homo sapiens	IC50	uM	3.7
	6268099	CHEMBL1805334	Inhibition of aurora A kinase using 5TAMRA-GRTGRRNSICOOH as substrate by fluorescent assay	B	Cc1cc(Nc2nccn3c(-c4cn[nH]c4)cnc23)sn1		CHEMBL1234822	<=	IC50	nM	4.0	CHEMBL4722	Homo sapiens	IC50	uM	0.004
	6268100	CHEMBL1805334	Inhibition of aurora A kinase using 5TAMRA-GRTGRRNSICOOH as substrate by fluorescent assay	B	CS(=O)(=O)N1CCC(c2cc(Nc3nccn4c(-c5cn[nH]c5)cnc34)sn2)CC1		CHEMBL1801109	=	IC50	nM	6.0	CHEMBL4722	Homo sapiens	IC50	uM	0.006
	6268101	CHEMBL1805334	Inhibition of aurora A kinase using 5TAMRA-GRTGRRNSICOOH as substrate by fluorescent assay	B	O=S(=O)(c1ccc(Nc2nccn3c(-c4cn[nH]c4)cnc23)cc1)N1CCOCC1		CHEMBL1801110	=	IC50	nM	81.0	CHEMBL4722	Homo sapiens	IC50	uM	0.081
	6268102	CHEMBL1805334	Inhibition of aurora A kinase using 5TAMRA-GRTGRRNSICOOH as substrate by fluorescent assay	B	Cc1cc(Nc2nc(C)cn3c(-c4cn[nH]c4)cnc23)sn1		CHEMBL1270796	<=	IC50	nM	4.0	CHEMBL4722	Homo sapiens	IC50	nM	4.0
	6268103	CHEMBL1805334	Inhibition of aurora A kinase using 5TAMRA-GRTGRRNSICOOH as substrate by fluorescent assay	B	Cc1cc(Nc2nc(CN3CCOCC3)cn3c(-c4cn[nH]c4)cnc23)sn1		CHEMBL1801111	=	IC50	nM	50.0	CHEMBL4722	Homo sapiens	IC50	nM	50.0
	6268104	CHEMBL1805334	Inhibition of aurora A kinase using 5TAMRA-GRTGRRNSICOOH as substrate by fluorescent assay	B	Cc1cc(Nc2nc(C(F)(F)F)cn3c(-c4cn[nH]c4)cnc23)sn1		CHEMBL1801112	=	IC50	nM	27.0	CHEMBL4722	Homo sapiens	IC50	nM	27.0
	6268105	CHEMBL1805334	Inhibition of aurora A kinase using 5TAMRA-GRTGRRNSICOOH as substrate by fluorescent assay	B	CCc1cn2c(-c3cn[nH]c3)cnc2c(Nc2cc(C)ns2)n1		CHEMBL1801113	<=	IC50	nM	4.0	CHEMBL4722	Homo sapiens	IC50	nM	4.0
	6268106	CHEMBL1805334	Inhibition of aurora A kinase using 5TAMRA-GRTGRRNSICOOH as substrate by fluorescent assay	B	Cc1cc(Nc2nc(CCN)cn3c(-c4cn[nH]c4)cnc23)sn1		CHEMBL1801114	=	IC50	nM	83.0	CHEMBL4722	Homo sapiens	IC50	nM	83.0
	6268107	CHEMBL1805334	Inhibition of aurora A kinase using 5TAMRA-GRTGRRNSICOOH as substrate by fluorescent assay	B	Cc1cc(Nc2nc(C3CC3)cn3c(-c4cn[nH]c4)cnc23)sn1		CHEMBL1801115	=	IC50	nM	17.0	CHEMBL4722	Homo sapiens	IC50	nM	17.0
	6268108	CHEMBL1805334	Inhibition of aurora A kinase using 5TAMRA-GRTGRRNSICOOH as substrate by fluorescent assay	B	Cc1cc(Nc2nc(C#N)cn3c(-c4cn[nH]c4)cnc23)sn1		CHEMBL1801128	=	IC50	nM	46.0	CHEMBL4722	Homo sapiens	IC50	nM	46.0
	6268109	CHEMBL1805334	Inhibition of aurora A kinase using 5TAMRA-GRTGRRNSICOOH as substrate by fluorescent assay	B	Cc1cc(Nc2nc(-c3cccnc3)cn3c(-c4cn[nH]c4)cnc23)sn1		CHEMBL1800086	=	IC50	nM	8.0	CHEMBL4722	Homo sapiens	IC50	nM	8.0
	6268110	CHEMBL1805334	Inhibition of aurora A kinase using 5TAMRA-GRTGRRNSICOOH as substrate by fluorescent assay	B	CSc1cn2c(-c3cn[nH]c3)cnc2c(Nc2cc(C)ns2)n1		CHEMBL1270795	<=	IC50	nM	4.0	CHEMBL4722	Homo sapiens	IC50	nM	4.0
	6268111	CHEMBL1805334	Inhibition of aurora A kinase using 5TAMRA-GRTGRRNSICOOH as substrate by fluorescent assay	B	Cc1cc(Nc2nc([S+](C)[O-])cn3c(-c4cn[nH]c4)cnc23)sn1		CHEMBL1801129	=	IC50	nM	30.0	CHEMBL4722	Homo sapiens	IC50	nM	30.0
	6268112	CHEMBL1805334	Inhibition of aurora A kinase using 5TAMRA-GRTGRRNSICOOH as substrate by fluorescent assay	B	Cc1cc(Nc2nc(S(C)(=O)=O)cn3c(-c4cn[nH]c4)cnc23)sn1		CHEMBL1801130	=	IC50	nM	603.0	CHEMBL4722	Homo sapiens	IC50	nM	603.0
	6268113	CHEMBL1805334	Inhibition of aurora A kinase using 5TAMRA-GRTGRRNSICOOH as substrate by fluorescent assay	B	CCSc1cn2c(-c3cn[nH]c3)cnc2c(Nc2cc(C)ns2)n1		CHEMBL1801131	=	IC50	nM	22.0	CHEMBL4722	Homo sapiens	IC50	nM	22.0
	6268114	CHEMBL1805334	Inhibition of aurora A kinase using 5TAMRA-GRTGRRNSICOOH as substrate by fluorescent assay	B	Cc1cc(Nc2nc(SCCN(C)C)cn3c(-c4cn[nH]c4)cnc23)sn1		CHEMBL1801132	=	IC50	nM	82.0	CHEMBL4722	Homo sapiens	IC50	nM	82.0
	6268115	CHEMBL1805334	Inhibition of aurora A kinase using 5TAMRA-GRTGRRNSICOOH as substrate by fluorescent assay	B	Cc1cc(Nc2nc(SC(C)(C)C)cn3c(-c4cn[nH]c4)cnc23)sn1		CHEMBL1801133	=	IC50	nM	105.0	CHEMBL4722	Homo sapiens	IC50	nM	105.0
	6268116	CHEMBL1805334	Inhibition of aurora A kinase using 5TAMRA-GRTGRRNSICOOH as substrate by fluorescent assay	B	Cc1cc(Nc2nc(Sc3ccc(F)cc3)cn3c(-c4cn[nH]c4)cnc23)sn1		CHEMBL1801134	=	IC50	nM	85.0	CHEMBL4722	Homo sapiens	IC50	nM	85.0
	6268117	CHEMBL1805334	Inhibition of aurora A kinase using 5TAMRA-GRTGRRNSICOOH as substrate by fluorescent assay	B	Cc1cc(Nc2nc(C(=O)N3CCCC3)cn3c(-c4cn[nH]c4)cnc23)sn1		CHEMBL1801135	=	IC50	nM	14.0	CHEMBL4722	Homo sapiens	IC50	nM	14.0
	6281549	CHEMBL1804348	Inhibition of human Aurora A	B	CN(C[C@@H]1COCCO1)S(=O)(=O)Nc1ccc2ccc3ncc(-c4cnn(C)c4)cc3c(=O)c2c1		CHEMBL1822792	=	IC50	nM	290.0	CHEMBL4722	Homo sapiens	IC50	nM	290.0
	6286523	CHEMBL1810160	Inhibition of recombinant GST-tagged Aurora A expressed in Sf9 insect cells after 90 mins by Kinase-Glo assay	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	=	IC50	nM	3800.0	CHEMBL4722	Homo sapiens	IC50	uM	3.8
	6286524	CHEMBL1810160	Inhibition of recombinant GST-tagged Aurora A expressed in Sf9 insect cells after 90 mins by Kinase-Glo assay	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	=	IC50	nM	760.0	CHEMBL4722	Homo sapiens	IC50	uM	0.76
	6286525	CHEMBL1810160	Inhibition of recombinant GST-tagged Aurora A expressed in Sf9 insect cells after 90 mins by Kinase-Glo assay	B	CN1CCN(c2ccc(C(=O)Nc3cc(-c4cccc(NS(=O)(=O)c5ccccc5)c4)n[nH]3)cc2)CC1		CHEMBL1807392	=	IC50	nM	340.0	CHEMBL4722	Homo sapiens	IC50	uM	0.34
	6286526	CHEMBL1810160	Inhibition of recombinant GST-tagged Aurora A expressed in Sf9 insect cells after 90 mins by Kinase-Glo assay	B	CN1CCN(c2ccc(C(=O)Nc3cc(-c4cccc(NS(=O)(=O)c5cccc(Cl)c5)c4)n[nH]3)cc2)CC1		CHEMBL1807467	=	IC50	nM	1710.0	CHEMBL4722	Homo sapiens	IC50	uM	1.71
	6286527	CHEMBL1810160	Inhibition of recombinant GST-tagged Aurora A expressed in Sf9 insect cells after 90 mins by Kinase-Glo assay	B	CN1CCN(c2ccc(C(=O)Nc3cc(-c4cccc(NS(=O)(=O)c5ccc(Cl)cc5)c4)n[nH]3)cc2)CC1		CHEMBL1807468	=	IC50	nM	4990.0	CHEMBL4722	Homo sapiens	IC50	uM	4.99
	6286528	CHEMBL1810160	Inhibition of recombinant GST-tagged Aurora A expressed in Sf9 insect cells after 90 mins by Kinase-Glo assay	B	Cc1cccc(S(=O)(=O)Nc2cccc(-c3cc(NC(=O)c4ccc(N5CCN(C)CC5)cc4)[nH]n3)c2)c1		CHEMBL1807469	=	IC50	nM	430.0	CHEMBL4722	Homo sapiens	IC50	uM	0.43
	6286529	CHEMBL1810160	Inhibition of recombinant GST-tagged Aurora A expressed in Sf9 insect cells after 90 mins by Kinase-Glo assay	B	COc1ccc(S(=O)(=O)Nc2cccc(-c3cc(NC(=O)c4ccc(N5CCN(C)CC5)cc4)[nH]n3)c2)cc1		CHEMBL1807471	>	IC50	nM	1000.0	CHEMBL4722	Homo sapiens	IC50	uM	1.0
	6286530	CHEMBL1810160	Inhibition of recombinant GST-tagged Aurora A expressed in Sf9 insect cells after 90 mins by Kinase-Glo assay	B	CCS(=O)(=O)Nc1cccc(-c2cc(NC(=O)c3ccc(N4CCN(C)CC4)cc3)[nH]n2)c1		CHEMBL1807472	>	IC50	nM	1000.0	CHEMBL4722	Homo sapiens	IC50	uM	1.0
	6286531	CHEMBL1810160	Inhibition of recombinant GST-tagged Aurora A expressed in Sf9 insect cells after 90 mins by Kinase-Glo assay	B	CCCS(=O)(=O)Nc1cccc(-c2cc(NC(=O)c3ccc(N4CCN(C)CC4)cc3)[nH]n2)c1		CHEMBL1807473	=	IC50	nM	1640.0	CHEMBL4722	Homo sapiens	IC50	uM	1.64
	6286532	CHEMBL1810160	Inhibition of recombinant GST-tagged Aurora A expressed in Sf9 insect cells after 90 mins by Kinase-Glo assay	B	CC(C)S(=O)(=O)Nc1cccc(-c2cc(NC(=O)c3ccc(N4CCN(C)CC4)cc3)[nH]n2)c1		CHEMBL1807474	>	IC50	nM	1000.0	CHEMBL4722	Homo sapiens	IC50	uM	1.0
	6286533	CHEMBL1810160	Inhibition of recombinant GST-tagged Aurora A expressed in Sf9 insect cells after 90 mins by Kinase-Glo assay	B	CN1CCN(c2cccc(C(=O)Nc3cc(-c4cccc(NS(=O)(=O)c5ccccc5)c4)n[nH]3)c2)CC1		CHEMBL1807475	=	IC50	nM	850.0	CHEMBL4722	Homo sapiens	IC50	uM	0.85
	6286534	CHEMBL1810160	Inhibition of recombinant GST-tagged Aurora A expressed in Sf9 insect cells after 90 mins by Kinase-Glo assay	B	O=C(Nc1cc(-c2cccc(NS(=O)(=O)c3ccccc3)c2)n[nH]1)c1cccc(N2CCOCC2)c1		CHEMBL1807476	>	IC50	nM	1000.0	CHEMBL4722	Homo sapiens	IC50	uM	1.0
	6286535	CHEMBL1810160	Inhibition of recombinant GST-tagged Aurora A expressed in Sf9 insect cells after 90 mins by Kinase-Glo assay	B	O=C(Nc1cc(-c2cccc(NS(=O)(=O)c3ccccc3)c2)n[nH]1)c1ccc(N2CCOCC2)cc1		CHEMBL1807477	=	IC50	nM	390.0	CHEMBL4722	Homo sapiens	IC50	uM	0.39
	6286536	CHEMBL1810160	Inhibition of recombinant GST-tagged Aurora A expressed in Sf9 insect cells after 90 mins by Kinase-Glo assay	B	O=C(Nc1cc(-c2cccc(NS(=O)(=O)c3ccccc3)c2)n[nH]1)c1ccc(OCCN2CCCC2)cc1		CHEMBL1807478	=	IC50	nM	1170.0	CHEMBL4722	Homo sapiens	IC50	uM	1.17
	6286537	CHEMBL1810160	Inhibition of recombinant GST-tagged Aurora A expressed in Sf9 insect cells after 90 mins by Kinase-Glo assay	B	O=C(Nc1cc(-c2cccc(NS(=O)(=O)c3ccccc3)c2)n[nH]1)c1ccc(CN2CCOCC2)cc1		CHEMBL1807480	=	IC50	nM	220.0	CHEMBL4722	Homo sapiens	IC50	uM	0.22
	6286538	CHEMBL1810160	Inhibition of recombinant GST-tagged Aurora A expressed in Sf9 insect cells after 90 mins by Kinase-Glo assay	B	Cc1nc(Nc2cc(-c3cccc(NS(=O)(=O)c4ccccc4)c3)n[nH]2)cc(N2CCN(C)CC2)n1		CHEMBL1807483	=	IC50	nM	290.0	CHEMBL4722	Homo sapiens	IC50	uM	0.29
	6286539	CHEMBL1810160	Inhibition of recombinant GST-tagged Aurora A expressed in Sf9 insect cells after 90 mins by Kinase-Glo assay	B	Cc1cccc(S(=O)(=O)Nc2cccc(-c3cc(Nc4cc(N5CCN(C)CC5)nc(C)n4)[nH]n3)c2)c1	Outside typical range	CHEMBL1807484	>	IC50	nM	1000000.0	CHEMBL4722	Homo sapiens	IC50	uM	1000.0
	6286540	CHEMBL1810160	Inhibition of recombinant GST-tagged Aurora A expressed in Sf9 insect cells after 90 mins by Kinase-Glo assay	B	CCCCS(=O)(=O)Nc1cccc(-c2cc(Nc3cc(N4CCN(C)CC4)nc(C)n3)[nH]n2)c1	Outside typical range	CHEMBL1807485	>	IC50	nM	1000000.0	CHEMBL4722	Homo sapiens	IC50	uM	1000.0
	6286541	CHEMBL1810160	Inhibition of recombinant GST-tagged Aurora A expressed in Sf9 insect cells after 90 mins by Kinase-Glo assay	B	Cc1nc(Nc2cc(-c3cccc(NS(=O)(=O)c4ccccc4)c3)n[nH]2)cc(N2CCC(O)CC2)n1		CHEMBL1807785	=	IC50	nM	540.0	CHEMBL4722	Homo sapiens	IC50	uM	0.54
	6286542	CHEMBL1810160	Inhibition of recombinant GST-tagged Aurora A expressed in Sf9 insect cells after 90 mins by Kinase-Glo assay	B	Cc1nc(Nc2cc(-c3cccc(NS(=O)(=O)c4ccccc4)c3)n[nH]2)cc(N2CCN(CCO)CC2)n1		CHEMBL1807786	=	IC50	nM	170.0	CHEMBL4722	Homo sapiens	IC50	uM	0.17
	6286543	CHEMBL1810160	Inhibition of recombinant GST-tagged Aurora A expressed in Sf9 insect cells after 90 mins by Kinase-Glo assay	B	Cc1nc(NCCN(C)C)cc(Nc2cc(-c3cccc(NS(=O)(=O)c4ccccc4)c3)n[nH]2)n1	Outside typical range	CHEMBL1807787	>	IC50	nM	1000000.0	CHEMBL4722	Homo sapiens	IC50	uM	1000.0
	6286544	CHEMBL1810160	Inhibition of recombinant GST-tagged Aurora A expressed in Sf9 insect cells after 90 mins by Kinase-Glo assay	B	Cc1nc(NCCN2CCOCC2)cc(Nc2cc(-c3cccc(NS(=O)(=O)c4ccccc4)c3)n[nH]2)n1	Outside typical range	CHEMBL1807788	>	IC50	nM	1000000.0	CHEMBL4722	Homo sapiens	IC50	uM	1000.0
	6286545	CHEMBL1810160	Inhibition of recombinant GST-tagged Aurora A expressed in Sf9 insect cells after 90 mins by Kinase-Glo assay	B	Cc1nc(NCCCN2CCOCC2)cc(Nc2cc(-c3cccc(NS(=O)(=O)c4ccccc4)c3)n[nH]2)n1		CHEMBL1807789	=	IC50	nM	680.0	CHEMBL4722	Homo sapiens	IC50	uM	0.68
	6286547	CHEMBL1810167	Inhibition of recombinant GST-tagged Aurora A expressed in Sf9 insect cells at 1 uM after 90 mins by Kinase-Glo assay	B	Cc1ccc(S(=O)(=O)Nc2cccc(-c3cc(NC(=O)c4ccc(N5CCN(C)CC5)cc4)[nH]n3)c2)cc1		CHEMBL1807470	=	Inhibition	%	50.0	CHEMBL4722	Homo sapiens	INH	%	50.0
	6286548	CHEMBL1810167	Inhibition of recombinant GST-tagged Aurora A expressed in Sf9 insect cells at 1 uM after 90 mins by Kinase-Glo assay	B	O=C(Nc1cc(-c2cccc(NS(=O)(=O)c3ccccc3)c2)n[nH]1)c1ccc(OCCN2CCOCC2)cc1		CHEMBL1807479	=	Inhibition	%	50.0	CHEMBL4722	Homo sapiens	INH	%	50.0
	6290258	CHEMBL1809662	Inhibition of Aur-A assessed as [33P]-gamma-ATP incorporation into substrate by gamma counting	B	Cn1nc(C(N)=O)c2c1-c1nc(Nc3ccccc3OC(F)(F)F)ncc1CC2		CHEMBL1272089	>	IC50	nM	10000.0	CHEMBL4722	Homo sapiens	IC50	uM	10.0
	6290259	CHEMBL1809662	Inhibition of Aur-A assessed as [33P]-gamma-ATP incorporation into substrate by gamma counting	B	Cn1nc(C(=O)Nc2ccccc2)c2c1-c1nc(Nc3ccccc3)ncc1CC2		CHEMBL563150	>	IC50	nM	10000.0	CHEMBL4722	Homo sapiens	IC50	uM	10.0
	6290260	CHEMBL1809662	Inhibition of Aur-A assessed as [33P]-gamma-ATP incorporation into substrate by gamma counting	B	CCc1cccc(CC)c1NC(=O)c1nn(C)c2c1CCc1cnc(Nc3ccccc3OC(F)(F)F)nc1-2		CHEMBL1808337	>	IC50	nM	10000.0	CHEMBL4722	Homo sapiens	IC50	uM	10.0
	6290261	CHEMBL1809662	Inhibition of Aur-A assessed as [33P]-gamma-ATP incorporation into substrate by gamma counting	B	CCc1cccc(CC)c1NC(=O)c1nn(C)c2c1CCc1cnc(Nc3ccc(C(N)=O)cc3OC(F)(F)F)nc1-2		CHEMBL1808339	>	IC50	nM	10000.0	CHEMBL4722	Homo sapiens	IC50	uM	10.0
	6290262	CHEMBL1809662	Inhibition of Aur-A assessed as [33P]-gamma-ATP incorporation into substrate by gamma counting	B	CCc1cccc(CC)c1NC(=O)c1nn(C)c2c1CCc1cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC(F)(F)F)nc1-2		CHEMBL1236095	>	IC50	nM	10000.0	CHEMBL4722	Homo sapiens	IC50	uM	10.0
	6290263	CHEMBL1809662	Inhibition of Aur-A assessed as [33P]-gamma-ATP incorporation into substrate by gamma counting	B	CCc1cccc(CC)c1NC(=O)c1nn(C)c2c1CCc1cnc(Nc3ccc(C(=O)N4CCC[C@@H]4CN4CCCC4)cc3OC(F)(F)F)nc1-2		CHEMBL1807300	>	IC50	nM	10000.0	CHEMBL4722	Homo sapiens	IC50	uM	10.0
	6290264	CHEMBL1809662	Inhibition of Aur-A assessed as [33P]-gamma-ATP incorporation into substrate by gamma counting	B	CCc1cccc(CC)c1NC(=O)c1nn(C)c2c1CCc1cnc(Nc3ccc(C(=O)N4CCC[C@H]4CN4CCCC4)cc3OC(F)(F)F)nc1-2		CHEMBL1807302	>	IC50	nM	10000.0	CHEMBL4722	Homo sapiens	IC50	uM	10.0
	6290265	CHEMBL1809662	Inhibition of Aur-A assessed as [33P]-gamma-ATP incorporation into substrate by gamma counting	B	CCc1cccc(CC)c1NC(=O)c1nn(C)c2c1CCc1cnc(Nc3ccc(C(=O)N4CCC(N(C)C)CC4)cc3OC(F)(F)F)nc1-2		CHEMBL1807304	>	IC50	nM	10000.0	CHEMBL4722	Homo sapiens	IC50	uM	10.0
	6290266	CHEMBL1809662	Inhibition of Aur-A assessed as [33P]-gamma-ATP incorporation into substrate by gamma counting	B	CCc1cccc(CC)c1NC(=O)c1nn(C)c2c1CCc1cnc(Nc3ccc(C(=O)N4CCCN(C)CC4)cc3OC(F)(F)F)nc1-2		CHEMBL1807306	>	IC50	nM	10000.0	CHEMBL4722	Homo sapiens	IC50	uM	10.0
	6290322	CHEMBL1809662	Inhibition of Aur-A assessed as [33P]-gamma-ATP incorporation into substrate by gamma counting	B	Cn1nc(C(N)=O)c2c1-c1nc(Nc3ccccc3)ncc1CC2		CHEMBL559845	=	IC50	nM	50.0	CHEMBL4722	Homo sapiens	IC50	uM	0.05
	6290323	CHEMBL1809662	Inhibition of Aur-A assessed as [33P]-gamma-ATP incorporation into substrate by gamma counting	B	Cc1ccccc1Nc1ncc2c(n1)-c1c(c(C(N)=O)nn1C)CC2		CHEMBL1094477	=	IC50	nM	605.0	CHEMBL4722	Homo sapiens	IC50	uM	0.605
	6290324	CHEMBL1809662	Inhibition of Aur-A assessed as [33P]-gamma-ATP incorporation into substrate by gamma counting	B	COc1ccccc1Nc1ncc2c(n1)-c1c(c(C(N)=O)nn1C)CC2		CHEMBL1094135	=	IC50	nM	607.0	CHEMBL4722	Homo sapiens	IC50	uM	0.607
	6290325	CHEMBL1809662	Inhibition of Aur-A assessed as [33P]-gamma-ATP incorporation into substrate by gamma counting	B	CCc1cccc(CC)c1NC(=O)c1nn(C)c2c1CCc1cnc(Nc3ccccc3)nc1-2		CHEMBL1808334	=	IC50	nM	152.0	CHEMBL4722	Homo sapiens	IC50	uM	0.152
	6290326	CHEMBL1809662	Inhibition of Aur-A assessed as [33P]-gamma-ATP incorporation into substrate by gamma counting	B	CNC(=O)c1nn(C)c2c1CCc1cnc(Nc3ccccc3)nc1-2		CHEMBL562104	=	IC50	nM	312.0	CHEMBL4722	Homo sapiens	IC50	uM	0.312
	6290327	CHEMBL1809662	Inhibition of Aur-A assessed as [33P]-gamma-ATP incorporation into substrate by gamma counting	B	Cn1nc(C(=O)NCc2ccccc2)c2c1-c1nc(Nc3ccccc3)ncc1CC2		CHEMBL562030	=	IC50	nM	374.0	CHEMBL4722	Homo sapiens	IC50	uM	0.374
	6290328	CHEMBL1809662	Inhibition of Aur-A assessed as [33P]-gamma-ATP incorporation into substrate by gamma counting	B	Cn1nc(C(=O)NCCc2ccccc2)c2c1-c1nc(Nc3ccccc3)ncc1CC2		CHEMBL1808335	=	IC50	nM	677.0	CHEMBL4722	Homo sapiens	IC50	uM	0.677
	6290329	CHEMBL1809662	Inhibition of Aur-A assessed as [33P]-gamma-ATP incorporation into substrate by gamma counting	B	CCc1cccc(CC)c1NC(=O)c1nn(C)c2c1CCc1cnc(Nc3ccccc3OC)nc1-2		CHEMBL1808336	=	IC50	nM	3168.0	CHEMBL4722	Homo sapiens	IC50	uM	3.168
	6290330	CHEMBL1809662	Inhibition of Aur-A assessed as [33P]-gamma-ATP incorporation into substrate by gamma counting	B	CCc1cccc(CC)c1NC(=O)c1nn(C)c2c1CCc1cnc(Nc3ccc(C(N)=O)cc3OC)nc1-2		CHEMBL1808338	=	IC50	nM	768.0	CHEMBL4722	Homo sapiens	IC50	uM	0.768
	6290331	CHEMBL1809662	Inhibition of Aur-A assessed as [33P]-gamma-ATP incorporation into substrate by gamma counting	B	CCc1cccc(CC)c1NC(=O)c1nn(C)c2c1CCc1cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc1-2		CHEMBL1808340	=	IC50	nM	1450.0	CHEMBL4722	Homo sapiens	IC50	uM	1.45
	6290332	CHEMBL1809662	Inhibition of Aur-A assessed as [33P]-gamma-ATP incorporation into substrate by gamma counting	B	CCc1cccc(CC)c1NC(=O)c1nn(C)c2c1CCc1cnc(Nc3ccc(C(=O)NCCN(C)C)cc3OC)nc1-2		CHEMBL1808341	=	IC50	nM	750.0	CHEMBL4722	Homo sapiens	IC50	uM	0.75
	6290333	CHEMBL1809662	Inhibition of Aur-A assessed as [33P]-gamma-ATP incorporation into substrate by gamma counting	B	CCc1cccc(CC)c1NC(=O)c1nn(C)c2c1CCc1cnc(Nc3ccc(C(=O)NCCN(C)C)cc3OC(F)(F)F)nc1-2		CHEMBL1808342	=	IC50	nM	1376.0	CHEMBL4722	Homo sapiens	IC50	uM	1.376
	6290334	CHEMBL1809662	Inhibition of Aur-A assessed as [33P]-gamma-ATP incorporation into substrate by gamma counting	B	CCc1cccc(CC)c1NC(=O)c1nn(C)c2c1CCc1cnc(Nc3ccc(C(=O)N4CCC[C@@H]4CN4CCCC4)cc3OC)nc1-2		CHEMBL1808343	=	IC50	nM	1376.0	CHEMBL4722	Homo sapiens	IC50	uM	1.376
	6290335	CHEMBL1809662	Inhibition of Aur-A assessed as [33P]-gamma-ATP incorporation into substrate by gamma counting	B	CCc1cccc(CC)c1NC(=O)c1nn(C)c2c1CCc1cnc(Nc3ccc(C(=O)N4CCC[C@H]4CN4CCCC4)cc3OC)nc1-2		CHEMBL1807301	=	IC50	nM	491.0	CHEMBL4722	Homo sapiens	IC50	uM	0.491
	6290336	CHEMBL1809662	Inhibition of Aur-A assessed as [33P]-gamma-ATP incorporation into substrate by gamma counting	B	CCc1cccc(CC)c1NC(=O)c1nn(C)c2c1CCc1cnc(Nc3ccc(C(=O)N4CCC(N(C)C)CC4)cc3OC)nc1-2		CHEMBL1807303	=	IC50	nM	484.0	CHEMBL4722	Homo sapiens	IC50	uM	0.484
	6290337	CHEMBL1809662	Inhibition of Aur-A assessed as [33P]-gamma-ATP incorporation into substrate by gamma counting	B	CCc1cccc(CC)c1NC(=O)c1nn(C)c2c1CCc1cnc(Nc3ccc(C(=O)N4CCCN(C)CC4)cc3OC)nc1-2		CHEMBL1807305	=	IC50	nM	372.0	CHEMBL4722	Homo sapiens	IC50	uM	0.372
	6314016	CHEMBL1815690	Inhibition of AurA at 30 uM by microfluidic mobility shift assay	B	Cc1cc2[nH]nc(N)c2c(=O)[nH]1		CHEMBL1813604	=	Inhibition	%	23.0	CHEMBL4722	Homo sapiens	INH	%	23.0
	6314017	CHEMBL1815690	Inhibition of AurA at 30 uM by microfluidic mobility shift assay	B	Nc1n[nH]c2cc(-c3cccnc3)[nH]c(=O)c12		CHEMBL1813606	=	Inhibition	%	42.0	CHEMBL4722	Homo sapiens	INH	%	42.0
	6314018	CHEMBL1815690	Inhibition of AurA at 30 uM by microfluidic mobility shift assay	B	Nc1n[nH]c2cc(-c3ccccn3)[nH]c(=O)c12		CHEMBL1813607	=	Inhibition	%	38.0	CHEMBL4722	Homo sapiens	INH	%	38.0
	6314019	CHEMBL1815690	Inhibition of AurA at 30 uM by microfluidic mobility shift assay	B	Nc1n[nH]c2cc(-c3ccncc3)[nH]c(=O)c12		CHEMBL1813608	=	Inhibition	%	43.0	CHEMBL4722	Homo sapiens	INH	%	43.0
	6314020	CHEMBL1815690	Inhibition of AurA at 30 uM by microfluidic mobility shift assay	B	COc1cccc(-c2cc3[nH]nc(N)c3c(=O)[nH]2)c1		CHEMBL1813609	=	Inhibition	%	49.0	CHEMBL4722	Homo sapiens	INH	%	49.0
	6314021	CHEMBL1815690	Inhibition of AurA at 30 uM by microfluidic mobility shift assay	B	COc1ccc(-c2cc3[nH]nc(N)c3c(=O)[nH]2)cc1		CHEMBL1813610	=	Inhibition	%	49.0	CHEMBL4722	Homo sapiens	INH	%	49.0
	6314022	CHEMBL1815690	Inhibition of AurA at 30 uM by microfluidic mobility shift assay	B	CN1CCN(c2ccc(-c3cc4[nH]nc(N)c4c(=O)[nH]3)cc2)CC1		CHEMBL1813611	=	Inhibition	%	51.0	CHEMBL4722	Homo sapiens	INH	%	51.0
	6314023	CHEMBL1815690	Inhibition of AurA at 30 uM by microfluidic mobility shift assay	B	Nc1n[nH]c2cc(-c3cccs3)[nH]c(=O)c12		CHEMBL1813612	=	Inhibition	%	67.0	CHEMBL4722	Homo sapiens	INH	%	67.0
	6314024	CHEMBL1815690	Inhibition of AurA at 30 uM by microfluidic mobility shift assay	B	CC(C)(C)c1cc2[nH]nc(N)c2c(=O)[nH]1		CHEMBL1813613	=	Inhibition	%	34.0	CHEMBL4722	Homo sapiens	INH	%	34.0
	6314025	CHEMBL1815690	Inhibition of AurA at 30 uM by microfluidic mobility shift assay	B	Nc1n[nH]c2cc(-c3ccc(N4CCOCC4)cc3)[nH]c(=O)c12		CHEMBL1813614	=	Inhibition	%	51.0	CHEMBL4722	Homo sapiens	INH	%	51.0
	6314026	CHEMBL1815690	Inhibition of AurA at 30 uM by microfluidic mobility shift assay	B	Nc1n[nH]c2cc(CC3CCNCC3)[nH]c(=O)c12		CHEMBL1813615	=	Inhibition	%	5.0	CHEMBL4722	Homo sapiens	INH	%	5.0
	6314027	CHEMBL1815690	Inhibition of AurA at 30 uM by microfluidic mobility shift assay	B	Nc1n[nH]c2c3c([nH]c(=O)c12)CCCC3		CHEMBL1813617	=	Inhibition	%	12.0	CHEMBL4722	Homo sapiens	INH	%	12.0
	6314028	CHEMBL1815690	Inhibition of AurA at 30 uM by microfluidic mobility shift assay	B	Cc1cc2[nH]nc(N)c2c(N2CCCCC2)n1		CHEMBL1813618	=	Inhibition	%	84.0	CHEMBL4722	Homo sapiens	INH	%	84.0
	6314029	CHEMBL1815690	Inhibition of AurA at 30 uM by microfluidic mobility shift assay	B	Cc1cc2[nH]nc(N)c2c(N2CCOCC2)n1		CHEMBL1813619	=	Inhibition	%	72.0	CHEMBL4722	Homo sapiens	INH	%	72.0
	6314030	CHEMBL1815690	Inhibition of AurA at 30 uM by microfluidic mobility shift assay	B	Cc1cc2c(c(N)nn2C)c(=O)[nH]1		CHEMBL1813620	=	Inhibition	%	4.0	CHEMBL4722	Homo sapiens	INH	%	4.0
	6314031	CHEMBL1815690	Inhibition of AurA at 30 uM by microfluidic mobility shift assay	B	Cn1nc(N)c2c(=O)[nH]c(-c3ccccc3)cc21		CHEMBL1813621	=	Inhibition	%	14.0	CHEMBL4722	Homo sapiens	INH	%	14.0
	6314032	CHEMBL1815690	Inhibition of AurA at 30 uM by microfluidic mobility shift assay	B	Cn1nc(N)c2c(=O)[nH]c(-c3ccccn3)cc21		CHEMBL1813622	=	Inhibition	%	7.0	CHEMBL4722	Homo sapiens	INH	%	7.0
	6314033	CHEMBL1815690	Inhibition of AurA at 30 uM by microfluidic mobility shift assay	B	COc1ccc(-c2cc3c(c(N)nn3C)c(=O)[nH]2)cc1		CHEMBL1813623	=	Inhibition	%	33.0	CHEMBL4722	Homo sapiens	INH	%	33.0
	6314034	CHEMBL1815690	Inhibition of AurA at 30 uM by microfluidic mobility shift assay	B	COc1cccc(-c2cc3c(c(N)nn3C)c(=O)[nH]2)c1		CHEMBL1813624	=	Inhibition	%	17.0	CHEMBL4722	Homo sapiens	INH	%	17.0
	6314035	CHEMBL1815690	Inhibition of AurA at 30 uM by microfluidic mobility shift assay	B	CN1CCN(c2ccc(-c3cc4c(c(N)nn4C)c(=O)[nH]3)cc2)CC1		CHEMBL1813625	=	Inhibition	%	52.0	CHEMBL4722	Homo sapiens	INH	%	52.0
	6314036	CHEMBL1815690	Inhibition of AurA at 30 uM by microfluidic mobility shift assay	B	COC(=O)CCc1c(C)[nH]c(=O)c2c(N)nn(C)c12		CHEMBL1813627	=	Inhibition	%	9.0	CHEMBL4722	Homo sapiens	INH	%	9.0
	6314037	CHEMBL1815690	Inhibition of AurA at 30 uM by microfluidic mobility shift assay	B	COc1ccc(-c2c(C)[nH]c(=O)c3c(N)nn(C)c23)cc1		CHEMBL1813628	=	Inhibition	%	31.0	CHEMBL4722	Homo sapiens	INH	%	31.0
	6314038	CHEMBL1815690	Inhibition of AurA at 30 uM by microfluidic mobility shift assay	B	Cc1cc2c(c(NC(=O)Nc3ccccc3)nn2C)c(=O)[nH]1		CHEMBL1813630	=	Inhibition	%	10.0	CHEMBL4722	Homo sapiens	INH	%	10.0
	6314039	CHEMBL1815690	Inhibition of AurA at 30 uM by microfluidic mobility shift assay	B	CC(=O)Nc1nn(C)c2cc(-c3ccccc3)[nH]c(=O)c12		CHEMBL1813777	=	Inhibition	%	2.0	CHEMBL4722	Homo sapiens	INH	%	2.0
	6314040	CHEMBL1815690	Inhibition of AurA at 30 uM by microfluidic mobility shift assay	B	Cc1cc2c(c(NS(C)(=O)=O)nn2C)c(=O)[nH]1		CHEMBL1813778	=	Inhibition	%	-8.0	CHEMBL4722	Homo sapiens	INH	%	-8.0
	6314041	CHEMBL1815690	Inhibition of AurA at 30 uM by microfluidic mobility shift assay	B	COc1ccc(S(=O)(=O)Nc2nn(C)c3cc(C)[nH]c(=O)c23)c(OC)c1		CHEMBL1813779	=	Inhibition	%	-9.0	CHEMBL4722	Homo sapiens	INH	%	-9.0
	6314042	CHEMBL1815690	Inhibition of AurA at 30 uM by microfluidic mobility shift assay	B	CC(=O)Nc1nn(C)c2cc(-c3ccc(N4CCN(C)CC4)cc3)[nH]c(=O)c12		CHEMBL1813780	=	Inhibition	%	15.0	CHEMBL4722	Homo sapiens	INH	%	15.0
	6314043	CHEMBL1815690	Inhibition of AurA at 30 uM by microfluidic mobility shift assay	B	Cc1cc2c(c(N)nn2C)c(N2CCCCC2)n1		CHEMBL1813781	=	Inhibition	%	41.0	CHEMBL4722	Homo sapiens	INH	%	41.0
	6314044	CHEMBL1815690	Inhibition of AurA at 30 uM by microfluidic mobility shift assay	B	Cc1cc2c(c(N)nn2C)c(N2CCOCC2)n1		CHEMBL1813782	=	Inhibition	%	17.0	CHEMBL4722	Homo sapiens	INH	%	17.0
	6314045	CHEMBL1815690	Inhibition of AurA at 30 uM by microfluidic mobility shift assay	B	Cc1cc2c(c(N)nn2C)c(N2CC[C@H](O)C2)n1		CHEMBL1813784	=	Inhibition	%	0.0	CHEMBL4722	Homo sapiens	INH	%	0.0
	6314046	CHEMBL1815690	Inhibition of AurA at 30 uM by microfluidic mobility shift assay	B	COCCNc1nc(C)cc2c1c(N)nn2C		CHEMBL1813785	=	Inhibition	%	15.0	CHEMBL4722	Homo sapiens	INH	%	15.0
	6314047	CHEMBL1815690	Inhibition of AurA at 30 uM by microfluidic mobility shift assay	B	COCCNc1nc(-c2ccccc2)cc2c1c(N)nn2C		CHEMBL1813786	=	Inhibition	%	10.0	CHEMBL4722	Homo sapiens	INH	%	10.0
	6314048	CHEMBL1815690	Inhibition of AurA at 30 uM by microfluidic mobility shift assay	B	COCCNc1nc(C)cc2nn(-c3ccccc3)c(N)c12		CHEMBL1813787	=	Inhibition	%	32.0	CHEMBL4722	Homo sapiens	INH	%	32.0
	6314049	CHEMBL1815690	Inhibition of AurA at 30 uM by microfluidic mobility shift assay	B	Cc1cc2nn(-c3ccccc3)c(N)c2c(=O)[nH]1		CHEMBL1813788	=	Inhibition	%	6.0	CHEMBL4722	Homo sapiens	INH	%	6.0
	6314050	CHEMBL1815690	Inhibition of AurA at 30 uM by microfluidic mobility shift assay	B	CC(C)(C)c1cc2nn(-c3ccccc3)c(N)c2c(=O)[nH]1		CHEMBL1813789	=	Inhibition	%	9.0	CHEMBL4722	Homo sapiens	INH	%	9.0
	6314051	CHEMBL1815690	Inhibition of AurA at 30 uM by microfluidic mobility shift assay	B	Nc1c2c(=O)[nH]c(-c3ccccc3)cc2nn1-c1ccccc1		CHEMBL1813790	=	Inhibition	%	61.0	CHEMBL4722	Homo sapiens	INH	%	61.0
	6314052	CHEMBL1815690	Inhibition of AurA at 30 uM by microfluidic mobility shift assay	B	Nc1c2c(=O)[nH]c(-c3ccccn3)cc2nn1-c1ccccc1		CHEMBL1813791	=	Inhibition	%	30.0	CHEMBL4722	Homo sapiens	INH	%	30.0
	6314053	CHEMBL1815690	Inhibition of AurA at 30 uM by microfluidic mobility shift assay	B	COc1ccccc1-c1cc2nn(-c3ccccc3)c(N)c2c(=O)[nH]1		CHEMBL1813792	=	Inhibition	%	7.0	CHEMBL4722	Homo sapiens	INH	%	7.0
	6314054	CHEMBL1815690	Inhibition of AurA at 30 uM by microfluidic mobility shift assay	B	COc1ccc(-c2cc3nn(-c4ccccc4)c(N)c3c(=O)[nH]2)cc1		CHEMBL1813793	=	Inhibition	%	10.0	CHEMBL4722	Homo sapiens	INH	%	10.0
	6314055	CHEMBL1815690	Inhibition of AurA at 30 uM by microfluidic mobility shift assay	B	CN1CCN(c2ccc(-c3cc4nn(-c5ccccc5)c(N)c4c(=O)[nH]3)cc2)CC1		CHEMBL1813795	=	Inhibition	%	66.0	CHEMBL4722	Homo sapiens	INH	%	66.0
	6314056	CHEMBL1815690	Inhibition of AurA at 30 uM by microfluidic mobility shift assay	B	Nc1c2c(=O)[nH]c(-c3ccccc3)cc2nn1-c1ccccn1		CHEMBL1813796	=	Inhibition	%	37.0	CHEMBL4722	Homo sapiens	INH	%	37.0
	6314057	CHEMBL1815690	Inhibition of AurA at 30 uM by microfluidic mobility shift assay	B	Cc1cc2nn(-c3ccccc3)c(N)c2c(N2CCCCC2)n1		CHEMBL1813797	=	Inhibition	%	10.0	CHEMBL4722	Homo sapiens	INH	%	10.0
	6314058	CHEMBL1815690	Inhibition of AurA at 30 uM by microfluidic mobility shift assay	B	Cc1[nH]c(=O)c2c(N)n(-c3ccccc3)nc2c1-c1ccccc1		CHEMBL1813798	=	Inhibition	%	4.0	CHEMBL4722	Homo sapiens	INH	%	4.0
	6314059	CHEMBL1815690	Inhibition of AurA at 30 uM by microfluidic mobility shift assay	B	Cn1nc2c3c(nc(-c4ccccc4)cc31)NCC(=O)N2		CHEMBL1813799	=	Inhibition	%	20.0	CHEMBL4722	Homo sapiens	INH	%	20.0
	6314060	CHEMBL1815690	Inhibition of AurA at 30 uM by microfluidic mobility shift assay	B	Cn1nc(N)c2cnc(-c3ccccc3)cc21		CHEMBL1813800	=	Inhibition	%	33.0	CHEMBL4722	Homo sapiens	INH	%	33.0
	6314061	CHEMBL1815690	Inhibition of AurA at 30 uM by microfluidic mobility shift assay	B	Cc1cc2c(cn1)c(N)nn2C		CHEMBL1813801	=	Inhibition	%	3.0	CHEMBL4722	Homo sapiens	INH	%	3.0
	6314062	CHEMBL1815690	Inhibition of AurA at 30 uM by microfluidic mobility shift assay	B	Nc1c2cnc(-c3ccccc3)cc2nn1-c1ccccc1		CHEMBL1813802	=	Inhibition	%	3.0	CHEMBL4722	Homo sapiens	INH	%	3.0
	6314063	CHEMBL1815690	Inhibition of AurA at 30 uM by microfluidic mobility shift assay	B	Cc1cc2[nH]nc(N)c2cn1		CHEMBL1813803	=	Inhibition	%	31.0	CHEMBL4722	Homo sapiens	INH	%	31.0
	6314064	CHEMBL1815690	Inhibition of AurA at 30 uM by microfluidic mobility shift assay	B	Cc1cc2[nH]ncc2c(=O)[nH]1		CHEMBL1813804	=	Inhibition	%	13.0	CHEMBL4722	Homo sapiens	INH	%	13.0
	6314065	CHEMBL1815690	Inhibition of AurA at 30 uM by microfluidic mobility shift assay	B	Cc1cc2nc(N)nc(N)c2c(=O)[nH]1		CHEMBL1813805	=	Inhibition	%	10.0	CHEMBL4722	Homo sapiens	INH	%	10.0
	6314066	CHEMBL1815690	Inhibition of AurA at 30 uM by microfluidic mobility shift assay	B	Cc1cc2nc(-c3ccccc3)nc(N)c2c(=O)[nH]1		CHEMBL1813806	=	Inhibition	%	34.0	CHEMBL4722	Homo sapiens	INH	%	34.0
	6314067	CHEMBL1815690	Inhibition of AurA at 30 uM by microfluidic mobility shift assay	B	Cc1nc(N)c2c(=O)[nH]c(C)cc2n1		CHEMBL1813807	=	Inhibition	%	3.0	CHEMBL4722	Homo sapiens	INH	%	3.0
	6314068	CHEMBL1815690	Inhibition of AurA at 30 uM by microfluidic mobility shift assay	B	O=S(=O)(NCCNC/C=C/c1ccc(Br)cc1)c1cccc2cnccc12		CHEMBL104264	=	Inhibition	%	71.0	CHEMBL4722	Homo sapiens	INH	%	71.0
	6318844	CHEMBL1815742	Inhibition of AurA by microfluidic mobility shift assay	B	CN1CCN(c2ccc(-c3cc4c(c(N)nn4C)c(=O)[nH]3)cc2)CC1		CHEMBL1813625	=	IC50	nM	33000.0	CHEMBL4722	Homo sapiens	IC50	uM	33.0
	6325305	CHEMBL1819984	Inhibition of AurA expressed in Escherichia coli or baculovirus-infected insect cells at 400 uM by IMAP assay	B	Nc1ncnc2[nH]cnc12		CHEMBL226345	=	Inhibition	%	90.0	CHEMBL4722	Homo sapiens	INH	%	90.0
	6325334	CHEMBL1819984	Inhibition of AurA expressed in Escherichia coli or baculovirus-infected insect cells at 400 uM by IMAP assay	B	c1ccc(Nc2ncccn2)cc1		CHEMBL1650061	=	Inhibition	%	89.0	CHEMBL4722	Homo sapiens	INH	%	89.0
	6325366	CHEMBL1819984	Inhibition of AurA expressed in Escherichia coli or baculovirus-infected insect cells at 400 uM by IMAP assay	B	c1cnc2[nH]ccc2c1		CHEMBL389685	=	Inhibition	%	36.0	CHEMBL4722	Homo sapiens	INH	%	36.0
	6325398	CHEMBL1819984	Inhibition of AurA expressed in Escherichia coli or baculovirus-infected insect cells at 400 uM by IMAP assay	B	c1ccc2[nH]ncc2c1		CHEMBL86795	=	Inhibition	%	37.0	CHEMBL4722	Homo sapiens	INH	%	37.0
	6325430	CHEMBL1819984	Inhibition of AurA expressed in Escherichia coli or baculovirus-infected insect cells at 400 uM by IMAP assay	B	Nc1ncccc1OCc1ccccc1		CHEMBL194009	=	Inhibition	%	40.0	CHEMBL4722	Homo sapiens	INH	%	40.0
	6325459	CHEMBL1819984	Inhibition of AurA expressed in Escherichia coli or baculovirus-infected insect cells at 400 uM by IMAP assay	B	Nc1[nH]nc2ccccc12		CHEMBL1331627	=	Inhibition	%	84.0	CHEMBL4722	Homo sapiens	INH	%	84.0
	6325489	CHEMBL1819984	Inhibition of AurA expressed in Escherichia coli or baculovirus-infected insect cells at 400 uM by IMAP assay	B	Nc1n[nH]c2ncccc12		CHEMBL1817865	=	Inhibition	%	92.0	CHEMBL4722	Homo sapiens	INH	%	92.0
	6325517	CHEMBL1819984	Inhibition of AurA expressed in Escherichia coli or baculovirus-infected insect cells at 400 uM by IMAP assay	B	c1n[nH]c2c1CCCC2		CHEMBL1817866	=	Inhibition	%	27.0	CHEMBL4722	Homo sapiens	INH	%	27.0
	6325860	CHEMBL1819984	Inhibition of AurA expressed in Escherichia coli or baculovirus-infected insect cells at 400 uM by IMAP assay	B	Nc1ccc2ncc(-c3ccccc3)n2n1		CHEMBL1817867	=	Inhibition	%	96.0	CHEMBL4722	Homo sapiens	INH	%	96.0
	6325890	CHEMBL1819984	Inhibition of AurA expressed in Escherichia coli or baculovirus-infected insect cells at 400 uM by IMAP assay	B	c1ccc(-c2cnc3nccnn23)cc1		CHEMBL1817868	=	Inhibition	%	0.0	CHEMBL4722	Homo sapiens	INH	%	0.0
	6325920	CHEMBL1819984	Inhibition of AurA expressed in Escherichia coli or baculovirus-infected insect cells at 400 uM by IMAP assay	B	Cc1ccc(NC(=O)Nc2cc(C(C)(C)C)nn2-c2ccccc2)cc1		CHEMBL1817869	=	Inhibition	%	7.0	CHEMBL4722	Homo sapiens	INH	%	7.0
	6325949	CHEMBL1819984	Inhibition of AurA expressed in Escherichia coli or baculovirus-infected insect cells at 400 uM by IMAP assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccccc2)no1		CHEMBL292785	=	Inhibition	%	27.0	CHEMBL4722	Homo sapiens	INH	%	27.0
	6325978	CHEMBL1819984	Inhibition of AurA expressed in Escherichia coli or baculovirus-infected insect cells at 400 uM by IMAP assay	B	Cc1ccc(NC(=O)Nc2cccc(C(F)(F)F)c2)cc1		CHEMBL1817870	=	Inhibition	%	7.0	CHEMBL4722	Homo sapiens	INH	%	7.0
	6326007	CHEMBL1819984	Inhibition of AurA expressed in Escherichia coli or baculovirus-infected insect cells at 400 uM by IMAP assay	B	O=C(Nc1ccccc1)Nc1cccc(C(F)(F)F)c1		CHEMBL1605296	=	Inhibition	%	17.0	CHEMBL4722	Homo sapiens	INH	%	17.0
	6326036	CHEMBL1819984	Inhibition of AurA expressed in Escherichia coli or baculovirus-infected insect cells at 400 uM by IMAP assay	B	O=C(Nc1ccccc1)Nc1ccccc1		CHEMBL354676	=	Inhibition	%	0.0	CHEMBL4722	Homo sapiens	INH	%	0.0
	6326066	CHEMBL1819984	Inhibition of AurA expressed in Escherichia coli or baculovirus-infected insect cells at 400 uM by IMAP assay	B	Cc1ccc(C(=O)NC2CC2)cc1F		CHEMBL1817871	=	Inhibition	%	5.0	CHEMBL4722	Homo sapiens	INH	%	5.0
	6326094	CHEMBL1819984	Inhibition of AurA expressed in Escherichia coli or baculovirus-infected insect cells at 400 uM by IMAP assay	B	c1ccc(Nc2ccccc2)cc1		CHEMBL38688	=	Inhibition	%	0.0	CHEMBL4722	Homo sapiens	INH	%	0.0
	6326121	CHEMBL1819975	Inhibition of AurA expressed in Escherichia coli or baculovirus-infected insect cells by IMAP assay	B	COc1ccccc1Nc1nc(Nc2ccc(O)cc2)ncc1F		CHEMBL522476	=	IC50	nM	20.0	CHEMBL4722	Homo sapiens	IC50	nM	20.0
	6338960	CHEMBL1825458	Inhibition of Aurora kinase A assessed as phosphorylation of Lats2 substrate at 0.017 to 30 nM by FRET assay	B	CS(=O)(=O)N(CCCN1CCOCC1)c1ccc(Nc2ncc3cnn(C4CCCCCC4)c3n2)cc1		CHEMBL1825090	=	IC50	nM	5.0	CHEMBL4722	Homo sapiens	IC50	uM	0.005
	6338961	CHEMBL1825458	Inhibition of Aurora kinase A assessed as phosphorylation of Lats2 substrate at 0.017 to 30 nM by FRET assay	B	CC(C)N(c1ccc(Nc2ncc3cnn(C4CCCCCC4)c3n2)cc1)S(C)(=O)=O		CHEMBL1825092	=	IC50	nM	5.0	CHEMBL4722	Homo sapiens	IC50	uM	0.005
	6338965	CHEMBL1825458	Inhibition of Aurora kinase A assessed as phosphorylation of Lats2 substrate at 0.017 to 30 nM by FRET assay	B	CS(=O)(=O)N(CCCO)c1ccc(Nc2ncc3cnn(C4CCCCCC4)c3n2)cc1		CHEMBL1825091	=	IC50	nM	6.0	CHEMBL4722	Homo sapiens	IC50	uM	0.006
	6338969	CHEMBL1825458	Inhibition of Aurora kinase A assessed as phosphorylation of Lats2 substrate at 0.017 to 30 nM by FRET assay	B	CS(=O)(=O)N(CCCN1CCCCC1)c1ccc(Nc2ncc3cnn(C4CCCCCC4)c3n2)cc1		CHEMBL1825095	=	IC50	nM	9.0	CHEMBL4722	Homo sapiens	IC50	uM	0.009
	6338972	CHEMBL1825458	Inhibition of Aurora kinase A assessed as phosphorylation of Lats2 substrate at 0.017 to 30 nM by FRET assay	B	CS(=O)(=O)N(CCO)c1ccc(Nc2ncc3cnn(C4CCCCCC4)c3n2)cc1		CHEMBL1821761	=	IC50	nM	13.0	CHEMBL4722	Homo sapiens	IC50	uM	0.013
	6338974	CHEMBL1825458	Inhibition of Aurora kinase A assessed as phosphorylation of Lats2 substrate at 0.017 to 30 nM by FRET assay	B	CS(=O)(=O)N(CCN1CCOCC1)c1ccc(Nc2ncc3cnn(C4CCCCCC4)c3n2)cc1		CHEMBL1825089	=	IC50	nM	14.0	CHEMBL4722	Homo sapiens	IC50	uM	0.014
	6338975	CHEMBL1825458	Inhibition of Aurora kinase A assessed as phosphorylation of Lats2 substrate at 0.017 to 30 nM by FRET assay	B	CS(=O)(=O)Nc1ccc(Nc2ncc3cnn(C4CCCCCC4)c3n2)cn1		CHEMBL1825096	=	IC50	nM	17.0	CHEMBL4722	Homo sapiens	IC50	uM	0.017
	6338976	CHEMBL1825458	Inhibition of Aurora kinase A assessed as phosphorylation of Lats2 substrate at 0.017 to 30 nM by FRET assay	B	CS(=O)(=O)N(CCN)c1ccc(Nc2ncc3cnn(C4CCCCCC4)c3n2)cc1		CHEMBL1825093	=	IC50	nM	20.0	CHEMBL4722	Homo sapiens	IC50	uM	0.02
	6338979	CHEMBL1825458	Inhibition of Aurora kinase A assessed as phosphorylation of Lats2 substrate at 0.017 to 30 nM by FRET assay	B	CS(=O)(=O)N(Cc1ccncc1)c1ccc(Nc2ncc3cnn(C4CCCCCC4)c3n2)cc1		CHEMBL1825094	=	IC50	nM	30.0	CHEMBL4722	Homo sapiens	IC50	uM	0.03
	6338990	CHEMBL1825458	Inhibition of Aurora kinase A assessed as phosphorylation of Lats2 substrate at 0.017 to 30 nM by FRET assay	B	CS(=O)(=O)N(Cc1ccncc1)c1ccc(Nc2ncc3cnn(C4CCCCCC4)c3n2)cn1		CHEMBL1825102	=	IC50	nM	95.0	CHEMBL4722	Homo sapiens	IC50	uM	0.095
	6338996	CHEMBL1825458	Inhibition of Aurora kinase A assessed as phosphorylation of Lats2 substrate at 0.017 to 30 nM by FRET assay	B	CS(=O)(=O)N(CCO)c1ccc(Nc2ncc3cnn(C4CCCCCC4)c3n2)cn1		CHEMBL1825100	=	IC50	nM	110.0	CHEMBL4722	Homo sapiens	IC50	uM	0.11
	6339000	CHEMBL1825458	Inhibition of Aurora kinase A assessed as phosphorylation of Lats2 substrate at 0.017 to 30 nM by FRET assay	B	CS(=O)(=O)N(CCN1CCOCC1)c1ccc(Nc2ncc3cnn(C4CCCCCC4)c3n2)cn1		CHEMBL1825097	=	IC50	nM	150.0	CHEMBL4722	Homo sapiens	IC50	uM	0.15
	6339003	CHEMBL1825458	Inhibition of Aurora kinase A assessed as phosphorylation of Lats2 substrate at 0.017 to 30 nM by FRET assay	B	CS(=O)(=O)N(CCN)c1ccc(Nc2ncc3cnn(C4CCCCCC4)c3n2)cn1		CHEMBL1825101	=	IC50	nM	180.0	CHEMBL4722	Homo sapiens	IC50	uM	0.18
	6339008	CHEMBL1825458	Inhibition of Aurora kinase A assessed as phosphorylation of Lats2 substrate at 0.017 to 30 nM by FRET assay	B	CN(C)CCN(c1ccc(Nc2ncc3cnn(C4CCCCCC4)c3n2)cn1)S(C)(=O)=O		CHEMBL1825099	=	IC50	nM	260.0	CHEMBL4722	Homo sapiens	IC50	uM	0.26
	6339017	CHEMBL1825458	Inhibition of Aurora kinase A assessed as phosphorylation of Lats2 substrate at 0.017 to 30 nM by FRET assay	B	CS(=O)(=O)N(CCN1CCCC1)c1ccc(Nc2ncc3cnn(C4CCCCCC4)c3n2)cn1		CHEMBL1825098	=	IC50	nM	350.0	CHEMBL4722	Homo sapiens	IC50	uM	0.35
	6339042	CHEMBL1825458	Inhibition of Aurora kinase A assessed as phosphorylation of Lats2 substrate at 0.017 to 30 nM by FRET assay	B	CS(=O)(=O)N(c1ccc(Nc2ncc3cnn(C4CCCCCC4)c3n2)nc1)S(C)(=O)=O		CHEMBL1825103	>	IC50	nM	10000.0	CHEMBL4722	Homo sapiens	IC50	uM	10.0
	6339237	CHEMBL1828184	Inhibition of Aurora-A activity by fluorescence polarization assay	B	CCc1cc2c(cc1N1CCN(C3COC3)CC1)C(C)(C)c1[nH]c3cc(C#N)ccc3c1C2=O		CHEMBL1823221	>	IC50	nM	50000.0	CHEMBL4722	Homo sapiens	IC50	uM	50.0
	6339238	CHEMBL1828184	Inhibition of Aurora-A activity by fluorescence polarization assay	B	CC1(C)c2cc(C3CCN(C4COC4)CC3)ccc2C(=O)c2c1[nH]c1cc(C#N)ccc21		CHEMBL1779202	>	IC50	nM	50000.0	CHEMBL4722	Homo sapiens	IC50	uM	50.0
	6340225	CHEMBL1827042	Inhibition of aurora A at 1 uM	B	COc1n[nH]c2ncc(NC(=O)c3c(F)ccc(NS(=O)(=O)c4cccc(F)c4)c3F)cc12		CHEMBL1822258	=	Inhibition	%	52.0	CHEMBL4722	Homo sapiens	INH	%	52.0
	6340226	CHEMBL1827042	Inhibition of aurora A at 1 uM	B	COc1n[nH]c2ncc(NC(=O)c3c(F)ccc(NS(=O)(=O)N4CCCC4)c3F)cc12		CHEMBL1822099	=	Inhibition	%	47.0	CHEMBL4722	Homo sapiens	INH	%	47.0
	6340227	CHEMBL1827042	Inhibition of aurora A at 1 uM	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)Nc2cnc3[nH]nc(OC)c3c2)c1F		CHEMBL1822067	=	Inhibition	%	1.0	CHEMBL4722	Homo sapiens	INH	%	1.0
	6341021	CHEMBL1827751	Activity of AURKA kinase at 1 uM	B	CC(=O)Nc1cn2nc(-c3cnc(Cl)c(NS(=O)(=O)c4ccc(F)cc4)c3)ccc2n1		CHEMBL1822054	=	Activity	%	100.0	CHEMBL4722	Homo sapiens	Activity	%	100.0
	6342724	CHEMBL1827218	Binding affinity to Aurora A kinase catalytic domain by competitive binding assay	B	Cc1cc(Nc2nc(Sc3ccc(NC(=O)CN4C[C@H](Oc5ccc(F)cc5)[C@H](O)C4)cc3)nn3cccc23)n[nH]1		CHEMBL1822661	=	Kd	nM	7.0	CHEMBL4722	Homo sapiens	Kd	nM	7.0
	6342729	CHEMBL1827218	Binding affinity to Aurora A kinase catalytic domain by competitive binding assay	B	Cc1cc(Nc2nc(Sc3ccc(NC(=O)CN4C[C@H](O)[C@@H](Oc5cc(F)cc(F)c5)C4)cc3)nn3cccc23)n[nH]1		CHEMBL1822660	=	Kd	nM	26.0	CHEMBL4722	Homo sapiens	Kd	nM	26.0
	6342734	CHEMBL1827218	Binding affinity to Aurora A kinase catalytic domain by competitive binding assay	B	Cc1cc(Nc2nc(Sc3ccc(NC(=O)CN4C[C@H](O)[C@@H](Oc5ccc(F)cc5F)C4)cc3)nn3cccc23)n[nH]1		CHEMBL1822659	=	Kd	nM	13.0	CHEMBL4722	Homo sapiens	Kd	nM	13.0
	6342746	CHEMBL1827218	Binding affinity to Aurora A kinase catalytic domain by competitive binding assay	B	Cc1cc(Nc2nc(Sc3ccc(NC(=O)CN4C[C@H](O)[C@@H](Oc5ccc(F)cc5)C4)cc3)nn3cccc23)n[nH]1		CHEMBL1822658	=	Kd	nM	15.0	CHEMBL4722	Homo sapiens	Kd	nM	15.0
	6342751	CHEMBL1827218	Binding affinity to Aurora A kinase catalytic domain by competitive binding assay	B	Cc1cc(Nc2nc(Sc3ccc(NC(=O)CN4C[C@H](O)[C@@H](Oc5cccc(F)c5)C4)cc3)nn3cccc23)n[nH]1		CHEMBL1822657	=	Kd	nM	17.0	CHEMBL4722	Homo sapiens	Kd	nM	17.0
	6342756	CHEMBL1827218	Binding affinity to Aurora A kinase catalytic domain by competitive binding assay	B	Cc1cc(Nc2nc(Sc3ccc(NC(=O)CN4C[C@H](O)[C@@H](Oc5ccccc5F)C4)cc3)nn3cccc23)n[nH]1		CHEMBL1822656	=	Kd	nM	10.0	CHEMBL4722	Homo sapiens	Kd	nM	10.0
	6342761	CHEMBL1827218	Binding affinity to Aurora A kinase catalytic domain by competitive binding assay	B	Cc1cc(Nc2nc(Sc3ccc(NC(=O)CN4CC(=NO)[C@@H](OC(C)(C)C)C4)cc3)nn3cccc23)n[nH]1		CHEMBL1822655	=	Kd	nM	9.0	CHEMBL4722	Homo sapiens	Kd	nM	9.0
	6342766	CHEMBL1827218	Binding affinity to Aurora A kinase catalytic domain by competitive binding assay	B	Cc1cc(Nc2nc(Sc3ccc(NC(=O)CN4C[C@H](O)[C@@H](OC5CCCC5)C4)cc3)nn3cccc23)n[nH]1		CHEMBL1822654	=	Kd	nM	11.0	CHEMBL4722	Homo sapiens	Kd	nM	11.0
	6342771	CHEMBL1827218	Binding affinity to Aurora A kinase catalytic domain by competitive binding assay	B	Cc1cc(Nc2nc(Sc3ccc(NC(=O)CN4C[C@H](O)[C@@H](OCC5CC5)C4)cc3)nn3cccc23)n[nH]1		CHEMBL1822653	=	Kd	nM	7.0	CHEMBL4722	Homo sapiens	Kd	nM	7.0
	6342776	CHEMBL1827218	Binding affinity to Aurora A kinase catalytic domain by competitive binding assay	B	Cc1cc(Nc2nc(Sc3ccc(NC(=O)CN4C[C@H](O)[C@@H](OC(C)C)C4)cc3)nn3cccc23)n[nH]1		CHEMBL1822652	=	Kd	nM	8.0	CHEMBL4722	Homo sapiens	Kd	nM	8.0
	6342781	CHEMBL1827218	Binding affinity to Aurora A kinase catalytic domain by competitive binding assay	B	COCCO[C@H]1CN(CC(=O)Nc2ccc(Sc3nc(Nc4cc(C)[nH]n4)c4cccn4n3)cc2)C[C@@H]1O		CHEMBL1822651	=	Kd	nM	5.0	CHEMBL4722	Homo sapiens	Kd	nM	5.0
	6342786	CHEMBL1827218	Binding affinity to Aurora A kinase catalytic domain by competitive binding assay	B	CCC(C)(C)O[C@H]1CN(CC(=O)Nc2ccc(Sc3nc(Nc4cc(C)[nH]n4)c4cccn4n3)cc2)C[C@@H]1O		CHEMBL1822650	=	Kd	nM	8.0	CHEMBL4722	Homo sapiens	Kd	nM	8.0
	6342791	CHEMBL1827218	Binding affinity to Aurora A kinase catalytic domain by competitive binding assay	B	Cc1cc(Nc2nc(Sc3ccc(NC(=O)CN4C[C@H](O)[C@@H](OC(C)(C)C(F)(F)F)C4)cc3)nn3cccc23)n[nH]1		CHEMBL1822649	=	Kd	nM	6.0	CHEMBL4722	Homo sapiens	Kd	nM	6.0
	6342796	CHEMBL1827218	Binding affinity to Aurora A kinase catalytic domain by competitive binding assay	B	Cc1cc(Nc2nc(Sc3ccc(NC(=O)CN4C[C@H](O)[C@@H](F)C4)cc3)nn3cccc23)n[nH]1		CHEMBL1822648	=	Kd	nM	5.0	CHEMBL4722	Homo sapiens	Kd	nM	5.0
	6342805	CHEMBL1827218	Binding affinity to Aurora A kinase catalytic domain by competitive binding assay	B	Cc1cc(Nc2nc(Sc3ccc(NC(=O)CN4C[C@H](O)[C@@H](OC(C)(C)C)C4)cc3)nn3cccc23)n[nH]1		CHEMBL1822647	=	Kd	nM	12.0	CHEMBL4722	Homo sapiens	Kd	nM	12.0
	6342810	CHEMBL1827218	Binding affinity to Aurora A kinase catalytic domain by competitive binding assay	B	Cc1cc(Nc2nc(Sc3ccc(NC(=O)CN4C[C@H](N)C[C@H]4CO)cc3)nn3cccc23)n[nH]1		CHEMBL1822646	=	Kd	nM	381.0	CHEMBL4722	Homo sapiens	Kd	nM	381.0
	6342815	CHEMBL1827218	Binding affinity to Aurora A kinase catalytic domain by competitive binding assay	B	Cc1cc(Nc2nc(Sc3ccc(NC(=O)CN4C[C@H](O)C[C@H]4CO)cc3)nn3cccc23)n[nH]1		CHEMBL1822645	=	Kd	nM	58.0	CHEMBL4722	Homo sapiens	Kd	nM	58.0
	6342820	CHEMBL1827218	Binding affinity to Aurora A kinase catalytic domain by competitive binding assay	B	Cc1cc(Nc2nc(Sc3ccc(NC(=O)CN4C[C@H](SC(C)(C)C)C[C@H]4CO)cc3)nn3cccc23)n[nH]1		CHEMBL1822644	=	Kd	nM	111.0	CHEMBL4722	Homo sapiens	Kd	nM	111.0
	6342825	CHEMBL1827218	Binding affinity to Aurora A kinase catalytic domain by competitive binding assay	B	Cc1cc(Nc2nc(Sc3ccc(NC(=O)CN4C[C@H](OC(C)(C)C)C[C@@H]4CO)cc3)nn3cccc23)n[nH]1		CHEMBL1822643	=	Kd	nM	301.0	CHEMBL4722	Homo sapiens	Kd	nM	301.0
	6342830	CHEMBL1827218	Binding affinity to Aurora A kinase catalytic domain by competitive binding assay	B	Cc1cc(Nc2nc(Sc3ccc(NC(=O)CN4C[C@H](Oc5ccc(F)cc5)C[C@H]4CO)cc3)nn3cccc23)n[nH]1		CHEMBL1822642	=	Kd	nM	53.0	CHEMBL4722	Homo sapiens	Kd	nM	53.0
	6342835	CHEMBL1827218	Binding affinity to Aurora A kinase catalytic domain by competitive binding assay	B	Cc1cc(Nc2nc(Sc3ccc(NC(=O)CN4C[C@H]5C[C@H]5[C@H]4CO)cc3)nn3cccc23)n[nH]1		CHEMBL1822641	=	Kd	nM	17.0	CHEMBL4722	Homo sapiens	Kd	nM	17.0
	6342840	CHEMBL1827218	Binding affinity to Aurora A kinase catalytic domain by competitive binding assay	B	Cc1cc(Nc2nc(Sc3ccc(NC(=O)CN4C[C@@H](F)C[C@H]4CO)cc3)nn3cccc23)n[nH]1		CHEMBL1822640	=	Kd	nM	8.0	CHEMBL4722	Homo sapiens	Kd	nM	8.0
	6342845	CHEMBL1827218	Binding affinity to Aurora A kinase catalytic domain by competitive binding assay	B	Cc1cc(Nc2nc(Sc3ccc(NC(=O)CN4C[C@H](F)C[C@H]4CO)cc3)nn3cccc23)n[nH]1		CHEMBL1822639	=	Kd	nM	15.0	CHEMBL4722	Homo sapiens	Kd	nM	15.0
	6342850	CHEMBL1827218	Binding affinity to Aurora A kinase catalytic domain by competitive binding assay	B	Cc1cc(Nc2nc(Sc3ccc(NC(=O)CN4CC(F)(F)C[C@H]4CO)cc3)nn3cccc23)n[nH]1		CHEMBL1822638	=	Kd	nM	8.0	CHEMBL4722	Homo sapiens	Kd	nM	8.0
	6342859	CHEMBL1827218	Binding affinity to Aurora A kinase catalytic domain by competitive binding assay	B	Cc1cc(Nc2nc(Sc3ccc(NC(=O)CN4C[C@H](OC(C)(C)C)C[C@H]4CO)cc3)nn3cccc23)n[nH]1		CHEMBL1822637	=	Kd	nM	9.0	CHEMBL4722	Homo sapiens	Kd	nM	9.0
	6342864	CHEMBL1827218	Binding affinity to Aurora A kinase catalytic domain by competitive binding assay	B	Cc1cc(Nc2nc(Sc3ccc(NC(=O)CN4CCC[C@H]4CO)cc3)nn3cccc23)n[nH]1		CHEMBL1822495	=	Kd	nM	14.0	CHEMBL4722	Homo sapiens	Kd	nM	14.0
	6342869	CHEMBL1827218	Binding affinity to Aurora A kinase catalytic domain by competitive binding assay	B	Cc1cc(Nc2nc(Sc3ccc(NC(=O)CN(C)C)cc3)nn3cccc23)n[nH]1		CHEMBL1822494	=	Kd	nM	31.0	CHEMBL4722	Homo sapiens	Kd	nM	31.0
	6342874	CHEMBL1827218	Binding affinity to Aurora A kinase catalytic domain by competitive binding assay	B	Cc1cc(Nc2nc(Sc3ccc(NC(=O)CN4CCOCC4)cc3)nn3cccc23)n[nH]1		CHEMBL1822493	=	Kd	nM	85.0	CHEMBL4722	Homo sapiens	Kd	nM	85.0
	6342879	CHEMBL1827218	Binding affinity to Aurora A kinase catalytic domain by competitive binding assay	B	Cc1cc(Nc2nc(Sc3ccc(NC(=O)CNC4CCCC4)cc3)nn3cccc23)n[nH]1		CHEMBL1822492	=	Kd	nM	143.0	CHEMBL4722	Homo sapiens	Kd	nM	143.0
	6342884	CHEMBL1827218	Binding affinity to Aurora A kinase catalytic domain by competitive binding assay	B	Cc1cc(Nc2nc(Sc3ccc(NC(=O)CNC4CC4)cc3)nn3cccc23)n[nH]1		CHEMBL1822491	=	Kd	nM	32.0	CHEMBL4722	Homo sapiens	Kd	nM	32.0
	6342893	CHEMBL1827218	Binding affinity to Aurora A kinase catalytic domain by competitive binding assay	B	Cc1cc(Nc2nc(Sc3ccc(NC(=O)C4CC4)cc3)nn3cccc23)n[nH]1		CHEMBL1822485	=	Kd	nM	12.0	CHEMBL4722	Homo sapiens	Kd	nM	12.0
	6342898	CHEMBL1827218	Binding affinity to Aurora A kinase catalytic domain by competitive binding assay	B	Cc1cc(Nc2nc(Sc3ccc(NC(=O)C4CC4)cc3)nn3cc(NC(=O)CCN4CCCCC4)cc23)n[nH]1		CHEMBL1822486	=	Kd	nM	38.0	CHEMBL4722	Homo sapiens	Kd	nM	38.0
	6342903	CHEMBL1827218	Binding affinity to Aurora A kinase catalytic domain by competitive binding assay	B	Cc1cc(Nc2nc(Sc3ccc(NC(=O)C4CC4)cc3)nn3cc(NC(=O)CN4CCOCC4)cc23)n[nH]1		CHEMBL1822487	=	Kd	nM	7.0	CHEMBL4722	Homo sapiens	Kd	nM	7.0
	6342908	CHEMBL1827218	Binding affinity to Aurora A kinase catalytic domain by competitive binding assay	B	Cc1cc(Nc2nc(Sc3ccc(NC(=O)C4CC4)cc3)nn3cc(NC(=O)CN4CCCC4)cc23)n[nH]1		CHEMBL1822488	=	Kd	nM	23.0	CHEMBL4722	Homo sapiens	Kd	nM	23.0
	6342913	CHEMBL1827218	Binding affinity to Aurora A kinase catalytic domain by competitive binding assay	B	Cc1cc(Nc2nc(Sc3ccc(NC(=O)C4CC4)cc3)nn3cc(NC(=O)CN4CCC[C@@H]4CO)cc23)n[nH]1		CHEMBL1822489	=	Kd	nM	10.0	CHEMBL4722	Homo sapiens	Kd	nM	10.0
	6342918	CHEMBL1827218	Binding affinity to Aurora A kinase catalytic domain by competitive binding assay	B	Cc1cc(Nc2nc(Sc3ccc(NC(=O)C4CC4)cc3)nn3cc(NC(=O)C(=O)N4CCN(C)CC4)cc23)n[nH]1		CHEMBL1822490	=	Kd	nM	7.0	CHEMBL4722	Homo sapiens	Kd	nM	7.0
	6342927	CHEMBL1827218	Binding affinity to Aurora A kinase catalytic domain by competitive binding assay	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	Kd	nM	4.0	CHEMBL4722	Homo sapiens	Kd	nM	4.0
	6347908	CHEMBL1828476	Inhibition of human AURKA activity using Ser/Thr 1 peptide as substrate by FRET assay	B	COc1ccc(CNC(=O)Nc2ncc([N+](=O)[O-])s2)cc1	Outside typical range	CHEMBL259850	>	IC50	nM	100000000.0	CHEMBL4722	Homo sapiens	IC50	mM	100.0
	6347914	CHEMBL1828476	Inhibition of human AURKA activity using Ser/Thr 1 peptide as substrate by FRET assay	B	COc1ccc(CNC(=O)Nc2cc(C#N)ccn2)cc1	Outside typical range	CHEMBL1824539	>	IC50	nM	100000000.0	CHEMBL4722	Homo sapiens	IC50	mM	100.0
	6347920	CHEMBL1828476	Inhibition of human AURKA activity using Ser/Thr 1 peptide as substrate by FRET assay	B	COc1ccc(CNC(=O)Nc2nc3ccc([N+](=O)[O-])cc3s2)cc1	Outside typical range	CHEMBL1824540	>	IC50	nM	100000000.0	CHEMBL4722	Homo sapiens	IC50	mM	100.0
	6347926	CHEMBL1828476	Inhibition of human AURKA activity using Ser/Thr 1 peptide as substrate by FRET assay	B	COc1ccc(CNC(=O)Nc2cc(-c3nnn[nH]3)ccn2)cc1	Outside typical range	CHEMBL1824334	>	IC50	nM	100000000.0	CHEMBL4722	Homo sapiens	IC50	mM	100.0
	6347932	CHEMBL1828476	Inhibition of human AURKA activity using Ser/Thr 1 peptide as substrate by FRET assay	B	COc1ccc(CNC(=O)Nc2nc3ccc(-c4nnn[nH]4)cc3s2)cc1	Outside typical range	CHEMBL1824332	=	IC50	nM	4800000.0	CHEMBL4722	Homo sapiens	IC50	mM	4.8
	6352189	CHEMBL1825644	Inhibition of Aurora A assessed as residual activity at 10 uM by radioactivity assay in presence of 5 uM ATP	B	Nc1n[nH]c(N)c1/N=N/c1ccc(O)cc1		CHEMBL215205	=	Activity	%	107.0	CHEMBL4722	Homo sapiens	Activity	%	107.0
	6353449	CHEMBL1825695	Inhibition of AURKA at 10 uM	B	O=C(Cn1c(=O)ccc2cc(C(F)(F)F)ccc21)Nc1scc(Br)c1-c1ncn[nH]1		CHEMBL1822146	=	Inhibition	%	5.0	CHEMBL4722	Homo sapiens	INH	%	5.0
	6360780	CHEMBL1831496	Inhibition of GST-tagged Aurora A kinase expressed in insect cells assessed as inhibition of [33P]gamma-ATP incorporation in substrate after 60 mins by scintillation counting	B	COc1ccc(-c2cc3ncc(S(=O)(=O)c4ccccc4)c(-c4ccccc4)n3n2)cc1		CHEMBL1830670	=	IC50	nM	25.0	CHEMBL4722	Homo sapiens	IC50	uM	0.025
	6360781	CHEMBL1831496	Inhibition of GST-tagged Aurora A kinase expressed in insect cells assessed as inhibition of [33P]gamma-ATP incorporation in substrate after 60 mins by scintillation counting	B	O=S(=O)(c1ccccc1)c1cnc2c(Br)c(-c3ccccc3)nn2c1-c1ccccc1		CHEMBL1830673	=	IC50	nM	39.0	CHEMBL4722	Homo sapiens	IC50	uM	0.039
	6360782	CHEMBL1831496	Inhibition of GST-tagged Aurora A kinase expressed in insect cells assessed as inhibition of [33P]gamma-ATP incorporation in substrate after 60 mins by scintillation counting	B	COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1		CHEMBL53463	=	IC50	nM	40.0	CHEMBL4722	Homo sapiens	IC50	uM	0.04
	6360783	CHEMBL1831496	Inhibition of GST-tagged Aurora A kinase expressed in insect cells assessed as inhibition of [33P]gamma-ATP incorporation in substrate after 60 mins by scintillation counting	B	O=S(=O)(c1ccccc1)c1cnc2cc(-c3ccccc3)nn2c1-c1ccccc1		CHEMBL1830669	=	IC50	nM	51.0	CHEMBL4722	Homo sapiens	IC50	uM	0.051
	6360784	CHEMBL1831496	Inhibition of GST-tagged Aurora A kinase expressed in insect cells assessed as inhibition of [33P]gamma-ATP incorporation in substrate after 60 mins by scintillation counting	B	Cc1cc2ncc(S(=O)(=O)c3ccccc3)c(-c3ccccc3)n2n1		CHEMBL1830668	=	IC50	nM	101.0	CHEMBL4722	Homo sapiens	IC50	uM	0.101
	6360785	CHEMBL1831496	Inhibition of GST-tagged Aurora A kinase expressed in insect cells assessed as inhibition of [33P]gamma-ATP incorporation in substrate after 60 mins by scintillation counting	B	O=S(=O)(c1ccccc1)c1cnc2ncnn2c1-c1ccccc1		CHEMBL1830680	=	IC50	nM	104.0	CHEMBL4722	Homo sapiens	IC50	uM	0.104
	6360786	CHEMBL1831496	Inhibition of GST-tagged Aurora A kinase expressed in insect cells assessed as inhibition of [33P]gamma-ATP incorporation in substrate after 60 mins by scintillation counting	B	O=S(=O)(c1ccccc1)c1cnc2cc(-c3ccc(Cl)cc3)nn2c1-c1ccccc1		CHEMBL1830671	=	IC50	nM	120.0	CHEMBL4722	Homo sapiens	IC50	uM	0.12
	6360867	CHEMBL1831496	Inhibition of GST-tagged Aurora A kinase expressed in insect cells assessed as inhibition of [33P]gamma-ATP incorporation in substrate after 60 mins by scintillation counting	B	O=S(=O)(c1ccccc1)c1cnc2ncnn2c1-c1ccc(Cl)cc1		CHEMBL1830681	=	IC50	nM	9238.0	CHEMBL4722	Homo sapiens	IC50	uM	9.238
Not Active	6360878	CHEMBL1831496	Inhibition of GST-tagged Aurora A kinase expressed in insect cells assessed as inhibition of [33P]gamma-ATP incorporation in substrate after 60 mins by scintillation counting	B	Cc1nn2c(-c3ccccc3)c(S(=O)(=O)c3ccccc3)cnc2c1Br		CHEMBL1830672		IC50			CHEMBL4722	Homo sapiens	IC50		
Not Active	6360879	CHEMBL1831496	Inhibition of GST-tagged Aurora A kinase expressed in insect cells assessed as inhibition of [33P]gamma-ATP incorporation in substrate after 60 mins by scintillation counting	B	O=S(=O)(c1ccccc1)c1cnc2cc(-c3ccccc3)nn2c1-c1ccc(Cl)cc1		CHEMBL1830674		IC50			CHEMBL4722	Homo sapiens	IC50		
Not Active	6360880	CHEMBL1831496	Inhibition of GST-tagged Aurora A kinase expressed in insect cells assessed as inhibition of [33P]gamma-ATP incorporation in substrate after 60 mins by scintillation counting	B	COc1ccc(-c2cc3ncc(S(=O)(=O)c4ccccc4)c(-c4ccc(Cl)cc4)n3n2)cc1		CHEMBL1830675		IC50			CHEMBL4722	Homo sapiens	IC50		
Not Active	6360881	CHEMBL1831496	Inhibition of GST-tagged Aurora A kinase expressed in insect cells assessed as inhibition of [33P]gamma-ATP incorporation in substrate after 60 mins by scintillation counting	B	Cc1ccc(-c2c(S(=O)(=O)c3ccccc3)cnc3cc(-c4ccccc4)nn23)cc1		CHEMBL486095		IC50			CHEMBL4722	Homo sapiens	IC50		
Not Active	6360882	CHEMBL1831496	Inhibition of GST-tagged Aurora A kinase expressed in insect cells assessed as inhibition of [33P]gamma-ATP incorporation in substrate after 60 mins by scintillation counting	B	Cc1ccc(-c2c(S(=O)(=O)c3ccccc3)cnc3c(Br)c(-c4ccccc4)nn23)cc1		CHEMBL487740		IC50			CHEMBL4722	Homo sapiens	IC50		
Not Active	6360883	CHEMBL1831496	Inhibition of GST-tagged Aurora A kinase expressed in insect cells assessed as inhibition of [33P]gamma-ATP incorporation in substrate after 60 mins by scintillation counting	B	Cc1ccc(-c2c(S(=O)(=O)c3ccccc3)cnc3cc(-c4ccc(Cl)cc4)nn23)cc1		CHEMBL1830676		IC50			CHEMBL4722	Homo sapiens	IC50		
Not Active	6360884	CHEMBL1831496	Inhibition of GST-tagged Aurora A kinase expressed in insect cells assessed as inhibition of [33P]gamma-ATP incorporation in substrate after 60 mins by scintillation counting	B	Cc1ccc(-c2cc3ncc(S(=O)(=O)c4ccccc4)c(-c4ccc(C)cc4)n3n2)cc1		CHEMBL521360		IC50			CHEMBL4722	Homo sapiens	IC50		
Not Active	6360885	CHEMBL1831496	Inhibition of GST-tagged Aurora A kinase expressed in insect cells assessed as inhibition of [33P]gamma-ATP incorporation in substrate after 60 mins by scintillation counting	B	O=S(=O)(c1ccccc1)c1cnc2nc3ccccc3n2c1-c1ccccc1		CHEMBL1830677		IC50			CHEMBL4722	Homo sapiens	IC50		
Not Active	6360886	CHEMBL1831496	Inhibition of GST-tagged Aurora A kinase expressed in insect cells assessed as inhibition of [33P]gamma-ATP incorporation in substrate after 60 mins by scintillation counting	B	O=S(=O)(c1ccccc1)c1cnc2nc3ccccc3n2c1-c1ccc(Cl)cc1		CHEMBL1830678		IC50			CHEMBL4722	Homo sapiens	IC50		
Not Active	6360887	CHEMBL1831496	Inhibition of GST-tagged Aurora A kinase expressed in insect cells assessed as inhibition of [33P]gamma-ATP incorporation in substrate after 60 mins by scintillation counting	B	O=S(=O)(c1ccccc1)c1cnc2nc3ccccc3n2c1-c1ccc(Br)cc1		CHEMBL1830679		IC50			CHEMBL4722	Homo sapiens	IC50		
	6373523	CHEMBL1840410	Inhibition of Aurora A by spectrophotometry	B	COc1ccccc1Nc1nc(N)n(-c2ccccn2)n1		CHEMBL1835741	>	Ki	nM	7000.0	CHEMBL4722	Homo sapiens	Ki	nM	7000.0
	6373528	CHEMBL1840410	Inhibition of Aurora A by spectrophotometry	B	Nc1nc(Nc2ccccc2Cl)nn1-c1ccccn1		CHEMBL1835742	=	Ki	nM	2000.0	CHEMBL4722	Homo sapiens	Ki	nM	2000.0
	6373533	CHEMBL1840410	Inhibition of Aurora A by spectrophotometry	B	COc1ccc(N2CCOCC2)cc1Nc1nc(N)n(-c2ccccn2)n1		CHEMBL1833992	>	Ki	nM	4000.0	CHEMBL4722	Homo sapiens	Ki	nM	4000.0
	6373538	CHEMBL1840410	Inhibition of Aurora A by spectrophotometry	B	Nc1nc(Nc2cc(N3CCOCC3)ccc2F)nn1-c1ccccn1		CHEMBL1835743	>	Ki	nM	3000.0	CHEMBL4722	Homo sapiens	Ki	nM	3000.0
	6373543	CHEMBL1840410	Inhibition of Aurora A by spectrophotometry	B	N#Cc1ccc(-n2nc(Nc3ccccc3Cl)nc2N)nc1		CHEMBL1835744	>	Ki	nM	2500.0	CHEMBL4722	Homo sapiens	Ki	nM	2500.0
	6373548	CHEMBL1840410	Inhibition of Aurora A by spectrophotometry	B	COc1cc(N2CCOCC2)ccc1Nc1nc(N)n(-c2ccc(C#N)cn2)n1		CHEMBL1835745	=	Ki	nM	2600.0	CHEMBL4722	Homo sapiens	Ki	nM	2600.0
	6373553	CHEMBL1840410	Inhibition of Aurora A by spectrophotometry	B	COc1ccccc1Nc1nc(N)n(-c2cc(NCCN(C)C)ncn2)n1		CHEMBL1835746	=	Ki	nM	2100.0	CHEMBL4722	Homo sapiens	Ki	nM	2100.0
	6374728	CHEMBL1840410	Inhibition of Aurora A by spectrophotometry	B	COc1ccc(Nc2nc(N)n(-c3ccccn3)n2)cc1OC		CHEMBL1835740	=	Ki	nM	103.0	CHEMBL4722	Homo sapiens	Ki	nM	103.0
	6375153	CHEMBL1838152	Inhibition of Aurora A at 1 uM	B	CC(=O)Nc1ccc(-c2cc3ncnc(SCC(=O)O)c3s2)cc1		CHEMBL1836724	=	Inhibition	%	50.5	CHEMBL4722	Homo sapiens	INH	%	50.5
	6375156	CHEMBL1838152	Inhibition of Aurora A at 1 uM	B	O=C(O)COc1ncnc2cc(-c3ccc4[nH]ncc4c3)sc12		CHEMBL1836641	=	Inhibition	%	88.5	CHEMBL4722	Homo sapiens	INH	%	88.5
	6385613	CHEMBL1837982	Inhibition of human AurA in HL60 cells lysate at 10 uM using post probe-labeling by LC-MS/MS analysis relative to control	B	Nc1c(F)c(NCCCc2ccccc2)c(F)c2c1c(=O)c(C(=O)O)cn2C1CC1		CHEMBL1834114	<	Inhibition	%	35.0	CHEMBL4722	Homo sapiens	INH	%	35.0
	6385614	CHEMBL1837982	Inhibition of human AurA in HL60 cells lysate at 10 uM using post probe-labeling by LC-MS/MS analysis relative to control	B	Nc1c(F)c(NCCNc2ccccn2)c(F)c2c1c(=O)c(C(=O)O)cn2C1CCCC1		CHEMBL1834318	<	Inhibition	%	35.0	CHEMBL4722	Homo sapiens	INH	%	35.0
	6385615	CHEMBL1837982	Inhibition of human AurA in HL60 cells lysate at 10 uM using post probe-labeling by LC-MS/MS analysis relative to control	B	C[C@H]1COc2c(NCCNc3ccccn3)c(F)c(N)c3c(=O)c(C(=O)O)cn1c23		CHEMBL1834323	<	Inhibition	%	35.0	CHEMBL4722	Homo sapiens	INH	%	35.0
	6385616	CHEMBL1837982	Inhibition of human AurA in HL60 cells lysate at 10 uM using post probe-labeling by LC-MS/MS analysis relative to control	B	CC(C)[C@@H]1COc2c(NCCNc3ccccn3)c(F)c(N)c3c(=O)c(C(=O)O)cn1c23		CHEMBL1834324	<	Inhibition	%	35.0	CHEMBL4722	Homo sapiens	INH	%	35.0
	6385617	CHEMBL1837982	Inhibition of human AurA in HL60 cells lysate at 10 uM using post probe-labeling by LC-MS/MS analysis relative to control	B	Nc1c(F)c(NCCNc2ccccn2)c2c3c1c(=O)c(C(=O)O)cn3C1(CCCC1)CO2		CHEMBL1834330	<	Inhibition	%	35.0	CHEMBL4722	Homo sapiens	INH	%	35.0
	6386370	CHEMBL1840403	Inhibition of recombinant Aurora A	B	CCN1CCN(c2ccc(Nc3cc(N(C)C(=O)Nc4c(Cl)c(OC)cc(OC)c4Cl)ncn3)cc2)CC1.O=P(O)(O)O		CHEMBL1834657	>	IC50	nM	10000.0	CHEMBL4722	Homo sapiens	IC50	uM	10.0
	7567314	CHEMBL1908616	Binding constant for AURKA kinase domain	B	COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1		CHEMBL491473	>	Kd	nM	10000.0	CHEMBL4722	Homo sapiens	Kd	nM	10000.0
	7567773	CHEMBL1908616	Binding constant for AURKA kinase domain	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	Kd	nM	10000.0	CHEMBL4722	Homo sapiens	Kd	nM	10000.0
	7568270	CHEMBL1908616	Binding constant for AURKA kinase domain	B	CSc1cccc(Nc2ncc3cc(-c4c(Cl)cccc4Cl)c(=O)n(C)c3n2)c1		CHEMBL386051	>	Kd	nM	10000.0	CHEMBL4722	Homo sapiens	Kd	nM	10000.0
	7568702	CHEMBL1908616	Binding constant for AURKA kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	>	Kd	nM	10000.0	CHEMBL4722	Homo sapiens	Kd	nM	10000.0
	7569287	CHEMBL1908616	Binding constant for AURKA kinase domain	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21		CHEMBL1614701	>	Kd	nM	10000.0	CHEMBL4722	Homo sapiens	Kd	nM	10000.0
	7569747	CHEMBL1908616	Binding constant for AURKA kinase domain	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	=	Kd	nM	260.0	CHEMBL4722	Homo sapiens	Kd	nM	260.0
	7569777	CHEMBL1908616	Binding constant for AURKA kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	Kd	nM	10000.0	CHEMBL4722	Homo sapiens	Kd	nM	10000.0
	7570240	CHEMBL1908616	Binding constant for AURKA kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1		CHEMBL450786	>	Kd	nM	10000.0	CHEMBL4722	Homo sapiens	Kd	nM	10000.0
	7570667	CHEMBL1908616	Binding constant for AURKA kinase domain	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Kd	nM	1700.0	CHEMBL4722	Homo sapiens	Kd	nM	1700.0
	7571263	CHEMBL1908616	Binding constant for AURKA kinase domain	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL513909	>	Kd	nM	10000.0	CHEMBL4722	Homo sapiens	Kd	nM	10000.0
	7571754	CHEMBL1908616	Binding constant for AURKA kinase domain	B	N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1		CHEMBL1789941	>	Kd	nM	10000.0	CHEMBL4722	Homo sapiens	Kd	nM	10000.0
	7572217	CHEMBL1908616	Binding constant for AURKA kinase domain	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	>	Kd	nM	10000.0	CHEMBL4722	Homo sapiens	Kd	nM	10000.0
	7572633	CHEMBL1908616	Binding constant for AURKA kinase domain	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL509032	=	Kd	nM	44.0	CHEMBL4722	Homo sapiens	Kd	nM	44.0
	7573259	CHEMBL1908616	Binding constant for AURKA kinase domain	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	=	Kd	nM	9300.0	CHEMBL4722	Homo sapiens	Kd	nM	9300.0
	7573735	CHEMBL1908616	Binding constant for AURKA kinase domain	B	CN(C)CC(=O)N1CCC(c2ccc(NC(=O)c3nc(C#N)c[nH]3)c(C3=CCCCC3)c2)CC1.Cl		CHEMBL1908395	>	Kd	nM	10000.0	CHEMBL4722	Homo sapiens	Kd	nM	10000.0
	7574204	CHEMBL1908616	Binding constant for AURKA kinase domain	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Kd	nM	120.0	CHEMBL4722	Homo sapiens	Kd	nM	120.0
	7574612	CHEMBL1908616	Binding constant for AURKA kinase domain	B	Nc1nc(N)c2nc(-c3cccc(O)c3)c(-c3cccc(O)c3)nc2n1		CHEMBL230011	>	Kd	nM	10000.0	CHEMBL4722	Homo sapiens	Kd	nM	10000.0
	7574780	CHEMBL1908616	Binding constant for AURKA kinase domain	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1		CHEMBL502835	>	Kd	nM	10000.0	CHEMBL4722	Homo sapiens	Kd	nM	10000.0
	7575241	CHEMBL1908616	Binding constant for AURKA kinase domain	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	=	Kd	nM	2200.0	CHEMBL4722	Homo sapiens	Kd	nM	2200.0
	7575712	CHEMBL1908616	Binding constant for AURKA kinase domain	B	COc1cc(Oc2ccnc3cc(OC)c(OC)cc23)ccc1NC(=O)NC(C)c1nccs1		CHEMBL1908396	=	Kd	nM	2300.0	CHEMBL4722	Homo sapiens	Kd	nM	2300.0
	7576177	CHEMBL1908616	Binding constant for AURKA kinase domain	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F		CHEMBL1230020	>	Kd	nM	10000.0	CHEMBL4722	Homo sapiens	Kd	nM	10000.0
	7576585	CHEMBL1908616	Binding constant for AURKA kinase domain	B	Cc1cnc(Nc2ccc(OCCN3CCCC3)cc2)nc1Nc1cccc(S(=O)(=O)NC(C)(C)C)c1		CHEMBL1287853	=	Kd	nM	4400.0	CHEMBL4722	Homo sapiens	Kd	nM	4400.0
	7576754	CHEMBL1908616	Binding constant for AURKA kinase domain	B	CN(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1		CHEMBL1173655	>	Kd	nM	10000.0	CHEMBL4722	Homo sapiens	Kd	nM	10000.0
	7577213	CHEMBL1908616	Binding constant for AURKA kinase domain	B	COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1		CHEMBL1230609	=	Kd	nM	440.0	CHEMBL4722	Homo sapiens	Kd	nM	440.0
	7577691	CHEMBL1908616	Binding constant for AURKA kinase domain	B	O=C(c1ccc(/C=C/c2n[nH]c3ccccc23)cc1)N1CCNCC1		CHEMBL1908397	=	Kd	nM	650.0	CHEMBL4722	Homo sapiens	Kd	nM	650.0
	7578161	CHEMBL1908616	Binding constant for AURKA kinase domain	B	CC(C)n1nc(-c2cc3cc(O)ccc3[nH]2)c2c(N)ncnc21		CHEMBL1241674	>	Kd	nM	10000.0	CHEMBL4722	Homo sapiens	Kd	nM	10000.0
	7578566	CHEMBL1908616	Binding constant for AURKA kinase domain	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	>	Kd	nM	10000.0	CHEMBL4722	Homo sapiens	Kd	nM	10000.0
	7578762	CHEMBL1908616	Binding constant for AURKA kinase domain	B	Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4ccccc4)c3)cc12		CHEMBL379218	>	Kd	nM	10000.0	CHEMBL4722	Homo sapiens	Kd	nM	10000.0
	7579136	CHEMBL1908616	Binding constant for AURKA kinase domain	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	>	Kd	nM	10000.0	CHEMBL4722	Homo sapiens	Kd	nM	10000.0
	7579586	CHEMBL1908616	Binding constant for AURKA kinase domain	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	>	Kd	nM	10000.0	CHEMBL4722	Homo sapiens	Kd	nM	10000.0
	7580060	CHEMBL1908616	Binding constant for AURKA kinase domain	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	10000.0	CHEMBL4722	Homo sapiens	Kd	nM	10000.0
	7580529	CHEMBL1908616	Binding constant for AURKA kinase domain	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	>	Kd	nM	10000.0	CHEMBL4722	Homo sapiens	Kd	nM	10000.0
	7581120	CHEMBL1908616	Binding constant for AURKA kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nc(-c2cccnc2)cs1		CHEMBL1908391	>	Kd	nM	10000.0	CHEMBL4722	Homo sapiens	Kd	nM	10000.0
	7581505	CHEMBL1908616	Binding constant for AURKA kinase domain	B	Cc1ccc2nc(NCCN)c3ncc(C)n3c2c1		CHEMBL249697	>	Kd	nM	10000.0	CHEMBL4722	Homo sapiens	Kd	nM	10000.0
	7581950	CHEMBL1908616	Binding constant for AURKA kinase domain	B	OCCn1cc(-c2ccc3c(c2)CC/C3=N\O)c(-c2ccncc2)n1		CHEMBL525191	>	Kd	nM	10000.0	CHEMBL4722	Homo sapiens	Kd	nM	10000.0
	7582421	CHEMBL1908616	Binding constant for AURKA kinase domain	B	Cn1cc(C2=C(c3cn(C4CCN(Cc5ccccn5)CC4)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL300138	>	Kd	nM	10000.0	CHEMBL4722	Homo sapiens	Kd	nM	10000.0
	7582843	CHEMBL1908616	Binding constant for AURKA kinase domain	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	Kd	nM	3.9	CHEMBL4722	Homo sapiens	Kd	nM	3.9
	7583466	CHEMBL1908616	Binding constant for AURKA kinase domain	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	=	Kd	nM	1600.0	CHEMBL4722	Homo sapiens	Kd	nM	1600.0
	7583863	CHEMBL1908616	Binding constant for AURKA kinase domain	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	=	Kd	nM	7400.0	CHEMBL4722	Homo sapiens	Kd	nM	7400.0
	7584308	CHEMBL1908616	Binding constant for AURKA kinase domain	B	CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL521851	>	Kd	nM	10000.0	CHEMBL4722	Homo sapiens	Kd	nM	10000.0
	7584799	CHEMBL1908616	Binding constant for AURKA kinase domain	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL475251	=	Kd	nM	160.0	CHEMBL4722	Homo sapiens	Kd	nM	160.0
	7585203	CHEMBL1908616	Binding constant for AURKA kinase domain	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	>	Kd	nM	10000.0	CHEMBL4722	Homo sapiens	Kd	nM	10000.0
	7585796	CHEMBL1908616	Binding constant for AURKA kinase domain	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	>	Kd	nM	10000.0	CHEMBL4722	Homo sapiens	Kd	nM	10000.0
	7586204	CHEMBL1908616	Binding constant for AURKA kinase domain	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)O)c(C)c34)ccc2[nH]1		CHEMBL377300	>	Kd	nM	10000.0	CHEMBL4722	Homo sapiens	Kd	nM	10000.0
	7586679	CHEMBL1908616	Binding constant for AURKA kinase domain	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	>	Kd	nM	10000.0	CHEMBL4722	Homo sapiens	Kd	nM	10000.0
	7587133	CHEMBL1908616	Binding constant for AURKA kinase domain	B	COc1ccc(F)c(F)c1C(=O)c1cnc(NC2CCN(S(C)(=O)=O)CC2)nc1N		CHEMBL384304	>	Kd	nM	10000.0	CHEMBL4722	Homo sapiens	Kd	nM	10000.0
	7587757	CHEMBL1908616	Binding constant for AURKA kinase domain	B	CNC(=O)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1		CHEMBL1289926	=	Kd	nM	72.0	CHEMBL4722	Homo sapiens	Kd	nM	72.0
	7588176	CHEMBL1908616	Binding constant for AURKA kinase domain	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	=	Kd	nM	16.0	CHEMBL4722	Homo sapiens	Kd	nM	16.0
	7588187	CHEMBL1908616	Binding constant for AURKA kinase domain	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	>	Kd	nM	10000.0	CHEMBL4722	Homo sapiens	Kd	nM	10000.0
	7588658	CHEMBL1908616	Binding constant for AURKA kinase domain	B	COc1c(Cl)cc2c([nH]c3cnccc32)c1NC(=O)c1cccnc1C		CHEMBL608154	>	Kd	nM	10000.0	CHEMBL4722	Homo sapiens	Kd	nM	10000.0
	7589109	CHEMBL1908616	Binding constant for AURKA kinase domain	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	>	Kd	nM	10000.0	CHEMBL4722	Homo sapiens	Kd	nM	10000.0
	7590171	CHEMBL1908616	Binding constant for AURKA kinase domain	B	CNC(=O)c1c(F)cccc1Nc1nc(Nc2cc3c(cc2OC)CCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL464552	>	Kd	nM	10000.0	CHEMBL4722	Homo sapiens	Kd	nM	10000.0
	7590645	CHEMBL1908616	Binding constant for AURKA kinase domain	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL4722	Homo sapiens	Kd	nM	10000.0
	7591096	CHEMBL1908616	Binding constant for AURKA kinase domain	B	Cn1cc(-c2ccc3nnc(Sc4ccc5ncccc5c4)n3n2)cn1		CHEMBL1236107	>	Kd	nM	10000.0	CHEMBL4722	Homo sapiens	Kd	nM	10000.0
	7591253	CHEMBL1908616	Binding constant for AURKA kinase domain	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	>	Kd	nM	10000.0	CHEMBL4722	Homo sapiens	Kd	nM	10000.0
	7591675	CHEMBL1908616	Binding constant for AURKA kinase domain	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	>	Kd	nM	10000.0	CHEMBL4722	Homo sapiens	Kd	nM	10000.0
	7592147	CHEMBL1908616	Binding constant for AURKA kinase domain	B	C[C@@H](Oc1cc(-n2cnc3ccc(CN4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1908394	>	Kd	nM	10000.0	CHEMBL4722	Homo sapiens	Kd	nM	10000.0
	7592620	CHEMBL1908616	Binding constant for AURKA kinase domain	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	=	Kd	nM	6.5	CHEMBL4722	Homo sapiens	Kd	nM	6.5
	7593073	CHEMBL1908616	Binding constant for AURKA kinase domain	B	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL288441	>	Kd	nM	10000.0	CHEMBL4722	Homo sapiens	Kd	nM	10000.0
	7593220	CHEMBL1908616	Binding constant for AURKA kinase domain	B	CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(Oc4cc(NC)ncn4)cc3)cc2C(F)(F)F)CC1		CHEMBL574738	>	Kd	nM	10000.0	CHEMBL4722	Homo sapiens	Kd	nM	10000.0
	7593655	CHEMBL1908616	Binding constant for AURKA kinase domain	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	>	Kd	nM	10000.0	CHEMBL4722	Homo sapiens	Kd	nM	10000.0
	7594127	CHEMBL1908616	Binding constant for AURKA kinase domain	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@H]3CCCNC3)c21		CHEMBL494089	>	Kd	nM	10000.0	CHEMBL4722	Homo sapiens	Kd	nM	10000.0
	7594600	CHEMBL1908616	Binding constant for AURKA kinase domain	B	Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1		CHEMBL255863	>	Kd	nM	10000.0	CHEMBL4722	Homo sapiens	Kd	nM	10000.0
	7595052	CHEMBL1908616	Binding constant for AURKA kinase domain	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	10000.0	CHEMBL4722	Homo sapiens	Kd	nM	10000.0
	7595188	CHEMBL1908616	Binding constant for AURKA kinase domain	B	O=C(NC1CCNCC1)c1n[nH]cc1NC(=O)c1c(Cl)cccc1Cl		CHEMBL445813	>	Kd	nM	10000.0	CHEMBL4722	Homo sapiens	Kd	nM	10000.0
	7595632	CHEMBL1908616	Binding constant for AURKA kinase domain	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	>	Kd	nM	10000.0	CHEMBL4722	Homo sapiens	Kd	nM	10000.0
	7596106	CHEMBL1908616	Binding constant for AURKA kinase domain	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	>	Kd	nM	10000.0	CHEMBL4722	Homo sapiens	Kd	nM	10000.0
	7596577	CHEMBL1908616	Binding constant for AURKA kinase domain	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	=	Kd	nM	7100.0	CHEMBL4722	Homo sapiens	Kd	nM	7100.0
	7597160	CHEMBL1908616	Binding constant for AURKA kinase domain	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	=	Kd	nM	400.0	CHEMBL4722	Homo sapiens	Kd	nM	400.0
	7597613	CHEMBL1908616	Binding constant for AURKA kinase domain	B	O=C(NOCC1CC1)c1ccc(F)c(F)c1Nc1ccc(I)cc1Cl		CHEMBL105442	>	Kd	nM	10000.0	CHEMBL4722	Homo sapiens	Kd	nM	10000.0
	7598086	CHEMBL1908616	Binding constant for AURKA kinase domain	B	CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL180022	>	Kd	nM	10000.0	CHEMBL4722	Homo sapiens	Kd	nM	10000.0
	7598556	CHEMBL1908616	Binding constant for AURKA kinase domain	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Kd	nM	17.0	CHEMBL4722	Homo sapiens	Kd	nM	17.0
Not Active	7841877	CHEMBL1913739	Inhibition of Aurora kinase A assessed as inhibition of substrate phosphorylation using fluorescent peptide substrate up to 100 uM by microplate reader assay	B	Cl.N=C(N)N/N=C\c1c(-c2cccc(C(F)(F)F)c2)nc2sccn12		CHEMBL1910604		Inhibition	%		CHEMBL4722	Homo sapiens	INH		
Not Active	7841878	CHEMBL1913739	Inhibition of Aurora kinase A assessed as inhibition of substrate phosphorylation using fluorescent peptide substrate up to 100 uM by microplate reader assay	B	Cl.N=C(N)N/N=C\c1c(-c2ccc(Br)c([N+](=O)[O-])c2)nc2sccn12		CHEMBL1909651		Inhibition	%		CHEMBL4722	Homo sapiens	INH		
Not Active	7841879	CHEMBL1913739	Inhibition of Aurora kinase A assessed as inhibition of substrate phosphorylation using fluorescent peptide substrate up to 100 uM by microplate reader assay	B	Cc1cn2c(/C=N\NC(=N)N)c(-c3ccc(F)cc3)nc2s1.Cl		CHEMBL1910605		Inhibition	%		CHEMBL4722	Homo sapiens	INH		
Not Active	7841880	CHEMBL1913739	Inhibition of Aurora kinase A assessed as inhibition of substrate phosphorylation using fluorescent peptide substrate up to 100 uM by microplate reader assay	B	Cc1cn2c(/C=N\NC(=N)N)c(-c3ccc(F)c([N+](=O)[O-])c3)nc2s1.Cl		CHEMBL1910606		Inhibition	%		CHEMBL4722	Homo sapiens	INH		
Not Active	7841881	CHEMBL1913739	Inhibition of Aurora kinase A assessed as inhibition of substrate phosphorylation using fluorescent peptide substrate up to 100 uM by microplate reader assay	B	Cl.N=C(N)N/N=C\c1c(-c2ccc([N+](=O)[O-])cc2)nc2sc(F)cn12		CHEMBL1910607		Inhibition	%		CHEMBL4722	Homo sapiens	INH		
Not Active	7841882	CHEMBL1913739	Inhibition of Aurora kinase A assessed as inhibition of substrate phosphorylation using fluorescent peptide substrate up to 100 uM by microplate reader assay	B	Cl.N=C(N)N/N=C\c1c(-c2ccc([N+](=O)[O-])cc2)nc2sc(Br)cn12		CHEMBL1910608		Inhibition	%		CHEMBL4722	Homo sapiens	INH		
Not Active	7841883	CHEMBL1913739	Inhibition of Aurora kinase A assessed as inhibition of substrate phosphorylation using fluorescent peptide substrate up to 100 uM by microplate reader assay	B	Br.Clc1cc(-c2nc3sc(Cl)cn3c2/C=N/NC2=NCCN2)c(Cl)s1		CHEMBL1910609		Inhibition	%		CHEMBL4722	Homo sapiens	INH		
Not Active	7841884	CHEMBL1913739	Inhibition of Aurora kinase A assessed as inhibition of substrate phosphorylation using fluorescent peptide substrate up to 100 uM by microplate reader assay	B	Br.Cc1nn2c(/C=N/NC3=NCCN3)c(-c3ccc(Cl)c([N+](=O)[O-])c3)nc2s1		CHEMBL1910610		Inhibition	%		CHEMBL4722	Homo sapiens	INH		
Not Active	7841885	CHEMBL1913739	Inhibition of Aurora kinase A assessed as inhibition of substrate phosphorylation using fluorescent peptide substrate up to 100 uM by microplate reader assay	B	Clc1cc(-c2cn3c(n2)sc2ccccc23)c(Cl)s1		CHEMBL1910611		Inhibition	%		CHEMBL4722	Homo sapiens	INH		
Not Active	7841886	CHEMBL1913739	Inhibition of Aurora kinase A assessed as inhibition of substrate phosphorylation using fluorescent peptide substrate up to 100 uM by microplate reader assay	B	COc1cc([N+](=O)[O-])c(OC)cc1-c1cn2c(n1)sc1ccccc12		CHEMBL1910612		Inhibition	%		CHEMBL4722	Homo sapiens	INH		
Not Active	7841887	CHEMBL1913739	Inhibition of Aurora kinase A assessed as inhibition of substrate phosphorylation using fluorescent peptide substrate up to 100 uM by microplate reader assay	B	O=Cc1c(-c2cc(Cl)sc2Cl)nc2sc3ccccc3n12		CHEMBL1910613		Inhibition	%		CHEMBL4722	Homo sapiens	INH		
Not Active	7841888	CHEMBL1913739	Inhibition of Aurora kinase A assessed as inhibition of substrate phosphorylation using fluorescent peptide substrate up to 100 uM by microplate reader assay	B	COc1cc([N+](=O)[O-])c(OC)cc1-c1nc2sc3ccccc3n2c1C=O		CHEMBL1910615		Inhibition	%		CHEMBL4722	Homo sapiens	INH		
Not Active	7841889	CHEMBL1913739	Inhibition of Aurora kinase A assessed as inhibition of substrate phosphorylation using fluorescent peptide substrate up to 100 uM by microplate reader assay	B	Cl.N=C(N)N/N=C/c1c(-c2cc(Cl)sc2Cl)nc2sc3ccccc3n12		CHEMBL1910616		Inhibition	%		CHEMBL4722	Homo sapiens	INH		
Not Active	7841890	CHEMBL1913739	Inhibition of Aurora kinase A assessed as inhibition of substrate phosphorylation using fluorescent peptide substrate up to 100 uM by microplate reader assay	B	COc1cc([N+](=O)[O-])c(OC)cc1-c1nc2sc3ccccc3n2c1/C=N/NC(=N)N.Cl		CHEMBL1910614		Inhibition	%		CHEMBL4722	Homo sapiens	INH		
Not Active	7841891	CHEMBL1913739	Inhibition of Aurora kinase A assessed as inhibition of substrate phosphorylation using fluorescent peptide substrate up to 100 uM by microplate reader assay	B	Br.Clc1cc(-c2nc3sc4ccccc4n3c2/C=N/NC2=NCCN2)c(Cl)s1		CHEMBL1910617		Inhibition	%		CHEMBL4722	Homo sapiens	INH		
Not Active	7841892	CHEMBL1913739	Inhibition of Aurora kinase A assessed as inhibition of substrate phosphorylation using fluorescent peptide substrate up to 100 uM by microplate reader assay	B	Clc1cc(-c2cn3ccccc3n2)c(Cl)s1		CHEMBL1910618		Inhibition	%		CHEMBL4722	Homo sapiens	INH		
Not Active	7841893	CHEMBL1913739	Inhibition of Aurora kinase A assessed as inhibition of substrate phosphorylation using fluorescent peptide substrate up to 100 uM by microplate reader assay	B	COc1cc([N+](=O)[O-])c(OC)cc1-c1cn2ccccc2n1		CHEMBL1910619		Inhibition	%		CHEMBL4722	Homo sapiens	INH		
Not Active	7841894	CHEMBL1913739	Inhibition of Aurora kinase A assessed as inhibition of substrate phosphorylation using fluorescent peptide substrate up to 100 uM by microplate reader assay	B	O=Cc1c(-c2cc(Cl)sc2Cl)nc2ccccn12		CHEMBL1910620		Inhibition	%		CHEMBL4722	Homo sapiens	INH		
Not Active	7841895	CHEMBL1913739	Inhibition of Aurora kinase A assessed as inhibition of substrate phosphorylation using fluorescent peptide substrate up to 100 uM by microplate reader assay	B	COc1cc([N+](=O)[O-])c(OC)cc1-c1nc2ccccn2c1C=O		CHEMBL1910621		Inhibition	%		CHEMBL4722	Homo sapiens	INH		
Not Active	7841896	CHEMBL1913739	Inhibition of Aurora kinase A assessed as inhibition of substrate phosphorylation using fluorescent peptide substrate up to 100 uM by microplate reader assay	B	Cl.N=C(N)N/N=C/c1c(-c2cc(Cl)sc2Cl)nc2ccccn12		CHEMBL1910622		Inhibition	%		CHEMBL4722	Homo sapiens	INH		
Not Active	7841897	CHEMBL1913739	Inhibition of Aurora kinase A assessed as inhibition of substrate phosphorylation using fluorescent peptide substrate up to 100 uM by microplate reader assay	B	COc1cc([N+](=O)[O-])c(OC)cc1-c1nc2ccccn2c1/C=N/NC(=N)N.Cl		CHEMBL1910623		Inhibition	%		CHEMBL4722	Homo sapiens	INH		
Not Active	7841898	CHEMBL1913739	Inhibition of Aurora kinase A assessed as inhibition of substrate phosphorylation using fluorescent peptide substrate up to 100 uM by microplate reader assay	B	Br.Clc1cc(-c2nc3ccccn3c2/C=N/NC2=NCCN2)c(Cl)s1		CHEMBL1910624		Inhibition	%		CHEMBL4722	Homo sapiens	INH		
	7841904	CHEMBL1913734	Inhibition of Aurora A using biotinylated substrate preincubated for 15 mins before substrate addition measured after 30 mins by fluorescence microplate analysis	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	IC50	nM	1837.0	CHEMBL4722	Homo sapiens	IC50	nM	1837.0
	7841913	CHEMBL1913734	Inhibition of Aurora A using biotinylated substrate preincubated for 15 mins before substrate addition measured after 30 mins by fluorescence microplate analysis	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	=	IC50	nM	2633.0	CHEMBL4722	Homo sapiens	IC50	nM	2633.0
	7841918	CHEMBL1913734	Inhibition of Aurora A using biotinylated substrate preincubated for 15 mins before substrate addition measured after 30 mins by fluorescence microplate analysis	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	0.6	CHEMBL4722	Homo sapiens	IC50	nM	0.6
	7842119	CHEMBL1913739	Inhibition of Aurora kinase A assessed as inhibition of substrate phosphorylation using fluorescent peptide substrate up to 100 uM by microplate reader assay	B	Cl.N=C(N)N/N=C/c1c(-c2ccc([N+](=O)[O-])cc2)nc2sc(Cl)cn12		CHEMBL1910625	=	Inhibition	%	50.0	CHEMBL4722	Homo sapiens	INH	%	50.0
	7855616	CHEMBL1913734	Inhibition of Aurora A using biotinylated substrate preincubated for 15 mins before substrate addition measured after 30 mins by fluorescence microplate analysis	B	Cl.N=C(N)N/N=C\c1c(-c2ccc([N+](=O)[O-])cc2)nc2sc(Br)cn12		CHEMBL1910608	>	IC50	nM	20000.0	CHEMBL4722	Homo sapiens	IC50	nM	20000.0
Not Active	7855617	CHEMBL1913739	Inhibition of Aurora kinase A assessed as inhibition of substrate phosphorylation using fluorescent peptide substrate up to 100 uM by microplate reader assay	B	Clc1cc(-c2cn3cc(Cl)sc3n2)c(Cl)s1		CHEMBL1910335		Inhibition	%		CHEMBL4722	Homo sapiens	INH		
Not Active	7855618	CHEMBL1913739	Inhibition of Aurora kinase A assessed as inhibition of substrate phosphorylation using fluorescent peptide substrate up to 100 uM by microplate reader assay	B	Fc1ccc(-c2cn3cc(Cl)sc3n2)cc1		CHEMBL1910336		Inhibition	%		CHEMBL4722	Homo sapiens	INH		
Not Active	7855619	CHEMBL1913739	Inhibition of Aurora kinase A assessed as inhibition of substrate phosphorylation using fluorescent peptide substrate up to 100 uM by microplate reader assay	B	O=[N+]([O-])c1cc(-c2cn3cc(Cl)sc3n2)ccc1F		CHEMBL1910337		Inhibition	%		CHEMBL4722	Homo sapiens	INH		
Not Active	7855620	CHEMBL1913739	Inhibition of Aurora kinase A assessed as inhibition of substrate phosphorylation using fluorescent peptide substrate up to 100 uM by microplate reader assay	B	N#Cc1ccc(-c2cn3cc(Cl)sc3n2)cc1		CHEMBL1910338		Inhibition	%		CHEMBL4722	Homo sapiens	INH		
Not Active	7855621	CHEMBL1913739	Inhibition of Aurora kinase A assessed as inhibition of substrate phosphorylation using fluorescent peptide substrate up to 100 uM by microplate reader assay	B	Cc1nn2cc(-c3cc(Cl)sc3Cl)nc2s1		CHEMBL1910339		Inhibition	%		CHEMBL4722	Homo sapiens	INH		
Not Active	7855622	CHEMBL1913739	Inhibition of Aurora kinase A assessed as inhibition of substrate phosphorylation using fluorescent peptide substrate up to 100 uM by microplate reader assay	B	COc1cc([N+](=O)[O-])c(OC)cc1-c1cn2nc(C)sc2n1		CHEMBL1910340		Inhibition	%		CHEMBL4722	Homo sapiens	INH		
Not Active	7855623	CHEMBL1913739	Inhibition of Aurora kinase A assessed as inhibition of substrate phosphorylation using fluorescent peptide substrate up to 100 uM by microplate reader assay	B	Fc1ccccc1-c1cn2ccsc2n1		CHEMBL1910341		Inhibition	%		CHEMBL4722	Homo sapiens	INH		
Not Active	7855624	CHEMBL1913739	Inhibition of Aurora kinase A assessed as inhibition of substrate phosphorylation using fluorescent peptide substrate up to 100 uM by microplate reader assay	B	Fc1cccc(F)c1-c1cn2ccsc2n1		CHEMBL1910342		Inhibition	%		CHEMBL4722	Homo sapiens	INH		
Not Active	7855625	CHEMBL1913739	Inhibition of Aurora kinase A assessed as inhibition of substrate phosphorylation using fluorescent peptide substrate up to 100 uM by microplate reader assay	B	Fc1ccc(-c2cn3ccsc3n2)cc1F		CHEMBL1910343		Inhibition	%		CHEMBL4722	Homo sapiens	INH		
Not Active	7855626	CHEMBL1913739	Inhibition of Aurora kinase A assessed as inhibition of substrate phosphorylation using fluorescent peptide substrate up to 100 uM by microplate reader assay	B	Fc1cc(F)c(-c2cn3ccsc3n2)cc1F		CHEMBL1910344		Inhibition	%		CHEMBL4722	Homo sapiens	INH		
Not Active	7855627	CHEMBL1913739	Inhibition of Aurora kinase A assessed as inhibition of substrate phosphorylation using fluorescent peptide substrate up to 100 uM by microplate reader assay	B	O=[N+]([O-])c1cc(-c2cn3ccsc3n2)ccc1F		CHEMBL1910345		Inhibition	%		CHEMBL4722	Homo sapiens	INH		
Not Active	7855628	CHEMBL1913739	Inhibition of Aurora kinase A assessed as inhibition of substrate phosphorylation using fluorescent peptide substrate up to 100 uM by microplate reader assay	B	O=[N+]([O-])c1cccc(-c2cn3ccsc3n2)c1F		CHEMBL1910346		Inhibition	%		CHEMBL4722	Homo sapiens	INH		
Not Active	7855629	CHEMBL1913739	Inhibition of Aurora kinase A assessed as inhibition of substrate phosphorylation using fluorescent peptide substrate up to 100 uM by microplate reader assay	B	O=[N+]([O-])c1cc(-c2cn3ccsc3n2)ccc1Br		CHEMBL1910347		Inhibition	%		CHEMBL4722	Homo sapiens	INH		
Not Active	7855630	CHEMBL1913739	Inhibition of Aurora kinase A assessed as inhibition of substrate phosphorylation using fluorescent peptide substrate up to 100 uM by microplate reader assay	B	Cc1cn2cc(-c3ccc(F)cc3)nc2s1		CHEMBL1910348		Inhibition	%		CHEMBL4722	Homo sapiens	INH		
Not Active	7855631	CHEMBL1913739	Inhibition of Aurora kinase A assessed as inhibition of substrate phosphorylation using fluorescent peptide substrate up to 100 uM by microplate reader assay	B	Cc1cn2cc(-c3ccc(F)c([N+](=O)[O-])c3)nc2s1		CHEMBL1910349		Inhibition	%		CHEMBL4722	Homo sapiens	INH		
Not Active	7855632	CHEMBL1913739	Inhibition of Aurora kinase A assessed as inhibition of substrate phosphorylation using fluorescent peptide substrate up to 100 uM by microplate reader assay	B	O=[N+]([O-])c1ccc(-c2cn3cc(F)sc3n2)cc1		CHEMBL1910350		Inhibition	%		CHEMBL4722	Homo sapiens	INH		
Not Active	7855633	CHEMBL1913739	Inhibition of Aurora kinase A assessed as inhibition of substrate phosphorylation using fluorescent peptide substrate up to 100 uM by microplate reader assay	B	O=[N+]([O-])c1ccc(-c2cn3cc(Br)sc3n2)cc1		CHEMBL1910351		Inhibition	%		CHEMBL4722	Homo sapiens	INH		
Not Active	7855634	CHEMBL1913739	Inhibition of Aurora kinase A assessed as inhibition of substrate phosphorylation using fluorescent peptide substrate up to 100 uM by microplate reader assay	B	O=Cc1c(-c2cc(Cl)sc2Cl)nc2sc(Cl)cn12		CHEMBL1910352		Inhibition	%		CHEMBL4722	Homo sapiens	INH		
Not Active	7855635	CHEMBL1913739	Inhibition of Aurora kinase A assessed as inhibition of substrate phosphorylation using fluorescent peptide substrate up to 100 uM by microplate reader assay	B	O=Cc1c(-c2ccc(F)cc2)nc2sc(Cl)cn12		CHEMBL1910353		Inhibition	%		CHEMBL4722	Homo sapiens	INH		
Not Active	7855636	CHEMBL1913739	Inhibition of Aurora kinase A assessed as inhibition of substrate phosphorylation using fluorescent peptide substrate up to 100 uM by microplate reader assay	B	O=Cc1c(-c2ccc(F)c([N+](=O)[O-])c2)nc2sc(Cl)cn12		CHEMBL1910354		Inhibition	%		CHEMBL4722	Homo sapiens	INH		
Not Active	7855637	CHEMBL1913739	Inhibition of Aurora kinase A assessed as inhibition of substrate phosphorylation using fluorescent peptide substrate up to 100 uM by microplate reader assay	B	N#Cc1ccc(-c2nc3sc(Cl)cn3c2C=O)cc1		CHEMBL1910355		Inhibition	%		CHEMBL4722	Homo sapiens	INH		
Not Active	7855638	CHEMBL1913739	Inhibition of Aurora kinase A assessed as inhibition of substrate phosphorylation using fluorescent peptide substrate up to 100 uM by microplate reader assay	B	Cc1nn2c(C=O)c(-c3cc(Cl)sc3Cl)nc2s1		CHEMBL1910356		Inhibition	%		CHEMBL4722	Homo sapiens	INH		
Not Active	7855639	CHEMBL1913739	Inhibition of Aurora kinase A assessed as inhibition of substrate phosphorylation using fluorescent peptide substrate up to 100 uM by microplate reader assay	B	COc1cc([N+](=O)[O-])c(OC)cc1-c1nc2sc(C)nn2c1C=O		CHEMBL1910357		Inhibition	%		CHEMBL4722	Homo sapiens	INH		
Not Active	7855640	CHEMBL1913739	Inhibition of Aurora kinase A assessed as inhibition of substrate phosphorylation using fluorescent peptide substrate up to 100 uM by microplate reader assay	B	Nc1nn2c(C=O)c(-c3ccccc3)nc2s1		CHEMBL1910358		Inhibition	%		CHEMBL4722	Homo sapiens	INH		
Not Active	7855641	CHEMBL1913739	Inhibition of Aurora kinase A assessed as inhibition of substrate phosphorylation using fluorescent peptide substrate up to 100 uM by microplate reader assay	B	O=Cc1c(-c2ccc(F)cc2)nc2sccn12		CHEMBL1910359		Inhibition	%		CHEMBL4722	Homo sapiens	INH		
Not Active	7855642	CHEMBL1913739	Inhibition of Aurora kinase A assessed as inhibition of substrate phosphorylation using fluorescent peptide substrate up to 100 uM by microplate reader assay	B	O=Cc1c(-c2ccccc2F)nc2sccn12		CHEMBL1910360		Inhibition	%		CHEMBL4722	Homo sapiens	INH		
Not Active	7855643	CHEMBL1913739	Inhibition of Aurora kinase A assessed as inhibition of substrate phosphorylation using fluorescent peptide substrate up to 100 uM by microplate reader assay	B	O=Cc1c(-c2c(F)cccc2F)nc2sccn12		CHEMBL1910361		Inhibition	%		CHEMBL4722	Homo sapiens	INH		
Not Active	7855644	CHEMBL1913739	Inhibition of Aurora kinase A assessed as inhibition of substrate phosphorylation using fluorescent peptide substrate up to 100 uM by microplate reader assay	B	O=Cc1c(-c2ccc(F)c(F)c2)nc2sccn12		CHEMBL1910362		Inhibition	%		CHEMBL4722	Homo sapiens	INH		
Not Active	7855645	CHEMBL1913739	Inhibition of Aurora kinase A assessed as inhibition of substrate phosphorylation using fluorescent peptide substrate up to 100 uM by microplate reader assay	B	O=Cc1c(-c2cc(F)c(F)cc2F)nc2sccn12		CHEMBL1910363		Inhibition	%		CHEMBL4722	Homo sapiens	INH		
Not Active	7855646	CHEMBL1913739	Inhibition of Aurora kinase A assessed as inhibition of substrate phosphorylation using fluorescent peptide substrate up to 100 uM by microplate reader assay	B	O=Cc1c(-c2ccc(F)c([N+](=O)[O-])c2)nc2sccn12		CHEMBL1910364		Inhibition	%		CHEMBL4722	Homo sapiens	INH		
Not Active	7855647	CHEMBL1913739	Inhibition of Aurora kinase A assessed as inhibition of substrate phosphorylation using fluorescent peptide substrate up to 100 uM by microplate reader assay	B	O=Cc1c(-c2cccc([N+](=O)[O-])c2F)nc2sccn12		CHEMBL1910365		Inhibition	%		CHEMBL4722	Homo sapiens	INH		
Not Active	7855648	CHEMBL1913739	Inhibition of Aurora kinase A assessed as inhibition of substrate phosphorylation using fluorescent peptide substrate up to 100 uM by microplate reader assay	B	O=Cc1c(-c2ccc(Br)c([N+](=O)[O-])c2)nc2sccn12		CHEMBL1910366		Inhibition	%		CHEMBL4722	Homo sapiens	INH		
Not Active	7855649	CHEMBL1913739	Inhibition of Aurora kinase A assessed as inhibition of substrate phosphorylation using fluorescent peptide substrate up to 100 uM by microplate reader assay	B	Cc1cn2c(C=O)c(-c3ccc(F)cc3)nc2s1		CHEMBL1910367		Inhibition	%		CHEMBL4722	Homo sapiens	INH		
Not Active	7855650	CHEMBL1913739	Inhibition of Aurora kinase A assessed as inhibition of substrate phosphorylation using fluorescent peptide substrate up to 100 uM by microplate reader assay	B	Cc1cn2c(C=O)c(-c3ccc(F)c([N+](=O)[O-])c3)nc2s1		CHEMBL1910368		Inhibition	%		CHEMBL4722	Homo sapiens	INH		
Not Active	7855651	CHEMBL1913739	Inhibition of Aurora kinase A assessed as inhibition of substrate phosphorylation using fluorescent peptide substrate up to 100 uM by microplate reader assay	B	O=Cc1c(-c2ccc([N+](=O)[O-])cc2)nc2sc(F)cn12		CHEMBL1910369		Inhibition	%		CHEMBL4722	Homo sapiens	INH		
Not Active	7855652	CHEMBL1913739	Inhibition of Aurora kinase A assessed as inhibition of substrate phosphorylation using fluorescent peptide substrate up to 100 uM by microplate reader assay	B	O=Cc1c(-c2ccc([N+](=O)[O-])cc2)nc2sc(Br)cn12		CHEMBL1910370		Inhibition	%		CHEMBL4722	Homo sapiens	INH		
Not Active	7855653	CHEMBL1913739	Inhibition of Aurora kinase A assessed as inhibition of substrate phosphorylation using fluorescent peptide substrate up to 100 uM by microplate reader assay	B	Cl.N=C(N)N/N=C/c1c(-c2cc(Cl)sc2Cl)nc2sc(Cl)cn12		CHEMBL1910371		Inhibition	%		CHEMBL4722	Homo sapiens	INH		
Not Active	7855654	CHEMBL1913739	Inhibition of Aurora kinase A assessed as inhibition of substrate phosphorylation using fluorescent peptide substrate up to 100 uM by microplate reader assay	B	Cl.N=C(N)N/N=C/c1c(-c2ccccc2)nc2sc(Cl)cn12		CHEMBL1910372		Inhibition	%		CHEMBL4722	Homo sapiens	INH		
Not Active	7855655	CHEMBL1913739	Inhibition of Aurora kinase A assessed as inhibition of substrate phosphorylation using fluorescent peptide substrate up to 100 uM by microplate reader assay	B	Cl.N=C(N)N/N=C/c1c(-c2ccc(F)cc2)nc2sc(Cl)cn12		CHEMBL1910373		Inhibition	%		CHEMBL4722	Homo sapiens	INH		
Not Active	7855656	CHEMBL1913739	Inhibition of Aurora kinase A assessed as inhibition of substrate phosphorylation using fluorescent peptide substrate up to 100 uM by microplate reader assay	B	Cl.N=C(N)N/N=C/c1c(-c2ccc(F)c([N+](=O)[O-])c2)nc2sc(Cl)cn12		CHEMBL1910374		Inhibition	%		CHEMBL4722	Homo sapiens	INH		
Not Active	7855657	CHEMBL1913739	Inhibition of Aurora kinase A assessed as inhibition of substrate phosphorylation using fluorescent peptide substrate up to 100 uM by microplate reader assay	B	Cl.N#Cc1ccc(-c2nc3sc(Cl)cn3c2/C=N/NC(=N)N)cc1		CHEMBL1910375		Inhibition	%		CHEMBL4722	Homo sapiens	INH		
Not Active	7855658	CHEMBL1913739	Inhibition of Aurora kinase A assessed as inhibition of substrate phosphorylation using fluorescent peptide substrate up to 100 uM by microplate reader assay	B	Cc1nn2c(/C=N/NC(=N)N)c(-c3cc(Cl)sc3Cl)nc2s1.Cl		CHEMBL1910376		Inhibition	%		CHEMBL4722	Homo sapiens	INH		
Not Active	7855659	CHEMBL1913739	Inhibition of Aurora kinase A assessed as inhibition of substrate phosphorylation using fluorescent peptide substrate up to 100 uM by microplate reader assay	B	COc1cc([N+](=O)[O-])c(OC)cc1-c1nc2sc(C)nn2c1/C=N\NC(=N)N.Cl		CHEMBL1910595		Inhibition	%		CHEMBL4722	Homo sapiens	INH		
Not Active	7855660	CHEMBL1913739	Inhibition of Aurora kinase A assessed as inhibition of substrate phosphorylation using fluorescent peptide substrate up to 100 uM by microplate reader assay	B	Cl.N=C(N)N/N=C\c1c(-c2ccccc2)nc2sc(N)nn12		CHEMBL1910596		Inhibition	%		CHEMBL4722	Homo sapiens	INH		
Not Active	7855661	CHEMBL1913739	Inhibition of Aurora kinase A assessed as inhibition of substrate phosphorylation using fluorescent peptide substrate up to 100 uM by microplate reader assay	B	Cl.N=C(N)N/N=C\c1c(-c2ccc(F)cc2)nc2sccn12		CHEMBL1910597		Inhibition	%		CHEMBL4722	Homo sapiens	INH		
Not Active	7855662	CHEMBL1913739	Inhibition of Aurora kinase A assessed as inhibition of substrate phosphorylation using fluorescent peptide substrate up to 100 uM by microplate reader assay	B	Cl.N=C(N)N/N=C\c1c(-c2ccccc2F)nc2sccn12		CHEMBL1910598		Inhibition	%		CHEMBL4722	Homo sapiens	INH		
Not Active	7855663	CHEMBL1913739	Inhibition of Aurora kinase A assessed as inhibition of substrate phosphorylation using fluorescent peptide substrate up to 100 uM by microplate reader assay	B	Cl.N=C(N)N/N=C\c1c(-c2c(F)cccc2F)nc2sccn12		CHEMBL1910599		Inhibition	%		CHEMBL4722	Homo sapiens	INH		
Not Active	7855664	CHEMBL1913739	Inhibition of Aurora kinase A assessed as inhibition of substrate phosphorylation using fluorescent peptide substrate up to 100 uM by microplate reader assay	B	Cl.N=C(N)N/N=C\c1c(-c2ccc(F)c(F)c2)nc2sccn12		CHEMBL1910600		Inhibition	%		CHEMBL4722	Homo sapiens	INH		
Not Active	7855665	CHEMBL1913739	Inhibition of Aurora kinase A assessed as inhibition of substrate phosphorylation using fluorescent peptide substrate up to 100 uM by microplate reader assay	B	Cl.N=C(N)N/N=C\c1c(-c2cc(F)c(F)cc2F)nc2sccn12		CHEMBL1910601		Inhibition	%		CHEMBL4722	Homo sapiens	INH		
Not Active	7855666	CHEMBL1913739	Inhibition of Aurora kinase A assessed as inhibition of substrate phosphorylation using fluorescent peptide substrate up to 100 uM by microplate reader assay	B	Cl.N=C(N)N/N=C\c1c(-c2ccc(F)c([N+](=O)[O-])c2)nc2sccn12		CHEMBL1910602		Inhibition	%		CHEMBL4722	Homo sapiens	INH		
Not Active	7855667	CHEMBL1913739	Inhibition of Aurora kinase A assessed as inhibition of substrate phosphorylation using fluorescent peptide substrate up to 100 uM by microplate reader assay	B	Cl.N=C(N)N/N=C\c1c(-c2cccc([N+](=O)[O-])c2F)nc2sccn12		CHEMBL1910603		Inhibition	%		CHEMBL4722	Homo sapiens	INH		
	7922676	CHEMBL1918825	Inhibition of human recombinant AURKA at 0.5 uM by radiometric filter-binding assay	B	Clc1ccccc1Nc1nc2c(-c3nnc[nH]3)cccc2c2cnccc12		CHEMBL1915438	=	Inhibition	%	57.0	CHEMBL4722	Homo sapiens	INH	%	57.0
	7939624	CHEMBL1921402	Inhibition of human Aurora-A	B	[O-][n+]1ccc2c(-c3ccc(F)cc3Cl)ccnc2c1-c1c(Cl)cccc1Cl		CHEMBL1916359	>	IC50	nM	10000.0	CHEMBL4722	Homo sapiens	IC50	uM	10.0
	7943723	CHEMBL1921566	Inhibition of Aurora-A	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	2.28	CHEMBL4722	Homo sapiens	IC50	nM	2.28
	7943763	CHEMBL1921420	Inhibition of Aurora-A at 10 uM	B	O=C1CC(c2cccc(NC(=O)c3ccc(Cl)c(C(F)(F)F)c3)c2)=Nc2cnn(Cc3ccccc3)c2N1		CHEMBL1917776	=	Inhibition	%	6.5	CHEMBL4722	Homo sapiens	INH	%	6.5
	7953326	CHEMBL1925565	Inhibition of AurA	B	Cn1cc(-c2ccc3nnc(Cc4cccc5c(=O)[nH]ccc45)n3n2)cn1		CHEMBL1922404	>	IC50	nM	10000.0	CHEMBL4722	Homo sapiens	IC50	uM	10.0
	7953327	CHEMBL1925565	Inhibition of AurA	B	O=c1[nH]ccc2c(Cc3nnc4ccc(-c5ccccc5)nn34)cccc12		CHEMBL1922405	>	IC50	nM	10000.0	CHEMBL4722	Homo sapiens	IC50	uM	10.0
	7959677	CHEMBL1932329	Inhibition of aurora A	B	CN(C)CCN1CCN(C(=O)c2cc(C(C)(C)C)sc2NC(=O)Nc2cccc(Cl)c2Cl)CCC1=O		CHEMBL1929238	>	IC50	nM	30000.0	CHEMBL4722	Homo sapiens	IC50	uM	30.0
	7959678	CHEMBL1932329	Inhibition of aurora A	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	>	IC50	nM	30000.0	CHEMBL4722	Homo sapiens	IC50	uM	30.0
	7969693	CHEMBL1930949	Inhibition of aurora-A assessed as residual activity at 10 uM using [33P-ATP] by radiometric filter binding assay	B	Cc1ccc(F)cc1-c1nc2[nH]nc(N)c2c2c1CCCC2		CHEMBL1927262	=	Activity	%	68.0	CHEMBL4722	Homo sapiens	Activity	%	68.0
	7970413	CHEMBL1930204	Inhibition of aurora A kinase at 10 uM	B	NCCN1C(=O)S/C(=C\CCC2CCCCC2)C1=O		CHEMBL1929247	=	Inhibition	%	-4.0	CHEMBL4722	Homo sapiens	INH	%	-4.0
	7984760	CHEMBL1936499	Inhibition of Aurora-A	B	NC(=O)c1c[nH]c(-c2ccnc(N)n2)c1		CHEMBL1933575	>	IC50	nM	10000.0	CHEMBL4722	Homo sapiens	IC50	uM	10.0
	7984761	CHEMBL1936499	Inhibition of Aurora-A	B	CN1CCN(c2ccc(OC(F)(F)F)c(Nc3nccc(-c4cc(C(N)=O)cn4C)n3)c2)CC1		CHEMBL1933576	>	IC50	nM	10000.0	CHEMBL4722	Homo sapiens	IC50	uM	10.0
	7984762	CHEMBL1936499	Inhibition of Aurora-A	B	CN1CCN(c2ccc(OC(F)(F)F)c(Nc3nccc(-c4cc(C(N)=O)cn4CC(F)(F)F)n3)c2)CC1		CHEMBL1933577	>	IC50	nM	10000.0	CHEMBL4722	Homo sapiens	IC50	uM	10.0
	7984763	CHEMBL1936499	Inhibition of Aurora-A	B	Cn1cc(C(N)=O)cc1-c1ccnc(Nc2cc(N3CCNCC3)ccc2OC(F)(F)F)n1		CHEMBL1933578	>	IC50	nM	10000.0	CHEMBL4722	Homo sapiens	IC50	uM	10.0
	7984764	CHEMBL1936499	Inhibition of Aurora-A	B	CN1CCN(c2ccc(OC(F)(F)F)c(Nc3nccc(-c4cc(C(N)=O)cn4CCO)n3)c2)CC1		CHEMBL1933579	>	IC50	nM	10000.0	CHEMBL4722	Homo sapiens	IC50	uM	10.0
	7984765	CHEMBL1936499	Inhibition of Aurora-A	B	CN1CCN(c2ccc(OC(F)(F)F)c(Nc3nccc(-c4cc(C(N)=O)cn4CCOC4CCCCO4)n3)c2)CC1		CHEMBL1933580	>	IC50	nM	10000.0	CHEMBL4722	Homo sapiens	IC50	uM	10.0
	7984766	CHEMBL1936499	Inhibition of Aurora-A	B	Cn1cc(C(N)=O)cc1-c1ccnc(Nc2cc(N3CCN(C(=O)OC(C)(C)C)CC3)ccc2OC(F)(F)F)n1		CHEMBL1933581	>	IC50	nM	10000.0	CHEMBL4722	Homo sapiens	IC50	uM	10.0
	7984767	CHEMBL1936499	Inhibition of Aurora-A	B	Nc1nccc(-c2cc3c([nH]2)CCNC3=O)n1		CHEMBL402272	>	IC50	nM	10000.0	CHEMBL4722	Homo sapiens	IC50	uM	10.0
	7984768	CHEMBL1936499	Inhibition of Aurora-A	B	CN1CCN(c2ccc(OC(F)(F)F)c(Nc3nccc(-c4cc5c(n4C)CCNC5=O)n3)c2)CC1		CHEMBL1933582	>	IC50	nM	10000.0	CHEMBL4722	Homo sapiens	IC50	uM	10.0
	7984769	CHEMBL1936499	Inhibition of Aurora-A	B	CN1CCN(c2ccc(OC(F)(F)F)c(Nc3nccc(-c4cc5c(n4CC(F)(F)F)CCNC5=O)n3)c2)CC1		CHEMBL1933583	>	IC50	nM	10000.0	CHEMBL4722	Homo sapiens	IC50	uM	10.0
	7984770	CHEMBL1936499	Inhibition of Aurora-A	B	CN1CCN(c2ccc(OC(F)(F)F)c(Nc3nccc(-c4cc5c(n4CCO)CCNC5=O)n3)c2)CC1		CHEMBL1933584	>	IC50	nM	10000.0	CHEMBL4722	Homo sapiens	IC50	uM	10.0
	7984771	CHEMBL1936499	Inhibition of Aurora-A	B	CN1CCN(c2ccc(OC(F)(F)F)c(Nc3nccc(-c4cc5c(n4C)CCN(C(=O)OC(C)(C)C)C5=O)n3)c2)CC1		CHEMBL1933585	>	IC50	nM	10000.0	CHEMBL4722	Homo sapiens	IC50	uM	10.0
	7987181	CHEMBL1935936	Inhibition of Aurora-A	B	C[C@@H]1CCC(N2CC[C@]3(CN(C(=O)c4cc5ccc(F)cc5[nH]4)c4ccccc43)C2)CN1		CHEMBL1933552	>	IC50	nM	30000.0	CHEMBL4722	Homo sapiens	IC50	uM	30.0
	7989299	CHEMBL1936693	Inhibition of human Aurora A at 3 uM	B	Cn1cc(NC(=O)c2ccc3cc4n(c3c2)C(C)(C)CNC4=O)nc1C(=O)NC1CCCC1		CHEMBL1933142	>=	Inhibition	%	80.0	CHEMBL4722	Homo sapiens	INH	%	80.0
	7989300	CHEMBL1936693	Inhibition of human Aurora A at 3 uM	B	Cc1cc(NC(=O)c2ccc3cc4n(c3c2)CCCNC4=O)on1		CHEMBL1933143	<	Inhibition	%	80.0	CHEMBL4722	Homo sapiens	INH	%	80.0
	7989301	CHEMBL1936693	Inhibition of human Aurora A at 3 uM	B	Cn1cc(NC(=O)c2ccc3cc4n(c3c2)CCCNC4=O)cn1		CHEMBL1933148	<	Inhibition	%	80.0	CHEMBL4722	Homo sapiens	INH	%	80.0
	7989302	CHEMBL1936693	Inhibition of human Aurora A at 3 uM	B	Cn1c(NC(=O)c2ccc3cc4n(c3c2)CCCNC4=O)nc2ccccc21		CHEMBL1933279	>=	Inhibition	%	80.0	CHEMBL4722	Homo sapiens	INH	%	80.0
	7991166	CHEMBL1937318	Inhibition of aurora-A	B	CN1CCC(COc2ccc3c(Nc4ccc(NC(=O)Nc5cccc(F)c5)cc4)ncnc3c2)CC1		CHEMBL1934327	=	IC50	nM	2680.0	CHEMBL4722	Homo sapiens	IC50	nM	2680.0
	7992174	CHEMBL1935982	Inhibition of AURKA at 1 uM	B	CN(c1ccccc1-c1cc(Cl)c2cnc(Nc3ccc(C4CCN(CC(N)=O)CC4)cc3)nn12)S(C)(=O)=O		CHEMBL1934353	=	Inhibition	%	99.0	CHEMBL4722	Homo sapiens	INH	%	99.0
	7995719	CHEMBL1935844	Inhibition of Aurora A	B	Cc1ncnc(Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1C#Cc1ccc(CN2CCCC2)c(F)c1		CHEMBL1934626	>	IC50	nM	100000.0	CHEMBL4722	Homo sapiens	IC50	uM	100.0
	7996676	CHEMBL1944007	Inhibition of AURKA at 1 uM	B	CNC(=O)c1cccc(F)c1Nc1nc(Nc2ccc3c(c2)NC(=O)[C@H](NC(=O)N2CCCC2)CC3(C)C)ncc1Cl		CHEMBL1939491	=	Inhibition	%	96.0	CHEMBL4722	Homo sapiens	INH	%	96.0
	7996739	CHEMBL1944007	Inhibition of AURKA at 1 uM	B	CNC(=O)c1cccc(F)c1Nc1nc(Nc2ccc3c(c2)NC(=O)[C@@H](NC(=O)N2CCCC2)CC3(C)C)ncc1Cl		CHEMBL1939492	=	Inhibition	%	92.0	CHEMBL4722	Homo sapiens	INH	%	92.0
Active	7996766	CHEMBL1941715	Inhibition of Aurora A at 10 uM by colorimetric analysis	B	Clc1ccc(-n2nncc2-c2ccncc2)cc1		CHEMBL62965		Inhibition	%		CHEMBL4722	Homo sapiens	INH		
Active	7996767	CHEMBL1941715	Inhibition of Aurora A at 10 uM by colorimetric analysis	B	Clc1cccc(-n2nncc2-c2ccncc2)c1		CHEMBL303351		Inhibition	%		CHEMBL4722	Homo sapiens	INH		
	8002071	CHEMBL1942173	Inhibition of STK6 at 1 uM	B	CC(C)n1cc(C(=O)c2cncc(N[C@@H]3CCN(C=O)[C@@H]3c3ccc(F)cc3)n2)c2c(N)ncnc21		CHEMBL1940251	=	Inhibition	%	81.0	CHEMBL4722	Homo sapiens	INH	%	81.0
	8002072	CHEMBL1942173	Inhibition of STK6 at 1 uM	B	CC(=O)N1CC[C@@H](Nc2cncc(C(=O)c3cn(C(C)C)c4ncnc(N)c34)n2)[C@H]1c1ccc(F)cc1		CHEMBL1940252	=	Inhibition	%	80.0	CHEMBL4722	Homo sapiens	INH	%	80.0
	8002073	CHEMBL1942173	Inhibition of STK6 at 1 uM	B	CC(=O)N1CC[C@@H](Nc2cncc(C(=O)c3cn(C(C)C)c4ncnc(N)c34)n2)[C@H]1c1ccccc1		CHEMBL1940253	=	Inhibition	%	54.0	CHEMBL4722	Homo sapiens	INH	%	54.0
	8002732	CHEMBL1942295	Inhibition of Aurora A	B	CC(C)n1cc(C(=O)c2cncc(N[C@@H]3CCN(C=O)[C@@H]3c3ccc(F)cc3)n2)c2c(N)ncnc21		CHEMBL1940251	=	IC50	nM	140.0	CHEMBL4722	Homo sapiens	IC50	nM	140.0
	8002733	CHEMBL1942295	Inhibition of Aurora A	B	CC(=O)N1CC[C@@H](Nc2cncc(C(=O)c3cn(C(C)C)c4ncnc(N)c34)n2)[C@H]1c1ccc(F)cc1		CHEMBL1940252	=	IC50	nM	460.0	CHEMBL4722	Homo sapiens	IC50	nM	460.0
	8002734	CHEMBL1942295	Inhibition of Aurora A	B	CC(=O)N1CC[C@@H](Nc2cncc(C(=O)c3cn(C(C)C)c4ncnc(N)c34)n2)[C@H]1c1ccccc1		CHEMBL1940253	=	IC50	nM	820.0	CHEMBL4722	Homo sapiens	IC50	nM	820.0
	8003548	CHEMBL1942477	Inhibition of human AurA in HL-60 cells lysate assessed as reduction of labeling of acyl-phosphate ATP probe at 100 nM	B	C[C@H]1COc2c(NCCCn3cccn3)c(F)c(N)c3c(=O)c(C(=O)O)cn1c23		CHEMBL1940980	<	Inhibition	%	35.0	CHEMBL4722	Homo sapiens	INH	%	35.0
	8003549	CHEMBL1942477	Inhibition of human AurA in HL-60 cells lysate assessed as reduction of labeling of acyl-phosphate ATP probe at 100 nM	B	C[C@H]1COc2c(NCCCn3cccn3)c(F)c(N)c3c(=O)c(C#N)cn1c23		CHEMBL1940981	<	Inhibition	%	35.0	CHEMBL4722	Homo sapiens	INH	%	35.0
	8003550	CHEMBL1942477	Inhibition of human AurA in HL-60 cells lysate assessed as reduction of labeling of acyl-phosphate ATP probe at 100 nM	B	C[C@H]1COc2c(NCCCc3ccccn3)c(F)c(N)c3c(=O)c(C(=O)O)cn1c23		CHEMBL1940987	<	Inhibition	%	35.0	CHEMBL4722	Homo sapiens	INH	%	35.0
	8003551	CHEMBL1942477	Inhibition of human AurA in HL-60 cells lysate assessed as reduction of labeling of acyl-phosphate ATP probe at 100 nM	B	C[C@H]1COc2c(NCCCc3ccccn3)c(F)c(N)c3c(=O)c(C#N)cn1c23		CHEMBL1940990	<	Inhibition	%	35.0	CHEMBL4722	Homo sapiens	INH	%	35.0
	8004486	CHEMBL1943918	Inhibition of Aurora A at 1 uM	B	O=c1c2ccccc2[se]n1-c1ccccc1		CHEMBL51085	=	Inhibition	%	0.0	CHEMBL4722	Homo sapiens	INH	%	0.0
	8004530	CHEMBL1943918	Inhibition of Aurora A at 1 uM	B	CC(=O)OC[C@H]1O[C@@H](O[C@H]2[C@H](OC(C)=O)[C@@H](OC(C)=O)[C@H](n3[se]c4ccccc4c3=O)O[C@@H]2COC(C)=O)[C@H](OC(C)=O)[C@@H](OC(C)=O)[C@H]1OC(C)=O		CHEMBL1940993	=	Inhibition	%	0.0	CHEMBL4722	Homo sapiens	INH	%	0.0
	8005194	CHEMBL1943918	Inhibition of Aurora A at 1 uM	B	CC(=O)OC[C@H]1O[C@@H](NC(=O)CCCn2[se]c3ccccc3c2=O)[C@H](OC(C)=O)[C@@H](OC(C)=O)[C@@H]1OC(C)=O		CHEMBL1940997	=	Inhibition	%	0.0	CHEMBL4722	Homo sapiens	INH	%	0.0
	8005237	CHEMBL1943918	Inhibition of Aurora A at 1 uM	B	O=C(CCCn1[se]c2ccccc2c1=O)N[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O		CHEMBL1940999	=	Inhibition	%	0.0	CHEMBL4722	Homo sapiens	INH	%	0.0
Active	8012311	CHEMBL1941715	Inhibition of Aurora A at 10 uM by colorimetric analysis	B	Clc1ccc(-n2cc(-c3ccncc3)nn2)cc1		CHEMBL1938953		Inhibition	%		CHEMBL4722	Homo sapiens	INH		
Active	8012312	CHEMBL1941715	Inhibition of Aurora A at 10 uM by colorimetric analysis	B	Clc1cccc(-n2cc(-c3ccncc3)nn2)c1		CHEMBL1938954		Inhibition	%		CHEMBL4722	Homo sapiens	INH		
	8013048	CHEMBL1947297	Inhibition of Aurora A using ATP as substrate	B	Cn1c2c(c3ccc(Cl)c(Cl)c31)C(C#N)C1(CCNCC1)NC2=O		CHEMBL1945559	>	IC50	nM	10000.0	CHEMBL4722	Homo sapiens	IC50	uM	10.0
	8017833	CHEMBL1948811	Inhibition of Aurora-A assessed as activity remaining at 10 uM	B	O=c1[nH]c2ncc(-c3ccc(-c4nc[nH]n4)cc3)nc2n1CC1CCOCC1		CHEMBL1945953	=	Activity	%	79.0	CHEMBL4722	Homo sapiens	Activity	%	79.0
	8017834	CHEMBL1948811	Inhibition of Aurora-A assessed as activity remaining at 10 uM	B	CC(C)(O)c1ccc(-c2cnc3[nH]c(=O)n(CC4CCCCC4)c3n2)cc1		CHEMBL1945950	=	Activity	%	58.0	CHEMBL4722	Homo sapiens	Activity	%	58.0
	8017835	CHEMBL1948811	Inhibition of Aurora-A assessed as activity remaining at 10 uM	B	O=c1[nH]c2ncc(-c3ccc4[nH]cnc4c3)nc2n1CC1CCCCC1		CHEMBL1946262	=	Activity	%	32.0	CHEMBL4722	Homo sapiens	Activity	%	32.0
	8042228	CHEMBL1952701	Inhibition of human Aurora A assessed as inhibition of [gamma-33P]ATP incorporation into substrate after 1 hr by liquid scintillation counting	B	CC(C)[C@@H]1NC(=O)CNC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)NCC(N)=O)NC(=O)[C@H](Cc2c[nH]cn2)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@@H]2CCCN2C1=O	Outside typical range	CHEMBL1950039	=	IC50	nM	242000.0	CHEMBL4722	Homo sapiens	IC50	uM	242.0
	8042229	CHEMBL1952701	Inhibition of human Aurora A assessed as inhibition of [gamma-33P]ATP incorporation into substrate after 1 hr by liquid scintillation counting	B	C[C@@H](O)[C@@H]1NC(=O)CNC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)NCC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]2CCCN2C1=O		CHEMBL1950040	=	IC50	nM	91000.0	CHEMBL4722	Homo sapiens	IC50	uM	91.0
	8042230	CHEMBL1952701	Inhibition of human Aurora A assessed as inhibition of [gamma-33P]ATP incorporation into substrate after 1 hr by liquid scintillation counting	B	C[C@@H](O)[C@@H]1NC(=O)[C@H](CC(=O)O)NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H]2CCCN2C(=O)[C@H](Cc2c[nH]cn2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)NCC(N)=O)NC1=O	Outside typical range	CHEMBL1950041	=	IC50	nM	137000.0	CHEMBL4722	Homo sapiens	IC50	uM	137.0
	8042231	CHEMBL1952701	Inhibition of human Aurora A assessed as inhibition of [gamma-33P]ATP incorporation into substrate after 1 hr by liquid scintillation counting	B	CC(C)[C@@H]1NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H]2CCCN2C(=O)[C@H](Cc2c[nH]cn2)NC(=O)CNC(=O)[C@@H](N)CSSC[C@@H](C(=O)NCC(N)=O)NC(=O)[C@@H]2CCCN2C1=O	Outside typical range	CHEMBL1950042	=	IC50	nM	234000.0	CHEMBL4722	Homo sapiens	IC50	uM	234.0
	8042232	CHEMBL1952701	Inhibition of human Aurora A assessed as inhibition of [gamma-33P]ATP incorporation into substrate after 1 hr by liquid scintillation counting	B	CC(C)C[C@@H]1NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@@H]2CCCN2C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)NCC(N)=O)NC1=O		CHEMBL1950043	=	IC50	nM	7000.0	CHEMBL4722	Homo sapiens	IC50	uM	7.0
	8042233	CHEMBL1952701	Inhibition of human Aurora A assessed as inhibition of [gamma-33P]ATP incorporation into substrate after 1 hr by liquid scintillation counting	B	CC(C)C[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](N)CSSC[C@@H](C(=O)NCC(N)=O)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@@H]2CCCN2C1=O		CHEMBL1950044	=	IC50	nM	6000.0	CHEMBL4722	Homo sapiens	IC50	uM	6.0
	8042234	CHEMBL1952702	Non-competitive inhibition of human aurora-A using kemptide as a substrate by double reciprocal plot analysis	B	CC(C)C[C@@H]1NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@@H]2CCCN2C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)NCC(N)=O)NC1=O		CHEMBL1950043	=	Ki	nM	31500.0	CHEMBL4722	Homo sapiens	Ki	uM	31.5
	8042235	CHEMBL1952703	Competitive inhibition of human aurora A using kemptide as a substrate by double reciprocal plot analysis	B	CC(C)C[C@@H]1NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@@H]2CCCN2C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)NCC(N)=O)NC1=O		CHEMBL1950043	=	Kic	uM	10.4	CHEMBL4722	Homo sapiens	Kic	uM	10.4
	8042236	CHEMBL1952704	Mixed type inhibition of human aurora A using kemptide as a substrate by double reciprocal plot analysis	B	CC(C)C[C@@H]1NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@@H]2CCCN2C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)NCC(N)=O)NC1=O		CHEMBL1950043	=	Ki	nM	27200.0	CHEMBL4722	Homo sapiens	Ki	uM	27.2
	8042237	CHEMBL1952705	Un-competitive inhibition of human aurora A using kemptide as substrate by double reciprocal plot analysis	B	CC(C)C[C@@H]1NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@@H]2CCCN2C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)NCC(N)=O)NC1=O		CHEMBL1950043	=	Kiuc	uM	17.6	CHEMBL4722	Homo sapiens	Kiuc	uM	17.6
Active	8042238	CHEMBL1952706	Inhibition of human aurora A assessed as [gamma-33P]ATP incorporation into kemptide substrate at 10 uM after 40 mins by liquid scintillation counting	B	CC(C)C[C@@H]1NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@@H]2CCCN2C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)NCC(N)=O)NC1=O		CHEMBL1950043		Inhibition	%		CHEMBL4722	Homo sapiens	INH		
Active	8042241	CHEMBL1952706	Inhibition of human aurora A assessed as [gamma-33P]ATP incorporation into kemptide substrate at 10 uM after 40 mins by liquid scintillation counting	B	CC(C)C[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](N)CSSC[C@@H](C(=O)NCC(N)=O)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@@H]2CCCN2C1=O		CHEMBL1950044		Inhibition	%		CHEMBL4722	Homo sapiens	INH		
	8046166	CHEMBL1960380	Inhibition of AurA	B	COc1ccc(-c2ocnc2C(=O)NCc2ccncc2)cc1		CHEMBL1957085	>	IC50	nM	10000.0	CHEMBL4722	Homo sapiens	IC50	uM	10.0
	8047078	CHEMBL1958813	Inhibition of AURKA at 1 uM	B	CN1CCN(c2ccc(Nc3nc(N)c(C(=O)c4ccc5c(c4)OCCO5)s3)cc2)CC1		CHEMBL1956070	<	Inhibition	%	50.0	CHEMBL4722	Homo sapiens	INH	%	50.0
	8060101	CHEMBL1961275	Inhibition of human recombinant aurora-A expressed in Sf9 cells using tetra(LRRWSLG) as substrate after 80 mins by scintillation counting	B	CC(C)n1c2c(c3c1-c1ccccc1C3=O)C(=O)CCC2		CHEMBL1957190	>	IC50	nM	35000.0	CHEMBL4722	Homo sapiens	IC50	uM	35.0
	8060102	CHEMBL1961275	Inhibition of human recombinant aurora-A expressed in Sf9 cells using tetra(LRRWSLG) as substrate after 80 mins by scintillation counting	B	O=c1oc2c(O)c(O)cc3c(=O)oc4c(O)c(O)cc1c4c23		CHEMBL6246	=	IC50	nM	2480.0	CHEMBL4722	Homo sapiens	IC50	uM	2.48
	8061331	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NCc1ccc(-c2nc(-c3ccc(Cl)c(O)c3)c(-c3ccncc3)[nH]2)cc1		CHEMBL1909412	=	Inhibition	%	1.53	CHEMBL4722	Homo sapiens	Inhibition	%	1.53
	8061508	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3Cc2ccccc2)ccc1O		CHEMBL1789962	=	Inhibition	%	25.65	CHEMBL4722	Homo sapiens	Inhibition	%	25.65
	8061839	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(Nc3ccccc3)n2)CC1		CHEMBL318892	=	Inhibition	%	5.7	CHEMBL4722	Homo sapiens	Inhibition	%	5.7
	8062030	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	Cn1cc(C=C2C(=O)Nc3cccnc32)c2ccccc21		CHEMBL1516890	=	Inhibition	%	5.95	CHEMBL4722	Homo sapiens	Inhibition	%	5.95
	8062370	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	Cn1c(-c2nonc2N)nc2cnccc21		CHEMBL188048	=	Inhibition	%	1.22	CHEMBL4722	Homo sapiens	Inhibition	%	1.22
	8062532	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1		CHEMBL261129	=	Inhibition	%	3.82	CHEMBL4722	Homo sapiens	Inhibition	%	3.82
	8062854	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccncc21		CHEMBL185710	=	Inhibition	%	6.98	CHEMBL4722	Homo sapiens	Inhibition	%	6.98
	8063210	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	Cl.NCc1ccc(-c2nc(-c3ccc(Cl)c(O)c3)c(-c3ccncc3)[nH]2)cc1		CHEMBL1909412	=	Inhibition	%	9.73	CHEMBL4722	Homo sapiens	Inhibition	%	9.73
	8063377	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(Cl)c(C(F)(F)F)c3)n2)cc1		CHEMBL188794	=	Inhibition	%	1.01	CHEMBL4722	Homo sapiens	Inhibition	%	1.01
	8063709	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL1909378	=	Inhibition	%	1.85	CHEMBL4722	Homo sapiens	Inhibition	%	1.85
	8063891	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	Cn1cc(C=C2C(=O)Nc3cccnc32)c2ccccc21		CHEMBL1516890	=	Inhibition	%	57.0	CHEMBL4722	Homo sapiens	Inhibition	%	57.0
	8064115	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)c1cccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)c1		CHEMBL362155	=	Inhibition	%	2.64	CHEMBL4722	Homo sapiens	Inhibition	%	2.64
	8064230	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	Cn1c(-c2nonc2N)nc2cnccc21		CHEMBL188048	=	Inhibition	%	7.19	CHEMBL4722	Homo sapiens	Inhibition	%	7.19
	8064440	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)C(=O)O[C@@H]1CN[C@@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL466412	=	Inhibition	%	1.79	CHEMBL4722	Homo sapiens	Inhibition	%	1.79
	8064802	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(Nc2ncc(-c3ccccc3)o2)cc1OC.Cl		CHEMBL1794060	=	Inhibition	%	9.76	CHEMBL4722	Homo sapiens	Inhibition	%	9.76
	8064968	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(Cl)c(C(F)(F)F)c3)n2)cc1		CHEMBL188794	=	Inhibition	%	6.68	CHEMBL4722	Homo sapiens	Inhibition	%	6.68
	8065192	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3n2)cc1		CHEMBL408732	=	Inhibition	%	1.67	CHEMBL4722	Homo sapiens	Inhibition	%	1.67
	8065308	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	Cl.NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL1909378	=	Inhibition	%	3.93	CHEMBL4722	Homo sapiens	Inhibition	%	3.93
	8065707	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)c1cccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)c1		CHEMBL362155	=	Inhibition	%	24.72	CHEMBL4722	Homo sapiens	Inhibition	%	24.72
	8065822	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(N(C)C)cc4)c3)cc21		CHEMBL220465	=	Inhibition	%	6.99	CHEMBL4722	Homo sapiens	Inhibition	%	6.99
	8066032	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	CN(C)C(=O)O[C@@H]1CN[C@@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL466412	=	Inhibition	%	8.44	CHEMBL4722	Homo sapiens	Inhibition	%	8.44
	8066256	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	CCc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL365072	=	Inhibition	%	2.35	CHEMBL4722	Homo sapiens	Inhibition	%	2.35
	8066392	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(Nc2ncc(-c3ccccc3)o2)cc1OC.Cl		CHEMBL1794060	=	Inhibition	%	75.41	CHEMBL4722	Homo sapiens	Inhibition	%	75.41
	8066782	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3n2)cc1		CHEMBL408732	=	Inhibition	%	9.18	CHEMBL4722	Homo sapiens	Inhibition	%	9.18
	8066906	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(Br)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909370	=	Inhibition	%	0.95	CHEMBL4722	Homo sapiens	Inhibition	%	0.95
	8067130	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(Br)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909370	=	Inhibition	%	7.48	CHEMBL4722	Homo sapiens	Inhibition	%	7.48
	8067305	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(S(=O)(=O)c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.Cl		CHEMBL1909367	=	Inhibition	%	3.13	CHEMBL4722	Homo sapiens	Inhibition	%	3.13
	8067426	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(N(C)C)cc4)c3)cc21		CHEMBL220465	=	Inhibition	%	79.18	CHEMBL4722	Homo sapiens	Inhibition	%	79.18
	8067650	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ccccc3c2-c2ccncc2)cc1		CHEMBL485745	=	Inhibition	%	1.94	CHEMBL4722	Homo sapiens	Inhibition	%	1.94
	8067860	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	CCc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL365072	=	Inhibition	%	11.23	CHEMBL4722	Homo sapiens	Inhibition	%	11.23
	8067995	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2nccc(-c3cnn4ncccc34)n2)cc(OC)c1		CHEMBL359999	=	Inhibition	%	20.86	CHEMBL4722	Homo sapiens	Inhibition	%	20.86
	8068219	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2nccc(-c3cnn4ncccc34)n2)cc(OC)c1		CHEMBL359999	=	Inhibition	%	94.25	CHEMBL4722	Homo sapiens	Inhibition	%	94.25
	8068383	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	Cl.N#Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL1794061	=	Inhibition	%	1.03	CHEMBL4722	Homo sapiens	Inhibition	%	1.03
	8068732	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)cc2)sc2c1CCCC2		CHEMBL397570	=	Inhibition	%	1.91	CHEMBL4722	Homo sapiens	Inhibition	%	1.91
	8068906	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(S(=O)(=O)c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.Cl		CHEMBL1909367	=	Inhibition	%	8.25	CHEMBL4722	Homo sapiens	Inhibition	%	8.25
	8069255	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ccccc3c2-c2ccncc2)cc1		CHEMBL485745	=	Inhibition	%	8.81	CHEMBL4722	Homo sapiens	Inhibition	%	8.81
	8069550	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(c2ccc(Nc3nccc(-c4cnn5ncccc45)n3)cc2C(F)(F)F)CC1		CHEMBL468963	=	Inhibition	%	8.21	CHEMBL4722	Homo sapiens	Inhibition	%	8.21
	8069711	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	Cl.N#Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL1794061	=	Inhibition	%	11.6	CHEMBL4722	Homo sapiens	Inhibition	%	11.6
	8070061	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)cc2)sc2c1CCCC2		CHEMBL397570	=	Inhibition	%	0.18	CHEMBL4722	Homo sapiens	Inhibition	%	0.18
	8070233	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4)n3C)ccc2c1		CHEMBL399410	=	Inhibition	%	3.45	CHEMBL4722	Homo sapiens	Inhibition	%	3.45
	8070582	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)c1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL206544	=	Inhibition	%	1.03	CHEMBL4722	Homo sapiens	Inhibition	%	1.03
	8070880	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(c2ccc(Nc3nccc(-c4cnn5ncccc45)n3)cc2C(F)(F)F)CC1		CHEMBL468963	=	Inhibition	%	74.19	CHEMBL4722	Homo sapiens	Inhibition	%	74.19
	8071037	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(Cl)cc2c1NC(=O)C2=NNc1ccc(S(N)(=O)=O)cc1		CHEMBL1909397	=	Inhibition	%	1.75	CHEMBL4722	Homo sapiens	Inhibition	%	1.75
	8071261	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(Cl)cc2c1NC(=O)C2=NNc1ccc(S(N)(=O)=O)cc1		CHEMBL1909397	=	Inhibition	%	4.36	CHEMBL4722	Homo sapiens	Inhibition	%	4.36
	8071387	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc(-c2n[nH]cc2-c2ccc3ncccc3n2)n1		CHEMBL185238	=	Inhibition	%	2.76	CHEMBL4722	Homo sapiens	Inhibition	%	2.76
	8071560	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4)n3C)ccc2c1		CHEMBL399410	=	Inhibition	%	9.25	CHEMBL4722	Homo sapiens	Inhibition	%	9.25
	8071784	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)c(Br)cc12)C1CC1		CHEMBL408564	=	Inhibition	%	2.52	CHEMBL4722	Homo sapiens	Inhibition	%	2.52
	8071909	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	CC(C)c1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL206544	=	Inhibition	%	3.72	CHEMBL4722	Homo sapiens	Inhibition	%	3.72
	8072223	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3cccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)c3)ccc2[nH]1.Cl		CHEMBL1909366	=	Inhibition	%	1.04	CHEMBL4722	Homo sapiens	Inhibition	%	1.04
	8072604	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4ccccc4)cc3)ccc2[nH]1.Cl		CHEMBL1909371	=	Inhibition	%	2.47	CHEMBL4722	Homo sapiens	Inhibition	%	2.47
	8072729	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc(-c2n[nH]cc2-c2ccc3ncccc3n2)n1		CHEMBL185238	=	Inhibition	%	2.37	CHEMBL4722	Homo sapiens	Inhibition	%	2.37
	8073120	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)c(Br)cc12)C1CC1		CHEMBL408564	=	Inhibition	%	45.56	CHEMBL4722	Homo sapiens	Inhibition	%	45.56
	8073245	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2s1.Cl		CHEMBL1909369	=	Inhibition	%	1.12	CHEMBL4722	Homo sapiens	Inhibition	%	1.12
	8073469	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2s1.Cl		CHEMBL1909369	=	Inhibition	%	7.02	CHEMBL4722	Homo sapiens	Inhibition	%	7.02
	8073588	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL271843	=	Inhibition	%	2.87	CHEMBL4722	Homo sapiens	Inhibition	%	2.87
	8073821	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3cccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)c3)ccc2[nH]1.Cl		CHEMBL1909366	=	Inhibition	%	1.22	CHEMBL4722	Homo sapiens	Inhibition	%	1.22
	8074197	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4ccccc4)cc3)ccc2[nH]1.Cl		CHEMBL1909371	=	Inhibition	%	3.53	CHEMBL4722	Homo sapiens	Inhibition	%	3.53
	8074327	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(=O)N(C)C)s3)c2cc1OC		CHEMBL482326	=	Inhibition	%	0.68	CHEMBL4722	Homo sapiens	Inhibition	%	0.68
	8074551	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(=O)N(C)C)s3)c2cc1OC		CHEMBL482326	=	Inhibition	%	9.82	CHEMBL4722	Homo sapiens	Inhibition	%	9.82
	8074708	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)Cc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785002	=	Inhibition	%	1.9	CHEMBL4722	Homo sapiens	Inhibition	%	1.9
	8075059	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc3ncccc23)c2cc[nH]c2n1		CHEMBL458438	=	Inhibition	%	0.64	CHEMBL4722	Homo sapiens	Inhibition	%	0.64
	8075170	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL271843	=	Inhibition	%	27.76	CHEMBL4722	Homo sapiens	Inhibition	%	27.76
	8075394	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(CCCN3CCOCC3)c2-c2ccncc2)cc1		CHEMBL14112	=	Inhibition	%	-0.48	CHEMBL4722	Homo sapiens	Inhibition	%	-0.48
	8075407	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(CN3CCCC3)cc21		CHEMBL1096290	=	Inhibition	%	0.54	CHEMBL4722	Homo sapiens	Inhibition	%	0.54
	8075631	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(CN3CCCC3)cc21		CHEMBL1096290	=	Inhibition	%	3.35	CHEMBL4722	Homo sapiens	Inhibition	%	3.35
	8075772	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL156987	=	Inhibition	%	2.92	CHEMBL4722	Homo sapiens	Inhibition	%	2.92
	8076138	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4C(F)(F)F)c(C(N)=O)s3)c2c1		CHEMBL522709	=	Inhibition	%	-0.03	CHEMBL4722	Homo sapiens	Inhibition	%	-0.03
	8076286	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	NC(=O)Cc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785002	=	Inhibition	%	0.49	CHEMBL4722	Homo sapiens	Inhibition	%	0.49
	8076644	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc3ncccc23)c2cc[nH]c2n1		CHEMBL458438	=	Inhibition	%	4.47	CHEMBL4722	Homo sapiens	Inhibition	%	4.47
	8076970	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(CCCN3CCOCC3)c2-c2ccncc2)cc1		CHEMBL14112	=	Inhibition	%	3.87	CHEMBL4722	Homo sapiens	Inhibition	%	3.87
	8077217	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(O[C@@H](CN)c3ccccc3)cc21.O=C(O)C(F)(F)F		CHEMBL1909349	=	Inhibition	%	0.22	CHEMBL4722	Homo sapiens	Inhibition	%	0.22
	8077345	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL156987	=	Inhibition	%	8.62	CHEMBL4722	Homo sapiens	Inhibition	%	8.62
	8077720	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4C(F)(F)F)c(C(N)=O)s3)c2c1		CHEMBL522709	=	Inhibition	%	5.59	CHEMBL4722	Homo sapiens	Inhibition	%	5.59
	8077863	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCCc4ccccc4)c(C(N)=O)s3)c2cc1OC		CHEMBL473629	=	Inhibition	%	2.54	CHEMBL4722	Homo sapiens	Inhibition	%	2.54
	8078087	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCCc4ccccc4)c(C(N)=O)s3)c2cc1OC		CHEMBL473629	=	Inhibition	%	8.4	CHEMBL4722	Homo sapiens	Inhibition	%	8.4
	8078226	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3ccc(O)c(F)c3)n[nH]2)cc1		CHEMBL103115	=	Inhibition	%	-2.14	CHEMBL4722	Homo sapiens	Inhibition	%	-2.14
	8078552	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	Cl.ON=C1CCc2cc(-c3nc(C4CCNCC4)[nH]c3-c3ccncc3)ccc21		CHEMBL1794071	=	Inhibition	%	-0.5	CHEMBL4722	Homo sapiens	Inhibition	%	-0.5
	8078802	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(O[C@@H](CN)c3ccccc3)cc21.O=C(O)C(F)(F)F		CHEMBL1909349	=	Inhibition	%	5.65	CHEMBL4722	Homo sapiens	Inhibition	%	5.65
	8078918	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)Nc4cccc(C#N)c4)cc3)c2)o1		CHEMBL270164	=	Inhibition	%	0.8	CHEMBL4722	Homo sapiens	Inhibition	%	0.8
	8079142	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)Nc4cccc(C#N)c4)cc3)c2)o1		CHEMBL270164	=	Inhibition	%	5.96	CHEMBL4722	Homo sapiens	Inhibition	%	5.96
	8079300	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC[C@@H](O)CO)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794067	=	Inhibition	%	-0.94	CHEMBL4722	Homo sapiens	Inhibition	%	-0.94
	8079666	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(F)c5)c4c3)o2)CC1		CHEMBL1909391	=	Inhibition	%	2.01	CHEMBL4722	Homo sapiens	Inhibition	%	2.01
	8079805	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3ccc(O)c(F)c3)n[nH]2)cc1		CHEMBL103115	=	Inhibition	%	37.34	CHEMBL4722	Homo sapiens	Inhibition	%	37.34
	8080134	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	Cl.ON=C1CCc2cc(-c3nc(C4CCNCC4)[nH]c3-c3ccncc3)ccc21		CHEMBL1794071	=	Inhibition	%	2.73	CHEMBL4722	Homo sapiens	Inhibition	%	2.73
	8080386	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)COC(=O)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL269883	=	Inhibition	%	3.84	CHEMBL4722	Homo sapiens	Inhibition	%	3.84
	8080725	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909411	=	Inhibition	%	1.97	CHEMBL4722	Homo sapiens	Inhibition	%	1.97
	8080889	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC[C@@H](O)CO)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794067	=	Inhibition	%	2.13	CHEMBL4722	Homo sapiens	Inhibition	%	2.13
	8081248	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(F)c5)c4c3)o2)CC1		CHEMBL1909391	=	Inhibition	%	5.78	CHEMBL4722	Homo sapiens	Inhibition	%	5.78
	8081392	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)CC1		CHEMBL476259	=	Inhibition	%	2.78	CHEMBL4722	Homo sapiens	Inhibition	%	2.78
	8081616	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)CC1		CHEMBL476259	=	Inhibition	%	10.4	CHEMBL4722	Homo sapiens	Inhibition	%	10.4
	8081719	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(O)c(Cl)c1		CHEMBL160333	=	Inhibition	%	2.24	CHEMBL4722	Homo sapiens	Inhibition	%	2.24
	8081971	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	CC(C)COC(=O)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL269883	=	Inhibition	%	61.0	CHEMBL4722	Homo sapiens	Inhibition	%	61.0
	8082308	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909411	=	Inhibition	%	8.54	CHEMBL4722	Homo sapiens	Inhibition	%	8.54
	8082481	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	-4.27	CHEMBL4722	Homo sapiens	Inhibition	%	-4.27
	8082705	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	2.76	CHEMBL4722	Homo sapiens	Inhibition	%	2.76
	8082828	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL517507	=	Inhibition	%	2.11	CHEMBL4722	Homo sapiens	Inhibition	%	2.11
	8083208	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCCn4ccnc4)cc32)cc1		CHEMBL272026	=	Inhibition	%	5.44	CHEMBL4722	Homo sapiens	Inhibition	%	5.44
	8083307	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(O)c(Cl)c1		CHEMBL160333	=	Inhibition	%	11.05	CHEMBL4722	Homo sapiens	Inhibition	%	11.05
	8083531	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL103080	=	Inhibition	%	2.68	CHEMBL4722	Homo sapiens	Inhibition	%	2.68
	8083561	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CCCCC1		CHEMBL189231	=	Inhibition	%	-0.63	CHEMBL4722	Homo sapiens	Inhibition	%	-0.63
	8083785	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CCCCC1		CHEMBL189231	=	Inhibition	%	5.79	CHEMBL4722	Homo sapiens	Inhibition	%	5.79
	8083895	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC1		CHEMBL95207	=	Inhibition	%	4.64	CHEMBL4722	Homo sapiens	Inhibition	%	4.64
	8084304	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc4ncccc4c32)cc1		CHEMBL409892	=	Inhibition	%	27.28	CHEMBL4722	Homo sapiens	Inhibition	%	27.28
	8084422	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL517507	=	Inhibition	%	7.83	CHEMBL4722	Homo sapiens	Inhibition	%	7.83
	8084646	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4c(cnn4Cc4ccccc4)c3)ncnc2cn1		CHEMBL30432	=	Inhibition	%	-1.73	CHEMBL4722	Homo sapiens	Inhibition	%	-1.73
	8084807	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCCn4ccnc4)cc32)cc1		CHEMBL272026	=	Inhibition	%	49.88	CHEMBL4722	Homo sapiens	Inhibition	%	49.88
	8085129	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL103080	=	Inhibition	%	12.42	CHEMBL4722	Homo sapiens	Inhibition	%	12.42
	8085385	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3Cc2ccccc2)ccc1O		CHEMBL1789962	=	Inhibition	%	2.88	CHEMBL4722	Homo sapiens	Inhibition	%	2.88
	8085493	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC1		CHEMBL95207	=	Inhibition	%	7.96	CHEMBL4722	Homo sapiens	Inhibition	%	7.96
	8085717	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(Nc3ccccc3)n2)CC1		CHEMBL318892	=	Inhibition	%	2.13	CHEMBL4722	Homo sapiens	Inhibition	%	2.13
	8085906	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc4ncccc4c32)cc1		CHEMBL409892	=	Inhibition	%	91.78	CHEMBL4722	Homo sapiens	Inhibition	%	91.78
	8086245	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4c(cnn4Cc4ccccc4)c3)ncnc2cn1		CHEMBL30432	=	Inhibition	%	12.85	CHEMBL4722	Homo sapiens	Inhibition	%	12.85
	8086407	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1		CHEMBL261129	=	Inhibition	%	-1.93	CHEMBL4722	Homo sapiens	Inhibition	%	-1.93
	8086730	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccncc21		CHEMBL185710	=	Inhibition	%	2.36	CHEMBL4722	Homo sapiens	Inhibition	%	2.36
	8086941	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(Cl)cccc2Cl)c1		CHEMBL263796	=	Inhibition	%	0.59	CHEMBL4722	Homo sapiens	Inhibition	%	0.59
	8087323	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	CCC(=O)Nc1ccc(C)c(-c2ccc(C(=O)NCC3CC3)cc2)c1		CHEMBL517666	=	Inhibition	%	1.72	CHEMBL4722	Homo sapiens	Inhibition	%	1.72
	8087437	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2nccc(N(C)c3ccc4c(C)n[nH]c4c3)n2)c1.Cl		CHEMBL1909358	=	Inhibition	%	6.77	CHEMBL4722	Homo sapiens	Inhibition	%	6.77
	8087661	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1Nc1ncc(-c2ccccc2)o1.Cl		CHEMBL1794062	=	Inhibition	%	4.71	CHEMBL4722	Homo sapiens	Inhibition	%	4.71
	8087799	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	6.51	CHEMBL4722	Homo sapiens	Inhibition	%	6.51
	8088165	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CCNCC3)c21.Cl		CHEMBL1909376	=	Inhibition	%	2.9	CHEMBL4722	Homo sapiens	Inhibition	%	2.9
	8088313	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2cc(-c3ccccc3)cc(C(N)=O)c2N)cc1		CHEMBL230597	=	Inhibition	%	1.29	CHEMBL4722	Homo sapiens	Inhibition	%	1.29
	8088665	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL521806	=	Inhibition	%	4.95	CHEMBL4722	Homo sapiens	Inhibition	%	4.95
	8088982	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccccc21		CHEMBL365286	=	Inhibition	%	7.95	CHEMBL4722	Homo sapiens	Inhibition	%	7.95
	8089110	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCC(Oc2cc(Nc3nc(Nc4cccc(F)c4C(N)=O)c4cc[nH]c4n3)c(OC)cc2Cl)CC1		CHEMBL517171	=	Inhibition	%	0.38	CHEMBL4722	Homo sapiens	Inhibition	%	0.38
	8089482	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)=Cc1cccc2c1/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL270544	=	Inhibition	%	25.61	CHEMBL4722	Homo sapiens	Inhibition	%	25.61
	8089602	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCOCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL476351	=	Inhibition	%	5.37	CHEMBL4722	Homo sapiens	Inhibition	%	5.37
	8089826	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3Cl)o2)c1		CHEMBL179453	=	Inhibition	%	1.49	CHEMBL4722	Homo sapiens	Inhibition	%	1.49
	8090006	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909402	=	Inhibition	%	1.39	CHEMBL4722	Homo sapiens	Inhibition	%	1.39
	8090171	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3cccc(F)c3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN1CCN(C(C)C)CC1)CC2		CHEMBL505915	=	Inhibition	%	0.69	CHEMBL4722	Homo sapiens	Inhibition	%	0.69
	8090395	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3cccc(F)c3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN1CCN(C(C)C)CC1)CC2		CHEMBL505915	=	Inhibition	%	0.34	CHEMBL4722	Homo sapiens	Inhibition	%	0.34
	8090562	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nc(-c2ccccc2)n2nc(NCCCN3CCOCC3)ncc12		CHEMBL486124	=	Inhibition	%	3.52	CHEMBL4722	Homo sapiens	Inhibition	%	3.52
	8090701	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL183993	=	Inhibition	%	7.68	CHEMBL4722	Homo sapiens	Inhibition	%	7.68
	8090925	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2ccc(OC(F)(F)F)cc2)cc1)c1ccnc(Nc2cccc(S(N)(=O)=O)c2)n1		CHEMBL188381	=	Inhibition	%	7.93	CHEMBL4722	Homo sapiens	Inhibition	%	7.93
	8091130	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)o1.Cl		CHEMBL1909385	=	Inhibition	%	3.51	CHEMBL4722	Homo sapiens	Inhibition	%	3.51
	8091267	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(Cl)cccc2Cl)c1		CHEMBL263796	=	Inhibition	%	0.47	CHEMBL4722	Homo sapiens	Inhibition	%	0.47
	8091491	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCC=C(c2ccc(Nc3nc(Nc4ccccc4C(N)=O)c4cc[nH]c4n3)c(C)c2)C1		CHEMBL513897	=	Inhibition	%	6.15	CHEMBL4722	Homo sapiens	Inhibition	%	6.15
	8091646	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	CCC(=O)Nc1ccc(C)c(-c2ccc(C(=O)NCC3CC3)cc2)c1		CHEMBL517666	=	Inhibition	%	4.11	CHEMBL4722	Homo sapiens	Inhibition	%	4.11
	8091986	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1Nc1ncc(-c2ccccc2)o1.Cl		CHEMBL1794062	=	Inhibition	%	8.83	CHEMBL4722	Homo sapiens	Inhibition	%	8.83
	8092123	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccccc3)n2)cc1		CHEMBL275798	=	Inhibition	%	-3.42	CHEMBL4722	Homo sapiens	Inhibition	%	-3.42
	8092498	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1cc(-c2cc3c(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)ncnc3s2)cs1		CHEMBL475599	=	Inhibition	%	4.18	CHEMBL4722	Homo sapiens	Inhibition	%	4.18
	8092646	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2cc(-c3ccccc3)cc(C(N)=O)c2N)cc1		CHEMBL230597	=	Inhibition	%	1.71	CHEMBL4722	Homo sapiens	Inhibition	%	1.71
	8092870	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5cccs5)cc34)cc2Cl)c1		CHEMBL506414	=	Inhibition	%	1.44	CHEMBL4722	Homo sapiens	Inhibition	%	1.44
	8092999	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL521806	=	Inhibition	%	18.13	CHEMBL4722	Homo sapiens	Inhibition	%	18.13
	8093311	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)/C=C/C(=O)O.OCCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909403	=	Inhibition	%	0.87	CHEMBL4722	Homo sapiens	Inhibition	%	0.87
	8093451	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCC(Oc2cc(Nc3nc(Nc4cccc(F)c4C(N)=O)c4cc[nH]c4n3)c(OC)cc2Cl)CC1		CHEMBL517171	=	Inhibition	%	5.9	CHEMBL4722	Homo sapiens	Inhibition	%	5.9
	8093675	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@@H](N)c3ccccc3)cc21		CHEMBL1096626	=	Inhibition	%	1.81	CHEMBL4722	Homo sapiens	Inhibition	%	1.81
	8093814	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	CC(C)=Cc1cccc2c1/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL270544	=	Inhibition	%	93.06	CHEMBL4722	Homo sapiens	Inhibition	%	93.06
	8094158	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3Cl)o2)c1		CHEMBL179453	=	Inhibition	%	10.91	CHEMBL4722	Homo sapiens	Inhibition	%	10.91
	8094338	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(-c2ccco2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909353	=	Inhibition	%	3.01	CHEMBL4722	Homo sapiens	Inhibition	%	3.01
	8094737	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(N)=O)c2cc[nH]c2n1		CHEMBL458865	=	Inhibition	%	2.91	CHEMBL4722	Homo sapiens	Inhibition	%	2.91
	8094893	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	Cc1nc(-c2ccccc2)n2nc(NCCCN3CCOCC3)ncc12		CHEMBL486124	=	Inhibition	%	5.63	CHEMBL4722	Homo sapiens	Inhibition	%	5.63
	8095257	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2ccc(OC(F)(F)F)cc2)cc1)c1ccnc(Nc2cccc(S(N)(=O)=O)c2)n1		CHEMBL188381	=	Inhibition	%	76.84	CHEMBL4722	Homo sapiens	Inhibition	%	76.84
	8095460	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)o1.Cl		CHEMBL1909385	=	Inhibition	%	7.7	CHEMBL4722	Homo sapiens	Inhibition	%	7.7
	8095825	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCC=C(c2ccc(Nc3nc(Nc4ccccc4C(N)=O)c4cc[nH]c4n3)c(C)c2)C1		CHEMBL513897	=	Inhibition	%	32.6	CHEMBL4722	Homo sapiens	Inhibition	%	32.6
	8095973	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc4c(cnn4Cc4ccccc4)c3)c2cc1OC.Cl		CHEMBL1909380	=	Inhibition	%	1.22	CHEMBL4722	Homo sapiens	Inhibition	%	1.22
	8096314	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL275666	=	Inhibition	%	5.21	CHEMBL4722	Homo sapiens	Inhibition	%	5.21
	8096453	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccccc3)n2)cc1		CHEMBL275798	=	Inhibition	%	-2.89	CHEMBL4722	Homo sapiens	Inhibition	%	-2.89
	8096677	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909393	=	Inhibition	%	1.75	CHEMBL4722	Homo sapiens	Inhibition	%	1.75
	8096833	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1cc(-c2cc3c(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)ncnc3s2)cs1		CHEMBL475599	=	Inhibition	%	4.87	CHEMBL4722	Homo sapiens	Inhibition	%	4.87
	8097204	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5cccs5)cc34)cc2Cl)c1		CHEMBL506414	=	Inhibition	%	2.05	CHEMBL4722	Homo sapiens	Inhibition	%	2.05
	8097291	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2c1		CHEMBL493326	=	Inhibition	%	0.29	CHEMBL4722	Homo sapiens	Inhibition	%	0.29
	8097511	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	O=C(O)/C=C/C(=O)O.OCCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909403	=	Inhibition	%	7.6	CHEMBL4722	Homo sapiens	Inhibition	%	7.6
	8097885	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@@H](N)c3ccccc3)cc21		CHEMBL1096626	=	Inhibition	%	11.74	CHEMBL4722	Homo sapiens	Inhibition	%	11.74
	8098018	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(C(=O)O)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909373	=	Inhibition	%	-1.89	CHEMBL4722	Homo sapiens	Inhibition	%	-1.89
	8098362	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(COc2cc(-n3cnc4ccccc43)sc2C(N)=O)c1		CHEMBL516248	=	Inhibition	%	2.16	CHEMBL4722	Homo sapiens	Inhibition	%	2.16
	8098542	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(-c2ccco2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909353	=	Inhibition	%	19.99	CHEMBL4722	Homo sapiens	Inhibition	%	19.99
	8098766	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(COc2ccc(Nc3ncnc4ccc(-c5ccco5)cc34)cc2)cc1		CHEMBL215993	=	Inhibition	%	2.29	CHEMBL4722	Homo sapiens	Inhibition	%	2.29
	8098951	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(N)=O)c2cc[nH]c2n1		CHEMBL458865	=	Inhibition	%	4.58	CHEMBL4722	Homo sapiens	Inhibition	%	4.58
	8099095	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1coc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)c1.Cl		CHEMBL1909386	=	Inhibition	%	2.4	CHEMBL4722	Homo sapiens	Inhibition	%	2.4
	8099461	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(C)=O)s3)c2cc1OC		CHEMBL471789	=	Inhibition	%	2.64	CHEMBL4722	Homo sapiens	Inhibition	%	2.64
	8099655	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1ccc2c(-c3ccnc(NC4CC4)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1885746	=	Inhibition	%	0.84	CHEMBL4722	Homo sapiens	Inhibition	%	0.84
	8100026	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C)cc4)ncnc32)c1		CHEMBL303687	=	Inhibition	%	3.98	CHEMBL4722	Homo sapiens	Inhibition	%	3.98
	8100172	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc4c(cnn4Cc4ccccc4)c3)c2cc1OC.Cl		CHEMBL1909380	=	Inhibition	%	7.82	CHEMBL4722	Homo sapiens	Inhibition	%	7.82
	8100396	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(-c4cnco4)cc32)cc1		CHEMBL269827	=	Inhibition	%	1.82	CHEMBL4722	Homo sapiens	Inhibition	%	1.82
	8100512	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL275666	=	Inhibition	%	5.75	CHEMBL4722	Homo sapiens	Inhibition	%	5.75
	8100876	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909393	=	Inhibition	%	2.75	CHEMBL4722	Homo sapiens	Inhibition	%	2.75
	8101036	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2ccncc2)cc1C(N)=O		CHEMBL231013	=	Inhibition	%	2.92	CHEMBL4722	Homo sapiens	Inhibition	%	2.92
	8101402	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1OC		CHEMBL443563	=	Inhibition	%	15.73	CHEMBL4722	Homo sapiens	Inhibition	%	15.73
	8101587	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2c1		CHEMBL493326	=	Inhibition	%	-1.27	CHEMBL4722	Homo sapiens	Inhibition	%	-1.27
	8101840	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-c2c[nH]c3c(N/N=C/c4ccncc4)ncnc23)c1		CHEMBL206010	=	Inhibition	%	4.07	CHEMBL4722	Homo sapiens	Inhibition	%	4.07
	8102219	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1cccc(Nc2nccc(Nc3cccc4[nH]ncc34)n2)c1		CHEMBL251549	=	Inhibition	%	36.43	CHEMBL4722	Homo sapiens	Inhibition	%	36.43
	8102350	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(C(=O)O)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909373	=	Inhibition	%	12.78	CHEMBL4722	Homo sapiens	Inhibition	%	12.78
	8102574	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	CCN(CC)S(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL275473	=	Inhibition	%	1.61	CHEMBL4722	Homo sapiens	Inhibition	%	1.61
	8102694	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(COc2cc(-n3cnc4ccccc43)sc2C(N)=O)c1		CHEMBL516248	=	Inhibition	%	2.21	CHEMBL4722	Homo sapiens	Inhibition	%	2.21
	8103096	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	c1ccc(COc2ccc(Nc3ncnc4ccc(-c5ccco5)cc34)cc2)cc1		CHEMBL215993	=	Inhibition	%	3.53	CHEMBL4722	Homo sapiens	Inhibition	%	3.53
	8103292	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@H](N)c3ccccc3)cc21		CHEMBL1096634	=	Inhibition	%	2.4	CHEMBL4722	Homo sapiens	Inhibition	%	2.4
	8103430	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1coc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)c1.Cl		CHEMBL1909386	=	Inhibition	%	4.78	CHEMBL4722	Homo sapiens	Inhibition	%	4.78
	8103654	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NC(=O)c1cccc(Nc2nccc(Nc3cccc(F)c3)n2)c1		CHEMBL1909382	=	Inhibition	%	14.86	CHEMBL4722	Homo sapiens	Inhibition	%	14.86
	8103804	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(C)=O)s3)c2cc1OC		CHEMBL471789	=	Inhibition	%	4.46	CHEMBL4722	Homo sapiens	Inhibition	%	4.46
	8103989	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	N#Cc1ccc2c(-c3ccnc(NC4CC4)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1885746	=	Inhibition	%	0.56	CHEMBL4722	Homo sapiens	Inhibition	%	0.56
	8104213	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)cc2[nH]1.Cl		CHEMBL1909364	=	Inhibition	%	2.85	CHEMBL4722	Homo sapiens	Inhibition	%	2.85
	8104361	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C)cc4)ncnc32)c1		CHEMBL303687	=	Inhibition	%	11.76	CHEMBL4722	Homo sapiens	Inhibition	%	11.76
	8104731	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(-c4cnco4)cc32)cc1		CHEMBL269827	=	Inhibition	%	33.14	CHEMBL4722	Homo sapiens	Inhibition	%	33.14
	8104845	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL13972	=	Inhibition	%	3.21	CHEMBL4722	Homo sapiens	Inhibition	%	3.21
	8105069	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	N#Cc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL13972	=	Inhibition	%	4.78	CHEMBL4722	Homo sapiens	Inhibition	%	4.78
	8105209	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Cl)cc3)n2)cc1		CHEMBL275168	=	Inhibition	%	0.56	CHEMBL4722	Homo sapiens	Inhibition	%	0.56
	8105375	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2ccncc2)cc1C(N)=O		CHEMBL231013	=	Inhibition	%	4.17	CHEMBL4722	Homo sapiens	Inhibition	%	4.17
	8105599	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794070	=	Inhibition	%	-0.97	CHEMBL4722	Homo sapiens	Inhibition	%	-0.97
	8105737	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1OC		CHEMBL443563	=	Inhibition	%	75.5	CHEMBL4722	Homo sapiens	Inhibition	%	75.5
	8106017	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL205798	=	Inhibition	%	2.48	CHEMBL4722	Homo sapiens	Inhibition	%	2.48
	8106182	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-c2c[nH]c3c(N/N=C/c4ccncc4)ncnc23)c1		CHEMBL206010	=	Inhibition	%	37.74	CHEMBL4722	Homo sapiens	Inhibition	%	37.74
	8106406	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1.CS(=O)(=O)O		CHEMBL1909405	=	Inhibition	%	-2.9	CHEMBL4722	Homo sapiens	Inhibition	%	-2.9
	8106562	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1cccc(Nc2nccc(Nc3cccc4[nH]ncc34)n2)c1		CHEMBL251549	=	Inhibition	%	96.75	CHEMBL4722	Homo sapiens	Inhibition	%	96.75
	8106915	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	CCN(CC)S(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL275473	=	Inhibition	%	13.91	CHEMBL4722	Homo sapiens	Inhibition	%	13.91
	8107036	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	CCn1cc(-c2ccnc3[nH]ccc23)c(-c2cccc(NC(=O)Nc3ccc(OCc4ccccc4)cc3)c2)n1		CHEMBL505187	=	Inhibition	%	2.05	CHEMBL4722	Homo sapiens	Inhibition	%	2.05
	8107260	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	CCn1cc(-c2ccnc3[nH]ccc23)c(-c2cccc(NC(=O)Nc3ccc(OCc4ccccc4)cc3)c2)n1		CHEMBL505187	=	Inhibition	%	7.41	CHEMBL4722	Homo sapiens	Inhibition	%	7.41
	8107432	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3cc(C(F)(F)F)ccc32)cc1OCc1ccccc1Br		CHEMBL480371	=	Inhibition	%	1.18	CHEMBL4722	Homo sapiens	Inhibition	%	1.18
	8107633	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@H](N)c3ccccc3)cc21		CHEMBL1096634	=	Inhibition	%	2.98	CHEMBL4722	Homo sapiens	Inhibition	%	2.98
	8107992	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	Cl.NC(=O)c1cccc(Nc2nccc(Nc3cccc(F)c3)n2)c1		CHEMBL1909382	=	Inhibition	%	65.45	CHEMBL4722	Homo sapiens	Inhibition	%	65.45
	8108150	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL518968	=	Inhibition	%	3.14	CHEMBL4722	Homo sapiens	Inhibition	%	3.14
	8108549	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)cc2[nH]1.Cl		CHEMBL1909364	=	Inhibition	%	0.65	CHEMBL4722	Homo sapiens	Inhibition	%	0.65
	8108696	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794069	=	Inhibition	%	3.84	CHEMBL4722	Homo sapiens	Inhibition	%	3.84
	8109062	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	O=S(=O)(CCOCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL212250	=	Inhibition	%	1.6	CHEMBL4722	Homo sapiens	Inhibition	%	1.6
	8109400	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)c1C.O=C(O)C(F)(F)F		CHEMBL1909400	=	Inhibition	%	3.78	CHEMBL4722	Homo sapiens	Inhibition	%	3.78
	8109530	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Cl)cc3)n2)cc1		CHEMBL275168	=	Inhibition	%	0.17	CHEMBL4722	Homo sapiens	Inhibition	%	0.17
	8109925	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794070	=	Inhibition	%	-0.02	CHEMBL4722	Homo sapiens	Inhibition	%	-0.02
	8110057	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1		CHEMBL176553	=	Inhibition	%	5.61	CHEMBL4722	Homo sapiens	Inhibition	%	5.61
	8110336	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL205798	=	Inhibition	%	8.44	CHEMBL4722	Homo sapiens	Inhibition	%	8.44
	8110726	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1.CS(=O)(=O)O		CHEMBL1909405	=	Inhibition	%	6.4	CHEMBL4722	Homo sapiens	Inhibition	%	6.4
	8110884	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CCN)ncc(OCCCN)c21.O=C(O)C(F)(F)F		CHEMBL1794064	=	Inhibition	%	-1.21	CHEMBL4722	Homo sapiens	Inhibition	%	-1.21
	8111231	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	CCc1cccc(NC(=O)Nc2ccc(Oc3ccc4nc(NC(=O)OC)[nH]c4c3)cc2)c1		CHEMBL243907	=	Inhibition	%	2.16	CHEMBL4722	Homo sapiens	Inhibition	%	2.16
	8111582	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@@H]3CCCN3)c21.O=C(O)C(F)(F)F		CHEMBL1909375	=	Inhibition	%	3.07	CHEMBL4722	Homo sapiens	Inhibition	%	3.07
	8111748	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3cc(C(F)(F)F)ccc32)cc1OCc1ccccc1Br		CHEMBL480371	=	Inhibition	%	2.05	CHEMBL4722	Homo sapiens	Inhibition	%	2.05
	8111953	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL192417	=	Inhibition	%	2.74	CHEMBL4722	Homo sapiens	Inhibition	%	2.74
	8112177	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL192417	=	Inhibition	%	7.93	CHEMBL4722	Homo sapiens	Inhibition	%	7.93
	8112314	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2nc(C)c3c(N/N=C(\C)c4ccncc4)ncnc32)c1		CHEMBL442363	=	Inhibition	%	1.27	CHEMBL4722	Homo sapiens	Inhibition	%	1.27
	8112482	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL518968	=	Inhibition	%	4.37	CHEMBL4722	Homo sapiens	Inhibition	%	4.37
	8112706	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncc(-c2cccc(S(N)(=O)=O)c2)c2scc(-c3ccc(F)c(Cl)c3)c12		CHEMBL241517	=	Inhibition	%	3.16	CHEMBL4722	Homo sapiens	Inhibition	%	3.16
	8112878	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccoc1-c1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909388	=	Inhibition	%	3.55	CHEMBL4722	Homo sapiens	Inhibition	%	3.55
	8113030	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794069	=	Inhibition	%	6.43	CHEMBL4722	Homo sapiens	Inhibition	%	6.43
	8113254	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OCCNC)cc21.Cl		CHEMBL1909350	=	Inhibition	%	1.75	CHEMBL4722	Homo sapiens	Inhibition	%	1.75
	8113390	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	O=S(=O)(CCOCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL212250	=	Inhibition	%	2.01	CHEMBL4722	Homo sapiens	Inhibition	%	2.01
	8113738	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)c1C.O=C(O)C(F)(F)F		CHEMBL1909400	=	Inhibition	%	1.24	CHEMBL4722	Homo sapiens	Inhibition	%	1.24
	8113854	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)CCc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785003	=	Inhibition	%	-3.22	CHEMBL4722	Homo sapiens	Inhibition	%	-3.22
	8114078	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	NC(=O)CCc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785003	=	Inhibition	%	-2.06	CHEMBL4722	Homo sapiens	Inhibition	%	-2.06
	8114254	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)o1.Cl		CHEMBL1909387	=	Inhibition	%	3.79	CHEMBL4722	Homo sapiens	Inhibition	%	3.79
	8114386	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1		CHEMBL176553	=	Inhibition	%	30.32	CHEMBL4722	Homo sapiens	Inhibition	%	30.32
	8114610	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5ccco5)cc34)cc2Cl)c1		CHEMBL514938	=	Inhibition	%	2.5	CHEMBL4722	Homo sapiens	Inhibition	%	2.5
	8114662	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCCCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477978	=	Inhibition	%	4.04	CHEMBL4722	Homo sapiens	Inhibition	%	4.04
	8114886	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCCCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477978	=	Inhibition	%	4.4	CHEMBL4722	Homo sapiens	Inhibition	%	4.4
	8115052	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL588025	=	Inhibition	%	3.16	CHEMBL4722	Homo sapiens	Inhibition	%	3.16
	8115217	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CCN)ncc(OCCCN)c21.O=C(O)C(F)(F)F		CHEMBL1794064	=	Inhibition	%	5.16	CHEMBL4722	Homo sapiens	Inhibition	%	5.16
	8115441	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL205765	=	Inhibition	%	-0.41	CHEMBL4722	Homo sapiens	Inhibition	%	-0.41
	8115561	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	CCc1cccc(NC(=O)Nc2ccc(Oc3ccc4nc(NC(=O)OC)[nH]c4c3)cc2)c1		CHEMBL243907	=	Inhibition	%	8.38	CHEMBL4722	Homo sapiens	Inhibition	%	8.38
	8115918	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@@H]3CCCN3)c21.O=C(O)C(F)(F)F		CHEMBL1909375	=	Inhibition	%	1.08	CHEMBL4722	Homo sapiens	Inhibition	%	1.08
	8116077	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)(CO)CNC(=O)c1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL410072	=	Inhibition	%	11.93	CHEMBL4722	Homo sapiens	Inhibition	%	11.93
	8116504	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794066	=	Inhibition	%	4.24	CHEMBL4722	Homo sapiens	Inhibition	%	4.24
	8116638	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2nc(C)c3c(N/N=C(\C)c4ccncc4)ncnc32)c1		CHEMBL442363	=	Inhibition	%	0.79	CHEMBL4722	Homo sapiens	Inhibition	%	0.79
	8117034	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	Nc1ncc(-c2cccc(S(N)(=O)=O)c2)c2scc(-c3ccc(F)c(Cl)c3)c12		CHEMBL241517	=	Inhibition	%	5.8	CHEMBL4722	Homo sapiens	Inhibition	%	5.8
	8117205	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccoc1-c1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909388	=	Inhibition	%	5.63	CHEMBL4722	Homo sapiens	Inhibition	%	5.63
	8117587	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OCCNC)cc21.Cl		CHEMBL1909350	=	Inhibition	%	4.63	CHEMBL4722	Homo sapiens	Inhibition	%	4.63
	8117717	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Cl)c4)c3c2)o1.Cl		CHEMBL529066	=	Inhibition	%	0.56	CHEMBL4722	Homo sapiens	Inhibition	%	0.56
	8117941	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Cl)c4)c3c2)o1.Cl		CHEMBL529066	=	Inhibition	%	1.2	CHEMBL4722	Homo sapiens	Inhibition	%	1.2
	8118079	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(F)c(F)c3)n2)cc1		CHEMBL1785004	=	Inhibition	%	-0.65	CHEMBL4722	Homo sapiens	Inhibition	%	-0.65
	8118419	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	COc1c(C(N)=O)cc(-c2ccc(Cl)cc2)cc1-c1ccc(S(N)(=O)=O)cc1		CHEMBL268885	=	Inhibition	%	2.86	CHEMBL4722	Homo sapiens	Inhibition	%	2.86
	8118591	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)o1.Cl		CHEMBL1909387	=	Inhibition	%	4.78	CHEMBL4722	Homo sapiens	Inhibition	%	4.78
	8118951	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5ccco5)cc34)cc2Cl)c1		CHEMBL514938	=	Inhibition	%	3.83	CHEMBL4722	Homo sapiens	Inhibition	%	3.83
	8119222	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C)c(NC(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL511765	=	Inhibition	%	2.06	CHEMBL4722	Homo sapiens	Inhibition	%	2.06
	8119381	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL588025	=	Inhibition	%	64.93	CHEMBL4722	Homo sapiens	Inhibition	%	64.93
	8119772	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL205765	=	Inhibition	%	2.65	CHEMBL4722	Homo sapiens	Inhibition	%	2.65
	8119891	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(F)c(Cl)c4)c3c2)cs1.Cl		CHEMBL1909355	=	Inhibition	%	1.71	CHEMBL4722	Homo sapiens	Inhibition	%	1.71
	8120115	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(F)c(Cl)c4)c3c2)cs1.Cl		CHEMBL1909355	=	Inhibition	%	9.04	CHEMBL4722	Homo sapiens	Inhibition	%	9.04
	8120254	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c(-c3ccc(C(F)(F)F)cc3)nn2n1		CHEMBL188247	=	Inhibition	%	3.93	CHEMBL4722	Homo sapiens	Inhibition	%	3.93
	8120414	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	CC(C)(CO)CNC(=O)c1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL410072	=	Inhibition	%	56.25	CHEMBL4722	Homo sapiens	Inhibition	%	56.25
	8120638	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(cnn5Cc5ccccc5)c4)c3s2)C1)N1CCOCC1		CHEMBL1909408	=	Inhibition	%	1.41	CHEMBL4722	Homo sapiens	Inhibition	%	1.41
	8120839	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794066	=	Inhibition	%	0.96	CHEMBL4722	Homo sapiens	Inhibition	%	0.96
	8120967	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)c1ccc2c(c1)NC(=O)/C2=N/Nc1ccc(S(N)(=O)=O)cc1		CHEMBL271594	=	Inhibition	%	1.5	CHEMBL4722	Homo sapiens	Inhibition	%	1.5
	8121191	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	CC(C)c1ccc2c(c1)NC(=O)/C2=N/Nc1ccc(S(N)(=O)=O)cc1		CHEMBL271594	=	Inhibition	%	8.05	CHEMBL4722	Homo sapiens	Inhibition	%	8.05
	8121363	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(Cc5ccccc5)cc4)c3s2)C1)N1CCOCC1		CHEMBL1909409	=	Inhibition	%	0.0	CHEMBL4722	Homo sapiens	Inhibition	%	0.0
	8121530	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3cccc(CCc4ccncc4)c32)cc1		CHEMBL1909399	=	Inhibition	%	28.06	CHEMBL4722	Homo sapiens	Inhibition	%	28.06
	8121754	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3cccc(CCc4ccncc4)c32)cc1		CHEMBL1909399	=	Inhibition	%	20.61	CHEMBL4722	Homo sapiens	Inhibition	%	20.61
	8121917	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccccc32)cc1OCc1ccccc1Br		CHEMBL518953	=	Inhibition	%	3.86	CHEMBL4722	Homo sapiens	Inhibition	%	3.86
	8122262	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL247228	=	Inhibition	%	-1.11	CHEMBL4722	Homo sapiens	Inhibition	%	-1.11
	8122400	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(F)c(F)c3)n2)cc1		CHEMBL1785004	=	Inhibition	%	-0.3	CHEMBL4722	Homo sapiens	Inhibition	%	-0.3
	8122744	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	COc1c(C(N)=O)cc(-c2ccc(Cl)cc2)cc1-c1ccc(S(N)(=O)=O)cc1		CHEMBL268885	=	Inhibition	%	3.86	CHEMBL4722	Homo sapiens	Inhibition	%	3.86
	8122911	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(F)c3)n2)cc1		CHEMBL14014	=	Inhibition	%	3.61	CHEMBL4722	Homo sapiens	Inhibition	%	3.61
	8123135	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(F)c3)n2)cc1		CHEMBL14014	=	Inhibition	%	4.59	CHEMBL4722	Homo sapiens	Inhibition	%	4.59
	8123277	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(N)=O)s3)c2cc1OC		CHEMBL514499	=	Inhibition	%	1.39	CHEMBL4722	Homo sapiens	Inhibition	%	1.39
	8123555	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C)c(NC(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL511765	=	Inhibition	%	13.54	CHEMBL4722	Homo sapiens	Inhibition	%	13.54
	8123705	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3-c2ccccc2)ccc1O		CHEMBL1789961	=	Inhibition	%	23.03	CHEMBL4722	Homo sapiens	Inhibition	%	23.03
	8123929	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3-c2ccccc2)ccc1O		CHEMBL1789961	=	Inhibition	%	94.0	CHEMBL4722	Homo sapiens	Inhibition	%	94.0
	8124096	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2cnc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL204934	=	Inhibition	%	-0.8	CHEMBL4722	Homo sapiens	Inhibition	%	-0.8
	8124439	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL187081	=	Inhibition	%	11.94	CHEMBL4722	Homo sapiens	Inhibition	%	11.94
	8124578	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c(-c3ccc(C(F)(F)F)cc3)nn2n1		CHEMBL188247	=	Inhibition	%	0.25	CHEMBL4722	Homo sapiens	Inhibition	%	0.25
	8124967	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(cnn5Cc5ccccc5)c4)c3s2)C1)N1CCOCC1		CHEMBL1909408	=	Inhibition	%	3.44	CHEMBL4722	Homo sapiens	Inhibition	%	3.44
	8125168	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	CCc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL428877	=	Inhibition	%	3.7	CHEMBL4722	Homo sapiens	Inhibition	%	3.7
	8125522	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nnc(-c3cccnc3)cc12)C1CC1.O=C(O)C(F)(F)F		CHEMBL1909343	=	Inhibition	%	0.85	CHEMBL4722	Homo sapiens	Inhibition	%	0.85
	8125690	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(Cc5ccccc5)cc4)c3s2)C1)N1CCOCC1		CHEMBL1909409	=	Inhibition	%	1.29	CHEMBL4722	Homo sapiens	Inhibition	%	1.29
	8126078	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	CCN1CCC(C(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.Cl		CHEMBL1909345	=	Inhibition	%	2.41	CHEMBL4722	Homo sapiens	Inhibition	%	2.41
	8126242	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccccc32)cc1OCc1ccccc1Br		CHEMBL518953	=	Inhibition	%	4.39	CHEMBL4722	Homo sapiens	Inhibition	%	4.39
	8126581	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL247228	=	Inhibition	%	29.88	CHEMBL4722	Homo sapiens	Inhibition	%	29.88
	8126717	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/C=C2\C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL271595	=	Inhibition	%	29.96	CHEMBL4722	Homo sapiens	Inhibition	%	29.96
	8126941	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/C=C2\C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL271595	=	Inhibition	%	80.23	CHEMBL4722	Homo sapiens	Inhibition	%	80.23
	8127063	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Oc4ccccc4)cc3)n2)cc1		CHEMBL13868	=	Inhibition	%	2.89	CHEMBL4722	Homo sapiens	Inhibition	%	2.89
	8127454	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(F)c3)o2)c1		CHEMBL179465	=	Inhibition	%	7.01	CHEMBL4722	Homo sapiens	Inhibition	%	7.01
	8127596	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(N)=O)s3)c2cc1OC		CHEMBL514499	=	Inhibition	%	13.73	CHEMBL4722	Homo sapiens	Inhibition	%	13.73
	8127884	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(Oc5ccccc5)c4)n3n2)cc(OC)c1OC		CHEMBL519881	=	Inhibition	%	2.19	CHEMBL4722	Homo sapiens	Inhibition	%	2.19
	8128260	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)N(C)C)c1		CHEMBL220244	=	Inhibition	%	2.58	CHEMBL4722	Homo sapiens	Inhibition	%	2.58
	8128427	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2cnc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL204934	=	Inhibition	%	13.0	CHEMBL4722	Homo sapiens	Inhibition	%	13.0
	8128770	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL187081	=	Inhibition	%	86.4	CHEMBL4722	Homo sapiens	Inhibition	%	86.4
	8128907	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc([N+](=O)[O-])c2)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL352222	=	Inhibition	%	4.32	CHEMBL4722	Homo sapiens	Inhibition	%	4.32
	8129131	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc([N+](=O)[O-])c2)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL352222	=	Inhibition	%	7.69	CHEMBL4722	Homo sapiens	Inhibition	%	7.69
	8129302	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2cc(-c3ccc4c(c3)CCC4=NO)c(-c3ccncc3)o2)cc1.Cl		CHEMBL1794072	=	Inhibition	%	0.13	CHEMBL4722	Homo sapiens	Inhibition	%	0.13
	8129491	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	CCc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL428877	=	Inhibition	%	2.66	CHEMBL4722	Homo sapiens	Inhibition	%	2.66
	8129854	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nnc(-c3cccnc3)cc12)C1CC1.O=C(O)C(F)(F)F		CHEMBL1909343	=	Inhibition	%	0.07	CHEMBL4722	Homo sapiens	Inhibition	%	0.07
	8130015	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)CNc1nccc(-c2cnn3ncccc23)n1		CHEMBL446024	=	Inhibition	%	2.68	CHEMBL4722	Homo sapiens	Inhibition	%	2.68
	8130239	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)CNc1nccc(-c2cnn3ncccc23)n1		CHEMBL446024	=	Inhibition	%	1.83	CHEMBL4722	Homo sapiens	Inhibition	%	1.83
	8130411	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	CCN1CCC(C(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.Cl		CHEMBL1909345	=	Inhibition	%	0.34	CHEMBL4722	Homo sapiens	Inhibition	%	0.34
	8130571	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	CCN(CC)Cc1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL1882194	=	Inhibition	%	4.39	CHEMBL4722	Homo sapiens	Inhibition	%	4.39
	8130911	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL418348	=	Inhibition	%	3.35	CHEMBL4722	Homo sapiens	Inhibition	%	3.35
	8131274	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL417804	=	Inhibition	%	4.52	CHEMBL4722	Homo sapiens	Inhibition	%	4.52
	8131394	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Oc4ccccc4)cc3)n2)cc1		CHEMBL13868	=	Inhibition	%	0.96	CHEMBL4722	Homo sapiens	Inhibition	%	0.96
	8131785	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(F)c3)o2)c1		CHEMBL179465	=	Inhibition	%	26.81	CHEMBL4722	Homo sapiens	Inhibition	%	26.81
	8131926	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)c12		CHEMBL273564	=	Inhibition	%	9.27	CHEMBL4722	Homo sapiens	Inhibition	%	9.27
	8132150	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)c12		CHEMBL273564	=	Inhibition	%	60.37	CHEMBL4722	Homo sapiens	Inhibition	%	60.37
	8132212	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(Oc5ccccc5)c4)n3n2)cc(OC)c1OC		CHEMBL519881	=	Inhibition	%	44.37	CHEMBL4722	Homo sapiens	Inhibition	%	44.37
	8132436	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C)c(N(C)C(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL467581	=	Inhibition	%	-0.3	CHEMBL4722	Homo sapiens	Inhibition	%	-0.3
	8132583	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)N(C)C)c1		CHEMBL220244	=	Inhibition	%	13.28	CHEMBL4722	Homo sapiens	Inhibition	%	13.28
	8132751	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2Cl)c1		CHEMBL218970	=	Inhibition	%	1.14	CHEMBL4722	Homo sapiens	Inhibition	%	1.14
	8132975	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2Cl)c1		CHEMBL218970	=	Inhibition	%	12.03	CHEMBL4722	Homo sapiens	Inhibition	%	12.03
	8133096	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	Clc1ccc(CNc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL513330	=	Inhibition	%	0.34	CHEMBL4722	Homo sapiens	Inhibition	%	0.34
	8133458	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062289	=	Inhibition	%	3.98	CHEMBL4722	Homo sapiens	Inhibition	%	3.98
	8133630	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2cc(-c3ccc4c(c3)CCC4=NO)c(-c3ccncc3)o2)cc1.Cl		CHEMBL1794072	=	Inhibition	%	0.04	CHEMBL4722	Homo sapiens	Inhibition	%	0.04
	8133810	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(N(C)c4ccnc(Nc5ccc(CS(C)(=O)=O)cc5)n4)cc3)cc2)CC1.Cl		CHEMBL1909360	=	Inhibition	%	84.33	CHEMBL4722	Homo sapiens	Inhibition	%	84.33
	8134034	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(N(C)c4ccnc(Nc5ccc(CS(C)(=O)=O)cc5)n4)cc3)cc2)CC1.Cl		CHEMBL1909360	=	Inhibition	%	85.94	CHEMBL4722	Homo sapiens	Inhibition	%	85.94
	8134182	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2cc3c(N)ncnc3o2)cc1		CHEMBL373073	=	Inhibition	%	0.51	CHEMBL4722	Homo sapiens	Inhibition	%	0.51
	8134566	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccoc2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477583	=	Inhibition	%	2.28	CHEMBL4722	Homo sapiens	Inhibition	%	2.28
	8134750	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(N/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL1794058	=	Inhibition	%	7.34	CHEMBL4722	Homo sapiens	Inhibition	%	7.34
	8134910	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	CCN(CC)Cc1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL1882194	=	Inhibition	%	34.31	CHEMBL4722	Homo sapiens	Inhibition	%	34.31
	8135134	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(-c2ccccn2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909354	=	Inhibition	%	1.9	CHEMBL4722	Homo sapiens	Inhibition	%	1.9
	8135249	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL418348	=	Inhibition	%	3.95	CHEMBL4722	Homo sapiens	Inhibition	%	3.95
	8135614	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL417804	=	Inhibition	%	4.15	CHEMBL4722	Homo sapiens	Inhibition	%	4.15
	8135735	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL269450	=	Inhibition	%	-1.57	CHEMBL4722	Homo sapiens	Inhibition	%	-1.57
	8135959	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL269450	=	Inhibition	%	-3.14	CHEMBL4722	Homo sapiens	Inhibition	%	-3.14
	8136127	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(/C=N/Nc2ncnc3c2cnn3-c2cccc(OC)c2)c1		CHEMBL305477	=	Inhibition	%	2.87	CHEMBL4722	Homo sapiens	Inhibition	%	2.87
	8136495	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc4c(c3)OCO4)n2)cc1		CHEMBL273611	=	Inhibition	%	4.04	CHEMBL4722	Homo sapiens	Inhibition	%	4.04
	8136785	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C)c(N(C)C(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL467581	=	Inhibition	%	-1.19	CHEMBL4722	Homo sapiens	Inhibition	%	-1.19
	8136920	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(Cl)c(Cl)c2)CC(=O)N1		CHEMBL374453	=	Inhibition	%	9.43	CHEMBL4722	Homo sapiens	Inhibition	%	9.43
	8137307	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	CCCNc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL67241	=	Inhibition	%	9.48	CHEMBL4722	Homo sapiens	Inhibition	%	9.48
	8137427	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	Clc1ccc(CNc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL513330	=	Inhibition	%	10.76	CHEMBL4722	Homo sapiens	Inhibition	%	10.76
	8137651	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(C)cccc2C)c1		CHEMBL218859	=	Inhibition	%	-1.77	CHEMBL4722	Homo sapiens	Inhibition	%	-1.77
	8137799	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062289	=	Inhibition	%	2.34	CHEMBL4722	Homo sapiens	Inhibition	%	2.34
	8137965	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccccc2F)sc2c1CCCC2		CHEMBL234838	=	Inhibition	%	-0.7	CHEMBL4722	Homo sapiens	Inhibition	%	-0.7
	8138368	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)cs1.Cl		CHEMBL1909356	=	Inhibition	%	3.8	CHEMBL4722	Homo sapiens	Inhibition	%	3.8
	8138516	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2cc3c(N)ncnc3o2)cc1		CHEMBL373073	=	Inhibition	%	1.33	CHEMBL4722	Homo sapiens	Inhibition	%	1.33
	8138898	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccoc2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477583	=	Inhibition	%	2.57	CHEMBL4722	Homo sapiens	Inhibition	%	2.57
	8139083	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(N/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL1794058	=	Inhibition	%	47.57	CHEMBL4722	Homo sapiens	Inhibition	%	47.57
	8139466	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(-c2ccccn2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909354	=	Inhibition	%	5.71	CHEMBL4722	Homo sapiens	Inhibition	%	5.71
	8139580	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(C(F)(F)F)c4)c3c2)o1.Cl		CHEMBL1909389	=	Inhibition	%	2.91	CHEMBL4722	Homo sapiens	Inhibition	%	2.91
	8139804	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(C(F)(F)F)c4)c3c2)o1.Cl		CHEMBL1909389	=	Inhibition	%	2.77	CHEMBL4722	Homo sapiens	Inhibition	%	2.77
	8139945	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909390	=	Inhibition	%	4.7	CHEMBL4722	Homo sapiens	Inhibition	%	4.7
	8140292	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	O=C([O-])c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1.[Li+]		CHEMBL1909401	=	Inhibition	%	2.47	CHEMBL4722	Homo sapiens	Inhibition	%	2.47
	8140451	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(/C=N/Nc2ncnc3c2cnn3-c2cccc(OC)c2)c1		CHEMBL305477	=	Inhibition	%	3.52	CHEMBL4722	Homo sapiens	Inhibition	%	3.52
	8140818	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc4c(c3)OCO4)n2)cc1		CHEMBL273611	=	Inhibition	%	2.71	CHEMBL4722	Homo sapiens	Inhibition	%	2.71
	8141120	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(N3CCc4ccccc43)c3cc[nH]c3n1)N(C(=O)CN(C)C)CC2		CHEMBL458415	=	Inhibition	%	1.58	CHEMBL4722	Homo sapiens	Inhibition	%	1.58
	8141250	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(Cl)c(Cl)c2)CC(=O)N1		CHEMBL374453	=	Inhibition	%	70.15	CHEMBL4722	Homo sapiens	Inhibition	%	70.15
	8141474	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)ccc12)C1CC1		CHEMBL101804	=	Inhibition	%	2.22	CHEMBL4722	Homo sapiens	Inhibition	%	2.22
	8141634	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	CCCNc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL67241	=	Inhibition	%	70.67	CHEMBL4722	Homo sapiens	Inhibition	%	70.67
	8141977	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(C)cccc2C)c1		CHEMBL218859	=	Inhibition	%	-0.78	CHEMBL4722	Homo sapiens	Inhibition	%	-0.78
	8142138	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL188257	=	Inhibition	%	18.49	CHEMBL4722	Homo sapiens	Inhibition	%	18.49
	8142306	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccccc2F)sc2c1CCCC2		CHEMBL234838	=	Inhibition	%	-2.59	CHEMBL4722	Homo sapiens	Inhibition	%	-2.59
	8142530	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1794068	=	Inhibition	%	-0.53	CHEMBL4722	Homo sapiens	Inhibition	%	-0.53
	8142706	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)cs1.Cl		CHEMBL1909356	=	Inhibition	%	2.26	CHEMBL4722	Homo sapiens	Inhibition	%	2.26
	8142855	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC(C)C)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477979	=	Inhibition	%	-3.2	CHEMBL4722	Homo sapiens	Inhibition	%	-3.2
	8143079	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC(C)C)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477979	=	Inhibition	%	-2.53	CHEMBL4722	Homo sapiens	Inhibition	%	-2.53
	8143234	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)cc1		CHEMBL205966	=	Inhibition	%	2.18	CHEMBL4722	Homo sapiens	Inhibition	%	2.18
	8143421	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccc(I)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1880739	=	Inhibition	%	3.6	CHEMBL4722	Homo sapiens	Inhibition	%	3.6
	8143645	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccc(I)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1880739	=	Inhibition	%	9.69	CHEMBL4722	Homo sapiens	Inhibition	%	9.69
	8143804	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)c(-c3ccccc3)nn2n1		CHEMBL434729	=	Inhibition	%	1.82	CHEMBL4722	Homo sapiens	Inhibition	%	1.82
	8144142	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Br)c4)c3c2)o1.Cl		CHEMBL1909392	=	Inhibition	%	-1.23	CHEMBL4722	Homo sapiens	Inhibition	%	-1.23
	8144281	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909390	=	Inhibition	%	4.74	CHEMBL4722	Homo sapiens	Inhibition	%	4.74
	8144505	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)(C)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275200	=	Inhibition	%	2.69	CHEMBL4722	Homo sapiens	Inhibition	%	2.69
	8144635	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	O=C([O-])c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1.[Li+]		CHEMBL1909401	=	Inhibition	%	3.12	CHEMBL4722	Homo sapiens	Inhibition	%	3.12
	8144788	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccc(S(=O)(=O)N3CCCC3)cc2)c1N		CHEMBL230592	=	Inhibition	%	0.79	CHEMBL4722	Homo sapiens	Inhibition	%	0.79
	8145012	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccc(S(=O)(=O)N3CCCC3)cc2)c1N		CHEMBL230592	=	Inhibition	%	0.86	CHEMBL4722	Homo sapiens	Inhibition	%	0.86
	8145149	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=S(=O)(CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL1909395	=	Inhibition	%	6.02	CHEMBL4722	Homo sapiens	Inhibition	%	6.02
	8145462	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(N3CCc4ccccc43)c3cc[nH]c3n1)N(C(=O)CN(C)C)CC2		CHEMBL458415	=	Inhibition	%	2.61	CHEMBL4722	Homo sapiens	Inhibition	%	2.61
	8145810	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)ccc12)C1CC1		CHEMBL101804	=	Inhibition	%	11.45	CHEMBL4722	Homo sapiens	Inhibition	%	11.45
	8145971	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2c(Cl)cccc2Cl)cc1)c1ccnc(Nc2cccc(CS(C)(=O)=O)c2)n1		CHEMBL189353	=	Inhibition	%	73.87	CHEMBL4722	Homo sapiens	Inhibition	%	73.87
	8146315	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Sc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.O=S(=O)(O)O		CHEMBL1909365	=	Inhibition	%	1.16	CHEMBL4722	Homo sapiens	Inhibition	%	1.16
	8146475	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL188257	=	Inhibition	%	63.19	CHEMBL4722	Homo sapiens	Inhibition	%	63.19
	8146866	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1794068	=	Inhibition	%	-0.47	CHEMBL4722	Homo sapiens	Inhibition	%	-0.47
	8147035	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1.O=C(O)/C=C\C(=O)O		CHEMBL1909347	=	Inhibition	%	2.95	CHEMBL4722	Homo sapiens	Inhibition	%	2.95
	8147401	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)c1cccc(Nc2nccc(-c3cnn4nc(-c5ccccc5)ccc34)n2)c1		CHEMBL189415	=	Inhibition	%	0.08	CHEMBL4722	Homo sapiens	Inhibition	%	0.08
	8147554	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	Nc1ccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)cc1		CHEMBL205966	=	Inhibition	%	0.03	CHEMBL4722	Homo sapiens	Inhibition	%	0.03
	8147965	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)c1ccc2c(c1)C(=Cc1cc(Br)c(O)c(Br)c1)C(=O)N2		CHEMBL1794052	=	Inhibition	%	30.78	CHEMBL4722	Homo sapiens	Inhibition	%	30.78
	8148123	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)c(-c3ccccc3)nn2n1		CHEMBL434729	=	Inhibition	%	6.06	CHEMBL4722	Homo sapiens	Inhibition	%	6.06
	8148461	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Br)c4)c3c2)o1.Cl		CHEMBL1909392	=	Inhibition	%	-1.79	CHEMBL4722	Homo sapiens	Inhibition	%	-1.79
	8148824	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	CC(C)(C)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275200	=	Inhibition	%	3.71	CHEMBL4722	Homo sapiens	Inhibition	%	3.71
	8148962	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275724	=	Inhibition	%	3.58	CHEMBL4722	Homo sapiens	Inhibition	%	3.58
	8149345	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCN(CC#N)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL384407	=	Inhibition	%	-2.58	CHEMBL4722	Homo sapiens	Inhibition	%	-2.58
	8149479	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	Cl.O=S(=O)(CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL1909395	=	Inhibition	%	6.24	CHEMBL4722	Homo sapiens	Inhibition	%	6.24
	8149703	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)NCCNC)c21		CHEMBL506153	=	Inhibition	%	3.09	CHEMBL4722	Homo sapiens	Inhibition	%	3.09
	8149801	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)Oc1cc(C)c(/C=C/c2cncc(C(=O)NC)c2)c(C)c1		CHEMBL218932	=	Inhibition	%	2.77	CHEMBL4722	Homo sapiens	Inhibition	%	2.77
	8150150	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccco4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909368	=	Inhibition	%	-1.76	CHEMBL4722	Homo sapiens	Inhibition	%	-1.76
	8150310	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2c(Cl)cccc2Cl)cc1)c1ccnc(Nc2cccc(CS(C)(=O)=O)c2)n1		CHEMBL189353	=	Inhibition	%	97.62	CHEMBL4722	Homo sapiens	Inhibition	%	97.62
	8150654	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Sc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.O=S(=O)(O)O		CHEMBL1909365	=	Inhibition	%	7.64	CHEMBL4722	Homo sapiens	Inhibition	%	7.64
	8150819	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2		CHEMBL456252	=	Inhibition	%	2.03	CHEMBL4722	Homo sapiens	Inhibition	%	2.03
	8151043	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2	Outside typical range	CHEMBL456252	=	Inhibition	%	-11.21	CHEMBL4722	Homo sapiens	Inhibition	%	-11.21
	8151206	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc2[nH]ncc2c1		CHEMBL495902	=	Inhibition	%	-3.2	CHEMBL4722	Homo sapiens	Inhibition	%	-3.2
	8151383	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1.O=C(O)/C=C\C(=O)O		CHEMBL1909347	=	Inhibition	%	3.89	CHEMBL4722	Homo sapiens	Inhibition	%	3.89
	8151607	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	CCc1nn2ncccc2c1-c1ccnc(NC2CC2)n1		CHEMBL524057	=	Inhibition	%	3.98	CHEMBL4722	Homo sapiens	Inhibition	%	3.98
	8151745	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)c1cccc(Nc2nccc(-c3cnn4nc(-c5ccccc5)ccc34)n2)c1		CHEMBL189415	=	Inhibition	%	3.33	CHEMBL4722	Homo sapiens	Inhibition	%	3.33
	8151899	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL186213	=	Inhibition	%	2.9	CHEMBL4722	Homo sapiens	Inhibition	%	2.9
	8152123	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL186213	=	Inhibition	%	5.62	CHEMBL4722	Homo sapiens	Inhibition	%	5.62
	8152311	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	COC(=O)c1ccc2c(c1)C(=Cc1cc(Br)c(O)c(Br)c1)C(=O)N2		CHEMBL1794052	=	Inhibition	%	80.4	CHEMBL4722	Homo sapiens	Inhibition	%	80.4
	8152469	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL318728	=	Inhibition	%	2.24	CHEMBL4722	Homo sapiens	Inhibition	%	2.24
	8152693	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL318728	=	Inhibition	%	15.16	CHEMBL4722	Homo sapiens	Inhibition	%	15.16
	8152807	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2nccc(N(C)c3ccc4c(C)n[nH]c4c3)n2)c1.Cl		CHEMBL1909358	=	Inhibition	%	4.98	CHEMBL4722	Homo sapiens	Inhibition	%	4.98
	8153170	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	1.75	CHEMBL4722	Homo sapiens	Inhibition	%	1.75
	8153307	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275724	=	Inhibition	%	2.99	CHEMBL4722	Homo sapiens	Inhibition	%	2.99
	8153531	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CCNCC3)c21.Cl		CHEMBL1909376	=	Inhibition	%	5.21	CHEMBL4722	Homo sapiens	Inhibition	%	5.21
	8153688	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCN(CC#N)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL384407	=	Inhibition	%	-0.17	CHEMBL4722	Homo sapiens	Inhibition	%	-0.17
	8154045	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)NCCNC)c21		CHEMBL506153	=	Inhibition	%	5.14	CHEMBL4722	Homo sapiens	Inhibition	%	5.14
	8154142	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)Oc1cc(C)c(/C=C/c2cncc(C(=O)NC)c2)c(C)c1		CHEMBL218932	=	Inhibition	%	4.58	CHEMBL4722	Homo sapiens	Inhibition	%	4.58
	8154366	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccccc21		CHEMBL365286	=	Inhibition	%	2.42	CHEMBL4722	Homo sapiens	Inhibition	%	2.42
	8154492	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccco4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909368	=	Inhibition	%	15.08	CHEMBL4722	Homo sapiens	Inhibition	%	15.08
	8154651	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207410	=	Inhibition	%	2.9	CHEMBL4722	Homo sapiens	Inhibition	%	2.9
	8154875	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207410	=	Inhibition	%	11.76	CHEMBL4722	Homo sapiens	Inhibition	%	11.76
	8154995	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCOCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL476351	=	Inhibition	%	0.63	CHEMBL4722	Homo sapiens	Inhibition	%	0.63
	8155395	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909402	=	Inhibition	%	0.97	CHEMBL4722	Homo sapiens	Inhibition	%	0.97
	8155556	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc2[nH]ncc2c1		CHEMBL495902	=	Inhibition	%	-1.72	CHEMBL4722	Homo sapiens	Inhibition	%	-1.72
	8155958	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	CCc1nn2ncccc2c1-c1ccnc(NC2CC2)n1		CHEMBL524057	=	Inhibition	%	14.79	CHEMBL4722	Homo sapiens	Inhibition	%	14.79
	8156096	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL183993	=	Inhibition	%	1.41	CHEMBL4722	Homo sapiens	Inhibition	%	1.41
	8156308	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL381604	=	Inhibition	%	15.17	CHEMBL4722	Homo sapiens	Inhibition	%	15.17
	8156532	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(-c2cc3c(NC(=O)C4CC4)ncnc3o2)cc1		CHEMBL182283	=	Inhibition	%	3.75	CHEMBL4722	Homo sapiens	Inhibition	%	3.75
	8156682	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(C(C)=O)c3)o2)c1		CHEMBL191705	=	Inhibition	%	15.32	CHEMBL4722	Homo sapiens	Inhibition	%	15.32
	8157049	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL194062	=	Inhibition	%	67.18	CHEMBL4722	Homo sapiens	Inhibition	%	67.18
	8157169	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]nc(C)c3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL218720	=	Inhibition	%	17.92	CHEMBL4722	Homo sapiens	Inhibition	%	17.92
	8157393	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]nc(C)c3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL218720	=	Inhibition	%	88.29	CHEMBL4722	Homo sapiens	Inhibition	%	88.29
	8157534	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(C(F)(F)F)c4)n3n2)cc(OC)c1OC		CHEMBL520037	=	Inhibition	%	2.65	CHEMBL4722	Homo sapiens	Inhibition	%	2.65
	8157888	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1C1=C(Nc2ccccc2)C(=O)NC1=O		CHEMBL156263	=	Inhibition	%	2.93	CHEMBL4722	Homo sapiens	Inhibition	%	2.93
	8158049	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Inhibition	%	2.3	CHEMBL4722	Homo sapiens	Inhibition	%	2.3
	8158299	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc(S(C)(=O)=O)cc4C)n3C)ccc2c1		CHEMBL237571	=	Inhibition	%	17.57	CHEMBL4722	Homo sapiens	Inhibition	%	17.57
	8158681	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477182	=	Inhibition	%	4.67	CHEMBL4722	Homo sapiens	Inhibition	%	4.67
	8158850	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3cc(F)ccc3F)ccc12)C1CC1		CHEMBL261440	=	Inhibition	%	2.63	CHEMBL4722	Homo sapiens	Inhibition	%	2.63
	8159209	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1)N1CCOCC1		CHEMBL507329	=	Inhibition	%	1.79	CHEMBL4722	Homo sapiens	Inhibition	%	1.79
	8159329	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2cc(Cl)c3[nH]ncc3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL427058	=	Inhibition	%	16.61	CHEMBL4722	Homo sapiens	Inhibition	%	16.61
	8159553	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2c(-c3ccncc3)nc3n2CCS3)cc1		CHEMBL266707	=	Inhibition	%	-2.71	CHEMBL4722	Homo sapiens	Inhibition	%	-2.71
	8159684	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3cccc(O)c3)n[nH]2)cc1		CHEMBL103104	=	Inhibition	%	17.19	CHEMBL4722	Homo sapiens	Inhibition	%	17.19
	8160049	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	Cl.c1ccc(-c2nc3n(c2-c2ccc4c(c2)OCO4)CCC3)nc1		CHEMBL1909377	=	Inhibition	%	2.32	CHEMBL4722	Homo sapiens	Inhibition	%	2.32
	8160186	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)CN2CCOCC2)sc2c1CCCC2.O=C(O)C(=O)O		CHEMBL1909342	=	Inhibition	%	2.73	CHEMBL4722	Homo sapiens	Inhibition	%	2.73
	8160560	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCC(O)CC2)n1		CHEMBL1888586	=	Inhibition	%	-2.33	CHEMBL4722	Homo sapiens	Inhibition	%	-2.33
	8160854	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(-c2cc3c(NC(=O)C4CC4)ncnc3o2)cc1		CHEMBL182283	=	Inhibition	%	15.76	CHEMBL4722	Homo sapiens	Inhibition	%	15.76
	8161004	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)NCCN2CCOCC2)cc1)c1ccnc(Nc2ccc(CS(C)(=O)=O)cc2)n1.Cl		CHEMBL1909361	=	Inhibition	%	24.49	CHEMBL4722	Homo sapiens	Inhibition	%	24.49
	8161371	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c2c1		CHEMBL361894	=	Inhibition	%	9.49	CHEMBL4722	Homo sapiens	Inhibition	%	9.49
	8161720	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cccc(O)c1		CHEMBL160937	=	Inhibition	%	3.17	CHEMBL4722	Homo sapiens	Inhibition	%	3.17
	8161858	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(C(F)(F)F)c4)n3n2)cc(OC)c1OC		CHEMBL520037	=	Inhibition	%	36.2	CHEMBL4722	Homo sapiens	Inhibition	%	36.2
	8162212	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1C1=C(Nc2ccccc2)C(=O)NC1=O		CHEMBL156263	=	Inhibition	%	8.25	CHEMBL4722	Homo sapiens	Inhibition	%	8.25
	8162372	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(CCCNc2nc3ccc(Oc4ccc(NC(=O)Nc5cc(C(F)(F)F)ccc5F)cc4)cc3[nH]2)CC1.Cl		CHEMBL1909372	=	Inhibition	%	-1.66	CHEMBL4722	Homo sapiens	Inhibition	%	-1.66
	8162596	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(CCCNc2nc3ccc(Oc4ccc(NC(=O)Nc5cc(C(F)(F)F)ccc5F)cc4)cc3[nH]2)CC1.Cl		CHEMBL1909372	=	Inhibition	%	-0.34	CHEMBL4722	Homo sapiens	Inhibition	%	-0.34
	8162625	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CC[C@H](N)C3)c21.Cl		CHEMBL1909384	=	Inhibition	%	3.07	CHEMBL4722	Homo sapiens	Inhibition	%	3.07
	8162849	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CC[C@H](N)C3)c21.Cl		CHEMBL1909384	=	Inhibition	%	3.21	CHEMBL4722	Homo sapiens	Inhibition	%	3.21
	8162997	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(NC=C2C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL1794055	=	Inhibition	%	34.62	CHEMBL4722	Homo sapiens	Inhibition	%	34.62
	8163166	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3cc(F)ccc3F)ccc12)C1CC1		CHEMBL261440	=	Inhibition	%	18.11	CHEMBL4722	Homo sapiens	Inhibition	%	18.11
	8163390	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Inhibition	%	2.42	CHEMBL4722	Homo sapiens	Inhibition	%	2.42
	8163524	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1)N1CCOCC1		CHEMBL507329	=	Inhibition	%	7.57	CHEMBL4722	Homo sapiens	Inhibition	%	7.57
	8163871	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2c(-c3ccncc3)nc3n2CCS3)cc1		CHEMBL266707	=	Inhibition	%	2.75	CHEMBL4722	Homo sapiens	Inhibition	%	2.75
	8164005	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)C1		CHEMBL477069	=	Inhibition	%	1.81	CHEMBL4722	Homo sapiens	Inhibition	%	1.81
	8164229	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)C1		CHEMBL477069	=	Inhibition	%	7.44	CHEMBL4722	Homo sapiens	Inhibition	%	7.44
	8164369	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	CC1(C)CC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC(C)(C)N1		CHEMBL95502	=	Inhibition	%	-0.03	CHEMBL4722	Homo sapiens	Inhibition	%	-0.03
	8164524	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)CN2CCOCC2)sc2c1CCCC2.O=C(O)C(=O)O		CHEMBL1909342	=	Inhibition	%	8.53	CHEMBL4722	Homo sapiens	Inhibition	%	8.53
	8164748	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL495696	=	Inhibition	%	11.29	CHEMBL4722	Homo sapiens	Inhibition	%	11.29
	8164892	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCC(O)CC2)n1		CHEMBL1888586	=	Inhibition	%	22.01	CHEMBL4722	Homo sapiens	Inhibition	%	22.01
	8165186	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1ncccc1Nc1nc(Nc2cc3c(cc2OC)CCCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL1895450	=	Inhibition	%	2.64	CHEMBL4722	Homo sapiens	Inhibition	%	2.64
	8165327	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)NCCN2CCOCC2)cc1)c1ccnc(Nc2ccc(CS(C)(=O)=O)cc2)n1.Cl		CHEMBL1909361	=	Inhibition	%	93.86	CHEMBL4722	Homo sapiens	Inhibition	%	93.86
	8165551	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL157258	=	Inhibition	%	1.59	CHEMBL4722	Homo sapiens	Inhibition	%	1.59
	8165694	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c2c1		CHEMBL361894	=	Inhibition	%	85.47	CHEMBL4722	Homo sapiens	Inhibition	%	85.47
	8166044	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cccc(O)c1		CHEMBL160937	=	Inhibition	%	11.59	CHEMBL4722	Homo sapiens	Inhibition	%	11.59
	8166182	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1cccc(Nc2cc(-c3ccc(F)cc3)n[nH]2)c1		CHEMBL1909351	=	Inhibition	%	1.29	CHEMBL4722	Homo sapiens	Inhibition	%	1.29
	8166406	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1cccc(Nc2cc(-c3ccc(F)cc3)n[nH]2)c1		CHEMBL1909351	=	Inhibition	%	8.81	CHEMBL4722	Homo sapiens	Inhibition	%	8.81
	8166536	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Oc1cccc(-c2nc(-c3ccccc3)[nH]c2-c2ccncc2)c1		CHEMBL1909413	=	Inhibition	%	2.96	CHEMBL4722	Homo sapiens	Inhibition	%	2.96
	8166861	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2nccc(Nc3ccc4c(C)n[nH]c4c3)n2)cc(OC)c1OC		CHEMBL479079	=	Inhibition	%	66.52	CHEMBL4722	Homo sapiens	Inhibition	%	66.52
	8167173	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc21.Cl		CHEMBL1909363	=	Inhibition	%	6.07	CHEMBL4722	Homo sapiens	Inhibition	%	6.07
	8167314	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(NC=C2C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL1794055	=	Inhibition	%	90.44	CHEMBL4722	Homo sapiens	Inhibition	%	90.44
	8167702	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Inhibition	%	5.29	CHEMBL4722	Homo sapiens	Inhibition	%	5.29
	8167835	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccc(F)cc21		CHEMBL426800	=	Inhibition	%	3.17	CHEMBL4722	Homo sapiens	Inhibition	%	3.17
	8168059	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccc(F)cc21		CHEMBL426800	=	Inhibition	%	4.08	CHEMBL4722	Homo sapiens	Inhibition	%	4.08
	8168183	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)NC(=O)N1		CHEMBL384073	=	Inhibition	%	7.75	CHEMBL4722	Homo sapiens	Inhibition	%	7.75
	8168548	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1ccc2c(-c3ccnc(NCCCO)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1909404	=	Inhibition	%	1.36	CHEMBL4722	Homo sapiens	Inhibition	%	1.36
	8168684	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	CC1(C)CC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC(C)(C)N1		CHEMBL95502	=	Inhibition	%	4.57	CHEMBL4722	Homo sapiens	Inhibition	%	4.57
	8169072	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	N#Cc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL495696	=	Inhibition	%	74.47	CHEMBL4722	Homo sapiens	Inhibition	%	74.47
	8169214	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL102936	=	Inhibition	%	2.55	CHEMBL4722	Homo sapiens	Inhibition	%	2.55
	8169518	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1ncccc1Nc1nc(Nc2cc3c(cc2OC)CCCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL1895450	=	Inhibition	%	6.59	CHEMBL4722	Homo sapiens	Inhibition	%	6.59
	8169876	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL157258	=	Inhibition	%	11.8	CHEMBL4722	Homo sapiens	Inhibition	%	11.8
	8170021	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)cc(C(F)(F)F)c4)cc3)c12		CHEMBL396107	=	Inhibition	%	2.66	CHEMBL4722	Homo sapiens	Inhibition	%	2.66
	8170245	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)cc(C(F)(F)F)c4)cc3)c12		CHEMBL396107	=	Inhibition	%	46.04	CHEMBL4722	Homo sapiens	Inhibition	%	46.04
	8170370	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc2c1NC(=O)/C2=N\Nc1ccc(S(N)(=O)=O)cc1		CHEMBL1909398	=	Inhibition	%	3.73	CHEMBL4722	Homo sapiens	Inhibition	%	3.73
	8170734	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OCC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794065	=	Inhibition	%	-1.94	CHEMBL4722	Homo sapiens	Inhibition	%	-1.94
	8170869	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	Cl.Oc1cccc(-c2nc(-c3ccccc3)[nH]c2-c2ccncc2)c1		CHEMBL1909413	=	Inhibition	%	4.61	CHEMBL4722	Homo sapiens	Inhibition	%	4.61
	8171290	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2nccc(Nc3ccc4c(C)n[nH]c4c3)n2)cc(OC)c1OC		CHEMBL479079	=	Inhibition	%	10.19	CHEMBL4722	Homo sapiens	Inhibition	%	10.19
	8171507	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc21.Cl		CHEMBL1909363	=	Inhibition	%	43.01	CHEMBL4722	Homo sapiens	Inhibition	%	43.01
	8171648	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2(C)C		CHEMBL463931	=	Inhibition	%	3.59	CHEMBL4722	Homo sapiens	Inhibition	%	3.59
	8171872	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2(C)C		CHEMBL463931	=	Inhibition	%	13.15	CHEMBL4722	Homo sapiens	Inhibition	%	13.15
	8172025	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4cccc(F)c4)ncnc32)c1		CHEMBL69757	=	Inhibition	%	-2.23	CHEMBL4722	Homo sapiens	Inhibition	%	-2.23
	8172381	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc2[nH]c(=O)[nH]c2c1		CHEMBL1794057	=	Inhibition	%	6.9	CHEMBL4722	Homo sapiens	Inhibition	%	6.9
	8172509	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)NC(=O)N1		CHEMBL384073	=	Inhibition	%	62.71	CHEMBL4722	Homo sapiens	Inhibition	%	62.71
	8172875	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1ccc2c(-c3ccnc(NCCCO)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1909404	=	Inhibition	%	3.29	CHEMBL4722	Homo sapiens	Inhibition	%	3.29
	8173011	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL407113	=	Inhibition	%	-1.3	CHEMBL4722	Homo sapiens	Inhibition	%	-1.3
	8173235	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL407113	=	Inhibition	%	14.4	CHEMBL4722	Homo sapiens	Inhibition	%	14.4
	8173400	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL306865	=	Inhibition	%	12.14	CHEMBL4722	Homo sapiens	Inhibition	%	12.14
	8173541	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL102936	=	Inhibition	%	20.18	CHEMBL4722	Homo sapiens	Inhibition	%	20.18
	8173765	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C1Nc2ccc(-c3cccnc3)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1794050	=	Inhibition	%	15.51	CHEMBL4722	Homo sapiens	Inhibition	%	15.51
	8173852	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCc4c[nH]cn4)cc32)cc1		CHEMBL272028	=	Inhibition	%	3.83	CHEMBL4722	Homo sapiens	Inhibition	%	3.83
	8174076	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCc4c[nH]cn4)cc32)cc1		CHEMBL272028	=	Inhibition	%	41.18	CHEMBL4722	Homo sapiens	Inhibition	%	41.18
	8174208	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)c1cncc(/C=C/c2c(C)cc(O)cc2C)c1		CHEMBL220243	=	Inhibition	%	2.33	CHEMBL4722	Homo sapiens	Inhibition	%	2.33
	8174580	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	O=C(NCC1CC1)c1ccc(-c2cccc(C(=O)NC3CC3)c2)cc1		CHEMBL479038	=	Inhibition	%	1.42	CHEMBL4722	Homo sapiens	Inhibition	%	1.42
	8174702	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc2c1NC(=O)/C2=N\Nc1ccc(S(N)(=O)=O)cc1		CHEMBL1909398	=	Inhibition	%	8.68	CHEMBL4722	Homo sapiens	Inhibition	%	8.68
	8175069	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OCC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794065	=	Inhibition	%	3.09	CHEMBL4722	Homo sapiens	Inhibition	%	3.09
	8175205	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)c1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL359963	=	Inhibition	%	6.2	CHEMBL4722	Homo sapiens	Inhibition	%	6.2
	8175429	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	CC(C)c1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL359963	=	Inhibition	%	65.79	CHEMBL4722	Homo sapiens	Inhibition	%	65.79
	8175461	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc(-n2cncn2)cc1		CHEMBL1794056	=	Inhibition	%	4.13	CHEMBL4722	Homo sapiens	Inhibition	%	4.13
	8175685	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc(-n2cncn2)cc1		CHEMBL1794056	=	Inhibition	%	36.29	CHEMBL4722	Homo sapiens	Inhibition	%	36.29
	8175848	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nn(C)c2cc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)ccc12.Cl		CHEMBL1794073	=	Inhibition	%	20.03	CHEMBL4722	Homo sapiens	Inhibition	%	20.03
	8176225	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	NCc1ccc(-n2c(-c3nonc3N)nc3cnccc32)cc1		CHEMBL188268	=	Inhibition	%	3.62	CHEMBL4722	Homo sapiens	Inhibition	%	3.62
	8176374	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4cccc(F)c4)ncnc32)c1		CHEMBL69757	=	Inhibition	%	16.86	CHEMBL4722	Homo sapiens	Inhibition	%	16.86
	8176730	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc2[nH]c(=O)[nH]c2c1		CHEMBL1794057	=	Inhibition	%	52.04	CHEMBL4722	Homo sapiens	Inhibition	%	52.04
	8176860	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCn4ccnc4)cc3)c2)nc1		CHEMBL208437	=	Inhibition	%	1.14	CHEMBL4722	Homo sapiens	Inhibition	%	1.14
	8177084	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCn4ccnc4)cc3)c2)nc1		CHEMBL208437	=	Inhibition	%	11.11	CHEMBL4722	Homo sapiens	Inhibition	%	11.11
	8177226	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909352	=	Inhibition	%	-1.67	CHEMBL4722	Homo sapiens	Inhibition	%	-1.67
	8177588	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2[nH]c3c4[nH]c5ccc(OC)cc5c4c4c(c3c2c1)C(=O)NC4=O		CHEMBL1956068	=	Inhibition	%	7.28	CHEMBL4722	Homo sapiens	Inhibition	%	7.28
	8177752	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL306865	=	Inhibition	%	73.77	CHEMBL4722	Homo sapiens	Inhibition	%	73.77
	8178116	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C1Nc2ccc(-c3cccnc3)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1794050	=	Inhibition	%	88.35	CHEMBL4722	Homo sapiens	Inhibition	%	88.35
	8178428	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)C(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL517123	=	Inhibition	%	1.25	CHEMBL4722	Homo sapiens	Inhibition	%	1.25
	8178555	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	COC(=O)c1cncc(/C=C/c2c(C)cc(O)cc2C)c1		CHEMBL220243	=	Inhibition	%	8.18	CHEMBL4722	Homo sapiens	Inhibition	%	8.18
	8178928	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	O=C(NCC1CC1)c1ccc(-c2cccc(C(=O)NC3CC3)c2)cc1		CHEMBL479038	=	Inhibition	%	6.45	CHEMBL4722	Homo sapiens	Inhibition	%	6.45
	8179051	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	CCNC(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL512076	=	Inhibition	%	1.24	CHEMBL4722	Homo sapiens	Inhibition	%	1.24
	8179275	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	CCNC(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL512076	=	Inhibition	%	9.61	CHEMBL4722	Homo sapiens	Inhibition	%	9.61
	8179419	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCc4ccncc4)cc32)cc1		CHEMBL272165	=	Inhibition	%	6.11	CHEMBL4722	Homo sapiens	Inhibition	%	6.11
	8179780	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	CCCN(CCS(C)(=O)=O)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1.Cl		CHEMBL1909394	=	Inhibition	%	1.47	CHEMBL4722	Homo sapiens	Inhibition	%	1.47
	8180037	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nnc(-c4ccccc4)cc23)CC1.Cl		CHEMBL1909344	=	Inhibition	%	3.39	CHEMBL4722	Homo sapiens	Inhibition	%	3.39
	8180191	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	Cc1nn(C)c2cc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)ccc12.Cl		CHEMBL1794073	=	Inhibition	%	89.75	CHEMBL4722	Homo sapiens	Inhibition	%	89.75
	8180571	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	NCc1ccc(-n2c(-c3nonc3N)nc3cnccc32)cc1		CHEMBL188268	=	Inhibition	%	8.79	CHEMBL4722	Homo sapiens	Inhibition	%	8.79
	8180719	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL272414	=	Inhibition	%	6.26	CHEMBL4722	Homo sapiens	Inhibition	%	6.26
	8180943	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	CN(C)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL272414	=	Inhibition	%	50.73	CHEMBL4722	Homo sapiens	Inhibition	%	50.73
	8181076	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2ccc(S(C)(=O)=O)cc12		CHEMBL237347	=	Inhibition	%	1.96	CHEMBL4722	Homo sapiens	Inhibition	%	1.96
	8181431	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	C/C(Nc1ccc(S(N)(=O)=O)cc1)=C1/C(=O)Nc2ccccc21		CHEMBL405042	=	Inhibition	%	2.21	CHEMBL4722	Homo sapiens	Inhibition	%	2.21
	8181571	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909352	=	Inhibition	%	-0.41	CHEMBL4722	Homo sapiens	Inhibition	%	-0.41
	8181934	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2[nH]c3c4[nH]c5ccc(OC)cc5c4c4c(c3c2c1)C(=O)NC4=O		CHEMBL1956068	=	Inhibition	%	68.85	CHEMBL4722	Homo sapiens	Inhibition	%	68.85
	8182097	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nc(-c2ccc(F)cc2)c(-c2ccc3ncccc3n2)s1		CHEMBL361237	=	Inhibition	%	4.14	CHEMBL4722	Homo sapiens	Inhibition	%	4.14
	8182321	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	Nc1nc(-c2ccc(F)cc2)c(-c2ccc3ncccc3n2)s1		CHEMBL361237	=	Inhibition	%	10.6	CHEMBL4722	Homo sapiens	Inhibition	%	10.6
	8182461	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(Nc2nccc(-c3c(-c4ccc(C(F)(F)F)cc4)nn4ncccc34)n2)cc1F		CHEMBL188784	=	Inhibition	%	3.59	CHEMBL4722	Homo sapiens	Inhibition	%	3.59
	8182777	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	CN(C)C(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL517123	=	Inhibition	%	9.61	CHEMBL4722	Homo sapiens	Inhibition	%	9.61
	8182899	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(F)cc4)ncnc32)c1		CHEMBL65884	=	Inhibition	%	2.1	CHEMBL4722	Homo sapiens	Inhibition	%	2.1
	8183123	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(F)cc4)ncnc32)c1		CHEMBL65884	=	Inhibition	%	18.51	CHEMBL4722	Homo sapiens	Inhibition	%	18.51
	8183272	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(OC)c3)o2)c1		CHEMBL179311	=	Inhibition	%	4.52	CHEMBL4722	Homo sapiens	Inhibition	%	4.52
	8183625	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)c1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL185939	=	Inhibition	%	-2.66	CHEMBL4722	Homo sapiens	Inhibition	%	-2.66
	8183767	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCc4ccncc4)cc32)cc1		CHEMBL272165	=	Inhibition	%	54.9	CHEMBL4722	Homo sapiens	Inhibition	%	54.9
	8184127	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	CCCN(CCS(C)(=O)=O)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1.Cl		CHEMBL1909394	=	Inhibition	%	11.83	CHEMBL4722	Homo sapiens	Inhibition	%	11.83
	8184393	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nnc(-c4ccccc4)cc23)CC1.Cl		CHEMBL1909344	=	Inhibition	%	8.78	CHEMBL4722	Homo sapiens	Inhibition	%	8.78
	8184540	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Fc1cccc(COc2ccc(Nc3ncnc4cc(-c5ccc[nH]5)sc34)cc2Cl)c1		CHEMBL1909415	=	Inhibition	%	-2.74	CHEMBL4722	Homo sapiens	Inhibition	%	-2.74
	8184764	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	Cl.Fc1cccc(COc2ccc(Nc3ncnc4cc(-c5ccc[nH]5)sc34)cc2Cl)c1		CHEMBL1909415	=	Inhibition	%	7.53	CHEMBL4722	Homo sapiens	Inhibition	%	7.53
	8184921	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL365297	=	Inhibition	%	2.98	CHEMBL4722	Homo sapiens	Inhibition	%	2.98
	8185294	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	CC(=O)NCc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207247	=	Inhibition	%	1.59	CHEMBL4722	Homo sapiens	Inhibition	%	1.59
	8185425	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2ccc(S(C)(=O)=O)cc12		CHEMBL237347	=	Inhibition	%	6.17	CHEMBL4722	Homo sapiens	Inhibition	%	6.17
	8185780	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	C/C(Nc1ccc(S(N)(=O)=O)cc1)=C1/C(=O)Nc2ccccc21		CHEMBL405042	=	Inhibition	%	37.76	CHEMBL4722	Homo sapiens	Inhibition	%	37.76
	8185919	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccccc3)ccc12)C1CC1		CHEMBL405021	=	Inhibition	%	1.71	CHEMBL4722	Homo sapiens	Inhibition	%	1.71
	8186143	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccccc3)ccc12)C1CC1		CHEMBL405021	=	Inhibition	%	13.2	CHEMBL4722	Homo sapiens	Inhibition	%	13.2
	8186284	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(F)c(F)c3)n2)cc1		CHEMBL427159	=	Inhibition	%	2.87	CHEMBL4722	Homo sapiens	Inhibition	%	2.87
	8186672	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(C2=C(N3CCc4ccccc43)C(=O)NC2=O)cc1		CHEMBL347580	=	Inhibition	%	1.27	CHEMBL4722	Homo sapiens	Inhibition	%	1.27
	8186811	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(Nc2nccc(-c3c(-c4ccc(C(F)(F)F)cc4)nn4ncccc34)n2)cc1F		CHEMBL188784	=	Inhibition	%	14.12	CHEMBL4722	Homo sapiens	Inhibition	%	14.12
	8187133	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(N)=O)c1		CHEMBL218088	=	Inhibition	%	2.32	CHEMBL4722	Homo sapiens	Inhibition	%	2.32
	8187481	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2c(-c3ccnc(Nc4cccc(OC(F)(F)F)c4)n3)cnn2n1		CHEMBL365248	=	Inhibition	%	0.72	CHEMBL4722	Homo sapiens	Inhibition	%	0.72
	8187629	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(OC)c3)o2)c1		CHEMBL179311	=	Inhibition	%	34.52	CHEMBL4722	Homo sapiens	Inhibition	%	34.52
	8187982	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)c1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL185939	=	Inhibition	%	29.24	CHEMBL4722	Homo sapiens	Inhibition	%	29.24
	8188125	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(Cl)cc32)cc1		CHEMBL270054	=	Inhibition	%	3.86	CHEMBL4722	Homo sapiens	Inhibition	%	3.86
	8188349	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(Cl)cc32)cc1		CHEMBL270054	=	Inhibition	%	26.8	CHEMBL4722	Homo sapiens	Inhibition	%	26.8
	8188484	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(S(C)(=O)=O)cc4)ncnc32)c1		CHEMBL66292	=	Inhibition	%	6.42	CHEMBL4722	Homo sapiens	Inhibition	%	6.42
	8188758	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	2.97	CHEMBL4722	Homo sapiens	Inhibition	%	2.97
	8189130	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3c2cnn3C(C)C)ccc1O		CHEMBL63728	=	Inhibition	%	3.73	CHEMBL4722	Homo sapiens	Inhibition	%	3.73
	8189286	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL365297	=	Inhibition	%	33.68	CHEMBL4722	Homo sapiens	Inhibition	%	33.68
	8189659	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	CC(=O)NCc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207247	=	Inhibition	%	5.66	CHEMBL4722	Homo sapiens	Inhibition	%	5.66
	8189791	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	C#Cc1cccc(Nc2ncnc3ccc(OCCCCNCCS(C)(=O)=O)cc23)c1		CHEMBL517907	=	Inhibition	%	-1.65	CHEMBL4722	Homo sapiens	Inhibition	%	-1.65
	8190015	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	C#Cc1cccc(Nc2ncnc3ccc(OCCCCNCCS(C)(=O)=O)cc23)c1		CHEMBL517907	=	Inhibition	%	-0.05	CHEMBL4722	Homo sapiens	Inhibition	%	-0.05
	8190147	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1-c1cc(/C=C2\C(=O)Nc3ncc(Br)cc32)cc(Br)c1O		CHEMBL176857	=	Inhibition	%	13.43	CHEMBL4722	Homo sapiens	Inhibition	%	13.43
	8190511	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccncc2)cc(-c2ccccc2)c1N		CHEMBL230911	=	Inhibition	%	2.73	CHEMBL4722	Homo sapiens	Inhibition	%	2.73
	8190648	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(F)c(F)c3)n2)cc1		CHEMBL427159	=	Inhibition	%	28.54	CHEMBL4722	Homo sapiens	Inhibition	%	28.54
	8190872	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(NCCO)n2)CC1		CHEMBL330422	=	Inhibition	%	1.7	CHEMBL4722	Homo sapiens	Inhibition	%	1.7
	8191036	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(C2=C(N3CCc4ccccc43)C(=O)NC2=O)cc1		CHEMBL347580	=	Inhibition	%	12.52	CHEMBL4722	Homo sapiens	Inhibition	%	12.52
	8191174	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCNC(=O)Nc1ccc(N(C)c2ccnc(Nc3ccc(CS(C)(=O)=O)cc3)n2)cc1.Cl		CHEMBL1909362	=	Inhibition	%	13.68	CHEMBL4722	Homo sapiens	Inhibition	%	13.68
	8191398	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCNC(=O)Nc1ccc(N(C)c2ccnc(Nc3ccc(CS(C)(=O)=O)cc3)n2)cc1.Cl		CHEMBL1909362	=	Inhibition	%	79.05	CHEMBL4722	Homo sapiens	Inhibition	%	79.05
	8191494	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(N)=O)c1		CHEMBL218088	=	Inhibition	%	11.73	CHEMBL4722	Homo sapiens	Inhibition	%	11.73
	8191840	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2c(-c3ccnc(Nc4cccc(OC(F)(F)F)c4)n3)cnn2n1		CHEMBL365248	=	Inhibition	%	33.92	CHEMBL4722	Homo sapiens	Inhibition	%	33.92
	8191989	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	CCc1cccc(CC)c1/C=C/c1cncc(C(=O)NC)c1		CHEMBL385426	=	Inhibition	%	2.26	CHEMBL4722	Homo sapiens	Inhibition	%	2.26
	8192213	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	CCc1cccc(CC)c1/C=C/c1cncc(C(=O)NC)c1		CHEMBL385426	=	Inhibition	%	6.42	CHEMBL4722	Homo sapiens	Inhibition	%	6.42
	8192342	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(CNC(=O)c2ccc(-c3cc(-c4nnc(C)o4)ccc3C)cc2)cc1		CHEMBL269985	=	Inhibition	%	-0.94	CHEMBL4722	Homo sapiens	Inhibition	%	-0.94
	8192710	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2C)c1		CHEMBL218969	=	Inhibition	%	1.35	CHEMBL4722	Homo sapiens	Inhibition	%	1.35
	8192846	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(S(C)(=O)=O)cc4)ncnc32)c1		CHEMBL66292	=	Inhibition	%	28.41	CHEMBL4722	Homo sapiens	Inhibition	%	28.41
	8193070	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cc(OC)cc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL188426	=	Inhibition	%	0.65	CHEMBL4722	Homo sapiens	Inhibition	%	0.65
	8193118	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	11.76	CHEMBL4722	Homo sapiens	Inhibition	%	11.76
	8193342	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccncc2)c1N		CHEMBL231623	=	Inhibition	%	3.42	CHEMBL4722	Homo sapiens	Inhibition	%	3.42
	8193487	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3c2cnn3C(C)C)ccc1O		CHEMBL63728	=	Inhibition	%	37.66	CHEMBL4722	Homo sapiens	Inhibition	%	37.66
	8193644	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(N/C=C2\C(=O)Nc3ccccc32)c1		CHEMBL1794059	=	Inhibition	%	7.85	CHEMBL4722	Homo sapiens	Inhibition	%	7.85
	8193868	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(N/C=C2\C(=O)Nc3ccccc32)c1		CHEMBL1794059	=	Inhibition	%	47.6	CHEMBL4722	Homo sapiens	Inhibition	%	47.6
	8194017	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(N3CCCC3)nccc21		CHEMBL187985	=	Inhibition	%	-1.86	CHEMBL4722	Homo sapiens	Inhibition	%	-1.86
	8194372	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc(C)c(O)c3)c2cc1OC.Cl		CHEMBL1909357	=	Inhibition	%	2.56	CHEMBL4722	Homo sapiens	Inhibition	%	2.56
	8194503	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1-c1cc(/C=C2\C(=O)Nc3ncc(Br)cc32)cc(Br)c1O		CHEMBL176857	=	Inhibition	%	93.04	CHEMBL4722	Homo sapiens	Inhibition	%	93.04
	8194727	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(N2CCc3ccccc32)=C1c1ccc(Cl)cc1		CHEMBL156524	=	Inhibition	%	2.79	CHEMBL4722	Homo sapiens	Inhibition	%	2.79
	8194870	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccncc2)cc(-c2ccccc2)c1N		CHEMBL230911	=	Inhibition	%	6.63	CHEMBL4722	Homo sapiens	Inhibition	%	6.63
	8195227	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(NCCO)n2)CC1		CHEMBL330422	=	Inhibition	%	9.26	CHEMBL4722	Homo sapiens	Inhibition	%	9.26
	8195391	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccc(C(=O)c3ccco3)cc2C1=Cc1cc(Cl)c(O)c(Cl)c1		CHEMBL1789963	=	Inhibition	%	7.35	CHEMBL4722	Homo sapiens	Inhibition	%	7.35
	8195754	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	OCc1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL267228	=	Inhibition	%	4.4	CHEMBL4722	Homo sapiens	Inhibition	%	4.4
	8195852	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)N=C(c2ccc(C(F)(F)F)nc2)N1		CHEMBL485598	=	Inhibition	%	4.97	CHEMBL4722	Homo sapiens	Inhibition	%	4.97
	8196076	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)N=C(c2ccc(C(F)(F)F)nc2)N1		CHEMBL485598	=	Inhibition	%	50.96	CHEMBL4722	Homo sapiens	Inhibition	%	50.96
	8196193	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	Cl.c1ccc(Cc2nc3ccc(Nc4ncnc5ccccc45)cc3[nH]2)cc1		CHEMBL1909379	=	Inhibition	%	2.6	CHEMBL4722	Homo sapiens	Inhibition	%	2.6
	8196567	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccccc4)n3)c(-c3ccc(F)cc3)nn2n1		CHEMBL189459	=	Inhibition	%	3.75	CHEMBL4722	Homo sapiens	Inhibition	%	3.75
	8196695	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(CNC(=O)c2ccc(-c3cc(-c4nnc(C)o4)ccc3C)cc2)cc1		CHEMBL269985	=	Inhibition	%	4.73	CHEMBL4722	Homo sapiens	Inhibition	%	4.73
	8196919	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4cccs4)c(C(N)=O)s3)c2cc1OC		CHEMBL480382	=	Inhibition	%	-6.64	CHEMBL4722	Homo sapiens	Inhibition	%	-6.64
	8197060	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2C)c1		CHEMBL218969	=	Inhibition	%	9.59	CHEMBL4722	Homo sapiens	Inhibition	%	9.59
	8197421	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cc(OC)cc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL188426	=	Inhibition	%	12.98	CHEMBL4722	Homo sapiens	Inhibition	%	12.98
	8197696	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccncc2)c1N		CHEMBL231623	=	Inhibition	%	4.02	CHEMBL4722	Homo sapiens	Inhibition	%	4.02
	8197836	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL514162	=	Inhibition	%	1.9	CHEMBL4722	Homo sapiens	Inhibition	%	1.9
	8198217	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL1909406	=	Inhibition	%	-1.28	CHEMBL4722	Homo sapiens	Inhibition	%	-1.28
	8198355	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(N3CCCC3)nccc21		CHEMBL187985	=	Inhibition	%	2.53	CHEMBL4722	Homo sapiens	Inhibition	%	2.53
	8198709	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc(C)c(O)c3)c2cc1OC.Cl		CHEMBL1909357	=	Inhibition	%	7.23	CHEMBL4722	Homo sapiens	Inhibition	%	7.23
	8199064	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(N2CCc3ccccc32)=C1c1ccc(Cl)cc1		CHEMBL156524	=	Inhibition	%	15.47	CHEMBL4722	Homo sapiens	Inhibition	%	15.47
	8199212	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4nc(Cc5ccccc5)[nH]c4c3)ncnc2cn1		CHEMBL531804	=	Inhibition	%	3.28	CHEMBL4722	Homo sapiens	Inhibition	%	3.28
	8199570	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncncc3C#Cc3ccccc3)cc2Cl)c1		CHEMBL379093	=	Inhibition	%	2.33	CHEMBL4722	Homo sapiens	Inhibition	%	2.33
	8199733	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccc(C(=O)c3ccco3)cc2C1=Cc1cc(Cl)c(O)c(Cl)c1		CHEMBL1789963	=	Inhibition	%	67.31	CHEMBL4722	Homo sapiens	Inhibition	%	67.31
	8200095	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	OCc1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL267228	=	Inhibition	%	11.02	CHEMBL4722	Homo sapiens	Inhibition	%	11.02
	8200423	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	Clc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccccc3)n2)cc1		CHEMBL189148	=	Inhibition	%	0.9	CHEMBL4722	Homo sapiens	Inhibition	%	0.9
	8200538	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	Cl.c1ccc(Cc2nc3ccc(Nc4ncnc5ccccc45)cc3[nH]2)cc1		CHEMBL1909379	=	Inhibition	%	11.61	CHEMBL4722	Homo sapiens	Inhibition	%	11.61
	8200762	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3[nH]ncc23)ccc1O		CHEMBL66004	=	Inhibition	%	6.3	CHEMBL4722	Homo sapiens	Inhibition	%	6.3
	8200912	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccccc4)n3)c(-c3ccc(F)cc3)nn2n1		CHEMBL189459	=	Inhibition	%	16.37	CHEMBL4722	Homo sapiens	Inhibition	%	16.37
	8201266	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4cccs4)c(C(N)=O)s3)c2cc1OC		CHEMBL480382	=	Inhibition	%	13.37	CHEMBL4722	Homo sapiens	Inhibition	%	13.37
	8201401	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2cc3ccncc3cc2OCc2ccccc2)cc1		CHEMBL483748	=	Inhibition	%	2.34	CHEMBL4722	Homo sapiens	Inhibition	%	2.34
	8201758	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4C)n3C)ccc2c1		CHEMBL237570	=	Inhibition	%	-0.61	CHEMBL4722	Homo sapiens	Inhibition	%	-0.61
	8202037	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(C(F)(F)F)c4)c3c2)o1		CHEMBL215814	=	Inhibition	%	4.12	CHEMBL4722	Homo sapiens	Inhibition	%	4.12
	8202177	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL514162	=	Inhibition	%	23.5	CHEMBL4722	Homo sapiens	Inhibition	%	23.5
	8202401	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1nc(-c2ccc3c(c2)C(=Cc2cc(Br)c(O)c(Br)c2)C(=O)N3)cs1		CHEMBL1794053	=	Inhibition	%	-1.16	CHEMBL4722	Homo sapiens	Inhibition	%	-1.16
	8202568	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	Cl.Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL1909406	=	Inhibition	%	1.43	CHEMBL4722	Homo sapiens	Inhibition	%	1.43
	8202693	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL381948	=	Inhibition	%	3.15	CHEMBL4722	Homo sapiens	Inhibition	%	3.15
	8202917	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL381948	=	Inhibition	%	4.79	CHEMBL4722	Homo sapiens	Inhibition	%	4.79
	8203047	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2)=C1Nc1ccccc1		CHEMBL346551	=	Inhibition	%	2.73	CHEMBL4722	Homo sapiens	Inhibition	%	2.73
	8203402	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	Cc1c2ccc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)cc2nn1C.Cl		CHEMBL1909359	=	Inhibition	%	11.72	CHEMBL4722	Homo sapiens	Inhibition	%	11.72
	8203548	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4nc(Cc5ccccc5)[nH]c4c3)ncnc2cn1		CHEMBL531804	=	Inhibition	%	11.53	CHEMBL4722	Homo sapiens	Inhibition	%	11.53
	8203772	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(NCCCN4CCOCC4)n3)c2c1		CHEMBL524901	=	Inhibition	%	2.65	CHEMBL4722	Homo sapiens	Inhibition	%	2.65
	8203906	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncncc3C#Cc3ccccc3)cc2Cl)c1		CHEMBL379093	=	Inhibition	%	9.0	CHEMBL4722	Homo sapiens	Inhibition	%	9.0
	8204072	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)OC(C)(C)C)c1		CHEMBL374060	=	Inhibition	%	2.02	CHEMBL4722	Homo sapiens	Inhibition	%	2.02
	8204296	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)OC(C)(C)C)c1		CHEMBL374060	=	Inhibition	%	14.88	CHEMBL4722	Homo sapiens	Inhibition	%	14.88
	8204433	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2cc(-c3ccccn3)ccc12.Cl		CHEMBL581096	=	Inhibition	%	2.82	CHEMBL4722	Homo sapiens	Inhibition	%	2.82
	8204762	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	Clc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccccc3)n2)cc1		CHEMBL189148	=	Inhibition	%	25.51	CHEMBL4722	Homo sapiens	Inhibition	%	25.51
	8205101	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3[nH]ncc23)ccc1O		CHEMBL66004	=	Inhibition	%	55.11	CHEMBL4722	Homo sapiens	Inhibition	%	55.11
	8205250	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	c1cc(-c2cnn3nc(N4CCOCC4)ccc23)nc(NC2CC2)n1		CHEMBL495771	=	Inhibition	%	1.84	CHEMBL4722	Homo sapiens	Inhibition	%	1.84
	8205610	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	CCOc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL188240	=	Inhibition	%	0.6	CHEMBL4722	Homo sapiens	Inhibition	%	0.6
	8205749	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2cc3ccncc3cc2OCc2ccccc2)cc1		CHEMBL483748	=	Inhibition	%	7.25	CHEMBL4722	Homo sapiens	Inhibition	%	7.25
	8205973	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)CC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL516908	=	Inhibition	%	4.04	CHEMBL4722	Homo sapiens	Inhibition	%	4.04
	8206105	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4C)n3C)ccc2c1		CHEMBL237570	=	Inhibition	%	4.24	CHEMBL4722	Homo sapiens	Inhibition	%	4.24
	8206381	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(C(F)(F)F)c4)c3c2)o1		CHEMBL215814	=	Inhibition	%	2.73	CHEMBL4722	Homo sapiens	Inhibition	%	2.73
	8206748	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1nc(-c2ccc3c(c2)C(=Cc2cc(Br)c(O)c(Br)c2)C(=O)N3)cs1		CHEMBL1794053	=	Inhibition	%	29.19	CHEMBL4722	Homo sapiens	Inhibition	%	29.19
	8206928	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCCn1c(-c2nonc2N)nc2cnccc21		CHEMBL191105	=	Inhibition	%	3.15	CHEMBL4722	Homo sapiens	Inhibition	%	3.15
	8207278	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nc(-c2cccc(Cl)c2)c(-c2ccc3ncccc3n2)s1		CHEMBL365663	=	Inhibition	%	2.19	CHEMBL4722	Homo sapiens	Inhibition	%	2.19
	8207408	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2)=C1Nc1ccccc1		CHEMBL346551	=	Inhibition	%	10.78	CHEMBL4722	Homo sapiens	Inhibition	%	10.78
	8207632	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccc(O)cc3)c(Br)cc12)C1CC1		CHEMBL260417	=	Inhibition	%	5.34	CHEMBL4722	Homo sapiens	Inhibition	%	5.34
	8207764	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	Cc1c2ccc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)cc2nn1C.Cl		CHEMBL1909359	=	Inhibition	%	72.15	CHEMBL4722	Homo sapiens	Inhibition	%	72.15
	8208133	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(NCCCN4CCOCC4)n3)c2c1		CHEMBL524901	=	Inhibition	%	8.82	CHEMBL4722	Homo sapiens	Inhibition	%	8.82
	8208265	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL202891	=	Inhibition	%	3.7	CHEMBL4722	Homo sapiens	Inhibition	%	3.7
	8208655	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc3ccccc3c2)CC(=O)N1		CHEMBL441702	=	Inhibition	%	7.34	CHEMBL4722	Homo sapiens	Inhibition	%	7.34
	8208788	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2cc(-c3ccccn3)ccc12.Cl		CHEMBL581096	=	Inhibition	%	17.71	CHEMBL4722	Homo sapiens	Inhibition	%	17.71
	8209012	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	3.77	CHEMBL4722	Homo sapiens	Inhibition	%	3.77
	8209117	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(-c4ccccc4F)c3)o2)c1		CHEMBL372474	=	Inhibition	%	0.79	CHEMBL4722	Homo sapiens	Inhibition	%	0.79
	8209457	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nc(-c2ccccn2)c(-c2ccc3ncccc3n2)s1		CHEMBL181361	=	Inhibition	%	2.15	CHEMBL4722	Homo sapiens	Inhibition	%	2.15
	8209607	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	c1cc(-c2cnn3nc(N4CCOCC4)ccc23)nc(NC2CC2)n1		CHEMBL495771	=	Inhibition	%	21.97	CHEMBL4722	Homo sapiens	Inhibition	%	21.97
	8209831	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL103098	=	Inhibition	%	3.44	CHEMBL4722	Homo sapiens	Inhibition	%	3.44
	8209967	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	CCOc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL188240	=	Inhibition	%	8.92	CHEMBL4722	Homo sapiens	Inhibition	%	8.92
	8210332	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)CC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL516908	=	Inhibition	%	8.68	CHEMBL4722	Homo sapiens	Inhibition	%	8.68
	8210468	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nc(-c4cccs4)c(Br)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062290	=	Inhibition	%	-2.72	CHEMBL4722	Homo sapiens	Inhibition	%	-2.72
	8210727	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)NCc4ccc(Cl)cc4)cc3)c2)o1		CHEMBL402108	=	Inhibition	%	-1.43	CHEMBL4722	Homo sapiens	Inhibition	%	-1.43
	8211095	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL473420	=	Inhibition	%	4.18	CHEMBL4722	Homo sapiens	Inhibition	%	4.18
	8211265	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCCn1c(-c2nonc2N)nc2cnccc21		CHEMBL191105	=	Inhibition	%	6.09	CHEMBL4722	Homo sapiens	Inhibition	%	6.09
	8211612	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	Nc1nc(-c2cccc(Cl)c2)c(-c2ccc3ncccc3n2)s1		CHEMBL365663	=	Inhibition	%	4.83	CHEMBL4722	Homo sapiens	Inhibition	%	4.83
	8211965	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccc(O)cc3)c(Br)cc12)C1CC1		CHEMBL260417	=	Inhibition	%	37.69	CHEMBL4722	Homo sapiens	Inhibition	%	37.69
	8212097	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2cc3ccncc3cc2OCc2ccccc2)c1		CHEMBL483747	=	Inhibition	%	3.18	CHEMBL4722	Homo sapiens	Inhibition	%	3.18
	8212462	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccc(F)cc3)ccc12)C1CC1		CHEMBL419903	=	Inhibition	%	2.98	CHEMBL4722	Homo sapiens	Inhibition	%	2.98
	8212595	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL202891	=	Inhibition	%	5.58	CHEMBL4722	Homo sapiens	Inhibition	%	5.58
	8212819	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nnc(-c2cccc(-c3ccc(C(=O)NCC4CC4)cc3)c2)o1		CHEMBL257113	=	Inhibition	%	1.82	CHEMBL4722	Homo sapiens	Inhibition	%	1.82
	8212989	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc3ccccc3c2)CC(=O)N1		CHEMBL441702	=	Inhibition	%	70.59	CHEMBL4722	Homo sapiens	Inhibition	%	70.59
	8213342	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	10.67	CHEMBL4722	Homo sapiens	Inhibition	%	10.67
	8213446	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(-c4ccccc4F)c3)o2)c1		CHEMBL372474	=	Inhibition	%	15.0	CHEMBL4722	Homo sapiens	Inhibition	%	15.0
	8213670	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccc(Cl)cc2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL160876	=	Inhibition	%	-3.12	CHEMBL4722	Homo sapiens	Inhibition	%	-3.12
	8213783	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	Nc1nc(-c2ccccn2)c(-c2ccc3ncccc3n2)s1		CHEMBL181361	=	Inhibition	%	9.43	CHEMBL4722	Homo sapiens	Inhibition	%	9.43
	8214154	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL103098	=	Inhibition	%	15.27	CHEMBL4722	Homo sapiens	Inhibition	%	15.27
	8214291	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL222419	=	Inhibition	%	2.7	CHEMBL4722	Homo sapiens	Inhibition	%	2.7
	8214649	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(Nc2ccnc(Nc3cccc(C(N)=O)c3)n2)cc1O.Cl		CHEMBL1909381	=	Inhibition	%	14.35	CHEMBL4722	Homo sapiens	Inhibition	%	14.35
	8214801	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nc(-c4cccs4)c(Br)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062290	=	Inhibition	%	0.27	CHEMBL4722	Homo sapiens	Inhibition	%	0.27
	8215025	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCN4CCOCC4)cc3)c2)nc1		CHEMBL205158	=	Inhibition	%	0.43	CHEMBL4722	Homo sapiens	Inhibition	%	0.43
	8215052	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)NCc4ccc(Cl)cc4)cc3)c2)o1		CHEMBL402108	=	Inhibition	%	-4.05	CHEMBL4722	Homo sapiens	Inhibition	%	-4.05
	8215276	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2CCCN2CCOCC2)n1		CHEMBL274863	=	Inhibition	%	3.86	CHEMBL4722	Homo sapiens	Inhibition	%	3.86
	8215429	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	COC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL473420	=	Inhibition	%	32.16	CHEMBL4722	Homo sapiens	Inhibition	%	32.16
	8215593	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(ccn5Cc5cc(F)ccc5F)c4)c3s2)C1)N1CCOCC1		CHEMBL1909410	=	Inhibition	%	4.5	CHEMBL4722	Homo sapiens	Inhibition	%	4.5
	8215817	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(ccn5Cc5cc(F)ccc5F)c4)c3s2)C1)N1CCOCC1		CHEMBL1909410	=	Inhibition	%	9.24	CHEMBL4722	Homo sapiens	Inhibition	%	9.24
	8215936	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(=O)NC[C@@H](O)CO)c2cc[nH]c2n1		CHEMBL450071	=	Inhibition	%	-1.18	CHEMBL4722	Homo sapiens	Inhibition	%	-1.18
	8216279	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccc(C(F)(F)F)cc32)cc1OCc1ccccc1Br		CHEMBL481510	=	Inhibition	%	2.74	CHEMBL4722	Homo sapiens	Inhibition	%	2.74
	8216415	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2cc3ccncc3cc2OCc2ccccc2)c1		CHEMBL483747	=	Inhibition	%	16.95	CHEMBL4722	Homo sapiens	Inhibition	%	16.95
	8216639	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C1\CCc2cc(O)ccc21		CHEMBL175321	=	Inhibition	%	8.42	CHEMBL4722	Homo sapiens	Inhibition	%	8.42
	8216777	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccc(F)cc3)ccc12)C1CC1		CHEMBL419903	=	Inhibition	%	12.78	CHEMBL4722	Homo sapiens	Inhibition	%	12.78
	8217135	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	Cc1nnc(-c2cccc(-c3ccc(C(=O)NCC4CC4)cc3)c2)o1		CHEMBL257113	=	Inhibition	%	7.79	CHEMBL4722	Homo sapiens	Inhibition	%	7.79
	8217309	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	Cl.c1ccc(Oc2ccc(Nc3ncc(-c4ccccc4)o3)cc2)cc1		CHEMBL1909341	=	Inhibition	%	1.36	CHEMBL4722	Homo sapiens	Inhibition	%	1.36
	8217664	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4S(C)(=O)=O)c(C#N)s3)c2cc1OC		CHEMBL373751	=	Inhibition	%	12.42	CHEMBL4722	Homo sapiens	Inhibition	%	12.42
	8217989	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccc(Cl)cc2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL160876	=	Inhibition	%	4.76	CHEMBL4722	Homo sapiens	Inhibition	%	4.76
	8218104	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2nc(-c3ccncc3)c(-c3ccc4c(c3)CC/C4=N\O)[nH]2)cc1.Cl.O		CHEMBL1909414	=	Inhibition	%	1.33	CHEMBL4722	Homo sapiens	Inhibition	%	1.33
	8218455	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C(=O)NCCN(C)C)cc4)ncnc32)c1.Cl		CHEMBL1909383	=	Inhibition	%	8.37	CHEMBL4722	Homo sapiens	Inhibition	%	8.37
	8218598	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL222419	=	Inhibition	%	30.06	CHEMBL4722	Homo sapiens	Inhibition	%	30.06
	8218822	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2oc3ncnc(N)c3c2-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)cc2)cc1.Cl		CHEMBL1909396	=	Inhibition	%	1.73	CHEMBL4722	Homo sapiens	Inhibition	%	1.73
	8218953	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(Nc2ccnc(Nc3cccc(C(N)=O)c3)n2)cc1O.Cl		CHEMBL1909381	=	Inhibition	%	73.41	CHEMBL4722	Homo sapiens	Inhibition	%	73.41
	8219337	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCN4CCOCC4)cc3)c2)nc1		CHEMBL205158	=	Inhibition	%	7.41	CHEMBL4722	Homo sapiens	Inhibition	%	7.41
	8219587	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2CCCN2CCOCC2)n1		CHEMBL274863	=	Inhibition	%	8.99	CHEMBL4722	Homo sapiens	Inhibition	%	8.99
	8219748	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2coc3ncnc(N)c23)cc1		CHEMBL196022	=	Inhibition	%	3.09	CHEMBL4722	Homo sapiens	Inhibition	%	3.09
	8220141	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)c3ccccc23)sc2c1CCCC2		CHEMBL233002	=	Inhibition	%	4.45	CHEMBL4722	Homo sapiens	Inhibition	%	4.45
	8220270	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(=O)NC[C@@H](O)CO)c2cc[nH]c2n1		CHEMBL450071	=	Inhibition	%	-2.23	CHEMBL4722	Homo sapiens	Inhibition	%	-2.23
	8220494	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCN2C(=O)C1CC1		CHEMBL232601	=	Inhibition	%	1.12	CHEMBL4722	Homo sapiens	Inhibition	%	1.12
	8220608	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccc(C(F)(F)F)cc32)cc1OCc1ccccc1Br		CHEMBL481510	=	Inhibition	%	5.5	CHEMBL4722	Homo sapiens	Inhibition	%	5.5
	8220970	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C1\CCc2cc(O)ccc21		CHEMBL175321	=	Inhibition	%	70.87	CHEMBL4722	Homo sapiens	Inhibition	%	70.87
	8221106	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	-2.63	CHEMBL4722	Homo sapiens	Inhibition	%	-2.63
	8221330	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	-0.07	CHEMBL4722	Homo sapiens	Inhibition	%	-0.07
	8221463	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc(F)c2C(=O)O)c2cc[nH]c2n1		CHEMBL514261	=	Inhibition	%	3.47	CHEMBL4722	Homo sapiens	Inhibition	%	3.47
	8221628	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	Cl.c1ccc(Oc2ccc(Nc3ncc(-c4ccccc4)o3)cc2)cc1		CHEMBL1909341	=	Inhibition	%	10.19	CHEMBL4722	Homo sapiens	Inhibition	%	10.19
	8221852	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	0.74	CHEMBL4722	Homo sapiens	Inhibition	%	0.74
	8221983	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4S(C)(=O)=O)c(C#N)s3)c2cc1OC		CHEMBL373751	=	Inhibition	%	77.24	CHEMBL4722	Homo sapiens	Inhibition	%	77.24
	8222305	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(C(C)=O)c3)o2)c1		CHEMBL191705	=	Inhibition	%	2.45	CHEMBL4722	Homo sapiens	Inhibition	%	2.45
	8222439	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2nc(-c3ccncc3)c(-c3ccc4c(c3)CC/C4=N\O)[nH]2)cc1.Cl.O		CHEMBL1909414	=	Inhibition	%	12.0	CHEMBL4722	Homo sapiens	Inhibition	%	12.0
	8222663	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL194062	=	Inhibition	%	8.3	CHEMBL4722	Homo sapiens	Inhibition	%	8.3
	8222781	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C(=O)NCCN(C)C)cc4)ncnc32)c1.Cl		CHEMBL1909383	=	Inhibition	%	62.74	CHEMBL4722	Homo sapiens	Inhibition	%	62.74
	8223149	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2oc3ncnc(N)c3c2-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)cc2)cc1.Cl		CHEMBL1909396	=	Inhibition	%	49.49	CHEMBL4722	Homo sapiens	Inhibition	%	49.49
	8223278	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccccc4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909374	=	Inhibition	%	1.31	CHEMBL4722	Homo sapiens	Inhibition	%	1.31
	8223502	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccccc4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909374	=	Inhibition	%	12.45	CHEMBL4722	Homo sapiens	Inhibition	%	12.45
	8223663	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Inhibition	%	4.1	CHEMBL4722	Homo sapiens	Inhibition	%	4.1
	8223913	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc(S(C)(=O)=O)cc4C)n3C)ccc2c1		CHEMBL237571	=	Inhibition	%	2.7	CHEMBL4722	Homo sapiens	Inhibition	%	2.7
	8224075	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2coc3ncnc(N)c23)cc1		CHEMBL196022	=	Inhibition	%	7.06	CHEMBL4722	Homo sapiens	Inhibition	%	7.06
	8224299	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477182	=	Inhibition	%	0.15	CHEMBL4722	Homo sapiens	Inhibition	%	0.15
	8224469	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)c3ccccc23)sc2c1CCCC2		CHEMBL233002	=	Inhibition	%	4.99	CHEMBL4722	Homo sapiens	Inhibition	%	4.99
	8224828	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCN2C(=O)C1CC1		CHEMBL232601	=	Inhibition	%	3.45	CHEMBL4722	Homo sapiens	Inhibition	%	3.45
	8224942	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2cc(Cl)c3[nH]ncc3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL427058	=	Inhibition	%	3.11	CHEMBL4722	Homo sapiens	Inhibition	%	3.11
	8225300	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3cccc(O)c3)n[nH]2)cc1		CHEMBL103104	=	Inhibition	%	3.17	CHEMBL4722	Homo sapiens	Inhibition	%	3.17
	8225662	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	Cl.c1ccc(-c2nc3n(c2-c2ccc4c(c2)OCO4)CCC3)nc1		CHEMBL1909377	=	Inhibition	%	0.45	CHEMBL4722	Homo sapiens	Inhibition	%	0.45
	8225797	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc(F)c2C(=O)O)c2cc[nH]c2n1		CHEMBL514261	=	Inhibition	%	6.46	CHEMBL4722	Homo sapiens	Inhibition	%	6.46
	8226179	CHEMBL1962195	GSK_PKIS: Aurora-A mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	3.22	CHEMBL4722	Homo sapiens	Inhibition	%	3.22
	8226304	CHEMBL1962194	GSK_PKIS: Aurora-A mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL381604	=	Inhibition	%	1.06	CHEMBL4722	Homo sapiens	Inhibition	%	1.06
active	9574713	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Nc1ncnc2onc(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)c12		CHEMBL213505	=	Ki	nM	398.11	CHEMBL4722	Homo sapiens	pKi		6.4
active	9574714	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	COc1cc2c(Nc3ccc(NC(=O)c4ccccc4)cc3)ncnc2cc1OCCCN1CCOCC1		CHEMBL202721	=	Ki	nM	398.11	CHEMBL4722	Homo sapiens	pKi		6.4
inactive	9574715	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	COc1ccc(OC)c(Nc2ccc3nnc(-c4ccccc4)n3n2)c1		CHEMBL1982880	<	Ki	nM	6309.57	CHEMBL4722	Homo sapiens	pKi		5.2
active	9574716	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	O=S(=O)(Nc1ccc2c(c1)C(=NO)c1ccccc1-2)c1ccccc1F		CHEMBL1988038	=	Ki	nM	794.33	CHEMBL4722	Homo sapiens	pKi		6.1
inactive	9574717	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	<	Ki	nM	3981.07	CHEMBL4722	Homo sapiens	pKi		5.4
inactive	9574718	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	CC(Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL1825138	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
active	9574719	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	N#CCOc1ccc(Nc2nc(Nc3cccc(S(N)(=O)=O)c3)ncc2Br)cc1		CHEMBL1987034	=	Ki	nM	1.585	CHEMBL4722	Homo sapiens	pKi		8.8
active	9574720	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	CCCn1cc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5cccc(F)c5)cc4)csc23)cn1		CHEMBL1993941	=	Ki	nM	6.31	CHEMBL4722	Homo sapiens	pKi		8.2
inactive	9574721	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	CCOc1nc(C(=O)NCc2ccc(S(C)(=O)=O)cc2)cc(N)c1Cl		CHEMBL377383	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
active	9574722	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	c1ccc(Nc2ccnc(Nc3ccccc3)n2)cc1		CHEMBL578061	=	Ki	nM	100.0	CHEMBL4722	Homo sapiens	pKi		7.0
active	9574723	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Cc1cc(N2CCOCC2)cc2[nH]c(-c3c(NCC(O)c4cccc(Cl)c4)cc[nH]c3=O)nc12		CHEMBL2005886	=	Ki	nM	79.43	CHEMBL4722	Homo sapiens	pKi		7.1
inactive	9574724	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	NC(=O)c1sc(-n2cnc3ccccc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL481491	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
active	9574725	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	c1ccc(Cn2cc(-c3ccc4[nH]ncc4c3)nn2)cc1		CHEMBL1682345	=	Ki	nM	316.23	CHEMBL4722	Homo sapiens	pKi		6.5
inactive	9574726	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	CC(=O)Nc1c(C(N)=O)sc2ccc(Cl)c(Cl)c12		CHEMBL1973142	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
active	9574727	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	NC(COc1cncc(-c2ccc3c(c2)C(=Cc2ccc[nH]2)C(=O)N3)c1)Cc1ccccc1		CHEMBL1980407	=	Ki	nM	251.19	CHEMBL4722	Homo sapiens	pKi		6.6
inactive	9574728	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4nc(N)nc(N)c34)cc2)c1		CHEMBL1973145	<	Ki	nM	3981.07	CHEMBL4722	Homo sapiens	pKi		5.4
inactive	9574729	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	COc1cccc(C(=O)Nc2cnc3[nH]cc(-c4ccccc4)c3c2)c1		CHEMBL1982924	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
active	9574730	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	CCCC(=O)Nc1n[nH]c2ccc(-c3nnn(Cc4ccccc4)c3-c3ccccc3)cc12		CHEMBL2005936	=	Ki	nM	398.11	CHEMBL4722	Homo sapiens	pKi		6.4
inactive	9574731	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	CN(C)CCCN(C)C(=O)c1cccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2cccc3ccccc23)c1		CHEMBL1964948	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
active	9574732	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	CN(C)C(=O)C=Cc1ccc(-c2ccc(NC(=O)Nc3cccc(C(F)(F)F)c3)cc2)c2c(N)n[nH]c12		CHEMBL1972472	=	Ki	nM	39.81	CHEMBL4722	Homo sapiens	pKi		7.4
inactive	9574733	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Cc1cccc(NC(=O)Nc2ccc(-c3cccc(C(N)=O)c3)cc2)c1		CHEMBL1971141	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
active	9574734	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Cc1ccc(-c2c(C#N)c(N)nc3cc(C)nn23)cc1		CHEMBL1968565	=	Ki	nM	501.19	CHEMBL4722	Homo sapiens	pKi		6.3
active	9574735	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Cc1c(C)n(Cc2ccccc2)c2ccc(C(=O)Nc3nc[nH]n3)cc12		CHEMBL1979718	=	Ki	nM	3981.07	CHEMBL4722	Homo sapiens	pKi		5.4
inactive	9574736	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	NC(COCc1ccccc1)COc1cncc(C=Cc2ccncc2)c1		CHEMBL1993781	<	Ki	nM	3981.07	CHEMBL4722	Homo sapiens	pKi		5.4
inactive	9574737	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	CCn1c2cc(Cl)c(O)cc2c(=O)c2c(=O)o[nH]c21		CHEMBL523823	<	Ki	nM	6309.57	CHEMBL4722	Homo sapiens	pKi		5.2
inactive	9574738	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	CC1(C)CC2=Nc3cc(Cl)ccc3SC2=C(O)C1		CHEMBL1562756	<	Ki	nM	6309.57	CHEMBL4722	Homo sapiens	pKi		5.2
inactive	9574739	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	CCCc1ccc2nccc(NC(=O)Nc3cccc(C(F)(F)F)n3)c2c1		CHEMBL1987430	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
inactive	9574740	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	CC(C)(CO)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3c(OCC(F)(F)F)nccn23)n1		CHEMBL2001957	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
inactive	9574741	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	COCCNc1nccc(-c2c(-c3ccc(F)cc3)nc3cnccn23)n1		CHEMBL1969372	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
inactive	9574742	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	O=C(Nc1cc(-c2c[nH]c3ncccc23)cc(Cl)n1)c1ccccc1		CHEMBL1993413	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
active	9574743	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	OC1CCC(Nc2nc(Cl)cc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL1986943	=	Ki	nM	794.33	CHEMBL4722	Homo sapiens	pKi		6.1
inactive	9574744	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	c1ccc(Nc2ncnc3ccccc23)cc1		CHEMBL289959	<	Ki	nM	63095.73	CHEMBL4722	Homo sapiens	pKi		4.2
active	9574745	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Cc1nc2ccc(NS(=O)(=O)c3ccc(N)cc3)cc2nc1C		CHEMBL2006263	=	Ki	nM	1000.0	CHEMBL4722	Homo sapiens	pKi		6.0
inactive	9574746	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	OC(COc1cncc(C=Cc2ccncc2)c1)Cc1c[nH]c2ccccc12		CHEMBL1993584	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
active	9574747	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	CCn1c(C)c(-c2ccnc(Nc3cccc(OC)c3)n2)sc1=O		CHEMBL1986263	=	Ki	nM	39.81	CHEMBL4722	Homo sapiens	pKi		7.4
active	9574748	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	CSc1c[nH]c2ncnc(NCCCO)c12		CHEMBL2000114	=	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
inactive	9574749	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	CCOc1nc(NC(=O)Cc2cc(OC)ccc2OC)cc(N)c1C#N		CHEMBL210618	<	Ki	nM	3981.07	CHEMBL4722	Homo sapiens	pKi		5.4
inactive	9574750	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	O=C(O)C1CN(Cc2ccc(OCc3cccc(C(F)(F)F)c3)cc2Cl)C1		CHEMBL1986265	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
active	9574751	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	O=C(Nc1cnccn1)Nc1ccnc2c(F)cccc12		CHEMBL1975647	=	Ki	nM	794.33	CHEMBL4722	Homo sapiens	pKi		6.1
inactive	9574752	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	CCC1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL1968380	<	Ki	nM	3981.07	CHEMBL4722	Homo sapiens	pKi		5.4
inactive	9574753	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Fc1ccc(-c2ccc3nccn3n2)cn1		CHEMBL1967211	<	Ki	nM	63095.73	CHEMBL4722	Homo sapiens	pKi		4.2
inactive	9574754	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	O=C(NCc1ccccc1)Nc1ncc([N+](=O)[O-])s1		CHEMBL1964644	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
active	9574755	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	CN1c2ccc(N)cc2C(c2ccccc2)c2cc(N)ccc21		CHEMBL1991734	=	Ki	nM	501.19	CHEMBL4722	Homo sapiens	pKi		6.3
active	9574756	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	O=C(NCc1ccc(Cl)c(Cl)c1)Nc1ccc2[nH]ncc2c1		CHEMBL1981782	=	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
inactive	9574757	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	CNC(=O)c1cc2c(-c3ccccc3F)n[nH]c2s1		CHEMBL1977681	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
active	9574758	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	CNC(=O)C(C)n1cc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5ccc(C)cc5)cc4)csc23)cn1		CHEMBL1970142	=	Ki	nM	7.943	CHEMBL4722	Homo sapiens	pKi		8.1
inactive	9574759	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	<	Ki	nM	3981.07	CHEMBL4722	Homo sapiens	pKi		5.4
inactive	9574760	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	OCCNc1cc2cc(-c3cccnc3)ccc2cn1		CHEMBL1990912	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
inactive	9574761	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	O=C1NCc2c1cccc2-c1cccs1		CHEMBL1991782	<	Ki	nM	31622.78	CHEMBL4722	Homo sapiens	pKi		4.5
active	9574762	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Nc1n[nH]c2ncc(Br)cc12		CHEMBL2002105	=	Ki	nM	25118.86	CHEMBL4722	Homo sapiens	pKi		4.6
inactive	9574763	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
active	9574764	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	CCCCN(CCC#N)C(=O)c1ccc2nc(-c3n[nH]c4ccccc34)[nH]c2c1		CHEMBL1983348	=	Ki	nM	100.0	CHEMBL4722	Homo sapiens	pKi		7.0
inactive	9574765	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Cc1cccc(-c2ccc3c(c2)C(=O)NC3)c1		CHEMBL1968394	<	Ki	nM	63095.73	CHEMBL4722	Homo sapiens	pKi		4.2
active	9574766	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	NS(=O)(=O)c1cccc(Nc2ncc3ccn(-c4ccccc4)c3n2)c1		CHEMBL1988163	=	Ki	nM	251.19	CHEMBL4722	Homo sapiens	pKi		6.6
active	9574767	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Cc1cc(O)ccc1-n1c2cc(Cl)ccc2c(=O)c2c(N)nc(N)nc21		CHEMBL1995592	=	Ki	nM	1000.0	CHEMBL4722	Homo sapiens	pKi		6.0
inactive	9574768	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Nc1ncnc2c1C(=O)Nc1ccccc1N2		CHEMBL1980671	<	Ki	nM	63095.73	CHEMBL4722	Homo sapiens	pKi		4.2
inactive	9574769	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	O=C1CCCc2oc3cc(C(F)(F)F)ccc3c(=O)c21		CHEMBL2006493	<	Ki	nM	3981.07	CHEMBL4722	Homo sapiens	pKi		5.4
inactive	9574770	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	O=C(Nc1cccc(Cl)c1)Nc1nc(CCNc2ncnc3ccsc23)cs1		CHEMBL1986177	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
inactive	9574771	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	COc1ccc(OC)c(CNC(=O)c2cc(N)c(C#N)c(OC(C)C)n2)c1		CHEMBL1982541	<	Ki	nM	6309.57	CHEMBL4722	Homo sapiens	pKi		5.2
inactive	9574772	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Clc1cc2nn[nH]c2cc1Cl		CHEMBL1996923	<	Ki	nM	3981.07	CHEMBL4722	Homo sapiens	pKi		5.4
inactive	9574773	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Cc1ccc(CNc2c(Nc3ccncc3)c(=O)c2=O)cc1C		CHEMBL1983449	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
inactive	9574774	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	O=c1[nH]cnc2c1oc1ccc(Cl)cc12		CHEMBL1992323	<	Ki	nM	3981.07	CHEMBL4722	Homo sapiens	pKi		5.4
inactive	9574775	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	CC(C)(CO)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3c(Cl)nccn23)n1		CHEMBL1969735	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
active	9574776	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	CCc1nc2c(c3cc(OC)c(OC)cc13)C(=O)NC2=O		CHEMBL2003524	=	Ki	nM	630.96	CHEMBL4722	Homo sapiens	pKi		6.2
active	9574777	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	COc1ccc2c(c1)C(=Cc1c[nH]cn1)C(=O)N2		CHEMBL2002649	=	Ki	nM	630.96	CHEMBL4722	Homo sapiens	pKi		6.2
inactive	9574778	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	c1ccc2c(c1)Cc1c[nH]nc1-2		CHEMBL1989423	<	Ki	nM	63095.73	CHEMBL4722	Homo sapiens	pKi		4.2
inactive	9574779	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Cc1ccnc(Nc2cc(C)nc(-c3ccccc3)n2)c1		CHEMBL1985367	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
inactive	9574780	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Cn1c(=O)n(-c2ccc(C(C)(C)C#N)cc2)c2c3cc(-c4cnc5ccccc5c4)ccc3ncc21		CHEMBL1879463	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
inactive	9574781	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1c1nc(N2CCNCC2)nc2ccccc12		CHEMBL1996510	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
inactive	9574782	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	CCCn1c(C2CCNCC2)nc(-c2ccc(Cl)c(Cl)c2)c1-c1ccnc(NC2CCCCC2)n1		CHEMBL437747	<	Ki	nM	6309.57	CHEMBL4722	Homo sapiens	pKi		5.2
inactive	9574783	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Brc1ccc2c(c1)-c1[nH]ncc1C2		CHEMBL1995172	<	Ki	nM	25118.86	CHEMBL4722	Homo sapiens	pKi		4.6
inactive	9574784	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Cn1cc(-c2cccc(NC(=O)c3ccc(C(C)(C)C)cc3)c2CO)cc(Nc2ccc(C(=O)N3CCOCC3)cn2)c1=O		CHEMBL2001584	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
active	9574785	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Cc1cccc(NC(=O)Nc2ccc(-c3ccc4nccnc4c3N)cc2)c1		CHEMBL507936	=	Ki	nM	1995.26	CHEMBL4722	Homo sapiens	pKi		5.7
active	9574786	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	O=CN(O)C(CS(=O)(=O)c1ccc(-c2ccc(C(F)(F)F)cc2)cc1)c1ccc(O)cc1		CHEMBL1971227	=	Ki	nM	1000.0	CHEMBL4722	Homo sapiens	pKi		6.0
active	9574787	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	O=S(=O)(NCCNCC=Cc1ccc(Br)cc1)c1cccc2cnccc12		CHEMBL1987756	=	Ki	nM	6309.57	CHEMBL4722	Homo sapiens	pKi		5.2
active	9574788	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	CCN1CCN(c2ccc(Nc3ncc(Cl)c(Nc4ccc5[nH]ncc5c4)n3)cc2)CC1		CHEMBL1967998	=	Ki	nM	25.12	CHEMBL4722	Homo sapiens	pKi		7.6
active	9574789	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#CCNS(C)(=O)=O)cnc(N)c34)cc2)c1		CHEMBL1994321	=	Ki	nM	50.12	CHEMBL4722	Homo sapiens	pKi		7.3
active	9574790	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Cn1cc(-c2cc3nc(Br)cnc3[nH]2)c2cc(C#N)ccc21		CHEMBL1978562	=	Ki	nM	794.33	CHEMBL4722	Homo sapiens	pKi		6.1
active	9574791	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	O=C1NCCc2[nH]c(-c3ccnc(C=Cc4ccccc4)c3)cc21		CHEMBL1997129	=	Ki	nM	316.23	CHEMBL4722	Homo sapiens	pKi		6.5
inactive	9574792	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	FC(F)(F)c1ccc(-c2nnc3ccc(NC4CC4)nn23)cc1		CHEMBL451964	<	Ki	nM	6309.57	CHEMBL4722	Homo sapiens	pKi		5.2
active	9574793	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	O=C(O)c1csc2c1NCCNC2=O		CHEMBL1974875	=	Ki	nM	31622.78	CHEMBL4722	Homo sapiens	pKi		4.5
active	9574794	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Cc1cccc(NC(=O)Cc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL1964307	=	Ki	nM	501.19	CHEMBL4722	Homo sapiens	pKi		6.3
active	9574795	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Cc1ccnc2[nH]c3cc(C(C)C)ccc3c(=O)c12		CHEMBL1989471	=	Ki	nM	1258.93	CHEMBL4722	Homo sapiens	pKi		5.9
active	9574796	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	N#CCC(C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1		CHEMBL2002099	=	Ki	nM	1258.93	CHEMBL4722	Homo sapiens	pKi		5.9
inactive	9574797	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Fc1ccc(-c2nc3sccn3c2-c2ccncc2)cc1		CHEMBL2000508	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
inactive	9574798	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	CCCCNc1n[s+]([O-])nc1Nc1ccc(F)cc1		CHEMBL1971694	<	Ki	nM	3981.07	CHEMBL4722	Homo sapiens	pKi		5.4
inactive	9574799	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	CCc1nccn2c(-c3ccnc(NCC(C)(C)O)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL2001547	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
inactive	9574800	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	CCOc1nc(NC(=O)Cc2cc(OC)c(S(C)(=O)=O)cc2OC)cc(N)c1Cl		CHEMBL210928	<	Ki	nM	3981.07	CHEMBL4722	Homo sapiens	pKi		5.4
inactive	9574801	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	NC(=O)c1cc2c(-c3ccc(Br)cc3)cncc2s1		CHEMBL1978195	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
inactive	9574802	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Nc1ccc(-c2cncc(OCC(N)Cc3c[nH]c4ccccc34)c2)cc1C(=O)c1ccccc1F		CHEMBL1994361	<	Ki	nM	6309.57	CHEMBL4722	Homo sapiens	pKi		5.2
inactive	9574803	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Cc1cc(NC(=O)CCNC(=O)Nc2nc(C)c(-c3ccc(-n4cccn4)cc3)s2)no1		CHEMBL1986603	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
inactive	9574804	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
active	9574805	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	CCCS(=O)(=O)Nc1ccc2c(c1)C(=NO)c1ccccc1-2		CHEMBL2005800	=	Ki	nM	1995.26	CHEMBL4722	Homo sapiens	pKi		5.7
inactive	9574806	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	NC(COc1cncc(-c2cc3cnccc3s2)c1)Cc1c[nH]c2ccccc12		CHEMBL1972840	<	Ki	nM	6309.57	CHEMBL4722	Homo sapiens	pKi		5.2
inactive	9574807	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	COc1ccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(CCO)c5)cnc(N)c34)cc2)cc1		CHEMBL1977148	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
inactive	9574808	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	COc1cc(C=C2SC(=O)NC2=O)ccc1O		CHEMBL2003286	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
active	9574809	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3cccc(C(F)(F)F)c3)cc2)ccn1		CHEMBL1992306	=	Ki	nM	501.19	CHEMBL4722	Homo sapiens	pKi		6.3
active	9574810	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	CC(O)Cn1cc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5cccc(F)c5)cc4)csc23)cn1		CHEMBL2002165	=	Ki	nM	1.995	CHEMBL4722	Homo sapiens	pKi		8.7
inactive	9574811	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	NCCOc1cncc(C=Cc2ccncc2)c1		CHEMBL1989518	<	Ki	nM	3981.07	CHEMBL4722	Homo sapiens	pKi		5.4
active	9574812	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Nc1ncnc2scc(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL1998585	=	Ki	nM	199.53	CHEMBL4722	Homo sapiens	pKi		6.7
active	9574813	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	CN(C(=O)C1CCCCC1)c1ccc2c(c1)nc(NC(=O)c1ccc(C#N)cc1)n2C		CHEMBL519697	=	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
active	9574814	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	COCCOC1CCC(n2nc(-c3ccc(Nc4nc5cc(Br)cc(C)c5o4)cc3)c3c(N)ncnc32)CC1		CHEMBL1972851	=	Ki	nM	3.981	CHEMBL4722	Homo sapiens	pKi		8.4
inactive	9574815	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3)c(F)c2)c1		CHEMBL2004934	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
active	9574816	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Cc1ccc(NC(=O)Nc2ccc(-c3c(Cc4cccnc4)sc4ncnc(N)c34)cc2)cc1		CHEMBL1983846	=	Ki	nM	63.1	CHEMBL4722	Homo sapiens	pKi		7.2
active	9574817	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	CCN1CCN(c2ccc(Nc3ncc(C#N)c(Nc4ccc5[nH]ncc5c4)n3)cc2)CC1		CHEMBL1973516	=	Ki	nM	100.0	CHEMBL4722	Homo sapiens	pKi		7.0
inactive	9574818	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	N#Cc1ccc2nc(N)n(-c3nc4c(s3)CCCC4)c2c1		CHEMBL1996345	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
active	9574819	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Nc1n[nH]c2ccc(-c3nnn(Cc4ccccc4)c3I)cc12		CHEMBL1975128	=	Ki	nM	50.12	CHEMBL4722	Homo sapiens	pKi		7.3
active	9574820	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	COCOc1cccc(OCOC)c1-c1ccc(NS(C)(=O)=O)cc1C(=O)OC		CHEMBL2004025	=	Ki	nM	398.11	CHEMBL4722	Homo sapiens	pKi		6.4
inactive	9574821	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Cc1ccc(-c2cc3c(NCCN)ccc(C(N)=O)c3[nH]2)cc1		CHEMBL1996048	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
inactive	9574822	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	COc1cc2c(cc1Nc1nc(Nc3cccc(F)c3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CC2		CHEMBL461876	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
inactive	9574823	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Cc1cc(=O)[nH]nc1-c1ccc(NC(=O)Nc2cc(C(F)(F)F)ccc2F)cc1		CHEMBL1965033	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
active	9574824	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Cc1ccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(C(C)C(=O)N(C)C)c5)cnc(N)c34)cc2)cc1		CHEMBL2001485	=	Ki	nM	100.0	CHEMBL4722	Homo sapiens	pKi		7.0
inactive	9574825	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1		CHEMBL491473	<	Ki	nM	3162.28	CHEMBL4722	Homo sapiens	pKi		5.5
inactive	9574826	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Nc1n[nH]c2cccc(-c3ccc(F)cc3)c12		CHEMBL1971519	<	Ki	nM	39810.72	CHEMBL4722	Homo sapiens	pKi		4.4
active	9574827	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Cc1cc(C)c2c(n1)sc1c(N)ncnc12		CHEMBL504950	=	Ki	nM	2511.89	CHEMBL4722	Homo sapiens	pKi		5.6
inactive	9574828	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	COc1ccc(C2=NNc3cccc4c(OC)ccc2c34)cc1OC		CHEMBL1997335	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
active	9574829	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Cc1cc(NC(=O)Cc2ccc(-c3cccc4[nH]nc(N)c34)cc2)ccc1F		CHEMBL1984363	=	Ki	nM	1000.0	CHEMBL4722	Homo sapiens	pKi		6.0
active	9574830	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	CNC(=O)COc1ccc(Nc2nc(Nc3ccc(C)c(S(N)(=O)=O)c3)ncc2F)cc1		CHEMBL1978099	=	Ki	nM	15.85	CHEMBL4722	Homo sapiens	pKi		7.8
active	9574831	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	COC(=O)c1c(-c2ccc(NC(=O)Nc3ccccc3)cc2)c2c(N)ncnn2c1C		CHEMBL1977041	=	Ki	nM	12.59	CHEMBL4722	Homo sapiens	pKi		7.9
active	9574832	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	NC(=O)c1cccc2c1Nc1nnc(Cl)cc1C(=O)N2		CHEMBL1968070	=	Ki	nM	316.23	CHEMBL4722	Homo sapiens	pKi		6.5
inactive	9574833	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	CC(=O)Nc1cccc(CNc2c(Nc3ccc4[nH]ncc4c3)c(=O)c2=O)c1		CHEMBL1988608	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
inactive	9574834	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Cc1ccc(NC(=O)Nc2ccc(-c3cccc4c3CNC4=O)cc2)cc1C		CHEMBL184847	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
inactive	9574835	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	CN(C)c1ccc(CNC(=O)c2cc3c(-c4ccccc4)n[nH]c3s2)cc1		CHEMBL1984367	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
active	9574836	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	O=C1NC(=O)C(c2cnc3ccccn23)=C1c1cn2c3c(cccc13)CN(C(=O)N1CCOCC1)CC2		CHEMBL178737	=	Ki	nM	1258.93	CHEMBL4722	Homo sapiens	pKi		5.9
inactive	9574837	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Cc1n[nH]c2cnc(-c3cncc(OCC(N)Cc4cccc(C(F)(F)F)c4)c3)cc12		CHEMBL1998159	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
inactive	9574838	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	COCC(C)(C)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3c(C)nccn23)n1		CHEMBL1982563	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
active	9574839	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	O=C1CCCN1Cc1ccc2c(c1)[nH]c(=O)c1cccn12		CHEMBL539474	=	Ki	nM	39.81	CHEMBL4722	Homo sapiens	pKi		7.4
inactive	9574840	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	NC(COc1cncc(-c2ccc3[nH]c(=O)oc3c2)c1)Cc1c[nH]c2ccccc12		CHEMBL1987679	<	Ki	nM	3162.28	CHEMBL4722	Homo sapiens	pKi		5.5
active	9574841	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Cn1cc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5ccc(OC(F)F)cc5)cc4)csc23)cn1		CHEMBL1988387	=	Ki	nM	25.12	CHEMBL4722	Homo sapiens	pKi		7.6
active	9574842	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Nc1ncnc2sc3c(c12)-c1ccc(NC(=O)Nc2cccc(C(F)(F)F)c2)cc1CC3		CHEMBL1985523	=	Ki	nM	100.0	CHEMBL4722	Homo sapiens	pKi		7.0
inactive	9574843	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Oc1cnc2ccc(-c3ccncc3)cc2c1		CHEMBL1973868	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
inactive	9574844	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	COc1cccc(NC(=O)c2cnn3c(-c4ccccc4)ccnc23)c1		CHEMBL1997759	<	Ki	nM	6309.57	CHEMBL4722	Homo sapiens	pKi		5.2
inactive	9574845	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Cn1c(SC(C(=O)O)c2ccccc2)nc2ccccc2c1=O		CHEMBL1981556	<	Ki	nM	1995.26	CHEMBL4722	Homo sapiens	pKi		5.7
inactive	9574846	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	CC(Nc1nccc(-c2c(-c3ccc(F)cc3)nc3occn23)n1)c1ccccc1		CHEMBL1990288	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
active	9574847	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(CC(C)O)c5)cnc(N)c34)cc2)c1		CHEMBL1989708	=	Ki	nM	6.31	CHEMBL4722	Homo sapiens	pKi		8.2
inactive	9578424	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Cc1n[nH]c2cccc(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)c12		CHEMBL1970074	<	Ki	nM	2511.89	CHEMBL4722	Homo sapiens	pKi		5.6
inactive	9578425	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
active	9578426	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	CC(Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL1825138	=	Ki	nM	316.23	CHEMBL4722	Homo sapiens	pKi		6.5
inactive	9578427	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	NC1CCN(C(=O)c2ccc3c(c2)[nH]c(=O)c2cccn23)CC1		CHEMBL1967620	<	Ki	nM	1995.26	CHEMBL4722	Homo sapiens	pKi		5.7
active	9578428	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	COCCN(C)C(=O)c1c(-c2ccc3[nH]ncc3c2)nnn1Cc1ccccc1		CHEMBL1986970	=	Ki	nM	316.23	CHEMBL4722	Homo sapiens	pKi		6.5
active	9578429	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	=	Ki	nM	630.96	CHEMBL4722	Homo sapiens	pKi		6.2
inactive	9578430	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	O=c1[nH]c2cc(-c3ccccc3)cnc2[nH]1		CHEMBL2003456	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
inactive	9578431	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	CC(N)C1CCC(C(=O)Nc2ccnc3[nH]ccc23)CC1		CHEMBL2002992	<	Ki	nM	1995.26	CHEMBL4722	Homo sapiens	pKi		5.7
inactive	9578432	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	N#Cc1cnc(NC(=O)Nc2ccc3cc(C(=O)O)ccc3c2)cn1		CHEMBL560813	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
inactive	9578433	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	CCCCNC(=O)c1cn(C(CC)CC)c(=O)c2cc(OC)c(OC)cc12		CHEMBL1982700	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
inactive	9578434	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Cc1c(-c2cccc(OCc3ccccc3)c2)c2c(N)ncnc2n1C1CC(CN2CCCC2)C1		CHEMBL1968791	<	Ki	nM	3981.07	CHEMBL4722	Homo sapiens	pKi		5.4
inactive	9578435	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	O=C1CC(c2ccc(Cl)cc2Cl)Cc2nc3cc(Cl)ccc3c(O)c21		CHEMBL326282	<	Ki	nM	6309.57	CHEMBL4722	Homo sapiens	pKi		5.2
inactive	9578436	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	CCOc1ccccc1C=NNC(=O)c1nnn(-c2nonc2N)c1N1CCCC1		CHEMBL1992732	<	Ki	nM	6309.57	CHEMBL4722	Homo sapiens	pKi		5.2
inactive	9578437	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Fc1ccc(-c2nc3occn3c2-c2ccnc(NC3CCNCC3)n2)cc1		CHEMBL1971186	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
inactive	9578438	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	O=C(Cc1ccc(Cl)cc1)Nc1[nH]nc2c1CCC2		CHEMBL2003482	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
inactive	9578439	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	CC(=O)Nc1cc2ccccn2n1		CHEMBL1976872	<	Ki	nM	63095.73	CHEMBL4722	Homo sapiens	pKi		4.2
inactive	9578440	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Nc1nccc2cnc(-c3ccccc3)n12		CHEMBL1969156	<	Ki	nM	63095.73	CHEMBL4722	Homo sapiens	pKi		4.2
active	9578441	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#CCN5CCCC5)cnc(N)c34)cc2)c1		CHEMBL1973211	=	Ki	nM	31.62	CHEMBL4722	Homo sapiens	pKi		7.5
inactive	9578442	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	CC(C)Oc1nccn2c(-c3ccnc(NCC(C)(C)O)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL1984700	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
inactive	9578443	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	<	Ki	nM	2511.89	CHEMBL4722	Homo sapiens	pKi		5.6
inactive	9578444	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Cc1c(-c2cccc(OCc3ccccc3)c2)c2c(N)ncnc2n1C1CCC(N2CCCC2)CC1		CHEMBL2007151	<	Ki	nM	6309.57	CHEMBL4722	Homo sapiens	pKi		5.2
inactive	9578445	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	CCCOc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3F)cc2)c1		CHEMBL1971606	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
active	9578446	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Cc1oc2ncnc(N)c2c1-c1ccc(NC(=O)Nc2cc(C(F)(F)F)ccc2F)cc1		CHEMBL2003604	=	Ki	nM	125.89	CHEMBL4722	Homo sapiens	pKi		6.9
inactive	9578447	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Nc1ccc(-c2cncc(OCC(N)Cc3c[nH]c4ccccc34)c2)cc1C(=O)c1ccccc1		CHEMBL1972125	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
inactive	9578448	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	<	Ki	nM	2511.89	CHEMBL4722	Homo sapiens	pKi		5.6
active	9578449	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	CC(C)c1cc(=O)[nH]c2[nH][nH]c(=O)c12		CHEMBL1999120	=	Ki	nM	15848.93	CHEMBL4722	Homo sapiens	pKi		4.8
inactive	9578450	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	c1cc2cc(-c3ccc4cn[nH]c4c3)cnc2[nH]1		CHEMBL1976134	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
inactive	9578451	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Cc1ccc(C(=O)Nc2c(C(N)=O)sc3ccc(Cl)c(Cl)c23)cc1		CHEMBL1965131	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
inactive	9578452	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	NCCOc1cccc(Nc2ccnc(N)n2)c1		CHEMBL1995448	<	Ki	nM	6309.57	CHEMBL4722	Homo sapiens	pKi		5.2
active	9578453	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Nc1n[nH]c2ccc(-c3nnn(Cc4ccccc4)c3-c3ccccc3)cc12		CHEMBL1972158	=	Ki	nM	158.49	CHEMBL4722	Homo sapiens	pKi		6.8
inactive	9578454	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	O=C(Nc1cccc(C(F)(F)F)n1)Nc1ccnc2cc(OC(F)F)ccc12		CHEMBL1981215	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
active	9578455	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	O=C(O)c1cc2c(-c3cccc(F)c3)cncc2s1		CHEMBL1974457	=	Ki	nM	794.33	CHEMBL4722	Homo sapiens	pKi		6.1
active	9578456	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	O=C(Nc1cccc(Cl)c1)Nc1ncc(CCN=c2[nH]cnc3ccsc23)s1		CHEMBL482767	=	Ki	nM	39.81	CHEMBL4722	Homo sapiens	pKi		7.4
active	9578457	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	CCN(CC)CCCNC(=O)c1cnc(N)c2c(-c3ccc(NC(=O)Nc4cccc(C)c4)cc3)csc12		CHEMBL1999414	=	Ki	nM	39.81	CHEMBL4722	Homo sapiens	pKi		7.4
inactive	9578458	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	O=C(Nc1cnccn1)Nc1ccnc2c(F)cc(F)cc12		CHEMBL1967336	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
inactive	9578459	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	CCOc1nc(C(=O)NCc2ccccc2S(N)(=O)=O)cc(N)c1Cl		CHEMBL2006581	<	Ki	nM	6309.57	CHEMBL4722	Homo sapiens	pKi		5.2
inactive	9578460	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Nc1noc2cccc(-c3cccc(O)c3)c12		CHEMBL1970340	<	Ki	nM	31622.78	CHEMBL4722	Homo sapiens	pKi		4.5
inactive	9578461	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	N#Cc1ccc(-c2ccncc2)cc1NCc1ccccc1		CHEMBL1967992	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
active	9578462	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(Oc4cc(NC)ncn4)cc3)cc2C(F)(F)F)CC1		CHEMBL574738	=	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
inactive	9578463	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	CC(C)NC(=O)COc1cccc(-c2nc(Nc3ccc4[nH]ncc4c3)c3ccccc3n2)c1		CHEMBL2005186	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
inactive	9578464	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	CCCCC(=O)Nc1cc(-c2c[nH]c3ncccc23)cc(Cl)n1		CHEMBL2006450	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
inactive	9578465	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	NCC(O)C(O)Cn1cc(I)c2c(N)ncnc21		CHEMBL1975534	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
active	9578466	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	NS(=O)(=O)c1cccc(Nc2ncc3ccn(Cc4ccccc4)c3n2)c1		CHEMBL1993424	=	Ki	nM	125.89	CHEMBL4722	Homo sapiens	pKi		6.9
inactive	9578467	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Cc1n[nH]c2c1C(c1ccccc1F)C1=C(CC(C)(C)CC1=O)N2		CHEMBL1966703	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
inactive	9578468	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	O=C(Nc1cccc(C(F)(F)F)n1)Nc1ccnc2c(F)ccc(F)c12		CHEMBL2001987	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
active	9578469	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Cc1ccc(Nc2nccc(Nc3ccccc3C(=O)O)n2)cc1F		CHEMBL243518	=	Ki	nM	15.85	CHEMBL4722	Homo sapiens	pKi		7.8
active	9578470	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	CC(C)N(C)C(=O)c1c(-c2ccc3[nH]ncc3c2)nnn1Cc1ccccc1		CHEMBL1969561	=	Ki	nM	100.0	CHEMBL4722	Homo sapiens	pKi		7.0
active	9578471	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	CCc1c(-c2ccc(C(C)=O)cc2)[nH]c2nccnc12		CHEMBL1994555	=	Ki	nM	398.11	CHEMBL4722	Homo sapiens	pKi		6.4
inactive	9578472	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3)cc2)c1		CHEMBL1975121	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
active	9578473	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3coc4c(C#CCN5CCOCC5)cnc(N)c34)cc2)c1		CHEMBL1983640	=	Ki	nM	125.89	CHEMBL4722	Homo sapiens	pKi		6.9
active	9578474	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	CN(C)c1cc2sncc2cc1NC(=O)C(=O)O		CHEMBL1997023	=	Ki	nM	1258.93	CHEMBL4722	Homo sapiens	pKi		5.9
active	9578475	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Cc1cc(C)cc(NC(=O)Nc2ccc3c(c2)CCc2sc4ncnc(N)c4c2-3)c1		CHEMBL1964687	=	Ki	nM	158.49	CHEMBL4722	Homo sapiens	pKi		6.8
inactive	9578476	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Cc1c[nH]c2nccc(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)c12		CHEMBL1971943	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
active	9578477	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	NC(=O)c1cc2c(-c3ccc(Br)c(F)c3F)cncc2s1		CHEMBL1999918	=	Ki	nM	2511.89	CHEMBL4722	Homo sapiens	pKi		5.6
active	9578478	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	CCOc1ccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(C)c5)cnc(N)c34)cc2)cc1		CHEMBL1974254	=	Ki	nM	10.0	CHEMBL4722	Homo sapiens	pKi		8.0
active	9578479	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	CC1(C)CC(C=Cc2ccc(Cl)cc2)=Cc2c1sc1ncnc(N)c21		CHEMBL1987334	=	Ki	nM	100.0	CHEMBL4722	Homo sapiens	pKi		7.0
active	9578480	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	COc1ccc(C(=O)N2c3ccccc3Sc3c(Cl)cncc32)cc1		CHEMBL1988537	=	Ki	nM	501.19	CHEMBL4722	Homo sapiens	pKi		6.3
inactive	9578481	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3)c(C)c2)c1		CHEMBL1969049	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
inactive	9578482	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Cc1ccc(NC(=O)Nc2ccc(-c3coc4ncnc(N)c34)cc2)cc1		CHEMBL2005828	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
inactive	9578483	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Nc1nc(SCC(=O)Nc2ncccn2)nc2nc[nH]c12		CHEMBL1982388	<	Ki	nM	1995.26	CHEMBL4722	Homo sapiens	pKi		5.7
active	9578484	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Nc1ccc(-c2csc3ccnc(N)c23)cc1		CHEMBL231153	=	Ki	nM	1258.93	CHEMBL4722	Homo sapiens	pKi		5.9
inactive	9578485	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	CCc1nc(-c2cccc(C)c2)c(-c2ccnc(NC(=O)c3ccccc3)c2)s1		CHEMBL363648	<	Ki	nM	3981.07	CHEMBL4722	Homo sapiens	pKi		5.4
active	9578486	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	CC(Nc1cncc(-n2cnc3ccc(C#N)cc32)n1)c1ccccc1F		CHEMBL1977138	=	Ki	nM	79.43	CHEMBL4722	Homo sapiens	pKi		7.1
active	9578487	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Cc1ccc(-n2nc(C)c3c(=O)c4cc(Cl)ccc4n(O)c32)cc1		CHEMBL1991143	=	Ki	nM	501.19	CHEMBL4722	Homo sapiens	pKi		6.3
active	9578488	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	=	Ki	nM	794.33	CHEMBL4722	Homo sapiens	pKi		6.1
active	9578489	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	NC(=O)c1sc2c(Br)ccc(Cl)c2c1N		CHEMBL1998611	=	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
inactive	9578490	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	CN(C(=O)C1CCCCC1)c1ccc2c(c1)nc(NC(=O)c1ccc(C#N)cc1)n2CCC(N)=O		CHEMBL485556	<	Ki	nM	6309.57	CHEMBL4722	Homo sapiens	pKi		5.2
inactive	9578491	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	O=c1c(NCc2ccc(Cl)c(Cl)c2)c(Nc2ccncc2)c1=O		CHEMBL1975900	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
inactive	9578492	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	COc1cc(C=C2SC(=S)NC2=O)ccc1O		CHEMBL1973098	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
active	9578493	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	CCCS(=O)(=O)Nc1ccc(-c2ccc3[nH]nc(NC(=O)CC)c3c2)cc1		CHEMBL1972221	=	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
active	9578494	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	CNC(=O)C=Cc1cnc(N)c2c(-c3cc(F)c4[nH]c(C)cc4c3)csc12		CHEMBL2006778	=	Ki	nM	398.11	CHEMBL4722	Homo sapiens	pKi		6.4
inactive	9578495	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	COc1cc(S(C)(=O)=O)c(OC)cc1CC(=O)Nc1cc(N)c(C#N)c(OC(C)C)n1		CHEMBL378627	<	Ki	nM	3981.07	CHEMBL4722	Homo sapiens	pKi		5.4
inactive	9578496	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	O=C(Nc1cnc2[nH]cc(-c3ccccc3)c2c1)c1c(F)cccc1F		CHEMBL1996979	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
inactive	9578497	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	NC(=O)c1cccc2[nH]c(-c3ccc(C4CCCNC4)cc3F)nc12		CHEMBL1997025	<	Ki	nM	3981.07	CHEMBL4722	Homo sapiens	pKi		5.4
active	9578498	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	CCc1cccc(NC(=O)Nc2ccc3c(c2)CCc2sc4ncnc(N)c4c2-3)c1		CHEMBL1968406	=	Ki	nM	501.19	CHEMBL4722	Homo sapiens	pKi		6.3
active	9578499	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	CCCCS(=O)(=O)Nc1ccc2c(c1)C(=NO)c1ccccc1-2		CHEMBL1966411	=	Ki	nM	1258.93	CHEMBL4722	Homo sapiens	pKi		5.9
active	9578500	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	O=c1[nH]c2cc(Br)cnc2[nH]1		CHEMBL1975921	=	Ki	nM	10000.0	CHEMBL4722	Homo sapiens	pKi		5.0
active	9578501	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	CNC(=O)c1cnc(N)c2c(-c3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)csc12		CHEMBL1982476	=	Ki	nM	3.162	CHEMBL4722	Homo sapiens	pKi		8.5
inactive	9578502	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	O=C(NC(CO)Cc1ccccc1)c1ccc(-c2ccncc2)cc1		CHEMBL1998545	<	Ki	nM	3981.07	CHEMBL4722	Homo sapiens	pKi		5.4
inactive	9578503	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Cc1csc(NC(=O)c2sc3nc(-c4ccncc4)ccc3c2N)n1		CHEMBL1986869	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
inactive	9578504	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	CC(CCC(=O)O)(c1ccc(O)c(N)c1)c1ccc(O)c(N)c1		CHEMBL1975923	<	Ki	nM	794.33	CHEMBL4722	Homo sapiens	pKi		6.1
active	9578505	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Cc1cc(Nc2nc(Cl)cc(NCc3ccccc3)n2)n[nH]1		CHEMBL2005449	=	Ki	nM	125.89	CHEMBL4722	Homo sapiens	pKi		6.9
inactive	9578506	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	O=C(O)C1CN(Cc2ccc(OCc3ccccc3)cc2Cl)C1		CHEMBL1987998	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
active	9578507	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Cc1cc(N2CCOCC2)cc2[nH]c(-c3c(NCC(O)c4ccccc4)cc[nH]c3=O)nc12		CHEMBL1992527	=	Ki	nM	251.19	CHEMBL4722	Homo sapiens	pKi		6.6
inactive	9578508	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Fc1ccc(-c2ncn(CCN3CCOCC3)c2-c2ccc3[nH]ncc3c2)cc1		CHEMBL1682558	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
active	9578509	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	NC(=O)c1cc2ccncc2s1		CHEMBL1971534	=	Ki	nM	63095.73	CHEMBL4722	Homo sapiens	pKi		4.2
inactive	9578510	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Cn1c(NCC(N)Cc2ccccc2)nc(-c2ccncc2)c(-c2ccc3ccccc3c2)c1=O		CHEMBL1990496	<	Ki	nM	3162.28	CHEMBL4722	Homo sapiens	pKi		5.5
active	9578511	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	O=C(O)c1ccccc1Nc1ccnc(Nc2ccc([N+](=O)[O-])cc2)n1		CHEMBL242865	=	Ki	nM	79.43	CHEMBL4722	Homo sapiens	pKi		7.1
active	9578512	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Nc1n[nH]c2cc(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)ccc12		CHEMBL1997623	=	Ki	nM	501.19	CHEMBL4722	Homo sapiens	pKi		6.3
active	9578513	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Cc1ccc(-c2nc3ccc(Br)cc3c(C(=O)O)c2CC(=O)O)cc1		CHEMBL1978973	=	Ki	nM	79.43	CHEMBL4722	Homo sapiens	pKi		7.1
inactive	9578514	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	CC(=NNC(=N)N)c1cc(NC(=O)NCCCN(C)CCCNC(=O)Nc2cc(C(C)=NNC(=N)N)cc(C(C)=NNC(=N)N)c2)cc(C(C)=NNC(=N)N)c1		CHEMBL1993166	<	Ki	nM	6309.57	CHEMBL4722	Homo sapiens	pKi		5.2
active	9578515	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	O=C(NCc1ccc(Cl)cc1)c1cc2c(-c3ccccc3)n[nH]c2s1		CHEMBL1967094	=	Ki	nM	100.0	CHEMBL4722	Homo sapiens	pKi		7.0
inactive	9578516	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	O=C(NC(CO)c1cc(Cl)cc(Cl)c1)c1ccc(-c2ccncc2)cc1		CHEMBL2003341	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
active	9578517	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Cc1ccc(C)c(NC(=O)Nc2ccc(-c3c(C)sc4ncnc(N)c34)cc2)c1		CHEMBL2000137	=	Ki	nM	251.19	CHEMBL4722	Homo sapiens	pKi		6.6
inactive	9578518	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	COc1cccc(S(=O)(=O)Nc2ccc3c(c2)C(=NO)c2ccccc2-3)c1		CHEMBL1971271	<	Ki	nM	1995.26	CHEMBL4722	Homo sapiens	pKi		5.7
active	9578519	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	c1ccc(-c2n[nH]cc2-c2ccncc2)cc1		CHEMBL1992644	=	Ki	nM	6309.57	CHEMBL4722	Homo sapiens	pKi		5.2
active	9578520	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	O=C(NS(=O)(=O)c1ccc(NCCSc2ccc(O)cc2)c([N+](=O)[O-])c1)c1ccc(-c2ccc(F)cc2)cc1		CHEMBL1992645	=	Ki	nM	199.53	CHEMBL4722	Homo sapiens	pKi		6.7
active	9578521	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	COc1cc(-c2ccc3c(c2)Nc2cc(OCCCCO)c(OC)cc2NC3=O)ccc1O		CHEMBL2000746	=	Ki	nM	1258.93	CHEMBL4722	Homo sapiens	pKi		5.9
inactive	9578522	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Oc1cccc(Nc2ncnc3scc(Cl)c23)c1		CHEMBL1982992	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
inactive	9578523	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	[2H]C([2H])([2H])Oc1cccc(C(C)NC(=O)c2sc(-c3ccncc3)nc2C)c1		CHEMBL1998110	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
inactive	9578524	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Cc1cc(-c2ccccc2)n(-c2cc(NN=Cc3ccco3)ncn2)n1		CHEMBL1999590	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
active	9578525	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#CCCCCCCCCN)cnc(N)c34)cc2)c1		CHEMBL1978166	=	Ki	nM	199.53	CHEMBL4722	Homo sapiens	pKi		6.7
inactive	9578526	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	O=c1c(NCc2ccc(Cl)cc2)c(Nc2ccncc2)c1=O		CHEMBL1980489	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
active	9578527	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	COc1cc(-c2ccc3c(c2)Nc2ccc(C(=O)NCc4cccc(F)c4)cc2NC3=O)ccc1O		CHEMBL2000832	=	Ki	nM	1000.0	CHEMBL4722	Homo sapiens	pKi		6.0
active	9578528	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(C)c5)cnc(N)c34)cc2)c1		CHEMBL1967116	=	Ki	nM	6.31	CHEMBL4722	Homo sapiens	pKi		8.2
active	9578529	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	CC(=O)n1ncc2cc(N)ccc21		CHEMBL1972454	=	Ki	nM	63095.73	CHEMBL4722	Homo sapiens	pKi		4.2
inactive	9578530	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Cc1cc(O)nc2[nH]nc(-c3cccc(-c4ccc(Cl)cc4)c3)c12		CHEMBL1990590	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
inactive	9578531	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Cc1nn(C)c2c1c(=O)c1cc(Cl)ccc1n2OCC(C)C		CHEMBL1977814	<	Ki	nM	3981.07	CHEMBL4722	Homo sapiens	pKi		5.4
active	9578532	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	O=C1Nc2ccccc2C1=Cc1ccc[nH]1		CHEMBL1996176	=	Ki	nM	1000.0	CHEMBL4722	Homo sapiens	pKi		6.0
inactive	9578533	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	O=C(NCc1ccc(Br)cc1)Nc1ccc2[nH]ncc2c1		CHEMBL1970709	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
active	9578534	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	OCc1cc(-c2ccc3[nH]ncc3c2)on1		CHEMBL1974617	=	Ki	nM	15848.93	CHEMBL4722	Homo sapiens	pKi		4.8
inactive	9578535	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	NC(=O)c1cc(-c2ccnc(N)n2)[nH]c1-c1ccc(Cl)cc1Cl		CHEMBL1965660	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
active	9578536	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	COc1cc(Nc2ncnc(N3CCCc4cc(C)ccc43)n2)cc(OC)c1OC		CHEMBL1992125	=	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
active	9578537	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	COc1ccc(-c2cc3nccn3c(Nc3ccccc3C(N)=O)n2)cc1OC		CHEMBL1998112	=	Ki	nM	39.81	CHEMBL4722	Homo sapiens	pKi		7.4
inactive	9578538	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	CC(C)n1nnc2ccc(-c3c(-c4ccc(F)cc4F)nc4occn34)cc21		CHEMBL1969126	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
active	9578539	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	COc1cc(Nc2ncc(C(F)(F)F)c(N)n2)cc(OC)c1OC		CHEMBL1998724	=	Ki	nM	199.53	CHEMBL4722	Homo sapiens	pKi		6.7
active	9578540	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Nc1ncnc2sc(Br)c(-c3ccc(NC(=O)Cc4cccc(Cl)c4)cc3)c12		CHEMBL1980896	=	Ki	nM	501.19	CHEMBL4722	Homo sapiens	pKi		6.3
active	9578541	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	CC(C)(C)c1ccc2nc(-c3n[nH]c4ccccc34)[nH]c2c1		CHEMBL1970104	=	Ki	nM	125.89	CHEMBL4722	Homo sapiens	pKi		6.9
active	9578542	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	O=C(Cc1ccccc1)Nc1cccc(-c2nc3sccn3c2-c2ccnc(Nc3cccc(N4CCCC4=O)c3)n2)c1		CHEMBL1991429	=	Ki	nM	63.1	CHEMBL4722	Homo sapiens	pKi		7.2
inactive	9578543	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Cc1nccn2c(-c3ccnc(NCC(C)(C)C(=O)O)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL1971149	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
inactive	9578544	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Cc1ccc2c(c1)NC(=O)c1ccccc1N2		CHEMBL1999714	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
inactive	9578545	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	O=C(Cc1ccccc1Cl)Nc1ccc2cn[nH]c2c1		CHEMBL1987533	<	Ki	nM	3981.07	CHEMBL4722	Homo sapiens	pKi		5.4
active	9578546	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	COc1ccc(-c2cc(-c3ccccc3)c3cc(Cl)ccc3n2)cc1		CHEMBL1979749	=	Ki	nM	50.12	CHEMBL4722	Homo sapiens	pKi		7.3
inactive	9578547	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	CC(C)(O)CNc1nccc(-c2c(-c3ccc(F)cc3F)nc3c(CC4CC4)nccn23)n1		CHEMBL1994040	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
active	9578548	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	CNC1CC2OC(C)(C1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL1980995	=	Ki	nM	2.512	CHEMBL4722	Homo sapiens	pKi		8.6
active	9578549	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	O=C(Nc1cccc(-c2nn3ccccc3c2-c2ccnc(Nc3ccc4c(c3)CNCC4)n2)c1)c1c(F)cccc1F		CHEMBL1969834	=	Ki	nM	199.53	CHEMBL4722	Homo sapiens	pKi		6.7
inactive	9578550	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	NC(COc1cncc(-c2ccc3c(c2)CC(=O)N3)c1)Cc1c[nH]c2ccccc12		CHEMBL1967302	<	Ki	nM	3981.07	CHEMBL4722	Homo sapiens	pKi		5.4
inactive	9578551	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	N#Cc1ccc(-c2n[nH]c3c2Cc2ccc(OCCCCN4CCOCC4)cc2-3)cn1		CHEMBL398951	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
inactive	9578552	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	COc1cc2cnc3c(c2cc1OC)C(=O)NC3=O		CHEMBL1982506	<	Ki	nM	1258.93	CHEMBL4722	Homo sapiens	pKi		5.9
active	9578553	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	CCN(CC)CCNC(=O)C=Cc1cnc(N)c2c(-c3ccc(NC(=O)Nc4cccc(C)c4)cc3)csc12		CHEMBL2004716	=	Ki	nM	12.59	CHEMBL4722	Homo sapiens	pKi		7.9
inactive	9578554	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	CN(C)CC(C)(C)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3occn23)n1		CHEMBL1968127	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
active	9578555	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	COc1cc(C)c(Cl)cc1NC(=O)Nc1cnc(C#N)cn1		CHEMBL1975233	=	Ki	nM	3981.07	CHEMBL4722	Homo sapiens	pKi		5.4
inactive	9578556	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	CCCC(=O)Nc1n[nH]c2ccc(-c3cccc(F)c3F)cc12		CHEMBL1985406	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
inactive	9578557	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Cn1nc(C(F)(F)F)c2c(=O)c3cc(Cl)ccc3n(O)c21		CHEMBL207400	<	Ki	nM	3981.07	CHEMBL4722	Homo sapiens	pKi		5.4
inactive	9578558	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Cc1cc(O)ccc1-n1cc(C(=O)NN)c(=O)c2ccc(-c3ccncc3)cc21		CHEMBL2000894	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
active	9578559	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	O=C(Cc1cccs1)Nc1nc2ccccc2s1		CHEMBL1421720	=	Ki	nM	398.11	CHEMBL4722	Homo sapiens	pKi		6.4
active	9578560	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Nc1nnc2cncc(Cl)n12		CHEMBL1968130	=	Ki	nM	31622.78	CHEMBL4722	Homo sapiens	pKi		4.5
active	9578561	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Cc1ccccc1NC(=O)Nc1ccc2c(c1)CCc1sc3ncnc(N)c3c1-2		CHEMBL1982135	=	Ki	nM	398.11	CHEMBL4722	Homo sapiens	pKi		6.4
active	9578562	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Nc1ncnc2c1sc1ncnc(N)c12		CHEMBL1976090	=	Ki	nM	501.19	CHEMBL4722	Homo sapiens	pKi		6.3
inactive	9578563	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	CNC(=O)C=Cc1cnc(N)c2c(-c3ccc4c(c3)OCO4)csc12		CHEMBL1993243	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
inactive	9578564	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	OCC(CO)Nc1ncnc2[nH]cc(-c3ccccc3)c12		CHEMBL1992922	<	Ki	nM	1995.26	CHEMBL4722	Homo sapiens	pKi		5.7
active	9578565	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Nc1ncnc2c1c(-c1cccc(OCc3ccccc3)c1)cn2C1CC(CN2CCCC2)C1		CHEMBL1988370	=	Ki	nM	3981.07	CHEMBL4722	Homo sapiens	pKi		5.4
inactive	9578566	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	CCS(=O)(=O)Nc1ccc(-c2ccc3[nH]nc(N)c3c2)cc1		CHEMBL1997597	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
inactive	9578567	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	S=c1[nH]nc2c3c4c(sc3n3c(=S)[nH]nc3n12)CCC4		CHEMBL1969537	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
active	9578568	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	NC(=NO)c1ccccc1S(=O)(=O)Nc1ccc2c(c1)C(=NO)c1ccccc1-2		CHEMBL1996539	=	Ki	nM	630.96	CHEMBL4722	Homo sapiens	pKi		6.2
inactive	9578569	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	CN(C)CC(C)(C)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3cnccn23)n1		CHEMBL1976093	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
inactive	9578570	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	NC(COc1cncc(-c2ccc(F)cc2)c1)Cc1c[nH]c2ccccc12		CHEMBL1996543	<	Ki	nM	6309.57	CHEMBL4722	Homo sapiens	pKi		5.2
active	9578571	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Nc1nonc1-n1nnc(C(=O)NN=Cc2cccs2)c1-c1cccs1		CHEMBL1975256	=	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
active	9578572	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Cc1cccc(NC(=O)Nc2ccc(-c3cnc4c(-c5cnn(C)c5)cnn4c3N)cc2)c1		CHEMBL508928	=	Ki	nM	79.43	CHEMBL4722	Homo sapiens	pKi		7.1
inactive	9578573	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	CS(=O)(=O)Nc1ccc(-c2ccc3[nH]nc(N)c3c2)cc1		CHEMBL2004892	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
active	9578574	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	O=c1[nH]cnc2c(Cl)cccc12		CHEMBL1949855	=	Ki	nM	10000.0	CHEMBL4722	Homo sapiens	pKi		5.0
inactive	9578575	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	NC(=O)c1cc2c(Oc3ccc(Br)cc3)cncc2s1		CHEMBL116070	<	Ki	nM	5011.87	CHEMBL4722	Homo sapiens	pKi		5.3
inactive	9578576	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	NC(=O)c1cc(-c2cccc(N)c2)cc2cccnc12		CHEMBL1970314	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
active	9578577	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Cc1cccc(Nc2nccc(Nc3ccccc3C(=O)O)n2)c1		CHEMBL243517	=	Ki	nM	6.31	CHEMBL4722	Homo sapiens	pKi		8.2
inactive	9578578	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	OCCCn1cnc(-c2ccc(F)cc2)c1-c1ccncc1		CHEMBL2004871	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
inactive	9578579	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	O=C1Nc2ccccc2Nc2ccccc21		CHEMBL1727312	<	Ki	nM	31622.78	CHEMBL4722	Homo sapiens	pKi		4.5
inactive	9578580	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	CC1CCN(C(=O)CO)CC1N(C)c1ncnc2[nH]ccc12		CHEMBL1969879	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
active	9578581	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	O=C(O)c1ccccc1Nc1nc(Nc2ccccc2)ncc1F		CHEMBL244793	=	Ki	nM	2.512	CHEMBL4722	Homo sapiens	pKi		8.6
active	9578582	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	O=S(=O)(Nc1ccc2c(c1)C(=NO)c1ccccc1-2)c1cccc(F)c1		CHEMBL1987658	=	Ki	nM	501.19	CHEMBL4722	Homo sapiens	pKi		6.3
inactive	9578583	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	CC(C)(c1cc(Br)c(O)c(I)c1)c1cc(Br)c(O)c(I)c1		CHEMBL1964382	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
inactive	9578584	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	CN(C)CC(O)COc1ccc(Nc2nccc(Nc3cc(Cl)ccc3Cl)n2)cc1		CHEMBL101311	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
inactive	9578585	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	O=C(Nc1cnccn1)Nc1ccnc2ccccc12		CHEMBL1981720	<	Ki	nM	3162.28	CHEMBL4722	Homo sapiens	pKi		5.5
inactive	9578586	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	CC(N)COc1cnc(Cl)c(C=Cc2ccncc2)c1		CHEMBL1993548	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
active	9578587	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3nsc4ncnc(N)c34)cc2)c1		CHEMBL262433	=	Ki	nM	199.53	CHEMBL4722	Homo sapiens	pKi		6.7
inactive	9578588	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Cc1ccc(-c2nn(C(C)(C)C)c3ncnc(N)c23)cc1		CHEMBL306380	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
active	9578589	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	O=C(NNC(=S)Nc1ccc(Cl)cc1)C(O)(c1ccccc1)c1ccccc1		CHEMBL1966722	=	Ki	nM	794.33	CHEMBL4722	Homo sapiens	pKi		6.1
active	9578590	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Cc1cc(=O)n2ccc(CN(C)C)c(O)c2n1		CHEMBL1988581	=	Ki	nM	39.81	CHEMBL4722	Homo sapiens	pKi		7.4
inactive	9578591	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	CC(C)(C)c1cc(NC(=O)C(=O)c2cccc3ccccc23)n(-c2ccc(OCC(=O)O)cc2)n1		CHEMBL2005699	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
inactive	9578592	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	COc1cc(-c2ccc3c(c2)Nc2ccc(C(=O)NCCNC(C)=O)cc2NC3=O)ccc1O		CHEMBL1975500	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
active	9578593	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Cc1cc(C)cc(NC(=O)Nc2ccc(-c3cccc4snc(N)c34)cc2)c1		CHEMBL1976328	=	Ki	nM	794.33	CHEMBL4722	Homo sapiens	pKi		6.1
active	9578594	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4ccnc(N)c34)cc2)c1		CHEMBL394619	=	Ki	nM	316.23	CHEMBL4722	Homo sapiens	pKi		6.5
active	9578595	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	CCN(C(C)=O)c1ccc(Nc2nc(NC3CC3)c3nc[nH]c3n2)cc1		CHEMBL2006564	=	Ki	nM	158.49	CHEMBL4722	Homo sapiens	pKi		6.8
active	9578596	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	COc1ccc(Nc2nccc(Nc3c(NC(C)C(C)(C)C)c(=O)c3=O)n2)cc1OC		CHEMBL1964399	=	Ki	nM	39.81	CHEMBL4722	Homo sapiens	pKi		7.4
inactive	9578597	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	O=C(O)c1c2c(nc3ccccc13)C(=C1CCCC1)CC2		CHEMBL1996831	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
active	9578598	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Nc1ncnc2c1N=C(c1ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)cc1)CCN2		CHEMBL411903	=	Ki	nM	25.12	CHEMBL4722	Homo sapiens	pKi		7.6
active	9578599	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Cn1cc(-c2cc3nc(Br)cnc3[nH]2)c2ccccc21		CHEMBL1978167	=	Ki	nM	100.0	CHEMBL4722	Homo sapiens	pKi		7.0
active	9578600	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#CCN)cnc(N)c34)cc2)c1		CHEMBL1965988	=	Ki	nM	63.1	CHEMBL4722	Homo sapiens	pKi		7.2
inactive	9578601	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	CN1CCC(c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)C(O)C1		CHEMBL422897	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
inactive	9578602	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Cc1c(-c2ccc3[nH]nc(N)c3c2)nnn1Cc1ccccc1		CHEMBL1989646	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
active	9578603	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	c1ccc(Cc2cc(-c3ccc4[nH]ncc4c3)on2)cc1		CHEMBL1682357	=	Ki	nM	501.19	CHEMBL4722	Homo sapiens	pKi		6.3
inactive	9578604	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	O=C1NCCc2[nH]c(-c3ccncc3)cc21		CHEMBL225519	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
inactive	9578605	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	CCOc1nc(C(=O)NCc2cccnc2)cc(N)c1C#N		CHEMBL209534	<	Ki	nM	6309.57	CHEMBL4722	Homo sapiens	pKi		5.2
inactive	9578606	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Cc1nccn2c(-c3ccnc(NCCC(C)(C)O)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL1978200	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
inactive	9578607	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	<	Ki	nM	1000.0	CHEMBL4722	Homo sapiens	pKi		6.0
active	9578608	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	CC(=O)c1cccc(-c2ccc3nccn3n2)c1		CHEMBL1994159	=	Ki	nM	50118.72	CHEMBL4722	Homo sapiens	pKi		4.3
inactive	9578609	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	COc1cc(C=C2SC(=Nc3ccccc3)NC2=O)ccc1O		CHEMBL1970522	<	Ki	nM	3162.28	CHEMBL4722	Homo sapiens	pKi		5.5
inactive	9578610	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	C(=Cc1cncc(OC2CCNC2)c1)c1ccncc1		CHEMBL1966087	<	Ki	nM	3981.07	CHEMBL4722	Homo sapiens	pKi		5.4
inactive	9578611	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Cn1nc(N)c2c(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)cncc21		CHEMBL1964692	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
inactive	9578612	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	O=C(NC(CO)Cc1ccc(Cl)cc1)c1ccc(-c2ccncc2)cc1		CHEMBL1996931	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
inactive	9578613	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	FC(F)(F)c1ccc(Cn2cc(-c3ccc4[nH]ncc4c3)nn2)c(C(F)(F)F)c1		CHEMBL1964413	<	Ki	nM	3981.07	CHEMBL4722	Homo sapiens	pKi		5.4
inactive	9578614	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	O=C(Nc1cccc(C(F)(F)F)n1)Nc1ccnc2cc(C(F)(F)F)ccc12		CHEMBL1973483	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
inactive	9578615	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	CCCC(=O)Nc1cc(-c2c[nH]c3ncccc23)cc(Cl)n1		CHEMBL1998470	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
active	9578616	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Cc1ccc(Cn2cc(-c3ccc4[nH]ncc4c3)nn2)c(C)c1		CHEMBL1984432	=	Ki	nM	794.33	CHEMBL4722	Homo sapiens	pKi		6.1
active	9578617	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Nc1n[nH]c2cccc(-c3ccc(NC(=O)Nc4ccccc4)cc3)c12		CHEMBL219722	=	Ki	nM	398.11	CHEMBL4722	Homo sapiens	pKi		6.4
active	9578618	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	COc1ccccc1-c1ccnc(Nc2cccc(S(C)(=O)=O)c2)n1		CHEMBL1975903	=	Ki	nM	398.11	CHEMBL4722	Homo sapiens	pKi		6.4
inactive	9578619	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	O=C(c1cc(-c2ccc3[nH]ncc3c2)on1)N1CCCC(O)C1		CHEMBL1997340	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
inactive	9578620	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	COc1cccc(Nc2ncnc3ccccc23)c1		CHEMBL117697	<	Ki	nM	31622.78	CHEMBL4722	Homo sapiens	pKi		4.5
active	9578621	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Cc1nc(N)sc1-c1ccnc(Nc2ccc(N3CCOCC3)cc2)n1		CHEMBL482967	=	Ki	nM	31.62	CHEMBL4722	Homo sapiens	pKi		7.5
inactive	9578622	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Cn1cc(-c2ccncn2)c(-c2ccc(F)cc2)n1		CHEMBL1989474	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
active	9578623	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	O=C(Cc1ccccc1)Nc1cccc(-c2nc3sccn3c2-c2ccnc(Nc3cccc(N4CCOCC4)c3)n2)c1		CHEMBL1090360	=	Ki	nM	100.0	CHEMBL4722	Homo sapiens	pKi		7.0
inactive	9578624	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	O=C(Nc1nc2ccccc2n1CCCO)c1cccc([N+](=O)[O-])c1		CHEMBL210887	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
active	9578625	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	CNC(=O)c1ccccc1Nc1nc(Nc2ccc(N3CCOCC3)cc2OC)ncc1Cl		CHEMBL458997	=	Ki	nM	39.81	CHEMBL4722	Homo sapiens	pKi		7.4
inactive	9578626	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Cc1cc(C)cc(NC(=O)Nc2ccc(-c3cccc4c3CNC4=O)c(C(F)(F)F)c2)c1		CHEMBL1971021	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
inactive	9578627	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Cc1n[nH]c2ccc(-c3cncc(OCC(N)Cc4cccc(OC(F)(F)F)c4)c3)cc12		CHEMBL1965836	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
active	9578628	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	O=c1[nH]cnc2c1sc1c(Cl)ccc(Cl)c12		CHEMBL583144	=	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
inactive	9578629	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	NC(=O)c1cc2c(-c3ccc(F)cc3)cncc2s1		CHEMBL1974310	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
active	9578630	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	O=C(Nc1ccc(-c2ccc3cn[nH]c3c2)cc1)Nc1cccc(F)c1		CHEMBL1969942	=	Ki	nM	251.19	CHEMBL4722	Homo sapiens	pKi		6.6
inactive	9578631	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	COc1cccc(C(C)NC(=O)c2sc(-c3ccncc3)nc2C)c1		CHEMBL1978567	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
active	9578632	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Nc1ncnc2sc3c(c12)-c1ccc(NC(=O)Nc2ccccc2)cc1CC3		CHEMBL1994693	=	Ki	nM	39.81	CHEMBL4722	Homo sapiens	pKi		7.4
active	9578633	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	NC(=O)c1cccc(-c2cnc3[nH]cc(-c4ccccc4)c3c2)c1		CHEMBL1982957	=	Ki	nM	316.23	CHEMBL4722	Homo sapiens	pKi		6.5
inactive	9578634	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	O=C1Nc2ccccc2C1=Cc1ccc[nH]1		CHEMBL1996176	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
inactive	9578635	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	O=C(NNC(=S)Nc1ccc(F)cc1)C(O)(c1ccccc1)c1ccccc1		CHEMBL1975138	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
inactive	9578636	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	CCOc1nc(C(=O)NCc2ccc(S(C)(=O)=O)cc2)cc(N)c1C#N		CHEMBL424872	<	Ki	nM	3162.28	CHEMBL4722	Homo sapiens	pKi		5.5
inactive	9578637	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	CC1=NN(c2ccc(C(=O)O)cc2)C(=O)C1=Cc1c(C)c(C#N)c2nc3ccccc3n2c1O		CHEMBL2006836	<	Ki	nM	3981.07	CHEMBL4722	Homo sapiens	pKi		5.4
active	9578638	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#Cc5cccnc5)cnc(N)c34)cc2)c1		CHEMBL1971947	=	Ki	nM	199.53	CHEMBL4722	Homo sapiens	pKi		6.7
inactive	9578639	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Cc1c[nH]c(-c2cnc(NCCNc3ccc(C#N)cn3)nc2-c2ccc(Cl)cc2Cl)n1		CHEMBL412142	<	Ki	nM	3162.28	CHEMBL4722	Homo sapiens	pKi		5.5
inactive	9578640	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	<	Ki	nM	3162.28	CHEMBL4722	Homo sapiens	pKi		5.5
inactive	9578641	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Cc1cc2nnc(SCc3cn4ccccc4n3)n2c2ccccc12		CHEMBL1980704	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
inactive	9578642	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	NC(=O)c1sc2ccc(Cl)c(Cl)c2c1NC(=O)c1ccc(Cl)cc1		CHEMBL2003271	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
inactive	9578643	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	O=c1[nH]c2sc3c(c2c2nc(-c4ccncc4)nn12)CCCC3		CHEMBL1966808	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
inactive	9578644	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	CCN(CC)CCOc1ccc(Nc2ncc3cc(-c4c(Cl)cccc4Cl)c(=O)n(C)c3n2)cc1		CHEMBL49120	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
inactive	9578645	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	CC(C)(C)c1n[nH]c2c1C(c1ccccc1F)C(C#N)=C(N)O2		CHEMBL2004447	<	Ki	nM	3981.07	CHEMBL4722	Homo sapiens	pKi		5.4
active	9578646	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	CC(=O)NCC(=O)N1C2CCC1c1cc(Nc3ncc(C(F)(F)F)c(NC4CCC4)n3)ccc12		CHEMBL1983111	=	Ki	nM	3.981	CHEMBL4722	Homo sapiens	pKi		8.4
inactive	9578647	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	OCCNc1cc2cc(-c3ccsc3)ccc2cn1		CHEMBL1973860	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
inactive	9578648	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Nc1n[nH]c2nnc(-c3ccccc3)c(-c3ccccc3)c12		CHEMBL260135	<	Ki	nM	3981.07	CHEMBL4722	Homo sapiens	pKi		5.4
active	9578649	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc21		CHEMBL220241	=	Ki	nM	501.19	CHEMBL4722	Homo sapiens	pKi		6.3
active	9578650	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	CCC(=O)Nc1ccc(C(=O)N2CCNCC2)c(O)c1		CHEMBL1988141	=	Ki	nM	158.49	CHEMBL4722	Homo sapiens	pKi		6.8
inactive	9578651	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	O=c1[nH]cc(I)c2nc(-c3cccc(Cl)c3)cn12		CHEMBL1982610	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
inactive	9578652	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Nc1c(-c2ccc(NC(=O)Nc3cccc(C(F)(F)F)c3)cc2)cnc2c(-c3ccc4c(c3)OCO4)cnn12		CHEMBL1977134	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
active	9578653	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	O=C1NC(=S)NC(=O)C1=Cc1ccc(-c2ccc(C(=O)O)c(O)c2)o1		CHEMBL496412	=	Ki	nM	125.89	CHEMBL4722	Homo sapiens	pKi		6.9
active	9578654	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	CN(C)c1ncnc2[nH]ncc12		CHEMBL1969787	=	Ki	nM	12589.25	CHEMBL4722	Homo sapiens	pKi		4.9
inactive	9578655	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Cc1cccc(C2(c3cccc(C)c3)CC2C(=O)Nc2ccncc2)c1		CHEMBL1999496	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
inactive	9578656	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Cc1ccc2c(c1)C(=O)Nc1ccccc1N2		CHEMBL1970873	<	Ki	nM	31622.78	CHEMBL4722	Homo sapiens	pKi		4.5
active	9578657	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	CSc1cnc2c(ccc3cnccc32)c1O		CHEMBL2006933	=	Ki	nM	794.33	CHEMBL4722	Homo sapiens	pKi		6.1
inactive	9578658	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	COCC#Cc1cccc2c1Cc1c(-c3cccs3)n[nH]c1-2		CHEMBL1985206	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
active	9578659	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Nc1ccc(-c2csc3c(C=Cc4nc5ccccc5[nH]4)cnc(N)c23)cc1		CHEMBL1988300	=	Ki	nM	1000.0	CHEMBL4722	Homo sapiens	pKi		6.0
active	9578660	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	COc1ccc(C(=O)Nc2n[nH]c3ccc(-c4cn(Cc5ccccc5)nn4)cc23)cc1OC		CHEMBL1991078	=	Ki	nM	398.11	CHEMBL4722	Homo sapiens	pKi		6.4
inactive	9578661	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	O=C1Nc2ccccc2Nc2cc(-c3ccccc3O)ccc21		CHEMBL1974365	<	Ki	nM	1995.26	CHEMBL4722	Homo sapiens	pKi		5.7
active	9578662	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	C=CCc1cccc2c(=NO)cc(-c3ccccc3)oc12		CHEMBL1977749	=	Ki	nM	794.33	CHEMBL4722	Homo sapiens	pKi		6.1
active	9582236	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Cc1cccc(NC(=O)Nc2ccc(-c3nn(C)c4ncnc(N)c34)cc2)c1		CHEMBL1982837	=	Ki	nM	39.81	CHEMBL4722	Homo sapiens	pKi		7.4
inactive	9582237	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Nc1ncnc2scc(-c3ccccc3)c12		CHEMBL1975212	<	Ki	nM	50118.72	CHEMBL4722	Homo sapiens	pKi		4.3
active	9582238	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	CC(=NNC(=N)N)c1cc(NC(=O)c2cccc(C(=O)Nc3cc(C(C)=NNC(=N)N)cc(C(C)=NNC(=N)N)c3)c2)cc(C(C)=NNC(=N)N)c1		CHEMBL2000685	=	Ki	nM	1258.93	CHEMBL4722	Homo sapiens	pKi		5.9
active	9582239	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	O=c1[nH][nH]c2ccc(Br)cc12		CHEMBL2001613	=	Ki	nM	7943.28	CHEMBL4722	Homo sapiens	pKi		5.1
inactive	9582240	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	CN1CCN(c2nc(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c3ccccc3n2)CC1		CHEMBL565612	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
inactive	9582241	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	NC(=O)c1cc2c(-c3ccc(Nc4nc5ccccc5o4)cc3)cnc(N)c2s1		CHEMBL1993904	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
inactive	9582242	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Cc1cccc(-c2cccc3onc(N)c23)c1		CHEMBL1980376	<	Ki	nM	63095.73	CHEMBL4722	Homo sapiens	pKi		4.2
inactive	9582243	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	O=C(Nc1cccc(C(F)(F)F)n1)Nc1ccnc2ccc(Cl)cc12		CHEMBL1967513	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
inactive	9582244	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Cc1cc(O)nc2[nH]nc(-c3cccc(-c4ccc(C#N)cc4)c3)c12		CHEMBL2000724	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
active	9582245	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Nc1n[nH]c2cccc(-c3ccc(NC(=O)Nc4cc(CO)ccc4F)cc3)c12		CHEMBL1985311	=	Ki	nM	398.11	CHEMBL4722	Homo sapiens	pKi		6.4
inactive	9582246	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	COc1ccc2c(NC(=O)Nc3cccc(C(F)(F)F)n3)ccnc2c1		CHEMBL1982660	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
inactive	9582247	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	CC1CSc2c(C(=O)O)c(=O)c3cc(F)c(N4CCC(N)C4)cc3n21		CHEMBL1989265	<	Ki	nM	3981.07	CHEMBL4722	Homo sapiens	pKi		5.4
inactive	9582248	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	CN(Cc1cc(Cl)c(O)c2ncccc12)C1CCCCC1		CHEMBL1982413	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
active	9582249	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	O=C1NN=Cc2c[nH]c3cc(NC(=O)C4CC4c4ccccc4)cc1c23		CHEMBL1969502	=	Ki	nM	501.19	CHEMBL4722	Homo sapiens	pKi		6.3
active	9582250	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Nc1ncnc2c1c(-c1cccc(OCc3ccccc3)c1)cn2C1CCC(N2CCCC2)CC1		CHEMBL1965910	=	Ki	nM	3162.28	CHEMBL4722	Homo sapiens	pKi		5.5
inactive	9582251	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	CC(C)Nc1c(-c2ccc3[nH]ncc3c2)nc2ncccn12		CHEMBL1682553	<	Ki	nM	3981.07	CHEMBL4722	Homo sapiens	pKi		5.4
inactive	9582252	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Cc1cccc(-c2c(-c3ccncc3)nc(NCC(N)Cc3ccccc3)n(C)c2=O)c1		CHEMBL1971430	<	Ki	nM	3162.28	CHEMBL4722	Homo sapiens	pKi		5.5
active	9582253	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Cc1cccc(NC(=O)Nc2ccc(-c3coc4ncnc(N)c34)cc2)c1		CHEMBL1983963	=	Ki	nM	50.12	CHEMBL4722	Homo sapiens	pKi		7.3
inactive	9582254	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	COc1ccc(C(=O)Nc2cnc3[nH]cc(-c4ccccc4)c3c2)cc1		CHEMBL1997764	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
active	9582255	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Cc1n[nH]c2ccc(-c3cncc(OCC(CN)Cc4ccccc4)c3)cc12		CHEMBL2000271	=	Ki	nM	1000.0	CHEMBL4722	Homo sapiens	pKi		6.0
active	9582256	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Cc1cc(=O)[nH]c2[nH]n(-c3ccccc3)c(=O)c12		CHEMBL1985042	=	Ki	nM	50118.72	CHEMBL4722	Homo sapiens	pKi		4.3
inactive	9582257	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	O=C(Nc1cccc(C(F)(F)F)n1)Nc1ccnc2cc(F)c(F)cc12		CHEMBL1981792	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
inactive	9582258	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	O=C(NCCc1cccs1)N1CC=C(c2c[nH]c3ncccc23)CC1		CHEMBL1987535	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
inactive	9582259	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	O=C(Nc1ccccc1)Nc1ccccc1		CHEMBL354676	<	Ki	nM	39810.72	CHEMBL4722	Homo sapiens	pKi		4.4
inactive	9582260	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Oc1ccc(-c2n[nH]c(Nc3cccc(Cl)c3)c2-c2ccc(O)cc2)cc1		CHEMBL1985092	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
inactive	9582261	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Nc1nonc1-n1nnc(C(=O)NN=Cc2cccs2)c1-c1ccccc1		CHEMBL2004692	<	Ki	nM	3981.07	CHEMBL4722	Homo sapiens	pKi		5.4
inactive	9582262	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	CNc1ncnc2c1N=C(c1ccc(NC(=O)Nc3cccc(C(F)(F)F)c3)cc1)CCN2		CHEMBL1981410	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
inactive	9582263	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Clc1cc(Nc2nc(NC3CC3)c3sccc3n2)ccc1N1CCOCC1		CHEMBL2002586	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
active	9582264	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	NC(=O)c1cc(-c2cccs2)n2nccc2n1		CHEMBL1987815	=	Ki	nM	63095.73	CHEMBL4722	Homo sapiens	pKi		4.2
inactive	9582265	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	CC1(O)CC(c2nc(-c3ccc4ccc(-c5ccccc5)nc4c3)c3c(N)nccn23)C1		CHEMBL1996234	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
inactive	9582266	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	NC(COc1cncc(-c2ccc3cnccc3c2)c1)Cc1c[nH]c2ccccc12		CHEMBL1981133	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
active	9582267	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	CC(C)Oc1cc(Nc2nc(NC(C)c3ccc(F)cn3)ncc2Cl)n[nH]1		CHEMBL2007421	=	Ki	nM	630.96	CHEMBL4722	Homo sapiens	pKi		6.2
inactive	9582268	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	COc1ccc(C=C2C(=O)ON=C2c2ccc(Br)cc2)cc1OC		CHEMBL1991434	<	Ki	nM	3981.07	CHEMBL4722	Homo sapiens	pKi		5.4
inactive	9582269	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	CN(C)c1cccc2c(S(=O)(=O)N(CCN)c3cncc(-c4ccc5cnccc5c4)c3)cccc12		CHEMBL1967544	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
inactive	9582270	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Cc1c(NC(=O)c2ccc(C(C)(C)C)cc2)cccc1-c1cc(Nc2ccc(C(=O)N3CCOCC3)cn2)c(=O)n(C)c1		CHEMBL1973138	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
inactive	9582271	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	N#Cc1ncc2nc1OCCCCCOc1cc(CCCO)c(Cl)cc1NC(=O)N2		CHEMBL223367	<	Ki	nM	3981.07	CHEMBL4722	Homo sapiens	pKi		5.4
active	9582272	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	O=c1[nH]c2ccc(Cl)cc2c2ncnn12		CHEMBL1992673	=	Ki	nM	15848.93	CHEMBL4722	Homo sapiens	pKi		4.8
active	9582273	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	CN1CCN(c2ccc(C(=O)Nc3n[nH]c4ccc(Cc5cc(F)cc(F)c5)cc34)c(NC3CCOCC3)c2)CC1		CHEMBL1983268	=	Ki	nM	251.19	CHEMBL4722	Homo sapiens	pKi		6.6
active	9582274	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	CN(C)c1ncnc2nc[nH]c12		CHEMBL407391	=	Ki	nM	3981.07	CHEMBL4722	Homo sapiens	pKi		5.4
inactive	9582275	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	NC(=O)c1cn(-c2ccc(O)cc2Cl)c2cc(-c3ccncc3)ccc2c1=O		CHEMBL340384	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
inactive	9582276	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	CN(C)C1CCC(Nc2nc(Cl)cc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL1969151	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
inactive	9582277	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	CC(C)(CO)c1nnc2ccc(-c3c(-c4ccc(F)cc4F)nc4n3CCC4)nn12		CHEMBL1996587	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
inactive	9582278	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	COC(=O)c1c(N)nc2ccccn12		CHEMBL1981492	<	Ki	nM	63095.73	CHEMBL4722	Homo sapiens	pKi		4.2
active	9582279	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Cn1cc(-c2cc3nc(Br)cnc3[nH]2)c2cc(F)ccc21		CHEMBL1993335	=	Ki	nM	50.12	CHEMBL4722	Homo sapiens	pKi		7.3
active	9582280	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	CC(C)NC1=NNC(=O)C1=Cc1cc2ccccc2[nH]1		CHEMBL1988692	=	Ki	nM	501.19	CHEMBL4722	Homo sapiens	pKi		6.3
inactive	9582281	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Nc1nc(Cl)cc(-c2c[nH]c3ncccc23)n1		CHEMBL2007574	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
inactive	9582282	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	CS(=O)(=O)NCCOc1cncc(-c2ccc3cnccc3c2)c1		CHEMBL1964804	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
active	9582283	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	COc1ccc(-c2cnc3c(Br)cnn3c2)cc1		CHEMBL443962	=	Ki	nM	199.53	CHEMBL4722	Homo sapiens	pKi		6.7
inactive	9582284	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	COc1ccc(C=C2SC(=Nc3ccccc3)NC2=O)cc1O		CHEMBL2000354	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
inactive	9582285	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL274064	<	Ki	nM	1995.26	CHEMBL4722	Homo sapiens	pKi		5.7
inactive	9582286	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	CCCC(=O)Nc1n[nH]c2nc3ccccc3cc12		CHEMBL1967564	<	Ki	nM	3981.07	CHEMBL4722	Homo sapiens	pKi		5.4
inactive	9582287	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	NCCCn1cc(-c2cc(-c3cc4ccccc4s3)c3[nH]ncc3c2)c2nc(N)ncc21		CHEMBL592030	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
active	9582288	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	OCCCNc1ncnc2[nH]cc(-c3ccccc3)c12		CHEMBL2000071	=	Ki	nM	794.33	CHEMBL4722	Homo sapiens	pKi		6.1
inactive	9582289	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	COc1ccc2c(NC(=O)Nc3cc(C(F)(F)F)ccn3)ccnc2c1		CHEMBL1979176	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
active	9582290	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Cn1cc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5cccc(F)c5)cc4)csc23)cn1		CHEMBL1970317	=	Ki	nM	3.981	CHEMBL4722	Homo sapiens	pKi		8.4
inactive	9582291	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Cc1cn2c(-c3ccnc(NCC(C)(C)CO)n3)c(-c3ccc(F)cc3F)nc2c(C)n1		CHEMBL2000408	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
inactive	9582292	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	N#Cc1ncc2nc1OCCCCOc1cc(NCc3cncs3)c(Cl)cc1NC(=O)N2		CHEMBL248757	<	Ki	nM	1995.26	CHEMBL4722	Homo sapiens	pKi		5.7
inactive	9582293	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	CN1CCC(C(=O)n2nc(N)c3cc(-c4cn(Cc5ccccc5)nn4)ccc32)CC1		CHEMBL1978014	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
active	9582294	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	CCCNC(=O)c1ccc(Nc2nc(CC)c3cc[nH]c3n2)cc1		CHEMBL1997007	=	Ki	nM	1258.93	CHEMBL4722	Homo sapiens	pKi		5.9
inactive	9582295	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	O=C(Nc1cnccn1)Nc1ccnc2c(C(F)(F)F)cccc12		CHEMBL1994538	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
active	9582296	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	CCc1cccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(C)c5)cnc(N)c34)cc2)c1		CHEMBL1990228	=	Ki	nM	7.943	CHEMBL4722	Homo sapiens	pKi		8.1
inactive	9582297	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	O=C(Nc1nc2c(O)cccc2s1)Nc1ccccc1-c1ccccc1		CHEMBL2002690	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
active	9582298	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	CCOC(=O)C(C(N)=O)C(=S)Nc1ccc(C)cc1		CHEMBL1984131	=	Ki	nM	50.12	CHEMBL4722	Homo sapiens	pKi		7.3
inactive	9582299	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	CC(=O)Nc1cc(N)c(C#N)c(-c2ccsc2)n1		CHEMBL2006567	<	Ki	nM	6309.57	CHEMBL4722	Homo sapiens	pKi		5.2
inactive	9582300	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Clc1csc2ncnc(Nc3ccccc3)c12		CHEMBL1986139	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
inactive	9582301	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Nc1ccc(-c2cccn3c(=O)[nH]nc23)cc1		CHEMBL1975503	<	Ki	nM	63095.73	CHEMBL4722	Homo sapiens	pKi		4.2
inactive	9582302	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	NC(Cc1cccc2ccccc12)C(=O)Nc1cncc(C=Cc2ccncc2)c1		CHEMBL1985580	<	Ki	nM	6309.57	CHEMBL4722	Homo sapiens	pKi		5.2
inactive	9582303	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
active	9582304	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#CCN(C)C)cnc(N)c34)cc2)c1		CHEMBL1979883	=	Ki	nM	31.62	CHEMBL4722	Homo sapiens	pKi		7.5
active	9582305	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Fc1cnc(Nc2ccccc2)nc1Nc1ccccc1		CHEMBL491758	=	Ki	nM	25.12	CHEMBL4722	Homo sapiens	pKi		7.6
active	9582306	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Nc1ccc(S(=O)(=O)O)c2cccc(O)c12		CHEMBL1618860	=	Ki	nM	79.43	CHEMBL4722	Homo sapiens	pKi		7.1
inactive	9582307	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	O=C1Nc2ccccc2C1=Cc1c[nH]c2ccccc12		CHEMBL1986590	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
inactive	9582308	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	CC(Nc1c(Nc2ccncc2)c(=O)c1=O)C(C)(C)C		CHEMBL1986186	<	Ki	nM	5011.87	CHEMBL4722	Homo sapiens	pKi		5.3
active	9582309	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	c1cc2[nH]ncc2cc1-c1cc(CN2CCCCC2)no1		CHEMBL1682360	=	Ki	nM	2511.89	CHEMBL4722	Homo sapiens	pKi		5.6
inactive	9582310	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Cc1n[nH]c2c1C(c1ccccc1Cl)C(C#N)=C(N)O2		CHEMBL1970189	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
inactive	9582311	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CCC(N)C3)c21		CHEMBL1870106	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
inactive	9582312	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Nc1ncnc2c1c(I)nn2C1CCC(O)CC1		CHEMBL1996791	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
active	9582313	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Cc1cc(C)cc(NC(=O)Nc2ccc(-c3c(C)sc4ncnc(N)c34)cc2)c1		CHEMBL371206	=	Ki	nM	25.12	CHEMBL4722	Homo sapiens	pKi		7.6
inactive	9582314	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	COc1ccc(C=NNc2ncnc3c2[nH]c2ccccc23)cc1OC		CHEMBL1974664	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
inactive	9582315	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	CC(C)(C)n1nc(-c2ccc(Cl)cc2)c2c(N)ncnc21		CHEMBL406845	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
active	9582316	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	CC(C)(C)c1ccc2nc(-c3n[nH]c4ccccc34)[nH]c2c1		CHEMBL1970104	=	Ki	nM	125.89	CHEMBL4722	Homo sapiens	pKi		6.9
inactive	9582317	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	c1ccc(-c2ccnc3[nH]ccc23)cc1		CHEMBL482538	<	Ki	nM	63095.73	CHEMBL4722	Homo sapiens	pKi		4.2
inactive	9582318	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	O=C(NC(CO)c1ccccc1)c1ccc(-c2ccncc2)cc1		CHEMBL1974288	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
active	9582319	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Cc1ccc(C)c(NC(=O)c2cc(-c3ccco3)nc3ccccc23)c1		CHEMBL1984296	=	Ki	nM	1000.0	CHEMBL4722	Homo sapiens	pKi		6.0
active	9582320	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4ncnc(N)c34)cc2)c1		CHEMBL196363	=	Ki	nM	19.95	CHEMBL4722	Homo sapiens	pKi		7.7
inactive	9582321	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Cc1nn(C)c2sc(C(N)=O)c(N)c12		CHEMBL1996837	<	Ki	nM	63095.73	CHEMBL4722	Homo sapiens	pKi		4.2
inactive	9582322	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	COc1ccc(-c2cc3nccn3c(Nc3ncccc3C(N)=O)n2)cc1OC		CHEMBL1190711	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
active	9582323	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Nc1n[nH]c2cccc(-c3ccc(Br)cc3)c12		CHEMBL1990346	=	Ki	nM	1000.0	CHEMBL4722	Homo sapiens	pKi		6.0
active	9582324	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	CC1=CN2CC(=O)NN=C2C=C1		CHEMBL1964718	=	Ki	nM	31622.78	CHEMBL4722	Homo sapiens	pKi		4.5
inactive	9582325	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	CCCC(=O)Nc1cccc(-c2nc(Nc3ccc4[nH]ncc4c3)c3cc(OCCN4CCCC4)ccc3n2)c1		CHEMBL1968705	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
active	9582326	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	CNCC#Cc1cnc(N)c2c(-c3ccc(NC(=O)Nc4cccc(C)c4)cc3)csc12		CHEMBL1964441	=	Ki	nM	100.0	CHEMBL4722	Homo sapiens	pKi		7.0
inactive	9582327	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	O=C(Nc1cc(-c2c[nH]c3ncccc23)cc(Cl)n1)c1c(F)cccc1F		CHEMBL1991410	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
active	9582328	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Cc1cc(C(N)=O)n2nc(C(C)(C)C)cc2n1		CHEMBL1986684	=	Ki	nM	50118.72	CHEMBL4722	Homo sapiens	pKi		4.3
active	9582329	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	ON=C(c1nc2ccccc2[nH]1)c1nc2ccccc2[nH]1		CHEMBL546797	=	Ki	nM	1258.93	CHEMBL4722	Homo sapiens	pKi		5.9
active	9582330	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Cc1cccc(NC(=O)Nc2ccc(-c3cncc4c3c(N)nn4C)cc2)c1		CHEMBL404367	=	Ki	nM	1000.0	CHEMBL4722	Homo sapiens	pKi		6.0
inactive	9582331	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	CC(C)Cc1cc(-c2ccc3[nH]nc(N)c3c2)on1		CHEMBL1966343	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
inactive	9582332	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	CC(C)(C)c1cc(NC(=O)Nc2cccc3ccccc23)n(-c2cccc(C(=O)NCCOCCO)c2)n1		CHEMBL1978271	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
inactive	9582333	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Cc1n[nH]c2ccc(-c3cncc(OCCN)c3)cc12		CHEMBL1967887	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
inactive	9582334	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3ccc(OCCCn4cccc4)c4[nH]nc(N)c34)cc2)c1		CHEMBL2007266	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
active	9582335	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Cc1ccc(NC(=O)Nc2ccc(-c3csc4ncnc(N)c34)cc2)cc1C		CHEMBL2000335	=	Ki	nM	39.81	CHEMBL4722	Homo sapiens	pKi		7.4
active	9582336	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Nc1nc(=O)[nH]c2sccc12		CHEMBL2007097	=	Ki	nM	31622.78	CHEMBL4722	Homo sapiens	pKi		4.5
active	9582337	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	CN(c1ncccc1CNc1nc(Nc2ccc3c(c2)CC(=O)N3)ncc1C(F)(F)F)S(C)(=O)=O		CHEMBL1084546	=	Ki	nM	125.89	CHEMBL4722	Homo sapiens	pKi		6.9
active	9582338	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	CCN1CCN(c2ccc(Nc3ncc(C#N)c(Nc4ccc5[nH]ncc5c4)n3)cc2)CC1		CHEMBL1973516	=	Ki	nM	125.89	CHEMBL4722	Homo sapiens	pKi		6.9
active	9582339	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Cn1cc(-c2cnn3c(N)c(-c4ccc(NC(=O)Nc5cccc(C(F)(F)F)c5)cc4)cnc23)cn1		CHEMBL1988717	=	Ki	nM	630.96	CHEMBL4722	Homo sapiens	pKi		6.2
inactive	9582340	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Cc1cccc(Nc2nc(NC3CCCCC3N)cnc2C(N)=O)c1		CHEMBL1974328	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
active	9582341	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL509032	=	Ki	nM	12.59	CHEMBL4722	Homo sapiens	pKi		7.9
inactive	9582342	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	O=C(Nc1ccccc1)Nc1ccccn1		CHEMBL143703	<	Ki	nM	63095.73	CHEMBL4722	Homo sapiens	pKi		4.2
active	9582343	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	CCc1cccc(NC(=O)Nc2ccc(-c3c(C)oc4ncnc(N)c34)cc2)c1		CHEMBL1979528	=	Ki	nM	158.49	CHEMBL4722	Homo sapiens	pKi		6.8
inactive	9582344	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	O=C(Nc1ccc2[nH]ncc2c1)c1ccc(Cl)cc1		CHEMBL1973808	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
inactive	9582345	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	CC(C)Oc1nccn2c(-c3ccnc(NCC(C)(C)CO)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL2000429	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
active	9582346	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(-c5ccc(NC(=O)CCCN(C)C)cc5)cnc(N)c34)cc2)c1		CHEMBL1986367	=	Ki	nM	50.12	CHEMBL4722	Homo sapiens	pKi		7.3
active	9582347	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Cc1ccc(NC(=O)Nc2ccc(NC(=O)c3csc4ncnc(N)c34)cc2)cc1		CHEMBL1972576	=	Ki	nM	0.631	CHEMBL4722	Homo sapiens	pKi		9.2
inactive	9582348	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	NCC(NC(=O)c1ccc(-c2ccncc2)cc1)c1ccccc1		CHEMBL1990254	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
active	9582349	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Fc1ccc2c(c1)-c1n[nH]cc1CS2		CHEMBL1989069	=	Ki	nM	5011.87	CHEMBL4722	Homo sapiens	pKi		5.3
inactive	9582350	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	CCCS(=O)(=O)Nc1ccc(-c2ccc3[nH]nc(N)c3c2)cc1		CHEMBL1992342	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
active	9582351	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	COCCOC1CCC(n2nc(-c3ccc(Nc4nc5cc(Cl)ccc5o4)c(F)c3)c3c(N)ncnc32)CC1		CHEMBL2001535	=	Ki	nM	39.81	CHEMBL4722	Homo sapiens	pKi		7.4
active	9582352	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Cc1cc(Cl)ccc1NC(=S)NNC(=O)C(O)(c1ccccc1)c1ccccc1		CHEMBL1988173	=	Ki	nM	199.53	CHEMBL4722	Homo sapiens	pKi		6.7
active	9582353	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Cc1cnc(Nc2nc(NC(C)C)ncc2Br)s1		CHEMBL1973013	=	Ki	nM	794.33	CHEMBL4722	Homo sapiens	pKi		6.1
inactive	9582354	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
inactive	9582355	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	CC(C)Cn1c(N)nc2ccc(-c3c(-c4ccc(F)cc4)nc4sccn34)cc21		CHEMBL1965423	<	Ki	nM	3981.07	CHEMBL4722	Homo sapiens	pKi		5.4
active	9582356	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cc(CO)c(F)c4[nH]nc(N)c34)cc2)c1		CHEMBL1993073	=	Ki	nM	125.89	CHEMBL4722	Homo sapiens	pKi		6.9
active	9582357	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	CCC(N)(C#Cc1cnc(N)c2c(-c3ccc(NC(=O)Nc4cccc(C)c4)cc3)csc12)CC		CHEMBL1983025	=	Ki	nM	158.49	CHEMBL4722	Homo sapiens	pKi		6.8
active	9582358	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	COc1ccc(-n2ccc3cnc(Nc4cc(OC)c(OC)c(OC)c4)nc32)cc1		CHEMBL1975927	=	Ki	nM	316.23	CHEMBL4722	Homo sapiens	pKi		6.5
inactive	9582359	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	NC(Cc1c[nH]c2ccccc12)C(=O)Nc1cncc(C=Cc2ccncc2)c1		CHEMBL1983945	<	Ki	nM	3162.28	CHEMBL4722	Homo sapiens	pKi		5.5
inactive	9582360	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	O=C(NCc1ccccc1)c1ccc(-c2ccncc2)cc1		CHEMBL1977135	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
active	9582361	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	O=C1NC(=S)SC1=C1C(=O)Nc2ccc(Br)cc21		CHEMBL2001920	=	Ki	nM	501.19	CHEMBL4722	Homo sapiens	pKi		6.3
inactive	9582362	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	NC(=O)c1cc2c(-c3cc(C(F)(F)F)cc(C(F)(F)F)c3)cncc2s1		CHEMBL2002322	<	Ki	nM	6309.57	CHEMBL4722	Homo sapiens	pKi		5.2
active	9582363	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Nc1ncc2cccc(-c3ccccc3)n12		CHEMBL1997119	=	Ki	nM	50118.72	CHEMBL4722	Homo sapiens	pKi		4.3
active	9582364	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	CC(Nc1cncc(-n2cnc3ccc(C#N)cc32)n1)c1ccccc1F		CHEMBL1977138	=	Ki	nM	199.53	CHEMBL4722	Homo sapiens	pKi		6.7
inactive	9582365	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Cc1ccc(F)c(-c2ccc3nnc(N)n3c2)c1		CHEMBL2002323	<	Ki	nM	6309.57	CHEMBL4722	Homo sapiens	pKi		5.2
inactive	9582366	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	COc1cc(Nc2ncc([N+](=O)[O-])c(Nc3ccccc3C(N)=O)n2)cc(OC)c1OC		CHEMBL1241473	<	Ki	nM	630.96	CHEMBL4722	Homo sapiens	pKi		6.2
inactive	9582367	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	CS(=O)(=O)N(Cc1ccc2[nH]c(=O)c3cccn3c2c1)C1CC1		CHEMBL1978448	<	Ki	nM	794.33	CHEMBL4722	Homo sapiens	pKi		6.1
inactive	9582368	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	NCCCOc1cncc(C=Cc2ccncc2)c1		CHEMBL1972258	<	Ki	nM	3981.07	CHEMBL4722	Homo sapiens	pKi		5.4
inactive	9582369	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	O=C1Nc2cc(-c3ccc(O)cc3)ccc2C1=Cc1ccc[nH]1		CHEMBL1980329	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
active	9582370	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	c1nc(-c2ccc3c(c2)OCO3)c2cc[nH]c2n1		CHEMBL2004515	=	Ki	nM	3981.07	CHEMBL4722	Homo sapiens	pKi		5.4
active	9582371	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	CCN(CC)CC#Cc1cnc(N)c2c(-c3ccc(NC(=O)Nc4cccc(C)c4)cc3)csc12		CHEMBL2001257	=	Ki	nM	199.53	CHEMBL4722	Homo sapiens	pKi		6.7
active	9582372	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	NC(=NO)c1cccc(S(=O)(=O)Nc2ccc3c(c2)C(=NO)c2ccccc2-3)c1		CHEMBL1968271	=	Ki	nM	1000.0	CHEMBL4722	Homo sapiens	pKi		6.0
active	9582373	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	O=C(Nc1cccc(C2Nc3ccc4ccccc4c3C3C=CCC32)c1)c1ccc(F)cc1		CHEMBL1992042	=	Ki	nM	501.19	CHEMBL4722	Homo sapiens	pKi		6.3
inactive	9582374	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	CC(C)(C)OC(=O)n1ncc2cc(Nc3c(NCc4ccc(Cl)cc4Cl)c(=O)c3=O)ccc21		CHEMBL2005548	<	Ki	nM	6309.57	CHEMBL4722	Homo sapiens	pKi		5.2
inactive	9582375	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	COc1ccc(CNc2c(Nc3ccc4[nH]ncc4c3)c(=O)c2=O)cc1		CHEMBL1992536	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
inactive	9582376	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	CC(C)(C)c1nc2c3ccc(F)cc3c3c(=O)[nH]ccc3c2[nH]1		CHEMBL21156	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
inactive	9582377	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	CCN1CCN(CCCC(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1		CHEMBL1992740	<	Ki	nM	3981.07	CHEMBL4722	Homo sapiens	pKi		5.4
active	9582378	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3)s2)c1		CHEMBL1994724	=	Ki	nM	199.53	CHEMBL4722	Homo sapiens	pKi		6.7
active	9582379	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	COc1cc(-c2csc3c(C=CC(=O)NCCN(C)C)cnc(N)c23)ccc1NC(=O)c1cc2ccccc2n1C		CHEMBL1989267	=	Ki	nM	199.53	CHEMBL4722	Homo sapiens	pKi		6.7
active	9582380	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	COc1ccc(Nc2nccc(Nc3ccccc3C(=O)O)n2)cc1O		CHEMBL1964519	=	Ki	nM	19.95	CHEMBL4722	Homo sapiens	pKi		7.7
inactive	9582381	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Nc1ccc(-c2cncc(OCC(N)Cc3c[nH]c4ccccc34)c2)cc1C(=O)c1cccc(Cl)c1		CHEMBL1973348	<	Ki	nM	3981.07	CHEMBL4722	Homo sapiens	pKi		5.4
active	9582382	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Nc1ccc2c(C(=O)O)n(-c3ccccc3)nc2c1		CHEMBL1974574	=	Ki	nM	1258.93	CHEMBL4722	Homo sapiens	pKi		5.9
active	9582383	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	CCN(CC)CCNC(=O)c1cccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2cccc3ccccc23)c1		CHEMBL1970290	=	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
active	9582384	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Nc1ncnc2scc(-c3ccc(NC(=O)Nc4ccccc4)cc3)c12		CHEMBL1967531	=	Ki	nM	5.012	CHEMBL4722	Homo sapiens	pKi		8.3
inactive	9582385	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	CCCC(=O)Nc1nn(C(=O)CC)c2nc3ccccc3cc12		CHEMBL1970913	<	Ki	nM	3981.07	CHEMBL4722	Homo sapiens	pKi		5.4
active	9582386	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	CCCS(=O)(=O)Nc1ccc(-c2ccc3[nH]nc(NC(C)=O)c3c2)cc1		CHEMBL1973893	=	Ki	nM	1000.0	CHEMBL4722	Homo sapiens	pKi		6.0
inactive	9582387	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	<	Ki	nM	1000.0	CHEMBL4722	Homo sapiens	pKi		6.0
inactive	9582388	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	C#Cc1cn(C2CCCC2)c2ncnc(N)c12		CHEMBL1993877	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
inactive	9582389	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Cc1nccn2c(-c3ccnc(NCC(C)(C)O)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL1996500	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
active	9582390	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	NC(=O)Cn1cc(-c2cc(-c3cc4ccccc4s3)c3[nH]ncc3c2)c2nc(N)ncc21		CHEMBL1985095	=	Ki	nM	1258.93	CHEMBL4722	Homo sapiens	pKi		5.9
active	9582391	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	COc1cccc(NC(=O)N2CCC(c3nc4c(C(N)=O)cccc4[nH]3)CC2)c1		CHEMBL1973363	=	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
active	9582392	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	COCc1nnn(-c2nonc2N)c1C(=O)NN=C(C)c1ccc(O)cc1O		CHEMBL1991180	=	Ki	nM	100.0	CHEMBL4722	Homo sapiens	pKi		7.0
active	9582393	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(CC(C)O)c5)cnc(N)c34)cc2)c1		CHEMBL1989708	=	Ki	nM	3.981	CHEMBL4722	Homo sapiens	pKi		8.4
inactive	9582394	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	c1cnc2nc(-c3ccc4[nH]ncc4c3)cn2c1		CHEMBL1682540	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
inactive	9582395	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Cc1c(O)cccc1NC(=O)c1cnn2c(-c3ccccc3)ccnc12		CHEMBL1978656	<	Ki	nM	6309.57	CHEMBL4722	Homo sapiens	pKi		5.2
active	9582396	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	CCc1c(-c2ccc(C(C)(C)O)cc2)[nH]c2nccnc12		CHEMBL1976420	=	Ki	nM	794.33	CHEMBL4722	Homo sapiens	pKi		6.1
active	9582397	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	N#Cc1ncc2nc1OCCCCCOc1cc(OCCO)c(Cl)cc1NC(=O)N2		CHEMBL413779	=	Ki	nM	501.19	CHEMBL4722	Homo sapiens	pKi		6.3
inactive	9582398	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	O=C(Nc1cccc(C(F)(F)F)n1)Nc1ccnc2cc(Cl)ccc12		CHEMBL1981744	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
inactive	9582399	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Cc1ccc(CNc2c(Nc3ccncc3)c(=O)c2=O)cc1		CHEMBL1994864	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
inactive	9582400	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	CN1CCN(Cc2ccc3c(c2)Cc2c(-c4csc(C#CCOCC5CC5)c4)n[nH]c2-3)CC1		CHEMBL2002446	<	Ki	nM	3981.07	CHEMBL4722	Homo sapiens	pKi		5.4
active	9582401	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	O=c1nc(-c2cc3c(Oc4ccc(I)cc4)cncc3s2)[nH]o1		CHEMBL497151	=	Ki	nM	794.33	CHEMBL4722	Homo sapiens	pKi		6.1
active	9582402	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Cc1ccccc1-c1c(-c2ccc3[nH]nc(N)c3c2)nnn1Cc1ccccc1		CHEMBL2000029	=	Ki	nM	1000.0	CHEMBL4722	Homo sapiens	pKi		6.0
inactive	9582403	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	COc1cc(N2CCN(C)CC2)ccc1C(=O)Nc1n[nH]c2ccc(Cc3cc(F)cc(F)c3)cc12		CHEMBL1973961	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
active	9582404	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	NC(=O)c1cccc2[nH]c(-c3ccc(N4CCN(Cc5ccccc5)CC4)nc3)nc12		CHEMBL2001099	=	Ki	nM	501.19	CHEMBL4722	Homo sapiens	pKi		6.3
inactive	9582405	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	NCC1CCC(CNc2nc(NCc3ccccc3Cl)ncc2[N+](=O)[O-])CC1		CHEMBL246970	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
inactive	9582406	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Cc1cc(O)ccc1-n1cc(C(N)=O)c(=O)c2ccc(-c3ccncc3)cc21		CHEMBL340921	<	Ki	nM	5011.87	CHEMBL4722	Homo sapiens	pKi		5.3
inactive	9582407	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	CC(C)(C)c1cc(NC(=O)Nc2cccc3ccccc23)n(-c2cccc(C(=O)NCCCCO)c2)n1		CHEMBL1994977	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
inactive	9582408	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	N#Cc1ncc2nc1OCCCCCOc1cc(OCCCO)c(Cl)cc1NC(=O)N2		CHEMBL373598	<	Ki	nM	6309.57	CHEMBL4722	Homo sapiens	pKi		5.2
inactive	9582409	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	N#Cc1ccc(NC(=O)Nc2ccnc3cc(C(F)(F)F)ccc23)nc1		CHEMBL1999718	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
active	9582410	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	COc1ccc2c(c1)c(-c1cc3nc(Br)cnc3[nH]1)cn2C		CHEMBL2005478	=	Ki	nM	50.12	CHEMBL4722	Homo sapiens	pKi		7.3
active	9582411	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	O=C1Nc2ccc3ncsc3c2C1=CNc1ccc(S(=O)(=O)Nc2ccccn2)cc1		CHEMBL1973540	=	Ki	nM	15.85	CHEMBL4722	Homo sapiens	pKi		7.8
active	9582412	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	COc1cccc(OC)c1CNc1nc(NC2CCCCC2)nc2ccc(Cl)cc12		CHEMBL1996646	=	Ki	nM	630.96	CHEMBL4722	Homo sapiens	pKi		6.2
inactive	9582413	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	CN(CCN)C(=O)c1cccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2cccc3ccccc23)c1		CHEMBL1979773	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
active	9582414	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	O=C1Nc2ccccc2Nc2nnc(I)cc21		CHEMBL1977346	=	Ki	nM	199.53	CHEMBL4722	Homo sapiens	pKi		6.7
inactive	9582415	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	CC(C)S(=O)(=O)n1c(N)nc2ccc(-c3c(-c4ccc(F)cc4)nc4sccn34)cc21		CHEMBL2003657	<	Ki	nM	6309.57	CHEMBL4722	Homo sapiens	pKi		5.2
inactive	9582416	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3ccc4nccnc4c3N)cc2)c1		CHEMBL1971649	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
inactive	9582417	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	c1ccc(-c2cccc3nccn23)cc1		CHEMBL1992723	<	Ki	nM	63095.73	CHEMBL4722	Homo sapiens	pKi		4.2
inactive	9582418	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	COc1cc(-c2ccc3c(c2)Nc2ccc(C(=O)NCCCN(C)C)cc2NC3=O)ccc1O		CHEMBL1996702	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
active	9582419	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	Ki	nM	3.162	CHEMBL4722	Homo sapiens	pKi		8.5
inactive	9582420	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	O=C(Nc1ccc(-c2ccc(=O)[nH]n2)cc1)Nc1cccc(C(F)(F)F)c1		CHEMBL2007124	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
active	9582421	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Cc1oc2ncnc(N)c2c1-c1ccc(NC(=O)Nc2cccc(C(F)(F)F)c2)cc1		CHEMBL1995068	=	Ki	nM	79.43	CHEMBL4722	Homo sapiens	pKi		7.1
inactive	9582422	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Clc1cc(-c2c[nH]c3ncccc23)nc(NC2CCCCC2)n1		CHEMBL2006439	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
active	9582423	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	N#Cc1ccc2c(c1)C(c1ccc3c(n1)CCCC3O)C(=O)N2		CHEMBL1985681	=	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
active	9582424	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	COc1ccc(-c2ccc(NC(=O)Nc3cc(F)cc(F)c3)cc2)c2c(N)noc12		CHEMBL1969190	=	Ki	nM	50.12	CHEMBL4722	Homo sapiens	pKi		7.3
active	9582425	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Cc1ccc(-c2ccc(NC(=O)Nc3cccc(Br)c3)cc2)c2c(N)n[nH]c12		CHEMBL1973937	=	Ki	nM	398.11	CHEMBL4722	Homo sapiens	pKi		6.4
active	9582426	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL475251	=	Ki	nM	501.19	CHEMBL4722	Homo sapiens	pKi		6.3
inactive	9582427	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	N#CCC(C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1		CHEMBL2002099	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
inactive	9582428	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	NC(=O)c1ccc(-c2c[nH]c3nccc(Cl)c23)cc1		CHEMBL1982711	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
active	9582429	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Cc1ccc(NC(=O)Nc2ccc(-c3c(C(C)C)sc4ncnc(N)c34)cc2)cc1		CHEMBL1989505	=	Ki	nM	79.43	CHEMBL4722	Homo sapiens	pKi		7.1
active	9582430	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Nc1ncnc2c1N=C(c1ccccc1)CCN2		CHEMBL262623	=	Ki	nM	7943.28	CHEMBL4722	Homo sapiens	pKi		5.1
inactive	9582431	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	CC(C)COc1nccn2c(-c3ccnc(NCC(C)(C)CO)n3)c(-c3ccc(F)cc3)nc12		CHEMBL1984842	<	Ki	nM	3981.07	CHEMBL4722	Homo sapiens	pKi		5.4
active	9582432	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(-c5cn[nH]c5)cnc(N)c34)cc2)c1		CHEMBL1969102	=	Ki	nM	25.12	CHEMBL4722	Homo sapiens	pKi		7.6
active	9582433	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	CCc1nc(Nc2ccc(N3CCOCC3)c(Cl)c2)nc2[nH]ccc12		CHEMBL2004118	=	Ki	nM	1000.0	CHEMBL4722	Homo sapiens	pKi		6.0
active	9582434	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Nc1n[nH]c2ccc(-c3cn(Cc4ccccc4)nn3)cc12		CHEMBL1682346	=	Ki	nM	251.19	CHEMBL4722	Homo sapiens	pKi		6.6
inactive	9582435	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	CCN(CC)CC#Cc1ccc2c(c1)-c1[nH]nc(-c3ccc(C#N)nc3)c1C2		CHEMBL2007044	<	Ki	nM	3981.07	CHEMBL4722	Homo sapiens	pKi		5.4
active	9582436	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	CNC(=O)N1CCN(CCCOc2ccc3c(c2)-c2[nH]nc(-c4ccc(C#N)nc4)c2C3)CC1		CHEMBL2001998	=	Ki	nM	630.96	CHEMBL4722	Homo sapiens	pKi		6.2
inactive	9582437	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	COc1cc(C=C(C#N)c2nc3ccccc3[nH]2)c(Br)cc1O		CHEMBL1994241	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
inactive	9582438	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	CS(=O)(=O)Nc1cc2c(cc1Cl)NC(=O)Nc1cnc(C#N)c(n1)OCCCCCO2		CHEMBL223460	<	Ki	nM	3981.07	CHEMBL4722	Homo sapiens	pKi		5.4
inactive	9582439	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	O=C(Nc1cnc2[nH]cc(-c3ccccc3)c2c1)c1ccc(Cl)cc1		CHEMBL1998829	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
inactive	9582440	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1		CHEMBL50894	<	Ki	nM	1995.26	CHEMBL4722	Homo sapiens	pKi		5.7
inactive	9582441	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	CC(C)(C)Nc1ncnc2[nH]cc(-c3ccccc3)c12		CHEMBL1995211	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
active	9582442	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Cc1cnc(Nc2cccc(S(N)(=O)=O)c2)nc1Nc1ccc(OCC(N)=O)cc1		CHEMBL1988838	=	Ki	nM	25.12	CHEMBL4722	Homo sapiens	pKi		7.6
active	9582443	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	CCN1CCN(c2ccc(Nc3nccc(-c4c(-c5cccc(C(=O)Nc6ccccc6F)c5)nc5ccccn45)n3)cc2)CC1		CHEMBL1981725	=	Ki	nM	31.62	CHEMBL4722	Homo sapiens	pKi		7.5
active	9582444	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Cc1cccc(NC(=O)Nc2ccc(-c3cccc4[nH]ncc34)cc2)c1		CHEMBL375284	=	Ki	nM	1258.93	CHEMBL4722	Homo sapiens	pKi		5.9
inactive	9582445	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	COc1cccc(CNC(=O)c2ccc(-c3ccncc3)cc2)c1		CHEMBL2006299	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
inactive	9582446	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Cc1ccc(-c2cc3nc(Br)cnc3[nH]2)cc1		CHEMBL1965169	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
inactive	9582447	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Nc1ncnc2c1c(-c1cnc3[nH]ccc3c1)nn2C1CCCC1		CHEMBL1081312	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
active	9582448	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	COc1ccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(CC(O)CO)c5)cnc(N)c34)cc2)cc1		CHEMBL1965170	=	Ki	nM	1.995	CHEMBL4722	Homo sapiens	pKi		8.7
inactive	9582449	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	COCCn1cc(-c2ccncn2)c(-c2ccc(Cl)cc2)n1		CHEMBL1982866	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
inactive	9582450	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	COc1nccn2c(-c3ccnc(NCC(C)(C)CO)n3)c(-c3ccc(F)cc3)nc12		CHEMBL2005792	<	Ki	nM	3981.07	CHEMBL4722	Homo sapiens	pKi		5.4
inactive	9582451	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	CCOc1nc(C(=O)NCc2ccncc2)cc(N)c1C#N		CHEMBL1984206	<	Ki	nM	6309.57	CHEMBL4722	Homo sapiens	pKi		5.2
inactive	9582452	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Nc1c(-c2ccccc2)c2cc(Cl)ccc2[nH]c1=O		CHEMBL462120	<	Ki	nM	3981.07	CHEMBL4722	Homo sapiens	pKi		5.4
inactive	9582453	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	CC(Nc1c(Nc2ccncc2)c(=O)c1=O)C1CCCCC1		CHEMBL1991577	<	Ki	nM	6309.57	CHEMBL4722	Homo sapiens	pKi		5.2
active	9582454	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Nc1n[nH]c2nc(Cl)sc12		CHEMBL1991867	=	Ki	nM	25118.86	CHEMBL4722	Homo sapiens	pKi		4.6
active	9582455	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Nc1ncc(-c2ccoc2)c2scc(-c3ccc(NC(=O)Nc4ccccc4F)cc3)c12		CHEMBL1965570	=	Ki	nM	10.0	CHEMBL4722	Homo sapiens	pKi		8.0
inactive	9582456	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	O=c1[nH]c2sc3c(c2c2nc(-c4ccccc4)nn12)CCCC3		CHEMBL2007592	<	Ki	nM	3981.07	CHEMBL4722	Homo sapiens	pKi		5.4
active	9582457	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	COc1c(-c2nc3ccccc3[nH]2)c(O)cc2oc(C)cc(=O)c12		CHEMBL1972355	=	Ki	nM	251.19	CHEMBL4722	Homo sapiens	pKi		6.6
inactive	9582458	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Cc1cc(=O)[nH]nc1-c1ccc(NC(=O)Nc2cc(C(F)(F)F)ccc2F)c(Cl)c1		CHEMBL1997892	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
active	9582459	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	CC(C)(O)c1cn(-c2ccc3[nH]ncc3c2)nn1		CHEMBL2001641	=	Ki	nM	25118.86	CHEMBL4722	Homo sapiens	pKi		4.6
active	9582460	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Cc1ccc(-c2cc(-c3cc(Br)ccc3O)[nH]c(=O)c2C#N)s1		CHEMBL1997193	=	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
inactive	9582461	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	CCOc1nc(NC(=O)Cc2cc(OC)c(S(C)(=O)=O)cc2OC)cc(N)c1C#N		CHEMBL210963	<	Ki	nM	3981.07	CHEMBL4722	Homo sapiens	pKi		5.4
inactive	9582462	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	CC(C)(C)c1cc(NC(=O)C(=O)c2cccc3ccccc23)n(-c2cccc(OCC(=O)O)c2)n1		CHEMBL1964902	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
active	9582463	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Cc1cncc2cccc(S(=O)(=O)N3CCCNCC3C)c12		CHEMBL1082440	=	Ki	nM	398.11	CHEMBL4722	Homo sapiens	pKi		6.4
inactive	9582464	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	O=C(CO)N1CCC(c2[nH]nc(-c3ccc(Cl)cc3F)c2-c2ccncn2)CC1		CHEMBL1614705	<	Ki	nM	3981.07	CHEMBL4722	Homo sapiens	pKi		5.4
active	9582465	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	CS(=O)(=O)c1ccc(-c2cncc3sc(C(N)=O)cc23)cc1		CHEMBL1972362	=	Ki	nM	3162.28	CHEMBL4722	Homo sapiens	pKi		5.5
active	9582466	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	CCCCN1CCN(c2ccc(-c3nc4c(C(N)=O)cccc4[nH]3)cn2)CC1		CHEMBL2003948	=	Ki	nM	1258.93	CHEMBL4722	Homo sapiens	pKi		5.9
inactive	9582467	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	<	Ki	nM	3162.28	CHEMBL4722	Homo sapiens	pKi		5.5
active	9582468	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	COc1cccc(C(C)NC(=O)N2CC=C(c3c[nH]c4ncccc34)CC2)c1		CHEMBL1965845	=	Ki	nM	63.1	CHEMBL4722	Homo sapiens	pKi		7.2
active	9582469	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	CCNc1nc(C)c(-c2ccnc(Nc3ccc(N4CCN(C(C)=O)CC4)cc3)n2)s1		CHEMBL1983715	=	Ki	nM	25.12	CHEMBL4722	Homo sapiens	pKi		7.6
inactive	9582470	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	COc1ccc(OC)c(NC(=O)c2cnn3c(-c4ccccc4)ccnc23)c1		CHEMBL1982167	<	Ki	nM	6309.57	CHEMBL4722	Homo sapiens	pKi		5.2
active	9582471	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	NC(=O)c1cc2c(-c3cccc(F)c3)cncc2s1		CHEMBL1971017	=	Ki	nM	2511.89	CHEMBL4722	Homo sapiens	pKi		5.6
active	9582472	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	O=C(Nc1cccc(-c2nc3sccn3c2-c2ccnc(Nc3cccc(N4CCCC4=O)c3)n2)c1)c1c(F)cccc1F		CHEMBL2006715	=	Ki	nM	10.0	CHEMBL4722	Homo sapiens	pKi		8.0
inactive	9582473	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	NC(=O)c1cccc2[nH]c(-c3ccncc3)nc12		CHEMBL1990482	<	Ki	nM	3981.07	CHEMBL4722	Homo sapiens	pKi		5.4
inactive	9582474	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Fc1ccc(-c2nc3cnccn3c2-c2ccnc(NCC3CC3)n2)cc1		CHEMBL1990904	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
active	9582475	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	CCS(=O)(=O)c1ccc(-c2cncc3sc(C(N)=O)cc23)cc1		CHEMBL2000104	=	Ki	nM	1258.93	CHEMBL4722	Homo sapiens	pKi		5.9
inactive	9586037	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	O=C(NCC1CCCCC1)c1cc2c(-c3ccccc3)n[nH]c2s1		CHEMBL2005475	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
active	9586038	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cncc4c3c(N)nn4C)cc2)c1		CHEMBL402846	=	Ki	nM	501.19	CHEMBL4722	Homo sapiens	pKi		6.3
inactive	9586039	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Cc1cccc(NC(=O)Nc2ccc(-c3cccc4c3CNC4=O)cc2C)c1		CHEMBL183844	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
active	9586040	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Cc1cccc(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL220057	=	Ki	nM	251.19	CHEMBL4722	Homo sapiens	pKi		6.6
inactive	9586041	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	c1ccc(Nc2nc(-c3ccc4[nH]ncc4c3)cs2)cc1		CHEMBL1682545	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
active	9586042	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	CCS(=O)(=O)c1ccc(-c2ccc(-c3n[nH]c4c3Cc3cc(O)c(OC)cc3-4)cc2)cc1		CHEMBL1992195	=	Ki	nM	794.33	CHEMBL4722	Homo sapiens	pKi		6.1
inactive	9586043	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	NC(COc1cncc(C=Cc2ccncc2)c1)Cc1c[nH]c2ccccc12		CHEMBL1974935	<	Ki	nM	3981.07	CHEMBL4722	Homo sapiens	pKi		5.4
inactive	9586044	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Cc1cc(OC2CCCC2)c(NC(=O)Nc2cnc(C#N)cn2)cc1Cl		CHEMBL2001224	<	Ki	nM	3981.07	CHEMBL4722	Homo sapiens	pKi		5.4
inactive	9586045	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	<	Ki	nM	3981.07	CHEMBL4722	Homo sapiens	pKi		5.4
active	9586046	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	c1ccc2c(c1)[nH]c1cnccc12		CHEMBL275224	=	Ki	nM	15848.93	CHEMBL4722	Homo sapiens	pKi		4.8
inactive	9586047	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	CC(C)(C)OC(=O)n1ncc2cc(Nc3c(NCc4ccc(S(N)(=O)=O)cc4)c(=O)c3=O)ccc21		CHEMBL1969506	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
active	9586048	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	CC(C)Cc1nc(Nc2ccc(N3CCOCC3)c(Cl)c2)nc2[nH]ccc12		CHEMBL1980763	=	Ki	nM	630.96	CHEMBL4722	Homo sapiens	pKi		6.2
inactive	9586049	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	O=C(NC(CO)c1ccccc1)N1CC=C(c2c[nH]c3ncccc23)CC1		CHEMBL1964937	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
active	9586050	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	O=C(O)c1ccccc1Nc1ccnc(Nc2ccc(O)cc2)n1		CHEMBL243297	=	Ki	nM	31.62	CHEMBL4722	Homo sapiens	pKi		7.5
inactive	9586051	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	c1ccc(COc2ccc(Nc3ncnc4ccccc34)cc2)cc1		CHEMBL1980163	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
active	9586052	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	NCCn1cc(-c2cc(-c3cc4ccccc4s3)c3[nH]ncc3c2)c2nc(N)ncc21		CHEMBL590109	=	Ki	nM	3162.28	CHEMBL4722	Homo sapiens	pKi		5.5
inactive	9586053	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	CC(=O)c1ccccc1-c1ncnc2[nH]ccc12		CHEMBL1977931	<	Ki	nM	63095.73	CHEMBL4722	Homo sapiens	pKi		4.2
active	9586054	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	COc1cc(-c2nn(C3CCC(N4CCN(C(C)=O)CC4)CC3)c3ncnc(N)c23)ccc1NC(=O)c1cc2ccccc2n1C		CHEMBL1970879	=	Ki	nM	199.53	CHEMBL4722	Homo sapiens	pKi		6.7
active	9586055	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Cc1c(C=O)c(O)n2c(nc3ccccc32)c1C#N		CHEMBL1989856	=	Ki	nM	794.33	CHEMBL4722	Homo sapiens	pKi		6.1
inactive	9586056	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	CC(=O)N(c1ccncc1)c1c(NC(C)C(C)(C)C)c(=O)c1=O		CHEMBL2005899	<	Ki	nM	3981.07	CHEMBL4722	Homo sapiens	pKi		5.4
inactive	9586057	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	c1cnc2nc(-c3ccc4[nH]ncc4c3)c(NC3CCCCC3)n2c1		CHEMBL1682552	<	Ki	nM	5011.87	CHEMBL4722	Homo sapiens	pKi		5.3
inactive	9586058	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	COc1ccc(CNC(=O)Nc2ncc([N+](=O)[O-])s2)cc1		CHEMBL259850	<	Ki	nM	6309.57	CHEMBL4722	Homo sapiens	pKi		5.2
inactive	9586059	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	CCCCNc1nc(N)c(C(=O)c2ccccc2)s1		CHEMBL2007479	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
inactive	9586060	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	CN1CCC1COc1cncc(CCc2ccncc2)c1		CHEMBL1996155	<	Ki	nM	6309.57	CHEMBL4722	Homo sapiens	pKi		5.2
active	9586061	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(CCO)c5)cnc(N)c34)cc2F)c1		CHEMBL1986851	=	Ki	nM	100.0	CHEMBL4722	Homo sapiens	pKi		7.0
active	9586062	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Cc1n[nH]c2ccc(-c3cncc(OCC(N)Cc4cccc(Cl)c4)c3)cc12		CHEMBL1974870	=	Ki	nM	630.96	CHEMBL4722	Homo sapiens	pKi		6.2
active	9586063	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Cc1cc(C)c(C=C2C(=O)Nc3ccccc32)[nH]1		CHEMBL2002702	=	Ki	nM	501.19	CHEMBL4722	Homo sapiens	pKi		6.3
active	9586064	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	CCCc1cc(-c2ccc3[nH]ncc3c2)on1		CHEMBL1682359	=	Ki	nM	3981.07	CHEMBL4722	Homo sapiens	pKi		5.4
active	9586065	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Nc1ncc(-c2cnn(CCO)c2)c2scc(-c3ccc(NC(=O)Nc4ccc(OC(F)F)cc4)cc3)c12		CHEMBL1972220	=	Ki	nM	1.585	CHEMBL4722	Homo sapiens	pKi		8.8
inactive	9586066	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Cc1n[nH]c2ccc(-c3cncc(OCC(N)Cc4c[nH]c5ccccc45)c3)cc12		CHEMBL1970903	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
active	9586067	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	COc1cccc(S(=O)(=O)Nc2ccc3c(c2)C(=NO)c2ccccc2-3)c1		CHEMBL1971271	=	Ki	nM	1995.26	CHEMBL4722	Homo sapiens	pKi		5.7
inactive	9586068	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	NC(=O)c1cnn2c(-c3ccccc3)ccnc12		CHEMBL1972583	<	Ki	nM	63095.73	CHEMBL4722	Homo sapiens	pKi		4.2
inactive	9586069	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	NC(COc1cncc(C=Cc2ccncc2)c1)Cc1ccccc1		CHEMBL1991846	<	Ki	nM	6309.57	CHEMBL4722	Homo sapiens	pKi		5.2
active	9586070	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Fc1cccc(CNc2ncnc3[nH]cnc23)c1		CHEMBL2003785	=	Ki	nM	39810.72	CHEMBL4722	Homo sapiens	pKi		4.4
inactive	9586071	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	NC1CCC(Nc2nc(Cl)cc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL1973720	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
active	9586072	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Cc1cccc(Nc2nccc(Nc3c(NC(C)C(C)(C)C)c(=O)c3=O)n2)c1		CHEMBL1969523	=	Ki	nM	125.89	CHEMBL4722	Homo sapiens	pKi		6.9
active	9586073	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	COc1cc(C=O)c(Cl)cc1NC(=O)Nc1cnc(C#N)cn1		CHEMBL207995	=	Ki	nM	3981.07	CHEMBL4722	Homo sapiens	pKi		5.4
inactive	9586074	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	O=C1Nc2cc(CCOc3ccc(N4CCOCC4)cc3)ccc2Nc2cc(-c3cn(Cc4cc(F)c(F)c(F)c4)c4cnccc34)ccc21		CHEMBL2001923	<	Ki	nM	3981.07	CHEMBL4722	Homo sapiens	pKi		5.4
inactive	9586075	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	CC(=O)N1CCC(Nc2nccc(-c3c(-c4ccc(F)cc4)nc4occn34)n2)CC1		CHEMBL1986781	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
inactive	9586076	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	CCOc1ccccc1-c1cccc(-c2n[nH]c3nc(O)cc(C)c23)c1		CHEMBL1983070	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
inactive	9586077	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	O=c1nc(-c2ccc3[nH]ncc3c2)cc(-c2ccccc2)[nH]1		CHEMBL526133	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
inactive	9586078	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	COc1cccc(C(C)NC(=O)c2cnc(-c3ccncc3)nc2)c1		CHEMBL2003514	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
inactive	9586079	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	OCCn1cc(-c2cnc3nnn(Cc4ccc5ncccc5c4)c3n2)cn1		CHEMBL2001019	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
inactive	9586080	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Cn1c(=O)c(Oc2ccc(F)cc2F)cc2cnc(NC3CCOCC3)nc21		CHEMBL1230122	<	Ki	nM	3981.07	CHEMBL4722	Homo sapiens	pKi		5.4
inactive	9586081	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	CN1CCN(c2ccc(Nc3nc(N)c(C(=O)c4c(Cl)cccc4Cl)s3)cc2)CC1		CHEMBL1989043	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
inactive	9586082	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
inactive	9586083	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Cc1nn(C)c2sc3c(=O)[nH]cnc3c12		CHEMBL1967538	<	Ki	nM	63095.73	CHEMBL4722	Homo sapiens	pKi		4.2
active	9586084	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	O=C1NCc2c1cccc2-c1ccc(Nc2nc3ccccc3[nH]2)cc1		CHEMBL1979057	=	Ki	nM	39.81	CHEMBL4722	Homo sapiens	pKi		7.4
inactive	9586085	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	COc1cc(-c2ccc3c(c2)Nc2ccc(CCOc4ccc(N5CCOCC5)cc4)cc2NC3=O)ccc1OCC(O)CO		CHEMBL1981045	<	Ki	nM	6309.57	CHEMBL4722	Homo sapiens	pKi		5.2
active	9586086	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	COCCOCC#Cc1cc(-c2n[nH]c3c2C(=O)c2cc(CN4CCN(C)CC4)ccc2-3)cs1		CHEMBL387971	=	Ki	nM	2511.89	CHEMBL4722	Homo sapiens	pKi		5.6
active	9586087	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	c1ccc(Cn2nnc(-c3ccc4[nH]ncc4c3)c2C2CC2)cc1		CHEMBL1975418	=	Ki	nM	63.1	CHEMBL4722	Homo sapiens	pKi		7.2
inactive	9586088	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	O=c1[nH]c2ccc(Cl)cc2c(-c2ccccc2)c1C1=NNC(c2ccccc2)C1		CHEMBL1992796	<	Ki	nM	6309.57	CHEMBL4722	Homo sapiens	pKi		5.2
inactive	9586089	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	O=C1CN2C(=NN1)COc1ccccc12		CHEMBL1968515	<	Ki	nM	63095.73	CHEMBL4722	Homo sapiens	pKi		4.2
active	9586090	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)cn2)CC1		CHEMBL1164180	=	Ki	nM	1000.0	CHEMBL4722	Homo sapiens	pKi		6.0
active	9586091	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Cc1ccc(-c2nc3ccc(Br)cc3c(C(=O)O)c2CC(=O)O)cc1C		CHEMBL1974408	=	Ki	nM	63.1	CHEMBL4722	Homo sapiens	pKi		7.2
active	9586092	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	CCN(CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1)CCOP(=O)(O)O		CHEMBL415049	=	Ki	nM	39.81	CHEMBL4722	Homo sapiens	pKi		7.4
inactive	9586093	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	N#Cc1ncc2nc1OCCCCCOc1cc(OCC(O)CO)c(Cl)cc1NC(=O)N2		CHEMBL223257	<	Ki	nM	6309.57	CHEMBL4722	Homo sapiens	pKi		5.2
inactive	9586094	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	CC(NC(=O)c1ccc(-c2ccncc2)cc1)c1ccccc1		CHEMBL1999428	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
inactive	9586095	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	CCN1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL1967560	<	Ki	nM	3981.07	CHEMBL4722	Homo sapiens	pKi		5.4
active	9586096	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Cn1cc(C=C2C(=O)Nc3cccnc32)c2ccccc21		CHEMBL1516890	=	Ki	nM	251.19	CHEMBL4722	Homo sapiens	pKi		6.6
inactive	9586097	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Cc1cccc(NC(=O)Nc2ccc(-c3noc4ncnc(N)c34)cc2)c1		CHEMBL211378	<	Ki	nM	1000.0	CHEMBL4722	Homo sapiens	pKi		6.0
active	9586098	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#CCN5CCOCC5)cnc(N)c34)cc2)c1		CHEMBL1982465	=	Ki	nM	31.62	CHEMBL4722	Homo sapiens	pKi		7.5
inactive	9586099	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	NC(COc1cncc(-c2ccc3c(c2)C(=Cc2ccco2)C(=O)N3)c1)Cc1c[nH]c2ccccc12		CHEMBL2001751	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
active	9586100	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Cc1ccccc1NC(=O)Nc1ccc(-c2coc3ncnc(N)c23)cc1		CHEMBL1984586	=	Ki	nM	63.1	CHEMBL4722	Homo sapiens	pKi		7.2
inactive	9586101	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Cc1c(Cl)c(N2CCC(CN)C2)nc2[nH]cc(C(=O)O)c(=O)c12		CHEMBL1999774	<	Ki	nM	6309.57	CHEMBL4722	Homo sapiens	pKi		5.2
inactive	9586102	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Cc1c(O)ccc2c1CCCC2=NNC(=O)Cc1cccc2ccccc12		CHEMBL1972659	<	Ki	nM	3981.07	CHEMBL4722	Homo sapiens	pKi		5.4
active	9586103	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	CC(=O)Nc1ccc(-n2nc3ccc(N)nc3n2)cc1		CHEMBL2002723	=	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
active	9586104	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	OC1CCN(c2ncnc3[nH]cc(-c4ccccc4)c23)CC1		CHEMBL1973395	=	Ki	nM	158.49	CHEMBL4722	Homo sapiens	pKi		6.8
active	9586105	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	COc1ccc(NC(=O)Nc2ccc(-c3cccc4onc(N)c34)cc2)cc1Cl		CHEMBL272453	=	Ki	nM	1000.0	CHEMBL4722	Homo sapiens	pKi		6.0
inactive	9586106	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3C)cc2)c1		CHEMBL1970217	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
active	9586107	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	O=C1Nc2ccccc2Nc2nnccc21		CHEMBL1971801	=	Ki	nM	1995.26	CHEMBL4722	Homo sapiens	pKi		5.7
active	9586108	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	O=C1Nc2ccccc2Nc2nnc(Cl)cc21		CHEMBL1968850	=	Ki	nM	794.33	CHEMBL4722	Homo sapiens	pKi		6.1
inactive	9586109	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	CCOC(=O)c1ccc2[nH]c3c(c2c1)CCNC3=O		CHEMBL2005528	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
active	9586110	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Cc1cccc(NC(=O)Nc2ccc(-c3cccc4c3CNC4=O)cc2)c1		CHEMBL185569	=	Ki	nM	125.89	CHEMBL4722	Homo sapiens	pKi		6.9
inactive	9586111	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	c1cc2[nH]ncc2cc1-c1cn(CC2CCOCC2)nn1		CHEMBL1969843	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
inactive	9586112	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	COc1cc(-c2ccc3[nH]nc(C(=O)Nc4ccccc4)c3c2)ccc1O		CHEMBL2007002	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
inactive	9586113	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
inactive	9586114	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	CN1CCC(NC(=O)c2cc3c(-c4ccccc4)n[nH]c3s2)CC1		CHEMBL1987007	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
inactive	9586115	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	CC(Nc1nccc(-c2c(-c3ccc(F)cc3)nc3occn23)n1)c1ccccc1		CHEMBL1990288	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
inactive	9586116	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	O=S(=O)(Nc1ccc2c(c1)C(=NO)c1ccccc1-2)c1cccc(Br)c1		CHEMBL1973793	<	Ki	nM	1995.26	CHEMBL4722	Homo sapiens	pKi		5.7
inactive	9586117	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	O=C(CCCCCCC(=NO)c1ncco1)Nc1cccc(-c2ccccc2)c1		CHEMBL1992935	<	Ki	nM	1995.26	CHEMBL4722	Homo sapiens	pKi		5.7
inactive	9586118	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Clc1cc(-c2c[nH]c3ncccc23)cc(NCc2ccccc2)n1		CHEMBL1969588	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
active	9586119	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	COc1cc(Nc2nccc(Nc3cc(C4CCCCC4)no3)n2)cc(OC)c1OC		CHEMBL1984711	=	Ki	nM	630.96	CHEMBL4722	Homo sapiens	pKi		6.2
active	9586120	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Cc1cc(Nc2ncc(F)c(NC3C4C=CC(C4)C3C(N)=O)n2)ccc1N1CCN(C)CC1		CHEMBL1967878	=	Ki	nM	3.981	CHEMBL4722	Homo sapiens	pKi		8.4
active	9586121	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Cc1n[nH]c2c1c(=O)n(C)c1ccccc21		CHEMBL1981183	=	Ki	nM	1000.0	CHEMBL4722	Homo sapiens	pKi		6.0
active	9586122	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	CCC1CC(NS(=O)(=O)C2CC2)CC1c1ncc2cnc3[nH]ccc3n12		CHEMBL1992073	=	Ki	nM	1258.93	CHEMBL4722	Homo sapiens	pKi		5.9
inactive	9586123	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	COc1cc(OC)c(Nc2ccc3nnc(-c4ccccc4)n3n2)cc1Cl		CHEMBL1990212	<	Ki	nM	6309.57	CHEMBL4722	Homo sapiens	pKi		5.2
inactive	9586124	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	CCCCn1c(NC(=O)c2ccc(C#N)cc2)nc2cc(N(C)C(=O)C3CCCCC3)ccc21		CHEMBL484390	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
inactive	9586125	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	NCC(NC(=O)c1ccc(-c2ccncc2)cc1)c1ccccc1		CHEMBL1990254	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
inactive	9586126	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	O=c1c(NCc2cccc(C(F)(F)F)c2)c(Nc2ccncc2)c1=O		CHEMBL1979252	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
inactive	9586127	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	O=C(NC(CCO)c1ccccc1)c1ccc(-c2ccncc2)cc1		CHEMBL1986143	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
active	9586128	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Nc1ncnc2sccc12		CHEMBL1972934	=	Ki	nM	19952.62	CHEMBL4722	Homo sapiens	pKi		4.7
inactive	9586129	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	CCCNC(=O)c1ccc(Nc2nc(NCC(F)(F)F)c3sccc3n2)cc1		CHEMBL2007559	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
inactive	9586130	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	O=C(Cc1ccc(-c2cccnc2)cc1)Nc1ccc(SC(F)F)cc1		CHEMBL1992581	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
active	9586131	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	c1ccc(Cc2cn(-c3ccc4[nH]ncc4c3)nn2)cc1		CHEMBL1682341	=	Ki	nM	1258.93	CHEMBL4722	Homo sapiens	pKi		5.9
active	9586132	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	COc1ccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(CC(C)(C)O)c5)cnc(N)c34)cc2)cc1		CHEMBL2004290	=	Ki	nM	6.31	CHEMBL4722	Homo sapiens	pKi		8.2
inactive	9586133	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	COc1cccc(C=C2SC(=Nc3ccccc3)NC2=O)c1		CHEMBL1972937	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
active	9586134	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	C#Cc1cc2c(cc1OC)-c1[nH]nc(-c3ccc(C#N)nc3)c1C2		CHEMBL1972250	=	Ki	nM	794.33	CHEMBL4722	Homo sapiens	pKi		6.1
active	9586135	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	O=c1[nH]c2cnc(-n3cnc4ccc(F)cc43)nc2n1C1CCOc2c(F)cccc21		CHEMBL2000393	=	Ki	nM	10.0	CHEMBL4722	Homo sapiens	pKi		8.0
active	9586136	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	O=C(Nc1ccc(-n2cnc3ccccc32)cc1)Nc1cccc(C(F)(F)F)c1		CHEMBL1993510	=	Ki	nM	501.19	CHEMBL4722	Homo sapiens	pKi		6.3
inactive	9586137	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	COC(=O)c1cc2c(-c3cccc(F)c3)cncc2s1		CHEMBL2004072	<	Ki	nM	6309.57	CHEMBL4722	Homo sapiens	pKi		5.2
inactive	9586138	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	C=Cc1ccc(-c2cccc3nnc(N)n23)cc1		CHEMBL1983573	<	Ki	nM	31622.78	CHEMBL4722	Homo sapiens	pKi		4.5
active	9586139	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Cc1cc(C)cc(NC(=O)Nc2ccc(-c3cccc4c3CNC4=O)c(C)c2)c1		CHEMBL2004311	=	Ki	nM	630.96	CHEMBL4722	Homo sapiens	pKi		6.2
active	9586140	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Brc1cnc2[nH]cc(-c3ccccc3)c2c1		CHEMBL1992634	=	Ki	nM	316.23	CHEMBL4722	Homo sapiens	pKi		6.5
active	9586141	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Cc1cccc(NC(=O)Nc2ccc3c(c2)CCc2sc4ncnc(N)c4c2-3)c1		CHEMBL1242373	=	Ki	nM	79.43	CHEMBL4722	Homo sapiens	pKi		7.1
active	9586142	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	CCNNc1cc(C)c(C#N)c2nc3ccccc3n12		CHEMBL2000433	=	Ki	nM	5011.87	CHEMBL4722	Homo sapiens	pKi		5.3
active	9586143	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	CS(=O)(=O)Nc1ccc2c(c1)C(=NO)c1ccccc1-2		CHEMBL1985433	=	Ki	nM	398.11	CHEMBL4722	Homo sapiens	pKi		6.4
inactive	9586144	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	CC(=O)OCCn1nc(-c2cccc(Br)c2)c2c(C(F)(F)F)cc(=O)[nH]c21		CHEMBL1984847	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
inactive	9586145	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	CC(=O)c1c(-c2ccccc2)nn(C)c(=O)c1N		CHEMBL1984402	<	Ki	nM	63095.73	CHEMBL4722	Homo sapiens	pKi		4.2
inactive	9586146	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Fc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL316264	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
active	9586147	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Cc1ccc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5cccc(F)c5)cc4)csc23)cn1		CHEMBL1988075	=	Ki	nM	63.1	CHEMBL4722	Homo sapiens	pKi		7.2
inactive	9586148	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	O=C(Cc1ccc(OC(F)(F)F)cc1)N1CCC2(CC1)NCCc1c2[nH]c2ccccc12		CHEMBL1996576	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
inactive	9586149	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Cc1nccn2c(-c3ccnc(NCC(C)(C)CO)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL1991678	<	Ki	nM	1995.26	CHEMBL4722	Homo sapiens	pKi		5.7
inactive	9586150	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Nc1ncnc(Nc2cc(CNC(=O)C(F)(F)F)c(O)c(-c3ccc(Cl)cc3)c2)n1		CHEMBL2001239	<	Ki	nM	3981.07	CHEMBL4722	Homo sapiens	pKi		5.4
inactive	9586151	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Nc1ncnc2c1c(I)nn2C1OC(CO)C(O)C1O		CHEMBL2001288	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
active	9586152	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Nc1ncnc2c1N=C(c1ccc(NC(=O)Nc3cccc(C(F)(F)F)c3)cc1)CCN2		CHEMBL260092	=	Ki	nM	19.95	CHEMBL4722	Homo sapiens	pKi		7.7
inactive	9586153	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	CC(Nc1cncc(-n2cnc3ccc(C#N)cc32)n1)c1ccccc1F		CHEMBL1977138	<	Ki	nM	1995.26	CHEMBL4722	Homo sapiens	pKi		5.7
active	9586154	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	NC(=O)c1c(OCc2c(F)cc(Br)cc2F)nsc1NC(=O)NCCCCN1CCCC1		CHEMBL253969	=	Ki	nM	630.96	CHEMBL4722	Homo sapiens	pKi		6.2
inactive	9586155	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	O=C(NN=Cc1ccc(O)cc1O)Nc1cccc2nsnc12		CHEMBL1999811	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
active	9586156	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Cc1n[nH]c2ncc(C#N)c(-c3ccccc3)c12		CHEMBL1965495	=	Ki	nM	251.19	CHEMBL4722	Homo sapiens	pKi		6.6
inactive	9586157	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	COc1cc2ncc3c(N)nc4c(C)c(N)ccc4c3c2cc1OC		CHEMBL235157	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
inactive	9586158	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	CSc1ccc2nc3c(c(Cl)c2c1)CCNC3=O		CHEMBL1985074	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
active	9586159	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Nc1nc2ccc(-c3c(-c4ccc(F)cc4)nc4sccn34)cc2n1CC1CC1		CHEMBL1982874	=	Ki	nM	1258.93	CHEMBL4722	Homo sapiens	pKi		5.9
inactive	9586160	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	CNCc1ccc(-c2[nH]c3cc(F)cc4c3c2CCNC4=O)cc1		CHEMBL1173055	<	Ki	nM	6309.57	CHEMBL4722	Homo sapiens	pKi		5.2
inactive	9586161	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	CN(C)CC(=O)NC(COc1cncc(-c2ccc3cnccc3c2)c1)Cc1c[nH]c2ccccc12		CHEMBL1991725	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
inactive	9586162	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Cc1cc(C)cc(NC(=O)Nc2ccc(-c3cccc4sncc34)cc2)c1		CHEMBL1992242	<	Ki	nM	3981.07	CHEMBL4722	Homo sapiens	pKi		5.4
inactive	9586163	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O		CHEMBL189963	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
inactive	9586164	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	CCOc1nc(NC(C)=O)cc(N)c1C#N		CHEMBL208637	<	Ki	nM	3981.07	CHEMBL4722	Homo sapiens	pKi		5.4
inactive	9586165	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	COc1cccc(CNC(=O)c2cnc(-c3ccncc3)nc2)c1		CHEMBL2004159	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
active	9586166	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	O=C1NC(=O)C(Nc2ccccc2)=C1Cl		CHEMBL2007138	=	Ki	nM	15848.93	CHEMBL4722	Homo sapiens	pKi		4.8
active	9586167	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	N#CC1=C(c2ccccc2)CC(c2ccc(Cl)cc2)C(C(=O)c2ccccc2)C1=O		CHEMBL1978371	=	Ki	nM	316.23	CHEMBL4722	Homo sapiens	pKi		6.5
active	9586168	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Cc1cc(C)cc(NC(=O)Nc2ccc(NC(=O)c3csc4ncnc(N)c34)cc2)c1		CHEMBL1970203	=	Ki	nM	2.512	CHEMBL4722	Homo sapiens	pKi		8.6
inactive	9586169	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	O=C(c1cc(Cc2n[nH]c(=O)c3c2CCCC3)ccc1F)N1CCN(c2ncccn2)CC1		CHEMBL1986530	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
inactive	9586170	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL440084	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
inactive	9586171	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	CNC(=O)C=Cc1cnc(N)c2c(-c3ccc4sc(C)nc4c3)csc12		CHEMBL1968590	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
inactive	9586172	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	COc1cc(Nc2ncnc3ccc(-c4ccc(CN5CC6C(CO)C6C5)cc4)cc23)ccc1Oc1ccccc1		CHEMBL1999749	<	Ki	nM	6309.57	CHEMBL4722	Homo sapiens	pKi		5.2
inactive	9586173	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	CCC1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCCCC4)cc3OC)nc2N1C1CCCC1		CHEMBL2005375	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
inactive	9586174	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Clc1ccc(-c2n[nH]cc2-c2ccncn2)cc1Cl		CHEMBL1984191	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
active	9586175	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	COc1cc(C(=O)O)c(Cl)cc1NC(=O)Nc1cnc(C#N)cn1		CHEMBL1983006	=	Ki	nM	3162.28	CHEMBL4722	Homo sapiens	pKi		5.5
active	9586176	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	CNS(=O)(=O)c1ccccc1Nc1nc(Nc2cc(N3CCN(C(C)=O)CC3)ccc2OC)ncc1Br		CHEMBL1971029	=	Ki	nM	19.95	CHEMBL4722	Homo sapiens	pKi		7.7
inactive	9586177	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	CC(C)Nc1n[nH]c2ccc(N)cc12		CHEMBL1995391	<	Ki	nM	15848.93	CHEMBL4722	Homo sapiens	pKi		4.8
active	9586178	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Nc1nccc2scc(-c3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)c12		CHEMBL394790	=	Ki	nM	199.53	CHEMBL4722	Homo sapiens	pKi		6.7
inactive	9586179	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	O=C1NCCc2[nH]c(-c3ccnc(-c4ccccc4F)c3)cc21		CHEMBL226471	<	Ki	nM	3981.07	CHEMBL4722	Homo sapiens	pKi		5.4
active	9586180	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Cc1nc2c(sc3c(Br)ccc(Cl)c32)c(=O)o1		CHEMBL1974702	=	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
active	9586181	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	CN(C)C(=O)c1c(-c2ccc3[nH]ncc3c2)nnn1Cc1ccccc1		CHEMBL1996111	=	Ki	nM	158.49	CHEMBL4722	Homo sapiens	pKi		6.8
inactive	9586182	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	CC1CCN(C(=O)CC#N)CC1c1ncc2cnc3[nH]ccc3n12		CHEMBL1966175	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
inactive	9586183	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Cc1nccn2c(-c3ccnc(NCC4(O)CC4)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL1965589	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
inactive	9586184	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	CC#Cc1ccc2nccc(NC(=O)Nc3cccc(C(F)(F)F)n3)c2c1		CHEMBL2007375	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
inactive	9586185	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	O=C1NC(=O)c2c1c(-c1ccccc1Cl)cc1[nH]c3ccc(O)cc3c21		CHEMBL379975	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
active	9586186	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(=O)O)s3)c2cc1OC		CHEMBL474432	=	Ki	nM	794.33	CHEMBL4722	Homo sapiens	pKi		6.1
inactive	9586187	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Nc1n[nH]c2c(OCCCn3cccc3)ccc(-c3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)c12		CHEMBL1965387	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
active	9586188	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	c1cc2c(s1)CCc1cn[nH]c1-2		CHEMBL2001539	=	Ki	nM	31622.78	CHEMBL4722	Homo sapiens	pKi		4.5
active	9586189	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Cc1cc(-c2ncnc3[nH]ccc23)ccc1F		CHEMBL1997041	=	Ki	nM	10000.0	CHEMBL4722	Homo sapiens	pKi		5.0
active	9586190	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	CCCCN1CCN(c2ccc(-c3nc4c(C(N)=O)cccc4[nH]3)cc2)CC1		CHEMBL1970534	=	Ki	nM	794.33	CHEMBL4722	Homo sapiens	pKi		6.1
inactive	9586191	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Cc1nnc(-c2cc3c(Oc4ccc(C(F)(F)F)cc4)cncc3s2)o1		CHEMBL1988153	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
active	9586192	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	O=C(Nc1ccccc1)Nc1nccs1		CHEMBL1487428	=	Ki	nM	15848.93	CHEMBL4722	Homo sapiens	pKi		4.8
inactive	9586193	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	COc1cc(-c2ccc3c(c2)Nc2c(O)cccc2NC3=O)ccc1O		CHEMBL550418	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
active	9586194	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	CC(=O)N1CCN(C2CCC(n3nc(-c4ccc(NC(=O)c5cc6ccccc6n5C)cc4)c4c(N)ncnc43)CC2)CC1		CHEMBL1972584	=	Ki	nM	7.943	CHEMBL4722	Homo sapiens	pKi		8.1
inactive	9586195	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	N#Cc1ccc2[nH]c(O)c(-c3ccc(CN4CCOCC4)cn3)c2c1		CHEMBL1969664	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
inactive	9586196	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	CCOc1ccc(C=C2SC(=N)NC2=O)c(O)c1		CHEMBL1971289	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
active	9586197	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	NC(=O)c1cc2c(-c3ccccc3)cncc2s1		CHEMBL1999556	=	Ki	nM	2511.89	CHEMBL4722	Homo sapiens	pKi		5.6
active	9586198	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	CNC(=O)c1ccccc1Sc1ccc2c(C=Cc3ccccn3)n[nH]c2c1		CHEMBL1988437	=	Ki	nM	15.85	CHEMBL4722	Homo sapiens	pKi		7.8
inactive	9586199	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	NC(COc1cc(C=Cc2ccncc2)cnc1Cl)Cc1c[nH]c2ccccc12		CHEMBL1968245	<	Ki	nM	6309.57	CHEMBL4722	Homo sapiens	pKi		5.2
active	9586200	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#CC(C)(C)N)cnc(N)c34)cc2)c1		CHEMBL1979577	=	Ki	nM	50.12	CHEMBL4722	Homo sapiens	pKi		7.3
inactive	9586201	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	NCCC(C(=O)Nc1ccc2[nH]ncc2c1)c1ccc(Cl)c(Cl)c1		CHEMBL1998121	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
inactive	9586202	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	COc1ccc2c(c1)c(-c1cc3nccnc3[nH]1)cn2C		CHEMBL1233887	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
inactive	9586203	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	CC(C)(CO)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3c(CC4CC4)nccn23)n1		CHEMBL1991800	<	Ki	nM	3981.07	CHEMBL4722	Homo sapiens	pKi		5.4
inactive	9586204	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	CCC(CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL52387	<	Ki	nM	3981.07	CHEMBL4722	Homo sapiens	pKi		5.4
active	9586205	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	COc1cc(-c2ccc3c(c2)Nc2ccc(CCOc4ccc(N5CCOCC5)cc4)cc2NC3=O)ccc1CC#N		CHEMBL1985566	=	Ki	nM	3981.07	CHEMBL4722	Homo sapiens	pKi		5.4
inactive	9586206	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Cc1nn(-c2ccccc2)c2c1c(=O)c1cc(Cl)ccc1n2O		CHEMBL379835	<	Ki	nM	3981.07	CHEMBL4722	Homo sapiens	pKi		5.4
active	9586207	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	CC(C)CC(CO)NC(=O)C=Cc1cnc(N)c2ccccc12		CHEMBL1969284	=	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
inactive	9586208	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Cn1cc(C(CN)c2cncc(C=Cc3ccncc3)c2)c2ccccc21		CHEMBL1979357	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
inactive	9586209	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	N#Cc1ncc2nc1OCC(O)C(O)COc1ccc(Cl)cc1NC(=O)N2		CHEMBL1980802	<	Ki	nM	6309.57	CHEMBL4722	Homo sapiens	pKi		5.2
active	9586210	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	CCN(CC)CCCNC(=O)c1cnc(N)c2c(-c3ccc(NC(=O)Nc4cccc(F)c4)cc3)csc12		CHEMBL1996649	=	Ki	nM	19.95	CHEMBL4722	Homo sapiens	pKi		7.7
inactive	9586211	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	CCCCOc1ncnc2[nH]cc(-c3ccccc3)c12		CHEMBL1996817	<	Ki	nM	794.33	CHEMBL4722	Homo sapiens	pKi		6.1
inactive	9586212	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	O=c1c(NCc2ccc(Cl)cc2Cl)c(Nc2ccc3[nH]ncc3c2)c1=O		CHEMBL1979554	<	Ki	nM	6309.57	CHEMBL4722	Homo sapiens	pKi		5.2
inactive	9586213	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	CCc1ccc2c(NC(=O)Nc3cccc(C(F)(F)F)n3)ccnc2c1		CHEMBL1986756	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
active	9586214	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	CCOc1nc(C(=O)NCc2ccc(S(N)(=O)=O)cc2)cc(N)c1C#N		CHEMBL2004355	=	Ki	nM	6309.57	CHEMBL4722	Homo sapiens	pKi		5.2
active	9586215	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	COc1cc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2OC)=NC3)ccc1C(=O)O		CHEMBL483158	=	Ki	nM	0.5012	CHEMBL4722	Homo sapiens	pKi		9.3
inactive	9586216	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	CCn1c2cc(Cl)c(F)cc2c(=O)c2c(=O)o[nH]c21		CHEMBL468280	<	Ki	nM	3162.28	CHEMBL4722	Homo sapiens	pKi		5.5
inactive	9586217	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Cc1cc(C)c2oc(Nc3ccc(-c4cccc(C(N)=O)c4N)cc3F)nc2c1		CHEMBL1990884	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
inactive	9586218	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	CCN(CC)CCNC(=O)c1c(C)[nH]c(C=C2C(=O)Nc3ccc(F)cc32)c1C		CHEMBL1990885	<	Ki	nM	630.96	CHEMBL4722	Homo sapiens	pKi		6.2
inactive	9586219	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	COc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCC(O)CC2)n1		CHEMBL256835	<	Ki	nM	2511.89	CHEMBL4722	Homo sapiens	pKi		5.6
active	9586220	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	O=C(Nc1cccc(C(F)(F)F)n1)Nc1ccnc2c(C(F)(F)F)cccc12		CHEMBL1980142	=	Ki	nM	1258.93	CHEMBL4722	Homo sapiens	pKi		5.9
inactive	9586221	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	CN(C)CCCC(=O)Nc1n[nH]c2nnc(-c3cccc(F)c3F)cc12		CHEMBL41783	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
inactive	9586222	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Nc1c(-c2ccc(NC(=O)Nc3cccc(C(F)(F)F)c3)cc2)ccc2nccnc12		CHEMBL2004438	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
inactive	9586223	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	COc1cccc2c1Nc1cc(Nc3ccncc3)ccc1C(=O)N2		CHEMBL2006276	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
active	9586224	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	=	Ki	nM	50.12	CHEMBL4722	Homo sapiens	pKi		7.3
active	9586225	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	COc1ccc(-c2ccc(NC(=O)Nc3cccc(Br)c3)cc2)c2c(N)noc12		CHEMBL271381	=	Ki	nM	125.89	CHEMBL4722	Homo sapiens	pKi		6.9
inactive	9586226	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Cc1ccc(C(=O)Nc2c(C#N)sc3ccc(Cl)c(Cl)c23)cc1		CHEMBL2006785	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
active	9586227	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Cc1ccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(C)c5)cnc(N)c34)cc2)cc1		CHEMBL1982466	=	Ki	nM	10.0	CHEMBL4722	Homo sapiens	pKi		8.0
active	9586228	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	NC(=O)c1ccc2nc(-c3ccc([N+](=O)[O-])o3)cn2c1		CHEMBL1973359	=	Ki	nM	125.89	CHEMBL4722	Homo sapiens	pKi		6.9
inactive	9586229	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	COc1cc(-c2ccc3c(c2)Nc2ccc([N+](=O)[O-])cc2NC3=O)ccc1O		CHEMBL1995740	<	Ki	nM	3981.07	CHEMBL4722	Homo sapiens	pKi		5.4
active	9586230	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	O=C(O)c1cc2c(-c3ccccc3)cncc2s1		CHEMBL1996390	=	Ki	nM	1000.0	CHEMBL4722	Homo sapiens	pKi		6.0
active	9586231	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	OC1CCC(Nc2nc(Cl)cc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL1986943	=	Ki	nM	794.33	CHEMBL4722	Homo sapiens	pKi		6.1
active	9586232	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	CN1CCN(c2ccc(Nc3ncc(Cl)c(Nc4ccc5[nH]ncc5c4)n3)cc2)CC1		CHEMBL1979690	=	Ki	nM	19.95	CHEMBL4722	Homo sapiens	pKi		7.7
inactive	9586233	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	CC1CCN(C(=O)CC#N)CC1N(C)c1ncnc2[nH]ccc12		CHEMBL234085	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
active	9586234	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Cc1n[nH]c2sc(C(=O)NCCc3ccc(Cl)cc3)cc12		CHEMBL1998414	=	Ki	nM	630.96	CHEMBL4722	Homo sapiens	pKi		6.2
inactive	9586235	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	COc1nccn2c(-c3ccnc(NCC(C)(C)CO)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL1995832	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
inactive	9586236	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Oc1ccc(Nc2[nH]nc(-c3ccc(O)cc3)c2-c2ccc(O)cc2)cc1		CHEMBL1969042	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
active	9586237	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Cc1cc(N2CCOCC2)cc2[nH]c(-c3c(NCCc4ccccc4)cc[nH]c3=O)nc12		CHEMBL2005714	=	Ki	nM	794.33	CHEMBL4722	Homo sapiens	pKi		6.1
inactive	9586238	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	COc1cc(C=C(C#N)c2nc3cc(C)ccc3[nH]2)c(Br)cc1O		CHEMBL2000345	<	Ki	nM	1258.93	CHEMBL4722	Homo sapiens	pKi		5.9
active	9586239	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	O=C(Nc1n[nH]c2ccc(-c3cn(Cc4ccccc4)nn3)cc12)c1ccccc1		CHEMBL1999931	=	Ki	nM	158.49	CHEMBL4722	Homo sapiens	pKi		6.8
inactive	9586240	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Nc1ncnc2c1c(-c1ccc(Oc3ccc(CO)cc3)cc1)cn2C1CCOC1		CHEMBL1976376	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
active	9586241	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	O=c1[nH]sc2c1c(=O)c1cc(F)c(NCc3ccccc3)c(F)c1n2C1CC1		CHEMBL1991640	=	Ki	nM	3981.07	CHEMBL4722	Homo sapiens	pKi		5.4
inactive	9586242	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	C(=Cc1ccc2nccn2n1)c1ccccc1		CHEMBL1988622	<	Ki	nM	63095.73	CHEMBL4722	Homo sapiens	pKi		4.2
active	9586243	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	O=C(NN=Cc1cc(Br)c(O)c(Br)c1)Nc1ccccc1		CHEMBL1983575	=	Ki	nM	50.12	CHEMBL4722	Homo sapiens	pKi		7.3
inactive	9586244	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	NC(=O)c1cccc2[nH]c(-c3ccc(-n4ccc(CN5CCCCC5)c4)cc3)nc12		CHEMBL2006873	<	Ki	nM	1995.26	CHEMBL4722	Homo sapiens	pKi		5.7
inactive	9586245	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	N#Cc1cccc(NC(=O)Nc2ccnc3cc(C(F)(F)F)ccc23)n1		CHEMBL1968868	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
active	9586246	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Cn1c2ccccc2c2c3c(c4c5ccccc5n(CCC#N)c4c21)CNC3=O		CHEMBL302449	=	Ki	nM	31.62	CHEMBL4722	Homo sapiens	pKi		7.5
active	9586247	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Cc1[nH]c(C=C2C(=O)Nc3ccccc32)c(C)c1CCC(=O)O		CHEMBL2007064	=	Ki	nM	15.85	CHEMBL4722	Homo sapiens	pKi		7.8
active	9586248	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	COC(C(=O)N1Cc2[nH]nc(NC(=O)c3ccc(N4CCN(C)CC4)cc3)c2C1)c1ccccc1		CHEMBL1981047	=	Ki	nM	7.943	CHEMBL4722	Homo sapiens	pKi		8.1
active	9586249	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Cc1n[nH]c2ccc(-c3cncc(OCC(N)Cc4ccc(Cl)c(Cl)c4)c3)cc12		CHEMBL1991063	=	Ki	nM	1000.0	CHEMBL4722	Homo sapiens	pKi		6.0
inactive	9586250	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	O=C(Nc1ccc([N+](=O)[O-])cc1)N1CCc2[nH]c3c(Cl)cc(Cl)cc3c2C1		CHEMBL1976196	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
inactive	9586251	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	COc1cccc(C(CN)NC(=O)c2ccc(-c3ccncc3)cc2)c1		CHEMBL1976240	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
inactive	9586252	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	COc1ccccc1CNC(=N)Nc1nccc(-c2cccs2)n1		CHEMBL1997197	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
active	9586253	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	O=C1Cc2cc(-c3ccccc3)cnc2N1		CHEMBL1983630	=	Ki	nM	19952.62	CHEMBL4722	Homo sapiens	pKi		4.7
active	9586254	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	COc1ccc(-c2ccc(NC(=O)Nc3ccc(F)c(C)c3)cc2)c2c(N)noc12		CHEMBL1979093	=	Ki	nM	100.0	CHEMBL4722	Homo sapiens	pKi		7.0
inactive	9586255	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	O=c1[nH]c2sccc2c2nc(-c3ccncc3)nn12		CHEMBL1968151	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
inactive	9586256	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Clc1ccc(CNc2ccc3nnc(-c4ccccc4)n3n2)cc1		CHEMBL1381197	<	Ki	nM	6309.57	CHEMBL4722	Homo sapiens	pKi		5.2
inactive	9586257	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	O=C1NCc2ccc(-c3ccccc3)cc21		CHEMBL1973795	<	Ki	nM	63095.73	CHEMBL4722	Homo sapiens	pKi		4.2
active	9586258	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	COc1cccc(CNC(=O)c2cc3c(-c4ccccc4)n[nH]c3s2)c1		CHEMBL1987009	=	Ki	nM	50.12	CHEMBL4722	Homo sapiens	pKi		7.3
active	9586259	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Cc1n[nH]c2ccc(-c3cncc(OCC(N)Cc4ccccc4)c3)cc12		CHEMBL2002726	=	Ki	nM	5011.87	CHEMBL4722	Homo sapiens	pKi		5.3
inactive	9586260	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	O=C(Nc1cnccn1)Nc1ccnc2cc(C(F)(F)F)ccc12		CHEMBL2003817	<	Ki	nM	3162.28	CHEMBL4722	Homo sapiens	pKi		5.5
inactive	9586261	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ncccc2N1		CHEMBL336961	<	Ki	nM	6309.57	CHEMBL4722	Homo sapiens	pKi		5.2
inactive	9586262	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Nc1nnc(-c2cc3c(Oc4ccc(Cl)cc4)cncc3s2)o1		CHEMBL1994830	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
active	9586263	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	COCCOC1CCC(n2nc(-c3ccc(Nc4nc5cc(C)cc(Cl)c5o4)cc3)c3c(N)ncnc32)CC1		CHEMBL1987054	=	Ki	nM	7.943	CHEMBL4722	Homo sapiens	pKi		8.1
active	9586264	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Nc1ncc(-c2ccncc2)c2scc(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL1970083	=	Ki	nM	100.0	CHEMBL4722	Homo sapiens	pKi		7.0
inactive	9586265	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	O=C1NCCc2[nH]c(-c3ccnc(-c4cnc5ccccc5c4)c3)cc21		CHEMBL226403	<	Ki	nM	1000.0	CHEMBL4722	Homo sapiens	pKi		6.0
active	9586266	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	CCS(=O)(=O)Nc1ccc2c(c1)C(=NO)c1ccccc1-2		CHEMBL1977652	=	Ki	nM	630.96	CHEMBL4722	Homo sapiens	pKi		6.2
active	9586267	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	CC(Nc1cncc(-n2cnc3ccccc32)n1)c1ccc(F)cc1		CHEMBL1976530	=	Ki	nM	1258.93	CHEMBL4722	Homo sapiens	pKi		5.9
active	9586268	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	O=C(O)c1ccccc1Nc1nc(Nc2cccc(O)c2)ncc1F		CHEMBL243749	=	Ki	nM	5.012	CHEMBL4722	Homo sapiens	pKi		8.3
active	9586269	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	CNC(=O)c1cnc(N)c2c(-c3ccc(NC(=O)Nc4cc(C)ccc4F)cc3)csc12		CHEMBL2005631	=	Ki	nM	6.31	CHEMBL4722	Homo sapiens	pKi		8.2
inactive	9586270	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Nc1ncc(C=CC(=O)NCCCn2ccnc2)c2scc(-c3ccc(Br)cc3)c12		CHEMBL1994938	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
active	9586271	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	CC(Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL1825138	=	Ki	nM	79.43	CHEMBL4722	Homo sapiens	pKi		7.1
active	9586272	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	CCCC(=O)Nc1n[nH]c2ccc(-c3cn(Cc4ccccc4)nn3)cc12		CHEMBL1977223	=	Ki	nM	501.19	CHEMBL4722	Homo sapiens	pKi		6.3
active	9586273	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Nc1cc(=O)[nH]n1-c1ccccn1		CHEMBL1995765	=	Ki	nM	7943.28	CHEMBL4722	Homo sapiens	pKi		5.1
inactive	9586274	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Cc1cc(-c2ccc3c(c2)CNC3=O)ccc1F		CHEMBL1976290	<	Ki	nM	63095.73	CHEMBL4722	Homo sapiens	pKi		4.2
inactive	9586275	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	CC(C)(C)C(=O)Oc1ccc2c(c1)nc(NC(=O)c1cccc([N+](=O)[O-])c1)n2CCCO		CHEMBL1236126	<	Ki	nM	3981.07	CHEMBL4722	Homo sapiens	pKi		5.4
inactive	9589841	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Clc1cc(NC2CCCCC2)nc(-c2c[nH]c3ncccc23)n1		CHEMBL1997846	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
active	9589842	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	CCCNC(=O)c1ccc(Nc2nc(CCC(F)(F)F)c3cc[nH]c3n2)cc1		CHEMBL1984760	=	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
inactive	9589843	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	CC(C)Cn1c(N)nc2c(F)cc(-c3c(-c4ccc(F)cc4)nc4sccn34)cc21		CHEMBL2004419	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
active	9589844	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	CC(=NNC(=N)N)c1cc(NC(=O)NCCCCCCNC(=O)Nc2cc(C(C)=NNC(=N)N)cc(C(C)=NNC(=N)N)c2)cc(C(C)=NNC(=N)N)c1		CHEMBL1991728	=	Ki	nM	5011.87	CHEMBL4722	Homo sapiens	pKi		5.3
inactive	9589845	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	CN(C)CC1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL360847	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
inactive	9589846	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	O=C(Nc1n[nH]c2ccc(-c3cn(Cc4ccccc4)nn3)cc12)c1cc(F)ccc1F		CHEMBL1995811	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
active	9589847	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	NC(=O)c1cc2c(-c3ccc(F)cc3F)cncc2s1		CHEMBL1975787	=	Ki	nM	2511.89	CHEMBL4722	Homo sapiens	pKi		5.6
inactive	9589848	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	CNC(=O)c1cc(-c2ccccc2)[nH]n1		CHEMBL1995916	<	Ki	nM	63095.73	CHEMBL4722	Homo sapiens	pKi		4.2
active	9589849	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	COc1cc(C=C(C#N)c2n[nH]c(N)c2C#N)ccc1O		CHEMBL2002407	=	Ki	nM	3981.07	CHEMBL4722	Homo sapiens	pKi		5.4
inactive	9589850	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	O=C(Nc1ccc2cn[nH]c2c1)c1ccc(Cl)cc1		CHEMBL1972489	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
inactive	9589851	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Brc1ccc2[nH]nc(-c3ccccc3)c2c1		CHEMBL1994074	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
inactive	9589852	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Cc1ccc(Nc2nc3ccc([N+](=O)[O-])cc3[nH]2)nc1		CHEMBL1992937	<	Ki	nM	1258.93	CHEMBL4722	Homo sapiens	pKi		5.9
active	9589853	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	NC(=O)c1cccc2cn[nH]c12		CHEMBL451401	=	Ki	nM	31622.78	CHEMBL4722	Homo sapiens	pKi		4.5
inactive	9589854	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	O=C(Nc1cccc(N2CCOCC2)n1)Nc1ccnc2c(C(F)(F)F)cccc12		CHEMBL1972119	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
inactive	9589855	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	CN(C)C(=O)Nc1ccc2nc(-c3ccco3)c(-c3ccco3)nc2c1		CHEMBL1986328	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
inactive	9589856	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	COc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL95692	<	Ki	nM	3981.07	CHEMBL4722	Homo sapiens	pKi		5.4
active	9589857	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	O=C(Cc1ccccc1)Nc1cccc(-c2nc3sccn3c2-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)c1		CHEMBL1090356	=	Ki	nM	630.96	CHEMBL4722	Homo sapiens	pKi		6.2
inactive	9589858	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	COc1ccc(-c2ccc(N)cc2)c2cnoc12		CHEMBL2002450	<	Ki	nM	50118.72	CHEMBL4722	Homo sapiens	pKi		4.3
active	9589859	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	O=C(Nc1cnccn1)Nc1ccnc2ccc(C(F)(F)F)cc12		CHEMBL1976455	=	Ki	nM	1995.26	CHEMBL4722	Homo sapiens	pKi		5.7
inactive	9589860	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
active	9589861	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(C=Cc3ccccc3)n2)n[nH]1		CHEMBL1983923	=	Ki	nM	15.85	CHEMBL4722	Homo sapiens	pKi		7.8
inactive	9589862	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	c1ccc(CNc2nc3ccc(-c4ccncc4)cc3s2)cc1		CHEMBL1983534	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
inactive	9589863	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	O=c1c(NCc2ccccc2F)c(Nc2ccncc2)c1=O		CHEMBL1982361	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
inactive	9589864	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	CCOC(=O)C1=c2sc(=Cc3ccco3)c(=O)n2C(N)=C(C#N)C1c1ccco1		CHEMBL1999112	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
inactive	9589865	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	OCCC(Nc1nc2ccc(-c3ccncc3)cc2s1)c1ccccc1		CHEMBL1982122	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
inactive	9589866	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	O=C(Nc1ccc(-c2cccc3sncc23)cc1)Nc1ccc(F)c(C(F)(F)F)c1		CHEMBL2000801	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
inactive	9589867	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	c1ccc(CNc2nc(-c3ccc4[nH]ncc4c3)cs2)cc1		CHEMBL1682546	<	Ki	nM	1995.26	CHEMBL4722	Homo sapiens	pKi		5.7
inactive	9589868	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	CC(C)(CO)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3cnccn23)n1		CHEMBL1991395	<	Ki	nM	3162.28	CHEMBL4722	Homo sapiens	pKi		5.5
inactive	9589869	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	CN1CCN(c2cccc(Nc3nccc(-c4c(C(N)=O)nc5ccccn45)n3)c2)CC1		CHEMBL1971245	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
active	9589870	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Cc1cc(N=Cc2ccc(O)c(O)c2)c2ccccc2n1		CHEMBL1991915	=	Ki	nM	25.12	CHEMBL4722	Homo sapiens	pKi		7.6
inactive	9589871	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Cc1nccn2c(-c3ccnc(NCC(C)(C)CO)n3)c(-c3ccc(F)cc3)nc12		CHEMBL1987648	<	Ki	nM	6309.57	CHEMBL4722	Homo sapiens	pKi		5.2
inactive	9589872	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	CCOC(=O)c1cn(-c2ccc(O)cc2C)c2cc(-c3ccncc3)ccc2c1=O		CHEMBL1996780	<	Ki	nM	6309.57	CHEMBL4722	Homo sapiens	pKi		5.2
active	9589873	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	COCCOC1CCC(n2nc(-c3ccc(Nc4nc5cc(Cl)cc(C)c5o4)c(F)c3)c3c(N)ncnc32)CC1		CHEMBL1988769	=	Ki	nM	125.89	CHEMBL4722	Homo sapiens	pKi		6.9
inactive	9589874	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	O=C(NCc1ccccc1)c1cccc(-c2cnc3[nH]ccc3c2)c1		CHEMBL1972142	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
active	9589875	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Nc1ncc(-c2ccoc2)c2scc(-c3ccc(NC(=O)Nc4cccc(F)c4)cc3)c12		CHEMBL1966514	=	Ki	nM	50.12	CHEMBL4722	Homo sapiens	pKi		7.3
inactive	9589876	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	CCCCCCCCCCCCOc1ccc(NC(=N)N)cc1NC(=N)N		CHEMBL1980715	<	Ki	nM	6309.57	CHEMBL4722	Homo sapiens	pKi		5.2
active	9589877	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	O=C(Nc1n[nH]c2ccc(-c3cn(Cc4ccccc4)nn3)cc12)c1cccc(F)c1		CHEMBL2003638	=	Ki	nM	125.89	CHEMBL4722	Homo sapiens	pKi		6.9
active	9589878	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ccccc2N1		CHEMBL296586	=	Ki	nM	1258.93	CHEMBL4722	Homo sapiens	pKi		5.9
inactive	9589879	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	N#Cc1ccc2nc(N)n(-c3nc(-c4ccccc4)cs3)c2c1		CHEMBL1996066	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
inactive	9589880	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	O=C(Nc1cccc(F)c1)Nc1cccc(-c2ccc3cn[nH]c3c2)c1		CHEMBL1983393	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
inactive	9589881	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	NC(COc1cncc(-c2cc3ccncc3s2)c1)Cc1c[nH]c2ccccc12		CHEMBL1966524	<	Ki	nM	6309.57	CHEMBL4722	Homo sapiens	pKi		5.2
inactive	9589882	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	O=S(=O)(Nc1ccc2c(c1)C(=NO)c1ccccc1-2)c1cccc(Cl)c1		CHEMBL1999910	<	Ki	nM	1995.26	CHEMBL4722	Homo sapiens	pKi		5.7
active	9589883	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Nc1n[nH]c2cccc(-c3ccc(NC(=O)Nc4cc(C(=O)O)ccc4F)cc3)c12		CHEMBL1993722	=	Ki	nM	316.23	CHEMBL4722	Homo sapiens	pKi		6.5
inactive	9589884	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	O=c1[nH]c2sc3c(c2c2nc(-c4cccnc4)nn12)CCCC3		CHEMBL1970806	<	Ki	nM	3162.28	CHEMBL4722	Homo sapiens	pKi		5.5
inactive	9589885	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCCC3CCO)nc12		CHEMBL2006674	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
inactive	9589886	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	CN(C)c1ccc(Nc2cc(-c3csc(Br)c3)[nH]n2)cc1		CHEMBL1984236	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
inactive	9589887	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	O=C(Nc1cnccn1)Nc1cccc2c(O)cccc12		CHEMBL1992371	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
inactive	9589888	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Cc1nc(COc2ccccc2Cl)sc1-c1ccnc(N)n1		CHEMBL1375640	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
inactive	9589889	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	CCCC(=O)Nc1n[nH]c2nnc(-c3cccc(F)c3F)cc12		CHEMBL1979970	<	Ki	nM	2511.89	CHEMBL4722	Homo sapiens	pKi		5.6
inactive	9589890	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	O=C(Nc1cnccn1)Nc1ccnc2ccc(N3CC4COCC4C3)cc12		CHEMBL2002599	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
inactive	9589891	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	N#Cc1ccc(-c2n[nH]c3c2Cc2ccc(OCCN4CCOCC4)cc2-3)cn1		CHEMBL249282	<	Ki	nM	1258.93	CHEMBL4722	Homo sapiens	pKi		5.9
active	9589892	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Cc1n[nH]c2ccc(-c3cccnc3)cc12		CHEMBL1967252	=	Ki	nM	15848.93	CHEMBL4722	Homo sapiens	pKi		4.8
active	9589893	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	COc1cc(Nc2ncc(C(F)(F)F)c(OC)n2)cc(OC)c1OC		CHEMBL1993966	=	Ki	nM	50.12	CHEMBL4722	Homo sapiens	pKi		7.3
inactive	9589894	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	CCN(CCN)C(=O)c1cccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2cccc3ccccc23)c1		CHEMBL2004637	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
inactive	9589895	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	CC(C)C(C)Nc1ncc(Cl)c(Nc2nccs2)n1		CHEMBL1993374	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
active	9589896	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	CC(C)(C)NC(=O)c1ccc2nc3[nH]c4ccccc4c3nc2c1		CHEMBL1969264	=	Ki	nM	1995.26	CHEMBL4722	Homo sapiens	pKi		5.7
active	9589897	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	N#Cc1c(O)[nH]c(=O)c2c(=N)oc3ccc(Cl)cc3c12		CHEMBL1973711	=	Ki	nM	2511.89	CHEMBL4722	Homo sapiens	pKi		5.6
inactive	9589898	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	CN1CCN(CCCNc2cccc(-c3nc4c(C(N)=O)cccc4[nH]3)n2)CC1		CHEMBL2006237	<	Ki	nM	3981.07	CHEMBL4722	Homo sapiens	pKi		5.4
active	9589899	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	CC(C)(C(N)=O)n1cc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5cccc(F)c5)cc4)csc23)cn1		CHEMBL1967720	=	Ki	nM	3.162	CHEMBL4722	Homo sapiens	pKi		8.5
inactive	9589900	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Nc1nccn2c(C3CC(CN4CCCC4)C3)nc(-c3cccc(OCc4ccccc4)c3)c12		CHEMBL1991138	<	Ki	nM	3981.07	CHEMBL4722	Homo sapiens	pKi		5.4
inactive	9589901	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	O=C(NC(CO)Cc1ccccc1)c1ccc(-c2ccncc2)cc1F		CHEMBL1969755	<	Ki	nM	3981.07	CHEMBL4722	Homo sapiens	pKi		5.4
active	9589902	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	CCNC(=O)c1cnc(N)c2c(-c3ccc(NC(=O)Nc4cccc(F)c4)cc3)csc12		CHEMBL1979516	=	Ki	nM	1.995	CHEMBL4722	Homo sapiens	pKi		8.7
inactive	9589903	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	CC(N)C1CCC(C(=O)Nc2ccncc2)CC1		CHEMBL1994526	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
active	9589904	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	CC(C)OC1=NNC(=O)C1=Cc1c[nH]c2ccccc12		CHEMBL1989029	=	Ki	nM	501.19	CHEMBL4722	Homo sapiens	pKi		6.3
inactive	9589905	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	CSc1ccccc1CNc1ncc([N+](=O)[O-])c(NCC2CCC(CN)CC2)n1		CHEMBL392642	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
inactive	9589906	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(N)=O)s3)c2cc1OC		CHEMBL514499	<	Ki	nM	3981.07	CHEMBL4722	Homo sapiens	pKi		5.4
active	9589907	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	CCOC(=O)c1c(C)n(-c2ccc(I)cc2)c2c1cc(O)c1ccccc12		CHEMBL1970352	=	Ki	nM	630.96	CHEMBL4722	Homo sapiens	pKi		6.2
inactive	9589908	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	CN(C)CC(=O)Nc1n[nH]c2ccc(-c3cn(Cc4ccccc4)nn3)cc12		CHEMBL1965631	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
active	9589909	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Cc1ccccc1NC(=O)Nc1ccc(NC(=O)c2csc3ncnc(N)c23)cc1		CHEMBL1980144	=	Ki	nM	6.31	CHEMBL4722	Homo sapiens	pKi		8.2
active	9589910	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	CN(C)c1ccc(-c2cc(-c3ccc([N+](=O)[O-])cc3)nc(NS(=O)(=O)c3ccc(N)cc3)n2)cc1		CHEMBL1980167	=	Ki	nM	501.19	CHEMBL4722	Homo sapiens	pKi		6.3
inactive	9589911	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	CCOc1nc(C(=O)NCc2ccccc2S(N)(=O)=O)cc(N)c1C#N		CHEMBL377408	<	Ki	nM	6309.57	CHEMBL4722	Homo sapiens	pKi		5.2
active	9589912	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	=	Ki	nM	316.23	CHEMBL4722	Homo sapiens	pKi		6.5
active	9589913	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Nc1nccc2scc(-c3ccc(NC(=O)Nc4cccc(F)c4)cc3)c12		CHEMBL231209	=	Ki	nM	501.19	CHEMBL4722	Homo sapiens	pKi		6.3
active	9589914	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Nc1nccc2scc(-c3ccc(NC(=O)Nc4cccc(Br)c4)cc3)c12		CHEMBL1976220	=	Ki	nM	125.89	CHEMBL4722	Homo sapiens	pKi		6.9
active	9589915	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	CCCNC(=O)c1ccc(Nc2nc(NCC(F)(F)F)c3cc[nH]c3n2)cc1		CHEMBL2006765	=	Ki	nM	199.53	CHEMBL4722	Homo sapiens	pKi		6.7
inactive	9589916	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Cc1ccc(C(=O)Nc2ccon2)cc1Nc1ncnc2c1cnn2-c1ccccc1		CHEMBL259922	<	Ki	nM	3981.07	CHEMBL4722	Homo sapiens	pKi		5.4
inactive	9589917	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	CN1CCN(C2CCC(n3cc(-c4ccc(Oc5ccccc5)cc4)c4c(N)ncnc43)CC2)CC1		CHEMBL1997617	<	Ki	nM	1258.93	CHEMBL4722	Homo sapiens	pKi		5.9
inactive	9589918	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	CCCCn1c(NC(=O)c2cccc(C#N)c2)nc2cc(N(C)C(=O)C3CCCCC3)ccc21		CHEMBL1969301	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
inactive	9589919	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	CC(C)(CO)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3c(CCN)nccn23)n1		CHEMBL1982383	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
inactive	9589920	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	CSc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL17370	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
inactive	9589921	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	NCc1cc(Nc2ncnc(-c3ccccc3)n2)ccc1O		CHEMBL1980246	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
inactive	9589922	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Nc1nccc2scc(-c3ccc(NC(=O)Nc4ccccc4C(F)(F)F)cc3)c12		CHEMBL1987910	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
inactive	9589923	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	COc1ccc2c(NC(=O)Nc3cccc(Br)n3)ccnc2c1		CHEMBL1983932	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
active	9589924	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	O=C(Nc1nc2ccccc2s1)c1cccc2c1CN(c1nc(C(=O)O)c(-c3ccc(CO)cc3)s1)CC2		CHEMBL1983980	=	Ki	nM	199.53	CHEMBL4722	Homo sapiens	pKi		6.7
active	9589925	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	COc1ccc(-c2cc(=O)c3c(O)c(OC)c(OC)cc3o2)cc1O		CHEMBL487402	=	Ki	nM	1000.0	CHEMBL4722	Homo sapiens	pKi		6.0
active	9589926	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	CNc1nc(C)c(-c2ccnc(Nc3ccc(N4CCNCC4)cc3)n2)s1		CHEMBL1999484	=	Ki	nM	125.89	CHEMBL4722	Homo sapiens	pKi		6.9
active	9589927	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Nc1ncc(-c2cnn(CCO)c2)c2scc(-c3ccc(NC(=O)Nc4cccc(F)c4)cc3)c12		CHEMBL1980297	=	Ki	nM	1.995	CHEMBL4722	Homo sapiens	pKi		8.7
inactive	9589928	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	NC(=O)c1csc2c1NCCC2=O		CHEMBL1973399	<	Ki	nM	63095.73	CHEMBL4722	Homo sapiens	pKi		4.2
active	9589929	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	c1ccc2c(c1)nnn2Cc1cn(-c2ccc3[nH]ncc3c2)nn1		CHEMBL1966069	=	Ki	nM	3162.28	CHEMBL4722	Homo sapiens	pKi		5.5
active	9589930	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Cc1ccc(NCc2ccc(-c3ccc(F)cc3)nc2)cc1		CHEMBL1986899	=	Ki	nM	316.23	CHEMBL4722	Homo sapiens	pKi		6.5
inactive	9589931	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Cc1cc(OCC2CCC(C(=O)O)C2)c(NC(=O)Nc2cnc(C#N)cn2)cc1Cl		CHEMBL1991285	<	Ki	nM	2511.89	CHEMBL4722	Homo sapiens	pKi		5.6
active	9589932	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Cc1cc2cc(-c3csc4c(-c5cccc(S(C)(=O)=O)c5)cnc(N)c34)ccc2[nH]1		CHEMBL1997822	=	Ki	nM	3981.07	CHEMBL4722	Homo sapiens	pKi		5.4
active	9589933	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	O=C(O)c1ccccc1Nc1ccnc(Nc2cccc(O)c2)n1		CHEMBL243088	=	Ki	nM	12.59	CHEMBL4722	Homo sapiens	pKi		7.9
inactive	9589934	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	COc1cc(-c2ccc3c(c2)NC(=O)c2ccc(-c4ccccc4NS(C)(=O)=O)cc2N3)cc(OC)c1OC		CHEMBL1984038	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
active	9589935	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	CNS(=O)(=O)c1ccccc1Nc1nc(Nc2cc(OC)c(OC)c(OC)c2)ncc1Cl		CHEMBL1993661	=	Ki	nM	5.012	CHEMBL4722	Homo sapiens	pKi		8.3
inactive	9589936	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	O=C(Nc1cnc2[nH]cc(-c3ccccc3)c2c1)c1cccc(F)c1F		CHEMBL1974416	<	Ki	nM	1584.89	CHEMBL4722	Homo sapiens	pKi		5.8
active	9589937	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	Nc1nccc(-c2ccccc2)n1		CHEMBL1834385	=	Ki	nM	15848.93	CHEMBL4722	Homo sapiens	pKi		4.8
active	9589938	CHEMBL1963727	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK6	F	COc1cc2c(cc1F)C(c1ccccc1Cl)=Nc1c(n[nH]c1C)N2		CHEMBL1980391	=	Ki	nM	25.12	CHEMBL4722	Homo sapiens	pKi		7.6
	10836856	CHEMBL2013811	Inhibition of aurora A kinase	B	O=C1N=C(NCc2cccs2)S/C1=C\c1ccc2ncccc2c1		CHEMBL393929	>	IC50	nM	10000.0	CHEMBL4722	Homo sapiens	IC50	uM	10.0
	10836857	CHEMBL2013811	Inhibition of aurora A kinase	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	=	IC50	nM	1.5	CHEMBL4722	Homo sapiens	IC50	uM	0.0015
	10836858	CHEMBL2013811	Inhibition of aurora A kinase	B	CC(C)n1ncc2cnc(Nc3cc(C(N)=O)n(C)c3)nc21		CHEMBL2012308	=	IC50	nM	230.0	CHEMBL4722	Homo sapiens	IC50	uM	0.23
	10836859	CHEMBL2013811	Inhibition of aurora A kinase	B	Cn1cc(Nc2ncc3cnn(C4CCC5(CC5)C4)c3n2)cc1C(N)=O		CHEMBL2012309	=	IC50	nM	150.0	CHEMBL4722	Homo sapiens	IC50	uM	0.15
	10836860	CHEMBL2013811	Inhibition of aurora A kinase	B	Cn1cc(Nc2ncc3cnn(C4C5CC6CC(C5)CC4C6)c3n2)cc1C(N)=O		CHEMBL2012397	=	IC50	nM	25.0	CHEMBL4722	Homo sapiens	IC50	uM	0.025
	10836861	CHEMBL2013811	Inhibition of aurora A kinase	B	Cn1cc(Nc2ncc3cnn([C@H]4CC[C@H]5CCC[C@@H]45)c3n2)cc1C(N)=O		CHEMBL2012398	=	IC50	nM	21.0	CHEMBL4722	Homo sapiens	IC50	uM	0.021
	10836862	CHEMBL2013811	Inhibition of aurora A kinase	B	Cn1cc(Nc2ncc3cnn(C4CCCCCC4)c3n2)cc1C(N)=O		CHEMBL2012399	=	IC50	nM	87.0	CHEMBL4722	Homo sapiens	IC50	uM	0.087
	10836863	CHEMBL2013811	Inhibition of aurora A kinase	B	Cn1cc(Nc2ncc3cnn(C4CCC5(CC4)CC5)c3n2)cc1C(N)=O		CHEMBL2012400	=	IC50	nM	40.0	CHEMBL4722	Homo sapiens	IC50	uM	0.04
	10837488	CHEMBL2013811	Inhibition of aurora A kinase	B	Cn1cc(Nc2ncc3cnn(C4CCC(C)(C)CC4)c3n2)cc1C(N)=O		CHEMBL2012401	=	IC50	nM	30.0	CHEMBL4722	Homo sapiens	IC50	uM	0.03
	10837489	CHEMBL2013811	Inhibition of aurora A kinase	B	Cn1cc(Nc2ncc3cnn([C@H]4C[C@@H]5C[C@@H]5C4)c3n2)cc1C(N)=O		CHEMBL2012402	=	IC50	nM	17.0	CHEMBL4722	Homo sapiens	IC50	uM	0.017
	10837490	CHEMBL2013811	Inhibition of aurora A kinase	B	Cn1cc(Nc2ncc3cnn([C@@H]4CC[C@H]5CCC[C@H]54)c3n2)cc1C(N)=O		CHEMBL2012403	=	IC50	nM	13.0	CHEMBL4722	Homo sapiens	IC50	uM	0.013
	10837491	CHEMBL2013811	Inhibition of aurora A kinase	B	CN(C)C(=O)[C@@H]1CCCN1C(=O)c1cc(Nc2ncc3cnn([C@H]4C[C@@H]5C[C@@H]5C4)c3n2)cn1C		CHEMBL2012404	=	IC50	nM	19.0	CHEMBL4722	Homo sapiens	IC50	uM	0.019
	10837492	CHEMBL2013811	Inhibition of aurora A kinase	B	CNC[C@@H]1CCCN1C(=O)c1cc(Nc2ncc3cnn([C@H]4C[C@@H]5C[C@@H]5C4)c3n2)cn1C		CHEMBL2012405	=	IC50	nM	80.0	CHEMBL4722	Homo sapiens	IC50	uM	0.08
	10837493	CHEMBL2013811	Inhibition of aurora A kinase	B	C[C@@H]1CCCN1C(=O)c1cc(Nc2ncc3cnn([C@H]4C[C@@H]5C[C@@H]5C4)c3n2)cn1C		CHEMBL2012406	=	IC50	nM	2.0	CHEMBL4722	Homo sapiens	IC50	uM	0.002
	10837494	CHEMBL2013811	Inhibition of aurora A kinase	B	Cn1cc(Nc2ncc3cnn([C@H]4C[C@@H]5C[C@@H]5C4)c3n2)cc1C(=O)N1CCCC1		CHEMBL2012407	=	IC50	nM	17.0	CHEMBL4722	Homo sapiens	IC50	uM	0.017
	10837495	CHEMBL2013811	Inhibition of aurora A kinase	B	Cn1cc(Nc2ncc3cnn([C@H]4C[C@@H]5C[C@@H]5C4)c3n2)cc1C(=O)N1CCC[C@H]1C(N)=O		CHEMBL2012408	=	IC50	nM	6.0	CHEMBL4722	Homo sapiens	IC50	uM	0.006
	10837496	CHEMBL2013811	Inhibition of aurora A kinase	B	Cn1cc(Nc2ncc3cnn([C@H]4C[C@@H]5C[C@@H]5C4)c3n2)cc1C(=O)N1CCC[C@H]1CO		CHEMBL2012409	=	IC50	nM	4.0	CHEMBL4722	Homo sapiens	IC50	uM	0.004
	10837497	CHEMBL2013811	Inhibition of aurora A kinase	B	Cn1cc(Nc2ncc3cnn([C@H]4C[C@@H]5C[C@@H]5C4)c3n2)cc1C(=O)N1CCC[C@H]1CN1CCCC1		CHEMBL2012410	=	IC50	nM	10.0	CHEMBL4722	Homo sapiens	IC50	uM	0.01
	10837498	CHEMBL2013811	Inhibition of aurora A kinase	B	COC[C@@H]1CCCN1C(=O)c1cc(Nc2ncc3cnn([C@H]4C[C@@H]5C[C@@H]5C4)c3n2)cn1C		CHEMBL2012411	=	IC50	nM	4.0	CHEMBL4722	Homo sapiens	IC50	uM	0.004
	10837499	CHEMBL2013811	Inhibition of aurora A kinase	B	Cn1cc(Nc2ncc3cnn([C@H]4C[C@@H]5C[C@@H]5C4)c3n2)cc1C(=O)N1CCC[C@H]1CN1CCOCC1		CHEMBL2012412	=	IC50	nM	3.0	CHEMBL4722	Homo sapiens	IC50	uM	0.003
	10837500	CHEMBL2013811	Inhibition of aurora A kinase	B	Cn1cc(Nc2ncc3cnn([C@H]4C[C@@H]5C[C@@H]5C4)c3n2)cc1C(=O)N1CCC[C@@H]1CO		CHEMBL2012413	=	IC50	nM	100.0	CHEMBL4722	Homo sapiens	IC50	uM	0.1
	10837501	CHEMBL2013811	Inhibition of aurora A kinase	B	COC[C@H]1CCCN1C(=O)c1cc(Nc2ncc3cnn([C@H]4C[C@@H]5C[C@@H]5C4)c3n2)cn1C		CHEMBL2012414	=	IC50	nM	16.0	CHEMBL4722	Homo sapiens	IC50	uM	0.016
	10837502	CHEMBL2013811	Inhibition of aurora A kinase	B	Cn1cc(Nc2ncc3cnn([C@H]4C[C@@H]5C[C@@H]5C4)c3n2)cc1C(=O)N1CCC[C@@H]1CN1CCOCC1		CHEMBL2012415	=	IC50	nM	1.5	CHEMBL4722	Homo sapiens	IC50	uM	0.0015
Active	10837573	CHEMBL2013816	Inhibition of aurora A kinase phosphorylation in human K562 cells at 0.003 to 1 uM by Western blot analysis	B	COC[C@@H]1CCCN1C(=O)c1cc(Nc2ncc3cnn([C@H]4C[C@@H]5C[C@@H]5C4)c3n2)cn1C		CHEMBL2012411		Inhibition	%		CHEMBL4722	Homo sapiens	INH		
	10838648	CHEMBL2014526	Inhibition of AurA at 10 uM	B	COc1ccc2c3ccnc(C(F)(F)F)c3n(CCCCN)c2c1		CHEMBL2012574	=	Inhibition	%	0.0	CHEMBL4722	Homo sapiens	INH	%	0.0
	10839641	CHEMBL2015831	Inhibition of Aurora A assessed as residual activity at 1 uM relative to control	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL509032	=	Activity	%	15.0	CHEMBL4722	Homo sapiens	Activity	%	15.0
	10840499	CHEMBL2015923	Inhibition of Aurora A assessed as residual activity at 10 uM relative to control	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL509032	=	Activity	%	2.0	CHEMBL4722	Homo sapiens	Activity	%	2.0
	10843864	CHEMBL2015704	Inhibition of human Aurora-A using ATP as substrate	B	CC(C)Cn1c2ccc(Nc3ncccn3)cc2c2c3c(c4c(c21)CCc1nn(C)cc1-4)C(=O)NC3		CHEMBL2010872	=	IC50	nM	42.0	CHEMBL4722	Homo sapiens	IC50	nM	42.0
	10845895	CHEMBL2013607	Competitive inhibition of Aurora A by DEL method	B	COc1ccc(Nc2nc(Nc3ccc4ncccc4c3)nc(NC(Cc3c[nH]c4ncccc34)C(N)=O)n2)cc1OC		CHEMBL1213152	=	IC50	nM	270.0	CHEMBL4722	Homo sapiens	IC50	nM	270.0
	10849703	CHEMBL2019662	Inhibition of Aurora A	B	CSc1ccccc1Nc1nc(N2CCNCC2)nc2c(NCC3CC3)ncnc12		CHEMBL2017214	>	IC50	nM	40000.0	CHEMBL4722	Homo sapiens	IC50	uM	40.0
	10850671	CHEMBL2019791	Inhibition of human Aurora A at 1 uM	B	Cn1cc(-c2cccc(-c3cnc(N)c(C(=O)N[C@H]4C5CC6CC4C[C@@](O)(C6)C5)n3)c2)cn1		CHEMBL2018022	>	Inhibition	%	50.0	CHEMBL4722	Homo sapiens	INH	%	50.0
Not Active	10853976	CHEMBL2020367	Inhibition of AURKA at 10 uM relative to control	B	Cc1ccc(S(=O)(=O)n2c(N)nc3ccccc32)cc1		CHEMBL1412853		Inhibition	%		CHEMBL4722	Homo sapiens	INH		
	10863742	CHEMBL2024897	Inhibition of Aurora A by TR-FRET assay	B	Nc1ncc(-c2cnn(CCO)c2)c2scc(-c3ccc(NC(=O)Nc4cccc(F)c4)cc3)c12		CHEMBL1980297	=	IC50	nM	12.0	CHEMBL4722	Homo sapiens	IC50	nM	12.0
	10870059	CHEMBL2027240	Inhibition of Aurora A at 200 nM	B	CN1CCN(Cc2ccc(Nc3ncc(Cl)c(Nc4ccccc4S(=O)(=O)N(C)C)n3)cc2)CC1		CHEMBL2022968	>	Inhibition	%	80.0	CHEMBL4722	Homo sapiens	INH	%	80.0
	10870065	CHEMBL2025258	Inhibition of Aurora A	B	CN1CCN(Cc2ccc(Nc3ncc(Cl)c(Nc4ccccc4S(=O)(=O)N(C)C)n3)cc2)CC1		CHEMBL2022968	=	IC50	nM	3.0	CHEMBL4722	Homo sapiens	IC50	nM	3.0
Active	10870066	CHEMBL2025258	Inhibition of Aurora A	B	CN1CCN(Cc2ccc(Nc3ncc(Cl)c(Nc4ccccc4C(=O)N4CCCC4)n3)cc2)CC1		CHEMBL2022973		Inhibition	%		CHEMBL4722	Homo sapiens	INH		
Active	10870067	CHEMBL2025258	Inhibition of Aurora A	B	CN1CCN(Cc2ccc(Nc3ncc(Cl)c(Nc4ccccc4C(=O)NC4CC4)n3)cc2)CC1		CHEMBL2022974		Inhibition	%		CHEMBL4722	Homo sapiens	INH		
Active	10870068	CHEMBL2025258	Inhibition of Aurora A	B	CN1CCN(Cc2ccc(Nc3ncc(Cl)c(Nc4ccccc4S(=O)(=O)N4CCCC4)n3)cc2)CC1		CHEMBL2022975		Inhibition	%		CHEMBL4722	Homo sapiens	INH		
Active	10870069	CHEMBL2025258	Inhibition of Aurora A	B	CN1CCN(Cc2ccc(Nc3ncc(Cl)c(-c4ccc(F)cc4S(=O)(=O)N(C)C)n3)cc2)CC1		CHEMBL2023345		Inhibition	%		CHEMBL4722	Homo sapiens	INH		
Active	10870070	CHEMBL2025258	Inhibition of Aurora A	B	CN1CCN(Cc2ccc(Nc3ncc(Cl)c(-c4ccc(F)cc4S(=O)(=O)N4CCCC4)n3)cc2)CC1		CHEMBL2023346		Inhibition	%		CHEMBL4722	Homo sapiens	INH		
	10870777	CHEMBL2024834	Inhibition of aurora A kinase using 5TAMRA-GRTGRRNSICOOH as substrate by fluorescent assay	B	Cc1cn2c(-c3cnn(CC(=O)N(C)Cc4ccccc4)c3)cnc2c(Nc2cc(CN3CCCC(C)C3)ns2)n1		CHEMBL2022122	=	IC50	nM	1627.0	CHEMBL4722	Homo sapiens	IC50	nM	1627.0
	10870778	CHEMBL2024834	Inhibition of aurora A kinase using 5TAMRA-GRTGRRNSICOOH as substrate by fluorescent assay	B	Cc1cn2c(-c3cnn(CC(=O)Nc4ccccc4)c3)cnc2c(Nc2cc(CN3CCCC(C)C3)ns2)n1		CHEMBL2022121	=	IC50	nM	34.0	CHEMBL4722	Homo sapiens	IC50	nM	34.0
	10870779	CHEMBL2024834	Inhibition of aurora A kinase using 5TAMRA-GRTGRRNSICOOH as substrate by fluorescent assay	B	Cc1cn2c(-c3cnn(CC(=O)NCc4ccccc4)c3)cnc2c(Nc2cc(CN3CCCC(C)C3)ns2)n1		CHEMBL2022120	=	IC50	nM	21.0	CHEMBL4722	Homo sapiens	IC50	nM	21.0
	10870780	CHEMBL2024834	Inhibition of aurora A kinase using 5TAMRA-GRTGRRNSICOOH as substrate by fluorescent assay	B	Cc1cn2c(-c3cnn(CC(=O)N4CCOCC4)c3)cnc2c(Nc2cc(CN3CCCCC3)ns2)n1		CHEMBL2022119	>	IC50	nM	3000.0	CHEMBL4722	Homo sapiens	IC50	nM	3000.0
	10870781	CHEMBL2024834	Inhibition of aurora A kinase using 5TAMRA-GRTGRRNSICOOH as substrate by fluorescent assay	B	Cc1cn2c(-c3cnn(CC(=O)NCCN(C)C)c3)cnc2c(Nc2cc(CN3CCCC(C)C3)ns2)n1		CHEMBL2022118	>	IC50	nM	3000.0	CHEMBL4722	Homo sapiens	IC50	nM	3000.0
	10870782	CHEMBL2024834	Inhibition of aurora A kinase using 5TAMRA-GRTGRRNSICOOH as substrate by fluorescent assay	B	Cc1cn2c(-c3cnn(CC(=O)N(C)C)c3)cnc2c(Nc2cc(CN3CCCCC3)ns2)n1		CHEMBL2022117	>	IC50	nM	3000.0	CHEMBL4722	Homo sapiens	IC50	nM	3000.0
	10870783	CHEMBL2024834	Inhibition of aurora A kinase using 5TAMRA-GRTGRRNSICOOH as substrate by fluorescent assay	B	Cc1cn2c(-c3cnn(CC(=O)NCCC(C)C)c3)cnc2c(Nc2cc(CN3CCCCC3)ns2)n1		CHEMBL2022116	=	IC50	nM	1803.0	CHEMBL4722	Homo sapiens	IC50	nM	1803.0
	10870784	CHEMBL2024834	Inhibition of aurora A kinase using 5TAMRA-GRTGRRNSICOOH as substrate by fluorescent assay	B	CNC(=O)Cn1cc(-c2cnc3c(Nc4cc(CN5CCCCC5)ns4)nc(C)cn23)cn1		CHEMBL2022115	>	IC50	nM	3000.0	CHEMBL4722	Homo sapiens	IC50	nM	3000.0
	10870785	CHEMBL2024834	Inhibition of aurora A kinase using 5TAMRA-GRTGRRNSICOOH as substrate by fluorescent assay	B	Cc1cn2c(-c3cnn(CC(N)=O)c3)cnc2c(Nc2cc(CN3CCCCC3)ns2)n1		CHEMBL2022114	=	IC50	nM	1567.0	CHEMBL4722	Homo sapiens	IC50	nM	1567.0
	10870786	CHEMBL2024834	Inhibition of aurora A kinase using 5TAMRA-GRTGRRNSICOOH as substrate by fluorescent assay	B	Cc1cn2c(-c3cnn(CC(=O)O)c3)cnc2c(Nc2cc(CN3CCCC(C)C3)ns2)n1		CHEMBL2022113	=	IC50	nM	836.0	CHEMBL4722	Homo sapiens	IC50	nM	836.0
	10870787	CHEMBL2024834	Inhibition of aurora A kinase using 5TAMRA-GRTGRRNSICOOH as substrate by fluorescent assay	B	Cc1cn2c(-c3cnn(CC(=O)O)c3)cnc2c(Nc2cc(CN3CCCCC3)ns2)n1		CHEMBL2022112	=	IC50	nM	1828.0	CHEMBL4722	Homo sapiens	IC50	nM	1828.0
	10870788	CHEMBL2024834	Inhibition of aurora A kinase using 5TAMRA-GRTGRRNSICOOH as substrate by fluorescent assay	B	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2cc(CN3CCCCC3)ns2)n1		CHEMBL1739550	<=	IC50	nM	4.0	CHEMBL4722	Homo sapiens	IC50	nM	4.0
	10870789	CHEMBL2024834	Inhibition of aurora A kinase using 5TAMRA-GRTGRRNSICOOH as substrate by fluorescent assay	B	Cc1cn2c(-c3cnn(Cc4nc5ccccc5[nH]4)c3)cnc2c(Nc2cc(CN3CCCC(C)C3)ns2)n1		CHEMBL2022123	=	IC50	nM	18.0	CHEMBL4722	Homo sapiens	IC50	nM	18.0
	10870790	CHEMBL2024834	Inhibition of aurora A kinase using 5TAMRA-GRTGRRNSICOOH as substrate by fluorescent assay	B	Cc1cn2c(-c3cnn(Cc4nc(-c5ccccc5)no4)c3)cnc2c(Nc2cc(CN3CCCCC3)ns2)n1		CHEMBL2022124	<=	IC50	nM	4.0	CHEMBL4722	Homo sapiens	IC50	nM	4.0
	10870791	CHEMBL2024834	Inhibition of aurora A kinase using 5TAMRA-GRTGRRNSICOOH as substrate by fluorescent assay	B	Cc1cn2c(-c3cnn(Cc4noc(-c5ccccc5)n4)c3)cnc2c(Nc2cc(CN3CCCCC3)ns2)n1		CHEMBL2023291	<=	IC50	nM	4.0	CHEMBL4722	Homo sapiens	IC50	nM	4.0
	10870792	CHEMBL2024834	Inhibition of aurora A kinase using 5TAMRA-GRTGRRNSICOOH as substrate by fluorescent assay	B	Cc1cn2c(-c3cnn(Cc4nc(-c5ccccc5)c[nH]4)c3)cnc2c(Nc2cc(CN3CCCCC3)ns2)n1		CHEMBL2023292	=	IC50	nM	583.0	CHEMBL4722	Homo sapiens	IC50	nM	583.0
	10870793	CHEMBL2024834	Inhibition of aurora A kinase using 5TAMRA-GRTGRRNSICOOH as substrate by fluorescent assay	B	Cc1cn2c(-c3cnn(CC(=O)NCc4ccccc4F)c3)cnc2c(Nc2cc(CN3CCCCC3)ns2)n1		CHEMBL2023293	=	IC50	nM	44.0	CHEMBL4722	Homo sapiens	IC50	nM	44.0
	10870794	CHEMBL2024834	Inhibition of aurora A kinase using 5TAMRA-GRTGRRNSICOOH as substrate by fluorescent assay	B	Cc1cn2c(-c3cnn(CC(=O)NCc4cccc(F)c4)c3)cnc2c(Nc2cc(CN3CCCCC3)ns2)n1		CHEMBL2023294	=	IC50	nM	30.0	CHEMBL4722	Homo sapiens	IC50	nM	30.0
	10870795	CHEMBL2024834	Inhibition of aurora A kinase using 5TAMRA-GRTGRRNSICOOH as substrate by fluorescent assay	B	Cc1cn2c(-c3cnn(CC(=O)NCc4ccc(F)cc4)c3)cnc2c(Nc2cc(CN3CCCCC3)ns2)n1		CHEMBL2023295	=	IC50	nM	40.0	CHEMBL4722	Homo sapiens	IC50	nM	40.0
	10870796	CHEMBL2024834	Inhibition of aurora A kinase using 5TAMRA-GRTGRRNSICOOH as substrate by fluorescent assay	B	Cc1cn2c(-c3cnn(CC(=O)NCc4cccc(F)c4F)c3)cnc2c(Nc2cc(CN3CCCCC3)ns2)n1		CHEMBL2023296	=	IC50	nM	45.0	CHEMBL4722	Homo sapiens	IC50	nM	45.0
	10870797	CHEMBL2024834	Inhibition of aurora A kinase using 5TAMRA-GRTGRRNSICOOH as substrate by fluorescent assay	B	Cc1cn2c(-c3cnn(CC(=O)NCc4cc(F)cc(F)c4)c3)cnc2c(Nc2cc(CN3CCCCC3)ns2)n1		CHEMBL2023297	=	IC50	nM	22.0	CHEMBL4722	Homo sapiens	IC50	nM	22.0
	10870798	CHEMBL2024834	Inhibition of aurora A kinase using 5TAMRA-GRTGRRNSICOOH as substrate by fluorescent assay	B	Cc1cn2c(-c3cnn(CC(=O)NCc4cccc(C(F)(F)F)c4)c3)cnc2c(Nc2cc(CN3CCCC(C)C3)ns2)n1		CHEMBL2023298	=	IC50	nM	413.0	CHEMBL4722	Homo sapiens	IC50	nM	413.0
	10870799	CHEMBL2024834	Inhibition of aurora A kinase using 5TAMRA-GRTGRRNSICOOH as substrate by fluorescent assay	B	Cc1cn2c(-c3cnn(CC(=O)NCc4ccc(C(F)(F)F)cc4)c3)cnc2c(Nc2cc(CN3CCCC(C)C3)ns2)n1		CHEMBL2023299	>	IC50	nM	3000.0	CHEMBL4722	Homo sapiens	IC50	nM	3000.0
	10870800	CHEMBL2024834	Inhibition of aurora A kinase using 5TAMRA-GRTGRRNSICOOH as substrate by fluorescent assay	B	Cc1cn2c(-c3cnn(CC(=O)NCc4cccc(N(C)C)c4)c3)cnc2c(Nc2cc(CN3CCCC(C)C3)ns2)n1		CHEMBL2023300	=	IC50	nM	859.0	CHEMBL4722	Homo sapiens	IC50	nM	859.0
	10870801	CHEMBL2024834	Inhibition of aurora A kinase using 5TAMRA-GRTGRRNSICOOH as substrate by fluorescent assay	B	COc1cccc(CNC(=O)Cn2cc(-c3cnc4c(Nc5cc(CN6CCCC(C)C6)ns5)nc(C)cn34)cn2)c1		CHEMBL2023301	=	IC50	nM	57.0	CHEMBL4722	Homo sapiens	IC50	nM	57.0
	10870802	CHEMBL2024834	Inhibition of aurora A kinase using 5TAMRA-GRTGRRNSICOOH as substrate by fluorescent assay	B	COc1ccc(CNC(=O)Cn2cc(-c3cnc4c(Nc5cc(CN6CCCC(C)C6)ns5)nc(C)cn34)cn2)cc1		CHEMBL2023302	=	IC50	nM	1931.0	CHEMBL4722	Homo sapiens	IC50	nM	1931.0
	10870803	CHEMBL2024834	Inhibition of aurora A kinase using 5TAMRA-GRTGRRNSICOOH as substrate by fluorescent assay	B	Cc1cn2c(-c3cnn(CC(=O)NCc4cccnc4)c3)cnc2c(Nc2cc(CN3CCCC(C)C3)ns2)n1		CHEMBL2023303	=	IC50	nM	434.0	CHEMBL4722	Homo sapiens	IC50	nM	434.0
	10870804	CHEMBL2024834	Inhibition of aurora A kinase using 5TAMRA-GRTGRRNSICOOH as substrate by fluorescent assay	B	Cc1cn2c(-c3cnn(CC(=O)NCc4ccncc4)c3)cnc2c(Nc2cc(CN3CCCC(C)C3)ns2)n1		CHEMBL2022366	=	IC50	nM	2447.0	CHEMBL4722	Homo sapiens	IC50	nM	2447.0
	10870805	CHEMBL2024834	Inhibition of aurora A kinase using 5TAMRA-GRTGRRNSICOOH as substrate by fluorescent assay	B	Cc1cn2c(-c3cnn(CC(=O)NCc4ncco4)c3)cnc2c(Nc2cc(CN3CCCC(C)C3)ns2)n1		CHEMBL2022367	=	IC50	nM	168.0	CHEMBL4722	Homo sapiens	IC50	nM	168.0
	10870806	CHEMBL2024834	Inhibition of aurora A kinase using 5TAMRA-GRTGRRNSICOOH as substrate by fluorescent assay	B	Cc1cn2c(-c3cnn(CC(=O)NCc4ccco4)c3)cnc2c(Nc2cc(CN3CCCC(C)C3)ns2)n1		CHEMBL2022368	=	IC50	nM	213.0	CHEMBL4722	Homo sapiens	IC50	nM	213.0
	10870807	CHEMBL2024834	Inhibition of aurora A kinase using 5TAMRA-GRTGRRNSICOOH as substrate by fluorescent assay	B	Cc1cn2c(-c3cnn(CC(=O)NCc4cccs4)c3)cnc2c(Nc2cc(CN3CCCC(C)C3)ns2)n1		CHEMBL2022369	=	IC50	nM	27.0	CHEMBL4722	Homo sapiens	IC50	nM	27.0
	10870808	CHEMBL2024834	Inhibition of aurora A kinase using 5TAMRA-GRTGRRNSICOOH as substrate by fluorescent assay	B	Cc1cn2c(-c3cnn(CC(=O)Nc4ccccc4F)c3)cnc2c(Nc2cc(CN3CCCCC3)ns2)n1		CHEMBL2022370	=	IC50	nM	198.0	CHEMBL4722	Homo sapiens	IC50	nM	198.0
	10870809	CHEMBL2024834	Inhibition of aurora A kinase using 5TAMRA-GRTGRRNSICOOH as substrate by fluorescent assay	B	Cc1cn2c(-c3cnn(CC(=O)Nc4cccc(F)c4)c3)cnc2c(Nc2cc(CN3CCCCC3)ns2)n1		CHEMBL2022371	=	IC50	nM	340.0	CHEMBL4722	Homo sapiens	IC50	nM	340.0
	10870810	CHEMBL2024834	Inhibition of aurora A kinase using 5TAMRA-GRTGRRNSICOOH as substrate by fluorescent assay	B	Cc1cn2c(-c3cnn(CC(=O)Nc4ccc(F)cc4)c3)cnc2c(Nc2cc(CN3CCCCC3)ns2)n1		CHEMBL2022372	=	IC50	nM	53.0	CHEMBL4722	Homo sapiens	IC50	nM	53.0
	10870811	CHEMBL2024834	Inhibition of aurora A kinase using 5TAMRA-GRTGRRNSICOOH as substrate by fluorescent assay	B	Cc1cn2c(-c3cnn(CC(=O)Nc4cccc(F)c4F)c3)cnc2c(Nc2cc(CN3CCCCC3)ns2)n1		CHEMBL2022373	=	IC50	nM	122.0	CHEMBL4722	Homo sapiens	IC50	nM	122.0
	10870812	CHEMBL2024834	Inhibition of aurora A kinase using 5TAMRA-GRTGRRNSICOOH as substrate by fluorescent assay	B	Cc1cn2c(-c3cnn(CC(=O)Nc4cc(F)cc(F)c4)c3)cnc2c(Nc2cc(CN3CCCCC3)ns2)n1		CHEMBL2022374	=	IC50	nM	1223.0	CHEMBL4722	Homo sapiens	IC50	nM	1223.0
	10870813	CHEMBL2024834	Inhibition of aurora A kinase using 5TAMRA-GRTGRRNSICOOH as substrate by fluorescent assay	B	Cc1cn2c(-c3cnn(CC(=O)Nc4nccs4)c3)cnc2c(Nc2cc(CN3CCCC(C)C3)ns2)n1		CHEMBL2022375	=	IC50	nM	100.0	CHEMBL4722	Homo sapiens	IC50	nM	100.0
	10870814	CHEMBL2024834	Inhibition of aurora A kinase using 5TAMRA-GRTGRRNSICOOH as substrate by fluorescent assay	B	Cc1cn2c(-c3cnn(CC(=O)NN4CC=CC=N4)c3)cnc2c(Nc2cc(CN3CCCC(C)C3)ns2)n1		CHEMBL2022376	=	IC50	nM	638.0	CHEMBL4722	Homo sapiens	IC50	nM	638.0
	10870815	CHEMBL2024834	Inhibition of aurora A kinase using 5TAMRA-GRTGRRNSICOOH as substrate by fluorescent assay	B	Cc1cn2c(-c3cnn(CC(=O)Nc4ccccn4)c3)cnc2c(Nc2cc(CN3CCCC(C)C3)ns2)n1		CHEMBL2022377	=	IC50	nM	185.0	CHEMBL4722	Homo sapiens	IC50	nM	185.0
	10870816	CHEMBL2024834	Inhibition of aurora A kinase using 5TAMRA-GRTGRRNSICOOH as substrate by fluorescent assay	B	Cc1cn2c(-c3cnn(CC(=O)Nc4cccnc4)c3)cnc2c(Nc2cc(CN3CCCC(C)C3)ns2)n1		CHEMBL2022378	=	IC50	nM	186.0	CHEMBL4722	Homo sapiens	IC50	nM	186.0
	10870817	CHEMBL2024834	Inhibition of aurora A kinase using 5TAMRA-GRTGRRNSICOOH as substrate by fluorescent assay	B	Cc1cn2c(-c3cnn(CC(=O)Nc4ccncc4)c3)cnc2c(Nc2cc(CN3CCCC(C)C3)ns2)n1		CHEMBL2022379	=	IC50	nM	12.0	CHEMBL4722	Homo sapiens	IC50	nM	12.0
	10870818	CHEMBL2024834	Inhibition of aurora A kinase using 5TAMRA-GRTGRRNSICOOH as substrate by fluorescent assay	B	Cc1cn2c(-c3cnn(CC(=O)Nc4cc[n+]([O-])cc4)c3)cnc2c(Nc2cc(CN3CCCC(C)C3)ns2)n1		CHEMBL2022709	=	IC50	nM	68.0	CHEMBL4722	Homo sapiens	IC50	nM	68.0
	10870819	CHEMBL2024834	Inhibition of aurora A kinase using 5TAMRA-GRTGRRNSICOOH as substrate by fluorescent assay	B	Cc1cn2c(-c3cnn(CC(=O)Nc4ccncc4O)c3)cnc2c(Nc2cc(CN3CCCC(C)C3)ns2)n1		CHEMBL2022710	=	IC50	nM	239.0	CHEMBL4722	Homo sapiens	IC50	nM	239.0
	10870820	CHEMBL2024834	Inhibition of aurora A kinase using 5TAMRA-GRTGRRNSICOOH as substrate by fluorescent assay	B	Cc1cn2c(-c3cnn(CC(=O)Nc4ccncc4F)c3)cnc2c(Nc2cc(CN3CCCC(C)C3)ns2)n1		CHEMBL2022711	<	IC50	nM	4.0	CHEMBL4722	Homo sapiens	IC50	nM	4.0
	10870821	CHEMBL2024834	Inhibition of aurora A kinase using 5TAMRA-GRTGRRNSICOOH as substrate by fluorescent assay	B	Cc1cn2c(-c3cnn(CC(=O)Nc4cccc(F)n4)c3)cnc2c(Nc2cc(CN3CCCC(C)C3)ns2)n1		CHEMBL2022712	=	IC50	nM	102.0	CHEMBL4722	Homo sapiens	IC50	nM	102.0
	10870822	CHEMBL2024834	Inhibition of aurora A kinase using 5TAMRA-GRTGRRNSICOOH as substrate by fluorescent assay	B	Cc1cn2c(-c3cnn(CC(=O)Nc4cccnc4F)c3)cnc2c(Nc2cc(CN3CCCC(C)C3)ns2)n1		CHEMBL2022713	=	IC50	nM	753.0	CHEMBL4722	Homo sapiens	IC50	nM	753.0
	10886024	CHEMBL2033406	Inhibition of Aurora A in human HEK293 cells after 1 hr by competition binding assay	B	COc1cc2ncnc(Oc3cccc(NC(=O)Nc4cc(C(C)(C)C(F)(F)F)on4)c3)c2cc1OC		CHEMBL2029988	>	Kd	nM	10000.0	CHEMBL4722	Homo sapiens	Kd	nM	10000.0
	10889055	CHEMBL2032460	Inhibition of aurora-1	B	COc1ccc2c(Oc3ccc(NC(=O)c4c(C)n(CC(C)(C)O)n(-c5ccccc5)c4=O)nc3)ccnc2c1		CHEMBL460472	=	IC50	nM	1000.0	CHEMBL4722	Homo sapiens	IC50	uM	1.0
	10889082	CHEMBL2032460	Inhibition of aurora-1	B	COc1cc2nccc(Oc3ccc(NC(=O)c4c(C)n(C)n(-c5ccccc5)c4=O)cc3F)c2cc1OC		CHEMBL2031893	=	IC50	nM	1000.0	CHEMBL4722	Homo sapiens	IC50	uM	1.0
	10889613	CHEMBL2034274	Inhibition of Aurora A	B	Nc1ncc(-c2cnn(C3CCNCC3)c2)cc1-c1nc2ccc(O)cc2o1.O=C(O)C(F)(F)F		CHEMBL2032274	=	IC50	nM	90.0	CHEMBL4722	Homo sapiens	IC50	uM	0.09
	10890697	CHEMBL2032821	Inhibition of aurora A kinase	B	CN1CCN(C(=O)c2cc(Nc3ncc4cc(/C=N/O)n(C5CCCC5)c4n3)cn2C)CC1		CHEMBL2029900	=	IC50	nM	11.0	CHEMBL4722	Homo sapiens	IC50	uM	0.011
	10890698	CHEMBL2032821	Inhibition of aurora A kinase	B	CN1CCN(C(=O)c2cc(Nc3ncc4cc(C#N)n(C5CCCC5)c4n3)cn2C)CC1		CHEMBL2029901	=	IC50	nM	7.5	CHEMBL4722	Homo sapiens	IC50	uM	0.0075
	10890699	CHEMBL2032821	Inhibition of aurora A kinase	B	CN1CCN(C(=O)c2cc(Nc3ncc4ccn(C5CCCC5)c4n3)cn2C)CC1		CHEMBL2029902	=	IC50	nM	38.0	CHEMBL4722	Homo sapiens	IC50	uM	0.038
	10890700	CHEMBL2032821	Inhibition of aurora A kinase	B	CN1CCN(C(=O)c2cc(Nc3ncc4cc(C(N)=O)n(C5CCCC5)c4n3)cn2C)CC1		CHEMBL2029903	=	IC50	nM	28.0	CHEMBL4722	Homo sapiens	IC50	uM	0.028
	10890701	CHEMBL2032821	Inhibition of aurora A kinase	B	CNCc1cc2cnc(Nc3cc(C(=O)N4CCN(C)CC4)n(C)c3)nc2n1C1CCCC1		CHEMBL2029904	=	IC50	nM	40.0	CHEMBL4722	Homo sapiens	IC50	uM	0.04
	10890702	CHEMBL2032821	Inhibition of aurora A kinase	B	CC(O)c1cc2cnc(Nc3cc(C(=O)N4CCN(C)CC4)n(C)c3)nc2n1C1CCCC1		CHEMBL2029905	=	IC50	nM	11.0	CHEMBL4722	Homo sapiens	IC50	uM	0.011
	10890703	CHEMBL2032821	Inhibition of aurora A kinase	B	CN1CCN(C(=O)c2cc(Nc3ncc4cc(CO)n(C5CCCC5)c4n3)cn2C)CC1		CHEMBL2029906	=	IC50	nM	20.0	CHEMBL4722	Homo sapiens	IC50	uM	0.02
	10890704	CHEMBL2032821	Inhibition of aurora A kinase	B	CN1CCN(C(=O)c2cc(Nc3ncc4cc(C(=O)O)n(C5CCCC5)c4n3)cn2C)CC1		CHEMBL2029907	=	IC50	nM	350.0	CHEMBL4722	Homo sapiens	IC50	uM	0.35
	10890705	CHEMBL2032821	Inhibition of aurora A kinase	B	CN1CCN(C(=O)c2cc(Nc3ncc4cc(-c5cnco5)n(C5CCCC5)c4n3)cn2C)CC1		CHEMBL2029908	=	IC50	nM	2.0	CHEMBL4722	Homo sapiens	IC50	uM	0.002
	10890706	CHEMBL2032821	Inhibition of aurora A kinase	B	CN1CCN(C(=O)c2cc(Nc3ncc4cc(-c5cnn(C)c5)n(C5CCCC5)c4n3)cn2C)CC1		CHEMBL2029909	=	IC50	nM	2.0	CHEMBL4722	Homo sapiens	IC50	uM	0.002
	10890707	CHEMBL2032821	Inhibition of aurora A kinase	B	CN1CCN(C(=O)c2cc(Nc3ncc4cc(-c5cncn5C)n(C5CCCC5)c4n3)cn2C)CC1		CHEMBL2029910	=	IC50	nM	2.0	CHEMBL4722	Homo sapiens	IC50	uM	0.002
	10890708	CHEMBL2032821	Inhibition of aurora A kinase	B	Cc1c(-c2cc3cnc(Nc4cc(C(=O)N5CCN(C)CC5)n(C)c4)nc3n2C2CCCC2)cnn1C		CHEMBL2029911	=	IC50	nM	2.0	CHEMBL4722	Homo sapiens	IC50	uM	0.002
	10890709	CHEMBL2032821	Inhibition of aurora A kinase	B	CC(C)CCn1cc(-c2cc3cnc(Nc4cc(C(=O)N5CCN(C)CC5)n(C)c4)nc3n2C2CCCC2)cn1		CHEMBL2029912	=	IC50	nM	2.0	CHEMBL4722	Homo sapiens	IC50	uM	0.002
	10890710	CHEMBL2032821	Inhibition of aurora A kinase	B	CN1CCN(C(=O)c2cc(Nc3ncc4cc(-c5ccnn5C)n(C5CCCC5)c4n3)cn2C)CC1		CHEMBL2029913	=	IC50	nM	5.0	CHEMBL4722	Homo sapiens	IC50	uM	0.005
	10890711	CHEMBL2032821	Inhibition of aurora A kinase	B	CN1CCN(C(=O)c2cc(Nc3ncc4cc(-c5cnn(Cc6ccccc6)c5)n(C5CCCC5)c4n3)cn2C)CC1		CHEMBL2029914	=	IC50	nM	2.0	CHEMBL4722	Homo sapiens	IC50	uM	0.002
Active	10894739	CHEMBL2033075	Inhibition of Aurora A kinase in human HCT116 cells at 0.5 to 2 uM by Western blot analysis	B	CCOc1ccc(NC(=O)c2cn(-c3ccccc3)nc2-c2ccc([N+](=O)[O-])cc2)cc1		CHEMBL2030993		Inhibition	%		CHEMBL4722	Homo sapiens	INH		
	10894792	CHEMBL2033074	Inhibition of human recombinant Aurora A kinase using biotinylated peptide substrate preincubated for 15 mins with compound measured after 30 mins by fluorescence analysis	B	O=C(Nc1ccccc1)c1cn(-c2ccccc2)nc1-c1ccccc1		CHEMBL1533728	=	IC50	nM	2340.0	CHEMBL4722	Homo sapiens	IC50	uM	2.34
	10894793	CHEMBL2033074	Inhibition of human recombinant Aurora A kinase using biotinylated peptide substrate preincubated for 15 mins with compound measured after 30 mins by fluorescence analysis	B	O=C(Nc1ccc(Cl)cc1)c1cn(-c2ccccc2)nc1-c1ccccc1		CHEMBL2030971	=	IC50	nM	3570.0	CHEMBL4722	Homo sapiens	IC50	uM	3.57
	10894794	CHEMBL2033074	Inhibition of human recombinant Aurora A kinase using biotinylated peptide substrate preincubated for 15 mins with compound measured after 30 mins by fluorescence analysis	B	O=C(Nc1ccc(Br)cc1)c1cn(-c2ccccc2)nc1-c1ccccc1		CHEMBL2030972	=	IC50	nM	7250.0	CHEMBL4722	Homo sapiens	IC50	uM	7.25
	10894795	CHEMBL2033074	Inhibition of human recombinant Aurora A kinase using biotinylated peptide substrate preincubated for 15 mins with compound measured after 30 mins by fluorescence analysis	B	COc1ccc(NC(=O)c2cn(-c3ccccc3)nc2-c2ccccc2)cc1		CHEMBL2030973	=	IC50	nM	1330.0	CHEMBL4722	Homo sapiens	IC50	uM	1.33
	10894796	CHEMBL2033074	Inhibition of human recombinant Aurora A kinase using biotinylated peptide substrate preincubated for 15 mins with compound measured after 30 mins by fluorescence analysis	B	CCOc1ccc(NC(=O)c2cn(-c3ccccc3)nc2-c2ccccc2)cc1		CHEMBL2030974	=	IC50	nM	420.0	CHEMBL4722	Homo sapiens	IC50	uM	0.42
	10894797	CHEMBL2033074	Inhibition of human recombinant Aurora A kinase using biotinylated peptide substrate preincubated for 15 mins with compound measured after 30 mins by fluorescence analysis	B	Cc1ccc(-c2nn(-c3ccccc3)cc2C(=O)Nc2ccccc2)cc1		CHEMBL2030975	=	IC50	nM	2650.0	CHEMBL4722	Homo sapiens	IC50	uM	2.65
	10894798	CHEMBL2033074	Inhibition of human recombinant Aurora A kinase using biotinylated peptide substrate preincubated for 15 mins with compound measured after 30 mins by fluorescence analysis	B	Cc1ccc(-c2nn(-c3ccccc3)cc2C(=O)Nc2ccc(Cl)cc2)cc1		CHEMBL2030976	=	IC50	nM	4790.0	CHEMBL4722	Homo sapiens	IC50	uM	4.79
	10894799	CHEMBL2033074	Inhibition of human recombinant Aurora A kinase using biotinylated peptide substrate preincubated for 15 mins with compound measured after 30 mins by fluorescence analysis	B	Cc1ccc(-c2nn(-c3ccccc3)cc2C(=O)Nc2ccc(Br)cc2)cc1		CHEMBL2030977	=	IC50	nM	7320.0	CHEMBL4722	Homo sapiens	IC50	uM	7.32
	10894800	CHEMBL2033074	Inhibition of human recombinant Aurora A kinase using biotinylated peptide substrate preincubated for 15 mins with compound measured after 30 mins by fluorescence analysis	B	COc1ccc(NC(=O)c2cn(-c3ccccc3)nc2-c2ccc(C)cc2)cc1		CHEMBL1512579	=	IC50	nM	1450.0	CHEMBL4722	Homo sapiens	IC50	uM	1.45
	10894801	CHEMBL2033074	Inhibition of human recombinant Aurora A kinase using biotinylated peptide substrate preincubated for 15 mins with compound measured after 30 mins by fluorescence analysis	B	CCOc1ccc(NC(=O)c2cn(-c3ccccc3)nc2-c2ccc(C)cc2)cc1		CHEMBL2030978	=	IC50	nM	650.0	CHEMBL4722	Homo sapiens	IC50	uM	0.65
	10894802	CHEMBL2033074	Inhibition of human recombinant Aurora A kinase using biotinylated peptide substrate preincubated for 15 mins with compound measured after 30 mins by fluorescence analysis	B	COc1ccc(-c2nn(-c3ccccc3)cc2C(=O)Nc2ccccc2)cc1		CHEMBL2030979	=	IC50	nM	2780.0	CHEMBL4722	Homo sapiens	IC50	uM	2.78
	10894803	CHEMBL2033074	Inhibition of human recombinant Aurora A kinase using biotinylated peptide substrate preincubated for 15 mins with compound measured after 30 mins by fluorescence analysis	B	COc1ccc(-c2nn(-c3ccccc3)cc2C(=O)Nc2ccc(Cl)cc2)cc1		CHEMBL2030980	=	IC50	nM	5590.0	CHEMBL4722	Homo sapiens	IC50	uM	5.59
	10894804	CHEMBL2033074	Inhibition of human recombinant Aurora A kinase using biotinylated peptide substrate preincubated for 15 mins with compound measured after 30 mins by fluorescence analysis	B	COc1ccc(-c2nn(-c3ccccc3)cc2C(=O)Nc2ccc(Br)cc2)cc1		CHEMBL2030981	=	IC50	nM	12370.0	CHEMBL4722	Homo sapiens	IC50	uM	12.37
	10894805	CHEMBL2033074	Inhibition of human recombinant Aurora A kinase using biotinylated peptide substrate preincubated for 15 mins with compound measured after 30 mins by fluorescence analysis	B	COc1ccc(NC(=O)c2cn(-c3ccccc3)nc2-c2ccc(OC)cc2)cc1		CHEMBL2030982	=	IC50	nM	1620.0	CHEMBL4722	Homo sapiens	IC50	uM	1.62
	10894806	CHEMBL2033074	Inhibition of human recombinant Aurora A kinase using biotinylated peptide substrate preincubated for 15 mins with compound measured after 30 mins by fluorescence analysis	B	CCOc1ccc(NC(=O)c2cn(-c3ccccc3)nc2-c2ccc(OC)cc2)cc1		CHEMBL2030983	=	IC50	nM	780.0	CHEMBL4722	Homo sapiens	IC50	uM	0.78
	10894807	CHEMBL2033074	Inhibition of human recombinant Aurora A kinase using biotinylated peptide substrate preincubated for 15 mins with compound measured after 30 mins by fluorescence analysis	B	O=C(Nc1ccccc1)c1cn(-c2ccccc2)nc1-c1ccc(Cl)cc1		CHEMBL2030984	=	IC50	nM	2100.0	CHEMBL4722	Homo sapiens	IC50	uM	2.1
	10894808	CHEMBL2033074	Inhibition of human recombinant Aurora A kinase using biotinylated peptide substrate preincubated for 15 mins with compound measured after 30 mins by fluorescence analysis	B	O=C(Nc1ccc(Cl)cc1)c1cn(-c2ccccc2)nc1-c1ccc(Cl)cc1		CHEMBL2030985	=	IC50	nM	3180.0	CHEMBL4722	Homo sapiens	IC50	uM	3.18
	10894809	CHEMBL2033074	Inhibition of human recombinant Aurora A kinase using biotinylated peptide substrate preincubated for 15 mins with compound measured after 30 mins by fluorescence analysis	B	O=C(Nc1ccc(Br)cc1)c1cn(-c2ccccc2)nc1-c1ccc(Cl)cc1		CHEMBL2030986	=	IC50	nM	5710.0	CHEMBL4722	Homo sapiens	IC50	uM	5.71
	10894810	CHEMBL2033074	Inhibition of human recombinant Aurora A kinase using biotinylated peptide substrate preincubated for 15 mins with compound measured after 30 mins by fluorescence analysis	B	COc1ccc(NC(=O)c2cn(-c3ccccc3)nc2-c2ccc(Cl)cc2)cc1		CHEMBL2030987	=	IC50	nM	840.0	CHEMBL4722	Homo sapiens	IC50	uM	0.84
	10894811	CHEMBL2033074	Inhibition of human recombinant Aurora A kinase using biotinylated peptide substrate preincubated for 15 mins with compound measured after 30 mins by fluorescence analysis	B	CCOc1ccc(NC(=O)c2cn(-c3ccccc3)nc2-c2ccc(Cl)cc2)cc1		CHEMBL2030988	=	IC50	nM	220.0	CHEMBL4722	Homo sapiens	IC50	uM	0.22
	10894812	CHEMBL2033074	Inhibition of human recombinant Aurora A kinase using biotinylated peptide substrate preincubated for 15 mins with compound measured after 30 mins by fluorescence analysis	B	O=C(Nc1ccccc1)c1cn(-c2ccccc2)nc1-c1ccc([N+](=O)[O-])cc1		CHEMBL2030989	=	IC50	nM	2100.0	CHEMBL4722	Homo sapiens	IC50	uM	2.1
	10894813	CHEMBL2033074	Inhibition of human recombinant Aurora A kinase using biotinylated peptide substrate preincubated for 15 mins with compound measured after 30 mins by fluorescence analysis	B	O=C(Nc1ccc(Cl)cc1)c1cn(-c2ccccc2)nc1-c1ccc([N+](=O)[O-])cc1		CHEMBL2030990	=	IC50	nM	3040.0	CHEMBL4722	Homo sapiens	IC50	uM	3.04
	10894814	CHEMBL2033074	Inhibition of human recombinant Aurora A kinase using biotinylated peptide substrate preincubated for 15 mins with compound measured after 30 mins by fluorescence analysis	B	O=C(Nc1ccc(Br)cc1)c1cn(-c2ccccc2)nc1-c1ccc([N+](=O)[O-])cc1		CHEMBL2030991	=	IC50	nM	5520.0	CHEMBL4722	Homo sapiens	IC50	uM	5.52
	10894815	CHEMBL2033074	Inhibition of human recombinant Aurora A kinase using biotinylated peptide substrate preincubated for 15 mins with compound measured after 30 mins by fluorescence analysis	B	COc1ccc(NC(=O)c2cn(-c3ccccc3)nc2-c2ccc([N+](=O)[O-])cc2)cc1		CHEMBL2030992	=	IC50	nM	790.0	CHEMBL4722	Homo sapiens	IC50	uM	0.79
	10894816	CHEMBL2033074	Inhibition of human recombinant Aurora A kinase using biotinylated peptide substrate preincubated for 15 mins with compound measured after 30 mins by fluorescence analysis	B	CCOc1ccc(NC(=O)c2cn(-c3ccccc3)nc2-c2ccc([N+](=O)[O-])cc2)cc1		CHEMBL2030993	=	IC50	nM	160.0	CHEMBL4722	Homo sapiens	IC50	uM	0.16
	10894817	CHEMBL2033074	Inhibition of human recombinant Aurora A kinase using biotinylated peptide substrate preincubated for 15 mins with compound measured after 30 mins by fluorescence analysis	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	IC50	nM	130.0	CHEMBL4722	Homo sapiens	IC50	uM	0.13
	10896858	CHEMBL2038922	Inhibition of Aurora A at 3 uM	B	C=CC(=O)NCc1coc(-c2c(N)ncnc2Nc2ccc(OCc3ccccn3)c(Cl)c2)n1		CHEMBL2035810	=	Inhibition	%	42.0	CHEMBL4722	Homo sapiens	INH	%	42.0
	10896877	CHEMBL2039251	Inhibition of Aurora A	B	C=CC(=O)NCc1coc(-c2c(N)ncnc2Nc2ccc(OCc3ccccn3)c(Cl)c2)n1		CHEMBL2035810	>	IC50	nM	3000.0	CHEMBL4722	Homo sapiens	IC50	uM	3.0
	10923005	CHEMBL2044154	Inhibition of Aurora A kinase by caliper method	B	CC(Oc1cc(-c2cc(-c3ccc(CN(C)C)cc3)cnc2N)ccc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL2042031	=	IC50	nM	7930.0	CHEMBL4722	Homo sapiens	IC50	uM	7.93
	10923006	CHEMBL2044154	Inhibition of Aurora A kinase by caliper method	B	C[C@@H](/C=C\C(F)(F)F)Oc1cc(-c2cc(-c3cc(CN(C)C)cs3)cnc2N)ccc1C(N)=O		CHEMBL2042042	=	IC50	nM	2330.0	CHEMBL4722	Homo sapiens	IC50	uM	2.33
	10923007	CHEMBL2044154	Inhibition of Aurora A kinase by caliper method	B	C[C@H](/C=C\C(F)(F)F)Oc1cc(-c2cc(-c3cc(CN(C)C)cs3)cnc2N)ccc1C(N)=O		CHEMBL2042135	=	IC50	nM	4940.0	CHEMBL4722	Homo sapiens	IC50	uM	4.94
	10923008	CHEMBL2044154	Inhibition of Aurora A kinase by caliper method	B	C[C@@H](Oc1cc(-c2cc(-c3cc(CN(C)C)cs3)cnc2N)ccc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL2042136	=	IC50	nM	8810.0	CHEMBL4722	Homo sapiens	IC50	uM	8.81
	10923963	CHEMBL2044157	Inhibition of AURA at 1 uM incubated for 30 mins prior to substrate addition study done at apparent ATP Km for enzyme	B	C[C@H](/C=C\C(F)(F)F)Oc1cc(-c2cc(-c3cc(CN(C)C)cs3)cnc2N)ccc1C(N)=O		CHEMBL2042135	=	Inhibition	%	19.0	CHEMBL4722	Homo sapiens	INH	%	19.0
	10925142	CHEMBL2046102	Inhibition of human Aurora-A assessed as remaining activity at 0.8 uM after 40 mins by scintillation counting	B	CC(C)Nc1cc(-c2oc3ccccc3c(=O)c2-c2ccc(F)cc2)ccn1		CHEMBL2041958	=	Activity	%	104.0	CHEMBL4722	Homo sapiens	Activity	%	104.0
	10925143	CHEMBL2046102	Inhibition of human Aurora-A assessed as remaining activity at 0.8 uM after 40 mins by scintillation counting	B	O=c1c(-c2ccc(F)cc2)c(-c2ccnc(NC3CCCCC3)c2)oc2ccccc12		CHEMBL2041962	=	Activity	%	107.0	CHEMBL4722	Homo sapiens	Activity	%	107.0
	10936270	CHEMBL2050063	Inhibition of human Aurora A	B	Cc1ccc(NC(=O)Nc2nnc(Sc3ncnc4cc(OCCCN5CCOCC5)ccc34)s2)cc1		CHEMBL2046883	=	IC50	nM	1500.0	CHEMBL4722	Homo sapiens	IC50	uM	1.5
	10945426	CHEMBL2049894	Inhibition of Aur A	B	Cc1cc(N2CCOCC2)ccc1Nc1nc(NC2CCCCC2)c2nc[nH]c2n1		CHEMBL2047943	>	IC50	nM	10000.0	CHEMBL4722	Homo sapiens	IC50	uM	10.0
	10945427	CHEMBL2049894	Inhibition of Aur A	B	c1nc2c(NC3CCCCC3)nc(Nc3ccc(N4CCOCC4)cc3)nc2[nH]1		CHEMBL188343	=	IC50	nM	110.0	CHEMBL4722	Homo sapiens	IC50	uM	0.11
	10974360	CHEMBL2066306	Inhibition of Aurora A	B	CN1CCN(c2ccc(C(=O)Nc3cc(-c4ccc(NC(=O)OCc5ccccc5)cc4)n[nH]3)cc2)CC1		CHEMBL2063319	>	IC50	nM	1000.0	CHEMBL4722	Homo sapiens	IC50	nM	1000.0
	10974361	CHEMBL2066306	Inhibition of Aurora A	B	CN1CCN(c2ccc(C(=O)Nc3cc(-c4ccc(NC(=O)Oc5ccccc5)cc4)n[nH]3)cc2)CC1		CHEMBL2063318	>	IC50	nM	1000.0	CHEMBL4722	Homo sapiens	IC50	nM	1000.0
	10974362	CHEMBL2066306	Inhibition of Aurora A	B	O=C(Nc1ccc(-c2cc(NC(=O)c3ccc(OCCN4CCCC4)cc3)[nH]n2)cc1)Oc1ccccc1		CHEMBL2063320	>	IC50	nM	1000.0	CHEMBL4722	Homo sapiens	IC50	nM	1000.0
	10974363	CHEMBL2066306	Inhibition of Aurora A	B	CN1CCN(c2ccc(C(=O)Nc3cc(-c4ccc(NS(=O)(=O)c5ccccc5)cc4)n[nH]3)cc2)CC1		CHEMBL1807466	>	IC50	nM	1000.0	CHEMBL4722	Homo sapiens	IC50	nM	1000.0
	10974364	CHEMBL2066306	Inhibition of Aurora A	B	CN1CCN(c2ccc(C(=O)Nc3cc(-c4ccc(CNC(=O)Oc5ccccc5)cc4)n[nH]3)cc2)CC1		CHEMBL2063321	>	IC50	nM	1000.0	CHEMBL4722	Homo sapiens	IC50	nM	1000.0
	10974365	CHEMBL2066306	Inhibition of Aurora A	B	CCOC(=O)NCc1ccc(-c2cc(NC(=O)c3ccc(N4CCN(C)CC4)cc3)[nH]n2)cc1		CHEMBL2063322	>	IC50	nM	1000.0	CHEMBL4722	Homo sapiens	IC50	nM	1000.0
	10974366	CHEMBL2066306	Inhibition of Aurora A	B	CN1CCN(c2ccc(C(=O)Nc3cc(-c4ccc(CNC(=O)OCc5ccccc5)cc4)n[nH]3)cc2)CC1		CHEMBL2063323	=	IC50	nM	880.0	CHEMBL4722	Homo sapiens	IC50	nM	880.0
	10974367	CHEMBL2066306	Inhibition of Aurora A	B	O=C(NCc1ccc(-c2cc(NC(=O)c3ccc(OCCN4CCCC4)cc3)[nH]n2)cc1)OCc1ccccc1		CHEMBL2063324	>	IC50	nM	1000.0	CHEMBL4722	Homo sapiens	IC50	nM	1000.0
	10974368	CHEMBL2066306	Inhibition of Aurora A	B	CN1CCN(Cc2ccc(C(=O)Nc3cc(-c4ccc(CNC(=O)OCc5ccccc5)cc4)n[nH]3)cc2)CC1		CHEMBL2063325	>	IC50	nM	1000.0	CHEMBL4722	Homo sapiens	IC50	nM	1000.0
	10974369	CHEMBL2066306	Inhibition of Aurora A	B	O=C(NCc1ccc(-c2cc(NC(=O)c3ccc(OCCN4CCOCC4)cc3)[nH]n2)cc1)OCc1ccccc1		CHEMBL2063326	=	IC50	nM	590.0	CHEMBL4722	Homo sapiens	IC50	nM	590.0
	10974370	CHEMBL2066306	Inhibition of Aurora A	B	O=C(NCc1ccc(-c2cc(NC(=O)c3ccc(OCCCN4CCCC4)cc3)[nH]n2)cc1)OCc1ccccc1		CHEMBL2063327	>	IC50	nM	1000.0	CHEMBL4722	Homo sapiens	IC50	nM	1000.0
	10974371	CHEMBL2066306	Inhibition of Aurora A	B	CN1CCN(c2ccc(C(=O)Nc3cc(-c4ccc(CNC(=O)OCc5cccnc5)cc4)n[nH]3)cc2)CC1		CHEMBL2063328	>	IC50	nM	1000.0	CHEMBL4722	Homo sapiens	IC50	nM	1000.0
	10974372	CHEMBL2066306	Inhibition of Aurora A	B	O=C(NCc1ccc(-c2cc(NC(=O)c3ccc(OCCN4CCCC4)cc3)[nH]n2)cc1)OCc1cccnc1		CHEMBL2063329	>	IC50	nM	1000.0	CHEMBL4722	Homo sapiens	IC50	nM	1000.0
	10974373	CHEMBL2066306	Inhibition of Aurora A	B	O=C(NCc1ccc(-c2cc(NC(=O)c3ccc(OCCN4CCOCC4)cc3)[nH]n2)cc1)OCc1cccnc1		CHEMBL2063330	>	IC50	nM	1000.0	CHEMBL4722	Homo sapiens	IC50	nM	1000.0
	10974374	CHEMBL2066306	Inhibition of Aurora A	B	Cc1cc(COC(=O)NCc2ccc(-c3cc(NC(=O)c4ccc(N5CCN(C)CC5)cc4)[nH]n3)cc2)no1		CHEMBL2063331	>	IC50	nM	1000.0	CHEMBL4722	Homo sapiens	IC50	nM	1000.0
	10974375	CHEMBL2066306	Inhibition of Aurora A	B	Cc1cc(COC(=O)NCc2ccc(-c3cc(NC(=O)c4ccc(OCCN5CCCC5)cc4)[nH]n3)cc2)no1		CHEMBL2063332	>	IC50	nM	1000.0	CHEMBL4722	Homo sapiens	IC50	nM	1000.0
	10974376	CHEMBL2066306	Inhibition of Aurora A	B	Cc1cc(COC(=O)NCc2ccc(-c3cc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)[nH]n3)cc2)no1		CHEMBL2063333	>	IC50	nM	1000.0	CHEMBL4722	Homo sapiens	IC50	nM	1000.0
	10974377	CHEMBL2066306	Inhibition of Aurora A	B	CN1CCN(c2ccc(C(=O)Nc3cc(-c4ccc(CNS(=O)(=O)c5ccccc5)cc4)n[nH]3)cc2)CC1		CHEMBL2063334	=	IC50	nM	1000.0	CHEMBL4722	Homo sapiens	IC50	nM	1000.0
	10974378	CHEMBL2066306	Inhibition of Aurora A	B	Cc1nc(Nc2cc(-c3ccc(CNC(=O)OCc4ccccc4)cc3)n[nH]2)cc(N2CCN(C)CC2)n1		CHEMBL2063335	=	IC50	nM	430.0	CHEMBL4722	Homo sapiens	IC50	nM	430.0
	10974379	CHEMBL2066306	Inhibition of Aurora A	B	Cc1nc(Nc2cc(-c3ccc(CNC(=O)OCc4cccnc4)cc3)n[nH]2)cc(N2CCN(C)CC2)n1		CHEMBL2063336	>	IC50	nM	1000.0	CHEMBL4722	Homo sapiens	IC50	nM	1000.0
	10974380	CHEMBL2066306	Inhibition of Aurora A	B	Cc1nc(Nc2cc(-c3ccc(CNC(=O)OCc4cc(C)on4)cc3)n[nH]2)cc(N2CCN(C)CC2)n1		CHEMBL2063337	>	IC50	nM	1000.0	CHEMBL4722	Homo sapiens	IC50	nM	1000.0
	10974381	CHEMBL2066306	Inhibition of Aurora A	B	Cc1nc(Nc2cc(-c3ccc(CNC(=O)OCc4ccccc4)cc3)n[nH]2)cc(N2CCN(CCO)CC2)n1		CHEMBL2063338	=	IC50	nM	170.0	CHEMBL4722	Homo sapiens	IC50	nM	170.0
	10974382	CHEMBL2066306	Inhibition of Aurora A	B	Cc1nc(Nc2cc(-c3ccc(CNC(=O)OCc4cccnc4)cc3)n[nH]2)cc(N2CCN(CCO)CC2)n1		CHEMBL2063434	>	IC50	nM	1000.0	CHEMBL4722	Homo sapiens	IC50	nM	1000.0
	10974383	CHEMBL2066306	Inhibition of Aurora A	B	Cc1nc(Nc2cc(-c3ccc(CNC(=O)OCc4cc(C)on4)cc3)n[nH]2)cc(N2CCN(CCO)CC2)n1		CHEMBL2063435	>	IC50	nM	1000.0	CHEMBL4722	Homo sapiens	IC50	nM	1000.0
	10974384	CHEMBL2066306	Inhibition of Aurora A	B	Cc1nc(Nc2cc(-c3ccc(CNC(=O)OCc4ccccc4)cc3)n[nH]2)cc(N2CCNCC2)n1		CHEMBL2063436	=	IC50	nM	350.0	CHEMBL4722	Homo sapiens	IC50	nM	350.0
	10974385	CHEMBL2066306	Inhibition of Aurora A	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	>	IC50	nM	10000.0	CHEMBL4722	Homo sapiens	IC50	nM	10000.0
	10974386	CHEMBL2066306	Inhibition of Aurora A	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	=	IC50	nM	3800.0	CHEMBL4722	Homo sapiens	IC50	nM	3800.0
	10974387	CHEMBL2066306	Inhibition of Aurora A	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	=	IC50	nM	760.0	CHEMBL4722	Homo sapiens	IC50	nM	760.0
	10975649	CHEMBL2064920	Inhibition of Aurora A kinase by HTRF analysis in presence of 1 mM ATP	B	Nc1noc2cccc(C(=O)Nc3cccc(CNC(=O)Cc4cccc(F)c4)c3)c12		CHEMBL2063452	>	IC50	nM	12500.0	CHEMBL4722	Homo sapiens	IC50	nM	12500.0
	10975650	CHEMBL2064920	Inhibition of Aurora A kinase by HTRF analysis in presence of 1 mM ATP	B	Nc1noc2cccc(C(=O)Nc3cccc(CC(=O)Nc4cccc(F)c4)c3)c12		CHEMBL2063451	>	IC50	nM	12500.0	CHEMBL4722	Homo sapiens	IC50	nM	12500.0
	10975651	CHEMBL2064920	Inhibition of Aurora A kinase by HTRF analysis in presence of 1 mM ATP	B	Nc1noc2cccc(C(=O)Nc3cccc(CNS(=O)(=O)c4ccccc4)c3)c12		CHEMBL2063450	>	IC50	nM	12500.0	CHEMBL4722	Homo sapiens	IC50	nM	12500.0
	10975652	CHEMBL2064920	Inhibition of Aurora A kinase by HTRF analysis in presence of 1 mM ATP	B	NCc1cccc(NC(=O)c2cccc3onc(N)c23)c1		CHEMBL2063449	>	IC50	nM	12500.0	CHEMBL4722	Homo sapiens	IC50	nM	12500.0
	10975653	CHEMBL2064920	Inhibition of Aurora A kinase by HTRF analysis in presence of 1 mM ATP	B	Nc1noc2cccc(C(=O)Nc3cccc(CNC(=O)Nc4ccccc4F)c3)c12		CHEMBL2063445	>	IC50	nM	12500.0	CHEMBL4722	Homo sapiens	IC50	nM	12500.0
	10975654	CHEMBL2064920	Inhibition of Aurora A kinase by HTRF analysis in presence of 1 mM ATP	B	Nc1noc2cccc(C(=O)Nc3ccc(NC(=O)Nc4ccc(Cl)cc4)cc3)c12		CHEMBL2063440	>	IC50	nM	12500.0	CHEMBL4722	Homo sapiens	IC50	nM	12500.0
	10975655	CHEMBL2064920	Inhibition of Aurora A kinase by HTRF analysis in presence of 1 mM ATP	B	Cc1ccc(NC(=O)Nc2ccc(NC(=O)c3cccc4onc(N)c34)cc2)cc1		CHEMBL2063439	>	IC50	nM	12500.0	CHEMBL4722	Homo sapiens	IC50	nM	12500.0
	10975656	CHEMBL2064920	Inhibition of Aurora A kinase by HTRF analysis in presence of 1 mM ATP	B	Nc1noc2cccc(C(=O)Nc3ccc(NC(=O)Nc4ccc(F)cc4)cc3)c12		CHEMBL2063438	>	IC50	nM	12500.0	CHEMBL4722	Homo sapiens	IC50	nM	12500.0
	10975669	CHEMBL2064924	Inhibition of Aurora A kinase in presence of 10 uM ATP	B	Nc1ncnn2ccc(C(=O)Nc3ccc(NC(=O)Nc4cccc(F)c4)cc3)c12		CHEMBL1990583	<	IC50	nM	3.0	CHEMBL4722	Homo sapiens	IC50	nM	3.0
	10975670	CHEMBL2064920	Inhibition of Aurora A kinase by HTRF analysis in presence of 1 mM ATP	B	Cn1nc(N)c2c(C(=O)Nc3cccc(CNC(=O)Nc4ccc(C(F)(F)F)cc4)c3)cccc21		CHEMBL2063458	=	IC50	nM	12500.0	CHEMBL4722	Homo sapiens	IC50	nM	12500.0
	10975671	CHEMBL2064920	Inhibition of Aurora A kinase by HTRF analysis in presence of 1 mM ATP	B	Cn1nc(N)c2c(C(=O)Nc3cccc(CNC(=O)Nc4cccc(F)c4)c3)cccc21		CHEMBL2063457	=	IC50	nM	12500.0	CHEMBL4722	Homo sapiens	IC50	nM	12500.0
	10975672	CHEMBL2064920	Inhibition of Aurora A kinase by HTRF analysis in presence of 1 mM ATP	B	Nc1nsc2cccc(C(=O)Nc3cccc(CNC(=O)Nc4ccc(F)c(F)c4)c3)c12		CHEMBL2063454	=	IC50	nM	12500.0	CHEMBL4722	Homo sapiens	IC50	nM	12500.0
	10975673	CHEMBL2064920	Inhibition of Aurora A kinase by HTRF analysis in presence of 1 mM ATP	B	Nc1nsc2cccc(C(=O)Nc3cccc(CNC(=O)Nc4ccc(C(F)(F)F)cc4)c3)c12		CHEMBL2063453	=	IC50	nM	12500.0	CHEMBL4722	Homo sapiens	IC50	nM	12500.0
	10975674	CHEMBL2064920	Inhibition of Aurora A kinase by HTRF analysis in presence of 1 mM ATP	B	Nc1nsc2cccc(C(=O)Nc3cccc(CNC(=O)Nc4cccc(F)c4)c3)c12		CHEMBL1986658	=	IC50	nM	12500.0	CHEMBL4722	Homo sapiens	IC50	nM	12500.0
	10975675	CHEMBL2064920	Inhibition of Aurora A kinase by HTRF analysis in presence of 1 mM ATP	B	Nc1noc2cccc(C(=O)Nc3cccc(CNC(=O)Nc4ccc(C(F)(F)F)cc4)c3)c12		CHEMBL2063447	=	IC50	nM	12500.0	CHEMBL4722	Homo sapiens	IC50	nM	12500.0
	10975676	CHEMBL2064920	Inhibition of Aurora A kinase by HTRF analysis in presence of 1 mM ATP	B	Nc1noc2cccc(C(=O)Nc3cccc(CNC(=O)Nc4ccc(F)cc4)c3)c12		CHEMBL2063442	=	IC50	nM	12200.0	CHEMBL4722	Homo sapiens	IC50	nM	12200.0
	10975679	CHEMBL2064920	Inhibition of Aurora A kinase by HTRF analysis in presence of 1 mM ATP	B	Nc1noc2cccc(C(=O)Nc3cccc(CNC(=O)Nc4ccc(F)c(F)c4)c3)c12		CHEMBL2063448	=	IC50	nM	4780.0	CHEMBL4722	Homo sapiens	IC50	nM	4780.0
	10975680	CHEMBL2064920	Inhibition of Aurora A kinase by HTRF analysis in presence of 1 mM ATP	B	Nc1noc2cccc(C(=O)Nc3cccc(CNC(=O)Nc4ccccc4)c3)c12		CHEMBL2063441	=	IC50	nM	3790.0	CHEMBL4722	Homo sapiens	IC50	nM	3790.0
	10975681	CHEMBL2064920	Inhibition of Aurora A kinase by HTRF analysis in presence of 1 mM ATP	B	Nc1noc2cccc(C(=O)Nc3cccc(CNC(=O)Nc4cccc(F)c4)c3)c12		CHEMBL2063446	=	IC50	nM	3180.0	CHEMBL4722	Homo sapiens	IC50	nM	3180.0
	10975684	CHEMBL2064920	Inhibition of Aurora A kinase by HTRF analysis in presence of 1 mM ATP	B	Nc1n[nH]c2cccc(C(=O)Nc3cccc(CNC(=O)Nc4ccc(F)c(F)c4)c3)c12		CHEMBL2063456	=	IC50	nM	1623.0	CHEMBL4722	Homo sapiens	IC50	nM	1623.0
	10975685	CHEMBL2064920	Inhibition of Aurora A kinase by HTRF analysis in presence of 1 mM ATP	B	Nc1n[nH]c2cccc(C(=O)Nc3cccc(CNC(=O)Nc4cccc(F)c4)c3)c12		CHEMBL2063455	=	IC50	nM	1279.0	CHEMBL4722	Homo sapiens	IC50	nM	1279.0
	10975689	CHEMBL2064920	Inhibition of Aurora A kinase by HTRF analysis in presence of 1 mM ATP	B	Nc1ncnn2ccc(C(=O)Nc3cccc(CNC(=O)Nc4ccc(C(F)(F)F)cc4)c3)c12		CHEMBL2063460	=	IC50	nM	786.0	CHEMBL4722	Homo sapiens	IC50	nM	786.0
	10975690	CHEMBL2064920	Inhibition of Aurora A kinase by HTRF analysis in presence of 1 mM ATP	B	Cc1ccc(NC(=O)NCc2cccc(NC(=O)c3cccc4onc(N)c34)c2)cc1		CHEMBL2063443	=	IC50	nM	586.0	CHEMBL4722	Homo sapiens	IC50	nM	586.0
	10975697	CHEMBL2064920	Inhibition of Aurora A kinase by HTRF analysis in presence of 1 mM ATP	B	Nc1ncnn2ccc(C(=O)Nc3cccc(CNC(=O)Nc4cccc(Cl)c4)c3)c12		CHEMBL2063463	=	IC50	nM	186.0	CHEMBL4722	Homo sapiens	IC50	nM	186.0
	10975699	CHEMBL2064920	Inhibition of Aurora A kinase by HTRF analysis in presence of 1 mM ATP	B	Cc1cccc(NC(=O)Nc2ccc(NC(=O)c3ccn4ncnc(N)c34)cc2)c1		CHEMBL2063464	=	IC50	nM	171.0	CHEMBL4722	Homo sapiens	IC50	nM	171.0
	10975700	CHEMBL2064920	Inhibition of Aurora A kinase by HTRF analysis in presence of 1 mM ATP	B	Nc1noc2cccc(C(=O)Nc3cccc(CNC(=O)Nc4ccc(Cl)cc4)c3)c12		CHEMBL2063444	=	IC50	nM	166.0	CHEMBL4722	Homo sapiens	IC50	nM	166.0
	10975706	CHEMBL2064920	Inhibition of Aurora A kinase by HTRF analysis in presence of 1 mM ATP	B	Nc1ncnn2ccc(C(=O)Nc3ccc(NC(=O)Nc4ccc(F)cc4)cc3)c12		CHEMBL2063465	=	IC50	nM	88.0	CHEMBL4722	Homo sapiens	IC50	nM	88.0
	10975708	CHEMBL2064920	Inhibition of Aurora A kinase by HTRF analysis in presence of 1 mM ATP	B	Nc1ncnn2ccc(C(=O)Nc3cccc(CNC(=O)Nc4cccc(F)c4)c3)c12		CHEMBL2063462	=	IC50	nM	67.0	CHEMBL4722	Homo sapiens	IC50	nM	67.0
	10975713	CHEMBL2064920	Inhibition of Aurora A kinase by HTRF analysis in presence of 1 mM ATP	B	Cc1ccc(NC(=O)NCc2cccc(NC(=O)c3ccn4ncnc(N)c34)c2)cc1		CHEMBL2063461	=	IC50	nM	46.0	CHEMBL4722	Homo sapiens	IC50	nM	46.0
	10975714	CHEMBL2064920	Inhibition of Aurora A kinase by HTRF analysis in presence of 1 mM ATP	B	Nc1ncnn2ccc(C(=O)Nc3cccc(CNC(=O)Nc4ccc(Cl)cc4)c3)c12		CHEMBL2063459	=	IC50	nM	46.0	CHEMBL4722	Homo sapiens	IC50	nM	46.0
	10975717	CHEMBL2064920	Inhibition of Aurora A kinase by HTRF analysis in presence of 1 mM ATP	B	Nc1ncnn2ccc(C(=O)Nc3ccc(NC(=O)NC4CCCC4)cc3)c12		CHEMBL2063466	=	IC50	nM	37.0	CHEMBL4722	Homo sapiens	IC50	nM	37.0
	10975740	CHEMBL2064920	Inhibition of Aurora A kinase by HTRF analysis in presence of 1 mM ATP	B	Nc1ncnn2ccc(C(=O)Nc3ccc(NC(=O)Nc4ccsc4)cc3)c12		CHEMBL2063467	=	IC50	nM	8.0	CHEMBL4722	Homo sapiens	IC50	nM	8.0
Not Determined	10975778	CHEMBL2064920	Inhibition of Aurora A kinase by HTRF analysis in presence of 1 mM ATP	B	Nc1noc2cccc(C(=O)Nc3ccc(NC(=O)Nc4ccccc4)cc3)c12		CHEMBL2063437		IC50			CHEMBL4722	Homo sapiens	IC50		
Not Determined	10975779	CHEMBL2064920	Inhibition of Aurora A kinase by HTRF analysis in presence of 1 mM ATP	B	Nc1ncnn2ccc(C(=O)Nc3ccc(NC(=O)Nc4cccc(F)c4)cc3)c12		CHEMBL1990583		IC50			CHEMBL4722	Homo sapiens	IC50		
	10978485	CHEMBL2066180	Inhibition of human recombinant AurA/Aur2 expressed in Sf21 cells using ulight-RRRSLLE as substrate assessed as residual activity at 1 uM after 15 mins by Cerep assay	B	N#Cc1ccc(-c2ccc(CSc3nnc(-c4ccc5c(c4)OCO5)o3)cc2)cc1		CHEMBL2064515	>	Activity	%	80.0	CHEMBL4722	Homo sapiens	Activity	%	80.0
	10978520	CHEMBL2066815	Inhibition of human recombinant AurKA by FRET assay	B	COC(=O)c1ccc(CSc2nnc(-c3ccc4c(c3)OCCO4)o2)cc1		CHEMBL2064520	>	IC50	nM	100000.0	CHEMBL4722	Homo sapiens	IC50	uM	100.0
	10978522	CHEMBL2066815	Inhibition of human recombinant AurKA by FRET assay	B	c1ccc(-c2ccc(CSc3nnc(-c4ccc5c(c4)OCO5)o3)cc2)cc1		CHEMBL2064531	>	IC50	nM	100000.0	CHEMBL4722	Homo sapiens	IC50	uM	100.0
	10978523	CHEMBL2066815	Inhibition of human recombinant AurKA by FRET assay	B	N#Cc1cc(F)ccc1-c1ccc(CSc2nnc(-c3ccc4c(c3)OCO4)o2)cc1		CHEMBL2064532	=	IC50	nM	30000.0	CHEMBL4722	Homo sapiens	IC50	uM	30.0
	10978524	CHEMBL2066815	Inhibition of human recombinant AurKA by FRET assay	B	N#Cc1ccc(-c2ccc(CSc3nnc(-c4ccc5c(c4)OCO5)o3)cc2)cc1		CHEMBL2064515	=	IC50	nM	30000.0	CHEMBL4722	Homo sapiens	IC50	uM	30.0
	10978525	CHEMBL2066815	Inhibition of human recombinant AurKA by FRET assay	B	N#Cc1ccccc1-c1ccc(CSc2nnc(-c3ccc4c(c3)OCO4)o2)cc1		CHEMBL2064533	>	IC50	nM	100000.0	CHEMBL4722	Homo sapiens	IC50	uM	100.0
	10978526	CHEMBL2066815	Inhibition of human recombinant AurKA by FRET assay	B	N#Cc1ccccc1-c1ccc(CSc2nnc(-c3ccc4c(c3)OCCO4)o2)cc1		CHEMBL2064534	>	IC50	nM	100000.0	CHEMBL4722	Homo sapiens	IC50	uM	100.0
	10978527	CHEMBL2066815	Inhibition of human recombinant AurKA by FRET assay	B	N#Cc1cc(F)ccc1-c1ccc(CSc2nnc(-c3ccc4c(c3)OCCO4)o2)cc1		CHEMBL2064535	=	IC50	nM	5000.0	CHEMBL4722	Homo sapiens	IC50	uM	5.0
	10978528	CHEMBL2066815	Inhibition of human recombinant AurKA by FRET assay	B	COCC1COc2ccc(-c3nnc(SCc4ccc(-c5ccccc5C#N)cc4)o3)cc2O1		CHEMBL2064537	=	IC50	nM	30000.0	CHEMBL4722	Homo sapiens	IC50	uM	30.0
	10978529	CHEMBL2066815	Inhibition of human recombinant AurKA by FRET assay	B	N#Cc1ccccc1-c1ccc(CSc2nnc(-c3ccncc3)o2)cc1		CHEMBL2064536	>	IC50	nM	100000.0	CHEMBL4722	Homo sapiens	IC50	uM	100.0
	10978530	CHEMBL2066815	Inhibition of human recombinant AurKA by FRET assay	B	COC[C@@H]1COc2ccc(-c3nnc(SCc4ccc(-c5ccccc5C#N)cc4)o3)cc2O1		CHEMBL2064538	>	IC50	nM	100000.0	CHEMBL4722	Homo sapiens	IC50	uM	100.0
	10978531	CHEMBL2066815	Inhibition of human recombinant AurKA by FRET assay	B	COC[C@H]1COc2ccc(-c3nnc(SCc4ccc(-c5ccccc5C#N)cc4)o3)cc2O1		CHEMBL2064539	>	IC50	nM	100000.0	CHEMBL4722	Homo sapiens	IC50	uM	100.0
	10980237	CHEMBL2065107	Inhibition of AURKA at 10 uM by FRET assay	B	CSc1ccccc1Nc1nc(N2CC3(CNC3)C2)nc2c(NCC3CC3)ncnc12		CHEMBL2017253	=	Inhibition	%	25.0	CHEMBL4722	Homo sapiens	INH	%	25.0
	10980238	CHEMBL2065107	Inhibition of AURKA at 10 uM by FRET assay	B	CSc1ccccc1Nc1nc(N2CCN(C3CCNCC3)CC2)nc2c(NCC3CC3)ncnc12		CHEMBL2063926	<	Inhibition	%	15.0	CHEMBL4722	Homo sapiens	INH	%	15.0
	10980294	CHEMBL2065138	Inhibition of AURKA by FRET assay	B	CSc1ccccc1Nc1nc(N2CCN(C3CCNCC3)CC2)nc2c(NCC3CC3)ncnc12		CHEMBL2063926	<	IC50	nM	10000.0	CHEMBL4722	Homo sapiens	IC50	uM	10.0
	10984735	CHEMBL2072031	Inhibition of human Aurora-A at 1 uM	B	Nc1cc(Nc2cnccn2)nc(-c2ccnc(N3CCNCC3)c2)c1		CHEMBL2069349	<	Inhibition	%	50.0	CHEMBL4722	Homo sapiens	INH	%	50.0
	10986193	CHEMBL2073509	Inhibition of Aurora A by TR-FRET analysis	B	Cn1cc(Nc2ncc(Br)c(N[C@H]3[C@@H](C(N)=O)[C@@H]4C=C[C@H]3C4)n2)cn1		CHEMBL2071201	=	IC50	nM	3.0	CHEMBL4722	Homo sapiens	IC50	nM	3.0
Active	12037003	CHEMBL2149649	Inhibition of Aurora A at 22500 nM by electrophoretic mobility shift assay	B	O=C1/C(=C/c2c[nH]c3ccccc23)Oc2c1ccc(O)c2CN1CCCCCC1		CHEMBL2147758		Inhibition	%		CHEMBL4722	Homo sapiens	INH		
	12046241	CHEMBL2157261	Inhibition of Aurora A at 1 uM	B	CC(C)(O)C1CCN(Cc2ccc3nc(-c4c(F)ccc5[nH]ccc45)nc(N4CCOCC4)c3n2)CC1		CHEMBL2152768	=	Inhibition	%	4.7	CHEMBL4722	Homo sapiens	INH	%	4.7
	12060918	CHEMBL2157050	Binding affinity to AURKA at 1 uM by high throughput binding assay relative to control	B	Nc1cc(NS(=O)(=O)c2cccc(C(F)(F)F)c2)cc(-c2cnc3[nH]cc(-c4ccncc4)c3c2)c1		CHEMBL2152288	=	Activity	%	100.0	CHEMBL4722	Homo sapiens	Activity	%	100.0
	12070717	CHEMBL2161898	Inhibition of human Aurora A kinase at 10 uM	B	CC(=O)n1nc(NC(=O)c2ccccc2)c2c1CN(C(=O)c1ccccc1)C2		CHEMBL2160091	=	Inhibition	%	33.0	CHEMBL4722	Homo sapiens	INH	%	33.0
	12074663	CHEMBL2161225	Inhibition of Aurora-A at 1 uM	B	CN(C)CC(=O)N1CCC(c2ccc(NC(=O)c3nc(C#N)c[nH]3)c(C3=CCCCC3)c2)CC1		CHEMBL1908842	<	Inhibition	%	50.0	CHEMBL4722	Homo sapiens	INH	%	50.0
	12077632	CHEMBL2162540	Inhibition of human recombinant Aurora A kinase using PLK as substrate incubated for 15 mins prior to substrate addition measured after 60 mins by immunofluorescence method	B	COc1ccc(C2=NN(C(=O)c3ccc(Cl)cc3O)C(c3ccc(Cl)cc3)C2)cc1		CHEMBL2159053	>	IC50	nM	25000.0	CHEMBL4722	Homo sapiens	IC50	uM	25.0
	12086220	CHEMBL2167309	Inhibition of Aurora kinase A autophosphorylation in human HEK293 cells after 2 hrs by phosphor antibody readout assay	B	Cc1cc(Nc2nc(Sc3ccc(NC(=O)CN4CC[C@@H](C(=O)NC5CCCC5)C4)cc3)nn3cccc23)n[nH]1		CHEMBL2163394	=	IC50	nM	2.0	CHEMBL4722	Homo sapiens	IC50	nM	2.0
	12086221	CHEMBL2167309	Inhibition of Aurora kinase A autophosphorylation in human HEK293 cells after 2 hrs by phosphor antibody readout assay	B	Cc1cc(Nc2nc(Sc3ccc(NC(=O)CN4CC[C@@H](C(=O)N5CCC(F)(F)C5)C4)cc3)nn3cccc23)n[nH]1		CHEMBL2163404	=	IC50	nM	1.0	CHEMBL4722	Homo sapiens	IC50	nM	1.0
	12086888	CHEMBL2167305	Binding affinity to Aurora kinase A catalytic domain by competition binding assay	B	Cc1cc(Nc2nc(Sc3ccc(NC(=O)CN4CC[C@@H](C(=O)NCC(F)(F)F)C4)cc3)nn3cccc23)n[nH]1		CHEMBL2163388	=	Kd	nM	2.5	CHEMBL4722	Homo sapiens	Kd	nM	2.5
	12086889	CHEMBL2167305	Binding affinity to Aurora kinase A catalytic domain by competition binding assay	B	Cc1cc(Nc2nc(Sc3ccc(NC(=O)CN4CC[C@@H](C(=O)NC(C)(C)C)C4)cc3)nn3cccc23)n[nH]1		CHEMBL2163387	=	Kd	nM	5.6	CHEMBL4722	Homo sapiens	Kd	nM	5.6
	12086890	CHEMBL2167305	Binding affinity to Aurora kinase A catalytic domain by competition binding assay	B	Cc1cc(Nc2nc(Sc3ccc(NC(=O)CN4CC[C@@H](C(=O)NC5CCC5)C4)cc3)nn3cccc23)n[nH]1		CHEMBL2163395	=	Kd	nM	4.2	CHEMBL4722	Homo sapiens	Kd	nM	4.2
	12086891	CHEMBL2167305	Binding affinity to Aurora kinase A catalytic domain by competition binding assay	B	Cc1cc(Nc2nc(Sc3ccc(NC(=O)CN4CC[C@@H](C(=O)NC5CCCC5)C4)cc3)nn3cccc23)n[nH]1		CHEMBL2163394	=	Kd	nM	9.3	CHEMBL4722	Homo sapiens	Kd	nM	9.3
	12086892	CHEMBL2167305	Binding affinity to Aurora kinase A catalytic domain by competition binding assay	B	Cc1cc(Nc2nc(Sc3ccc(NC(=O)CN4CC[C@@H](C(=O)Nc5ccc(F)cc5)C4)cc3)nn3cccc23)n[nH]1		CHEMBL2163393	=	Kd	nM	19.5	CHEMBL4722	Homo sapiens	Kd	nM	19.5
	12086893	CHEMBL2167305	Binding affinity to Aurora kinase A catalytic domain by competition binding assay	B	Cc1cc(Nc2nc(Sc3ccc(NC(=O)CN4CC[C@@H](C(=O)NCCN5CCOCC5)C4)cc3)nn3cccc23)n[nH]1		CHEMBL2163392	=	Kd	nM	6.3	CHEMBL4722	Homo sapiens	Kd	nM	6.3
	12086894	CHEMBL2167305	Binding affinity to Aurora kinase A catalytic domain by competition binding assay	B	Cc1cc(Nc2nc(Sc3ccc(NC(=O)CN4CC[C@@H](C(=O)N5CCC(O)CC5)C4)cc3)nn3cccc23)n[nH]1		CHEMBL2163391	=	Kd	nM	4.0	CHEMBL4722	Homo sapiens	Kd	nM	4.0
	12086895	CHEMBL2167305	Binding affinity to Aurora kinase A catalytic domain by competition binding assay	B	Cc1cc(Nc2nc(Sc3ccc(NC(=O)CN4CC[C@@H](C(=O)N5CCOCC5)C4)cc3)nn3cccc23)n[nH]1		CHEMBL2163390	=	Kd	nM	4.0	CHEMBL4722	Homo sapiens	Kd	nM	4.0
	12086896	CHEMBL2167305	Binding affinity to Aurora kinase A catalytic domain by competition binding assay	B	Cc1cc(Nc2nc(Sc3ccc(NC(=O)CN4CC[C@@H](C(=O)N5CCCCC5)C4)cc3)nn3cccc23)n[nH]1		CHEMBL2163389	=	Kd	nM	6.4	CHEMBL4722	Homo sapiens	Kd	nM	6.4
	12086897	CHEMBL2167305	Binding affinity to Aurora kinase A catalytic domain by competition binding assay	B	Cc1cc(Nc2nc(Sc3ccc(NC(=O)CN4CC[C@@H](C(=O)N5CCC(F)(F)C5)C4)cc3)nn3cccc23)n[nH]1		CHEMBL2163404	=	Kd	nM	5.8	CHEMBL4722	Homo sapiens	Kd	nM	5.8
	12086898	CHEMBL2167305	Binding affinity to Aurora kinase A catalytic domain by competition binding assay	B	Cc1cc(Nc2nc(Sc3ccc(NC(=O)CN4CC[C@@H](C(=O)N5CCCC5)C4)cc3)nn3cccc23)n[nH]1		CHEMBL2163403	=	Kd	nM	6.3	CHEMBL4722	Homo sapiens	Kd	nM	6.3
	12086899	CHEMBL2167305	Binding affinity to Aurora kinase A catalytic domain by competition binding assay	B	Cc1cc(Nc2nc(Sc3ccc(NC(=O)CN4CC[C@H](C(=O)N5CCCC5)C4)cc3)nn3cccc23)n[nH]1		CHEMBL2163402	=	Kd	nM	10.1	CHEMBL4722	Homo sapiens	Kd	nM	10.1
	12086900	CHEMBL2167305	Binding affinity to Aurora kinase A catalytic domain by competition binding assay	B	Cc1cc(Nc2nc(Sc3ccc(NC(=O)CN4CC[C@@H](S(=O)(=O)C(C)(C)C)C4)cc3)nn3cccc23)n[nH]1		CHEMBL2163401	=	Kd	nM	4.0	CHEMBL4722	Homo sapiens	Kd	nM	4.0
	12086901	CHEMBL2167305	Binding affinity to Aurora kinase A catalytic domain by competition binding assay	B	Cc1cc(Nc2nc(Sc3ccc(NC(=O)CN4CC[C@@H]([S+]([O-])C(C)(C)C)C4)cc3)nn3cccc23)n[nH]1		CHEMBL2163400	=	Kd	nM	2.8	CHEMBL4722	Homo sapiens	Kd	nM	2.8
	12086902	CHEMBL2167305	Binding affinity to Aurora kinase A catalytic domain by competition binding assay	B	Cc1cc(Nc2nc(Sc3ccc(NC(=O)CN4CC[C@@H](SC(C)(C)C)C4)cc3)nn3cccc23)n[nH]1		CHEMBL2163399	=	Kd	nM	25.2	CHEMBL4722	Homo sapiens	Kd	nM	25.2
	12086903	CHEMBL2167305	Binding affinity to Aurora kinase A catalytic domain by competition binding assay	B	Cc1cc(Nc2nc(Sc3ccc(NC(=O)CN4CCC(C(=O)N5CCCC5)C4)cc3)nn3cccc23)n[nH]1		CHEMBL2163398	=	Kd	nM	8.8	CHEMBL4722	Homo sapiens	Kd	nM	8.8
	12086904	CHEMBL2167305	Binding affinity to Aurora kinase A catalytic domain by competition binding assay	B	Cc1cc(Nc2nc(Sc3ccc(NC(=O)CN4CCC(C(=O)C(C)(C)C)C4)cc3)nn3cccc23)n[nH]1		CHEMBL2163397	=	Kd	nM	16.9	CHEMBL4722	Homo sapiens	Kd	nM	16.9
	12086905	CHEMBL2167305	Binding affinity to Aurora kinase A catalytic domain by competition binding assay	B	Cc1cc(Nc2nc(Sc3ccc(NC(=O)CN4CC[C@@H](NS(C)(=O)=O)C4)cc3)nn3cccc23)n[nH]1		CHEMBL2163396	=	Kd	nM	12.3	CHEMBL4722	Homo sapiens	Kd	nM	12.3
	12086906	CHEMBL2167305	Binding affinity to Aurora kinase A catalytic domain by competition binding assay	B	Cc1cc(Nc2nc(Sc3ccc(NC(=O)CN4CC[C@@H](NC(=O)C(C)C)C4)cc3)nn3cccc23)n[nH]1		CHEMBL2163413	=	Kd	nM	13.1	CHEMBL4722	Homo sapiens	Kd	nM	13.1
	12086907	CHEMBL2167305	Binding affinity to Aurora kinase A catalytic domain by competition binding assay	B	Cc1cc(Nc2nc(Sc3ccc(NC(=O)CN4CC[C@@H](OC(C)(C)C)C4)cc3)nn3cccc23)n[nH]1		CHEMBL2163412	=	Kd	nM	25.0	CHEMBL4722	Homo sapiens	Kd	nM	25.0
	12086908	CHEMBL2167305	Binding affinity to Aurora kinase A catalytic domain by competition binding assay	B	Cc1cc(Nc2nc(Sc3ccc(NC(=O)CN4CC[C@@H](OCCCN5CCOCC5)C4)cc3)nn3cccc23)n[nH]1		CHEMBL2163411	=	Kd	nM	5.1	CHEMBL4722	Homo sapiens	Kd	nM	5.1
	12086909	CHEMBL2167305	Binding affinity to Aurora kinase A catalytic domain by competition binding assay	B	Cc1cc(Nc2nc(Sc3ccc(NC(=O)CN4CC[C@@H](OCCN5CCN(C)CC5)C4)cc3)nn3cccc23)n[nH]1		CHEMBL2163410	=	Kd	nM	12.5	CHEMBL4722	Homo sapiens	Kd	nM	12.5
	12086910	CHEMBL2167305	Binding affinity to Aurora kinase A catalytic domain by competition binding assay	B	Cc1cc(Nc2nc(Sc3ccc(NC(=O)CN4CC[C@@H](OCCN5CCOCC5)C4)cc3)nn3cccc23)n[nH]1		CHEMBL2163409	=	Kd	nM	11.0	CHEMBL4722	Homo sapiens	Kd	nM	11.0
	12086911	CHEMBL2167305	Binding affinity to Aurora kinase A catalytic domain by competition binding assay	B	COCCO[C@@H]1CCN(CC(=O)Nc2ccc(Sc3nc(Nc4cc(C)[nH]n4)c4cccn4n3)cc2)C1		CHEMBL2163408	=	Kd	nM	11.5	CHEMBL4722	Homo sapiens	Kd	nM	11.5
	12086912	CHEMBL2167305	Binding affinity to Aurora kinase A catalytic domain by competition binding assay	B	Cc1cc(Nc2nc(Sc3ccc(NC(=O)CN4CC[C@@H](OCCO)C4)cc3)nn3cccc23)n[nH]1		CHEMBL2163407	=	Kd	nM	4.5	CHEMBL4722	Homo sapiens	Kd	nM	4.5
	12086913	CHEMBL2167305	Binding affinity to Aurora kinase A catalytic domain by competition binding assay	B	Cc1cc(Nc2nc(Sc3ccc(NC(=O)CN4CC[C@@H](O)C4)cc3)nn3cccc23)n[nH]1		CHEMBL2163406	=	Kd	nM	10.5	CHEMBL4722	Homo sapiens	Kd	nM	10.5
	12086914	CHEMBL2167305	Binding affinity to Aurora kinase A catalytic domain by competition binding assay	B	Cc1cc(Nc2nc(Sc3ccc(NC(=O)CN4CC[C@H](O)C4)cc3)nn3cccc23)n[nH]1		CHEMBL2163405	=	Kd	nM	39.0	CHEMBL4722	Homo sapiens	Kd	nM	39.0
	12086915	CHEMBL2167305	Binding affinity to Aurora kinase A catalytic domain by competition binding assay	B	Cc1cc(Nc2nc(Sc3ccc(NC(=O)CN4C[C@H](O)[C@@H](Oc5ccc(F)cc5)C4)cc3)nn3cccc23)n[nH]1		CHEMBL1822658	=	Kd	nM	15.0	CHEMBL4722	Homo sapiens	Kd	nM	15.0
	12112542	CHEMBL2173310	Inhibition of autophosphorylation of Aurora A kinase at Thr288 in human MDA-MB-468 cells after 2 hrs by Western blot analysis	B	O=C(O)c1ccc(Nc2nccc(Nc3ccccc3C(=O)O)n2)cc1		CHEMBL2170592	>	IC50	nM	100000.0	CHEMBL4722	Homo sapiens	IC50	uM	100.0
	12112543	CHEMBL2174324	Inhibition of Aurora A by 33P minase hotspot assay	B	O=C(O)c1ccc(Nc2nccc(Nc3ccccc3)n2)cc1		CHEMBL2170597	=	IC50	nM	8.9	CHEMBL4722	Homo sapiens	IC50	nM	8.9
	12112544	CHEMBL2174324	Inhibition of Aurora A by 33P minase hotspot assay	B	O=C(O)c1ccc(Nc2nccc(Nc3ccccc3C(=O)O)n2)cc1		CHEMBL2170592	=	IC50	nM	5.1	CHEMBL4722	Homo sapiens	IC50	nM	5.1
	12112547	CHEMBL2173310	Inhibition of autophosphorylation of Aurora A kinase at Thr288 in human MDA-MB-468 cells after 2 hrs by Western blot analysis	B	NC(=O)c1ccc(Nc2nccc(Nc3ccccc3Cl)n2)cc1	Potential transcription error	CHEMBL2170442	<	IC50	nM	1000.0	CHEMBL4722	Homo sapiens	IC50	uM	1.0
	12112552	CHEMBL2174324	Inhibition of Aurora A by 33P minase hotspot assay	B	O=C(O)c1ccc(Nc2ncc(F)c(Nc3ccccc3Cl)n2)cc1		CHEMBL2170419	=	IC50	nM	0.2	CHEMBL4722	Homo sapiens	IC50	nM	0.2
	12112553	CHEMBL2174324	Inhibition of Aurora A by 33P minase hotspot assay	B	O=C(O)c1ccc(Nc2nccc(Nc3ccccc3Cl)n2)cc1		CHEMBL2170601	=	IC50	nM	0.74	CHEMBL4722	Homo sapiens	IC50	nM	0.74
	12112554	CHEMBL2174324	Inhibition of Aurora A by 33P minase hotspot assay	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	IC50	nM	0.24	CHEMBL4722	Homo sapiens	IC50	nM	0.24
	12112556	CHEMBL2174326	Inhibition of Aurora A	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	IC50	nM	0.6	CHEMBL4722	Homo sapiens	IC50	nM	0.6
	12112560	CHEMBL2174330	Inhibition of recombinant Aurora A by radioactive flash plate assay	B	COc1cc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2OC)=NC3)ccc1C(=O)O		CHEMBL483158	=	IC50	nM	1.2	CHEMBL4722	Homo sapiens	IC50	nM	1.2
	12112567	CHEMBL2174337	Inhibition of Aurora A kinase using [33P]ATP at 0.5 uM by filter-binding assay	B	O=C(O)c1ccc(Nc2ncc(F)c(Nc3ccccc3Cl)n2)cc1		CHEMBL2170419	=	Inhibition	%	97.0	CHEMBL4722	Homo sapiens	INH	%	97.0
	12112602	CHEMBL2174422	Inhibition of Aurora A kinase at 1 uM by 33P kinase hotspot assay	B	NC(=O)c1ccc(Nc2ncc(F)c(Nc3ccccc3Cl)n2)cc1		CHEMBL2170414	=	Inhibition	%	99.0	CHEMBL4722	Homo sapiens	INH	%	99.0
	12112603	CHEMBL2174422	Inhibition of Aurora A kinase at 1 uM by 33P kinase hotspot assay	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	Inhibition	%	100.0	CHEMBL4722	Homo sapiens	INH	%	100.0
	12112660	CHEMBL2173310	Inhibition of autophosphorylation of Aurora A kinase at Thr288 in human MDA-MB-468 cells after 2 hrs by Western blot analysis	B	Clc1ccccc1Nc1nc(Nc2ccc(-c3nnn[nH]3)cc2)ncc1Cl	Potential transcription error	CHEMBL2170418	=	IC50	nM	3000.0	CHEMBL4722	Homo sapiens	IC50	uM	3.0
	12112661	CHEMBL2173310	Inhibition of autophosphorylation of Aurora A kinase at Thr288 in human MDA-MB-468 cells after 2 hrs by Western blot analysis	B	Oc1cc(Nc2ncc(F)c(Nc3ccccc3Cl)n2)ccc1-c1nnn[nH]1		CHEMBL2170417	>	IC50	nM	10000.0	CHEMBL4722	Homo sapiens	IC50	uM	10.0
	12112662	CHEMBL2173310	Inhibition of autophosphorylation of Aurora A kinase at Thr288 in human MDA-MB-468 cells after 2 hrs by Western blot analysis	B	Fc1cnc(Nc2ccc(-c3nnn[nH]3)cc2)nc1Nc1ccccc1Cl		CHEMBL2169893	=	IC50	nM	3000.0	CHEMBL4722	Homo sapiens	IC50	uM	3.0
	12112663	CHEMBL2173310	Inhibition of autophosphorylation of Aurora A kinase at Thr288 in human MDA-MB-468 cells after 2 hrs by Western blot analysis	B	Clc1ccccc1Nc1ccnc(Nc2ccc(-c3nnn[nH]3)cc2)n1		CHEMBL2170416	>	IC50	nM	10000.0	CHEMBL4722	Homo sapiens	IC50	uM	10.0
	12112664	CHEMBL2173310	Inhibition of autophosphorylation of Aurora A kinase at Thr288 in human MDA-MB-468 cells after 2 hrs by Western blot analysis	B	NS(=O)(=O)c1ccc(Nc2ncc(F)c(Nc3ccccc3Cl)n2)cc1		CHEMBL2170415	<	IC50	nM	1000.0	CHEMBL4722	Homo sapiens	IC50	uM	1.0
	12113580	CHEMBL2173310	Inhibition of autophosphorylation of Aurora A kinase at Thr288 in human MDA-MB-468 cells after 2 hrs by Western blot analysis	B	NC(=O)c1ccc(Nc2ncc(F)c(Nc3ccccc3Cl)n2)cc1		CHEMBL2170414	<	IC50	nM	300.0	CHEMBL4722	Homo sapiens	IC50	uM	0.3
	12113581	CHEMBL2173310	Inhibition of autophosphorylation of Aurora A kinase at Thr288 in human MDA-MB-468 cells after 2 hrs by Western blot analysis	B	O=C(NCCO)c1ccc(Nc2nccc(Nc3ccccc3Cl)n2)cc1	Potential transcription error	CHEMBL2170413	<	IC50	nM	1000.0	CHEMBL4722	Homo sapiens	IC50	uM	1.0
	12113582	CHEMBL2173310	Inhibition of autophosphorylation of Aurora A kinase at Thr288 in human MDA-MB-468 cells after 2 hrs by Western blot analysis	B	Fc1cnc(Nc2ccc(CN3CCOCC3)cc2)nc1Nc1ccccc1Cl	Potential transcription error	CHEMBL2170412	<	IC50	nM	1000.0	CHEMBL4722	Homo sapiens	IC50	uM	1.0
	12113583	CHEMBL2173310	Inhibition of autophosphorylation of Aurora A kinase at Thr288 in human MDA-MB-468 cells after 2 hrs by Western blot analysis	B	Fc1cnc(Nc2ccc(N3CCOCC3)cc2)nc1Nc1ccccc1Cl	Potential transcription error	CHEMBL2170411	<	IC50	nM	1000.0	CHEMBL4722	Homo sapiens	IC50	uM	1.0
	12113584	CHEMBL2173310	Inhibition of autophosphorylation of Aurora A kinase at Thr288 in human MDA-MB-468 cells after 2 hrs by Western blot analysis	B	NS(=O)(=O)c1ccc(Nc2nccc(Nc3ccccc3Cl)n2)cc1	Potential transcription error	CHEMBL2170410	<	IC50	nM	1000.0	CHEMBL4722	Homo sapiens	IC50	uM	1.0
	12113585	CHEMBL2173310	Inhibition of autophosphorylation of Aurora A kinase at Thr288 in human MDA-MB-468 cells after 2 hrs by Western blot analysis	B	Clc1ccccc1Nc1ccnc(Nc2ccc(N3CCOCC3)cc2)n1	Potential transcription error	CHEMBL2170409	<	IC50	nM	1000.0	CHEMBL4722	Homo sapiens	IC50	uM	1.0
	12113586	CHEMBL2173310	Inhibition of autophosphorylation of Aurora A kinase at Thr288 in human MDA-MB-468 cells after 2 hrs by Western blot analysis	B	COc1cc(Nc2nccc(Nc3ccccc3Cl)n2)ccc1C(=O)O		CHEMBL2170408	=	IC50	nM	3000.0	CHEMBL4722	Homo sapiens	IC50	uM	3.0
	12113587	CHEMBL2173310	Inhibition of autophosphorylation of Aurora A kinase at Thr288 in human MDA-MB-468 cells after 2 hrs by Western blot analysis	B	O=c1[nH]c2ccc(Nc3nccc(Nc4ccccc4Cl)n3)cc2[nH]1		CHEMBL2170407	=	IC50	nM	3000.0	CHEMBL4722	Homo sapiens	IC50	uM	3.0
	12113588	CHEMBL2173310	Inhibition of autophosphorylation of Aurora A kinase at Thr288 in human MDA-MB-468 cells after 2 hrs by Western blot analysis	B	CC(=O)Nc1cccc(Nc2nccc(Nc3ccccc3Cl)n2)c1		CHEMBL2170406	=	IC50	nM	1000.0	CHEMBL4722	Homo sapiens	IC50	uM	1.0
	12113589	CHEMBL2173310	Inhibition of autophosphorylation of Aurora A kinase at Thr288 in human MDA-MB-468 cells after 2 hrs by Western blot analysis	B	CS(=O)(=O)c1ccc(Nc2nccc(Nc3ccccc3Cl)n2)cc1		CHEMBL2170405	<	IC50	nM	1000.0	CHEMBL4722	Homo sapiens	IC50	uM	1.0
	12113590	CHEMBL2173310	Inhibition of autophosphorylation of Aurora A kinase at Thr288 in human MDA-MB-468 cells after 2 hrs by Western blot analysis	B	COCCNC(=O)c1ccc(Nc2nccc(Nc3ccccc3Cl)n2)cc1		CHEMBL2170404	=	IC50	nM	1000.0	CHEMBL4722	Homo sapiens	IC50	uM	1.0
	12113591	CHEMBL2173310	Inhibition of autophosphorylation of Aurora A kinase at Thr288 in human MDA-MB-468 cells after 2 hrs by Western blot analysis	B	CN(C)CCNC(=O)c1ccc(Nc2nccc(Nc3ccccc3Cl)n2)cc1		CHEMBL2170591	<	IC50	nM	1000.0	CHEMBL4722	Homo sapiens	IC50	uM	1.0
	12113592	CHEMBL2173310	Inhibition of autophosphorylation of Aurora A kinase at Thr288 in human MDA-MB-468 cells after 2 hrs by Western blot analysis	B	O=C(NCCN1CCOCC1)c1ccc(Nc2nccc(Nc3ccccc3Cl)n2)cc1		CHEMBL2170590	=	IC50	nM	1000.0	CHEMBL4722	Homo sapiens	IC50	uM	1.0
	12113593	CHEMBL2173311	Inhibition of Aurora A kinase expressed in Escherichia coli using LRRASLG as substrate by coupled enzyme assay	B	Clc1ccccc1Nc1nc(Nc2ccc(-c3nnn[nH]3)cc2)ncc1Cl		CHEMBL2170418	=	IC50	nM	3.0	CHEMBL4722	Homo sapiens	IC50	nM	3.0
	12113594	CHEMBL2173311	Inhibition of Aurora A kinase expressed in Escherichia coli using LRRASLG as substrate by coupled enzyme assay	B	Oc1cc(Nc2ncc(F)c(Nc3ccccc3Cl)n2)ccc1-c1nnn[nH]1		CHEMBL2170417	=	IC50	nM	17.3	CHEMBL4722	Homo sapiens	IC50	nM	17.3
	12113595	CHEMBL2173311	Inhibition of Aurora A kinase expressed in Escherichia coli using LRRASLG as substrate by coupled enzyme assay	B	Fc1cnc(Nc2ccc(-c3nnn[nH]3)cc2)nc1Nc1ccccc1Cl		CHEMBL2169893	=	IC50	nM	2.9	CHEMBL4722	Homo sapiens	IC50	nM	2.9
	12113596	CHEMBL2173311	Inhibition of Aurora A kinase expressed in Escherichia coli using LRRASLG as substrate by coupled enzyme assay	B	Clc1ccccc1Nc1ccnc(Nc2ccc(-c3nnn[nH]3)cc2)n1		CHEMBL2170416	=	IC50	nM	3.1	CHEMBL4722	Homo sapiens	IC50	nM	3.1
	12113597	CHEMBL2173311	Inhibition of Aurora A kinase expressed in Escherichia coli using LRRASLG as substrate by coupled enzyme assay	B	NS(=O)(=O)c1ccc(Nc2ncc(F)c(Nc3ccccc3Cl)n2)cc1		CHEMBL2170415	=	IC50	nM	21.2	CHEMBL4722	Homo sapiens	IC50	nM	21.2
	12113598	CHEMBL2173311	Inhibition of Aurora A kinase expressed in Escherichia coli using LRRASLG as substrate by coupled enzyme assay	B	NC(=O)c1ccc(Nc2ncc(F)c(Nc3ccccc3Cl)n2)cc1		CHEMBL2170414	=	IC50	nM	14.4	CHEMBL4722	Homo sapiens	IC50	nM	14.4
	12113599	CHEMBL2173311	Inhibition of Aurora A kinase expressed in Escherichia coli using LRRASLG as substrate by coupled enzyme assay	B	O=C(NCCO)c1ccc(Nc2nccc(Nc3ccccc3Cl)n2)cc1		CHEMBL2170413	=	IC50	nM	12.3	CHEMBL4722	Homo sapiens	IC50	nM	12.3
	12113600	CHEMBL2173311	Inhibition of Aurora A kinase expressed in Escherichia coli using LRRASLG as substrate by coupled enzyme assay	B	Fc1cnc(Nc2ccc(CN3CCOCC3)cc2)nc1Nc1ccccc1Cl		CHEMBL2170412	=	IC50	nM	23.2	CHEMBL4722	Homo sapiens	IC50	nM	23.2
	12113601	CHEMBL2173311	Inhibition of Aurora A kinase expressed in Escherichia coli using LRRASLG as substrate by coupled enzyme assay	B	Fc1cnc(Nc2ccc(N3CCOCC3)cc2)nc1Nc1ccccc1Cl		CHEMBL2170411	=	IC50	nM	21.4	CHEMBL4722	Homo sapiens	IC50	nM	21.4
	12113602	CHEMBL2173311	Inhibition of Aurora A kinase expressed in Escherichia coli using LRRASLG as substrate by coupled enzyme assay	B	NS(=O)(=O)c1ccc(Nc2nccc(Nc3ccccc3Cl)n2)cc1		CHEMBL2170410	=	IC50	nM	253.0	CHEMBL4722	Homo sapiens	IC50	nM	253.0
	12113603	CHEMBL2173311	Inhibition of Aurora A kinase expressed in Escherichia coli using LRRASLG as substrate by coupled enzyme assay	B	Clc1ccccc1Nc1ccnc(Nc2ccc(N3CCOCC3)cc2)n1		CHEMBL2170409	=	IC50	nM	27.0	CHEMBL4722	Homo sapiens	IC50	nM	27.0
	12113604	CHEMBL2173311	Inhibition of Aurora A kinase expressed in Escherichia coli using LRRASLG as substrate by coupled enzyme assay	B	COc1cc(Nc2nccc(Nc3ccccc3Cl)n2)ccc1C(=O)O		CHEMBL2170408	=	IC50	nM	116.5	CHEMBL4722	Homo sapiens	IC50	nM	116.5
	12113605	CHEMBL2173311	Inhibition of Aurora A kinase expressed in Escherichia coli using LRRASLG as substrate by coupled enzyme assay	B	O=c1[nH]c2ccc(Nc3nccc(Nc4ccccc4Cl)n3)cc2[nH]1		CHEMBL2170407	=	IC50	nM	316.0	CHEMBL4722	Homo sapiens	IC50	nM	316.0
	12113606	CHEMBL2173311	Inhibition of Aurora A kinase expressed in Escherichia coli using LRRASLG as substrate by coupled enzyme assay	B	CC(=O)Nc1cccc(Nc2nccc(Nc3ccccc3Cl)n2)c1		CHEMBL2170406	=	IC50	nM	71.2	CHEMBL4722	Homo sapiens	IC50	nM	71.2
	12113607	CHEMBL2173311	Inhibition of Aurora A kinase expressed in Escherichia coli using LRRASLG as substrate by coupled enzyme assay	B	CS(=O)(=O)c1ccc(Nc2nccc(Nc3ccccc3Cl)n2)cc1		CHEMBL2170405	=	IC50	nM	44.9	CHEMBL4722	Homo sapiens	IC50	nM	44.9
	12113608	CHEMBL2173311	Inhibition of Aurora A kinase expressed in Escherichia coli using LRRASLG as substrate by coupled enzyme assay	B	COCCNC(=O)c1ccc(Nc2nccc(Nc3ccccc3Cl)n2)cc1		CHEMBL2170404	=	IC50	nM	18.0	CHEMBL4722	Homo sapiens	IC50	nM	18.0
	12113609	CHEMBL2173311	Inhibition of Aurora A kinase expressed in Escherichia coli using LRRASLG as substrate by coupled enzyme assay	B	CN(C)CCNC(=O)c1ccc(Nc2nccc(Nc3ccccc3Cl)n2)cc1		CHEMBL2170591	=	IC50	nM	28.1	CHEMBL4722	Homo sapiens	IC50	nM	28.1
	12113610	CHEMBL2173311	Inhibition of Aurora A kinase expressed in Escherichia coli using LRRASLG as substrate by coupled enzyme assay	B	O=C(NCCN1CCOCC1)c1ccc(Nc2nccc(Nc3ccccc3Cl)n2)cc1		CHEMBL2170590	=	IC50	nM	216.0	CHEMBL4722	Homo sapiens	IC50	nM	216.0
	12113611	CHEMBL2173311	Inhibition of Aurora A kinase expressed in Escherichia coli using LRRASLG as substrate by coupled enzyme assay	B	O=C(O)c1cccc(Nc2ncc(F)c(Nc3ccccc3Cl)n2)c1		CHEMBL2170589	=	IC50	nM	4.5	CHEMBL4722	Homo sapiens	IC50	nM	4.5
	12113612	CHEMBL2173311	Inhibition of Aurora A kinase expressed in Escherichia coli using LRRASLG as substrate by coupled enzyme assay	B	CCN(c1ccnc(Nc2ccc(C(=O)O)cc2)n1)c1ccccc1Cl		CHEMBL2170588	=	IC50	nM	50.2	CHEMBL4722	Homo sapiens	IC50	nM	50.2
	12113613	CHEMBL2173311	Inhibition of Aurora A kinase expressed in Escherichia coli using LRRASLG as substrate by coupled enzyme assay	B	CN(c1ccnc(Nc2ccc(C(=O)O)cc2)n1)c1ccccc1Cl		CHEMBL2170587	=	IC50	nM	8.5	CHEMBL4722	Homo sapiens	IC50	nM	8.5
	12113614	CHEMBL2173311	Inhibition of Aurora A kinase expressed in Escherichia coli using LRRASLG as substrate by coupled enzyme assay	B	O=C(O)c1ccc(Nc2nccc(Nc3ccccc3-c3ccccc3)n2)cc1		CHEMBL2170586	=	IC50	nM	149.0	CHEMBL4722	Homo sapiens	IC50	nM	149.0
	12113615	CHEMBL2173311	Inhibition of Aurora A kinase expressed in Escherichia coli using LRRASLG as substrate by coupled enzyme assay	B	NC(=O)c1ccc(Nc2nccc(Nc3ccccc3Cl)n2)cc1		CHEMBL2170442	=	IC50	nM	30.2	CHEMBL4722	Homo sapiens	IC50	nM	30.2
	12113616	CHEMBL2173311	Inhibition of Aurora A kinase expressed in Escherichia coli using LRRASLG as substrate by coupled enzyme assay	B	O=C(O)c1cccc(Nc2nccc(Nc3ccccc3Cl)n2)c1		CHEMBL2170441	=	IC50	nM	18.7	CHEMBL4722	Homo sapiens	IC50	nM	18.7
	12113617	CHEMBL2173311	Inhibition of Aurora A kinase expressed in Escherichia coli using LRRASLG as substrate by coupled enzyme assay	B	N#Cc1ccccc1Nc1ccnc(Nc2ccc(C(=O)O)cc2)n1		CHEMBL2170440	=	IC50	nM	43.0	CHEMBL4722	Homo sapiens	IC50	nM	43.0
	12113618	CHEMBL2173311	Inhibition of Aurora A kinase expressed in Escherichia coli using LRRASLG as substrate by coupled enzyme assay	B	O=C(O)c1ccc(Nc2nccc(Nc3ccccc3I)n2)cc1		CHEMBL2170439	=	IC50	nM	35.0	CHEMBL4722	Homo sapiens	IC50	nM	35.0
	12113619	CHEMBL2173311	Inhibition of Aurora A kinase expressed in Escherichia coli using LRRASLG as substrate by coupled enzyme assay	B	Fc1ccccc1Nc1ccnc(Nc2ccccc2)n1		CHEMBL2170438	=	IC50	nM	284.0	CHEMBL4722	Homo sapiens	IC50	nM	284.0
	12113620	CHEMBL2173311	Inhibition of Aurora A kinase expressed in Escherichia coli using LRRASLG as substrate by coupled enzyme assay	B	O=C(O)c1ccc(Nc2nccc(Nc3ccccc3Cl)n2)cc1O		CHEMBL2170437	=	IC50	nM	6.6	CHEMBL4722	Homo sapiens	IC50	nM	6.6
	12113621	CHEMBL2173311	Inhibition of Aurora A kinase expressed in Escherichia coli using LRRASLG as substrate by coupled enzyme assay	B	O=C(O)Cc1ccc(Nc2nccc(Nc3ccccc3Cl)n2)cc1		CHEMBL2170436	=	IC50	nM	3.3	CHEMBL4722	Homo sapiens	IC50	nM	3.3
	12113622	CHEMBL2173311	Inhibition of Aurora A kinase expressed in Escherichia coli using LRRASLG as substrate by coupled enzyme assay	B	O=C(O)c1ccc(Nc2nccc(Nc3ccccc3Br)n2)cc1		CHEMBL2170435	=	IC50	nM	2.1	CHEMBL4722	Homo sapiens	IC50	nM	2.1
	12113623	CHEMBL2173311	Inhibition of Aurora A kinase expressed in Escherichia coli using LRRASLG as substrate by coupled enzyme assay	B	O=C(O)c1ccc(Nc2nccc(Nc3ccccc3C(F)(F)F)n2)cc1		CHEMBL2170434	=	IC50	nM	35.1	CHEMBL4722	Homo sapiens	IC50	nM	35.1
	12113624	CHEMBL2173311	Inhibition of Aurora A kinase expressed in Escherichia coli using LRRASLG as substrate by coupled enzyme assay	B	N#Cc1ccccc1Nc1ccnc(Nc2ccccc2)n1		CHEMBL2170433	=	IC50	nM	560.0	CHEMBL4722	Homo sapiens	IC50	nM	560.0
	12113625	CHEMBL2173311	Inhibition of Aurora A kinase expressed in Escherichia coli using LRRASLG as substrate by coupled enzyme assay	B	COc1ccccc1Nc1ccnc(Nc2ccccc2)n1		CHEMBL2170432	=	IC50	nM	46.6	CHEMBL4722	Homo sapiens	IC50	nM	46.6
	12113626	CHEMBL2173311	Inhibition of Aurora A kinase expressed in Escherichia coli using LRRASLG as substrate by coupled enzyme assay	B	COc1ccccc1Nc1ccnc(Nc2ccc(C(=O)O)cc2)n1		CHEMBL2170431	=	IC50	nM	4.0	CHEMBL4722	Homo sapiens	IC50	nM	4.0
	12113627	CHEMBL2173311	Inhibition of Aurora A kinase expressed in Escherichia coli using LRRASLG as substrate by coupled enzyme assay	B	O=C(O)c1ccc(Nc2nccc(Nc3ccccc3OC(F)(F)F)n2)cc1		CHEMBL2170430	=	IC50	nM	28.0	CHEMBL4722	Homo sapiens	IC50	nM	28.0
	12113628	CHEMBL2173311	Inhibition of Aurora A kinase expressed in Escherichia coli using LRRASLG as substrate by coupled enzyme assay	B	O=C(O)c1ccc(Nc2nccc(Nc3ccc(F)cc3Cl)n2)cc1		CHEMBL2170429	=	IC50	nM	2.0	CHEMBL4722	Homo sapiens	IC50	nM	2.0
	12113629	CHEMBL2173311	Inhibition of Aurora A kinase expressed in Escherichia coli using LRRASLG as substrate by coupled enzyme assay	B	FC(F)(F)c1ccccc1Nc1ccnc(Nc2ccccc2)n1		CHEMBL2170428	=	IC50	nM	1773.0	CHEMBL4722	Homo sapiens	IC50	nM	1773.0
	12113630	CHEMBL2173311	Inhibition of Aurora A kinase expressed in Escherichia coli using LRRASLG as substrate by coupled enzyme assay	B	O=C(O)c1ccc(Nc2nccc(Nc3ccccc3F)n2)cc1		CHEMBL2170427	=	IC50	nM	3.7	CHEMBL4722	Homo sapiens	IC50	nM	3.7
	12113631	CHEMBL2173311	Inhibition of Aurora A kinase expressed in Escherichia coli using LRRASLG as substrate by coupled enzyme assay	B	Nc1cc(Nc2ccccc2C(=O)O)nc(Nc2ccc(C(=O)O)cc2)n1		CHEMBL2170426	>	IC50	nM	50000.0	CHEMBL4722	Homo sapiens	IC50	uM	50.0
	12113632	CHEMBL2173311	Inhibition of Aurora A kinase expressed in Escherichia coli using LRRASLG as substrate by coupled enzyme assay	B	Nc1cnc(Nc2ccc(C(=O)O)cc2)nc1Nc1ccccc1C(=O)O		CHEMBL2170425	=	IC50	nM	376.0	CHEMBL4722	Homo sapiens	IC50	nM	376.0
	12113633	CHEMBL2173311	Inhibition of Aurora A kinase expressed in Escherichia coli using LRRASLG as substrate by coupled enzyme assay	B	O=C(O)c1ccc(Nc2ncc(Cl)c(Nc3ccccc3C(=O)O)n2)cc1		CHEMBL2170424	=	IC50	nM	3.17	CHEMBL4722	Homo sapiens	IC50	nM	3.17
	12113634	CHEMBL2173311	Inhibition of Aurora A kinase expressed in Escherichia coli using LRRASLG as substrate by coupled enzyme assay	B	O=C(O)c1ccc(Nc2nc(Cl)c(Cl)c(Nc3ccccc3C(=O)O)n2)cc1		CHEMBL2170423	=	IC50	nM	1490.0	CHEMBL4722	Homo sapiens	IC50	uM	1.49
	12113635	CHEMBL2173311	Inhibition of Aurora A kinase expressed in Escherichia coli using LRRASLG as substrate by coupled enzyme assay	B	O=C(O)c1cccc(Nc2ncc(F)c(Nc3ccccc3C(=O)O)n2)c1		CHEMBL2170422	=	IC50	nM	5.1	CHEMBL4722	Homo sapiens	IC50	nM	5.1
	12113636	CHEMBL2173311	Inhibition of Aurora A kinase expressed in Escherichia coli using LRRASLG as substrate by coupled enzyme assay	B	O=C(O)c1cccc(Nc2nccc(Nc3ccccc3C(=O)O)n2)c1		CHEMBL2170421	=	IC50	nM	18.3	CHEMBL4722	Homo sapiens	IC50	nM	18.3
	12113637	CHEMBL2173311	Inhibition of Aurora A kinase expressed in Escherichia coli using LRRASLG as substrate by coupled enzyme assay	B	Fc1cnc(Nc2ccccc2)nc1Nc1ccccc1Cl		CHEMBL2170420	=	IC50	nM	19.9	CHEMBL4722	Homo sapiens	IC50	nM	19.9
	12113638	CHEMBL2173311	Inhibition of Aurora A kinase expressed in Escherichia coli using LRRASLG as substrate by coupled enzyme assay	B	O=C(O)c1ccc(Nc2ncc(F)c(Nc3ccccc3Cl)n2)cc1		CHEMBL2170419	=	IC50	nM	0.8	CHEMBL4722	Homo sapiens	IC50	nM	0.8
	12113639	CHEMBL2173311	Inhibition of Aurora A kinase expressed in Escherichia coli using LRRASLG as substrate by coupled enzyme assay	B	O=C(O)c1ccc(Nc2ncc(F)c(Nc3ccccc3C(=O)O)n2)cc1		CHEMBL2170602	=	IC50	nM	3.9	CHEMBL4722	Homo sapiens	IC50	nM	3.9
	12113640	CHEMBL2173311	Inhibition of Aurora A kinase expressed in Escherichia coli using LRRASLG as substrate by coupled enzyme assay	B	O=C(O)c1ccccc1Nc1nc(Nc2ccccc2)ncc1F		CHEMBL244793	=	IC50	nM	11.3	CHEMBL4722	Homo sapiens	IC50	nM	11.3
	12113641	CHEMBL2173311	Inhibition of Aurora A kinase expressed in Escherichia coli using LRRASLG as substrate by coupled enzyme assay	B	O=C(O)c1ccc(Nc2nccc(Nc3ccccc3Cl)n2)cc1		CHEMBL2170601	=	IC50	nM	2.5	CHEMBL4722	Homo sapiens	IC50	nM	2.5
	12113642	CHEMBL2173311	Inhibition of Aurora A kinase expressed in Escherichia coli using LRRASLG as substrate by coupled enzyme assay	B	Cc1cc(Nc2ccccc2C(=O)O)nc(Nc2ccc(C(=O)O)cc2)n1		CHEMBL2170600	>	IC50	nM	50000.0	CHEMBL4722	Homo sapiens	IC50	uM	50.0
	12113643	CHEMBL2173311	Inhibition of Aurora A kinase expressed in Escherichia coli using LRRASLG as substrate by coupled enzyme assay	B	Cc1cnc(Nc2ccc(C(=O)O)cc2)nc1Nc1ccccc1C(=O)O		CHEMBL2170599	=	IC50	nM	281.0	CHEMBL4722	Homo sapiens	IC50	nM	281.0
	12113644	CHEMBL2173311	Inhibition of Aurora A kinase expressed in Escherichia coli using LRRASLG as substrate by coupled enzyme assay	B	O=C(O)c1ccc(Nc2ccnc(Nc3ccc(C(=O)O)cc3)n2)cc1		CHEMBL2170598	=	IC50	nM	256.0	CHEMBL4722	Homo sapiens	IC50	nM	256.0
	12113645	CHEMBL2173311	Inhibition of Aurora A kinase expressed in Escherichia coli using LRRASLG as substrate by coupled enzyme assay	B	O=C(O)c1ccc(Nc2nccc(Nc3ccccc3)n2)cc1		CHEMBL2170597	=	IC50	nM	10.0	CHEMBL4722	Homo sapiens	IC50	nM	10.0
	12113646	CHEMBL2173311	Inhibition of Aurora A kinase expressed in Escherichia coli using LRRASLG as substrate by coupled enzyme assay	B	NC(=O)c1ccc(Nc2nccc(Nc3ccccc3C(N)=O)n2)cc1		CHEMBL2170596	=	IC50	nM	38.2	CHEMBL4722	Homo sapiens	IC50	nM	38.2
	12113647	CHEMBL2173311	Inhibition of Aurora A kinase expressed in Escherichia coli using LRRASLG as substrate by coupled enzyme assay	B	c1ccc(Nc2ccnc(Nc3ccccc3)n2)cc1		CHEMBL578061	=	IC50	nM	423.0	CHEMBL4722	Homo sapiens	IC50	nM	423.0
	12113648	CHEMBL2173311	Inhibition of Aurora A kinase expressed in Escherichia coli using LRRASLG as substrate by coupled enzyme assay	B	COC(=O)c1ccc(Nc2nccc(Nc3ccccc3C(=O)OC)n2)cc1		CHEMBL2170595	=	IC50	nM	24600.0	CHEMBL4722	Homo sapiens	IC50	uM	24.6
	12113649	CHEMBL2173311	Inhibition of Aurora A kinase expressed in Escherichia coli using LRRASLG as substrate by coupled enzyme assay	B	O=C(O)c1ccccc1Nc1ccnc(Nc2ccccc2C(=O)O)n1		CHEMBL2170594	=	IC50	nM	31300.0	CHEMBL4722	Homo sapiens	IC50	uM	31.3
	12113650	CHEMBL2173311	Inhibition of Aurora A kinase expressed in Escherichia coli using LRRASLG as substrate by coupled enzyme assay	B	O=C(O)c1ccccc1Nc1ccnc(Nc2ccc(N3CCOCC3)cc2)n1		CHEMBL394816	=	IC50	nM	57.6	CHEMBL4722	Homo sapiens	IC50	nM	57.6
	12113651	CHEMBL2173311	Inhibition of Aurora A kinase expressed in Escherichia coli using LRRASLG as substrate by coupled enzyme assay	B	O=C(O)c1ccccc1Nc1ccnc(Nc2ccccc2)n1		CHEMBL244839	=	IC50	nM	79.4	CHEMBL4722	Homo sapiens	IC50	nM	79.4
	12113652	CHEMBL2173311	Inhibition of Aurora A kinase expressed in Escherichia coli using LRRASLG as substrate by coupled enzyme assay	B	NC(=O)c1ccccc1Nc1nccc(Nc2ccccc2C(=O)O)n1		CHEMBL2170593	=	IC50	nM	9000.0	CHEMBL4722	Homo sapiens	IC50	uM	9.0
	12113654	CHEMBL2173313	Inhibition of Aurora A kinase using LRRASLG as substrate by Z-LYTE assay	B	O=C(O)c1ccc(Nc2nccc(Nc3ccccc3C(=O)O)n2)cc1		CHEMBL2170592	=	IC50	nM	75.0	CHEMBL4722	Homo sapiens	IC50	uM	0.075
	12113655	CHEMBL2173311	Inhibition of Aurora A kinase expressed in Escherichia coli using LRRASLG as substrate by coupled enzyme assay	B	O=C(O)c1ccc(Nc2nccc(Nc3ccccc3C(=O)O)n2)cc1		CHEMBL2170592	=	IC50	nM	6.1	CHEMBL4722	Homo sapiens	IC50	nM	6.1
Active	12136265	CHEMBL2185476	Inhibition of Aurora A kinase at 10 uM in presence of ATP at Km level by kinase profiler method	B	N[C@H]1CC[C@H](Nc2c(C(=O)NCc3ccc(Cl)cc3Cl)nc(Br)c3cccnc23)CC1		CHEMBL2180568		Inhibition	%		CHEMBL4722	Homo sapiens	INH		
Active	12136266	CHEMBL2185476	Inhibition of Aurora A kinase at 10 uM in presence of ATP at Km level by kinase profiler method	B	N[C@H]1CC[C@H](Nc2c(C(=O)NCc3ccc(Cl)cc3)nc(Br)c3cccnc23)CC1		CHEMBL2180567		Inhibition	%		CHEMBL4722	Homo sapiens	INH		
	12139729	CHEMBL2184332	Inhibition of human Aurora kinase A/TPX2 complex using gamma-[32P]ATP incubated for 1 hr by autoradiography	B	COc1cc2c(Nc3ccc(NC(=O)c4ccccc4)cc3)ncnc2cc1OCCCN1CCOCC1		CHEMBL202721	=	IC50	nM	360.0	CHEMBL4722	Homo sapiens	IC50	nM	360.0
	12139732	CHEMBL2184332	Inhibition of human Aurora kinase A/TPX2 complex using gamma-[32P]ATP incubated for 1 hr by autoradiography	B	CCS(=O)(=O)Nc1ccc2c(c1)/C(=C(/Nc1ccc(CN3CCCCC3)cc1)c1ccccc1)C(=O)N2		CHEMBL514409	=	IC50	nM	11.0	CHEMBL4722	Homo sapiens	IC50	nM	11.0
	12139735	CHEMBL2184332	Inhibition of human Aurora kinase A/TPX2 complex using gamma-[32P]ATP incubated for 1 hr by autoradiography	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	IC50	nM	15.0	CHEMBL4722	Homo sapiens	IC50	nM	15.0
	12166139	CHEMBL2211612	Binding affinity to Aurora A at 1 uM	B	Cc1nc(N)nc(-c2cc(Cl)cnc2Nc2cnc(Cl)c(NS(=O)(=O)N(C)C)c2)n1		CHEMBL2206921	<	Activity	%	50.0	CHEMBL4722	Homo sapiens	Activity	%	50.0
	12170842	CHEMBL2212709	Inhibition of Aurora A assessed as residual activity at 1 uM	B	O=C(Nc1cccnc1)c1cc(-c2ccnc(F)c2)ccc1OCc1ccccc1		CHEMBL2204495	=	Activity	%	100.0	CHEMBL4722	Homo sapiens	Activity	%	100.0
	12172143	CHEMBL2209221	Inhibition of Aurora A assessed as residual activity at 10 uM	B	O=C(Nc1cccnc1)c1cc(-c2ccnc(F)c2)ccc1OCc1ccccc1		CHEMBL2204495	=	Activity	%	94.0	CHEMBL4722	Homo sapiens	Activity	%	94.0
	12173733	CHEMBL2212071	Inhibition of AURKA assessed as residual activity at 10 uM relative to control	B	O=C(Nc1cccnc1)c1cc(-c2ccnc(F)c2)ccc1OCc1ccccc1		CHEMBL2204495	=	Activity	%	96.0	CHEMBL4722	Homo sapiens	Activity	%	96.0
	12175313	CHEMBL2214093	Binding affinity to Aurora A kinase	B	Cc1nn(C)cc1-c1nc2c(N3CCN(Cc4ccc(Cl)cc4)CC3)c(Cl)cnc2[nH]1		CHEMBL2207503	=	Kd	nM	7.5	CHEMBL4722	Homo sapiens	Kd	nM	7.5
	12175336	CHEMBL2214100	Inhibition of GST-tagged human Aurora A kinase expressed in baculovirus system	B	Cc1cc(CN2CCN(c3c(Br)cnc4[nH]c(-c5nc(C)oc5C)nc34)CC2)no1		CHEMBL2207509	=	IC50	nM	2200.0	CHEMBL4722	Homo sapiens	IC50	uM	2.2
	12175357	CHEMBL2214100	Inhibition of GST-tagged human Aurora A kinase expressed in baculovirus system	B	Cc1cc(CN2CCN(c3c(Br)cnc4[nH]c(-c5csnn5)nc34)CC2)no1		CHEMBL2207511	=	IC50	nM	600.0	CHEMBL4722	Homo sapiens	IC50	uM	0.6
	12175360	CHEMBL2214100	Inhibition of GST-tagged human Aurora A kinase expressed in baculovirus system	B	Cc1cc(CN2CCN(c3c(Cl)cnc4[nH]c(-c5nccn5C)nc34)CC2)no1		CHEMBL2207507	=	IC50	nM	564.0	CHEMBL4722	Homo sapiens	IC50	uM	0.564
	12175362	CHEMBL2214100	Inhibition of GST-tagged human Aurora A kinase expressed in baculovirus system	B	Cc1cc(CN2CCN(c3c(Cl)cnc4[nH]c(-c5cc(C)on5)nc34)CC2)no1		CHEMBL2207510	=	IC50	nM	434.0	CHEMBL4722	Homo sapiens	IC50	uM	0.434
	12175372	CHEMBL2214100	Inhibition of GST-tagged human Aurora A kinase expressed in baculovirus system	B	Cc1cc(CN2CCN(c3c(Cl)cnc4[nH]c(-c5ccnn5C)nc34)CC2)no1		CHEMBL2207513	=	IC50	nM	147.0	CHEMBL4722	Homo sapiens	IC50	uM	0.147
	12175373	CHEMBL2214100	Inhibition of GST-tagged human Aurora A kinase expressed in baculovirus system	B	Cc1cc(CN2CCN(c3c(Cl)cnc4[nH]c(-c5cccc(OCCN(C)C)c5)nc34)CC2)no1		CHEMBL2203772	=	IC50	nM	130.0	CHEMBL4722	Homo sapiens	IC50	uM	0.13
	12175374	CHEMBL2214100	Inhibition of GST-tagged human Aurora A kinase expressed in baculovirus system	B	Cc1cc(CN2CCN(c3c(Cl)cnc4[nH]c(-c5ccn(C)n5)nc34)CC2)no1		CHEMBL2207512	=	IC50	nM	118.0	CHEMBL4722	Homo sapiens	IC50	uM	0.118
	12175377	CHEMBL2214100	Inhibition of GST-tagged human Aurora A kinase expressed in baculovirus system	B	Cc1nn(C)cc1-c1nc2c(N3CCN(Cc4ncn(C)n4)CC3)c(Cl)cnc2[nH]1		CHEMBL2207502	=	IC50	nM	93.0	CHEMBL4722	Homo sapiens	IC50	uM	0.093
	12175378	CHEMBL2214100	Inhibition of GST-tagged human Aurora A kinase expressed in baculovirus system	B	Cc1cc(CN2CCN(c3c(Cl)cnc4[nH]c(-c5ccc(N6CCN(C)CC6)cc5F)nc34)CC2)no1		CHEMBL2203771	=	IC50	nM	87.0	CHEMBL4722	Homo sapiens	IC50	uM	0.087
	12175379	CHEMBL2214100	Inhibition of GST-tagged human Aurora A kinase expressed in baculovirus system	B	Cc1cc(CN2CCN(c3c(Cl)cnc4[nH]c(-c5ccoc5)nc34)CC2)no1		CHEMBL2207508	=	IC50	nM	68.0	CHEMBL4722	Homo sapiens	IC50	uM	0.068
	12175382	CHEMBL2214100	Inhibition of GST-tagged human Aurora A kinase expressed in baculovirus system	B	Cc1cc(CN2CCN(c3c(Cl)cnc4[nH]c(-c5cccc(CN(C)C)c5)nc34)CC2)no1		CHEMBL2203773	=	IC50	nM	54.0	CHEMBL4722	Homo sapiens	IC50	uM	0.054
	12175383	CHEMBL2214100	Inhibition of GST-tagged human Aurora A kinase expressed in baculovirus system	B	Cc1nc(CN2CCN(c3c(Cl)cnc4[nH]c(-c5cn(C)nc5C)nc34)CC2)no1		CHEMBL2207501	=	IC50	nM	52.0	CHEMBL4722	Homo sapiens	IC50	uM	0.052
	12175384	CHEMBL2214100	Inhibition of GST-tagged human Aurora A kinase expressed in baculovirus system	B	Cc1cc(CN2CCN(c3c(Cl)cnc4[nH]c(-c5cccc(CN6CCOCC6)c5)nc34)CC2)no1		CHEMBL2203774	=	IC50	nM	47.0	CHEMBL4722	Homo sapiens	IC50	uM	0.047
	12175385	CHEMBL2214100	Inhibition of GST-tagged human Aurora A kinase expressed in baculovirus system	B	Cc1cc(CN2CCN(c3c(Cl)cnc4[nH]c(-c5cnn(CC(F)F)c5)nc34)CC2)no1		CHEMBL2207517	=	IC50	nM	45.0	CHEMBL4722	Homo sapiens	IC50	uM	0.045
	12175386	CHEMBL2214100	Inhibition of GST-tagged human Aurora A kinase expressed in baculovirus system	B	Cc1cc(CN2CCN(c3c(Cl)cnc4[nH]c(-c5cnn(C)c5)nc34)CC2)no1		CHEMBL2207514	=	IC50	nM	45.0	CHEMBL4722	Homo sapiens	IC50	uM	0.045
	12175387	CHEMBL2214100	Inhibition of GST-tagged human Aurora A kinase expressed in baculovirus system	B	CCn1cc(-c2nc3c(N4CCN(Cc5cc(C)on5)CC4)c(Cl)cnc3[nH]2)cn1		CHEMBL2207515	=	IC50	nM	41.0	CHEMBL4722	Homo sapiens	IC50	uM	0.041
	12175388	CHEMBL2214100	Inhibition of GST-tagged human Aurora A kinase expressed in baculovirus system	B	Cc1nn(C)cc1-c1nc2c(N3CCN(Cc4ncon4)CC3)c(Cl)cnc2[nH]1		CHEMBL2207500	=	IC50	nM	40.0	CHEMBL4722	Homo sapiens	IC50	uM	0.04
	12175389	CHEMBL2214100	Inhibition of GST-tagged human Aurora A kinase expressed in baculovirus system	B	Cc1nn(C)cc1-c1nc2c(N3CCN(Cc4ccc(Cl)cc4)CC3)c(Cl)cnc2[nH]1		CHEMBL2207503	=	IC50	nM	38.0	CHEMBL4722	Homo sapiens	IC50	uM	0.038
	12175390	CHEMBL2214100	Inhibition of GST-tagged human Aurora A kinase expressed in baculovirus system	B	Cc1cc(CN2CCN(c3c(Cl)cnc4[nH]c(-c5cnn(C(C)C)c5)nc34)CC2)no1		CHEMBL2207516	=	IC50	nM	35.0	CHEMBL4722	Homo sapiens	IC50	uM	0.035
	12175391	CHEMBL2214100	Inhibition of GST-tagged human Aurora A kinase expressed in baculovirus system	B	Cc1cc(CN2CCN(c3c(Cl)cnc4[nH]c(-c5ccc(N6CCN[C@@H](C)C6)cc5)nc34)CC2)no1		CHEMBL2203769	=	IC50	nM	34.0	CHEMBL4722	Homo sapiens	IC50	uM	0.034
	12175392	CHEMBL2211568	Inhibition of Aurora A kinase autophosphorylation at T288 in human HeLa cells	B	Cc1nn(C)cc1-c1nc2c(N3CCN(Cc4ccc(Cl)cc4)CC3)c(Cl)cnc2[nH]1		CHEMBL2207503	=	IC50	nM	30.0	CHEMBL4722	Homo sapiens	IC50	uM	0.03
	12175393	CHEMBL2214100	Inhibition of GST-tagged human Aurora A kinase expressed in baculovirus system	B	Cc1nn(C)cc1-c1nc2c(N3CCN(Cc4cnccn4)CC3)c(Cl)cnc2[nH]1		CHEMBL2207505	=	IC50	nM	27.0	CHEMBL4722	Homo sapiens	IC50	uM	0.027
	12175394	CHEMBL2214100	Inhibition of GST-tagged human Aurora A kinase expressed in baculovirus system	B	Cc1cc(CN2CCN(c3c(Cl)cnc4[nH]c(-c5cccc(N6CCN(C)CC6)c5)nc34)CC2)no1		CHEMBL2203775	=	IC50	nM	26.0	CHEMBL4722	Homo sapiens	IC50	uM	0.026
	12175395	CHEMBL2214100	Inhibition of GST-tagged human Aurora A kinase expressed in baculovirus system	B	Cc1nn(C)cc1-c1nc2c(N3CCN(Cc4cncnc4)CC3)c(Cl)cnc2[nH]1		CHEMBL2207504	=	IC50	nM	22.0	CHEMBL4722	Homo sapiens	IC50	uM	0.022
	12175396	CHEMBL2214100	Inhibition of GST-tagged human Aurora A kinase expressed in baculovirus system	B	Cc1cc(CN2CCN(c3c(Br)cnc4[nH]c(-c5cncn5C)nc34)CC2)no1		CHEMBL2207506	=	IC50	nM	15.0	CHEMBL4722	Homo sapiens	IC50	uM	0.015
	12175397	CHEMBL2214100	Inhibition of GST-tagged human Aurora A kinase expressed in baculovirus system	B	Cc1cc(CN2CCN(c3c(Cl)cnc4[nH]c(-c5cn(C)nc5C)nc34)CC2)no1		CHEMBL2207518	=	IC50	nM	13.0	CHEMBL4722	Homo sapiens	IC50	uM	0.013
	12175398	CHEMBL2214100	Inhibition of GST-tagged human Aurora A kinase expressed in baculovirus system	B	COCCN1CCN(c2ccc(-c3nc4c(N5CCN(Cc6cc(C)on6)CC5)c(Br)cnc4[nH]3)cc2)CC1		CHEMBL2203768	=	IC50	nM	12.0	CHEMBL4722	Homo sapiens	IC50	uM	0.012
	12175399	CHEMBL2214100	Inhibition of GST-tagged human Aurora A kinase expressed in baculovirus system	B	Cc1cc(CN2CCN(c3c(Cl)cnc4[nH]c(-c5ccc(N6CCN(C)CC6)c(F)c5)nc34)CC2)no1		CHEMBL2203770	=	IC50	nM	11.0	CHEMBL4722	Homo sapiens	IC50	uM	0.011
	12175400	CHEMBL2214100	Inhibition of GST-tagged human Aurora A kinase expressed in baculovirus system	B	CC(=O)N1CCN(c2ccc(-c3nc4c(N5CCN(Cc6cc(C)on6)CC5)c(Br)cnc4[nH]3)cc2)CC1		CHEMBL2203766	=	IC50	nM	9.0	CHEMBL4722	Homo sapiens	IC50	uM	0.009
	12175401	CHEMBL2214100	Inhibition of GST-tagged human Aurora A kinase expressed in baculovirus system	B	Cc1cc(CN2CCN(c3c(Br)cnc4[nH]c(-c5ccc(N6CCOCC6)cc5)nc34)CC2)no1		CHEMBL2203765	=	IC50	nM	7.0	CHEMBL4722	Homo sapiens	IC50	uM	0.007
	12175402	CHEMBL2214100	Inhibition of GST-tagged human Aurora A kinase expressed in baculovirus system	B	Cc1nn(C)cc1-c1nc2c(N3CCN(Cc4nonc4C)CC3)c(Cl)cnc2[nH]1		CHEMBL2207499	=	IC50	nM	6.0	CHEMBL4722	Homo sapiens	IC50	uM	0.006
	12175403	CHEMBL2214100	Inhibition of GST-tagged human Aurora A kinase expressed in baculovirus system	B	CCN1CCN(c2ccc(-c3nc4c(N5CCN(Cc6cc(C)on6)CC5)c(Cl)cnc4[nH]3)cc2)CC1		CHEMBL2203767	=	IC50	nM	6.0	CHEMBL4722	Homo sapiens	IC50	uM	0.006
	12175404	CHEMBL2214100	Inhibition of GST-tagged human Aurora A kinase expressed in baculovirus system	B	Cc1cc(CN2CCN(c3c(Cl)cnc4[nH]c(-c5cn(C)nc5C5CC5)nc34)CC2)no1		CHEMBL2203764	=	IC50	nM	4.0	CHEMBL4722	Homo sapiens	IC50	uM	0.004
	12185159	CHEMBL2216372	Inhibition of AURKA	B	CC(C)(C)NS(=O)(=O)c1cncc(-c2ccn3nc(N)nc3c2)c1		CHEMBL2205766	<	IC50	nM	10000.0	CHEMBL4722	Homo sapiens	pIC50		5.0
	12195628	CHEMBL2212877	Inhibition of human recombinant Aurora A expressed in Sf21 cells using Ulight-RRRSLLE as substrate assessed as residual activity at 1 uM after 15 mins relative to staurosporine	B	CCN(CC)CCOc1ccc(/C=C2\C(=O)Nc3ccc(Cl)cc32)cc1		CHEMBL2206008	=	Activity	%	99.6	CHEMBL4722	Homo sapiens	Activity	%	99.6
	12207616	CHEMBL2218948	Millipore: Percentage of residual kinase activity of AURKA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	CC(C)(C)c1cc(C=C(C#N)C#N)cc(Br)c1O		CHEMBL2218926	=	Residual Activity	%	104.0	CHEMBL4722	Homo sapiens	Residual Activity	%	104.0
	12207617	CHEMBL2218948	Millipore: Percentage of residual kinase activity of AURKA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1c1c[nH]c2ccccc12		CHEMBL266487	=	Residual Activity	%	80.0	CHEMBL4722	Homo sapiens	Residual Activity	%	80.0
	12207618	CHEMBL2218948	Millipore: Percentage of residual kinase activity of AURKA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	O=C(Nc1cccc(Nc2cc(Nc3cccc(C(F)(F)F)c3)ncn2)c1)C1CC1		CHEMBL387187	=	Residual Activity	%	95.0	CHEMBL4722	Homo sapiens	Residual Activity	%	95.0
	12207619	CHEMBL2218948	Millipore: Percentage of residual kinase activity of AURKA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	COc1ccc(Cl)cc1NC(=O)Nc1cc(C)nc2ccccc12		CHEMBL439259	=	Residual Activity	%	89.0	CHEMBL4722	Homo sapiens	Residual Activity	%	89.0
	12207620	CHEMBL2218948	Millipore: Percentage of residual kinase activity of AURKA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	CNc1cc2c(Nc3cccc(Br)c3)ncnc2cn1		CHEMBL53753	=	Residual Activity	%	60.0	CHEMBL4722	Homo sapiens	Residual Activity	%	60.0
	12207621	CHEMBL2218948	Millipore: Percentage of residual kinase activity of AURKA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	Nc1ncnc2c1cnn2-c1ccccc1		CHEMBL65063	=	Residual Activity	%	105.0	CHEMBL4722	Homo sapiens	Residual Activity	%	105.0
	12207622	CHEMBL2218948	Millipore: Percentage of residual kinase activity of AURKA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	Cn1cc(/C=C2\C(=O)Nc3ccc(S(N)(=O)=O)cc32)c2ccccc21		CHEMBL104279	=	Residual Activity	%	-4.0	CHEMBL4722	Homo sapiens	Residual Activity	%	-4.0
	12207623	CHEMBL2218948	Millipore: Percentage of residual kinase activity of AURKA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	COc1cc2ncnc(Nc3cccc(Cl)c3)c2cc1OC		CHEMBL7917	=	Residual Activity	%	94.0	CHEMBL4722	Homo sapiens	Residual Activity	%	94.0
	12207624	CHEMBL2218948	Millipore: Percentage of residual kinase activity of AURKA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	Cc1nc2cc3nc(-c4cccs4)cnc3cc2n1C		CHEMBL2218927	=	Residual Activity	%	88.0	CHEMBL4722	Homo sapiens	Residual Activity	%	88.0
	12207625	CHEMBL2218948	Millipore: Percentage of residual kinase activity of AURKA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	Cn1cnc2cc3c(Nc4cccc(Br)c4)ncnc3cc21		CHEMBL174426	=	Residual Activity	%	78.0	CHEMBL4722	Homo sapiens	Residual Activity	%	78.0
	12207626	CHEMBL2218948	Millipore: Percentage of residual kinase activity of AURKA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	CC#CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cn1		CHEMBL203644	=	Residual Activity	%	106.0	CHEMBL4722	Homo sapiens	Residual Activity	%	106.0
	12207627	CHEMBL2218948	Millipore: Percentage of residual kinase activity of AURKA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	O=C(Nc1nc2ccccc2n1CCN1CCOCC1)c1cccc([N+](=O)[O-])c1		CHEMBL379787	=	Residual Activity	%	101.0	CHEMBL4722	Homo sapiens	Residual Activity	%	101.0
	12207628	CHEMBL2218948	Millipore: Percentage of residual kinase activity of AURKA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	CCC(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1		CHEMBL188762	=	Residual Activity	%	73.0	CHEMBL4722	Homo sapiens	Residual Activity	%	73.0
	12207629	CHEMBL2218948	Millipore: Percentage of residual kinase activity of AURKA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	CC(C)(C)n1nc(Cc2cccc3ccccc23)c2c(N)ncnc21		CHEMBL573578	=	Residual Activity	%	93.0	CHEMBL4722	Homo sapiens	Residual Activity	%	93.0
	12207630	CHEMBL2218948	Millipore: Percentage of residual kinase activity of AURKA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	NCCNc1ncc(C(N)=O)c(Nc2cccc(C(F)(F)F)c2)n1		CHEMBL471901	=	Residual Activity	%	81.0	CHEMBL4722	Homo sapiens	Residual Activity	%	81.0
	12207631	CHEMBL2218948	Millipore: Percentage of residual kinase activity of AURKA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	CCOC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccccc32)c1C		CHEMBL86943	=	Residual Activity	%	105.0	CHEMBL4722	Homo sapiens	Residual Activity	%	105.0
	12207632	CHEMBL2218948	Millipore: Percentage of residual kinase activity of AURKA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	CC[n+]1c(/C=C/N(C)c2ccccc2)n(-c2ccccc2)c2ccc(-c3nc4ccccc4s3)cc21		CHEMBL1186409	=	Residual Activity	%	117.0	CHEMBL4722	Homo sapiens	Residual Activity	%	117.0
	12207633	CHEMBL2218948	Millipore: Percentage of residual kinase activity of AURKA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	COc1ccc2c(c[n+](C)c3c4cc5c(cc4ccc23)OCO5)c1OC		CHEMBL13045	=	Residual Activity	%	83.0	CHEMBL4722	Homo sapiens	Residual Activity	%	83.0
	12207634	CHEMBL2218948	Millipore: Percentage of residual kinase activity of AURKA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	COc1ccc(C(=O)Nc2sc3c(c2C(N)=O)CCCC3)cc1OC		CHEMBL210833	=	Residual Activity	%	93.0	CHEMBL4722	Homo sapiens	Residual Activity	%	93.0
	12207635	CHEMBL2218948	Millipore: Percentage of residual kinase activity of AURKA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	CC(C)(C)c1nc2c3ccc(F)cc3c3c(=O)[nH]ccc3c2[nH]1		CHEMBL21156	=	Residual Activity	%	13.0	CHEMBL4722	Homo sapiens	Residual Activity	%	13.0
	12207636	CHEMBL2218948	Millipore: Percentage of residual kinase activity of AURKA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	CCCC(=O)Oc1ccc2[nH]c(C(=O)c3cc4ccccc4[nH]3)cc2c1		CHEMBL266325	=	Residual Activity	%	71.0	CHEMBL4722	Homo sapiens	Residual Activity	%	71.0
	12207637	CHEMBL2218948	Millipore: Percentage of residual kinase activity of AURKA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	O=C1NC(=O)c2cc(Nc3ccc(F)cc3)c(Nc3ccc(F)cc3)cc21		CHEMBL7939	=	Residual Activity	%	89.0	CHEMBL4722	Homo sapiens	Residual Activity	%	89.0
	12207638	CHEMBL2218948	Millipore: Percentage of residual kinase activity of AURKA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	O=[N+]([O-])/C=C/c1ccc2c(c1)OCO2		CHEMBL596380	=	Residual Activity	%	99.0	CHEMBL4722	Homo sapiens	Residual Activity	%	99.0
	12207639	CHEMBL2218948	Millipore: Percentage of residual kinase activity of AURKA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	O=C(Nc1ccc(Cl)cc1)c1ccccc1NCc1ccncc1		CHEMBL101683	=	Residual Activity	%	39.0	CHEMBL4722	Homo sapiens	Residual Activity	%	39.0
	12207640	CHEMBL2218948	Millipore: Percentage of residual kinase activity of AURKA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	CN1N=C(N)c2cn([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c3ncnc1c23		CHEMBL331237	=	Residual Activity	%	77.0	CHEMBL4722	Homo sapiens	Residual Activity	%	77.0
	12207641	CHEMBL2218948	Millipore: Percentage of residual kinase activity of AURKA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	CCOc1cc2ncnc(Nc3cccc(Br)c3)c2cc1OCC		CHEMBL35820	=	Residual Activity	%	55.0	CHEMBL4722	Homo sapiens	Residual Activity	%	55.0
	12207642	CHEMBL2218948	Millipore: Percentage of residual kinase activity of AURKA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	O=C(c1cc2cc(O)ccc2[nH]1)c1cc2cc(O)ccc2[nH]1		CHEMBL377193	=	Residual Activity	%	23.0	CHEMBL4722	Homo sapiens	Residual Activity	%	23.0
	12207643	CHEMBL2218948	Millipore: Percentage of residual kinase activity of AURKA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	COc1cc2ncnc(Nc3ccc(O)c(Br)c3)c2cc1OC		CHEMBL473773	=	Residual Activity	%	49.0	CHEMBL4722	Homo sapiens	Residual Activity	%	49.0
	12207644	CHEMBL2218948	Millipore: Percentage of residual kinase activity of AURKA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	COc1cc2ncnc(N3CCN(C(=O)Nc4ccc(Oc5ccccc5)cc4)CC3)c2cc1OC		CHEMBL102346	=	Residual Activity	%	51.0	CHEMBL4722	Homo sapiens	Residual Activity	%	51.0
	12207645	CHEMBL2218948	Millipore: Percentage of residual kinase activity of AURKA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	O=C1NC(=O)C(c2cn(CCCn3ccnc3)c3ccccc23)=C1Nc1ccccc1		CHEMBL366266	=	Residual Activity	%	86.0	CHEMBL4722	Homo sapiens	Residual Activity	%	86.0
	12207646	CHEMBL2218948	Millipore: Percentage of residual kinase activity of AURKA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	c1ccc(-c2n[nH]cc2-c2ccnc3ccccc23)nc1		CHEMBL261454	=	Residual Activity	%	99.0	CHEMBL4722	Homo sapiens	Residual Activity	%	99.0
	12207647	CHEMBL2218948	Millipore: Percentage of residual kinase activity of AURKA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC		CHEMBL1289494	=	Residual Activity	%	7.0	CHEMBL4722	Homo sapiens	Residual Activity	%	7.0
	12207648	CHEMBL2218948	Millipore: Percentage of residual kinase activity of AURKA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	O=c1[nH]c2ccccc2n1C1CCN(Cc2ccc(-c3nc4cc5[nH]cnc5cc4nc3-c3ccccc3)cc2)CC1		CHEMBL258844	=	Residual Activity	%	70.0	CHEMBL4722	Homo sapiens	Residual Activity	%	70.0
	12207649	CHEMBL2218948	Millipore: Percentage of residual kinase activity of AURKA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	O=c1cc(N2CCOCC2)oc2c1ccc1ccccc12		CHEMBL104468	=	Residual Activity	%	125.0	CHEMBL4722	Homo sapiens	Residual Activity	%	125.0
	12207650	CHEMBL2218948	Millipore: Percentage of residual kinase activity of AURKA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Residual Activity	%	108.0	CHEMBL4722	Homo sapiens	Residual Activity	%	108.0
	12207651	CHEMBL2218948	Millipore: Percentage of residual kinase activity of AURKA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	CC(C)N(CCC(=O)c1ccc2ccccc2c1)Cc1ccccc1		CHEMBL596674	=	Residual Activity	%	95.0	CHEMBL4722	Homo sapiens	Residual Activity	%	95.0
	12207652	CHEMBL2218948	Millipore: Percentage of residual kinase activity of AURKA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	COc1cc2c(cc1OC)-c1n[nH]c(Nc3cccc(F)c3)c1C2		CHEMBL120077	=	Residual Activity	%	47.0	CHEMBL4722	Homo sapiens	Residual Activity	%	47.0
	12207653	CHEMBL2218948	Millipore: Percentage of residual kinase activity of AURKA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413	=	Residual Activity	%	87.0	CHEMBL4722	Homo sapiens	Residual Activity	%	87.0
	12207654	CHEMBL2218948	Millipore: Percentage of residual kinase activity of AURKA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	Cc1cccc(-c2[nH]c(C(C)(C)C)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL226838	=	Residual Activity	%	93.0	CHEMBL4722	Homo sapiens	Residual Activity	%	93.0
	12207655	CHEMBL2218948	Millipore: Percentage of residual kinase activity of AURKA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	O=C1Nc2ccc(Br)cc2/C1=C\c1cc2c([nH]1)CCCC2		CHEMBL2218925	=	Residual Activity	%	85.0	CHEMBL4722	Homo sapiens	Residual Activity	%	85.0
	12207656	CHEMBL2218948	Millipore: Percentage of residual kinase activity of AURKA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	CCN(CC)CCCCN1c2ccccc2Oc2ccc(Cl)cc21		CHEMBL1398474	=	Residual Activity	%	97.0	CHEMBL4722	Homo sapiens	Residual Activity	%	97.0
	12207657	CHEMBL2218948	Millipore: Percentage of residual kinase activity of AURKA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	CC(=O)c1ccc(N2CCOCC2)cc1O		CHEMBL1317546	=	Residual Activity	%	109.0	CHEMBL4722	Homo sapiens	Residual Activity	%	109.0
	12207658	CHEMBL2218948	Millipore: Percentage of residual kinase activity of AURKA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	Cn1c2ccccc2c2c3c(c4c5ccccc5n(CCC#N)c4c21)CNC3=O		CHEMBL302449	=	Residual Activity	%	4.0	CHEMBL4722	Homo sapiens	Residual Activity	%	4.0
	12207659	CHEMBL2218948	Millipore: Percentage of residual kinase activity of AURKA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	O=C1Nc2ccc(-c3cccnc3)cc2/C1=C\c1ccc[nH]1		CHEMBL2218929	=	Residual Activity	%	4.0	CHEMBL4722	Homo sapiens	Residual Activity	%	4.0
	12207660	CHEMBL2218948	Millipore: Percentage of residual kinase activity of AURKA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	COc1cc2nccc(Oc3ccc(NC(=S)NC(=O)c4ccccc4C)cc3)c2cc1OC		CHEMBL2218930	=	Residual Activity	%	0.0	CHEMBL4722	Homo sapiens	Residual Activity	%	0.0
	12207661	CHEMBL2218948	Millipore: Percentage of residual kinase activity of AURKA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	c1ccc2c(-c3ccncc3)c[nH]c2c1		CHEMBL380071	=	Residual Activity	%	99.0	CHEMBL4722	Homo sapiens	Residual Activity	%	99.0
	12207662	CHEMBL2218948	Millipore: Percentage of residual kinase activity of AURKA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	COc1ccc(C=C(C#N)C#N)cc1		CHEMBL77456	=	Residual Activity	%	98.0	CHEMBL4722	Homo sapiens	Residual Activity	%	98.0
	12210495	CHEMBL2218948	Millipore: Percentage of residual kinase activity of AURKA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	Cc1cc(C)c(/C=C2\C(=O)Nc3ccccc32)[nH]1		CHEMBL276711	=	Residual Activity	%	29.0	CHEMBL4722	Homo sapiens	Residual Activity	%	29.0
	12210496	CHEMBL2218948	Millipore: Percentage of residual kinase activity of AURKA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	O=C1c2ccccc2-c2nc3nnnn3nc21		CHEMBL599894	=	Residual Activity	%	71.0	CHEMBL4722	Homo sapiens	Residual Activity	%	71.0
	12210497	CHEMBL2218948	Millipore: Percentage of residual kinase activity of AURKA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	=	Residual Activity	%	104.0	CHEMBL4722	Homo sapiens	Residual Activity	%	104.0
	12210498	CHEMBL2218948	Millipore: Percentage of residual kinase activity of AURKA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	COc1ccc2c(c1)c(C1=C(c3c[nH]c4ccccc34)C(=O)NC1=O)cn2CCCN(C)C		CHEMBL261491	=	Residual Activity	%	100.0	CHEMBL4722	Homo sapiens	Residual Activity	%	100.0
	12210499	CHEMBL2218948	Millipore: Percentage of residual kinase activity of AURKA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)cn2C1CCCC1		CHEMBL47940	=	Residual Activity	%	35.0	CHEMBL4722	Homo sapiens	Residual Activity	%	35.0
	12210500	CHEMBL2218948	Millipore: Percentage of residual kinase activity of AURKA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	O=C1Nc2ccc3ncsc3c2/C1=C/c1c[nH]cn1		CHEMBL235641	=	Residual Activity	%	0.0	CHEMBL4722	Homo sapiens	Residual Activity	%	0.0
	12210501	CHEMBL2218948	Millipore: Percentage of residual kinase activity of AURKA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	Cc1cncc2cccc(S(=O)(=O)N3CCCN(C(=O)CN)C[C@H]3C)c12		CHEMBL2218931	=	Residual Activity	%	64.0	CHEMBL4722	Homo sapiens	Residual Activity	%	64.0
	12210502	CHEMBL2218948	Millipore: Percentage of residual kinase activity of AURKA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	N#C/C(=C\c1ccc(O)c(O)c1)C(=O)NCc1ccccc1		CHEMBL56543	=	Residual Activity	%	95.0	CHEMBL4722	Homo sapiens	Residual Activity	%	95.0
	12210503	CHEMBL2218948	Millipore: Percentage of residual kinase activity of AURKA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	COc1ccc(-c2cnc3c(-c4ccsc4)cnn3c2)cc1		CHEMBL92461	=	Residual Activity	%	106.0	CHEMBL4722	Homo sapiens	Residual Activity	%	106.0
	12210504	CHEMBL2218948	Millipore: Percentage of residual kinase activity of AURKA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	COc1cc2ncnc(Nc3ccc(NC(=O)c4ccccc4)cc3)c2cc1OC		CHEMBL382590	=	Residual Activity	%	18.0	CHEMBL4722	Homo sapiens	Residual Activity	%	18.0
	12210505	CHEMBL2218948	Millipore: Percentage of residual kinase activity of AURKA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	O=c1c2ccccc2[nH]c(=S)n1CCN1CCC(=C(c2ccc(F)cc2)c2ccc(F)cc2)CC1		CHEMBL261131	=	Residual Activity	%	119.0	CHEMBL4722	Homo sapiens	Residual Activity	%	119.0
	12210506	CHEMBL2218948	Millipore: Percentage of residual kinase activity of AURKA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	c1ccc(-c2n[nH]c3c2oc2ccccc23)cc1		CHEMBL406375	=	Residual Activity	%	53.0	CHEMBL4722	Homo sapiens	Residual Activity	%	53.0
	12210507	CHEMBL2218948	Millipore: Percentage of residual kinase activity of AURKA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12		CHEMBL98350	=	Residual Activity	%	78.0	CHEMBL4722	Homo sapiens	Residual Activity	%	78.0
	12210508	CHEMBL2218948	Millipore: Percentage of residual kinase activity of AURKA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	O=C1Nc2ccc(Cl)cc2/C1=C/c1cc(Cl)c(O)c(Cl)c1		CHEMBL2218932	=	Residual Activity	%	57.0	CHEMBL4722	Homo sapiens	Residual Activity	%	57.0
	12210509	CHEMBL2218948	Millipore: Percentage of residual kinase activity of AURKA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Residual Activity	%	-3.0	CHEMBL4722	Homo sapiens	Residual Activity	%	-3.0
	12210510	CHEMBL2218948	Millipore: Percentage of residual kinase activity of AURKA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	N#CC(C#N)=C(N)/C(C#N)=C/c1ccc(O)cc1		CHEMBL76589	=	Residual Activity	%	83.0	CHEMBL4722	Homo sapiens	Residual Activity	%	83.0
	12210511	CHEMBL2218948	Millipore: Percentage of residual kinase activity of AURKA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	O=C(c1ccccc1)c1ccc(N2CCOCC2)cc1O		CHEMBL478980	=	Residual Activity	%	77.0	CHEMBL4722	Homo sapiens	Residual Activity	%	77.0
	12210512	CHEMBL2218948	Millipore: Percentage of residual kinase activity of AURKA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	NC(=O)c1cccc(-c2cc(Nc3ccc(OC(F)(F)F)cc3)ncn2)c1		CHEMBL483847	=	Residual Activity	%	83.0	CHEMBL4722	Homo sapiens	Residual Activity	%	83.0
	12210513	CHEMBL2218948	Millipore: Percentage of residual kinase activity of AURKA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	CN(C)c1ccc(/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL328710	=	Residual Activity	%	56.0	CHEMBL4722	Homo sapiens	Residual Activity	%	56.0
	12210514	CHEMBL2218948	Millipore: Percentage of residual kinase activity of AURKA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	CO[C@H]1/C=C/C=C(\C)C(=O)NC2=CC(=O)C=C(C2=O)[C@H](OC)[C@@H](C)C[C@H](OC)[C@H](OC)[C@@H](C)/C=C(\C)[C@@H]1OC(N)=O		CHEMBL479533	=	Residual Activity	%	77.0	CHEMBL4722	Homo sapiens	Residual Activity	%	77.0
	12210515	CHEMBL2218948	Millipore: Percentage of residual kinase activity of AURKA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	O=c1cc(N2CCNCC2)oc2c(-c3ccccc3)cccc12		CHEMBL1363184	=	Residual Activity	%	95.0	CHEMBL4722	Homo sapiens	Residual Activity	%	95.0
	12210516	CHEMBL2218948	Millipore: Percentage of residual kinase activity of AURKA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	O=C1NC(=O)/C(=C\c2ccc3nccnc3c2)S1		CHEMBL2218934	=	Residual Activity	%	94.0	CHEMBL4722	Homo sapiens	Residual Activity	%	94.0
	12210517	CHEMBL2218948	Millipore: Percentage of residual kinase activity of AURKA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	COc1cc2ncnc(Nc3ccc(Oc4ccccc4)cc3)c2cc1OC		CHEMBL97771	=	Residual Activity	%	52.0	CHEMBL4722	Homo sapiens	Residual Activity	%	52.0
	12210518	CHEMBL2218948	Millipore: Percentage of residual kinase activity of AURKA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	Cc1cc2ncc(-c3ccccc3)nc2cc1C		CHEMBL7724	=	Residual Activity	%	77.0	CHEMBL4722	Homo sapiens	Residual Activity	%	77.0
	12210519	CHEMBL2218948	Millipore: Percentage of residual kinase activity of AURKA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	O=C(Nc1cccc(Nc2nccc(Nc3cccc(C(F)(F)F)c3)n2)c1)C1CC1		CHEMBL383899	=	Residual Activity	%	24.0	CHEMBL4722	Homo sapiens	Residual Activity	%	24.0
	12210520	CHEMBL2218948	Millipore: Percentage of residual kinase activity of AURKA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	CN(C)CCCn1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL7463	=	Residual Activity	%	100.0	CHEMBL4722	Homo sapiens	Residual Activity	%	100.0
	12210521	CHEMBL2218948	Millipore: Percentage of residual kinase activity of AURKA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	COc1cc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2cc1OC		CHEMBL563845	=	Residual Activity	%	41.0	CHEMBL4722	Homo sapiens	Residual Activity	%	41.0
	12210522	CHEMBL2218948	Millipore: Percentage of residual kinase activity of AURKA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	c1ccc(-c2cnc(Nc3ccc(OCCN4CCCC4)cc3)s2)cc1		CHEMBL2218935	=	Residual Activity	%	100.0	CHEMBL4722	Homo sapiens	Residual Activity	%	100.0
	12210523	CHEMBL2218948	Millipore: Percentage of residual kinase activity of AURKA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	CC1=C(C(=O)N2CCN(C)CC2)C(C)=C(/C=C2\C(=O)Nc3ccc(S(=O)(=O)N(C)c4cccc(Cl)c4)cc32)C1		CHEMBL2218936	=	Residual Activity	%	5.0	CHEMBL4722	Homo sapiens	Residual Activity	%	5.0
	12210524	CHEMBL2218948	Millipore: Percentage of residual kinase activity of AURKA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	O=C1NC(=O)/C(=C/c2ccc3c(c2)OC(F)(F)O3)S1		CHEMBL1231533	=	Residual Activity	%	90.0	CHEMBL4722	Homo sapiens	Residual Activity	%	90.0
	12210525	CHEMBL2218948	Millipore: Percentage of residual kinase activity of AURKA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(Cl)cc32)c1C		CHEMBL13485	=	Residual Activity	%	47.0	CHEMBL4722	Homo sapiens	Residual Activity	%	47.0
	12210526	CHEMBL2218948	Millipore: Percentage of residual kinase activity of AURKA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	COc1cc2ncc(-c3ccccc3)nc2cc1OC		CHEMBL71191	=	Residual Activity	%	83.0	CHEMBL4722	Homo sapiens	Residual Activity	%	83.0
	12210527	CHEMBL2218948	Millipore: Percentage of residual kinase activity of AURKA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Residual Activity	%	-9.0	CHEMBL4722	Homo sapiens	Residual Activity	%	-9.0
	12210528	CHEMBL2218948	Millipore: Percentage of residual kinase activity of AURKA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	CN([C@@H](Cc1ccc(OS(=O)(=O)c2cccc3cnccc23)cc1)C(=O)N1CCN(c2ccccc2)CC1)S(=O)(=O)c1cccc2cnccc12		CHEMBL28324	=	Residual Activity	%	97.0	CHEMBL4722	Homo sapiens	Residual Activity	%	97.0
	12210529	CHEMBL2218948	Millipore: Percentage of residual kinase activity of AURKA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	=	Residual Activity	%	0.0	CHEMBL4722	Homo sapiens	Residual Activity	%	0.0
	12210530	CHEMBL2218948	Millipore: Percentage of residual kinase activity of AURKA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1c1[nH]c3cc(Br)ccc3c21		CHEMBL64758	=	Residual Activity	%	93.0	CHEMBL4722	Homo sapiens	Residual Activity	%	93.0
	12210531	CHEMBL2218948	Millipore: Percentage of residual kinase activity of AURKA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	C[C@@H](N)[C@H]1CC[C@H](C(=O)Nc2ccncc2)CC1		CHEMBL559147	=	Residual Activity	%	95.0	CHEMBL4722	Homo sapiens	Residual Activity	%	95.0
	12210532	CHEMBL2218948	Millipore: Percentage of residual kinase activity of AURKA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	CN(C)S(=O)(=O)c1ccc2c(c1)/C(=C/c1cc3c([nH]1)CCCC3)C(=O)N2		CHEMBL605003	=	Residual Activity	%	36.0	CHEMBL4722	Homo sapiens	Residual Activity	%	36.0
	12210533	CHEMBL2218948	Millipore: Percentage of residual kinase activity of AURKA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	O=C(CCCc1ccc(-c2ccccc2F)cc1)Nc1ccc(O)cc1		CHEMBL235658	=	Residual Activity	%	130.0	CHEMBL4722	Homo sapiens	Residual Activity	%	130.0
	12210534	CHEMBL2218948	Millipore: Percentage of residual kinase activity of AURKA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(C)c3ccccc3)c2)[nH]1		CHEMBL111364	=	Residual Activity	%	115.0	CHEMBL4722	Homo sapiens	Residual Activity	%	115.0
	12210535	CHEMBL2218948	Millipore: Percentage of residual kinase activity of AURKA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Residual Activity	%	117.0	CHEMBL4722	Homo sapiens	Residual Activity	%	117.0
	12210536	CHEMBL2218948	Millipore: Percentage of residual kinase activity of AURKA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	O=c1cc(-c2cccc3c2Sc2ccccc2S3)oc(N2CCOCC2)c1		CHEMBL222102	=	Residual Activity	%	101.0	CHEMBL4722	Homo sapiens	Residual Activity	%	101.0
	12210537	CHEMBL2218948	Millipore: Percentage of residual kinase activity of AURKA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	O=Nc1c(-c2c(O)[nH]c3ccccc23)[nH]c2ccccc12		CHEMBL126077	=	Residual Activity	%	7.0	CHEMBL4722	Homo sapiens	Residual Activity	%	7.0
	12210538	CHEMBL2218948	Millipore: Percentage of residual kinase activity of AURKA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	COc1ccc(OC)c2c(=S)c3ccccc3[nH]c12		CHEMBL1331734	=	Residual Activity	%	116.0	CHEMBL4722	Homo sapiens	Residual Activity	%	116.0
	12210539	CHEMBL2218948	Millipore: Percentage of residual kinase activity of AURKA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	Nc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL259551	=	Residual Activity	%	105.0	CHEMBL4722	Homo sapiens	Residual Activity	%	105.0
	12210540	CHEMBL2218948	Millipore: Percentage of residual kinase activity of AURKA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	Cc1cc(Nc2nc(-c3ccccc3)nc3ccccc23)n[nH]1		CHEMBL359482	=	Residual Activity	%	1.0	CHEMBL4722	Homo sapiens	Residual Activity	%	1.0
	12210541	CHEMBL2218948	Millipore: Percentage of residual kinase activity of AURKA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	CCOc1nc(NC(=O)Cc2cc(OC)ccc2OC)cc(N)c1C#N		CHEMBL210618	=	Residual Activity	%	106.0	CHEMBL4722	Homo sapiens	Residual Activity	%	106.0
	12210542	CHEMBL2218948	Millipore: Percentage of residual kinase activity of AURKA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	Oc1c(-c2ccc(F)cc2)c(-c2ccncc2)nn1-c1ccc(Cl)cc1		CHEMBL91730	=	Residual Activity	%	112.0	CHEMBL4722	Homo sapiens	Residual Activity	%	112.0
	12210543	CHEMBL2218948	Millipore: Percentage of residual kinase activity of AURKA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	=	Residual Activity	%	116.0	CHEMBL4722	Homo sapiens	Residual Activity	%	116.0
	12210544	CHEMBL2218948	Millipore: Percentage of residual kinase activity of AURKA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	O=C(NC(NC(=S)Nc1ccc(F)c([N+](=O)[O-])c1)C(Cl)(Cl)Cl)C(c1ccccc1)c1ccccc1		CHEMBL1221601	=	Residual Activity	%	83.0	CHEMBL4722	Homo sapiens	Residual Activity	%	83.0
	12210545	CHEMBL2218948	Millipore: Percentage of residual kinase activity of AURKA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	Cc1ccc(S(=O)(=O)/C=C/C#N)cc1		CHEMBL403183	=	Residual Activity	%	118.0	CHEMBL4722	Homo sapiens	Residual Activity	%	118.0
	12210546	CHEMBL2218948	Millipore: Percentage of residual kinase activity of AURKA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	Cc1ccc(NC2=CC(=O)c3sc(C)nc3C2=O)cc1		CHEMBL290904	=	Residual Activity	%	116.0	CHEMBL4722	Homo sapiens	Residual Activity	%	116.0
	12210547	CHEMBL2218948	Millipore: Percentage of residual kinase activity of AURKA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	Oc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL2218938	=	Residual Activity	%	104.0	CHEMBL4722	Homo sapiens	Residual Activity	%	104.0
	12210548	CHEMBL2218948	Millipore: Percentage of residual kinase activity of AURKA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1n1cncc21		CHEMBL413188	=	Residual Activity	%	14.0	CHEMBL4722	Homo sapiens	Residual Activity	%	14.0
	12210549	CHEMBL2218948	Millipore: Percentage of residual kinase activity of AURKA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	COC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL281948	=	Residual Activity	%	2.0	CHEMBL4722	Homo sapiens	Residual Activity	%	2.0
	12210550	CHEMBL2218948	Millipore: Percentage of residual kinase activity of AURKA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	COc1cccc(-c2cc(=O)c3ccccc3o2)c1N		CHEMBL35482	=	Residual Activity	%	122.0	CHEMBL4722	Homo sapiens	Residual Activity	%	122.0
	12210551	CHEMBL2218948	Millipore: Percentage of residual kinase activity of AURKA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	O=C1NC(=O)c2c1c1c3ccccc3n3c1c1c2c2ccccc2n1C1CCC3O1		CHEMBL304428	=	Residual Activity	%	95.0	CHEMBL4722	Homo sapiens	Residual Activity	%	95.0
	12210552	CHEMBL2218948	Millipore: Percentage of residual kinase activity of AURKA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1		CHEMBL50894	=	Residual Activity	%	85.0	CHEMBL4722	Homo sapiens	Residual Activity	%	85.0
	12210553	CHEMBL2218948	Millipore: Percentage of residual kinase activity of AURKA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	CC(C)n1cnc2c(NCc3ccccc3)nc(NCCCO)nc21		CHEMBL83980	=	Residual Activity	%	109.0	CHEMBL4722	Homo sapiens	Residual Activity	%	109.0
	12210554	CHEMBL2218948	Millipore: Percentage of residual kinase activity of AURKA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	CCN1/C(=C/C(C)=O)Sc2ccc(OC)cc21		CHEMBL408982	=	Residual Activity	%	80.0	CHEMBL4722	Homo sapiens	Residual Activity	%	80.0
	12210555	CHEMBL2218948	Millipore: Percentage of residual kinase activity of AURKA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	O=C1c2ccccc2-[n+]2ccc3c([nH]c4ccccc43)c21		CHEMBL602937	=	Residual Activity	%	101.0	CHEMBL4722	Homo sapiens	Residual Activity	%	101.0
	12210556	CHEMBL2218948	Millipore: Percentage of residual kinase activity of AURKA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	COc1cc(OC)c(/C=C2\C(=O)Nc3ccccc32)c(OC)c1		CHEMBL404941	=	Residual Activity	%	107.0	CHEMBL4722	Homo sapiens	Residual Activity	%	107.0
	12210557	CHEMBL2218948	Millipore: Percentage of residual kinase activity of AURKA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ccccc2N1		CHEMBL296586	=	Residual Activity	%	97.0	CHEMBL4722	Homo sapiens	Residual Activity	%	97.0
	12210558	CHEMBL2218948	Millipore: Percentage of residual kinase activity of AURKA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	O=[N+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL17331	=	Residual Activity	%	103.0	CHEMBL4722	Homo sapiens	Residual Activity	%	103.0
	12210559	CHEMBL2218948	Millipore: Percentage of residual kinase activity of AURKA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	Cc1nc(-c2ccccc2)c(-c2ccncc2)o1		CHEMBL36450	=	Residual Activity	%	122.0	CHEMBL4722	Homo sapiens	Residual Activity	%	122.0
	12210560	CHEMBL2218948	Millipore: Percentage of residual kinase activity of AURKA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	N#CCCc1ccc2c(c1)-c1[nH]c3ccc([N+](=O)[O-])cc3c1CC(=O)N2		CHEMBL260138	=	Residual Activity	%	61.0	CHEMBL4722	Homo sapiens	Residual Activity	%	61.0
	12210561	CHEMBL2218948	Millipore: Percentage of residual kinase activity of AURKA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	O=C1Nc2ccccc2/C1=C\c1c(Cl)[nH]c2ccccc12		CHEMBL261425	=	Residual Activity	%	99.0	CHEMBL4722	Homo sapiens	Residual Activity	%	99.0
	12210562	CHEMBL2218948	Millipore: Percentage of residual kinase activity of AURKA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	NC(=O)c1ccc2[nH]c(-c3ccc(Oc4ccc(Cl)cc4)cc3)nc2c1		CHEMBL179583	=	Residual Activity	%	88.0	CHEMBL4722	Homo sapiens	Residual Activity	%	88.0
	12210563	CHEMBL2218948	Millipore: Percentage of residual kinase activity of AURKA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	Cn1sc(=O)n(Cc2ccccc2)c1=O		CHEMBL284861	=	Residual Activity	%	83.0	CHEMBL4722	Homo sapiens	Residual Activity	%	83.0
	12210564	CHEMBL2218948	Millipore: Percentage of residual kinase activity of AURKA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	NC(=O)Nc1sc(-c2ccc(F)cc2)cc1C(N)=O		CHEMBL257167	=	Residual Activity	%	32.0	CHEMBL4722	Homo sapiens	Residual Activity	%	32.0
	12210565	CHEMBL2218948	Millipore: Percentage of residual kinase activity of AURKA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	COc1ccc(S(=O)(=O)N(CCO)c2ccccc2CN(C)C/C=C/c2ccc(Cl)cc2)cc1		CHEMBL155333	=	Residual Activity	%	122.0	CHEMBL4722	Homo sapiens	Residual Activity	%	122.0
	12210566	CHEMBL2218948	Millipore: Percentage of residual kinase activity of AURKA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL274064	=	Residual Activity	%	124.0	CHEMBL4722	Homo sapiens	Residual Activity	%	124.0
	12210567	CHEMBL2218948	Millipore: Percentage of residual kinase activity of AURKA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL313417	=	Residual Activity	%	123.0	CHEMBL4722	Homo sapiens	Residual Activity	%	123.0
	12210568	CHEMBL2218948	Millipore: Percentage of residual kinase activity of AURKA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	CCCCc1c(-c2ccc(O)cc2)[nH]c2nccnc12		CHEMBL75680	=	Residual Activity	%	6.0	CHEMBL4722	Homo sapiens	Residual Activity	%	6.0
	12210569	CHEMBL2218948	Millipore: Percentage of residual kinase activity of AURKA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	CCn1cnc2c(Nc3cccc(Cl)c3)nc(N[C@@H]3CCCC[C@@H]3N)nc21		CHEMBL367625	=	Residual Activity	%	85.0	CHEMBL4722	Homo sapiens	Residual Activity	%	85.0
	12210570	CHEMBL2218948	Millipore: Percentage of residual kinase activity of AURKA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	CC(C)n1cnc2/c(=N/c3cccc(Cl)c3)nc(NCCO)[nH]c21		CHEMBL311228	=	Residual Activity	%	88.0	CHEMBL4722	Homo sapiens	Residual Activity	%	88.0
	12210571	CHEMBL2218948	Millipore: Percentage of residual kinase activity of AURKA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	Ic1cccc(CSc2nnc(-c3ccncc3)o2)c1		CHEMBL288064	=	Residual Activity	%	83.0	CHEMBL4722	Homo sapiens	Residual Activity	%	83.0
	12210572	CHEMBL2218948	Millipore: Percentage of residual kinase activity of AURKA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	O=C1Nc2ccccc2/C1=C1/Nc2ccccc2/C1=N\OCCC(O)CO		CHEMBL1802727	=	Residual Activity	%	7.0	CHEMBL4722	Homo sapiens	Residual Activity	%	7.0
	12210573	CHEMBL2218948	Millipore: Percentage of residual kinase activity of AURKA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	N#C/C(=C(/N)SC1C=CC=CC1)c1cccc(C(O)c2ccncc2)c1		CHEMBL2218939	=	Residual Activity	%	108.0	CHEMBL4722	Homo sapiens	Residual Activity	%	108.0
	12210574	CHEMBL2218948	Millipore: Percentage of residual kinase activity of AURKA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	CC(C)[C@H](CO)Nc1nc(Nc2cccc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL23327	=	Residual Activity	%	111.0	CHEMBL4722	Homo sapiens	Residual Activity	%	111.0
	12210575	CHEMBL2218948	Millipore: Percentage of residual kinase activity of AURKA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	Oc1ccc(Nc2nc(-c3ccc(Cl)cc3)cs2)cc1		CHEMBL1076555	=	Residual Activity	%	115.0	CHEMBL4722	Homo sapiens	Residual Activity	%	115.0
	12210576	CHEMBL2218948	Millipore: Percentage of residual kinase activity of AURKA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	CCCCc1c(-c2ccc(OC)cc2)[nH]c2nccnc12		CHEMBL306498	=	Residual Activity	%	9.0	CHEMBL4722	Homo sapiens	Residual Activity	%	9.0
	12210577	CHEMBL2218948	Millipore: Percentage of residual kinase activity of AURKA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=S)Nc1c(F)cccc1F		CHEMBL261720	=	Residual Activity	%	1.0	CHEMBL4722	Homo sapiens	Residual Activity	%	1.0
	12210578	CHEMBL2218948	Millipore: Percentage of residual kinase activity of AURKA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	COc1ccc(CNc2nc(N(CCO)CCO)nc3c2ncn3C(C)C)cc1		CHEMBL80713	=	Residual Activity	%	89.0	CHEMBL4722	Homo sapiens	Residual Activity	%	89.0
	12210579	CHEMBL2218948	Millipore: Percentage of residual kinase activity of AURKA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	COc1ccc(CNC(=O)Nc2ncc([N+](=O)[O-])s2)cc1		CHEMBL259850	=	Residual Activity	%	89.0	CHEMBL4722	Homo sapiens	Residual Activity	%	89.0
	12210580	CHEMBL2218948	Millipore: Percentage of residual kinase activity of AURKA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	Oc1c2ccccc2c2c3c(cccc13)N=N2		CHEMBL1725279	=	Residual Activity	%	19.0	CHEMBL4722	Homo sapiens	Residual Activity	%	19.0
	12210581	CHEMBL2218948	Millipore: Percentage of residual kinase activity of AURKA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	O=C1C(Cl)=C(N2C(=O)CCC2=O)C(=O)c2ccccc21		CHEMBL404939	=	Residual Activity	%	98.0	CHEMBL4722	Homo sapiens	Residual Activity	%	98.0
	12210582	CHEMBL2218948	Millipore: Percentage of residual kinase activity of AURKA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	Nc1cccc(-c2cc3c(Oc4cccc(O)c4)ncnc3[nH]2)c1		CHEMBL405759	=	Residual Activity	%	28.0	CHEMBL4722	Homo sapiens	Residual Activity	%	28.0
	12210583	CHEMBL2218948	Millipore: Percentage of residual kinase activity of AURKA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	CC(C)[C@H](CO)Nc1nc(Nc2cc(N)cc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL286721	=	Residual Activity	%	70.0	CHEMBL4722	Homo sapiens	Residual Activity	%	70.0
	12210584	CHEMBL2218948	Millipore: Percentage of residual kinase activity of AURKA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	Nc1n[nH]c2nc3ccccc3nc12		CHEMBL259389	=	Residual Activity	%	91.0	CHEMBL4722	Homo sapiens	Residual Activity	%	91.0
	12210585	CHEMBL2218948	Millipore: Percentage of residual kinase activity of AURKA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	CCN(CC)C(=O)c1ccc(Nc2nc(OCC3CCCCC3)c3nc[nH]c3n2)cc1		CHEMBL1802728	=	Residual Activity	%	1.0	CHEMBL4722	Homo sapiens	Residual Activity	%	1.0
	12210586	CHEMBL2218948	Millipore: Percentage of residual kinase activity of AURKA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	O=C1Nc2cc(Br)ccc2/C1=C1/Nc2ccccc2/C1=N\O		CHEMBL409450	=	Residual Activity	%	31.0	CHEMBL4722	Homo sapiens	Residual Activity	%	31.0
	12210587	CHEMBL2218948	Millipore: Percentage of residual kinase activity of AURKA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	Cn1nc2c3c(cccc31)C(=O)c1ccccc1-2		CHEMBL1802485	=	Residual Activity	%	79.0	CHEMBL4722	Homo sapiens	Residual Activity	%	79.0
	12210588	CHEMBL2218948	Millipore: Percentage of residual kinase activity of AURKA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	N#C/C(=C(\N)Sc1ccc(N)cc1)c1ccccc1C(F)(F)F		CHEMBL2218940	=	Residual Activity	%	75.0	CHEMBL4722	Homo sapiens	Residual Activity	%	75.0
	12210589	CHEMBL2218948	Millipore: Percentage of residual kinase activity of AURKA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	O=S(=O)(NCCNC/C=C/c1ccc(Br)cc1)c1cccc2cnccc12		CHEMBL104264	=	Residual Activity	%	112.0	CHEMBL4722	Homo sapiens	Residual Activity	%	112.0
	12210590	CHEMBL2218948	Millipore: Percentage of residual kinase activity of AURKA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	O=C(O)c1ccc2c3c1cccc3c(=O)n1c3ccccc3nc21		CHEMBL1182777	=	Residual Activity	%	72.0	CHEMBL4722	Homo sapiens	Residual Activity	%	72.0
	12210591	CHEMBL2218948	Millipore: Percentage of residual kinase activity of AURKA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	c1cc(-c2cnn3cc(-c4ccc(OCCN5CCCCC5)cc4)cnc23)ccn1		CHEMBL478629	=	Residual Activity	%	64.0	CHEMBL4722	Homo sapiens	Residual Activity	%	64.0
	12210592	CHEMBL2218948	Millipore: Percentage of residual kinase activity of AURKA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	NC(=O)c1ccc(-c2nc(-c3ccc4c(c3)OCCO4)c(-c3ccccn3)[nH]2)cc1		CHEMBL410456	=	Residual Activity	%	86.0	CHEMBL4722	Homo sapiens	Residual Activity	%	86.0
	12210593	CHEMBL2218948	Millipore: Percentage of residual kinase activity of AURKA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	CC(C)c1nn(-c2c(Cl)cccc2Cl)c2nc(Cc3ccc(OCCO)cc3)[nH]c(=O)c12		CHEMBL258721	=	Residual Activity	%	83.0	CHEMBL4722	Homo sapiens	Residual Activity	%	83.0
	12210594	CHEMBL2218948	Millipore: Percentage of residual kinase activity of AURKA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	CC(=O)O/N=C1C(=C2\C(=O)Nc3cc(Br)ccc32)\Nc2ccccc2\1		CHEMBL2218941	=	Residual Activity	%	41.0	CHEMBL4722	Homo sapiens	Residual Activity	%	41.0
	12210595	CHEMBL2218948	Millipore: Percentage of residual kinase activity of AURKA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	N#C/C(=C1/Nc2ccccc2S1)c1ccnc(NCCc2cccnc2)n1		CHEMBL191384	=	Residual Activity	%	64.0	CHEMBL4722	Homo sapiens	Residual Activity	%	64.0
	12210596	CHEMBL2218948	Millipore: Percentage of residual kinase activity of AURKA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	Nc1ncnc2[nH]nc(Nc3ccc(F)cc3)c12		CHEMBL1240885	=	Residual Activity	%	96.0	CHEMBL4722	Homo sapiens	Residual Activity	%	96.0
	12210597	CHEMBL2218948	Millipore: Percentage of residual kinase activity of AURKA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	CCc1nc(-c2ccc(OC)cc2)[nH]c1-c1ccncc1		CHEMBL278724	=	Residual Activity	%	99.0	CHEMBL4722	Homo sapiens	Residual Activity	%	99.0
	12210598	CHEMBL2218948	Millipore: Percentage of residual kinase activity of AURKA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	COc1ccc2c(c1)/C(=C/c1cnc[nH]1)C(=O)N2		CHEMBL258805	=	Residual Activity	%	42.0	CHEMBL4722	Homo sapiens	Residual Activity	%	42.0
	12210599	CHEMBL2218948	Millipore: Percentage of residual kinase activity of AURKA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	O=C(O)/C=C/c1cc(Br)c(Br)c(Br)c1Br		CHEMBL270724	=	Residual Activity	%	83.0	CHEMBL4722	Homo sapiens	Residual Activity	%	83.0
	12210600	CHEMBL2218948	Millipore: Percentage of residual kinase activity of AURKA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	N/C(=N\[N+](=O)[O-])N/N=C\c1ccc(-c2cccc([N+](=O)[O-])c2)o1		CHEMBL221271	=	Residual Activity	%	86.0	CHEMBL4722	Homo sapiens	Residual Activity	%	86.0
	12210601	CHEMBL2218948	Millipore: Percentage of residual kinase activity of AURKA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	O=C1NC(=O)C(c2cn(CCCO)c3ncccc23)=C1c1cnccn1		CHEMBL272629	=	Residual Activity	%	78.0	CHEMBL4722	Homo sapiens	Residual Activity	%	78.0
	12210602	CHEMBL2218948	Millipore: Percentage of residual kinase activity of AURKA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Residual Activity	%	92.0	CHEMBL4722	Homo sapiens	Residual Activity	%	92.0
	12210603	CHEMBL2218948	Millipore: Percentage of residual kinase activity of AURKA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	Nc1ccc2ncnc(NCCc3ccc(Oc4ccccc4)cc3)c2c1		CHEMBL522502	=	Residual Activity	%	102.0	CHEMBL4722	Homo sapiens	Residual Activity	%	102.0
	12210604	CHEMBL2218948	Millipore: Percentage of residual kinase activity of AURKA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	=	Residual Activity	%	105.0	CHEMBL4722	Homo sapiens	Residual Activity	%	105.0
	12210605	CHEMBL2218948	Millipore: Percentage of residual kinase activity of AURKA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	N#Cc1cnc2cnc(NCc3cccnc3)cc2c1Nc1ccc(F)c(Cl)c1		CHEMBL200381	=	Residual Activity	%	31.0	CHEMBL4722	Homo sapiens	Residual Activity	%	31.0
	12210606	CHEMBL2218949	Millipore: Percentage of residual kinase activity of AURKA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	CC(C)(C)c1cc(C=C(C#N)C#N)cc(Br)c1O		CHEMBL2218926	=	Residual Activity	%	122.0	CHEMBL4722	Homo sapiens	Residual Activity	%	122.0
	12210607	CHEMBL2218949	Millipore: Percentage of residual kinase activity of AURKA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1c1c[nH]c2ccccc12		CHEMBL266487	=	Residual Activity	%	45.0	CHEMBL4722	Homo sapiens	Residual Activity	%	45.0
	12210608	CHEMBL2218949	Millipore: Percentage of residual kinase activity of AURKA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	O=C(Nc1cccc(Nc2cc(Nc3cccc(C(F)(F)F)c3)ncn2)c1)C1CC1		CHEMBL387187	=	Residual Activity	%	82.0	CHEMBL4722	Homo sapiens	Residual Activity	%	82.0
	12210609	CHEMBL2218949	Millipore: Percentage of residual kinase activity of AURKA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	COc1ccc(Cl)cc1NC(=O)Nc1cc(C)nc2ccccc12		CHEMBL439259	=	Residual Activity	%	136.0	CHEMBL4722	Homo sapiens	Residual Activity	%	136.0
	12210610	CHEMBL2218949	Millipore: Percentage of residual kinase activity of AURKA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	CNc1cc2c(Nc3cccc(Br)c3)ncnc2cn1		CHEMBL53753	=	Residual Activity	%	71.0	CHEMBL4722	Homo sapiens	Residual Activity	%	71.0
	12210611	CHEMBL2218949	Millipore: Percentage of residual kinase activity of AURKA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	Nc1ncnc2c1cnn2-c1ccccc1		CHEMBL65063	=	Residual Activity	%	95.0	CHEMBL4722	Homo sapiens	Residual Activity	%	95.0
	12210612	CHEMBL2218949	Millipore: Percentage of residual kinase activity of AURKA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	Cn1cc(/C=C2\C(=O)Nc3ccc(S(N)(=O)=O)cc32)c2ccccc21		CHEMBL104279	=	Residual Activity	%	4.0	CHEMBL4722	Homo sapiens	Residual Activity	%	4.0
	12210613	CHEMBL2218949	Millipore: Percentage of residual kinase activity of AURKA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	COc1cc2ncnc(Nc3cccc(Cl)c3)c2cc1OC		CHEMBL7917	=	Residual Activity	%	49.0	CHEMBL4722	Homo sapiens	Residual Activity	%	49.0
	12210614	CHEMBL2218949	Millipore: Percentage of residual kinase activity of AURKA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	Cc1nc2cc3nc(-c4cccs4)cnc3cc2n1C		CHEMBL2218927	=	Residual Activity	%	69.0	CHEMBL4722	Homo sapiens	Residual Activity	%	69.0
	12210615	CHEMBL2218949	Millipore: Percentage of residual kinase activity of AURKA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	Cn1cnc2cc3c(Nc4cccc(Br)c4)ncnc3cc21		CHEMBL174426	=	Residual Activity	%	45.0	CHEMBL4722	Homo sapiens	Residual Activity	%	45.0
	12210616	CHEMBL2218949	Millipore: Percentage of residual kinase activity of AURKA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	CC#CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cn1		CHEMBL203644	=	Residual Activity	%	108.0	CHEMBL4722	Homo sapiens	Residual Activity	%	108.0
	12210617	CHEMBL2218949	Millipore: Percentage of residual kinase activity of AURKA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	O=C(Nc1nc2ccccc2n1CCN1CCOCC1)c1cccc([N+](=O)[O-])c1		CHEMBL379787	=	Residual Activity	%	103.0	CHEMBL4722	Homo sapiens	Residual Activity	%	103.0
	12210618	CHEMBL2218949	Millipore: Percentage of residual kinase activity of AURKA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	CCC(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1		CHEMBL188762	=	Residual Activity	%	127.0	CHEMBL4722	Homo sapiens	Residual Activity	%	127.0
	12210619	CHEMBL2218949	Millipore: Percentage of residual kinase activity of AURKA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	CC(C)(C)n1nc(Cc2cccc3ccccc23)c2c(N)ncnc21		CHEMBL573578	=	Residual Activity	%	104.0	CHEMBL4722	Homo sapiens	Residual Activity	%	104.0
	12210620	CHEMBL2218949	Millipore: Percentage of residual kinase activity of AURKA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	NCCNc1ncc(C(N)=O)c(Nc2cccc(C(F)(F)F)c2)n1		CHEMBL471901	=	Residual Activity	%	121.0	CHEMBL4722	Homo sapiens	Residual Activity	%	121.0
	12210621	CHEMBL2218949	Millipore: Percentage of residual kinase activity of AURKA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	CCOC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccccc32)c1C		CHEMBL86943	=	Residual Activity	%	86.0	CHEMBL4722	Homo sapiens	Residual Activity	%	86.0
	12210622	CHEMBL2218949	Millipore: Percentage of residual kinase activity of AURKA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	CC[n+]1c(/C=C/N(C)c2ccccc2)n(-c2ccccc2)c2ccc(-c3nc4ccccc4s3)cc21		CHEMBL1186409	=	Residual Activity	%	139.0	CHEMBL4722	Homo sapiens	Residual Activity	%	139.0
	12210623	CHEMBL2218949	Millipore: Percentage of residual kinase activity of AURKA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	COc1ccc2c(c[n+](C)c3c4cc5c(cc4ccc23)OCO5)c1OC		CHEMBL13045	=	Residual Activity	%	75.0	CHEMBL4722	Homo sapiens	Residual Activity	%	75.0
	12210624	CHEMBL2218949	Millipore: Percentage of residual kinase activity of AURKA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	COc1ccc(C(=O)Nc2sc3c(c2C(N)=O)CCCC3)cc1OC		CHEMBL210833	=	Residual Activity	%	96.0	CHEMBL4722	Homo sapiens	Residual Activity	%	96.0
	12210625	CHEMBL2218949	Millipore: Percentage of residual kinase activity of AURKA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	CC(C)(C)c1nc2c3ccc(F)cc3c3c(=O)[nH]ccc3c2[nH]1		CHEMBL21156	=	Residual Activity	%	25.0	CHEMBL4722	Homo sapiens	Residual Activity	%	25.0
	12210626	CHEMBL2218949	Millipore: Percentage of residual kinase activity of AURKA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	CCCC(=O)Oc1ccc2[nH]c(C(=O)c3cc4ccccc4[nH]3)cc2c1		CHEMBL266325	=	Residual Activity	%	110.0	CHEMBL4722	Homo sapiens	Residual Activity	%	110.0
	12210627	CHEMBL2218949	Millipore: Percentage of residual kinase activity of AURKA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	O=C1NC(=O)c2cc(Nc3ccc(F)cc3)c(Nc3ccc(F)cc3)cc21		CHEMBL7939	=	Residual Activity	%	79.0	CHEMBL4722	Homo sapiens	Residual Activity	%	79.0
	12210628	CHEMBL2218949	Millipore: Percentage of residual kinase activity of AURKA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	O=[N+]([O-])/C=C/c1ccc2c(c1)OCO2		CHEMBL596380	=	Residual Activity	%	109.0	CHEMBL4722	Homo sapiens	Residual Activity	%	109.0
	12210629	CHEMBL2218949	Millipore: Percentage of residual kinase activity of AURKA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	O=C(Nc1ccc(Cl)cc1)c1ccccc1NCc1ccncc1		CHEMBL101683	=	Residual Activity	%	18.0	CHEMBL4722	Homo sapiens	Residual Activity	%	18.0
	12210630	CHEMBL2218949	Millipore: Percentage of residual kinase activity of AURKA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	CN1N=C(N)c2cn([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c3ncnc1c23		CHEMBL331237	=	Residual Activity	%	84.0	CHEMBL4722	Homo sapiens	Residual Activity	%	84.0
	12210631	CHEMBL2218949	Millipore: Percentage of residual kinase activity of AURKA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	CCOc1cc2ncnc(Nc3cccc(Br)c3)c2cc1OCC		CHEMBL35820	=	Residual Activity	%	46.0	CHEMBL4722	Homo sapiens	Residual Activity	%	46.0
	12210632	CHEMBL2218949	Millipore: Percentage of residual kinase activity of AURKA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	O=C(c1cc2cc(O)ccc2[nH]1)c1cc2cc(O)ccc2[nH]1		CHEMBL377193	=	Residual Activity	%	6.0	CHEMBL4722	Homo sapiens	Residual Activity	%	6.0
	12210633	CHEMBL2218949	Millipore: Percentage of residual kinase activity of AURKA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	COc1cc2ncnc(Nc3ccc(O)c(Br)c3)c2cc1OC		CHEMBL473773	=	Residual Activity	%	26.0	CHEMBL4722	Homo sapiens	Residual Activity	%	26.0
	12210634	CHEMBL2218949	Millipore: Percentage of residual kinase activity of AURKA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	COc1cc2ncnc(N3CCN(C(=O)Nc4ccc(Oc5ccccc5)cc4)CC3)c2cc1OC		CHEMBL102346	=	Residual Activity	%	48.0	CHEMBL4722	Homo sapiens	Residual Activity	%	48.0
	12210635	CHEMBL2218949	Millipore: Percentage of residual kinase activity of AURKA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	O=C1NC(=O)C(c2cn(CCCn3ccnc3)c3ccccc23)=C1Nc1ccccc1		CHEMBL366266	=	Residual Activity	%	72.0	CHEMBL4722	Homo sapiens	Residual Activity	%	72.0
	12210636	CHEMBL2218949	Millipore: Percentage of residual kinase activity of AURKA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	c1ccc(-c2n[nH]cc2-c2ccnc3ccccc23)nc1		CHEMBL261454	=	Residual Activity	%	103.0	CHEMBL4722	Homo sapiens	Residual Activity	%	103.0
	12210637	CHEMBL2218949	Millipore: Percentage of residual kinase activity of AURKA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC		CHEMBL1289494	=	Residual Activity	%	7.0	CHEMBL4722	Homo sapiens	Residual Activity	%	7.0
	12210638	CHEMBL2218949	Millipore: Percentage of residual kinase activity of AURKA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	O=c1[nH]c2ccccc2n1C1CCN(Cc2ccc(-c3nc4cc5[nH]cnc5cc4nc3-c3ccccc3)cc2)CC1		CHEMBL258844	=	Residual Activity	%	92.0	CHEMBL4722	Homo sapiens	Residual Activity	%	92.0
	12210639	CHEMBL2218949	Millipore: Percentage of residual kinase activity of AURKA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	O=c1cc(N2CCOCC2)oc2c1ccc1ccccc12		CHEMBL104468	=	Residual Activity	%	108.0	CHEMBL4722	Homo sapiens	Residual Activity	%	108.0
	12210640	CHEMBL2218949	Millipore: Percentage of residual kinase activity of AURKA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Residual Activity	%	111.0	CHEMBL4722	Homo sapiens	Residual Activity	%	111.0
	12210641	CHEMBL2218949	Millipore: Percentage of residual kinase activity of AURKA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	CC(C)N(CCC(=O)c1ccc2ccccc2c1)Cc1ccccc1		CHEMBL596674	=	Residual Activity	%	100.0	CHEMBL4722	Homo sapiens	Residual Activity	%	100.0
	12210642	CHEMBL2218949	Millipore: Percentage of residual kinase activity of AURKA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	COc1cc2c(cc1OC)-c1n[nH]c(Nc3cccc(F)c3)c1C2		CHEMBL120077	=	Residual Activity	%	22.0	CHEMBL4722	Homo sapiens	Residual Activity	%	22.0
	12210643	CHEMBL2218949	Millipore: Percentage of residual kinase activity of AURKA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413	=	Residual Activity	%	118.0	CHEMBL4722	Homo sapiens	Residual Activity	%	118.0
	12210644	CHEMBL2218949	Millipore: Percentage of residual kinase activity of AURKA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	Cc1cccc(-c2[nH]c(C(C)(C)C)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL226838	=	Residual Activity	%	110.0	CHEMBL4722	Homo sapiens	Residual Activity	%	110.0
	12210645	CHEMBL2218949	Millipore: Percentage of residual kinase activity of AURKA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	O=C1Nc2ccc(Br)cc2/C1=C\c1cc2c([nH]1)CCCC2		CHEMBL2218925	=	Residual Activity	%	82.0	CHEMBL4722	Homo sapiens	Residual Activity	%	82.0
	12210646	CHEMBL2218949	Millipore: Percentage of residual kinase activity of AURKA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	CCN(CC)CCCCN1c2ccccc2Oc2ccc(Cl)cc21		CHEMBL1398474	=	Residual Activity	%	140.0	CHEMBL4722	Homo sapiens	Residual Activity	%	140.0
	12210647	CHEMBL2218949	Millipore: Percentage of residual kinase activity of AURKA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	CC(=O)c1ccc(N2CCOCC2)cc1O		CHEMBL1317546	=	Residual Activity	%	100.0	CHEMBL4722	Homo sapiens	Residual Activity	%	100.0
	12210648	CHEMBL2218949	Millipore: Percentage of residual kinase activity of AURKA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	Cn1c2ccccc2c2c3c(c4c5ccccc5n(CCC#N)c4c21)CNC3=O		CHEMBL302449	=	Residual Activity	%	19.0	CHEMBL4722	Homo sapiens	Residual Activity	%	19.0
	12210649	CHEMBL2218949	Millipore: Percentage of residual kinase activity of AURKA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	O=C1Nc2ccc(-c3cccnc3)cc2/C1=C\c1ccc[nH]1		CHEMBL2218929	=	Residual Activity	%	0.0	CHEMBL4722	Homo sapiens	Residual Activity	%	0.0
	12210650	CHEMBL2218949	Millipore: Percentage of residual kinase activity of AURKA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	COc1cc2nccc(Oc3ccc(NC(=S)NC(=O)c4ccccc4C)cc3)c2cc1OC		CHEMBL2218930	=	Residual Activity	%	1.0	CHEMBL4722	Homo sapiens	Residual Activity	%	1.0
	12210651	CHEMBL2218949	Millipore: Percentage of residual kinase activity of AURKA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	c1ccc2c(-c3ccncc3)c[nH]c2c1		CHEMBL380071	=	Residual Activity	%	76.0	CHEMBL4722	Homo sapiens	Residual Activity	%	76.0
	12210652	CHEMBL2218949	Millipore: Percentage of residual kinase activity of AURKA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	COc1ccc(C=C(C#N)C#N)cc1		CHEMBL77456	=	Residual Activity	%	122.0	CHEMBL4722	Homo sapiens	Residual Activity	%	122.0
	12210653	CHEMBL2218949	Millipore: Percentage of residual kinase activity of AURKA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	Cc1cc(C)c(/C=C2\C(=O)Nc3ccccc32)[nH]1		CHEMBL276711	=	Residual Activity	%	43.0	CHEMBL4722	Homo sapiens	Residual Activity	%	43.0
	12210654	CHEMBL2218949	Millipore: Percentage of residual kinase activity of AURKA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	O=C1c2ccccc2-c2nc3nnnn3nc21		CHEMBL599894	=	Residual Activity	%	86.0	CHEMBL4722	Homo sapiens	Residual Activity	%	86.0
	12210655	CHEMBL2218949	Millipore: Percentage of residual kinase activity of AURKA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	=	Residual Activity	%	113.0	CHEMBL4722	Homo sapiens	Residual Activity	%	113.0
	12210656	CHEMBL2218949	Millipore: Percentage of residual kinase activity of AURKA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	COc1ccc2c(c1)c(C1=C(c3c[nH]c4ccccc34)C(=O)NC1=O)cn2CCCN(C)C		CHEMBL261491	=	Residual Activity	%	97.0	CHEMBL4722	Homo sapiens	Residual Activity	%	97.0
	12210657	CHEMBL2218949	Millipore: Percentage of residual kinase activity of AURKA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)cn2C1CCCC1		CHEMBL47940	=	Residual Activity	%	7.0	CHEMBL4722	Homo sapiens	Residual Activity	%	7.0
	12210658	CHEMBL2218949	Millipore: Percentage of residual kinase activity of AURKA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	O=C1Nc2ccc3ncsc3c2/C1=C/c1c[nH]cn1		CHEMBL235641	=	Residual Activity	%	-2.0	CHEMBL4722	Homo sapiens	Residual Activity	%	-2.0
	12210659	CHEMBL2218949	Millipore: Percentage of residual kinase activity of AURKA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	Cc1cncc2cccc(S(=O)(=O)N3CCCN(C(=O)CN)C[C@H]3C)c12		CHEMBL2218931	=	Residual Activity	%	36.0	CHEMBL4722	Homo sapiens	Residual Activity	%	36.0
	12210660	CHEMBL2218949	Millipore: Percentage of residual kinase activity of AURKA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	N#C/C(=C\c1ccc(O)c(O)c1)C(=O)NCc1ccccc1		CHEMBL56543	=	Residual Activity	%	98.0	CHEMBL4722	Homo sapiens	Residual Activity	%	98.0
	12210661	CHEMBL2218949	Millipore: Percentage of residual kinase activity of AURKA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	COc1ccc(-c2cnc3c(-c4ccsc4)cnn3c2)cc1		CHEMBL92461	=	Residual Activity	%	99.0	CHEMBL4722	Homo sapiens	Residual Activity	%	99.0
	12210662	CHEMBL2218949	Millipore: Percentage of residual kinase activity of AURKA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	COc1cc2ncnc(Nc3ccc(NC(=O)c4ccccc4)cc3)c2cc1OC		CHEMBL382590	=	Residual Activity	%	12.0	CHEMBL4722	Homo sapiens	Residual Activity	%	12.0
	12210663	CHEMBL2218949	Millipore: Percentage of residual kinase activity of AURKA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	O=c1c2ccccc2[nH]c(=S)n1CCN1CCC(=C(c2ccc(F)cc2)c2ccc(F)cc2)CC1		CHEMBL261131	=	Residual Activity	%	108.0	CHEMBL4722	Homo sapiens	Residual Activity	%	108.0
	12210664	CHEMBL2218949	Millipore: Percentage of residual kinase activity of AURKA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	c1ccc(-c2n[nH]c3c2oc2ccccc23)cc1		CHEMBL406375	=	Residual Activity	%	31.0	CHEMBL4722	Homo sapiens	Residual Activity	%	31.0
	12210665	CHEMBL2218949	Millipore: Percentage of residual kinase activity of AURKA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12		CHEMBL98350	=	Residual Activity	%	84.0	CHEMBL4722	Homo sapiens	Residual Activity	%	84.0
	12210666	CHEMBL2218949	Millipore: Percentage of residual kinase activity of AURKA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	O=C1Nc2ccc(Cl)cc2/C1=C/c1cc(Cl)c(O)c(Cl)c1		CHEMBL2218932	=	Residual Activity	%	24.0	CHEMBL4722	Homo sapiens	Residual Activity	%	24.0
	12210667	CHEMBL2218949	Millipore: Percentage of residual kinase activity of AURKA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Residual Activity	%	-2.0	CHEMBL4722	Homo sapiens	Residual Activity	%	-2.0
	12210668	CHEMBL2218949	Millipore: Percentage of residual kinase activity of AURKA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	N#CC(C#N)=C(N)/C(C#N)=C/c1ccc(O)cc1		CHEMBL76589	=	Residual Activity	%	85.0	CHEMBL4722	Homo sapiens	Residual Activity	%	85.0
	12210669	CHEMBL2218949	Millipore: Percentage of residual kinase activity of AURKA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	O=C(c1ccccc1)c1ccc(N2CCOCC2)cc1O		CHEMBL478980	=	Residual Activity	%	91.0	CHEMBL4722	Homo sapiens	Residual Activity	%	91.0
	12210670	CHEMBL2218949	Millipore: Percentage of residual kinase activity of AURKA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	NC(=O)c1cccc(-c2cc(Nc3ccc(OC(F)(F)F)cc3)ncn2)c1		CHEMBL483847	=	Residual Activity	%	112.0	CHEMBL4722	Homo sapiens	Residual Activity	%	112.0
	12210671	CHEMBL2218949	Millipore: Percentage of residual kinase activity of AURKA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	CN(C)c1ccc(/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL328710	=	Residual Activity	%	26.0	CHEMBL4722	Homo sapiens	Residual Activity	%	26.0
	12210672	CHEMBL2218949	Millipore: Percentage of residual kinase activity of AURKA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	CO[C@H]1/C=C/C=C(\C)C(=O)NC2=CC(=O)C=C(C2=O)[C@H](OC)[C@@H](C)C[C@H](OC)[C@H](OC)[C@@H](C)/C=C(\C)[C@@H]1OC(N)=O		CHEMBL479533	=	Residual Activity	%	86.0	CHEMBL4722	Homo sapiens	Residual Activity	%	86.0
	12210673	CHEMBL2218949	Millipore: Percentage of residual kinase activity of AURKA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	O=c1cc(N2CCNCC2)oc2c(-c3ccccc3)cccc12		CHEMBL1363184	=	Residual Activity	%	80.0	CHEMBL4722	Homo sapiens	Residual Activity	%	80.0
	12210674	CHEMBL2218949	Millipore: Percentage of residual kinase activity of AURKA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	O=C1NC(=O)/C(=C\c2ccc3nccnc3c2)S1		CHEMBL2218934	=	Residual Activity	%	46.0	CHEMBL4722	Homo sapiens	Residual Activity	%	46.0
	12210675	CHEMBL2218949	Millipore: Percentage of residual kinase activity of AURKA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	COc1cc2ncnc(Nc3ccc(Oc4ccccc4)cc3)c2cc1OC		CHEMBL97771	=	Residual Activity	%	30.0	CHEMBL4722	Homo sapiens	Residual Activity	%	30.0
	12210676	CHEMBL2218949	Millipore: Percentage of residual kinase activity of AURKA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	Cc1cc2ncc(-c3ccccc3)nc2cc1C		CHEMBL7724	=	Residual Activity	%	96.0	CHEMBL4722	Homo sapiens	Residual Activity	%	96.0
	12210677	CHEMBL2218949	Millipore: Percentage of residual kinase activity of AURKA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	O=C(Nc1cccc(Nc2nccc(Nc3cccc(C(F)(F)F)c3)n2)c1)C1CC1		CHEMBL383899	=	Residual Activity	%	7.0	CHEMBL4722	Homo sapiens	Residual Activity	%	7.0
	12210678	CHEMBL2218949	Millipore: Percentage of residual kinase activity of AURKA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	CN(C)CCCn1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL7463	=	Residual Activity	%	80.0	CHEMBL4722	Homo sapiens	Residual Activity	%	80.0
	12210679	CHEMBL2218949	Millipore: Percentage of residual kinase activity of AURKA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	COc1cc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2cc1OC		CHEMBL563845	=	Residual Activity	%	38.0	CHEMBL4722	Homo sapiens	Residual Activity	%	38.0
	12210680	CHEMBL2218949	Millipore: Percentage of residual kinase activity of AURKA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	c1ccc(-c2cnc(Nc3ccc(OCCN4CCCC4)cc3)s2)cc1		CHEMBL2218935	=	Residual Activity	%	91.0	CHEMBL4722	Homo sapiens	Residual Activity	%	91.0
	12210681	CHEMBL2218949	Millipore: Percentage of residual kinase activity of AURKA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	CC1=C(C(=O)N2CCN(C)CC2)C(C)=C(/C=C2\C(=O)Nc3ccc(S(=O)(=O)N(C)c4cccc(Cl)c4)cc32)C1		CHEMBL2218936	=	Residual Activity	%	17.0	CHEMBL4722	Homo sapiens	Residual Activity	%	17.0
	12210682	CHEMBL2218949	Millipore: Percentage of residual kinase activity of AURKA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	O=C1NC(=O)/C(=C/c2ccc3c(c2)OC(F)(F)O3)S1		CHEMBL1231533	=	Residual Activity	%	57.0	CHEMBL4722	Homo sapiens	Residual Activity	%	57.0
	12210683	CHEMBL2218949	Millipore: Percentage of residual kinase activity of AURKA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(Cl)cc32)c1C		CHEMBL13485	=	Residual Activity	%	30.0	CHEMBL4722	Homo sapiens	Residual Activity	%	30.0
	12210684	CHEMBL2218949	Millipore: Percentage of residual kinase activity of AURKA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	COc1cc2ncc(-c3ccccc3)nc2cc1OC		CHEMBL71191	=	Residual Activity	%	98.0	CHEMBL4722	Homo sapiens	Residual Activity	%	98.0
	12210685	CHEMBL2218949	Millipore: Percentage of residual kinase activity of AURKA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Residual Activity	%	-2.0	CHEMBL4722	Homo sapiens	Residual Activity	%	-2.0
	12210686	CHEMBL2218949	Millipore: Percentage of residual kinase activity of AURKA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	CN([C@@H](Cc1ccc(OS(=O)(=O)c2cccc3cnccc23)cc1)C(=O)N1CCN(c2ccccc2)CC1)S(=O)(=O)c1cccc2cnccc12		CHEMBL28324	=	Residual Activity	%	112.0	CHEMBL4722	Homo sapiens	Residual Activity	%	112.0
	12210687	CHEMBL2218949	Millipore: Percentage of residual kinase activity of AURKA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	=	Residual Activity	%	-2.0	CHEMBL4722	Homo sapiens	Residual Activity	%	-2.0
	12210688	CHEMBL2218949	Millipore: Percentage of residual kinase activity of AURKA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1c1[nH]c3cc(Br)ccc3c21		CHEMBL64758	=	Residual Activity	%	75.0	CHEMBL4722	Homo sapiens	Residual Activity	%	75.0
	12210689	CHEMBL2218949	Millipore: Percentage of residual kinase activity of AURKA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	C[C@@H](N)[C@H]1CC[C@H](C(=O)Nc2ccncc2)CC1		CHEMBL559147	=	Residual Activity	%	89.0	CHEMBL4722	Homo sapiens	Residual Activity	%	89.0
	12210690	CHEMBL2218949	Millipore: Percentage of residual kinase activity of AURKA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	CN(C)S(=O)(=O)c1ccc2c(c1)/C(=C/c1cc3c([nH]1)CCCC3)C(=O)N2		CHEMBL605003	=	Residual Activity	%	13.0	CHEMBL4722	Homo sapiens	Residual Activity	%	13.0
	12210691	CHEMBL2218949	Millipore: Percentage of residual kinase activity of AURKA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	O=C(CCCc1ccc(-c2ccccc2F)cc1)Nc1ccc(O)cc1		CHEMBL235658	=	Residual Activity	%	102.0	CHEMBL4722	Homo sapiens	Residual Activity	%	102.0
	12210692	CHEMBL2218949	Millipore: Percentage of residual kinase activity of AURKA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(C)c3ccccc3)c2)[nH]1		CHEMBL111364	=	Residual Activity	%	109.0	CHEMBL4722	Homo sapiens	Residual Activity	%	109.0
	12210693	CHEMBL2218949	Millipore: Percentage of residual kinase activity of AURKA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Residual Activity	%	118.0	CHEMBL4722	Homo sapiens	Residual Activity	%	118.0
	12210694	CHEMBL2218949	Millipore: Percentage of residual kinase activity of AURKA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	O=c1cc(-c2cccc3c2Sc2ccccc2S3)oc(N2CCOCC2)c1		CHEMBL222102	=	Residual Activity	%	120.0	CHEMBL4722	Homo sapiens	Residual Activity	%	120.0
	12210695	CHEMBL2218949	Millipore: Percentage of residual kinase activity of AURKA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	O=Nc1c(-c2c(O)[nH]c3ccccc23)[nH]c2ccccc12		CHEMBL126077	=	Residual Activity	%	0.0	CHEMBL4722	Homo sapiens	Residual Activity	%	0.0
	12210696	CHEMBL2218949	Millipore: Percentage of residual kinase activity of AURKA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	COc1ccc(OC)c2c(=S)c3ccccc3[nH]c12		CHEMBL1331734	=	Residual Activity	%	90.0	CHEMBL4722	Homo sapiens	Residual Activity	%	90.0
	12210697	CHEMBL2218949	Millipore: Percentage of residual kinase activity of AURKA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	Nc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL259551	=	Residual Activity	%	92.0	CHEMBL4722	Homo sapiens	Residual Activity	%	92.0
	12210698	CHEMBL2218949	Millipore: Percentage of residual kinase activity of AURKA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	Cc1cc(Nc2nc(-c3ccccc3)nc3ccccc23)n[nH]1		CHEMBL359482	=	Residual Activity	%	0.0	CHEMBL4722	Homo sapiens	Residual Activity	%	0.0
	12210699	CHEMBL2218949	Millipore: Percentage of residual kinase activity of AURKA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	CCOc1nc(NC(=O)Cc2cc(OC)ccc2OC)cc(N)c1C#N		CHEMBL210618	=	Residual Activity	%	98.0	CHEMBL4722	Homo sapiens	Residual Activity	%	98.0
	12210700	CHEMBL2218949	Millipore: Percentage of residual kinase activity of AURKA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	Oc1c(-c2ccc(F)cc2)c(-c2ccncc2)nn1-c1ccc(Cl)cc1		CHEMBL91730	=	Residual Activity	%	90.0	CHEMBL4722	Homo sapiens	Residual Activity	%	90.0
	12210701	CHEMBL2218949	Millipore: Percentage of residual kinase activity of AURKA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	=	Residual Activity	%	115.0	CHEMBL4722	Homo sapiens	Residual Activity	%	115.0
	12210702	CHEMBL2218949	Millipore: Percentage of residual kinase activity of AURKA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	O=C(NC(NC(=S)Nc1ccc(F)c([N+](=O)[O-])c1)C(Cl)(Cl)Cl)C(c1ccccc1)c1ccccc1		CHEMBL1221601	=	Residual Activity	%	69.0	CHEMBL4722	Homo sapiens	Residual Activity	%	69.0
	12210703	CHEMBL2218949	Millipore: Percentage of residual kinase activity of AURKA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	Cc1ccc(S(=O)(=O)/C=C/C#N)cc1		CHEMBL403183	=	Residual Activity	%	103.0	CHEMBL4722	Homo sapiens	Residual Activity	%	103.0
	12210704	CHEMBL2218949	Millipore: Percentage of residual kinase activity of AURKA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	Cc1ccc(NC2=CC(=O)c3sc(C)nc3C2=O)cc1		CHEMBL290904	=	Residual Activity	%	96.0	CHEMBL4722	Homo sapiens	Residual Activity	%	96.0
	12210705	CHEMBL2218949	Millipore: Percentage of residual kinase activity of AURKA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	Oc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL2218938	=	Residual Activity	%	93.0	CHEMBL4722	Homo sapiens	Residual Activity	%	93.0
	12210706	CHEMBL2218949	Millipore: Percentage of residual kinase activity of AURKA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1n1cncc21		CHEMBL413188	=	Residual Activity	%	1.0	CHEMBL4722	Homo sapiens	Residual Activity	%	1.0
	12210707	CHEMBL2218949	Millipore: Percentage of residual kinase activity of AURKA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	COC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL281948	=	Residual Activity	%	-1.0	CHEMBL4722	Homo sapiens	Residual Activity	%	-1.0
	12210708	CHEMBL2218949	Millipore: Percentage of residual kinase activity of AURKA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	COc1cccc(-c2cc(=O)c3ccccc3o2)c1N		CHEMBL35482	=	Residual Activity	%	107.0	CHEMBL4722	Homo sapiens	Residual Activity	%	107.0
	12210709	CHEMBL2218949	Millipore: Percentage of residual kinase activity of AURKA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	O=C1NC(=O)c2c1c1c3ccccc3n3c1c1c2c2ccccc2n1C1CCC3O1		CHEMBL304428	=	Residual Activity	%	88.0	CHEMBL4722	Homo sapiens	Residual Activity	%	88.0
	12210710	CHEMBL2218949	Millipore: Percentage of residual kinase activity of AURKA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1		CHEMBL50894	=	Residual Activity	%	105.0	CHEMBL4722	Homo sapiens	Residual Activity	%	105.0
	12210711	CHEMBL2218949	Millipore: Percentage of residual kinase activity of AURKA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	CC(C)n1cnc2c(NCc3ccccc3)nc(NCCCO)nc21		CHEMBL83980	=	Residual Activity	%	114.0	CHEMBL4722	Homo sapiens	Residual Activity	%	114.0
	12210712	CHEMBL2218949	Millipore: Percentage of residual kinase activity of AURKA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	CCN1/C(=C/C(C)=O)Sc2ccc(OC)cc21		CHEMBL408982	=	Residual Activity	%	90.0	CHEMBL4722	Homo sapiens	Residual Activity	%	90.0
	12210713	CHEMBL2218949	Millipore: Percentage of residual kinase activity of AURKA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	O=C1c2ccccc2-[n+]2ccc3c([nH]c4ccccc43)c21		CHEMBL602937	=	Residual Activity	%	89.0	CHEMBL4722	Homo sapiens	Residual Activity	%	89.0
	12210714	CHEMBL2218949	Millipore: Percentage of residual kinase activity of AURKA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	COc1cc(OC)c(/C=C2\C(=O)Nc3ccccc32)c(OC)c1		CHEMBL404941	=	Residual Activity	%	107.0	CHEMBL4722	Homo sapiens	Residual Activity	%	107.0
	12210715	CHEMBL2218949	Millipore: Percentage of residual kinase activity of AURKA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ccccc2N1		CHEMBL296586	=	Residual Activity	%	66.0	CHEMBL4722	Homo sapiens	Residual Activity	%	66.0
	12210716	CHEMBL2218949	Millipore: Percentage of residual kinase activity of AURKA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	O=[N+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL17331	=	Residual Activity	%	109.0	CHEMBL4722	Homo sapiens	Residual Activity	%	109.0
	12210717	CHEMBL2218949	Millipore: Percentage of residual kinase activity of AURKA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	Cc1nc(-c2ccccc2)c(-c2ccncc2)o1		CHEMBL36450	=	Residual Activity	%	86.0	CHEMBL4722	Homo sapiens	Residual Activity	%	86.0
	12210718	CHEMBL2218949	Millipore: Percentage of residual kinase activity of AURKA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	N#CCCc1ccc2c(c1)-c1[nH]c3ccc([N+](=O)[O-])cc3c1CC(=O)N2		CHEMBL260138	=	Residual Activity	%	37.0	CHEMBL4722	Homo sapiens	Residual Activity	%	37.0
	12210719	CHEMBL2218949	Millipore: Percentage of residual kinase activity of AURKA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	O=C1Nc2ccccc2/C1=C\c1c(Cl)[nH]c2ccccc12		CHEMBL261425	=	Residual Activity	%	96.0	CHEMBL4722	Homo sapiens	Residual Activity	%	96.0
	12210720	CHEMBL2218949	Millipore: Percentage of residual kinase activity of AURKA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	NC(=O)c1ccc2[nH]c(-c3ccc(Oc4ccc(Cl)cc4)cc3)nc2c1		CHEMBL179583	=	Residual Activity	%	86.0	CHEMBL4722	Homo sapiens	Residual Activity	%	86.0
	12210721	CHEMBL2218949	Millipore: Percentage of residual kinase activity of AURKA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	Cn1sc(=O)n(Cc2ccccc2)c1=O		CHEMBL284861	=	Residual Activity	%	91.0	CHEMBL4722	Homo sapiens	Residual Activity	%	91.0
	12210722	CHEMBL2218949	Millipore: Percentage of residual kinase activity of AURKA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	NC(=O)Nc1sc(-c2ccc(F)cc2)cc1C(N)=O		CHEMBL257167	=	Residual Activity	%	3.0	CHEMBL4722	Homo sapiens	Residual Activity	%	3.0
	12210723	CHEMBL2218949	Millipore: Percentage of residual kinase activity of AURKA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	COc1ccc(S(=O)(=O)N(CCO)c2ccccc2CN(C)C/C=C/c2ccc(Cl)cc2)cc1		CHEMBL155333	=	Residual Activity	%	127.0	CHEMBL4722	Homo sapiens	Residual Activity	%	127.0
	12210724	CHEMBL2218949	Millipore: Percentage of residual kinase activity of AURKA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL274064	=	Residual Activity	%	86.0	CHEMBL4722	Homo sapiens	Residual Activity	%	86.0
	12210725	CHEMBL2218949	Millipore: Percentage of residual kinase activity of AURKA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL313417	=	Residual Activity	%	104.0	CHEMBL4722	Homo sapiens	Residual Activity	%	104.0
	12210726	CHEMBL2218949	Millipore: Percentage of residual kinase activity of AURKA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	CCCCc1c(-c2ccc(O)cc2)[nH]c2nccnc12		CHEMBL75680	=	Residual Activity	%	20.0	CHEMBL4722	Homo sapiens	Residual Activity	%	20.0
	12210727	CHEMBL2218949	Millipore: Percentage of residual kinase activity of AURKA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	CCn1cnc2c(Nc3cccc(Cl)c3)nc(N[C@@H]3CCCC[C@@H]3N)nc21		CHEMBL367625	=	Residual Activity	%	68.0	CHEMBL4722	Homo sapiens	Residual Activity	%	68.0
	12210728	CHEMBL2218949	Millipore: Percentage of residual kinase activity of AURKA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	CC(C)n1cnc2/c(=N/c3cccc(Cl)c3)nc(NCCO)[nH]c21		CHEMBL311228	=	Residual Activity	%	47.0	CHEMBL4722	Homo sapiens	Residual Activity	%	47.0
	12210729	CHEMBL2218949	Millipore: Percentage of residual kinase activity of AURKA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	Ic1cccc(CSc2nnc(-c3ccncc3)o2)c1		CHEMBL288064	=	Residual Activity	%	80.0	CHEMBL4722	Homo sapiens	Residual Activity	%	80.0
	12210730	CHEMBL2218949	Millipore: Percentage of residual kinase activity of AURKA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	O=C1Nc2ccccc2/C1=C1/Nc2ccccc2/C1=N\OCCC(O)CO		CHEMBL1802727	=	Residual Activity	%	3.0	CHEMBL4722	Homo sapiens	Residual Activity	%	3.0
	12210731	CHEMBL2218949	Millipore: Percentage of residual kinase activity of AURKA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	N#C/C(=C(/N)SC1C=CC=CC1)c1cccc(C(O)c2ccncc2)c1		CHEMBL2218939	=	Residual Activity	%	108.0	CHEMBL4722	Homo sapiens	Residual Activity	%	108.0
	12210732	CHEMBL2218949	Millipore: Percentage of residual kinase activity of AURKA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	CC(C)[C@H](CO)Nc1nc(Nc2cccc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL23327	=	Residual Activity	%	72.0	CHEMBL4722	Homo sapiens	Residual Activity	%	72.0
	12210733	CHEMBL2218949	Millipore: Percentage of residual kinase activity of AURKA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	Oc1ccc(Nc2nc(-c3ccc(Cl)cc3)cs2)cc1		CHEMBL1076555	=	Residual Activity	%	122.0	CHEMBL4722	Homo sapiens	Residual Activity	%	122.0
	12213562	CHEMBL2218949	Millipore: Percentage of residual kinase activity of AURKA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	CCCCc1c(-c2ccc(OC)cc2)[nH]c2nccnc12		CHEMBL306498	=	Residual Activity	%	13.0	CHEMBL4722	Homo sapiens	Residual Activity	%	13.0
	12213563	CHEMBL2218949	Millipore: Percentage of residual kinase activity of AURKA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=S)Nc1c(F)cccc1F		CHEMBL261720	=	Residual Activity	%	10.0	CHEMBL4722	Homo sapiens	Residual Activity	%	10.0
	12213564	CHEMBL2218949	Millipore: Percentage of residual kinase activity of AURKA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	COc1ccc(CNc2nc(N(CCO)CCO)nc3c2ncn3C(C)C)cc1		CHEMBL80713	=	Residual Activity	%	96.0	CHEMBL4722	Homo sapiens	Residual Activity	%	96.0
	12213565	CHEMBL2218949	Millipore: Percentage of residual kinase activity of AURKA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	COc1ccc(CNC(=O)Nc2ncc([N+](=O)[O-])s2)cc1		CHEMBL259850	=	Residual Activity	%	113.0	CHEMBL4722	Homo sapiens	Residual Activity	%	113.0
	12213566	CHEMBL2218949	Millipore: Percentage of residual kinase activity of AURKA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	Oc1c2ccccc2c2c3c(cccc13)N=N2		CHEMBL1725279	=	Residual Activity	%	2.0	CHEMBL4722	Homo sapiens	Residual Activity	%	2.0
	12213567	CHEMBL2218949	Millipore: Percentage of residual kinase activity of AURKA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	O=C1C(Cl)=C(N2C(=O)CCC2=O)C(=O)c2ccccc21		CHEMBL404939	=	Residual Activity	%	103.0	CHEMBL4722	Homo sapiens	Residual Activity	%	103.0
	12213568	CHEMBL2218949	Millipore: Percentage of residual kinase activity of AURKA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	Nc1cccc(-c2cc3c(Oc4cccc(O)c4)ncnc3[nH]2)c1		CHEMBL405759	=	Residual Activity	%	1.0	CHEMBL4722	Homo sapiens	Residual Activity	%	1.0
	12213569	CHEMBL2218949	Millipore: Percentage of residual kinase activity of AURKA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	CC(C)[C@H](CO)Nc1nc(Nc2cc(N)cc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL286721	=	Residual Activity	%	47.0	CHEMBL4722	Homo sapiens	Residual Activity	%	47.0
	12213570	CHEMBL2218949	Millipore: Percentage of residual kinase activity of AURKA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	Nc1n[nH]c2nc3ccccc3nc12		CHEMBL259389	=	Residual Activity	%	77.0	CHEMBL4722	Homo sapiens	Residual Activity	%	77.0
	12213571	CHEMBL2218949	Millipore: Percentage of residual kinase activity of AURKA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	CCN(CC)C(=O)c1ccc(Nc2nc(OCC3CCCCC3)c3nc[nH]c3n2)cc1		CHEMBL1802728	=	Residual Activity	%	5.0	CHEMBL4722	Homo sapiens	Residual Activity	%	5.0
	12213572	CHEMBL2218949	Millipore: Percentage of residual kinase activity of AURKA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	O=C1Nc2cc(Br)ccc2/C1=C1/Nc2ccccc2/C1=N\O		CHEMBL409450	=	Residual Activity	%	25.0	CHEMBL4722	Homo sapiens	Residual Activity	%	25.0
	12213573	CHEMBL2218949	Millipore: Percentage of residual kinase activity of AURKA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	Cn1nc2c3c(cccc31)C(=O)c1ccccc1-2		CHEMBL1802485	=	Residual Activity	%	74.0	CHEMBL4722	Homo sapiens	Residual Activity	%	74.0
	12213574	CHEMBL2218949	Millipore: Percentage of residual kinase activity of AURKA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	N#C/C(=C(\N)Sc1ccc(N)cc1)c1ccccc1C(F)(F)F		CHEMBL2218940	=	Residual Activity	%	70.0	CHEMBL4722	Homo sapiens	Residual Activity	%	70.0
	12213575	CHEMBL2218949	Millipore: Percentage of residual kinase activity of AURKA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	O=S(=O)(NCCNC/C=C/c1ccc(Br)cc1)c1cccc2cnccc12		CHEMBL104264	=	Residual Activity	%	81.0	CHEMBL4722	Homo sapiens	Residual Activity	%	81.0
	12213576	CHEMBL2218949	Millipore: Percentage of residual kinase activity of AURKA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	O=C(O)c1ccc2c3c1cccc3c(=O)n1c3ccccc3nc21		CHEMBL1182777	=	Residual Activity	%	16.0	CHEMBL4722	Homo sapiens	Residual Activity	%	16.0
	12213577	CHEMBL2218949	Millipore: Percentage of residual kinase activity of AURKA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	c1cc(-c2cnn3cc(-c4ccc(OCCN5CCCCC5)cc4)cnc23)ccn1		CHEMBL478629	=	Residual Activity	%	48.0	CHEMBL4722	Homo sapiens	Residual Activity	%	48.0
	12213578	CHEMBL2218949	Millipore: Percentage of residual kinase activity of AURKA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	NC(=O)c1ccc(-c2nc(-c3ccc4c(c3)OCCO4)c(-c3ccccn3)[nH]2)cc1		CHEMBL410456	=	Residual Activity	%	107.0	CHEMBL4722	Homo sapiens	Residual Activity	%	107.0
	12213579	CHEMBL2218949	Millipore: Percentage of residual kinase activity of AURKA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	CC(C)c1nn(-c2c(Cl)cccc2Cl)c2nc(Cc3ccc(OCCO)cc3)[nH]c(=O)c12		CHEMBL258721	=	Residual Activity	%	82.0	CHEMBL4722	Homo sapiens	Residual Activity	%	82.0
	12213580	CHEMBL2218949	Millipore: Percentage of residual kinase activity of AURKA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	CC(=O)O/N=C1C(=C2\C(=O)Nc3cc(Br)ccc32)\Nc2ccccc2\1		CHEMBL2218941	=	Residual Activity	%	17.0	CHEMBL4722	Homo sapiens	Residual Activity	%	17.0
	12213581	CHEMBL2218949	Millipore: Percentage of residual kinase activity of AURKA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	N#C/C(=C1/Nc2ccccc2S1)c1ccnc(NCCc2cccnc2)n1		CHEMBL191384	=	Residual Activity	%	48.0	CHEMBL4722	Homo sapiens	Residual Activity	%	48.0
	12213582	CHEMBL2218949	Millipore: Percentage of residual kinase activity of AURKA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	Nc1ncnc2[nH]nc(Nc3ccc(F)cc3)c12		CHEMBL1240885	=	Residual Activity	%	73.0	CHEMBL4722	Homo sapiens	Residual Activity	%	73.0
	12213583	CHEMBL2218949	Millipore: Percentage of residual kinase activity of AURKA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	CCc1nc(-c2ccc(OC)cc2)[nH]c1-c1ccncc1		CHEMBL278724	=	Residual Activity	%	84.0	CHEMBL4722	Homo sapiens	Residual Activity	%	84.0
	12213584	CHEMBL2218949	Millipore: Percentage of residual kinase activity of AURKA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	COc1ccc2c(c1)/C(=C/c1cnc[nH]1)C(=O)N2		CHEMBL258805	=	Residual Activity	%	2.0	CHEMBL4722	Homo sapiens	Residual Activity	%	2.0
	12213585	CHEMBL2218949	Millipore: Percentage of residual kinase activity of AURKA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	O=C(O)/C=C/c1cc(Br)c(Br)c(Br)c1Br		CHEMBL270724	=	Residual Activity	%	38.0	CHEMBL4722	Homo sapiens	Residual Activity	%	38.0
	12213586	CHEMBL2218949	Millipore: Percentage of residual kinase activity of AURKA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	N/C(=N\[N+](=O)[O-])N/N=C\c1ccc(-c2cccc([N+](=O)[O-])c2)o1		CHEMBL221271	=	Residual Activity	%	105.0	CHEMBL4722	Homo sapiens	Residual Activity	%	105.0
	12213587	CHEMBL2218949	Millipore: Percentage of residual kinase activity of AURKA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	O=C1NC(=O)C(c2cn(CCCO)c3ncccc23)=C1c1cnccn1		CHEMBL272629	=	Residual Activity	%	81.0	CHEMBL4722	Homo sapiens	Residual Activity	%	81.0
	12213588	CHEMBL2218949	Millipore: Percentage of residual kinase activity of AURKA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Residual Activity	%	107.0	CHEMBL4722	Homo sapiens	Residual Activity	%	107.0
	12213589	CHEMBL2218949	Millipore: Percentage of residual kinase activity of AURKA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	Nc1ccc2ncnc(NCCc3ccc(Oc4ccccc4)cc3)c2c1		CHEMBL522502	=	Residual Activity	%	110.0	CHEMBL4722	Homo sapiens	Residual Activity	%	110.0
	12213590	CHEMBL2218949	Millipore: Percentage of residual kinase activity of AURKA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	=	Residual Activity	%	89.0	CHEMBL4722	Homo sapiens	Residual Activity	%	89.0
	12213591	CHEMBL2218949	Millipore: Percentage of residual kinase activity of AURKA at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 50 mM NaCl, 0.1% v/v Triton-X-100	B	N#Cc1cnc2cnc(NCc3cccnc3)cc2c1Nc1ccc(F)c(Cl)c1		CHEMBL200381	=	Residual Activity	%	24.0	CHEMBL4722	Homo sapiens	Residual Activity	%	24.0
	12582822	CHEMBL3075222	Inhibition of Aurora2 (unknown origin)	B	O=[N+]([O-])c1ccc2c(c1)[n+]([O-])c1c3ccccc3[nH]c1[n+]2[O-]		CHEMBL2297164	<	IC50	nM	5000.0	CHEMBL4722	Homo sapiens	IC50	uM	5.0
	12582823	CHEMBL3075222	Inhibition of Aurora2 (unknown origin)	B	Cc1cccn2cc(CN(Cc3nc4ccccc4c(=O)[nH]3)C(C)C)nc12		CHEMBL2297163	<	Ki	nM	100000.0	CHEMBL4722	Homo sapiens	Ki	mM	0.1
	12582824	CHEMBL3075222	Inhibition of Aurora2 (unknown origin)	B	Cc1nc[nH]c1[C@H]1c2nc[nH]c2CCN1Cc1nc2ccccc2[nH]1		CHEMBL2297162	<	Ki	nM	100000.0	CHEMBL4722	Homo sapiens	Ki	mM	0.1
	12582825	CHEMBL3075222	Inhibition of Aurora2 (unknown origin)	B	Cc1nc[nH]c1[C@@H]1c2nc[nH]c2CCN1Cc1nc2ccccc2[nH]1		CHEMBL2297161	<	Ki	nM	100000.0	CHEMBL4722	Homo sapiens	Ki	mM	0.1
	12626725	CHEMBL2316996	Inhibition of aurora A (unknown origin) at 1 uM	B	COc1cc(Nc2ncc(Cl)c(-c3cccc(CC#N)c3)n2)ccc1N1CCN(C)CC1		CHEMBL2312140	>	Inhibition	%	95.0	CHEMBL4722	Homo sapiens	INH	%	95.0
	12629561	CHEMBL2319138	Inhibition of Aurora A (unknown origin)	B	O=C(NCCCN1CCOC1=O)c1cnc(NCc2cc(Cl)ccc2Cl)nc1NC1CCCC1		CHEMBL2312304	>	IC50	nM	30000.0	CHEMBL4722	Homo sapiens	IC50	uM	30.0
	12629562	CHEMBL2319138	Inhibition of Aurora A (unknown origin)	B	O=C(NCCCN1CCCC1=O)c1cnc(NCc2cc(Cl)ccc2Cl)nc1NC1CCCC1		CHEMBL2312303	>	IC50	nM	30000.0	CHEMBL4722	Homo sapiens	IC50	uM	30.0
Not Determined	12629563	CHEMBL2319138	Inhibition of Aurora A (unknown origin)	B	COc1ccccc1CNc1ncc(C(=O)NCCCN2CCCC2=O)c(NC2CCCC2)n1		CHEMBL2312301		IC50			CHEMBL4722	Homo sapiens	IC50		
Not Determined	12629564	CHEMBL2319138	Inhibition of Aurora A (unknown origin)	B	COc1ccc(CCNc2ncc(C(=O)NCCCN3CCCC3=O)c(NC3CCCC3)n2)cc1OC		CHEMBL2312290		IC50			CHEMBL4722	Homo sapiens	IC50		
	12631752	CHEMBL2317785	Inhibition of Aurora-A (unknown origin) in presence of ATP	B	Cc1cc(-c2cnc(Nc3cc(Cl)cc(Cl)c3)nc2NC2CCC(N(C)C)CC2)on1		CHEMBL2312654	=	IC50	nM	1550.0	CHEMBL4722	Homo sapiens	IC50	uM	1.55
	12631753	CHEMBL2317785	Inhibition of Aurora-A (unknown origin) in presence of ATP	B	CN1CCC(NC(=O)c2cnc(Nc3cc(Cl)cc(Cl)c3)nc2N[C@@H]2COC[C@H]2O)CC1		CHEMBL2312652	=	IC50	nM	30000.0	CHEMBL4722	Homo sapiens	IC50	uM	30.0
	12631754	CHEMBL2317785	Inhibition of Aurora-A (unknown origin) in presence of ATP	B	CN1CCC(NC(=O)c2cnc(Nc3cc(Cl)cc(Cl)c3)nc2NC2CCC(N(C)C)CC2)CC1		CHEMBL2312649	=	IC50	nM	30000.0	CHEMBL4722	Homo sapiens	IC50	uM	30.0
	12631755	CHEMBL2317785	Inhibition of Aurora-A (unknown origin) in presence of ATP	B	CN1CCC(NC(=O)c2cnc(NCc3cc(Cl)ccc3Cl)nc2NC2CCCC2)CC1		CHEMBL2312646	=	IC50	nM	30000.0	CHEMBL4722	Homo sapiens	IC50	uM	30.0
	12631756	CHEMBL2317785	Inhibition of Aurora-A (unknown origin) in presence of ATP	B	COc1ccccc1CNc1ncc(C(=O)NC2CCN(C)CC2)c(NC2CCCC2)n1		CHEMBL2312645	=	IC50	nM	30000.0	CHEMBL4722	Homo sapiens	IC50	uM	30.0
	12648019	CHEMBL2329394	Inhibition of Aurora kinase A (unknown origin) at 1 uM	B	CC(C)(C)[C@@H](NC(=O)c1c[nH]c2ncc(C3CC3)nc12)C(=O)N1CC(C#N)C1		CHEMBL2325895	=	Inhibition	%	78.0	CHEMBL4722	Homo sapiens	INH	%	78.0
	12648020	CHEMBL2329394	Inhibition of Aurora kinase A (unknown origin) at 1 uM	B	C[C@@H](NC(=O)c1c[nH]c2ncc(C3CC3)nc12)C(=O)N1CC(C#N)C1		CHEMBL2325894	=	Inhibition	%	33.0	CHEMBL4722	Homo sapiens	INH	%	33.0
	12648021	CHEMBL2329394	Inhibition of Aurora kinase A (unknown origin) at 1 uM	B	C[C@H](NC(=O)c1c[nH]c2ncc(C3CC3)nc12)C(C)(C)C#N		CHEMBL2325906	=	Inhibition	%	55.0	CHEMBL4722	Homo sapiens	INH	%	55.0
	12648022	CHEMBL2329394	Inhibition of Aurora kinase A (unknown origin) at 1 uM	B	C[C@H](NC(=O)c1c[nH]c2ncc(C3CC3)nc12)C(C)(C)C		CHEMBL2325903	=	Inhibition	%	90.0	CHEMBL4722	Homo sapiens	INH	%	90.0
	12649675	CHEMBL2329564	Inhibition of Aurora kinase A (unknown origin) at 10 uM	B	C[C@@H](NC(=O)c1c[nH]c2ncc(C3CC3)nc12)C(=O)N1CC(C#N)C1		CHEMBL2325894	=	Inhibition	%	93.0	CHEMBL4722	Homo sapiens	INH	%	93.0
	12649676	CHEMBL2329564	Inhibition of Aurora kinase A (unknown origin) at 10 uM	B	C[C@H](NC(=O)c1c[nH]c2ncc(C3CC3)nc12)C(C)(C)O		CHEMBL2325904	=	Inhibition	%	95.0	CHEMBL4722	Homo sapiens	INH	%	95.0
	12649677	CHEMBL2329564	Inhibition of Aurora kinase A (unknown origin) at 10 uM	B	CC(C)NC(=O)c1c[nH]c2ncc(C3CC3)nc12		CHEMBL2325901	=	Inhibition	%	89.0	CHEMBL4722	Homo sapiens	INH	%	89.0
	12656868	CHEMBL2327149	Inhibition of aurora-A (unknown origin)	B	COc1cc2c(cc1F)C(c1ccccc1Cl)=Nc1c(n[nH]c1C)N2		CHEMBL1980391	=	IC50	nM	58.0	CHEMBL4722	Homo sapiens	IC50	nM	58.0
	12659927	CHEMBL2327347	Inhibition of Aurora 1 (unknown origin) after 2.5 hrs by time-resolved fluorescence resonance energy transfer assay in presence of 100 uM ATP	B	c1cc2c(ncc3cnc(C4CCCCC4)n32)[nH]1		CHEMBL2322134	=	IC50	nM	270.0	CHEMBL4722	Homo sapiens	IC50	uM	0.27
	12659928	CHEMBL2327347	Inhibition of Aurora 1 (unknown origin) after 2.5 hrs by time-resolved fluorescence resonance energy transfer assay in presence of 100 uM ATP	B	c1cc2c(ncc3ccc(C4CCCCC4)n32)[nH]1		CHEMBL2322143	=	IC50	nM	30.0	CHEMBL4722	Homo sapiens	IC50	uM	0.03
	12659929	CHEMBL2327347	Inhibition of Aurora 1 (unknown origin) after 2.5 hrs by time-resolved fluorescence resonance energy transfer assay in presence of 100 uM ATP	B	c1cc2c(ncc3ncc(C4CCCCC4)n32)[nH]1		CHEMBL2322142	=	IC50	nM	40.0	CHEMBL4722	Homo sapiens	IC50	uM	0.04
	12659930	CHEMBL2327347	Inhibition of Aurora 1 (unknown origin) after 2.5 hrs by time-resolved fluorescence resonance energy transfer assay in presence of 100 uM ATP	B	c1cc2c(ncc3nnc(C4CCCCC4)n32)[nH]1		CHEMBL2322141	=	IC50	nM	15300.0	CHEMBL4722	Homo sapiens	IC50	uM	15.3
	12659931	CHEMBL2327347	Inhibition of Aurora 1 (unknown origin) after 2.5 hrs by time-resolved fluorescence resonance energy transfer assay in presence of 100 uM ATP	B	c1cc2c3c(cnc2[nH]1)CCCN3C1CCCCC1		CHEMBL2322140	=	IC50	nM	3200.0	CHEMBL4722	Homo sapiens	IC50	uM	3.2
	12659932	CHEMBL2327347	Inhibition of Aurora 1 (unknown origin) after 2.5 hrs by time-resolved fluorescence resonance energy transfer assay in presence of 100 uM ATP	B	FC(F)(F)c1nc2cnc3[nH]ccc3c2n1C1CCCCC1		CHEMBL2322139	=	IC50	nM	4300.0	CHEMBL4722	Homo sapiens	IC50	uM	4.3
	12659933	CHEMBL2327347	Inhibition of Aurora 1 (unknown origin) after 2.5 hrs by time-resolved fluorescence resonance energy transfer assay in presence of 100 uM ATP	B	Cc1nc2cnc3[nH]ccc3c2n1C1CCCCC1		CHEMBL2159198	=	IC50	nM	640.0	CHEMBL4722	Homo sapiens	IC50	uM	0.64
	12659934	CHEMBL2327347	Inhibition of Aurora 1 (unknown origin) after 2.5 hrs by time-resolved fluorescence resonance energy transfer assay in presence of 100 uM ATP	B	c1cc2c(ncc3ncn(C4CCCCC4)c32)[nH]1		CHEMBL2322138	=	IC50	nM	740.0	CHEMBL4722	Homo sapiens	IC50	uM	0.74
	12659935	CHEMBL2327347	Inhibition of Aurora 1 (unknown origin) after 2.5 hrs by time-resolved fluorescence resonance energy transfer assay in presence of 100 uM ATP	B	c1cc2c(ncc3onc(C4CCCCC4)c32)[nH]1		CHEMBL2322137	=	IC50	nM	570.0	CHEMBL4722	Homo sapiens	IC50	uM	0.57
	12659936	CHEMBL2327347	Inhibition of Aurora 1 (unknown origin) after 2.5 hrs by time-resolved fluorescence resonance energy transfer assay in presence of 100 uM ATP	B	Cn1nc(C2CCCCC2)c2c3cc[nH]c3ncc21		CHEMBL2322136	=	IC50	nM	340.0	CHEMBL4722	Homo sapiens	IC50	uM	0.34
	12659937	CHEMBL2327347	Inhibition of Aurora 1 (unknown origin) after 2.5 hrs by time-resolved fluorescence resonance energy transfer assay in presence of 100 uM ATP	B	c1cc2c(ncc3[nH]nc(C4CCCCC4)c32)[nH]1		CHEMBL2322135	=	IC50	nM	130.0	CHEMBL4722	Homo sapiens	IC50	uM	0.13
	12670880	CHEMBL2338944	Inhibition of Aurora A kinase (unknown origin) using [33P]-ATP at 10 uM after 20 to 40 mins by scintillation counting analysis	B	O=C(Nc1ccc(Cl)cc1)Nc1ccc2c(c1)C(Nc1ccc(Cl)cc1Cl)=NS2(=O)=O	Outside typical range	CHEMBL2334805	=	Inhibition	%	-12.0	CHEMBL4722	Homo sapiens	INH	%	-12.0
	12671112	CHEMBL2345090	Inhibition of Aurora A (unknown origin) at 10 uM relative to control	B	CC(C)Nc1c(C(N)=O)nnc2cc(N3CCOCC3)ccc12		CHEMBL2333120	=	Inhibition	%	81.0	CHEMBL4722	Homo sapiens	INH	%	81.0
	12671113	CHEMBL2345090	Inhibition of Aurora A (unknown origin) at 10 uM relative to control	B	CC(C)Nc1c(C(N)=O)nnc2ccc(-c3cn[nH]c3)cc12		CHEMBL2333115	=	Inhibition	%	100.0	CHEMBL4722	Homo sapiens	INH	%	100.0
	12671114	CHEMBL2345090	Inhibition of Aurora A (unknown origin) at 10 uM relative to control	B	CC(C)Nc1c(C(N)=O)nnc2ccc(-c3ccncc3)cc12		CHEMBL2333114	=	Inhibition	%	83.0	CHEMBL4722	Homo sapiens	INH	%	83.0
	12671115	CHEMBL2345090	Inhibition of Aurora A (unknown origin) at 10 uM relative to control	B	CC(C)Nc1c(C(N)=O)nnc2cc(-c3ccncc3)ccc12		CHEMBL2333112	=	Inhibition	%	90.0	CHEMBL4722	Homo sapiens	INH	%	90.0
	12671116	CHEMBL2345090	Inhibition of Aurora A (unknown origin) at 10 uM relative to control	B	CS(=O)(=O)c1ccc(-c2ccc3c(NC4CCC4)c(C(N)=O)nnc3c2)cc1		CHEMBL2333129	=	Inhibition	%	34.0	CHEMBL4722	Homo sapiens	INH	%	34.0
	12671117	CHEMBL2345090	Inhibition of Aurora A (unknown origin) at 10 uM relative to control	B	C[C@@H](Nc1c(C(N)=O)nnc2cc(-c3ccc(S(C)(=O)=O)cc3)ccc12)C1CC1		CHEMBL2333128	=	Inhibition	%	68.0	CHEMBL4722	Homo sapiens	INH	%	68.0
	12671118	CHEMBL2345090	Inhibition of Aurora A (unknown origin) at 10 uM relative to control	B	CC(C)Nc1c(C(N)=O)cnc2cc(-c3ccc(S(C)(=O)=O)cc3)ccc12		CHEMBL2333125	=	Inhibition	%	60.0	CHEMBL4722	Homo sapiens	INH	%	60.0
	12671321	CHEMBL2344168	Inhibition of aurora-A (unknown origin)	B	O=C(NCCc1ccc(O)c(Br)c1)/C(Cc1cc(Br)c(O)c(Oc2ccc(CCNC(=O)/C(Cc3cc(Br)c(O)c(-c4cc(C/C(=N\O)C(=O)NCCc5ccc(O)c(Br)c5)cc(Br)c4O)c3)=N/O)cc2Br)c1)=N/O		CHEMBL2333163	=	IC50	nM	2600.0	CHEMBL4722	Homo sapiens	IC50	uM	2.6
	12671322	CHEMBL2344168	Inhibition of aurora-A (unknown origin)	B	O=C(NCCc1ccc(O)c(Br)c1)/C(Cc1cc(Br)c(O)c(-c2cc(C/C(=N/O)C(=O)NCCc3ccc(O)c(Br)c3)cc(Br)c2O)c1)=N\O		CHEMBL505637	=	IC50	nM	100.0	CHEMBL4722	Homo sapiens	IC50	uM	0.1
	12671323	CHEMBL2344168	Inhibition of aurora-A (unknown origin)	B	O=C1NCCc2cc(Br)c(O)c(c2)Oc2c(Br)cc(cc2Br)CCNC(=O)/C(=N/O)Cc2cc(Br)c(O)c(c2)Oc2c(Br)cc(cc2Br)C/C1=N\O		CHEMBL510730	=	IC50	nM	1700.0	CHEMBL4722	Homo sapiens	IC50	uM	1.7
	12671324	CHEMBL2344168	Inhibition of aurora-A (unknown origin)	B	O=C1N/C=C/c2ccc(c(Br)c2)Oc2cc(cc(Br)c2O)CCNC(=O)/C(=N/O)Cc2ccc(c(Br)c2)Oc2cc(cc(Br)c2O)C/C1=N\O		CHEMBL360190	=	IC50	nM	3900.0	CHEMBL4722	Homo sapiens	IC50	uM	3.9
	12671325	CHEMBL2344168	Inhibition of aurora-A (unknown origin)	B	O=C1NCCc2ccc(O)c(c2)Oc2c(Br)cc(cc2Br)CCNC(=O)/C(=N/O)Cc2cc(Br)c(O)c(c2)Oc2c(Br)cc(cc2Br)C/C1=N\O		CHEMBL2333164	=	IC50	nM	1300.0	CHEMBL4722	Homo sapiens	IC50	uM	1.3
	12673097	CHEMBL2345634	Inhibition of recombinant AURA (unknown origin) assessed as residual activity using [gamma-33P]ATP as substrate at 1 uM	B	CC[C@@H](CO)Nc1nc(NC(=N)N)c2ncn(C(C)C)c2n1		CHEMBL2336379	=	Activity	%	30.0	CHEMBL4722	Homo sapiens	Activity	%	30.0
	12673098	CHEMBL2345634	Inhibition of recombinant AURA (unknown origin) assessed as residual activity using [gamma-33P]ATP as substrate at 1 uM	B	CC[C@H](CO)Nc1nc(NC(=N)N)c2ncn(C(C)C)c2n1		CHEMBL2336377	=	Activity	%	39.0	CHEMBL4722	Homo sapiens	Activity	%	39.0
	12675478	CHEMBL2344400	Inhibition of aurora-A (unknown origin)	B	O=C(Nc1ccc(Oc2ncnc3[nH]ncc23)cc1)Nc1ccc(Cl)c(C(F)(F)F)c1		CHEMBL2332840	>	IC50	nM	10000.0	CHEMBL4722	Homo sapiens	IC50	uM	10.0
	12679752	CHEMBL2346292	Inhibition of STK6 (unknown origin) at 1 uM	B	Cc1ccc(-c2ccc3ncc4c(c3n2)n(C2CCN(C(=O)[C@H](C)O)CC2)c(=O)n4C)cn1		CHEMBL2331664	=	Inhibition	%	1.0	CHEMBL4722	Homo sapiens	INH	%	1.0
	12693255	CHEMBL2343940	Inhibition of Aurora kinase A (unknown origin)	B	Cc1c(C(=O)N2CCOc3ccc(-c4ccc(N)nc4)cc3C2)ccc(S(C)(=O)=O)c1F		CHEMBL2333365	>	IC50	nM	10000.0	CHEMBL4722	Homo sapiens	IC50	nM	10000.0
	12700150	CHEMBL2342689	Inhibition of recombinant AURKA (unknown origin) at 5 uM by FRET-based Z'-LYTE assay	B	O=C1/C(=C/c2ccccn2)CNC/C1=C\c1ccccn1		CHEMBL574646	=	Inhibition	%	77.0	CHEMBL4722	Homo sapiens	INH	%	77.0
	12721826	CHEMBL2353812	Inhibition of AURKA (unknown origin) at 1 uM relative to control	B	CCNC(=O)Nc1nc2ccc(-c3ccccc3OC)cc2s1		CHEMBL2347710	=	Inhibition	%	100.0	CHEMBL4722	Homo sapiens	INH	%	100.0
	12723673	CHEMBL2350771	Inhibition of AURKA (unknown origin) at 10 uM by single point assay	B	C[C@@H](Nc1c(C#N)cnc2cc(-c3ccc(-n4ccoc4=O)cc3)ccc12)C1CC1		CHEMBL2347818	=	Inhibition	%	67.0	CHEMBL4722	Homo sapiens	INH	%	67.0
	12724788	CHEMBL2352292	Inhibition of AURKA (unknown origin) at 1 uM by single point assay	B	CC(C)Nc1c(C#N)cnc2cc(-c3cnn(C)c3)ccc12		CHEMBL2347824	=	Inhibition	%	89.0	CHEMBL4722	Homo sapiens	INH	%	89.0
	12724789	CHEMBL2352292	Inhibition of AURKA (unknown origin) at 1 uM by single point assay	B	CC(C)Nc1c(C#N)cnc2cc(-c3ccc(S(C)(=O)=O)cc3)ccc12		CHEMBL2347823	=	Inhibition	%	71.0	CHEMBL4722	Homo sapiens	INH	%	71.0
	12728896	CHEMBL2350230	Inhibition of Aurora A (unknown origin) assessed as remaining activity at 10 uM relative to control	B	O=c1[nH]c2ncc(-c3ccc(-c4nc[nH]n4)cc3)nc2n1CCC1CCOCC1		CHEMBL2348865	=	Activity	%	79.0	CHEMBL4722	Homo sapiens	Activity	%	79.0
	12729358	CHEMBL2351458	Inhibition of Aurora A (unknown origin) at 1 uM	B	FC(F)(F)c1cccc(Sc2ccc3nnc(-c4ccccc4)n3n2)c1		CHEMBL2348936	>	Inhibition	%	18.0	CHEMBL4722	Homo sapiens	INH	%	18.0
	12730038	CHEMBL2353913	Inhibition of Aurora A (unknown origin) assessed as remaining activity at 1 uM relative to control	B	CC(C)(O)c1ccc(-c2cnc3c(n2)N(CC2CCOCC2)CC(=O)N3)cn1		CHEMBL2348862	=	Activity	%	99.0	CHEMBL4722	Homo sapiens	Activity	%	99.0
	12730932	CHEMBL2350105	Inhibition of Aurora A (unknown origin) using [gamma-33P]ATP assessed as residual activity at 3 uM	B	CCc1ccc(-c2ccc3c(c2)-c2[nH]ncc2S(=O)(=O)N3C)cc1		CHEMBL2333445	=	Activity	%	90.0	CHEMBL4722	Homo sapiens	Activity	%	90.0
	12731155	CHEMBL2352235	Inhibition of human Aurora A using Kemptide as substrate assessed as residual activity at 10 uM incubated for 10 mins prior to ATP addition measured after 20 mins by liquid scintillation counting analysis	B	O=C(O)CCN1C(=O)/C(=C/c2ccc(-c3ccccc3F)o2)SC1=S		CHEMBL2349212	=	Activity	%	39.0	CHEMBL4722	Homo sapiens	Activity	%	39.0
	12731156	CHEMBL2352235	Inhibition of human Aurora A using Kemptide as substrate assessed as residual activity at 10 uM incubated for 10 mins prior to ATP addition measured after 20 mins by liquid scintillation counting analysis	B	O=C(O)CCCCCN1C(=O)/C(=C/c2ccc(-c3ccc(Br)cc3)o2)SC1=S		CHEMBL2349206	=	Activity	%	21.0	CHEMBL4722	Homo sapiens	Activity	%	21.0
	12731157	CHEMBL2352235	Inhibition of human Aurora A using Kemptide as substrate assessed as residual activity at 10 uM incubated for 10 mins prior to ATP addition measured after 20 mins by liquid scintillation counting analysis	B	O=C(O)CCCN1C(=O)/C(=C/c2ccc(-c3ccc(Br)cc3)o2)SC1=S		CHEMBL2349205	=	Activity	%	100.0	CHEMBL4722	Homo sapiens	Activity	%	100.0
	12731158	CHEMBL2352235	Inhibition of human Aurora A using Kemptide as substrate assessed as residual activity at 10 uM incubated for 10 mins prior to ATP addition measured after 20 mins by liquid scintillation counting analysis	B	CC(C(=O)O)N1C(=O)/C(=C/c2ccc(-c3ccc(Cl)c(Cl)c3)o2)SC1=S		CHEMBL2346710	=	Activity	%	14.0	CHEMBL4722	Homo sapiens	Activity	%	14.0
	12731159	CHEMBL2352235	Inhibition of human Aurora A using Kemptide as substrate assessed as residual activity at 10 uM incubated for 10 mins prior to ATP addition measured after 20 mins by liquid scintillation counting analysis	B	O=C(O)CCCN1C(=O)/C(=C/c2ccc(-c3ccccc3Cl)o2)SC1=S		CHEMBL2348833	=	Activity	%	14.0	CHEMBL4722	Homo sapiens	Activity	%	14.0
	12731175	CHEMBL2350230	Inhibition of Aurora A (unknown origin) assessed as remaining activity at 10 uM relative to control	B	CC(C)(O)c1ccc(-c2cnc3c(n2)N(CC2CCOCC2)CC(=O)N3)cn1		CHEMBL2348862	=	Activity	%	100.0	CHEMBL4722	Homo sapiens	Activity	%	100.0
	13282432	CHEMBL2378501	Inhibition of Aurora A (unknown origin) at 10 uM relative to control	B	C[C@@H](NC(=O)c1c[nH]c2ncc(-c3ncn4cc(F)cc(F)c34)nc12)C(=O)N1CC(C#N)C1		CHEMBL2376158	=	Inhibition	%	61.0	CHEMBL4722	Homo sapiens	INH	%	61.0
	13282433	CHEMBL2378501	Inhibition of Aurora A (unknown origin) at 10 uM relative to control	B	Cn1nc(-c2cnc3[nH]cc(C(=O)N[C@@H](C(=O)N4CC(C#N)C4)C4CC4)c3n2)c2ccc(Cl)cc21		CHEMBL2376154	=	Inhibition	%	93.0	CHEMBL4722	Homo sapiens	INH	%	93.0
	13282434	CHEMBL2378501	Inhibition of Aurora A (unknown origin) at 10 uM relative to control	B	CC[C@@H](NC(=O)c1c[nH]c2ncc(-c3nn(C)c4cc(Cl)ccc34)nc12)C(=O)N1CC(C#N)C1		CHEMBL2376153	=	Inhibition	%	92.0	CHEMBL4722	Homo sapiens	INH	%	92.0
	13282435	CHEMBL2378501	Inhibition of Aurora A (unknown origin) at 10 uM relative to control	B	C[C@@H](NC(=O)c1c[nH]c2ncc(-c3nn(C)c4cc(Cl)cc(F)c34)nc12)C(=O)N1CC(C#N)C1		CHEMBL2376152	=	Inhibition	%	36.0	CHEMBL4722	Homo sapiens	INH	%	36.0
	13282436	CHEMBL2378501	Inhibition of Aurora A (unknown origin) at 10 uM relative to control	B	C[C@@H](NC(=O)c1c[nH]c2ncc(-c3nn(C)c4cc(Cl)ccc34)nc12)C(=O)N1CC(C#N)C1		CHEMBL2376144	=	Inhibition	%	12.0	CHEMBL4722	Homo sapiens	INH	%	12.0
	13282437	CHEMBL2378501	Inhibition of Aurora A (unknown origin) at 10 uM relative to control	B	C[C@@H](NC(=O)c1c[nH]c2ncc(-c3cn(C)c4cc(Cl)ccc34)nc12)C(=O)N1CC(C#N)C1		CHEMBL2376143	=	Inhibition	%	87.0	CHEMBL4722	Homo sapiens	INH	%	87.0
	13301334	CHEMBL2382841	Inhibition of aurora-A (unknown origin)	B	COc1cccc(F)c1C(=O)Nc1ccc(Nc2ccnc3[nH]c(=O)c4ccccc4c23)cc1		CHEMBL2380838	=	IC50	nM	3.0	CHEMBL4722	Homo sapiens	IC50	nM	3.0
	13301335	CHEMBL2382841	Inhibition of aurora-A (unknown origin)	B	O=C(Nc1ccc(Nc2ccnc3[nH]c(=O)c4ccccc4c23)cc1)c1cc(F)cc(C(F)(F)F)c1		CHEMBL2380837	=	IC50	nM	9.0	CHEMBL4722	Homo sapiens	IC50	nM	9.0
	13301336	CHEMBL2382841	Inhibition of aurora-A (unknown origin)	B	O=C(Nc1ccc(Nc2ccnc3[nH]c(=O)c4ccccc4c23)cc1)c1ccc(C(F)(F)F)cc1F		CHEMBL2380836	=	IC50	nM	9.0	CHEMBL4722	Homo sapiens	IC50	nM	9.0
	13301337	CHEMBL2382841	Inhibition of aurora-A (unknown origin)	B	O=C(Nc1ccc(Nc2ccnc3[nH]c(=O)c4ccccc4c23)cc1)c1cccc(C(F)(F)F)c1F		CHEMBL2380835	=	IC50	nM	7.0	CHEMBL4722	Homo sapiens	IC50	nM	7.0
	13301338	CHEMBL2382841	Inhibition of aurora-A (unknown origin)	B	O=C(Nc1ccc(Nc2ccnc3[nH]c(=O)c4ccccc4c23)cc1)c1ccc(F)cc1C(F)(F)F		CHEMBL2380834	=	IC50	nM	0.3	CHEMBL4722	Homo sapiens	IC50	nM	0.3
	13301339	CHEMBL2382841	Inhibition of aurora-A (unknown origin)	B	O=C(Nc1ccc(Nc2ccnc3[nH]c(=O)c4ccccc4c23)cc1)c1cc(F)cc(F)c1		CHEMBL2380833	=	IC50	nM	7.0	CHEMBL4722	Homo sapiens	IC50	nM	7.0
	13301340	CHEMBL2382841	Inhibition of aurora-A (unknown origin)	B	O=C(Nc1ccc(Nc2ccnc3[nH]c(=O)c4ccccc4c23)cc1)c1ccc(F)c(F)c1		CHEMBL2380832	=	IC50	nM	7.0	CHEMBL4722	Homo sapiens	IC50	nM	7.0
	13301341	CHEMBL2382841	Inhibition of aurora-A (unknown origin)	B	O=C(Nc1ccc(Nc2ccnc3[nH]c(=O)c4ccccc4c23)cc1)c1c(F)cccc1F		CHEMBL2380831	=	IC50	nM	5.0	CHEMBL4722	Homo sapiens	IC50	nM	5.0
	13301342	CHEMBL2382841	Inhibition of aurora-A (unknown origin)	B	O=C(Nc1ccc(Nc2ccnc3[nH]c(=O)c4ccccc4c23)cc1)c1ccc(F)cc1F		CHEMBL2380830	=	IC50	nM	2.0	CHEMBL4722	Homo sapiens	IC50	nM	2.0
	13301343	CHEMBL2382841	Inhibition of aurora-A (unknown origin)	B	O=C(Nc1ccc(Nc2ccnc3[nH]c(=O)c4ccccc4c23)cc1)c1cccc(F)c1F		CHEMBL2380829	=	IC50	nM	2.0	CHEMBL4722	Homo sapiens	IC50	nM	2.0
	13301344	CHEMBL2382841	Inhibition of aurora-A (unknown origin)	B	O=C(Nc1ccc(Nc2ccnc3[nH]c(=O)c4ccccc4c23)cc1)c1ccc(C(F)(F)F)cc1		CHEMBL2380828	=	IC50	nM	27.0	CHEMBL4722	Homo sapiens	IC50	nM	27.0
	13301345	CHEMBL2382841	Inhibition of aurora-A (unknown origin)	B	O=C(Nc1ccc(Nc2ccnc3[nH]c(=O)c4ccccc4c23)cc1)c1ccc(F)cc1		CHEMBL2380827	=	IC50	nM	4.0	CHEMBL4722	Homo sapiens	IC50	nM	4.0
	13301346	CHEMBL2382841	Inhibition of aurora-A (unknown origin)	B	Cc1ccc(C(=O)Nc2ccc(Nc3ccnc4[nH]c(=O)c5ccccc5c34)cc2)cc1		CHEMBL2380826	=	IC50	nM	3.0	CHEMBL4722	Homo sapiens	IC50	nM	3.0
	13301347	CHEMBL2382841	Inhibition of aurora-A (unknown origin)	B	O=C(Nc1ccc(Nc2ccnc3[nH]c(=O)c4ccccc4c23)cc1)c1cccc(F)c1		CHEMBL2380825	=	IC50	nM	7.0	CHEMBL4722	Homo sapiens	IC50	nM	7.0
	13301348	CHEMBL2382841	Inhibition of aurora-A (unknown origin)	B	O=C(Nc1ccc(Nc2ccnc3[nH]c(=O)c4ccccc4c23)cc1)c1ccccc1C(F)(F)F		CHEMBL2380824	=	IC50	nM	4.0	CHEMBL4722	Homo sapiens	IC50	nM	4.0
	13301349	CHEMBL2382841	Inhibition of aurora-A (unknown origin)	B	O=C(Nc1ccc(Nc2ccnc3[nH]c(=O)c4ccccc4c23)cc1)c1ccccc1F		CHEMBL2380823	=	IC50	nM	9.0	CHEMBL4722	Homo sapiens	IC50	nM	9.0
	13301350	CHEMBL2382841	Inhibition of aurora-A (unknown origin)	B	COc1ccccc1C(=O)Nc1ccc(Nc2ccnc3[nH]c(=O)c4ccccc4c23)cc1		CHEMBL2380839	=	IC50	nM	7.0	CHEMBL4722	Homo sapiens	IC50	nM	7.0
	13301351	CHEMBL2382841	Inhibition of aurora-A (unknown origin)	B	O=C(Nc1ncc(Nc2ccnc3[nH]c(=O)c4ccccc4c23)cn1)c1ccccc1		CHEMBL2380848	=	IC50	nM	88.0	CHEMBL4722	Homo sapiens	IC50	nM	88.0
	13301352	CHEMBL2382841	Inhibition of aurora-A (unknown origin)	B	O=C(Nc1ccc(Nc2ccnc3[nH]c(=O)c4ccccc4c23)nc1)c1ccccc1		CHEMBL2380847	=	IC50	nM	615.0	CHEMBL4722	Homo sapiens	IC50	nM	615.0
	13301353	CHEMBL2382841	Inhibition of aurora-A (unknown origin)	B	O=C(Nc1ccc(Nc2ccnc3[nH]c(=O)c4ccccc4c23)cn1)c1ccccc1		CHEMBL2380846	=	IC50	nM	70.0	CHEMBL4722	Homo sapiens	IC50	nM	70.0
	13301354	CHEMBL2382841	Inhibition of aurora-A (unknown origin)	B	O=C(Nc1ccc(Nc2ccnc3[nH]c(=O)c4ccccc4c23)cc1)c1ccccc1		CHEMBL2380845	=	IC50	nM	4.0	CHEMBL4722	Homo sapiens	IC50	nM	4.0
	13301355	CHEMBL2382841	Inhibition of aurora-A (unknown origin)	B	CNc1ccc(Nc2ccnc3[nH]c(=O)c4ccccc4c23)cc1		CHEMBL2380844	=	IC50	nM	471.0	CHEMBL4722	Homo sapiens	IC50	nM	471.0
	13301356	CHEMBL2382841	Inhibition of aurora-A (unknown origin)	B	Nc1ccc(Nc2ccnc3[nH]c(=O)c4ccccc4c23)cc1		CHEMBL2380843	=	IC50	nM	1150.0	CHEMBL4722	Homo sapiens	IC50	nM	1150.0
	13301357	CHEMBL2382841	Inhibition of aurora-A (unknown origin)	B	O=c1[nH]c2nccc(Nc3ccccc3)c2c2ccccc12		CHEMBL2380842	=	IC50	nM	1030.0	CHEMBL4722	Homo sapiens	IC50	nM	1030.0
	13301358	CHEMBL2382841	Inhibition of aurora-A (unknown origin)	B	Nc1ccnc2[nH]c(=O)c3ccccc3c12		CHEMBL2380841	=	IC50	nM	3010.0	CHEMBL4722	Homo sapiens	IC50	nM	3010.0
	13301359	CHEMBL2382841	Inhibition of aurora-A (unknown origin)	B	Oc1nc2ncccc2c2ccccc12		CHEMBL110381	=	IC50	nM	5540.0	CHEMBL4722	Homo sapiens	IC50	nM	5540.0
	13301360	CHEMBL2382841	Inhibition of aurora-A (unknown origin)	B	O=c1[nH]c2nccc(Cl)c2c2ccccc12		CHEMBL2380840	=	IC50	nM	3010.0	CHEMBL4722	Homo sapiens	IC50	nM	3010.0
	13301891	CHEMBL2383380	Inhibition of human AURKA at 1 uM relative to control	B	CCOc1cc2c(-c3cccc(S(N)(=O)=O)c3)n[nH]c2cc1-c1cnn(C)c1		CHEMBL2380582	>	Inhibition	%	50.0	CHEMBL4722	Homo sapiens	INH	%	50.0
	13301923	CHEMBL2383380	Inhibition of human AURKA at 1 uM relative to control	B	CC(=O)Nc1cccc(-c2n[nH]c3cc(-c4cnn(C)c4)c(NC4CCCCC4)cc23)c1		CHEMBL2380587	>	Inhibition	%	50.0	CHEMBL4722	Homo sapiens	INH	%	50.0
	13301924	CHEMBL2383380	Inhibition of human AURKA at 1 uM relative to control	B	Cn1cc(-c2cc3[nH]nc(-c4cccc(S(N)(=O)=O)c4)c3cc2NC2CCCCC2)cn1		CHEMBL2380586	>	Inhibition	%	50.0	CHEMBL4722	Homo sapiens	INH	%	50.0
Not Active	13324726	CHEMBL2390471	Activity at Aurora A (unknown origin)	B	O=C(O)c1cccc(CN2C(=O)/C(=C(\c3ccccc3)c3ccc(Cl)cc3)c3ccccc32)c1		CHEMBL2386114		Activity			CHEMBL4722	Homo sapiens	Activity		
	13327706	CHEMBL2390009	Inhibition of AURKA (unknown origin) at 1 uM	B	Cc1cc(-c2cc(NC(=O)c3ccc(CN4CCN(C)CC4)cc3)[nH]n2)ccc1NC(=O)Nc1cc(C(C)(C)C)on1		CHEMBL2386796	=	Inhibition	%	66.0	CHEMBL4722	Homo sapiens	INH	%	66.0
	13327750	CHEMBL2390016	Inhibition of recombinant GST tagged Aurora A kinase (123 to 401) (unknown origin) transfected in insect sf9 cells after 90 mins by wallac counting analysis	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	=	IC50	nM	760.0	CHEMBL4722	Homo sapiens	IC50	uM	0.76
	13327751	CHEMBL2390016	Inhibition of recombinant GST tagged Aurora A kinase (123 to 401) (unknown origin) transfected in insect sf9 cells after 90 mins by wallac counting analysis	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	=	IC50	nM	3800.0	CHEMBL4722	Homo sapiens	IC50	uM	3.8
	13327752	CHEMBL2390016	Inhibition of recombinant GST tagged Aurora A kinase (123 to 401) (unknown origin) transfected in insect sf9 cells after 90 mins by wallac counting analysis	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1.Cl.Cl		CHEMBL2105709	>	IC50	nM	10000.0	CHEMBL4722	Homo sapiens	IC50	uM	10.0
	13327753	CHEMBL2390016	Inhibition of recombinant GST tagged Aurora A kinase (123 to 401) (unknown origin) transfected in insect sf9 cells after 90 mins by wallac counting analysis	B	Cc1nc(Nc2cc(-c3ccc(CNC(=O)Nc4cccc(Cl)c4)cc3)n[nH]2)cc(N2CCNCC2)n1		CHEMBL2386810	=	IC50	nM	790.0	CHEMBL4722	Homo sapiens	IC50	uM	0.79
	13327754	CHEMBL2390016	Inhibition of recombinant GST tagged Aurora A kinase (123 to 401) (unknown origin) transfected in insect sf9 cells after 90 mins by wallac counting analysis	B	Cc1nc(Nc2cc(-c3ccc(CNC(=O)Nc4cc(C(C)(C)C)on4)cc3)n[nH]2)cc(N2CCNCC2)n1		CHEMBL2386809	=	IC50	nM	710.0	CHEMBL4722	Homo sapiens	IC50	uM	0.71
	13327755	CHEMBL2390016	Inhibition of recombinant GST tagged Aurora A kinase (123 to 401) (unknown origin) transfected in insect sf9 cells after 90 mins by wallac counting analysis	B	Cc1nc(Nc2cc(-c3ccc(CNC(=O)Nc4cc(C(C)(C)C)on4)cc3)n[nH]2)cc(N2CCN(CCO)CC2)n1		CHEMBL2386808	=	IC50	nM	490.0	CHEMBL4722	Homo sapiens	IC50	uM	0.49
	13327756	CHEMBL2390016	Inhibition of recombinant GST tagged Aurora A kinase (123 to 401) (unknown origin) transfected in insect sf9 cells after 90 mins by wallac counting analysis	B	Cc1nc(Nc2cc(-c3ccc(CNC(=O)Nc4cc(C)on4)cc3)n[nH]2)cc(N2CCN(CCO)CC2)n1		CHEMBL2386807	=	IC50	nM	98.0	CHEMBL4722	Homo sapiens	IC50	uM	0.098
	13327757	CHEMBL2390016	Inhibition of recombinant GST tagged Aurora A kinase (123 to 401) (unknown origin) transfected in insect sf9 cells after 90 mins by wallac counting analysis	B	Cc1nc(Nc2cc(-c3ccc(CNC(=O)Nc4cc(C(C)(C)C)on4)cc3)n[nH]2)cc(N2CCN(C)CC2)n1		CHEMBL2386806	=	IC50	nM	120.0	CHEMBL4722	Homo sapiens	IC50	uM	0.12
	13327758	CHEMBL2390016	Inhibition of recombinant GST tagged Aurora A kinase (123 to 401) (unknown origin) transfected in insect sf9 cells after 90 mins by wallac counting analysis	B	Cc1nc(Nc2cc(-c3ccc(CNC(=O)Nc4cc(C)on4)cc3)n[nH]2)cc(N2CCN(C)CC2)n1		CHEMBL2386805	=	IC50	nM	320.0	CHEMBL4722	Homo sapiens	IC50	uM	0.32
	13327759	CHEMBL2390016	Inhibition of recombinant GST tagged Aurora A kinase (123 to 401) (unknown origin) transfected in insect sf9 cells after 90 mins by wallac counting analysis	B	Cc1nc(Nc2cc(-c3ccc(NC(=O)Nc4ccccc4)cc3)n[nH]2)cc(N2CCN(C)CC2)n1		CHEMBL2386804	=	IC50	nM	500.0	CHEMBL4722	Homo sapiens	IC50	uM	0.5
	13327760	CHEMBL2390016	Inhibition of recombinant GST tagged Aurora A kinase (123 to 401) (unknown origin) transfected in insect sf9 cells after 90 mins by wallac counting analysis	B	CN1CCN(Cc2ccc(C(=O)Nc3cc(-c4ccc(CNC(=O)Nc5cc(C(C)(C)C)on5)cc4)n[nH]3)cc2)CC1		CHEMBL2386803	>	IC50	nM	1000.0	CHEMBL4722	Homo sapiens	IC50	uM	1.0
	13327761	CHEMBL2390016	Inhibition of recombinant GST tagged Aurora A kinase (123 to 401) (unknown origin) transfected in insect sf9 cells after 90 mins by wallac counting analysis	B	CC(C)(C)c1cc(NC(=O)NCc2ccc(-c3cc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)[nH]n3)cc2)no1		CHEMBL2386802	>	IC50	nM	1000.0	CHEMBL4722	Homo sapiens	IC50	uM	1.0
	13327762	CHEMBL2390016	Inhibition of recombinant GST tagged Aurora A kinase (123 to 401) (unknown origin) transfected in insect sf9 cells after 90 mins by wallac counting analysis	B	Cc1cc(NC(=O)NCc2ccc(-c3cc(NC(=O)c4ccc(N5CCN(C)CC5)cc4)[nH]n3)cc2)no1		CHEMBL2386801	=	IC50	nM	940.0	CHEMBL4722	Homo sapiens	IC50	uM	0.94
	13327763	CHEMBL2390016	Inhibition of recombinant GST tagged Aurora A kinase (123 to 401) (unknown origin) transfected in insect sf9 cells after 90 mins by wallac counting analysis	B	O=C(NCc1ccc(-c2cc(NC(=O)c3ccc(OCCN4CCOCC4)cc3)[nH]n2)cc1)Nc1ccc(Cl)cc1		CHEMBL2386800	>	IC50	nM	1000.0	CHEMBL4722	Homo sapiens	IC50	uM	1.0
	13327764	CHEMBL2390016	Inhibition of recombinant GST tagged Aurora A kinase (123 to 401) (unknown origin) transfected in insect sf9 cells after 90 mins by wallac counting analysis	B	O=C(NCc1ccc(-c2cc(NC(=O)c3ccc(OCCN4CCOCC4)cc3)[nH]n2)cc1)Nc1ccc(F)cc1		CHEMBL2386799	>	IC50	nM	1000.0	CHEMBL4722	Homo sapiens	IC50	uM	1.0
	13327765	CHEMBL2390016	Inhibition of recombinant GST tagged Aurora A kinase (123 to 401) (unknown origin) transfected in insect sf9 cells after 90 mins by wallac counting analysis	B	CN1CCN(Cc2ccc(C(=O)Nc3cc(-c4ccc(CNC(=O)Nc5ccccc5)cc4)n[nH]3)cc2)CC1		CHEMBL2386798	>	IC50	nM	1000.0	CHEMBL4722	Homo sapiens	IC50	uM	1.0
	13327766	CHEMBL2390016	Inhibition of recombinant GST tagged Aurora A kinase (123 to 401) (unknown origin) transfected in insect sf9 cells after 90 mins by wallac counting analysis	B	O=C(NCc1ccc(-c2cc(NC(=O)c3ccc(OCCN4CCOCC4)cc3)[nH]n2)cc1)Nc1ccccc1		CHEMBL2386797	=	IC50	nM	760.0	CHEMBL4722	Homo sapiens	IC50	uM	0.76
	13327767	CHEMBL2390016	Inhibition of recombinant GST tagged Aurora A kinase (123 to 401) (unknown origin) transfected in insect sf9 cells after 90 mins by wallac counting analysis	B	Cc1cc(-c2cc(NC(=O)c3ccc(CN4CCN(C)CC4)cc3)[nH]n2)ccc1NC(=O)Nc1cc(C(C)(C)C)on1		CHEMBL2386796	=	IC50	nM	73.0	CHEMBL4722	Homo sapiens	IC50	uM	0.073
	13327768	CHEMBL2390016	Inhibition of recombinant GST tagged Aurora A kinase (123 to 401) (unknown origin) transfected in insect sf9 cells after 90 mins by wallac counting analysis	B	Cc1cc(-c2cc(NC(=O)c3ccc(OCCN4CCOCC4)cc3)[nH]n2)ccc1NC(=O)Nc1cc(C(C)(C)C)on1		CHEMBL2386795	=	IC50	nM	69.0	CHEMBL4722	Homo sapiens	IC50	uM	0.069
	13327769	CHEMBL2390016	Inhibition of recombinant GST tagged Aurora A kinase (123 to 401) (unknown origin) transfected in insect sf9 cells after 90 mins by wallac counting analysis	B	CN1CCN(Cc2ccc(C(=O)Nc3cc(-c4ccc(NC(=O)Nc5cc(C(C)(C)C)on5)cc4)n[nH]3)cc2)CC1		CHEMBL2386794	=	IC50	nM	160.0	CHEMBL4722	Homo sapiens	IC50	uM	0.16
	13327770	CHEMBL2390016	Inhibition of recombinant GST tagged Aurora A kinase (123 to 401) (unknown origin) transfected in insect sf9 cells after 90 mins by wallac counting analysis	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)[nH]n3)cc2)no1		CHEMBL2386793	=	IC50	nM	160.0	CHEMBL4722	Homo sapiens	IC50	uM	0.16
	13327771	CHEMBL2390016	Inhibition of recombinant GST tagged Aurora A kinase (123 to 401) (unknown origin) transfected in insect sf9 cells after 90 mins by wallac counting analysis	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cc(NC(=O)c4ccc(OCCN5CCCC5)cc4)[nH]n3)cc2)no1		CHEMBL2386792	=	IC50	nM	47.0	CHEMBL4722	Homo sapiens	IC50	uM	0.047
	13327772	CHEMBL2390016	Inhibition of recombinant GST tagged Aurora A kinase (123 to 401) (unknown origin) transfected in insect sf9 cells after 90 mins by wallac counting analysis	B	Cc1cc(NC(=O)Nc2ccc(-c3cc(NC(=O)c4ccc(N5CCN(C)CC5)cc4)[nH]n3)cc2Cl)no1		CHEMBL2386791	=	IC50	nM	600.0	CHEMBL4722	Homo sapiens	IC50	uM	0.6
	13327773	CHEMBL2390016	Inhibition of recombinant GST tagged Aurora A kinase (123 to 401) (unknown origin) transfected in insect sf9 cells after 90 mins by wallac counting analysis	B	Cc1cc(NC(=O)Nc2ccc(-c3cc(NC(=O)c4ccc(N5CCN(C)CC5)cc4)[nH]n3)cc2C)no1		CHEMBL2386790	=	IC50	nM	250.0	CHEMBL4722	Homo sapiens	IC50	uM	0.25
	13327774	CHEMBL2390016	Inhibition of recombinant GST tagged Aurora A kinase (123 to 401) (unknown origin) transfected in insect sf9 cells after 90 mins by wallac counting analysis	B	CN1CCN(c2ccc(C(=O)Nc3cc(-c4ccc(NC(=O)Nc5cc(C(C)(C)C)on5)cc4)n[nH]3)cc2)CC1		CHEMBL2386789	=	IC50	nM	53.0	CHEMBL4722	Homo sapiens	IC50	uM	0.053
	13327775	CHEMBL2390016	Inhibition of recombinant GST tagged Aurora A kinase (123 to 401) (unknown origin) transfected in insect sf9 cells after 90 mins by wallac counting analysis	B	Cc1cc(NC(=O)Nc2ccc(-c3cc(NC(=O)c4ccc(N5CCN(C)CC5)cc4)[nH]n3)cc2)no1		CHEMBL2386788	=	IC50	nM	120.0	CHEMBL4722	Homo sapiens	IC50	uM	0.12
	13327776	CHEMBL2390016	Inhibition of recombinant GST tagged Aurora A kinase (123 to 401) (unknown origin) transfected in insect sf9 cells after 90 mins by wallac counting analysis	B	Cc1cnc(NC(=O)Nc2ccc(-c3cc(NC(=O)c4ccc(N5CCN(C)CC5)cc4)[nH]n3)cc2)s1		CHEMBL2386818	=	IC50	nM	65.0	CHEMBL4722	Homo sapiens	IC50	uM	0.065
	13327777	CHEMBL2390016	Inhibition of recombinant GST tagged Aurora A kinase (123 to 401) (unknown origin) transfected in insect sf9 cells after 90 mins by wallac counting analysis	B	CN1CCN(c2ccc(C(=O)Nc3cc(-c4ccc(NC(=O)Nc5cccnc5)cc4)n[nH]3)cc2)CC1		CHEMBL2386817	=	IC50	nM	300.0	CHEMBL4722	Homo sapiens	IC50	uM	0.3
	13327778	CHEMBL2390016	Inhibition of recombinant GST tagged Aurora A kinase (123 to 401) (unknown origin) transfected in insect sf9 cells after 90 mins by wallac counting analysis	B	CN1CCN(c2ccc(C(=O)Nc3cc(-c4ccc(NC(=O)Nc5ccccn5)cc4)n[nH]3)cc2)CC1		CHEMBL2386816	=	IC50	nM	610.0	CHEMBL4722	Homo sapiens	IC50	uM	0.61
	13327779	CHEMBL2390016	Inhibition of recombinant GST tagged Aurora A kinase (123 to 401) (unknown origin) transfected in insect sf9 cells after 90 mins by wallac counting analysis	B	CN1CCN(c2ccc(C(=O)Nc3cc(-c4ccc(NC(=O)N5CCCC5)cc4)n[nH]3)cc2)CC1		CHEMBL2386815	>	IC50	nM	1000.0	CHEMBL4722	Homo sapiens	IC50	uM	1.0
	13327780	CHEMBL2390016	Inhibition of recombinant GST tagged Aurora A kinase (123 to 401) (unknown origin) transfected in insect sf9 cells after 90 mins by wallac counting analysis	B	CN1CCN(c2ccc(C(=O)Nc3cc(-c4ccc(NC(=O)NC5CC5)cc4)n[nH]3)cc2)CC1		CHEMBL2386814	>	IC50	nM	1000.0	CHEMBL4722	Homo sapiens	IC50	uM	1.0
	13327781	CHEMBL2390016	Inhibition of recombinant GST tagged Aurora A kinase (123 to 401) (unknown origin) transfected in insect sf9 cells after 90 mins by wallac counting analysis	B	CCNC(=O)Nc1ccc(-c2cc(NC(=O)c3ccc(N4CCN(C)CC4)cc3)[nH]n2)cc1		CHEMBL2386813	>	IC50	nM	1000.0	CHEMBL4722	Homo sapiens	IC50	uM	1.0
	13327782	CHEMBL2390016	Inhibition of recombinant GST tagged Aurora A kinase (123 to 401) (unknown origin) transfected in insect sf9 cells after 90 mins by wallac counting analysis	B	CN1CCN(c2ccc(C(=O)Nc3cc(-c4ccc(NC(=O)Nc5ccccc5)cc4)n[nH]3)cc2)CC1		CHEMBL2386812	=	IC50	nM	330.0	CHEMBL4722	Homo sapiens	IC50	uM	0.33
	13327783	CHEMBL2390016	Inhibition of recombinant GST tagged Aurora A kinase (123 to 401) (unknown origin) transfected in insect sf9 cells after 90 mins by wallac counting analysis	B	O=C(NCc1ccc(-c2cc(NC(=O)c3ccc(OCCN4CCCC4)cc3)[nH]n2)cc1)OCc1ccccc1		CHEMBL2063324	>	IC50	nM	1000.0	CHEMBL4722	Homo sapiens	IC50	uM	1.0
	13327784	CHEMBL2390016	Inhibition of recombinant GST tagged Aurora A kinase (123 to 401) (unknown origin) transfected in insect sf9 cells after 90 mins by wallac counting analysis	B	CN1CCN(c2ccc(C(=O)Nc3cc(-c4cccc(NS(=O)(=O)c5ccccc5)c4)n[nH]3)cc2)CC1		CHEMBL1807392	=	IC50	nM	340.0	CHEMBL4722	Homo sapiens	IC50	uM	0.34
Not Active	13328782	CHEMBL2388648	Inhibition of AURKA (unknown origin)	B	Cc1cccc2nc(Cn3cnc4ccccc43)cc(=O)n12		CHEMBL2386917		Inhibition	%		CHEMBL4722	Homo sapiens	INH		
	13337545	CHEMBL2393651	Inhibition of human recombinant AURKA by FRET assay	B	CC(=O)Nc1cc(-c2nnc(SCc3ccc(-c4ccccc4C#N)cc3)o2)ccn1		CHEMBL2391102	>	IC50	nM	100000.0	CHEMBL4722	Homo sapiens	IC50	uM	100.0
	13337546	CHEMBL2393651	Inhibition of human recombinant AURKA by FRET assay	B	CC(=O)Nc1cc(-c2nnc(SCc3cccc(C#N)c3)o2)ccn1		CHEMBL2391101	>	IC50	nM	100000.0	CHEMBL4722	Homo sapiens	IC50	uM	100.0
	13337547	CHEMBL2393651	Inhibition of human recombinant AURKA by FRET assay	B	c1ccc(-c2ccc(CSc3nnc(-c4ccncc4)o3)cc2)cc1		CHEMBL2391099	>	IC50	nM	100000.0	CHEMBL4722	Homo sapiens	IC50	uM	100.0
	13337548	CHEMBL2393651	Inhibition of human recombinant AURKA by FRET assay	B	N#Cc1cc(F)ccc1-c1ccc(CSc2nnc(-c3ccncc3)o2)cc1		CHEMBL2391098	>	IC50	nM	100000.0	CHEMBL4722	Homo sapiens	IC50	uM	100.0
	13337549	CHEMBL2393651	Inhibition of human recombinant AURKA by FRET assay	B	COc1ccc(-c2ccc(CSc3nnc(-c4ccncc4)o3)cc2)cc1		CHEMBL2391131	>	IC50	nM	100000.0	CHEMBL4722	Homo sapiens	IC50	uM	100.0
	13337550	CHEMBL2393651	Inhibition of human recombinant AURKA by FRET assay	B	N#Cc1ccc(-c2ccc(CSc3nnc(-c4ccncc4)o3)cc2)cc1		CHEMBL2390958	>	IC50	nM	100000.0	CHEMBL4722	Homo sapiens	IC50	uM	100.0
	13337551	CHEMBL2393651	Inhibition of human recombinant AURKA by FRET assay	B	Fc1cc(F)cc(-c2ccc(CSc3nnc(-c4ccc5c(c4)OCO5)o3)cc2)c1		CHEMBL2391117	>	IC50	nM	100000.0	CHEMBL4722	Homo sapiens	IC50	uM	100.0
	13337552	CHEMBL2393651	Inhibition of human recombinant AURKA by FRET assay	B	O=[N+]([O-])c1cccc(-c2ccc(CSc3nnc(-c4ccc5c(c4)OCO5)o3)cc2)c1		CHEMBL2391120	>	IC50	nM	100000.0	CHEMBL4722	Homo sapiens	IC50	uM	100.0
	13337553	CHEMBL2393651	Inhibition of human recombinant AURKA by FRET assay	B	N#Cc1cccc(-c2ccc(CSc3nnc(-c4ccc5c(c4)OCO5)o3)cc2)c1		CHEMBL2391121	>	IC50	nM	100000.0	CHEMBL4722	Homo sapiens	IC50	uM	100.0
	13337554	CHEMBL2393651	Inhibition of human recombinant AURKA by FRET assay	B	O=[N+]([O-])c1ccccc1-c1ccc(CSc2nnc(-c3ccc4c(c3)OCO4)o2)cc1		CHEMBL2391122	>	IC50	nM	100000.0	CHEMBL4722	Homo sapiens	IC50	uM	100.0
	13337555	CHEMBL2393651	Inhibition of human recombinant AURKA by FRET assay	B	c1ccc(-c2ccc(CSc3nnc(-c4ccc5c(c4)OCCO5)o3)cc2)cc1		CHEMBL2391123	>	IC50	nM	100000.0	CHEMBL4722	Homo sapiens	IC50	uM	100.0
	13337556	CHEMBL2393651	Inhibition of human recombinant AURKA by FRET assay	B	Fc1cc(F)cc(-c2ccc(CSc3nnc(-c4ccc5c(c4)OCCO5)o3)cc2)c1		CHEMBL2391124	>	IC50	nM	100000.0	CHEMBL4722	Homo sapiens	IC50	uM	100.0
	13337557	CHEMBL2393651	Inhibition of human recombinant AURKA by FRET assay	B	COc1ccc(-c2ccc(CSc3nnc(-c4ccc5c(c4)OCCO5)o3)cc2)c(C#N)c1		CHEMBL2391125	>	IC50	nM	100000.0	CHEMBL4722	Homo sapiens	IC50	uM	100.0
	13337558	CHEMBL2393651	Inhibition of human recombinant AURKA by FRET assay	B	COc1ccc(-c2ccc(CSc3nnc(-c4ccc5c(c4)OCCO5)o3)cc2)cc1		CHEMBL2391126	>	IC50	nM	100000.0	CHEMBL4722	Homo sapiens	IC50	uM	100.0
	13337559	CHEMBL2393651	Inhibition of human recombinant AURKA by FRET assay	B	O=[N+]([O-])c1cccc(-c2ccc(CSc3nnc(-c4ccc5c(c4)OCCO5)o3)cc2)c1		CHEMBL2391128	>	IC50	nM	100000.0	CHEMBL4722	Homo sapiens	IC50	uM	100.0
	13337560	CHEMBL2393651	Inhibition of human recombinant AURKA by FRET assay	B	N#Cc1cccc(-c2ccc(CSc3nnc(-c4ccc5c(c4)OCCO5)o3)cc2)c1		CHEMBL2391130	>	IC50	nM	100000.0	CHEMBL4722	Homo sapiens	IC50	uM	100.0
	13337561	CHEMBL2393651	Inhibition of human recombinant AURKA by FRET assay	B	O=[N+]([O-])c1ccccc1-c1ccc(CSc2nnc(-c3ccc4c(c3)OCCO4)o2)cc1		CHEMBL2391129	>	IC50	nM	100000.0	CHEMBL4722	Homo sapiens	IC50	uM	100.0
	13337614	CHEMBL2393651	Inhibition of human recombinant AURKA by FRET assay	B	CC(=O)Nc1cc(-c2nnc(SCc3ccccc3)o2)ccn1		CHEMBL2391100	=	IC50	nM	60000.0	CHEMBL4722	Homo sapiens	IC50	uM	60.0
	13337615	CHEMBL2393651	Inhibition of human recombinant AURKA by FRET assay	B	N#Cc1cccc(-c2ccc(CSc3nnc(-c4ccncc4)o3)cc2)c1		CHEMBL2391132	=	IC50	nM	60000.0	CHEMBL4722	Homo sapiens	IC50	uM	60.0
	13337636	CHEMBL2393651	Inhibition of human recombinant AURKA by FRET assay	B	N#Cc1ccc(-c2ccc(CSc3nnc(-c4ccc5c(c4)OCCO5)o3)cc2)cc1		CHEMBL2391127	=	IC50	nM	50000.0	CHEMBL4722	Homo sapiens	IC50	uM	50.0
	13337638	CHEMBL2393651	Inhibition of human recombinant AURKA by FRET assay	B	COc1ccc(-c2ccc(CSc3nnc(-c4ccc5c(c4)OCO5)o3)cc2)c(C#N)c1		CHEMBL2391118	=	IC50	nM	45000.0	CHEMBL4722	Homo sapiens	IC50	uM	45.0
	13337639	CHEMBL2393651	Inhibition of human recombinant AURKA by FRET assay	B	COc1ccc(-c2ccc(CSc3nnc(-c4ccc5c(c4)OCO5)o3)cc2)cc1		CHEMBL2391119	=	IC50	nM	40000.0	CHEMBL4722	Homo sapiens	IC50	uM	40.0
	13337643	CHEMBL2393651	Inhibition of human recombinant AURKA by FRET assay	B	O=[N+]([O-])c1ccccc1-c1ccc(CSc2nnc(-c3ccncc3)o2)cc1		CHEMBL2391133	=	IC50	nM	5000.0	CHEMBL4722	Homo sapiens	IC50	uM	5.0
	13343477	CHEMBL2396196	Inhibition of aurora A (unknown origin)	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	Ki	nM	0.6	CHEMBL4722	Homo sapiens	Ki	nM	0.6
	13343478	CHEMBL2396196	Inhibition of aurora A (unknown origin)	B	COc1cc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2OC)=NC3)ccc1C(=O)O		CHEMBL483158	=	IC50	nM	1.0	CHEMBL4722	Homo sapiens	IC50	nM	1.0
	13343479	CHEMBL2396196	Inhibition of aurora A (unknown origin)	B	CCN(CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1)CCOP(=O)(O)O		CHEMBL415049	=	Ki	nM	1368.0	CHEMBL4722	Homo sapiens	Ki	nM	1368.0
	13343496	CHEMBL2396200	Inhibition of aurora A (unknown origin) after 1 hr by HTRF assay	B	O=C(Nc1c[nH]nc1-c1nc2ccc(CN3CCOCC3)cc2[nH]1)NC1CC1		CHEMBL495727	=	IC50	nM	3.3	CHEMBL4722	Homo sapiens	IC50	nM	3.3
	13343497	CHEMBL2396200	Inhibition of aurora A (unknown origin) after 1 hr by HTRF assay	B	CCN(CC)Cc1ccc2[nH]c(-c3n[nH]cc3Nc3cc(Cl)nc(S(C)(=O)=O)n3)nc2c1		CHEMBL2392113	=	IC50	nM	77.9	CHEMBL4722	Homo sapiens	IC50	nM	77.9
	13343498	CHEMBL2396200	Inhibition of aurora A (unknown origin) after 1 hr by HTRF assay	B	Cc1ccc2[nH]c(-c3n[nH]cc3Nc3cc(Cl)nc(S(C)(=O)=O)n3)nc2c1		CHEMBL2392112	=	IC50	nM	45.1	CHEMBL4722	Homo sapiens	IC50	nM	45.1
	13343499	CHEMBL2396200	Inhibition of aurora A (unknown origin) after 1 hr by HTRF assay	B	CS(=O)(=O)c1nc(Cl)cc(Nc2c[nH]nc2-c2nc3cc(CN4CCOCC4)ccc3[nH]2)n1		CHEMBL2392111	=	IC50	nM	28.9	CHEMBL4722	Homo sapiens	IC50	nM	28.9
	13343500	CHEMBL2396200	Inhibition of aurora A (unknown origin) after 1 hr by HTRF assay	B	CCN(CC)Cc1ccc2[nH]c(-c3n[nH]cc3Nc3cc(Cl)nc(Sc4ccc(NC(=O)C5CC5)cc4)n3)nc2c1		CHEMBL2392110	=	IC50	nM	248.8	CHEMBL4722	Homo sapiens	IC50	nM	248.8
	13343501	CHEMBL2396200	Inhibition of aurora A (unknown origin) after 1 hr by HTRF assay	B	CCN(CC)Cc1ccc2[nH]c(-c3n[nH]cc3Nc3cc(Cl)nc(SC)n3)nc2c1		CHEMBL2392109	=	IC50	nM	86.1	CHEMBL4722	Homo sapiens	IC50	nM	86.1
Not Determined	13343502	CHEMBL2396200	Inhibition of aurora A (unknown origin) after 1 hr by HTRF assay	B	CCN(CC)Cc1ccc2[nH]c(-c3n[nH]cc3Nc3cc(Cl)nc(C)n3)nc2c1		CHEMBL2392108		IC50			CHEMBL4722	Homo sapiens	IC50		
	13343503	CHEMBL2396200	Inhibition of aurora A (unknown origin) after 1 hr by HTRF assay	B	Cc1ccc2[nH]c(-c3n[nH]cc3Nc3cc(Cl)nc(Sc4ccc(NC(=O)C5CC5)cc4)n3)nc2c1		CHEMBL2392107	=	IC50	nM	1134.0	CHEMBL4722	Homo sapiens	IC50	nM	1134.0
	13343504	CHEMBL2396200	Inhibition of aurora A (unknown origin) after 1 hr by HTRF assay	B	CSc1nc(Cl)cc(Nc2c[nH]nc2-c2nc3cc(C)ccc3[nH]2)n1		CHEMBL2392106	=	IC50	nM	321.3	CHEMBL4722	Homo sapiens	IC50	nM	321.3
	13343505	CHEMBL2396200	Inhibition of aurora A (unknown origin) after 1 hr by HTRF assay	B	Cc1ccc2[nH]c(-c3n[nH]cc3Nc3cc(Cl)nc(C)n3)nc2c1		CHEMBL2392105	=	IC50	nM	91.1	CHEMBL4722	Homo sapiens	IC50	nM	91.1
	13343506	CHEMBL2396200	Inhibition of aurora A (unknown origin) after 1 hr by HTRF assay	B	O=C(Nc1ccc(Sc2nc(Cl)cc(Nc3c[nH]nc3-c3nc4cc(CN5CCCCC5)ccc4[nH]3)n2)cc1)C1CC1		CHEMBL2392104	=	IC50	nM	124.9	CHEMBL4722	Homo sapiens	IC50	nM	124.9
	13343507	CHEMBL2396200	Inhibition of aurora A (unknown origin) after 1 hr by HTRF assay	B	O=C(Nc1ccc(Sc2nc(Cl)cc(Nc3c[nH]nc3-c3nc4cc(CN5CCOCC5)ccc4[nH]3)n2)cc1)C1CC1		CHEMBL2392103	=	IC50	nM	214.9	CHEMBL4722	Homo sapiens	IC50	nM	214.9
	13343508	CHEMBL2396200	Inhibition of aurora A (unknown origin) after 1 hr by HTRF assay	B	CSc1nc(Cl)cc(Nc2c[nH]nc2-c2nc3cc(CN4CCOCC4)ccc3[nH]2)n1		CHEMBL2392102	=	IC50	nM	71.9	CHEMBL4722	Homo sapiens	IC50	nM	71.9
	13343509	CHEMBL2396200	Inhibition of aurora A (unknown origin) after 1 hr by HTRF assay	B	Cc1nc(Cl)cc(Nc2c[nH]nc2-c2nc3cc(CN4CCOCC4)ccc3[nH]2)n1		CHEMBL2392101	=	IC50	nM	68.5	CHEMBL4722	Homo sapiens	IC50	nM	68.5
Active	13358544	CHEMBL2400275	Inhibition of Aurora kinase A in human HeLa cells assessed as delay in mitotic arrest by reformed nuclear envelope without cell division at 1 uM after 18 hrs by immunofluorescence staining based confocal microscopic analysis	B	CN(C)CCOc1ccc(-c2cc3c(NCCc4ccc(NC(=O)Nc5ccccc5)cc4)ncnc3o2)cc1		CHEMBL2398657		Activity			CHEMBL4722	Homo sapiens	Activity		
Active	13358545	CHEMBL2400276	Inhibition of Aurora kinase A in human HeLa cells assessed as delay in mitotic arrest by measuring flattened cells with decondensed chromosomes at 1 uM after 18 hrs by immunofluorescence staining based confocal microscopic analysis	B	CN(C)CCOc1ccc(-c2cc3c(NCCc4ccc(NC(=O)Nc5ccccc5)cc4)ncnc3o2)cc1		CHEMBL2398657		Activity			CHEMBL4722	Homo sapiens	Activity		
Active	13358546	CHEMBL2400277	Inhibition of Aurora kinase A in human HeLa cells assessed as mitotic arrest at >500 nM for 4 hrs by double thymidine block assay	B	CN(C)CCOc1ccc(-c2cc3c(NCCc4ccc(NC(=O)Nc5ccccc5)cc4)ncnc3o2)cc1		CHEMBL2398657		Activity			CHEMBL4722	Homo sapiens	Activity		
Not Active	13358547	CHEMBL2400278	Inhibition of Aurora kinase A phosphorylation at Thr288 in human HCT116 cells at 50 nM after 2 hrs by Western blotting analysis	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878		Inhibition	%		CHEMBL4722	Homo sapiens	INH		
Active	13358549	CHEMBL2400280	Inhibition of Aurora kinase A phosphorylation at Thr288 in human HCT116 cells at 4 to 1000 nM after 2 hrs by Western blotting analysis	B	CN(C)CCOc1ccc(-c2cc3c(NCCc4ccc(NC(=O)Nc5ccccc5)cc4)ncnc3o2)cc1		CHEMBL2398657		Inhibition	%		CHEMBL4722	Homo sapiens	INH		
Dose-dependent effect	13358550	CHEMBL2400281	Inhibition of Aurora kinase A phosphorylation at Thr288 in human HCT116 cells after 2 hrs by Western blotting analysis	B	CN(C)CCOc1ccc(-c2cc3c(NCCc4ccc(NC(=O)Nc5ccccc5)cc4)ncnc3o2)cc1		CHEMBL2398657		Inhibition	%		CHEMBL4722	Homo sapiens	INH		
	13358557	CHEMBL2400289	Inhibition of GST-tagged Aurora kinase A catalytic domain (123 to 401 amino acids) (unknown origin) expressed in sf9 cells using tetra(LRRWSLG) as substrate preincubated for 15 mins prior to substrate addition measured after 90 mins by luminescence assay	B	O=C(Nc1ccccc1)Nc1ccc(CCCNc2ncnc3oc(-c4ccccc4)c(-c4ccccc4)c23)cc1		CHEMBL2398648	>	IC50	nM	10000.0	CHEMBL4722	Homo sapiens	IC50	nM	10000.0
	13358558	CHEMBL2400289	Inhibition of GST-tagged Aurora kinase A catalytic domain (123 to 401 amino acids) (unknown origin) expressed in sf9 cells using tetra(LRRWSLG) as substrate preincubated for 15 mins prior to substrate addition measured after 90 mins by luminescence assay	B	O=C(Nc1ccccc1)Nc1cccc(CCNc2ncnc3oc(-c4ccccc4)c(-c4ccccc4)c23)c1		CHEMBL2398645	>	IC50	nM	10000.0	CHEMBL4722	Homo sapiens	IC50	nM	10000.0
	13358564	CHEMBL2400289	Inhibition of GST-tagged Aurora kinase A catalytic domain (123 to 401 amino acids) (unknown origin) expressed in sf9 cells using tetra(LRRWSLG) as substrate preincubated for 15 mins prior to substrate addition measured after 90 mins by luminescence assay	B	NC(=O)Nc1ccc(CCNc2ncnc3oc(-c4ccccc4)c(-c4ccccc4)c23)cc1		CHEMBL2398650	=	IC50	nM	929.0	CHEMBL4722	Homo sapiens	IC50	nM	929.0
	13358565	CHEMBL2400289	Inhibition of GST-tagged Aurora kinase A catalytic domain (123 to 401 amino acids) (unknown origin) expressed in sf9 cells using tetra(LRRWSLG) as substrate preincubated for 15 mins prior to substrate addition measured after 90 mins by luminescence assay	B	O=C(Nc1ccccc1)Nc1ccc(CNc2ncnc3oc(-c4ccccc4)c(-c4ccccc4)c23)cc1		CHEMBL2398647	=	IC50	nM	852.0	CHEMBL4722	Homo sapiens	IC50	nM	852.0
	13358569	CHEMBL2400289	Inhibition of GST-tagged Aurora kinase A catalytic domain (123 to 401 amino acids) (unknown origin) expressed in sf9 cells using tetra(LRRWSLG) as substrate preincubated for 15 mins prior to substrate addition measured after 90 mins by luminescence assay	B	COc1ccc(NC(=O)Nc2ccc(CCNc3ncnc4oc(-c5ccccc5)c(-c5ccccc5)c34)cc2)cc1		CHEMBL2398653	=	IC50	nM	367.0	CHEMBL4722	Homo sapiens	IC50	nM	367.0
	13358570	CHEMBL2400289	Inhibition of GST-tagged Aurora kinase A catalytic domain (123 to 401 amino acids) (unknown origin) expressed in sf9 cells using tetra(LRRWSLG) as substrate preincubated for 15 mins prior to substrate addition measured after 90 mins by luminescence assay	B	O=C(Nc1ccccc1)Nc1ccc(CCNc2ncnc3occ(-c4ccccc4)c23)cc1		CHEMBL2398656	=	IC50	nM	342.0	CHEMBL4722	Homo sapiens	IC50	nM	342.0
	13358572	CHEMBL2400292	Inhibition of Aurora kinase A (unknown origin)	B	OCCNc1ncnc2oc(-c3ccccc3)c(-c3ccccc3)c12		CHEMBL189434	=	IC50	nM	273.0	CHEMBL4722	Homo sapiens	IC50	nM	273.0
	13358576	CHEMBL2400289	Inhibition of GST-tagged Aurora kinase A catalytic domain (123 to 401 amino acids) (unknown origin) expressed in sf9 cells using tetra(LRRWSLG) as substrate preincubated for 15 mins prior to substrate addition measured after 90 mins by luminescence assay	B	CNC(=O)Nc1ccc(CCNc2ncnc3oc(-c4ccccc4)c(-c4ccccc4)c23)cc1		CHEMBL2398651	=	IC50	nM	203.0	CHEMBL4722	Homo sapiens	IC50	nM	203.0
	13358577	CHEMBL2400289	Inhibition of GST-tagged Aurora kinase A catalytic domain (123 to 401 amino acids) (unknown origin) expressed in sf9 cells using tetra(LRRWSLG) as substrate preincubated for 15 mins prior to substrate addition measured after 90 mins by luminescence assay	B	O=C(Nc1ccccc1)Nc1ccc(Nc2ncnc3oc(-c4ccccc4)c(-c4ccccc4)c23)cc1		CHEMBL2398646	=	IC50	nM	201.0	CHEMBL4722	Homo sapiens	IC50	nM	201.0
	13358578	CHEMBL2400292	Inhibition of Aurora kinase A (unknown origin)	B	O=C(Nc1ccccc1)Nc1ccc(CCNc2ncnc3oc(-c4ccc(OCCN5CCC(O)CC5)cc4)cc23)cc1		CHEMBL2398642	=	IC50	nM	41.0	CHEMBL4722	Homo sapiens	IC50	nM	41.0
	13358583	CHEMBL2400289	Inhibition of GST-tagged Aurora kinase A catalytic domain (123 to 401 amino acids) (unknown origin) expressed in sf9 cells using tetra(LRRWSLG) as substrate preincubated for 15 mins prior to substrate addition measured after 90 mins by luminescence assay	B	O=C(NCc1ccccc1)Nc1ccc(CCNc2ncnc3oc(-c4ccccc4)c(-c4ccccc4)c23)cc1		CHEMBL2398649	=	IC50	nM	160.0	CHEMBL4722	Homo sapiens	IC50	nM	160.0
	13358584	CHEMBL2400289	Inhibition of GST-tagged Aurora kinase A catalytic domain (123 to 401 amino acids) (unknown origin) expressed in sf9 cells using tetra(LRRWSLG) as substrate preincubated for 15 mins prior to substrate addition measured after 90 mins by luminescence assay	B	O=C(Nc1ccc(CCNc2ncnc3oc(-c4ccccc4)c(-c4ccccc4)c23)cc1)NC1CCCCC1		CHEMBL2398652	=	IC50	nM	141.0	CHEMBL4722	Homo sapiens	IC50	nM	141.0
	13358585	CHEMBL2400289	Inhibition of GST-tagged Aurora kinase A catalytic domain (123 to 401 amino acids) (unknown origin) expressed in sf9 cells using tetra(LRRWSLG) as substrate preincubated for 15 mins prior to substrate addition measured after 90 mins by luminescence assay	B	O=C(Nc1ccccc1)Nc1ccc(CCNc2ncnc3oc(-c4ccccc4)cc23)cc1		CHEMBL2398655	=	IC50	nM	140.0	CHEMBL4722	Homo sapiens	IC50	nM	140.0
	13358587	CHEMBL2400289	Inhibition of GST-tagged Aurora kinase A catalytic domain (123 to 401 amino acids) (unknown origin) expressed in sf9 cells using tetra(LRRWSLG) as substrate preincubated for 15 mins prior to substrate addition measured after 90 mins by luminescence assay	B	CCCCN(CCCC)CCOc1ccc(-c2cc3c(NCCc4ccc(NC(=O)Nc5ccccc5)cc4)ncnc3o2)cc1		CHEMBL2398659	=	IC50	nM	124.0	CHEMBL4722	Homo sapiens	IC50	nM	124.0
	13358588	CHEMBL2400289	Inhibition of GST-tagged Aurora kinase A catalytic domain (123 to 401 amino acids) (unknown origin) expressed in sf9 cells using tetra(LRRWSLG) as substrate preincubated for 15 mins prior to substrate addition measured after 90 mins by luminescence assay	B	O=C(Nc1ccc(F)cc1)Nc1ccc(CCNc2ncnc3oc(-c4ccccc4)c(-c4ccccc4)c23)cc1		CHEMBL2398654	=	IC50	nM	123.0	CHEMBL4722	Homo sapiens	IC50	nM	123.0
	13358591	CHEMBL2400289	Inhibition of GST-tagged Aurora kinase A catalytic domain (123 to 401 amino acids) (unknown origin) expressed in sf9 cells using tetra(LRRWSLG) as substrate preincubated for 15 mins prior to substrate addition measured after 90 mins by luminescence assay	B	O=C(Nc1ccccc1)Nc1ccc(CCNc2ncnc3oc(-c4ccc(OCCN5CCCC5)cc4)cc23)cc1		CHEMBL2398660	=	IC50	nM	107.0	CHEMBL4722	Homo sapiens	IC50	nM	107.0
	13358597	CHEMBL2400289	Inhibition of GST-tagged Aurora kinase A catalytic domain (123 to 401 amino acids) (unknown origin) expressed in sf9 cells using tetra(LRRWSLG) as substrate preincubated for 15 mins prior to substrate addition measured after 90 mins by luminescence assay	B	CCN(CCO)CCOc1ccc(-c2cc3c(NCCc4ccc(NC(=O)Nc5ccccc5)cc4)ncnc3o2)cc1		CHEMBL2398641	=	IC50	nM	99.0	CHEMBL4722	Homo sapiens	IC50	nM	99.0
	13358599	CHEMBL2400289	Inhibition of GST-tagged Aurora kinase A catalytic domain (123 to 401 amino acids) (unknown origin) expressed in sf9 cells using tetra(LRRWSLG) as substrate preincubated for 15 mins prior to substrate addition measured after 90 mins by luminescence assay	B	CN(C)CCOc1cccc(-c2cc3c(NCCc4ccc(NC(=O)Nc5ccccc5)cc4)ncnc3o2)c1		CHEMBL2398644	=	IC50	nM	80.0	CHEMBL4722	Homo sapiens	IC50	nM	80.0
	13359779	CHEMBL2400289	Inhibition of GST-tagged Aurora kinase A catalytic domain (123 to 401 amino acids) (unknown origin) expressed in sf9 cells using tetra(LRRWSLG) as substrate preincubated for 15 mins prior to substrate addition measured after 90 mins by luminescence assay	B	CN(C)CCCOc1ccc(-c2cc3c(NCCc4ccc(NC(=O)Nc5ccccc5)cc4)ncnc3o2)cc1		CHEMBL2398643	=	IC50	nM	61.0	CHEMBL4722	Homo sapiens	IC50	nM	61.0
	13359790	CHEMBL2400111	Inhibition of Aurora kinase A (unknown origin) at 1 uM relative to control	B	CN(C)CCOc1ccc(-c2cc3c(NCCc4ccc(NC(=O)Nc5ccccc5)cc4)ncnc3o2)cc1		CHEMBL2398657	>	Inhibition	%	50.0	CHEMBL4722	Homo sapiens	INH	%	50.0
	13359791	CHEMBL2400288	Inhibition of GST-tagged Aurora kinase A catalytic domain (123 to 401 amino acids) (unknown origin) expressed in sf9 cells using tetra(LRRWSLG) as substrate at 10 uM preincubated for 15 mins prior to substrate addition measured after 90 mins by luminescence assay relative to control	B	O=C(Nc1ccccc1)Nc1ccc(CCCNc2ncnc3oc(-c4ccccc4)c(-c4ccccc4)c23)cc1		CHEMBL2398648	<	Inhibition	%	50.0	CHEMBL4722	Homo sapiens	INH	%	50.0
	13359792	CHEMBL2400288	Inhibition of GST-tagged Aurora kinase A catalytic domain (123 to 401 amino acids) (unknown origin) expressed in sf9 cells using tetra(LRRWSLG) as substrate at 10 uM preincubated for 15 mins prior to substrate addition measured after 90 mins by luminescence assay relative to control	B	O=C(Nc1ccccc1)Nc1cccc(CCNc2ncnc3oc(-c4ccccc4)c(-c4ccccc4)c23)c1		CHEMBL2398645	<	Inhibition	%	50.0	CHEMBL4722	Homo sapiens	INH	%	50.0
	13359793	CHEMBL2400289	Inhibition of GST-tagged Aurora kinase A catalytic domain (123 to 401 amino acids) (unknown origin) expressed in sf9 cells using tetra(LRRWSLG) as substrate preincubated for 15 mins prior to substrate addition measured after 90 mins by luminescence assay	B	O=C(Nc1ccccc1)Nc1ccc(CCNc2ncnc3oc(-c4ccc(OCCN5CCOCC5)cc4)cc23)cc1		CHEMBL2398640	=	IC50	nM	50.0	CHEMBL4722	Homo sapiens	IC50	nM	50.0
	13359794	CHEMBL2400289	Inhibition of GST-tagged Aurora kinase A catalytic domain (123 to 401 amino acids) (unknown origin) expressed in sf9 cells using tetra(LRRWSLG) as substrate preincubated for 15 mins prior to substrate addition measured after 90 mins by luminescence assay	B	CN1CCN(CCOc2ccc(-c3cc4c(NCCc5ccc(NC(=O)Nc6ccccc6)cc5)ncnc4o3)cc2)CC1		CHEMBL2398639	=	IC50	nM	49.0	CHEMBL4722	Homo sapiens	IC50	nM	49.0
	13359795	CHEMBL2400289	Inhibition of GST-tagged Aurora kinase A catalytic domain (123 to 401 amino acids) (unknown origin) expressed in sf9 cells using tetra(LRRWSLG) as substrate preincubated for 15 mins prior to substrate addition measured after 90 mins by luminescence assay	B	O=C(Nc1ccccc1)Nc1ccc(CCNc2ncnc3oc(-c4ccc(OCCN5CCCCC5)cc4)cc23)cc1		CHEMBL2398638	=	IC50	nM	49.0	CHEMBL4722	Homo sapiens	IC50	nM	49.0
	13359802	CHEMBL2400292	Inhibition of Aurora kinase A (unknown origin)	B	CN(C)CCOc1ccc(-c2cc3c(NCCc4ccc(NC(=O)Nc5ccccc5)cc4)ncnc3o2)cc1		CHEMBL2398657	=	IC50	nM	24.0	CHEMBL4722	Homo sapiens	IC50	nM	24.0
	13359803	CHEMBL2400289	Inhibition of GST-tagged Aurora kinase A catalytic domain (123 to 401 amino acids) (unknown origin) expressed in sf9 cells using tetra(LRRWSLG) as substrate preincubated for 15 mins prior to substrate addition measured after 90 mins by luminescence assay	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	IC50	nM	20.0	CHEMBL4722	Homo sapiens	IC50	nM	20.0
	13359804	CHEMBL2400292	Inhibition of Aurora kinase A (unknown origin)	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	IC50	nM	20.0	CHEMBL4722	Homo sapiens	IC50	nM	20.0
	13359805	CHEMBL2400289	Inhibition of GST-tagged Aurora kinase A catalytic domain (123 to 401 amino acids) (unknown origin) expressed in sf9 cells using tetra(LRRWSLG) as substrate preincubated for 15 mins prior to substrate addition measured after 90 mins by luminescence assay	B	CCN(CC)CCOc1ccc(-c2cc3c(NCCc4ccc(NC(=O)Nc5ccccc5)cc4)ncnc3o2)cc1		CHEMBL2398658	=	IC50	nM	18.0	CHEMBL4722	Homo sapiens	IC50	nM	18.0
	13360656	CHEMBL2400322	Inhibition of human aurora-A	B	COc1ccc2c(c1)C=C(C(=O)/C=C/c1c(OC)cc(OC)cc1OC)CO2		CHEMBL2396883	=	Inhibition	%	69.0	CHEMBL4722	Homo sapiens	INH	%	69.0
	13371345	CHEMBL2403991	Inhibition of Aurora A kinase (unknown origin) by Z'-LYTE kinase assay	B	c1ccc(-c2csc3ncnc(N4CCc5ccccc5C4)c23)cc1		CHEMBL1483261	=	IC50	nM	5.559	CHEMBL4722	Homo sapiens	IC50	nM	5.559
	13371360	CHEMBL2404113	Inhibition of Aurora A kinase (unknown origin) at 10 uM by Z'-LYTE kinase assay	B	c1ccc(-c2csc3ncnc(N4CCc5ccccc5C4)c23)cc1		CHEMBL1483261	=	Inhibition	%	65.29	CHEMBL4722	Homo sapiens	INH	%	65.29
	13375944	CHEMBL2406106	Inhibition of AURKA (unknown origin) at 10 uM relative to control	B	CC[C@@H]1C(=O)N(C)c2cnc(-n3ccnc3-c3ccc(F)cc3)nc2N1c1ccn(C)n1		CHEMBL2402081	=	Inhibition	%	3.0	CHEMBL4722	Homo sapiens	INH	%	3.0
Active	13376811	CHEMBL2404397	Inhibition of Aurora A kinase (unknown origin) at 0.5 uM	B	COc1cc(Nc2ncc(Br)c(-c3cccc(CC#N)c3)n2)ccc1N1CCN(C)[C@@H](C)C1		CHEMBL2403079		Inhibition	%		CHEMBL4722	Homo sapiens	INH		
	13389887	CHEMBL2410835	Inhibition of aurora A (unknown origin) in presence of [gamma-33P]-ATP	B	Cc1cc(C(=O)Nc2cc(Oc3ccc4nc(NC(=O)C5CC5)nn4c3)ccc2F)n(C)n1		CHEMBL2409778	=	IC50	nM	2900.0	CHEMBL4722	Homo sapiens	IC50	nM	2900.0
	13389888	CHEMBL2410835	Inhibition of aurora A (unknown origin) in presence of [gamma-33P]-ATP	B	Cc1cc(C(=O)Nc2cc(Oc3ccc4nc(NC(=O)C5CC5)nn4c3)ccc2F)n(C)n1		CHEMBL2409778	>	IC50	nM	10000.0	CHEMBL4722	Homo sapiens	IC50	nM	10000.0
	13389941	CHEMBL2410835	Inhibition of aurora A (unknown origin) in presence of [gamma-33P]-ATP	B	Cc1cc(C(=O)Nc2cccc(Oc3ccc4nc(NC(=O)C5CC5)sc4c3)c2)n(C)n1		CHEMBL2409790	=	IC50	nM	680.0	CHEMBL4722	Homo sapiens	IC50	nM	680.0
	13389942	CHEMBL2410835	Inhibition of aurora A (unknown origin) in presence of [gamma-33P]-ATP	B	Cc1cc(C(=O)Nc2cccc(Oc3ccc4nc(NC(=O)C5CC5)sc4n3)c2)n(C)n1		CHEMBL2409781	>	IC50	nM	1000.0	CHEMBL4722	Homo sapiens	IC50	nM	1000.0
	13389943	CHEMBL2410835	Inhibition of aurora A (unknown origin) in presence of [gamma-33P]-ATP	B	Cc1cc(C(=O)Nc2cccc(Oc3ccc4nc(NC(=O)C5CC5)cn4c3)c2)n(C)n1		CHEMBL2409779	=	IC50	nM	170.0	CHEMBL4722	Homo sapiens	IC50	nM	170.0
	13389944	CHEMBL2410835	Inhibition of aurora A (unknown origin) in presence of [gamma-33P]-ATP	B	Cc1cc(C(=O)Nc2cccc(Oc3ccc4nc(NC(=O)C5CC5)nn4c3)c2)n(C)n1		CHEMBL2409775	=	IC50	nM	120.0	CHEMBL4722	Homo sapiens	IC50	nM	120.0
	13389945	CHEMBL2410835	Inhibition of aurora A (unknown origin) in presence of [gamma-33P]-ATP	B	Cc1cc(C(=O)Nc2cccc(Oc3ccc4nc(NC(=O)C5CC5)cn4n3)c2)n(C)n1		CHEMBL2348996	=	IC50	nM	360.0	CHEMBL4722	Homo sapiens	IC50	nM	360.0
	13395048	CHEMBL2410115	Inhibition of aurora A (unknown origin) by FRET-based homogeneous assay	B	COc1ccc2c(c1)/C(=C\c1ccc3c(/C=C/c4ccc(N5CCN(C)CC5)nc4)n[nH]c3c1)C(=O)N2		CHEMBL2407900	=	IC50	nM	370.0	CHEMBL4722	Homo sapiens	IC50	uM	0.37
	13418826	CHEMBL2422661	Inhibition of AURKA (unknown origin)	B	COc1cc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2OC)=NC3)ccc1C(=O)O		CHEMBL483158	=	IC50	nM	100.0	CHEMBL4722	Homo sapiens	pIC50		7.0
	13418827	CHEMBL2422661	Inhibition of AURKA (unknown origin)	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	IC50	nM	31.62	CHEMBL4722	Homo sapiens	pIC50		7.5
	13419551	CHEMBL2424125	Inhibition of AURA (unknown origin) by microfluidic mobility shift assay	B	O=C(O)C1CCC2(CCN(c3ncnc4[nH]cnc34)CC2)NC1		CHEMBL2420904	=	IC50	nM	6100.0	CHEMBL4722	Homo sapiens	IC50	uM	6.1
	13420991	CHEMBL2424125	Inhibition of AURA (unknown origin) by microfluidic mobility shift assay	B	c1nc(N2CCC3(CCCNC3)CC2)c2nc[nH]c2n1		CHEMBL2420911	=	IC50	nM	9800.0	CHEMBL4722	Homo sapiens	IC50	uM	9.8
	13420992	CHEMBL2424125	Inhibition of AURA (unknown origin) by microfluidic mobility shift assay	B	c1nc(N2CCC3(CCCCN3)CC2)c2nc[nH]c2n1		CHEMBL2420909	=	IC50	nM	7800.0	CHEMBL4722	Homo sapiens	IC50	uM	7.8
	13421013	CHEMBL2424133	Inhibition of AURA (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	O=S(=O)(NCCNC/C=C/c1ccc(Br)cc1)c1cccc2cnccc12		CHEMBL104264	=	Inhibition	%	75.0	CHEMBL4722	Homo sapiens	INH	%	75.0
	13421014	CHEMBL2424133	Inhibition of AURA (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	O=C(C1CCC2(CCN(c3ncnc4[nH]cnc34)CC2)NC1)N1CCOCC1		CHEMBL2420907	=	Inhibition	%	72.0	CHEMBL4722	Homo sapiens	INH	%	72.0
	13421015	CHEMBL2424133	Inhibition of AURA (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	CN(C)C(=O)C1CCC2(CCN(c3ncnc4[nH]cnc34)CC2)NC1		CHEMBL2420906	=	Inhibition	%	69.0	CHEMBL4722	Homo sapiens	INH	%	69.0
	13421016	CHEMBL2424133	Inhibition of AURA (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	CNC(=O)C1CCC2(CCN(c3ncnc4[nH]cnc34)CC2)NC1		CHEMBL2420905	=	Inhibition	%	74.0	CHEMBL4722	Homo sapiens	INH	%	74.0
	13421017	CHEMBL2424133	Inhibition of AURA (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	OCC1CCC2(CCN(c3ncnc4[nH]cnc34)CC2)NC1		CHEMBL2417586	=	Inhibition	%	84.0	CHEMBL4722	Homo sapiens	INH	%	84.0
	13421018	CHEMBL2424133	Inhibition of AURA (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	O=C(O)C1CCC2(CCN(c3ncnc4[nH]cnc34)CC2)NC1		CHEMBL2420904	=	Inhibition	%	95.0	CHEMBL4722	Homo sapiens	INH	%	95.0
	13421019	CHEMBL2424133	Inhibition of AURA (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	COC(=O)C1CCC2(CCN(c3ncnc4[nH]cnc34)CC2)NC1		CHEMBL2420903	=	Inhibition	%	64.0	CHEMBL4722	Homo sapiens	INH	%	64.0
	13421020	CHEMBL2424133	Inhibition of AURA (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	c1ccc(C2CCC3(CCN(c4ncnc5[nH]cnc45)CC3)NC2)cc1		CHEMBL2420902	=	Inhibition	%	90.0	CHEMBL4722	Homo sapiens	INH	%	90.0
	13421021	CHEMBL2424133	Inhibition of AURA (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	c1ccc(CC2CCC3(CCN(c4ncnc5[nH]cnc45)CC3)NC2)cc1		CHEMBL2420901	=	Inhibition	%	89.0	CHEMBL4722	Homo sapiens	INH	%	89.0
	13421022	CHEMBL2424133	Inhibition of AURA (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	c1ccc(CC2CCNC3(CCN(c4ncnc5[nH]cnc45)CC3)C2)cc1		CHEMBL2420900	=	Inhibition	%	64.0	CHEMBL4722	Homo sapiens	INH	%	64.0
	13421023	CHEMBL2424133	Inhibition of AURA (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	c1ccc(C2CCNC3(CCN(c4ncnc5[nH]cnc45)CC3)C2)cc1		CHEMBL2420899	=	Inhibition	%	76.0	CHEMBL4722	Homo sapiens	INH	%	76.0
	13421024	CHEMBL2424133	Inhibition of AURA (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	O=S(=O)(c1cccc2cnccc12)N1CCC2(CC1)CC(O)CCN2		CHEMBL2420898	=	Inhibition	%	39.0	CHEMBL4722	Homo sapiens	INH	%	39.0
	13421025	CHEMBL2424133	Inhibition of AURA (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	OC1CCNC2(CCN(c3ncnc4[nH]cnc34)CC2)C1		CHEMBL2420897	=	Inhibition	%	63.0	CHEMBL4722	Homo sapiens	INH	%	63.0
	13421026	CHEMBL2424133	Inhibition of AURA (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	O=S(=O)(c1cccc2cnccc12)N1CCC2(CCC(O)CN2)CC1		CHEMBL2420928	=	Inhibition	%	87.0	CHEMBL4722	Homo sapiens	INH	%	87.0
	13421027	CHEMBL2424133	Inhibition of AURA (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	OC1CCC2(CCN(c3ncnc4[nH]cnc34)CC2)NC1		CHEMBL2420927	=	Inhibition	%	80.0	CHEMBL4722	Homo sapiens	INH	%	80.0
	13421028	CHEMBL2424133	Inhibition of AURA (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	c1nc(N2CCC3(CCCOC3)CC2)c2nc[nH]c2n1		CHEMBL2420926	=	Inhibition	%	67.0	CHEMBL4722	Homo sapiens	INH	%	67.0
	13421029	CHEMBL2424133	Inhibition of AURA (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	c1nc(N2CCC3(CCCCO3)CC2)c2nc[nH]c2n1		CHEMBL2420925	=	Inhibition	%	92.0	CHEMBL4722	Homo sapiens	INH	%	92.0
	13421030	CHEMBL2424133	Inhibition of AURA (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	c1nc(N2CCC3(CCCCC3)CC2)c2nc[nH]c2n1		CHEMBL2420924	=	Inhibition	%	71.0	CHEMBL4722	Homo sapiens	INH	%	71.0
	13421031	CHEMBL2424133	Inhibition of AURA (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	O=S(=O)(c1cccc2cnccc12)N1CCCC12CCNCC2		CHEMBL2420923	=	Inhibition	%	27.0	CHEMBL4722	Homo sapiens	INH	%	27.0
	13421032	CHEMBL2424133	Inhibition of AURA (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	O=S(=O)(c1cccc2cnccc12)N1CCCC2(CCCNC2)C1		CHEMBL2420922	=	Inhibition	%	37.0	CHEMBL4722	Homo sapiens	INH	%	37.0
	13421033	CHEMBL2424133	Inhibition of AURA (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	O=S(=O)(c1cccc2cnccc12)N1CCCC2(CCNCC2)C1		CHEMBL2420921	=	Inhibition	%	36.0	CHEMBL4722	Homo sapiens	INH	%	36.0
	13421034	CHEMBL2424133	Inhibition of AURA (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	O=S(=O)(c1cccc2cnccc12)N1CCC2(CCNC2)CC1		CHEMBL2420920	=	Inhibition	%	51.0	CHEMBL4722	Homo sapiens	INH	%	51.0
	13421035	CHEMBL2424133	Inhibition of AURA (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	O=S(=O)(c1cccc2cnccc12)N1CCC2(CCCNC2)CC1		CHEMBL2420919	=	Inhibition	%	24.0	CHEMBL4722	Homo sapiens	INH	%	24.0
	13421036	CHEMBL2424133	Inhibition of AURA (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	O=S(=O)(c1cccc2cnccc12)N1CCC2(CCCN2)CC1		CHEMBL2420918	=	Inhibition	%	43.0	CHEMBL4722	Homo sapiens	INH	%	43.0
	13421037	CHEMBL2424133	Inhibition of AURA (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	O=S(=O)(c1cccc2cnccc12)N1CCC2(CCCCN2)CC1		CHEMBL2420917	=	Inhibition	%	71.0	CHEMBL4722	Homo sapiens	INH	%	71.0
	13421038	CHEMBL2424133	Inhibition of AURA (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	NC1(Cc2ccccc2)CCN(S(=O)(=O)c2cccc3cnccc23)CC1		CHEMBL2420916	=	Inhibition	%	43.0	CHEMBL4722	Homo sapiens	INH	%	43.0
	13421039	CHEMBL2424133	Inhibition of AURA (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	c1nc(N2CCCC23CCNCC3)c2nc[nH]c2n1		CHEMBL2420915	=	Inhibition	%	18.0	CHEMBL4722	Homo sapiens	INH	%	18.0
	13421040	CHEMBL2424133	Inhibition of AURA (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	c1nc(N2CCCC3(CCCNC3)C2)c2nc[nH]c2n1		CHEMBL2420914	=	Inhibition	%	34.0	CHEMBL4722	Homo sapiens	INH	%	34.0
	13421041	CHEMBL2424133	Inhibition of AURA (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	c1nc(N2CCCC3(CCNCC3)C2)c2nc[nH]c2n1		CHEMBL2420913	=	Inhibition	%	70.0	CHEMBL4722	Homo sapiens	INH	%	70.0
	13421042	CHEMBL2424133	Inhibition of AURA (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	c1nc(N2CCC3(CCNC3)CC2)c2nc[nH]c2n1		CHEMBL2420912	=	Inhibition	%	59.0	CHEMBL4722	Homo sapiens	INH	%	59.0
	13421043	CHEMBL2424133	Inhibition of AURA (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	c1nc(N2CCC3(CCCNC3)CC2)c2nc[nH]c2n1		CHEMBL2420911	=	Inhibition	%	67.0	CHEMBL4722	Homo sapiens	INH	%	67.0
	13421044	CHEMBL2424133	Inhibition of AURA (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	c1nc(N2CCC3(CCCN3)CC2)c2nc[nH]c2n1		CHEMBL2420910	=	Inhibition	%	55.0	CHEMBL4722	Homo sapiens	INH	%	55.0
	13421045	CHEMBL2424133	Inhibition of AURA (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	c1nc(N2CCC3(CCCCN3)CC2)c2nc[nH]c2n1		CHEMBL2420909	=	Inhibition	%	81.0	CHEMBL4722	Homo sapiens	INH	%	81.0
	13421046	CHEMBL2424133	Inhibition of AURA (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control	B	NC1(Cc2ccccc2)CCN(c2ncnc3[nH]cnc23)CC1		CHEMBL2420908	=	Inhibition	%	96.0	CHEMBL4722	Homo sapiens	INH	%	96.0
	13437620	CHEMBL2423633	Inhibition of aurora A kinase (unknown origin) at 100 nM	B	Cc1nn(Cc2cc(F)cc(F)c2)c(C)c1-c1c[nH]c2ncc(-c3cnn(C)c3)cc12	Outside typical range	CHEMBL2418749	=	Inhibition	%	768.3	CHEMBL4722	Homo sapiens	INH	%	768.3
	13437621	CHEMBL2423633	Inhibition of aurora A kinase (unknown origin) at 100 nM	B	Cc1nn(Cc2cc(F)ccc2F)c(C)c1-c1c[nH]c2ncc(-c3cnn(C)c3)cc12	Outside typical range	CHEMBL2418748	=	Inhibition	%	216.2	CHEMBL4722	Homo sapiens	INH	%	216.2
	13437622	CHEMBL2423633	Inhibition of aurora A kinase (unknown origin) at 100 nM	B	Cc1nn(Cc2cccc(F)c2)c(C)c1-c1c[nH]c2ncc(-c3cnn(C)c3)cc12	Outside typical range	CHEMBL2418747	=	Inhibition	%	355.9	CHEMBL4722	Homo sapiens	INH	%	355.9
	13437623	CHEMBL2423633	Inhibition of aurora A kinase (unknown origin) at 100 nM	B	Cc1nn(Cc2cccc(F)c2)cc1-c1c[nH]c2ncc(-c3cnn(C)c3)cc12		CHEMBL2418746	=	Inhibition	%	37.13	CHEMBL4722	Homo sapiens	INH	%	37.13
	13437624	CHEMBL2423633	Inhibition of aurora A kinase (unknown origin) at 100 nM	B	Cn1cc(-c2cnc3[nH]cc(-c4cnn(Cc5cc(F)cc(F)c5)c4)c3c2)cn1		CHEMBL2418763	=	Inhibition	%	74.0	CHEMBL4722	Homo sapiens	INH	%	74.0
	13437625	CHEMBL2423633	Inhibition of aurora A kinase (unknown origin) at 100 nM	B	Cn1cc(-c2cnc3[nH]cc(-c4cnn(Cc5ccc(F)c(F)c5)c4)c3c2)cn1		CHEMBL2418762	=	Inhibition	%	84.0	CHEMBL4722	Homo sapiens	INH	%	84.0
	13437626	CHEMBL2423633	Inhibition of aurora A kinase (unknown origin) at 100 nM	B	Cn1cc(-c2cnc3[nH]cc(-c4cnn(Cc5cc(F)ccc5F)c4)c3c2)cn1		CHEMBL2418761	=	Inhibition	%	75.0	CHEMBL4722	Homo sapiens	INH	%	75.0
	13437627	CHEMBL2423633	Inhibition of aurora A kinase (unknown origin) at 100 nM	B	Cn1cc(-c2cnc3[nH]cc(-c4cnn(Cc5cccc(O)c5)c4)c3c2)cn1		CHEMBL2418760	=	Inhibition	%	93.0	CHEMBL4722	Homo sapiens	INH	%	93.0
Not Determined	13437628	CHEMBL2423633	Inhibition of aurora A kinase (unknown origin) at 100 nM	B	Cn1cc(-c2cnc3[nH]cc(-c4cnn(Cc5cccc(N)c5)c4)c3c2)cn1		CHEMBL2418759		Inhibition	%		CHEMBL4722	Homo sapiens	INH		
Not Determined	13437629	CHEMBL2423633	Inhibition of aurora A kinase (unknown origin) at 100 nM	B	Cn1cc(-c2cnc3[nH]cc(-c4cnn(Cc5cccc([N+](=O)[O-])c5)c4)c3c2)cn1		CHEMBL2418758		Inhibition	%		CHEMBL4722	Homo sapiens	INH		
Not Determined	13437630	CHEMBL2423633	Inhibition of aurora A kinase (unknown origin) at 100 nM	B	Cn1cc(-c2cnc3[nH]cc(-c4cnn(Cc5cccc(C(=O)O)c5)c4)c3c2)cn1		CHEMBL2418757		Inhibition	%		CHEMBL4722	Homo sapiens	INH		
	13437631	CHEMBL2423633	Inhibition of aurora A kinase (unknown origin) at 100 nM	B	Cn1cc(-c2cnc3[nH]cc(-c4cnn(Cc5cccc(C(F)(F)F)c5)c4)c3c2)cn1		CHEMBL2418756	=	Inhibition	%	84.0	CHEMBL4722	Homo sapiens	INH	%	84.0
	13437632	CHEMBL2423633	Inhibition of aurora A kinase (unknown origin) at 100 nM	B	Cn1cc(-c2cnc3[nH]cc(-c4cnn(Cc5cccc(C#N)c5)c4)c3c2)cn1		CHEMBL2418755	=	Inhibition	%	85.0	CHEMBL4722	Homo sapiens	INH	%	85.0
	13437633	CHEMBL2423633	Inhibition of aurora A kinase (unknown origin) at 100 nM	B	Cn1cc(-c2cnc3[nH]cc(-c4cnn(Cc5cccc(Cl)c5)c4)c3c2)cn1		CHEMBL2418754	=	Inhibition	%	87.0	CHEMBL4722	Homo sapiens	INH	%	87.0
	13437634	CHEMBL2423633	Inhibition of aurora A kinase (unknown origin) at 100 nM	B	Cn1cc(-c2cnc3[nH]cc(-c4cnn(Cc5ccc(F)cc5)c4)c3c2)cn1		CHEMBL2418753	=	Inhibition	%	74.0	CHEMBL4722	Homo sapiens	INH	%	74.0
	13437635	CHEMBL2423633	Inhibition of aurora A kinase (unknown origin) at 100 nM	B	Cn1cc(-c2cnc3[nH]cc(-c4cnn(Cc5cccc(F)c5)c4)c3c2)cn1		CHEMBL2418752	=	Inhibition	%	84.0	CHEMBL4722	Homo sapiens	INH	%	84.0
	13437636	CHEMBL2423633	Inhibition of aurora A kinase (unknown origin) at 100 nM	B	Cn1cc(-c2cnc3[nH]cc(-c4cnn(Cc5ccccc5F)c4)c3c2)cn1		CHEMBL2418751	=	Inhibition	%	64.0	CHEMBL4722	Homo sapiens	INH	%	64.0
	13437637	CHEMBL2423633	Inhibition of aurora A kinase (unknown origin) at 100 nM	B	Cn1cc(-c2cnc3[nH]cc(-c4cnn(Cc5ccccc5)c4)c3c2)cn1		CHEMBL2418750	=	Inhibition	%	84.0	CHEMBL4722	Homo sapiens	INH	%	84.0
	13442404	CHEMBL2428026	Competitive binding affinity to AURKA (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3ccc4ccccc43)n2)CC1		CHEMBL2425646	<	Inhibition	%	50.0	CHEMBL4722	Homo sapiens	INH	%	50.0
	13445539	CHEMBL2428026	Competitive binding affinity to AURKA (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-c3n[nH]c4ccccc34)n2)CC1		CHEMBL2425644	=	Inhibition	%	92.0	CHEMBL4722	Homo sapiens	INH	%	92.0
	13448594	CHEMBL2428026	Competitive binding affinity to AURKA (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3ncc4ccccc43)n2)CC1		CHEMBL2425645	<	Inhibition	%	50.0	CHEMBL4722	Homo sapiens	INH	%	50.0
	13448730	CHEMBL2428026	Competitive binding affinity to AURKA (unknown origin) at 10 uM in presence of ATP relative to control	B	O=C([C@H]1CC[C@H](Nc2nccc(-n3nnc4ccccc43)n2)CC1)N1CCOCC1		CHEMBL2425649	=	Inhibition	%	80.0	CHEMBL4722	Homo sapiens	INH	%	80.0
	13451525	CHEMBL2428026	Competitive binding affinity to AURKA (unknown origin) at 10 uM in presence of ATP relative to control	B	N[C@H]1CC[C@H](Nc2nccc(-n3nnc4ccccc43)n2)CC1		CHEMBL2425652	<	Inhibition	%	50.0	CHEMBL4722	Homo sapiens	INH	%	50.0
	13454710	CHEMBL2428026	Competitive binding affinity to AURKA (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3nnc4ccccc43)n2)CC1		CHEMBL2425654	<	Inhibition	%	50.0	CHEMBL4722	Homo sapiens	INH	%	50.0
	13476373	CHEMBL2439771	Inhibition of wild type human Aurora kinase A by high throughput ATP-[33P] radiolabeled assay	B	CN1CCN(Cc2ccc(-c3cnc4[nH]cc(-c5ccc6[nH]ccc6c5)c4c3)cc2)CC1		CHEMBL2436978	=	IC50	nM	108.0	CHEMBL4722	Homo sapiens	IC50	nM	108.0
	13476378	CHEMBL2438994	Inhibition of human wild type Aurora kinase A at 1 uM by qPCR analysis relative to control	B	CCSCc1ccc2c(c1)c1c3c(c4c5cc(CSCC)ccc5n5c4c1n2[C@H]1C[C@](O)(C(=O)OC)[C@]5(C)O1)CNC3=O		CHEMBL290352	>	Inhibition	%	99.0	CHEMBL4722	Homo sapiens	INH	%	99.0
	13502859	CHEMBL2446253	Inhibition of human aurora-A kinase	B	COc1ccc(C2CC(c3c(O)ccc4ccccc34)=NN2)c(OC)c1	Non standard unit for type	CHEMBL2442816	=	INH	uM	69.9	CHEMBL4722	Homo sapiens	INH	uM	69.9
	13503626	CHEMBL2447749	Inhibition of Aurora kinase A (unknown origin) assessed as residual activity at 10 uM relative to control	B	COc1cc(-c2cc(=O)c3cc(Br)cc(Br)c3o2)ccc1O		CHEMBL2442531	=	Activity	%	55.0	CHEMBL4722	Homo sapiens	Activity	%	55.0
	13503627	CHEMBL2447749	Inhibition of Aurora kinase A (unknown origin) assessed as residual activity at 10 uM relative to control	B	COc1cc(-c2cc(=O)c3cc(Br)cc(Br)c3o2)cc(Cl)c1O		CHEMBL2442530	=	Activity	%	19.0	CHEMBL4722	Homo sapiens	Activity	%	19.0
	13503628	CHEMBL2447749	Inhibition of Aurora kinase A (unknown origin) assessed as residual activity at 10 uM relative to control	B	COc1cc(-c2cc(=O)c3cc(Cl)cc(C)c3o2)ccc1O		CHEMBL2442529	=	Activity	%	57.0	CHEMBL4722	Homo sapiens	Activity	%	57.0
	13503629	CHEMBL2447749	Inhibition of Aurora kinase A (unknown origin) assessed as residual activity at 10 uM relative to control	B	COc1cc(-c2cc(=O)c3cc(Cl)cc(Cl)c3o2)ccc1O		CHEMBL2442424	=	Activity	%	54.0	CHEMBL4722	Homo sapiens	Activity	%	54.0
	13507647	CHEMBL2444016	Inhibition of Aurora kinase-2 (unknown origin)	B	CN(C)c1ccc(Oc2cc(O)cc(O)c2-c2cc(C(=O)NC3CCN(C4CCC5(CC4)OCCO5)CC3)no2)cc1		CHEMBL2443026	>	IC50	nM	10.0	CHEMBL4722	Homo sapiens	IC50	nM	10.0
	13507648	CHEMBL2444016	Inhibition of Aurora kinase-2 (unknown origin)	B	CC(C)Nc1ccc(Oc2cc(O)cc(O)c2-c2cc(C(=O)NC3CCN(C)CC3)no2)cc1		CHEMBL2443139	>	IC50	nM	10.0	CHEMBL4722	Homo sapiens	IC50	nM	10.0
	13507649	CHEMBL2444016	Inhibition of Aurora kinase-2 (unknown origin)	B	CN1CCC(NC(=O)c2cc(-c3c(O)cc(O)cc3Oc3ccc(N(C)C)cc3)on2)CC1		CHEMBL2443138	>	IC50	nM	10.0	CHEMBL4722	Homo sapiens	IC50	nM	10.0
	13507650	CHEMBL2444016	Inhibition of Aurora kinase-2 (unknown origin)	B	CN1CCC(NC(=O)c2cc(-c3c(O)cc(O)cc3Oc3ccc([N+](=O)[O-])cc3)on2)CC1		CHEMBL2443044	>	IC50	nM	10.0	CHEMBL4722	Homo sapiens	IC50	nM	10.0
Not Active	13825957	CHEMBL3088422	Activity at Aurora kinase A (unknown origin)	B	c1ccc2[nH]c(Nc3ccc(Oc4nccnc4N4CCOCC4)cc3)nc2c1		CHEMBL2180803		Activity			CHEMBL4722	Homo sapiens	Activity		
Active	13826014	CHEMBL3088422	Activity at Aurora kinase A (unknown origin)	B	CNc1cc(-c2cccnc2Oc2ccc(Nc3nc4ccc(F)c(F)c4[nH]3)cc2)ccn1		CHEMBL3086086		Activity			CHEMBL4722	Homo sapiens	Activity		
Active	13835417	CHEMBL3090486	Inhibition of autophosphorylation of N-terminal Myc tagged aurora-A at T288 in human HCT116 cells at 1.5 uM after 2 hrs	B	Cc1nn(C)cc1-c1nc2c(Oc3ccc(C(=O)NC4CCC4)cc3)c(Cl)cnc2[nH]1		CHEMBL3087823		Inhibition	%		CHEMBL4722	Homo sapiens	INH		
	13835421	CHEMBL3090489	Inhibition of autophosphorylation of aurora-A R220K mutant at T288 in human HCT116 cells after 2 hrs	B	Cc1nn(C)cc1-c1nc2c(Oc3ccc(C(=O)NC4CCC4)cc3)c(Cl)cnc2[nH]1		CHEMBL3087823	=	IC50	nM	42.0	CHEMBL4722	Homo sapiens	IC50	uM	0.042
	13835422	CHEMBL3090489	Inhibition of autophosphorylation of aurora-A R220K mutant at T288 in human HCT116 cells after 2 hrs	B	Cc1nn(C)cc1-c1nc2c(Oc3ccc(C(=O)Nc4ccccc4)cc3)c(Cl)cnc2[nH]1		CHEMBL3087784	=	IC50	nM	27.0	CHEMBL4722	Homo sapiens	IC50	uM	0.027
	13835423	CHEMBL3090490	Inhibition of autophosphorylation of aurora-A L215R mutant at T288 in human HCT116 cells after 2 hrs	B	Cc1nn(C)cc1-c1nc2c(Oc3ccc(C(=O)NC4CCC4)cc3)c(Cl)cnc2[nH]1		CHEMBL3087823	=	IC50	nM	43.0	CHEMBL4722	Homo sapiens	IC50	uM	0.043
	13835424	CHEMBL3090490	Inhibition of autophosphorylation of aurora-A L215R mutant at T288 in human HCT116 cells after 2 hrs	B	Cc1nn(C)cc1-c1nc2c(Oc3ccc(C(=O)Nc4ccccc4)cc3)c(Cl)cnc2[nH]1		CHEMBL3087784	=	IC50	nM	27.0	CHEMBL4722	Homo sapiens	IC50	uM	0.027
	13835425	CHEMBL3090491	Inhibition of autophosphorylation of aurora-A T217E mutant at T288 in human HCT116 cells after 2 hrs	B	Cc1nn(C)cc1-c1nc2c(Oc3ccc(C(=O)NC4CCC4)cc3)c(Cl)cnc2[nH]1		CHEMBL3087823	=	IC50	nM	2290.0	CHEMBL4722	Homo sapiens	IC50	uM	2.29
	13835426	CHEMBL3090491	Inhibition of autophosphorylation of aurora-A T217E mutant at T288 in human HCT116 cells after 2 hrs	B	Cc1nn(C)cc1-c1nc2c(Oc3ccc(C(=O)Nc4ccccc4)cc3)c(Cl)cnc2[nH]1		CHEMBL3087784	=	IC50	nM	960.0	CHEMBL4722	Homo sapiens	IC50	uM	0.96
	13835427	CHEMBL3090492	Inhibition of autophosphorylation of N-terminal Myc tagged wild type aurora-A at T288 in human HCT116 cells after 2 hrs	B	Cc1nn(C)cc1-c1nc2c(Oc3ccc(C(=O)NC4CCC4)cc3)c(Cl)cnc2[nH]1		CHEMBL3087823	=	IC50	nM	36.0	CHEMBL4722	Homo sapiens	IC50	uM	0.036
	13835428	CHEMBL3090492	Inhibition of autophosphorylation of N-terminal Myc tagged wild type aurora-A at T288 in human HCT116 cells after 2 hrs	B	Cc1nn(C)cc1-c1nc2c(Oc3ccc(C(=O)Nc4ccccc4)cc3)c(Cl)cnc2[nH]1		CHEMBL3087784	=	IC50	nM	29.0	CHEMBL4722	Homo sapiens	IC50	uM	0.029
	13835430	CHEMBL3090494	Inhibition of autophosphorylation of aurora-A T217E mutant at T288 in human HeLa cells after 2 hrs	B	Cc1nn(C)cc1-c1nc2c(Oc3ccc(C(=O)Nc4ccccc4)cc3)c(Cl)cnc2[nH]1		CHEMBL3087784	=	IC50	nM	4110.0	CHEMBL4722	Homo sapiens	IC50	uM	4.11
	13835445	CHEMBL3090738	Inhibition of N-terminal HIS-tagged aurora-A (unknown origin) using 5FAM-LRRASLG-CONH2 as substrate at 1 uM after 60 mins	B	Cc1nn(C)cc1-c1nc2c(Oc3ccc(C(=O)Nc4ccccc4)cc3)c(Cl)cnc2[nH]1		CHEMBL3087784	>	Inhibition	%	80.0	CHEMBL4722	Homo sapiens	INH	%	80.0
	13835448	CHEMBL3090774	Inhibition of autophosphorylation of N-terminal Myc tagged aurora-A at T288 in human HCT116 cells after 2 hrs	B	Cc1cc(NC(=O)c2ccc(Oc3c(Cl)cnc4[nH]c(-c5cn(C)nc5C)nc34)cc2)on1		CHEMBL3085798	=	IC50	nM	95.0	CHEMBL4722	Homo sapiens	IC50	uM	0.095
	13835449	CHEMBL3090774	Inhibition of autophosphorylation of N-terminal Myc tagged aurora-A at T288 in human HCT116 cells after 2 hrs	B	Cc1nn(C)cc1-c1nc2c(Oc3ccc(C(=O)Nc4ccccc4)cc3)c(Cl)cnc2[nH]1		CHEMBL3087784	=	IC50	nM	65.0	CHEMBL4722	Homo sapiens	IC50	uM	0.065
	13835458	CHEMBL3090777	Inhibition of autophosphorylation of N-terminal Myc tagged aurora-A at T288 in human HeLa cells after 2 hrs	B	Cc1nn(C)cc1-c1nc2c(Oc3ccc(C(=O)NC4CCC4)cc3)c(Cl)cnc2[nH]1		CHEMBL3087823	=	IC50	nM	70.0	CHEMBL4722	Homo sapiens	IC50	uM	0.07
	13835459	CHEMBL3090777	Inhibition of autophosphorylation of N-terminal Myc tagged aurora-A at T288 in human HeLa cells after 2 hrs	B	Cc1nn(C)cc1-c1nc2c(Oc3ccc(C(=O)Nc4cccnc4)cc3)c(Cl)cnc2[nH]1		CHEMBL3087820	=	IC50	nM	280.0	CHEMBL4722	Homo sapiens	IC50	uM	0.28
	13835460	CHEMBL3090777	Inhibition of autophosphorylation of N-terminal Myc tagged aurora-A at T288 in human HeLa cells after 2 hrs	B	Cc1nn(C)cc1-c1nc2c(Oc3ccc(C(=O)Nc4ccncc4)cc3)c(Cl)cnc2[nH]1		CHEMBL3087819	=	IC50	nM	580.0	CHEMBL4722	Homo sapiens	IC50	uM	0.58
	13835461	CHEMBL3090777	Inhibition of autophosphorylation of N-terminal Myc tagged aurora-A at T288 in human HeLa cells after 2 hrs	B	Cc1nn(C)cc1-c1nc2c(Oc3ccc(C(=O)Nc4ccccc4)cc3)c(Cl)cnc2[nH]1		CHEMBL3087784	=	IC50	nM	107.0	CHEMBL4722	Homo sapiens	IC50	uM	0.107
	13835464	CHEMBL3090780	Inhibition of autophosphorylation of N-terminal Myc tagged aurora-A at T288 (unknown origin) after 2 hrs	B	Cc1nn(C)cc1-c1nc2c(Nc3ccc(C(=O)Nc4ccccc4)cc3)c(Cl)cnc2[nH]1		CHEMBL3087783	=	IC50	nM	320.0	CHEMBL4722	Homo sapiens	IC50	uM	0.32
	13835484	CHEMBL3090782	Inhibition of N-terminal HIS-tagged aurora-A (unknown origin) using 5FAM-LRRASLG-CONH2 as substrate after 60 mins	B	Cc1nn(C)cc1-c1nc2c(Oc3ccc(C(=O)NC4CCC4)cc3)c(Cl)cnc2[nH]1		CHEMBL3087823	=	IC50	nM	15.0	CHEMBL4722	Homo sapiens	IC50	uM	0.015
	13835485	CHEMBL3090782	Inhibition of N-terminal HIS-tagged aurora-A (unknown origin) using 5FAM-LRRASLG-CONH2 as substrate after 60 mins	B	Cc1nn(C)cc1-c1nc2c(Oc3ccc(C(=O)N4CCCC4)cc3)c(Cl)cnc2[nH]1		CHEMBL3087822	=	IC50	nM	45.0	CHEMBL4722	Homo sapiens	IC50	uM	0.045
	13835486	CHEMBL3090782	Inhibition of N-terminal HIS-tagged aurora-A (unknown origin) using 5FAM-LRRASLG-CONH2 as substrate after 60 mins	B	Cc1nn(C)cc1-c1nc2c(Oc3ccc(C(=O)NCc4ccccc4)cc3)c(Cl)cnc2[nH]1		CHEMBL3087821	=	IC50	nM	204.0	CHEMBL4722	Homo sapiens	IC50	uM	0.204
	13835487	CHEMBL3090782	Inhibition of N-terminal HIS-tagged aurora-A (unknown origin) using 5FAM-LRRASLG-CONH2 as substrate after 60 mins	B	Cc1nn(C)cc1-c1nc2c(Oc3ccc(C(=O)Nc4cccnc4)cc3)c(Cl)cnc2[nH]1		CHEMBL3087820	=	IC50	nM	58.0	CHEMBL4722	Homo sapiens	IC50	uM	0.058
	13835488	CHEMBL3090782	Inhibition of N-terminal HIS-tagged aurora-A (unknown origin) using 5FAM-LRRASLG-CONH2 as substrate after 60 mins	B	Cc1nn(C)cc1-c1nc2c(Oc3ccc(C(=O)Nc4ccncc4)cc3)c(Cl)cnc2[nH]1		CHEMBL3087819	=	IC50	nM	190.0	CHEMBL4722	Homo sapiens	IC50	uM	0.19
	13835489	CHEMBL3090782	Inhibition of N-terminal HIS-tagged aurora-A (unknown origin) using 5FAM-LRRASLG-CONH2 as substrate after 60 mins	B	Cc1cc(NC(=O)c2ccc(Oc3c(Cl)cnc4[nH]c(-c5cn(C)nc5C)nc34)cc2)on1		CHEMBL3085798	=	IC50	nM	71.0	CHEMBL4722	Homo sapiens	IC50	uM	0.071
	13835490	CHEMBL3090782	Inhibition of N-terminal HIS-tagged aurora-A (unknown origin) using 5FAM-LRRASLG-CONH2 as substrate after 60 mins	B	O=C(Nc1ccccc1)c1ccc(Oc2c(Cl)cnc3[nH]cnc23)cc1		CHEMBL3087818	=	IC50	nM	25840.0	CHEMBL4722	Homo sapiens	IC50	uM	25.84
	13835491	CHEMBL3090782	Inhibition of N-terminal HIS-tagged aurora-A (unknown origin) using 5FAM-LRRASLG-CONH2 as substrate after 60 mins	B	Cc1nn(C)cc1-c1nc2c(Oc3ccc(C(=O)Nc4ccccc4)cc3)ccnc2[nH]1		CHEMBL3087817	=	IC50	nM	618.0	CHEMBL4722	Homo sapiens	IC50	uM	0.618
	13835492	CHEMBL3090782	Inhibition of N-terminal HIS-tagged aurora-A (unknown origin) using 5FAM-LRRASLG-CONH2 as substrate after 60 mins	B	Cc1nn(C)cc1-c1nc2c(Oc3ccc(C(=O)Nc4ccccc4)cc3)c(Cl)cnc2[nH]1		CHEMBL3087784	=	IC50	nM	67.0	CHEMBL4722	Homo sapiens	IC50	uM	0.067
	13835493	CHEMBL3090782	Inhibition of N-terminal HIS-tagged aurora-A (unknown origin) using 5FAM-LRRASLG-CONH2 as substrate after 60 mins	B	Cc1nn(C)cc1-c1nc2c(Nc3ccc(C(=O)Nc4ccccc4)cc3)c(Cl)cnc2[nH]1		CHEMBL3087783	=	IC50	nM	75.0	CHEMBL4722	Homo sapiens	IC50	uM	0.075
	13835494	CHEMBL3090782	Inhibition of N-terminal HIS-tagged aurora-A (unknown origin) using 5FAM-LRRASLG-CONH2 as substrate after 60 mins	B	Cc1nn(C)cc1-c1nc2c(N(C)Cc3ccccc3)c(Cl)cnc2[nH]1		CHEMBL3087782	=	IC50	nM	255.0	CHEMBL4722	Homo sapiens	IC50	uM	0.255
	13835495	CHEMBL3090782	Inhibition of N-terminal HIS-tagged aurora-A (unknown origin) using 5FAM-LRRASLG-CONH2 as substrate after 60 mins	B	Cc1nn(C)cc1-c1nc2c(N3CCC[C@H](CN(C)S(C)(=O)=O)C3)c(Cl)cnc2[nH]1		CHEMBL3087781	=	IC50	nM	5.0	CHEMBL4722	Homo sapiens	IC50	uM	0.005
	13835496	CHEMBL3090782	Inhibition of N-terminal HIS-tagged aurora-A (unknown origin) using 5FAM-LRRASLG-CONH2 as substrate after 60 mins	B	Cc1nn(C)cc1-c1nc2c(N3CCC[C@@H](CNS(C)(=O)=O)C3)c(Cl)cnc2[nH]1		CHEMBL3087780	=	IC50	nM	7.0	CHEMBL4722	Homo sapiens	IC50	uM	0.007
	13835497	CHEMBL3090782	Inhibition of N-terminal HIS-tagged aurora-A (unknown origin) using 5FAM-LRRASLG-CONH2 as substrate after 60 mins	B	Cc1nn(C)cc1-c1nc2c(N3CCC[C@H](CNS(C)(=O)=O)C3)c(Cl)cnc2[nH]1		CHEMBL3087779	=	IC50	nM	5.0	CHEMBL4722	Homo sapiens	IC50	uM	0.005
	13835498	CHEMBL3090782	Inhibition of N-terminal HIS-tagged aurora-A (unknown origin) using 5FAM-LRRASLG-CONH2 as substrate after 60 mins	B	CC(=O)NC[C@@H]1CCN(c2c(Cl)cnc3[nH]c(-c4cn(C)nc4C)nc23)C1		CHEMBL3087778	=	IC50	nM	9.0	CHEMBL4722	Homo sapiens	IC50	uM	0.009
	13835499	CHEMBL3090782	Inhibition of N-terminal HIS-tagged aurora-A (unknown origin) using 5FAM-LRRASLG-CONH2 as substrate after 60 mins	B	CC(=O)N[C@@H]1CCN(c2c(Cl)cnc3[nH]c(-c4cn(C)nc4C)nc23)C1		CHEMBL3087777	=	IC50	nM	4.0	CHEMBL4722	Homo sapiens	IC50	uM	0.004
	13835500	CHEMBL3090782	Inhibition of N-terminal HIS-tagged aurora-A (unknown origin) using 5FAM-LRRASLG-CONH2 as substrate after 60 mins	B	CC(=O)N[C@H]1CCN(c2c(Cl)cnc3[nH]c(-c4cn(C)nc4C)nc23)C1		CHEMBL3087776	=	IC50	nM	270.0	CHEMBL4722	Homo sapiens	IC50	uM	0.27
	13835501	CHEMBL3090782	Inhibition of N-terminal HIS-tagged aurora-A (unknown origin) using 5FAM-LRRASLG-CONH2 as substrate after 60 mins	B	COc1ccc(-c2[nH]c3ncc(Cl)cc3c2-c2cccc(CNC(C)=O)c2)cc1		CHEMBL3087775	=	IC50	nM	743.0	CHEMBL4722	Homo sapiens	IC50	uM	0.743
	13835502	CHEMBL3090782	Inhibition of N-terminal HIS-tagged aurora-A (unknown origin) using 5FAM-LRRASLG-CONH2 as substrate after 60 mins	B	CC(=O)NCc1cccc(-c2c(-c3cnn(C)c3)[nH]c3ncc(Cl)cc23)c1		CHEMBL3087774	=	IC50	nM	118.0	CHEMBL4722	Homo sapiens	IC50	uM	0.118
	13835503	CHEMBL3090782	Inhibition of N-terminal HIS-tagged aurora-A (unknown origin) using 5FAM-LRRASLG-CONH2 as substrate after 60 mins	B	COc1ccc(-c2[nH]c3ncc(Cl)cc3c2-c2cccc(CNS(C)(=O)=O)c2)cc1		CHEMBL3087773	=	IC50	nM	1941.0	CHEMBL4722	Homo sapiens	IC50	uM	1.941
	13835504	CHEMBL3090782	Inhibition of N-terminal HIS-tagged aurora-A (unknown origin) using 5FAM-LRRASLG-CONH2 as substrate after 60 mins	B	Cn1cc(-c2[nH]c3ncc(Cl)cc3c2-c2cccc(CNS(C)(=O)=O)c2)cn1		CHEMBL3087772	=	IC50	nM	211.0	CHEMBL4722	Homo sapiens	IC50	uM	0.211
	13863636	CHEMBL3102609	Inhibition of recombinant aurora kinase A (unknown origin) expressed in Escherichia coli	B	CC(C)n1cc(C2=C(c3nn(CCCN4CCOCC4)c4ncccc34)C(=O)NC2=O)c2ccccc21		CHEMBL3099835	>	IC50	nM	40000.0	CHEMBL4722	Homo sapiens	IC50	uM	40.0
	13863637	CHEMBL3102609	Inhibition of recombinant aurora kinase A (unknown origin) expressed in Escherichia coli	B	Cn1cc(C2=C(c3nn(CCN4CCOCC4)c4ncccc34)C(=O)NC2=O)c2ccccc21		CHEMBL3099832	>	IC50	nM	40000.0	CHEMBL4722	Homo sapiens	IC50	uM	40.0
	13863638	CHEMBL3102609	Inhibition of recombinant aurora kinase A (unknown origin) expressed in Escherichia coli	B	Cn1cc(C2=C(c3nn(CCn4ccnc4)c4ncccc34)C(=O)NC2=O)c2ccccc21		CHEMBL563560	>	IC50	nM	40000.0	CHEMBL4722	Homo sapiens	IC50	uM	40.0
	13863639	CHEMBL3102609	Inhibition of recombinant aurora kinase A (unknown origin) expressed in Escherichia coli	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	18.0	CHEMBL4722	Homo sapiens	IC50	uM	0.018
	13872205	CHEMBL3102392	Inhibition of human Aurora-A assessed as residual activity at 1 uM relative to control	B	O=C1Nc2ncccc2/C1=C1/Nc2ncccc2C1=O		CHEMBL3099673	=	Activity	%	60.0	CHEMBL4722	Homo sapiens	Activity	%	60.0
	13872241	CHEMBL3102547	Inhibition of Aurora-A (unknown origin) assessed as residual activity at 10 uM relative to control	B	O=C1Nc2ncccc2/C1=C1/Nc2ncccc2C1=O		CHEMBL3099673	=	Activity	%	61.0	CHEMBL4722	Homo sapiens	Activity	%	61.0
	13872271	CHEMBL3100474	Inhibition of Aurora-A (unknown origin) assessed as residual activity at 1 uM relative to control	B	O=C1Nc2ncccc2/C1=C1/Nc2ncccc2C1=O		CHEMBL3099673	=	Activity	%	85.0	CHEMBL4722	Homo sapiens	Activity	%	85.0
	13895871	CHEMBL3111604	Inhibition of N-terminal His-tagged Aurora A (unknown origin) using 5FAM-LRRASLG-CONH2 as substrate after 60 mins by fluorescence assay	B	CN(C)C(=O)c1ccc(Nc2cc3c(cn2)cc(-c2cnco2)n3C(=O)OC(C)(C)C)c(Cl)c1		CHEMBL3109940	=	IC50	nM	75000.0	CHEMBL4722	Homo sapiens	IC50	uM	75.0
	13895875	CHEMBL3111604	Inhibition of N-terminal His-tagged Aurora A (unknown origin) using 5FAM-LRRASLG-CONH2 as substrate after 60 mins by fluorescence assay	B	COC1CCN(C(=O)c2ccc(Nc3cc4c(cn3)cc(-c3cnn(C)c3)n4C(=O)OC(C)(C)C)c(Cl)c2)CC1		CHEMBL3109937	=	IC50	nM	65000.0	CHEMBL4722	Homo sapiens	IC50	uM	65.0
	13895885	CHEMBL3111604	Inhibition of N-terminal His-tagged Aurora A (unknown origin) using 5FAM-LRRASLG-CONH2 as substrate after 60 mins by fluorescence assay	B	Cn1cc(-c2cc3cnc(Nc4ccc(C(=O)N5CCS(=O)(=O)CC5)cc4Cl)cc3n2C(=O)OC(C)(C)C)cn1		CHEMBL3109939	=	IC50	nM	53000.0	CHEMBL4722	Homo sapiens	IC50	uM	53.0
	13895914	CHEMBL3111604	Inhibition of N-terminal His-tagged Aurora A (unknown origin) using 5FAM-LRRASLG-CONH2 as substrate after 60 mins by fluorescence assay	B	CN(C)C(=O)c1ccc(Nc2cc3c(cn2)cc(-c2cnn(C)c2)n3C(=O)OC(C)(C)C)c(Cl)c1		CHEMBL3109933	=	IC50	nM	23000.0	CHEMBL4722	Homo sapiens	IC50	uM	23.0
	13895922	CHEMBL3111604	Inhibition of N-terminal His-tagged Aurora A (unknown origin) using 5FAM-LRRASLG-CONH2 as substrate after 60 mins by fluorescence assay	B	CN(C)C1CCN(C(=O)c2ccc(Nc3cc4c(cn3)cc(-c3cnn(C)c3)n4C(=O)OC(C)(C)C)c(Cl)c2)CC1		CHEMBL3109938	=	IC50	nM	17000.0	CHEMBL4722	Homo sapiens	IC50	uM	17.0
	13895953	CHEMBL3111604	Inhibition of N-terminal His-tagged Aurora A (unknown origin) using 5FAM-LRRASLG-CONH2 as substrate after 60 mins by fluorescence assay	B	COc1ccc(Nc2cc3[nH]c(-c4cn[nH]c4)cc3cn2)cc1OC		CHEMBL3109932	=	IC50	nM	2600.0	CHEMBL4722	Homo sapiens	IC50	uM	2.6
	13895993	CHEMBL3111604	Inhibition of N-terminal His-tagged Aurora A (unknown origin) using 5FAM-LRRASLG-CONH2 as substrate after 60 mins by fluorescence assay	B	CCc1cccc(CC)c1NC(=O)c1nn(C)c2c1CCc1cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC(F)(F)F)nc1-2		CHEMBL1236095	>	IC50	nM	30000.0	CHEMBL4722	Homo sapiens	IC50	uM	30.0
	13895994	CHEMBL3111604	Inhibition of N-terminal His-tagged Aurora A (unknown origin) using 5FAM-LRRASLG-CONH2 as substrate after 60 mins by fluorescence assay	B	COc1ccccc1Nc1cc2[nH]c(-c3c(C)noc3C)cc2cn1		CHEMBL3109963	>	IC50	nM	100000.0	CHEMBL4722	Homo sapiens	IC50	uM	100.0
	13895995	CHEMBL3111604	Inhibition of N-terminal His-tagged Aurora A (unknown origin) using 5FAM-LRRASLG-CONH2 as substrate after 60 mins by fluorescence assay	B	COc1ccccc1Nc1cc2[nH]c(-c3cnn(C)c3C)cc2cn1		CHEMBL3109961	>	IC50	nM	100000.0	CHEMBL4722	Homo sapiens	IC50	uM	100.0
	13896000	CHEMBL3111604	Inhibition of N-terminal His-tagged Aurora A (unknown origin) using 5FAM-LRRASLG-CONH2 as substrate after 60 mins by fluorescence assay	B	CC(C)(C)Nc1nc(Nc2ccc(C(N)=O)cc2)cc(N)c1C#N		CHEMBL2089255	>	IC50	nM	100000.0	CHEMBL4722	Homo sapiens	IC50	uM	100.0
	13896002	CHEMBL3111604	Inhibition of N-terminal His-tagged Aurora A (unknown origin) using 5FAM-LRRASLG-CONH2 as substrate after 60 mins by fluorescence assay	B	COc1ccccc1Nc1cc2[nH]c(-c3cnn(CC(F)(F)F)c3)cc2cn1		CHEMBL3109958	>	IC50	nM	100000.0	CHEMBL4722	Homo sapiens	IC50	uM	100.0
	13896004	CHEMBL3111604	Inhibition of N-terminal His-tagged Aurora A (unknown origin) using 5FAM-LRRASLG-CONH2 as substrate after 60 mins by fluorescence assay	B	Cn1cc(-c2cc3cnc(Nc4ccc(C(=O)N5CCC5)cc4Cl)cc3n2C(=O)OC(C)(C)C)cn1		CHEMBL3109936	>	IC50	nM	100000.0	CHEMBL4722	Homo sapiens	IC50	uM	100.0
	13896013	CHEMBL3111604	Inhibition of N-terminal His-tagged Aurora A (unknown origin) using 5FAM-LRRASLG-CONH2 as substrate after 60 mins by fluorescence assay	B	COc1ccccc1Nc1cc2[nH]c(-c3cnn(C(F)F)c3)cc2cn1		CHEMBL3109959	>	IC50	nM	40000.0	CHEMBL4722	Homo sapiens	IC50	uM	40.0
	13896014	CHEMBL3111604	Inhibition of N-terminal His-tagged Aurora A (unknown origin) using 5FAM-LRRASLG-CONH2 as substrate after 60 mins by fluorescence assay	B	COc1ccc(C(F)(F)F)cc1Nc1cc2[nH]c(-c3cnn(C)c3)cc2cn1		CHEMBL3109965	>	IC50	nM	100000.0	CHEMBL4722	Homo sapiens	IC50	uM	100.0
	13896015	CHEMBL3111604	Inhibition of N-terminal His-tagged Aurora A (unknown origin) using 5FAM-LRRASLG-CONH2 as substrate after 60 mins by fluorescence assay	B	CN(C)S(=O)(=O)c1ccc(Nc2cc3c(cn2)cc(-c2cnn(C)c2)n3C(=O)OC(C)(C)C)c(Cl)c1		CHEMBL3109935	>	IC50	nM	100000.0	CHEMBL4722	Homo sapiens	IC50	uM	100.0
	13896016	CHEMBL3111604	Inhibition of N-terminal His-tagged Aurora A (unknown origin) using 5FAM-LRRASLG-CONH2 as substrate after 60 mins by fluorescence assay	B	Cn1cc(-c2cc3cnc(Nc4ccccc4Cl)cc3n2C(=O)OC(C)(C)C)cn1		CHEMBL3109934	>	IC50	nM	100000.0	CHEMBL4722	Homo sapiens	IC50	uM	100.0
	13896019	CHEMBL3111604	Inhibition of N-terminal His-tagged Aurora A (unknown origin) using 5FAM-LRRASLG-CONH2 as substrate after 60 mins by fluorescence assay	B	Cn1cc(-c2cc3cnc(Nc4ccccc4Cl)cc3[nH]2)cn1		CHEMBL3109966	>	IC50	nM	100000.0	CHEMBL4722	Homo sapiens	IC50	uM	100.0
	13896020	CHEMBL3111604	Inhibition of N-terminal His-tagged Aurora A (unknown origin) using 5FAM-LRRASLG-CONH2 as substrate after 60 mins by fluorescence assay	B	COc1ccccc1Nc1cc2[nH]c(-c3cnn(C)c3)cc2cn1		CHEMBL3109957	>	IC50	nM	100000.0	CHEMBL4722	Homo sapiens	IC50	uM	100.0
	13896021	CHEMBL3111604	Inhibition of N-terminal His-tagged Aurora A (unknown origin) using 5FAM-LRRASLG-CONH2 as substrate after 60 mins by fluorescence assay	B	CN(C)C(=O)c1ccc(Nc2cc3[nH]c(-c4cnn(C)c4)cc3cn2)c(Cl)c1		CHEMBL3109967	>	IC50	nM	40000.0	CHEMBL4722	Homo sapiens	IC50	uM	40.0
	13896022	CHEMBL3111604	Inhibition of N-terminal His-tagged Aurora A (unknown origin) using 5FAM-LRRASLG-CONH2 as substrate after 60 mins by fluorescence assay	B	COc1ccccc1Nc1cc2[nH]c(-c3cnco3)cc2cn1		CHEMBL3109962	>	IC50	nM	40000.0	CHEMBL4722	Homo sapiens	IC50	uM	40.0
	13896319	CHEMBL3111604	Inhibition of N-terminal His-tagged Aurora A (unknown origin) using 5FAM-LRRASLG-CONH2 as substrate after 60 mins by fluorescence assay	B	Cn1cc(-c2cc3cnc(Nc4ccc(-c5cnccn5)cc4Cl)cc3n2C(=O)OC(C)(C)C)cn1		CHEMBL3109947	>	IC50	nM	100000.0	CHEMBL4722	Homo sapiens	IC50	uM	100.0
	13896320	CHEMBL3111604	Inhibition of N-terminal His-tagged Aurora A (unknown origin) using 5FAM-LRRASLG-CONH2 as substrate after 60 mins by fluorescence assay	B	Cn1cc(-c2cc3cnc(Nc4ccc(-c5cccnc5)cc4Cl)cc3n2C(=O)OC(C)(C)C)cn1		CHEMBL3109946	>	IC50	nM	100000.0	CHEMBL4722	Homo sapiens	IC50	uM	100.0
	13896321	CHEMBL3111604	Inhibition of N-terminal His-tagged Aurora A (unknown origin) using 5FAM-LRRASLG-CONH2 as substrate after 60 mins by fluorescence assay	B	Cn1cc(-c2cc3cnc(Nc4ccc(-c5cnco5)cc4Cl)cc3n2C(=O)OC(C)(C)C)cn1		CHEMBL3109944	>	IC50	nM	100000.0	CHEMBL4722	Homo sapiens	IC50	uM	100.0
	13896322	CHEMBL3111604	Inhibition of N-terminal His-tagged Aurora A (unknown origin) using 5FAM-LRRASLG-CONH2 as substrate after 60 mins by fluorescence assay	B	Cn1cc(-c2cc3cnc(Nc4ccc(-c5ccn(C)n5)cc4Cl)cc3n2C(=O)OC(C)(C)C)cn1		CHEMBL3109943	>	IC50	nM	100000.0	CHEMBL4722	Homo sapiens	IC50	uM	100.0
	13896323	CHEMBL3111604	Inhibition of N-terminal His-tagged Aurora A (unknown origin) using 5FAM-LRRASLG-CONH2 as substrate after 60 mins by fluorescence assay	B	Cn1cc(-c2ccc(Nc3cc4[nH]c(-c5cnn(C)c5)cc4cn3)c(Cl)c2)cn1		CHEMBL3109942	>	IC50	nM	100000.0	CHEMBL4722	Homo sapiens	IC50	uM	100.0
	13896324	CHEMBL3111604	Inhibition of N-terminal His-tagged Aurora A (unknown origin) using 5FAM-LRRASLG-CONH2 as substrate after 60 mins by fluorescence assay	B	Cn1cc(-c2ccc(Nc3cc4c(cn3)cc(-c3cnn(C)c3)n4C(=O)OC(C)(C)C)c(Cl)c2)cn1		CHEMBL3109941	>	IC50	nM	100000.0	CHEMBL4722	Homo sapiens	IC50	uM	100.0
	13896325	CHEMBL3111604	Inhibition of N-terminal His-tagged Aurora A (unknown origin) using 5FAM-LRRASLG-CONH2 as substrate after 60 mins by fluorescence assay	B	Cn1cc(-c2cc3cnc(Nc4ccc(C(=O)N5CCS(=O)(=O)CC5)cc4Cl)cc3[nH]2)cn1		CHEMBL3109972	>	IC50	nM	100000.0	CHEMBL4722	Homo sapiens	IC50	uM	100.0
	13896326	CHEMBL3111604	Inhibition of N-terminal His-tagged Aurora A (unknown origin) using 5FAM-LRRASLG-CONH2 as substrate after 60 mins by fluorescence assay	B	CN(C)C1CCN(C(=O)c2ccc(Nc3cc4[nH]c(-c5cnn(C)c5)cc4cn3)c(Cl)c2)CC1		CHEMBL3109971	>	IC50	nM	100000.0	CHEMBL4722	Homo sapiens	IC50	uM	100.0
	13896327	CHEMBL3111604	Inhibition of N-terminal His-tagged Aurora A (unknown origin) using 5FAM-LRRASLG-CONH2 as substrate after 60 mins by fluorescence assay	B	COC1CCN(C(=O)c2ccc(Nc3cc4[nH]c(-c5cnn(C)c5)cc4cn3)c(Cl)c2)CC1		CHEMBL3109970	>	IC50	nM	100000.0	CHEMBL4722	Homo sapiens	IC50	uM	100.0
	13896328	CHEMBL3111604	Inhibition of N-terminal His-tagged Aurora A (unknown origin) using 5FAM-LRRASLG-CONH2 as substrate after 60 mins by fluorescence assay	B	CN(C)S(=O)(=O)c1ccc(Nc2cc3[nH]c(-c4cnn(C)c4)cc3cn2)c(Cl)c1		CHEMBL3109969	>	IC50	nM	100000.0	CHEMBL4722	Homo sapiens	IC50	uM	100.0
	13896329	CHEMBL3111604	Inhibition of N-terminal His-tagged Aurora A (unknown origin) using 5FAM-LRRASLG-CONH2 as substrate after 60 mins by fluorescence assay	B	COc1cc(C(=O)N(C)C)ccc1Nc1cc2[nH]c(-c3cnn(C)c3)cc2cn1		CHEMBL3109968	>	IC50	nM	100000.0	CHEMBL4722	Homo sapiens	IC50	uM	100.0
	13896330	CHEMBL3111604	Inhibition of N-terminal His-tagged Aurora A (unknown origin) using 5FAM-LRRASLG-CONH2 as substrate after 60 mins by fluorescence assay	B	Cn1cc(-c2cc3cnc(Nc4ccc(-c5cncnc5)cc4Cl)cc3n2C(=O)OC(C)(C)C)cn1		CHEMBL3109948	>	IC50	nM	50000.0	CHEMBL4722	Homo sapiens	IC50	uM	50.0
	13896331	CHEMBL3111604	Inhibition of N-terminal His-tagged Aurora A (unknown origin) using 5FAM-LRRASLG-CONH2 as substrate after 60 mins by fluorescence assay	B	Cn1cc(-c2cc3cnc(Nc4ccc(-c5cncn5C)cc4Cl)cc3n2C(=O)OC(C)(C)C)cn1		CHEMBL3109945	>	IC50	nM	40000.0	CHEMBL4722	Homo sapiens	IC50	uM	40.0
	13896332	CHEMBL3111604	Inhibition of N-terminal His-tagged Aurora A (unknown origin) using 5FAM-LRRASLG-CONH2 as substrate after 60 mins by fluorescence assay	B	COc1ccc(Nc2cc3[nH]c(-c4cn(C)nc4C(F)(F)F)cc3cn2)c(OC)c1		CHEMBL3109960	>	IC50	nM	100000.0	CHEMBL4722	Homo sapiens	IC50	uM	100.0
	13896334	CHEMBL3111604	Inhibition of N-terminal His-tagged Aurora A (unknown origin) using 5FAM-LRRASLG-CONH2 as substrate after 60 mins by fluorescence assay	B	COc1ccccc1Nc1cc2[nH]c(-c3cncn3C)cc2cn1		CHEMBL3109964	=	IC50	nM	72000.0	CHEMBL4722	Homo sapiens	IC50	uM	72.0
	13896336	CHEMBL3111604	Inhibition of N-terminal His-tagged Aurora A (unknown origin) using 5FAM-LRRASLG-CONH2 as substrate after 60 mins by fluorescence assay	B	Clc1ccccc1Nc1cc2[nH]c(-c3cn[nH]c3)cc2cn1		CHEMBL3109955	=	IC50	nM	49000.0	CHEMBL4722	Homo sapiens	IC50	uM	49.0
	13896340	CHEMBL3111604	Inhibition of N-terminal His-tagged Aurora A (unknown origin) using 5FAM-LRRASLG-CONH2 as substrate after 60 mins by fluorescence assay	B	COc1ccccc1Nc1cc2[nH]c(-c3cn[nH]c3)cc2cn1		CHEMBL3109953	=	IC50	nM	28000.0	CHEMBL4722	Homo sapiens	IC50	uM	28.0
	13896341	CHEMBL3111604	Inhibition of N-terminal His-tagged Aurora A (unknown origin) using 5FAM-LRRASLG-CONH2 as substrate after 60 mins by fluorescence assay	B	COc1ccc(Nc2cc3[nH]c(-c4cn[nH]c4)cc3cn2)c(Cl)c1		CHEMBL3109956	=	IC50	nM	21000.0	CHEMBL4722	Homo sapiens	IC50	uM	21.0
	13896342	CHEMBL3111604	Inhibition of N-terminal His-tagged Aurora A (unknown origin) using 5FAM-LRRASLG-CONH2 as substrate after 60 mins by fluorescence assay	B	COc1cc(OC2CCN(C)CC2)ccc1Nc1ncc2c(n1)n(C1CCCC1)c(=O)n2C		CHEMBL2140523	=	IC50	nM	21000.0	CHEMBL4722	Homo sapiens	IC50	uM	21.0
	13896346	CHEMBL3111604	Inhibition of N-terminal His-tagged Aurora A (unknown origin) using 5FAM-LRRASLG-CONH2 as substrate after 60 mins by fluorescence assay	B	CCOc1ccccc1Nc1cc2[nH]c(-c3cn[nH]c3)cc2cn1		CHEMBL3109954	=	IC50	nM	8500.0	CHEMBL4722	Homo sapiens	IC50	uM	8.5
	13896347	CHEMBL3111604	Inhibition of N-terminal His-tagged Aurora A (unknown origin) using 5FAM-LRRASLG-CONH2 as substrate after 60 mins by fluorescence assay	B	c1cc(OCCN2CCOCC2)ccc1Nc1cc2[nH]c(-c3cn[nH]c3)cc2cn1		CHEMBL3109952	=	IC50	nM	8100.0	CHEMBL4722	Homo sapiens	IC50	uM	8.1
	13896355	CHEMBL3111604	Inhibition of N-terminal His-tagged Aurora A (unknown origin) using 5FAM-LRRASLG-CONH2 as substrate after 60 mins by fluorescence assay	B	c1cnn(Cc2ccc(Nc3cc4[nH]c(-c5cn[nH]c5)cc4cn3)cc2)c1		CHEMBL3109951	=	IC50	nM	4200.0	CHEMBL4722	Homo sapiens	IC50	uM	4.2
	13896357	CHEMBL3111604	Inhibition of N-terminal His-tagged Aurora A (unknown origin) using 5FAM-LRRASLG-CONH2 as substrate after 60 mins by fluorescence assay	B	CN(C)S(=O)(=O)c1ccc(Nc2cc3[nH]c(-c4cn[nH]c4)cc3cn2)cc1		CHEMBL3109950	=	IC50	nM	3200.0	CHEMBL4722	Homo sapiens	IC50	uM	3.2
	13896361	CHEMBL3111604	Inhibition of N-terminal His-tagged Aurora A (unknown origin) using 5FAM-LRRASLG-CONH2 as substrate after 60 mins by fluorescence assay	B	COc1ccc(Nc2cc3[nH]c(-c4cn[nH]c4)cc3cn2)cc1		CHEMBL3109949	=	IC50	nM	1800.0	CHEMBL4722	Homo sapiens	IC50	uM	1.8
	13899604	CHEMBL3112011	Inhibition of human recombinant Aurora A expressed in insect sf21 cells using ATP/Ulight-RRRSLLE as substrate at 1 uM after 15 mins by LANCE assay	B	Cc1nn(-c2ccc(Cl)cc2Cl)c2c1c1c(c3cccn32)C(=O)NC1=O		CHEMBL3110144	<	Inhibition	%	10.0	CHEMBL4722	Homo sapiens	INH	%	10.0
Not Active	13907194	CHEMBL3118669	Inhibition of aurora-A (unknown origin) at 10 uM	B	CCCCCCCCCC(NC(=O)CNC(=O)OCc1ccccc1)C(=O)NCCc1ccccc1		CHEMBL3113587		Inhibition	%		CHEMBL4722	Homo sapiens	INH		
	13918695	CHEMBL3117035	Inhibition of human aurora A kinase	B	C[C@H](Nc1nc(Nc2cn(C)cn2)c2cc[nH]c2n1)c1ncc(F)cn1		CHEMBL3116050	=	IC50	nM	58.0	CHEMBL4722	Homo sapiens	IC50	uM	0.058
	13919569	CHEMBL3118642	Inhibition of Aurora A (unknown origin)	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	15.0	CHEMBL4722	Homo sapiens	IC50	uM	0.015
	13919579	CHEMBL3118841	Inhibition of Aurora A (unknown origin) at 0.8 ug/ml	B	CC(C)(C)NC(c1ccc(Cl)cc1)c1ccc(-c2cn[nH]c2)cc1		CHEMBL3112595	=	Inhibition	%	28.3	CHEMBL4722	Homo sapiens	INH	%	28.3
	13953831	CHEMBL3130121	Inhibition of human aurora A kinase using LRRASLG as substrate by scintillation counting in presence of [gamma-33P]ATP	B	COc1cc(OC)c(/C=C/C(=O)c2c(O)cccc2OC)c(OC)c1		CHEMBL3125820	=	IC50	nM	66400.0	CHEMBL4722	Homo sapiens	IC50	uM	66.4
	13966016	CHEMBL3136067	Inhibition of human full length AurA expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 1000 uM after 90 mins by microfluidic peptide phosphorylation assay	B	c1cnc2[nH]ccc2c1		CHEMBL389685	=	Inhibition	%	88.0	CHEMBL4722	Homo sapiens	INH	%	88.0
	13973291	CHEMBL3136765	Inhibition of human full length AurA expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 0.1 uM after 90 mins by microfluidic peptide phosphorylation assay	B	C[C@H](CN(C)C)Oc1nc(Nc2cc3cccc(Cl)c3cn2)cnc1C#N		CHEMBL1928705	=	Inhibition	%	0.0	CHEMBL4722	Homo sapiens	INH	%	0.0
	13973394	CHEMBL3134650	Inhibition of aurora-A (unknown origin) using tetra(LRRWSLG) as substrate after 60 mins by scintillation counting	B	Oc1cccc(Nc2ccnc3[nH]c4ccccc4c23)c1		CHEMBL3133821	=	IC50	nM	250.0	CHEMBL4722	Homo sapiens	IC50	nM	250.0
	13974009	CHEMBL3136035	Inhibition of human full length AurA expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 0.35 uM after 90 mins by microfluidic peptide phosphorylation assay	B	COC(=O)c1cnc(Nc2cnc(C#N)cn2)cc1NCC1CCNCC1		CHEMBL1928692	=	Inhibition	%	6.5	CHEMBL4722	Homo sapiens	INH	%	6.5
	13974100	CHEMBL3135611	Inhibition of human full length AurA expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 9 uM after 90 mins by microfluidic peptide phosphorylation assay	B	NCC1CN(c2ncnc3[nH]c4cnccc4c23)CCO1		CHEMBL1928677	=	Inhibition	%	23.5	CHEMBL4722	Homo sapiens	INH	%	23.5
	13974191	CHEMBL3137131	Inhibition of human full length AurA expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 90 uM after 90 mins by microfluidic peptide phosphorylation assay	B	NCC1CN(c2ncnc3[nH]cnc23)CCO1		CHEMBL560373	=	Inhibition	%	98.0	CHEMBL4722	Homo sapiens	INH	%	98.0
	13974282	CHEMBL3136260	Inhibition of human full length AurA expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 420 uM after 90 mins by microfluidic peptide phosphorylation assay	B	c1nc(N2CCOCC2)c2nc[nH]c2n1		CHEMBL271138	=	Inhibition	%	96.0	CHEMBL4722	Homo sapiens	INH	%	96.0
	13975020	CHEMBL3135980	Inhibition of human full length AurA expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 0.02 uM after 90 mins by microfluidic peptide phosphorylation assay	B	NC1(C(=O)NCc2ccc(Cl)cc2)CCN(c2ncnc3[nH]ccc23)CC1		CHEMBL598194	=	Inhibition	%	0.0	CHEMBL4722	Homo sapiens	INH	%	0.0
	13975111	CHEMBL3135707	Inhibition of human full length AurA expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 0.06 uM after 90 mins by microfluidic peptide phosphorylation assay	B	NC1(Cc2ccc(Cl)cc2)CCN(c2ncnc3[nH]ccc23)CC1		CHEMBL263664	=	Inhibition	%	7.5	CHEMBL4722	Homo sapiens	INH	%	7.5
	13975202	CHEMBL3135791	Inhibition of human full length AurA expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 2 uM after 90 mins by microfluidic peptide phosphorylation assay	B	NC1CCN(c2ncnc3[nH]ccc23)CC1		CHEMBL259141	=	Inhibition	%	64.5	CHEMBL4722	Homo sapiens	INH	%	64.5
	13975845	CHEMBL3134768	Inhibition of human full length AurA expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 8 uM after 90 mins by microfluidic peptide phosphorylation assay	B	NCC1CCN(c2ncnc3[nH]ccc23)CC1		CHEMBL261249	=	Inhibition	%	87.5	CHEMBL4722	Homo sapiens	INH	%	87.5
	13975938	CHEMBL3136875	Inhibition of human full length AurA expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 0.2 uM after 90 mins by microfluidic peptide phosphorylation assay	B	Clc1ccc(C2(c3ccc(-c4ncnc5[nH]cnc45)cc3)CCNCC2)cc1		CHEMBL228133	=	Inhibition	%	49.0	CHEMBL4722	Homo sapiens	INH	%	49.0
	13976029	CHEMBL3135385	Inhibition of human full length AurA expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 95 uM after 90 mins by microfluidic peptide phosphorylation assay	B	NCCc1ccc(-c2ncnc3[nH]cnc23)cc1		CHEMBL227727	=	Inhibition	%	85.0	CHEMBL4722	Homo sapiens	INH	%	85.0
	13976120	CHEMBL3136910	Inhibition of human full length AurA expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 70 uM after 90 mins by microfluidic peptide phosphorylation assay	B	CNCc1ccc(-c2ncnc3[nH]cnc23)cc1		CHEMBL376388	=	Inhibition	%	68.0	CHEMBL4722	Homo sapiens	INH	%	68.0
	14536273	CHEMBL3222411	Inhibition of Aurora A kinase (unknown origin)	B	COC(c1ccc(C)cc1)c1cnn2c(-c3ccccc3)cc3c(Cl)cccc3c12		CHEMBL3219384	=	IC50	nM	13430.0	CHEMBL4722	Homo sapiens	IC50	uM	13.43
	14545790	CHEMBL3224460	Inhibition of Aurora-A (unknown origin) assessed as residual activity at 1 uM	B	CS(=O)(=O)O.O=C(NCc1cccc(O)c1)Nc1nc(-c2ccncc2)cs1		CHEMBL3218297	=	Activity	%	61.4	CHEMBL4722	Homo sapiens	Activity	%	61.4
	14545813	CHEMBL3224480	Inhibition of Aurora-A (unknown origin)	B	CS(=O)(=O)O.O=C(NCc1cccc(O)c1)Nc1nc(-c2ccncc2)cs1		CHEMBL3218297	<	IC50	nM	1.0	CHEMBL4722	Homo sapiens	IC50	nM	1.0
	14545832	CHEMBL3224491	Inhibition of Aurora-A (unknown origin) using KKRPQRRSNVF as substrate by Z-Lyte-based FRET assay	B	O=C(Nc1nc(-c2ccncc2)cs1)C1COc2ccccc2O1		CHEMBL510515	>	IC50	nM	100000.0	CHEMBL4722	Homo sapiens	IC50	uM	100.0
	14553656	CHEMBL3223948	Inhibition of Aurora A (unknown origin) at 10 uM assessed as residual enzyme activity	B	COc1ccc(-c2n[nH]c3ncc(-c4ccc(Cl)cc4N)cc23)cc1		CHEMBL3220823	=	Activity	%	87.7	CHEMBL4722	Homo sapiens	Activity	%	87.7
	14582437	CHEMBL3240220	Inhibition of human AURKA assessed as enzyme activity at 1 uM relative to control	B	CCCS(=O)(=O)Nc1cccc(Nc2ccc3ncn(C)c(=O)c3c2)c1C#N		CHEMBL3236464	=	Activity	%	97.5	CHEMBL4722	Homo sapiens	Activity	%	97.5
	14600182	CHEMBL3243849	Inhibition of N-terminal His-6-tagged recombinant Aurora 1 (62 to 344) (unknown origin) expressed in baculovirus expression system by radiometric assay	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	Ki	nM	0.6	CHEMBL4722	Homo sapiens	Ki	nM	0.6
	14600184	CHEMBL3243852	Inhibition of recombinant human Aurora A using peptide substrate PanVera Z'-Lyte kinase assay	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(/C=C/c3ccccc3)n2)n[nH]1.O=C(O)C(O)C(O)C(=O)O		CHEMBL3237191	=	IC50	nM	14.0	CHEMBL4722	Homo sapiens	IC50	nM	14.0
	14600189	CHEMBL3243854	Inhibition of Aurora A (unknown origin) using FAM-labeled peptide as substrate preincubated for 10 mins followed by substrate addition measured after 60 mins	B	COC(=O)c1ccc(Nc2nc(Nc3cc(C)[nH]n3)cc(N3CCN(C)CC3)n2)cc1		CHEMBL3237172	=	IC50	nM	46.0	CHEMBL4722	Homo sapiens	IC50	nM	46.0
	14600190	CHEMBL3243854	Inhibition of Aurora A (unknown origin) using FAM-labeled peptide as substrate preincubated for 10 mins followed by substrate addition measured after 60 mins	B	COC(=O)c1ccc(Nc2nc(Nc3cc(C)[nH]n3)cc(N3CCNCC3)n2)cc1		CHEMBL3237173	=	IC50	nM	135.0	CHEMBL4722	Homo sapiens	IC50	nM	135.0
	14600191	CHEMBL3243854	Inhibition of Aurora A (unknown origin) using FAM-labeled peptide as substrate preincubated for 10 mins followed by substrate addition measured after 60 mins	B	COC(=O)c1ccc(Nc2nc(Nc3cc(C)[nH]n3)cc(N3CCOCC3)n2)cc1		CHEMBL3237174	=	IC50	nM	25.0	CHEMBL4722	Homo sapiens	IC50	nM	25.0
	14600192	CHEMBL3243854	Inhibition of Aurora A (unknown origin) using FAM-labeled peptide as substrate preincubated for 10 mins followed by substrate addition measured after 60 mins	B	COC(=O)c1ccc(Nc2nc(Nc3cc(C)[nH]n3)cc(N3C[C@H](C)O[C@H](C)C3)n2)cc1		CHEMBL3237175	=	IC50	nM	113.0	CHEMBL4722	Homo sapiens	IC50	nM	113.0
	14600193	CHEMBL3243854	Inhibition of Aurora A (unknown origin) using FAM-labeled peptide as substrate preincubated for 10 mins followed by substrate addition measured after 60 mins	B	COC(=O)c1ccc(Nc2nc(Nc3cc(C)[nH]n3)cc(N3CCN(S(C)(=O)=O)CC3)n2)cc1		CHEMBL3237176	=	IC50	nM	34.0	CHEMBL4722	Homo sapiens	IC50	nM	34.0
	14600194	CHEMBL3243854	Inhibition of Aurora A (unknown origin) using FAM-labeled peptide as substrate preincubated for 10 mins followed by substrate addition measured after 60 mins	B	COC(=O)c1ccc(Nc2nc(Nc3cc(C)[nH]n3)cc(N3CCN(S(=O)(=O)c4ccc(C)cc4)CC3)n2)cc1		CHEMBL3237177	=	IC50	nM	573.0	CHEMBL4722	Homo sapiens	IC50	nM	573.0
	14600195	CHEMBL3243854	Inhibition of Aurora A (unknown origin) using FAM-labeled peptide as substrate preincubated for 10 mins followed by substrate addition measured after 60 mins	B	COC(=O)c1ccc(Nc2nc(NCCN3CCCCC3)cc(Nc3cc(C)[nH]n3)n2)cc1		CHEMBL3237178	=	IC50	nM	228.0	CHEMBL4722	Homo sapiens	IC50	nM	228.0
	14600196	CHEMBL3243854	Inhibition of Aurora A (unknown origin) using FAM-labeled peptide as substrate preincubated for 10 mins followed by substrate addition measured after 60 mins	B	COC(=O)c1ccc(Nc2nc(NCCN3CCOCC3)cc(Nc3cc(C)[nH]n3)n2)cc1		CHEMBL3237179	=	IC50	nM	72.0	CHEMBL4722	Homo sapiens	IC50	nM	72.0
	14600197	CHEMBL3243854	Inhibition of Aurora A (unknown origin) using FAM-labeled peptide as substrate preincubated for 10 mins followed by substrate addition measured after 60 mins	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Nc3ccc(C(=O)O)cc3)n2)n[nH]1		CHEMBL3237180	=	IC50	nM	32.0	CHEMBL4722	Homo sapiens	IC50	nM	32.0
	14600198	CHEMBL3243854	Inhibition of Aurora A (unknown origin) using FAM-labeled peptide as substrate preincubated for 10 mins followed by substrate addition measured after 60 mins	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Nc3ccc(C(=O)OC(C)C)cc3)n2)n[nH]1		CHEMBL3237181	=	IC50	nM	22.0	CHEMBL4722	Homo sapiens	IC50	nM	22.0
	14600199	CHEMBL3243854	Inhibition of Aurora A (unknown origin) using FAM-labeled peptide as substrate preincubated for 10 mins followed by substrate addition measured after 60 mins	B	CNC(=O)c1ccc(Nc2nc(Nc3cc(C)[nH]n3)cc(N3CCN(C)CC3)n2)cc1		CHEMBL3237182	=	IC50	nM	101.0	CHEMBL4722	Homo sapiens	IC50	nM	101.0
	14600200	CHEMBL3243854	Inhibition of Aurora A (unknown origin) using FAM-labeled peptide as substrate preincubated for 10 mins followed by substrate addition measured after 60 mins	B	COc1ccccc1Nc1nc(Nc2cc(C)[nH]n2)cc(N2CCN(C)CC2)n1		CHEMBL3237183	=	IC50	nM	200.0	CHEMBL4722	Homo sapiens	IC50	nM	200.0
	14600201	CHEMBL3243854	Inhibition of Aurora A (unknown origin) using FAM-labeled peptide as substrate preincubated for 10 mins followed by substrate addition measured after 60 mins	B	COc1cccc(Nc2nc(Nc3cc(C)[nH]n3)cc(N3CCN(C)CC3)n2)c1		CHEMBL3237184	=	IC50	nM	22.0	CHEMBL4722	Homo sapiens	IC50	nM	22.0
	14600202	CHEMBL3243854	Inhibition of Aurora A (unknown origin) using FAM-labeled peptide as substrate preincubated for 10 mins followed by substrate addition measured after 60 mins	B	COc1ccc(Nc2nc(Nc3cc(C)[nH]n3)cc(N3CCN(C)CC3)n2)cc1		CHEMBL3237185	=	IC50	nM	34.0	CHEMBL4722	Homo sapiens	IC50	nM	34.0
	14600203	CHEMBL3243854	Inhibition of Aurora A (unknown origin) using FAM-labeled peptide as substrate preincubated for 10 mins followed by substrate addition measured after 60 mins	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Nc3ccccc3Cl)n2)n[nH]1		CHEMBL3237186	=	IC50	nM	147.0	CHEMBL4722	Homo sapiens	IC50	nM	147.0
	14600204	CHEMBL3243854	Inhibition of Aurora A (unknown origin) using FAM-labeled peptide as substrate preincubated for 10 mins followed by substrate addition measured after 60 mins	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Nc3cccc(Cl)c3)n2)n[nH]1		CHEMBL3237187	=	IC50	nM	10.0	CHEMBL4722	Homo sapiens	IC50	nM	10.0
	14600205	CHEMBL3243854	Inhibition of Aurora A (unknown origin) using FAM-labeled peptide as substrate preincubated for 10 mins followed by substrate addition measured after 60 mins	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Nc3ccc(Cl)cc3)n2)n[nH]1		CHEMBL3237188	=	IC50	nM	13.0	CHEMBL4722	Homo sapiens	IC50	nM	13.0
	14600206	CHEMBL3243854	Inhibition of Aurora A (unknown origin) using FAM-labeled peptide as substrate preincubated for 10 mins followed by substrate addition measured after 60 mins	B	CC(=O)Nc1ccc(Nc2nc(Nc3cc(C)[nH]n3)cc(N3CCN(C)CC3)n2)cc1		CHEMBL3237189	=	IC50	nM	118.0	CHEMBL4722	Homo sapiens	IC50	nM	118.0
	14600207	CHEMBL3243854	Inhibition of Aurora A (unknown origin) using FAM-labeled peptide as substrate preincubated for 10 mins followed by substrate addition measured after 60 mins	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Nc3ccc(N4CCOCC4)cc3)n2)n[nH]1		CHEMBL3237190	=	IC50	nM	112.0	CHEMBL4722	Homo sapiens	IC50	nM	112.0
	14600208	CHEMBL3243854	Inhibition of Aurora A (unknown origin) using FAM-labeled peptide as substrate preincubated for 10 mins followed by substrate addition measured after 60 mins	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Nc3ccc(N4CC(=O)N(C5CC5)CC4=O)cc3)n2)n[nH]1		CHEMBL3237163	=	IC50	nM	549.0	CHEMBL4722	Homo sapiens	IC50	nM	549.0
	14600209	CHEMBL3243854	Inhibition of Aurora A (unknown origin) using FAM-labeled peptide as substrate preincubated for 10 mins followed by substrate addition measured after 60 mins	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Nc3ccc([N+](=O)[O-])cc3)n2)n[nH]1		CHEMBL3237164	=	IC50	nM	12.0	CHEMBL4722	Homo sapiens	IC50	nM	12.0
	14600210	CHEMBL3243854	Inhibition of Aurora A (unknown origin) using FAM-labeled peptide as substrate preincubated for 10 mins followed by substrate addition measured after 60 mins	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Nc3cccc([N+](=O)[O-])c3)n2)n[nH]1		CHEMBL3237165	=	IC50	nM	16.0	CHEMBL4722	Homo sapiens	IC50	nM	16.0
	14600211	CHEMBL3243854	Inhibition of Aurora A (unknown origin) using FAM-labeled peptide as substrate preincubated for 10 mins followed by substrate addition measured after 60 mins	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Nc3ccc(C#N)cc3)n2)n[nH]1		CHEMBL3237166	=	IC50	nM	8.0	CHEMBL4722	Homo sapiens	IC50	nM	8.0
	14600212	CHEMBL3243854	Inhibition of Aurora A (unknown origin) using FAM-labeled peptide as substrate preincubated for 10 mins followed by substrate addition measured after 60 mins	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Nc3ccc(S(N)(=O)=O)cc3)n2)n[nH]1		CHEMBL3237167	=	IC50	nM	5.0	CHEMBL4722	Homo sapiens	IC50	nM	5.0
	14600213	CHEMBL3243854	Inhibition of Aurora A (unknown origin) using FAM-labeled peptide as substrate preincubated for 10 mins followed by substrate addition measured after 60 mins	B	Cc1cc(Nc2cc(N3CCOCC3)nc(Nc3ccc([N+](=O)[O-])cc3)n2)n[nH]1		CHEMBL3237168	=	IC50	nM	11.0	CHEMBL4722	Homo sapiens	IC50	nM	11.0
	14600214	CHEMBL3243854	Inhibition of Aurora A (unknown origin) using FAM-labeled peptide as substrate preincubated for 10 mins followed by substrate addition measured after 60 mins	B	COC(=O)c1ccc(Nc2nc(Nc3cc(C)[nH]n3)cc(N3CCN(C)CC3)n2)cc1Cl		CHEMBL3237169	=	IC50	nM	7.7	CHEMBL4722	Homo sapiens	IC50	nM	7.7
	14600215	CHEMBL3243854	Inhibition of Aurora A (unknown origin) using FAM-labeled peptide as substrate preincubated for 10 mins followed by substrate addition measured after 60 mins	B	COC(=O)c1ccc(CNc2nc(Nc3cc(C)[nH]n3)cc(N3CCN(C)CC3)n2)cc1		CHEMBL3237170	=	IC50	nM	127.0	CHEMBL4722	Homo sapiens	IC50	nM	127.0
	14600216	CHEMBL3243854	Inhibition of Aurora A (unknown origin) using FAM-labeled peptide as substrate preincubated for 10 mins followed by substrate addition measured after 60 mins	B	COC(=O)c1ccc(CNc2nc(Nc3cc(C)[nH]n3)cc(N3CCOCC3)n2)cc1		CHEMBL3237171	=	IC50	nM	97.0	CHEMBL4722	Homo sapiens	IC50	nM	97.0
	14663208	CHEMBL3268845	Inhibition of AURKA (unknown origin) at 1 uM relative to control	B	CCOC(=O)c1sc(-c2ccncc2)nc1O		CHEMBL3261228	=	Inhibition	%	100.0	CHEMBL4722	Homo sapiens	INH	%	100.0
	14663209	CHEMBL3268845	Inhibition of AURKA (unknown origin) at 1 uM relative to control	B	NC(=O)c1sc(-c2ccnc(N)n2)nc1-c1ccc(Cl)cc1Cl		CHEMBL3261514	=	Inhibition	%	77.0	CHEMBL4722	Homo sapiens	INH	%	77.0
	14663210	CHEMBL3268845	Inhibition of AURKA (unknown origin) at 1 uM relative to control	B	COc1ccc(-c2nc(-c3ccnc(N)n3)sc2C(N)=O)c(Cl)c1		CHEMBL3261517	=	Inhibition	%	55.0	CHEMBL4722	Homo sapiens	INH	%	55.0
	14666342	CHEMBL3270461	Inhibition of aurora A (unknown origin) assessed as [33P] incorporation in substrate by TopCount microplate scintillation counting analysis	B	COc1ccc(Oc2cc(C)c(-c3csc(NC(=O)c4ccnc(F)c4)n3)c(C)c2)cc1		CHEMBL3263869	>	IC50	nM	10000.0	CHEMBL4722	Homo sapiens	IC50	uM	10.0
	14668866	CHEMBL3269289	Inhibition of aurora-A kinase (unknown origin) assessed as residual activity at 1 uM	B	CN(C)CCNc1cncc(-c2ccc3[nH]cc(-c4ccnc(N)n4)c3c2)n1		CHEMBL3264257	=	Activity	%	104.0	CHEMBL4722	Homo sapiens	Activity	%	104.0
	14751167	CHEMBL3301290	Inhibition of aurora kinase 1 (unknown origin)	B	CC(C)(C)CNC(=O)CC1CNC(=O)c2cc(-c3ccsc3)cn21		CHEMBL3298400	>	IC50	nM	10000.0	CHEMBL4722	Homo sapiens	IC50	uM	10.0
	14751168	CHEMBL3301290	Inhibition of aurora kinase 1 (unknown origin)	B	CN1CCN(C[C@@H](NC(=O)C[C@H]2CNC(=O)c3cc(-c4cccc(Cl)c4)cn32)C2CCCCC2)CC1		CHEMBL3297762	>	IC50	nM	10000.0	CHEMBL4722	Homo sapiens	IC50	uM	10.0
	14984399	CHEMBL3384392	Inhibition of AURKA (unknown origin) at 1 uM	B	CN1CCN(c2ccc(-c3cnc4[nH]c5cnc(C#N)cc5c4c3)cc2)CC1		CHEMBL3359895	=	Inhibition	%	11.0	CHEMBL4722	Homo sapiens	INH	%	11.0
	14984465	CHEMBL3381882	Inhibition of AURKA (unknown origin) at 0.1 uM	B	CN1CCN(c2ccc(-c3cnc4[nH]c5cnc(C#N)cc5c4c3)cc2)CC1		CHEMBL3359895	=	Inhibition	%	17.0	CHEMBL4722	Homo sapiens	INH	%	17.0
	14992865	CHEMBL3372224	Inhibition of recombinant AURKA (unknown origin) after 60 mins by z'-lyte kinase assay	B	O=C1/C(=C\c2ccc(O)c(O)c2)Oc2ccccc21		CHEMBL3361128	=	IC50	nM	1340.0	CHEMBL4722	Homo sapiens	IC50	uM	1.34
	14992921	CHEMBL3372796	Binding affinity to AURKA (unknown origin)	B	O=C1/C(=C\c2ccc(O)c(O)c2)Oc2ccccc21		CHEMBL3361128	=	Kd	nM	12900.0	CHEMBL4722	Homo sapiens	Kd	10'-5M	1.29
	15001751	CHEMBL3380550	Inhibition of human His-tagged full length AURKA using kemptide peptide as substrate after 60 mins	B	O=C(Nc1cnn(Cc2ccccc2)c1)c1n[nH]c2c1CCC1(CCOC1)C2		CHEMBL3298367	>	Ki	nM	5700.0	CHEMBL4722	Homo sapiens	Ki	nM	5700.0
	15002489	CHEMBL3366565	Inhibition of aurora A kinase (unknown origin) assessed as residual activity at 10 uM relative to control	B	Cc1cc(O)cc(-c2nn(C)cc2-c2cc(N3CCOCC3)nc(-c3cccnc3)n2)c1		CHEMBL3310332	=	Activity	%	31.0	CHEMBL4722	Homo sapiens	Activity	%	31.0
	15003393	CHEMBL3370359	Inhibition of Aurora A (unknown origin) expressed in Escherichia coli by ZLYTETM assay	B	O=c1[nH]c2sccc2c(NC2CCCNC2)c1-c1nc2ccccc2[nH]1		CHEMBL3330132	=	IC50	nM	790.81	CHEMBL4722	Homo sapiens	IC50	nM	790.81
	15003394	CHEMBL3370359	Inhibition of Aurora A (unknown origin) expressed in Escherichia coli by ZLYTETM assay	B	O=c1[nH]c2sccc2c(N[C@H]2CCCNC2)c1-c1nc2ccccc2[nH]1		CHEMBL3330133	=	IC50	nM	495.14	CHEMBL4722	Homo sapiens	IC50	nM	495.14
	15003395	CHEMBL3370359	Inhibition of Aurora A (unknown origin) expressed in Escherichia coli by ZLYTETM assay	B	O=c1[nH]c2sccc2c(NC2CN3CCC2CC3)c1-c1nc2ccccc2[nH]1		CHEMBL3330136	>	IC50	nM	10000.0	CHEMBL4722	Homo sapiens	IC50	nM	10000.0
	15003396	CHEMBL3370359	Inhibition of Aurora A (unknown origin) expressed in Escherichia coli by ZLYTETM assay	B	O=c1[nH]c2sc(Cl)cc2c(NC2CCCNC2)c1-c1nc2ccccc2[nH]1		CHEMBL3330148	=	IC50	nM	1051.51	CHEMBL4722	Homo sapiens	IC50	nM	1051.51
	15003397	CHEMBL3370359	Inhibition of Aurora A (unknown origin) expressed in Escherichia coli by ZLYTETM assay	B	O=c1[nH]c2sc(Cl)cc2c(NC2CN3CCC2CC3)c1-c1nc2ccccc2[nH]1		CHEMBL3330229	>	IC50	nM	10000.0	CHEMBL4722	Homo sapiens	IC50	nM	10000.0
	15003398	CHEMBL3370359	Inhibition of Aurora A (unknown origin) expressed in Escherichia coli by ZLYTETM assay	B	O=c1[nH]c2sc(Br)cc2c(NC2CCCNC2)c1-c1nc2ccccc2[nH]1		CHEMBL3330230	=	IC50	nM	1591.65	CHEMBL4722	Homo sapiens	IC50	nM	1591.65
	15003399	CHEMBL3370359	Inhibition of Aurora A (unknown origin) expressed in Escherichia coli by ZLYTETM assay	B	COc1ccc2[nH]c(-c3c(N[C@H]4CCCNC4)c4cc(Cl)sc4[nH]c3=O)nc2c1		CHEMBL3330232	=	IC50	nM	328.2	CHEMBL4722	Homo sapiens	IC50	nM	328.2
	15003400	CHEMBL3370359	Inhibition of Aurora A (unknown origin) expressed in Escherichia coli by ZLYTETM assay	B	COc1ccc2[nH]c(-c3c(NC4CN5CCC4CC5)c4cc(Cl)sc4[nH]c3=O)nc2c1		CHEMBL3330233	=	IC50	nM	1400.34	CHEMBL4722	Homo sapiens	IC50	nM	1400.34
	15003401	CHEMBL3370359	Inhibition of Aurora A (unknown origin) expressed in Escherichia coli by ZLYTETM assay	B	O=c1[nH]c2ccsc2c(NC2CCCNC2)c1-c1nc2ccccc2[nH]1		CHEMBL3330236	=	IC50	nM	201.86	CHEMBL4722	Homo sapiens	IC50	nM	201.86
	15003443	CHEMBL3370367	Inhibition of Aurora A (unknown origin) at 10 uM	B	COc1cc(OC)cc(-c2cn(-c3ccc(O)c(C(=O)Nc4cccc(C(F)(F)F)c4)c3)nn2)c1		CHEMBL1169635	=	Inhibition	%	74.5	CHEMBL4722	Homo sapiens	INH	%	74.5
	15003444	CHEMBL3370368	Inhibition of Aurora A (unknown origin) at 10 uM using [33P]-ATP and 10 uM ATP after 2 hrs	B	COc1cc(OC)cc(-c2cn(-c3cccc(C(=O)Nc4cccc(C(F)(F)F)c4)c3)nn2)c1		CHEMBL3322930	=	Inhibition	%	30.0	CHEMBL4722	Homo sapiens	INH	%	30.0
	15003445	CHEMBL3370368	Inhibition of Aurora A (unknown origin) at 10 uM using [33P]-ATP and 10 uM ATP after 2 hrs	B	COc1cc(OC)cc(-c2cn(-c3ccc(O)c(C(=O)Nc4ccccc4)c3)nn2)c1		CHEMBL3322931	=	Inhibition	%	88.8	CHEMBL4722	Homo sapiens	INH	%	88.8
	15003446	CHEMBL3370368	Inhibition of Aurora A (unknown origin) at 10 uM using [33P]-ATP and 10 uM ATP after 2 hrs	B	COc1cc(OC)cc(-c2cn(-c3ccc(O)c(C(=O)Nc4cccc(C)c4)c3)nn2)c1		CHEMBL3321769	=	Inhibition	%	4.2	CHEMBL4722	Homo sapiens	INH	%	4.2
	15003447	CHEMBL3370368	Inhibition of Aurora A (unknown origin) at 10 uM using [33P]-ATP and 10 uM ATP after 2 hrs	B	COc1cccc(NC(=O)c2cc(-n3cc(-c4cc(OC)cc(OC)c4)nn3)ccc2O)c1		CHEMBL3322932	=	Inhibition	%	83.3	CHEMBL4722	Homo sapiens	INH	%	83.3
	15003448	CHEMBL3370368	Inhibition of Aurora A (unknown origin) at 10 uM using [33P]-ATP and 10 uM ATP after 2 hrs	B	COc1cc(OC)cc(-c2cn(-c3ccc(O)c(C(=O)Nc4cccc(Cl)c4)c3)nn2)c1		CHEMBL3322933	=	Inhibition	%	91.8	CHEMBL4722	Homo sapiens	INH	%	91.8
	15003449	CHEMBL3370368	Inhibition of Aurora A (unknown origin) at 10 uM using [33P]-ATP and 10 uM ATP after 2 hrs	B	COc1cc(OC)cc(-c2cn(-c3ccc(O)c(C(=O)Nc4ccccc4C(F)(F)F)c3)nn2)c1		CHEMBL3322934	=	Inhibition	%	22.4	CHEMBL4722	Homo sapiens	INH	%	22.4
	15003450	CHEMBL3370368	Inhibition of Aurora A (unknown origin) at 10 uM using [33P]-ATP and 10 uM ATP after 2 hrs	B	COC(=O)c1cccc(NC(=O)c2cc(-n3cc(-c4cc(OC)cc(OC)c4)nn3)ccc2O)c1		CHEMBL3322935	=	Inhibition	%	90.2	CHEMBL4722	Homo sapiens	INH	%	90.2
	15003451	CHEMBL3370368	Inhibition of Aurora A (unknown origin) at 10 uM using [33P]-ATP and 10 uM ATP after 2 hrs	B	COc1cc(OC)cc(-c2cn(-c3ccc(O)c(C(=O)Nc4cccc(C(=O)O)c4)c3)nn2)c1		CHEMBL3322936	=	Inhibition	%	67.9	CHEMBL4722	Homo sapiens	INH	%	67.9
	15003452	CHEMBL3370368	Inhibition of Aurora A (unknown origin) at 10 uM using [33P]-ATP and 10 uM ATP after 2 hrs	B	O=C(Nc1cccc(C(F)(F)F)c1)c1cc(-n2cc(-c3cc(C(F)(F)F)cc(C(F)(F)F)c3)nn2)ccc1O		CHEMBL3322937	=	Inhibition	%	91.0	CHEMBL4722	Homo sapiens	INH	%	91.0
	15003453	CHEMBL3370368	Inhibition of Aurora A (unknown origin) at 10 uM using [33P]-ATP and 10 uM ATP after 2 hrs	B	O=C(Nc1cccc(C(F)(F)F)c1)c1cc(-n2cc(-c3cc(F)cc(F)c3)nn2)ccc1O		CHEMBL3322938	=	Inhibition	%	88.9	CHEMBL4722	Homo sapiens	INH	%	88.9
	15003454	CHEMBL3370368	Inhibition of Aurora A (unknown origin) at 10 uM using [33P]-ATP and 10 uM ATP after 2 hrs	B	CN(C)c1ccc(-c2cn(-c3ccc(O)c(C(=O)Nc4cccc(C(F)(F)F)c4)c3)nn2)cc1		CHEMBL3322939	=	Inhibition	%	45.7	CHEMBL4722	Homo sapiens	INH	%	45.7
	15003455	CHEMBL3370368	Inhibition of Aurora A (unknown origin) at 10 uM using [33P]-ATP and 10 uM ATP after 2 hrs	B	N#Cc1ccc(-c2cn(-c3ccc(O)c(C(=O)Nc4cccc(C(F)(F)F)c4)c3)nn2)cc1		CHEMBL3322940	=	Inhibition	%	92.8	CHEMBL4722	Homo sapiens	INH	%	92.8
	15003456	CHEMBL3370368	Inhibition of Aurora A (unknown origin) at 10 uM using [33P]-ATP and 10 uM ATP after 2 hrs	B	COc1cc(OC)c(-c2cn(-c3ccc(O)c(C(=O)Nc4cccc(C(F)(F)F)c4)c3)nn2)cc1Cl		CHEMBL3323022	=	Inhibition	%	94.4	CHEMBL4722	Homo sapiens	INH	%	94.4
	15003457	CHEMBL3370368	Inhibition of Aurora A (unknown origin) at 10 uM using [33P]-ATP and 10 uM ATP after 2 hrs	B	O=C(Nc1cccc(C(F)(F)F)c1)c1cc(-n2cc(-c3cccc(Cl)c3)nn2)ccc1O		CHEMBL3323023	=	Inhibition	%	94.7	CHEMBL4722	Homo sapiens	INH	%	94.7
	15003458	CHEMBL3370368	Inhibition of Aurora A (unknown origin) at 10 uM using [33P]-ATP and 10 uM ATP after 2 hrs	B	COC(=O)c1ccc(-c2cn(-c3ccc(O)c(C(=O)Nc4cccc(C(F)(F)F)c4)c3)nn2)cc1		CHEMBL3323024	=	Inhibition	%	92.6	CHEMBL4722	Homo sapiens	INH	%	92.6
	15003459	CHEMBL3370368	Inhibition of Aurora A (unknown origin) at 10 uM using [33P]-ATP and 10 uM ATP after 2 hrs	B	Cc1cccc(-c2cn(-c3ccc(O)c(C(=O)Nc4cccc(C(F)(F)F)c4)c3)nn2)c1		CHEMBL3323025	=	Inhibition	%	92.5	CHEMBL4722	Homo sapiens	INH	%	92.5
	15003460	CHEMBL3370368	Inhibition of Aurora A (unknown origin) at 10 uM using [33P]-ATP and 10 uM ATP after 2 hrs	B	Cc1ccc(-c2cn(-c3ccc(O)c(C(=O)Nc4cccc(C(F)(F)F)c4)c3)nn2)cc1		CHEMBL3323026	=	Inhibition	%	85.7	CHEMBL4722	Homo sapiens	INH	%	85.7
	15003461	CHEMBL3370368	Inhibition of Aurora A (unknown origin) at 10 uM using [33P]-ATP and 10 uM ATP after 2 hrs	B	O=C(Nc1cccc(C(F)(F)F)c1)c1cc(-n2cc(-c3ccc(F)cc3)nn2)ccc1O		CHEMBL3323027	=	Inhibition	%	79.3	CHEMBL4722	Homo sapiens	INH	%	79.3
	15003462	CHEMBL3370368	Inhibition of Aurora A (unknown origin) at 10 uM using [33P]-ATP and 10 uM ATP after 2 hrs	B	O=C(Nc1cccc(C(F)(F)F)c1)c1cc(-n2cc(-c3cccnc3)nn2)ccc1O		CHEMBL3323028	=	Inhibition	%	75.8	CHEMBL4722	Homo sapiens	INH	%	75.8
	15003463	CHEMBL3370368	Inhibition of Aurora A (unknown origin) at 10 uM using [33P]-ATP and 10 uM ATP after 2 hrs	B	O=C(Nc1cccc(C(F)(F)F)c1)c1cc(-n2cc(-c3ccsc3)nn2)ccc1O		CHEMBL3323029	=	Inhibition	%	91.3	CHEMBL4722	Homo sapiens	INH	%	91.3
	15003464	CHEMBL3370368	Inhibition of Aurora A (unknown origin) at 10 uM using [33P]-ATP and 10 uM ATP after 2 hrs	B	CC(=O)Nc1cccc(-c2cn(-c3ccc(O)c(C(=O)Nc4cccc(C(F)(F)F)c4)c3)nn2)c1		CHEMBL3323030	=	Inhibition	%	92.5	CHEMBL4722	Homo sapiens	INH	%	92.5
	15003465	CHEMBL3370368	Inhibition of Aurora A (unknown origin) at 10 uM using [33P]-ATP and 10 uM ATP after 2 hrs	B	COC(=O)c1cccc(-c2cn(-c3ccc(O)c(C(=O)Nc4cccc(C(F)(F)F)c4)c3)nn2)c1		CHEMBL3321770	=	Inhibition	%	90.5	CHEMBL4722	Homo sapiens	INH	%	90.5
	15003466	CHEMBL3370368	Inhibition of Aurora A (unknown origin) at 10 uM using [33P]-ATP and 10 uM ATP after 2 hrs	B	O=C(Nc1cccc(C(F)(F)F)c1)c1cc(-n2cc(-c3ccccn3)nn2)ccc1O		CHEMBL3323031	=	Inhibition	%	78.0	CHEMBL4722	Homo sapiens	INH	%	78.0
	15003467	CHEMBL3370368	Inhibition of Aurora A (unknown origin) at 10 uM using [33P]-ATP and 10 uM ATP after 2 hrs	B	Cn1cncc1-c1cn(-c2ccc(O)c(C(=O)Nc3cccc(C(F)(F)F)c3)c2)nn1		CHEMBL3323032	=	Inhibition	%	46.4	CHEMBL4722	Homo sapiens	INH	%	46.4
	15003468	CHEMBL3370368	Inhibition of Aurora A (unknown origin) at 10 uM using [33P]-ATP and 10 uM ATP after 2 hrs	B	O=C(O)c1ccc(-c2cn(-c3ccc(O)c(C(=O)Nc4cccc(C(F)(F)F)c4)c3)nn2)cc1		CHEMBL3323033	=	Inhibition	%	63.5	CHEMBL4722	Homo sapiens	INH	%	63.5
	15003469	CHEMBL3370368	Inhibition of Aurora A (unknown origin) at 10 uM using [33P]-ATP and 10 uM ATP after 2 hrs	B	O=C(O)c1cccc(-c2cn(-c3ccc(O)c(C(=O)Nc4cccc(C(F)(F)F)c4)c3)nn2)c1		CHEMBL3323034	=	Inhibition	%	52.5	CHEMBL4722	Homo sapiens	INH	%	52.5
	15003496	CHEMBL3370370	Inhibition of Aurora A (unknown origin) using [33P]-ATP and 10 uM ATP after 2 hrs	B	COc1cc(OC)cc(-c2cn(-c3ccc(O)c(C(=O)Nc4cccc(Cl)c4)c3)nn2)c1		CHEMBL3322933	=	IC50	nM	1890.0	CHEMBL4722	Homo sapiens	IC50	uM	1.89
	15003497	CHEMBL3370370	Inhibition of Aurora A (unknown origin) using [33P]-ATP and 10 uM ATP after 2 hrs	B	COC(=O)c1cccc(NC(=O)c2cc(-n3cc(-c4cc(OC)cc(OC)c4)nn3)ccc2O)c1		CHEMBL3322935	=	IC50	nM	370.0	CHEMBL4722	Homo sapiens	IC50	uM	0.37
	15003498	CHEMBL3370370	Inhibition of Aurora A (unknown origin) using [33P]-ATP and 10 uM ATP after 2 hrs	B	O=C(Nc1cccc(C(F)(F)F)c1)c1cc(-n2cc(-c3cc(C(F)(F)F)cc(C(F)(F)F)c3)nn2)ccc1O		CHEMBL3322937	=	IC50	nM	690.0	CHEMBL4722	Homo sapiens	IC50	uM	0.69
	15003499	CHEMBL3370370	Inhibition of Aurora A (unknown origin) using [33P]-ATP and 10 uM ATP after 2 hrs	B	N#Cc1ccc(-c2cn(-c3ccc(O)c(C(=O)Nc4cccc(C(F)(F)F)c4)c3)nn2)cc1		CHEMBL3322940	=	IC50	nM	1440.0	CHEMBL4722	Homo sapiens	IC50	uM	1.44
	15003500	CHEMBL3370370	Inhibition of Aurora A (unknown origin) using [33P]-ATP and 10 uM ATP after 2 hrs	B	COc1cc(OC)c(-c2cn(-c3ccc(O)c(C(=O)Nc4cccc(C(F)(F)F)c4)c3)nn2)cc1Cl		CHEMBL3323022	=	IC50	nM	720.0	CHEMBL4722	Homo sapiens	IC50	uM	0.72
	15003501	CHEMBL3370370	Inhibition of Aurora A (unknown origin) using [33P]-ATP and 10 uM ATP after 2 hrs	B	O=C(Nc1cccc(C(F)(F)F)c1)c1cc(-n2cc(-c3cccc(Cl)c3)nn2)ccc1O		CHEMBL3323023	=	IC50	nM	1560.0	CHEMBL4722	Homo sapiens	IC50	uM	1.56
	15003502	CHEMBL3370370	Inhibition of Aurora A (unknown origin) using [33P]-ATP and 10 uM ATP after 2 hrs	B	COC(=O)c1ccc(-c2cn(-c3ccc(O)c(C(=O)Nc4cccc(C(F)(F)F)c4)c3)nn2)cc1		CHEMBL3323024	=	IC50	nM	1500.0	CHEMBL4722	Homo sapiens	IC50	uM	1.5
	15003503	CHEMBL3370370	Inhibition of Aurora A (unknown origin) using [33P]-ATP and 10 uM ATP after 2 hrs	B	Cc1cccc(-c2cn(-c3ccc(O)c(C(=O)Nc4cccc(C(F)(F)F)c4)c3)nn2)c1		CHEMBL3323025	=	IC50	nM	3830.0	CHEMBL4722	Homo sapiens	IC50	uM	3.83
	15003504	CHEMBL3370370	Inhibition of Aurora A (unknown origin) using [33P]-ATP and 10 uM ATP after 2 hrs	B	O=C(Nc1cccc(C(F)(F)F)c1)c1cc(-n2cc(-c3ccsc3)nn2)ccc1O		CHEMBL3323029	=	IC50	nM	1880.0	CHEMBL4722	Homo sapiens	IC50	uM	1.88
	15003505	CHEMBL3370370	Inhibition of Aurora A (unknown origin) using [33P]-ATP and 10 uM ATP after 2 hrs	B	CC(=O)Nc1cccc(-c2cn(-c3ccc(O)c(C(=O)Nc4cccc(C(F)(F)F)c4)c3)nn2)c1		CHEMBL3323030	=	IC50	nM	4160.0	CHEMBL4722	Homo sapiens	IC50	uM	4.16
	15003506	CHEMBL3370370	Inhibition of Aurora A (unknown origin) using [33P]-ATP and 10 uM ATP after 2 hrs	B	COC(=O)c1cccc(-c2cn(-c3ccc(O)c(C(=O)Nc4cccc(C(F)(F)F)c4)c3)nn2)c1		CHEMBL3321770	=	IC50	nM	1820.0	CHEMBL4722	Homo sapiens	IC50	uM	1.82
	15003507	CHEMBL3370370	Inhibition of Aurora A (unknown origin) using [33P]-ATP and 10 uM ATP after 2 hrs	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	<=	IC50	nM	1.0	CHEMBL4722	Homo sapiens	IC50	uM	0.001
	15005912	CHEMBL3380550	Inhibition of human His-tagged full length AURKA using kemptide peptide as substrate after 60 mins	B	CC1(C)CCc2c(C(=O)Nc3cnn([C@H](c4ccccc4)C4CCNCC4)c3)n[nH]c2C1		CHEMBL3298373	=	Ki	nM	19.0	CHEMBL4722	Homo sapiens	Ki	nM	19.0
	15005937	CHEMBL3380550	Inhibition of human His-tagged full length AURKA using kemptide peptide as substrate after 60 mins	B	CC12Cc3[nH]nc(C(=O)Nc4cnn(Cc5ccccc5)c4)c3CC1C2		CHEMBL3298369	=	Ki	nM	54.0	CHEMBL4722	Homo sapiens	Ki	nM	54.0
	15005944	CHEMBL3380550	Inhibition of human His-tagged full length AURKA using kemptide peptide as substrate after 60 mins	B	N#Cc1cccc(Cn2cc(NC(=O)c3n[nH]c4cc(-c5cn[nH]c5)ccc34)cn2)c1		CHEMBL3263036	=	Ki	nM	72.0	CHEMBL4722	Homo sapiens	Ki	nM	72.0
	15005961	CHEMBL3380550	Inhibition of human His-tagged full length AURKA using kemptide peptide as substrate after 60 mins	B	CN(C)CC[C@H](c1ccccc1)n1cc(NC(=O)c2n[nH]c3c2CCC(C)(C)C3)cn1		CHEMBL3298372	=	Ki	nM	170.0	CHEMBL4722	Homo sapiens	Ki	nM	170.0
	15005964	CHEMBL3380550	Inhibition of human His-tagged full length AURKA using kemptide peptide as substrate after 60 mins	B	O=C(Nc1cnn(Cc2ccccc2)c1)c1n[nH]c2c1CCC1(CC1)C2		CHEMBL3298291	=	Ki	nM	180.0	CHEMBL4722	Homo sapiens	Ki	nM	180.0
	15005967	CHEMBL3380550	Inhibition of human His-tagged full length AURKA using kemptide peptide as substrate after 60 mins	B	CC1(CO)CCc2c(C(=O)Nc3cnn(Cc4ccccc4)c3)n[nH]c2C1		CHEMBL3298293	=	Ki	nM	200.0	CHEMBL4722	Homo sapiens	Ki	nM	200.0
	15005969	CHEMBL3380550	Inhibition of human His-tagged full length AURKA using kemptide peptide as substrate after 60 mins	B	N#Cc1cccc(Cn2cc(NC(=O)c3n[nH]c4c3CC(c3cn[nH]c3)CC4)cn2)c1		CHEMBL3298286	=	Ki	nM	210.0	CHEMBL4722	Homo sapiens	Ki	nM	210.0
	15005970	CHEMBL3380550	Inhibition of human His-tagged full length AURKA using kemptide peptide as substrate after 60 mins	B	CN(C)C[C@@H](c1ccccc1)n1cc(NC(=O)c2n[nH]c3c2CCC(C)(C)C3)cn1		CHEMBL3298370	=	Ki	nM	210.0	CHEMBL4722	Homo sapiens	Ki	nM	210.0
	15005971	CHEMBL3380550	Inhibition of human His-tagged full length AURKA using kemptide peptide as substrate after 60 mins	B	N#Cc1cccc(Cn2cc(NC(=O)c3n[nH]c4c3CC(c3cn[nH]c3)CC4)cn2)c1		CHEMBL3298286	=	Ki	nM	220.0	CHEMBL4722	Homo sapiens	Ki	nM	220.0
	15005975	CHEMBL3380550	Inhibition of human His-tagged full length AURKA using kemptide peptide as substrate after 60 mins	B	CN(C)CC[C@@H](c1cccc(Cl)c1)n1cc(NC(=O)c2n[nH]c3c2CCC(C)(C)C3)cn1		CHEMBL3298376	=	Ki	nM	290.0	CHEMBL4722	Homo sapiens	Ki	nM	290.0
	15005980	CHEMBL3380550	Inhibition of human His-tagged full length AURKA using kemptide peptide as substrate after 60 mins	B	CC12Cc3[nH]nc(C(=O)Nc4cnn(Cc5ccccc5)c4)c3CC1C2		CHEMBL3298369	=	Ki	nM	440.0	CHEMBL4722	Homo sapiens	Ki	nM	440.0
	15005981	CHEMBL3380550	Inhibition of human His-tagged full length AURKA using kemptide peptide as substrate after 60 mins	B	CN(C)CC[C@@H](c1ccccc1)n1cc(NC(=O)c2n[nH]c3c2CCC(C)(C)C3)cn1		CHEMBL3298371	=	Ki	nM	460.0	CHEMBL4722	Homo sapiens	Ki	nM	460.0
	15005982	CHEMBL3380550	Inhibition of human His-tagged full length AURKA using kemptide peptide as substrate after 60 mins	B	CC1(C)CCc2c(C(=O)Nc3cnn(Cc4ccccc4)c3)n[nH]c2C1		CHEMBL3298288	=	Ki	nM	480.0	CHEMBL4722	Homo sapiens	Ki	nM	480.0
	15005983	CHEMBL3380550	Inhibition of human His-tagged full length AURKA using kemptide peptide as substrate after 60 mins	B	Cc1cccc([C@H](CCN(C)C)n2cc(NC(=O)c3n[nH]c4c3CCC(C)(C)C4)cn2)c1		CHEMBL3298375	=	Ki	nM	500.0	CHEMBL4722	Homo sapiens	Ki	nM	500.0
	15005985	CHEMBL3380550	Inhibition of human His-tagged full length AURKA using kemptide peptide as substrate after 60 mins	B	CC1CCc2c(C(=O)Nc3cnn(Cc4ccccc4)c3)n[nH]c2C1		CHEMBL3298287	=	Ki	nM	520.0	CHEMBL4722	Homo sapiens	Ki	nM	520.0
	15005989	CHEMBL3380550	Inhibition of human His-tagged full length AURKA using kemptide peptide as substrate after 60 mins	B	N#Cc1cccc(Cn2cc(NC(=O)c3n[nH]c4c3CCCC4)cn2)c1		CHEMBL3298285	=	Ki	nM	780.0	CHEMBL4722	Homo sapiens	Ki	nM	780.0
	15005991	CHEMBL3380550	Inhibition of human His-tagged full length AURKA using kemptide peptide as substrate after 60 mins	B	N#Cc1cccc(Cn2cc(NC(=O)c3n[nH]c4ccccc34)cn2)c1		CHEMBL3262780	=	Ki	nM	870.0	CHEMBL4722	Homo sapiens	Ki	nM	870.0
	15005992	CHEMBL3380550	Inhibition of human His-tagged full length AURKA using kemptide peptide as substrate after 60 mins	B	O=C(Nc1cnn(Cc2ccccc2)c1)c1n[nH]c2c1CC1CC1C2		CHEMBL3298368	=	Ki	nM	870.0	CHEMBL4722	Homo sapiens	Ki	nM	870.0
	15005995	CHEMBL3380550	Inhibition of human His-tagged full length AURKA using kemptide peptide as substrate after 60 mins	B	O=C(Nc1cnn(Cc2ccccc2)c1)c1n[nH]c2c1CCC(F)(F)C2		CHEMBL3298290	=	Ki	nM	950.0	CHEMBL4722	Homo sapiens	Ki	nM	950.0
	15005996	CHEMBL3380550	Inhibition of human His-tagged full length AURKA using kemptide peptide as substrate after 60 mins	B	CC1CCc2c(C(=O)Nc3cnn(Cc4ccccc4)c3)n[nH]c2C1		CHEMBL3298287	=	Ki	nM	1100.0	CHEMBL4722	Homo sapiens	Ki	nM	1100.0
	15005998	CHEMBL3380550	Inhibition of human His-tagged full length AURKA using kemptide peptide as substrate after 60 mins	B	CC1(C)CCc2[nH]nc(C(=O)Nc3cnn(Cc4ccccc4)c3)c2C1		CHEMBL3298289	=	Ki	nM	1700.0	CHEMBL4722	Homo sapiens	Ki	nM	1700.0
	15005999	CHEMBL3380550	Inhibition of human His-tagged full length AURKA using kemptide peptide as substrate after 60 mins	B	O=C(Nc1cnn(Cc2ccccc2)c1)c1n[nH]c2c1CC1CC1C2		CHEMBL3298368	=	Ki	nM	2000.0	CHEMBL4722	Homo sapiens	Ki	nM	2000.0
	15006000	CHEMBL3380550	Inhibition of human His-tagged full length AURKA using kemptide peptide as substrate after 60 mins	B	CC1(C)CCc2c(C(=O)Nc3cnn([C@@H](CCS(C)(=O)=O)c4ccccc4)c3)n[nH]c2C1		CHEMBL3298374	=	Ki	nM	2100.0	CHEMBL4722	Homo sapiens	Ki	nM	2100.0
	15006002	CHEMBL3380550	Inhibition of human His-tagged full length AURKA using kemptide peptide as substrate after 60 mins	B	CC1(CO)CCc2c(C(=O)Nc3cnn(Cc4ccccc4)c3)n[nH]c2C1		CHEMBL3298293	=	Ki	nM	2300.0	CHEMBL4722	Homo sapiens	Ki	nM	2300.0
	15006003	CHEMBL3380550	Inhibition of human His-tagged full length AURKA using kemptide peptide as substrate after 60 mins	B	O=C(Nc1cnn(Cc2ccccc2)c1)c1n[nH]c2c1CCC1(COC1)C2		CHEMBL3298366	=	Ki	nM	2900.0	CHEMBL4722	Homo sapiens	Ki	nM	2900.0
	15006008	CHEMBL3380550	Inhibition of human His-tagged full length AURKA using kemptide peptide as substrate after 60 mins	B	CN(C)CC[C@@H](c1ccccc1)n1cc(NC(=O)c2n[nH]c3cc(-c4cn[nH]c4)ccc23)cn1		CHEMBL3263053	=	Ki	nM	15.0	CHEMBL4722	Homo sapiens	Ki	nM	15.0
Not Determined	15007932	CHEMBL3367527	Inhibition of Aurora A (unknown origin) by FRET-based homogenous assay	B	CCc1cccc(CC)c1NC(=O)Nc1ccc2[nH]nc(-c3cccc(S(N)(=O)=O)c3)c2c1		CHEMBL3330260		IC50			CHEMBL4722	Homo sapiens	IC50		
	15007933	CHEMBL3367527	Inhibition of Aurora A (unknown origin) by FRET-based homogenous assay	B	NS(=O)(=O)c1cccc(-c2n[nH]c3ccc(NC(=O)C(c4ccsc4)N4CCCC4)cc23)c1		CHEMBL3330410	=	IC50	nM	900.0	CHEMBL4722	Homo sapiens	IC50	uM	0.9
	15007934	CHEMBL3367527	Inhibition of Aurora A (unknown origin) by FRET-based homogenous assay	B	CCc1ccccc1C(C(=O)Nc1ccc2[nH]nc(-c3cccc(S(N)(=O)=O)c3)c2c1)N(C)C		CHEMBL3330409	=	IC50	nM	400.0	CHEMBL4722	Homo sapiens	IC50	uM	0.4
	15007970	CHEMBL3367749	Inhibition of human Aurora-A at 1 uM by radiometric Assay	B	NS(=O)(=O)c1cccc(-c2n[nH]c3ccc(NC(=O)Cc4ccccc4)cc23)c1		CHEMBL3330255	=	Inhibition	%	96.0	CHEMBL4722	Homo sapiens	INH	%	96.0
	15007971	CHEMBL3367749	Inhibition of human Aurora-A at 1 uM by radiometric Assay	B	COC(C(=O)Nc1ccc2[nH]nc(-c3cccc(S(N)(=O)=O)c3)c2c1)c1ccccc1		CHEMBL3330401	=	Inhibition	%	91.0	CHEMBL4722	Homo sapiens	INH	%	91.0
	15007972	CHEMBL3367749	Inhibition of human Aurora-A at 1 uM by radiometric Assay	B	NS(=O)(=O)c1cccc(-c2n[nH]c3ccc(NC(=O)C(c4ccsc4)N4CCCC4)cc23)c1		CHEMBL3330410	=	Inhibition	%	51.0	CHEMBL4722	Homo sapiens	INH	%	51.0
	15009819	CHEMBL3363736	Inhibition of Aurora A (unknown origin) at 10 uM	B	C[C@H](O)CNc1nccc(-n2ccnc2Cc2cccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)c2)n1		CHEMBL3309549	=	Inhibition	%	17.6	CHEMBL4722	Homo sapiens	INH	%	17.6
	15013916	CHEMBL3364476	Inhibition of Aurora A (unknown origin)	B	c1ccc2[nH]c(-c3cc[nH]n3)nc2c1		CHEMBL495758	=	IC50	nM	910.0	CHEMBL4722	Homo sapiens	IC50	uM	0.91
	15013917	CHEMBL3364476	Inhibition of Aurora A (unknown origin)	B	O=C(Nc1c[nH]nc1-c1nc2ccccc2[nH]1)c1ccccc1		CHEMBL522891	=	IC50	nM	5.9	CHEMBL4722	Homo sapiens	IC50	uM	0.0059
	15014103	CHEMBL3361858	Inhibition of Aurora-A (unknown origin) at 100 nM	B	O=C(N[C@H](CO)c1ccc(Cl)c(F)c1)N1CCc2cnc(NC3CCOCC3)nc2C1		CHEMBL3298678	=	Inhibition	%	4.2	CHEMBL4722	Homo sapiens	INH	%	4.2
	15019170	CHEMBL3364363	Inhibition of AURKA (unknown origin) at 1 uM in presence of 100 uM ATP	B	C=CC(=O)[C@H](Cc1ccccc1)NC(=O)OC(C)(C)C		CHEMBL3298512	=	Inhibition	%	35.0	CHEMBL4722	Homo sapiens	INH	%	35.0
	15022481	CHEMBL3380446	Inhibition of Aurora A (unknown origin) at 1 uM	B	COc1ccc(C(=O)NC(=O)Nc2ccc3c(c2)NC(=O)/C3=C\c2ccc[nH]2)cc1		CHEMBL3329652	=	Inhibition	%	11.0	CHEMBL4722	Homo sapiens	INH	%	11.0
	15022482	CHEMBL3380446	Inhibition of Aurora A (unknown origin) at 1 uM	B	COc1ccc(C(=O)NC(=O)Nc2ccc3c(c2)NC(=O)/C3=C\c2[nH]c(C)c(C(=O)NCCN3CCCC3)c2C)c(F)c1		CHEMBL3329684	=	Inhibition	%	21.0	CHEMBL4722	Homo sapiens	INH	%	21.0
	15025223	CHEMBL3362100	Inhibition of Aurora A (unknown origin) using H-LRRASLG substrate at 1 uM by radioisotope-based P81 filter-binding assay	B	COc1ccc(NC(=O)CC(=O)Nc2ccc3c(c2)NC(=O)/C3=C\c2[nH]c(C)c(C(=O)NCCN3CCCC3)c2C)cc1		CHEMBL3322566	=	Inhibition	%	54.0	CHEMBL4722	Homo sapiens	INH	%	54.0
	15025224	CHEMBL3362100	Inhibition of Aurora A (unknown origin) using H-LRRASLG substrate at 1 uM by radioisotope-based P81 filter-binding assay	B	COc1ccc(NC(=O)CC(=O)Nc2ccc3c(c2)NC(=O)/C3=C\c2ccc[nH]2)cc1		CHEMBL3322564	=	Inhibition	%	24.0	CHEMBL4722	Homo sapiens	INH	%	24.0
	15025225	CHEMBL3362099	Inhibition of Aurora A (unknown origin) using H-LRRASLG substrate by radioisotope-based P81 filter-binding assay	B	COc1ccc(NC(=O)CC(=O)Nc2ccc3c(c2)NC(=O)/C3=C\c2[nH]c(C)c(C(=O)O)c2C)cc1		CHEMBL3322565	=	IC50	nM	203.0	CHEMBL4722	Homo sapiens	IC50	nM	203.0
	15025226	CHEMBL3362099	Inhibition of Aurora A (unknown origin) using H-LRRASLG substrate by radioisotope-based P81 filter-binding assay	B	O=C(CC(=O)Nc1ccc2c(c1)NC(=O)/C2=C\c1ccc[nH]1)Nc1ccc(F)cc1		CHEMBL3322563	=	IC50	nM	551.9	CHEMBL4722	Homo sapiens	IC50	nM	551.9
	15025227	CHEMBL3362100	Inhibition of Aurora A (unknown origin) using H-LRRASLG substrate at 1 uM by radioisotope-based P81 filter-binding assay	B	O=C1Nc2cc(NC(=O)C3(C(=O)Nc4ccc(F)cc4)CC3)ccc2/C1=C/c1ccc[nH]1		CHEMBL3322567	=	Inhibition	%	10.0	CHEMBL4722	Homo sapiens	INH	%	10.0
	15025228	CHEMBL3362100	Inhibition of Aurora A (unknown origin) using H-LRRASLG substrate at 1 uM by radioisotope-based P81 filter-binding assay	B	COc1ccc(NC(=O)C2(C(=O)Nc3ccc4c(c3)NC(=O)/C4=C\c3ccc[nH]3)CC2)cc1		CHEMBL3322568	=	Inhibition	%	4.0	CHEMBL4722	Homo sapiens	INH	%	4.0
	15025419	CHEMBL3362100	Inhibition of Aurora A (unknown origin) using H-LRRASLG substrate at 1 uM by radioisotope-based P81 filter-binding assay	B	O=C1Nc2cc(NC(=O)c3c[nH]cc(-c4ccccc4F)c3=O)ccc2/C1=C/c1ccc[nH]1		CHEMBL3322590	=	Inhibition	%	10.6	CHEMBL4722	Homo sapiens	INH	%	10.6
	15035067	CHEMBL3368762	Inhibition of aurora A (unknown origin)	B	COc1cc(Nc2nc3cccc(-c4cccc5[nH]cnc45)c3o2)cc(OC)c1OC		CHEMBL3298194	=	IC50	nM	600.0	CHEMBL4722	Homo sapiens	IC50	uM	0.6
	15036723	CHEMBL3381060	Inhibition of Aurora 1 (unknown origin)	B	Nc1nc2c3c(F)cccc3nc(Cc3ccc4c(c3)OCO4)n2n1		CHEMBL3309990	>	IC50	nM	10000.0	CHEMBL4722	Homo sapiens	IC50	uM	10.0
	15036724	CHEMBL3381060	Inhibition of Aurora 1 (unknown origin)	B	Nc1ccc2c(c1)nc(Cc1ccc3c(c1)OCO3)n1nc(N)nc21		CHEMBL3309995	>	IC50	nM	10000.0	CHEMBL4722	Homo sapiens	IC50	uM	10.0
	15036725	CHEMBL3381060	Inhibition of Aurora 1 (unknown origin)	B	OCCCNc1ccc2c(c1)nc(-c1ccc3c(c1)OCO3)n1ncnc21		CHEMBL3309997	>	IC50	nM	10000.0	CHEMBL4722	Homo sapiens	IC50	uM	10.0
	15036726	CHEMBL3381060	Inhibition of Aurora 1 (unknown origin)	B	Nc1nc2c3ccc(NCCO)cc3nc(Cc3ccc4c(c3)OCO4)n2n1		CHEMBL3309998	>	IC50	nM	10000.0	CHEMBL4722	Homo sapiens	IC50	uM	10.0
	15036727	CHEMBL3381060	Inhibition of Aurora 1 (unknown origin)	B	CN1CCN(c2cc(F)c3c(c2)nc(Cc2ccc4c(c2)OCO4)n2nc(N)nc32)CC1		CHEMBL3310151	>	IC50	nM	10000.0	CHEMBL4722	Homo sapiens	IC50	uM	10.0
	15037153	CHEMBL3368326	Inhibition of AURKA (unknown origin) at 1 uM by KINOMEscanning assay relative to control	B	COc1ccc(-c2cnc3[nH]cc(-c4ccc(OC)c(OC)c4)c3c2)cc1OC		CHEMBL3102948	=	Inhibition	%	13.0	CHEMBL4722	Homo sapiens	INH	%	13.0
	15037154	CHEMBL3368326	Inhibition of AURKA (unknown origin) at 1 uM by KINOMEscanning assay relative to control	B	COc1cc(-c2c[nH]c3ncc(-c4cccc(N)c4)cc23)cc(OC)c1OC		CHEMBL3319457	=	Inhibition	%	8.9	CHEMBL4722	Homo sapiens	INH	%	8.9
	15037155	CHEMBL3368326	Inhibition of AURKA (unknown origin) at 1 uM by KINOMEscanning assay relative to control	B	COc1ccc(-c2c[nH]c3ncc(-c4ccc(C(=O)N5CCOCC5)c(N)c4)cc23)cc1OC		CHEMBL3319467	=	Inhibition	%	0.85	CHEMBL4722	Homo sapiens	INH	%	0.85
	15037156	CHEMBL3368326	Inhibition of AURKA (unknown origin) at 1 uM by KINOMEscanning assay relative to control	B	COc1ccc(-c2c[nH]c3ncc(-c4cc(OC)c(OC)c(OC)c4)cc23)cc1OC		CHEMBL3319468	=	Inhibition	%	25.0	CHEMBL4722	Homo sapiens	INH	%	25.0
	15037157	CHEMBL3368326	Inhibition of AURKA (unknown origin) at 1 uM by KINOMEscanning assay relative to control	B	COc1ccc(-c2cnc3[nH]cc(-c4ccc(OC)c(OC)c4)c3c2)cc1N		CHEMBL3319470	=	Inhibition	%	17.0	CHEMBL4722	Homo sapiens	INH	%	17.0
	15055292	CHEMBL3380462	Inhibition of human recombinant Aurora A using Tetra(LRRWSLG) substrate	B	COc1cc(-c2nc(-c3c[nH]c4ccccc34)c[nH]c2=O)cc(OC)c1OC		CHEMBL3358966	>	IC50	nM	100000.0	CHEMBL4722	Homo sapiens	IC50	uM	100.0
Not Active	15062595	CHEMBL3370529	Inhibition of human Aurora A by Off-chip mobility shift assay	B	O=C(Cc1c(F)cccc1Cl)Nc1onc(-c2ccc(F)cc2)c1-c1ccncn1		CHEMBL3310142		Inhibition	%		CHEMBL4722	Homo sapiens	INH		
	15068287	CHEMBL3388438	Inhibition of Aurora-A (unknown origin) using STK substrate 2-biotin by HTRF-KinEASE-STK assay	B	O=C(NCc1ccccc1)Nc1ccc(Nc2ncnc3cc(OCCCN4CCOCC4)ccc23)cc1		CHEMBL3343308	=	IC50	nM	212.0	CHEMBL4722	Homo sapiens	IC50	nM	212.0
	15068288	CHEMBL3388438	Inhibition of Aurora-A (unknown origin) using STK substrate 2-biotin by HTRF-KinEASE-STK assay	B	CN1CCN(CCCOc2ccc3c(Nc4ccc(NC(=O)NCc5ccccc5)cc4)ncnc3c2)CC1		CHEMBL3343309	=	IC50	nM	195.0	CHEMBL4722	Homo sapiens	IC50	nM	195.0
	15068289	CHEMBL3388438	Inhibition of Aurora-A (unknown origin) using STK substrate 2-biotin by HTRF-KinEASE-STK assay	B	O=C(NCc1ccccc1)Nc1ccc(Nc2ncnc3cc(OCCCN4CCCCC4)ccc23)cc1		CHEMBL3343310	=	IC50	nM	78.0	CHEMBL4722	Homo sapiens	IC50	nM	78.0
	15068290	CHEMBL3388438	Inhibition of Aurora-A (unknown origin) using STK substrate 2-biotin by HTRF-KinEASE-STK assay	B	CC1CCCCN1CCCOc1ccc2c(Nc3ccc(NC(=O)NCc4ccccc4)cc3)ncnc2c1		CHEMBL3343311	=	IC50	nM	61.0	CHEMBL4722	Homo sapiens	IC50	nM	61.0
	15068291	CHEMBL3388438	Inhibition of Aurora-A (unknown origin) using STK substrate 2-biotin by HTRF-KinEASE-STK assay	B	CC1CCN(CCCOc2ccc3c(Nc4ccc(NC(=O)NCc5ccccc5)cc4)ncnc3c2)CC1		CHEMBL3343312	=	IC50	nM	219.0	CHEMBL4722	Homo sapiens	IC50	nM	219.0
	15068292	CHEMBL3388438	Inhibition of Aurora-A (unknown origin) using STK substrate 2-biotin by HTRF-KinEASE-STK assay	B	O=C(NCc1ccccc1)Nc1ccc(Nc2ncnc3cc(OCCCN4CCCC4)ccc23)cc1		CHEMBL3706674	=	IC50	nM	143.0	CHEMBL4722	Homo sapiens	IC50	nM	143.0
	15068293	CHEMBL3388438	Inhibition of Aurora-A (unknown origin) using STK substrate 2-biotin by HTRF-KinEASE-STK assay	B	CCN(CC)CCCOc1ccc2c(Nc3ccc(NC(=O)NCc4ccccc4)cc3)ncnc2c1		CHEMBL3706673	=	IC50	nM	128.0	CHEMBL4722	Homo sapiens	IC50	nM	128.0
	15068294	CHEMBL3388438	Inhibition of Aurora-A (unknown origin) using STK substrate 2-biotin by HTRF-KinEASE-STK assay	B	CCN(CCO)CCCOc1ccc2c(Nc3ccc(NC(=O)NCc4ccccc4)cc3)ncnc2c1		CHEMBL3706675	=	IC50	nM	468.0	CHEMBL4722	Homo sapiens	IC50	nM	468.0
	15068295	CHEMBL3388438	Inhibition of Aurora-A (unknown origin) using STK substrate 2-biotin by HTRF-KinEASE-STK assay	B	O=C(NCc1ccccc1)Nc1ccc(Nc2ncnc3cc(OCCCN4CCN(CCO)CC4)ccc23)cc1		CHEMBL3706676	=	IC50	nM	496.0	CHEMBL4722	Homo sapiens	IC50	nM	496.0
	15068296	CHEMBL3388438	Inhibition of Aurora-A (unknown origin) using STK substrate 2-biotin by HTRF-KinEASE-STK assay	B	O=C(NCc1ccccc1)Nc1ccc(Nc2ncnc3cc(OCCCN4CCC(CO)CC4)ccc23)cc1		CHEMBL3706677	=	IC50	nM	564.0	CHEMBL4722	Homo sapiens	IC50	nM	564.0
	15068297	CHEMBL3388438	Inhibition of Aurora-A (unknown origin) using STK substrate 2-biotin by HTRF-KinEASE-STK assay	B	O=C(Nc1ccc(Nc2ncnc3cc(OCCCN4CCOCC4)ccc23)cc1)NC1CCCCC1		CHEMBL3706678	=	IC50	nM	193.0	CHEMBL4722	Homo sapiens	IC50	nM	193.0
	15068298	CHEMBL3388438	Inhibition of Aurora-A (unknown origin) using STK substrate 2-biotin by HTRF-KinEASE-STK assay	B	CN1CCN(CCCOc2ccc3c(Nc4ccc(NC(=O)NC5CCCCC5)cc4)ncnc3c2)CC1		CHEMBL3706679	=	IC50	nM	202.0	CHEMBL4722	Homo sapiens	IC50	nM	202.0
	15068299	CHEMBL3388438	Inhibition of Aurora-A (unknown origin) using STK substrate 2-biotin by HTRF-KinEASE-STK assay	B	O=C(Nc1ccc(Nc2ncnc3cc(OCCCN4CCCCC4)ccc23)cc1)NC1CCCCC1		CHEMBL3706680	=	IC50	nM	103.0	CHEMBL4722	Homo sapiens	IC50	nM	103.0
	15068300	CHEMBL3388438	Inhibition of Aurora-A (unknown origin) using STK substrate 2-biotin by HTRF-KinEASE-STK assay	B	CC1CCCCN1CCCOc1ccc2c(Nc3ccc(NC(=O)NC4CCCCC4)cc3)ncnc2c1		CHEMBL3706681	=	IC50	nM	82.0	CHEMBL4722	Homo sapiens	IC50	nM	82.0
	15068301	CHEMBL3388438	Inhibition of Aurora-A (unknown origin) using STK substrate 2-biotin by HTRF-KinEASE-STK assay	B	CC1CCN(CCCOc2ccc3c(Nc4ccc(NC(=O)NC5CCCCC5)cc4)ncnc3c2)CC1		CHEMBL3706682	=	IC50	nM	157.0	CHEMBL4722	Homo sapiens	IC50	nM	157.0
	15068302	CHEMBL3388438	Inhibition of Aurora-A (unknown origin) using STK substrate 2-biotin by HTRF-KinEASE-STK assay	B	O=C(Nc1ccc(Nc2ncnc3cc(OCCCN4CCCC4)ccc23)cc1)NC1CCCCC1		CHEMBL3706683	=	IC50	nM	115.0	CHEMBL4722	Homo sapiens	IC50	nM	115.0
	15068303	CHEMBL3388438	Inhibition of Aurora-A (unknown origin) using STK substrate 2-biotin by HTRF-KinEASE-STK assay	B	CCN(CC)CCCOc1ccc2c(Nc3ccc(NC(=O)NC4CCCCC4)cc3)ncnc2c1		CHEMBL3706684	=	IC50	nM	123.0	CHEMBL4722	Homo sapiens	IC50	nM	123.0
	15068304	CHEMBL3388438	Inhibition of Aurora-A (unknown origin) using STK substrate 2-biotin by HTRF-KinEASE-STK assay	B	CCN(CCO)CCCOc1ccc2c(Nc3ccc(NC(=O)NC4CCCCC4)cc3)ncnc2c1		CHEMBL3706685	=	IC50	nM	312.0	CHEMBL4722	Homo sapiens	IC50	nM	312.0
	15068305	CHEMBL3388438	Inhibition of Aurora-A (unknown origin) using STK substrate 2-biotin by HTRF-KinEASE-STK assay	B	O=C(Nc1ccc(Nc2ncnc3cc(OCCCN4CCN(CCO)CC4)ccc23)cc1)NC1CCCCC1		CHEMBL3706686	=	IC50	nM	436.0	CHEMBL4722	Homo sapiens	IC50	nM	436.0
	15068306	CHEMBL3388438	Inhibition of Aurora-A (unknown origin) using STK substrate 2-biotin by HTRF-KinEASE-STK assay	B	O=C(Nc1ccc(Nc2ncnc3cc(OCCCN4CCC(CO)CC4)ccc23)cc1)NC1CCCCC1		CHEMBL3706687	=	IC50	nM	796.0	CHEMBL4722	Homo sapiens	IC50	nM	796.0
	15068307	CHEMBL3388438	Inhibition of Aurora-A (unknown origin) using STK substrate 2-biotin by HTRF-KinEASE-STK assay	B	COc1cc2c(Nc3ccc(NC(=O)c4ccccc4)cc3)ncnc2cc1OCCCN1CCOCC1		CHEMBL202721	=	IC50	nM	138.0	CHEMBL4722	Homo sapiens	IC50	nM	138.0
	15068351	CHEMBL3388441	Inhibition of Aurora-A (unknown origin)	B	COc1cc2c(Nc3ccc(NC(=O)c4ccccc4)cc3)ncnc2cc1OCCCN1CCOCC1		CHEMBL202721	=	IC50	nM	110.0	CHEMBL4722	Homo sapiens	IC50	nM	110.0
	15072451	CHEMBL3380123	Inhibition of Aurora A (unknown origin) assessed as remaining enzyme activity at 10 uM by radioactive [33P]-ATP filter binding assay	B	Cc1ccc(-c2cc(C(=O)Nc3ccnc(Cl)c3)nn2-c2ccc3ccccc3n2)cc1		CHEMBL3338802	=	Activity	%	120.0	CHEMBL4722	Homo sapiens	Activity	%	120.0
	15075119	CHEMBL3376331	Inhibition of Aurora A (unknown origin) at 1 uM	B	CC(C)(O)Cn1cc(-c2ccc(-c3cc4c(Nc5ccncc5)ncnn4c3)cc2)cn1		CHEMBL3326802	=	Inhibition	%	87.0	CHEMBL4722	Homo sapiens	INH	%	87.0
	15091123	CHEMBL3390658	Inhibition of human recombinant AurA/Aur2 kinase expressed Sf21 cells using Ulight-RRRSLLE substrate assessed as remaining enzyme activity at 1 uM after 15 mins relative to control	B	O=C1Nc2ccc(Cl)cc2/C1=C/c1cc(Br)c(O)c(Br)c1		CHEMBL2206014	=	Activity	%	73.0	CHEMBL4722	Homo sapiens	Activity	%	73.0
Active	15100340	CHEMBL3389101	Inhibition of Aurora A kinase phosphorylation in human HT-29 cells at 10 uM incubated for 15 to 120 mins by Western blotting method	B	COc1c2c(cc3oc(C)cc(=O)c13)OC(C(C)(C)O[C@H]1O[C@@H](CO)[C@H](O)[C@@H](O)[C@@H]1O)C2		CHEMBL2059296		Inhibition	%		CHEMBL4722	Homo sapiens	INH		
	15149909	CHEMBL3395789	Inhibition of AURKA (unknown origin) at 5.5 uM by Caliper Mobility Shift Assay	B	CC(=O)Nc1cc(-c2c(-c3ccc(F)cc3)nc(Sc3cccc(I)n3)n2C2CCCCC2)ccn1		CHEMBL3394118	<	Inhibition	%	50.0	CHEMBL4722	Homo sapiens	INH	%	50.0
	15149910	CHEMBL3395789	Inhibition of AURKA (unknown origin) at 5.5 uM by Caliper Mobility Shift Assay	B	CC(=O)Nc1cc(-c2c(-c3ccc(F)cc3)nc(S/C=C\C(=O)O)n2CC2CCCO2)ccn1		CHEMBL3394108	<	Inhibition	%	50.0	CHEMBL4722	Homo sapiens	INH	%	50.0
	15149911	CHEMBL3395789	Inhibition of AURKA (unknown origin) at 5.5 uM by Caliper Mobility Shift Assay	B	CC(=O)Nc1cc(-c2c(-c3ccc(F)cc3)nc(S/C=C\C(=O)O)n2C2CC2)ccn1		CHEMBL3394102	<	Inhibition	%	50.0	CHEMBL4722	Homo sapiens	INH	%	50.0
	15149920	CHEMBL3395789	Inhibition of AURKA (unknown origin) at 5.5 uM by Caliper Mobility Shift Assay	B	COC(Cn1c(SC2CCC(C(=O)O)CC2O)nc(-c2ccc(F)cc2)c1-c1ccnc(NC(C)=O)c1)OC		CHEMBL3394112	<	Inhibition	%	50.0	CHEMBL4722	Homo sapiens	INH	%	50.0
	15149921	CHEMBL3395789	Inhibition of AURKA (unknown origin) at 5.5 uM by Caliper Mobility Shift Assay	B	CC(=O)Nc1cc(-c2c(-c3ccc(F)cc3)nc(S/C=C\C(=O)O)n2C2CCCCC2)ccn1		CHEMBL3394105	<	Inhibition	%	50.0	CHEMBL4722	Homo sapiens	INH	%	50.0
	15152264	CHEMBL3396725	Inhibition of poly-histidine tagged full length recombinant aurora A (unknown origin) assessed as phosphorylation of NuMA-histidine substrate by scintillation counting analysis	B	CCOC(=O)c1[nH]cc2c1NC1=C(C(=O)CCC1)[C@H]2c1cccc(Oc2nc3ccccc3[nH]2)c1		CHEMBL3393498	=	IC50	nM	0.6	CHEMBL4722	Homo sapiens	IC50	nM	0.6
	15152265	CHEMBL3396725	Inhibition of poly-histidine tagged full length recombinant aurora A (unknown origin) assessed as phosphorylation of NuMA-histidine substrate by scintillation counting analysis	B	CCOC(=O)c1[nH]cc2c1NC1=C(C(=O)CCC1)C2c1cccc(Oc2nc3ccccc3[nH]2)c1		CHEMBL3393497	=	IC50	nM	17.0	CHEMBL4722	Homo sapiens	IC50	nM	17.0
	15152266	CHEMBL3396725	Inhibition of poly-histidine tagged full length recombinant aurora A (unknown origin) assessed as phosphorylation of NuMA-histidine substrate by scintillation counting analysis	B	CCOC(=O)c1[nH]cc2c1NC1=C(C(=O)CCC1)C2c1ccnc(Sc2nc3ccccc3[nH]2)c1		CHEMBL3393496	=	IC50	nM	5200.0	CHEMBL4722	Homo sapiens	IC50	nM	5200.0
	15152267	CHEMBL3396725	Inhibition of poly-histidine tagged full length recombinant aurora A (unknown origin) assessed as phosphorylation of NuMA-histidine substrate by scintillation counting analysis	B	CCOC(=O)c1[nH]cc2c1NC1=C(C(=O)CCC1)C2c1cccc(Sc2nc3ccccc3[nH]2)n1		CHEMBL3393495	=	IC50	nM	31.0	CHEMBL4722	Homo sapiens	IC50	nM	31.0
	15152268	CHEMBL3396725	Inhibition of poly-histidine tagged full length recombinant aurora A (unknown origin) assessed as phosphorylation of NuMA-histidine substrate by scintillation counting analysis	B	CCOC(=O)c1[nH]cc2c1NC1=C(C(=O)CCC1)C2c1cccc(Sc2nc3ccccc3[nH]2)c1		CHEMBL3393494	=	IC50	nM	70.0	CHEMBL4722	Homo sapiens	IC50	nM	70.0
	15152269	CHEMBL3396725	Inhibition of poly-histidine tagged full length recombinant aurora A (unknown origin) assessed as phosphorylation of NuMA-histidine substrate by scintillation counting analysis	B	CCOC(=O)c1[nH]cc2c1NC1=C(C(=O)CCC1)C2c1cc(Sc2nc3ccccc3[nH]2)cs1		CHEMBL3393065	=	IC50	nM	11.0	CHEMBL4722	Homo sapiens	IC50	nM	11.0
	15152270	CHEMBL3396725	Inhibition of poly-histidine tagged full length recombinant aurora A (unknown origin) assessed as phosphorylation of NuMA-histidine substrate by scintillation counting analysis	B	CCOC(=O)c1[nH]cc2c1NC1=C(C(=O)CCC1)C2c1cnc(Sc2nc3ccccc3[nH]2)s1		CHEMBL3393493	>	IC50	nM	10000.0	CHEMBL4722	Homo sapiens	IC50	nM	10000.0
	15152271	CHEMBL3396725	Inhibition of poly-histidine tagged full length recombinant aurora A (unknown origin) assessed as phosphorylation of NuMA-histidine substrate by scintillation counting analysis	B	CCOC(=O)c1[nH]cc2c1NC1=C(C(=O)CCC1)C2c1ccc(Sc2nc3ccccc3[nH]2)s1		CHEMBL3393492	=	IC50	nM	2300.0	CHEMBL4722	Homo sapiens	IC50	nM	2300.0
	15152272	CHEMBL3396725	Inhibition of poly-histidine tagged full length recombinant aurora A (unknown origin) assessed as phosphorylation of NuMA-histidine substrate by scintillation counting analysis	B	CCOC(=O)c1[nH]cc2c1NC1=C(C(=O)CN(Cc3ccccc3)C1)C2c1ccc(Sc2nc3ccccc3[nH]2)o1		CHEMBL3393491	=	IC50	nM	11.0	CHEMBL4722	Homo sapiens	IC50	nM	11.0
	15152273	CHEMBL3396725	Inhibition of poly-histidine tagged full length recombinant aurora A (unknown origin) assessed as phosphorylation of NuMA-histidine substrate by scintillation counting analysis	B	CCOC(=O)c1[nH]cc2c1NC1=C(C(=O)CN(C(=O)OC(C)(C)C)C1)C2c1ccc(Sc2nc3ccccc3[nH]2)o1		CHEMBL3393490	=	IC50	nM	6.0	CHEMBL4722	Homo sapiens	IC50	nM	6.0
	15152274	CHEMBL3396725	Inhibition of poly-histidine tagged full length recombinant aurora A (unknown origin) assessed as phosphorylation of NuMA-histidine substrate by scintillation counting analysis	B	CCOC(=O)c1[nH]cc2c1NC1=C(C(=O)CC(C)(C)C1)C2c1ccc(Sc2nc3ccccc3[nH]2)o1		CHEMBL3393489	=	IC50	nM	17.0	CHEMBL4722	Homo sapiens	IC50	nM	17.0
	15152275	CHEMBL3396725	Inhibition of poly-histidine tagged full length recombinant aurora A (unknown origin) assessed as phosphorylation of NuMA-histidine substrate by scintillation counting analysis	B	CCOC(=O)c1[nH]cc2c1NC1=C(C(=O)CNC1)C2c1ccc(Sc2nc3c(F)cccc3[nH]2)o1		CHEMBL3393488	=	IC50	nM	21.0	CHEMBL4722	Homo sapiens	IC50	nM	21.0
	15152276	CHEMBL3396725	Inhibition of poly-histidine tagged full length recombinant aurora A (unknown origin) assessed as phosphorylation of NuMA-histidine substrate by scintillation counting analysis	B	CCOC(=O)c1[nH]cc2c1NC1=C(C(=O)CNC1)C2c1ccc(Sc2nc3cccc(Cl)c3[nH]2)o1		CHEMBL3393487	=	IC50	nM	22.0	CHEMBL4722	Homo sapiens	IC50	nM	22.0
	15152277	CHEMBL3396725	Inhibition of poly-histidine tagged full length recombinant aurora A (unknown origin) assessed as phosphorylation of NuMA-histidine substrate by scintillation counting analysis	B	CCOC(=O)c1[nH]cc2c1NC1=C(C(=O)CN(C(=O)CN)C1)[C@H]2c1ccc(Sc2nc3c(F)cccc3[nH]2)o1.Cl		CHEMBL3393486	=	IC50	nM	15.0	CHEMBL4722	Homo sapiens	IC50	nM	15.0
	15152278	CHEMBL3396725	Inhibition of poly-histidine tagged full length recombinant aurora A (unknown origin) assessed as phosphorylation of NuMA-histidine substrate by scintillation counting analysis	B	CCOC(=O)c1[nH]cc2c1NC1=C(C(=O)CN(C(=O)CN)C1)[C@H]2c1ccc(Sc2nc3ccccc3[nH]2)o1.Cl		CHEMBL3393485	=	IC50	nM	20.0	CHEMBL4722	Homo sapiens	IC50	nM	20.0
	15152279	CHEMBL3396725	Inhibition of poly-histidine tagged full length recombinant aurora A (unknown origin) assessed as phosphorylation of NuMA-histidine substrate by scintillation counting analysis	B	CCOC(=O)c1[nH]cc2c1NC1=C(C(=O)CN(CC)C1)C2c1ccc(Sc2nc3ccccc3[nH]2)o1		CHEMBL3393484	=	IC50	nM	8.0	CHEMBL4722	Homo sapiens	IC50	nM	8.0
	15152280	CHEMBL3396725	Inhibition of poly-histidine tagged full length recombinant aurora A (unknown origin) assessed as phosphorylation of NuMA-histidine substrate by scintillation counting analysis	B	CCOC(=O)c1[nH]cc2c1NC1=C(C(=O)CCC1)C2c1ccc(Sc2nc3c(N)cccc3[nH]2)o1		CHEMBL3393483	=	IC50	nM	60.0	CHEMBL4722	Homo sapiens	IC50	nM	60.0
	15152281	CHEMBL3396725	Inhibition of poly-histidine tagged full length recombinant aurora A (unknown origin) assessed as phosphorylation of NuMA-histidine substrate by scintillation counting analysis	B	CCOC(=O)c1[nH]cc2c1NC1=C(C(=O)CCC1)C2c1ccc(Sc2nc3c(O)cccc3[nH]2)o1		CHEMBL3393482	=	IC50	nM	25.0	CHEMBL4722	Homo sapiens	IC50	nM	25.0
	15152282	CHEMBL3396725	Inhibition of poly-histidine tagged full length recombinant aurora A (unknown origin) assessed as phosphorylation of NuMA-histidine substrate by scintillation counting analysis	B	CCOC(=O)c1[nH]cc2c1NC1=C(C(=O)CCC1)C2c1ccc(Sc2nc3cccnc3[nH]2)o1		CHEMBL3393481	=	IC50	nM	31.0	CHEMBL4722	Homo sapiens	IC50	nM	31.0
	15152283	CHEMBL3396725	Inhibition of poly-histidine tagged full length recombinant aurora A (unknown origin) assessed as phosphorylation of NuMA-histidine substrate by scintillation counting analysis	B	CCOC(=O)c1[nH]cc2c1NC1=C(C(=O)CCC1)C2c1ccc(Sc2nc3cc(Cl)ccc3[nH]2)o1		CHEMBL3393480	=	IC50	nM	34.0	CHEMBL4722	Homo sapiens	IC50	nM	34.0
	15152284	CHEMBL3396725	Inhibition of poly-histidine tagged full length recombinant aurora A (unknown origin) assessed as phosphorylation of NuMA-histidine substrate by scintillation counting analysis	B	CCOC(=O)c1[nH]cc2c1NC1=C(C(=O)CCC1)C2c1ccc(Sc2nc3cccc(Cl)c3[nH]2)o1		CHEMBL3393479	=	IC50	nM	4.0	CHEMBL4722	Homo sapiens	IC50	nM	4.0
	15152285	CHEMBL3396725	Inhibition of poly-histidine tagged full length recombinant aurora A (unknown origin) assessed as phosphorylation of NuMA-histidine substrate by scintillation counting analysis	B	CCOC(=O)c1[nH]cc2c1NC1=C(C(=O)CCC1)C2c1ccc(Sc2nc3c(F)c(F)c(F)cc3[nH]2)o1		CHEMBL3393478	=	IC50	nM	22.0	CHEMBL4722	Homo sapiens	IC50	nM	22.0
	15152286	CHEMBL3396725	Inhibition of poly-histidine tagged full length recombinant aurora A (unknown origin) assessed as phosphorylation of NuMA-histidine substrate by scintillation counting analysis	B	CCOC(=O)c1[nH]cc2c1NC1=C(C(=O)CCC1)C2c1ccc(Sc2nc3ccc(F)c(F)c3[nH]2)o1		CHEMBL3393477	=	IC50	nM	10.0	CHEMBL4722	Homo sapiens	IC50	nM	10.0
	15152287	CHEMBL3396725	Inhibition of poly-histidine tagged full length recombinant aurora A (unknown origin) assessed as phosphorylation of NuMA-histidine substrate by scintillation counting analysis	B	CCOC(=O)c1[nH]cc2c1NC1=C(C(=O)CCC1)C2c1ccc(Sc2nc3cc(F)c(F)cc3[nH]2)o1		CHEMBL3393476	=	IC50	nM	22.0	CHEMBL4722	Homo sapiens	IC50	nM	22.0
	15152288	CHEMBL3396725	Inhibition of poly-histidine tagged full length recombinant aurora A (unknown origin) assessed as phosphorylation of NuMA-histidine substrate by scintillation counting analysis	B	CCOC(=O)c1[nH]cc2c1NC1=C(C(=O)CCC1)C2c1ccc(Sc2nc3c(F)cc(F)cc3[nH]2)o1		CHEMBL3393475	=	IC50	nM	8.0	CHEMBL4722	Homo sapiens	IC50	nM	8.0
	15152289	CHEMBL3396725	Inhibition of poly-histidine tagged full length recombinant aurora A (unknown origin) assessed as phosphorylation of NuMA-histidine substrate by scintillation counting analysis	B	CCOC(=O)c1[nH]cc2c1NC1=C(C(=O)CCC1)C2c1ccc(Sc2nc3cccc(F)c3[nH]2)o1		CHEMBL3393474	=	IC50	nM	4.0	CHEMBL4722	Homo sapiens	IC50	nM	4.0
	15152290	CHEMBL3396725	Inhibition of poly-histidine tagged full length recombinant aurora A (unknown origin) assessed as phosphorylation of NuMA-histidine substrate by scintillation counting analysis	B	CCOC(=O)c1[nH]cc2c1NC1=C(C(=O)CCC1)C2c1ccc(Sc2nc3cc(F)ccc3[nH]2)o1		CHEMBL3393473	=	IC50	nM	15.0	CHEMBL4722	Homo sapiens	IC50	nM	15.0
	15152291	CHEMBL3396725	Inhibition of poly-histidine tagged full length recombinant aurora A (unknown origin) assessed as phosphorylation of NuMA-histidine substrate by scintillation counting analysis	B	CCOC(=O)c1[nH]cc2c1NC1=C(C(=O)CNC1)C2c1ccc(Sc2nc3ccccc3[nH]2)o1.Cl.O		CHEMBL3393472	=	IC50	nM	3.0	CHEMBL4722	Homo sapiens	IC50	nM	3.0
	15152292	CHEMBL3396725	Inhibition of poly-histidine tagged full length recombinant aurora A (unknown origin) assessed as phosphorylation of NuMA-histidine substrate by scintillation counting analysis	B	O=C1CCCC2=C1C(c1ccc(Sc3nc4ccccc4[nH]3)o1)c1c[nH]c(C(=O)O)c1N2		CHEMBL3393471	=	IC50	nM	75.0	CHEMBL4722	Homo sapiens	IC50	nM	75.0
	15152293	CHEMBL3396725	Inhibition of poly-histidine tagged full length recombinant aurora A (unknown origin) assessed as phosphorylation of NuMA-histidine substrate by scintillation counting analysis	B	COC(=O)c1[nH]cc2c1NC1=C(C(=O)CCC1)C2c1ccc(Sc2nc3ccccc3[nH]2)o1		CHEMBL3393470	=	IC50	nM	2.0	CHEMBL4722	Homo sapiens	IC50	nM	2.0
	15152294	CHEMBL3396725	Inhibition of poly-histidine tagged full length recombinant aurora A (unknown origin) assessed as phosphorylation of NuMA-histidine substrate by scintillation counting analysis	B	CCOC(=O)c1[nH]cc2c1NC1=C(C(=O)CCC1)C2c1ccc(Sc2nc3ccccc3[nH]2)o1		CHEMBL3393469	>	IC50	nM	500.0	CHEMBL4722	Homo sapiens	IC50	nM	500.0
	15152295	CHEMBL3396725	Inhibition of poly-histidine tagged full length recombinant aurora A (unknown origin) assessed as phosphorylation of NuMA-histidine substrate by scintillation counting analysis	B	CCOC(=O)c1[nH]cc2c1NC1=C(C(=O)CCC1)C2c1ccc(Sc2nc3ccccc3[nH]2)o1		CHEMBL3393469	=	IC50	nM	4.0	CHEMBL4722	Homo sapiens	IC50	nM	4.0
	15152296	CHEMBL3396725	Inhibition of poly-histidine tagged full length recombinant aurora A (unknown origin) assessed as phosphorylation of NuMA-histidine substrate by scintillation counting analysis	B	CCOC(=O)c1[nH]cc2c1NC1=C(C(=O)CCC1)C2c1ccc(Sc2nc3ccccc3[nH]2)o1		CHEMBL3393469	=	IC50	nM	9.0	CHEMBL4722	Homo sapiens	IC50	nM	9.0
	15152297	CHEMBL3396725	Inhibition of poly-histidine tagged full length recombinant aurora A (unknown origin) assessed as phosphorylation of NuMA-histidine substrate by scintillation counting analysis	B	O=C1CCCC2=C1C(c1ccc(Sc3nc4ccccc4[nH]3)o1)c1c[nH]cc1N2		CHEMBL3393468	=	IC50	nM	377.0	CHEMBL4722	Homo sapiens	IC50	nM	377.0
	15152298	CHEMBL3396725	Inhibition of poly-histidine tagged full length recombinant aurora A (unknown origin) assessed as phosphorylation of NuMA-histidine substrate by scintillation counting analysis	B	COC(=O)c1csc2c1NC1=C(C(=O)CCC1)C2c1ccc(Sc2nc3ccccc3[nH]2)o1		CHEMBL3393467	=	IC50	nM	11.0	CHEMBL4722	Homo sapiens	IC50	nM	11.0
	15152299	CHEMBL3396725	Inhibition of poly-histidine tagged full length recombinant aurora A (unknown origin) assessed as phosphorylation of NuMA-histidine substrate by scintillation counting analysis	B	Nc1nc(O)c2c(n1)NC1=C(C(=O)CCC1)C2c1ccc(Sc2nc3ccccc3[nH]2)o1		CHEMBL3393466	>	IC50	nM	10000.0	CHEMBL4722	Homo sapiens	IC50	nM	10000.0
	15152300	CHEMBL3396725	Inhibition of poly-histidine tagged full length recombinant aurora A (unknown origin) assessed as phosphorylation of NuMA-histidine substrate by scintillation counting analysis	B	NC(=O)c1[nH]nc2c1NC1=C(C(=O)CCC1)C2c1ccc(Sc2nc3ccccc3[nH]2)o1		CHEMBL3393465	=	IC50	nM	2344.0	CHEMBL4722	Homo sapiens	IC50	nM	2344.0
	15152301	CHEMBL3396725	Inhibition of poly-histidine tagged full length recombinant aurora A (unknown origin) assessed as phosphorylation of NuMA-histidine substrate by scintillation counting analysis	B	CCOC(=O)c1[nH]nc2c1NC1=C(C(=O)CCC1)C2c1ccc(Sc2nc3ccccc3[nH]2)o1		CHEMBL3393464	=	IC50	nM	706.0	CHEMBL4722	Homo sapiens	IC50	nM	706.0
	15152302	CHEMBL3396725	Inhibition of poly-histidine tagged full length recombinant aurora A (unknown origin) assessed as phosphorylation of NuMA-histidine substrate by scintillation counting analysis	B	O=C1CCCC2=C1C(c1ccc(Sc3nc4ccccc4[nH]3)o1)c1n[nH]cc1N2		CHEMBL3393463	>	IC50	nM	10000.0	CHEMBL4722	Homo sapiens	IC50	nM	10000.0
	15152303	CHEMBL3396725	Inhibition of poly-histidine tagged full length recombinant aurora A (unknown origin) assessed as phosphorylation of NuMA-histidine substrate by scintillation counting analysis	B	O=C1CCCC2=C1C(c1ccc(Sc3nc4ccccc4[nH]3)o1)c1cn[nH]c1N2		CHEMBL3393462	=	IC50	nM	18.0	CHEMBL4722	Homo sapiens	IC50	nM	18.0
	15152304	CHEMBL3396725	Inhibition of poly-histidine tagged full length recombinant aurora A (unknown origin) assessed as phosphorylation of NuMA-histidine substrate by scintillation counting analysis	B	O=C1CNCC2=C1C(c1ccc(Sc3nc4ccccc4[nH]3)o1)c1c[nH]nc1N2		CHEMBL3393461	=	IC50	nM	100.0	CHEMBL4722	Homo sapiens	IC50	nM	100.0
	15152305	CHEMBL3396725	Inhibition of poly-histidine tagged full length recombinant aurora A (unknown origin) assessed as phosphorylation of NuMA-histidine substrate by scintillation counting analysis	B	O=C1CNCC2=C1C(c1cccc(Oc3ccc(Cl)c(Cl)c3)c1)c1c[nH]nc1N2		CHEMBL3393460	=	IC50	nM	600.0	CHEMBL4722	Homo sapiens	IC50	nM	600.0
	15152306	CHEMBL3396725	Inhibition of poly-histidine tagged full length recombinant aurora A (unknown origin) assessed as phosphorylation of NuMA-histidine substrate by scintillation counting analysis	B	COc1ccc(Oc2cccc(C3C4=C(CNCC4=O)Nc4n[nH]cc43)c2)cc1		CHEMBL3393459	=	IC50	nM	6288.0	CHEMBL4722	Homo sapiens	IC50	nM	6288.0
	15152307	CHEMBL3396725	Inhibition of poly-histidine tagged full length recombinant aurora A (unknown origin) assessed as phosphorylation of NuMA-histidine substrate by scintillation counting analysis	B	O=C1CNCC2=C1C(c1cccc(Oc3ccc(Cl)cc3)c1)c1c[nH]nc1N2		CHEMBL3393458	=	IC50	nM	2739.0	CHEMBL4722	Homo sapiens	IC50	nM	2739.0
	15152308	CHEMBL3396725	Inhibition of poly-histidine tagged full length recombinant aurora A (unknown origin) assessed as phosphorylation of NuMA-histidine substrate by scintillation counting analysis	B	O=C1CNCC2=C1C(c1cccc(Oc3ccccc3)c1)c1c[nH]nc1N2		CHEMBL3393457	=	IC50	nM	5082.0	CHEMBL4722	Homo sapiens	IC50	nM	5082.0
	15152309	CHEMBL3396725	Inhibition of poly-histidine tagged full length recombinant aurora A (unknown origin) assessed as phosphorylation of NuMA-histidine substrate by scintillation counting analysis	B	O=C1CNCC2=C1C(c1cccc(Oc3cc(Cl)cc(Cl)c3)c1)c1c[nH]nc1N2		CHEMBL3393456	=	IC50	nM	300.0	CHEMBL4722	Homo sapiens	IC50	nM	300.0
	15152310	CHEMBL3396725	Inhibition of poly-histidine tagged full length recombinant aurora A (unknown origin) assessed as phosphorylation of NuMA-histidine substrate by scintillation counting analysis	B	O=C1CNCC2=C1C(c1ccccc1F)c1c[nH]nc1N2		CHEMBL3393455	=	IC50	nM	9800.0	CHEMBL4722	Homo sapiens	IC50	nM	9800.0
	15152435	CHEMBL3395867	Inhibition of aurora A (unknown origin)	B	CO[C@@H](C(=O)N1Cc2n[nH]c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)c2C1)c1ccccc1		CHEMBL402548	=	IC50	nM	13.0	CHEMBL4722	Homo sapiens	IC50	nM	13.0
	15152438	CHEMBL3395867	Inhibition of aurora A (unknown origin)	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	IC50	nM	0.7	CHEMBL4722	Homo sapiens	IC50	nM	0.7
	15152439	CHEMBL3395867	Inhibition of aurora A (unknown origin)	B	COc1cc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2OC)=NC3)ccc1C(=O)O		CHEMBL483158	=	IC50	nM	1.0	CHEMBL4722	Homo sapiens	IC50	nM	1.0
	15152440	CHEMBL3395867	Inhibition of aurora A (unknown origin)	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(/C=C/c3ccccc3)n2)n[nH]1		CHEMBL482968	=	IC50	nM	14.0	CHEMBL4722	Homo sapiens	IC50	nM	14.0
	15169305	CHEMBL3406327	Inhibition of human full length Aurora A by HTRF assay	B	CN(C(=O)c1ccccc1)c1ccc2[nH]c(-c3n[nH]c4ccccc34)cc2n1		CHEMBL3403010	=	IC50	nM	32.0	CHEMBL4722	Homo sapiens	IC50	uM	0.032
	15169306	CHEMBL3406327	Inhibition of human full length Aurora A by HTRF assay	B	CN(C(=O)c1ccc(Cl)cc1)c1ccc2[nH]c(-c3n[nH]c4ccccc34)cc2n1		CHEMBL3403013	=	IC50	nM	46.0	CHEMBL4722	Homo sapiens	IC50	uM	0.046
	15169307	CHEMBL3406327	Inhibition of human full length Aurora A by HTRF assay	B	CN(C(=O)Nc1ccccc1)c1ccc2[nH]c(-c3n[nH]c4ccccc34)cc2n1		CHEMBL3403031	=	IC50	nM	519.0	CHEMBL4722	Homo sapiens	IC50	uM	0.519
	15169308	CHEMBL3406328	Inhibition of human full length Aurora A at 1 ug/ml by HTRF assay	B	CN(C(=O)c1ccccc1)c1ccc2[nH]c(-c3n[nH]c4ccccc34)cc2n1		CHEMBL3403010	=	Inhibition	%	95.8	CHEMBL4722	Homo sapiens	INH	%	95.8
	15169309	CHEMBL3406328	Inhibition of human full length Aurora A at 1 ug/ml by HTRF assay	B	CN(C(=O)c1ccc(Cl)cc1)c1ccc2[nH]c(-c3n[nH]c4ccccc34)cc2n1		CHEMBL3403013	=	Inhibition	%	95.0	CHEMBL4722	Homo sapiens	INH	%	95.0
	15169310	CHEMBL3406328	Inhibition of human full length Aurora A at 1 ug/ml by HTRF assay	B	CN(C(=O)Nc1ccccc1)c1ccc2[nH]c(-c3n[nH]c4ccccc34)cc2n1		CHEMBL3403031	=	Inhibition	%	75.4	CHEMBL4722	Homo sapiens	INH	%	75.4
	15181192	CHEMBL3405550	Inhibition of Aurora A (unknown origin) assessed as residual enzyme activity at 10 uM using kemptide substrate	B	COc1ccc2nc(N3C(=O)C(O)=C(C(=O)c4ccco4)C3c3ccc(Cl)cc3)sc2c1		CHEMBL3400828	=	Activity	%	48.06	CHEMBL4722	Homo sapiens	Activity	%	48.06
	15181193	CHEMBL3405550	Inhibition of Aurora A (unknown origin) assessed as residual enzyme activity at 10 uM using kemptide substrate	B	Cc1ccc(C(=O)C2=C(O)C(=O)N(c3nc4ccc(F)cc4s3)C2c2ccc(C(C)(C)C)cc2)o1		CHEMBL3402485	=	Activity	%	100.0	CHEMBL4722	Homo sapiens	Activity	%	100.0
	15181194	CHEMBL3405550	Inhibition of Aurora A (unknown origin) assessed as residual enzyme activity at 10 uM using kemptide substrate	B	CCOc1ccc2nc(N3C(=O)C(O)=C(C(=O)c4cccs4)C3c3ccc(C)cc3)sc2c1		CHEMBL3400173	=	Activity	%	45.41	CHEMBL4722	Homo sapiens	Activity	%	45.41
	15181195	CHEMBL3405550	Inhibition of Aurora A (unknown origin) assessed as residual enzyme activity at 10 uM using kemptide substrate	B	O=C(C1=C(O)C(=O)N(c2nc3ccc(F)cc3s2)C1c1cccc(Cl)c1)c1cccs1		CHEMBL3402489	=	Activity	%	28.11	CHEMBL4722	Homo sapiens	Activity	%	28.11
	15181196	CHEMBL3405550	Inhibition of Aurora A (unknown origin) assessed as residual enzyme activity at 10 uM using kemptide substrate	B	CCOc1ccc2nc(N3C(=O)C(O)=C(C(=O)c4ccccc4)C3c3ccc(Cl)cc3)sc2c1		CHEMBL3402491	=	Activity	%	36.45	CHEMBL4722	Homo sapiens	Activity	%	36.45
	15181197	CHEMBL3405550	Inhibition of Aurora A (unknown origin) assessed as residual enzyme activity at 10 uM using kemptide substrate	B	CCOc1ccc2nc(N3C(=O)C(O)=C(C(=O)c4ccc(C)cc4)C3c3ccc(C(C)(C)C)cc3)sc2c1		CHEMBL3402493	=	Activity	%	52.03	CHEMBL4722	Homo sapiens	Activity	%	52.03
	15181198	CHEMBL3405550	Inhibition of Aurora A (unknown origin) assessed as residual enzyme activity at 10 uM using kemptide substrate	B	CCCOc1ccc(C2C(C(=O)c3ccc4c(c3)OCCO4)=C(O)C(=O)N2c2nc3ccc(C)cc3s2)cc1		CHEMBL3402500	=	Activity	%	49.55	CHEMBL4722	Homo sapiens	Activity	%	49.55
	15181199	CHEMBL3405550	Inhibition of Aurora A (unknown origin) assessed as residual enzyme activity at 10 uM using kemptide substrate	B	CC(C)(C)c1ccc(C2C(C(=O)c3ccc4c(c3)OCCO4)=C(O)C(=O)N2c2nc3ccc(Cl)cc3s2)cc1		CHEMBL3402501	=	Activity	%	52.93	CHEMBL4722	Homo sapiens	Activity	%	52.93
	15181200	CHEMBL3405550	Inhibition of Aurora A (unknown origin) assessed as residual enzyme activity at 10 uM using kemptide substrate	B	CCCCOc1ccc(C2C(C(=O)c3ccc4c(c3)OCCO4)=C(O)C(=O)N2c2nc3ccc(Cl)cc3s2)cc1OCC		CHEMBL3402502	=	Activity	%	28.83	CHEMBL4722	Homo sapiens	Activity	%	28.83
	15181201	CHEMBL3405550	Inhibition of Aurora A (unknown origin) assessed as residual enzyme activity at 10 uM using kemptide substrate	B	CCCCOc1ccc(C2C(C(=O)c3ccc4c(c3)OCCO4)=C(O)C(=O)N2c2nc3ccc(C)cc3s2)cc1		CHEMBL3402503	=	Activity	%	20.52	CHEMBL4722	Homo sapiens	Activity	%	20.52
	15181202	CHEMBL3405550	Inhibition of Aurora A (unknown origin) assessed as residual enzyme activity at 10 uM using kemptide substrate	B	CCCCOc1ccc(C2C(C(=O)c3ccc4c(c3)OCCO4)=C(O)C(=O)N2c2nc3ccc(Cl)cc3s2)cc1		CHEMBL3402505	=	Activity	%	35.16	CHEMBL4722	Homo sapiens	Activity	%	35.16
	15181203	CHEMBL3405550	Inhibition of Aurora A (unknown origin) assessed as residual enzyme activity at 10 uM using kemptide substrate	B	CCCCCOc1ccc(C2C(C(=O)c3ccc4c(c3)OCCO4)=C(O)C(=O)N2c2nc3ccc(C)cc3s2)cc1		CHEMBL3402506	=	Activity	%	28.11	CHEMBL4722	Homo sapiens	Activity	%	28.11
	15181204	CHEMBL3405550	Inhibition of Aurora A (unknown origin) assessed as residual enzyme activity at 10 uM using kemptide substrate	B	CCCCCOc1ccc(C2C(C(=O)c3ccc4c(c3)CC(C)O4)=C(O)C(=O)N2c2nc3ccc(F)cc3s2)cc1		CHEMBL3402507	=	Activity	%	28.41	CHEMBL4722	Homo sapiens	Activity	%	28.41
	15181205	CHEMBL3405550	Inhibition of Aurora A (unknown origin) assessed as residual enzyme activity at 10 uM using kemptide substrate	B	CC(C)CCOc1cccc(C2C(C(=O)c3ccc4c(c3)CC(C)O4)=C(O)C(=O)N2c2nc3ccc(F)cc3s2)c1		CHEMBL3402508	=	Activity	%	44.67	CHEMBL4722	Homo sapiens	Activity	%	44.67
	15186236	CHEMBL3405647	Inhibition of Aurora A (unknown origin) assessed as residual activity at 33 uM relative to control	B	Oc1cccc(Nc2ncnc3scc(-c4ccccc4)c23)c1		CHEMBL3401781	=	Activity	%	43.5	CHEMBL4722	Homo sapiens	Activity	%	43.5
	15186237	CHEMBL3405647	Inhibition of Aurora A (unknown origin) assessed as residual activity at 33 uM relative to control	B	Oc1cccc(Nc2ncnc3sc(-c4ccccc4)cc23)c1		CHEMBL3401782	=	Activity	%	61.8	CHEMBL4722	Homo sapiens	Activity	%	61.8
	15188668	CHEMBL3411309	Inhibition of human Aurora A using H-LRRASLG substrate, ATP and [gamma33P]ATP at 1 uM	B	Cc1c[nH]c2ncnc(-c3ccc(NC(=O)N(CCO)c4ccccc4)cc3)c12		CHEMBL3410036	>	Inhibition	%	50.0	CHEMBL4722	Homo sapiens	INH	%	50.0
	15192467	CHEMBL3413730	Inhibition of Aurora A kinase (unknown origin) assessed as inhibition of peptide phosphorylation at 30 uM by based microfluidic mobility shift assay	B	N#Cc1c(-c2ccccc2)cc(-c2ccccc2)nc1NC(=S)Nc1ccccc1		CHEMBL3408381	=	Inhibition	%	0.0	CHEMBL4722	Homo sapiens	INH	%	0.0
	15192468	CHEMBL3413730	Inhibition of Aurora A kinase (unknown origin) assessed as inhibition of peptide phosphorylation at 30 uM by based microfluidic mobility shift assay	B	N#Cc1c(-c2ccccc2)cc(-c2ccccc2)nc1/N=c1\sc(-c2ccccc2)nn1-c1ccccc1		CHEMBL3408382	=	Inhibition	%	76.0	CHEMBL4722	Homo sapiens	INH	%	76.0
	15192469	CHEMBL3413730	Inhibition of Aurora A kinase (unknown origin) assessed as inhibition of peptide phosphorylation at 30 uM by based microfluidic mobility shift assay	B	CC(=O)c1nn(-c2ccccc2)/c(=N/c2nc(-c3ccccc3)cc(-c3ccccc3)c2C#N)s1		CHEMBL3408383	=	Inhibition	%	4.0	CHEMBL4722	Homo sapiens	INH	%	4.0
	15192470	CHEMBL3413730	Inhibition of Aurora A kinase (unknown origin) assessed as inhibition of peptide phosphorylation at 30 uM by based microfluidic mobility shift assay	B	CC(=O)c1nn(-c2ccc(C)cc2)/c(=N/c2nc(-c3ccccc3)cc(-c3ccccc3)c2C#N)s1		CHEMBL3408384	=	Inhibition	%	12.0	CHEMBL4722	Homo sapiens	INH	%	12.0
	15192471	CHEMBL3413730	Inhibition of Aurora A kinase (unknown origin) assessed as inhibition of peptide phosphorylation at 30 uM by based microfluidic mobility shift assay	B	COc1ccc(-n2nc(C(C)=O)s/c2=N\c2nc(-c3ccccc3)cc(-c3ccccc3)c2C#N)cc1		CHEMBL3408385	=	Inhibition	%	24.0	CHEMBL4722	Homo sapiens	INH	%	24.0
	15192472	CHEMBL3413730	Inhibition of Aurora A kinase (unknown origin) assessed as inhibition of peptide phosphorylation at 30 uM by based microfluidic mobility shift assay	B	CC(=O)c1nn(-c2ccc(Cl)cc2)/c(=N/c2nc(-c3ccccc3)cc(-c3ccccc3)c2C#N)s1		CHEMBL3408386	=	Inhibition	%	35.0	CHEMBL4722	Homo sapiens	INH	%	35.0
	15192473	CHEMBL3413730	Inhibition of Aurora A kinase (unknown origin) assessed as inhibition of peptide phosphorylation at 30 uM by based microfluidic mobility shift assay	B	CCOC(=O)c1nn(-c2ccccc2)/c(=N/c2nc(-c3ccccc3)cc(-c3ccccc3)c2C#N)s1		CHEMBL3408387	=	Inhibition	%	46.0	CHEMBL4722	Homo sapiens	INH	%	46.0
	15192474	CHEMBL3413730	Inhibition of Aurora A kinase (unknown origin) assessed as inhibition of peptide phosphorylation at 30 uM by based microfluidic mobility shift assay	B	CCOC(=O)c1nn(-c2ccc(C)cc2)/c(=N/c2nc(-c3ccccc3)cc(-c3ccccc3)c2C#N)s1		CHEMBL3408388	=	Inhibition	%	37.0	CHEMBL4722	Homo sapiens	INH	%	37.0
	15192475	CHEMBL3413730	Inhibition of Aurora A kinase (unknown origin) assessed as inhibition of peptide phosphorylation at 30 uM by based microfluidic mobility shift assay	B	CCOC(=O)c1nn(-c2ccc(Cl)cc2)/c(=N/c2nc(-c3ccccc3)cc(-c3ccccc3)c2C#N)s1		CHEMBL3408389	=	Inhibition	%	8.0	CHEMBL4722	Homo sapiens	INH	%	8.0
	15192476	CHEMBL3413730	Inhibition of Aurora A kinase (unknown origin) assessed as inhibition of peptide phosphorylation at 30 uM by based microfluidic mobility shift assay	B	N#Cc1c(-c2ccccc2)cc(-c2ccccc2)nc1/N=c1\sc(C(=O)Nc2ccccc2)nn1-c1ccccc1		CHEMBL3408390	=	Inhibition	%	9.0	CHEMBL4722	Homo sapiens	INH	%	9.0
	15192477	CHEMBL3413730	Inhibition of Aurora A kinase (unknown origin) assessed as inhibition of peptide phosphorylation at 30 uM by based microfluidic mobility shift assay	B	N#Cc1c(-c2ccccc2)cc(-c2ccccc2)nc1/N=C1\SCC(=O)N1c1ccccc1		CHEMBL3408391	=	Inhibition	%	2.0	CHEMBL4722	Homo sapiens	INH	%	2.0
	15192478	CHEMBL3413730	Inhibition of Aurora A kinase (unknown origin) assessed as inhibition of peptide phosphorylation at 30 uM by based microfluidic mobility shift assay	B	N#Cc1c(-c2ccccc2)cc(-c2ccccc2)nc1/N=c1\scc(-c2ccccc2)n1-c1ccccc1		CHEMBL3408392	=	Inhibition	%	0.0	CHEMBL4722	Homo sapiens	INH	%	0.0
	15192479	CHEMBL3413730	Inhibition of Aurora A kinase (unknown origin) assessed as inhibition of peptide phosphorylation at 30 uM by based microfluidic mobility shift assay	B	N#Cc1c(-c2ccccc2)cc(-c2ccccc2)nc1/N=C1\S/C(=C2\SC(c3ccccc3)=NN2c2ccccc2)C(=O)N1c1ccccc1		CHEMBL3408393	=	Inhibition	%	98.0	CHEMBL4722	Homo sapiens	INH	%	98.0
	15192480	CHEMBL3413730	Inhibition of Aurora A kinase (unknown origin) assessed as inhibition of peptide phosphorylation at 30 uM by based microfluidic mobility shift assay	B	CC(=O)C1=NN(c2ccccc2)/C(=C2/S/C(=N\c3nc(-c4ccccc4)cc(-c4ccccc4)c3C#N)N(c3ccccc3)C2=O)S1		CHEMBL3408394	=	Inhibition	%	6.0	CHEMBL4722	Homo sapiens	INH	%	6.0
	15192481	CHEMBL3413730	Inhibition of Aurora A kinase (unknown origin) assessed as inhibition of peptide phosphorylation at 30 uM by based microfluidic mobility shift assay	B	CCOC(=O)C1=NN(c2ccccc2)/C(=C2/S/C(=N\c3nc(-c4ccccc4)cc(-c4ccccc4)c3C#N)N(c3ccccc3)C2=O)S1		CHEMBL3408395	=	Inhibition	%	36.0	CHEMBL4722	Homo sapiens	INH	%	36.0
	15192482	CHEMBL3413730	Inhibition of Aurora A kinase (unknown origin) assessed as inhibition of peptide phosphorylation at 30 uM by based microfluidic mobility shift assay	B	N#Cc1c(-c2ccccc2)cc(-c2ccccc2)nc1/N=C1\S/C(=C2\SC(C(=O)Nc3ccccc3)=NN2c2ccccc2)C(=O)N1c1ccccc1		CHEMBL3408396	=	Inhibition	%	0.0	CHEMBL4722	Homo sapiens	INH	%	0.0
	15193018	CHEMBL3411672	Inhibition of AURKA (unknown origin) by FRET analysis	B	COc1ccc2c(c1)[C@]1(C[C@H]1c1ccc3c(/C=C/c4ccc(CN5C[C@H](C)O[C@H](C)C5)cc4)n[nH]c3c1)C(=O)N2		CHEMBL3408947	=	IC50	nM	140.0	CHEMBL4722	Homo sapiens	IC50	nM	140.0
	15193024	CHEMBL3411678	Inhibition of AURKA (unknown origin) by cell-based assay	B	COc1ccc2c(c1)[C@]1(C[C@H]1c1ccc3c(/C=C/c4ccc(CN5C[C@H](C)O[C@H](C)C5)cc4)n[nH]c3c1)C(=O)N2		CHEMBL3408947	=	EC50	nM	510.0	CHEMBL4722	Homo sapiens	EC50	nM	510.0
	15211855	CHEMBL3420205	Inhibition of AURKA (unknown origin)	B	COc1ccc2c(c1)[C@]1(C[C@H]1c1ccc3c(/C=C/c4ccc(CN5C[C@H](C)O[C@H](C)C5)cc4)n[nH]c3c1)C(=O)N2		CHEMBL3408947	=	EC50	nM	510.0	CHEMBL4722	Homo sapiens	EC50	nM	510.0
Dose-dependent effect	15220462	CHEMBL3418594	Inhibition of Aurora A in human HeLa cells after 12 hrs by Western blot method	B	CN1CCC(NC(=O)c2ccc(Nc3ncc(Br)c(NC4CCCC4)n3)cc2)CC1		CHEMBL3417325		Inhibition	%		CHEMBL4722	Homo sapiens	INH		
Dose-dependent effect	15220463	CHEMBL3418594	Inhibition of Aurora A in human HeLa cells after 12 hrs by Western blot method	B	COc1cc(C(=O)NC2CCN(C)CC2)ccc1Nc1ncc(F)c(NC2CCCC2)n1		CHEMBL3417327		Inhibition	%		CHEMBL4722	Homo sapiens	INH		
Not Active	15220466	CHEMBL3418773	Inhibition of Aurora A in human HeLa cells at	B	CN1CCC(NC(=O)c2ccc(Nc3ncc(Br)c(NC4CCCC4)n3)cc2)CC1		CHEMBL3417325		Inhibition	%		CHEMBL4722	Homo sapiens	INH		
	15220468	CHEMBL3418775	Inhibition of Aurora A in human HeLa cells after 12 hrs by ELISA method	B	CN1CCC(NC(=O)c2ccc(Nc3ncc(Br)c(NC4CCCC4)n3)cc2)CC1		CHEMBL3417325	=	IC50	nM	12.0	CHEMBL4722	Homo sapiens	IC50	uM	0.012
	15220469	CHEMBL3418775	Inhibition of Aurora A in human HeLa cells after 12 hrs by ELISA method	B	COc1cc(C(=O)NC2CCN(C)CC2)ccc1Nc1ncc(F)c(NC2CCCC2)n1		CHEMBL3417327	=	IC50	nM	43.0	CHEMBL4722	Homo sapiens	IC50	uM	0.043
	15220470	CHEMBL3418775	Inhibition of Aurora A in human HeLa cells after 12 hrs by ELISA method	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	IC50	nM	261.0	CHEMBL4722	Homo sapiens	IC50	uM	0.261
Active	15220474	CHEMBL3418777	Inhibition of Aurora A in human HeLa cells at >10 nM after 12 hrs by ELISA method	B	CN1CCC(NC(=O)c2ccc(Nc3ncc(Br)c(NC4CCCC4)n3)cc2)CC1		CHEMBL3417325		Inhibition	%		CHEMBL4722	Homo sapiens	INH		
	15237112	CHEMBL3423900	Inhibition of recombinant AURKA (unknown origin) preincubated for 15 mins prior to ATP addition by FRET-based homogenous assay	B	O=C(CC1(N2CCOCC2)CCCCC1)Nc1ccc2[nH]nc(-c3ccc(N4CCOCC4)cc3)c2c1		CHEMBL3422066	=	IC50	nM	2100.0	CHEMBL4722	Homo sapiens	IC50	uM	2.1
	15237113	CHEMBL3423900	Inhibition of recombinant AURKA (unknown origin) preincubated for 15 mins prior to ATP addition by FRET-based homogenous assay	B	O=C(NCC1(N2CCOCC2)CCCCC1)c1ccc2[nH]nc(-c3ccc(N4CCOCC4)cc3)c2c1		CHEMBL3422067	=	IC50	nM	2300.0	CHEMBL4722	Homo sapiens	IC50	uM	2.3
	15237114	CHEMBL3423900	Inhibition of recombinant AURKA (unknown origin) preincubated for 15 mins prior to ATP addition by FRET-based homogenous assay	B	CN1CCC(Oc2ccc(-c3n[nH]c4ccc(NC(=O)C(c5ccsc5)C5CCCC5)cc34)cc2)CC1		CHEMBL3422068	=	IC50	nM	2300.0	CHEMBL4722	Homo sapiens	IC50	uM	2.3
	15237115	CHEMBL3423900	Inhibition of recombinant AURKA (unknown origin) preincubated for 15 mins prior to ATP addition by FRET-based homogenous assay	B	CN1CCC(Oc2ccc(-c3n[nH]c4ccc(C(=O)NC(c5ccsc5)C5CCCC5)cc34)cc2)CC1		CHEMBL3422069	=	IC50	nM	2000.0	CHEMBL4722	Homo sapiens	IC50	uM	2.0
	15237116	CHEMBL3423900	Inhibition of recombinant AURKA (unknown origin) preincubated for 15 mins prior to ATP addition by FRET-based homogenous assay	B	CN1CCC(Oc2ccc(-c3n[nH]c4ccc(NC(=O)C(c5ccccn5)C5CCCC5)cc34)cc2)CC1		CHEMBL3422070	=	IC50	nM	2000.0	CHEMBL4722	Homo sapiens	IC50	uM	2.0
	15237117	CHEMBL3423900	Inhibition of recombinant AURKA (unknown origin) preincubated for 15 mins prior to ATP addition by FRET-based homogenous assay	B	CN1CCC(Oc2ccc(-c3n[nH]c4ccc(C(=O)NC(c5ccccn5)C5CCCC5)cc34)cc2)CC1		CHEMBL3422071	>	IC50	nM	10000.0	CHEMBL4722	Homo sapiens	IC50	uM	10.0
	15237118	CHEMBL3423900	Inhibition of recombinant AURKA (unknown origin) preincubated for 15 mins prior to ATP addition by FRET-based homogenous assay	B	O=C(N[C@@H](c1ccccn1)C1CC1)c1ccc2[nH]nc(-c3ccc(N4[C@H]5CC[C@H]4CC(O)C5)cc3)c2c1		CHEMBL3422092	=	IC50	nM	1300.0	CHEMBL4722	Homo sapiens	IC50	nM	1300.0
	15237692	CHEMBL3423975	Inhibition of AURKA (unknown origin) transfected in human HCT116 cells after 4 hrs by near infrared imager analysis	B	O=C(N[C@@H](c1ccccn1)C1CC1)c1ccc2[nH]nc(-c3ccc(N4[C@H]5CC[C@H]4CC(O)C5)cc3)c2c1		CHEMBL3422092	>	EC50	nM	6000.0	CHEMBL4722	Homo sapiens	EC50	nM	6000.0
	15251872	CHEMBL3427830	Inhibition of Aurora A (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	O=C(O)[C@H]1CSC(c2nc3ccc(O)cc3s2)=N1		CHEMBL443738	=	Activity	%	16.0	CHEMBL4722	Homo sapiens	Activity	%	16.0
	15251925	CHEMBL3427830	Inhibition of Aurora A (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	O=C(O)[C@@H]1CSC(c2nc3ccc(O)cc3s2)=N1		CHEMBL3427170	=	Activity	%	64.0	CHEMBL4722	Homo sapiens	Activity	%	64.0
	15252027	CHEMBL3427830	Inhibition of Aurora A (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COC(=O)[C@H]1CSC(c2nc3ccc(O)cc3s2)=N1		CHEMBL3427171	=	Activity	%	96.0	CHEMBL4722	Homo sapiens	Activity	%	96.0
	15252672	CHEMBL3427830	Inhibition of Aurora A (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COC(=O)[C@@H]1CSC(c2nc3ccc(O)cc3s2)=N1		CHEMBL3427172	=	Activity	%	42.0	CHEMBL4722	Homo sapiens	Activity	%	42.0
	15252774	CHEMBL3427830	Inhibition of Aurora A (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COc1ccc2nc(C3=N[C@@H](C(=O)O)CS3)sc2c1		CHEMBL3427173	=	Activity	%	76.0	CHEMBL4722	Homo sapiens	Activity	%	76.0
	15252876	CHEMBL3427830	Inhibition of Aurora A (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COc1ccc2nc(C3=N[C@H](C(=O)O)CS3)sc2c1		CHEMBL3427174	=	Activity	%	81.0	CHEMBL4722	Homo sapiens	Activity	%	81.0
	15253550	CHEMBL3427830	Inhibition of Aurora A (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COC(=O)[C@H]1CSC(c2nc3ccc(OC)cc3s2)=N1		CHEMBL3427175	=	Activity	%	43.0	CHEMBL4722	Homo sapiens	Activity	%	43.0
	15253652	CHEMBL3427830	Inhibition of Aurora A (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COC(=O)[C@@H]1CSC(c2nc3ccc(OC)cc3s2)=N1		CHEMBL3427176	=	Activity	%	81.0	CHEMBL4722	Homo sapiens	Activity	%	81.0
	15253754	CHEMBL3427830	Inhibition of Aurora A (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COc1ccc2nc(C3=N[C@@H](C(=O)O)C(C)(C)S3)sc2c1		CHEMBL3427177	=	Activity	%	57.0	CHEMBL4722	Homo sapiens	Activity	%	57.0
	15253806	CHEMBL3429888	Inhibition of human Aurora-A	B	CCn1nc(C#Cc2cc(C(=O)Nc3ccc(CN4CCN(C)CC4)c(C(F)(F)F)c3)ccc2C)c2c(N)ncnc21		CHEMBL3426225	>	IC50	nM	10000.0	CHEMBL4722	Homo sapiens	IC50	uM	10.0
	15254420	CHEMBL3427830	Inhibition of Aurora A (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COc1ccc2nc(C3=N[C@H](C(=O)O)C(C)(C)S3)sc2c1		CHEMBL3427178	=	Activity	%	37.0	CHEMBL4722	Homo sapiens	Activity	%	37.0
	15254522	CHEMBL3427830	Inhibition of Aurora A (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	CC1(C)SC(c2nc3ccc(O)cc3s2)=N[C@H]1C(=O)O		CHEMBL3427179	=	Activity	%	58.0	CHEMBL4722	Homo sapiens	Activity	%	58.0
	15254624	CHEMBL3427830	Inhibition of Aurora A (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	CC1(C)SC(c2nc3ccc(O)cc3s2)=N[C@@H]1C(=O)O		CHEMBL3427180	=	Activity	%	26.0	CHEMBL4722	Homo sapiens	Activity	%	26.0
	15255315	CHEMBL3427830	Inhibition of Aurora A (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	O=C(O)[C@H]1CSC(c2ccc3cc(O)ccc3n2)=N1		CHEMBL3427181	=	Activity	%	75.0	CHEMBL4722	Homo sapiens	Activity	%	75.0
	15255417	CHEMBL3427830	Inhibition of Aurora A (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	O=C(O)[C@@H]1CSC(c2ccc3cc(O)ccc3n2)=N1		CHEMBL3427182	=	Activity	%	95.0	CHEMBL4722	Homo sapiens	Activity	%	95.0
	15255520	CHEMBL3427830	Inhibition of Aurora A (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	O=C(O)[C@H]1CSC(c2ccc3cccc(O)c3n2)=N1		CHEMBL3427183	=	Activity	%	60.0	CHEMBL4722	Homo sapiens	Activity	%	60.0
	15256251	CHEMBL3427830	Inhibition of Aurora A (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	O=C(O)[C@@H]1CSC(c2ccc3cccc(O)c3n2)=N1		CHEMBL3427184	=	Activity	%	78.0	CHEMBL4722	Homo sapiens	Activity	%	78.0
	15619276	CHEMBL3584533	Inhibition of aurora A (unknown origin) at 100 nM relative to control	B	CCN(Cc1ccc2[nH]cnc2c1Cl)c1nccc(Nc2cc(C3CC3)[nH]n2)n1		CHEMBL3580976	>	Inhibition	%	50.0	CHEMBL4722	Homo sapiens	INH	%	50.0
	15619277	CHEMBL3584534	Inhibition of aurora A (unknown origin)	B	CCN(Cc1ccc2[nH]cnc2c1Cl)c1nccc(Nc2cc(C3CC3)[nH]n2)n1		CHEMBL3580976	=	Ki	nM	5.3	CHEMBL4722	Homo sapiens	Ki	nM	5.3
	15622934	CHEMBL3586965	Inhibition of aurora kinase A autophosphorylation at T288 in human HCT116 cells by immunofluorescence analysis	B	COc1cc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2OC)=NC3)ccc1C(=O)O		CHEMBL483158	=	IC50	nM	7.0	CHEMBL4722	Homo sapiens	IC50	nM	7.0
	15622935	CHEMBL3586965	Inhibition of aurora kinase A autophosphorylation at T288 in human HCT116 cells by immunofluorescence analysis	B	COc1cccc(F)c1C1=NCc2cnc(Nc3ccc(C(=O)O)cc3)nc2-c2ccc(Cl)cc21		CHEMBL3586473	=	IC50	nM	18.0	CHEMBL4722	Homo sapiens	IC50	nM	18.0
	15622936	CHEMBL3586965	Inhibition of aurora kinase A autophosphorylation at T288 in human HCT116 cells by immunofluorescence analysis	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	=	IC50	nM	34.0	CHEMBL4722	Homo sapiens	IC50	nM	34.0
	15622937	CHEMBL3586965	Inhibition of aurora kinase A autophosphorylation at T288 in human HCT116 cells by immunofluorescence analysis	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2ccccc2F)=NC3)cc1		CHEMBL3586468	=	IC50	nM	170.0	CHEMBL4722	Homo sapiens	IC50	nM	170.0
	15622938	CHEMBL3586965	Inhibition of aurora kinase A autophosphorylation at T288 in human HCT116 cells by immunofluorescence analysis	B	Nc1ncc2c(n1)-c1ccc(Cl)cc1C(c1ccccc1F)=NC2		CHEMBL41816	=	IC50	nM	6000.0	CHEMBL4722	Homo sapiens	IC50	nM	6000.0
	15649720	CHEMBL3595385	Inhibition of human AURKA at 0.1 uM relative to control	B	CCc1cc(NC(=O)Nc2ccc(-c3cnc(Nc4cc(N5CCN(CC)CC5)nc(C)n4)s3)cc2)no1		CHEMBL3593290	=	Inhibition	%	96.0	CHEMBL4722	Homo sapiens	INH	%	96.0
	15650064	CHEMBL3595191	Inhibition of recombinant GST-tagged Aurora-A kinase domain (S123 to S401) (unknown origin) expressed in insect Sf9 cells using tetra(LRRASLG) peptide as substrate after 90 mins by Kinase-Glo assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	>	IC50	nM	10000.0	CHEMBL4722	Homo sapiens	IC50	uM	10.0
	15650065	CHEMBL3595191	Inhibition of recombinant GST-tagged Aurora-A kinase domain (S123 to S401) (unknown origin) expressed in insect Sf9 cells using tetra(LRRASLG) peptide as substrate after 90 mins by Kinase-Glo assay	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	=	IC50	nM	3800.0	CHEMBL4722	Homo sapiens	IC50	uM	3.8
	15650066	CHEMBL3595191	Inhibition of recombinant GST-tagged Aurora-A kinase domain (S123 to S401) (unknown origin) expressed in insect Sf9 cells using tetra(LRRASLG) peptide as substrate after 90 mins by Kinase-Glo assay	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	IC50	nM	80.0	CHEMBL4722	Homo sapiens	IC50	uM	0.08
	15650067	CHEMBL3595191	Inhibition of recombinant GST-tagged Aurora-A kinase domain (S123 to S401) (unknown origin) expressed in insect Sf9 cells using tetra(LRRASLG) peptide as substrate after 90 mins by Kinase-Glo assay	B	Cc1cc(NC(=O)Nc2ccc(-c3cnc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)s3)cc2)no1		CHEMBL3593296	=	IC50	nM	25.0	CHEMBL4722	Homo sapiens	IC50	uM	0.025
	15650068	CHEMBL3595191	Inhibition of recombinant GST-tagged Aurora-A kinase domain (S123 to S401) (unknown origin) expressed in insect Sf9 cells using tetra(LRRASLG) peptide as substrate after 90 mins by Kinase-Glo assay	B	CCN1CCN(c2cc(Nc3ncc(-c4ccc(NC(=O)c5ccccc5)cc4)s3)nc(C)n2)CC1		CHEMBL3593295	=	IC50	nM	140.0	CHEMBL4722	Homo sapiens	IC50	uM	0.14
	15650069	CHEMBL3595191	Inhibition of recombinant GST-tagged Aurora-A kinase domain (S123 to S401) (unknown origin) expressed in insect Sf9 cells using tetra(LRRASLG) peptide as substrate after 90 mins by Kinase-Glo assay	B	CCN1CCN(c2cc(Nc3ncc(-c4ccc(NC(=O)OCc5ccccc5)cc4)s3)nc(C)n2)CC1		CHEMBL3593294	=	IC50	nM	320.0	CHEMBL4722	Homo sapiens	IC50	uM	0.32
	15650070	CHEMBL3595191	Inhibition of recombinant GST-tagged Aurora-A kinase domain (S123 to S401) (unknown origin) expressed in insect Sf9 cells using tetra(LRRASLG) peptide as substrate after 90 mins by Kinase-Glo assay	B	CCN1CCN(c2cc(Nc3ncc(-c4ccc(NS(=O)(=O)c5ccccc5)cc4)s3)nc(C)n2)CC1		CHEMBL3593293	=	IC50	nM	43.0	CHEMBL4722	Homo sapiens	IC50	uM	0.043
	15650071	CHEMBL3595191	Inhibition of recombinant GST-tagged Aurora-A kinase domain (S123 to S401) (unknown origin) expressed in insect Sf9 cells using tetra(LRRASLG) peptide as substrate after 90 mins by Kinase-Glo assay	B	CCN1CCN(c2cc(Nc3ncc(-c4ccc(NC(=O)Nc5cc(C6CC6)on5)cc4)s3)nc(C)n2)CC1		CHEMBL3593292	=	IC50	nM	36.0	CHEMBL4722	Homo sapiens	IC50	uM	0.036
	15650072	CHEMBL3595191	Inhibition of recombinant GST-tagged Aurora-A kinase domain (S123 to S401) (unknown origin) expressed in insect Sf9 cells using tetra(LRRASLG) peptide as substrate after 90 mins by Kinase-Glo assay	B	CCc1cc(NC(=O)Nc2ccc(-c3cnc(Nc4cc(N5CCC(N)C5)nc(C)n4)s3)cc2)no1		CHEMBL3593291	=	IC50	nM	38.0	CHEMBL4722	Homo sapiens	IC50	uM	0.038
	15650073	CHEMBL3595191	Inhibition of recombinant GST-tagged Aurora-A kinase domain (S123 to S401) (unknown origin) expressed in insect Sf9 cells using tetra(LRRASLG) peptide as substrate after 90 mins by Kinase-Glo assay	B	CCc1cc(NC(=O)Nc2ccc(-c3cnc(Nc4cc(N5CCN(CC)CC5)nc(C)n4)s3)cc2)no1		CHEMBL3593290	=	IC50	nM	32.0	CHEMBL4722	Homo sapiens	IC50	uM	0.032
	15650074	CHEMBL3595191	Inhibition of recombinant GST-tagged Aurora-A kinase domain (S123 to S401) (unknown origin) expressed in insect Sf9 cells using tetra(LRRASLG) peptide as substrate after 90 mins by Kinase-Glo assay	B	CCCCc1cc(NC(=O)Nc2ccc(-c3cnc(Nc4cc(N5CCN(C)CC5)nc(C)n4)s3)cc2)no1		CHEMBL3593289	=	IC50	nM	38.0	CHEMBL4722	Homo sapiens	IC50	uM	0.038
	15650075	CHEMBL3595191	Inhibition of recombinant GST-tagged Aurora-A kinase domain (S123 to S401) (unknown origin) expressed in insect Sf9 cells using tetra(LRRASLG) peptide as substrate after 90 mins by Kinase-Glo assay	B	CCc1cc(NC(=O)Nc2ccc(-c3cnc(Nc4cc(N5CCN(C)CC5)nc(C)n4)s3)cc2)no1		CHEMBL3593288	=	IC50	nM	41.0	CHEMBL4722	Homo sapiens	IC50	uM	0.041
	15650076	CHEMBL3595191	Inhibition of recombinant GST-tagged Aurora-A kinase domain (S123 to S401) (unknown origin) expressed in insect Sf9 cells using tetra(LRRASLG) peptide as substrate after 90 mins by Kinase-Glo assay	B	Cc1nc(Nc2ncc(-c3ccc(NC(=O)Nc4cc(C)on4)cc3)s2)cc(N2CCN(C)CC2)n1		CHEMBL3593287	=	IC50	nM	56.0	CHEMBL4722	Homo sapiens	IC50	uM	0.056
	15650077	CHEMBL3595191	Inhibition of recombinant GST-tagged Aurora-A kinase domain (S123 to S401) (unknown origin) expressed in insect Sf9 cells using tetra(LRRASLG) peptide as substrate after 90 mins by Kinase-Glo assay	B	Cc1nc(Nc2ncc(-c3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)s2)cc(N2CCNCC2)n1		CHEMBL3593286	=	IC50	nM	270.0	CHEMBL4722	Homo sapiens	IC50	uM	0.27
	15650078	CHEMBL3595191	Inhibition of recombinant GST-tagged Aurora-A kinase domain (S123 to S401) (unknown origin) expressed in insect Sf9 cells using tetra(LRRASLG) peptide as substrate after 90 mins by Kinase-Glo assay	B	CCN1CCN(c2cc(Nc3ncc(-c4ccc(NC(=O)Nc5ccc(Cl)cc5)cc4)s3)nc(C)n2)CC1		CHEMBL3593285	=	IC50	nM	95.0	CHEMBL4722	Homo sapiens	IC50	uM	0.095
	15650079	CHEMBL3595191	Inhibition of recombinant GST-tagged Aurora-A kinase domain (S123 to S401) (unknown origin) expressed in insect Sf9 cells using tetra(LRRASLG) peptide as substrate after 90 mins by Kinase-Glo assay	B	Cc1nc(Nc2ncc(-c3ccc(NC(=O)Nc4ccccc4)cc3)s2)cc(N2CCC(N)CC2)n1		CHEMBL3593284	=	IC50	nM	150.0	CHEMBL4722	Homo sapiens	IC50	uM	0.15
	15650080	CHEMBL3595191	Inhibition of recombinant GST-tagged Aurora-A kinase domain (S123 to S401) (unknown origin) expressed in insect Sf9 cells using tetra(LRRASLG) peptide as substrate after 90 mins by Kinase-Glo assay	B	Cc1nc(Nc2ncc(-c3ccc(NC(=O)Nc4ccccc4)cc3)s2)cc(N2CCN(C)CC2)n1		CHEMBL3593283	>	IC50	nM	10000.0	CHEMBL4722	Homo sapiens	IC50	uM	10.0
	15651909	CHEMBL3595328	Inhibition of Aurora A (unknown origin)	B	CN(Cc1ccc2[nH]cnc2c1Cl)c1nccc(Nc2cc(C3CC3)[nH]n2)n1		CHEMBL3580975	=	Ki	nM	3.0	CHEMBL4722	Homo sapiens	Ki	uM	0.003
	15651910	CHEMBL3595328	Inhibition of Aurora A (unknown origin)	B	Clc1c(CNc2nccc(Nc3cc(C4CCCO4)[nH]n3)n2)ccc2[nH]cnc12		CHEMBL3593823	=	Ki	nM	25.0	CHEMBL4722	Homo sapiens	Ki	uM	0.025
	15651911	CHEMBL3595328	Inhibition of Aurora A (unknown origin)	B	CN(Cc1ccc2[nH]cnc2c1Cl)c1nccc(Nc2cc(C3CCC(=O)C3)[nH]n2)n1		CHEMBL3593824	=	Ki	nM	17.0	CHEMBL4722	Homo sapiens	Ki	uM	0.017
	15651912	CHEMBL3595328	Inhibition of Aurora A (unknown origin)	B	COCC(C)c1cc(Nc2ccnc(N(C)Cc3ccc4[nH]cnc4c3Cl)n2)n[nH]1		CHEMBL3593825	=	Ki	nM	131.0	CHEMBL4722	Homo sapiens	Ki	uM	0.131
	15651913	CHEMBL3595328	Inhibition of Aurora A (unknown origin)	B	CC(=O)N(C)Cc1cc(Nc2ccnc(N(C)Cc3ccc4[nH]cnc4c3Cl)n2)n[nH]1		CHEMBL3594173	=	Ki	nM	893.0	CHEMBL4722	Homo sapiens	Ki	uM	0.893
	15651914	CHEMBL3595328	Inhibition of Aurora A (unknown origin)	B	CN1CC[C@@H](c2cc(Nc3ccnc(N(C)Cc4ccc5[nH]cnc5c4Cl)n3)n[nH]2)C1=O		CHEMBL3594174	>	Ki	nM	5400.0	CHEMBL4722	Homo sapiens	Ki	uM	5.4
	15651915	CHEMBL3595328	Inhibition of Aurora A (unknown origin)	B	CN1CC[C@H](c2cc(Nc3ccnc(N(C)Cc4ccc5[nH]cnc5c4Cl)n3)n[nH]2)C1=O		CHEMBL3594175	>	Ki	nM	5400.0	CHEMBL4722	Homo sapiens	Ki	uM	5.4
	15651916	CHEMBL3595328	Inhibition of Aurora A (unknown origin)	B	CN1CC[C@H](c2cc(Nc3ccnc(NC[C@H]4CC[C@H](N)CC4)n3)n[nH]2)C1=O		CHEMBL3594176	>	Ki	nM	5400.0	CHEMBL4722	Homo sapiens	Ki	uM	5.4
	15651917	CHEMBL3595328	Inhibition of Aurora A (unknown origin)	B	CN1CC[C@H](c2cc(Nc3ccnc(N(C)C[C@H]4CC[C@H](N)CC4)n3)n[nH]2)C1=O		CHEMBL3594177	=	Ki	nM	3500.0	CHEMBL4722	Homo sapiens	Ki	uM	3.5
	15651918	CHEMBL3595328	Inhibition of Aurora A (unknown origin)	B	CCN(C[C@H]1CC[C@H](N)CC1)c1nccc(Nc2cc([C@H]3CCN(C)C3=O)[nH]n2)n1		CHEMBL3594178	>	Ki	nM	5400.0	CHEMBL4722	Homo sapiens	Ki	uM	5.4
	15651919	CHEMBL3595328	Inhibition of Aurora A (unknown origin)	B	CN1CCCC(c2cc(Nc3ccnc(N(C)C[C@H]4CC[C@H](N)CC4)n3)n[nH]2)C1=O		CHEMBL3594179	>	Ki	nM	5400.0	CHEMBL4722	Homo sapiens	Ki	uM	5.4
	15651920	CHEMBL3595328	Inhibition of Aurora A (unknown origin)	B	CCN1CC[C@H](c2cc(Nc3ccnc(N(C)C[C@H]4CC[C@H](N)CC4)n3)n[nH]2)C1=O		CHEMBL3594180	>	Ki	nM	5400.0	CHEMBL4722	Homo sapiens	Ki	uM	5.4
	15651921	CHEMBL3595328	Inhibition of Aurora A (unknown origin)	B	C[C@H]1CN(C)C(=O)[C@@H]1c1cc(Nc2ccnc(N(C)C[C@H]3CC[C@H](N)CC3)n2)n[nH]1		CHEMBL3594181	>	Ki	nM	5400.0	CHEMBL4722	Homo sapiens	Ki	uM	5.4
	15651922	CHEMBL3595328	Inhibition of Aurora A (unknown origin)	B	CN1CC(C)(C)C(c2cc(Nc3ccnc(N(C)C[C@H]4CC[C@H](N)CC4)n3)n[nH]2)C1=O		CHEMBL3594182	>	Ki	nM	5400.0	CHEMBL4722	Homo sapiens	Ki	uM	5.4
	15651969	CHEMBL3595339	Inhibition of recombinant human Aurora A at 1 uM relative to control	B	C[C@H]1CN(C)C(=O)[C@@H]1c1cc(Nc2ccnc(N(C)C[C@H]3CC[C@H](N)CC3)n2)n[nH]1		CHEMBL3594181	<	Inhibition	%	75.0	CHEMBL4722	Homo sapiens	INH	%	75.0
	15654955	CHEMBL3599525	Inhibition of Aurora A (unknown origin) at 0.5 uM relative to control	B	Nc1nccc(-c2c[nH]c3ccccc23)n1		CHEMBL48082	=	Inhibition	%	5.1	CHEMBL4722	Homo sapiens	INH	%	5.1
	15654956	CHEMBL3599525	Inhibition of Aurora A (unknown origin) at 0.5 uM relative to control	B	Nc1nccc(-c2cn(C(=O)N3CCOCC3)c3ccc(Br)cc23)n1		CHEMBL3133762	=	Inhibition	%	0.0	CHEMBL4722	Homo sapiens	INH	%	0.0
	15654957	CHEMBL3599525	Inhibition of Aurora A (unknown origin) at 0.5 uM relative to control	B	Cc1noc(C)c1Cn1cc(-c2ccnc(N)n2)c2ccccc21		CHEMBL3133770	=	Inhibition	%	0.0	CHEMBL4722	Homo sapiens	INH	%	0.0
	15666966	CHEMBL3603339	Inhibition of aurora-A (unknown origin) assessed as residual enzyme activity at 100 nM by Z'-Lyte assay relative to control	B	C=CC(=O)Nc1cccc(CNc2nc(Nc3cnn(CCOC)c3)ncc2Cl)c1		CHEMBL3601115	=	Activity	%	2.7	CHEMBL4722	Homo sapiens	Activity	%	2.7
	15668073	CHEMBL3602168	Inhibition of aurora-A (unknown origin) by Z'-Lyte assay	B	C=CC(=O)Nc1cccc(CNc2nc(Nc3cnn(CCOC)c3)ncc2Cl)c1		CHEMBL3601115	=	IC50	nM	43.0	CHEMBL4722	Homo sapiens	IC50	nM	43.0
	15671846	CHEMBL3602982	Inhibition of purified recombinant full-length Aurora A (unknown origin) assessed as residual enzyme activity at 2 mM using kemptide analogue substrate and 5 mM ATP in presence of TPX2 (1 to 43 residues)	B	CN(C)c1ccc2c(-c3ccc(C(=O)NCCCOCCOCCOCCCNC(=O)[C@@H](Cc4ccc(N=[N+]=[N-])cc4)NC(=O)CCNC(=O)[C@]4(Cc5cccc(Nc6nccs6)n5)CC[C@@H](Oc5cccc(Cl)c5F)CC4)cc3C(=O)O)c3ccc(=[N+](C)C)cc-3oc2c1		CHEMBL3600760	=	Activity	%	73.0	CHEMBL4722	Homo sapiens	Activity	%	73.0
	15671847	CHEMBL3602982	Inhibition of purified recombinant full-length Aurora A (unknown origin) assessed as residual enzyme activity at 2 mM using kemptide analogue substrate and 5 mM ATP in presence of TPX2 (1 to 43 residues)	B	CCN1/C(=C/C=C/C2=[N+](CC)c3ccc(S(=O)(=O)O)cc3C2(C)C)C(C)(CCCC(=O)NCCCC[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc2ccc(C(=O)c3ccccc3)cc2)NC(=O)[C@H](Cc2ccc(C(=O)c3ccccc3)cc2)NC(=O)CCCNC(=O)[C@]2(Cc3cccc(Nc4nccs4)n3)CC[C@@H](Oc3cccc(Cl)c3F)CC2)C(N)=O)c2cc(S(=O)(=O)O)ccc21		CHEMBL3600761	=	Activity	%	100.0	CHEMBL4722	Homo sapiens	Activity	%	100.0
	15671848	CHEMBL3602982	Inhibition of purified recombinant full-length Aurora A (unknown origin) assessed as residual enzyme activity at 2 mM using kemptide analogue substrate and 5 mM ATP in presence of TPX2 (1 to 43 residues)	B	CCN1/C(=C/C=C/C2=[N+](CC)c3ccc(S(=O)(=O)O)cc3C2(C)C)C(C)(CCCC(=O)NCCCC[C@@H](NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@H](Cc2ccc(C(=O)c3ccccc3)cc2)NC(=O)[C@H](Cc2ccc(C(=O)c3ccccc3)cc2)NC(=O)CCCNC(=O)[C@]2(Cc3cccc(Nc4nccs4)n3)CC[C@@H](Oc3cccc(Cl)c3F)CC2)C(N)=O)c2cc(S(=O)(=O)O)ccc21		CHEMBL3600762	=	Activity	%	100.0	CHEMBL4722	Homo sapiens	Activity	%	100.0
	15671849	CHEMBL3602982	Inhibition of purified recombinant full-length Aurora A (unknown origin) assessed as residual enzyme activity at 2 mM using kemptide analogue substrate and 5 mM ATP in presence of TPX2 (1 to 43 residues)	B	CCN1/C(=C/C=C/C2=[N+](CC)c3ccc(S(=O)(=O)O)cc3C2(C)C)C(C)(CCCC(=O)NCCCC[C@@H](NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](Cc2ccc(C(=O)c3ccccc3)cc2)NC(=O)[C@@H](Cc2ccc(C(=O)c3ccccc3)cc2)NC(=O)CCCNC(=O)[C@]2(Cc3cccc(Nc4nccs4)n3)CC[C@@H](Oc3cccc(Cl)c3F)CC2)C(N)=O)c2cc(S(=O)(=O)O)ccc21		CHEMBL3600763	=	Activity	%	110.0	CHEMBL4722	Homo sapiens	Activity	%	110.0
	15671850	CHEMBL3602982	Inhibition of purified recombinant full-length Aurora A (unknown origin) assessed as residual enzyme activity at 2 mM using kemptide analogue substrate and 5 mM ATP in presence of TPX2 (1 to 43 residues)	B	CCN1/C(=C/C=C/C2=[N+](CC)c3ccc(S(=O)(=O)O)cc3C2(C)C)C(C)(CCCC(=O)NCCCC[C@@H](NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@H](Cc2ccc(N=[N+]=[N-])cc2)NC(=O)[C@H](Cc2ccc(N=[N+]=[N-])cc2)NC(=O)CCNC(=O)[C@]2(Cc3cccc(Nc4nccs4)n3)CC[C@@H](Oc3cccc(Cl)c3F)CC2)C(N)=O)c2cc(S(=O)(=O)O)ccc21		CHEMBL3600764	=	Activity	%	71.0	CHEMBL4722	Homo sapiens	Activity	%	71.0
	15671851	CHEMBL3602982	Inhibition of purified recombinant full-length Aurora A (unknown origin) assessed as residual enzyme activity at 2 mM using kemptide analogue substrate and 5 mM ATP in presence of TPX2 (1 to 43 residues)	B	CCN1/C(=C/C=C/C2=[N+](CC)c3ccc(S(=O)(=O)O)cc3C2(C)C)C(C)(CCCC(=O)NCCCC[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](Cc2ccc(N=[N+]=[N-])cc2)NC(=O)[C@@H](Cc2ccc(N=[N+]=[N-])cc2)NC(=O)CCNC(=O)[C@]2(Cc3cccc(Nc4nccs4)n3)CC[C@@H](Oc3cccc(Cl)c3F)CC2)C(N)=O)c2cc(S(=O)(=O)O)ccc21		CHEMBL3600868	=	Activity	%	74.0	CHEMBL4722	Homo sapiens	Activity	%	74.0
	15671852	CHEMBL3602982	Inhibition of purified recombinant full-length Aurora A (unknown origin) assessed as residual enzyme activity at 2 mM using kemptide analogue substrate and 5 mM ATP in presence of TPX2 (1 to 43 residues)	B	CCN1/C(=C/C=C/C2=[N+](CC)c3ccc(S(=O)(=O)O)cc3C2(C)C)C(C)(CCCC(=O)NCCCC[C@@H](NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](Cc2ccc(N=[N+]=[N-])cc2)NC(=O)[C@@H](Cc2ccc(N=[N+]=[N-])cc2)NC(=O)CCNC(=O)[C@]2(Cc3cccc(Nc4nccs4)n3)CC[C@@H](Oc3cccc(Cl)c3F)CC2)C(N)=O)c2cc(S(=O)(=O)O)ccc21		CHEMBL3600869	=	Activity	%	96.0	CHEMBL4722	Homo sapiens	Activity	%	96.0
	15671853	CHEMBL3602982	Inhibition of purified recombinant full-length Aurora A (unknown origin) assessed as residual enzyme activity at 2 mM using kemptide analogue substrate and 5 mM ATP in presence of TPX2 (1 to 43 residues)	B	CN(C)c1ccc2c(c1)OC1=CC(=[N+](C)C)C=CC1C2c1ccc(C(=O)NCCCC[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc2ccc(N=[N+]=[N-])cc2)NC(=O)CCCCCNC(=O)[C@]2(Cc3cccc(Nc4nccs4)n3)CC[C@@H](Oc3cccc(Cl)c3F)CC2)C(N)=O)cc1C(=O)O		CHEMBL3600870	=	Activity	%	66.0	CHEMBL4722	Homo sapiens	Activity	%	66.0
	15671854	CHEMBL3602982	Inhibition of purified recombinant full-length Aurora A (unknown origin) assessed as residual enzyme activity at 2 mM using kemptide analogue substrate and 5 mM ATP in presence of TPX2 (1 to 43 residues)	B	CN(C)c1ccc2c(-c3ccc(C(=O)NCCCC[C@H](NC(=O)[C@H](Cc4ccccc4)NC(=O)[C@H](Cc4ccccc4)NC(=O)CCCNC(=O)[C@]4(Cc5cccc(Nc6nccs6)n5)CC[C@@H](Oc5cccc(Cl)c5F)CC4)C(N)=O)cc3C(=O)O)c3ccc(=[N+](C)C)cc-3oc2c1		CHEMBL3600871	=	Activity	%	110.0	CHEMBL4722	Homo sapiens	Activity	%	110.0
	15671855	CHEMBL3602982	Inhibition of purified recombinant full-length Aurora A (unknown origin) assessed as residual enzyme activity at 2 mM using kemptide analogue substrate and 5 mM ATP in presence of TPX2 (1 to 43 residues)	B	N=C(N)NCCC[C@@H](NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)CCCCCNC(=O)[C@]1(Cc2cccc(Nc3nccs3)n2)CC[C@@H](Oc2cccc(Cl)c2F)CC1)C(N)=O		CHEMBL3600872	=	Activity	%	10.0	CHEMBL4722	Homo sapiens	Activity	%	10.0
	15671856	CHEMBL3602982	Inhibition of purified recombinant full-length Aurora A (unknown origin) assessed as residual enzyme activity at 2 mM using kemptide analogue substrate and 5 mM ATP in presence of TPX2 (1 to 43 residues)	B	O=C(O)[C@]1(Cc2cccc(Nc3nccs3)n2)CC[C@@H](Oc2cccc(Cl)c2F)CC1		CHEMBL3600873	=	Activity	%	67.0	CHEMBL4722	Homo sapiens	Activity	%	67.0
Not Active	15671857	CHEMBL3602988	Binding affinity to Aurora A in human HeLa cells assessed as covalent irreversible complex formation at 1 uM irradiated for 15 mins with near-UV light in presence of Aurora A inhibitor MLN8237 by SDS-PAGE and Western blot method	B	CCN1/C(=C/C=C/C2=[N+](CC)c3ccc(S(=O)(=O)O)cc3C2(C)C)C(C)(CCCC(=O)NCCCC[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](Cc2ccc(N=[N+]=[N-])cc2)NC(=O)[C@@H](Cc2ccc(N=[N+]=[N-])cc2)NC(=O)CCNC(=O)[C@]2(Cc3cccc(Nc4nccs4)n3)CC[C@@H](Oc3cccc(Cl)c3F)CC2)C(N)=O)c2cc(S(=O)(=O)O)ccc21		CHEMBL3600868		Activity			CHEMBL4722	Homo sapiens	Activity		
Not Active	15671858	CHEMBL3602988	Binding affinity to Aurora A in human HeLa cells assessed as covalent irreversible complex formation at 1 uM irradiated for 15 mins with near-UV light in presence of Aurora A inhibitor MLN8237 by SDS-PAGE and Western blot method	B	CCN1/C(=C/C=C/C2=[N+](CC)c3ccc(S(=O)(=O)O)cc3C2(C)C)C(C)(CCCC(=O)NCCCC[C@@H](NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@H](Cc2ccc(N=[N+]=[N-])cc2)NC(=O)[C@H](Cc2ccc(N=[N+]=[N-])cc2)NC(=O)CCNC(=O)[C@]2(Cc3cccc(Nc4nccs4)n3)CC[C@@H](Oc3cccc(Cl)c3F)CC2)C(N)=O)c2cc(S(=O)(=O)O)ccc21		CHEMBL3600764		Activity			CHEMBL4722	Homo sapiens	Activity		
Active	15671859	CHEMBL3602988	Binding affinity to Aurora A in human HeLa cells assessed as covalent irreversible complex formation at 1 uM irradiated for 15 mins with near-UV light in presence of Aurora A inhibitor MLN8237 by SDS-PAGE and Western blot method	B	CN(C)c1ccc2c(-c3ccc(C(=O)NCCCC[C@H](NC(=O)[C@H](Cc4ccc(C(=O)c5ccccc5)cc4)NC(=O)[C@H](Cc4ccc(C(=O)c5ccccc5)cc4)NC(=O)CCCNC(=O)[C@]4(Cc5cccc(Nc6nccs6)n5)CC[C@@H](Oc5cccc(Cl)c5F)CC4)C(N)=O)cc3C(=O)O)c3ccc(=[N+](C)C)cc-3oc2c1		CHEMBL3600654		Activity			CHEMBL4722	Homo sapiens	Activity		
Active	15671860	CHEMBL3602988	Binding affinity to Aurora A in human HeLa cells assessed as covalent irreversible complex formation at 1 uM irradiated for 15 mins with near-UV light in presence of Aurora A inhibitor MLN8237 by SDS-PAGE and Western blot method	B	CN(C)c1ccc2c(-c3ccc(C(=O)NCCCC[C@H](NC(=O)[C@H](Cc4ccc(N=[N+]=[N-])cc4)NC(=O)[C@H](Cc4ccc(N=[N+]=[N-])cc4)NC(=O)CCCNC(=O)[C@]4(Cc5cccc(Nc6nccs6)n5)CC[C@@H](Oc5cccc(Cl)c5F)CC4)C(N)=O)cc3C(=O)O)c3ccc(=[N+](C)C)cc-3oc2c1		CHEMBL3600653		Activity			CHEMBL4722	Homo sapiens	Activity		
Active	15671861	CHEMBL3602987	Binding affinity to Aurora A in human HeLa cells assessed as covalent irreversible complex formation at 1 uM irradiated for 15 mins with near-UV light by SDS-PAGE and Western blot method	B	CCN1/C(=C/C=C/C2=[N+](CC)c3ccc(S(=O)(=O)O)cc3C2(C)C)C(C)(CCCC(=O)NCCCC[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](Cc2ccc(N=[N+]=[N-])cc2)NC(=O)[C@@H](Cc2ccc(N=[N+]=[N-])cc2)NC(=O)CCNC(=O)[C@]2(Cc3cccc(Nc4nccs4)n3)CC[C@@H](Oc3cccc(Cl)c3F)CC2)C(N)=O)c2cc(S(=O)(=O)O)ccc21		CHEMBL3600868		Activity			CHEMBL4722	Homo sapiens	Activity		
Active	15671862	CHEMBL3602987	Binding affinity to Aurora A in human HeLa cells assessed as covalent irreversible complex formation at 1 uM irradiated for 15 mins with near-UV light by SDS-PAGE and Western blot method	B	CCN1/C(=C/C=C/C2=[N+](CC)c3ccc(S(=O)(=O)O)cc3C2(C)C)C(C)(CCCC(=O)NCCCC[C@@H](NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@H](Cc2ccc(N=[N+]=[N-])cc2)NC(=O)[C@H](Cc2ccc(N=[N+]=[N-])cc2)NC(=O)CCNC(=O)[C@]2(Cc3cccc(Nc4nccs4)n3)CC[C@@H](Oc3cccc(Cl)c3F)CC2)C(N)=O)c2cc(S(=O)(=O)O)ccc21		CHEMBL3600764		Activity			CHEMBL4722	Homo sapiens	Activity		
Active	15671863	CHEMBL3602987	Binding affinity to Aurora A in human HeLa cells assessed as covalent irreversible complex formation at 1 uM irradiated for 15 mins with near-UV light by SDS-PAGE and Western blot method	B	CN(C)c1ccc2c(-c3ccc(C(=O)NCCCC[C@H](NC(=O)[C@H](Cc4ccc(C(=O)c5ccccc5)cc4)NC(=O)[C@H](Cc4ccc(C(=O)c5ccccc5)cc4)NC(=O)CCCNC(=O)[C@]4(Cc5cccc(Nc6nccs6)n5)CC[C@@H](Oc5cccc(Cl)c5F)CC4)C(N)=O)cc3C(=O)O)c3ccc(=[N+](C)C)cc-3oc2c1		CHEMBL3600654		Activity			CHEMBL4722	Homo sapiens	Activity		
Active	15671864	CHEMBL3602987	Binding affinity to Aurora A in human HeLa cells assessed as covalent irreversible complex formation at 1 uM irradiated for 15 mins with near-UV light by SDS-PAGE and Western blot method	B	CN(C)c1ccc2c(-c3ccc(C(=O)NCCCC[C@H](NC(=O)[C@H](Cc4ccc(N=[N+]=[N-])cc4)NC(=O)[C@H](Cc4ccc(N=[N+]=[N-])cc4)NC(=O)CCCNC(=O)[C@]4(Cc5cccc(Nc6nccs6)n5)CC[C@@H](Oc5cccc(Cl)c5F)CC4)C(N)=O)cc3C(=O)O)c3ccc(=[N+](C)C)cc-3oc2c1		CHEMBL3600653		Activity			CHEMBL4722	Homo sapiens	Activity		
Not Active	15671865	CHEMBL3602986	Binding affinity to 1 uM and >100 uM VX689-prre-treated purified recombinant full-length Aurora A (unknown origin) assessed as covalent irreversible complex formation at 1 uM irradiated for 15 mins with near-UV light by SDS-PAGE and Western blot method	B	CCN1/C(=C/C=C/C2=[N+](CC)c3ccc(S(=O)(=O)O)cc3C2(C)C)C(C)(CCCC(=O)NCCCC[C@@H](NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](Cc2ccc(N=[N+]=[N-])cc2)NC(=O)[C@@H](Cc2ccc(N=[N+]=[N-])cc2)NC(=O)CCNC(=O)[C@]2(Cc3cccc(Nc4nccs4)n3)CC[C@@H](Oc3cccc(Cl)c3F)CC2)C(N)=O)c2cc(S(=O)(=O)O)ccc21		CHEMBL3600869		Activity			CHEMBL4722	Homo sapiens	Activity		
Not Active	15671866	CHEMBL3602986	Binding affinity to 1 uM and >100 uM VX689-prre-treated purified recombinant full-length Aurora A (unknown origin) assessed as covalent irreversible complex formation at 1 uM irradiated for 15 mins with near-UV light by SDS-PAGE and Western blot method	B	CCN1/C(=C/C=C/C2=[N+](CC)c3ccc(S(=O)(=O)O)cc3C2(C)C)C(C)(CCCC(=O)NCCCC[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](Cc2ccc(N=[N+]=[N-])cc2)NC(=O)[C@@H](Cc2ccc(N=[N+]=[N-])cc2)NC(=O)CCNC(=O)[C@]2(Cc3cccc(Nc4nccs4)n3)CC[C@@H](Oc3cccc(Cl)c3F)CC2)C(N)=O)c2cc(S(=O)(=O)O)ccc21		CHEMBL3600868		Activity			CHEMBL4722	Homo sapiens	Activity		
Not Active	15671867	CHEMBL3602986	Binding affinity to 1 uM and >100 uM VX689-prre-treated purified recombinant full-length Aurora A (unknown origin) assessed as covalent irreversible complex formation at 1 uM irradiated for 15 mins with near-UV light by SDS-PAGE and Western blot method	B	CCN1/C(=C/C=C/C2=[N+](CC)c3ccc(S(=O)(=O)O)cc3C2(C)C)C(C)(CCCC(=O)NCCCC[C@@H](NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@H](Cc2ccc(N=[N+]=[N-])cc2)NC(=O)[C@H](Cc2ccc(N=[N+]=[N-])cc2)NC(=O)CCNC(=O)[C@]2(Cc3cccc(Nc4nccs4)n3)CC[C@@H](Oc3cccc(Cl)c3F)CC2)C(N)=O)c2cc(S(=O)(=O)O)ccc21		CHEMBL3600764		Activity			CHEMBL4722	Homo sapiens	Activity		
Not Active	15671868	CHEMBL3602986	Binding affinity to 1 uM and >100 uM VX689-prre-treated purified recombinant full-length Aurora A (unknown origin) assessed as covalent irreversible complex formation at 1 uM irradiated for 15 mins with near-UV light by SDS-PAGE and Western blot method	B	CN(C)c1ccc2c(-c3ccc(C(=O)NCCCOCCOCCOCCCNC(=O)[C@@H](Cc4ccc(N=[N+]=[N-])cc4)NC(=O)CCNC(=O)[C@]4(Cc5cccc(Nc6nccs6)n5)CC[C@@H](Oc5cccc(Cl)c5F)CC4)cc3C(=O)O)c3ccc(=[N+](C)C)cc-3oc2c1		CHEMBL3600760		Activity			CHEMBL4722	Homo sapiens	Activity		
Not Active	15671869	CHEMBL3602986	Binding affinity to 1 uM and >100 uM VX689-prre-treated purified recombinant full-length Aurora A (unknown origin) assessed as covalent irreversible complex formation at 1 uM irradiated for 15 mins with near-UV light by SDS-PAGE and Western blot method	B	CN(C)c1ccc2c(-c3ccc(C(=O)NCCCC[C@H](NC(=O)[C@H](Cc4ccc(N=[N+]=[N-])cc4)NC(=O)[C@H](Cc4ccc(N=[N+]=[N-])cc4)NC(=O)CCCNC(=O)[C@]4(Cc5cccc(Nc6nccs6)n5)CC[C@@H](Oc5cccc(Cl)c5F)CC4)C(N)=O)cc3C(=O)O)c3ccc(=[N+](C)C)cc-3oc2c1		CHEMBL3600653		Activity			CHEMBL4722	Homo sapiens	Activity		
Not Active	15671870	CHEMBL3602985	Binding affinity to purified recombinant full-length Aurora A (unknown origin) assessed as covalent irreversible complex formation at 4.8 uM irradiated for 15 mins with near-UV light using 200 nM Aurora A by SDS-PAGE and Western blot method	B	CN(C)c1ccc2c(-c3ccc(C(=O)NCCCC[C@H](NC(=O)[C@H](Cc4ccc(N=[N+]=[N-])cc4)NC(=O)[C@H](Cc4ccc(N=[N+]=[N-])cc4)NC(=O)CCCNC(=O)[C@]4(Cc5cccc(Nc6nccs6)n5)CC[C@@H](Oc5cccc(Cl)c5F)CC4)C(N)=O)cc3C(=O)O)c3ccc(=[N+](C)C)cc-3oc2c1		CHEMBL3600653		Activity			CHEMBL4722	Homo sapiens	Activity		
Active	15671871	CHEMBL3602984	Binding affinity to purified recombinant full-length Aurora A (unknown origin) assessed as covalent irreversible complex formation at 1.2 uM irradiated for 15 mins with near-UV light in presence of TPX2 by SDS-PAGE and Western blot method	B	CN(C)c1ccc2c(-c3ccc(C(=O)NCCCC[C@H](NC(=O)[C@H](Cc4ccccc4)NC(=O)[C@H](Cc4ccccc4)NC(=O)CCCNC(=O)[C@]4(Cc5cccc(Nc6nccs6)n5)CC[C@@H](Oc5cccc(Cl)c5F)CC4)C(N)=O)cc3C(=O)O)c3ccc(=[N+](C)C)cc-3oc2c1		CHEMBL3600871		Activity			CHEMBL4722	Homo sapiens	Activity		
Active	15671872	CHEMBL3602984	Binding affinity to purified recombinant full-length Aurora A (unknown origin) assessed as covalent irreversible complex formation at 1.2 uM irradiated for 15 mins with near-UV light in presence of TPX2 by SDS-PAGE and Western blot method	B	CN(C)c1ccc2c(-c3ccc(C(=O)NCCCC[C@H](NC(=O)[C@H](Cc4ccc(C(=O)c5ccccc5)cc4)NC(=O)[C@H](Cc4ccc(C(=O)c5ccccc5)cc4)NC(=O)CCCNC(=O)[C@]4(Cc5cccc(Nc6nccs6)n5)CC[C@@H](Oc5cccc(Cl)c5F)CC4)C(N)=O)cc3C(=O)O)c3ccc(=[N+](C)C)cc-3oc2c1		CHEMBL3600654		Activity			CHEMBL4722	Homo sapiens	Activity		
Active	15671873	CHEMBL3602983	Binding affinity to purified recombinant full-length Aurora A (unknown origin) assessed as covalent irreversible complex formation at 2.4 uM irradiated for 15 mins with near-UV light in presence of TPX2 by SDS-PAGE and Western blot method	B	CN(C)c1ccc2c(-c3ccc(C(=O)NCCCC[C@H](NC(=O)[C@H](Cc4ccc(N=[N+]=[N-])cc4)NC(=O)[C@H](Cc4ccc(N=[N+]=[N-])cc4)NC(=O)CCCNC(=O)[C@]4(Cc5cccc(Nc6nccs6)n5)CC[C@@H](Oc5cccc(Cl)c5F)CC4)C(N)=O)cc3C(=O)O)c3ccc(=[N+](C)C)cc-3oc2c1		CHEMBL3600653		Activity			CHEMBL4722	Homo sapiens	Activity		
	15671874	CHEMBL3602982	Inhibition of purified recombinant full-length Aurora A (unknown origin) assessed as residual enzyme activity at 2 mM using kemptide analogue substrate and 5 mM ATP in presence of TPX2 (1 to 43 residues)	B	CN(C)c1ccc2c(-c3ccc(C(=O)NCCCC[C@H](NC(=O)[C@H](Cc4ccc(C(=O)c5ccccc5)cc4)NC(=O)[C@H](Cc4ccc(C(=O)c5ccccc5)cc4)NC(=O)CCCNC(=O)[C@]4(Cc5cccc(Nc6nccs6)n5)CC[C@@H](Oc5cccc(Cl)c5F)CC4)C(N)=O)cc3C(=O)O)c3ccc(=[N+](C)C)cc-3oc2c1		CHEMBL3600654	=	Activity	%	100.0	CHEMBL4722	Homo sapiens	Activity	%	100.0
	15671875	CHEMBL3602982	Inhibition of purified recombinant full-length Aurora A (unknown origin) assessed as residual enzyme activity at 2 mM using kemptide analogue substrate and 5 mM ATP in presence of TPX2 (1 to 43 residues)	B	CN(C)c1ccc2c(-c3ccc(C(=O)NCCCC[C@H](NC(=O)[C@H](Cc4ccc(N=[N+]=[N-])cc4)NC(=O)[C@H](Cc4ccc(N=[N+]=[N-])cc4)NC(=O)CCCNC(=O)[C@]4(Cc5cccc(Nc6nccs6)n5)CC[C@@H](Oc5cccc(Cl)c5F)CC4)C(N)=O)cc3C(=O)O)c3ccc(=[N+](C)C)cc-3oc2c1		CHEMBL3600653	=	Activity	%	100.0	CHEMBL4722	Homo sapiens	Activity	%	100.0
Not Determined	15671876	CHEMBL3602981	Binding affinity to purified recombinant full-length Aurora A (unknown origin) by fluorescence polarisation/anisotropy based equilibrium binding assay	B	O=C(O)[C@]1(Cc2cccc(Nc3nccs3)n2)CC[C@@H](Oc2cccc(Cl)c2F)CC1		CHEMBL3600873		Kd			CHEMBL4722	Homo sapiens	Kd		
Not Determined	15671877	CHEMBL3602981	Binding affinity to purified recombinant full-length Aurora A (unknown origin) by fluorescence polarisation/anisotropy based equilibrium binding assay	B	N=C(N)NCCC[C@@H](NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)CCCCCNC(=O)[C@]1(Cc2cccc(Nc3nccs3)n2)CC[C@@H](Oc2cccc(Cl)c2F)CC1)C(N)=O		CHEMBL3600872		Kd			CHEMBL4722	Homo sapiens	Kd		
	15671878	CHEMBL3602981	Binding affinity to purified recombinant full-length Aurora A (unknown origin) by fluorescence polarisation/anisotropy based equilibrium binding assay	B	CN(C)c1ccc2c(-c3ccc(C(=O)NCCCC[C@H](NC(=O)[C@H](Cc4ccccc4)NC(=O)[C@H](Cc4ccccc4)NC(=O)CCCNC(=O)[C@]4(Cc5cccc(Nc6nccs6)n5)CC[C@@H](Oc5cccc(Cl)c5F)CC4)C(N)=O)cc3C(=O)O)c3ccc(=[N+](C)C)cc-3oc2c1		CHEMBL3600871	=	Kd	nM	0.44	CHEMBL4722	Homo sapiens	Kd	nM	0.44
	15671879	CHEMBL3602981	Binding affinity to purified recombinant full-length Aurora A (unknown origin) by fluorescence polarisation/anisotropy based equilibrium binding assay	B	CN(C)c1ccc2c(c1)OC1=CC(=[N+](C)C)C=CC1C2c1ccc(C(=O)NCCCC[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc2ccc(N=[N+]=[N-])cc2)NC(=O)CCCCCNC(=O)[C@]2(Cc3cccc(Nc4nccs4)n3)CC[C@@H](Oc3cccc(Cl)c3F)CC2)C(N)=O)cc1C(=O)O		CHEMBL3600870	=	Kd	nM	0.73	CHEMBL4722	Homo sapiens	Kd	nM	0.73
	15671880	CHEMBL3602981	Binding affinity to purified recombinant full-length Aurora A (unknown origin) by fluorescence polarisation/anisotropy based equilibrium binding assay	B	CCN1/C(=C/C=C/C2=[N+](CC)c3ccc(S(=O)(=O)O)cc3C2(C)C)C(C)(CCCC(=O)NCCCC[C@@H](NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](Cc2ccc(N=[N+]=[N-])cc2)NC(=O)[C@@H](Cc2ccc(N=[N+]=[N-])cc2)NC(=O)CCNC(=O)[C@]2(Cc3cccc(Nc4nccs4)n3)CC[C@@H](Oc3cccc(Cl)c3F)CC2)C(N)=O)c2cc(S(=O)(=O)O)ccc21		CHEMBL3600869	=	Kd	nM	2.5	CHEMBL4722	Homo sapiens	Kd	nM	2.5
	15671881	CHEMBL3602981	Binding affinity to purified recombinant full-length Aurora A (unknown origin) by fluorescence polarisation/anisotropy based equilibrium binding assay	B	CCN1/C(=C/C=C/C2=[N+](CC)c3ccc(S(=O)(=O)O)cc3C2(C)C)C(C)(CCCC(=O)NCCCC[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](Cc2ccc(N=[N+]=[N-])cc2)NC(=O)[C@@H](Cc2ccc(N=[N+]=[N-])cc2)NC(=O)CCNC(=O)[C@]2(Cc3cccc(Nc4nccs4)n3)CC[C@@H](Oc3cccc(Cl)c3F)CC2)C(N)=O)c2cc(S(=O)(=O)O)ccc21		CHEMBL3600868	=	Kd	nM	6.1	CHEMBL4722	Homo sapiens	Kd	nM	6.1
	15671882	CHEMBL3602981	Binding affinity to purified recombinant full-length Aurora A (unknown origin) by fluorescence polarisation/anisotropy based equilibrium binding assay	B	CCN1/C(=C/C=C/C2=[N+](CC)c3ccc(S(=O)(=O)O)cc3C2(C)C)C(C)(CCCC(=O)NCCCC[C@@H](NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@H](Cc2ccc(N=[N+]=[N-])cc2)NC(=O)[C@H](Cc2ccc(N=[N+]=[N-])cc2)NC(=O)CCNC(=O)[C@]2(Cc3cccc(Nc4nccs4)n3)CC[C@@H](Oc3cccc(Cl)c3F)CC2)C(N)=O)c2cc(S(=O)(=O)O)ccc21		CHEMBL3600764	=	Kd	nM	5.7	CHEMBL4722	Homo sapiens	Kd	nM	5.7
	15671883	CHEMBL3602981	Binding affinity to purified recombinant full-length Aurora A (unknown origin) by fluorescence polarisation/anisotropy based equilibrium binding assay	B	CCN1/C(=C/C=C/C2=[N+](CC)c3ccc(S(=O)(=O)O)cc3C2(C)C)C(C)(CCCC(=O)NCCCC[C@@H](NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](Cc2ccc(C(=O)c3ccccc3)cc2)NC(=O)[C@@H](Cc2ccc(C(=O)c3ccccc3)cc2)NC(=O)CCCNC(=O)[C@]2(Cc3cccc(Nc4nccs4)n3)CC[C@@H](Oc3cccc(Cl)c3F)CC2)C(N)=O)c2cc(S(=O)(=O)O)ccc21		CHEMBL3600763	=	Kd	nM	6.5	CHEMBL4722	Homo sapiens	Kd	nM	6.5
	15671884	CHEMBL3602981	Binding affinity to purified recombinant full-length Aurora A (unknown origin) by fluorescence polarisation/anisotropy based equilibrium binding assay	B	CCN1/C(=C/C=C/C2=[N+](CC)c3ccc(S(=O)(=O)O)cc3C2(C)C)C(C)(CCCC(=O)NCCCC[C@@H](NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@H](Cc2ccc(C(=O)c3ccccc3)cc2)NC(=O)[C@H](Cc2ccc(C(=O)c3ccccc3)cc2)NC(=O)CCCNC(=O)[C@]2(Cc3cccc(Nc4nccs4)n3)CC[C@@H](Oc3cccc(Cl)c3F)CC2)C(N)=O)c2cc(S(=O)(=O)O)ccc21		CHEMBL3600762	=	Kd	nM	9.1	CHEMBL4722	Homo sapiens	Kd	nM	9.1
Not Determined	15671885	CHEMBL3602981	Binding affinity to purified recombinant full-length Aurora A (unknown origin) by fluorescence polarisation/anisotropy based equilibrium binding assay	B	CCN1/C(=C/C=C/C2=[N+](CC)c3ccc(S(=O)(=O)O)cc3C2(C)C)C(C)(CCCC(=O)NCCCC[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc2ccc(C(=O)c3ccccc3)cc2)NC(=O)[C@H](Cc2ccc(C(=O)c3ccccc3)cc2)NC(=O)CCCNC(=O)[C@]2(Cc3cccc(Nc4nccs4)n3)CC[C@@H](Oc3cccc(Cl)c3F)CC2)C(N)=O)c2cc(S(=O)(=O)O)ccc21		CHEMBL3600761		Kd			CHEMBL4722	Homo sapiens	Kd		
	15671886	CHEMBL3602981	Binding affinity to purified recombinant full-length Aurora A (unknown origin) by fluorescence polarisation/anisotropy based equilibrium binding assay	B	CN(C)c1ccc2c(-c3ccc(C(=O)NCCCOCCOCCOCCCNC(=O)[C@@H](Cc4ccc(N=[N+]=[N-])cc4)NC(=O)CCNC(=O)[C@]4(Cc5cccc(Nc6nccs6)n5)CC[C@@H](Oc5cccc(Cl)c5F)CC4)cc3C(=O)O)c3ccc(=[N+](C)C)cc-3oc2c1		CHEMBL3600760	=	Kd	nM	2.2	CHEMBL4722	Homo sapiens	Kd	nM	2.2
Not Determined	15671887	CHEMBL3602981	Binding affinity to purified recombinant full-length Aurora A (unknown origin) by fluorescence polarisation/anisotropy based equilibrium binding assay	B	CN(C)c1ccc2c(-c3ccc(C(=O)NCCCC[C@H](NC(=O)[C@H](Cc4ccc(C(=O)c5ccccc5)cc4)NC(=O)[C@H](Cc4ccc(C(=O)c5ccccc5)cc4)NC(=O)CCCNC(=O)[C@]4(Cc5cccc(Nc6nccs6)n5)CC[C@@H](Oc5cccc(Cl)c5F)CC4)C(N)=O)cc3C(=O)O)c3ccc(=[N+](C)C)cc-3oc2c1		CHEMBL3600654		Kd			CHEMBL4722	Homo sapiens	Kd		
	15671888	CHEMBL3602981	Binding affinity to purified recombinant full-length Aurora A (unknown origin) by fluorescence polarisation/anisotropy based equilibrium binding assay	B	CN(C)c1ccc2c(-c3ccc(C(=O)NCCCC[C@H](NC(=O)[C@H](Cc4ccc(N=[N+]=[N-])cc4)NC(=O)[C@H](Cc4ccc(N=[N+]=[N-])cc4)NC(=O)CCCNC(=O)[C@]4(Cc5cccc(Nc6nccs6)n5)CC[C@@H](Oc5cccc(Cl)c5F)CC4)C(N)=O)cc3C(=O)O)c3ccc(=[N+](C)C)cc-3oc2c1		CHEMBL3600653	=	Kd	nM	1.9	CHEMBL4722	Homo sapiens	Kd	nM	1.9
	15671889	CHEMBL3602822	Binding affinity to purified recombinant full-length Aurora A (unknown origin) assessed as covalent irreversible complex formation at 1.2 uM irradiated for 30 mins with near-UV light by SDS-PAGE and Western blot method	B	CN(C)c1ccc2c(-c3ccc(C(=O)NCCCC[C@H](NC(=O)[C@H](Cc4ccccc4)NC(=O)[C@H](Cc4ccccc4)NC(=O)CCCNC(=O)[C@]4(Cc5cccc(Nc6nccs6)n5)CC[C@@H](Oc5cccc(Cl)c5F)CC4)C(N)=O)cc3C(=O)O)c3ccc(=[N+](C)C)cc-3oc2c1		CHEMBL3600871	=	Activity	%	1.5	CHEMBL4722	Homo sapiens	Activity	%	1.5
	15671890	CHEMBL3602822	Binding affinity to purified recombinant full-length Aurora A (unknown origin) assessed as covalent irreversible complex formation at 1.2 uM irradiated for 30 mins with near-UV light by SDS-PAGE and Western blot method	B	CN(C)c1ccc2c(-c3ccc(C(=O)NCCCOCCOCCOCCCNC(=O)[C@@H](Cc4ccc(N=[N+]=[N-])cc4)NC(=O)CCNC(=O)[C@]4(Cc5cccc(Nc6nccs6)n5)CC[C@@H](Oc5cccc(Cl)c5F)CC4)cc3C(=O)O)c3ccc(=[N+](C)C)cc-3oc2c1		CHEMBL3600760	=	Activity	%	20.0	CHEMBL4722	Homo sapiens	Activity	%	20.0
	15671891	CHEMBL3602822	Binding affinity to purified recombinant full-length Aurora A (unknown origin) assessed as covalent irreversible complex formation at 1.2 uM irradiated for 30 mins with near-UV light by SDS-PAGE and Western blot method	B	CN(C)c1ccc2c(-c3ccc(C(=O)NCCCC[C@H](NC(=O)[C@H](Cc4ccc(C(=O)c5ccccc5)cc4)NC(=O)[C@H](Cc4ccc(C(=O)c5ccccc5)cc4)NC(=O)CCCNC(=O)[C@]4(Cc5cccc(Nc6nccs6)n5)CC[C@@H](Oc5cccc(Cl)c5F)CC4)C(N)=O)cc3C(=O)O)c3ccc(=[N+](C)C)cc-3oc2c1		CHEMBL3600654	=	Activity	%	9.0	CHEMBL4722	Homo sapiens	Activity	%	9.0
Not Determined	15671892	CHEMBL3602821	Binding affinity to purified recombinant full-length Aurora A (unknown origin) assessed as covalent irreversible complex formation at 2.4 uM irradiated for 15 mins with near-UV light by SDS-PAGE and Western blot method	B	O=C(O)[C@]1(Cc2cccc(Nc3nccs3)n2)CC[C@@H](Oc2cccc(Cl)c2F)CC1		CHEMBL3600873		Activity			CHEMBL4722	Homo sapiens	Activity		
Not Determined	15671893	CHEMBL3602821	Binding affinity to purified recombinant full-length Aurora A (unknown origin) assessed as covalent irreversible complex formation at 2.4 uM irradiated for 15 mins with near-UV light by SDS-PAGE and Western blot method	B	N=C(N)NCCC[C@@H](NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)CCCCCNC(=O)[C@]1(Cc2cccc(Nc3nccs3)n2)CC[C@@H](Oc2cccc(Cl)c2F)CC1)C(N)=O		CHEMBL3600872		Activity			CHEMBL4722	Homo sapiens	Activity		
	15671894	CHEMBL3602821	Binding affinity to purified recombinant full-length Aurora A (unknown origin) assessed as covalent irreversible complex formation at 2.4 uM irradiated for 15 mins with near-UV light by SDS-PAGE and Western blot method	B	CN(C)c1ccc2c(c1)OC1=CC(=[N+](C)C)C=CC1C2c1ccc(C(=O)NCCCC[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc2ccc(N=[N+]=[N-])cc2)NC(=O)CCCCCNC(=O)[C@]2(Cc3cccc(Nc4nccs4)n3)CC[C@@H](Oc3cccc(Cl)c3F)CC2)C(N)=O)cc1C(=O)O		CHEMBL3600870	=	Activity	%	3.6	CHEMBL4722	Homo sapiens	Activity	%	3.6
	15671895	CHEMBL3602821	Binding affinity to purified recombinant full-length Aurora A (unknown origin) assessed as covalent irreversible complex formation at 2.4 uM irradiated for 15 mins with near-UV light by SDS-PAGE and Western blot method	B	CCN1/C(=C/C=C/C2=[N+](CC)c3ccc(S(=O)(=O)O)cc3C2(C)C)C(C)(CCCC(=O)NCCCC[C@@H](NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](Cc2ccc(N=[N+]=[N-])cc2)NC(=O)[C@@H](Cc2ccc(N=[N+]=[N-])cc2)NC(=O)CCNC(=O)[C@]2(Cc3cccc(Nc4nccs4)n3)CC[C@@H](Oc3cccc(Cl)c3F)CC2)C(N)=O)c2cc(S(=O)(=O)O)ccc21		CHEMBL3600869	=	Activity	%	11.0	CHEMBL4722	Homo sapiens	Activity	%	11.0
	15671896	CHEMBL3602821	Binding affinity to purified recombinant full-length Aurora A (unknown origin) assessed as covalent irreversible complex formation at 2.4 uM irradiated for 15 mins with near-UV light by SDS-PAGE and Western blot method	B	CCN1/C(=C/C=C/C2=[N+](CC)c3ccc(S(=O)(=O)O)cc3C2(C)C)C(C)(CCCC(=O)NCCCC[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](Cc2ccc(N=[N+]=[N-])cc2)NC(=O)[C@@H](Cc2ccc(N=[N+]=[N-])cc2)NC(=O)CCNC(=O)[C@]2(Cc3cccc(Nc4nccs4)n3)CC[C@@H](Oc3cccc(Cl)c3F)CC2)C(N)=O)c2cc(S(=O)(=O)O)ccc21		CHEMBL3600868	=	Activity	%	15.0	CHEMBL4722	Homo sapiens	Activity	%	15.0
	15671897	CHEMBL3602821	Binding affinity to purified recombinant full-length Aurora A (unknown origin) assessed as covalent irreversible complex formation at 2.4 uM irradiated for 15 mins with near-UV light by SDS-PAGE and Western blot method	B	CCN1/C(=C/C=C/C2=[N+](CC)c3ccc(S(=O)(=O)O)cc3C2(C)C)C(C)(CCCC(=O)NCCCC[C@@H](NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@H](Cc2ccc(N=[N+]=[N-])cc2)NC(=O)[C@H](Cc2ccc(N=[N+]=[N-])cc2)NC(=O)CCNC(=O)[C@]2(Cc3cccc(Nc4nccs4)n3)CC[C@@H](Oc3cccc(Cl)c3F)CC2)C(N)=O)c2cc(S(=O)(=O)O)ccc21		CHEMBL3600764	=	Activity	%	18.0	CHEMBL4722	Homo sapiens	Activity	%	18.0
	15671898	CHEMBL3602821	Binding affinity to purified recombinant full-length Aurora A (unknown origin) assessed as covalent irreversible complex formation at 2.4 uM irradiated for 15 mins with near-UV light by SDS-PAGE and Western blot method	B	CCN1/C(=C/C=C/C2=[N+](CC)c3ccc(S(=O)(=O)O)cc3C2(C)C)C(C)(CCCC(=O)NCCCC[C@@H](NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](Cc2ccc(C(=O)c3ccccc3)cc2)NC(=O)[C@@H](Cc2ccc(C(=O)c3ccccc3)cc2)NC(=O)CCCNC(=O)[C@]2(Cc3cccc(Nc4nccs4)n3)CC[C@@H](Oc3cccc(Cl)c3F)CC2)C(N)=O)c2cc(S(=O)(=O)O)ccc21		CHEMBL3600763	=	Activity	%	6.9	CHEMBL4722	Homo sapiens	Activity	%	6.9
	15671899	CHEMBL3602821	Binding affinity to purified recombinant full-length Aurora A (unknown origin) assessed as covalent irreversible complex formation at 2.4 uM irradiated for 15 mins with near-UV light by SDS-PAGE and Western blot method	B	CCN1/C(=C/C=C/C2=[N+](CC)c3ccc(S(=O)(=O)O)cc3C2(C)C)C(C)(CCCC(=O)NCCCC[C@@H](NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@H](Cc2ccc(C(=O)c3ccccc3)cc2)NC(=O)[C@H](Cc2ccc(C(=O)c3ccccc3)cc2)NC(=O)CCCNC(=O)[C@]2(Cc3cccc(Nc4nccs4)n3)CC[C@@H](Oc3cccc(Cl)c3F)CC2)C(N)=O)c2cc(S(=O)(=O)O)ccc21		CHEMBL3600762	=	Activity	%	8.1	CHEMBL4722	Homo sapiens	Activity	%	8.1
	15671900	CHEMBL3602821	Binding affinity to purified recombinant full-length Aurora A (unknown origin) assessed as covalent irreversible complex formation at 2.4 uM irradiated for 15 mins with near-UV light by SDS-PAGE and Western blot method	B	CCN1/C(=C/C=C/C2=[N+](CC)c3ccc(S(=O)(=O)O)cc3C2(C)C)C(C)(CCCC(=O)NCCCC[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc2ccc(C(=O)c3ccccc3)cc2)NC(=O)[C@H](Cc2ccc(C(=O)c3ccccc3)cc2)NC(=O)CCCNC(=O)[C@]2(Cc3cccc(Nc4nccs4)n3)CC[C@@H](Oc3cccc(Cl)c3F)CC2)C(N)=O)c2cc(S(=O)(=O)O)ccc21		CHEMBL3600761	=	Activity	%	8.5	CHEMBL4722	Homo sapiens	Activity	%	8.5
	15671901	CHEMBL3602821	Binding affinity to purified recombinant full-length Aurora A (unknown origin) assessed as covalent irreversible complex formation at 2.4 uM irradiated for 15 mins with near-UV light by SDS-PAGE and Western blot method	B	CN(C)c1ccc2c(-c3ccc(C(=O)NCCCC[C@H](NC(=O)[C@H](Cc4ccc(N=[N+]=[N-])cc4)NC(=O)[C@H](Cc4ccc(N=[N+]=[N-])cc4)NC(=O)CCCNC(=O)[C@]4(Cc5cccc(Nc6nccs6)n5)CC[C@@H](Oc5cccc(Cl)c5F)CC4)C(N)=O)cc3C(=O)O)c3ccc(=[N+](C)C)cc-3oc2c1		CHEMBL3600653	=	Activity	%	40.0	CHEMBL4722	Homo sapiens	Activity	%	40.0
	15685873	CHEMBL3607949	Inhibition of human AUR2	B	NC(=O)c1cc(F)cc2c1C(=O)N(C1CCN(C3CCC(F)(F)CC3)CC1)C2		CHEMBL3606021	>	IC50	nM	10000.0	CHEMBL4722	Homo sapiens	IC50	uM	10.0
	15709807	CHEMBL3615454	Inhibition of aurora-A (unknown origin) at 10 uM	B	CC(C)c1nn(C)cc1-c1nc2c(N3CCN(Cc4cccnc4)CC3)c(Br)cnc2[nH]1		CHEMBL3613597	>	Inhibition	%	90.0	CHEMBL4722	Homo sapiens	INH	%	90.0
	15723365	CHEMBL3619882	Inhibition of Aurora A (unknown origin) at 10 uM after 40 mins by scintillation counting analysis	B	Cc1ccc(NC(=O)c2cc(N3CCN(C)CC3)cc(C(F)(F)F)c2)cc1NC(=O)c1cnoc1C		CHEMBL3616960	=	Inhibition	%	0.0	CHEMBL4722	Homo sapiens	INH	%	0.0
Not Active	15723366	CHEMBL3619882	Inhibition of Aurora A (unknown origin) at 10 uM after 40 mins by scintillation counting analysis	B	Cc1ccccc1C(=O)Nc1cnoc1C		CHEMBL3616990		Inhibition	%		CHEMBL4722	Homo sapiens	INH		
	15723423	CHEMBL3620017	Inhibition of Aurora A (unknown origin) after 40 mins by scintillation counting analysis	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	<	IC50	nM	1.0	CHEMBL4722	Homo sapiens	IC50	nM	1.0
	15730405	CHEMBL3627428	Inhibition of Aurora-A (unknown origin)	B	CN1CCN(C(=O)c2ccc3c(c2)[nH]c2c(C(N)=O)ccc(-c4ccccc4F)c23)CC1		CHEMBL3621496	=	IC50	nM	444.0	CHEMBL4722	Homo sapiens	IC50	nM	444.0
	15730406	CHEMBL3627428	Inhibition of Aurora-A (unknown origin)	B	CC(=O)Nc1cccc(-c2ccc(C(N)=O)c3[nH]c4cc(C(=O)N5CCN(C)CC5)ccc4c23)c1C		CHEMBL3621515	>	IC50	nM	2000.0	CHEMBL4722	Homo sapiens	IC50	nM	2000.0
	15730407	CHEMBL3627428	Inhibition of Aurora-A (unknown origin)	B	CN1CCN(C(=O)c2ccc3c(c2)[nH]c2c(C(N)=O)ccc(-c4cccc(NC(=O)c5ccc(N(C)C)cc5)c4F)c23)CC1		CHEMBL3622193	=	IC50	nM	493.0	CHEMBL4722	Homo sapiens	IC50	nM	493.0
	15732765	CHEMBL3626658	Inhibition of aurora A kinase (unknown origin) by enzymatic assay	B	C[C@@H](Oc1nc(-c2cnn(C(F)F)c2)cc2ncsc12)[C@H]1CNC(=O)O1		CHEMBL3622203	=	IC50	nM	57.0	CHEMBL4722	Homo sapiens	IC50	nM	57.0
	15732766	CHEMBL3626658	Inhibition of aurora A kinase (unknown origin) by enzymatic assay	B	C[C@@H](Oc1cc(-c2cnn(C)c2)cc2ncsc12)[C@H]1CNC(=O)C1		CHEMBL3622204	<=	IC50	nM	100.0	CHEMBL4722	Homo sapiens	IC50	nM	100.0
	15732767	CHEMBL3626658	Inhibition of aurora A kinase (unknown origin) by enzymatic assay	B	C[C@@H](Oc1cc(-c2cnn(C)c2)cc2nscc12)[C@H]1CNC(=O)C1		CHEMBL3622206	=	IC50	nM	576.0	CHEMBL4722	Homo sapiens	IC50	nM	576.0
	15732768	CHEMBL3626658	Inhibition of aurora A kinase (unknown origin) by enzymatic assay	B	C[C@@H](Oc1nc(-c2cnn(C)c2)cc2nscc12)[C@H]1CNC(=O)C1		CHEMBL3622207	=	IC50	nM	800.0	CHEMBL4722	Homo sapiens	IC50	nM	800.0
	15732769	CHEMBL3626658	Inhibition of aurora A kinase (unknown origin) by enzymatic assay	B	COc1ccc(-c2cc3ncsc3c(O[C@H](C)[C@H]3CNC(=O)C3)n2)cc1OC		CHEMBL3622208	<=	IC50	nM	100.0	CHEMBL4722	Homo sapiens	IC50	nM	100.0
	15732770	CHEMBL3626658	Inhibition of aurora A kinase (unknown origin) by enzymatic assay	B	C[C@@H](Oc1cc(-c2cnn(C)c2)cc2nscc12)[C@H]1CNC(=O)O1		CHEMBL3622209	<=	IC50	nM	100.0	CHEMBL4722	Homo sapiens	IC50	nM	100.0
	15732771	CHEMBL3626658	Inhibition of aurora A kinase (unknown origin) by enzymatic assay	B	C[C@@H](Oc1cc(-c2cnn(C(F)F)c2)cc2nscc12)[C@H]1CNC(=O)O1		CHEMBL3622697	<=	IC50	nM	100.0	CHEMBL4722	Homo sapiens	IC50	nM	100.0
	15732772	CHEMBL3626658	Inhibition of aurora A kinase (unknown origin) by enzymatic assay	B	C[C@@H](Oc1cc(-c2cnn(C(F)F)c2)cc2ncsc12)[C@H]1CNC(=O)O1		CHEMBL3622698	<=	IC50	nM	100.0	CHEMBL4722	Homo sapiens	IC50	nM	100.0
	15736702	CHEMBL3624522	Inhibition of human recombinant Aurora-A	B	CN(C)CCCNC(=O)c1csc2nc(-c3ccc(NC(=O)Nc4cc(C(C)(C)C)on4)cc3)cn12		CHEMBL3623375	>	IC50	nM	10000.0	CHEMBL4722	Homo sapiens	IC50	uM	10.0
	15742906	CHEMBL3626293	Inhibition of Aurora-A (unknown origin) at 1 uM	B	O=C(C1CC1)n1ccc2c3c(=O)cc(-c4ccccc4)[nH]c3ccc21		CHEMBL3623601	=	Inhibition	%	50.0	CHEMBL4722	Homo sapiens	INH	%	50.0
	15747312	CHEMBL3626375	Inhibition of Aurora-A (unknown origin) assessed as residual enzyme activity at 10 uM by kinaseprolier assay	B	NCCn1c(C2CCNCC2)nc2cc(C(N)=O)ccc21		CHEMBL3622826	>	Activity	%	65.0	CHEMBL4722	Homo sapiens	Activity	%	65.0
	15753841	CHEMBL3630457	Inhibition of human AurA kinase at 10 uM by kinase inhibition assay	B	COc1ccc(Nc2ncc3c(n2)-c2ccccc2SC3)cc1		CHEMBL3628537	=	Inhibition	%	71.7	CHEMBL4722	Homo sapiens	INH	%	71.7
	15753884	CHEMBL3630467	Inhibition of human AurA kinase by kinase inhibition assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	11.0	CHEMBL4722	Homo sapiens	IC50	10'-8M	1.1
	15753918	CHEMBL3630457	Inhibition of human AurA kinase at 10 uM by kinase inhibition assay	B	COc1ccc2c(c1)SCc1cnc(-c3ccccc3)nc1-2		CHEMBL481789	=	Inhibition	%	-2.2	CHEMBL4722	Homo sapiens	INH	%	-2.2
	15753984	CHEMBL3630457	Inhibition of human AurA kinase at 10 uM by kinase inhibition assay	B	Clc1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2SC3)cc1		CHEMBL3628818	=	Inhibition	%	0.0	CHEMBL4722	Homo sapiens	INH	%	0.0
	15755844	CHEMBL3630632	Inhibition of AURKA (unknown origin) assessed as remaining activity at 10 uM by high-throughput assay relative to control	B	O=C1c2ccccc2-c2c1oc1ccccc1c2=O		CHEMBL3629616	=	Activity	%	82.0	CHEMBL4722	Homo sapiens	Activity	%	82.0
	15756106	CHEMBL3631728	Inhibition of Aurora A (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	CS(=O)(=O)c1cccc(Nc2nccc(-c3sc(N4CCOCC4)nc3-c3cccc(NS(=O)(=O)c4c(F)cccc4F)c3)n2)c1		CHEMBL3628627	=	Inhibition	%	83.43	CHEMBL4722	Homo sapiens	INH	%	83.43
	15757656	CHEMBL3631096	Inhibition of Aurora A (unknown origin)	B	Cc1ccccc1Cn1nnc2c1C(=O)c1ccccc1C2=O		CHEMBL1442185	>	IC50	nM	10000.0	CHEMBL4722	Homo sapiens	IC50	nM	10000.0
	15757657	CHEMBL3631096	Inhibition of Aurora A (unknown origin)	B	CN1CCN(C(=O)c2cccc(Cn3nnc4c3C(=O)c3ccccc3C4=O)c2)CC1		CHEMBL3628599	>	IC50	nM	10000.0	CHEMBL4722	Homo sapiens	IC50	nM	10000.0
	15757701	CHEMBL3631728	Inhibition of Aurora A (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccncc3)cc2)no1		CHEMBL166031	=	Inhibition	%	48.43	CHEMBL4722	Homo sapiens	INH	%	48.43
	15757993	CHEMBL3631728	Inhibition of Aurora A (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	COCCNC(=O)c1ccc2c(c1)nc(-c1cnc(-c3ccc(Cl)cc3)[nH]1)n2CCOC		CHEMBL3628628	=	Inhibition	%	13.93	CHEMBL4722	Homo sapiens	INH	%	13.93
242596	16258884	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	CN(C)CC(Nc1ncnc2c(C(N)=O)cccc12)c1cccc(NCc2ccc(Br)cc2)c1		CHEMBL3680433	=	IC50	nM	8.2	CHEMBL4722	Homo sapiens	IC50	nM	8.2
311297	16259039	CHEMBL3705895	Radioactive Assay: The capacity to inhibit the kinase activity of the enzyme is estimated by measuring the residual kinase activity of the enzyme in the presence of different concentrations of the test compound (generally from 0.17 to 10 000 nM). A dose-response curve is produced, which allows an IC50 (50% inhibitory concentration) to be determined. The kinase activity is measured by a radioactive assay of the amount of radioactive phosphate (33P) incorporated into a fragment of the protein NuMA (Nuclear Mitotic Apparatus protein) after 30 minutes of incubation at 37Â° C. The test compound is first dissolved at different concentrations in dimethyl sulphoxide (DMS (J). Reaction takes place in the wells of a FlashPlate microtiter plate (Nickel Chelate FlashPlate-96, PerkinElmer). Each well (100 Î¼l) contains 10 nM Aurora A, 500 nM NuMA, 1 Î¼M ATP and 0.2 Î¼Ci ATP-Î³-33P in a buffer of 50 mM Tris-HCl, pH=7.5; 10 mM MgCl2; 50 mM NaCl, 1 mM dithiothreitol. The final percentage of DMSO is 3%.	B	CCOC(=O)c1[nH]cc2c1NC1=C(C(=O)CCC1)C2c1ccc(Sc2nc3cccc(OC)c3[nH]2)o1		CHEMBL3663742	=	IC50	nM	11.0	CHEMBL4722	Homo sapiens	IC50	nM	11.0
242717	16259230	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	COc1ccc(C(=O)Nc2cccc(CNc3ncnc4c(C(N)=O)cc(CO)cc34)c2)cc1		CHEMBL3680567	=	IC50	nM	0.58	CHEMBL4722	Homo sapiens	IC50	nM	0.58
242665	16259359	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(NCc3cccc(NC(=O)c4csc(N)n4)c3)ncnc12		CHEMBL3680513	=	IC50	nM	12.0	CHEMBL4722	Homo sapiens	IC50	nM	12.0
242304	16259382	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(NCc3cccc(NC(=O)NCCN4CCOCC4)c3)ncnc12		CHEMBL3670463	=	IC50	nM	1700.0	CHEMBL4722	Homo sapiens	IC50	nM	1700.0
242868	16259418	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	COc1ccc(C(=O)Nc2cccc(CNc3ncnc4c(C(N)=O)cc(O)cc34)c2)cc1		CHEMBL3685307	=	IC50	nM	0.12	CHEMBL4722	Homo sapiens	IC50	nM	0.12
242328	16259446	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	COc1cc(C(N)=O)c2ncnc(N[C@H](C)c3ccccc3)c2c1		CHEMBL3670488	=	IC50	nM	33.0	CHEMBL4722	Homo sapiens	IC50	nM	33.0
242463	16259513	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	CCNC[C@@H](Nc1ncnc2c1=CCCC=2C(N)=O)c1cccc(F)c1		CHEMBL3675435	=	IC50	nM	310.0	CHEMBL4722	Homo sapiens	IC50	nM	310.0
242702	16259589	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	N#Cc1ccnc(Nc2cccc(CNc3ncnc4c(C(N)=O)cccc34)c2)c1		CHEMBL3680552	=	IC50	nM	0.22	CHEMBL4722	Homo sapiens	IC50	nM	0.22
242405	16259645	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1ccc(CNc2ncnc3c(C(N)=O)cccc23)cc1		CHEMBL3675376	=	IC50	nM	10000.0	CHEMBL4722	Homo sapiens	IC50	nM	10000.0
242528	16259913	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	CN(C)CC(Nc1ncnc2c(C(N)=O)cccc12)c1cccc(N)c1		CHEMBL3675507	=	IC50	nM	1000.0	CHEMBL4722	Homo sapiens	IC50	nM	1000.0
242758	16260043	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(NCC3CC=C/C(=N/C(O)c4c[nH]c5ncccc45)C3)ncnc12		CHEMBL4114812	=	IC50	nM	4.2	CHEMBL4722	Homo sapiens	IC50	nM	4.2
242781	16260046	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(NC(CCN3CCCC3)c3cccc(Nc4ccccn4)c3)ncnc12		CHEMBL3685221	=	IC50	nM	29.0	CHEMBL4722	Homo sapiens	IC50	nM	29.0
242480	16260170	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	CN(C)CCC(Nc1ncnc2c(C(N)=O)cccc12)c1cccc(NC(=O)c2ccc(C(F)(F)F)cc2)c1		CHEMBL3675449	=	IC50	nM	0.99	CHEMBL4722	Homo sapiens	IC50	nM	0.99
242689	16260289	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	COc1ccc(C(=O)NC2=CCCC([C@H](C)Nc3ncnc4c(C(N)=O)cccc34)=C2)cc1F		CHEMBL3680539	=	IC50	nM	14.0	CHEMBL4722	Homo sapiens	IC50	nM	14.0
242509	16260341	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	CNCCC(Nc1ncnc2c(C(N)=O)cccc12)c1cccc([N+](=O)[O-])c1		CHEMBL3675485	=	IC50	nM	1000.0	CHEMBL4722	Homo sapiens	IC50	nM	1000.0
311289	16260383	CHEMBL3705895	Radioactive Assay: The capacity to inhibit the kinase activity of the enzyme is estimated by measuring the residual kinase activity of the enzyme in the presence of different concentrations of the test compound (generally from 0.17 to 10 000 nM). A dose-response curve is produced, which allows an IC50 (50% inhibitory concentration) to be determined. The kinase activity is measured by a radioactive assay of the amount of radioactive phosphate (33P) incorporated into a fragment of the protein NuMA (Nuclear Mitotic Apparatus protein) after 30 minutes of incubation at 37Â° C. The test compound is first dissolved at different concentrations in dimethyl sulphoxide (DMS (J). Reaction takes place in the wells of a FlashPlate microtiter plate (Nickel Chelate FlashPlate-96, PerkinElmer). Each well (100 Î¼l) contains 10 nM Aurora A, 500 nM NuMA, 1 Î¼M ATP and 0.2 Î¼Ci ATP-Î³-33P in a buffer of 50 mM Tris-HCl, pH=7.5; 10 mM MgCl2; 50 mM NaCl, 1 mM dithiothreitol. The final percentage of DMSO is 3%.	B	O=C1CCCC2=C1C(c1cccc(Oc3nc4ccccc4[nH]3)c1)c1c[nH]nc1N2		CHEMBL3663735	=	IC50	nM	23.0	CHEMBL4722	Homo sapiens	IC50	nM	23.0
242375	16260452	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	COc1ccccc1CNc1ncnc2c(C(N)=O)cccc12		CHEMBL3675347	=	IC50	nM	32.0	CHEMBL4722	Homo sapiens	IC50	nM	32.0
242734	16260570	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	CCOC(=O)c1coc(Nc2cccc(CNc3ncnc4c(C(N)=O)cccc34)c2)n1		CHEMBL3680583	=	IC50	nM	1.4	CHEMBL4722	Homo sapiens	IC50	nM	1.4
242692	16260592	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(NCc3cccc(Nc4ccccn4)c3)ncnc12		CHEMBL3680542	=	IC50	nM	0.15	CHEMBL4722	Homo sapiens	IC50	nM	0.15
242503	16260637	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	CN(C)CC(Nc1ncnc2c(C(N)=O)cccc12)c1ccc(F)cc1		CHEMBL3675479	=	IC50	nM	920.0	CHEMBL4722	Homo sapiens	IC50	nM	920.0
242838	16260710	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(NCc3cccc(NC(=O)c4cc(C5CC5)n[nH]4)c3)ncnc12		CHEMBL3685277	=	IC50	nM	0.23	CHEMBL4722	Homo sapiens	IC50	nM	0.23
242618	16260830	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	CN(C)CCC(Nc1ncnc2c(C(N)=O)cccc12)c1cccc(NC(=O)c2cc(F)ccc2F)c1		CHEMBL3680458	=	IC50	nM	5.5	CHEMBL4722	Homo sapiens	IC50	nM	5.5
242660	16260876	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(NCc3ccc(NC(=O)c4cc(C(F)(F)F)n[nH]4)cc3)ncnc12		CHEMBL3680508	=	IC50	nM	0.57	CHEMBL4722	Homo sapiens	IC50	nM	0.57
242461	16261126	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	CCNC[C@@H](Nc1ncnc2c(C(N)=O)cc(OC)cc12)c1ccccc1		CHEMBL3675433	=	IC50	nM	180.0	CHEMBL4722	Homo sapiens	IC50	nM	180.0
242293	16261545	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(NCc3ccc(NC(=O)c4cccc(C(F)(F)F)c4)cc3)ncnc12		CHEMBL3670452	=	IC50	nM	210.0	CHEMBL4722	Homo sapiens	IC50	nM	210.0
242381	16262005	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(NCc3ccccc3C(F)(F)F)ncnc12		CHEMBL3675352	=	IC50	nM	8.1	CHEMBL4722	Homo sapiens	IC50	nM	8.1
242873	16262065	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cc(C2=CCC(C(N)=O)C=C2)cc2c(N[C@H]3CCCNC3)ncnc12		CHEMBL3685318	=	IC50	nM	640.0	CHEMBL4722	Homo sapiens	IC50	nM	640.0
242721	16262194	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(NCc3cccc(NC(=O)c4ccc(CO)cc4)c3)ncnc12		CHEMBL3680571	=	IC50	nM	0.83	CHEMBL4722	Homo sapiens	IC50	nM	0.83
311292	16262510	CHEMBL3705895	Radioactive Assay: The capacity to inhibit the kinase activity of the enzyme is estimated by measuring the residual kinase activity of the enzyme in the presence of different concentrations of the test compound (generally from 0.17 to 10 000 nM). A dose-response curve is produced, which allows an IC50 (50% inhibitory concentration) to be determined. The kinase activity is measured by a radioactive assay of the amount of radioactive phosphate (33P) incorporated into a fragment of the protein NuMA (Nuclear Mitotic Apparatus protein) after 30 minutes of incubation at 37Â° C. The test compound is first dissolved at different concentrations in dimethyl sulphoxide (DMS (J). Reaction takes place in the wells of a FlashPlate microtiter plate (Nickel Chelate FlashPlate-96, PerkinElmer). Each well (100 Î¼l) contains 10 nM Aurora A, 500 nM NuMA, 1 Î¼M ATP and 0.2 Î¼Ci ATP-Î³-33P in a buffer of 50 mM Tris-HCl, pH=7.5; 10 mM MgCl2; 50 mM NaCl, 1 mM dithiothreitol. The final percentage of DMSO is 3%.	B	CCc1[nH]cc2c1NC1=C(C(=O)CC(C)(C)C1)C2c1cccc(Sc2nc3ccccc3[nH]2)c1		CHEMBL3663738	=	IC50	nM	102.0	CHEMBL4722	Homo sapiens	IC50	nM	102.0
242438	16262658	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	CN(C)CC(Nc1ncnc2c(C(N)=O)cccc12)c1cccc(NC(=O)c2ccnc(N3CCCCC3)c2)c1		CHEMBL3675410	=	IC50	nM	0.61	CHEMBL4722	Homo sapiens	IC50	nM	0.61
242343	16262682	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	CN(C)CCOc1cc(C(N)=O)c2ncnc(NCc3ccc(C(F)(F)F)cc3)c2c1		CHEMBL3670502	=	IC50	nM	10000.0	CHEMBL4722	Homo sapiens	IC50	nM	10000.0
242387	16262905	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	CC(C)(C)OC(=O)Nc1ccc(CNc2ncnc3c(C(N)=O)cccc23)cc1		CHEMBL3675358	=	IC50	nM	7500.0	CHEMBL4722	Homo sapiens	IC50	nM	7500.0
242851	16263078	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	COc1ccc(C(=O)Nc2cccc(C(C)Nc3ncnc4c(C(N)=O)cc(F)cc34)c2)cc1F		CHEMBL3685290	=	IC50	nM	0.83	CHEMBL4722	Homo sapiens	IC50	nM	0.83
242315	16263094	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(NCc3cccc(NC(=O)c4ccc(SC(F)(F)F)cc4)c3)ncnc12		CHEMBL3670474	=	IC50	nM	0.39	CHEMBL4722	Homo sapiens	IC50	nM	0.39
242637	16263151	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	CCN(C[C@@H](Nc1ccccc(C(N)=O)cncn1)C1C=CC=CC1)C(C)C		CHEMBL3680482	=	IC50	nM	56.0	CHEMBL4722	Homo sapiens	IC50	nM	56.0
242578	16263261	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	CN(C)Cc1cccc(C(=O)Nc2cccc(CNc3ncnc4c(C(N)=O)cccc34)c2)c1		CHEMBL3680412	=	IC50	nM	22.0	CHEMBL4722	Homo sapiens	IC50	nM	22.0
242462	16263538	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	COc1cc(C(N)=O)c2ncnc(N[C@H](CN(C)C)c3cccc(F)c3)c2c1		CHEMBL3675434	=	IC50	nM	110.0	CHEMBL4722	Homo sapiens	IC50	nM	110.0
242370	16263562	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	C[C@H](Nc1ncnc2c(C(N)=O)cccc12)c1ccccc1		CHEMBL3675342	=	IC50	nM	410.0	CHEMBL4722	Homo sapiens	IC50	nM	410.0
242244	16263619	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NCC(Nc1ncnc2c(C(N)=O)cccc12)c1ccc(Cl)c(Cl)c1		CHEMBL3670401	=	IC50	nM	430.0	CHEMBL4722	Homo sapiens	IC50	nM	430.0
242614	16263761	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	CN(C)CCNC(=O)CC(Nc1ncnc2c(C(N)=O)cccc12)c1cccc(NC(=O)c2ccc(Br)cc2)c1		CHEMBL3680454	=	IC50	nM	0.4	CHEMBL4722	Homo sapiens	IC50	nM	0.4
242726	16263765	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	C[C@@H](Nc1ncnc2c(C(N)=O)cccc12)c1cccc(NC(=O)c2cnc(C(F)(F)F)cn2)c1		CHEMBL3680576	=	IC50	nM	0.88	CHEMBL4722	Homo sapiens	IC50	nM	0.88
242317	16263907	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(NCc3cccc(NC(=O)c4cccc(CN5CCOCC5)c4)c3)ncnc12		CHEMBL3670477	=	IC50	nM	200.0	CHEMBL4722	Homo sapiens	IC50	nM	200.0
242465	16264124	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	COc1ccc(C(=O)Nc2cccc([C@@H](C)Nc3ncnc4c(C(N)=O)cccc34)c2)cn1		CHEMBL3675437	=	IC50	nM	0.07	CHEMBL4722	Homo sapiens	IC50	nM	0.07
242403	16264191	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cc(N)cc2c(NCc3cccc(C(F)(F)F)c3)ncnc12		CHEMBL3675374	=	IC50	nM	1200.0	CHEMBL4722	Homo sapiens	IC50	nM	1200.0
242388	16264304	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(NCc3ccc(O)cc3)ncnc12		CHEMBL3675359	=	IC50	nM	580.0	CHEMBL4722	Homo sapiens	IC50	nM	580.0
242638	16264438	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	CN(C)CCOc1ccc(NC(=O)Nc2cccc(CNc3ncnc4c(C(N)=O)cccc34)c2)cc1		CHEMBL3680483	=	IC50	nM	51.0	CHEMBL4722	Homo sapiens	IC50	nM	51.0
242504	16264742	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	COCCC(Nc1ncnc2c(C(N)=O)cccc12)c1cccc(NC(=O)c2ccc(C(F)(F)F)cc2)c1		CHEMBL3675480	=	IC50	nM	0.18	CHEMBL4722	Homo sapiens	IC50	nM	0.18
242281	16264774	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	C[C@@H](Nc1ncnc2c(C(N)=O)cccc12)c1cccc2ccccc12		CHEMBL3670439	=	IC50	nM	0.66	CHEMBL4722	Homo sapiens	IC50	nM	0.66
242723	16265087	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	Cc1ccc(C(=O)Nc2cccc(C(C)Nc3ncnc4c(C(N)=O)cc(Cl)cc34)c2)cn1		CHEMBL3680573	=	IC50	nM	0.86	CHEMBL4722	Homo sapiens	IC50	nM	0.86
242805	16265284	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(NCc3cccc(NC(=O)c4ccc(C(F)(F)F)cc4F)c3)ncnc12		CHEMBL3685245	=	IC50	nM	0.12	CHEMBL4722	Homo sapiens	IC50	nM	0.12
242397	16265596	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(NCc3cccc(NC(=O)c4ccc(F)cc4)c3)ncnc12		CHEMBL3675368	=	IC50	nM	580.0	CHEMBL4722	Homo sapiens	IC50	nM	580.0
242841	16265740	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(NCc3cccc(NC(=O)c4ccccc4F)c3)ncnc12		CHEMBL3685280	=	IC50	nM	1.6	CHEMBL4722	Homo sapiens	IC50	nM	1.6
242677	16265907	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	CN1CCN(CCOc2cccc(NC(=O)Nc3cccc(CNc4ncnc5c(C(N)=O)cccc45)c3)c2)CC1		CHEMBL3680526	=	IC50	nM	32.0	CHEMBL4722	Homo sapiens	IC50	nM	32.0
242807	16265930	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	CCOc1ccc(C(=O)Nc2cccc(CNc3ncnc4c(C(N)=O)cccc34)c2)cc1		CHEMBL3685247	=	IC50	nM	0.13	CHEMBL4722	Homo sapiens	IC50	nM	0.13
242319	16266004	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	CCOc1cc(C(N)=O)c2ncnc(NCc3cccc(NC(=O)c4ccc(F)cc4)c3)c2c1		CHEMBL3670479	=	IC50	nM	0.63	CHEMBL4722	Homo sapiens	IC50	nM	0.63
242299	16266017	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	[N-]=[N+]=NC[C@@H](Nc1ncnc2c(C(N)=O)cccc12)c1ccccc1		CHEMBL3670458	=	IC50	nM	450.0	CHEMBL4722	Homo sapiens	IC50	nM	450.0
242837	16266183	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(NCC3CC=C/C(=N/C(O)c4ccn[nH]4)C3)ncnc12		CHEMBL4114796	=	IC50	nM	2.8	CHEMBL4722	Homo sapiens	IC50	nM	2.8
242783	16266185	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(NCc3cccc(Nc4ccc5ccccc5n4)c3)ncnc12		CHEMBL3685223	=	IC50	nM	34.0	CHEMBL4722	Homo sapiens	IC50	nM	34.0
242546	16266248	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(NCc3cccc(NC(O)c4cc(C(F)(F)F)ccc4F)c3)ncnc12		CHEMBL3675525	=	IC50	nM	0.17	CHEMBL4722	Homo sapiens	IC50	nM	0.17
242439	16266697	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	CN(C)CC(Nc1ncnc2c(C(N)=O)cccc12)c1cccc(NC(=O)c2ccnc(Cl)c2)c1		CHEMBL3675411	=	IC50	nM	1.3	CHEMBL4722	Homo sapiens	IC50	nM	1.3
242514	16266701	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	Cc1nc(C)c(C(=O)Nc2cccc([C@@H](C)Nc3ncnc4c(C(N)=O)cccc34)c2)s1		CHEMBL3675490	=	IC50	nM	0.73	CHEMBL4722	Homo sapiens	IC50	nM	0.73
242816	16266749	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	CN(C)CCC(Nc1ncnc2c(C(N)=O)cccc12)c1cccc(NC(=O)c2ccccc2)c1		CHEMBL3685255	=	IC50	nM	0.18	CHEMBL4722	Homo sapiens	IC50	nM	0.18
242818	16266923	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	COc1ccc(C(=O)Nc2cccc(CNc3ncnc4c(C(N)=O)cccc34)c2)cc1OC		CHEMBL3685257	=	IC50	nM	0.31	CHEMBL4722	Homo sapiens	IC50	nM	0.31
242667	16267075	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	CNCC(Nc1ncnc2c(C(N)=O)cc(OCCCN(C)C)cc12)c1ccccc1		CHEMBL3680515	=	IC50	nM	1000.0	CHEMBL4722	Homo sapiens	IC50	nM	1000.0
242255	16267081	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	CNCC(Nc1ncnc2c(C(N)=O)cccc12)c1ccccc1		CHEMBL3670413	=	IC50	nM	450.0	CHEMBL4722	Homo sapiens	IC50	nM	450.0
242688	16267169	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(NCc3cc(F)c(F)c(F)c3)ncnc12		CHEMBL3680537	=	IC50	nM	1600.0	CHEMBL4722	Homo sapiens	IC50	nM	1600.0
242635	16267183	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	CCOc1cc(C(=O)Nc2cccc(C(C)Nc3ncnc4c(C(N)=O)cccc34)c2)ccn1		CHEMBL3680480	=	IC50	nM	0.47	CHEMBL4722	Homo sapiens	IC50	nM	0.47
242780	16267250	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(NCc3cccc(-n4c(=O)[nH]c5ccccc5c4=O)c3)ncnc12		CHEMBL3685220	=	IC50	nM	29.0	CHEMBL4722	Homo sapiens	IC50	nM	29.0
242707	16267366	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	Cc1cc(C(=O)Nc2cccc(CNc3ncnc4c(C(N)=O)cccc34)c2)ccc1N1CCOCC1		CHEMBL3680557	=	IC50	nM	0.3	CHEMBL4722	Homo sapiens	IC50	nM	0.3
242573	16267461	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(NCC3=CC(Cl)=CCC3)ncnc12		CHEMBL3680405	=	IC50	nM	140.0	CHEMBL4722	Homo sapiens	IC50	nM	140.0
242285	16267483	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(NCc3cccc(NC(=O)Nc4ccc(Cl)cc4)c3)ncnc12		CHEMBL3670443	=	IC50	nM	720.0	CHEMBL4722	Homo sapiens	IC50	nM	720.0
242427	16267606	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	CNCC(Nc1ncnc2c(C(N)=O)cccc12)c1cccc(NC(=O)c2ccc(F)c(F)c2)c1		CHEMBL3675398	=	IC50	nM	0.44	CHEMBL4722	Homo sapiens	IC50	nM	0.44
242743	16267621	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	CNCc1cc(C(N)=O)c2ncnc(NCc3cccc(NC(=O)c4ccc(OC)cc4)c3)c2c1		CHEMBL3680592	=	IC50	nM	2.0	CHEMBL4722	Homo sapiens	IC50	nM	2.0
242776	16268835	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	COc1ccc(C(=O)Nc2ccc3c(c2)CN(c2ncnc4c(C(N)=O)cccc24)CC3)cc1		CHEMBL3685216	=	IC50	nM	19.0	CHEMBL4722	Homo sapiens	IC50	nM	19.0
242263	16269009	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(NCc3cccc(NC(=O)Nc4ccccc4F)c3)ncnc12		CHEMBL3670421	=	IC50	nM	310.0	CHEMBL4722	Homo sapiens	IC50	nM	310.0
242526	16269234	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(NC(CCN3CCCC3)c3cccc(NC(=O)c4ccc(F)cc4F)c3)ncnc12		CHEMBL3675505	=	IC50	nM	3.9	CHEMBL4722	Homo sapiens	IC50	nM	3.9
242821	16269609	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	CC(Nc1ncnc2c(C(N)=O)cc(OCc3ccccc3)cc12)c1cccc(NC(=O)c2ccc(Br)cc2)c1		CHEMBL3685260	=	IC50	nM	9.0	CHEMBL4722	Homo sapiens	IC50	nM	9.0
242404	16269897	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cc([N+](=O)[O-])cc2c(NCc3ccc(Cl)c(C(F)(F)F)c3)ncnc12		CHEMBL3675375	=	IC50	nM	10000.0	CHEMBL4722	Homo sapiens	IC50	nM	10000.0
242339	16270222	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	CN(C)c1cc(C(=O)Nc2cccc(CNc3ncnc4c(C(N)=O)cccc34)c2)ccn1		CHEMBL3639693	=	IC50	nM	1.5	CHEMBL4722	Homo sapiens	IC50	nM	1.5
242246	16270249	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NCC(Nc1ncnc2c(C(N)=O)cccc12)c1cccc(Cl)c1		CHEMBL3670403	=	IC50	nM	4900.0	CHEMBL4722	Homo sapiens	IC50	nM	4900.0
242728	16270443	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(NCc3cccc(NC(=O)c4ccc5nc[nH]c5c4)c3)ncnc12		CHEMBL3680578	=	IC50	nM	1.0	CHEMBL4722	Homo sapiens	IC50	nM	1.0
242408	16270828	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(NCc3cccc(C(F)(F)F)c3)ccnc12		CHEMBL3675379	=	IC50	nM	3.9	CHEMBL4722	Homo sapiens	IC50	nM	3.9
242634	16270915	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	COCCC(Nc1ncnc2c(C(N)=O)cccc12)c1cccc(NC(=O)c2ccc(OC(F)(F)F)cc2)c1		CHEMBL3680479	=	IC50	nM	0.05	CHEMBL4722	Homo sapiens	IC50	nM	0.05
242602	16270967	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	O=C(Nc1cccc(C(CCN2CCCC2)NC2=N/C=N\C=C/CC/C=C\2)c1)C1=C(F)C=CCC1F		CHEMBL3891886	=	IC50	nM	3.6	CHEMBL4722	Homo sapiens	IC50	nM	3.6
242335	16271056	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	COc1ccc(C(CN)Nc2ncnc3c(C(N)=O)cccc23)cc1		CHEMBL3670495	=	IC50	nM	2000.0	CHEMBL4722	Homo sapiens	IC50	nM	2000.0
242733	16271425	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(NCc3cccc(NC(=O)c4ccc(N5CCOCC5)c(C(F)(F)F)c4)c3)ncnc12		CHEMBL3680582	=	IC50	nM	1.4	CHEMBL4722	Homo sapiens	IC50	nM	1.4
242655	16271632	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	COc1ccc(C(=O)Nc2cccc(C(CN(C)C(=O)OC(C)(C)C)Nc3ncnc4c(C(N)=O)cccc34)c2)cc1F		CHEMBL3680502	=	IC50	nM	8.3	CHEMBL4722	Homo sapiens	IC50	nM	8.3
242641	16272079	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	CCn1nc(C(=O)Nc2ccccc2)cc1C		CHEMBL3680486	=	IC50	nM	1.3	CHEMBL4722	Homo sapiens	IC50	nM	1.3
242534	16272284	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	CN(C)CC(Nc1ncnc2c(C(N)=O)cc(OC3CCC3)cc12)c1cccc(F)c1		CHEMBL3675513	=	IC50	nM	73.0	CHEMBL4722	Homo sapiens	IC50	nM	73.0
242332	16272366	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	CCOC(=O)N1CCN(CCOc2cccc(CNc3ncnc4c(C(N)=O)cccc34)c2)CC1		CHEMBL3670492	=	IC50	nM	920.0	CHEMBL4722	Homo sapiens	IC50	nM	920.0
242495	16272391	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	COc1cccc(C(CN(C)C)Nc2ncnc3c(C(N)=O)cccc23)c1		CHEMBL3675468	=	IC50	nM	570.0	CHEMBL4722	Homo sapiens	IC50	nM	570.0
242441	16272412	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	CNCC(Nc1ncnc2c(C(N)=O)cccc12)c1cccc(NC(=O)c2c(F)cccc2F)c1		CHEMBL3675413	=	IC50	nM	1.0	CHEMBL4722	Homo sapiens	IC50	nM	1.0
242719	16272446	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(NCc3cccc(NC(=O)c4cccc5[nH]ccc45)c3)ncnc12		CHEMBL3680569	=	IC50	nM	0.72	CHEMBL4722	Homo sapiens	IC50	nM	0.72
242753	16272618	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	CC(Nc1ncnc2c(C(N)=O)cccc12)c1cccc(NC(=O)c2ccc(=O)[nH]c2)c1		CHEMBL3680601	=	IC50	nM	2.7	CHEMBL4722	Homo sapiens	IC50	nM	2.7
242425	16272625	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	CNCC(Nc1ncnc2c(C(N)=O)cccc12)c1ccc(Cl)c(Cl)c1		CHEMBL3675396	=	IC50	nM	540.0	CHEMBL4722	Homo sapiens	IC50	nM	540.0
242442	16272757	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	CN(C)CC(Nc1ncnc2c(C(N)=O)cccc12)c1cccc(Br)c1		CHEMBL3675414	=	IC50	nM	480.0	CHEMBL4722	Homo sapiens	IC50	nM	480.0
242829	16272970	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	CC(Nc1ncnc2c(C(N)=O)cccc12)c1cccc(NC(=O)c2ccc(CN(C)C)cc2)c1		CHEMBL3685268	=	IC50	nM	3.1	CHEMBL4722	Homo sapiens	IC50	nM	3.1
242583	16273168	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	CN(C)CCC(Nc1ncnc2c(C(N)=O)cccc12)C1=CCCC(NC(=O)c2c(F)cccc2F)=C1		CHEMBL3680418	=	IC50	nM	1.1	CHEMBL4722	Homo sapiens	IC50	nM	1.1
242386	16273505	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(NCc3ccccc3F)ncnc12		CHEMBL3675357	=	IC50	nM	1000.0	CHEMBL4722	Homo sapiens	IC50	nM	1000.0
242566	16273549	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	CCN(C)CC(Nc1ncnc2c(C(N)=O)cccc12)c1ccccc1		CHEMBL3680397	=	IC50	nM	500.0	CHEMBL4722	Homo sapiens	IC50	nM	500.0
242558	16273555	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	Cc1occc1C(=O)Nc1cccc(C(C)Nc2ncnc3c(C(N)=O)cccc23)c1		CHEMBL3680389	=	IC50	nM	0.94	CHEMBL4722	Homo sapiens	IC50	nM	0.94
242622	16273697	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	CC(Nc1ncnc2c(C(N)=O)cccc12)c1cccc(NC(=O)c2ccoc2)c1		CHEMBL3680462	=	IC50	nM	0.56	CHEMBL4722	Homo sapiens	IC50	nM	0.56
242624	16274499	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	CC(NC1=NC=NC2C(C(N)=O)=CCC=C12)c1cccc(NC(=O)c2ccc(N3CCOCC3)cc2)c1		CHEMBL3680466	=	IC50	nM	0.38	CHEMBL4722	Homo sapiens	IC50	nM	0.38
242385	16274619	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	Cc1cccc(CNc2ncnc3c(C(N)=O)cccc23)c1		CHEMBL3675356	=	IC50	nM	100.0	CHEMBL4722	Homo sapiens	IC50	nM	100.0
242373	16274677	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	Cc1ccccc1CNc1ncnc2c(C(N)=O)cccc12		CHEMBL3675345	=	IC50	nM	8800.0	CHEMBL4722	Homo sapiens	IC50	nM	8800.0
242661	16274710	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	COc1ccc(C(=O)Nc2cccc(CNc3ncnc4c(C(N)=O)cccc34)c2)c(OC)c1		CHEMBL3680509	=	IC50	nM	0.77	CHEMBL4722	Homo sapiens	IC50	nM	0.77
242701	16274897	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NCc1cnc(Nc2cccc(CNc3ncnc4c(C(N)=O)cccc34)c2)s1		CHEMBL3680551	=	IC50	nM	0.22	CHEMBL4722	Homo sapiens	IC50	nM	0.22
242693	16275229	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(NCc3cccc(Nc4cc(C(F)(F)F)ccn4)c3)ncnc12		CHEMBL3680543	=	IC50	nM	0.15	CHEMBL4722	Homo sapiens	IC50	nM	0.15
242814	16275230	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	COc1ccc(C(=O)Nc2cccc(CN(C)c3ncnc4c(C(N)=O)cccc34)c2)cc1		CHEMBL3685253	=	IC50	nM	3.3	CHEMBL4722	Homo sapiens	IC50	nM	3.3
242745	16275368	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	Cn1cc(C(=O)Nc2cccc(CNc3ncnc4c(C(N)=O)cccc34)c2)c2ccccc21		CHEMBL3680594	=	IC50	nM	2.1	CHEMBL4722	Homo sapiens	IC50	nM	2.1
242876	16275394	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(NC(CCN3CCOCC3)c3cccc(NC(=O)c4cc(C5CC5)n[nH]4)c3)ncnc12		CHEMBL3685332	=	IC50	nM	11.0	CHEMBL4722	Homo sapiens	IC50	nM	11.0
242725	16275502	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	CC(Nc1ncnc2c(C(N)=O)cccc12)c1cccc(NC(=O)C2(C(F)(F)F)CC2)c1		CHEMBL3680575	=	IC50	nM	0.86	CHEMBL4722	Homo sapiens	IC50	nM	0.86
242584	16275562	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(NC(CCN3CCCCC3)c3cccc(NC(=O)c4c(F)cccc4F)c3)ncnc12		CHEMBL3680419	=	IC50	nM	3.1	CHEMBL4722	Homo sapiens	IC50	nM	3.1
242553	16275999	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	C[C@@H](Nc1ncnc2c(C(N)=O)cccc12)c1cccc(Nc2cc(C#N)ccn2)c1		CHEMBL3675537	=	IC50	nM	0.08	CHEMBL4722	Homo sapiens	IC50	nM	0.08
242798	16276134	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	CNc1cccc(C(=O)Nc2cccc(CNc3ncnc4c(C(N)=O)cccc34)c2)c1		CHEMBL3685238	=	IC50	nM	10.0	CHEMBL4722	Homo sapiens	IC50	nM	10.0
242266	16276284	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	COc1ccccc1NC(=O)Nc1cccc(CNc2ncnc3c(C(N)=O)cccc23)c1		CHEMBL3670424	=	IC50	nM	2.6	CHEMBL4722	Homo sapiens	IC50	nM	2.6
242417	16276566	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cc(NC(=O)c2ccno2)cc2c(NCc3ccc(Cl)c(C(F)(F)F)c3)ncnc12		CHEMBL3675388	=	IC50	nM	340.0	CHEMBL4722	Homo sapiens	IC50	nM	340.0
242543	16276635	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	CN(C)CC(Nc1ncnc2c(C(N)=O)cc(O)cc12)c1cccc(F)c1		CHEMBL3675522	=	IC50	nM	160.0	CHEMBL4722	Homo sapiens	IC50	nM	160.0
242447	16276718	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	CNCC(Nc1ncnc2c(C(N)=O)cccc12)c1cccc(NC(=O)c2ccc(OC)cc2)c1		CHEMBL3675419	=	IC50	nM	0.24	CHEMBL4722	Homo sapiens	IC50	nM	0.24
242676	16276726	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(NCc3cccc(NC(=O)Nc4cccc(OCCN5CCOCC5)c4)c3)ncnc12		CHEMBL3680525	=	IC50	nM	7.7	CHEMBL4722	Homo sapiens	IC50	nM	7.7
242735	16276727	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(NCc3cccc(NC(=O)c4ccc(N5CCCCC5=O)cc4)c3)ncnc12		CHEMBL3680584	=	IC50	nM	1.5	CHEMBL4722	Homo sapiens	IC50	nM	1.5
242515	16276740	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	CC(Nc1ncnc2c(C(N)=O)cccc12)c1cccc(NC(=O)c2ccc(Cl)c(F)c2)c1		CHEMBL3675491	=	IC50	nM	0.2	CHEMBL4722	Homo sapiens	IC50	nM	0.2
242813	16276845	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(NCc3cccc(NC(=O)c4cccc(Cl)c4)c3)ncnc12		CHEMBL3685252	=	IC50	nM	0.17	CHEMBL4722	Homo sapiens	IC50	nM	0.17
242458	16276863	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	CCN(CC)C1CCN(c2cc(C(=O)Nc3cccc(C(CN(C)C)Nc4ncnc5c(C(N)=O)cccc45)c3)ccn2)C1		CHEMBL3675430	=	IC50	nM	19.0	CHEMBL4722	Homo sapiens	IC50	nM	19.0
242579	16277267	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	CN(C)CCOc1cccc(C(=O)Nc2cccc(CNc3ncnc4c(C(N)=O)cccc34)c2)c1		CHEMBL3680413	=	IC50	nM	40.0	CHEMBL4722	Homo sapiens	IC50	nM	40.0
242316	16277602	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	COc1cc(C(N)=O)c2ncnc(NCc3cccc(NC(=O)c4ccc(F)cc4)c3)c2c1		CHEMBL3670476	=	IC50	nM	0.4	CHEMBL4722	Homo sapiens	IC50	nM	0.4
242274	16277654	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cc(NCc2ccccc2)cc2c(NCc3ccccc3)ncnc12		CHEMBL3670432	=	IC50	nM	340.0	CHEMBL4722	Homo sapiens	IC50	nM	340.0
242646	16277971	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	CC(Nc1ncnc2c(C(N)=O)cccc12)c1cccc(NC(=O)c2ccc(OC(F)(F)F)cc2)c1		CHEMBL3680491	=	IC50	nM	0.53	CHEMBL4722	Homo sapiens	IC50	nM	0.53
242861	16278336	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	COc1ccc(C(=O)Nc2cccc(C(C)Nc3ncnc4c(C(N)=O)cc(C)cc34)c2)cc1F		CHEMBL3685300	=	IC50	nM	2.4	CHEMBL4722	Homo sapiens	IC50	nM	2.4
242323	16278512	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	COCCOc1cccc(CNc2ncnc3c(C(N)=O)cccc23)c1		CHEMBL3670483	=	IC50	nM	6200.0	CHEMBL4722	Homo sapiens	IC50	nM	6200.0
242833	16278726	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(NCc3cccc(NC(=O)c4ccc(Cl)c(C(F)(F)F)c4)c3)ncnc12		CHEMBL3685272	=	IC50	nM	0.08	CHEMBL4722	Homo sapiens	IC50	nM	0.08
242594	16278960	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	CCCN(C)CC(Nc1ncnc2c(C(N)=O)cccc12)c1ccccc1		CHEMBL3680431	=	IC50	nM	390.0	CHEMBL4722	Homo sapiens	IC50	nM	390.0
242321	16278978	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(N[C@H](Cn3ccnn3)c3ccccc3)ncnc12		CHEMBL3670481	=	IC50	nM	4200.0	CHEMBL4722	Homo sapiens	IC50	nM	4200.0
242749	16279119	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(NCc3cccc(Nc4nc5ccccc5s4)c3)ncnc12		CHEMBL3680597	=	IC50	nM	2.3	CHEMBL4722	Homo sapiens	IC50	nM	2.3
242478	16279173	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	CNCC(Nc1ncnc2c1=CCCC=2C(N)=O)c1cccc(NC(=O)c2ccc(C(F)(F)F)cc2)c1		CHEMBL3675448	=	IC50	nM	0.62	CHEMBL4722	Homo sapiens	IC50	nM	0.62
242489	16279181	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	CN(C)CCC(Nc1ncnc2c(C(N)=O)cccc12)c1cccc(NC(=O)c2ccc(Br)cc2)c1		CHEMBL3675459	=	IC50	nM	0.12	CHEMBL4722	Homo sapiens	IC50	nM	0.12
242551	16279244	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(NCc3cccc(NC(=O)c4cncc(N5CCOCC5)c4)c3)ncnc12		CHEMBL3675533	=	IC50	nM	4.4	CHEMBL4722	Homo sapiens	IC50	nM	4.4
242765	16279335	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	CCN(CC)CCNCc1cc(C(N)=O)c2ncnc(NCc3cccc(NC(O)c4ccc(OC)cc4)c3)c2c1		CHEMBL3685205	=	IC50	nM	7.0	CHEMBL4722	Homo sapiens	IC50	nM	7.0
242302	16279429	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(NCc3cccc(NC(=O)N4CCOCC4)c3)ncnc12		CHEMBL3670461	=	IC50	nM	3500.0	CHEMBL4722	Homo sapiens	IC50	nM	3500.0
242672	16279443	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(N[C@H](CN3CCCC3)c3ccccc3)ncnc12		CHEMBL3680521	=	IC50	nM	690.0	CHEMBL4722	Homo sapiens	IC50	nM	690.0
242259	16279645	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(NCc3ccco3)ncnc12		CHEMBL3670417	=	IC50	nM	6.6	CHEMBL4722	Homo sapiens	IC50	nM	6.6
242871	16279684	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	COc1ccc(C(=O)Nc2cccc(C(C)Nc3ncnc4c(C(N)=O)cc(C#N)cc34)c2)cc1F		CHEMBL3685310	=	IC50	nM	0.26	CHEMBL4722	Homo sapiens	IC50	nM	0.26
242354	16279711	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NCC(Nc1ncnc2c(C(N)=O)cccc12)c1cccc(F)c1		CHEMBL3675326	=	IC50	nM	280.0	CHEMBL4722	Homo sapiens	IC50	nM	280.0
242311	16279831	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	CN(C)c1ccc(C(=O)Nc2cccc(CNc3ncnc4c(C(N)=O)cccc34)c2)cc1		CHEMBL3670470	=	IC50	nM	0.11	CHEMBL4722	Homo sapiens	IC50	nM	0.11
242864	16280036	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	COCC(Nc1ncnc2c(C(N)=O)cccc12)c1cccc(NC(=O)c2ccc(Br)cc2)c1		CHEMBL3685303	=	IC50	nM	0.55	CHEMBL4722	Homo sapiens	IC50	nM	0.55
242848	16280043	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(NCc3ccc(F)c(NC(=O)c4ccc(OC(F)(F)F)cc4)c3)ncnc12		CHEMBL3685287	=	IC50	nM	0.22	CHEMBL4722	Homo sapiens	IC50	nM	0.22
242391	16280426	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(NCc3cccc(N)c3)ncnc12		CHEMBL3675362	=	IC50	nM	1800.0	CHEMBL4722	Homo sapiens	IC50	nM	1800.0
242619	16280433	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	CC(C)Oc1cc(C(N)=O)c2ncnc(NC(CN(C)C)c3cccc(F)c3)c2c1		CHEMBL3680459	=	IC50	nM	160.0	CHEMBL4722	Homo sapiens	IC50	nM	160.0
242869	16280537	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)C1=c2ncnc(NCc3cccc(NC(=O)c4ccc(C(F)(F)F)cc4)c3)c2=CCC1		CHEMBL3685308	=	IC50	nM	0.18	CHEMBL4722	Homo sapiens	IC50	nM	0.18
242410	16280761	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cc(N)cc2c(NCc3ccc(Cl)c(C(F)(F)F)c3)ncnc12		CHEMBL3675381	=	IC50	nM	4.9	CHEMBL4722	Homo sapiens	IC50	nM	4.9
242437	16280953	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	CN(C)CC(Nc1ncnc2c(C(N)=O)cccc12)c1ccc(Cl)c(Cl)c1		CHEMBL3675409	=	IC50	nM	140.0	CHEMBL4722	Homo sapiens	IC50	nM	140.0
242485	16281075	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	Cc1ccc(C(=O)Nc2cccc([C@@H](C)Nc3ncnc4c(C(N)=O)cccc34)c2)cc1C		CHEMBL3675455	=	IC50	nM	0.27	CHEMBL4722	Homo sapiens	IC50	nM	0.27
242453	16281389	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	CNCC(Nc1ccccc(C(N)=O)cncn1)c1cccc(NC(=O)c2ccc(OC(F)(F)F)cc2)c1		CHEMBL3675425	=	IC50	nM	0.17	CHEMBL4722	Homo sapiens	IC50	nM	0.17
242577	16281433	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	COCCN(C)c1cc(C(=O)Nc2cccc(CNc3ncnc4c(C(N)=O)cccc34)c2)ccn1		CHEMBL3680411	=	IC50	nM	5.0	CHEMBL4722	Homo sapiens	IC50	nM	5.0
242849	16281720	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	COc1ccc(C(=O)Nc2cccc(C(CCN3CCCC3)Nc3ncnc4c(C(N)=O)cccc34)c2)cc1		CHEMBL3685288	=	IC50	nM	0.77	CHEMBL4722	Homo sapiens	IC50	nM	0.77
242390	16281745	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(NCc3ccc(NC(=O)c4ccc(F)cc4)cc3)ncnc12		CHEMBL3675361	=	IC50	nM	1700.0	CHEMBL4722	Homo sapiens	IC50	nM	1700.0
242790	16281861	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(NCc3cccc(NC(=O)c4n[nH]c5ccc(Br)cc45)c3)ncnc12		CHEMBL3685230	=	IC50	nM	51.0	CHEMBL4722	Homo sapiens	IC50	nM	51.0
242265	16281881	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(NCc3cccc(NC(=O)Nc4cccc(Cl)c4)c3)ncnc12		CHEMBL3670423	=	IC50	nM	1000.0	CHEMBL4722	Homo sapiens	IC50	nM	1000.0
242708	16281953	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	CNCCC(Nc1ncnc2c(C(N)=O)cccc12)c1cccc(NC(O)c2cc(C3CC3)n[nH]2)c1		CHEMBL3680558	=	IC50	nM	0.31	CHEMBL4722	Homo sapiens	IC50	nM	0.31
242283	16282220	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(N[C@@H](CO)c3ccccc3)ncnc12		CHEMBL3670441	=	IC50	nM	1900.0	CHEMBL4722	Homo sapiens	IC50	nM	1900.0
242547	16282247	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	CC(C)N(C)C[C@@H](Nc1ncnc2c(C(N)=O)cccc12)c1ccccc1		CHEMBL3675526	=	IC50	nM	140.0	CHEMBL4722	Homo sapiens	IC50	nM	140.0
242853	16282742	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	COc1ccc(C(=O)Nc2cccc(C(C)NC3=NC=NC4C(C(N)=O)=CC(Cl)C=C34)c2)cc1F		CHEMBL3685292	=	IC50	nM	0.3	CHEMBL4722	Homo sapiens	IC50	nM	0.3
242712	16282755	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(NC(CCO)c3cccc(NC(=O)C4CC4(F)F)c3)ncnc12		CHEMBL3680562	=	IC50	nM	0.49	CHEMBL4722	Homo sapiens	IC50	nM	0.49
242493	16283032	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	CC(Nc1ncnc2c(C(N)=O)cccc12)c1cccc(NC(=O)C2=CCC(Br)C=C2)c1		CHEMBL3675466	=	IC50	nM	0.26	CHEMBL4722	Homo sapiens	IC50	nM	0.26
311290	16284185	CHEMBL3705895	Radioactive Assay: The capacity to inhibit the kinase activity of the enzyme is estimated by measuring the residual kinase activity of the enzyme in the presence of different concentrations of the test compound (generally from 0.17 to 10 000 nM). A dose-response curve is produced, which allows an IC50 (50% inhibitory concentration) to be determined. The kinase activity is measured by a radioactive assay of the amount of radioactive phosphate (33P) incorporated into a fragment of the protein NuMA (Nuclear Mitotic Apparatus protein) after 30 minutes of incubation at 37Â° C. The test compound is first dissolved at different concentrations in dimethyl sulphoxide (DMS (J). Reaction takes place in the wells of a FlashPlate microtiter plate (Nickel Chelate FlashPlate-96, PerkinElmer). Each well (100 Î¼l) contains 10 nM Aurora A, 500 nM NuMA, 1 Î¼M ATP and 0.2 Î¼Ci ATP-Î³-33P in a buffer of 50 mM Tris-HCl, pH=7.5; 10 mM MgCl2; 50 mM NaCl, 1 mM dithiothreitol. The final percentage of DMSO is 3%.	B	O=C1CNCC2=C1C(c1cccc(Oc3nc4ccccc4[nH]3)c1)c1c[nH]nc1N2		CHEMBL3663736	=	IC50	nM	109.0	CHEMBL4722	Homo sapiens	IC50	nM	109.0
242420	16284198	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cc(NC(=O)Cc2cccs2)cc2c(NCc3ccc(Cl)c(C(F)(F)F)c3)ncnc12		CHEMBL3675391	=	IC50	nM	7300.0	CHEMBL4722	Homo sapiens	IC50	nM	7300.0
242791	16284217	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	COC1C=CC(C(=O)Nc2cccc(CNc3ncnc4c3=CC(CN3CCN(C)CC3)CC=4C(N)=O)c2)=CC1		CHEMBL3685231	=	IC50	nM	69.0	CHEMBL4722	Homo sapiens	IC50	nM	69.0
242416	16284421	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cc(NCc2ccccc2)cc2c(NCc3ccc(Cl)c(C(F)(F)F)c3)ncnc12		CHEMBL3675387	=	IC50	nM	1200.0	CHEMBL4722	Homo sapiens	IC50	nM	1200.0
242430	16284422	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	CN(C)CC(Nc1ncnc2c(C(N)=O)cccc12)c1cccc(NC(=O)c2ccccc2F)c1		CHEMBL3675402	=	IC50	nM	0.76	CHEMBL4722	Homo sapiens	IC50	nM	0.76
242788	16284461	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	C=CCC(/C=C/NC(=O)C1=CCCC(OCCCN(C)C)=C1)CNc1ncnc2c(C(N)=O)cccc12		CHEMBL3685228	=	IC50	nM	9.6	CHEMBL4722	Homo sapiens	IC50	nM	9.6
242599	16284465	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	COc1cc(C(=O)NC2=CCCC(C(C)Nc3ncnc4c(C(N)=O)cccc34)=C2)ccn1		CHEMBL3680436	=	IC50	nM	0.53	CHEMBL4722	Homo sapiens	IC50	nM	0.53
242852	16284899	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	COc1ccc(C(=O)Nc2cccc([C@@H](CCN3CCCC3)Nc3ncnc4c(C(N)=O)cccc34)c2)cc1		CHEMBL3685291	=	IC50	nM	0.78	CHEMBL4722	Homo sapiens	IC50	nM	0.78
242779	16284943	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	COc1ccc(C(=O)Nc2cccc(CNc3ncnc4c(C(N)=O)cc(CN5CCOCC5)cc34)c2)cc1		CHEMBL3685219	=	IC50	nM	27.0	CHEMBL4722	Homo sapiens	IC50	nM	27.0
242574	16285047	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	COCCC(Nc1ncnc2c(C(N)=O)cccc12)C1=CCCC(NC(=O)c2ccccc2F)=C1		CHEMBL3680406	=	IC50	nM	0.99	CHEMBL4722	Homo sapiens	IC50	nM	0.99
242658	16285315	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	C=CCN(C)CCC(Nc1ncnc2c(C(N)=O)cccc12)C1=CC([N+](=O)[O-])=CCC1		CHEMBL3680506	=	IC50	nM	1500.0	CHEMBL4722	Homo sapiens	IC50	nM	1500.0
311294	16285530	CHEMBL3705895	Radioactive Assay: The capacity to inhibit the kinase activity of the enzyme is estimated by measuring the residual kinase activity of the enzyme in the presence of different concentrations of the test compound (generally from 0.17 to 10 000 nM). A dose-response curve is produced, which allows an IC50 (50% inhibitory concentration) to be determined. The kinase activity is measured by a radioactive assay of the amount of radioactive phosphate (33P) incorporated into a fragment of the protein NuMA (Nuclear Mitotic Apparatus protein) after 30 minutes of incubation at 37Â° C. The test compound is first dissolved at different concentrations in dimethyl sulphoxide (DMS (J). Reaction takes place in the wells of a FlashPlate microtiter plate (Nickel Chelate FlashPlate-96, PerkinElmer). Each well (100 Î¼l) contains 10 nM Aurora A, 500 nM NuMA, 1 Î¼M ATP and 0.2 Î¼Ci ATP-Î³-33P in a buffer of 50 mM Tris-HCl, pH=7.5; 10 mM MgCl2; 50 mM NaCl, 1 mM dithiothreitol. The final percentage of DMSO is 3%.	B	CC1(C)CC(=O)C2=C(C1)Nc1n[nH]cc1C2c1cccc(Oc2nc3ccccc3[nH]2)c1		CHEMBL3663740	=	IC50	nM	22.0	CHEMBL4722	Homo sapiens	IC50	nM	22.0
242261	16285721	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(NCc3cccc(Br)c3)ncnc12		CHEMBL3670419	=	IC50	nM	190.0	CHEMBL4722	Homo sapiens	IC50	nM	190.0
242722	16285729	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	Cc1ccnc(Nc2cccc(CNc3ncnc4c(C(N)=O)cccc34)c2)c1		CHEMBL3680572	=	IC50	nM	0.85	CHEMBL4722	Homo sapiens	IC50	nM	0.85
242324	16285749	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(NCc3cccc(OCCN4CCOCC4)c3)ncnc12		CHEMBL3670484	=	IC50	nM	1300.0	CHEMBL4722	Homo sapiens	IC50	nM	1300.0
242784	16285800	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	CC(Nc1ncnc2c(C(N)=O)cccc12)c1cccc(NC(=O)C2CNC(=O)C2)c1		CHEMBL3685224	=	IC50	nM	35.0	CHEMBL4722	Homo sapiens	IC50	nM	35.0
242691	16285903	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(NC(CCO)c3cccc(NC(O)c4cc(C5CC5)n[nH]4)c3)ncnc12		CHEMBL3680541	=	IC50	nM	0.1	CHEMBL4722	Homo sapiens	IC50	nM	0.1
242252	16285976	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(N[C@H]3CCCNC3)c(C(=O)O)cnc12		CHEMBL3670410	=	IC50	nM	1300.0	CHEMBL4722	Homo sapiens	IC50	nM	1300.0
242303	16286013	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	COCCCNC(=O)Nc1cccc(CNc2ncnc3c(C(N)=O)cccc23)c1		CHEMBL3670462	=	IC50	nM	9700.0	CHEMBL4722	Homo sapiens	IC50	nM	9700.0
242856	16286041	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	COc1ccc(C(=O)Nc2cccc([C@@H](CCN3CCCCC3)Nc3ncnc4c(C(N)=O)cccc34)c2)cc1		CHEMBL3685295	=	IC50	nM	0.33	CHEMBL4722	Homo sapiens	IC50	nM	0.33
242541	16286351	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	CC(Nc1ncnc2c(C(N)=O)cccc12)c1cccc(NC(=O)c2ccc3c(c2)OCCO3)c1		CHEMBL3675520	=	IC50	nM	1.1	CHEMBL4722	Homo sapiens	IC50	nM	1.1
242640	16286708	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	C[C@@H](Nc1ncnc2c(C(N)=O)cccc12)c1cccc(NC(=O)c2ccc(C(F)(F)F)c(F)c2)c1		CHEMBL3680485	=	IC50	nM	0.41	CHEMBL4722	Homo sapiens	IC50	nM	0.41
242287	16286721	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc(CNc2ncnc3c(C(N)=O)cccc23)c1		CHEMBL3670445	=	IC50	nM	13.0	CHEMBL4722	Homo sapiens	IC50	nM	13.0
242497	16286750	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	Cc1cc(C(=O)Nc2cccc([C@@H](C)Nc3ncnc4c(C(N)=O)cccc34)c2)ccc1Cl		CHEMBL3675470	=	IC50	nM	0.38	CHEMBL4722	Homo sapiens	IC50	nM	0.38
242424	16286880	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	CNC[C@H](/N=C1\NC=NC2C=CCC=C12)c1ccccc1		CHEMBL3675395	=	IC50	nM	220.0	CHEMBL4722	Homo sapiens	IC50	nM	220.0
242770	16286979	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(NCc3cccc(NC(=O)c4cnn5c4CNCC5)c3)ncnc12		CHEMBL3685210	=	IC50	nM	9.0	CHEMBL4722	Homo sapiens	IC50	nM	9.0
242506	16287106	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NCC(Cc1ccccc1)Nc1ncnc2c(C(N)=O)cccc12		CHEMBL3675482	=	IC50	nM	130.0	CHEMBL4722	Homo sapiens	IC50	nM	130.0
242355	16287258	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(NCC(O)c3ccccc3)ncnc12		CHEMBL3675327	=	IC50	nM	490.0	CHEMBL4722	Homo sapiens	IC50	nM	490.0
242484	16287312	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	CN(C)CC(Nc1ncnc2c(C(N)=O)cc(OCC3CC3)cc12)c1cccc(F)c1		CHEMBL3675454	=	IC50	nM	57.0	CHEMBL4722	Homo sapiens	IC50	nM	57.0
242766	16287400	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(NCc3cccc(NC(=O)[C@@H]4CCCN4C(=O)C(F)(F)F)c3)ncnc12		CHEMBL3685206	=	IC50	nM	7.0	CHEMBL4722	Homo sapiens	IC50	nM	7.0
242748	16287503	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	COc1ccc2nc(Nc3cccc(CNc4ncnc5c(C(N)=O)cccc45)c3)sc2c1		CHEMBL3639794	=	IC50	nM	2.3	CHEMBL4722	Homo sapiens	IC50	nM	2.3
242581	16287742	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	COc1ncc(C(=O)Nc2cccc([C@@H](C)Nc3ncnc4c(C(N)=O)cccc34)c2)cn1		CHEMBL3680416	=	IC50	nM	0.25	CHEMBL4722	Homo sapiens	IC50	nM	0.25
242542	16287987	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	CN(CC(Nc1ncnc2c(C(N)=O)cccc12)c1cccc(NC(=O)c2c(F)cccc2F)c1)C(=O)OC(C)(C)C		CHEMBL3675521	=	IC50	nM	3.73	CHEMBL4722	Homo sapiens	IC50	nM	3.73
242763	16288283	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	CN(C)CCCOC1C=CC(C(=O)Nc2cccc(CNc3ncnc4c(C(N)=O)cccc34)c2)=CC1		CHEMBL3685203	=	IC50	nM	6.6	CHEMBL4722	Homo sapiens	IC50	nM	6.6
242508	16288406	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	COc1ccc(C(=O)Nc2cccc(C(C)Nc3ncnc4c(C(N)=O)cccc34)c2)cn1		CHEMBL3675484	=	IC50	nM	0.1	CHEMBL4722	Homo sapiens	IC50	nM	0.1
242479	16288458	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	Cc1ccc(C(=O)Nc2cccc([C@@H](C)Nc3ncnc4c(C(N)=O)cccc34)c2)cn1		CHEMBL3639743	=	IC50	nM	0.3	CHEMBL4722	Homo sapiens	IC50	nM	0.3
242336	16288521	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cc(OCc2ccccc2)cc2c(NCc3ccc(C(F)(F)F)cc3)ncnc12		CHEMBL3670496	=	IC50	nM	2600.0	CHEMBL4722	Homo sapiens	IC50	nM	2600.0
242803	16288999	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	Cc1cccc(C(=O)Nc2cccc(CNc3ncnc4c(C(N)=O)cccc34)c2)c1		CHEMBL3685243	=	IC50	nM	0.17	CHEMBL4722	Homo sapiens	IC50	nM	0.17
242592	16289276	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	COc1ccc(C(O)/N=C2\C=CCC(CNc3ncnc4c(C(N)=O)cccc34)C2)cc1C		CHEMBL3680429	=	IC50	nM	0.2	CHEMBL4722	Homo sapiens	IC50	nM	0.2
242382	16289372	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(NCc3ccc4c(c3)OCO4)ncnc12		CHEMBL3675353	=	IC50	nM	0.37	CHEMBL4722	Homo sapiens	IC50	nM	0.37
242625	16289609	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(NCC3C=CC=C(NC=O)C3)ncnc12		CHEMBL3680467	=	IC50	nM	0.49	CHEMBL4722	Homo sapiens	IC50	nM	0.49
242601	16289691	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	Cc1cnc(C(=O)Nc2cccc([C@@H](C)Nc3ncnc4c(C(N)=O)cccc34)c2)cn1		CHEMBL3680438	=	IC50	nM	3.1	CHEMBL4722	Homo sapiens	IC50	nM	3.1
242550	16289737	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	CNc1cc(C(=O)Nc2cccc(CNc3ncnc4c(C(N)=O)cccc34)c2)ccn1		CHEMBL3675532	=	IC50	nM	0.15	CHEMBL4722	Homo sapiens	IC50	nM	0.15
242673	16289780	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	COc1ccc(C(=O)Nc2cccc(CNc3ccnc4c(C(N)=O)cccc34)c2)cc1F		CHEMBL3680522	=	IC50	nM	0.73	CHEMBL4722	Homo sapiens	IC50	nM	0.73
242278	16289905	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(NCc3cccc(NC(=O)Nc4cccc(C(F)(F)F)c4)c3)ncnc12		CHEMBL3670436	=	IC50	nM	7800.0	CHEMBL4722	Homo sapiens	IC50	nM	7800.0
242632	16289975	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	COCCN(C)c1ccc(C(=O)Nc2cccc(CNc3ncnc4c(C(N)=O)cccc34)c2)cn1		CHEMBL3680477	=	IC50	nM	0.09	CHEMBL4722	Homo sapiens	IC50	nM	0.09
242477	16290078	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	CCC(Nc1ncnc2c(C(N)=O)cccc12)c1cccc(NC(=O)c2ccc(OC)nc2)c1		CHEMBL3675447	=	IC50	nM	0.33	CHEMBL4722	Homo sapiens	IC50	nM	0.33
242272	16290106	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	CC(=O)Nc1cc(C(N)=O)c2ncnc(NCc3ccccc3)c2c1		CHEMBL3670430	=	IC50	nM	1400.0	CHEMBL4722	Homo sapiens	IC50	nM	1400.0
242379	16290231	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(NCc3ccccc3Cl)ncnc12		CHEMBL3675350	=	IC50	nM	740.0	CHEMBL4722	Homo sapiens	IC50	nM	740.0
242407	16290248	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(NCc3ccc4occc4c3)ncnc12		CHEMBL3675378	=	IC50	nM	1000.0	CHEMBL4722	Homo sapiens	IC50	nM	1000.0
242564	16290663	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	CN(C)CCC(Nc1ncnc2c(C(N)=O)cccc12)c1cccc(NC(=O)c2ccc(OC(F)(F)F)cc2)c1		CHEMBL3680395	=	IC50	nM	0.42	CHEMBL4722	Homo sapiens	IC50	nM	0.42
242828	16290706	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	COc1ccc(C(=O)Nc2cc(CNc3ncnc4c(C(N)=O)cccc34)ccc2C)cc1		CHEMBL3685267	=	IC50	nM	0.33	CHEMBL4722	Homo sapiens	IC50	nM	0.33
242507	16290836	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	CC(Nc1ncnc2c(C(N)=O)cccc12)c1cccc(NC(=O)c2ccc(C(F)(F)F)nc2)c1		CHEMBL3675483	=	IC50	nM	0.21	CHEMBL4722	Homo sapiens	IC50	nM	0.21
242448	16290976	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	CN(C)CC(Nc1ncnc2c(C(N)=O)cccc12)c1cccc(NC(=O)c2cncc(N3CCCC3)c2)c1		CHEMBL3675420	=	IC50	nM	0.84	CHEMBL4722	Homo sapiens	IC50	nM	0.84
242331	16291554	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(NCc3cccc(OCCN(CCO)CCO)c3)ncnc12		CHEMBL3670491	=	IC50	nM	58.0	CHEMBL4722	Homo sapiens	IC50	nM	58.0
242875	16291640	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	COc1ccc(C(=O)N(C)c2cccc(CNc3ncnc4c(C(N)=O)cccc34)c2)cc1		CHEMBL3685331	=	IC50	nM	649.0	CHEMBL4722	Homo sapiens	IC50	nM	649.0
242538	16291765	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	Cc1ccc(C(=O)Nc2cccc([C@@H](C)Nc3ncnc4c(C(N)=O)cccc34)c2)cc1Cl		CHEMBL3675517	=	IC50	nM	0.56	CHEMBL4722	Homo sapiens	IC50	nM	0.56
242307	16291854	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(NCCNCc3ccccc3)ncnc12		CHEMBL3670466	=	IC50	nM	29.0	CHEMBL4722	Homo sapiens	IC50	nM	29.0
242568	16292027	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	Cc1cnc(C(=O)Nc2cccc(C(C)Nc3ncnc4c(C(N)=O)cccc34)c2)cn1		CHEMBL3680399	=	IC50	nM	3.6	CHEMBL4722	Homo sapiens	IC50	nM	3.6
242757	16292752	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(Nc3cccc(CNC(=O)c4ccc(C(F)(F)F)cc4)c3)ncnc12		CHEMBL3680605	=	IC50	nM	4.2	CHEMBL4722	Homo sapiens	IC50	nM	4.2
242608	16292894	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(NC(CCO)c3cccc([N+](=O)[O-])c3)ncnc12		CHEMBL3680445	=	IC50	nM	520.0	CHEMBL4722	Homo sapiens	IC50	nM	520.0
242801	16292975	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	Cc1ccccc1C(=O)Nc1cccc(CNc2ncnc3c(C(N)=O)cccc23)c1		CHEMBL3685241	=	IC50	nM	0.1	CHEMBL4722	Homo sapiens	IC50	nM	0.1
242860	16293039	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	CC[C@@H](Nc1ncnc2c(C(N)=O)cccc12)C1=CC(NC(=O)c2ccc(OC)c(F)c2)=CCC1		CHEMBL3685299	=	IC50	nM	12.0	CHEMBL4722	Homo sapiens	IC50	nM	12.0
242519	16293440	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	CNCC(Nc1ncnc2c(C(N)=O)cc(O)cc12)c1ccccc1		CHEMBL3675497	=	IC50	nM	560.0	CHEMBL4722	Homo sapiens	IC50	nM	560.0
242645	16293473	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	C[C@@H](Nc1ncnc2c(C(N)=O)cccc12)c1cccc(NC(=O)c2cncnc2)c1		CHEMBL3680490	=	IC50	nM	1.2	CHEMBL4722	Homo sapiens	IC50	nM	1.2
242633	16293498	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	CC(Nc1ncnc2c(C(N)=O)cccc12)c1cccc(NC(=O)C2=C[NH+]([O-])CC=C2)c1		CHEMBL3680478	=	IC50	nM	44.0	CHEMBL4722	Homo sapiens	IC50	nM	44.0
242309	16293558	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(NCc3cccc(NC(=O)c4ccc(Br)cc4)c3)ncnc12		CHEMBL3670468	=	IC50	nM	0.65	CHEMBL4722	Homo sapiens	IC50	nM	0.65
242744	16293807	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	C[C@@H](Nc1ncnc2c(C(N)=O)cccc12)c1cccc(NC(=O)Oc2ccccc2)c1		CHEMBL3680593	=	IC50	nM	2.1	CHEMBL4722	Homo sapiens	IC50	nM	2.1
242377	16293911	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(NCC3CCCO3)ncnc12		CHEMBL3675349	=	IC50	nM	5800.0	CHEMBL4722	Homo sapiens	IC50	nM	5800.0
242400	16294269	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(NCc3cccc(NC(=O)Nc4ccccc4)c3)ncnc12		CHEMBL3675371	=	IC50	nM	1.6	CHEMBL4722	Homo sapiens	IC50	nM	1.6
242454	16294342	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	COc1cc(C(N)=O)c2ncnc(NC(CN(C)C)c3ccc(Cl)cc3)c2c1		CHEMBL3675426	=	IC50	nM	380.0	CHEMBL4722	Homo sapiens	IC50	nM	380.0
242570	16294547	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	COc1ccc(C(=O)Nc2cc([C@@H](C)Nc3nccc4c(C(N)=O)cccc34)ccc2F)cc1F		CHEMBL3680402	=	IC50	nM	0.12	CHEMBL4722	Homo sapiens	IC50	nM	0.12
242337	16294837	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	CN(C)c1ccc(C(=O)Nc2cccc(CNc3ncnc4c(C(N)=O)cccc34)c2)cn1		CHEMBL3670497	=	IC50	nM	0.97	CHEMBL4722	Homo sapiens	IC50	nM	0.97
242565	16295195	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(NC(CCO)C3=CCCC(NC(=O)c4ccccc4)=C3)ncnc12		CHEMBL3680396	=	IC50	nM	1.8	CHEMBL4722	Homo sapiens	IC50	nM	1.8
242727	16295552	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	N#CCc1ccc(Nc2cccc(CNc3ncnc4c(C(N)=O)cccc34)c2)nc1		CHEMBL3680577	=	IC50	nM	1.0	CHEMBL4722	Homo sapiens	IC50	nM	1.0
242305	16295575	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC[C@@H](Nc1ncnc2c(C(N)=O)cccc12)c1ccccc1		CHEMBL3670464	=	IC50	nM	310.0	CHEMBL4722	Homo sapiens	IC50	nM	310.0
242620	16295588	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	COc1ccc(C(=O)Nc2cccc([C@@H](C)Nc3ncnc4c(C(N)=O)cccc34)c2)cc1F		CHEMBL3680460	=	IC50	nM	0.13	CHEMBL4722	Homo sapiens	IC50	nM	0.13
242710	16295616	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(NCc3cccc(NC(=O)c4cc5cc(Cl)ccc5[nH]4)c3)ncnc12		CHEMBL3680560	=	IC50	nM	0.37	CHEMBL4722	Homo sapiens	IC50	nM	0.37
242330	16295621	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	CN(C)CCOc1cccc(CNc2ncnc3c(C(N)=O)cccc23)c1		CHEMBL3670490	=	IC50	nM	1600.0	CHEMBL4722	Homo sapiens	IC50	nM	1600.0
242817	16295640	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(NCc3cccc(NC(=O)C4=CCC(N5CCOCC5)C=C4)c3)ncnc12		CHEMBL3685256	=	IC50	nM	0.08	CHEMBL4722	Homo sapiens	IC50	nM	0.08
242627	16295724	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(NCc3cc(F)cc(Cl)c3)ncnc12		CHEMBL3680469	=	IC50	nM	750.0	CHEMBL4722	Homo sapiens	IC50	nM	750.0
242452	16295819	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	CNCC(Nc1ncnc2c(C(N)=O)cccc12)c1ccc(OC)cc1		CHEMBL3675424	=	IC50	nM	2400.0	CHEMBL4722	Homo sapiens	IC50	nM	2400.0
242399	16295837	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(NCc3cccc(NS(=O)(=O)c4ccccc4)c3)ncnc12		CHEMBL3675370	=	IC50	nM	4900.0	CHEMBL4722	Homo sapiens	IC50	nM	4900.0
242350	16296160	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	COC[C@@H]1CCCN1CCCOc1cc(C(N)=O)c2ncnc(NCc3ccc(C(F)(F)F)cc3)c2c1		CHEMBL3675322	=	IC50	nM	7500.0	CHEMBL4722	Homo sapiens	IC50	nM	7500.0
242358	16296300	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	COc1ccccc1C(CNC(C)=O)Nc1ncnc2c(C(N)=O)cccc12		CHEMBL3675330	=	IC50	nM	1.9	CHEMBL4722	Homo sapiens	IC50	nM	1.9
242767	16296488	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	COCCOc1ccccc1C(=O)Nc1cccc(CNc2ncnc3c(C(N)=O)cccc23)c1		CHEMBL3685207	=	IC50	nM	7.3	CHEMBL4722	Homo sapiens	IC50	nM	7.3
242395	16296658	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(NCc3cc(C(F)(F)F)cc(C(F)(F)F)c3)ncnc12		CHEMBL3675366	=	IC50	nM	1500.0	CHEMBL4722	Homo sapiens	IC50	nM	1500.0
242562	16296824	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	CN(C)CCC(Nc1ncnc2c(C(N)=O)cccc12)C1=CCCC(NC(=O)c2ccccc2F)=C1		CHEMBL3680393	=	IC50	nM	19.0	CHEMBL4722	Homo sapiens	IC50	nM	19.0
242657	16297173	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	COc1ccc(C(=O)Nc2cccc(C(CCN(C)C)Nc3ncnc4c(C(N)=O)cccc34)c2)cc1F		CHEMBL3680505	=	IC50	nM	5.0	CHEMBL4722	Homo sapiens	IC50	nM	5.0
242342	16297246	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cc(OCCN2CCOCC2)cc2c(NCc3ccc(C(F)(F)F)cc3)ncnc12		CHEMBL3670501	=	IC50	nM	360.0	CHEMBL4722	Homo sapiens	IC50	nM	360.0
242502	16297257	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NCC[C@@H](Nc1ncnc2c(C(N)=O)cccc12)c1ccccc1		CHEMBL3675478	=	IC50	nM	110.0	CHEMBL4722	Homo sapiens	IC50	nM	110.0
242820	16297433	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	COc1ccccc1C(=O)Nc1cccc(CNc2ncnc3c(C(N)=O)cccc23)c1		CHEMBL3685259	=	IC50	nM	0.37	CHEMBL4722	Homo sapiens	IC50	nM	0.37
242473	16297557	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	CC(Nc1ncnc2c(C(N)=O)cccc12)c1cccc(NC(=O)c2ccc(F)c(O)c2)c1		CHEMBL3675444	=	IC50	nM	0.97	CHEMBL4722	Homo sapiens	IC50	nM	0.97
242322	16297665	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	COc1cc(C(N)=O)c2ncnc(NCc3ccc(Cl)c(C(F)(F)F)c3)c2c1		CHEMBL3670482	=	IC50	nM	378.0	CHEMBL4722	Homo sapiens	IC50	nM	378.0
242802	16297711	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	CN(C)c1cccc(C(=O)Nc2cccc(CNc3ncnc4c3=CCCC=4C(N)=O)c2)c1		CHEMBL3685242	=	IC50	nM	0.22	CHEMBL4722	Homo sapiens	IC50	nM	0.22
242297	16297830	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	Cc1cc(C(N)=O)c2ncnc(NCc3cccc(F)c3)c2c1		CHEMBL3670456	=	IC50	nM	1300.0	CHEMBL4722	Homo sapiens	IC50	nM	1300.0
242684	16298422	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	CC(Nc1ncnc2c(C(N)=O)cccc12)c1cccc(Nc2cc(C(F)(F)F)ccn2)c1		CHEMBL3680533	=	IC50	nM	0.31	CHEMBL4722	Homo sapiens	IC50	nM	0.31
242435	16298782	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	CNC[C@@H](Nc1ncnc2c(C(N)=O)cc(OC)cc12)c1cccc(F)c1		CHEMBL3675407	=	IC50	nM	100.0	CHEMBL4722	Homo sapiens	IC50	nM	100.0
242348	16298851	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cc(OCCCN2CCC(O)C2)cc2c(NCc3ccc(C(F)(F)F)cc3)ncnc12		CHEMBL3675320	=	IC50	nM	1300.0	CHEMBL4722	Homo sapiens	IC50	nM	1300.0
242611	16298985	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	COc1ccc(C(N)=O)c2ncnc(NCc3cccc(F)c3)c12		CHEMBL3680448	=	IC50	nM	600.0	CHEMBL4722	Homo sapiens	IC50	nM	600.0
242369	16299076	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(NCc3cccc4ccccc34)ncnc12		CHEMBL3675341	=	IC50	nM	340.0	CHEMBL4722	Homo sapiens	IC50	nM	340.0
242396	16299408	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(NCc3ccc4c(c3)OCO4)ccnc12		CHEMBL3675367	=	IC50	nM	5200.0	CHEMBL4722	Homo sapiens	IC50	nM	5200.0
242639	16299428	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(NC(Cn3ccnc3)c3ccccc3)ncnc12		CHEMBL3680484	=	IC50	nM	300.0	CHEMBL4722	Homo sapiens	IC50	nM	300.0
242720	16299522	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	C[C@@H](Nc1ncnc2c(C(N)=O)cccc12)c1cccc(NC(=O)C2CC2(C)C)c1		CHEMBL3680570	=	IC50	nM	0.75	CHEMBL4722	Homo sapiens	IC50	nM	0.75
242418	16299749	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cc(NC(=O)c2ccc(S(=O)(=O)F)cc2)cc2c(NCc3ccc(Cl)c(C(F)(F)F)c3)ncnc12		CHEMBL3675389	=	IC50	nM	110.0	CHEMBL4722	Homo sapiens	IC50	nM	110.0
242800	16299751	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	Cc1cc(C(=O)Nc2cccc(CNc3ncnc4c(C(N)=O)cccc34)c2)[nH]n1		CHEMBL3685240	=	IC50	nM	0.47	CHEMBL4722	Homo sapiens	IC50	nM	0.47
242294	16299774	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(NCc3cccc(NC(=O)Nc4ccccc4C(F)(F)F)c3)ncnc12		CHEMBL3670453	=	IC50	nM	4.7	CHEMBL4722	Homo sapiens	IC50	nM	4.7
242267	16299784	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(NCc3cccc(NC(=O)Nc4cccc(F)c4)c3)ncnc12		CHEMBL3670425	=	IC50	nM	1.1	CHEMBL4722	Homo sapiens	IC50	nM	1.1
242731	16300101	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(NC(CCN3CCNCC3)c3cccc(NC(=O)c4cc(C5CC5)n[nH]4)c3)ncnc12		CHEMBL3680580	=	IC50	nM	1.2	CHEMBL4722	Homo sapiens	IC50	nM	1.2
242291	16300569	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(N[C@H]3CCCc4ccccc43)ncnc12		CHEMBL3670450	=	IC50	nM	1600.0	CHEMBL4722	Homo sapiens	IC50	nM	1600.0
242866	16300882	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(NCc3cccc(NC(=O)c4c(F)cc(Cl)cc4F)c3)ncnc12		CHEMBL3685305	=	IC50	nM	0.08	CHEMBL4722	Homo sapiens	IC50	nM	0.08
242256	16300959	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	N#CC[C@@H](Nc1ncnc2c(C(N)=O)cccc12)c1ccccc1		CHEMBL3670414	=	IC50	nM	280.0	CHEMBL4722	Homo sapiens	IC50	nM	280.0
242609	16301037	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	COc1ccc(C(=O)Nc2cccc(C(C)Nc3ncnc4c(C(N)=O)cccc34)c2)cc1F		CHEMBL3680446	=	IC50	nM	0.25	CHEMBL4722	Homo sapiens	IC50	nM	0.25
242471	16301154	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	CN(C)C[C@@H](Nc1ncnc2c(C(N)=O)cccc12)c1ccccc1		CHEMBL3675442	=	IC50	nM	130.0	CHEMBL4722	Homo sapiens	IC50	nM	130.0
242761	16301277	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	C[C@@H](Nc1ncnc2c(C(N)=O)cccc12)c1cccc(Nc2ccc(CN3CCOCC3)cn2)c1		CHEMBL3685201	=	IC50	nM	6.2	CHEMBL4722	Homo sapiens	IC50	nM	6.2
242409	16301289	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	C[C@@H](Nc1ncnc2c(C(N)=O)cccc12)c1ccccc1		CHEMBL3675380	=	IC50	nM	2.0	CHEMBL4722	Homo sapiens	IC50	nM	2.0
242754	16301408	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	CC(Nc1ncnc2c(C(N)=O)cccc12)c1cccc(NC(=O)CC(F)(F)F)c1		CHEMBL3680602	=	IC50	nM	3.1	CHEMBL4722	Homo sapiens	IC50	nM	3.1
242545	16301875	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	COc1ccc(C(=O)Nc2cccc(C(CCO)Nc3ncnc4c(C(N)=O)cccc34)c2)cc1		CHEMBL3675524	=	IC50	nM	0.09	CHEMBL4722	Homo sapiens	IC50	nM	0.09
242549	16302105	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	COc1cc(C(N)=O)c2ncnc(NC(CN(C)C)c3ccc(F)cc3)c2c1		CHEMBL3675528	=	IC50	nM	530.0	CHEMBL4722	Homo sapiens	IC50	nM	530.0
242289	16302124	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(N[C@H](C(=O)O)c3ccccc3)ncnc12		CHEMBL3670447	=	IC50	nM	5200.0	CHEMBL4722	Homo sapiens	IC50	nM	5200.0
242652	16302208	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	COCCC(Nc1ncnc2c(C(N)=O)cccc12)c1cccc(NC(=O)c2ccc(OC)cc2)c1		CHEMBL3680499	=	IC50	nM	0.42	CHEMBL4722	Homo sapiens	IC50	nM	0.42
242675	16302251	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	COc1cc(C(N)=O)c2ncnc(NC(CN(C)C)c3ccccc3OC)c2c1		CHEMBL3680524	=	IC50	nM	470.0	CHEMBL4722	Homo sapiens	IC50	nM	470.0
242384	16302339	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(NCc3ccc(C(F)(F)F)cc3)ncnc12		CHEMBL3675355	=	IC50	nM	550.0	CHEMBL4722	Homo sapiens	IC50	nM	550.0
242857	16302515	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	CN(C)CCOc1cc(C(N)=O)c2ncnc(NCc3cccc(NC(=O)c4ccnc(N5CCCC5)c4)c3)c2c1		CHEMBL3685296	=	IC50	nM	7.8	CHEMBL4722	Homo sapiens	IC50	nM	7.8
242476	16302653	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(NCc3cccc(NC(=O)c4ccc(Cl)cc4Cl)c3)ncnc12		CHEMBL3675446	=	IC50	nM	0.12	CHEMBL4722	Homo sapiens	IC50	nM	0.12
242607	16302759	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	COc1ccc(C(=O)Nc2cccc(CNc3ncnc4c(C(N)=O)cccc34)c2)cn1		CHEMBL3680444	=	IC50	nM	0.66	CHEMBL4722	Homo sapiens	IC50	nM	0.66
242290	16302799	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(N[C@H](CO)c3ccccc3)ncnc12		CHEMBL3670448	=	IC50	nM	540.0	CHEMBL4722	Homo sapiens	IC50	nM	540.0
242535	16302864	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	CN(C)CC(Nc1ncnc2c(C(N)=O)cc(O)cc12)c1cccc(Cl)c1		CHEMBL3675514	=	IC50	nM	330.0	CHEMBL4722	Homo sapiens	IC50	nM	330.0
242334	16302941	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	COc1cc(C(N)=O)c2ncnc(NCc3ccc(Cl)c(Cl)c3)c2c1		CHEMBL3670494	=	IC50	nM	220.0	CHEMBL4722	Homo sapiens	IC50	nM	220.0
242460	16302957	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	C[C@@H](Nc1ncnc2c(C(N)=O)cccc12)c1cccc(NC(=O)c2ccc(C(F)(F)F)cc2F)c1		CHEMBL3675432	=	IC50	nM	0.25	CHEMBL4722	Homo sapiens	IC50	nM	0.25
242825	16303184	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(NCc3cccc(NC(=O)c4ccccc4OCCO)c3)ncnc12		CHEMBL3685264	=	IC50	nM	0.91	CHEMBL4722	Homo sapiens	IC50	nM	0.91
242347	16303352	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	CN(CCO)CCCOc1cc(C(N)=O)c2ncnc(NCc3ccc(C(F)(F)F)cc3)c2c1		CHEMBL3675319	=	IC50	nM	1100.0	CHEMBL4722	Homo sapiens	IC50	nM	1100.0
242697	16303466	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	CC(Nc1ncnc2c(C(N)=O)cccc12)c1cccc(NC(=O)C2CC2(F)F)c1		CHEMBL3680547	=	IC50	nM	0.18	CHEMBL4722	Homo sapiens	IC50	nM	0.18
242718	16303632	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	CCOC(=O)Nc1cccc([C@@H](C)Nc2ncnc3c(C(N)=O)cccc23)c1		CHEMBL3680568	=	IC50	nM	0.6	CHEMBL4722	Homo sapiens	IC50	nM	0.6
242865	16303818	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	C[C@@H](Nc1ncnc2c(C(N)=O)cccc12)c1cccc(NC(=O)c2ccc(F)c(O)c2)c1		CHEMBL3685304	=	IC50	nM	0.01	CHEMBL4722	Homo sapiens	IC50	nM	0.01
242333	16303855	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(NCc3cccc(NC(=O)c4ccnc(Cl)c4)c3)ncnc12		CHEMBL3670493	=	IC50	nM	29.0	CHEMBL4722	Homo sapiens	IC50	nM	29.0
242378	16303935	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(NCc3ccc(F)cc3F)ncnc12		CHEMBL3639742	=	IC50	nM	2.2	CHEMBL4722	Homo sapiens	IC50	nM	2.2
242518	16304115	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC[C@H](Cc1ccccc1)Nc1ncnc2c(C(N)=O)cccc12		CHEMBL3675496	=	IC50	nM	50.0	CHEMBL4722	Homo sapiens	IC50	nM	50.0
242621	16304205	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(NCc3cccc(F)c3F)ncnc12		CHEMBL3680461	=	IC50	nM	1900.0	CHEMBL4722	Homo sapiens	IC50	nM	1900.0
242617	16304380	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	Cn1cnc2c(Nc3cccc(CNc4ncnc5c(C(N)=O)cccc45)c3)nccc21		CHEMBL3680457	=	IC50	nM	5.1	CHEMBL4722	Homo sapiens	IC50	nM	5.1
242809	16304469	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	CC(=O)Nc1ccc(C(=O)Nc2cccc(CNc3ncnc4c(C(N)=O)cccc34)c2)cc1		CHEMBL3685249	=	IC50	nM	0.65	CHEMBL4722	Homo sapiens	IC50	nM	0.65
242824	16304545	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	CC(Nc1ncnc2c(C(N)=O)cccc12)c1cccc(NC(=O)c2ccc(O)c(F)c2)c1		CHEMBL3685263	=	IC50	nM	10.0	CHEMBL4722	Homo sapiens	IC50	nM	10.0
242759	16304592	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	CCN1CCC(C(=O)Nc2cccc([C@@H](C)Nc3ncnc4c(C(N)=O)cccc34)c2)C1		CHEMBL3680607	=	IC50	nM	4.2	CHEMBL4722	Homo sapiens	IC50	nM	4.2
242257	16304601	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(NCc3ccc(Br)cc3)ncnc12		CHEMBL3670415	=	IC50	nM	230.0	CHEMBL4722	Homo sapiens	IC50	nM	230.0
242421	16304925	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(Nc3ccc(OCc4ccccn4)c(Cl)c3)ncnc12		CHEMBL3675392	=	IC50	nM	1000.0	CHEMBL4722	Homo sapiens	IC50	nM	1000.0
242326	16304944	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	COc1cc(C(N)=O)c2ncnc(NCc3ccc(C(F)(F)F)cc3)c2c1		CHEMBL3670486	=	IC50	nM	590.0	CHEMBL4722	Homo sapiens	IC50	nM	590.0
242756	16305076	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(NCc3cccc(Nc4ccc(C(F)(F)F)cn4)c3)ncnc12		CHEMBL3680604	=	IC50	nM	3.6	CHEMBL4722	Homo sapiens	IC50	nM	3.6
242487	16305166	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	C[C@@H](Nc1ncnc2c(C(N)=O)cccc12)c1cccc(NC(=O)c2cc(C(F)(F)F)ccc2F)c1		CHEMBL3675457	=	IC50	nM	0.11	CHEMBL4722	Homo sapiens	IC50	nM	0.11
198775	16305428	CHEMBL3705772	Inhibitory Assay: The method for measuring the in-vitro inhibitory activity of a test compound against Aurora B kinase activity was substantially the same as in the case of Aurora A. A purified recombinant human Aurora B protein was purchased from Carna Biosciences, Inc. The composition of a reaction buffer was 20 mM HEPES (pH 7.4), 2 mM DTT, 0.01% Tween-20, magnesium chloride (final concentration: 1 mM) and ATP (final concentration: 40 μM), and incubation time was set to 60 minutes.	B	COc1cc(Nc2ncc3c(n2)-c2cccc(Cl)c2C(c2c(F)cccc2OC)=NC3)ccc1C(=O)O		CHEMBL3692218	=	IC50	nM	0.6	CHEMBL4722	Homo sapiens	IC50	nM	0.6
242569	16305529	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	CNCC(Nc1ncnc2c(C(N)=O)cc(OCCN(C)C)cc12)c1cccc(F)c1		CHEMBL3680400	=	IC50	nM	1000.0	CHEMBL4722	Homo sapiens	IC50	nM	1000.0
242537	16305819	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	C=CCN(C)CCC(Nc1ncnc2c(C(N)=O)cccc12)c1cccc(NC(=O)c2ccc(OC)cc2)c1		CHEMBL3675516	=	IC50	nM	0.16	CHEMBL4722	Homo sapiens	IC50	nM	0.16
242563	16305864	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	CCC(Nc1ncnc2c(C(N)=O)cccc12)c1cccc(NC(=O)c2ccc(OC(F)(F)F)cc2)c1		CHEMBL3680394	=	IC50	nM	0.32	CHEMBL4722	Homo sapiens	IC50	nM	0.32
242777	16305962	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(NCc3cccc(NC(=O)c4n[nH]c5ccc(Cl)cc45)c3)ncnc12		CHEMBL3685217	=	IC50	nM	20.0	CHEMBL4722	Homo sapiens	IC50	nM	20.0
242847	16305990	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(NC(CCN3CCCCC3)c3cccc(NC(O)c4ccccc4)c3)ncnc12		CHEMBL3685286	=	IC50	nM	7.5	CHEMBL4722	Homo sapiens	IC50	nM	7.5
242250	16306447	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(NC3CCNCC3)ncnc12		CHEMBL3670408	=	IC50	nM	10000.0	CHEMBL4722	Homo sapiens	IC50	nM	10000.0
242651	16306908	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	COC1=CC=CCC1C(CN(C)C)Nc1ncnc2c(C(N)=O)cccc12		CHEMBL3680498	=	IC50	nM	820.0	CHEMBL4722	Homo sapiens	IC50	nM	820.0
242797	16307093	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	CC(C)c1cc(C(=O)Nc2cccc(CNc3ncnc4c(C(N)=O)cccc34)c2)[nH]n1		CHEMBL3685237	=	IC50	nM	0.12	CHEMBL4722	Homo sapiens	IC50	nM	0.12
242457	16307145	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	CC1CCCN1c1cc(C(=O)Nc2cccc(C(CN(C)C)Nc3ncnc4c(C(N)=O)cccc34)c2)ccn1		CHEMBL3675428	=	IC50	nM	1.1	CHEMBL4722	Homo sapiens	IC50	nM	1.1
242642	16307219	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	CC(Nc1ncnc2c(C(N)=O)cccc12)c1cccc(NC(=O)c2ccc(N3CCN(C)CC3)cc2)c1		CHEMBL3680487	=	IC50	nM	8.8	CHEMBL4722	Homo sapiens	IC50	nM	8.8
242739	16307261	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	CCC(Nc1ncnc2c(C(N)=O)cccc12)c1cccc(NC(=O)C2CC(F)(F)C2)c1		CHEMBL3680588	=	IC50	nM	1.8	CHEMBL4722	Homo sapiens	IC50	nM	1.8
242747	16307390	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	N#CCc1ccnc(Nc2cccc(CNc3ncnc4c(C(N)=O)cccc34)c2)c1		CHEMBL3680596	=	IC50	nM	2.3	CHEMBL4722	Homo sapiens	IC50	nM	2.3
242804	16307509	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	COCCOc1cc(C(N)=O)c2ncnc(NCc3cccc(NC(=O)c4ccc(OC)cc4)c3)c2c1		CHEMBL3685244	=	IC50	nM	0.06	CHEMBL4722	Homo sapiens	IC50	nM	0.06
242548	16307679	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	COCCOc1cc(C(N)=O)c2ncnc(NC(CN(C)C)c3cccc(F)c3)c2c1		CHEMBL3675527	=	IC50	nM	210.0	CHEMBL4722	Homo sapiens	IC50	nM	210.0
242292	16307784	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(NCc3cccc(NC(=O)c4cccc(C(F)(F)F)c4)c3)ncnc12		CHEMBL3670451	=	IC50	nM	1200.0	CHEMBL4722	Homo sapiens	IC50	nM	1200.0
242724	16307840	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	CC(Nc1ncnc2c(C(N)=O)cccc12)c1cccc(NC(=O)C2CC(F)(F)C2)c1		CHEMBL3680574	=	IC50	nM	0.86	CHEMBL4722	Homo sapiens	IC50	nM	0.86
242433	16308115	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	CNCC(Nc1ncnc2c(C(N)=O)cccc12)c1cccc(Cl)c1		CHEMBL3675405	=	IC50	nM	94.0	CHEMBL4722	Homo sapiens	IC50	nM	94.0
242436	16308122	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	CNCC(Nc1ncnc2c(C(N)=O)cc(OC)cc12)c1cccc(Cl)c1		CHEMBL3675408	=	IC50	nM	210.0	CHEMBL4722	Homo sapiens	IC50	nM	210.0
242284	16308189	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cc(NCc2ncc[nH]2)cc2c(NCc3ccccc3)ncnc12		CHEMBL3670442	=	IC50	nM	700.0	CHEMBL4722	Homo sapiens	IC50	nM	700.0
242714	16308223	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(NCc3cccc(NC(=O)c4ccc5c(c4)OCCO5)c3)ncnc12		CHEMBL3680564	=	IC50	nM	0.53	CHEMBL4722	Homo sapiens	IC50	nM	0.53
242666	16308312	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	CN(C)CC(Nc1ncnc2c(C(N)=O)cc(OCc3ccc(F)cc3)cc12)c1cccc(F)c1		CHEMBL3680514	=	IC50	nM	300.0	CHEMBL4722	Homo sapiens	IC50	nM	300.0
242605	16308330	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	CC(Nc1ncnc2c(C(N)=O)cccc12)c1cccc(NC(=O)c2cccn2C)c1		CHEMBL3680442	=	IC50	nM	0.36	CHEMBL4722	Homo sapiens	IC50	nM	0.36
242648	16308761	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	CC(C)CNc1cc(C(=O)Nc2cccc(CNc3ncnc4c(C(N)=O)cccc34)c2)ccn1		CHEMBL3680495	=	IC50	nM	0.22	CHEMBL4722	Homo sapiens	IC50	nM	0.22
242349	16308981	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cc(OCCCN2CCC[C@H]2CO)cc2c(NCc3ccc(C(F)(F)F)cc3)ncnc12		CHEMBL3675321	=	IC50	nM	6.7	CHEMBL4722	Homo sapiens	IC50	nM	6.7
242768	16309429	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(NCc3cccc(Nc4ccc(N)cn4)c3)ncnc12		CHEMBL3685208	=	IC50	nM	7.6	CHEMBL4722	Homo sapiens	IC50	nM	7.6
242308	16309492	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	COc1ccc(C(=O)Nc2cccc(CNc3ncnc4c(C(N)=O)cccc34)c2)cc1		CHEMBL3670467	=	IC50	nM	0.29	CHEMBL4722	Homo sapiens	IC50	nM	0.29
242428	16309500	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	CNCC(Nc1ncnc2c(C(N)=O)cc(OC)cc12)c1cccc(F)c1		CHEMBL3675399	=	IC50	nM	480.0	CHEMBL4722	Homo sapiens	IC50	nM	480.0
242313	16309837	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(NCc3cccc(NC(=O)Cc4ccccc4)c3)ncnc12		CHEMBL3670472	=	IC50	nM	2.6	CHEMBL4722	Homo sapiens	IC50	nM	2.6
242389	16309972	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(NCc3ccc(N)cc3)ncnc12		CHEMBL3675360	=	IC50	nM	9300.0	CHEMBL4722	Homo sapiens	IC50	nM	9300.0
242737	16310169	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	CC(Nc1ncnc2c(C(N)=O)cccc12)C1=CC(NC(=O)C2(C(F)(F)F)CCC2)=CCC1		CHEMBL3680586	=	IC50	nM	1.6	CHEMBL4722	Homo sapiens	IC50	nM	1.6
242327	16310332	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(NCc3cccc(NC(=O)c4cccc(Cl)n4)c3)ncnc12		CHEMBL3670487	=	IC50	nM	5.0	CHEMBL4722	Homo sapiens	IC50	nM	5.0
242431	16310370	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	CNCC(Nc1ncnc2c(C(N)=O)cccc12)c1cccc(NC(=O)c2ccc(Br)cc2)c1		CHEMBL3675403	=	IC50	nM	0.17	CHEMBL4722	Homo sapiens	IC50	nM	0.17
242835	16310421	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	COCC[C@H](Nc1ncnc2c(C(N)=O)cccc12)c1cccc(NC(=O)c2ccc(OC)cc2)c1		CHEMBL3685274	=	IC50	nM	340.0	CHEMBL4722	Homo sapiens	IC50	nM	340.0
242406	16310519	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(NCc3ccc4c(c3)CCO4)ncnc12		CHEMBL3675377	=	IC50	nM	660.0	CHEMBL4722	Homo sapiens	IC50	nM	660.0
242426	16310570	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	COc1cc(C(N)=O)c2ncnc(N[C@H](CN)c3ccccc3)c2c1		CHEMBL3675397	=	IC50	nM	48.0	CHEMBL4722	Homo sapiens	IC50	nM	48.0
242450	16310642	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	COc1ccc(C(=O)Nc2cccc(C(CN(C)C)Nc3ncnc4c(C(N)=O)cccc34)c2)cc1		CHEMBL3675422	=	IC50	nM	0.67	CHEMBL4722	Homo sapiens	IC50	nM	0.67
242394	16310673	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(NCc3ccc(Cl)c(C(F)(F)F)c3)ncnc12		CHEMBL3675365	=	IC50	nM	740.0	CHEMBL4722	Homo sapiens	IC50	nM	740.0
242729	16310890	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	CCC(C)C(=O)Nc1cccc([C@@H](C)Nc2ncnc3c(C(N)=O)cccc23)c1		CHEMBL3680579	=	IC50	nM	1.1	CHEMBL4722	Homo sapiens	IC50	nM	1.1
242275	16311281	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	COc1cccc(NC(=O)Nc2cccc(CNc3ncnc4c(C(N)=O)cccc34)c2)c1		CHEMBL3670433	=	IC50	nM	720.0	CHEMBL4722	Homo sapiens	IC50	nM	720.0
311287	16311901	CHEMBL3705895	Radioactive Assay: The capacity to inhibit the kinase activity of the enzyme is estimated by measuring the residual kinase activity of the enzyme in the presence of different concentrations of the test compound (generally from 0.17 to 10 000 nM). A dose-response curve is produced, which allows an IC50 (50% inhibitory concentration) to be determined. The kinase activity is measured by a radioactive assay of the amount of radioactive phosphate (33P) incorporated into a fragment of the protein NuMA (Nuclear Mitotic Apparatus protein) after 30 minutes of incubation at 37Â° C. The test compound is first dissolved at different concentrations in dimethyl sulphoxide (DMS (J). Reaction takes place in the wells of a FlashPlate microtiter plate (Nickel Chelate FlashPlate-96, PerkinElmer). Each well (100 Î¼l) contains 10 nM Aurora A, 500 nM NuMA, 1 Î¼M ATP and 0.2 Î¼Ci ATP-Î³-33P in a buffer of 50 mM Tris-HCl, pH=7.5; 10 mM MgCl2; 50 mM NaCl, 1 mM dithiothreitol. The final percentage of DMSO is 3%.	B	CCc1[nH]cc2c1NC1=C(C(=O)CCC1)C2c1cccc(Oc2nc3ccccc3[nH]2)c1		CHEMBL3663733	=	IC50	nM	6.0	CHEMBL4722	Homo sapiens	IC50	nM	6.0
242544	16312081	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1ccccc(N[C@H](CNCCS)c2ccccc2)ncnc1		CHEMBL3675523	=	IC50	nM	330.0	CHEMBL4722	Homo sapiens	IC50	nM	330.0
242295	16312172	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	Cc1cccc(NC(=O)Nc2cccc(CNc3ncnc4c(C(N)=O)cccc34)c2)c1		CHEMBL3670454	=	IC50	nM	2.1	CHEMBL4722	Homo sapiens	IC50	nM	2.1
242363	16312364	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(Nc3cccc(Br)c3)ncnc12		CHEMBL3675335	=	IC50	nM	1480.0	CHEMBL4722	Homo sapiens	IC50	nM	1480.0
242419	16312428	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cc(NC(=O)c2cnc3ccccc3n2)cc2c(NCc3ccc(Cl)c(C(F)(F)F)c3)ncnc12		CHEMBL3675390	=	IC50	nM	10000.0	CHEMBL4722	Homo sapiens	IC50	nM	10000.0
242771	16312620	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	COc1ccc(C(=O)Nc2ccc(C)c(CNc3ncnc4c(C(N)=O)cccc34)c2)cc1		CHEMBL3685211	=	IC50	nM	9.1	CHEMBL4722	Homo sapiens	IC50	nM	9.1
242567	16312740	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	COCCC(Nc1ncnc2c(C(N)=O)cccc12)c1cccc(NC(=O)c2ccccc2)c1		CHEMBL3639792	=	IC50	nM	0.38	CHEMBL4722	Homo sapiens	IC50	nM	0.38
242444	16312901	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	CNCC(Nc1ncnc2c(C(N)=O)cccc12)c1cccc(NC(=O)c2ccc(OC)c(F)c2)c1		CHEMBL3675416	=	IC50	nM	1.1	CHEMBL4722	Homo sapiens	IC50	nM	1.1
242364	16313127	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(Nc3ccc(F)c(Cl)c3)ncnc12		CHEMBL3675336	=	IC50	nM	6000.0	CHEMBL4722	Homo sapiens	IC50	nM	6000.0
242854	16313207	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(NCc3cccc(NC(=O)c4ccc(N5CCCCC5)nc4)c3)ncnc12		CHEMBL3685293	=	IC50	nM	0.4	CHEMBL4722	Homo sapiens	IC50	nM	0.4
242863	16313532	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cc(OCc2ccccc2)cc2c(NCc3cccc(NC(=O)c4ccnc(N5CCCC5)c4)c3)ncnc12		CHEMBL3685302	=	IC50	nM	24.0	CHEMBL4722	Homo sapiens	IC50	nM	24.0
242762	16315015	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	COCCOc1cccc(C(=O)Nc2cccc(CNc3ncnc4c(C(N)=O)cccc34)c2)c1		CHEMBL3685202	=	IC50	nM	1.0	CHEMBL4722	Homo sapiens	IC50	nM	1.0
242383	16315118	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	COc1cccc(CNc2ncnc3c(C(N)=O)cccc23)c1		CHEMBL3675354	=	IC50	nM	350.0	CHEMBL4722	Homo sapiens	IC50	nM	350.0
242345	16315197	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cc(OCCCN2CCN(CCO)CC2)cc2c(NCc3ccc(C(F)(F)F)cc3)ncnc12		CHEMBL3670505	=	IC50	nM	3.4	CHEMBL4722	Homo sapiens	IC50	nM	3.4
242361	16315215	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(NCc3ccccc3)ncnc12		CHEMBL3675333	=	IC50	nM	4300.0	CHEMBL4722	Homo sapiens	IC50	nM	4300.0
242557	16315555	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	CC(Nc1ncnc2c(C(N)=O)cccc12)c1cccc(NC(=O)c2ccccc2)c1		CHEMBL3680388	=	IC50	nM	0.91	CHEMBL4722	Homo sapiens	IC50	nM	0.91
242839	16316004	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(NC(CCN3CCCC3)c3cccc(NC(=O)c4ccc(C(F)(F)F)cc4F)c3)ncnc12		CHEMBL3685278	=	IC50	nM	1.2	CHEMBL4722	Homo sapiens	IC50	nM	1.2
242301	16316286	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	COc1cc(C(N)=O)c2ncnc(NCc3cccc(C(F)(F)F)c3)c2c1		CHEMBL3670460	=	IC50	nM	200.0	CHEMBL4722	Homo sapiens	IC50	nM	200.0
242251	16316291	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(NCC3CCNCC3)ncnc12		CHEMBL3670409	=	IC50	nM	1000.0	CHEMBL4722	Homo sapiens	IC50	nM	1000.0
242630	16316361	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	Cc1cc(C(=O)Nc2cccc(C(C)Nc3ncnc4c(C(N)=O)cccc34)c2)c(C(F)(F)F)o1		CHEMBL3680474	=	IC50	nM	1.6	CHEMBL4722	Homo sapiens	IC50	nM	1.6
242850	16316519	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	COc1ccc(C(=O)Nc2cccc(C(CCN3CCC3)Nc3ncnc4c(C(N)=O)cccc34)c2)cc1		CHEMBL3685289	=	IC50	nM	5.9	CHEMBL4722	Homo sapiens	IC50	nM	5.9
242341	16316674	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(NCC(N)c3ccc(Cl)c(C(F)(F)F)c3)ncnc12		CHEMBL3670500	=	IC50	nM	1000.0	CHEMBL4722	Homo sapiens	IC50	nM	1000.0
242792	16316848	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	COc1ccc(C(=O)NCc2cccc(Nc3ncnc4c(C(N)=O)cc(O)cc34)c2)cc1		CHEMBL3685232	=	IC50	nM	110.0	CHEMBL4722	Homo sapiens	IC50	nM	110.0
242556	16317371	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	CN(CCO)c1ccc(C(=O)Nc2cccc(CNc3ncnc4c(C(N)=O)cccc34)c2)cn1		CHEMBL3680387	=	IC50	nM	0.69	CHEMBL4722	Homo sapiens	IC50	nM	0.69
242270	16317385	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	CC(C)NC(=O)Nc1cccc(CNc2ncnc3c(C(N)=O)cccc23)c1		CHEMBL3670428	=	IC50	nM	160.0	CHEMBL4722	Homo sapiens	IC50	nM	160.0
242826	16317438	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	COc1ccc(C(=O)Nc2ccc(F)c(CNc3ncnc4c(C(N)=O)cccc34)c2)cc1		CHEMBL3685265	=	IC50	nM	2.9	CHEMBL4722	Homo sapiens	IC50	nM	2.9
242380	16317565	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(NCc3ccccn3)ncnc12		CHEMBL3675351	=	IC50	nM	10000.0	CHEMBL4722	Homo sapiens	IC50	nM	10000.0
242685	16317826	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	CC(C)OC(=O)N(C)CC(Nc1ncnc2c1=CCCC=2C(N)=O)c1cccc(NC(=O)c2ccc(Br)cc2)c1		CHEMBL3680534	=	IC50	nM	5.89	CHEMBL4722	Homo sapiens	IC50	nM	5.89
242523	16317835	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	COc1ccc(COc2cc(C(N)=O)c3ncnc(NC(CN(C)C)c4cccc(F)c4)c3c2)cc1		CHEMBL3675502	=	IC50	nM	27.0	CHEMBL4722	Homo sapiens	IC50	nM	27.0
242736	16317902	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(NCc3cccc(Nc4ccc(C5CCNCC5)cn4)c3)ncnc12		CHEMBL3680585	=	IC50	nM	1.5	CHEMBL4722	Homo sapiens	IC50	nM	1.5
242356	16317929	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	COCCCOc1cc(C(N)=O)c2ncnc(NCc3ccc(C(F)(F)F)cc3)c2c1		CHEMBL3675328	=	IC50	nM	78.0	CHEMBL4722	Homo sapiens	IC50	nM	78.0
242593	16318410	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	COCCC(Nc1ncnc2c(C(N)=O)cccc12)c1cccc(NC(=O)c2cc(C3CC3)n[nH]2)c1		CHEMBL3680430	=	IC50	nM	0.3	CHEMBL4722	Homo sapiens	IC50	nM	0.3
242273	16318518	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(NCc3ccccc3Br)ncnc12		CHEMBL3670431	=	IC50	nM	1500.0	CHEMBL4722	Homo sapiens	IC50	nM	1500.0
242269	16318727	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(NCc3cc(F)cc(F)c3)ncnc12		CHEMBL3670427	=	IC50	nM	0.86	CHEMBL4722	Homo sapiens	IC50	nM	0.86
242698	16318818	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(NCc3cccc(Nc4nccs4)c3)ncnc12		CHEMBL3680548	=	IC50	nM	0.19	CHEMBL4722	Homo sapiens	IC50	nM	0.19
242741	16318857	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(NCc3cccc(NC(=O)c4cccc(N5CCOCC5)c4)c3)ncnc12		CHEMBL3680590	=	IC50	nM	1.8	CHEMBL4722	Homo sapiens	IC50	nM	1.8
242488	16318935	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	CN(CCO)c1cc(C(=O)Nc2cccc(CNc3ncnc4c(C(N)=O)cccc34)c2)ccn1		CHEMBL3675458	=	IC50	nM	1.7	CHEMBL4722	Homo sapiens	IC50	nM	1.7
242703	16318982	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	COc1ccc(C(O)Nc2cccc(CNc3ncnc4c(C(N)=O)cccc34)c2F)cc1		CHEMBL3680553	=	IC50	nM	0.22	CHEMBL4722	Homo sapiens	IC50	nM	0.22
242481	16318990	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	COCCC(Nc1ncnc2c(C(N)=O)cccc12)C1=CCCC(NC(=O)c2ccc(F)cc2F)=C1		CHEMBL3675450	=	IC50	nM	0.52	CHEMBL4722	Homo sapiens	IC50	nM	0.52
242260	16319037	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(NCc3cccs3)ncnc12		CHEMBL3670418	=	IC50	nM	2600.0	CHEMBL4722	Homo sapiens	IC50	nM	2600.0
242681	16319040	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	CC(C)CNc1ccc(C(=O)Nc2cccc(CNc3ncnc4c(C(N)=O)cccc34)c2)cn1		CHEMBL3680530	=	IC50	nM	0.48	CHEMBL4722	Homo sapiens	IC50	nM	0.48
242314	16319194	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(NCc3cccc(NC(=O)c4ccc(F)c(F)c4)c3)ncnc12		CHEMBL3670473	=	IC50	nM	1.1	CHEMBL4722	Homo sapiens	IC50	nM	1.1
242700	16319215	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	COCC[C@@H](Nc1ncnc2c(C(N)=O)cccc12)c1cccc(NC(=O)c2ccc(OC)cc2)c1		CHEMBL3680550	=	IC50	nM	0.21	CHEMBL4722	Homo sapiens	IC50	nM	0.21
242371	16319624	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(NCc3ccc(F)cc3)ncnc12		CHEMBL3675343	=	IC50	nM	92.0	CHEMBL4722	Homo sapiens	IC50	nM	92.0
242446	16319625	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	CN(C)CC(Nc1ncnc2c(C(N)=O)cccc12)c1cccc(NC(=O)c2ccnc(N(C)C)c2)c1		CHEMBL3675418	=	IC50	nM	4.9	CHEMBL4722	Homo sapiens	IC50	nM	4.9
242867	16319934	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	COc1cc(F)c(C(=O)Nc2cccc(CNc3ncnc4c(C(N)=O)cccc34)c2)c(F)c1		CHEMBL3685306	=	IC50	nM	0.11	CHEMBL4722	Homo sapiens	IC50	nM	0.11
242412	16319940	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cc(NS(=O)(=O)c2ccccc2)cc2c(NCc3ccc(Cl)c(C(F)(F)F)c3)ncnc12		CHEMBL3675383	=	IC50	nM	3400.0	CHEMBL4722	Homo sapiens	IC50	nM	3400.0
242597	16320006	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(NCc3ccc(F)c(F)c3)ncnc12		CHEMBL3680434	=	IC50	nM	430.0	CHEMBL4722	Homo sapiens	IC50	nM	430.0
242827	16320014	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(NCc3cccc(NC(=O)c4c(F)cccc4F)c3)ncnc12		CHEMBL3685266	=	IC50	nM	0.31	CHEMBL4722	Homo sapiens	IC50	nM	0.31
242603	16320189	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	CN1CCN(c2ccc(NC(=O)Nc3cccc(CNc4ncnc5c(C(N)=O)cccc45)c3)cc2)CC1		CHEMBL3680440	=	IC50	nM	40.0	CHEMBL4722	Homo sapiens	IC50	nM	40.0
242467	16320214	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	CC(C)c1cc(C(=O)Nc2cccc([C@@H](C)Nc3ncnc4c(C(N)=O)cccc34)c2)[nH]n1		CHEMBL3675439	=	IC50	nM	0.03	CHEMBL4722	Homo sapiens	IC50	nM	0.03
242694	16320309	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	CCOC(=O)c1cnc(Nc2cccc(CNc3ncnc4c(C(N)=O)cccc34)c2)s1		CHEMBL3680544	=	IC50	nM	0.16	CHEMBL4722	Homo sapiens	IC50	nM	0.16
242815	16320548	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(NCc3cccc(NC(=O)C4CCCNC4)c3)ncnc12		CHEMBL3685254	=	IC50	nM	3.0	CHEMBL4722	Homo sapiens	IC50	nM	3.0
242247	16320595	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	Cc1ccc(C(CN)Nc2ncnc3c(C(N)=O)cccc23)cc1		CHEMBL3670404	=	IC50	nM	660.0	CHEMBL4722	Homo sapiens	IC50	nM	660.0
242785	16320622	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	COc1ccc(C(=O)Nc2cccc(CNc3c(C(N)=O)cnc4c(C(N)=O)cccc34)c2)cc1		CHEMBL3685225	=	IC50	nM	36.0	CHEMBL4722	Homo sapiens	IC50	nM	36.0
242552	16320634	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	COCCNC[C@@H](Nc1ncnc2c(C(N)=O)cccc12)c1ccccc1		CHEMBL3675536	=	IC50	nM	790.0	CHEMBL4722	Homo sapiens	IC50	nM	790.0
242613	16320707	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	CNCCOc1cccc(C(=O)Nc2cccc(CNc3ncnc4c(C(N)=O)cccc34)c2)c1		CHEMBL3680451	=	IC50	nM	20.0	CHEMBL4722	Homo sapiens	IC50	nM	20.0
242623	16320869	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(NCc3cccc(NC(=O)c4ccnc(N5CCCCC5)c4)c3)ncnc12		CHEMBL3680464	=	IC50	nM	0.89	CHEMBL4722	Homo sapiens	IC50	nM	0.89
242516	16320912	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	COCCC(Nc1ncnc2c(C(N)=O)cccc12)c1cccc(NC(=O)c2cccc(F)c2F)c1		CHEMBL3675492	=	IC50	nM	1.2	CHEMBL4722	Homo sapiens	IC50	nM	1.2
242511	16321285	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	CCC(Nc1ncnc2c(C(N)=O)cccc12)c1cccc(NC(=O)c2ccc(C(F)(F)F)nc2)c1		CHEMBL3675487	=	IC50	nM	1.1	CHEMBL4722	Homo sapiens	IC50	nM	1.1
242286	16321614	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(NCc3cccc(C(=O)Nc4ccccc4)c3)ncnc12		CHEMBL3670444	=	IC50	nM	9100.0	CHEMBL4722	Homo sapiens	IC50	nM	9100.0
242320	16321617	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	COc1ccc(CC(=O)Nc2cccc(CNc3ncnc4c(C(N)=O)cccc34)c2)cc1		CHEMBL3670480	=	IC50	nM	2100.0	CHEMBL4722	Homo sapiens	IC50	nM	2100.0
242631	16321651	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	COc1ccc(C(=O)Nc2cccc(C(CCN(C)C)Nc3ncnc4c(C(N)=O)cccc34)c2)cc1		CHEMBL3680476	=	IC50	nM	0.81	CHEMBL4722	Homo sapiens	IC50	nM	0.81
242522	16321798	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	Cc1ccc(C(=O)Nc2cccc(C(C)Nc3ncnc4c(C(N)=O)cccc34)c2)cn1		CHEMBL3675501	=	IC50	nM	0.85	CHEMBL4722	Homo sapiens	IC50	nM	0.85
242751	16322112	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	CCC(Nc1ncnc2c(C(N)=O)cccc12)c1cccc(NC(=O)C2CC2(F)F)c1		CHEMBL3680599	=	IC50	nM	2.5	CHEMBL4722	Homo sapiens	IC50	nM	2.5
242786	16322126	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(Nc3cccc(CNC(=O)C4CCCNC4)c3)ncnc12		CHEMBL3685226	=	IC50	nM	40.0	CHEMBL4722	Homo sapiens	IC50	nM	40.0
242531	16322282	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(NCc3cccc(NC(=O)C4=CC(F)C(Cl)C=C4)c3)ncnc12		CHEMBL3675510	=	IC50	nM	0.35	CHEMBL4722	Homo sapiens	IC50	nM	0.35
242810	16322507	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(NCc3cccc(NC(=O)c4ccc5c(c4)OC(F)(F)O5)c3)ncnc12		CHEMBL3639841	=	IC50	nM	0.06	CHEMBL4722	Homo sapiens	IC50	nM	0.06
242344	16322726	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	COCCN(C)CCCOc1cc(C(N)=O)c2ncnc(NCc3ccc(C(F)(F)F)cc3)c2c1		CHEMBL3670504	=	IC50	nM	3.5	CHEMBL4722	Homo sapiens	IC50	nM	3.5
242591	16322786	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	COCCC(Nc1ncnc2c(C(N)=O)cccc12)c1cccc(NC(=O)c2ccc(OC)cc2F)c1		CHEMBL3680428	=	IC50	nM	0.18	CHEMBL4722	Homo sapiens	IC50	nM	0.18
242874	16322956	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc(-c2cc(C(N)=O)c3ncnc(N[C@H]4CCCNC4)c3c2)c1		CHEMBL3685320	=	IC50	nM	740.0	CHEMBL4722	Homo sapiens	IC50	nM	740.0
242808	16323037	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(NCc3cccc(NC(=O)C4CCCCC4)c3)ncnc12		CHEMBL3685248	=	IC50	nM	0.16	CHEMBL4722	Homo sapiens	IC50	nM	0.16
242318	16323473	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(NCc3cccc(NC(=O)Cc4ccc(Cl)cc4)c3)ncnc12		CHEMBL3670478	=	IC50	nM	8.4	CHEMBL4722	Homo sapiens	IC50	nM	8.4
242822	16323502	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	N#Cc1ccc(C(=O)Nc2cccc(CNc3ncnc4c(C(N)=O)cccc34)c2)cc1		CHEMBL3685261	=	IC50	nM	0.63	CHEMBL4722	Homo sapiens	IC50	nM	0.63
242647	16323585	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	CN1CCN(c2ccc(C(=O)Nc3cccc(CNc4nncc5c(C(N)=O)cccc45)c3)cc2C(F)(F)F)CC1		CHEMBL3680492	=	IC50	nM	3.4	CHEMBL4722	Homo sapiens	IC50	nM	3.4
242662	16324200	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	CNC[C@H](Cc1ccccc1)Nc1ncnc2c(C(N)=O)cccc12		CHEMBL3680510	=	IC50	nM	1000.0	CHEMBL4722	Homo sapiens	IC50	nM	1000.0
242296	16324323	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cc(N)cc2c(NCc3ccccc3)ncnc12		CHEMBL3670455	=	IC50	nM	140.0	CHEMBL4722	Homo sapiens	IC50	nM	140.0
242276	16324432	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(NCc3cccc(NC(=O)NC(=O)c4ccccc4)c3)ncnc12		CHEMBL3670434	=	IC50	nM	830.0	CHEMBL4722	Homo sapiens	IC50	nM	830.0
242532	16324525	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	COCCC(Nc1ncnc2c(C(N)=O)cccc12)C1=CCCC(NC(=O)c2cc(F)ccc2F)=C1		CHEMBL3675511	=	IC50	nM	0.63	CHEMBL4722	Homo sapiens	IC50	nM	0.63
242612	16324966	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	COCCCOC1C=C(C(=O)Nc2cccc(CNc3ncnc4c(C(N)=O)cccc34)c2)C=CC1		CHEMBL3680450	=	IC50	nM	4.5	CHEMBL4722	Homo sapiens	IC50	nM	4.5
242819	16324984	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(NCc3cccc(NC(=O)c4cccc(OC(F)(F)F)c4)c3)ncnc12		CHEMBL3685258	=	IC50	nM	0.72	CHEMBL4722	Homo sapiens	IC50	nM	0.72
242696	16325291	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(NCc3cccc(NC(=O)c4ccc5cc[nH]c5c4)c3)ncnc12		CHEMBL3680546	=	IC50	nM	0.17	CHEMBL4722	Homo sapiens	IC50	nM	0.17
242533	16325293	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	CC(Nc1ncnc2c(C(N)=O)cccc12)c1cccc(NC(=O)c2cccc(F)c2)c1		CHEMBL3675512	=	IC50	nM	0.94	CHEMBL4722	Homo sapiens	IC50	nM	0.94
242571	16325326	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(NCc3cccc(NC(=O)c4ccc(Cl)c(Cl)c4)c3)ncnc12		CHEMBL3680403	=	IC50	nM	0.29	CHEMBL4722	Homo sapiens	IC50	nM	0.29
242769	16325688	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	Cc1nc2ccnc(Nc3cccc(CNc4ncnc5c(C(N)=O)cccc45)c3)c2[nH]1		CHEMBL3685209	=	IC50	nM	8.6	CHEMBL4722	Homo sapiens	IC50	nM	8.6
242456	16325725	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	CNCC(Nc1ncnc2c(C(N)=O)cccc12)c1cccc(NC(=O)c2ccc(OC)cc2F)c1		CHEMBL3675427	=	IC50	nM	0.34	CHEMBL4722	Homo sapiens	IC50	nM	0.34
242859	16325998	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cc(OCCN2CCOCC2)cc2c(NCc3cccc(NC(=O)c4ccnc(N5CCCC5)c4)c3)ncnc12		CHEMBL3685298	=	IC50	nM	12.0	CHEMBL4722	Homo sapiens	IC50	nM	12.0
242811	16326321	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(NCc3cccc(NC(=O)c4ccc(C(F)(F)F)nc4)c3)ncnc12		CHEMBL3685250	=	IC50	nM	0.11	CHEMBL4722	Homo sapiens	IC50	nM	0.11
242429	16326440	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	CN(C)CC(Nc1ncnc2c(C(N)=O)cccc12)c1cccc(NC(=O)c2ccc(C(F)(F)F)cc2)c1		CHEMBL3675401	=	IC50	nM	0.26	CHEMBL4722	Homo sapiens	IC50	nM	0.26
242855	16326522	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	COc1ccc(C(=O)Nc2cccc(C(CCN3CCCCC3)Nc3ncnc4c(C(N)=O)cccc34)c2)cc1		CHEMBL3685294	=	IC50	nM	1.8	CHEMBL4722	Homo sapiens	IC50	nM	1.8
242668	16326523	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(NCc3cccc(NC(=O)c4c[nH]c5ccccc45)c3)ncnc12		CHEMBL3680517	=	IC50	nM	3.4	CHEMBL4722	Homo sapiens	IC50	nM	3.4
311288	16326646	CHEMBL3705895	Radioactive Assay: The capacity to inhibit the kinase activity of the enzyme is estimated by measuring the residual kinase activity of the enzyme in the presence of different concentrations of the test compound (generally from 0.17 to 10 000 nM). A dose-response curve is produced, which allows an IC50 (50% inhibitory concentration) to be determined. The kinase activity is measured by a radioactive assay of the amount of radioactive phosphate (33P) incorporated into a fragment of the protein NuMA (Nuclear Mitotic Apparatus protein) after 30 minutes of incubation at 37Â° C. The test compound is first dissolved at different concentrations in dimethyl sulphoxide (DMS (J). Reaction takes place in the wells of a FlashPlate microtiter plate (Nickel Chelate FlashPlate-96, PerkinElmer). Each well (100 Î¼l) contains 10 nM Aurora A, 500 nM NuMA, 1 Î¼M ATP and 0.2 Î¼Ci ATP-Î³-33P in a buffer of 50 mM Tris-HCl, pH=7.5; 10 mM MgCl2; 50 mM NaCl, 1 mM dithiothreitol. The final percentage of DMSO is 3%.	B	CCc1[nH]cc2c1NC1=C(C(=O)CCC1)C2c1cccc(Sc2nc3ccccc3[nH]2)c1		CHEMBL3663734	=	IC50	nM	72.0	CHEMBL4722	Homo sapiens	IC50	nM	72.0
311293	16326867	CHEMBL3705895	Radioactive Assay: The capacity to inhibit the kinase activity of the enzyme is estimated by measuring the residual kinase activity of the enzyme in the presence of different concentrations of the test compound (generally from 0.17 to 10 000 nM). A dose-response curve is produced, which allows an IC50 (50% inhibitory concentration) to be determined. The kinase activity is measured by a radioactive assay of the amount of radioactive phosphate (33P) incorporated into a fragment of the protein NuMA (Nuclear Mitotic Apparatus protein) after 30 minutes of incubation at 37Â° C. The test compound is first dissolved at different concentrations in dimethyl sulphoxide (DMS (J). Reaction takes place in the wells of a FlashPlate microtiter plate (Nickel Chelate FlashPlate-96, PerkinElmer). Each well (100 Î¼l) contains 10 nM Aurora A, 500 nM NuMA, 1 Î¼M ATP and 0.2 Î¼Ci ATP-Î³-33P in a buffer of 50 mM Tris-HCl, pH=7.5; 10 mM MgCl2; 50 mM NaCl, 1 mM dithiothreitol. The final percentage of DMSO is 3%.	B	CCc1[nH]cc2c1NC1=C(C(=O)CNC1)C2c1cccc(Sc2nc3ccccc3[nH]2)c1		CHEMBL3663739	=	IC50	nM	15.0	CHEMBL4722	Homo sapiens	IC50	nM	15.0
242411	16327003	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	CC(=O)Nc1cc(C(N)=O)c2ncnc(NCc3ccc(Cl)c(C(F)(F)F)c3)c2c1		CHEMBL3675382	=	IC50	nM	3600.0	CHEMBL4722	Homo sapiens	IC50	nM	3600.0
242365	16327289	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(NCc3cccc(F)c3)ncnc12		CHEMBL3675337	=	IC50	nM	760.0	CHEMBL4722	Homo sapiens	IC50	nM	760.0
242656	16327425	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	CC(C)c1csc(C(=O)Nc2cccc([C@@H](C)Nc3ncnc4c(C(N)=O)cccc34)c2)n1		CHEMBL3680504	=	IC50	nM	0.78	CHEMBL4722	Homo sapiens	IC50	nM	0.78
242392	16327682	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(NCc3cccc(O)c3)ncnc12		CHEMBL3675363	=	IC50	nM	1900.0	CHEMBL4722	Homo sapiens	IC50	nM	1900.0
242629	16327717	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	CC(Nc1ncnc2c(C(N)=O)cccc12)c1cccc(NC(=O)c2cc[n+]([O-])cc2)c1		CHEMBL3680471	=	IC50	nM	17.0	CHEMBL4722	Homo sapiens	IC50	nM	17.0
242310	16327804	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(NCc3cccc(NC(=O)c4ccc(OC(F)(F)F)cc4)c3)ncnc12		CHEMBL3670469	=	IC50	nM	1900.0	CHEMBL4722	Homo sapiens	IC50	nM	1900.0
242742	16327924	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	C[C@@H](Nc1ncnc2c(C(N)=O)cccc12)c1cccc(Nc2ccc(C(F)(F)F)cn2)c1		CHEMBL3680591	=	IC50	nM	2.0	CHEMBL4722	Homo sapiens	IC50	nM	2.0
242794	16328152	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	Cc1ccnc(Nc2cccc(C(C)Nc3ncnc4c(C(N)=O)cccc34)c2)c1		CHEMBL3685234	=	IC50	nM	0.39	CHEMBL4722	Homo sapiens	IC50	nM	0.39
242500	16328557	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	CC(Nc1ncnc2c(C(N)=O)cccc12)c1cccc(NC(=O)c2ccc(Br)c(F)c2)c1		CHEMBL3675474	=	IC50	nM	0.21	CHEMBL4722	Homo sapiens	IC50	nM	0.21
242271	16328560	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	CS(=O)(=O)c1ccc(CNc2ncnc3c(C(N)=O)cccc23)cc1		CHEMBL3670429	=	IC50	nM	580.0	CHEMBL4722	Homo sapiens	IC50	nM	580.0
242575	16328578	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	CN(C)CCC(Nc1ncnc2c(C(N)=O)cccc12)c1cccc([N+](=O)[O-])c1		CHEMBL3680407	=	IC50	nM	1600.0	CHEMBL4722	Homo sapiens	IC50	nM	1600.0
242445	16328695	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	CN(C)CC(Nc1ncnc2c(C(N)=O)cccc12)c1cccc(NC(=O)c2ccc(C(F)(F)F)cc2F)c1		CHEMBL3675417	=	IC50	nM	0.25	CHEMBL4722	Homo sapiens	IC50	nM	0.25
242434	16328855	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	CN(C)CC(Nc1ncnc2c(C(N)=O)cccc12)c1cccc(NC(=O)c2ccnc(N3CCCC3)c2)c1		CHEMBL3675406	=	IC50	nM	0.27	CHEMBL4722	Homo sapiens	IC50	nM	0.27
242679	16328913	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	COCCNc1ccc(C(=O)Nc2cccc(CNc3ncnc4c(C(N)=O)cccc34)c2)cn1		CHEMBL3680528	=	IC50	nM	0.66	CHEMBL4722	Homo sapiens	IC50	nM	0.66
242414	16329375	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cc(NC(=O)c2ccncc2)cc2c(NCc3ccc(Cl)c(C(F)(F)F)c3)ncnc12		CHEMBL3675385	=	IC50	nM	950.0	CHEMBL4722	Homo sapiens	IC50	nM	950.0
242346	16329475	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cc(OCCCN2CCOCC2)cc2c(NCc3ccc(C(F)(F)F)cc3)ncnc12		CHEMBL3670506	=	IC50	nM	88.0	CHEMBL4722	Homo sapiens	IC50	nM	88.0
242764	16330053	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(NCc3cccc(Nc4ncnc5nc[nH]c45)c3)ncnc12		CHEMBL3685204	=	IC50	nM	7.0	CHEMBL4722	Homo sapiens	IC50	nM	7.0
242561	16330378	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(NCc3cccc(NC(=O)c4ccnc(N5CCCC5)c4)c3)ncnc12		CHEMBL3680392	=	IC50	nM	1.8	CHEMBL4722	Homo sapiens	IC50	nM	1.8
242258	16330479	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	COc1cc(CNc2cncc3c(C(N)=O)cccc23)cc(OC)c1		CHEMBL3670416	=	IC50	nM	7.2	CHEMBL4722	Homo sapiens	IC50	nM	7.2
242654	16330669	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	CN(C[C@@H](Nc1ncnc2c1=CCCC=2C(N)=O)c1ccccc1)C1CC1		CHEMBL3680501	=	IC50	nM	150.0	CHEMBL4722	Homo sapiens	IC50	nM	150.0
242846	16330704	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	CC(Nc1ncnc2c(C(N)=O)cccc12)c1cccc(NC(=O)c2ccc(CN3CCCC3)cc2)c1		CHEMBL3685285	=	IC50	nM	4.0	CHEMBL4722	Homo sapiens	IC50	nM	4.0
242795	16330738	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	C[C@@H](Nc1ncnc2c(C(N)=O)cccc12)c1ccc(F)c(NC(=O)c2ccc(OC(F)(F)F)cc2)c1		CHEMBL3685235	=	IC50	nM	0.44	CHEMBL4722	Homo sapiens	IC50	nM	0.44
242279	16330756	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(N[C@@H]3CCCc4ccccc43)ncnc12		CHEMBL3670437	=	IC50	nM	7900.0	CHEMBL4722	Homo sapiens	IC50	nM	7900.0
242796	16330789	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	C[C@@H](Nc1ncnc2c(C(N)=O)cccc12)c1cccc(NC(=O)c2nc(C(C)(C)C)cs2)c1		CHEMBL3685236	=	IC50	nM	1.31	CHEMBL4722	Homo sapiens	IC50	nM	1.31
242353	16330952	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cc(OCCCNCCO)cc2c(NCc3ccc(C(F)(F)F)cc3)ncnc12		CHEMBL3675325	=	IC50	nM	5.8	CHEMBL4722	Homo sapiens	IC50	nM	5.8
242486	16330998	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	CNCC(Nc1ncnc2c(C(N)=O)cc(OCc3ccccc3)cc12)c1cccc(Cl)c1		CHEMBL3675456	=	IC50	nM	300.0	CHEMBL4722	Homo sapiens	IC50	nM	300.0
242491	16331011	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	COc1cc(C(=O)Nc2cccc([C@@H](C)Nc3ncnc4c(C(N)=O)cccc34)c2)ccn1		CHEMBL3675463	=	IC50	nM	0.22	CHEMBL4722	Homo sapiens	IC50	nM	0.22
311291	16331041	CHEMBL3705895	Radioactive Assay: The capacity to inhibit the kinase activity of the enzyme is estimated by measuring the residual kinase activity of the enzyme in the presence of different concentrations of the test compound (generally from 0.17 to 10 000 nM). A dose-response curve is produced, which allows an IC50 (50% inhibitory concentration) to be determined. The kinase activity is measured by a radioactive assay of the amount of radioactive phosphate (33P) incorporated into a fragment of the protein NuMA (Nuclear Mitotic Apparatus protein) after 30 minutes of incubation at 37Â° C. The test compound is first dissolved at different concentrations in dimethyl sulphoxide (DMS (J). Reaction takes place in the wells of a FlashPlate microtiter plate (Nickel Chelate FlashPlate-96, PerkinElmer). Each well (100 Î¼l) contains 10 nM Aurora A, 500 nM NuMA, 1 Î¼M ATP and 0.2 Î¼Ci ATP-Î³-33P in a buffer of 50 mM Tris-HCl, pH=7.5; 10 mM MgCl2; 50 mM NaCl, 1 mM dithiothreitol. The final percentage of DMSO is 3%.	B	CCc1[nH]cc2c1NC1=C(C(=O)CC(C)(C)C1)C2c1cccc(Oc2nc3ccccc3[nH]2)c1		CHEMBL3663737	=	IC50	nM	3.0	CHEMBL4722	Homo sapiens	IC50	nM	3.0
242616	16331058	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	COc1ccc(C(=O)Nc2cccc(C(CCN(C)C(=O)OC(C)(C)C)Nc3ncnc4c(C(N)=O)cccc34)c2)cc1		CHEMBL3680456	=	IC50	nM	1.0	CHEMBL4722	Homo sapiens	IC50	nM	1.0
242366	16331070	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	COc1ccc(CCNc2ncnc3c(C(N)=O)cccc23)cc1		CHEMBL3675338	=	IC50	nM	10000.0	CHEMBL4722	Homo sapiens	IC50	nM	10000.0
242678	16331078	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	C[C@@H](Nc1ncnc2c(C(N)=O)cccc12)c1cccc(NC(=O)N2CCC(F)(F)C2)c1		CHEMBL3680527	=	IC50	nM	0.72	CHEMBL4722	Homo sapiens	IC50	nM	0.72
242732	16331128	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	CN1CCN(CCC(Nc2ncnc3c(C(N)=O)cccc23)c2cccc(NC(=O)c3cc(C4CC4)n[nH]3)c2)CC1		CHEMBL3680581	=	IC50	nM	1.3	CHEMBL4722	Homo sapiens	IC50	nM	1.3
242706	16331188	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(NCc3cccc(NC(=O)c4ccc(-c5ncc[nH]5)cc4)c3)ncnc12		CHEMBL3680556	=	IC50	nM	0.29	CHEMBL4722	Homo sapiens	IC50	nM	0.29
242643	16331259	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	C[C@@H](Nc1ncnc2c(C(N)=O)cccc12)c1cccc(NC(=O)C2CCCC2)c1		CHEMBL3680488	=	IC50	nM	0.12	CHEMBL4722	Homo sapiens	IC50	nM	0.12
242843	16331460	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(NC(CCN3CCCCC3)c3cccc(NC(=O)c4cc(C(F)(F)F)ccc4F)c3)ncnc12		CHEMBL3685282	=	IC50	nM	0.39	CHEMBL4722	Homo sapiens	IC50	nM	0.39
242649	16331517	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(NCc3cccc(NC(=O)c4ccnc(NCCO)c4)c3)ncnc12		CHEMBL3680497	=	IC50	nM	4.4	CHEMBL4722	Homo sapiens	IC50	nM	4.4
242525	16331538	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	CN(C)CCC(Nc1ncnc2c(C(N)=O)cccc12)C1=CCCC(NC(=O)c2cccc(F)c2F)=C1		CHEMBL3675504	=	IC50	nM	3.9	CHEMBL4722	Homo sapiens	IC50	nM	3.9
242440	16331705	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	CNCC(Nc1ncnc2c(C(N)=O)cccc12)c1cccc(NC(=O)c2ccccc2)c1		CHEMBL3675412	=	IC50	nM	0.74	CHEMBL4722	Homo sapiens	IC50	nM	0.74
242598	16331740	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	C=[N+]([O-])c1cccc(C(COC)Nc2ncnc3c(C(N)=O)cccc23)c1		CHEMBL3680435	=	IC50	nM	550.0	CHEMBL4722	Homo sapiens	IC50	nM	550.0
242559	16331858	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)C1=c2ncnc(NC(CCN3CCCC3)c3cccc(NC(=O)c4ccc(Br)cc4)c3)c2=CCC1		CHEMBL3680390	=	IC50	nM	1.0	CHEMBL4722	Homo sapiens	IC50	nM	1.0
242823	16331979	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(NCc3cccc(NC(=O)c4ccc(Cl)cc4)c3)ncnc12		CHEMBL3685262	=	IC50	nM	0.08	CHEMBL4722	Homo sapiens	IC50	nM	0.08
242475	16332009	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	CN(C)CCC(Nc1ncnc2c(C(N)=O)cccc12)c1cccc(NC(=O)c2ccc(F)cc2F)c1		CHEMBL3675445	=	IC50	nM	2.3	CHEMBL4722	Homo sapiens	IC50	nM	2.3
242812	16332280	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(NCc3cccc(NC(=O)c4cccc(Br)c4)c3)ncnc12		CHEMBL3685251	=	IC50	nM	0.54	CHEMBL4722	Homo sapiens	IC50	nM	0.54
242376	16332338	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(NC3CCc4ccccc43)ncnc12		CHEMBL3675348	=	IC50	nM	4300.0	CHEMBL4722	Homo sapiens	IC50	nM	4300.0
242494	16332484	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	CN(CC(Nc1ncnc2c(C(N)=O)cccc12)c1cccc(NC(=O)c2ccccc2)c1)C(=O)OC(C)(C)C		CHEMBL3675467	=	IC50	nM	13.0	CHEMBL4722	Homo sapiens	IC50	nM	13.0
242401	16332669	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(NCc3ccc(NC(=O)Nc4ccccc4)cc3)ncnc12		CHEMBL3675372	=	IC50	nM	410.0	CHEMBL4722	Homo sapiens	IC50	nM	410.0
242468	16332861	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	COc1cccc(C(CN)Nc2ncnc3c(C(N)=O)cccc23)c1		CHEMBL3670411	=	IC50	nM	770.0	CHEMBL4722	Homo sapiens	IC50	nM	770.0
242844	16333135	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	C[C@@H](Nc1ncnc2c(C(N)=O)cccc12)c1cccc(N)c1		CHEMBL3685283	=	IC50	nM	20.0	CHEMBL4722	Homo sapiens	IC50	nM	20.0
242492	16333145	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	CC(Nc1ncnc2c(C(N)=O)cccc12)c1cccc(NC(=O)c2cc(C(C)(C)C)n[nH]2)c1		CHEMBL3675465	=	IC50	nM	0.08	CHEMBL4722	Homo sapiens	IC50	nM	0.08
242449	16333249	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	CN(C)CC(Nc1ncnc2c(C(N)=O)cccc12)c1cccc(Cl)c1		CHEMBL3675421	=	IC50	nM	380.0	CHEMBL4722	Homo sapiens	IC50	nM	380.0
242772	16333335	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(NCc3cccc(Nc4ncccn4)c3)ncnc12		CHEMBL3685212	=	IC50	nM	11.0	CHEMBL4722	Homo sapiens	IC50	nM	11.0
242626	16333383	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cc(O)cc2c(NCc3cccc(NC(=O)c4ccnc(N5CCCC5)c4)c3)ncnc12		CHEMBL3680468	=	IC50	nM	2.3	CHEMBL4722	Homo sapiens	IC50	nM	2.3
242576	16333428	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(NCc3cccc(NC(=O)c4cccc(OCCCO)c4)c3)ncnc12		CHEMBL3680410	=	IC50	nM	2.7	CHEMBL4722	Homo sapiens	IC50	nM	2.7
242469	16333436	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	CN(CC(Nc1ncnc2c(C(N)=O)cccc12)c1cccc([N+](=O)[O-])c1)C(=O)OC(C)(C)C		CHEMBL3675440	=	IC50	nM	1000.0	CHEMBL4722	Homo sapiens	IC50	nM	1000.0
242372	16333438	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(NCc3cccc(C(F)(F)F)c3)ncnc12		CHEMBL3675344	=	IC50	nM	580.0	CHEMBL4722	Homo sapiens	IC50	nM	580.0
242572	16333628	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(NCc3cccc(NC(=O)c4ccnc(N5CCOCC5)c4)c3)ncnc12		CHEMBL3680404	=	IC50	nM	1.1	CHEMBL4722	Homo sapiens	IC50	nM	1.1
242760	16333670	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(NCC3C=C(NC(=O)c4ccncc4)C=CC3)ncnc12		CHEMBL3685200	=	IC50	nM	5.5	CHEMBL4722	Homo sapiens	IC50	nM	5.5
242329	16333699	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	COc1ccc(OC)c(CNc2ncnc3c(C(N)=O)cccc23)c1		CHEMBL3670489	=	IC50	nM	341.0	CHEMBL4722	Homo sapiens	IC50	nM	341.0
242586	16333997	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	CCn1nc(C(F)(F)F)cc1C(=O)Nc1cccc(C(C)Nc2ncnc3c(C(N)=O)cccc23)c1		CHEMBL3680421	=	IC50	nM	2.9	CHEMBL4722	Homo sapiens	IC50	nM	2.9
242249	16334203	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(N[C@H]3CCCNC3)ncnc12		CHEMBL3670407	=	IC50	nM	4300.0	CHEMBL4722	Homo sapiens	IC50	nM	4300.0
242713	16334321	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	COc1cnc(C(=O)Nc2cccc([C@@H](C)Nc3ncnc4c(C(N)=O)cccc34)c2)cn1		CHEMBL3680563	=	IC50	nM	0.51	CHEMBL4722	Homo sapiens	IC50	nM	0.51
242540	16334368	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	COCC(Nc1ncnc2c(C(N)=O)cccc12)c1cccc(NC(=O)c2ccc(OC)cc2)c1		CHEMBL3675519	=	IC50	nM	0.97	CHEMBL4722	Homo sapiens	IC50	nM	0.97
242312	16334520	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(NCc3cccc(NC(=O)c4ccc5c(c4)OCO5)c3)ncnc12		CHEMBL3670471	=	IC50	nM	0.51	CHEMBL4722	Homo sapiens	IC50	nM	0.51
242536	16334583	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	CNCC(Nc1ncnc2c(C(N)=O)cccc12)c1ccccc1		CHEMBL3670413	=	IC50	nM	2500.0	CHEMBL4722	Homo sapiens	IC50	nM	2500.0
242501	16334642	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	COCC(Nc1ncnc2c(C(N)=O)cccc12)c1cccc(NC(=O)c2ccccc2)c1		CHEMBL3675475	=	IC50	nM	0.39	CHEMBL4722	Homo sapiens	IC50	nM	0.39
242367	16334995	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(NCc3ccc(Cl)c(Cl)c3)ncnc12		CHEMBL3675339	=	IC50	nM	130.0	CHEMBL4722	Homo sapiens	IC50	nM	130.0
242683	16335010	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	COc1ccc(C(=O)Nc2cccc(CNc3ncnc4c(C(N)=O)cccc34)c2)cc1C(F)(F)F		CHEMBL3680532	=	IC50	nM	0.12	CHEMBL4722	Homo sapiens	IC50	nM	0.12
242858	16335154	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	COc1ccc(C(=O)Nc2cccc(CNc3ncnc4c(C(N)=O)cc(OCCCN(C)C)cc34)c2)cc1		CHEMBL3685297	=	IC50	nM	1.1	CHEMBL4722	Homo sapiens	IC50	nM	1.1
242422	16335399	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	CNCC(Nc1ncnc2c(C(N)=O)cc(OC)cc12)c1ccccc1		CHEMBL3675393	=	IC50	nM	230.0	CHEMBL4722	Homo sapiens	IC50	nM	230.0
242280	16335414	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(N[C@H]3c4ccccc4C[C@H]3O)ncnc12		CHEMBL3670438	=	IC50	nM	4600.0	CHEMBL4722	Homo sapiens	IC50	nM	4600.0
242498	16335430	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	CCOc1cc(C(N)=O)c2ncnc(NC(CN(C)C)c3cccc(F)c3)c2c1		CHEMBL3675471	=	IC50	nM	98.0	CHEMBL4722	Homo sapiens	IC50	nM	98.0
242413	16335436	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cc(NC(=O)Nc2ccccc2)cc2c(NCc3ccc(Cl)c(C(F)(F)F)c3)ncnc12		CHEMBL3675384	=	IC50	nM	6800.0	CHEMBL4722	Homo sapiens	IC50	nM	6800.0
242782	16335665	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	CC(C)N1CCC(C(=O)Nc2cccc(CNC3=NC=NC4C(C(N)=O)=CCC=C34)c2)CC1		CHEMBL3685222	=	IC50	nM	32.0	CHEMBL4722	Homo sapiens	IC50	nM	32.0
242340	16335824	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cc(O)cc2c(NCc3ccc(C(F)(F)F)cc3)ncnc12		CHEMBL3670499	=	IC50	nM	0.32	CHEMBL4722	Homo sapiens	IC50	nM	0.32
242834	16335956	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	CN1CCN(c2ccc(C(=O)Nc3cccc(CNc4ncnc5c(C(N)=O)cccc45)c3)cc2)CC1		CHEMBL3685273	=	IC50	nM	12.0	CHEMBL4722	Homo sapiens	IC50	nM	12.0
242604	16335995	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(N3CCc4ccc([N+](=O)[O-])cc4C3)ncnc12		CHEMBL3680441	=	IC50	nM	690.0	CHEMBL4722	Homo sapiens	IC50	nM	690.0
242699	16336104	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(NCc3cccc(NC(=O)c4cn[nH]c4N)c3)ncnc12		CHEMBL3680549	=	IC50	nM	0.19	CHEMBL4722	Homo sapiens	IC50	nM	0.19
311296	16336379	CHEMBL3705895	Radioactive Assay: The capacity to inhibit the kinase activity of the enzyme is estimated by measuring the residual kinase activity of the enzyme in the presence of different concentrations of the test compound (generally from 0.17 to 10 000 nM). A dose-response curve is produced, which allows an IC50 (50% inhibitory concentration) to be determined. The kinase activity is measured by a radioactive assay of the amount of radioactive phosphate (33P) incorporated into a fragment of the protein NuMA (Nuclear Mitotic Apparatus protein) after 30 minutes of incubation at 37Â° C. The test compound is first dissolved at different concentrations in dimethyl sulphoxide (DMS (J). Reaction takes place in the wells of a FlashPlate microtiter plate (Nickel Chelate FlashPlate-96, PerkinElmer). Each well (100 Î¼l) contains 10 nM Aurora A, 500 nM NuMA, 1 Î¼M ATP and 0.2 Î¼Ci ATP-Î³-33P in a buffer of 50 mM Tris-HCl, pH=7.5; 10 mM MgCl2; 50 mM NaCl, 1 mM dithiothreitol. The final percentage of DMSO is 3%.	B	CCOC(=O)c1[nH]cc2c1NC1=C(C(=O)CCC1)[C@@H]2c1ccc(Sc2nc3ccccc3[nH]2)o1		CHEMBL3663741	=	IC50	nM	4.0	CHEMBL4722	Homo sapiens	IC50	nM	4.0
242288	16336728	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	CNC(=O)c1cccc(CNc2ncnc3c(C(N)=O)cccc23)c1		CHEMBL3670446	=	IC50	nM	1200.0	CHEMBL4722	Homo sapiens	IC50	nM	1200.0
242793	16336960	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	C[C@@H](Nc1ncnc2c(C(N)=O)cccc12)c1cccc(NC(=O)c2ccc(-n3cccc3)cc2)c1		CHEMBL3685233	=	IC50	nM	0.25	CHEMBL4722	Homo sapiens	IC50	nM	0.25
242687	16337077	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NCCOc1ccc(C(N)=O)c2ncnc(NCc3cccc(F)c3)c12		CHEMBL3680536	=	IC50	nM	1000.0	CHEMBL4722	Homo sapiens	IC50	nM	1000.0
242374	16337139	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(N3CCOCC3)ncnc12		CHEMBL3675346	=	IC50	nM	7400.0	CHEMBL4722	Homo sapiens	IC50	nM	7400.0
242455	16337147	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NCC(Nc1ncnc2c(C(N)=O)cccc12)c1cccc(NC(=O)c2ccc(F)cc2)c1		CHEMBL3670412	=	IC50	nM	1.2	CHEMBL4722	Homo sapiens	IC50	nM	1.2
242510	16337426	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	CC(Nc1ncnc2c(C(N)=O)cccc12)c1cccc(NC(=O)c2ccc(C#N)c(F)c2)c1		CHEMBL3675486	=	IC50	nM	0.46	CHEMBL4722	Homo sapiens	IC50	nM	0.46
242554	16337434	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	COCCC(Nc1ncnc2c(C(N)=O)cccc12)c1cccc(NC(=O)c2ccc(F)c(F)c2)c1		CHEMBL3675538	=	IC50	nM	0.2	CHEMBL4722	Homo sapiens	IC50	nM	0.2
242774	16338568	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(NC(CCN3CCCCC3)c3cccc(Nc4ccccn4)c3)ncnc12		CHEMBL3685214	=	IC50	nM	15.0	CHEMBL4722	Homo sapiens	IC50	nM	15.0
242268	16338615	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(NCc3cccc(NC(=O)Nc4ccc(F)cc4)c3)ncnc12		CHEMBL3670426	=	IC50	nM	4900.0	CHEMBL4722	Homo sapiens	IC50	nM	4900.0
242799	16338659	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	CCN(CC)CCOc1cc(C(N)=O)c2ncnc(NCc3cccc(NC(=O)c4ccc(OC)cc4)c3)c2c1		CHEMBL3685239	=	IC50	nM	4.8	CHEMBL4722	Homo sapiens	IC50	nM	4.8
242482	16338995	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	CN(C)CC(Nc1ncnc2c(C(N)=O)cccc12)c1cccc([N+](=O)[O-])c1		CHEMBL3675451	=	IC50	nM	1000.0	CHEMBL4722	Homo sapiens	IC50	nM	1000.0
242505	16339060	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	COc1ccc(C(=O)Nc2cccc(C(CN(C)C(=O)OC(C)(C)C)Nc3ncnc4c(C(N)=O)cccc34)c2)c(F)c1		CHEMBL3675481	=	IC50	nM	2.2	CHEMBL4722	Homo sapiens	IC50	nM	2.2
242674	16339099	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	COCCNc1cc(C(=O)Nc2cccc(CNc3ncnc4c(C(N)=O)cccc34)c2)ccn1		CHEMBL3680523	=	IC50	nM	7.1	CHEMBL4722	Homo sapiens	IC50	nM	7.1
242402	16339176	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cc([N+](=O)[O-])cc2c(NCc3cccc(C(F)(F)F)c3)ncnc12		CHEMBL3675373	=	IC50	nM	5900.0	CHEMBL4722	Homo sapiens	IC50	nM	5900.0
242773	16339395	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(Nc3cccc(CNC(=O)c4cccnc4)c3)ncnc12		CHEMBL3685213	=	IC50	nM	11.0	CHEMBL4722	Homo sapiens	IC50	nM	11.0
242359	16339749	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	COc1ccc(C(CN)Nc2ncnc3c(C(N)=O)cccc23)cc1OC		CHEMBL3675331	=	IC50	nM	4900.0	CHEMBL4722	Homo sapiens	IC50	nM	4900.0
242806	16339986	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	COc1ccc(C(=O)Nc2cccc(CNc3ncnc4c(C(N)=O)cc(CCCCO)cc34)c2)cc1		CHEMBL3685246	=	IC50	nM	0.2	CHEMBL4722	Homo sapiens	IC50	nM	0.2
242393	16340132	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	CC(C)(C)OC(=O)Nc1cccc(CNc2ncnc3c(C(N)=O)cccc23)c1		CHEMBL3675364	=	IC50	nM	570.0	CHEMBL4722	Homo sapiens	IC50	nM	570.0
242555	16340331	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	C=CCN(C)CCC(Nc1ncnc2c(C(N)=O)cccc12)c1cccc(NC(=O)c2ccccc2)c1		CHEMBL3675540	=	IC50	nM	0.49	CHEMBL4722	Homo sapiens	IC50	nM	0.49
242704	16340337	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(NCc3cccc(NC(=O)c4[nH]nc5c4CCCC5)c3)ncnc12		CHEMBL3680554	=	IC50	nM	0.24	CHEMBL4722	Homo sapiens	IC50	nM	0.24
242253	16340347	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	COc1cccc(C(CN)Nc2ncnc3c(C(N)=O)cccc23)c1		CHEMBL3670411	=	IC50	nM	770.0	CHEMBL4722	Homo sapiens	IC50	nM	770.0
242560	16340789	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	COc1ccc(C(=O)NC2=CC(C(CCN(C)C)Nc3ncnc4c(C(N)=O)cccc34)=CCC2)c(F)c1		CHEMBL3680391	=	IC50	nM	1.4	CHEMBL4722	Homo sapiens	IC50	nM	1.4
242680	16340793	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(NCc3cccc(NC(=O)c4ccc(N5CCOCC5)nc4)c3)ncnc12		CHEMBL3680529	=	IC50	nM	0.48	CHEMBL4722	Homo sapiens	IC50	nM	0.48
242671	16341001	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	COCCC(Nc1ncnc2c(C(N)=O)cccc12)c1cccc(NC(=O)c2ccc(OC)c(F)c2)c1		CHEMBL3680520	=	IC50	nM	0.37	CHEMBL4722	Homo sapiens	IC50	nM	0.37
242715	16341794	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(NC(CCN3CCCCC3)c3cccc(NC(=O)c4cc(C5CC5)n[nH]4)c3)ncnc12		CHEMBL3680565	=	IC50	nM	0.54	CHEMBL4722	Homo sapiens	IC50	nM	0.54
242682	16341849	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)C1=c2ncnc(NC(CCN3CCCC3)c3cccc(NC(=O)c4ccccc4)c3)c2=CCC1		CHEMBL3680531	=	IC50	nM	12.0	CHEMBL4722	Homo sapiens	IC50	nM	12.0
242740	16341923	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	CC(Nc1ncnc2c(C(N)=O)cccc12)c1cccc(NC(=O)C(F)(F)C(F)(F)F)c1		CHEMBL3680589	=	IC50	nM	1.8	CHEMBL4722	Homo sapiens	IC50	nM	1.8
242606	16342024	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(NC(CCN3CCCC3)c3cccc(NC(=O)c4ccc(F)c(F)c4)c3)ncnc12		CHEMBL3680443	=	IC50	nM	0.61	CHEMBL4722	Homo sapiens	IC50	nM	0.61
242398	16342342	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(NCc3ccc(NS(=O)(=O)c4ccccc4)cc3)ncnc12		CHEMBL3675369	=	IC50	nM	4200.0	CHEMBL4722	Homo sapiens	IC50	nM	4200.0
242862	16342414	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	CC(Nc1ncnc2c(C(N)=O)cc(OCc3ccccc3)cc12)c1cccc(NC(=O)OC(C)(C)C)c1		CHEMBL3685301	=	IC50	nM	3.8	CHEMBL4722	Homo sapiens	IC50	nM	3.8
242580	16342515	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	CC(C)NC[C@@H](Nc1ncnc2c(C(N)=O)cccc12)c1ccccc1		CHEMBL3680414	=	IC50	nM	800.0	CHEMBL4722	Homo sapiens	IC50	nM	800.0
242845	16342739	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	C[C@@H](Nc1ncnc2c(C(N)=O)cccc12)c1cccc(NC(=O)c2ccc(OC(F)(F)F)c(F)c2)c1		CHEMBL3685284	=	IC50	nM	0.18	CHEMBL4722	Homo sapiens	IC50	nM	0.18
242368	16343053	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	COc1ccc(CNc2ncnc3c(C(N)=O)cccc23)cc1		CHEMBL3675340	=	IC50	nM	230.0	CHEMBL4722	Homo sapiens	IC50	nM	230.0
242490	16343072	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	C[C@@H](Nc1ncnc2c(C(N)=O)cccc12)c1cccc(NC(=O)c2cc(C(C)(C)C)n[nH]2)c1		CHEMBL3675462	=	IC50	nM	0.03	CHEMBL4722	Homo sapiens	IC50	nM	0.03
242653	16343218	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	CNc1ccc(C(=O)Nc2cccc(CNc3ncnc4c(C(N)=O)cccc34)c2)cn1		CHEMBL3680500	=	IC50	nM	0.69	CHEMBL4722	Homo sapiens	IC50	nM	0.69
242709	16343418	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(NC(CCN3CCCC3)c3cccc(NC(=O)c4cc(C5CC5)n[nH]4)c3)ncnc12		CHEMBL3680559	=	IC50	nM	0.33	CHEMBL4722	Homo sapiens	IC50	nM	0.33
242750	16343665	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(NC(CCN3CCCC3)c3cccc(NC(=O)C4CC4(F)F)c3)ncnc12		CHEMBL3680598	=	IC50	nM	2.4	CHEMBL4722	Homo sapiens	IC50	nM	2.4
242517	16343733	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	CC(Nc1ncnc2c(C(N)=O)cccc12)c1cccc(NC(=O)C2=CCC(Cl)N=C2)c1		CHEMBL3675493	=	IC50	nM	1.3	CHEMBL4722	Homo sapiens	IC50	nM	1.3
242466	16343951	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	CC(Nc1ncnc2c(C(N)=O)cccc12)c1cccc(NC(=O)c2ccc3c(c2)OCO3)c1		CHEMBL3675438	=	IC50	nM	15.0	CHEMBL4722	Homo sapiens	IC50	nM	15.0
242752	16343979	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	CC(CC(F)(F)F)C(=O)Nc1cccc([C@@H](C)Nc2ncnc3c(C(N)=O)cccc23)c1		CHEMBL3680600	=	IC50	nM	2.5	CHEMBL4722	Homo sapiens	IC50	nM	2.5
242595	16344002	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(NC(CCN3CCCCC3)c3cccc(NC(=O)c4ccc(C(F)(F)F)cc4F)c3)ncnc12		CHEMBL3680432	=	IC50	nM	6.1	CHEMBL4722	Homo sapiens	IC50	nM	6.1
242650	16344191	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	C[C@@H](Nc1ncnc2c(C(N)=O)cccc12)c1cccc(NC(=O)c2ccc(CN3CCCC3)cc2)c1		CHEMBL3639793	=	IC50	nM	4.4	CHEMBL4722	Homo sapiens	IC50	nM	4.4
242705	16344269	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(NCc3cccc(NC(=O)c4cccc5cc[nH]c45)c3)ncnc12		CHEMBL3680555	=	IC50	nM	0.26	CHEMBL4722	Homo sapiens	IC50	nM	0.26
242474	16344280	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	CNCC(Nc1ncnc2c(C(N)=O)cccc12)c1ccccc1		CHEMBL3670413	=	IC50	nM	450.0	CHEMBL4722	Homo sapiens	IC50	nM	450.0
242351	16344323	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	CN1CCN(CCCOc2cc(C(N)=O)c3ncnc(NCc4ccc(C(F)(F)F)cc4)c3c2)CC1		CHEMBL3675323	=	IC50	nM	6.8	CHEMBL4722	Homo sapiens	IC50	nM	6.8
242262	16344951	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(NCc3ccc(Oc4ccccc4)cc3)ncnc12		CHEMBL3670420	=	IC50	nM	4400.0	CHEMBL4722	Homo sapiens	IC50	nM	4400.0
242628	16344977	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	CN(C)CCC(Nc1ncnc2c(C(N)=O)cccc12)c1cccc(NC(O)c2cc(C3CC3)n[nH]2)c1		CHEMBL3680470	=	IC50	nM	0.44	CHEMBL4722	Homo sapiens	IC50	nM	0.44
242243	16345293	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	COc1ccccc1C(CNS(C)(=O)=O)Nc1ncnc2c(C(N)=O)cccc12		CHEMBL3670400	=	IC50	nM	910.0	CHEMBL4722	Homo sapiens	IC50	nM	910.0
242496	16345426	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	COCCC(Nc1ncnc2c(C(N)=O)cccc12)c1cccc(NC(=O)c2c(F)cccc2F)c1		CHEMBL3675469	=	IC50	nM	0.4	CHEMBL4722	Homo sapiens	IC50	nM	0.4
242590	16345570	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(NC(CCN3CCCCC3)c3cccc(NC(=O)c4ccc(F)cc4F)c3)ncnc12		CHEMBL3680425	=	IC50	nM	8.0	CHEMBL4722	Homo sapiens	IC50	nM	8.0
242600	16345621	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	COc1cc(C(=O)Nc2cccc(CNc3ncnc4c(C(N)=O)cccc34)c2)ccn1		CHEMBL3680437	=	IC50	nM	0.93	CHEMBL4722	Homo sapiens	IC50	nM	0.93
242775	16345629	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	Cc1cc(C(F)(F)F)nn1CC(=O)Nc1cccc(CNc2ncnc3c(C(N)=O)cccc23)c1		CHEMBL3685215	=	IC50	nM	19.0	CHEMBL4722	Homo sapiens	IC50	nM	19.0
242464	16345647	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	C=CCN(C)CCC(Nc1ncnc2c(C(N)=O)cccc12)c1cccc(NC(=O)c2ccc(Br)cc2)c1		CHEMBL3675436	=	IC50	nM	0.4	CHEMBL4722	Homo sapiens	IC50	nM	0.4
242264	16345959	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(NCc3cccc(NC(=O)Nc4ccccc4Cl)c3)ncnc12		CHEMBL3670422	=	IC50	nM	130.0	CHEMBL4722	Homo sapiens	IC50	nM	130.0
242870	16346070	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(NCc3cccc(NC(=O)c4ccccc4C(F)(F)F)c3)ncnc12		CHEMBL3685309	=	IC50	nM	0.22	CHEMBL4722	Homo sapiens	IC50	nM	0.22
242587	16346302	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	CNCC(Nc1ncnc2c(C(N)=O)cc(OCc3ccccc3)cc12)c1ccccc1		CHEMBL3680422	=	IC50	nM	400.0	CHEMBL4722	Homo sapiens	IC50	nM	400.0
242539	16346314	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(NC(CCN3CCC3)c3cccc(NC(=O)c4ccc(Br)cc4)c3)ncnc12		CHEMBL3675518	=	IC50	nM	0.58	CHEMBL4722	Homo sapiens	IC50	nM	0.58
242778	16346401	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	CC(N)c1cccc(NC(=O)c2ccoc2CN2CCOCC2)c1		CHEMBL3685218	=	IC50	nM	25.0	CHEMBL4722	Homo sapiens	IC50	nM	25.0
242325	16346414	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(NCc3cccc(NC(=O)c4ccc(Cl)nc4)c3)ncnc12		CHEMBL3670485	=	IC50	nM	0.65	CHEMBL4722	Homo sapiens	IC50	nM	0.65
242615	16346676	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(NCc3cccc(NC(=O)c4cc(C(F)(F)F)n[nH]4)c3)ncnc12		CHEMBL3680455	=	IC50	nM	0.22	CHEMBL4722	Homo sapiens	IC50	nM	0.22
242716	16346953	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	Cn1ccc2cc(C(=O)Nc3cccc(CNc4ncnc5c(C(N)=O)cccc45)c3)ccc21		CHEMBL3680566	=	IC50	nM	0.56	CHEMBL4722	Homo sapiens	IC50	nM	0.56
242357	16347404	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	COc1ccccc1C(CN)Nc1ncnc2c(C(N)=O)cccc12		CHEMBL3675329	=	IC50	nM	1500.0	CHEMBL4722	Homo sapiens	IC50	nM	1500.0
242529	16347464	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	COCCC(Nc1ncnc2c(C(N)=O)cccc12)c1cccc(NC(=O)c2ccc(Br)cc2)c1		CHEMBL3675508	=	IC50	nM	0.05	CHEMBL4722	Homo sapiens	IC50	nM	0.05
242362	16347506	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	C#Cc1cccc(Nc2ncnc3c(C(N)=O)cccc23)c1		CHEMBL3675334	=	IC50	nM	1000.0	CHEMBL4722	Homo sapiens	IC50	nM	1000.0
242836	16347641	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(NCc3cccc(Nc4nc5ccc(C(F)(F)F)cc5[nH]4)c3)ncnc12		CHEMBL3685275	=	IC50	nM	11.0	CHEMBL4722	Homo sapiens	IC50	nM	11.0
242588	16347692	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(N[C@H](CNC3CC3)c3ccccc3)ncnc12		CHEMBL3680423	=	IC50	nM	460.0	CHEMBL4722	Homo sapiens	IC50	nM	460.0
311295	16348098	CHEMBL3705895	Radioactive Assay: The capacity to inhibit the kinase activity of the enzyme is estimated by measuring the residual kinase activity of the enzyme in the presence of different concentrations of the test compound (generally from 0.17 to 10 000 nM). A dose-response curve is produced, which allows an IC50 (50% inhibitory concentration) to be determined. The kinase activity is measured by a radioactive assay of the amount of radioactive phosphate (33P) incorporated into a fragment of the protein NuMA (Nuclear Mitotic Apparatus protein) after 30 minutes of incubation at 37Â° C. The test compound is first dissolved at different concentrations in dimethyl sulphoxide (DMS (J). Reaction takes place in the wells of a FlashPlate microtiter plate (Nickel Chelate FlashPlate-96, PerkinElmer). Each well (100 Î¼l) contains 10 nM Aurora A, 500 nM NuMA, 1 Î¼M ATP and 0.2 Î¼Ci ATP-Î³-33P in a buffer of 50 mM Tris-HCl, pH=7.5; 10 mM MgCl2; 50 mM NaCl, 1 mM dithiothreitol. The final percentage of DMSO is 3%.	B	CCc1[nH]cc2c1NC1=C(C(=O)CNC1)C2c1cccc(Sc2nc3ccccc3[nH]2)c1		CHEMBL3663739	=	IC50	nM	1755.0	CHEMBL4722	Homo sapiens	IC50	nM	1755.0
242527	16348418	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(NCc3ccc(F)c(NC(=O)c4ccc(Br)cc4)c3)ncnc12		CHEMBL3675506	=	IC50	nM	0.73	CHEMBL4722	Homo sapiens	IC50	nM	0.73
242521	16348518	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	CC(Nc1ncnc2c(C(N)=O)cccc12)c1cccc(NC(=O)c2cc(C(F)F)n[nH]2)c1		CHEMBL3675500	=	IC50	nM	0.2	CHEMBL4722	Homo sapiens	IC50	nM	0.2
242423	16348623	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	CN(C)CC(Nc1ncnc2c(C(N)=O)cccc12)c1ccc(C(F)(F)F)cc1		CHEMBL3675394	=	IC50	nM	1000.0	CHEMBL4722	Homo sapiens	IC50	nM	1000.0
242530	16348888	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	C[C@@H](Nc1ncnc2c(C(N)=O)cccc12)c1cccc(NC(=O)c2ccc(C(F)(F)F)nc2)c1		CHEMBL3675509	=	IC50	nM	0.07	CHEMBL4722	Homo sapiens	IC50	nM	0.07
242582	16348953	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(NCc3cccc(NC(=O)c4ccc5c(c4)CCO5)c3)ncnc12		CHEMBL3680417	=	IC50	nM	0.23	CHEMBL4722	Homo sapiens	IC50	nM	0.23
242472	16349048	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	CC1CC=C(C(=O)Nc2cccc(C(C)Nc3ncnc4c(C(N)=O)cccc34)c2)C=C1F		CHEMBL3675443	=	IC50	nM	0.09	CHEMBL4722	Homo sapiens	IC50	nM	0.09
242589	16349446	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(NCc3cccc(NC(=O)c4cccc(OCCO)c4)c3)ncnc12		CHEMBL3680424	=	IC50	nM	5.0	CHEMBL4722	Homo sapiens	IC50	nM	5.0
242245	16349647	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NCCCOc1cc(C(N)=O)c2ncnc(NCc3ccc(C(F)(F)F)cc3)c2c1		CHEMBL3670402	=	IC50	nM	7600.0	CHEMBL4722	Homo sapiens	IC50	nM	7600.0
242520	16349662	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	Cc1ncc(C(=O)Nc2cccc([C@@H](C)Nc3ncnc4c(C(N)=O)cccc34)c2)s1		CHEMBL3675499	=	IC50	nM	0.35	CHEMBL4722	Homo sapiens	IC50	nM	0.35
242524	16349690	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	CN1CCN(c2ccc(C(=O)Nc3cccc(CNc4ncnc5c(C(N)=O)cccc45)c3)cn2)CC1		CHEMBL3675503	=	IC50	nM	2.3	CHEMBL4722	Homo sapiens	IC50	nM	2.3
242636	16349750	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	CS(=O)(=O)c1ccc(C(=O)Nc2cccc(CNc3ncnc4c(C(N)=O)cccc34)c2)cc1		CHEMBL3680481	=	IC50	nM	1.4	CHEMBL4722	Homo sapiens	IC50	nM	1.4
242415	16349819	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cc(NC(=O)CCc2ccccc2)cc2c(NCc3ccc(Cl)c(C(F)(F)F)c3)ncnc12		CHEMBL3675386	=	IC50	nM	3400.0	CHEMBL4722	Homo sapiens	IC50	nM	3400.0
242610	16350076	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	CCN(CC)c1ccc(C(=O)Nc2cccc(C(C)Nc3ncnc4c(C(N)=O)cccc34)c2)cc1		CHEMBL3680447	=	IC50	nM	0.37	CHEMBL4722	Homo sapiens	IC50	nM	0.37
242499	16350190	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	CCNC[C@@H](Nc1ncnc2c(C(N)=O)cccc12)c1ccccc1		CHEMBL3675473	=	IC50	nM	670.0	CHEMBL4722	Homo sapiens	IC50	nM	670.0
242840	16350308	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	COc1cccc(OC)c1C(=O)Nc1cccc(CNc2ncnc3c(C(N)=O)cccc23)c1		CHEMBL3685279	=	IC50	nM	5.4	CHEMBL4722	Homo sapiens	IC50	nM	5.4
242842	16350414	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	CCC(Nc1ncnc2c(C(N)=O)cccc12)c1cccc(NC(=O)c2ccc(OC)c(F)c2)c1		CHEMBL3685281	=	IC50	nM	0.46	CHEMBL4722	Homo sapiens	IC50	nM	0.46
242659	16350676	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(NC(CCN3CCCCC3)c3cccc(NC(=O)c4ccc(Br)cc4)c3)ncnc12		CHEMBL3680507	=	IC50	nM	0.42	CHEMBL4722	Homo sapiens	IC50	nM	0.42
242432	16350716	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	CN(C)CC(Nc1ncnc2c(C(N)=O)cccc12)c1cccc(NC(=O)c2ccc(Br)cc2)c1		CHEMBL3675404	=	IC50	nM	0.58	CHEMBL4722	Homo sapiens	IC50	nM	0.58
242306	16350813	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(NCc3cccc(NC(=O)N4CCCCC4)c3)ncnc12		CHEMBL3670465	=	IC50	nM	8.4	CHEMBL4722	Homo sapiens	IC50	nM	8.4
242512	16351009	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	CN(CC(Nc1ncnc2c(C(N)=O)cccc12)c1cccc(NC(=O)c2ccc(F)c(F)c2)c1)C(=O)OC(C)(C)C		CHEMBL3675488	=	IC50	nM	7.4	CHEMBL4722	Homo sapiens	IC50	nM	7.4
242248	16351032	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(NC3CCCNC3)ncnc12		CHEMBL3670406	=	IC50	nM	6500.0	CHEMBL4722	Homo sapiens	IC50	nM	6500.0
242831	16351483	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	CN1CCN(Cc2ccc(C(=O)Nc3cccc(CNc4ncnc5c(C(N)=O)cccc45)c3)cc2)CC1		CHEMBL3685270	=	IC50	nM	7.3	CHEMBL4722	Homo sapiens	IC50	nM	7.3
242669	16351791	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(NCc3cccc(NC(=O)c4ccc(CN5CCCC5)cc4)c3)ncnc12		CHEMBL3680518	=	IC50	nM	7.4	CHEMBL4722	Homo sapiens	IC50	nM	7.4
242644	16352254	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	CCOC(=O)c1ccc(C(=O)NC2=CCCC([C@H](C)Nc3ncnc4c(C(N)=O)cccc34)=C2)cn1		CHEMBL3680489	=	IC50	nM	0.23	CHEMBL4722	Homo sapiens	IC50	nM	0.23
242277	16352706	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	CCNC(=O)Nc1cccc(CNc2ncnc3c(C(N)=O)cccc23)c1		CHEMBL3670435	=	IC50	nM	1800.0	CHEMBL4722	Homo sapiens	IC50	nM	1800.0
242664	16352900	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(NC(CCN3CCCCC3)c3cccc(NC(=O)c4ccc(F)c(F)c4)c3)ncnc12		CHEMBL3680512	=	IC50	nM	1.4	CHEMBL4722	Homo sapiens	IC50	nM	1.4
242789	16352974	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	CCN(CC)CCOC1C=CC(C(O)Nc2cccc(CNc3ncnc4c(C(N)=O)cccc34)c2)=CC1		CHEMBL3685229	=	IC50	nM	9.8	CHEMBL4722	Homo sapiens	IC50	nM	9.8
242690	16353204	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	C[C@@H](Nc1ncnc2c(C(N)=O)cccc12)c1cccc(NC(=O)C2CC2(F)F)c1		CHEMBL3680540	=	IC50	nM	0.04	CHEMBL4722	Homo sapiens	IC50	nM	0.04
242663	16353295	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	COc1ccc(C(N)=O)c2ncnc(NCc3ccccc3)c12		CHEMBL3680511	=	IC50	nM	300.0	CHEMBL4722	Homo sapiens	IC50	nM	300.0
242451	16353449	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	CNCC(Nc1ncnc2c(C(N)=O)ccc(OC)c12)c1ccccc1		CHEMBL3675423	=	IC50	nM	670.0	CHEMBL4722	Homo sapiens	IC50	nM	670.0
242360	16353737	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(Nc3ccc(NC(=O)c4ccccc4)cc3)ncnc12		CHEMBL3675332	=	IC50	nM	590.0	CHEMBL4722	Homo sapiens	IC50	nM	590.0
242298	16353957	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	COC[C@@H](Nc1ncnc2c(C(N)=O)cccc12)c1ccccc1		CHEMBL3670457	=	IC50	nM	2500.0	CHEMBL4722	Homo sapiens	IC50	nM	2500.0
242670	16354067	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	CC(Nc1ncnc2c(C(N)=O)cc(F)cc12)c1cccc(NC(=O)c2ccc(C(F)(F)F)nc2)c1		CHEMBL3680519	=	IC50	nM	0.61	CHEMBL4722	Homo sapiens	IC50	nM	0.61
242711	16354174	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(NCc3cccc(NC(=O)c4ccc5[nH]ccc5c4)c3)ncnc12		CHEMBL3680561	=	IC50	nM	0.46	CHEMBL4722	Homo sapiens	IC50	nM	0.46
242443	16354272	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	CNCC(Nc1ncnc2c(C(N)=O)cccc12)c1cccc(F)c1		CHEMBL3675415	=	IC50	nM	230.0	CHEMBL4722	Homo sapiens	IC50	nM	230.0
242738	16354393	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	Cc1nc(-c2cccc(C(=O)Nc3cccc(CNc4ncnc5c(C(N)=O)cccc45)c3)c2)no1		CHEMBL3680587	=	IC50	nM	1.7	CHEMBL4722	Homo sapiens	IC50	nM	1.7
242352	16354748	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cc(OCCCN2CCCCC2)cc2c(NCc3ccc(C(F)(F)F)cc3)ncnc12		CHEMBL3675324	=	IC50	nM	0.18	CHEMBL4722	Homo sapiens	IC50	nM	0.18
242872	16355039	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	CC(C)n1cc(-c2cc(C(N)=O)c3ncnc(N[C@H]4CCCNC4)c3c2)cn1		CHEMBL3685317	=	IC50	nM	120.0	CHEMBL4722	Homo sapiens	IC50	nM	120.0
242338	16355102	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	CN(C)c1cccc(C(=O)Nc2cccc(CNc3ncnc4c(C(N)=O)cccc34)c2)n1		CHEMBL3670498	=	IC50	nM	6.3	CHEMBL4722	Homo sapiens	IC50	nM	6.3
242686	16355316	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(NC(CO)c3cccc(NC(O)c4ccc(Br)cc4)c3)ncnc12		CHEMBL3680535	=	IC50	nM	61.0	CHEMBL4722	Homo sapiens	IC50	nM	61.0
242470	16355318	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(NCc3cccc(NC(=O)c4ccc(F)cc4F)c3)ncnc12		CHEMBL3675441	=	IC50	nM	0.16	CHEMBL4722	Homo sapiens	IC50	nM	0.16
242832	16355485	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	COc1ccc(C(=O)Nc2cccc(CNc3ncnc4c(C(N)=O)cc(F)cc34)c2)cc1		CHEMBL3685271	=	IC50	nM	0.25	CHEMBL4722	Homo sapiens	IC50	nM	0.25
242282	16355521	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cc(NCc2cccnc2)cc2c(NCc3ccccc3)ncnc12		CHEMBL3670440	=	IC50	nM	6900.0	CHEMBL4722	Homo sapiens	IC50	nM	6900.0
242585	16355710	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	CC(C)c1cc(C(=O)Nc2cccc(C(C)Nc3ncnc4c(C(N)=O)cccc34)c2)[nH]n1		CHEMBL3680420	=	IC50	nM	0.06	CHEMBL4722	Homo sapiens	IC50	nM	0.06
242459	16355802	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	COc1ccc(C(=O)Nc2cccc(C(CN(C)C)Nc3ncnc4c3=CCCC=4C(N)=O)c2)cc1F		CHEMBL3675431	=	IC50	nM	1.3	CHEMBL4722	Homo sapiens	IC50	nM	1.3
242746	16355942	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	C[C@@H](Nc1ncnc2c(C(N)=O)cccc12)c1cccc(Nc2ncc(C(F)(F)F)cc2Cl)c1		CHEMBL3680595	=	IC50	nM	2.3	CHEMBL4722	Homo sapiens	IC50	nM	2.3
242483	16356084	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NC(=O)c1cccc2c(NCc3cccc(NC(=O)c4cncc(N5CCCC5)c4)c3)ncnc12		CHEMBL3675453	=	IC50	nM	0.34	CHEMBL4722	Homo sapiens	IC50	nM	0.34
242513	16356235	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	CCNC[C@@H](Nc1ncnc2c(C(N)=O)cc(OC)cc12)c1cccc(F)c1		CHEMBL3675489	=	IC50	nM	570.0	CHEMBL4722	Homo sapiens	IC50	nM	570.0
242300	16356340	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NCC1(c2ccc(OC(F)(F)F)cc2)CCN(c2ncnc3c(C(N)=O)cccc23)CC1		CHEMBL3670459	=	IC50	nM	5500.0	CHEMBL4722	Homo sapiens	IC50	nM	5500.0
242695	16356447	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	COc1ccc(C(=O)Nc2cccc(C(CCCO)Nc3ncnc4c(C(N)=O)cccc34)c2)cc1		CHEMBL3680545	=	IC50	nM	0.16	CHEMBL4722	Homo sapiens	IC50	nM	0.16
242830	16356534	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	N#Cc1ccccc1C(=O)Nc1cccc(CNc2ncnc3c(C(N)=O)cccc23)c1		CHEMBL3685269	=	IC50	nM	7.8	CHEMBL4722	Homo sapiens	IC50	nM	7.8
242787	16356578	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	CCN(CC)CCOc1ccccc1C(=O)Nc1cccc(CNc2ncnc3c(C(N)=O)cccc23)c1		CHEMBL3685227	=	IC50	nM	47.0	CHEMBL4722	Homo sapiens	IC50	nM	47.0
242755	16356636	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	Cc1ccc2ccnc(Nc3cccc(CNc4ncnc5c(C(N)=O)cccc45)c3)c2c1		CHEMBL3680603	=	IC50	nM	3.5	CHEMBL4722	Homo sapiens	IC50	nM	3.5
242254	16356928	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	NCC(Nc1ncnc2c(C(N)=O)cccc12)c1cccc(NC(=O)c2ccc(F)cc2)c1		CHEMBL3670412	=	IC50	nM	1.2	CHEMBL4722	Homo sapiens	IC50	nM	1.2
	16357255	CHEMBL3721219	Inhibition of N-terminal His6-tagged recombinant full-length human Aurora A expressed in Sf21 cells	B	O=C(CNc1cccc(O)c1)Nc1nc2ccc3[nH]ncc3c2s1		CHEMBL3717170	=	IC50	nM	148.0	CHEMBL4722	Homo sapiens	IC50	nM	148.0
	16357256	CHEMBL3721219	Inhibition of N-terminal His6-tagged recombinant full-length human Aurora A expressed in Sf21 cells	B	O=C(CNc1ccc(Cl)c(O)c1)Nc1nc2ccc3[nH]ncc3c2s1		CHEMBL3716298	=	IC50	nM	257.0	CHEMBL4722	Homo sapiens	IC50	nM	257.0
	16357257	CHEMBL3721219	Inhibition of N-terminal His6-tagged recombinant full-length human Aurora A expressed in Sf21 cells	B	CC(=O)Nc1cc(NCC(=O)Nc2nc3ccc4[nH]ncc4c3s2)ccc1Cl		CHEMBL3716346	=	IC50	nM	278.0	CHEMBL4722	Homo sapiens	IC50	nM	278.0
	16357258	CHEMBL3721219	Inhibition of N-terminal His6-tagged recombinant full-length human Aurora A expressed in Sf21 cells	B	COc1cccc(NC(C)C(=O)Nc2nc3ccc4[nH]ncc4c3s2)c1		CHEMBL3716547	=	IC50	nM	387.0	CHEMBL4722	Homo sapiens	IC50	nM	387.0
	16357259	CHEMBL3721219	Inhibition of N-terminal His6-tagged recombinant full-length human Aurora A expressed in Sf21 cells	B	CC(Nc1cccc(O)c1)C(=O)Nc1nc2ccc3[nH]ncc3c2s1		CHEMBL3716347	=	IC50	nM	47.0	CHEMBL4722	Homo sapiens	IC50	nM	47.0
	16357260	CHEMBL3721219	Inhibition of N-terminal His6-tagged recombinant full-length human Aurora A expressed in Sf21 cells	B	CC(C)CC(Nc1cccc(O)c1)C(=O)Nc1nc2ccc3[nH]ncc3c2s1		CHEMBL3717942	=	IC50	nM	137.0	CHEMBL4722	Homo sapiens	IC50	nM	137.0
	16357261	CHEMBL3721219	Inhibition of N-terminal His6-tagged recombinant full-length human Aurora A expressed in Sf21 cells	B	O=C(Nc1nc2ccc3[nH]ncc3c2s1)C(Nc1cccc(O)c1)c1ccccc1		CHEMBL3717261	=	IC50	nM	115.0	CHEMBL4722	Homo sapiens	IC50	nM	115.0
	16357262	CHEMBL3721219	Inhibition of N-terminal His6-tagged recombinant full-length human Aurora A expressed in Sf21 cells	B	CC(C)(Nc1cccc(O)c1)C(=O)Nc1nc2ccc3[nH]ncc3c2s1		CHEMBL3718495	=	IC50	nM	29.0	CHEMBL4722	Homo sapiens	IC50	nM	29.0
	16357263	CHEMBL3721219	Inhibition of N-terminal His6-tagged recombinant full-length human Aurora A expressed in Sf21 cells	B	COc1cccc(NC(C)(C)C(=O)Nc2nc3ccc4[nH]ncc4c3s2)c1		CHEMBL3716959	=	IC50	nM	332.0	CHEMBL4722	Homo sapiens	IC50	nM	332.0
	16357264	CHEMBL3721219	Inhibition of N-terminal His6-tagged recombinant full-length human Aurora A expressed in Sf21 cells	B	CC(C)(Nc1ccc(Cl)cc1)C(=O)Nc1nc2ccc3[nH]ncc3c2s1		CHEMBL3716615	=	IC50	nM	428.0	CHEMBL4722	Homo sapiens	IC50	nM	428.0
	16357265	CHEMBL3721219	Inhibition of N-terminal His6-tagged recombinant full-length human Aurora A expressed in Sf21 cells	B	COc1cc(NC(C)(C)C(=O)Nc2nc3ccc4[nH]ncc4c3s2)ccc1Cl		CHEMBL3716840	=	IC50	nM	347.0	CHEMBL4722	Homo sapiens	IC50	nM	347.0
	16357266	CHEMBL3721219	Inhibition of N-terminal His6-tagged recombinant full-length human Aurora A expressed in Sf21 cells	B	CCOC(=O)c1cc(NC(C)(C)C(=O)Nc2nc3ccc4[nH]ncc4c3s2)ccc1Cl		CHEMBL3715109	=	IC50	nM	107.0	CHEMBL4722	Homo sapiens	IC50	nM	107.0
	16357267	CHEMBL3721219	Inhibition of N-terminal His6-tagged recombinant full-length human Aurora A expressed in Sf21 cells	B	CC(C)OC(=O)c1cc(NC(C)(C)C(=O)Nc2nc3ccc4[nH]ncc4c3s2)ccc1Cl		CHEMBL3718679	=	IC50	nM	148.0	CHEMBL4722	Homo sapiens	IC50	nM	148.0
	16357268	CHEMBL3721219	Inhibition of N-terminal His6-tagged recombinant full-length human Aurora A expressed in Sf21 cells	B	CCOC(=O)c1cc(NC(C)(C)C(=O)Nc2nc3ccc4[nH]ncc4c3s2)ccc1F		CHEMBL3716951	=	IC50	nM	265.0	CHEMBL4722	Homo sapiens	IC50	nM	265.0
	16357269	CHEMBL3721219	Inhibition of N-terminal His6-tagged recombinant full-length human Aurora A expressed in Sf21 cells	B	COC(=O)Nc1cc(NC(C)(C)C(=O)Nc2nc3ccc4[nH]ncc4c3s2)ccc1Cl		CHEMBL3716977	=	IC50	nM	426.0	CHEMBL4722	Homo sapiens	IC50	nM	426.0
	16357270	CHEMBL3721219	Inhibition of N-terminal His6-tagged recombinant full-length human Aurora A expressed in Sf21 cells	B	CC(=O)Nc1cc(NC(C)(C)C(=O)Nc2nc3c(C(F)(F)F)cc4[nH]ncc4c3s2)ccc1Cl		CHEMBL3716385	=	IC50	nM	227.0	CHEMBL4722	Homo sapiens	IC50	nM	227.0
	16357271	CHEMBL3721219	Inhibition of N-terminal His6-tagged recombinant full-length human Aurora A expressed in Sf21 cells	B	CNC(=O)c1cc(NC(C)(C)C(=O)Nc2nc3c(C(F)(F)F)cc4[nH]ncc4c3s2)ccc1Cl		CHEMBL3717041	=	IC50	nM	185.0	CHEMBL4722	Homo sapiens	IC50	nM	185.0
	16357272	CHEMBL3721219	Inhibition of N-terminal His6-tagged recombinant full-length human Aurora A expressed in Sf21 cells	B	CCNC(=O)c1cc(NC(C)(C)C(=O)Nc2nc3c(C(F)(F)F)cc4[nH]ncc4c3s2)ccc1Cl		CHEMBL3719096	=	IC50	nM	163.0	CHEMBL4722	Homo sapiens	IC50	nM	163.0
	16357273	CHEMBL3721219	Inhibition of N-terminal His6-tagged recombinant full-length human Aurora A expressed in Sf21 cells	B	CC(C)(Nc1cccc(C(=O)O)c1)C(=O)Nc1nc2c(C(F)(F)F)cc3[nH]ncc3c2s1		CHEMBL3716427	=	IC50	nM	294.0	CHEMBL4722	Homo sapiens	IC50	nM	294.0
	16357274	CHEMBL3721219	Inhibition of N-terminal His6-tagged recombinant full-length human Aurora A expressed in Sf21 cells	B	CC(C)(Nc1ccc(Cl)c(C(=O)NC2CC2)c1)C(=O)Nc1nc2c(C(F)(F)F)cc3[nH]ncc3c2s1		CHEMBL3716279	=	IC50	nM	472.0	CHEMBL4722	Homo sapiens	IC50	nM	472.0
	16357275	CHEMBL3721219	Inhibition of N-terminal His6-tagged recombinant full-length human Aurora A expressed in Sf21 cells	B	CC(=O)Nc1cc(NC(C)(C)C(=O)Nc2nc3c(C(F)(F)F)cc4[nH]ncc4c3s2)ccc1F		CHEMBL3716850	=	IC50	nM	444.0	CHEMBL4722	Homo sapiens	IC50	nM	444.0
	16357276	CHEMBL3721219	Inhibition of N-terminal His6-tagged recombinant full-length human Aurora A expressed in Sf21 cells	B	CC(C)(Nc1cccc(S(N)(=O)=O)c1)C(=O)Nc1nc2c(C(F)(F)F)cc3[nH]ncc3c2s1		CHEMBL3717691	=	IC50	nM	14.0	CHEMBL4722	Homo sapiens	IC50	nM	14.0
	16357277	CHEMBL3721219	Inhibition of N-terminal His6-tagged recombinant full-length human Aurora A expressed in Sf21 cells	B	CC(C)(Nc1ccc(Cl)c(NS(C)(=O)=O)c1)C(=O)Nc1nc2c(C(F)(F)F)cc3[nH]ncc3c2s1		CHEMBL3716892	=	IC50	nM	247.0	CHEMBL4722	Homo sapiens	IC50	nM	247.0
	16357278	CHEMBL3721219	Inhibition of N-terminal His6-tagged recombinant full-length human Aurora A expressed in Sf21 cells	B	CC(C)(Nc1ccc(Cl)c(C(=O)NCC(N)=O)c1)C(=O)Nc1nc2c(C(F)(F)F)cc3[nH]ncc3c2s1		CHEMBL3716786	=	IC50	nM	71.0	CHEMBL4722	Homo sapiens	IC50	nM	71.0
	16357279	CHEMBL3721219	Inhibition of N-terminal His6-tagged recombinant full-length human Aurora A expressed in Sf21 cells	B	CC(C)(Nc1cccc(C(=O)NCC(=O)OCCO)c1)C(=O)Nc1nc2c(C(F)(F)F)cc3[nH]ncc3c2s1		CHEMBL3714963	=	IC50	nM	66.0	CHEMBL4722	Homo sapiens	IC50	nM	66.0
	16357280	CHEMBL3721219	Inhibition of N-terminal His6-tagged recombinant full-length human Aurora A expressed in Sf21 cells	B	CC(C)(Nc1ccc(Cl)c(O)c1)C(=O)Nc1nc2c(C(F)(F)F)cc3[nH]ncc3c2s1		CHEMBL3719241	=	IC50	nM	340.0	CHEMBL4722	Homo sapiens	IC50	nM	340.0
	16357281	CHEMBL3721219	Inhibition of N-terminal His6-tagged recombinant full-length human Aurora A expressed in Sf21 cells	B	CC(C)(Nc1ccc(Cl)c(C(=O)NOCc2ccccc2)c1)C(=O)Nc1nc2c(C(F)(F)F)cc3[nH]ncc3c2s1		CHEMBL3717019	=	IC50	nM	65.0	CHEMBL4722	Homo sapiens	IC50	nM	65.0
	16357282	CHEMBL3721219	Inhibition of N-terminal His6-tagged recombinant full-length human Aurora A expressed in Sf21 cells	B	CC(C)(Nc1ccc(Cl)c(OCC(O)CO)c1)C(=O)Nc1nc2c(C(F)(F)F)cc3[nH]ncc3c2s1		CHEMBL3717995	=	IC50	nM	142.0	CHEMBL4722	Homo sapiens	IC50	nM	142.0
	16357283	CHEMBL3721219	Inhibition of N-terminal His6-tagged recombinant full-length human Aurora A expressed in Sf21 cells	B	CC(C)(Nc1cccc(C(=O)NCCC(N)=O)c1)C(=O)Nc1nc2c(C(F)(F)F)cc3[nH]ncc3c2s1		CHEMBL3716783	=	IC50	nM	118.0	CHEMBL4722	Homo sapiens	IC50	nM	118.0
	16357284	CHEMBL3721219	Inhibition of N-terminal His6-tagged recombinant full-length human Aurora A expressed in Sf21 cells	B	CC(C)(Nc1ccc(Cl)c(C(=O)NCCCS(N)(=O)=O)c1)C(=O)Nc1nc2c(C(F)(F)F)cc3[nH]ncc3c2s1		CHEMBL3715917	=	IC50	nM	39.0	CHEMBL4722	Homo sapiens	IC50	nM	39.0
	16357285	CHEMBL3721219	Inhibition of N-terminal His6-tagged recombinant full-length human Aurora A expressed in Sf21 cells	B	NC(=O)CC(Nc1cccc(O)c1)C(=O)Nc1nc2ccc3[nH]ncc3c2s1		CHEMBL3715951	=	IC50	nM	364.0	CHEMBL4722	Homo sapiens	IC50	nM	364.0
	16357286	CHEMBL3721219	Inhibition of N-terminal His6-tagged recombinant full-length human Aurora A expressed in Sf21 cells	B	O=C(Nc1nc2ccc3[nH]ncc3c2s1)C1(Nc2ccc(Cl)cc2)CC1		CHEMBL3718984	=	IC50	nM	317.0	CHEMBL4722	Homo sapiens	IC50	nM	317.0
	16357287	CHEMBL3721219	Inhibition of N-terminal His6-tagged recombinant full-length human Aurora A expressed in Sf21 cells	B	CCOC(=O)c1cc(NC2(C(=O)Nc3nc4ccc5[nH]ncc5c4s3)CC2)ccc1Cl		CHEMBL3715386	=	IC50	nM	236.0	CHEMBL4722	Homo sapiens	IC50	nM	236.0
	16357288	CHEMBL3721219	Inhibition of N-terminal His6-tagged recombinant full-length human Aurora A expressed in Sf21 cells	B	CC(=O)Nc1cc(NC2(C(=O)Nc3nc4ccc5[nH]ncc5c4s3)CC2)ccc1F		CHEMBL3718067	=	IC50	nM	164.0	CHEMBL4722	Homo sapiens	IC50	nM	164.0
	16357289	CHEMBL3721219	Inhibition of N-terminal His6-tagged recombinant full-length human Aurora A expressed in Sf21 cells	B	CCC(=O)Nc1cc(NC2(C(=O)Nc3nc4ccc5[nH]ncc5c4s3)CC2)ccc1F		CHEMBL3715310	=	IC50	nM	307.0	CHEMBL4722	Homo sapiens	IC50	nM	307.0
	16357290	CHEMBL3721219	Inhibition of N-terminal His6-tagged recombinant full-length human Aurora A expressed in Sf21 cells	B	O=C(Nc1nc2ccc3[nH]ncc3c2s1)C1(Nc2cccc(O)c2)CC1		CHEMBL3715796	=	IC50	nM	168.0	CHEMBL4722	Homo sapiens	IC50	nM	168.0
	16357291	CHEMBL3721219	Inhibition of N-terminal His6-tagged recombinant full-length human Aurora A expressed in Sf21 cells	B	CNC(=O)c1cc(NC2(C(=O)Nc3nc4ccc5[nH]ncc5c4s3)CC2)ccc1Cl		CHEMBL3717989	=	IC50	nM	58.0	CHEMBL4722	Homo sapiens	IC50	nM	58.0
	16357292	CHEMBL3721219	Inhibition of N-terminal His6-tagged recombinant full-length human Aurora A expressed in Sf21 cells	B	CC(=O)Nc1cc(NC(C)(C)C(=O)Nc2nc3ccc4[nH]ncc4c3s2)ccc1Cl		CHEMBL3718650	=	IC50	nM	39.0	CHEMBL4722	Homo sapiens	IC50	nM	39.0
	16357293	CHEMBL3721219	Inhibition of N-terminal His6-tagged recombinant full-length human Aurora A expressed in Sf21 cells	B	CCC(=O)Nc1cc(NC(C)(C)C(=O)Nc2nc3ccc4[nH]ncc4c3s2)ccc1Cl		CHEMBL3718849	=	IC50	nM	113.0	CHEMBL4722	Homo sapiens	IC50	nM	113.0
	16357294	CHEMBL3721219	Inhibition of N-terminal His6-tagged recombinant full-length human Aurora A expressed in Sf21 cells	B	CC(=O)Nc1cc(NC(C(=O)Nc2nc3ccc4[nH]ncc4c3s2)c2ccccc2)ccc1Cl		CHEMBL3718596	=	IC50	nM	94.0	CHEMBL4722	Homo sapiens	IC50	nM	94.0
	16357295	CHEMBL3721219	Inhibition of N-terminal His6-tagged recombinant full-length human Aurora A expressed in Sf21 cells	B	CC(C)(Nc1ccc(Cl)c(C(N)=O)c1)C(=O)Nc1nc2c(C(F)(F)F)cc3[nH]ncc3c2s1		CHEMBL3719041	=	IC50	nM	40.0	CHEMBL4722	Homo sapiens	IC50	nM	40.0
	16357296	CHEMBL3721219	Inhibition of N-terminal His6-tagged recombinant full-length human Aurora A expressed in Sf21 cells	B	CC(C)(Nc1ccc(Cl)c(C(=O)O)c1)C(=O)Nc1nc2c(C(F)(F)F)cc3[nH]ncc3c2s1		CHEMBL3717203	=	IC50	nM	19.0	CHEMBL4722	Homo sapiens	IC50	nM	19.0
	16357297	CHEMBL3721219	Inhibition of N-terminal His6-tagged recombinant full-length human Aurora A expressed in Sf21 cells	B	CC(C)(Nc1ccc(F)c(C(N)=O)c1)C(=O)Nc1nc2c(C(F)(F)F)cc3[nH]ncc3c2s1		CHEMBL3719311	=	IC50	nM	263.0	CHEMBL4722	Homo sapiens	IC50	nM	263.0
	16357298	CHEMBL3721219	Inhibition of N-terminal His6-tagged recombinant full-length human Aurora A expressed in Sf21 cells	B	CC(C)(Nc1ccc(Cl)c(C(=O)NCCC(=O)O)c1)C(=O)Nc1nc2c(C(F)(F)F)cc3[nH]ncc3c2s1		CHEMBL3716523	=	IC50	nM	106.0	CHEMBL4722	Homo sapiens	IC50	nM	106.0
	16357299	CHEMBL3721219	Inhibition of N-terminal His6-tagged recombinant full-length human Aurora A expressed in Sf21 cells	B	CC(C)(Nc1cccc(C(=O)NCCCC(=O)O)c1)C(=O)Nc1nc2c(C(F)(F)F)cc3[nH]ncc3c2s1		CHEMBL3716391	=	IC50	nM	247.0	CHEMBL4722	Homo sapiens	IC50	nM	247.0
	16357300	CHEMBL3721219	Inhibition of N-terminal His6-tagged recombinant full-length human Aurora A expressed in Sf21 cells	B	CC(C)(Nc1ccc(Cl)c(C(=O)NCCCC(=O)O)c1)C(=O)Nc1nc2c(C(F)(F)F)cc3[nH]ncc3c2s1		CHEMBL3716175	=	IC50	nM	88.0	CHEMBL4722	Homo sapiens	IC50	nM	88.0
	16357301	CHEMBL3721219	Inhibition of N-terminal His6-tagged recombinant full-length human Aurora A expressed in Sf21 cells	B	CC(C)(Nc1ccc(Cl)c(C(=O)NCC(=O)O)c1)C(=O)Nc1nc2c(C(F)(F)F)cc3[nH]ncc3c2s1		CHEMBL3717935	=	IC50	nM	76.0	CHEMBL4722	Homo sapiens	IC50	nM	76.0
	16376436	CHEMBL3734460	Inhibition of recombinant human Aurora A using fluorescein-labeled peptide as substrate by fluorescence-electrophoretic mobility shift assay	B	Cl.NCCN1C(=O)S/C(=C\CCC2CCCCC2)C1=O		CHEMBL3732044	=	Inhibition	%	-4.0	CHEMBL4722	Homo sapiens	INH	%	-4.0
	16379643	CHEMBL3738550	Inhibition of AurA (unknown origin) at 200 nM by electrophoretic mobility shift assay	B	COc1ccc2c(c1CN1CCNCC1)O/C(=C\c1n[nH]c3ncccc13)C2=O		CHEMBL3735816	=	Inhibition	%	5.1	CHEMBL4722	Homo sapiens	INH	%	5.1
	16379644	CHEMBL3738550	Inhibition of AurA (unknown origin) at 200 nM by electrophoretic mobility shift assay	B	COc1ccc2c(c1C(C)N1CCNCC1)O/C(=C\c1n[nH]c3ncccc13)C2=O		CHEMBL3735890	=	Inhibition	%	-0.4	CHEMBL4722	Homo sapiens	INH	%	-0.4
	16388284	CHEMBL3738897	Inhibition of AURKA (unknown origin) at 1 uM by selectscreen kinase profiling assay in presence of ATP	B	COc1cc2c(cc1OC)CN(CC(=O)Nc1ccc3c(c1)/C(=C/c1cnc[nH]1)C(=O)N3)CC2		CHEMBL3091673	=	Inhibition	%	37.0	CHEMBL4722	Homo sapiens	INH	%	37.0
	16398601	CHEMBL3744321	Inhibition of AurA (unknown origin) at 30 uM by microfluidic assay relative to control	B	CC(=O)c1nn(-c2ccccc2)cc1C(=O)c1c(C)[nH]c(-c2ccccc2)c1-c1ccccc1		CHEMBL3739750	=	Inhibition	%	8.0	CHEMBL4722	Homo sapiens	INH	%	8.0
	16398602	CHEMBL3744321	Inhibition of AurA (unknown origin) at 30 uM by microfluidic assay relative to control	B	CC(=O)c1nn(-c2ccc(C)cc2)cc1C(=O)c1c(C)[nH]c(-c2ccccc2)c1-c1ccccc1		CHEMBL3740247	=	Inhibition	%	11.0	CHEMBL4722	Homo sapiens	INH	%	11.0
	16398603	CHEMBL3744321	Inhibition of AurA (unknown origin) at 30 uM by microfluidic assay relative to control	B	CC(=O)c1nn(-c2ccc(Cl)cc2)cc1C(=O)c1c(C)[nH]c(-c2ccccc2)c1-c1ccccc1		CHEMBL3739587	=	Inhibition	%	1.0	CHEMBL4722	Homo sapiens	INH	%	1.0
	16398604	CHEMBL3744321	Inhibition of AurA (unknown origin) at 30 uM by microfluidic assay relative to control	B	CCOC(=O)c1nn(-c2ccccc2)cc1C(=O)c1c(C)[nH]c(-c2ccccc2)c1-c1ccccc1		CHEMBL3740131	=	Inhibition	%	24.0	CHEMBL4722	Homo sapiens	INH	%	24.0
	16398605	CHEMBL3744321	Inhibition of AurA (unknown origin) at 30 uM by microfluidic assay relative to control	B	CCOC(=O)c1nn(-c2ccc(C)cc2)cc1C(=O)c1c(C)[nH]c(-c2ccccc2)c1-c1ccccc1		CHEMBL3742349	=	Inhibition	%	13.0	CHEMBL4722	Homo sapiens	INH	%	13.0
	16398606	CHEMBL3744321	Inhibition of AurA (unknown origin) at 30 uM by microfluidic assay relative to control	B	CCOC(=O)c1nn(-c2ccc(Cl)cc2)cc1C(=O)c1c(C)[nH]c(-c2ccccc2)c1-c1ccccc1		CHEMBL3741526	=	Inhibition	%	12.0	CHEMBL4722	Homo sapiens	INH	%	12.0
	16398607	CHEMBL3744321	Inhibition of AurA (unknown origin) at 30 uM by microfluidic assay relative to control	B	Cc1[nH]c(-c2ccccc2)c(-c2ccccc2)c1C(=O)c1cn(-c2ccccc2)nc1C(=O)Nc1ccccc1		CHEMBL3740930	=	Inhibition	%	2.0	CHEMBL4722	Homo sapiens	INH	%	2.0
	16398608	CHEMBL3744321	Inhibition of AurA (unknown origin) at 30 uM by microfluidic assay relative to control	B	Cc1ccc(-n2cc(C(=O)c3c(C)[nH]c(-c4ccccc4)c3-c3ccccc3)c(C(=O)Nc3ccccc3)n2)cc1		CHEMBL3740713	=	Inhibition	%	12.0	CHEMBL4722	Homo sapiens	INH	%	12.0
	16398609	CHEMBL3744321	Inhibition of AurA (unknown origin) at 30 uM by microfluidic assay relative to control	B	Cc1[nH]c(-c2ccccc2)c(-c2ccccc2)c1C(=O)c1cn(-c2ccc(Cl)cc2)nc1C(=O)Nc1ccccc1		CHEMBL3740385	=	Inhibition	%	3.0	CHEMBL4722	Homo sapiens	INH	%	3.0
	16398610	CHEMBL3744321	Inhibition of AurA (unknown origin) at 30 uM by microfluidic assay relative to control	B	Cc1[nH]c(-c2ccccc2)c(-c2ccccc2)c1C(=O)c1cn(-c2ccccc2)nc1-c1ccccc1		CHEMBL3741069	=	Inhibition	%	12.0	CHEMBL4722	Homo sapiens	INH	%	12.0
	16398611	CHEMBL3744321	Inhibition of AurA (unknown origin) at 30 uM by microfluidic assay relative to control	B	Cc1[nH]c(-c2ccccc2)c(-c2ccccc2)c1-c1nnc(C)c2nn(-c3ccccc3)cc12		CHEMBL3740582	=	Inhibition	%	32.0	CHEMBL4722	Homo sapiens	INH	%	32.0
	16398612	CHEMBL3744321	Inhibition of AurA (unknown origin) at 30 uM by microfluidic assay relative to control	B	Cc1ccc(-n2cc3c(-c4c(C)[nH]c(-c5ccccc5)c4-c4ccccc4)nnc(C)c3n2)cc1		CHEMBL3742060	=	Inhibition	%	12.0	CHEMBL4722	Homo sapiens	INH	%	12.0
	16398613	CHEMBL3744321	Inhibition of AurA (unknown origin) at 30 uM by microfluidic assay relative to control	B	Cc1[nH]c(-c2ccccc2)c(-c2ccccc2)c1-c1nnc(C)c2nn(-c3ccc(Cl)cc3)cc12		CHEMBL3741655	=	Inhibition	%	12.0	CHEMBL4722	Homo sapiens	INH	%	12.0
	16398614	CHEMBL3744321	Inhibition of AurA (unknown origin) at 30 uM by microfluidic assay relative to control	B	Oc1nnc(-c2c[nH]c(-c3ccccc3)c2-c2ccccc2)c2cn(-c3ccccc3)nc12		CHEMBL3740923	=	Inhibition	%	32.0	CHEMBL4722	Homo sapiens	INH	%	32.0
	16398615	CHEMBL3744321	Inhibition of AurA (unknown origin) at 30 uM by microfluidic assay relative to control	B	Cc1ccc(-n2cc3c(-c4c[nH]c(-c5ccccc5)c4-c4ccccc4)nnc(O)c3n2)cc1		CHEMBL3739586	=	Inhibition	%	32.0	CHEMBL4722	Homo sapiens	INH	%	32.0
	16398616	CHEMBL3744321	Inhibition of AurA (unknown origin) at 30 uM by microfluidic assay relative to control	B	Oc1nnc(-c2c[nH]c(-c3ccccc3)c2-c2ccccc2)c2cn(-c3ccc(Cl)cc3)nc12		CHEMBL3742200	=	Inhibition	%	4.0	CHEMBL4722	Homo sapiens	INH	%	4.0
	16398617	CHEMBL3744321	Inhibition of AurA (unknown origin) at 30 uM by microfluidic assay relative to control	B	Cc1[nH]c(-c2ccccc2)c(-c2ccccc2)c1-c1ccc(NC(=O)c2ccccc2)c(=O)o1		CHEMBL3740003	=	Inhibition	%	12.0	CHEMBL4722	Homo sapiens	INH	%	12.0
	16398618	CHEMBL3744321	Inhibition of AurA (unknown origin) at 30 uM by microfluidic assay relative to control	B	Cc1c(C(=O)c2coc3ccc(O)cc23)[nH]c(-c2ccccc2)c1-c1ccccc1		CHEMBL3741960	=	Inhibition	%	12.0	CHEMBL4722	Homo sapiens	INH	%	12.0
	16398619	CHEMBL3744321	Inhibition of AurA (unknown origin) at 30 uM by microfluidic assay relative to control	B	Cc1c(C(=O)c2coc3c2cc(O)c2ccccc23)[nH]c(-c2ccccc2)c1-c1ccccc1		CHEMBL3740492	=	Inhibition	%	23.0	CHEMBL4722	Homo sapiens	INH	%	23.0
	16407054	CHEMBL3743406	Inhibition of aurora kinase A (unknown origin) incubated for 60 mins by fluorescence analysis	B	COC(=O)C1=C2CCC3=C2[C@@]2(C1)C(=O)[C@H]1C[C@@]4(O)N(C[C@H]1C)C[C@@H](CC3)[C@]42C		CHEMBL3740004	>	Inhibition	%	30.0	CHEMBL4722	Homo sapiens	INH	%	30.0
	16413408	CHEMBL3743736	Inhibition of Aurora2 (unknown origin)	B	O=C(O)C1CN(Cc2ccc(OCc3ccc(Cl)c(Cl)c3)cc2)C1		CHEMBL3741589	>	IC50	nM	10000.0	CHEMBL4722	Homo sapiens	IC50	uM	10.0
	16417061	CHEMBL3751442	Inhibition of AurA (unknown origin) at 10 uM	B	Cn1c(=O)c(Oc2ccc(F)cc2F)cc2cnc(NC3CCN(S(C)(=O)=O)CC3)nc21		CHEMBL3747699	=	Inhibition	%	32.0	CHEMBL4722	Homo sapiens	INH	%	32.0
	16417062	CHEMBL3751442	Inhibition of AurA (unknown origin) at 10 uM	B	Cn1c(=O)c(Oc2ccc(F)cc2F)cc2cnc(Nc3ccc(N4CCC(O)CC4)cc3)nc21		CHEMBL3746959	=	Inhibition	%	66.0	CHEMBL4722	Homo sapiens	INH	%	66.0
	16417063	CHEMBL3751442	Inhibition of AurA (unknown origin) at 10 uM	B	CN1CCN(CCCNc2ncc3cc(Oc4ccc(F)cc4F)c(=O)n(C)c3n2)CC1		CHEMBL3746022	=	Inhibition	%	6.0	CHEMBL4722	Homo sapiens	INH	%	6.0
	16417064	CHEMBL3751442	Inhibition of AurA (unknown origin) at 10 uM	B	CN1CCN(c2ccc(Nc3ncc4cc(Oc5ccc(F)cc5F)c(=O)n(C)c4n3)cc2)CC1		CHEMBL3745734	=	Inhibition	%	54.0	CHEMBL4722	Homo sapiens	INH	%	54.0
	16417065	CHEMBL3751442	Inhibition of AurA (unknown origin) at 10 uM	B	Cn1c(=O)c(Oc2c(Cl)cccc2Cl)cc2cnc(NC3CCOCC3)nc21		CHEMBL3747351	=	Inhibition	%	3.0	CHEMBL4722	Homo sapiens	INH	%	3.0
	16417066	CHEMBL3751442	Inhibition of AurA (unknown origin) at 10 uM	B	CN1CCN(c2ccc(Nc3ncc4cc(Oc5c(Cl)cccc5Cl)c(=O)n(C)c4n3)cc2)CC1		CHEMBL3747023	=	Inhibition	%	12.0	CHEMBL4722	Homo sapiens	INH	%	12.0
	16417067	CHEMBL3751442	Inhibition of AurA (unknown origin) at 10 uM	B	Cn1c(=O)c(Oc2ccc(F)cc2F)cc2cnc(NCCc3ccccn3)nc21		CHEMBL3746951	=	Inhibition	%	4.0	CHEMBL4722	Homo sapiens	INH	%	4.0
	16417068	CHEMBL3751442	Inhibition of AurA (unknown origin) at 10 uM	B	Cn1c(=O)c(Oc2ccc(F)cc2F)cc2cnc(Nc3ccc(N4CCCCC4)cc3)nc21		CHEMBL3746973	=	Inhibition	%	14.0	CHEMBL4722	Homo sapiens	INH	%	14.0
	16417069	CHEMBL3751442	Inhibition of AurA (unknown origin) at 10 uM	B	CN(C)CCNc1ncc2cc(Oc3ccc(F)cc3F)c(=O)n(C)c2n1		CHEMBL3745857	=	Inhibition	%	7.0	CHEMBL4722	Homo sapiens	INH	%	7.0
	16421897	CHEMBL3750237	Inhibition of Aurora A (unknown origin)	B	C[C@@H]1C[C@H](N)C[C@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cccc3F)n2)C1		CHEMBL3651966	>	IC50	nM	10000.0	CHEMBL4722	Homo sapiens	IC50	uM	10.0
	16425401	CHEMBL3751052	Inhibition of AuroraA (unknown origin) at 1 uM	B	Cc1c(-c2cc(Nc3cc4n(n3)CCN(C)C4)c(=O)[nH]n2)ccc(F)c1NC(=O)c1cc2ccccc2s1		CHEMBL3746293	=	Inhibition	%	1.1	CHEMBL4722	Homo sapiens	INH	%	1.1
	16429044	CHEMBL3750782	Inhibition of AurA (unknown origin) at 1 uM	B	Cn1c(=O)c(Oc2ccc(F)cc2F)cc2cnc(NC3CCN(S(N)(=O)=O)CC3)nc21		CHEMBL3747489	=	Inhibition	%	1.0	CHEMBL4722	Homo sapiens	INH	%	1.0
	16431733	CHEMBL3748625	Inhibition of human Aurora A using [H-LRRASLG] as substrate	B	Cn1c(=O)c(S(=O)(=O)c2ccc(F)cc2F)cc2cnc(Nc3ccc4[nH]ccc4c3)nc21		CHEMBL3745885	>	IC50	nM	10000.0	CHEMBL4722	Homo sapiens	IC50	uM	10.0
	16433829	CHEMBL3756751	Inhibition of human AURA using kemptide as substrate at 10 uM after 1 hr in presence of 30 uM ATP	B	CN1CCN(c2ccc(NC(=O)c3ccc(-c4cc(Cl)ccc4Cl)o3)cc2)CC1		CHEMBL3754324	=	Inhibition	%	19.5	CHEMBL4722	Homo sapiens	INH	%	19.5
	16433830	CHEMBL3756751	Inhibition of human AURA using kemptide as substrate at 10 uM after 1 hr in presence of 30 uM ATP	B	Cc1c(Cl)cccc1-c1ccc(C(=O)Nc2ccc(S(N)(=O)=O)cc2)o1		CHEMBL3752265	=	Inhibition	%	17.4	CHEMBL4722	Homo sapiens	INH	%	17.4
Not Active	16437063	CHEMBL3757360	Inhibition of human aurora A at 10 uM after 20 to 40 mins by liquid scintillation counting analysis in presence of [28P]-ATP	B	O=C(Nc1ccc(Nc2ncnc3c2cnn3-c2ccccc2)cc1)Nc1cccc(Cl)c1		CHEMBL3753426		Inhibition	%		CHEMBL4722	Homo sapiens	INH		
	16438256	CHEMBL3757184	Inhibition of Aurora A (unknown origin) using poly(Glu:Tyr) as substrate by ELISA-based method	B	CC(C)n1ncc2cnc(Nc3cc(C(N)=O)n(C)c3)nc21		CHEMBL2012308	=	IC50	nM	17.0	CHEMBL4722	Homo sapiens	IC50	uM	0.017
	16450764	CHEMBL3762150	Inhibition of Aurora A (unknown origin) at 100 nM	B	CC1(C)OCc2c(Nc3n[nH]c4ccccc34)nc(-c3cn[nH]c3)nc21		CHEMBL3758502	=	Inhibition	%	-5.4	CHEMBL4722	Homo sapiens	INH	%	-5.4
	16457590	CHEMBL3761560	Inhibition of AURKA (unknown origin) at 500 nM	B	C[C@@H](Nc1ncnc2sc(-c3ccccc3C(N)=O)cc12)c1ccccc1		CHEMBL3759085	=	Inhibition	%	6.0	CHEMBL4722	Homo sapiens	INH	%	6.0
	16457591	CHEMBL3761560	Inhibition of AURKA (unknown origin) at 500 nM	B	C[C@@H](Nc1ncnc2sc(-c3ccc(C(=O)NCCN(C)C)cc3)cc12)c1ccccc1		CHEMBL3758800	=	Inhibition	%	3.0	CHEMBL4722	Homo sapiens	INH	%	3.0
	16457592	CHEMBL3761560	Inhibition of AURKA (unknown origin) at 500 nM	B	CN(C)CCNC(=O)c1ccc(-c2cc3c(N[C@H](CO)c4ccccc4)ncnc3s2)cc1		CHEMBL3758376	=	Inhibition	%	6.0	CHEMBL4722	Homo sapiens	INH	%	6.0
	16457593	CHEMBL3761560	Inhibition of AURKA (unknown origin) at 500 nM	B	COc1cc(C(N)=O)ccc1-c1cc2c(N[C@H](CO)c3ccccc3)ncnc2s1		CHEMBL3759480	=	Inhibition	%	6.0	CHEMBL4722	Homo sapiens	INH	%	6.0
	16457594	CHEMBL3761560	Inhibition of AURKA (unknown origin) at 500 nM	B	COc1ccc(C(=O)NCCN(C)C)cc1-c1cc2c(N[C@H](C)c3ccccc3)ncnc2s1		CHEMBL3758582	=	Inhibition	%	-4.0	CHEMBL4722	Homo sapiens	INH	%	-4.0
	16457595	CHEMBL3761560	Inhibition of AURKA (unknown origin) at 500 nM	B	COc1cc(CO)ccc1-c1cc2c(N[C@H](C)c3ccccc3)ncnc2s1		CHEMBL3759559	=	Inhibition	%	1.0	CHEMBL4722	Homo sapiens	INH	%	1.0
	16457596	CHEMBL3761560	Inhibition of AURKA (unknown origin) at 500 nM	B	COc1cc(CO)ccc1-c1cc2c(N[C@H](CO)c3ccccc3)ncnc2s1		CHEMBL3758682	=	Inhibition	%	5.0	CHEMBL4722	Homo sapiens	INH	%	5.0
	16457597	CHEMBL3761560	Inhibition of AURKA (unknown origin) at 500 nM	B	COc1cc(CO)ccc1-c1cc2c(Nc3ccccc3)ncnc2s1		CHEMBL3758768	=	Inhibition	%	-3.0	CHEMBL4722	Homo sapiens	INH	%	-3.0
	16457598	CHEMBL3761560	Inhibition of AURKA (unknown origin) at 500 nM	B	C#Cc1cccc(Nc2ncnc3sc(-c4ccc(CO)cc4OC)cc23)c1		CHEMBL3758802	=	Inhibition	%	14.0	CHEMBL4722	Homo sapiens	INH	%	14.0
	16457599	CHEMBL3761560	Inhibition of AURKA (unknown origin) at 500 nM	B	COc1cc(CO)ccc1-c1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2s1		CHEMBL3758351	=	Inhibition	%	-6.0	CHEMBL4722	Homo sapiens	INH	%	-6.0
	16457600	CHEMBL3761560	Inhibition of AURKA (unknown origin) at 500 nM	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	=	Inhibition	%	20.0	CHEMBL4722	Homo sapiens	INH	%	20.0
	16465843	CHEMBL3768032	Inhibition of human Aurora A at 10 uM	B	Cc1cncn1-c1cc(C(=O)Nc2cccc(CNc3ccc4c(C(=O)N[C@@H](C)C(N)=O)[nH]nc4c3)c2)cc(C(F)(F)F)c1		CHEMBL3764798	=	Inhibition	%	4.99	CHEMBL4722	Homo sapiens	INH	%	4.99
	16474669	CHEMBL3767155	Inhibition of Aurora A (unknown origin) at 10 uM	B	CN1CCN(CCCOc2ccc(N3C(=O)/C(=C/c4ccc(Oc5ccc(F)cc5)cc4)SC3=S)cc2)CC1		CHEMBL3765499	=	Inhibition	%	0.0	CHEMBL4722	Homo sapiens	INH	%	0.0
	16485700	CHEMBL3773981	Inhibition of human recombinant AURKA assessed as residual activity at 10 uM after 1 hr by qPCR analysis relative to control	B	Cc1c(Cl)cccc1NC(=O)c1sc2nc3c(cc2c1N)C(=O)CC3		CHEMBL3771285	=	Activity	%	98.0	CHEMBL4722	Homo sapiens	Activity	%	98.0
	16495336	CHEMBL3776649	Inhibition of N-terminal His6-tagged recombinant human AURKA expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control	B	Cn1cc(-c2ccc(Cc3n[nH]c4ccc(C(=O)N5CCOCC5)cc34)cc2)cn1		CHEMBL3774885	=	Activity	%	-6.0	CHEMBL4722	Homo sapiens	Activity	%	-6.0
	16508105	CHEMBL3776649	Inhibition of N-terminal His6-tagged recombinant human AURKA expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control	B	CNC(=O)c1ccc2[nH]nc(Cc3ccc4c(cnn4C)c3)c2c1		CHEMBL3775576	=	Activity	%	-2.0	CHEMBL4722	Homo sapiens	Activity	%	-2.0
	16509082	CHEMBL3776649	Inhibition of N-terminal His6-tagged recombinant human AURKA expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control	B	Cn1cc(-c2ccc(Cc3n[nH]c4ccc(C(=O)N5CC[C@@H](O)C5)cc34)cc2)cn1		CHEMBL3775317	=	Activity	%	-11.0	CHEMBL4722	Homo sapiens	Activity	%	-11.0
	16509794	CHEMBL3782938	Inhibition of N-terminal His6-tagged recombinant full length human Aurora A expressed in Sf21 cells assessed as residual activity at 10 uM	B	Cc1ccc2nc(C3=C(N)N(c4cccc(O)c4)CC3=O)[nH]c2c1		CHEMBL3781980	=	Activity	%	75.8	CHEMBL4722	Homo sapiens	Activity	%	75.8
	16509806	CHEMBL3782938	Inhibition of N-terminal His6-tagged recombinant full length human Aurora A expressed in Sf21 cells assessed as residual activity at 10 uM	B	NC1=C(c2nc3ccccc3[nH]2)C(=O)CN1c1cccc(O)c1		CHEMBL3781511	=	Activity	%	85.8	CHEMBL4722	Homo sapiens	Activity	%	85.8
Not Active	16514099	CHEMBL3782147	Inhibition of partial length human Aurora A expressed in mammalian system at 1 uM	B	Cc1cnc(N)nc1OCC(C)(C)CO		CHEMBL3780032		Inhibition	%		CHEMBL4722	Homo sapiens	INH		
	16525717	CHEMBL3789975	Inhibition of AURKA (unknown origin) in presence of [gamma33P]ATP	B	Nc1ncnc2c1c(-c1cccc(OC[C@@H]3CCCO3)c1)cn2[C@H]1C[C@@H](CN2CCC2)C1		CHEMBL3787614	>	IC50	nM	10000.0	CHEMBL4722	Homo sapiens	IC50	uM	10.0
	16525718	CHEMBL3789975	Inhibition of AURKA (unknown origin) in presence of [gamma33P]ATP	B	CC(=O)N1CCN([C@H]2C[C@@H](n3cc(-c4cccc(OC[C@@H]5CCCO5)c4F)c4c(N)ncnc43)C2)CC1		CHEMBL3786167	>	IC50	nM	10000.0	CHEMBL4722	Homo sapiens	IC50	uM	10.0
	16534415	CHEMBL3789285	Inhibition of human Aurora A at 1 uM after 30 mins by fluorescence assay in presence of ATP	B	COc1cc2c(cc1Nc1ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n1)CCC(N)C2(C)C		CHEMBL3786892	=	Inhibition	%	99.0	CHEMBL4722	Homo sapiens	INH	%	99.0
	16540739	CHEMBL3789975	Inhibition of AURKA (unknown origin) in presence of [gamma33P]ATP	B	Nc1ncnc2c1c(-c1cccc(OCc3ccccc3)c1)cn2[C@H]1C[C@@H](CN2CCC2)C1		CHEMBL1614712	>	IC50	nM	10000.0	CHEMBL4722	Homo sapiens	IC50	uM	10.0
	16540740	CHEMBL3789975	Inhibition of AURKA (unknown origin) in presence of [gamma33P]ATP	B	Nc1ncnc2c1c(-c1cccc(O)c1)cn2[C@H]1C[C@@H](CN2CCC2)C1		CHEMBL3787112	=	IC50	nM	3100.0	CHEMBL4722	Homo sapiens	IC50	uM	3.1
	16540741	CHEMBL3789975	Inhibition of AURKA (unknown origin) in presence of [gamma33P]ATP	B	Nc1ncnc2c1c(-c1cccc(OCC34CCC(CC3)O4)c1)cn2[C@H]1C[C@@H](CN2CCC2)C1		CHEMBL3785500	>	IC50	nM	10000.0	CHEMBL4722	Homo sapiens	IC50	uM	10.0
	16540742	CHEMBL3789975	Inhibition of AURKA (unknown origin) in presence of [gamma33P]ATP	B	CC(=O)N1CCN([C@H]2C[C@@H](n3cc(-c4cc(OC[C@@H]5CCCO5)ccc4F)c4c(N)ncnc43)C2)CC1		CHEMBL3785951	>	IC50	nM	10000.0	CHEMBL4722	Homo sapiens	IC50	uM	10.0
	16552220	CHEMBL3795296	Inhibition of human Aurora A using H-LRRASLG as substrate at 10 uM after 2 hrs by HotSpot assay in presence of 33P-ATP and 1 uM ATP	B	COC(=O)c1cccc(NC(=O)c2cc(-n3cc(CCNC(C)=O)nn3)ccc2O)c1		CHEMBL3792982	=	Inhibition	%	13.2	CHEMBL4722	Homo sapiens	INH	%	13.2
	16552221	CHEMBL3795296	Inhibition of human Aurora A using H-LRRASLG as substrate at 10 uM after 2 hrs by HotSpot assay in presence of 33P-ATP and 1 uM ATP	B	COC(=O)c1cccc(NC(=O)c2cc(-n3cc(CCN(C)C)nn3)ccc2O)c1		CHEMBL3792798	=	Inhibition	%	6.44	CHEMBL4722	Homo sapiens	INH	%	6.44
	16552222	CHEMBL3795296	Inhibition of human Aurora A using H-LRRASLG as substrate at 10 uM after 2 hrs by HotSpot assay in presence of 33P-ATP and 1 uM ATP	B	COC(=O)c1cccc(NC(=O)c2cc(-n3cc(CNCCN4CCOCC4)nn3)ccc2O)c1		CHEMBL3793006	=	Inhibition	%	15.3	CHEMBL4722	Homo sapiens	INH	%	15.3
	16552223	CHEMBL3795296	Inhibition of human Aurora A using H-LRRASLG as substrate at 10 uM after 2 hrs by HotSpot assay in presence of 33P-ATP and 1 uM ATP	B	COC(=O)c1cccc(NC(=O)c2cc(-n3cc(CN4CCOCC4)nn3)ccc2O)c1		CHEMBL3793815	=	Inhibition	%	11.7	CHEMBL4722	Homo sapiens	INH	%	11.7
	16552224	CHEMBL3795296	Inhibition of human Aurora A using H-LRRASLG as substrate at 10 uM after 2 hrs by HotSpot assay in presence of 33P-ATP and 1 uM ATP	B	COC(=O)c1cccc(NC(=O)c2cc(-n3cc(CCNc4ncnc5ccsc45)nn3)ccc2O)c1		CHEMBL3792712	=	Inhibition	%	69.1	CHEMBL4722	Homo sapiens	INH	%	69.1
	16552225	CHEMBL3795296	Inhibition of human Aurora A using H-LRRASLG as substrate at 10 uM after 2 hrs by HotSpot assay in presence of 33P-ATP and 1 uM ATP	B	COC(=O)c1cccc(NC(=O)c2cc(-n3cc(CNc4ncnc5ccsc45)nn3)ccc2O)c1		CHEMBL3794018	=	Inhibition	%	62.5	CHEMBL4722	Homo sapiens	INH	%	62.5
	16552226	CHEMBL3795296	Inhibition of human Aurora A using H-LRRASLG as substrate at 10 uM after 2 hrs by HotSpot assay in presence of 33P-ATP and 1 uM ATP	B	COC(=O)c1cccc(NC(=O)c2cc(-n3cc(CNc4nc5ccccc5o4)nn3)ccc2O)c1		CHEMBL3792621	=	Inhibition	%	75.4	CHEMBL4722	Homo sapiens	INH	%	75.4
	16552227	CHEMBL3795296	Inhibition of human Aurora A using H-LRRASLG as substrate at 10 uM after 2 hrs by HotSpot assay in presence of 33P-ATP and 1 uM ATP	B	COC(=O)c1cccc(NC(=O)c2cc(-n3cc(CNc4ncco4)nn3)ccc2O)c1		CHEMBL3794530	=	Inhibition	%	0.0	CHEMBL4722	Homo sapiens	INH	%	0.0
	16552228	CHEMBL3795296	Inhibition of human Aurora A using H-LRRASLG as substrate at 10 uM after 2 hrs by HotSpot assay in presence of 33P-ATP and 1 uM ATP	B	COC(=O)c1cccc(NC(=O)c2cc(-n3cc(CCNc4ncccn4)nn3)ccc2O)c1		CHEMBL3792988	=	Inhibition	%	70.2	CHEMBL4722	Homo sapiens	INH	%	70.2
	16552229	CHEMBL3795296	Inhibition of human Aurora A using H-LRRASLG as substrate at 10 uM after 2 hrs by HotSpot assay in presence of 33P-ATP and 1 uM ATP	B	COC(=O)c1cccc(NC(=O)c2cc(-n3cc(CNc4ncccn4)nn3)ccc2O)c1		CHEMBL3794376	=	Inhibition	%	29.2	CHEMBL4722	Homo sapiens	INH	%	29.2
	16552230	CHEMBL3795296	Inhibition of human Aurora A using H-LRRASLG as substrate at 10 uM after 2 hrs by HotSpot assay in presence of 33P-ATP and 1 uM ATP	B	COC(=O)c1cccc(NC(=O)c2cc(-n3cc(CNc4cccc(C)n4)nn3)ccc2O)c1		CHEMBL3793818	=	Inhibition	%	55.9	CHEMBL4722	Homo sapiens	INH	%	55.9
	16552231	CHEMBL3795296	Inhibition of human Aurora A using H-LRRASLG as substrate at 10 uM after 2 hrs by HotSpot assay in presence of 33P-ATP and 1 uM ATP	B	COC(=O)c1cccc(NC(=O)c2cc(-n3cc(CNc4cc(C)on4)nn3)ccc2O)c1		CHEMBL3794450	=	Inhibition	%	71.8	CHEMBL4722	Homo sapiens	INH	%	71.8
	16552232	CHEMBL3795296	Inhibition of human Aurora A using H-LRRASLG as substrate at 10 uM after 2 hrs by HotSpot assay in presence of 33P-ATP and 1 uM ATP	B	COC(=O)c1cccc(NC(=O)c2cc(-n3cc(CNc4ccccc4)nn3)ccc2O)c1		CHEMBL3792563	=	Inhibition	%	64.7	CHEMBL4722	Homo sapiens	INH	%	64.7
	16552233	CHEMBL3795296	Inhibition of human Aurora A using H-LRRASLG as substrate at 10 uM after 2 hrs by HotSpot assay in presence of 33P-ATP and 1 uM ATP	B	COC(=O)c1cccc(NC(=O)c2cc(-n3cc(-c4ccc5c(c4)OCO5)nn3)ccc2O)c1		CHEMBL3793405	=	Inhibition	%	67.9	CHEMBL4722	Homo sapiens	INH	%	67.9
	16552234	CHEMBL3795296	Inhibition of human Aurora A using H-LRRASLG as substrate at 10 uM after 2 hrs by HotSpot assay in presence of 33P-ATP and 1 uM ATP	B	COC(=O)c1cccc(NC(=O)c2cc(-n3cc(-c4ccc5c(c4)OCCO5)nn3)ccc2O)c1		CHEMBL3793254	=	Inhibition	%	61.7	CHEMBL4722	Homo sapiens	INH	%	61.7
	16552235	CHEMBL3795296	Inhibition of human Aurora A using H-LRRASLG as substrate at 10 uM after 2 hrs by HotSpot assay in presence of 33P-ATP and 1 uM ATP	B	COC(=O)c1cccc(NC(=O)c2cc(-n3cc(-c4ccc5nccnc5c4)nn3)ccc2O)c1		CHEMBL3793945	=	Inhibition	%	62.3	CHEMBL4722	Homo sapiens	INH	%	62.3
	16552236	CHEMBL3795296	Inhibition of human Aurora A using H-LRRASLG as substrate at 10 uM after 2 hrs by HotSpot assay in presence of 33P-ATP and 1 uM ATP	B	COC(=O)c1cccc(NC(=O)c2cc(-n3cc(-c4cccc([N+](=O)[O-])c4)nn3)ccc2O)c1		CHEMBL3794572	=	Inhibition	%	77.0	CHEMBL4722	Homo sapiens	INH	%	77.0
	16552252	CHEMBL3795294	Inhibition of human Aurora A using H-LRRASLG as substrate after 2 hrs by HotSpot assay in presence of 33P-ATP and 10 uM ATP	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	2.0	CHEMBL4722	Homo sapiens	IC50	uM	0.002
	16552253	CHEMBL3795294	Inhibition of human Aurora A using H-LRRASLG as substrate after 2 hrs by HotSpot assay in presence of 33P-ATP and 10 uM ATP	B	COC(=O)c1cccc(NC(=O)c2cc(-n3cc(-c4cc(OC)cc(OC)c4)nn3)ccc2O)c1		CHEMBL3322935	=	IC50	nM	768.0	CHEMBL4722	Homo sapiens	IC50	uM	0.768
	16552254	CHEMBL3795294	Inhibition of human Aurora A using H-LRRASLG as substrate after 2 hrs by HotSpot assay in presence of 33P-ATP and 10 uM ATP	B	COC(=O)c1cccc(NC(=O)c2cc(-n3cc(CNc4cc(C)ccn4)nn3)ccc2O)c1		CHEMBL3792856	=	IC50	nM	6070.0	CHEMBL4722	Homo sapiens	IC50	uM	6.07
	16552255	CHEMBL3795294	Inhibition of human Aurora A using H-LRRASLG as substrate after 2 hrs by HotSpot assay in presence of 33P-ATP and 10 uM ATP	B	COC(=O)c1cccc(NC(=O)c2cc(-n3cc(CNc4ccccn4)nn3)ccc2O)c1		CHEMBL3793352	=	IC50	nM	6430.0	CHEMBL4722	Homo sapiens	IC50	uM	6.43
	16552256	CHEMBL3795294	Inhibition of human Aurora A using H-LRRASLG as substrate after 2 hrs by HotSpot assay in presence of 33P-ATP and 10 uM ATP	B	COC(=O)c1cccc(NC(=O)c2cc(-n3cc(CNc4cc(C)[nH]n4)nn3)ccc2O)c1		CHEMBL3792583	=	IC50	nM	13700.0	CHEMBL4722	Homo sapiens	IC50	uM	13.7
	16552257	CHEMBL3795294	Inhibition of human Aurora A using H-LRRASLG as substrate after 2 hrs by HotSpot assay in presence of 33P-ATP and 10 uM ATP	B	COC(=O)c1cccc(NC(=O)c2cc(-n3cc(CCNc4ncnc5ccsc45)nn3)ccc2O)c1		CHEMBL3792712	=	IC50	nM	2970.0	CHEMBL4722	Homo sapiens	IC50	uM	2.97
	16552258	CHEMBL3795294	Inhibition of human Aurora A using H-LRRASLG as substrate after 2 hrs by HotSpot assay in presence of 33P-ATP and 10 uM ATP	B	COC(=O)c1cccc(NC(=O)c2cc(-n3cc(CNc4ncnc5ccsc45)nn3)ccc2O)c1		CHEMBL3794018	=	IC50	nM	801.0	CHEMBL4722	Homo sapiens	IC50	uM	0.801
	16552259	CHEMBL3795294	Inhibition of human Aurora A using H-LRRASLG as substrate after 2 hrs by HotSpot assay in presence of 33P-ATP and 10 uM ATP	B	COC(=O)c1cccc(NC(=O)c2cc(-n3cc(CNc4nc5ccccc5o4)nn3)ccc2O)c1		CHEMBL3792621	=	IC50	nM	3520.0	CHEMBL4722	Homo sapiens	IC50	uM	3.52
	16552260	CHEMBL3795294	Inhibition of human Aurora A using H-LRRASLG as substrate after 2 hrs by HotSpot assay in presence of 33P-ATP and 10 uM ATP	B	COC(=O)c1cccc(NC(=O)c2cc(-n3cc(CCNc4ncccn4)nn3)ccc2O)c1		CHEMBL3792988	=	IC50	nM	7670.0	CHEMBL4722	Homo sapiens	IC50	uM	7.67
	16552261	CHEMBL3795294	Inhibition of human Aurora A using H-LRRASLG as substrate after 2 hrs by HotSpot assay in presence of 33P-ATP and 10 uM ATP	B	COC(=O)c1cccc(NC(=O)c2cc(-n3cc(CNc4ncccn4)nn3)ccc2O)c1		CHEMBL3794376	=	IC50	nM	15400.0	CHEMBL4722	Homo sapiens	IC50	uM	15.4
	16552262	CHEMBL3795294	Inhibition of human Aurora A using H-LRRASLG as substrate after 2 hrs by HotSpot assay in presence of 33P-ATP and 10 uM ATP	B	COC(=O)c1cccc(NC(=O)c2cc(-n3cc(CNc4cc(C)on4)nn3)ccc2O)c1		CHEMBL3794450	=	IC50	nM	12400.0	CHEMBL4722	Homo sapiens	IC50	uM	12.4
	16552263	CHEMBL3795294	Inhibition of human Aurora A using H-LRRASLG as substrate after 2 hrs by HotSpot assay in presence of 33P-ATP and 10 uM ATP	B	COC(=O)c1cccc(NC(=O)c2cc(-n3cc(CNc4ccccc4)nn3)ccc2O)c1		CHEMBL3792563	=	IC50	nM	5150.0	CHEMBL4722	Homo sapiens	IC50	uM	5.15
	16552264	CHEMBL3795294	Inhibition of human Aurora A using H-LRRASLG as substrate after 2 hrs by HotSpot assay in presence of 33P-ATP and 10 uM ATP	B	COC(=O)c1cccc(NC(=O)c2cc(-n3cc(-c4ccc5c(c4)OCO5)nn3)ccc2O)c1		CHEMBL3793405	=	IC50	nM	638.0	CHEMBL4722	Homo sapiens	IC50	uM	0.638
	16552265	CHEMBL3795294	Inhibition of human Aurora A using H-LRRASLG as substrate after 2 hrs by HotSpot assay in presence of 33P-ATP and 10 uM ATP	B	COC(=O)c1cccc(NC(=O)c2cc(-n3cc(-c4ccc5nccnc5c4)nn3)ccc2O)c1		CHEMBL3793945	=	IC50	nM	607.0	CHEMBL4722	Homo sapiens	IC50	uM	0.607
	16552266	CHEMBL3795294	Inhibition of human Aurora A using H-LRRASLG as substrate after 2 hrs by HotSpot assay in presence of 33P-ATP and 10 uM ATP	B	COC(=O)c1cccc(NC(=O)c2cc(-n3cc(-c4cccc([N+](=O)[O-])c4)nn3)ccc2O)c1		CHEMBL3794572	=	IC50	nM	284.0	CHEMBL4722	Homo sapiens	IC50	uM	0.284
	16552267	CHEMBL3795296	Inhibition of human Aurora A using H-LRRASLG as substrate at 10 uM after 2 hrs by HotSpot assay in presence of 33P-ATP and 1 uM ATP	B	COC(=O)c1cccc(NC(=O)c2cc(-n3cc(CNc4cc(C)[nH]n4)nn3)ccc2O)c1		CHEMBL3792583	=	Inhibition	%	66.9	CHEMBL4722	Homo sapiens	INH	%	66.9
	16552268	CHEMBL3795296	Inhibition of human Aurora A using H-LRRASLG as substrate at 10 uM after 2 hrs by HotSpot assay in presence of 33P-ATP and 1 uM ATP	B	COC(=O)c1cccc(NC(=O)c2cc(-n3cc(CNc4nccs4)nn3)ccc2O)c1		CHEMBL3794561	=	Inhibition	%	54.1	CHEMBL4722	Homo sapiens	INH	%	54.1
	16552269	CHEMBL3795296	Inhibition of human Aurora A using H-LRRASLG as substrate at 10 uM after 2 hrs by HotSpot assay in presence of 33P-ATP and 1 uM ATP	B	COC(=O)c1cccc(NC(=O)c2cc(-n3cc(CNc4ncc[nH]4)nn3)ccc2O)c1		CHEMBL3792760	=	Inhibition	%	30.0	CHEMBL4722	Homo sapiens	INH	%	30.0
	16552270	CHEMBL3795296	Inhibition of human Aurora A using H-LRRASLG as substrate at 10 uM after 2 hrs by HotSpot assay in presence of 33P-ATP and 1 uM ATP	B	COC(=O)c1cccc(NC(=O)c2cc(-n3cc(CNc4ccccn4)nn3)ccc2O)c1		CHEMBL3793352	=	Inhibition	%	79.6	CHEMBL4722	Homo sapiens	INH	%	79.6
	16552271	CHEMBL3795296	Inhibition of human Aurora A using H-LRRASLG as substrate at 10 uM after 2 hrs by HotSpot assay in presence of 33P-ATP and 1 uM ATP	B	COC(=O)c1cccc(NC(=O)c2cc(-n3cc(CNc4cc(C)ccn4)nn3)ccc2O)c1		CHEMBL3792856	=	Inhibition	%	75.3	CHEMBL4722	Homo sapiens	INH	%	75.3
	16552272	CHEMBL3795296	Inhibition of human Aurora A using H-LRRASLG as substrate at 10 uM after 2 hrs by HotSpot assay in presence of 33P-ATP and 1 uM ATP	B	COC(=O)c1cccc(NC(=O)c2cc(-n3cc(CNc4ccncc4)nn3)ccc2O)c1		CHEMBL3793284	=	Inhibition	%	9.25	CHEMBL4722	Homo sapiens	INH	%	9.25
	16552273	CHEMBL3795296	Inhibition of human Aurora A using H-LRRASLG as substrate at 10 uM after 2 hrs by HotSpot assay in presence of 33P-ATP and 1 uM ATP	B	COC(=O)c1cccc(NC(=O)c2cc(-n3cc(CNc4ccncn4)nn3)ccc2O)c1		CHEMBL3793725	=	Inhibition	%	29.5	CHEMBL4722	Homo sapiens	INH	%	29.5
	16552274	CHEMBL3795296	Inhibition of human Aurora A using H-LRRASLG as substrate at 10 uM after 2 hrs by HotSpot assay in presence of 33P-ATP and 1 uM ATP	B	COC(=O)c1cccc(NC(=O)c2cc(-n3cc(-c4cc(OC)cc(OC)c4)nn3)ccc2O)c1		CHEMBL3322935	=	Inhibition	%	64.1	CHEMBL4722	Homo sapiens	INH	%	64.1
	16552314	CHEMBL3795299	Inhibition of human Aurora A using H-LRRASLG as substrate after 2 hrs by HotSpot assay in presence of 33P-ATP and 1 uM ATP	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	<	IC50	nM	1.0	CHEMBL4722	Homo sapiens	IC50	uM	0.001
	16556373	CHEMBL3796370	Inhibition of human recombinant Aurora-A assessed as residual activity at 10 uM in presence of [gamma-32P]ATP by radiometric protein kinase assay	B	Cc1sc2ncnc(Nc3cccc(C(=O)O)c3)c2c1-c1ccccc1		CHEMBL3792965	=	Activity	%	15.3	CHEMBL4722	Homo sapiens	Activity	%	15.3
	16556374	CHEMBL3796370	Inhibition of human recombinant Aurora-A assessed as residual activity at 10 uM in presence of [gamma-32P]ATP by radiometric protein kinase assay	B	O=C(O)c1cccc(Nc2ncnc3scc(-c4ccccc4)c23)c1		CHEMBL1719248	=	Activity	%	38.9	CHEMBL4722	Homo sapiens	Activity	%	38.9
	16556375	CHEMBL3796370	Inhibition of human recombinant Aurora-A assessed as residual activity at 10 uM in presence of [gamma-32P]ATP by radiometric protein kinase assay	B	Cc1ccc(-c2csc3ncnc(Nc4cccc(C(=O)O)c4)c23)cc1		CHEMBL3401764	=	Activity	%	36.2	CHEMBL4722	Homo sapiens	Activity	%	36.2
	16559682	CHEMBL3794923	Inhibition of full length human N-terminal GST-tagged Aurora A (1 to 403 residues) expressed in baculovirus expression system using fluorescence labelled kemptide as substrate at 50 times IC50 by electrophoretic mobility shift assay relative to control	B	O=C(Nc1ccccc1)c1n[nH]c2ccccc12		CHEMBL508964	=	Inhibition	%	45.2	CHEMBL4722	Homo sapiens	INH	%	45.2
	16559683	CHEMBL3794923	Inhibition of full length human N-terminal GST-tagged Aurora A (1 to 403 residues) expressed in baculovirus expression system using fluorescence labelled kemptide as substrate at 50 times IC50 by electrophoretic mobility shift assay relative to control	B	O=C(Nc1ccc(C(=O)N2CCN(c3ccccc3)CC2)cc1)c1n[nH]c2ccccc12		CHEMBL3793843	=	Inhibition	%	31.3	CHEMBL4722	Homo sapiens	INH	%	31.3
	16559684	CHEMBL3794923	Inhibition of full length human N-terminal GST-tagged Aurora A (1 to 403 residues) expressed in baculovirus expression system using fluorescence labelled kemptide as substrate at 50 times IC50 by electrophoretic mobility shift assay relative to control	B	O=C(Nc1ccc(CN2CCN(c3ccccc3)CC2)cc1)c1n[nH]c2ccccc12		CHEMBL3792850	=	Inhibition	%	6.1	CHEMBL4722	Homo sapiens	INH	%	6.1
	16562707	CHEMBL3802091	Inhibition of Aurora A (unknown origin) at 1 uM	B	CSc1sc(-c2cc[nH]n2)c2c1C(=O)NCC2		CHEMBL3800053	=	Inhibition	%	40.0	CHEMBL4722	Homo sapiens	INH	%	40.0
	16562708	CHEMBL3802091	Inhibition of Aurora A (unknown origin) at 1 uM	B	CSc1sc(-c2cc[nH]n2)c2c1C(=O)N[C@@H](c1ccccc1)C2		CHEMBL3800284	=	Inhibition	%	40.0	CHEMBL4722	Homo sapiens	INH	%	40.0
	16562709	CHEMBL3802091	Inhibition of Aurora A (unknown origin) at 1 uM	B	CC1(C)CC(=O)c2c(SC3CCCC3)sc(-c3cc[nH]n3)c2C1		CHEMBL3800282	<	Inhibition	%	10.0	CHEMBL4722	Homo sapiens	INH	%	10.0
	16562716	CHEMBL3802091	Inhibition of Aurora A (unknown origin) at 1 uM	B	CSc1sc(-c2cc[nH]n2)c2c1C(=O)CCC2		CHEMBL3799347	=	Inhibition	%	40.0	CHEMBL4722	Homo sapiens	INH	%	40.0
	16575573	CHEMBL3802209	Inhibition of human Aurora-A at 10 uM measured after 40 mins by scintillation counting	B	CNC(=O)c1cc(Oc2ccc3nc(NC(=O)Nc4cc(C(F)(F)F)cc(C(F)(F)F)c4)sc3c2)ccn1		CHEMBL3797601	<	Inhibition	%	40.0	CHEMBL4722	Homo sapiens	INH	%	40.0
	16578327	CHEMBL3804381	Inhibition of partial length wild type human AURKA expressed in mammalian system assessed as enzyme activity at 1 uM relative to control	B	CN(C)S(=O)(=O)Nc1ccc(F)c(Nc2ncccc2-c2ncnc3[nH]cnc23)c1F		CHEMBL3798256	=	Activity	%	73.0	CHEMBL4722	Homo sapiens	Activity	%	73.0
	16587007	CHEMBL3807419	Inhibition of AUR2 (unknown origin) in presence of gamma33-ATP	B	CN1CCN(c2ccc(C(=O)Nc3n[nH]c4ccc(Cc5cc(F)cc(F)c5)cc34)c(NC3CCOCC3)c2)CC1		CHEMBL1983268	=	IC50	nM	215.0	CHEMBL4722	Homo sapiens	IC50	uM	0.215
	16589174	CHEMBL3807596	Inhibition of Aurora A (unknown origin) at 1 ug/ml after 1 hr by HTRF assay	B	Cn1ncc(Cl)c1-c1cc(C(=O)NC2(c3ccc(Cl)c(Cl)c3)CCNCC2)oc1Cl		CHEMBL3805228	=	Inhibition	%	0.43	CHEMBL4722	Homo sapiens	INH	%	0.43
	16589723	CHEMBL3807911	Inhibition of Aurora A (unknown origin) after 1 hr by HTRF assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	7.63	CHEMBL4722	Homo sapiens	IC50	nM	7.63
	16593472	CHEMBL3812156	Inhibition of full length His-tagged human recombinant Aurora A expressed in baculovirus using Fluorescein-CREBtide as substrate at 100 nM	B	COC(=O)c1cc2cc(NCc3cc(NC(=O)c4cc(-n5cnc(C)c5)cc(C(F)(F)F)c4)ccc3C)cnc2[nH]1		CHEMBL3808884	<	Inhibition	%	40.0	CHEMBL4722	Homo sapiens	INH	%	40.0
	16594915	CHEMBL3812224	Inhibition of human AURKA (122 to 401 amino acid residues) assessed as enzyme activity at 10 uM by KINOMEScan assay	B	O=C1C2=C(C(=O)c3c(O)ccc(O)c31)[C@@H](O)[C@@H](O)[C@@H](O)C2		CHEMBL1987813	=	Activity	%	87.0	CHEMBL4722	Homo sapiens	Activity	%	87.0
	16604329	CHEMBL3813582	Inhibition of Aurora A (unknown origin) using myelin protein as substrate assessed as ADP generation at 10 uM after 60 mins by ADP-glo assay relative to staurosporine	B	COc1ccc(NC(=O)Nc2ccc(CNc3nc4ccc(OCCN5CCOCC5)cc4o3)cc2)cc1		CHEMBL3810060	=	Inhibition	%	10.0	CHEMBL4722	Homo sapiens	INH	%	10.0
Not Active	16604330	CHEMBL3813582	Inhibition of Aurora A (unknown origin) using myelin protein as substrate assessed as ADP generation at 10 uM after 60 mins by ADP-glo assay relative to staurosporine	B	O=C(Nc1ccc(Br)cc1)Nc1ccc(CNc2nc3ccc(OCCN4CCOCC4)cc3o2)cc1		CHEMBL3809624		Inhibition	%		CHEMBL4722	Homo sapiens	INH		
	16604331	CHEMBL3813582	Inhibition of Aurora A (unknown origin) using myelin protein as substrate assessed as ADP generation at 10 uM after 60 mins by ADP-glo assay relative to staurosporine	B	O=C(Nc1ccc(Cl)cc1)Nc1ccc(CNc2nc3ccc(OCCN4CCOCC4)cc3o2)cc1		CHEMBL3809709	=	Inhibition	%	5.0	CHEMBL4722	Homo sapiens	INH	%	5.0
Not Active	16604332	CHEMBL3813582	Inhibition of Aurora A (unknown origin) using myelin protein as substrate assessed as ADP generation at 10 uM after 60 mins by ADP-glo assay relative to staurosporine	B	O=C(Nc1ccc(F)cc1)Nc1ccc(CNc2nc3ccc(OCCN4CCOCC4)cc3o2)cc1		CHEMBL3810263		Inhibition	%		CHEMBL4722	Homo sapiens	INH		
	16604333	CHEMBL3813582	Inhibition of Aurora A (unknown origin) using myelin protein as substrate assessed as ADP generation at 10 uM after 60 mins by ADP-glo assay relative to staurosporine	B	O=C(Nc1ccc(CNc2nc3ccc(OCCN4CCOCC4)cc3o2)cc1)Nc1cccc(Cl)c1		CHEMBL3809119	=	Inhibition	%	13.0	CHEMBL4722	Homo sapiens	INH	%	13.0
	16604334	CHEMBL3813582	Inhibition of Aurora A (unknown origin) using myelin protein as substrate assessed as ADP generation at 10 uM after 60 mins by ADP-glo assay relative to staurosporine	B	O=C(Nc1ccc(CNc2nc3ccc(OCCN4CCOCC4)cc3o2)cc1)Nc1cccc(F)c1		CHEMBL3808577	=	Inhibition	%	7.0	CHEMBL4722	Homo sapiens	INH	%	7.0
	16604335	CHEMBL3813582	Inhibition of Aurora A (unknown origin) using myelin protein as substrate assessed as ADP generation at 10 uM after 60 mins by ADP-glo assay relative to staurosporine	B	O=C(Nc1ccccc1)Nc1ccc(CNc2nc3ccc(OCCN4CCOCC4)cc3o2)cc1		CHEMBL3808897	=	Inhibition	%	15.0	CHEMBL4722	Homo sapiens	INH	%	15.0
	16604336	CHEMBL3813582	Inhibition of Aurora A (unknown origin) using myelin protein as substrate assessed as ADP generation at 10 uM after 60 mins by ADP-glo assay relative to staurosporine	B	O=C(Nc1ccc(Cl)cc1)Nc1cccc(CNc2nc3ccc(OCCN4CCOCC4)cc3o2)c1		CHEMBL3808447	=	Inhibition	%	8.0	CHEMBL4722	Homo sapiens	INH	%	8.0
Not Determined	16604337	CHEMBL3813582	Inhibition of Aurora A (unknown origin) using myelin protein as substrate assessed as ADP generation at 10 uM after 60 mins by ADP-glo assay relative to staurosporine	B	O=C(Nc1cccc(Cl)c1)Nc1cccc(CNc2nc3ccc(OCCN4CCOCC4)cc3o2)c1		CHEMBL3809652		Inhibition	%		CHEMBL4722	Homo sapiens	INH		
Not Determined	16604338	CHEMBL3813582	Inhibition of Aurora A (unknown origin) using myelin protein as substrate assessed as ADP generation at 10 uM after 60 mins by ADP-glo assay relative to staurosporine	B	O=C(Nc1ccccc1)Nc1cccc(CNc2nc3ccc(OCCN4CCOCC4)cc3o2)c1		CHEMBL3809747		Inhibition	%		CHEMBL4722	Homo sapiens	INH		
Not Determined	16604339	CHEMBL3813582	Inhibition of Aurora A (unknown origin) using myelin protein as substrate assessed as ADP generation at 10 uM after 60 mins by ADP-glo assay relative to staurosporine	B	O=C(Nc1ccc(CNc2nc3ccc(OCCN4CCOCC4)cc3o2)cc1)c1ccccc1		CHEMBL3809346		Inhibition	%		CHEMBL4722	Homo sapiens	INH		
Not Determined	16604340	CHEMBL3813582	Inhibition of Aurora A (unknown origin) using myelin protein as substrate assessed as ADP generation at 10 uM after 60 mins by ADP-glo assay relative to staurosporine	B	O=C(Nc1cccc(CNc2nc3ccc(OCCN4CCOCC4)cc3o2)c1)c1ccccc1		CHEMBL3808825		Inhibition	%		CHEMBL4722	Homo sapiens	INH		
Not Determined	16604341	CHEMBL3813582	Inhibition of Aurora A (unknown origin) using myelin protein as substrate assessed as ADP generation at 10 uM after 60 mins by ADP-glo assay relative to staurosporine	B	O=C(Nc1ccccc1CNc1nc2ccc(OCCN3CCOCC3)cc2o1)c1ccccc1		CHEMBL3809535		Inhibition	%		CHEMBL4722	Homo sapiens	INH		
	16604368	CHEMBL3813578	Inhibition of Aurora A (unknown origin)	B	O=C(O)[C@]1(Cc2cccc(Nc3nccs3)n2)CC[C@@H](Oc2cccc(Cl)c2F)CC1		CHEMBL3600873	=	IC50	nM	0.064	CHEMBL4722	Homo sapiens	IC50	nM	0.064
Not Active	16604369	CHEMBL3813582	Inhibition of Aurora A (unknown origin) using myelin protein as substrate assessed as ADP generation at 10 uM after 60 mins by ADP-glo assay relative to staurosporine	B	Cc1ccc(NC(=O)Nc2ccc(CNc3nc4ccc(OCCN5CCOCC5)cc4o3)cc2)cc1		CHEMBL3808578		Inhibition	%		CHEMBL4722	Homo sapiens	INH		
	16604370	CHEMBL3813582	Inhibition of Aurora A (unknown origin) using myelin protein as substrate assessed as ADP generation at 10 uM after 60 mins by ADP-glo assay relative to staurosporine	B	O=C(Nc1ccc(CNc2nc3ccc(OCCN4CCOCC4)cc3o2)cc1)Nc1ccc(Cl)cc1Cl		CHEMBL3809311	=	Inhibition	%	8.0	CHEMBL4722	Homo sapiens	INH	%	8.0
	16604371	CHEMBL3813582	Inhibition of Aurora A (unknown origin) using myelin protein as substrate assessed as ADP generation at 10 uM after 60 mins by ADP-glo assay relative to staurosporine	B	O=C(Nc1ccc(CNc2nc3ccc(OCCN4CCOCC4)cc3o2)cc1)Nc1ccc(Cl)c(Cl)c1		CHEMBL3808793	=	Inhibition	%	24.0	CHEMBL4722	Homo sapiens	INH	%	24.0
	16604372	CHEMBL3813582	Inhibition of Aurora A (unknown origin) using myelin protein as substrate assessed as ADP generation at 10 uM after 60 mins by ADP-glo assay relative to staurosporine	B	O=C(Nc1ccc(Cl)cc1)Nc1ccc(CNc2nc3cc(OCCN4CCOCC4)ccc3o2)cc1		CHEMBL3810344	=	Inhibition	%	8.0	CHEMBL4722	Homo sapiens	INH	%	8.0
	16604373	CHEMBL3813582	Inhibition of Aurora A (unknown origin) using myelin protein as substrate assessed as ADP generation at 10 uM after 60 mins by ADP-glo assay relative to staurosporine	B	O=C(Nc1ccc(Br)cc1)Nc1ccc(CNc2nc3cc(OCCN4CCOCC4)ccc3o2)cc1		CHEMBL3810372	=	Inhibition	%	6.0	CHEMBL4722	Homo sapiens	INH	%	6.0
	16604374	CHEMBL3813582	Inhibition of Aurora A (unknown origin) using myelin protein as substrate assessed as ADP generation at 10 uM after 60 mins by ADP-glo assay relative to staurosporine	B	O=C(Nc1ccccc1)Nc1cccc(COc2ccc3nc(NCCN4CCOCC4)oc3c2)c1		CHEMBL3809982	=	Inhibition	%	1.0	CHEMBL4722	Homo sapiens	INH	%	1.0
Not Active	16604375	CHEMBL3813582	Inhibition of Aurora A (unknown origin) using myelin protein as substrate assessed as ADP generation at 10 uM after 60 mins by ADP-glo assay relative to staurosporine	B	O=C(Nc1ccc(Cl)cc1)Nc1ccc(COc2ccc3nc(NCCN4CCOCC4)oc3c2)cc1		CHEMBL3808569		Inhibition	%		CHEMBL4722	Homo sapiens	INH		
Not Active	16604376	CHEMBL3813582	Inhibition of Aurora A (unknown origin) using myelin protein as substrate assessed as ADP generation at 10 uM after 60 mins by ADP-glo assay relative to staurosporine	B	O=C(Nc1ccc(Br)cc1)Nc1ccc(COc2ccc3nc(NCCN4CCOCC4)oc3c2)cc1		CHEMBL3809347		Inhibition	%		CHEMBL4722	Homo sapiens	INH		
	16604377	CHEMBL3813582	Inhibition of Aurora A (unknown origin) using myelin protein as substrate assessed as ADP generation at 10 uM after 60 mins by ADP-glo assay relative to staurosporine	B	O=C(Nc1ccc(COc2ccc3nc(NCCN4CCOCC4)oc3c2)cc1)Nc1ccc(Cl)c(Cl)c1		CHEMBL3808933	=	Inhibition	%	2.0	CHEMBL4722	Homo sapiens	INH	%	2.0
	16604378	CHEMBL3813582	Inhibition of Aurora A (unknown origin) using myelin protein as substrate assessed as ADP generation at 10 uM after 60 mins by ADP-glo assay relative to staurosporine	B	O=C(Nc1ccc(Cl)cc1)Nc1ccc(COc2ccc3oc(NCCN4CCOCC4)nc3c2)cc1		CHEMBL3808570	=	Inhibition	%	4.0	CHEMBL4722	Homo sapiens	INH	%	4.0
	16604379	CHEMBL3813582	Inhibition of Aurora A (unknown origin) using myelin protein as substrate assessed as ADP generation at 10 uM after 60 mins by ADP-glo assay relative to staurosporine	B	O=C(Nc1ccc(Br)cc1)Nc1ccc(COc2ccc3oc(NCCN4CCOCC4)nc3c2)cc1		CHEMBL3809161	=	Inhibition	%	3.0	CHEMBL4722	Homo sapiens	INH	%	3.0
	16604380	CHEMBL3813582	Inhibition of Aurora A (unknown origin) using myelin protein as substrate assessed as ADP generation at 10 uM after 60 mins by ADP-glo assay relative to staurosporine	B	O=C(Nc1ccc(COc2ccc3oc(NCCN4CCOCC4)nc3c2)cc1)Nc1ccc(Cl)c(Cl)c1		CHEMBL3809855	=	Inhibition	%	5.0	CHEMBL4722	Homo sapiens	INH	%	5.0
Not Active	16605011	CHEMBL3811382	Inhibition of N-terminal His-tagged AuroraA (unknown origin) using 5FAM-LRRASLG-CONH2 as substrate after 60 mins	B	COc1cc(-c2cnn(C)c2)ccc1Nc1ncc2ccnc(N[C@@H](C)C(C)(C)C)c2n1		CHEMBL3809829		Inhibition	%		CHEMBL4722	Homo sapiens	INH		
	16611903	CHEMBL3816639	Inhibition of human Aurora A (2 to 403 residues) assessed as enzyme activity at 1 uM using 33P ATP by radioactive filter binding assay	B	Nc1nccc(-c2c[nH]c3ncccc23)n1		CHEMBL405665	=	Activity	%	1.0	CHEMBL4722	Homo sapiens	Activity	%	1.0
	16613772	CHEMBL3817208	Inhibition of human Aurora A at 1 uM using [H-LRRASLG] as substrate	B	CNS(=O)(=O)c1ccc(N(C)C)c(Nc2ncnc3cc(OC)c(OC)cc23)c1		CHEMBL3815093	=	Inhibition	%	-1.0	CHEMBL4722	Homo sapiens	INH	%	-1.0
	16618279	CHEMBL3817006	Inhibition of full length recombinant human His-tagged AURKA expressed in baculovirus expression system at 1 uM relative to control	B	CC1(C)OCCn2c1nc1c(N3CCOCC3)nc(-c3cnc(N)nc3)nc12		CHEMBL3813842	<	Inhibition	%	50.0	CHEMBL4722	Homo sapiens	INH	%	50.0
	16621478	CHEMBL3820471	Inhibition of Aurora A (unknown origin) incubated for 1 hr by spectrophotometric analysis	B	CN1C(=O)COc2c1cnc1ccc(Sc3nnc4c(F)cc(-c5cnn(C)c5)cn34)cc21		CHEMBL3818247	>	IC50	nM	30000.0	CHEMBL4722	Homo sapiens	IC50	nM	30000.0
	16622193	CHEMBL3820471	Inhibition of Aurora A (unknown origin) incubated for 1 hr by spectrophotometric analysis	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	2.4	CHEMBL4722	Homo sapiens	IC50	nM	2.4
	16625351	CHEMBL3821726	Inhibition of Aurora A (unknown origin) at 10 uM	B	COc1cccc(Nc2nccc(Nc3ccc4[nH]ncc4c3)n2)c1		CHEMBL3818017	=	Inhibition	%	76.0	CHEMBL4722	Homo sapiens	INH	%	76.0
	16625352	CHEMBL3821726	Inhibition of Aurora A (unknown origin) at 10 uM	B	COc1ccc(Nc2nccc(Nc3ccc4[nH]ncc4c3)n2)cc1		CHEMBL3819461	=	Inhibition	%	91.0	CHEMBL4722	Homo sapiens	INH	%	91.0
	16627482	CHEMBL3820210	Inhibition of full length recombinant human N-terminal His6-tagged Aurora A expressed in Sf21 cells at 1 uM by radiometric assay relative to control	B	Cc1cc(-c2cnn3c(NCC4CCOCC4)nc(Oc4ccccc4)nc23)ccc1C(=O)NC1CC1	Outside typical range	CHEMBL3819210	=	Inhibition	%	-13.0	CHEMBL4722	Homo sapiens	INH	%	-13.0
	16627483	CHEMBL3820210	Inhibition of full length recombinant human N-terminal His6-tagged Aurora A expressed in Sf21 cells at 1 uM by radiometric assay relative to control	B	O=C(N[C@@H](c1ccccn1)C1CC1)c1ccc2[nH]nc(-c3ccc(N4C5CCC4CC(O)C5)cc3)c2c1		CHEMBL3818239	=	Inhibition	%	56.0	CHEMBL4722	Homo sapiens	INH	%	56.0
	16627589	CHEMBL3820511	Inhibition of full length recombinant human N-terminal His6-tagged Aurora A expressed in Sf21 cells by radiometric assay	B	Cc1cc(-c2cnn3c(NCC4CCOCC4)nc(Oc4ccccc4)nc23)ccc1C(=O)NC1CC1		CHEMBL3819210	>	IC50	nM	50000.0	CHEMBL4722	Homo sapiens	IC50	uM	50.0
	16638360	CHEMBL3825648	Inhibition of human full length N-terminal GST-tagged aurora-a expressed in baculovirus expression system at 1 uM	B	CC(C)(C)S(=O)(=O)c1ccc2nccc(Nc3n[nH]c4ccc(F)cc34)c2c1		CHEMBL3823499	=	Inhibition	%	30.0	CHEMBL4722	Homo sapiens	INH	%	30.0
	16641961	CHEMBL3826286	Inhibition of His-tagged full-length recombinant human Aurora A expressed in baculovirus system at 100 nM by Z-lyte assay	B	O=C(CNC(=O)c1cccn(Cc2ccc(F)c(F)c2)c1=O)Nc1ccc2c(c1)/C(=C/c1cnc[nH]1)C(=O)N2		CHEMBL3824119	=	Inhibition	%	38.0	CHEMBL4722	Homo sapiens	INH	%	38.0
	16654131	CHEMBL3830813	Inhibition of human Aurora A (2 to 403 residues) assessed as remaining enzyme activity at 50 uM after 30 mins by 33P-ATP filter-binding assay	B	Cc1cc(=O)c2c(O)cc(O)c([C@H]3CCN(C)C[C@H]3O)c2o1		CHEMBL1077604	=	Activity	%	91.0	CHEMBL4722	Homo sapiens	Activity	%	91.0
	16673438	CHEMBL3855896	Inhibition of human Aurora kinase A (E122 to K401 residues) expressed in mammalian expression system by Z'LYTE assay	B	Cc1ccc2c(c1)C(=O)N(C)c1cnc(Nc3ccc(S(N)(=O)=O)cc3)nc1N2C		CHEMBL3950648	=	IC50	nM	16.0	CHEMBL4722	Homo sapiens	IC50	nM	16.0
	16673439	CHEMBL3855896	Inhibition of human Aurora kinase A (E122 to K401 residues) expressed in mammalian expression system by Z'LYTE assay	B	CCC(=O)N1CCN(S(=O)(=O)c2cccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)c2)CC1		CHEMBL3942643	=	IC50	nM	110.0	CHEMBL4722	Homo sapiens	IC50	nM	110.0
	16673440	CHEMBL3855896	Inhibition of human Aurora kinase A (E122 to K401 residues) expressed in mammalian expression system by Z'LYTE assay	B	C=CC(=O)Nc1ccc(NS(=O)(=O)c2ccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)cc2)cc1		CHEMBL3926951	=	IC50	nM	49.0	CHEMBL4722	Homo sapiens	IC50	nM	49.0
	16673441	CHEMBL3855896	Inhibition of human Aurora kinase A (E122 to K401 residues) expressed in mammalian expression system by Z'LYTE assay	B	C=CC(=O)NC1CCN(S(=O)(=O)c2cccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)c2)CC1		CHEMBL3889977	=	IC50	nM	350.0	CHEMBL4722	Homo sapiens	IC50	nM	350.0
	16673442	CHEMBL3855896	Inhibition of human Aurora kinase A (E122 to K401 residues) expressed in mammalian expression system by Z'LYTE assay	B	C=CC(=O)N1CCN(S(=O)(=O)c2cccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)c2)CC1		CHEMBL3979343	=	IC50	nM	59.0	CHEMBL4722	Homo sapiens	IC50	nM	59.0
	16673445	CHEMBL3855896	Inhibition of human Aurora kinase A (E122 to K401 residues) expressed in mammalian expression system by Z'LYTE assay	B	Cc1ccc2c(c1)C(=O)N(C)c1cnc(Nc3cccc(S(=O)(=O)N4CCC(O)CC4)c3)nc1N2C		CHEMBL3959351	=	IC50	nM	150.0	CHEMBL4722	Homo sapiens	IC50	nM	150.0
	16673446	CHEMBL3855896	Inhibition of human Aurora kinase A (E122 to K401 residues) expressed in mammalian expression system by Z'LYTE assay	B	C=CC(=O)Nc1cccc(NS(=O)(=O)c2cccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)c2)c1		CHEMBL3907932	=	IC50	nM	190.0	CHEMBL4722	Homo sapiens	IC50	nM	190.0
	16673447	CHEMBL3855896	Inhibition of human Aurora kinase A (E122 to K401 residues) expressed in mammalian expression system by Z'LYTE assay	B	C=CC(=O)Nc1ccc(NS(=O)(=O)c2cccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)c2)cc1		CHEMBL3898901	=	IC50	nM	270.0	CHEMBL4722	Homo sapiens	IC50	nM	270.0
	16673448	CHEMBL3855896	Inhibition of human Aurora kinase A (E122 to K401 residues) expressed in mammalian expression system by Z'LYTE assay	B	C=CC(=O)N1CCN(S(=O)(=O)c2ccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)cc2)CC1		CHEMBL3909068	=	IC50	nM	23.0	CHEMBL4722	Homo sapiens	IC50	nM	23.0
	16673546	CHEMBL3855896	Inhibition of human Aurora kinase A (E122 to K401 residues) expressed in mammalian expression system by Z'LYTE assay	B	Cc1cc(S(N)(=O)=O)ccc1Nc1ncc2c(n1)N(C)c1ccccc1C(=O)N2C		CHEMBL3932938	=	IC50	nM	4900.0	CHEMBL4722	Homo sapiens	IC50	nM	4900.0
	16673547	CHEMBL3855896	Inhibition of human Aurora kinase A (E122 to K401 residues) expressed in mammalian expression system by Z'LYTE assay	B	CN1C(=O)c2ccccc2N(C)c2nc(Nc3cccc(S(N)(=O)=O)c3)ncc21		CHEMBL3904942	=	IC50	nM	2.1	CHEMBL4722	Homo sapiens	IC50	nM	2.1
	16673548	CHEMBL3855896	Inhibition of human Aurora kinase A (E122 to K401 residues) expressed in mammalian expression system by Z'LYTE assay	B	CN1C(=O)c2ccccc2N(C)c2nc(Nc3ccc(S(N)(=O)=O)cc3)ncc21		CHEMBL1673047	=	IC50	nM	4.8	CHEMBL4722	Homo sapiens	IC50	nM	4.8
	16737927	CHEMBL3856645	Inhibition of recombinant human AURORA A expressed in insect Sf21 cells assessed as remaining activity at 10 uM preincubated for 15 mins followed by Kemptide substrate addition for 30 mins in presence of [gamma-32P]ATP by TR-FRET assay	B	CNCCOc1ccc(-c2sc3nc(-c4cccs4)nc(NN4C(=O)C=C(C)C4=O)c3c2C)cc1.Cl		CHEMBL3966536	=	Activity	%	67.0	CHEMBL4722	Homo sapiens	Activity	%	67.0
	16763100	CHEMBL3862736	Inhibition of His-tagged human Aurora A kinase (122 to 40 residues) expressed in Escherichia coli BL21 (DE3) Rosetta cells using biotinylated STK2 substrate incubated for 30 mins in presence of 0.002 uM TPX2 by HTRF assay	B	CCc1ccc(/N=C2\S/C(=C\c3ccnc(Nc4ccc(C(=O)O)cn4)c3)C(=O)N2C)cc1		CHEMBL3921246	=	IC50	nM	1.7	CHEMBL4722	Homo sapiens	IC50	uM	0.0017
	16763102	CHEMBL3862723	Inhibition of His-tagged human Aurora A kinase (122 to 40 residues) expressed in Escherichia coli BL21 (DE3) Rosetta cells using biotinylated STK2 substrate incubated for 30 mins by HTRF assay	B	O=c1[nH]c2ccccc2n1-c1nc2ccccc2[nH]1		CHEMBL3976213	=	IC50	nM	6500.0	CHEMBL4722	Homo sapiens	IC50	uM	6.5
	16763103	CHEMBL3862723	Inhibition of His-tagged human Aurora A kinase (122 to 40 residues) expressed in Escherichia coli BL21 (DE3) Rosetta cells using biotinylated STK2 substrate incubated for 30 mins by HTRF assay	B	O=c1[nH]c2cc(O)ccc2n1-c1nc2ccccc2[nH]1		CHEMBL3949078	=	IC50	nM	2300.0	CHEMBL4722	Homo sapiens	IC50	uM	2.3
	16763104	CHEMBL3862723	Inhibition of His-tagged human Aurora A kinase (122 to 40 residues) expressed in Escherichia coli BL21 (DE3) Rosetta cells using biotinylated STK2 substrate incubated for 30 mins by HTRF assay	B	COc1cc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2OC)=NC3)ccc1C(=O)O		CHEMBL483158	=	IC50	nM	0.04	CHEMBL4722	Homo sapiens	IC50	nM	0.04
	16763105	CHEMBL3862723	Inhibition of His-tagged human Aurora A kinase (122 to 40 residues) expressed in Escherichia coli BL21 (DE3) Rosetta cells using biotinylated STK2 substrate incubated for 30 mins by HTRF assay	B	Cc1cccc2[nH]c(-n3c(=O)[nH]c4ccccc43)nc12		CHEMBL3981269	=	IC50	nM	14000.0	CHEMBL4722	Homo sapiens	IC50	uM	14.0
	16763106	CHEMBL3862723	Inhibition of His-tagged human Aurora A kinase (122 to 40 residues) expressed in Escherichia coli BL21 (DE3) Rosetta cells using biotinylated STK2 substrate incubated for 30 mins by HTRF assay	B	Cc1ccc2[nH]c(-n3c(=O)[nH]c4ccccc43)nc2c1		CHEMBL3920194	=	IC50	nM	7800.0	CHEMBL4722	Homo sapiens	IC50	uM	7.8
	16763107	CHEMBL3862723	Inhibition of His-tagged human Aurora A kinase (122 to 40 residues) expressed in Escherichia coli BL21 (DE3) Rosetta cells using biotinylated STK2 substrate incubated for 30 mins by HTRF assay	B	O=c1[nH]c2ccccc2n1-c1nc2cc(Br)ccc2[nH]1		CHEMBL3905664	=	IC50	nM	9000.0	CHEMBL4722	Homo sapiens	IC50	uM	9.0
	16763108	CHEMBL3862723	Inhibition of His-tagged human Aurora A kinase (122 to 40 residues) expressed in Escherichia coli BL21 (DE3) Rosetta cells using biotinylated STK2 substrate incubated for 30 mins by HTRF assay	B	O=c1[nH]c2ccccc2n1-c1nc2cc(C(F)(F)F)ccc2[nH]1		CHEMBL3893267	>	IC50	nM	70000.0	CHEMBL4722	Homo sapiens	IC50	uM	70.0
	16763109	CHEMBL3862723	Inhibition of His-tagged human Aurora A kinase (122 to 40 residues) expressed in Escherichia coli BL21 (DE3) Rosetta cells using biotinylated STK2 substrate incubated for 30 mins by HTRF assay	B	O=c1[nH]c2ccccc2n1-c1nc2cc(Cl)c(Cl)cc2[nH]1	Potential missing data	CHEMBL3962294		IC50			CHEMBL4722	Homo sapiens	IC50		
	16763110	CHEMBL3862723	Inhibition of His-tagged human Aurora A kinase (122 to 40 residues) expressed in Escherichia coli BL21 (DE3) Rosetta cells using biotinylated STK2 substrate incubated for 30 mins by HTRF assay	B	O=c1[nH]c2cccc(O)c2n1-c1nc2ccccc2[nH]1		CHEMBL3902875	=	IC50	nM	15000.0	CHEMBL4722	Homo sapiens	IC50	uM	15.0
	16763111	CHEMBL3862723	Inhibition of His-tagged human Aurora A kinase (122 to 40 residues) expressed in Escherichia coli BL21 (DE3) Rosetta cells using biotinylated STK2 substrate incubated for 30 mins by HTRF assay	B	O=c1[nH]c2ccc(Cl)cc2n1-c1nc2ccccc2[nH]1		CHEMBL3930861	=	IC50	nM	23000.0	CHEMBL4722	Homo sapiens	IC50	uM	23.0
	16763112	CHEMBL3862723	Inhibition of His-tagged human Aurora A kinase (122 to 40 residues) expressed in Escherichia coli BL21 (DE3) Rosetta cells using biotinylated STK2 substrate incubated for 30 mins by HTRF assay	B	O=c1[nH]c2ccc(O)cc2n1-c1nc2ccccc2[nH]1		CHEMBL3915966	=	IC50	nM	12000.0	CHEMBL4722	Homo sapiens	IC50	uM	12.0
	16763113	CHEMBL3862723	Inhibition of His-tagged human Aurora A kinase (122 to 40 residues) expressed in Escherichia coli BL21 (DE3) Rosetta cells using biotinylated STK2 substrate incubated for 30 mins by HTRF assay	B	O=C(O)c1ccc2[nH]c(=O)n(-c3nc4ccccc4[nH]3)c2c1		CHEMBL3921919	=	IC50	nM	3500.0	CHEMBL4722	Homo sapiens	IC50	uM	3.5
	16763114	CHEMBL3862723	Inhibition of His-tagged human Aurora A kinase (122 to 40 residues) expressed in Escherichia coli BL21 (DE3) Rosetta cells using biotinylated STK2 substrate incubated for 30 mins by HTRF assay	B	CNC(=O)c1ccc2[nH]c(=O)n(-c3nc4ccccc4[nH]3)c2c1		CHEMBL3982818	=	IC50	nM	11000.0	CHEMBL4722	Homo sapiens	IC50	uM	11.0
	16763115	CHEMBL3862723	Inhibition of His-tagged human Aurora A kinase (122 to 40 residues) expressed in Escherichia coli BL21 (DE3) Rosetta cells using biotinylated STK2 substrate incubated for 30 mins by HTRF assay	B	O=c1[nH]c2cc(Cl)ccc2n1-c1nc2ccccc2[nH]1	Outside typical range	CHEMBL3912939	>	IC50	nM	200000.0	CHEMBL4722	Homo sapiens	IC50	uM	200.0
	16763116	CHEMBL3862723	Inhibition of His-tagged human Aurora A kinase (122 to 40 residues) expressed in Escherichia coli BL21 (DE3) Rosetta cells using biotinylated STK2 substrate incubated for 30 mins by HTRF assay	B	O=C(O)c1ccc2c(c1)[nH]c(=O)n2-c1nc2ccccc2[nH]1		CHEMBL3974813	=	IC50	nM	3500.0	CHEMBL4722	Homo sapiens	IC50	uM	3.5
	16763117	CHEMBL3862723	Inhibition of His-tagged human Aurora A kinase (122 to 40 residues) expressed in Escherichia coli BL21 (DE3) Rosetta cells using biotinylated STK2 substrate incubated for 30 mins by HTRF assay	B	CNC(=O)c1ccc2c(c1)[nH]c(=O)n2-c1nc2ccccc2[nH]1		CHEMBL3903930	>	IC50	nM	50000.0	CHEMBL4722	Homo sapiens	IC50	uM	50.0
	16763118	CHEMBL3862723	Inhibition of His-tagged human Aurora A kinase (122 to 40 residues) expressed in Escherichia coli BL21 (DE3) Rosetta cells using biotinylated STK2 substrate incubated for 30 mins by HTRF assay	B	O=c1[nH]c2c(O)cccc2n1-c1nc2ccccc2[nH]1		CHEMBL3966317	=	IC50	nM	21000.0	CHEMBL4722	Homo sapiens	IC50	uM	21.0
	16763119	CHEMBL3862723	Inhibition of His-tagged human Aurora A kinase (122 to 40 residues) expressed in Escherichia coli BL21 (DE3) Rosetta cells using biotinylated STK2 substrate incubated for 30 mins by HTRF assay	B	Cn1c(-n2c(=O)[nH]c3ccccc32)nc2ccccc21	Potential missing data	CHEMBL3894995		IC50			CHEMBL4722	Homo sapiens	IC50		
	16763120	CHEMBL3862723	Inhibition of His-tagged human Aurora A kinase (122 to 40 residues) expressed in Escherichia coli BL21 (DE3) Rosetta cells using biotinylated STK2 substrate incubated for 30 mins by HTRF assay	B	Cn1c(=O)n(-c2nc3ccccc3[nH]2)c2ccccc21	Potential missing data	CHEMBL3947173		IC50			CHEMBL4722	Homo sapiens	IC50		
	16763121	CHEMBL3862723	Inhibition of His-tagged human Aurora A kinase (122 to 40 residues) expressed in Escherichia coli BL21 (DE3) Rosetta cells using biotinylated STK2 substrate incubated for 30 mins by HTRF assay	B	CCc1ccc(/N=C2\S/C(=C\c3ccncc3)C(=O)N2CC2CCCCC2)cc1	Outside typical range	CHEMBL3970952	>	IC50	nM	200000.0	CHEMBL4722	Homo sapiens	IC50	uM	200.0
	16763122	CHEMBL3862723	Inhibition of His-tagged human Aurora A kinase (122 to 40 residues) expressed in Escherichia coli BL21 (DE3) Rosetta cells using biotinylated STK2 substrate incubated for 30 mins by HTRF assay	B	CCc1ccc(/N=C2/SC3(CC3c3ccnc(N)c3)C(=O)N2C)cc1	Outside typical range	CHEMBL3985380	>	IC50	nM	200000.0	CHEMBL4722	Homo sapiens	IC50	uM	200.0
	16763123	CHEMBL3862723	Inhibition of His-tagged human Aurora A kinase (122 to 40 residues) expressed in Escherichia coli BL21 (DE3) Rosetta cells using biotinylated STK2 substrate incubated for 30 mins by HTRF assay	B	O=C(O)[C@]1(Cc2cccc(Nc3nccs3)n2)CC[C@@H](Oc2cccc(Cl)c2F)CC1		CHEMBL3600873	=	IC50	nM	0.064	CHEMBL4722	Homo sapiens	IC50	nM	0.064
	16763138	CHEMBL3862727	Binding affinity to human Aurora A kinase expressed in Escherichia coli BL21 cells incubated for 1 hr by active site directed binding competition assay	B	CCc1ccc(/N=C2\S/C(=C\c3ccnc(Nc4ccc(C(=O)O)cn4)c3)C(=O)N2C)cc1		CHEMBL3921246	=	Kd	nM	5.0	CHEMBL4722	Homo sapiens	Kd	nM	5.0
Active	16763146	CHEMBL3862735	Binding affinity to His-tagged human Aurora A kinase (122 to 40 residues) expressed in Escherichia coli BL21 (DE3) Rosetta cells assessed as reduction in Aurora A binding to TPX-labeled human TPX2 N-terminal domain (1 to 43 residues) at 125 uM incubated for 30 mins by microscale thermophoresis method	B	CCc1ccc(/N=C2\S/C(=C\c3ccnc(Nc4ccc(C(=O)O)cn4)c3)C(=O)N2C)cc1		CHEMBL3921246		Activity			CHEMBL4722	Homo sapiens	Activity		
	16763147	CHEMBL3862737	Inhibition of His-tagged human Aurora A kinase (122 to 40 residues) expressed in Escherichia coli BL21 (DE3) Rosetta cells using biotinylated STK2 substrate incubated for 30 mins in presence of 2 uM TPX2 by HTRF assay	B	CCc1ccc(/N=C2\S/C(=C\c3ccnc(Nc4ccc(C(=O)O)cn4)c3)C(=O)N2C)cc1		CHEMBL3921246	=	IC50	nM	1400.0	CHEMBL4722	Homo sapiens	IC50	uM	1.4
Active	16763148	CHEMBL3862738	Inhibition of Aurora A kinase localization at spindle microtubules in human HeLa Kyoto cells at 10 uM incubated for 20 hrs	B	CCc1ccc(/N=C2\S/C(=C\c3ccnc(Nc4ccc(C(=O)O)cn4)c3)C(=O)N2C)cc1		CHEMBL3921246		Inhibition	%		CHEMBL4722	Homo sapiens	INH		
Active	16763149	CHEMBL3862739	Inhibition of Aurora A kinase localization at spindle microtubules in human HeLa Kyoto cells at 0.25 uM incubated for 20 hrs	B	COc1cc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2OC)=NC3)ccc1C(=O)O		CHEMBL483158		Inhibition	%		CHEMBL4722	Homo sapiens	INH		
	16763150	CHEMBL3862740	Inhibition of Aurora A kinase localization at centrosomes in human HeLa Kyoto cells at 10 uM incubated for 20 hrs	B	CCc1ccc(/N=C2\S/C(=C\c3ccnc(Nc4ccc(C(=O)O)cn4)c3)C(=O)N2C)cc1		CHEMBL3921246		Inhibition	%		CHEMBL4722	Homo sapiens	INH		
	16763153	CHEMBL3862742	Inhibition of Aurora A kinase autophosphorylation at Thr288 in human HeLa Kyoto cells incubated for 20 hrs	B	CCc1ccc(/N=C2\S/C(=C\c3ccnc(Nc4ccc(C(=O)O)cn4)c3)C(=O)N2C)cc1		CHEMBL3921246	=	IC50	nM	760.0	CHEMBL4722	Homo sapiens	IC50	nM	760.0
	16763154	CHEMBL3862742	Inhibition of Aurora A kinase autophosphorylation at Thr288 in human HeLa Kyoto cells incubated for 20 hrs	B	COc1cc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2OC)=NC3)ccc1C(=O)O		CHEMBL483158	=	IC50	nM	6.7	CHEMBL4722	Homo sapiens	IC50	nM	6.7
	16763155	CHEMBL3862742	Inhibition of Aurora A kinase autophosphorylation at Thr288 in human HeLa Kyoto cells incubated for 20 hrs	B	CCc1ccc(/N=C2\SC(Cc3ccnc(Nc4ccc(C(=O)O)cn4)c3)C(=O)N2C)cc1		CHEMBL3896597	=	IC50	nM	24.0	CHEMBL4722	Homo sapiens	IC50	nM	24.0
	16763156	CHEMBL3862742	Inhibition of Aurora A kinase autophosphorylation at Thr288 in human HeLa Kyoto cells incubated for 20 hrs	B	O=C(O)[C@]1(Cc2cccc(Nc3nccs3)n2)CC[C@@H](Oc2cccc(Cl)c2F)CC1		CHEMBL3600873	=	IC50	nM	300.0	CHEMBL4722	Homo sapiens	IC50	nM	300.0
	16763157	CHEMBL3862743	Inhibition of Aurora A kinase in human HeLa Kyoto cells assessed as induction of defective chromosome alignment during metaphase incubated for 20 hrs	B	CCc1ccc(/N=C2\S/C(=C\c3ccnc(Nc4ccc(C(=O)O)cn4)c3)C(=O)N2C)cc1		CHEMBL3921246	=	EC50	nM	6000.0	CHEMBL4722	Homo sapiens	EC50	uM	6.0
Active	16763166	CHEMBL3862749	Inhibition of Aurora A kinase in human HeLa Kyoto cells assessed as induction of defective chromosome alignment during metaphase at 10 uM incubated for 20 hrs	B	CCc1ccc(/N=C2\S/C(=C\c3ccnc(Nc4ccc(C(=O)O)cn4)c3)C(=O)N2C)cc1		CHEMBL3921246		Inhibition	%		CHEMBL4722	Homo sapiens	INH		
	16763170	CHEMBL3862723	Inhibition of His-tagged human Aurora A kinase (122 to 40 residues) expressed in Escherichia coli BL21 (DE3) Rosetta cells using biotinylated STK2 substrate incubated for 30 mins by HTRF assay	B	Cc1ccc(/N=C2\S/C(=C\c3ccncc3)C(=O)N2C)cc1C		CHEMBL3914435	=	IC50	nM	2000.0	CHEMBL4722	Homo sapiens	IC50	uM	2.0
	16763171	CHEMBL3862723	Inhibition of His-tagged human Aurora A kinase (122 to 40 residues) expressed in Escherichia coli BL21 (DE3) Rosetta cells using biotinylated STK2 substrate incubated for 30 mins by HTRF assay	B	CCc1ccc(/N=C2\S/C(=C\c3ccncc3)C(=O)N2C)cc1		CHEMBL3984254	=	IC50	nM	390.0	CHEMBL4722	Homo sapiens	IC50	uM	0.39
	16763172	CHEMBL3862723	Inhibition of His-tagged human Aurora A kinase (122 to 40 residues) expressed in Escherichia coli BL21 (DE3) Rosetta cells using biotinylated STK2 substrate incubated for 30 mins by HTRF assay	B	CCc1ccc(/N=C2\S/C(=C\c3ccnc(Nc4ccc(C(=O)O)cn4)c3)C(=O)N2C)cc1		CHEMBL3921246	=	IC50	nM	2.0	CHEMBL4722	Homo sapiens	IC50	uM	0.002
	16763173	CHEMBL3862723	Inhibition of His-tagged human Aurora A kinase (122 to 40 residues) expressed in Escherichia coli BL21 (DE3) Rosetta cells using biotinylated STK2 substrate incubated for 30 mins by HTRF assay	B	CN1C(=O)/C(=C/c2ccncc2)S/C1=N\c1ccccc1		CHEMBL3955906	=	IC50	nM	9000.0	CHEMBL4722	Homo sapiens	IC50	uM	9.0
	16763174	CHEMBL3862723	Inhibition of His-tagged human Aurora A kinase (122 to 40 residues) expressed in Escherichia coli BL21 (DE3) Rosetta cells using biotinylated STK2 substrate incubated for 30 mins by HTRF assay	B	CCc1cccc(/N=C2\S/C(=C\c3ccncc3)C(=O)N2C)c1		CHEMBL3984529	=	IC50	nM	4900.0	CHEMBL4722	Homo sapiens	IC50	uM	4.9
	16763175	CHEMBL3862723	Inhibition of His-tagged human Aurora A kinase (122 to 40 residues) expressed in Escherichia coli BL21 (DE3) Rosetta cells using biotinylated STK2 substrate incubated for 30 mins by HTRF assay	B	CCc1ccccc1/N=C1\S/C(=C\c2ccncc2)C(=O)N1C		CHEMBL3929346	=	IC50	nM	52000.0	CHEMBL4722	Homo sapiens	IC50	uM	52.0
	16763176	CHEMBL3862723	Inhibition of His-tagged human Aurora A kinase (122 to 40 residues) expressed in Escherichia coli BL21 (DE3) Rosetta cells using biotinylated STK2 substrate incubated for 30 mins by HTRF assay	B	CCCc1ccc(/N=C2\S/C(=C\c3ccncc3)C(=O)N2C)cc1		CHEMBL3956916	=	IC50	nM	1900.0	CHEMBL4722	Homo sapiens	IC50	uM	1.9
	16763177	CHEMBL3862723	Inhibition of His-tagged human Aurora A kinase (122 to 40 residues) expressed in Escherichia coli BL21 (DE3) Rosetta cells using biotinylated STK2 substrate incubated for 30 mins by HTRF assay	B	CC(C)c1ccc(/N=C2\S/C(=C\c3ccncc3)C(=O)N2C)cc1		CHEMBL3938394	=	IC50	nM	780.0	CHEMBL4722	Homo sapiens	IC50	uM	0.78
	16763178	CHEMBL3862723	Inhibition of His-tagged human Aurora A kinase (122 to 40 residues) expressed in Escherichia coli BL21 (DE3) Rosetta cells using biotinylated STK2 substrate incubated for 30 mins by HTRF assay	B	CCCCc1ccc(/N=C2\S/C(=C\c3ccncc3)C(=O)N2C)cc1		CHEMBL3967949	=	IC50	nM	3300.0	CHEMBL4722	Homo sapiens	IC50	uM	3.3
	16763179	CHEMBL3862723	Inhibition of His-tagged human Aurora A kinase (122 to 40 residues) expressed in Escherichia coli BL21 (DE3) Rosetta cells using biotinylated STK2 substrate incubated for 30 mins by HTRF assay	B	CN1C(=O)/C(=C/c2ccncc2)S/C1=N\c1ccc(C(C)(C)C)cc1		CHEMBL3911508	=	IC50	nM	1600.0	CHEMBL4722	Homo sapiens	IC50	uM	1.6
	16763180	CHEMBL3862723	Inhibition of His-tagged human Aurora A kinase (122 to 40 residues) expressed in Escherichia coli BL21 (DE3) Rosetta cells using biotinylated STK2 substrate incubated for 30 mins by HTRF assay	B	CN1C(=O)/C(=C/c2ccncc2)S/C1=N\c1ccc(C(F)(F)F)cc1		CHEMBL3939478	=	IC50	nM	370.0	CHEMBL4722	Homo sapiens	IC50	uM	0.37
	16763181	CHEMBL3862723	Inhibition of His-tagged human Aurora A kinase (122 to 40 residues) expressed in Escherichia coli BL21 (DE3) Rosetta cells using biotinylated STK2 substrate incubated for 30 mins by HTRF assay	B	CN1C(=O)/C(=C/c2ccncc2)S/C1=N\c1ccc(Br)cc1		CHEMBL3951166	=	IC50	nM	300.0	CHEMBL4722	Homo sapiens	IC50	uM	0.3
	16763182	CHEMBL3862723	Inhibition of His-tagged human Aurora A kinase (122 to 40 residues) expressed in Escherichia coli BL21 (DE3) Rosetta cells using biotinylated STK2 substrate incubated for 30 mins by HTRF assay	B	CCc1ccc(/N=C2/NC(=O)/C(=C/c3ccncc3)S2)cc1		CHEMBL3923442	=	IC50	nM	430.0	CHEMBL4722	Homo sapiens	IC50	uM	0.43
	16763183	CHEMBL3862723	Inhibition of His-tagged human Aurora A kinase (122 to 40 residues) expressed in Escherichia coli BL21 (DE3) Rosetta cells using biotinylated STK2 substrate incubated for 30 mins by HTRF assay	B	CCc1ccc(/N=C2\S/C(=C\c3ccncc3)C(=O)N2CC)cc1		CHEMBL3935395	=	IC50	nM	380.0	CHEMBL4722	Homo sapiens	IC50	uM	0.38
	16763184	CHEMBL3862723	Inhibition of His-tagged human Aurora A kinase (122 to 40 residues) expressed in Escherichia coli BL21 (DE3) Rosetta cells using biotinylated STK2 substrate incubated for 30 mins by HTRF assay	B	CCc1ccc(/N=C2\S/C(=C\c3ccncc3)C(=O)N2CCOC)cc1		CHEMBL3941909	=	IC50	nM	480.0	CHEMBL4722	Homo sapiens	IC50	uM	0.48
	16763185	CHEMBL3862723	Inhibition of His-tagged human Aurora A kinase (122 to 40 residues) expressed in Escherichia coli BL21 (DE3) Rosetta cells using biotinylated STK2 substrate incubated for 30 mins by HTRF assay	B	CCc1ccc(/N=C2\S/C(=C\c3ccnc(N)c3)C(=O)N2C)cc1		CHEMBL3941377	=	IC50	nM	190.0	CHEMBL4722	Homo sapiens	IC50	uM	0.19
	16763186	CHEMBL3862723	Inhibition of His-tagged human Aurora A kinase (122 to 40 residues) expressed in Escherichia coli BL21 (DE3) Rosetta cells using biotinylated STK2 substrate incubated for 30 mins by HTRF assay	B	CCc1ccc(/N=C2\S/C(=C\c3ccnc(NC(=O)CCN)c3)C(=O)N2C)cc1		CHEMBL3924918	=	IC50	nM	190.0	CHEMBL4722	Homo sapiens	IC50	uM	0.19
	16763187	CHEMBL3862723	Inhibition of His-tagged human Aurora A kinase (122 to 40 residues) expressed in Escherichia coli BL21 (DE3) Rosetta cells using biotinylated STK2 substrate incubated for 30 mins by HTRF assay	B	CCc1ccc(/N=C2\S/C(=C\c3ccnc(NC(=O)CC(=O)O)c3)C(=O)N2C)cc1		CHEMBL3932394	=	IC50	nM	6.0	CHEMBL4722	Homo sapiens	IC50	uM	0.006
	16763188	CHEMBL3862723	Inhibition of His-tagged human Aurora A kinase (122 to 40 residues) expressed in Escherichia coli BL21 (DE3) Rosetta cells using biotinylated STK2 substrate incubated for 30 mins by HTRF assay	B	CCc1ccc(/N=C2\S/C(=C\c3ccnc(NC(=O)CCC(=O)O)c3)C(=O)N2C)cc1		CHEMBL3915550	=	IC50	nM	4.0	CHEMBL4722	Homo sapiens	IC50	uM	0.004
	16763189	CHEMBL3862723	Inhibition of His-tagged human Aurora A kinase (122 to 40 residues) expressed in Escherichia coli BL21 (DE3) Rosetta cells using biotinylated STK2 substrate incubated for 30 mins by HTRF assay	B	CCc1ccc(/N=C2\S/C(=C\c3ccnc(NC(=O)CCCC(=O)O)c3)C(=O)N2C)cc1		CHEMBL3985313	=	IC50	nM	6.2	CHEMBL4722	Homo sapiens	IC50	uM	0.0062
	16763190	CHEMBL3862723	Inhibition of His-tagged human Aurora A kinase (122 to 40 residues) expressed in Escherichia coli BL21 (DE3) Rosetta cells using biotinylated STK2 substrate incubated for 30 mins by HTRF assay	B	CCc1ccc(/N=C2\S/C(=C\c3ccnc(Nc4ccccc4)c3)C(=O)N2C)cc1		CHEMBL3983087	=	IC50	nM	600.0	CHEMBL4722	Homo sapiens	IC50	uM	0.6
	16763191	CHEMBL3862723	Inhibition of His-tagged human Aurora A kinase (122 to 40 residues) expressed in Escherichia coli BL21 (DE3) Rosetta cells using biotinylated STK2 substrate incubated for 30 mins by HTRF assay	B	CCc1ccc(/N=C2\S/C(=C\c3ccnc(Nc4ccccn4)c3)C(=O)N2C)cc1		CHEMBL3913242	=	IC50	nM	220.0	CHEMBL4722	Homo sapiens	IC50	uM	0.22
	16763192	CHEMBL3862723	Inhibition of His-tagged human Aurora A kinase (122 to 40 residues) expressed in Escherichia coli BL21 (DE3) Rosetta cells using biotinylated STK2 substrate incubated for 30 mins by HTRF assay	B	CCc1ccc(/N=C2\S/C(=C\c3ccnc(Nc4ccc(CO)cc4)c3)C(=O)N2C)cc1		CHEMBL3975102	=	IC50	nM	130.0	CHEMBL4722	Homo sapiens	IC50	uM	0.13
	16763193	CHEMBL3862723	Inhibition of His-tagged human Aurora A kinase (122 to 40 residues) expressed in Escherichia coli BL21 (DE3) Rosetta cells using biotinylated STK2 substrate incubated for 30 mins by HTRF assay	B	CCc1ccc(/N=C2\S/C(=C\c3ccnc(Nc4ccc(C(=O)O)cc4)c3)C(=O)N2C)cc1		CHEMBL3904239	=	IC50	nM	6.2	CHEMBL4722	Homo sapiens	IC50	uM	0.0062
	16763194	CHEMBL3862723	Inhibition of His-tagged human Aurora A kinase (122 to 40 residues) expressed in Escherichia coli BL21 (DE3) Rosetta cells using biotinylated STK2 substrate incubated for 30 mins by HTRF assay	B	CCc1ccc(/N=C2\S/C(=C\c3ccnc(Nc4ccc(-c5nnn[nH]5)cc4)c3)C(=O)N2C)cc1		CHEMBL3903187	=	IC50	nM	25.0	CHEMBL4722	Homo sapiens	IC50	uM	0.025
	16763195	CHEMBL3862723	Inhibition of His-tagged human Aurora A kinase (122 to 40 residues) expressed in Escherichia coli BL21 (DE3) Rosetta cells using biotinylated STK2 substrate incubated for 30 mins by HTRF assay	B	CCc1ccc(/N=C2\SC3(CC3c3ccnc(N)c3)C(=O)N2C)cc1		CHEMBL3915641	=	IC50	nM	76000.0	CHEMBL4722	Homo sapiens	IC50	uM	76.0
	16763196	CHEMBL3862723	Inhibition of His-tagged human Aurora A kinase (122 to 40 residues) expressed in Escherichia coli BL21 (DE3) Rosetta cells using biotinylated STK2 substrate incubated for 30 mins by HTRF assay	B	CCc1ccc(/N=C2\SC(Cc3ccnc(N)c3)C(=O)N2C)cc1		CHEMBL3924626	=	IC50	nM	1290.0	CHEMBL4722	Homo sapiens	IC50	uM	1.29
	16763197	CHEMBL3862723	Inhibition of His-tagged human Aurora A kinase (122 to 40 residues) expressed in Escherichia coli BL21 (DE3) Rosetta cells using biotinylated STK2 substrate incubated for 30 mins by HTRF assay	B	CCc1ccc(/N=C2\SC(Cc3ccnc(Nc4ccc(C(=O)O)cn4)c3)C(=O)N2C)cc1		CHEMBL3896597	=	IC50	nM	24.0	CHEMBL4722	Homo sapiens	IC50	uM	0.024
	16815386	CHEMBL3871598	Inhibition of human recombinant His-tagged Aurora A expressed in Escherichia coli using RRR(GLRRASLG)4R-NH2 as substrate after 40 mins in presence of [gamma-33P]-ATP by liquid scintillation counting	B	O=C(O)[C@]1(Cc2cccc(Nc3nccs3)n2)CC[C@@H](Oc2cccc(Cl)c2F)CC1		CHEMBL3600873	=	IC50	nM	0.046	CHEMBL4722	Homo sapiens	IC50	nM	0.046
	16815392	CHEMBL3871604	Inhibition of GST-tagged Aurora A (123 to 401 residues) (unknown origin) preincubated for 15 mins followed by tetra(LRRWSLG) substrate addition measured for 90 mins by Kinase-Glo luminescence assay	B	Nc1cccc(-c2n[nH]c3ccccc23)c1		CHEMBL3970521	=	IC50	nM	13560.0	CHEMBL4722	Homo sapiens	IC50	uM	13.56
	16815393	CHEMBL3871604	Inhibition of GST-tagged Aurora A (123 to 401 residues) (unknown origin) preincubated for 15 mins followed by tetra(LRRWSLG) substrate addition measured for 90 mins by Kinase-Glo luminescence assay	B	C=CC(=O)Nc1cccc(-c2n[nH]c3ccccc23)c1		CHEMBL3901151	=	IC50	nM	1660.0	CHEMBL4722	Homo sapiens	IC50	uM	1.66
	16815394	CHEMBL3871604	Inhibition of GST-tagged Aurora A (123 to 401 residues) (unknown origin) preincubated for 15 mins followed by tetra(LRRWSLG) substrate addition measured for 90 mins by Kinase-Glo luminescence assay	B	O=C(O)/C=C\C(=O)Nc1cccc(-c2n[nH]c3ccccc23)c1		CHEMBL3929110	=	IC50	nM	790.0	CHEMBL4722	Homo sapiens	IC50	uM	0.79
	16815395	CHEMBL3871604	Inhibition of GST-tagged Aurora A (123 to 401 residues) (unknown origin) preincubated for 15 mins followed by tetra(LRRWSLG) substrate addition measured for 90 mins by Kinase-Glo luminescence assay	B	CCNC(=O)/C=C\C(=O)Nc1cccc(-c2n[nH]c3ccccc23)c1		CHEMBL3901743	=	IC50	nM	2860.0	CHEMBL4722	Homo sapiens	IC50	uM	2.86
	16815396	CHEMBL3871604	Inhibition of GST-tagged Aurora A (123 to 401 residues) (unknown origin) preincubated for 15 mins followed by tetra(LRRWSLG) substrate addition measured for 90 mins by Kinase-Glo luminescence assay	B	CCOC(=O)/C=C/C(=O)Nc1cccc(-c2n[nH]c3ccccc23)c1		CHEMBL3972822	=	IC50	nM	9610.0	CHEMBL4722	Homo sapiens	IC50	uM	9.61
	16815397	CHEMBL3871604	Inhibition of GST-tagged Aurora A (123 to 401 residues) (unknown origin) preincubated for 15 mins followed by tetra(LRRWSLG) substrate addition measured for 90 mins by Kinase-Glo luminescence assay	B	O=C(O)/C=C\C(=O)Nc1cccc(-c2n[nH]c3ccc(NC(=O)Nc4ccccc4)cc23)c1		CHEMBL3901797	=	IC50	nM	260.0	CHEMBL4722	Homo sapiens	IC50	uM	0.26
	16815398	CHEMBL3871604	Inhibition of GST-tagged Aurora A (123 to 401 residues) (unknown origin) preincubated for 15 mins followed by tetra(LRRWSLG) substrate addition measured for 90 mins by Kinase-Glo luminescence assay	B	O=C(O)/C=C\C(=O)Nc1cccc(-c2n[nH]c3ccc(NC(=O)c4ccccc4)cc23)c1		CHEMBL3909328	=	IC50	nM	950.0	CHEMBL4722	Homo sapiens	IC50	uM	0.95
	16815399	CHEMBL3871604	Inhibition of GST-tagged Aurora A (123 to 401 residues) (unknown origin) preincubated for 15 mins followed by tetra(LRRWSLG) substrate addition measured for 90 mins by Kinase-Glo luminescence assay	B	O=C(O)/C=C\C(=O)Nc1cccc(-c2n[nH]c3ccc(NCc4ccccc4)cc23)c1		CHEMBL3961791	=	IC50	nM	790.0	CHEMBL4722	Homo sapiens	IC50	uM	0.79
	16815400	CHEMBL3871604	Inhibition of GST-tagged Aurora A (123 to 401 residues) (unknown origin) preincubated for 15 mins followed by tetra(LRRWSLG) substrate addition measured for 90 mins by Kinase-Glo luminescence assay	B	O=C(O)/C=C\C(=O)Nc1cccc(-c2n[nH]c3ccc(NS(=O)(=O)c4ccccc4)cc23)c1		CHEMBL3986609	=	IC50	nM	26.0	CHEMBL4722	Homo sapiens	IC50	uM	0.026
	16815401	CHEMBL3871604	Inhibition of GST-tagged Aurora A (123 to 401 residues) (unknown origin) preincubated for 15 mins followed by tetra(LRRWSLG) substrate addition measured for 90 mins by Kinase-Glo luminescence assay	B	O=C(O)/C=C\C(=O)Nc1cccc(-c2n[nH]c3cc(NS(=O)(=O)c4ccccc4)ccc23)c1		CHEMBL3912937	=	IC50	nM	260.0	CHEMBL4722	Homo sapiens	IC50	uM	0.26
	16815402	CHEMBL3871604	Inhibition of GST-tagged Aurora A (123 to 401 residues) (unknown origin) preincubated for 15 mins followed by tetra(LRRWSLG) substrate addition measured for 90 mins by Kinase-Glo luminescence assay	B	Cc1ccc(S(=O)(=O)Nc2ccc3[nH]nc(-c4cccc(NC(=O)/C=C\C(=O)O)c4)c3c2)cc1		CHEMBL3974375	=	IC50	nM	310.0	CHEMBL4722	Homo sapiens	IC50	uM	0.31
	16815403	CHEMBL3871604	Inhibition of GST-tagged Aurora A (123 to 401 residues) (unknown origin) preincubated for 15 mins followed by tetra(LRRWSLG) substrate addition measured for 90 mins by Kinase-Glo luminescence assay	B	O=C(O)/C=C\C(=O)Nc1cccc(-c2n[nH]c3ccc(NS(=O)(=O)c4ccc(-c5ccccc5)cc4)cc23)c1		CHEMBL3964280	>	IC50	nM	1000.0	CHEMBL4722	Homo sapiens	IC50	uM	1.0
	16815404	CHEMBL3871604	Inhibition of GST-tagged Aurora A (123 to 401 residues) (unknown origin) preincubated for 15 mins followed by tetra(LRRWSLG) substrate addition measured for 90 mins by Kinase-Glo luminescence assay	B	CC(C)(C)c1ccc(S(=O)(=O)Nc2ccc3[nH]nc(-c4cccc(NC(=O)/C=C\C(=O)O)c4)c3c2)cc1		CHEMBL3946537	>	IC50	nM	1000.0	CHEMBL4722	Homo sapiens	IC50	uM	1.0
	16815405	CHEMBL3871604	Inhibition of GST-tagged Aurora A (123 to 401 residues) (unknown origin) preincubated for 15 mins followed by tetra(LRRWSLG) substrate addition measured for 90 mins by Kinase-Glo luminescence assay	B	COc1ccc(S(=O)(=O)Nc2ccc3[nH]nc(-c4cccc(NC(=O)/C=C\C(=O)O)c4)c3c2)cc1		CHEMBL3894492	=	IC50	nM	480.0	CHEMBL4722	Homo sapiens	IC50	uM	0.48
	16815406	CHEMBL3871604	Inhibition of GST-tagged Aurora A (123 to 401 residues) (unknown origin) preincubated for 15 mins followed by tetra(LRRWSLG) substrate addition measured for 90 mins by Kinase-Glo luminescence assay	B	O=C(O)/C=C\C(=O)Nc1cccc(-c2n[nH]c3ccc(NS(=O)(=O)c4ccc([N+](=O)[O-])cc4)cc23)c1		CHEMBL3954695	=	IC50	nM	480.0	CHEMBL4722	Homo sapiens	IC50	uM	0.48
	16815407	CHEMBL3871595	Inhibition of recombinant N-terminal His6-tagged Aurora A (1 to 403 residues) (unknown origin) expressed in baculovirus expression system	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	Ki	nM	0.7	CHEMBL4722	Homo sapiens	Ki	nM	0.7
	16815408	CHEMBL3871604	Inhibition of GST-tagged Aurora A (123 to 401 residues) (unknown origin) preincubated for 15 mins followed by tetra(LRRWSLG) substrate addition measured for 90 mins by Kinase-Glo luminescence assay	B	O=C(O)/C=C\C(=O)Nc1cccc(-c2n[nH]c3ccc(NS(=O)(=O)c4ccc(F)cc4)cc23)c1		CHEMBL3983327	=	IC50	nM	60.0	CHEMBL4722	Homo sapiens	IC50	uM	0.06
	16815409	CHEMBL3871604	Inhibition of GST-tagged Aurora A (123 to 401 residues) (unknown origin) preincubated for 15 mins followed by tetra(LRRWSLG) substrate addition measured for 90 mins by Kinase-Glo luminescence assay	B	O=C(O)/C=C/C(=O)Nc1cccc(-c2n[nH]c3ccc(NS(=O)(=O)c4ccccc4)cc23)c1		CHEMBL3946005	=	IC50	nM	51.0	CHEMBL4722	Homo sapiens	IC50	uM	0.051
	16815410	CHEMBL3871604	Inhibition of GST-tagged Aurora A (123 to 401 residues) (unknown origin) preincubated for 15 mins followed by tetra(LRRWSLG) substrate addition measured for 90 mins by Kinase-Glo luminescence assay	B	O=C(O)CCC(=O)Nc1cccc(-c2n[nH]c3ccc(NS(=O)(=O)c4ccccc4)cc23)c1		CHEMBL3975342	=	IC50	nM	74.0	CHEMBL4722	Homo sapiens	IC50	uM	0.074
	16815411	CHEMBL3871604	Inhibition of GST-tagged Aurora A (123 to 401 residues) (unknown origin) preincubated for 15 mins followed by tetra(LRRWSLG) substrate addition measured for 90 mins by Kinase-Glo luminescence assay	B	NC(=O)CCC(=O)Nc1cccc(-c2n[nH]c3ccc(NS(=O)(=O)c4ccccc4)cc23)c1		CHEMBL3923159	=	IC50	nM	66.0	CHEMBL4722	Homo sapiens	IC50	uM	0.066
	16815412	CHEMBL3871604	Inhibition of GST-tagged Aurora A (123 to 401 residues) (unknown origin) preincubated for 15 mins followed by tetra(LRRWSLG) substrate addition measured for 90 mins by Kinase-Glo luminescence assay	B	COC(=O)CCC(=O)Nc1cccc(-c2n[nH]c3ccc(NS(=O)(=O)c4ccccc4)cc23)c1		CHEMBL3939365	=	IC50	nM	83.0	CHEMBL4722	Homo sapiens	IC50	uM	0.083
	16815413	CHEMBL3871604	Inhibition of GST-tagged Aurora A (123 to 401 residues) (unknown origin) preincubated for 15 mins followed by tetra(LRRWSLG) substrate addition measured for 90 mins by Kinase-Glo luminescence assay	B	CCOC(=O)CCC(=O)Nc1cccc(-c2n[nH]c3ccc(NS(=O)(=O)c4ccccc4)cc23)c1		CHEMBL3922175	=	IC50	nM	208.0	CHEMBL4722	Homo sapiens	IC50	uM	0.208
	16815414	CHEMBL3871604	Inhibition of GST-tagged Aurora A (123 to 401 residues) (unknown origin) preincubated for 15 mins followed by tetra(LRRWSLG) substrate addition measured for 90 mins by Kinase-Glo luminescence assay	B	CC(C)OC(=O)CCC(=O)Nc1cccc(-c2n[nH]c3ccc(NS(=O)(=O)c4ccccc4)cc23)c1		CHEMBL3935219	=	IC50	nM	314.0	CHEMBL4722	Homo sapiens	IC50	uM	0.314
	16815415	CHEMBL3871604	Inhibition of GST-tagged Aurora A (123 to 401 residues) (unknown origin) preincubated for 15 mins followed by tetra(LRRWSLG) substrate addition measured for 90 mins by Kinase-Glo luminescence assay	B	CC#CC(=O)Nc1cccc(-c2n[nH]c3ccc(NS(=O)(=O)c4ccccc4)cc23)c1		CHEMBL3953964	=	IC50	nM	85.0	CHEMBL4722	Homo sapiens	IC50	uM	0.085
	16815416	CHEMBL3871605	Inhibition of GST-tagged Aurora A (123 to 401 residues) (unknown origin) at 1 uM preincubated for 15 mins followed by tetra(LRRWSLG) substrate addition measured for 90 mins by Kinase-Glo luminescence assay	B	O=C(/C=C/c1ccccc1)Nc1cccc(-c2n[nH]c3ccccc23)c1		CHEMBL3919416	=	Inhibition	%	12.9	CHEMBL4722	Homo sapiens	INH	%	12.9
	16815417	CHEMBL3871605	Inhibition of GST-tagged Aurora A (123 to 401 residues) (unknown origin) at 1 uM preincubated for 15 mins followed by tetra(LRRWSLG) substrate addition measured for 90 mins by Kinase-Glo luminescence assay	B	O=C(O)CCC(=O)Nc1cccc(-c2n[nH]c3ccccc23)c1		CHEMBL3980851	=	Inhibition	%	42.8	CHEMBL4722	Homo sapiens	INH	%	42.8
	16815418	CHEMBL3871605	Inhibition of GST-tagged Aurora A (123 to 401 residues) (unknown origin) at 1 uM preincubated for 15 mins followed by tetra(LRRWSLG) substrate addition measured for 90 mins by Kinase-Glo luminescence assay	B	O=C(O)/C=C/C(=O)Nc1cccc(-c2n[nH]c3ccccc23)c1		CHEMBL3981806	=	Inhibition	%	32.3	CHEMBL4722	Homo sapiens	INH	%	32.3
	16815448	CHEMBL3871609	Inhibition of human recombinant full-length His-tagged Aurora A expressed in baculovirus expression system at 1 uM	B	O=C(O)/C=C\C(=O)Nc1cccc(-c2n[nH]c3ccc(NS(=O)(=O)c4ccccc4)cc23)c1		CHEMBL3986609	=	Inhibition	%	86.0	CHEMBL4722	Homo sapiens	INH	%	86.0
	16815471	CHEMBL3871632	Inhibition of GST-tagged Aurora A (123 to 401 residues) (unknown origin) at 50 uM preincubated for 15 mins followed by tetra(LRRWSLG) substrate addition measured for 90 mins by Kinase-Glo luminescence assay	B	Nc1cccc(-c2n[nH]c3ccccc23)c1		CHEMBL3970521	=	Inhibition	%	71.0	CHEMBL4722	Homo sapiens	INH	%	71.0
	16815472	CHEMBL3871632	Inhibition of GST-tagged Aurora A (123 to 401 residues) (unknown origin) at 50 uM preincubated for 15 mins followed by tetra(LRRWSLG) substrate addition measured for 90 mins by Kinase-Glo luminescence assay	B	O=C1c2ccccc2C2=C3C(=CC=CC13)NN2		CHEMBL3926331	=	Inhibition	%	84.0	CHEMBL4722	Homo sapiens	INH	%	84.0
	16815473	CHEMBL3871632	Inhibition of GST-tagged Aurora A (123 to 401 residues) (unknown origin) at 50 uM preincubated for 15 mins followed by tetra(LRRWSLG) substrate addition measured for 90 mins by Kinase-Glo luminescence assay	B	Fc1c(F)c(F)c2c(-c3ccccc3)n[nH]c2c1F		CHEMBL596549	=	Inhibition	%	3.0	CHEMBL4722	Homo sapiens	INH	%	3.0
	16815474	CHEMBL3871632	Inhibition of GST-tagged Aurora A (123 to 401 residues) (unknown origin) at 50 uM preincubated for 15 mins followed by tetra(LRRWSLG) substrate addition measured for 90 mins by Kinase-Glo luminescence assay	B	O=C(Nc1ccc2cn[nH]c2c1)/C(=C/c1ccccc1)NC(=O)c1ccccc1		CHEMBL3964616	=	Inhibition	%	39.0	CHEMBL4722	Homo sapiens	INH	%	39.0
	16815475	CHEMBL3871632	Inhibition of GST-tagged Aurora A (123 to 401 residues) (unknown origin) at 50 uM preincubated for 15 mins followed by tetra(LRRWSLG) substrate addition measured for 90 mins by Kinase-Glo luminescence assay	B	O=[N+]([O-])c1cc([N+](=O)[O-])c2cn[nH]c2c1		CHEMBL3973669	=	Inhibition	%	22.0	CHEMBL4722	Homo sapiens	INH	%	22.0
	16815476	CHEMBL3871632	Inhibition of GST-tagged Aurora A (123 to 401 residues) (unknown origin) at 50 uM preincubated for 15 mins followed by tetra(LRRWSLG) substrate addition measured for 90 mins by Kinase-Glo luminescence assay	B	O=[N+]([O-])c1ccc2[nH]nc(-c3ccccc3)c2c1		CHEMBL90146	=	Inhibition	%	77.0	CHEMBL4722	Homo sapiens	INH	%	77.0
	16815477	CHEMBL3871632	Inhibition of GST-tagged Aurora A (123 to 401 residues) (unknown origin) at 50 uM preincubated for 15 mins followed by tetra(LRRWSLG) substrate addition measured for 90 mins by Kinase-Glo luminescence assay	B	c1ccc2[nH]ncc2c1		CHEMBL86795	=	Inhibition	%	17.0	CHEMBL4722	Homo sapiens	INH	%	17.0
	16815478	CHEMBL3871632	Inhibition of GST-tagged Aurora A (123 to 401 residues) (unknown origin) at 50 uM preincubated for 15 mins followed by tetra(LRRWSLG) substrate addition measured for 90 mins by Kinase-Glo luminescence assay	B	O=[N+]([O-])c1cc([N+](=O)[O-])c2[nH]nc(-c3ccccc3)c2c1		CHEMBL1382698	=	Inhibition	%	2.0	CHEMBL4722	Homo sapiens	INH	%	2.0
	16815479	CHEMBL3871632	Inhibition of GST-tagged Aurora A (123 to 401 residues) (unknown origin) at 50 uM preincubated for 15 mins followed by tetra(LRRWSLG) substrate addition measured for 90 mins by Kinase-Glo luminescence assay	B	c1ccc(Cc2n[nH]c3ccccc23)cc1		CHEMBL3965465	=	Inhibition	%	4.0	CHEMBL4722	Homo sapiens	INH	%	4.0
	16815480	CHEMBL3871632	Inhibition of GST-tagged Aurora A (123 to 401 residues) (unknown origin) at 50 uM preincubated for 15 mins followed by tetra(LRRWSLG) substrate addition measured for 90 mins by Kinase-Glo luminescence assay	B	Cc1ccc(S(=O)(=O)CCc2noc(-c3n[nH]c4ccccc34)n2)cc1		CHEMBL3940612	=	Inhibition	%	23.0	CHEMBL4722	Homo sapiens	INH	%	23.0
	16815481	CHEMBL3871632	Inhibition of GST-tagged Aurora A (123 to 401 residues) (unknown origin) at 50 uM preincubated for 15 mins followed by tetra(LRRWSLG) substrate addition measured for 90 mins by Kinase-Glo luminescence assay	B	O=C(O)C1=C2NNC3=C2C(C=C1)C(=O)c1ccccc13		CHEMBL3921589	=	Inhibition	%	97.0	CHEMBL4722	Homo sapiens	INH	%	97.0
	16815482	CHEMBL3871632	Inhibition of GST-tagged Aurora A (123 to 401 residues) (unknown origin) at 50 uM preincubated for 15 mins followed by tetra(LRRWSLG) substrate addition measured for 90 mins by Kinase-Glo luminescence assay	B	Nc1c(S(=O)(=O)O)cc2[nH]nc3c2c1C(=O)c1ccccc1-3		CHEMBL3949373	=	Inhibition	%	89.0	CHEMBL4722	Homo sapiens	INH	%	89.0
	16815483	CHEMBL3871632	Inhibition of GST-tagged Aurora A (123 to 401 residues) (unknown origin) at 50 uM preincubated for 15 mins followed by tetra(LRRWSLG) substrate addition measured for 90 mins by Kinase-Glo luminescence assay	B	N#Cc1cccc(-c2n[nH]c3ccccc23)c1		CHEMBL3894653	=	Inhibition	%	71.0	CHEMBL4722	Homo sapiens	INH	%	71.0
	16815484	CHEMBL3871632	Inhibition of GST-tagged Aurora A (123 to 401 residues) (unknown origin) at 50 uM preincubated for 15 mins followed by tetra(LRRWSLG) substrate addition measured for 90 mins by Kinase-Glo luminescence assay	B	Oc1cccc(-c2n[nH]c3ccccc23)c1		CHEMBL3893374	=	Inhibition	%	84.0	CHEMBL4722	Homo sapiens	INH	%	84.0
	16815485	CHEMBL3871632	Inhibition of GST-tagged Aurora A (123 to 401 residues) (unknown origin) at 50 uM preincubated for 15 mins followed by tetra(LRRWSLG) substrate addition measured for 90 mins by Kinase-Glo luminescence assay	B	c1ccc(-c2[nH]nc3ccccc23)cc1		CHEMBL315708	=	Inhibition	%	62.0	CHEMBL4722	Homo sapiens	INH	%	62.0
	16815486	CHEMBL3871632	Inhibition of GST-tagged Aurora A (123 to 401 residues) (unknown origin) at 50 uM preincubated for 15 mins followed by tetra(LRRWSLG) substrate addition measured for 90 mins by Kinase-Glo luminescence assay	B	Cc1cccc(-c2n[nH]c3ccccc23)c1		CHEMBL3931592	=	Inhibition	%	79.0	CHEMBL4722	Homo sapiens	INH	%	79.0
	16815487	CHEMBL3871632	Inhibition of GST-tagged Aurora A (123 to 401 residues) (unknown origin) at 50 uM preincubated for 15 mins followed by tetra(LRRWSLG) substrate addition measured for 90 mins by Kinase-Glo luminescence assay	B	O=[N+]([O-])c1cccc(-c2n[nH]c3ccccc23)c1		CHEMBL3948307	=	Inhibition	%	67.0	CHEMBL4722	Homo sapiens	INH	%	67.0
	16815488	CHEMBL3871633	Inhibition of GST-tagged Aurora A (123 to 401 residues) (unknown origin) at 20 uM preincubated for 15 mins followed by tetra(LRRWSLG) substrate addition measured for 90 mins by Kinase-Glo luminescence assay	B	Nc1cccc(-c2n[nH]c3ccccc23)c1		CHEMBL3970521	=	Inhibition	%	67.0	CHEMBL4722	Homo sapiens	INH	%	67.0
	16815489	CHEMBL3871633	Inhibition of GST-tagged Aurora A (123 to 401 residues) (unknown origin) at 20 uM preincubated for 15 mins followed by tetra(LRRWSLG) substrate addition measured for 90 mins by Kinase-Glo luminescence assay	B	O=C1c2ccccc2C2=C3C(=CC=CC13)NN2		CHEMBL3926331	=	Inhibition	%	84.0	CHEMBL4722	Homo sapiens	INH	%	84.0
	16815490	CHEMBL3871633	Inhibition of GST-tagged Aurora A (123 to 401 residues) (unknown origin) at 20 uM preincubated for 15 mins followed by tetra(LRRWSLG) substrate addition measured for 90 mins by Kinase-Glo luminescence assay	B	Fc1c(F)c(F)c2c(-c3ccccc3)n[nH]c2c1F		CHEMBL596549	=	Inhibition	%	9.0	CHEMBL4722	Homo sapiens	INH	%	9.0
	16815491	CHEMBL3871633	Inhibition of GST-tagged Aurora A (123 to 401 residues) (unknown origin) at 20 uM preincubated for 15 mins followed by tetra(LRRWSLG) substrate addition measured for 90 mins by Kinase-Glo luminescence assay	B	O=C(Nc1ccc2cn[nH]c2c1)/C(=C/c1ccccc1)NC(=O)c1ccccc1		CHEMBL3964616	=	Inhibition	%	21.0	CHEMBL4722	Homo sapiens	INH	%	21.0
	16815492	CHEMBL3871633	Inhibition of GST-tagged Aurora A (123 to 401 residues) (unknown origin) at 20 uM preincubated for 15 mins followed by tetra(LRRWSLG) substrate addition measured for 90 mins by Kinase-Glo luminescence assay	B	O=[N+]([O-])c1cc([N+](=O)[O-])c2cn[nH]c2c1		CHEMBL3973669	=	Inhibition	%	10.0	CHEMBL4722	Homo sapiens	INH	%	10.0
	16815493	CHEMBL3871633	Inhibition of GST-tagged Aurora A (123 to 401 residues) (unknown origin) at 20 uM preincubated for 15 mins followed by tetra(LRRWSLG) substrate addition measured for 90 mins by Kinase-Glo luminescence assay	B	O=[N+]([O-])c1ccc2[nH]nc(-c3ccccc3)c2c1		CHEMBL90146	=	Inhibition	%	31.0	CHEMBL4722	Homo sapiens	INH	%	31.0
	16815494	CHEMBL3871633	Inhibition of GST-tagged Aurora A (123 to 401 residues) (unknown origin) at 20 uM preincubated for 15 mins followed by tetra(LRRWSLG) substrate addition measured for 90 mins by Kinase-Glo luminescence assay	B	c1ccc2[nH]ncc2c1		CHEMBL86795	=	Inhibition	%	9.0	CHEMBL4722	Homo sapiens	INH	%	9.0
	16815495	CHEMBL3871633	Inhibition of GST-tagged Aurora A (123 to 401 residues) (unknown origin) at 20 uM preincubated for 15 mins followed by tetra(LRRWSLG) substrate addition measured for 90 mins by Kinase-Glo luminescence assay	B	O=[N+]([O-])c1cc([N+](=O)[O-])c2[nH]nc(-c3ccccc3)c2c1		CHEMBL1382698	=	Inhibition	%	9.0	CHEMBL4722	Homo sapiens	INH	%	9.0
	16815496	CHEMBL3871633	Inhibition of GST-tagged Aurora A (123 to 401 residues) (unknown origin) at 20 uM preincubated for 15 mins followed by tetra(LRRWSLG) substrate addition measured for 90 mins by Kinase-Glo luminescence assay	B	c1ccc(Cc2n[nH]c3ccccc23)cc1		CHEMBL3965465	=	Inhibition	%	2.0	CHEMBL4722	Homo sapiens	INH	%	2.0
	16815497	CHEMBL3871633	Inhibition of GST-tagged Aurora A (123 to 401 residues) (unknown origin) at 20 uM preincubated for 15 mins followed by tetra(LRRWSLG) substrate addition measured for 90 mins by Kinase-Glo luminescence assay	B	Cc1ccc(S(=O)(=O)CCc2noc(-c3n[nH]c4ccccc34)n2)cc1		CHEMBL3940612	=	Inhibition	%	0.0	CHEMBL4722	Homo sapiens	INH	%	0.0
	16815498	CHEMBL3871633	Inhibition of GST-tagged Aurora A (123 to 401 residues) (unknown origin) at 20 uM preincubated for 15 mins followed by tetra(LRRWSLG) substrate addition measured for 90 mins by Kinase-Glo luminescence assay	B	O=C(O)C1=C2NNC3=C2C(C=C1)C(=O)c1ccccc13		CHEMBL3921589	=	Inhibition	%	100.0	CHEMBL4722	Homo sapiens	INH	%	100.0
	16815499	CHEMBL3871633	Inhibition of GST-tagged Aurora A (123 to 401 residues) (unknown origin) at 20 uM preincubated for 15 mins followed by tetra(LRRWSLG) substrate addition measured for 90 mins by Kinase-Glo luminescence assay	B	Nc1c(S(=O)(=O)O)cc2[nH]nc3c2c1C(=O)c1ccccc1-3		CHEMBL3949373	=	Inhibition	%	95.0	CHEMBL4722	Homo sapiens	INH	%	95.0
	16815500	CHEMBL3871633	Inhibition of GST-tagged Aurora A (123 to 401 residues) (unknown origin) at 20 uM preincubated for 15 mins followed by tetra(LRRWSLG) substrate addition measured for 90 mins by Kinase-Glo luminescence assay	B	N#Cc1cccc(-c2n[nH]c3ccccc23)c1		CHEMBL3894653	=	Inhibition	%	55.0	CHEMBL4722	Homo sapiens	INH	%	55.0
	16815501	CHEMBL3871633	Inhibition of GST-tagged Aurora A (123 to 401 residues) (unknown origin) at 20 uM preincubated for 15 mins followed by tetra(LRRWSLG) substrate addition measured for 90 mins by Kinase-Glo luminescence assay	B	Oc1cccc(-c2n[nH]c3ccccc23)c1		CHEMBL3893374	=	Inhibition	%	71.0	CHEMBL4722	Homo sapiens	INH	%	71.0
	16815502	CHEMBL3871633	Inhibition of GST-tagged Aurora A (123 to 401 residues) (unknown origin) at 20 uM preincubated for 15 mins followed by tetra(LRRWSLG) substrate addition measured for 90 mins by Kinase-Glo luminescence assay	B	c1ccc(-c2[nH]nc3ccccc23)cc1		CHEMBL315708	=	Inhibition	%	13.0	CHEMBL4722	Homo sapiens	INH	%	13.0
	16815503	CHEMBL3871633	Inhibition of GST-tagged Aurora A (123 to 401 residues) (unknown origin) at 20 uM preincubated for 15 mins followed by tetra(LRRWSLG) substrate addition measured for 90 mins by Kinase-Glo luminescence assay	B	Cc1cccc(-c2n[nH]c3ccccc23)c1		CHEMBL3931592	=	Inhibition	%	44.0	CHEMBL4722	Homo sapiens	INH	%	44.0
	16815504	CHEMBL3871633	Inhibition of GST-tagged Aurora A (123 to 401 residues) (unknown origin) at 20 uM preincubated for 15 mins followed by tetra(LRRWSLG) substrate addition measured for 90 mins by Kinase-Glo luminescence assay	B	O=[N+]([O-])c1cccc(-c2n[nH]c3ccccc23)c1		CHEMBL3948307	=	Inhibition	%	46.0	CHEMBL4722	Homo sapiens	INH	%	46.0
	16817217	CHEMBL3871905	Inhibition of recombinant Aurora A kinase derived from human Hela cells using kemptide as substrate in presence of [c-32P]ATP	B	Cc1cc(Nc2cc(C)c(C#N)c(N[C@@H](C)CCCC(C)(C)O)n2)n[nH]1		CHEMBL1778663	<	Ki	nM	1.0	CHEMBL4722	Homo sapiens	Ki	uM	0.001
	16817218	CHEMBL3871905	Inhibition of recombinant Aurora A kinase derived from human Hela cells using kemptide as substrate in presence of [c-32P]ATP	B	Cc1cc(Nc2cc(C)c(C#N)c(NCCOc3ccccc3)n2)n[nH]1		CHEMBL3966303	=	Ki	nM	2.0	CHEMBL4722	Homo sapiens	Ki	uM	0.002
	16817219	CHEMBL3871905	Inhibition of recombinant Aurora A kinase derived from human Hela cells using kemptide as substrate in presence of [c-32P]ATP	B	Cc1cc(Nc2cc(C)c(C#N)c(NCCOc3ccccc3F)n2)n[nH]1		CHEMBL3903916	<	Ki	nM	1.0	CHEMBL4722	Homo sapiens	Ki	uM	0.001
	16817220	CHEMBL3871905	Inhibition of recombinant Aurora A kinase derived from human Hela cells using kemptide as substrate in presence of [c-32P]ATP	B	Cc1cc(Nc2cc(C)c(C#N)c(NCCOc3ccccc3Cl)n2)n[nH]1		CHEMBL3974799	=	Ki	nM	1.0	CHEMBL4722	Homo sapiens	Ki	uM	0.001
	16817221	CHEMBL3871905	Inhibition of recombinant Aurora A kinase derived from human Hela cells using kemptide as substrate in presence of [c-32P]ATP	B	Cc1cc(Nc2cc(C)c(C#N)c(NCCOc3cccnc3)n2)n[nH]1		CHEMBL3912923	=	Ki	nM	2.0	CHEMBL4722	Homo sapiens	Ki	uM	0.002
	16817222	CHEMBL3871905	Inhibition of recombinant Aurora A kinase derived from human Hela cells using kemptide as substrate in presence of [c-32P]ATP	B	Cc1cc(Nc2cc(C)c(C#N)c(NCCOc3ccccn3)n2)n[nH]1		CHEMBL3922893	=	Ki	nM	6.0	CHEMBL4722	Homo sapiens	Ki	uM	0.006
	16817223	CHEMBL3871905	Inhibition of recombinant Aurora A kinase derived from human Hela cells using kemptide as substrate in presence of [c-32P]ATP	B	Cc1cc(Nc2cc(C)c(C#N)c(NCCOc3ccncc3)n2)n[nH]1		CHEMBL3921905	=	Ki	nM	29.0	CHEMBL4722	Homo sapiens	Ki	uM	0.029
	16817224	CHEMBL3871905	Inhibition of recombinant Aurora A kinase derived from human Hela cells using kemptide as substrate in presence of [c-32P]ATP	B	Cc1ccc(OCCNc2nc(Nc3cc(C)[nH]n3)cc(C)c2C#N)cn1		CHEMBL3893914	=	Ki	nM	4.0	CHEMBL4722	Homo sapiens	Ki	uM	0.004
	16817225	CHEMBL3871905	Inhibition of recombinant Aurora A kinase derived from human Hela cells using kemptide as substrate in presence of [c-32P]ATP	B	Cc1cc(Nc2cc(C)c(C#N)c(NCCOc3cccnc3C)n2)n[nH]1		CHEMBL3937431	=	Ki	nM	4.0	CHEMBL4722	Homo sapiens	Ki	uM	0.004
	16817226	CHEMBL3871905	Inhibition of recombinant Aurora A kinase derived from human Hela cells using kemptide as substrate in presence of [c-32P]ATP	B	Cc1ccc(OCCNc2nc(Nc3cc(C)[nH]n3)cc(C)c2C#N)c(C)n1		CHEMBL3967136	=	Ki	nM	10.0	CHEMBL4722	Homo sapiens	Ki	uM	0.01
	16817227	CHEMBL3871905	Inhibition of recombinant Aurora A kinase derived from human Hela cells using kemptide as substrate in presence of [c-32P]ATP	B	CCc1ccc(OCCNc2nc(Nc3cc(C)[nH]n3)cc(C)c2C#N)cn1		CHEMBL3928420	=	Ki	nM	6.0	CHEMBL4722	Homo sapiens	Ki	uM	0.006
	16817228	CHEMBL3871905	Inhibition of recombinant Aurora A kinase derived from human Hela cells using kemptide as substrate in presence of [c-32P]ATP	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	Ki	nM	2.0	CHEMBL4722	Homo sapiens	Ki	uM	0.002
	16817229	CHEMBL3871906	Activity at Aurora 2 kinase (unknown origin)	B	Cc1ccc(OCCNc2nc(Nc3cc(C)[nH]n3)cc(C)c2C#N)cn1		CHEMBL3893914	=	Km	nM	28000.0	CHEMBL4722	Homo sapiens	Km	uM	28.0
	16835842	CHEMBL3875833	Inhibition of human AURKA	B	CNC(=O)c1ccccc1Nc1nc(Nc2ccc(N3CCOCC3)cc2OC)ncc1Cl		CHEMBL458997	=	IC50	nM	4.0	CHEMBL4722	Homo sapiens	IC50	nM	4.0
	16880213	CHEMBL3880809	Inhibition of Aurora-2 (unknown origin) pre-incubated with substrate for 10 mins before enzyme addition and measured after 10 mins post enzyme addition using Kemptide substrate by pyruvate kinase and LDH based standard coupled enzyme assay	B	Cc1cc(Nc2cc(N3CC(F)(C4CC4)C3)nc(O[C@H]3CCN(C(=O)c4cc(Cl)ccc4F)C3)n2)n[nH]1		CHEMBL3545378	<	Ki	nM	10.0	CHEMBL4722	Homo sapiens	Ki	uM	0.01
	16880214	CHEMBL3880809	Inhibition of Aurora-2 (unknown origin) pre-incubated with substrate for 10 mins before enzyme addition and measured after 10 mins post enzyme addition using Kemptide substrate by pyruvate kinase and LDH based standard coupled enzyme assay	B	Cc1cc(Nc2cc(N3CC(F)(C4CC4)C3)nc(O[C@H]3CCN(C(=O)OC(C)(C)C)C3)n2)[nH]n1		CHEMBL3905298	<	Ki	nM	10.0	CHEMBL4722	Homo sapiens	Ki	uM	0.01
	16880215	CHEMBL3880809	Inhibition of Aurora-2 (unknown origin) pre-incubated with substrate for 10 mins before enzyme addition and measured after 10 mins post enzyme addition using Kemptide substrate by pyruvate kinase and LDH based standard coupled enzyme assay	B	Cc1cc(Nc2cc(N3CCC3)nc(O[C@H]3CCN(C(=O)OC(C)(C)C)C3)n2)[nH]n1		CHEMBL3936298	<	Ki	nM	50.0	CHEMBL4722	Homo sapiens	Ki	uM	0.05
	16896528	CHEMBL3882306	Inhibition of human N-terminal His-tagged Aurora A expressed in Escherichia coli BL21-Codon-Plus(DE3)-RIL cells using 5-carboxy-fluorescein-y-aminobutyric acid-Ala-Leu-Arg-Arg-Ala-Ser-Leu-Gly-NH2 as substrate after 120 mins by fluorescence polarization assay	B	Fc1c(O[C@H]2CC[C@](Cc3cccc(Nc4cc[nH]n4)n3)(c3n[nH]c(=S)o3)CC2)cccc1C(F)(F)F.O=C(O)C(F)(F)F		CHEMBL3951876	=	IC50	nM	0.23	CHEMBL4722	Homo sapiens	IC50	nM	0.23
	16896550	CHEMBL3882306	Inhibition of human N-terminal His-tagged Aurora A expressed in Escherichia coli BL21-Codon-Plus(DE3)-RIL cells using 5-carboxy-fluorescein-y-aminobutyric acid-Ala-Leu-Arg-Arg-Ala-Ser-Leu-Gly-NH2 as substrate after 120 mins by fluorescence polarization assay	B	Cc1cc(Nc2cc[nH]n2)nc(C[C@]2(c3n[nH]c(=O)o3)CC[C@H](Oc3cccc(Cl)c3F)CC2)n1.O=C(O)C(F)(F)F		CHEMBL3889916	=	IC50	nM	0.18	CHEMBL4722	Homo sapiens	IC50	nM	0.18
	16896551	CHEMBL3882306	Inhibition of human N-terminal His-tagged Aurora A expressed in Escherichia coli BL21-Codon-Plus(DE3)-RIL cells using 5-carboxy-fluorescein-y-aminobutyric acid-Ala-Leu-Arg-Arg-Ala-Ser-Leu-Gly-NH2 as substrate after 120 mins by fluorescence polarization assay	B	Cl.O=C(O)[C@]1(Cc2cc(Br)cc(Nc3nccs3)n2)CC[C@@H](Oc2cccc(Cl)c2F)CC1		CHEMBL3892660	=	IC50	nM	0.09	CHEMBL4722	Homo sapiens	IC50	nM	0.09
	16896552	CHEMBL3882306	Inhibition of human N-terminal His-tagged Aurora A expressed in Escherichia coli BL21-Codon-Plus(DE3)-RIL cells using 5-carboxy-fluorescein-y-aminobutyric acid-Ala-Leu-Arg-Arg-Ala-Ser-Leu-Gly-NH2 as substrate after 120 mins by fluorescence polarization assay	B	O=C(O)C(F)(F)F.O=c1[nH]nc([C@]2(Cc3cccc(Nc4cc[nH]n4)n3)CC[C@@H](S(=O)(=O)c3cccc(Cl)c3Cl)CC2)o1		CHEMBL3979540	=	IC50	nM	0.43	CHEMBL4722	Homo sapiens	IC50	nM	0.43
	16896553	CHEMBL3882306	Inhibition of human N-terminal His-tagged Aurora A expressed in Escherichia coli BL21-Codon-Plus(DE3)-RIL cells using 5-carboxy-fluorescein-y-aminobutyric acid-Ala-Leu-Arg-Arg-Ala-Ser-Leu-Gly-NH2 as substrate after 120 mins by fluorescence polarization assay	B	O=C(O)C(F)(F)F.O=c1[nH]nc([C@]2(Cc3cccc(Nc4cc[nH]n4)n3)CC[C@@H]([S+]([O-])c3cccc(Cl)c3Cl)CC2)o1		CHEMBL3952770	=	IC50	nM	0.31	CHEMBL4722	Homo sapiens	IC50	nM	0.31
	16896554	CHEMBL3882306	Inhibition of human N-terminal His-tagged Aurora A expressed in Escherichia coli BL21-Codon-Plus(DE3)-RIL cells using 5-carboxy-fluorescein-y-aminobutyric acid-Ala-Leu-Arg-Arg-Ala-Ser-Leu-Gly-NH2 as substrate after 120 mins by fluorescence polarization assay	B	O=C(O)C(F)(F)F.O=c1[nH]nc([C@]2(Cc3cccc(Nc4cc[nH]n4)n3)CC[C@@H](Sc3cccc(Cl)c3Cl)CC2)o1		CHEMBL3897107	=	IC50	nM	0.47	CHEMBL4722	Homo sapiens	IC50	nM	0.47
	16896555	CHEMBL3882306	Inhibition of human N-terminal His-tagged Aurora A expressed in Escherichia coli BL21-Codon-Plus(DE3)-RIL cells using 5-carboxy-fluorescein-y-aminobutyric acid-Ala-Leu-Arg-Arg-Ala-Ser-Leu-Gly-NH2 as substrate after 120 mins by fluorescence polarization assay	B	O=C(O)C(F)(F)F.O=C(O)[C@]1(Cc2cccc(Nc3cc[nH]n3)n2)CC[C@@H](Sc2cccc(Cl)c2Cl)CC1		CHEMBL3899823	=	IC50	nM	0.13	CHEMBL4722	Homo sapiens	IC50	nM	0.13
	16896556	CHEMBL3882306	Inhibition of human N-terminal His-tagged Aurora A expressed in Escherichia coli BL21-Codon-Plus(DE3)-RIL cells using 5-carboxy-fluorescein-y-aminobutyric acid-Ala-Leu-Arg-Arg-Ala-Ser-Leu-Gly-NH2 as substrate after 120 mins by fluorescence polarization assay	B	O=C(O)C(F)(F)F.O=C(O)[C@]1(Cc2cccc(Nc3nccs3)n2)CC[C@@H](S(=O)(=O)c2cccc(Cl)c2Cl)CC1		CHEMBL3949419	=	IC50	nM	0.15	CHEMBL4722	Homo sapiens	IC50	nM	0.15
	16896557	CHEMBL3882306	Inhibition of human N-terminal His-tagged Aurora A expressed in Escherichia coli BL21-Codon-Plus(DE3)-RIL cells using 5-carboxy-fluorescein-y-aminobutyric acid-Ala-Leu-Arg-Arg-Ala-Ser-Leu-Gly-NH2 as substrate after 120 mins by fluorescence polarization assay	B	O=C(O)C(F)(F)F.O=C(O)[C@]1(Cc2cccc(Nc3nccs3)n2)CC[C@@H]([S+]([O-])c2cccc(Cl)c2Cl)CC1		CHEMBL3958845	=	IC50	nM	0.19	CHEMBL4722	Homo sapiens	IC50	nM	0.19
	16896558	CHEMBL3882306	Inhibition of human N-terminal His-tagged Aurora A expressed in Escherichia coli BL21-Codon-Plus(DE3)-RIL cells using 5-carboxy-fluorescein-y-aminobutyric acid-Ala-Leu-Arg-Arg-Ala-Ser-Leu-Gly-NH2 as substrate after 120 mins by fluorescence polarization assay	B	O=C(O)C(F)(F)F.O=C(O)[C@]1(Cc2cccc(Nc3nccs3)n2)CC[C@@H](Sc2cccc(Cl)c2Cl)CC1		CHEMBL3904174	=	IC50	nM	0.08	CHEMBL4722	Homo sapiens	IC50	nM	0.08
	16896559	CHEMBL3882306	Inhibition of human N-terminal His-tagged Aurora A expressed in Escherichia coli BL21-Codon-Plus(DE3)-RIL cells using 5-carboxy-fluorescein-y-aminobutyric acid-Ala-Leu-Arg-Arg-Ala-Ser-Leu-Gly-NH2 as substrate after 120 mins by fluorescence polarization assay	B	O=c1[nH]nc([C@]2(Cc3cncc(Nc4cc[nH]n4)n3)CC[C@@H](Oc3cccc(Cl)c3F)CC2)o1		CHEMBL3914249	=	IC50	nM	0.19	CHEMBL4722	Homo sapiens	IC50	nM	0.19
	16896560	CHEMBL3882306	Inhibition of human N-terminal His-tagged Aurora A expressed in Escherichia coli BL21-Codon-Plus(DE3)-RIL cells using 5-carboxy-fluorescein-y-aminobutyric acid-Ala-Leu-Arg-Arg-Ala-Ser-Leu-Gly-NH2 as substrate after 120 mins by fluorescence polarization assay	B	Cc1nnc([C@]2(Cc3cccc(Nc4cc[nH]n4)n3)CC[C@@H](Oc3cccc(C(F)(F)F)c3F)CC2)s1		CHEMBL3942869	=	IC50	nM	3.5	CHEMBL4722	Homo sapiens	IC50	nM	3.5
	16896561	CHEMBL3882306	Inhibition of human N-terminal His-tagged Aurora A expressed in Escherichia coli BL21-Codon-Plus(DE3)-RIL cells using 5-carboxy-fluorescein-y-aminobutyric acid-Ala-Leu-Arg-Arg-Ala-Ser-Leu-Gly-NH2 as substrate after 120 mins by fluorescence polarization assay	B	Fc1c(O[C@H]2CC[C@](Cc3cccc(Nc4cc[nH]n4)n3)(c3nncs3)CC2)cccc1C(F)(F)F		CHEMBL3945581	=	IC50	nM	2.4	CHEMBL4722	Homo sapiens	IC50	nM	2.4
	16896562	CHEMBL3882306	Inhibition of human N-terminal His-tagged Aurora A expressed in Escherichia coli BL21-Codon-Plus(DE3)-RIL cells using 5-carboxy-fluorescein-y-aminobutyric acid-Ala-Leu-Arg-Arg-Ala-Ser-Leu-Gly-NH2 as substrate after 120 mins by fluorescence polarization assay	B	Cn1nc([C@]2(Cc3cccc(Nc4cc[nH]n4)n3)CC[C@@H](Oc3cccc(Cl)c3F)CC2)oc1=O		CHEMBL3934177	=	IC50	nM	1.4	CHEMBL4722	Homo sapiens	IC50	nM	1.4
	16896563	CHEMBL3882306	Inhibition of human N-terminal His-tagged Aurora A expressed in Escherichia coli BL21-Codon-Plus(DE3)-RIL cells using 5-carboxy-fluorescein-y-aminobutyric acid-Ala-Leu-Arg-Arg-Ala-Ser-Leu-Gly-NH2 as substrate after 120 mins by fluorescence polarization assay	B	Cc1nnc([C@]2(Cc3cccc(Nc4cc[nH]n4)n3)CC[C@@H](Oc3cccc(Cl)c3F)CC2)o1		CHEMBL3946400	=	IC50	nM	0.87	CHEMBL4722	Homo sapiens	IC50	nM	0.87
	16896564	CHEMBL3882306	Inhibition of human N-terminal His-tagged Aurora A expressed in Escherichia coli BL21-Codon-Plus(DE3)-RIL cells using 5-carboxy-fluorescein-y-aminobutyric acid-Ala-Leu-Arg-Arg-Ala-Ser-Leu-Gly-NH2 as substrate after 120 mins by fluorescence polarization assay	B	Fc1c(Cl)cccc1O[C@H]1CC[C@](Cc2cccc(Nc3cc[nH]n3)n2)(c2n[nH]c(=S)o2)CC1		CHEMBL3967012	=	IC50	nM	0.12	CHEMBL4722	Homo sapiens	IC50	nM	0.12
	16896565	CHEMBL3882306	Inhibition of human N-terminal His-tagged Aurora A expressed in Escherichia coli BL21-Codon-Plus(DE3)-RIL cells using 5-carboxy-fluorescein-y-aminobutyric acid-Ala-Leu-Arg-Arg-Ala-Ser-Leu-Gly-NH2 as substrate after 120 mins by fluorescence polarization assay	B	O=c1[nH]nc([C@]2(Cc3cccc(Nc4cc[nH]n4)n3)CC[C@@H](Oc3cccc(Cl)c3F)CC2)o1		CHEMBL3966216	=	IC50	nM	0.39	CHEMBL4722	Homo sapiens	IC50	nM	0.39
	16896566	CHEMBL3882306	Inhibition of human N-terminal His-tagged Aurora A expressed in Escherichia coli BL21-Codon-Plus(DE3)-RIL cells using 5-carboxy-fluorescein-y-aminobutyric acid-Ala-Leu-Arg-Arg-Ala-Ser-Leu-Gly-NH2 as substrate after 120 mins by fluorescence polarization assay	B	Fc1c(O[C@H]2CC[C@](Cc3cccc(Nc4cc[nH]n4)n3)(c3nnco3)CC2)cccc1C(F)(F)F		CHEMBL3955990	=	IC50	nM	4.1	CHEMBL4722	Homo sapiens	IC50	nM	4.1
	16896567	CHEMBL3882306	Inhibition of human N-terminal His-tagged Aurora A expressed in Escherichia coli BL21-Codon-Plus(DE3)-RIL cells using 5-carboxy-fluorescein-y-aminobutyric acid-Ala-Leu-Arg-Arg-Ala-Ser-Leu-Gly-NH2 as substrate after 120 mins by fluorescence polarization assay	B	N=c1[nH]nc([C@]2(Cc3cccc(Nc4cc[nH]n4)n3)CC[C@@H](Oc3cccc(C(F)(F)F)c3F)CC2)o1.O=C(O)C(F)(F)F		CHEMBL3964756	=	IC50	nM	2.8	CHEMBL4722	Homo sapiens	IC50	nM	2.8
	16896568	CHEMBL3882306	Inhibition of human N-terminal His-tagged Aurora A expressed in Escherichia coli BL21-Codon-Plus(DE3)-RIL cells using 5-carboxy-fluorescein-y-aminobutyric acid-Ala-Leu-Arg-Arg-Ala-Ser-Leu-Gly-NH2 as substrate after 120 mins by fluorescence polarization assay	B	O=c1[nH]nc([C@]2(Cc3cccc(Nc4cc[nH]n4)n3)CC[C@@H](Oc3cccc(C(F)(F)F)c3F)CC2)o1		CHEMBL3964452	=	IC50	nM	1.0	CHEMBL4722	Homo sapiens	IC50	nM	1.0
	16896569	CHEMBL3882306	Inhibition of human N-terminal His-tagged Aurora A expressed in Escherichia coli BL21-Codon-Plus(DE3)-RIL cells using 5-carboxy-fluorescein-y-aminobutyric acid-Ala-Leu-Arg-Arg-Ala-Ser-Leu-Gly-NH2 as substrate after 120 mins by fluorescence polarization assay	B	CC(=O)N[C@]1(Cc2cccc(Nc3nccs3)n2)CC[C@@H](Oc2cccc(Cl)c2F)CC1		CHEMBL3894185	=	IC50	nM	0.82	CHEMBL4722	Homo sapiens	IC50	nM	0.82
	16896570	CHEMBL3882306	Inhibition of human N-terminal His-tagged Aurora A expressed in Escherichia coli BL21-Codon-Plus(DE3)-RIL cells using 5-carboxy-fluorescein-y-aminobutyric acid-Ala-Leu-Arg-Arg-Ala-Ser-Leu-Gly-NH2 as substrate after 120 mins by fluorescence polarization assay	B	CONC(=O)[C@]1(Cc2cccc(Nc3nccs3)n2)CC[C@@H](Oc2cccc(Cl)c2F)CC1		CHEMBL3941969	=	IC50	nM	0.49	CHEMBL4722	Homo sapiens	IC50	nM	0.49
	16896571	CHEMBL3882306	Inhibition of human N-terminal His-tagged Aurora A expressed in Escherichia coli BL21-Codon-Plus(DE3)-RIL cells using 5-carboxy-fluorescein-y-aminobutyric acid-Ala-Leu-Arg-Arg-Ala-Ser-Leu-Gly-NH2 as substrate after 120 mins by fluorescence polarization assay	B	Fc1c(Cl)cccc1O[C@H]1CC[C@](Cc2cccc(Nc3cc[nH]n3)n2)(c2nn[nH]n2)CC1.O=C(O)C(F)(F)F		CHEMBL3939277	=	IC50	nM	0.45	CHEMBL4722	Homo sapiens	IC50	nM	0.45
	16896572	CHEMBL3882306	Inhibition of human N-terminal His-tagged Aurora A expressed in Escherichia coli BL21-Codon-Plus(DE3)-RIL cells using 5-carboxy-fluorescein-y-aminobutyric acid-Ala-Leu-Arg-Arg-Ala-Ser-Leu-Gly-NH2 as substrate after 120 mins by fluorescence polarization assay	B	N#C[C@]1(Cc2cccc(Nc3cc[nH]n3)n2)CC[C@@H](Oc2cccc(Cl)c2F)CC1		CHEMBL3936303	=	IC50	nM	1.6	CHEMBL4722	Homo sapiens	IC50	nM	1.6
	16896573	CHEMBL3882306	Inhibition of human N-terminal His-tagged Aurora A expressed in Escherichia coli BL21-Codon-Plus(DE3)-RIL cells using 5-carboxy-fluorescein-y-aminobutyric acid-Ala-Leu-Arg-Arg-Ala-Ser-Leu-Gly-NH2 as substrate after 120 mins by fluorescence polarization assay	B	NC(=O)[C@]1(Cc2cncc(Nc3cc[nH]n3)n2)CC[C@@H](Oc2cccc(Cl)c2F)CC1		CHEMBL3948611	=	IC50	nM	2.0	CHEMBL4722	Homo sapiens	IC50	nM	2.0
	16896574	CHEMBL3882306	Inhibition of human N-terminal His-tagged Aurora A expressed in Escherichia coli BL21-Codon-Plus(DE3)-RIL cells using 5-carboxy-fluorescein-y-aminobutyric acid-Ala-Leu-Arg-Arg-Ala-Ser-Leu-Gly-NH2 as substrate after 120 mins by fluorescence polarization assay	B	CN(C)C(=O)[C@]1(Cc2cccc(Nc3cc[nH]n3)n2)CC[C@@H](Oc2cccc(Cl)c2F)CC1		CHEMBL3986649	=	IC50	nM	1.3	CHEMBL4722	Homo sapiens	IC50	nM	1.3
	16896575	CHEMBL3882306	Inhibition of human N-terminal His-tagged Aurora A expressed in Escherichia coli BL21-Codon-Plus(DE3)-RIL cells using 5-carboxy-fluorescein-y-aminobutyric acid-Ala-Leu-Arg-Arg-Ala-Ser-Leu-Gly-NH2 as substrate after 120 mins by fluorescence polarization assay	B	CNC(=O)[C@]1(Cc2cccc(Nc3cc[nH]n3)n2)CC[C@@H](Oc2cccc(Cl)c2F)CC1		CHEMBL3891605	=	IC50	nM	2.5	CHEMBL4722	Homo sapiens	IC50	nM	2.5
	16896576	CHEMBL3882306	Inhibition of human N-terminal His-tagged Aurora A expressed in Escherichia coli BL21-Codon-Plus(DE3)-RIL cells using 5-carboxy-fluorescein-y-aminobutyric acid-Ala-Leu-Arg-Arg-Ala-Ser-Leu-Gly-NH2 as substrate after 120 mins by fluorescence polarization assay	B	NC(=O)[C@]1(Cc2cccc(Nc3cc[nH]n3)n2)CC[C@@H](Oc2cccc(Cl)c2F)CC1		CHEMBL3976822	=	IC50	nM	1.8	CHEMBL4722	Homo sapiens	IC50	nM	1.8
	16896577	CHEMBL3882306	Inhibition of human N-terminal His-tagged Aurora A expressed in Escherichia coli BL21-Codon-Plus(DE3)-RIL cells using 5-carboxy-fluorescein-y-aminobutyric acid-Ala-Leu-Arg-Arg-Ala-Ser-Leu-Gly-NH2 as substrate after 120 mins by fluorescence polarization assay	B	O=C(O)C(F)(F)F.O=C(O)[C@]1(Cc2cccc(Nc3cc[nH]n3)n2)CC[C@@H](Oc2cccc(Cl)c2F)CC1		CHEMBL3929632	=	IC50	nM	0.15	CHEMBL4722	Homo sapiens	IC50	nM	0.15
	16896578	CHEMBL3882306	Inhibition of human N-terminal His-tagged Aurora A expressed in Escherichia coli BL21-Codon-Plus(DE3)-RIL cells using 5-carboxy-fluorescein-y-aminobutyric acid-Ala-Leu-Arg-Arg-Ala-Ser-Leu-Gly-NH2 as substrate after 120 mins by fluorescence polarization assay	B	O=C(O)C(F)(F)F.O=C(O)[C@]1(Cc2cccc(Nc3cc[nH]n3)n2)CC[C@@H](Oc2cccc(C(F)(F)F)c2F)CC1		CHEMBL3966740	=	IC50	nM	0.16	CHEMBL4722	Homo sapiens	IC50	nM	0.16
	16896579	CHEMBL3882306	Inhibition of human N-terminal His-tagged Aurora A expressed in Escherichia coli BL21-Codon-Plus(DE3)-RIL cells using 5-carboxy-fluorescein-y-aminobutyric acid-Ala-Leu-Arg-Arg-Ala-Ser-Leu-Gly-NH2 as substrate after 120 mins by fluorescence polarization assay	B	O=C(O)[C@]1(Cc2cccc(Nc3nccs3)n2)CC[C@@H](Oc2cccc(Cl)c2F)CC1		CHEMBL3600873	=	IC50	nM	0.54	CHEMBL4722	Homo sapiens	IC50	nM	0.54
	16896580	CHEMBL3882306	Inhibition of human N-terminal His-tagged Aurora A expressed in Escherichia coli BL21-Codon-Plus(DE3)-RIL cells using 5-carboxy-fluorescein-y-aminobutyric acid-Ala-Leu-Arg-Arg-Ala-Ser-Leu-Gly-NH2 as substrate after 120 mins by fluorescence polarization assay	B	Cl.O=C(O)[C@]1(Cc2cccc(Nc3nccs3)n2)CC[C@@H](Oc2cccc(C(F)(F)F)c2)CC1		CHEMBL3930205	=	IC50	nM	0.17	CHEMBL4722	Homo sapiens	IC50	nM	0.17
	16896581	CHEMBL3882306	Inhibition of human N-terminal His-tagged Aurora A expressed in Escherichia coli BL21-Codon-Plus(DE3)-RIL cells using 5-carboxy-fluorescein-y-aminobutyric acid-Ala-Leu-Arg-Arg-Ala-Ser-Leu-Gly-NH2 as substrate after 120 mins by fluorescence polarization assay	B	Cl.O=C(O)[C@]1(Cc2cccc(Nc3nccs3)n2)CC[C@@H](Oc2cccc(Cl)c2Cl)CC1		CHEMBL3915221	=	IC50	nM	0.07	CHEMBL4722	Homo sapiens	IC50	nM	0.07
	16896582	CHEMBL3882306	Inhibition of human N-terminal His-tagged Aurora A expressed in Escherichia coli BL21-Codon-Plus(DE3)-RIL cells using 5-carboxy-fluorescein-y-aminobutyric acid-Ala-Leu-Arg-Arg-Ala-Ser-Leu-Gly-NH2 as substrate after 120 mins by fluorescence polarization assay	B	Cl.O=C(O)[C@]1(Cc2cccc(Nc3nccs3)n2)CC[C@@H](Oc2cccc(Cl)c2)CC1		CHEMBL3977678	=	IC50	nM	0.12	CHEMBL4722	Homo sapiens	IC50	nM	0.12
	16896583	CHEMBL3882306	Inhibition of human N-terminal His-tagged Aurora A expressed in Escherichia coli BL21-Codon-Plus(DE3)-RIL cells using 5-carboxy-fluorescein-y-aminobutyric acid-Ala-Leu-Arg-Arg-Ala-Ser-Leu-Gly-NH2 as substrate after 120 mins by fluorescence polarization assay	B	Cl.O=C(O)[C@]1(Cc2cccc(Nc3nccs3)n2)CC[C@@H](Oc2cccc(C(F)(F)F)c2F)CC1		CHEMBL3923139	=	IC50	nM	0.11	CHEMBL4722	Homo sapiens	IC50	nM	0.11
	16896584	CHEMBL3882306	Inhibition of human N-terminal His-tagged Aurora A expressed in Escherichia coli BL21-Codon-Plus(DE3)-RIL cells using 5-carboxy-fluorescein-y-aminobutyric acid-Ala-Leu-Arg-Arg-Ala-Ser-Leu-Gly-NH2 as substrate after 120 mins by fluorescence polarization assay	B	Cl.O=C(O)[C@]1(Cc2cccc(Nc3nccs3)n2)CC[C@@H](Oc2cccc(F)c2F)CC1		CHEMBL3897985	=	IC50	nM	0.12	CHEMBL4722	Homo sapiens	IC50	nM	0.12
	16896585	CHEMBL3882306	Inhibition of human N-terminal His-tagged Aurora A expressed in Escherichia coli BL21-Codon-Plus(DE3)-RIL cells using 5-carboxy-fluorescein-y-aminobutyric acid-Ala-Leu-Arg-Arg-Ala-Ser-Leu-Gly-NH2 as substrate after 120 mins by fluorescence polarization assay	B	Cl.O=C(O)[C@]1(Cc2cccc(Nc3nccs3)n2)CC[C@@H](Oc2cccc(Cl)c2F)CC1		CHEMBL3951333	=	IC50	nM	0.07	CHEMBL4722	Homo sapiens	IC50	nM	0.07
	16896854	CHEMBL3882369	Inhibition of human Aurora A assessed as residual activity using H-LRRASLG as substrate in presence of [gamma-33P]-ATP	B	Cc1ccc(N/C=C2\C(=O)CCc3c2oc2c(Cl)c(Cl)c(O)cc32)cc1		CHEMBL3920024	=	Activity	%	11.0	CHEMBL4722	Homo sapiens	Activity	%	11.0
	16897334	CHEMBL3882686	Inhibition of human recombinant aurora-A kinase using kemptide as substrate measured after 2 hrs by kinase-Glo luminescent kinase assay	B	COc1cc2[nH]c3ncnc(N4CCN(C(=S)Nc5ccc(S(=O)(=O)Nc6ncccn6)cc5)CC4)c3c2cc1OC		CHEMBL456689	=	IC50	nM	900.0	CHEMBL4722	Homo sapiens	IC50	uM	0.9
	16897362	CHEMBL3882682	Inhibition of human recombinant aurora-2 kinase expressed in Sf9 cells using kemptide as substrate by kinase-Glo luciferase assay	B	COc1cc2[nH]c3ncnc(N4CCN(C(=S)Nc5ccc(S(=O)(=O)Nc6ncccn6)cc5)CC4)c3c2cc1OC		CHEMBL456689	=	IC50	nM	900.0	CHEMBL4722	Homo sapiens	IC50	uM	0.9
	16897363	CHEMBL3882682	Inhibition of human recombinant aurora-2 kinase expressed in Sf9 cells using kemptide as substrate by kinase-Glo luciferase assay	B	COc1cc2ncnc(N3CCN(C(=S)Nc4ccc(S(=O)(=O)Nc5ncccn5)cc4)CC3)c2cc1OC		CHEMBL3926830	=	IC50	nM	4700.0	CHEMBL4722	Homo sapiens	IC50	uM	4.7
Active	16897376	CHEMBL3882694	Inhibition of human recombinant aurora-2 kinase expressed in Sf9 cells at 20 uM using kemptide as substrate by kinase-Glo luciferase assay	B	COc1cc2[nH]c3ncnc(N4CCN(C(=S)Nc5ccc(S(=O)(=O)Nc6ncccn6)cc5)CC4)c3c2cc1OC		CHEMBL456689		Inhibition	%		CHEMBL4722	Homo sapiens	INH		
Active	16897377	CHEMBL3882694	Inhibition of human recombinant aurora-2 kinase expressed in Sf9 cells at 20 uM using kemptide as substrate by kinase-Glo luciferase assay	B	COc1cc2ncnc(N3CCN(C(=S)Nc4ccc(S(=O)(=O)Nc5ncccn5)cc4)CC3)c2cc1OC		CHEMBL3926830		Inhibition	%		CHEMBL4722	Homo sapiens	INH		
Active	16897378	CHEMBL3882694	Inhibition of human recombinant aurora-2 kinase expressed in Sf9 cells at 20 uM using kemptide as substrate by kinase-Glo luciferase assay	B	O=S(=O)(Nc1ncccn1)c1ccc(Nc2ncnc3c2oc2ccccc23)cc1		CHEMBL3929433		Inhibition	%		CHEMBL4722	Homo sapiens	INH		
Active	16897379	CHEMBL3882694	Inhibition of human recombinant aurora-2 kinase expressed in Sf9 cells at 20 uM using kemptide as substrate by kinase-Glo luciferase assay	B	O=S(=O)(Nc1ncccn1)c1ccc(Nc2ncnc3c2sc2ncccc23)cc1		CHEMBL3986041		Inhibition	%		CHEMBL4722	Homo sapiens	INH		
Active	16897380	CHEMBL3882694	Inhibition of human recombinant aurora-2 kinase expressed in Sf9 cells at 20 uM using kemptide as substrate by kinase-Glo luciferase assay	B	COc1cc2ncnc(Nc3cccc(Br)c3)c2cc1OC		CHEMBL29197		Inhibition	%		CHEMBL4722	Homo sapiens	INH		
Interpretation: Specific Binding	16914587	CHEMBL3885761	Further kinetic evaluation of compounds supplied by Sanofi against AuroraA within a BIAcore3000 instrument	B	COc1cc(CCc2cc(NC(=O)c3ccc(N4C[C@H](C)N[C@H](C)C4)cc3)n[nH]2)cc(OC)c1		CHEMBL3348846	=	k_off	s-1	0.2979	CHEMBL4722	Homo sapiens	koff	s-1	0.297933333333333
Interpretation: Specific Binding	16914588	CHEMBL3885761	Further kinetic evaluation of compounds supplied by Sanofi against AuroraA within a BIAcore3000 instrument	B	C[C@@]1(C(=O)Nc2ccc(F)nc2)CCCN1c1nc(Nc2cc(C3CC3)n[nH]2)c2cccn2n1		CHEMBL575448	=	Kd	nM	32.74	CHEMBL4722	Homo sapiens	KD	M	3.27449E-8
Interpretation: Specific Binding	16914589	CHEMBL3885761	Further kinetic evaluation of compounds supplied by Sanofi against AuroraA within a BIAcore3000 instrument	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	=	k_off	s-1	0.171	CHEMBL4722	Homo sapiens	koff	s-1	0.171033333333333
Interpretation: Specific Binding	16914590	CHEMBL3885761	Further kinetic evaluation of compounds supplied by Sanofi against AuroraA within a BIAcore3000 instrument	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL475251	=	k_off	s-1	0.03517	CHEMBL4722	Homo sapiens	koff	s-1	0.0351666666666666
Interpretation: Specific Binding	16914591	CHEMBL3885761	Further kinetic evaluation of compounds supplied by Sanofi against AuroraA within a BIAcore3000 instrument	B	CN1CCN(c2ccc(Nc3nccc(-c4cnn5ncccc45)n3)cc2C(F)(F)F)CC1	Non standard unit for type	CHEMBL468963	=	kon	Ms-1	2664.97	CHEMBL4722	Homo sapiens	kon	Ms-1	2664.96666666666
Interpretation: Specific Binding	16914592	CHEMBL3885761	Further kinetic evaluation of compounds supplied by Sanofi against AuroraA within a BIAcore3000 instrument	B	COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1	Non standard unit for type	CHEMBL1230609	=	kon	Ms-1	27548.57	CHEMBL4722	Homo sapiens	kon	Ms-1	27548.5666666666
Interpretation: Specific Binding	16914593	CHEMBL3885761	Further kinetic evaluation of compounds supplied by Sanofi against AuroraA within a BIAcore3000 instrument	B	CNC(=O)c1ccccc1Sc1ccc2c(C=Cc3ccccn3)n[nH]c2c1		CHEMBL1988437	=	Kd	nM	110.29	CHEMBL4722	Homo sapiens	KD	M	1.1029433333333E-7
Interpretation: Specific Binding	16914594	CHEMBL3885761	Further kinetic evaluation of compounds supplied by Sanofi against AuroraA within a BIAcore3000 instrument	B	O=C(O)c1ccc(-c2c[nH]c3ncc(-c4ccccc4)cc23)cc1C1CCCC1	Non standard unit for type	CHEMBL558642	=	kon	Ms-1	327033.33	CHEMBL4722	Homo sapiens	kon	Ms-1	327033.333333333
Interpretation: Specific Binding	16914595	CHEMBL3885761	Further kinetic evaluation of compounds supplied by Sanofi against AuroraA within a BIAcore3000 instrument	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl	Non standard unit for type	CHEMBL601719	=	kon	Ms-1	772633.33	CHEMBL4722	Homo sapiens	kon	Ms-1	772633.333333333
Interpretation: Specific Binding	16914596	CHEMBL3885761	Further kinetic evaluation of compounds supplied by Sanofi against AuroraA within a BIAcore3000 instrument	B	COc1cc(CCc2cc(NC(=O)c3ccc(N4C[C@H](C)N[C@H](C)C4)cc3)n[nH]2)cc(OC)c1		CHEMBL3348846	=	Kd	nM	381.1	CHEMBL4722	Homo sapiens	KD	M	3.8110333333333E-7
Interpretation: Specific Binding	16914597	CHEMBL3885761	Further kinetic evaluation of compounds supplied by Sanofi against AuroraA within a BIAcore3000 instrument	B	CN1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(N(C)c4ccnc(Nc5ccc(CS(C)(=O)=O)cc5)n4)cc3)cc2)CC1.Cl	Non standard unit for type	CHEMBL1909360	=	kon	Ms-1	423833.33	CHEMBL4722	Homo sapiens	kon	Ms-1	423833.333333333
Interpretation: Specific Binding	16914598	CHEMBL3885761	Further kinetic evaluation of compounds supplied by Sanofi against AuroraA within a BIAcore3000 instrument	B	C[C@@H](Oc1ccc2[nH]nc(C=Cc3cnn(CCO)c3)c2c1)c1c(Cl)cncc1Cl		CHEMBL3923667	=	Kd	nM	12.29	CHEMBL4722	Homo sapiens	KD	M	1.229012666667E-8
Interpretation: Specific Binding	16914599	CHEMBL3885761	Further kinetic evaluation of compounds supplied by Sanofi against AuroraA within a BIAcore3000 instrument	B	CN(c1ccccc1CNc1nc(Nc2ccc3c(c2)CC(=O)N3)ncc1C(F)(F)F)S(C)(=O)=O		CHEMBL472212	=	Kd	nM	247.33	CHEMBL4722	Homo sapiens	KD	M	2.4732533333333E-7
Interpretation: Specific Binding	16914600	CHEMBL3885761	Further kinetic evaluation of compounds supplied by Sanofi against AuroraA within a BIAcore3000 instrument	B	O=C(Nc1c[nH]nc1-c1nc2ccc(CN3CCOCC3)cc2[nH]1)NC1CC1	Non standard unit for type	CHEMBL495727	=	kon	Ms-1	374966.67	CHEMBL4722	Homo sapiens	kon	Ms-1	374966.666666666
Interpretation: Specific Binding	16914601	CHEMBL3885761	Further kinetic evaluation of compounds supplied by Sanofi against AuroraA within a BIAcore3000 instrument	B	COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1		CHEMBL1230609	=	Kd	nM	1713.64	CHEMBL4722	Homo sapiens	KD	M	0.00000171363666666667
Interpretation: Specific Binding	16914602	CHEMBL3885761	Further kinetic evaluation of compounds supplied by Sanofi against AuroraA within a BIAcore3000 instrument	B	CN(c1ccc(NC(=O)Nc2ccc(OC(F)(F)F)cc2)cc1)c1ccnc(Nc2cccc(S(N)(=O)=O)c2)n1	Non standard unit for type	CHEMBL188381	=	kon	Ms-1	779.9	CHEMBL4722	Homo sapiens	kon	Ms-1	779.9
Interpretation: Specific Binding	16914603	CHEMBL3885761	Further kinetic evaluation of compounds supplied by Sanofi against AuroraA within a BIAcore3000 instrument	B	O=C(Nc1cccc(Nc2ncc(Br)c(NCCc3cnc[nH]3)n2)c1)N1CCCC1		CHEMBL3916849	=	Kd	nM	13.79	CHEMBL4722	Homo sapiens	KD	M	1.379466666667E-8
Interpretation: Specific Binding	16914604	CHEMBL3885761	Further kinetic evaluation of compounds supplied by Sanofi against AuroraA within a BIAcore3000 instrument	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	=	Kd	nM	89.24	CHEMBL4722	Homo sapiens	KD	M	8.92368E-8
Interpretation: Specific Binding	16914605	CHEMBL3885761	Further kinetic evaluation of compounds supplied by Sanofi against AuroraA within a BIAcore3000 instrument	B	O=C(Nc1cccc(Nc2ncc(Br)c(NCCc3cnc[nH]3)n2)c1)N1CCCC1	Non standard unit for type	CHEMBL3916849	=	kon	Ms-1	3181000.0	CHEMBL4722	Homo sapiens	kon	Ms-1	3181000.0
Interpretation: Specific Binding	16914606	CHEMBL3885761	Further kinetic evaluation of compounds supplied by Sanofi against AuroraA within a BIAcore3000 instrument	B	CN(c1ccccc1CNc1nc(Nc2ccc3c(c2)CC(=O)N3)ncc1C(F)(F)F)S(C)(=O)=O		CHEMBL472212	=	k_off	s-1	0.06795	CHEMBL4722	Homo sapiens	koff	s-1	0.0679533333333333
Interpretation: Specific Binding	16914607	CHEMBL3885761	Further kinetic evaluation of compounds supplied by Sanofi against AuroraA within a BIAcore3000 instrument	B	Cc1[nH]c(C=C2C(=O)Nc3ccccc32)c(C)c1CCC(=O)O	Non standard unit for type	CHEMBL2007064	=	kon	Ms-1	3730000.0	CHEMBL4722	Homo sapiens	kon	Ms-1	3730000.0
Interpretation: Specific Binding	16914608	CHEMBL3885761	Further kinetic evaluation of compounds supplied by Sanofi against AuroraA within a BIAcore3000 instrument	B	COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1		CHEMBL1230609	=	k_off	s-1	0.2092	CHEMBL4722	Homo sapiens	koff	s-1	0.209166666666666
Interpretation: Specific Binding	16914609	CHEMBL3885761	Further kinetic evaluation of compounds supplied by Sanofi against AuroraA within a BIAcore3000 instrument	B	O=C(O)c1ccc(-c2c[nH]c3ncc(-c4ccccc4)cc23)cc1C1CCCC1		CHEMBL558642	=	k_off	s-1	0.09215	CHEMBL4722	Homo sapiens	koff	s-1	0.0921466666666666
Interpretation: Specific Binding	16914610	CHEMBL3885761	Further kinetic evaluation of compounds supplied by Sanofi against AuroraA within a BIAcore3000 instrument	B	Cc1cc(Nc2nc(NC(C)c3ncc(F)cn3)ncc2Cl)n[nH]1		CHEMBL2141865	=	k_off	s-1	0.04559	CHEMBL4722	Homo sapiens	koff	s-1	0.0455866666666666
Interpretation: Specific Binding	16914611	CHEMBL3885761	Further kinetic evaluation of compounds supplied by Sanofi against AuroraA within a BIAcore3000 instrument	B	Cc1[nH]c(C=C2C(=O)Nc3ccccc32)c(C)c1CCC(=O)O		CHEMBL2007064	=	k_off	s-1	0.1532	CHEMBL4722	Homo sapiens	koff	s-1	0.15319
Interpretation: Specific Binding	16914612	CHEMBL3885761	Further kinetic evaluation of compounds supplied by Sanofi against AuroraA within a BIAcore3000 instrument	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O	Non standard unit for type	CHEMBL477772	=	kon	Ms-1	175966.67	CHEMBL4722	Homo sapiens	kon	Ms-1	175966.666666666
Interpretation: Specific Binding	16914613	CHEMBL3885761	Further kinetic evaluation of compounds supplied by Sanofi against AuroraA within a BIAcore3000 instrument	B	C[C@@]1(C(=O)Nc2ccc(F)nc2)CCCN1c1nc(Nc2cc(C3CC3)n[nH]2)c2cccn2n1	Non standard unit for type	CHEMBL575448	=	kon	Ms-1	411866.67	CHEMBL4722	Homo sapiens	kon	Ms-1	411866.666666666
Interpretation: Specific Binding	16914614	CHEMBL3885761	Further kinetic evaluation of compounds supplied by Sanofi against AuroraA within a BIAcore3000 instrument	B	CN1CCN(c2ccc(Nc3nccc(-c4cnn5ncccc45)n3)cc2C(F)(F)F)CC1		CHEMBL468963	=	k_off	s-1	0.08452	CHEMBL4722	Homo sapiens	koff	s-1	0.08452
Interpretation: Specific Binding	16914615	CHEMBL3885761	Further kinetic evaluation of compounds supplied by Sanofi against AuroraA within a BIAcore3000 instrument	B	COC(=O)c1ccc2c(c1)C(=Cc1cc(Br)c(O)c(Br)c1)C(=O)N2		CHEMBL1794052	=	Kd	nM	89.35	CHEMBL4722	Homo sapiens	KD	M	8.93507E-8
Interpretation: Specific Binding	16914616	CHEMBL3885761	Further kinetic evaluation of compounds supplied by Sanofi against AuroraA within a BIAcore3000 instrument	B	O=C(Nc1c[nH]nc1-c1nc2ccc(CN3CCOCC3)cc2[nH]1)NC1CC1		CHEMBL495727	=	Kd	nM	46.97	CHEMBL4722	Homo sapiens	KD	M	4.696736E-8
Interpretation: Specific Binding	16914617	CHEMBL3885761	Further kinetic evaluation of compounds supplied by Sanofi against AuroraA within a BIAcore3000 instrument	B	COc1cc(N2CCC(N(C)C)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2P(C)(C)=O)n1		CHEMBL3397300	=	k_off	s-1	0.08693	CHEMBL4722	Homo sapiens	koff	s-1	0.0869299999999999
Interpretation: Specific Binding	16914618	CHEMBL3885761	Further kinetic evaluation of compounds supplied by Sanofi against AuroraA within a BIAcore3000 instrument	B	COC(=O)c1ccc2c(c1)C(=Cc1cc(Br)c(O)c(Br)c1)C(=O)N2		CHEMBL1794052	=	k_off	s-1	0.05345	CHEMBL4722	Homo sapiens	koff	s-1	0.0534533333333333
Interpretation: Specific Binding	16914619	CHEMBL3885761	Further kinetic evaluation of compounds supplied by Sanofi against AuroraA within a BIAcore3000 instrument	B	CN1CCN(c2ccc(Nc3nccc(-c4cnn5ncccc45)n3)cc2C(F)(F)F)CC1		CHEMBL468963	=	Kd	nM	33279.93	CHEMBL4722	Homo sapiens	KD	M	0.0000332799333333333
Interpretation: Specific Binding	16914620	CHEMBL3885761	Further kinetic evaluation of compounds supplied by Sanofi against AuroraA within a BIAcore3000 instrument	B	COc1cc2nccc(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3)c2cc1OC		CHEMBL2105717	=	Kd	nM	3363.13	CHEMBL4722	Homo sapiens	KD	M	0.00000336313
Interpretation: Specific Binding	16914621	CHEMBL3885761	Further kinetic evaluation of compounds supplied by Sanofi against AuroraA within a BIAcore3000 instrument	B	O=C(O)c1ccc(-c2c[nH]c3ncc(-c4ccccc4)cc23)cc1C1CCCC1		CHEMBL558642	=	Kd	nM	298.01	CHEMBL4722	Homo sapiens	KD	M	2.9800766666667E-7
Interpretation: Specific Binding	16914622	CHEMBL3885761	Further kinetic evaluation of compounds supplied by Sanofi against AuroraA within a BIAcore3000 instrument	B	C[C@@H](Oc1ccc2[nH]nc(C=Cc3cnn(CCO)c3)c2c1)c1c(Cl)cncc1Cl		CHEMBL3923667	=	k_off	s-1	0.007164	CHEMBL4722	Homo sapiens	koff	s-1	0.007164
Interpretation: Specific Binding	16914623	CHEMBL3885761	Further kinetic evaluation of compounds supplied by Sanofi against AuroraA within a BIAcore3000 instrument	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Kd	nM	19.29	CHEMBL4722	Homo sapiens	KD	M	1.929233333333E-8
Interpretation: Specific Binding	16914624	CHEMBL3885761	Further kinetic evaluation of compounds supplied by Sanofi against AuroraA within a BIAcore3000 instrument	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	=	Kd	nM	963.95	CHEMBL4722	Homo sapiens	KD	M	9.6395466666667E-7
Interpretation: Specific Binding	16914625	CHEMBL3885761	Further kinetic evaluation of compounds supplied by Sanofi against AuroraA within a BIAcore3000 instrument	B	CO[C@@H](C(=O)N1Cc2n[nH]c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)c2C1)c1ccccc1		CHEMBL402548	=	Kd	nM	9.799	CHEMBL4722	Homo sapiens	KD	M	9.79884333333E-9
Interpretation: Specific Binding	16914626	CHEMBL3885761	Further kinetic evaluation of compounds supplied by Sanofi against AuroraA within a BIAcore3000 instrument	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4	Non standard unit for type	CHEMBL608533	=	kon	Ms-1	238000.0	CHEMBL4722	Homo sapiens	kon	Ms-1	238000.0
Interpretation: Specific Binding	16914627	CHEMBL3885761	Further kinetic evaluation of compounds supplied by Sanofi against AuroraA within a BIAcore3000 instrument	B	COc1cc2nccc(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3)c2cc1OC	Non standard unit for type	CHEMBL2105717	=	kon	Ms-1	42580.67	CHEMBL4722	Homo sapiens	kon	Ms-1	42580.6666666666
Interpretation: Specific Binding	16914628	CHEMBL3885761	Further kinetic evaluation of compounds supplied by Sanofi against AuroraA within a BIAcore3000 instrument	B	Cl.Cl.Cl.Cn1cc(-c2[nH]c3cc(NC(=O)[C@H](N)C4CCCCC4)cc4c3c2C=NNC4=O)cn1	Non standard unit for type	CHEMBL4299711	=	kon	Ms-1	1674333.33	CHEMBL4722	Homo sapiens	kon	Ms-1	1674333.33333333
Interpretation: Specific Binding	16914629	CHEMBL3885761	Further kinetic evaluation of compounds supplied by Sanofi against AuroraA within a BIAcore3000 instrument	B	Cn1cnc(-c2cc3nccc(Oc4ccc(NC(=S)NC(=O)Cc5ccccc5)cc4F)c3s2)c1		CHEMBL254760	=	k_off	s-1	0.08604	CHEMBL4722	Homo sapiens	koff	s-1	0.08604
Interpretation: Specific Binding	16914630	CHEMBL3885761	Further kinetic evaluation of compounds supplied by Sanofi against AuroraA within a BIAcore3000 instrument	B	CCS(=O)(=O)c1cccc(-c2cc(C(=O)NC3CCN(C)CC3)c(C)c3[nH]c4ncc(C)cc4c23)c1	Non standard unit for type	CHEMBL3544932	=	kon	Ms-1	629666.67	CHEMBL4722	Homo sapiens	kon	Ms-1	629666.666666666
Interpretation: Specific Binding	16914631	CHEMBL3885761	Further kinetic evaluation of compounds supplied by Sanofi against AuroraA within a BIAcore3000 instrument	B	O=C(Nc1c[nH]nc1-c1nc2ccc(CN3CCOCC3)cc2[nH]1)NC1CC1		CHEMBL495727	=	k_off	s-1	0.01723	CHEMBL4722	Homo sapiens	koff	s-1	0.0172333333333333
Interpretation: Specific Binding	16914632	CHEMBL3885761	Further kinetic evaluation of compounds supplied by Sanofi against AuroraA within a BIAcore3000 instrument	B	COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1		CHEMBL1230609	=	k_off	s-1	0.0435	CHEMBL4722	Homo sapiens	koff	s-1	0.0435033333333333
Interpretation: Specific Binding	16914633	CHEMBL3885761	Further kinetic evaluation of compounds supplied by Sanofi against AuroraA within a BIAcore3000 instrument	B	C[C@@]1(C(=O)Nc2ccc(F)nc2)CCCN1c1nc(Nc2cc(C3CC3)n[nH]2)c2cccn2n1		CHEMBL575448	=	k_off	s-1	0.01331	CHEMBL4722	Homo sapiens	koff	s-1	0.013306
Interpretation: Specific Binding	16914634	CHEMBL3885761	Further kinetic evaluation of compounds supplied by Sanofi against AuroraA within a BIAcore3000 instrument	B	O=C(Nc1cccc(Nc2ncc(Br)c(NCCc3cnc[nH]3)n2)c1)N1CCCC1		CHEMBL3916849	=	k_off	s-1	0.04098	CHEMBL4722	Homo sapiens	koff	s-1	0.0409766666666666
Interpretation: Specific Binding	16914635	CHEMBL3885761	Further kinetic evaluation of compounds supplied by Sanofi against AuroraA within a BIAcore3000 instrument	B	COc1cc2nccc(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3)c2cc1OC		CHEMBL2105717	=	k_off	s-1	0.1353	CHEMBL4722	Homo sapiens	koff	s-1	0.135293333333333
Interpretation: Specific Binding	16914636	CHEMBL3885761	Further kinetic evaluation of compounds supplied by Sanofi against AuroraA within a BIAcore3000 instrument	B	CN1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(N(C)c4ccnc(Nc5ccc(CS(C)(=O)=O)cc5)n4)cc3)cc2)CC1.Cl		CHEMBL1909360	=	k_off	s-1	0.008266	CHEMBL4722	Homo sapiens	koff	s-1	0.00826633333333333
Interpretation: Specific Binding	16914637	CHEMBL3885761	Further kinetic evaluation of compounds supplied by Sanofi against AuroraA within a BIAcore3000 instrument	B	CO[C@@H](C(=O)N1Cc2n[nH]c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)c2C1)c1ccccc1	Non standard unit for type	CHEMBL402548	=	kon	Ms-1	211400.0	CHEMBL4722	Homo sapiens	kon	Ms-1	211400.0
Interpretation: Specific Binding	16914638	CHEMBL3885761	Further kinetic evaluation of compounds supplied by Sanofi against AuroraA within a BIAcore3000 instrument	B	Cn1cnc(-c2cc3nccc(Oc4ccc(NC(=S)NC(=O)Cc5ccccc5)cc4F)c3s2)c1	Non standard unit for type	CHEMBL254760	=	kon	Ms-1	677000.0	CHEMBL4722	Homo sapiens	kon	Ms-1	677000.0
Interpretation: Specific Binding	16914639	CHEMBL3885761	Further kinetic evaluation of compounds supplied by Sanofi against AuroraA within a BIAcore3000 instrument	B	COC(=O)c1ccc2c(c1)C(=Cc1cc(Br)c(O)c(Br)c1)C(=O)N2	Non standard unit for type	CHEMBL1794052	=	kon	Ms-1	601133.33	CHEMBL4722	Homo sapiens	kon	Ms-1	601133.333333333
Interpretation: Specific Binding	16914640	CHEMBL3885761	Further kinetic evaluation of compounds supplied by Sanofi against AuroraA within a BIAcore3000 instrument	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL475251	=	Kd	nM	29.88	CHEMBL4722	Homo sapiens	KD	M	2.987786666667E-8
Interpretation: Specific Binding	16914641	CHEMBL3885761	Further kinetic evaluation of compounds supplied by Sanofi against AuroraA within a BIAcore3000 instrument	B	CNC(=O)c1ccccc1Sc1ccc2c(C=Cc3ccccn3)n[nH]c2c1	Non standard unit for type	CHEMBL1988437	=	kon	Ms-1	781200.0	CHEMBL4722	Homo sapiens	kon	Ms-1	781200.0
Interpretation: Specific Binding	16914642	CHEMBL3885761	Further kinetic evaluation of compounds supplied by Sanofi against AuroraA within a BIAcore3000 instrument	B	CNC(=O)c1ccccc1Sc1ccc2c(C=Cc3ccccn3)n[nH]c2c1		CHEMBL1988437	=	k_off	s-1	0.086	CHEMBL4722	Homo sapiens	koff	s-1	0.086
Interpretation: Specific Binding	16914643	CHEMBL3885761	Further kinetic evaluation of compounds supplied by Sanofi against AuroraA within a BIAcore3000 instrument	B	C[C@@H](Oc1ccc2[nH]nc(C=Cc3cnn(CCO)c3)c2c1)c1c(Cl)cncc1Cl	Non standard unit for type	CHEMBL3923667	=	kon	Ms-1	662433.33	CHEMBL4722	Homo sapiens	kon	Ms-1	662433.333333333
Interpretation: Specific Binding	16914644	CHEMBL3885761	Further kinetic evaluation of compounds supplied by Sanofi against AuroraA within a BIAcore3000 instrument	B	Cc1cc(Nc2nc(NC(C)c3ncc(F)cn3)ncc2Cl)n[nH]1		CHEMBL2141865	=	Kd	nM	12766.11	CHEMBL4722	Homo sapiens	KD	M	0.0000127661133333333
Interpretation: Specific Binding	16914645	CHEMBL3885761	Further kinetic evaluation of compounds supplied by Sanofi against AuroraA within a BIAcore3000 instrument	B	CN(c1ccc(NC(=O)Nc2ccc(OC(F)(F)F)cc2)cc1)c1ccnc(Nc2cccc(S(N)(=O)=O)c2)n1		CHEMBL188381	=	k_off	s-1	0.009703	CHEMBL4722	Homo sapiens	koff	s-1	0.009703
Interpretation: Specific Binding	16914646	CHEMBL3885761	Further kinetic evaluation of compounds supplied by Sanofi against AuroraA within a BIAcore3000 instrument	B	COc1cc(N2CCC(N(C)C)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2P(C)(C)=O)n1		CHEMBL3397300	=	Kd	nM	334.12	CHEMBL4722	Homo sapiens	KD	M	3.34118E-7
Interpretation: Specific Binding	16914647	CHEMBL3885761	Further kinetic evaluation of compounds supplied by Sanofi against AuroraA within a BIAcore3000 instrument	B	CCS(=O)(=O)c1cccc(-c2cc(C(=O)NC3CCN(C)CC3)c(C)c3[nH]c4ncc(C)cc4c23)c1		CHEMBL3544932	=	k_off	s-1	0.008821	CHEMBL4722	Homo sapiens	koff	s-1	0.008821
Interpretation: Specific Binding	16914648	CHEMBL3885761	Further kinetic evaluation of compounds supplied by Sanofi against AuroraA within a BIAcore3000 instrument	B	Cc1cc(Nc2nc(NC(C)c3ncc(F)cn3)ncc2Cl)n[nH]1	Non standard unit for type	CHEMBL2141865	=	kon	Ms-1	3803.03	CHEMBL4722	Homo sapiens	kon	Ms-1	3803.03333333333
Interpretation: Specific Binding	16914649	CHEMBL3885761	Further kinetic evaluation of compounds supplied by Sanofi against AuroraA within a BIAcore3000 instrument	B	Cc1[nH]c(C=C2C(=O)Nc3ccccc32)c(C)c1CCC(=O)O		CHEMBL2007064	=	Kd	nM	78.9	CHEMBL4722	Homo sapiens	KD	M	7.89E-8
Interpretation: Specific Binding	16914650	CHEMBL3885761	Further kinetic evaluation of compounds supplied by Sanofi against AuroraA within a BIAcore3000 instrument	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC	Non standard unit for type	CHEMBL475251	=	kon	Ms-1	1183666.67	CHEMBL4722	Homo sapiens	kon	Ms-1	1183666.66666666
Interpretation: Specific Binding	16914651	CHEMBL3885761	Further kinetic evaluation of compounds supplied by Sanofi against AuroraA within a BIAcore3000 instrument	B	Cc1cc(Nc2cc(CN3CCOCC3)c3nc(C)c(Cc4ccc(Cl)cc4F)n3n2)n[nH]1		CHEMBL2107823	=	Kd	nM	15.05	CHEMBL4722	Homo sapiens	KD	M	1.50514E-8
Interpretation: Specific Binding	16914652	CHEMBL3885761	Further kinetic evaluation of compounds supplied by Sanofi against AuroraA within a BIAcore3000 instrument	B	CC(C)Oc1cc(Nc2nc(N[C@@H](C)c3ccc(F)cn3)ncc2Cl)n[nH]1		CHEMBL457614	=	Kd	nM	1908.0	CHEMBL4722	Homo sapiens	KD	M	0.000001908
Interpretation: Specific Binding	16914653	CHEMBL3885761	Further kinetic evaluation of compounds supplied by Sanofi against AuroraA within a BIAcore3000 instrument	B	CN(c1ccc(NC(=O)Nc2ccc(OC(F)(F)F)cc2)cc1)c1ccnc(Nc2cccc(S(N)(=O)=O)c2)n1		CHEMBL188381	=	Kd	nM	12461.05	CHEMBL4722	Homo sapiens	KD	M	0.00001246105
Interpretation: Specific Binding	16914654	CHEMBL3885761	Further kinetic evaluation of compounds supplied by Sanofi against AuroraA within a BIAcore3000 instrument	B	CC(C)Oc1cc(Nc2nc(N[C@@H](C)c3ccc(F)cn3)ncc2Cl)n[nH]1	Non standard unit for type	CHEMBL457614	=	kon	Ms-1	60860.0	CHEMBL4722	Homo sapiens	kon	Ms-1	60860.0
Interpretation: Specific Binding	16914655	CHEMBL3885761	Further kinetic evaluation of compounds supplied by Sanofi against AuroraA within a BIAcore3000 instrument	B	CCS(=O)(=O)c1cccc(-c2cc(C(=O)NC3CCN(C)CC3)c(C)c3[nH]c4ncc(C)cc4c23)c1		CHEMBL3544932	=	Kd	nM	14.02	CHEMBL4722	Homo sapiens	KD	M	1.401546666667E-8
Interpretation: Specific Binding	16914656	CHEMBL3885761	Further kinetic evaluation of compounds supplied by Sanofi against AuroraA within a BIAcore3000 instrument	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	k_off	s-1	0.004557	CHEMBL4722	Homo sapiens	koff	s-1	0.00455699999999999
Interpretation: Specific Binding	16914657	CHEMBL3885761	Further kinetic evaluation of compounds supplied by Sanofi against AuroraA within a BIAcore3000 instrument	B	CC(C)Oc1cc(Nc2nc(N[C@@H](C)c3ccc(F)cn3)ncc2Cl)n[nH]1		CHEMBL457614	=	k_off	s-1	0.06539	CHEMBL4722	Homo sapiens	koff	s-1	0.0653933333333333
Interpretation: Specific Binding	16914658	CHEMBL3885761	Further kinetic evaluation of compounds supplied by Sanofi against AuroraA within a BIAcore3000 instrument	B	COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1		CHEMBL1230609	=	Kd	nM	1427.2	CHEMBL4722	Homo sapiens	KD	M	0.00000142720333333333
Interpretation: Specific Binding	16914659	CHEMBL3885761	Further kinetic evaluation of compounds supplied by Sanofi against AuroraA within a BIAcore3000 instrument	B	COc1cc(N2CCC(N(C)C)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2P(C)(C)=O)n1	Non standard unit for type	CHEMBL3397300	=	kon	Ms-1	269733.33	CHEMBL4722	Homo sapiens	kon	Ms-1	269733.333333333
Interpretation: Specific Binding	16914660	CHEMBL3885761	Further kinetic evaluation of compounds supplied by Sanofi against AuroraA within a BIAcore3000 instrument	B	Cl.Cl.Cl.Cn1cc(-c2[nH]c3cc(NC(=O)[C@H](N)C4CCCCC4)cc4c3c2C=NNC4=O)cn1		CHEMBL4299711	=	Kd	nM	81.97	CHEMBL4722	Homo sapiens	KD	M	8.197373333333E-8
Interpretation: Specific Binding	16914661	CHEMBL3885761	Further kinetic evaluation of compounds supplied by Sanofi against AuroraA within a BIAcore3000 instrument	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	=	k_off	s-1	0.06407	CHEMBL4722	Homo sapiens	koff	s-1	0.0640666666666666
Interpretation: Specific Binding	16914662	CHEMBL3885761	Further kinetic evaluation of compounds supplied by Sanofi against AuroraA within a BIAcore3000 instrument	B	Cc1cc(Nc2cc(CN3CCOCC3)c3nc(C)c(Cc4ccc(Cl)cc4F)n3n2)n[nH]1	Non standard unit for type	CHEMBL2107823	=	kon	Ms-1	497966.67	CHEMBL4722	Homo sapiens	kon	Ms-1	497966.666666666
Interpretation: Specific Binding	16914663	CHEMBL3885761	Further kinetic evaluation of compounds supplied by Sanofi against AuroraA within a BIAcore3000 instrument	B	COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1	Non standard unit for type	CHEMBL1230609	=	kon	Ms-1	152833.33	CHEMBL4722	Homo sapiens	kon	Ms-1	152833.333333333
Interpretation: Specific Binding	16914664	CHEMBL3885761	Further kinetic evaluation of compounds supplied by Sanofi against AuroraA within a BIAcore3000 instrument	B	CN1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(N(C)c4ccnc(Nc5ccc(CS(C)(=O)=O)cc5)n4)cc3)cc2)CC1.Cl		CHEMBL1909360	=	Kd	nM	20.51	CHEMBL4722	Homo sapiens	KD	M	2.05051E-8
Interpretation: Specific Binding	16914665	CHEMBL3885761	Further kinetic evaluation of compounds supplied by Sanofi against AuroraA within a BIAcore3000 instrument	B	CO[C@@H](C(=O)N1Cc2n[nH]c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)c2C1)c1ccccc1		CHEMBL402548	=	k_off	s-1	0.002083	CHEMBL4722	Homo sapiens	koff	s-1	0.00208326666666666
Interpretation: Specific Binding	16914666	CHEMBL3885761	Further kinetic evaluation of compounds supplied by Sanofi against AuroraA within a BIAcore3000 instrument	B	Cn1cnc(-c2cc3nccc(Oc4ccc(NC(=S)NC(=O)Cc5ccccc5)cc4F)c3s2)c1		CHEMBL254760	=	Kd	nM	127.56	CHEMBL4722	Homo sapiens	KD	M	1.2755866666667E-7
Interpretation: Specific Binding	16914667	CHEMBL3885761	Further kinetic evaluation of compounds supplied by Sanofi against AuroraA within a BIAcore3000 instrument	B	Cl.Cl.Cl.Cn1cc(-c2[nH]c3cc(NC(=O)[C@H](N)C4CCCCC4)cc4c3c2C=NNC4=O)cn1		CHEMBL4299711	=	k_off	s-1	0.1357	CHEMBL4722	Homo sapiens	koff	s-1	0.1357
Interpretation: Specific Binding	16914668	CHEMBL3885761	Further kinetic evaluation of compounds supplied by Sanofi against AuroraA within a BIAcore3000 instrument	B	COc1cc(CCc2cc(NC(=O)c3ccc(N4C[C@H](C)N[C@H](C)C4)cc3)n[nH]2)cc(OC)c1	Non standard unit for type	CHEMBL3348846	=	kon	Ms-1	991600.0	CHEMBL4722	Homo sapiens	kon	Ms-1	991600.0
Interpretation: Specific Binding	16914669	CHEMBL3885761	Further kinetic evaluation of compounds supplied by Sanofi against AuroraA within a BIAcore3000 instrument	B	CN(c1ccccc1CNc1nc(Nc2ccc3c(c2)CC(=O)N3)ncc1C(F)(F)F)S(C)(=O)=O	Non standard unit for type	CHEMBL472212	=	kon	Ms-1	304000.0	CHEMBL4722	Homo sapiens	kon	Ms-1	304000.0
Interpretation: Specific Binding	16914670	CHEMBL3885761	Further kinetic evaluation of compounds supplied by Sanofi against AuroraA within a BIAcore3000 instrument	B	Cc1cc(Nc2cc(CN3CCOCC3)c3nc(C)c(Cc4ccc(Cl)cc4F)n3n2)n[nH]1		CHEMBL2107823	=	k_off	s-1	0.007504	CHEMBL4722	Homo sapiens	koff	s-1	0.00750399999999999
Interpretation: Specific Binding	16914790	CHEMBL3885758	Single-Cycle Kinetic parameter establishment of 8 compounds to gain n=3	B	CCn1cc(-c2ccnc3[nH]c(-c4cccc(CN(C)C)c4)cc23)c(-c2ccc(NC(=O)N(C)C)cc2)n1		CHEMBL1090479	=	Kd	nM	11.82	CHEMBL4722	Homo sapiens	KD	M	1.181666666667E-8
Interpretation: Specific Binding	16914791	CHEMBL3885758	Single-Cycle Kinetic parameter establishment of 8 compounds to gain n=3	B	CCc1cccc(CC)c1NC(=O)N1Cc2[nH]nc(NC(=O)c3ccc(N4CCN(C)CC4)cc3)c2C1		CHEMBL363160	=	Kd	nM	4.41	CHEMBL4722	Homo sapiens	KD	M	4.41E-9
Interpretation: Specific Binding	16914792	CHEMBL3885758	Single-Cycle Kinetic parameter establishment of 8 compounds to gain n=3	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	=	k_off	s-1	0.09105	CHEMBL4722	Homo sapiens	koff	s-1	0.0910533333333333
Interpretation: Specific Binding	16914793	CHEMBL3885758	Single-Cycle Kinetic parameter establishment of 8 compounds to gain n=3	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1	Non standard unit for type	CHEMBL572878	=	kon	Ms-1	3787333.33	CHEMBL4722	Homo sapiens	kon	Ms-1	3787333.33333333
Interpretation: Specific Binding	16914794	CHEMBL3885758	Single-Cycle Kinetic parameter establishment of 8 compounds to gain n=3	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	=	Kd	nM	96.67	CHEMBL4722	Homo sapiens	KD	M	9.666666666667E-8
Interpretation: Specific Binding	16914795	CHEMBL3885758	Single-Cycle Kinetic parameter establishment of 8 compounds to gain n=3	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	=	Kd	nM	3.31	CHEMBL4722	Homo sapiens	KD	M	3.31E-9
Interpretation: Specific Binding	16914796	CHEMBL3885758	Single-Cycle Kinetic parameter establishment of 8 compounds to gain n=3	B	CO[C@@H](C(=O)N1Cc2n[nH]c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)c2C1)c1ccccc1	Non standard unit for type	CHEMBL402548	=	kon	Ms-1	2413500.0	CHEMBL4722	Homo sapiens	kon	Ms-1	2413500.0
Interpretation: Specific Binding	16914797	CHEMBL3885758	Single-Cycle Kinetic parameter establishment of 8 compounds to gain n=3	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	=	k_off	s-1	0.007559	CHEMBL4722	Homo sapiens	koff	s-1	0.007559
Interpretation: Specific Binding	16914798	CHEMBL3885758	Single-Cycle Kinetic parameter establishment of 8 compounds to gain n=3	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1	Non standard unit for type	CHEMBL259084	=	kon	Ms-1	3828833.33	CHEMBL4722	Homo sapiens	kon	Ms-1	3828833.33333333
Interpretation: Specific Binding	16914799	CHEMBL3885758	Single-Cycle Kinetic parameter establishment of 8 compounds to gain n=3	B	CO[C@@H](C(=O)N1Cc2n[nH]c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)c2C1)c1ccccc1		CHEMBL402548	=	k_off	s-1	0.00898	CHEMBL4722	Homo sapiens	koff	s-1	0.00897966666666666
Interpretation: Specific Binding	16914800	CHEMBL3885758	Single-Cycle Kinetic parameter establishment of 8 compounds to gain n=3	B	CCn1cc(-c2ccnc3[nH]c(-c4cccc(CN(C)C)c4)cc23)c(-c2ccc(NC(=O)N(C)C)cc2)n1	Non standard unit for type	CHEMBL1090479	=	kon	Ms-1	443066.67	CHEMBL4722	Homo sapiens	kon	Ms-1	443066.666666666
Interpretation: Specific Binding	16914801	CHEMBL3885758	Single-Cycle Kinetic parameter establishment of 8 compounds to gain n=3	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1	Non standard unit for type	CHEMBL215152	=	kon	Ms-1	179900.0	CHEMBL4722	Homo sapiens	kon	Ms-1	179900.0
Interpretation: Specific Binding	16914802	CHEMBL3885758	Single-Cycle Kinetic parameter establishment of 8 compounds to gain n=3	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	Kd	nM	1.697	CHEMBL4722	Homo sapiens	KD	M	1.69666666667E-9
Interpretation: Specific Binding	16914803	CHEMBL3885758	Single-Cycle Kinetic parameter establishment of 8 compounds to gain n=3	B	CCc1cccc(CC)c1NC(=O)N1Cc2[nH]nc(NC(=O)c3ccc(N4CCN(C)CC4)cc3)c2C1		CHEMBL363160	=	k_off	s-1	0.009916	CHEMBL4722	Homo sapiens	koff	s-1	0.00991566666666666
Interpretation: Specific Binding	16914804	CHEMBL3885758	Single-Cycle Kinetic parameter establishment of 8 compounds to gain n=3	B	CO[C@@H](C(=O)N1Cc2n[nH]c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)c2C1)c1ccccc1		CHEMBL402548	=	Kd	nM	3.943	CHEMBL4722	Homo sapiens	KD	M	3.94333333333E-9
Interpretation: Specific Binding	16914805	CHEMBL3885758	Single-Cycle Kinetic parameter establishment of 8 compounds to gain n=3	B	CCn1cc(-c2ccnc3[nH]c(-c4cccc(CN(C)C)c4)cc23)c(-c2ccc(NC(=O)N(C)C)cc2)n1		CHEMBL1090479	=	k_off	s-1	0.005113	CHEMBL4722	Homo sapiens	koff	s-1	0.00511333333333333
Interpretation: Specific Binding	16914806	CHEMBL3885758	Single-Cycle Kinetic parameter establishment of 8 compounds to gain n=3	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	=	k_off	s-1	0.08842	CHEMBL4722	Homo sapiens	koff	s-1	0.0884166666666666
Interpretation: Specific Binding	16914807	CHEMBL3885758	Single-Cycle Kinetic parameter establishment of 8 compounds to gain n=3	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	k_off	s-1	0.009987	CHEMBL4722	Homo sapiens	koff	s-1	0.00998733333333333
Interpretation: Specific Binding	16914808	CHEMBL3885758	Single-Cycle Kinetic parameter establishment of 8 compounds to gain n=3	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F	Non standard unit for type	CHEMBL191003	=	kon	Ms-1	1536733.33	CHEMBL4722	Homo sapiens	kon	Ms-1	1536733.33333333
Interpretation: Specific Binding	16914809	CHEMBL3885758	Single-Cycle Kinetic parameter establishment of 8 compounds to gain n=3	B	CCc1cccc(CC)c1NC(=O)N1Cc2[nH]nc(NC(=O)c3ccc(N4CCN(C)CC4)cc3)c2C1	Non standard unit for type	CHEMBL363160	=	kon	Ms-1	2278533.33	CHEMBL4722	Homo sapiens	kon	Ms-1	2278533.33333333
Interpretation: Specific Binding	16914810	CHEMBL3885758	Single-Cycle Kinetic parameter establishment of 8 compounds to gain n=3	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	=	Kd	nM	722.0	CHEMBL4722	Homo sapiens	KD	M	7.22E-7
Interpretation: Specific Binding	16914811	CHEMBL3885757	Single-Cycle Kinetic parameter establishment of 8 compounds to gain n=3	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1	Non standard unit for type	CHEMBL259084	=	kon	Ms-1	2199000.0	CHEMBL4722	Homo sapiens	kon	Ms-1	2199000.0
Interpretation: Specific Binding	16914812	CHEMBL3885757	Single-Cycle Kinetic parameter establishment of 8 compounds to gain n=3	B	CCc1cccc(CC)c1NC(=O)N1Cc2[nH]nc(NC(=O)c3ccc(N4CCN(C)CC4)cc3)c2C1		CHEMBL363160	=	k_off	s-1	0.01476	CHEMBL4722	Homo sapiens	koff	s-1	0.014761
Interpretation: Specific Binding	16914813	CHEMBL3885757	Single-Cycle Kinetic parameter establishment of 8 compounds to gain n=3	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1	Non standard unit for type	CHEMBL572878	=	kon	Ms-1	20289000.0	CHEMBL4722	Homo sapiens	kon	Ms-1	20289000.0
Interpretation: Specific Binding	16914814	CHEMBL3885757	Single-Cycle Kinetic parameter establishment of 8 compounds to gain n=3	B	CCn1cc(-c2ccnc3[nH]c(-c4cccc(CN(C)C)c4)cc23)c(-c2ccc(NC(=O)N(C)C)cc2)n1		CHEMBL1090479	=	k_off	s-1	0.004305	CHEMBL4722	Homo sapiens	koff	s-1	0.00430466666666666
Interpretation: Specific Binding	16914815	CHEMBL3885757	Single-Cycle Kinetic parameter establishment of 8 compounds to gain n=3	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	=	Kd	nM	1.977	CHEMBL4722	Homo sapiens	KD	M	1.97666666667E-9
Interpretation: Specific Binding	16914816	CHEMBL3885757	Single-Cycle Kinetic parameter establishment of 8 compounds to gain n=3	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F	Non standard unit for type	CHEMBL191003	=	kon	Ms-1	2910066.67	CHEMBL4722	Homo sapiens	kon	Ms-1	2910066.66666666
Interpretation: Specific Binding	16914817	CHEMBL3885757	Single-Cycle Kinetic parameter establishment of 8 compounds to gain n=3	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	Kd	nM	1.306	CHEMBL4722	Homo sapiens	KD	M	1.30566666667E-9
Interpretation: Specific Binding	16914818	CHEMBL3885757	Single-Cycle Kinetic parameter establishment of 8 compounds to gain n=3	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	=	k_off	s-1	0.04738	CHEMBL4722	Homo sapiens	koff	s-1	0.04738
Interpretation: Specific Binding	16914819	CHEMBL3885757	Single-Cycle Kinetic parameter establishment of 8 compounds to gain n=3	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	k_off	s-1	0.004268	CHEMBL4722	Homo sapiens	koff	s-1	0.00426833333333333
Interpretation: Specific Binding	16914820	CHEMBL3885757	Single-Cycle Kinetic parameter establishment of 8 compounds to gain n=3	B	CO[C@@H](C(=O)N1Cc2n[nH]c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)c2C1)c1ccccc1	Non standard unit for type	CHEMBL402548	=	kon	Ms-1	2385333.33	CHEMBL4722	Homo sapiens	kon	Ms-1	2385333.33333333
Interpretation: Specific Binding	16914821	CHEMBL3885757	Single-Cycle Kinetic parameter establishment of 8 compounds to gain n=3	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	=	k_off	s-1	0.1847	CHEMBL4722	Homo sapiens	koff	s-1	0.184666666666666
Interpretation: Specific Binding	16914822	CHEMBL3885757	Single-Cycle Kinetic parameter establishment of 8 compounds to gain n=3	B	CCc1cccc(CC)c1NC(=O)N1Cc2[nH]nc(NC(=O)c3ccc(N4CCN(C)CC4)cc3)c2C1	Non standard unit for type	CHEMBL363160	=	kon	Ms-1	3968000.0	CHEMBL4722	Homo sapiens	kon	Ms-1	3968000.0
Interpretation: Specific Binding	16914823	CHEMBL3885757	Single-Cycle Kinetic parameter establishment of 8 compounds to gain n=3	B	CO[C@@H](C(=O)N1Cc2n[nH]c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)c2C1)c1ccccc1		CHEMBL402548	=	k_off	s-1	0.008097	CHEMBL4722	Homo sapiens	koff	s-1	0.008097
Interpretation: Specific Binding	16914824	CHEMBL3885757	Single-Cycle Kinetic parameter establishment of 8 compounds to gain n=3	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	=	Kd	nM	400.67	CHEMBL4722	Homo sapiens	KD	M	4.0066666666667E-7
Interpretation: Specific Binding	16914825	CHEMBL3885757	Single-Cycle Kinetic parameter establishment of 8 compounds to gain n=3	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	=	k_off	s-1	0.005574	CHEMBL4722	Homo sapiens	koff	s-1	0.00557433333333333
Interpretation: Specific Binding	16914826	CHEMBL3885757	Single-Cycle Kinetic parameter establishment of 8 compounds to gain n=3	B	CO[C@@H](C(=O)N1Cc2n[nH]c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)c2C1)c1ccccc1		CHEMBL402548	=	Kd	nM	3.72	CHEMBL4722	Homo sapiens	KD	M	3.72E-9
Interpretation: Specific Binding	16914827	CHEMBL3885757	Single-Cycle Kinetic parameter establishment of 8 compounds to gain n=3	B	CCn1cc(-c2ccnc3[nH]c(-c4cccc(CN(C)C)c4)cc23)c(-c2ccc(NC(=O)N(C)C)cc2)n1		CHEMBL1090479	=	Kd	nM	12.3	CHEMBL4722	Homo sapiens	KD	M	1.230333333333E-8
Interpretation: Specific Binding	16914828	CHEMBL3885757	Single-Cycle Kinetic parameter establishment of 8 compounds to gain n=3	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	=	Kd	nM	65.21	CHEMBL4722	Homo sapiens	KD	M	6.521333333333E-8
Interpretation: Specific Binding	16914829	CHEMBL3885757	Single-Cycle Kinetic parameter establishment of 8 compounds to gain n=3	B	CCn1cc(-c2ccnc3[nH]c(-c4cccc(CN(C)C)c4)cc23)c(-c2ccc(NC(=O)N(C)C)cc2)n1	Non standard unit for type	CHEMBL1090479	=	kon	Ms-1	426533.33	CHEMBL4722	Homo sapiens	kon	Ms-1	426533.333333333
Interpretation: Specific Binding	16914830	CHEMBL3885757	Single-Cycle Kinetic parameter establishment of 8 compounds to gain n=3	B	CCc1cccc(CC)c1NC(=O)N1Cc2[nH]nc(NC(=O)c3ccc(N4CCN(C)CC4)cc3)c2C1		CHEMBL363160	=	Kd	nM	3.927	CHEMBL4722	Homo sapiens	KD	M	3.92666666667E-9
Interpretation: Specific Binding	16914831	CHEMBL3885757	Single-Cycle Kinetic parameter establishment of 8 compounds to gain n=3	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1	Non standard unit for type	CHEMBL215152	=	kon	Ms-1	492466.67	CHEMBL4722	Homo sapiens	kon	Ms-1	492466.666666666
Interpretation: Specific Binding	16914832	CHEMBL3885756	Single-Cycle Kinetic parameter establishment of 8 compounds to gain n=3	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	=	k_off	s-1	0.07547	CHEMBL4722	Homo sapiens	koff	s-1	0.0754733333333333
Interpretation: Specific Binding	16914833	CHEMBL3885756	Single-Cycle Kinetic parameter establishment of 8 compounds to gain n=3	B	CCc1cccc(CC)c1NC(=O)N1Cc2[nH]nc(NC(=O)c3ccc(N4CCN(C)CC4)cc3)c2C1		CHEMBL363160	=	k_off	s-1	0.008226	CHEMBL4722	Homo sapiens	koff	s-1	0.00822566666666666
Interpretation: Specific Binding	16914834	CHEMBL3885756	Single-Cycle Kinetic parameter establishment of 8 compounds to gain n=3	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	=	Kd	nM	50.94	CHEMBL4722	Homo sapiens	KD	M	5.094E-8
Interpretation: Specific Binding	16914835	CHEMBL3885756	Single-Cycle Kinetic parameter establishment of 8 compounds to gain n=3	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1	Non standard unit for type	CHEMBL572878	=	kon	Ms-1	2682000.0	CHEMBL4722	Homo sapiens	kon	Ms-1	2682000.0
Interpretation: Specific Binding	16914836	CHEMBL3885756	Single-Cycle Kinetic parameter establishment of 8 compounds to gain n=3	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1	Non standard unit for type	CHEMBL215152	=	kon	Ms-1	1774666.67	CHEMBL4722	Homo sapiens	kon	Ms-1	1774666.66666666
Interpretation: Specific Binding	16914837	CHEMBL3885756	Single-Cycle Kinetic parameter establishment of 8 compounds to gain n=3	B	CO[C@@H](C(=O)N1Cc2n[nH]c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)c2C1)c1ccccc1		CHEMBL402548	=	k_off	s-1	0.007767	CHEMBL4722	Homo sapiens	koff	s-1	0.007767
Interpretation: Specific Binding	16914838	CHEMBL3885756	Single-Cycle Kinetic parameter establishment of 8 compounds to gain n=3	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	=	Kd	nM	1.66	CHEMBL4722	Homo sapiens	KD	M	1.66E-9
Interpretation: Specific Binding	16914839	CHEMBL3885756	Single-Cycle Kinetic parameter establishment of 8 compounds to gain n=3	B	CCn1cc(-c2ccnc3[nH]c(-c4cccc(CN(C)C)c4)cc23)c(-c2ccc(NC(=O)N(C)C)cc2)n1	Non standard unit for type	CHEMBL1090479	=	kon	Ms-1	423233.33	CHEMBL4722	Homo sapiens	kon	Ms-1	423233.333333333
Interpretation: Specific Binding	16914840	CHEMBL3885756	Single-Cycle Kinetic parameter establishment of 8 compounds to gain n=3	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1	Non standard unit for type	CHEMBL259084	=	kon	Ms-1	3446333.33	CHEMBL4722	Homo sapiens	kon	Ms-1	3446333.33333333
Interpretation: Specific Binding	16914841	CHEMBL3885756	Single-Cycle Kinetic parameter establishment of 8 compounds to gain n=3	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F	Non standard unit for type	CHEMBL191003	=	kon	Ms-1	2467966.67	CHEMBL4722	Homo sapiens	kon	Ms-1	2467966.66666666
Interpretation: Specific Binding	16914842	CHEMBL3885756	Single-Cycle Kinetic parameter establishment of 8 compounds to gain n=3	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	=	Kd	nM	162.57	CHEMBL4722	Homo sapiens	KD	M	1.6256666666667E-7
Interpretation: Specific Binding	16914843	CHEMBL3885756	Single-Cycle Kinetic parameter establishment of 8 compounds to gain n=3	B	CCn1cc(-c2ccnc3[nH]c(-c4cccc(CN(C)C)c4)cc23)c(-c2ccc(NC(=O)N(C)C)cc2)n1		CHEMBL1090479	=	Kd	nM	12.96	CHEMBL4722	Homo sapiens	KD	M	1.295666666667E-8
Interpretation: Specific Binding	16914844	CHEMBL3885756	Single-Cycle Kinetic parameter establishment of 8 compounds to gain n=3	B	CCc1cccc(CC)c1NC(=O)N1Cc2[nH]nc(NC(=O)c3ccc(N4CCN(C)CC4)cc3)c2C1		CHEMBL363160	=	Kd	nM	3.513	CHEMBL4722	Homo sapiens	KD	M	3.51333333333E-9
Interpretation: Specific Binding	16914845	CHEMBL3885756	Single-Cycle Kinetic parameter establishment of 8 compounds to gain n=3	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	k_off	s-1	0.003383	CHEMBL4722	Homo sapiens	koff	s-1	0.00338333333333333
Interpretation: Specific Binding	16914846	CHEMBL3885756	Single-Cycle Kinetic parameter establishment of 8 compounds to gain n=3	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	=	k_off	s-1	0.2607	CHEMBL4722	Homo sapiens	koff	s-1	0.260733333333333
Interpretation: Specific Binding	16914847	CHEMBL3885756	Single-Cycle Kinetic parameter establishment of 8 compounds to gain n=3	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	=	k_off	s-1	0.00588	CHEMBL4722	Homo sapiens	koff	s-1	0.00587963333333333
Interpretation: Specific Binding	16914848	CHEMBL3885756	Single-Cycle Kinetic parameter establishment of 8 compounds to gain n=3	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	Kd	nM	1.23	CHEMBL4722	Homo sapiens	KD	M	1.23E-9
Interpretation: Specific Binding	16914849	CHEMBL3885756	Single-Cycle Kinetic parameter establishment of 8 compounds to gain n=3	B	CCc1cccc(CC)c1NC(=O)N1Cc2[nH]nc(NC(=O)c3ccc(N4CCN(C)CC4)cc3)c2C1	Non standard unit for type	CHEMBL363160	=	kon	Ms-1	2395333.33	CHEMBL4722	Homo sapiens	kon	Ms-1	2395333.33333333
Interpretation: Specific Binding	16914850	CHEMBL3885756	Single-Cycle Kinetic parameter establishment of 8 compounds to gain n=3	B	CO[C@@H](C(=O)N1Cc2n[nH]c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)c2C1)c1ccccc1		CHEMBL402548	=	Kd	nM	3.387	CHEMBL4722	Homo sapiens	KD	M	3.38666666667E-9
Interpretation: Specific Binding	16914851	CHEMBL3885756	Single-Cycle Kinetic parameter establishment of 8 compounds to gain n=3	B	CO[C@@H](C(=O)N1Cc2n[nH]c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)c2C1)c1ccccc1	Non standard unit for type	CHEMBL402548	=	kon	Ms-1	2592666.67	CHEMBL4722	Homo sapiens	kon	Ms-1	2592666.66666666
Interpretation: Specific Binding	16914852	CHEMBL3885756	Single-Cycle Kinetic parameter establishment of 8 compounds to gain n=3	B	CCn1cc(-c2ccnc3[nH]c(-c4cccc(CN(C)C)c4)cc23)c(-c2ccc(NC(=O)N(C)C)cc2)n1		CHEMBL1090479	=	k_off	s-1	0.005378	CHEMBL4722	Homo sapiens	koff	s-1	0.005378
Interpretation: Specific Binding	16914853	CHEMBL3885755	Multi-Cycle Kinetic parameter establishment of 8 compounds to gain n=3 Completed over 3 identical immbolized CM5 chips	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	=	Kd	nM	109.8	CHEMBL4722	Homo sapiens	KD	M	1.098E-7
Interpretation: Specific Binding	16914854	CHEMBL3885755	Multi-Cycle Kinetic parameter establishment of 8 compounds to gain n=3 Completed over 3 identical immbolized CM5 chips	B	CCc1cccc(CC)c1NC(=O)N1Cc2[nH]nc(NC(=O)c3ccc(N4CCN(C)CC4)cc3)c2C1	Non standard unit for type	CHEMBL363160	=	kon	Ms-1	1629000.0	CHEMBL4722	Homo sapiens	kon	Ms-1	1629000.0
Interpretation: Specific Binding	16914855	CHEMBL3885755	Multi-Cycle Kinetic parameter establishment of 8 compounds to gain n=3 Completed over 3 identical immbolized CM5 chips	B	CCc1cccc(CC)c1NC(=O)N1Cc2[nH]nc(NC(=O)c3ccc(N4CCN(C)CC4)cc3)c2C1		CHEMBL363160	=	k_off	s-1	0.00295	CHEMBL4722	Homo sapiens	koff	s-1	0.0029505
Interpretation: Specific Binding	16914856	CHEMBL3885755	Multi-Cycle Kinetic parameter establishment of 8 compounds to gain n=3 Completed over 3 identical immbolized CM5 chips	B	CCc1cccc(CC)c1NC(=O)N1Cc2[nH]nc(NC(=O)c3ccc(N4CCN(C)CC4)cc3)c2C1		CHEMBL363160	=	Kd	nM	1.84	CHEMBL4722	Homo sapiens	KD	M	1.84E-9
Interpretation: Specific Binding	16914857	CHEMBL3885755	Multi-Cycle Kinetic parameter establishment of 8 compounds to gain n=3 Completed over 3 identical immbolized CM5 chips	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	=	k_off	s-1	0.1353	CHEMBL4722	Homo sapiens	koff	s-1	0.135333333333333
Interpretation: Specific Binding	16914858	CHEMBL3885755	Multi-Cycle Kinetic parameter establishment of 8 compounds to gain n=3 Completed over 3 identical immbolized CM5 chips	B	CCn1cc(-c2ccnc3[nH]c(-c4cccc(CN(C)C)c4)cc23)c(-c2ccc(NC(=O)N(C)C)cc2)n1		CHEMBL1090479	=	k_off	s-1	0.004272	CHEMBL4722	Homo sapiens	koff	s-1	0.0042715
Interpretation: Specific Binding	16914859	CHEMBL3885755	Multi-Cycle Kinetic parameter establishment of 8 compounds to gain n=3 Completed over 3 identical immbolized CM5 chips	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	k_off	s-1	0.000996	CHEMBL4722	Homo sapiens	koff	s-1	0.000995999999999999
Interpretation: Specific Binding	16914860	CHEMBL3885755	Multi-Cycle Kinetic parameter establishment of 8 compounds to gain n=3 Completed over 3 identical immbolized CM5 chips	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	=	Kd	nM	0.9133	CHEMBL4722	Homo sapiens	KD	M	9.1333333333E-10
Interpretation: Specific Binding	16914861	CHEMBL3885755	Multi-Cycle Kinetic parameter establishment of 8 compounds to gain n=3 Completed over 3 identical immbolized CM5 chips	B	COc1cc2c(Nc3ccc(NC(=O)c4ccccc4)cc3)ncnc2cc1OCCCN1CCOCC1		CHEMBL202721	=	Kd	nM	86.03	CHEMBL4722	Homo sapiens	KD	M	8.603333333333E-8
Interpretation: Specific Binding	16914862	CHEMBL3885755	Multi-Cycle Kinetic parameter establishment of 8 compounds to gain n=3 Completed over 3 identical immbolized CM5 chips	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1	Non standard unit for type	CHEMBL259084	=	kon	Ms-1	1426000.0	CHEMBL4722	Homo sapiens	kon	Ms-1	1426000.0
Interpretation: Specific Binding	16914863	CHEMBL3885755	Multi-Cycle Kinetic parameter establishment of 8 compounds to gain n=3 Completed over 3 identical immbolized CM5 chips	B	COc1cc2c(Nc3ccc(NC(=O)c4ccccc4)cc3)ncnc2cc1OCCCN1CCOCC1	Non standard unit for type	CHEMBL202721	=	kon	Ms-1	1320933.33	CHEMBL4722	Homo sapiens	kon	Ms-1	1320933.33333333
Interpretation: Specific Binding	16914864	CHEMBL3885755	Multi-Cycle Kinetic parameter establishment of 8 compounds to gain n=3 Completed over 3 identical immbolized CM5 chips	B	CCn1cc(-c2ccnc3[nH]c(-c4cccc(CN(C)C)c4)cc23)c(-c2ccc(NC(=O)N(C)C)cc2)n1		CHEMBL1090479	=	Kd	nM	10.65	CHEMBL4722	Homo sapiens	KD	M	1.065E-8
Interpretation: Specific Binding	16914865	CHEMBL3885755	Multi-Cycle Kinetic parameter establishment of 8 compounds to gain n=3 Completed over 3 identical immbolized CM5 chips	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F	Non standard unit for type	CHEMBL191003	=	kon	Ms-1	1400666.67	CHEMBL4722	Homo sapiens	kon	Ms-1	1400666.66666666
Interpretation: Specific Binding	16914866	CHEMBL3885755	Multi-Cycle Kinetic parameter establishment of 8 compounds to gain n=3 Completed over 3 identical immbolized CM5 chips	B	CCn1cc(-c2ccnc3[nH]c(-c4cccc(CN(C)C)c4)cc23)c(-c2ccc(NC(=O)N(C)C)cc2)n1	Non standard unit for type	CHEMBL1090479	=	kon	Ms-1	401100.0	CHEMBL4722	Homo sapiens	kon	Ms-1	401100.0
Interpretation: Specific Binding	16914867	CHEMBL3885755	Multi-Cycle Kinetic parameter establishment of 8 compounds to gain n=3 Completed over 3 identical immbolized CM5 chips	B	CO[C@@H](C(=O)N1Cc2n[nH]c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)c2C1)c1ccccc1	Non standard unit for type	CHEMBL402548	=	kon	Ms-1	2451000.0	CHEMBL4722	Homo sapiens	kon	Ms-1	2451000.0
Interpretation: Specific Binding	16914868	CHEMBL3885755	Multi-Cycle Kinetic parameter establishment of 8 compounds to gain n=3 Completed over 3 identical immbolized CM5 chips	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1	Non standard unit for type	CHEMBL572878	=	kon	Ms-1	1570000.0	CHEMBL4722	Homo sapiens	kon	Ms-1	1570000.0
Interpretation: Specific Binding	16914869	CHEMBL3885755	Multi-Cycle Kinetic parameter establishment of 8 compounds to gain n=3 Completed over 3 identical immbolized CM5 chips	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	=	Kd	nM	30.13	CHEMBL4722	Homo sapiens	KD	M	3.013333333333E-8
Interpretation: Specific Binding	16914870	CHEMBL3885755	Multi-Cycle Kinetic parameter establishment of 8 compounds to gain n=3 Completed over 3 identical immbolized CM5 chips	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	Kd	nM	0.645	CHEMBL4722	Homo sapiens	KD	M	6.45E-10
Interpretation: Specific Binding	16914871	CHEMBL3885755	Multi-Cycle Kinetic parameter establishment of 8 compounds to gain n=3 Completed over 3 identical immbolized CM5 chips	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	=	k_off	s-1	0.0441	CHEMBL4722	Homo sapiens	koff	s-1	0.0441
Interpretation: Specific Binding	16914872	CHEMBL3885755	Multi-Cycle Kinetic parameter establishment of 8 compounds to gain n=3 Completed over 3 identical immbolized CM5 chips	B	COc1cc2c(Nc3ccc(NC(=O)c4ccccc4)cc3)ncnc2cc1OCCCN1CCOCC1		CHEMBL202721	=	k_off	s-1	0.05584	CHEMBL4722	Homo sapiens	koff	s-1	0.0558433333333333
Interpretation: Specific Binding	16914873	CHEMBL3885755	Multi-Cycle Kinetic parameter establishment of 8 compounds to gain n=3 Completed over 3 identical immbolized CM5 chips	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	=	k_off	s-1	0.04991	CHEMBL4722	Homo sapiens	koff	s-1	0.0499133333333333
Interpretation: Specific Binding	16914874	CHEMBL3885755	Multi-Cycle Kinetic parameter establishment of 8 compounds to gain n=3 Completed over 3 identical immbolized CM5 chips	B	CO[C@@H](C(=O)N1Cc2n[nH]c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)c2C1)c1ccccc1		CHEMBL402548	=	Kd	nM	2.155	CHEMBL4722	Homo sapiens	KD	M	2.155E-9
Interpretation: Specific Binding	16914875	CHEMBL3885755	Multi-Cycle Kinetic parameter establishment of 8 compounds to gain n=3 Completed over 3 identical immbolized CM5 chips	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1	Non standard unit for type	CHEMBL215152	=	kon	Ms-1	1263666.67	CHEMBL4722	Homo sapiens	kon	Ms-1	1263666.66666666
Interpretation: Specific Binding	16914876	CHEMBL3885755	Multi-Cycle Kinetic parameter establishment of 8 compounds to gain n=3 Completed over 3 identical immbolized CM5 chips	B	CO[C@@H](C(=O)N1Cc2n[nH]c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)c2C1)c1ccccc1		CHEMBL402548	=	k_off	s-1	0.005393	CHEMBL4722	Homo sapiens	koff	s-1	0.005393
Interpretation: Specific Binding	16914877	CHEMBL3885751	Multi-Cycle Kinetic parameter establishment of 8 compounds to gain n=3Completed over 3 identical immbolized CM5 chips	B	CO[C@@H](C(=O)N1Cc2n[nH]c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)c2C1)c1ccccc1		CHEMBL402548	=	k_off	s-1	0.005561	CHEMBL4722	Homo sapiens	koff	s-1	0.00556133333333333
Interpretation: Specific Binding	16914878	CHEMBL3885751	Multi-Cycle Kinetic parameter establishment of 8 compounds to gain n=3Completed over 3 identical immbolized CM5 chips	B	CCn1cc(-c2ccnc3[nH]c(-c4cccc(CN(C)C)c4)cc23)c(-c2ccc(NC(=O)N(C)C)cc2)n1		CHEMBL1090479	=	Kd	nM	15.07	CHEMBL4722	Homo sapiens	KD	M	1.506666666667E-8
Interpretation: Specific Binding	16914879	CHEMBL3885751	Multi-Cycle Kinetic parameter establishment of 8 compounds to gain n=3Completed over 3 identical immbolized CM5 chips	B	CO[C@@H](C(=O)N1Cc2n[nH]c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)c2C1)c1ccccc1	Non standard unit for type	CHEMBL402548	=	kon	Ms-1	2275333.33	CHEMBL4722	Homo sapiens	kon	Ms-1	2275333.33333333
Interpretation: Specific Binding	16914880	CHEMBL3885751	Multi-Cycle Kinetic parameter establishment of 8 compounds to gain n=3Completed over 3 identical immbolized CM5 chips	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	=	k_off	s-1	0.1986	CHEMBL4722	Homo sapiens	koff	s-1	0.198566666666666
Interpretation: Specific Binding	16914881	CHEMBL3885751	Multi-Cycle Kinetic parameter establishment of 8 compounds to gain n=3Completed over 3 identical immbolized CM5 chips	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	=	Kd	nM	115.67	CHEMBL4722	Homo sapiens	KD	M	1.1566666666667E-7
Interpretation: Specific Binding	16914882	CHEMBL3885751	Multi-Cycle Kinetic parameter establishment of 8 compounds to gain n=3Completed over 3 identical immbolized CM5 chips	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	=	k_off	s-1	0.0007416	CHEMBL4722	Homo sapiens	koff	s-1	0.000741566666666666
Interpretation: Specific Binding	16914883	CHEMBL3885751	Multi-Cycle Kinetic parameter establishment of 8 compounds to gain n=3Completed over 3 identical immbolized CM5 chips	B	CCn1cc(-c2ccnc3[nH]c(-c4cccc(CN(C)C)c4)cc23)c(-c2ccc(NC(=O)N(C)C)cc2)n1	Non standard unit for type	CHEMBL1090479	=	kon	Ms-1	339000.0	CHEMBL4722	Homo sapiens	kon	Ms-1	339000.0
Interpretation: Specific Binding	16914884	CHEMBL3885751	Multi-Cycle Kinetic parameter establishment of 8 compounds to gain n=3Completed over 3 identical immbolized CM5 chips	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1	Non standard unit for type	CHEMBL572878	=	kon	Ms-1	6723333.33	CHEMBL4722	Homo sapiens	kon	Ms-1	6723333.33333333
Interpretation: Specific Binding	16914885	CHEMBL3885751	Multi-Cycle Kinetic parameter establishment of 8 compounds to gain n=3Completed over 3 identical immbolized CM5 chips	B	CO[C@@H](C(=O)N1Cc2n[nH]c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)c2C1)c1ccccc1		CHEMBL402548	=	Kd	nM	2.667	CHEMBL4722	Homo sapiens	KD	M	2.66666666667E-9
Interpretation: Specific Binding	16914886	CHEMBL3885751	Multi-Cycle Kinetic parameter establishment of 8 compounds to gain n=3Completed over 3 identical immbolized CM5 chips	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	=	k_off	s-1	0.08487	CHEMBL4722	Homo sapiens	koff	s-1	0.0848733333333333
Interpretation: Specific Binding	16914887	CHEMBL3885751	Multi-Cycle Kinetic parameter establishment of 8 compounds to gain n=3Completed over 3 identical immbolized CM5 chips	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	Kd	nM	0.3333	CHEMBL4722	Homo sapiens	KD	M	3.3333333333E-10
Interpretation: Specific Binding	16914888	CHEMBL3885751	Multi-Cycle Kinetic parameter establishment of 8 compounds to gain n=3Completed over 3 identical immbolized CM5 chips	B	CCc1cccc(CC)c1NC(=O)N1Cc2[nH]nc(NC(=O)c3ccc(N4CCN(C)CC4)cc3)c2C1	Non standard unit for type	CHEMBL363160	=	kon	Ms-1	1347666.67	CHEMBL4722	Homo sapiens	kon	Ms-1	1347666.66666666
Interpretation: Specific Binding	16914889	CHEMBL3885751	Multi-Cycle Kinetic parameter establishment of 8 compounds to gain n=3Completed over 3 identical immbolized CM5 chips	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	k_off	s-1	0.002135	CHEMBL4722	Homo sapiens	koff	s-1	0.00213466666666666
Interpretation: Specific Binding	16914890	CHEMBL3885751	Multi-Cycle Kinetic parameter establishment of 8 compounds to gain n=3Completed over 3 identical immbolized CM5 chips	B	CCc1cccc(CC)c1NC(=O)N1Cc2[nH]nc(NC(=O)c3ccc(N4CCN(C)CC4)cc3)c2C1		CHEMBL363160	=	k_off	s-1	0.003665	CHEMBL4722	Homo sapiens	koff	s-1	0.00366466666666666
Interpretation: Specific Binding	16914891	CHEMBL3885751	Multi-Cycle Kinetic parameter establishment of 8 compounds to gain n=3Completed over 3 identical immbolized CM5 chips	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1	Non standard unit for type	CHEMBL215152	=	kon	Ms-1	1711333.33	CHEMBL4722	Homo sapiens	kon	Ms-1	1711333.33333333
Interpretation: Specific Binding	16914892	CHEMBL3885751	Multi-Cycle Kinetic parameter establishment of 8 compounds to gain n=3Completed over 3 identical immbolized CM5 chips	B	CCc1cccc(CC)c1NC(=O)N1Cc2[nH]nc(NC(=O)c3ccc(N4CCN(C)CC4)cc3)c2C1		CHEMBL363160	=	Kd	nM	2.613	CHEMBL4722	Homo sapiens	KD	M	2.61333333333E-9
Interpretation: Specific Binding	16914893	CHEMBL3885751	Multi-Cycle Kinetic parameter establishment of 8 compounds to gain n=3Completed over 3 identical immbolized CM5 chips	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	=	Kd	nM	33.2	CHEMBL4722	Homo sapiens	KD	M	3.32E-8
Interpretation: Specific Binding	16914894	CHEMBL3885751	Multi-Cycle Kinetic parameter establishment of 8 compounds to gain n=3Completed over 3 identical immbolized CM5 chips	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1	Non standard unit for type	CHEMBL259084	=	kon	Ms-1	2213333.33	CHEMBL4722	Homo sapiens	kon	Ms-1	2213333.33333333
Interpretation: Specific Binding	16914895	CHEMBL3885751	Multi-Cycle Kinetic parameter establishment of 8 compounds to gain n=3Completed over 3 identical immbolized CM5 chips	B	COc1cc2c(Nc3ccc(NC(=O)c4ccccc4)cc3)ncnc2cc1OCCCN1CCOCC1		CHEMBL202721	=	k_off	s-1	0.1692	CHEMBL4722	Homo sapiens	koff	s-1	0.1692
Interpretation: Specific Binding	16914896	CHEMBL3885751	Multi-Cycle Kinetic parameter establishment of 8 compounds to gain n=3Completed over 3 identical immbolized CM5 chips	B	CCn1cc(-c2ccnc3[nH]c(-c4cccc(CN(C)C)c4)cc23)c(-c2ccc(NC(=O)N(C)C)cc2)n1		CHEMBL1090479	=	k_off	s-1	0.005121	CHEMBL4722	Homo sapiens	koff	s-1	0.00512133333333333
Interpretation: Specific Binding	16914897	CHEMBL3885751	Multi-Cycle Kinetic parameter establishment of 8 compounds to gain n=3Completed over 3 identical immbolized CM5 chips	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F	Non standard unit for type	CHEMBL191003	=	kon	Ms-1	2556333.33	CHEMBL4722	Homo sapiens	kon	Ms-1	2556333.33333333
Interpretation: Specific Binding	16914898	CHEMBL3885751	Multi-Cycle Kinetic parameter establishment of 8 compounds to gain n=3Completed over 3 identical immbolized CM5 chips	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	=	Kd	nM	0.3467	CHEMBL4722	Homo sapiens	KD	M	3.4666666667E-10
Interpretation: Specific Binding	16914899	CHEMBL3885751	Multi-Cycle Kinetic parameter establishment of 8 compounds to gain n=3Completed over 3 identical immbolized CM5 chips	B	COc1cc2c(Nc3ccc(NC(=O)c4ccccc4)cc3)ncnc2cc1OCCCN1CCOCC1	Non standard unit for type	CHEMBL202721	=	kon	Ms-1	2486066.67	CHEMBL4722	Homo sapiens	kon	Ms-1	2486066.66666666
Interpretation: Specific Binding	16914900	CHEMBL3885751	Multi-Cycle Kinetic parameter establishment of 8 compounds to gain n=3Completed over 3 identical immbolized CM5 chips	B	COc1cc2c(Nc3ccc(NC(=O)c4ccccc4)cc3)ncnc2cc1OCCCN1CCOCC1		CHEMBL202721	=	Kd	nM	138.4	CHEMBL4722	Homo sapiens	KD	M	1.384E-7
198755	17602269	CHEMBL3887039	Enzyme Assay-Time Dependence: Compounds were assessed for their ability to inhibit the enzymatic activity of a recombinant form of Glutaminase 1 (GAC) using a biochemical assay that couples the production of glutamate (liberated by GAC) to glutamate dehydrogenase (GDH) and measuring the change in absorbance for the reduction of NAD+ to NADH.	B	CCc1[nH]cc2c1NC1=C(C(=O)CCC1)[C@H]2c1cccc(Oc2nc3ccccc3[nH]2)c1		CHEMBL3897011	=	IC50	nM	1.0	CHEMBL4722	Homo sapiens	IC50	nM	1.0
217624	17606276	CHEMBL3887044	HTRF Assay: The effect of the compounds of the invention on the activity of the enzyme PDE3 was evaluated by the company CEREP (Le bois I'Evêque, 86600 Celle I'Evescault, France; http://www.cerep.fr) in accordance with its standard protocol (see Bender, A. T., Beavo, J. A. Pharmacol Rev. 2006, 58, 488-520: the enzyme PDE3A in recombinant form is expressed in Sf9 cells, the substrate is cAMP and the residual AMPc is measured by HTRF. The reference inhibitor in the test is milrinone, whose IC50 is 270 nM. The residual activity % are related to the control without inhibitor). The results are expressed either as the concentration which induces inhibition by 50% (IC50) or as a percentage inhibition measured at a set concentration of the compound.	B	CCc1[nH]cc2c1NC1=C(C(=O)CCC1)[C@@H]2c1cccc(Oc2nc3ccccc3[nH]2)c1		CHEMBL4112853	=	IC50	nM	900.0	CHEMBL4722	Homo sapiens	IC50	nM	900.0
242730	17626225	CHEMBL3706327	Enzyme Assay: The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.	B	COc1ccc(C(=O)Nc2cccc(CNc3ncnc4c(C(N)=O)cc(C(O)CO)cc34)c2)cc1		CHEMBL3962025	=	IC50	nM	1.2	CHEMBL4722	Homo sapiens	IC50	nM	1.2
249784	17633020	CHEMBL3705426	Enzyme Inhibtion Assay: To determine Aurora A and C activity of representative compounds of the invention, Active Aurora A or C enzyme was incubated in wells of a 384 well plate with biotinylated STK substrate-2 (Upstate), 1 mM ATP, and various concentrations of inhibitors in a Hepes buffer, pH 7.4 containing MgCl2, sodium othrovanadate, and Triton X-100. After 1 hour, the reaction was stopped with EDTA and anti-phospho-STK antibody Europium Cryptate (Upstate) and SA-XL665 (Upstate) were added to detect the phosphopeptide. The amount of phosphorylation was determined by the time-resolved fluorescence ratio of signals at 665 nm and 615 nm.	B	Nc1ncc(-c2cnn(CCO)c2)c2scc(-c3ccc(NC(=O)Nc4cccc(F)c4)cc3)c12		CHEMBL1980297	=	IC50	nM	675.42	CHEMBL4722	Homo sapiens	IC50	nM	675.42
249785	17633021	CHEMBL3705426	Enzyme Inhibtion Assay: To determine Aurora A and C activity of representative compounds of the invention, Active Aurora A or C enzyme was incubated in wells of a 384 well plate with biotinylated STK substrate-2 (Upstate), 1 mM ATP, and various concentrations of inhibitors in a Hepes buffer, pH 7.4 containing MgCl2, sodium othrovanadate, and Triton X-100. After 1 hour, the reaction was stopped with EDTA and anti-phospho-STK antibody Europium Cryptate (Upstate) and SA-XL665 (Upstate) were added to detect the phosphopeptide. The amount of phosphorylation was determined by the time-resolved fluorescence ratio of signals at 665 nm and 615 nm.	B	Nc1ncc(-c2cnn(CCO)c2)c2scc(-c3ccc(NC(=O)Nc4cccc(F)c4)cc3)c12		CHEMBL1980297	=	IC50	nM	4743.1	CHEMBL4722	Homo sapiens	IC50	nM	4743.1
249786	17633022	CHEMBL3705426	Enzyme Inhibtion Assay: To determine Aurora A and C activity of representative compounds of the invention, Active Aurora A or C enzyme was incubated in wells of a 384 well plate with biotinylated STK substrate-2 (Upstate), 1 mM ATP, and various concentrations of inhibitors in a Hepes buffer, pH 7.4 containing MgCl2, sodium othrovanadate, and Triton X-100. After 1 hour, the reaction was stopped with EDTA and anti-phospho-STK antibody Europium Cryptate (Upstate) and SA-XL665 (Upstate) were added to detect the phosphopeptide. The amount of phosphorylation was determined by the time-resolved fluorescence ratio of signals at 665 nm and 615 nm.	B	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(C[C@H](C)O)c5)cnc(N)c34)cc2)c1		CHEMBL3646210	=	IC50	nM	248.31	CHEMBL4722	Homo sapiens	IC50	nM	248.31
249787	17633023	CHEMBL3705426	Enzyme Inhibtion Assay: To determine Aurora A and C activity of representative compounds of the invention, Active Aurora A or C enzyme was incubated in wells of a 384 well plate with biotinylated STK substrate-2 (Upstate), 1 mM ATP, and various concentrations of inhibitors in a Hepes buffer, pH 7.4 containing MgCl2, sodium othrovanadate, and Triton X-100. After 1 hour, the reaction was stopped with EDTA and anti-phospho-STK antibody Europium Cryptate (Upstate) and SA-XL665 (Upstate) were added to detect the phosphopeptide. The amount of phosphorylation was determined by the time-resolved fluorescence ratio of signals at 665 nm and 615 nm.	B	COc1ccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(CC(C)(C)O)c5)cnc(N)c34)cc2)cc1		CHEMBL2004290	=	IC50	nM	3619.85	CHEMBL4722	Homo sapiens	IC50	nM	3619.85
249788	17633024	CHEMBL3705426	Enzyme Inhibtion Assay: To determine Aurora A and C activity of representative compounds of the invention, Active Aurora A or C enzyme was incubated in wells of a 384 well plate with biotinylated STK substrate-2 (Upstate), 1 mM ATP, and various concentrations of inhibitors in a Hepes buffer, pH 7.4 containing MgCl2, sodium othrovanadate, and Triton X-100. After 1 hour, the reaction was stopped with EDTA and anti-phospho-STK antibody Europium Cryptate (Upstate) and SA-XL665 (Upstate) were added to detect the phosphopeptide. The amount of phosphorylation was determined by the time-resolved fluorescence ratio of signals at 665 nm and 615 nm.	B	COc1ccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(C[C@H](O)CO)c5)cnc(N)c34)cc2)cc1		CHEMBL3646211	=	IC50	nM	570.14	CHEMBL4722	Homo sapiens	IC50	nM	570.14
249789	17633025	CHEMBL3705426	Enzyme Inhibtion Assay: To determine Aurora A and C activity of representative compounds of the invention, Active Aurora A or C enzyme was incubated in wells of a 384 well plate with biotinylated STK substrate-2 (Upstate), 1 mM ATP, and various concentrations of inhibitors in a Hepes buffer, pH 7.4 containing MgCl2, sodium othrovanadate, and Triton X-100. After 1 hour, the reaction was stopped with EDTA and anti-phospho-STK antibody Europium Cryptate (Upstate) and SA-XL665 (Upstate) were added to detect the phosphopeptide. The amount of phosphorylation was determined by the time-resolved fluorescence ratio of signals at 665 nm and 615 nm.	B	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(-c5cn[nH]c5)cnc(N)c34)cc2)c1		CHEMBL1969102	=	IC50	nM	357.2	CHEMBL4722	Homo sapiens	IC50	nM	357.2
298004	17678834	CHEMBL3705704	Inhibitory Assay: An inhibitory activity of the above compound in-vitro against Aurora A kinase activity was measured with reference to a method described in JP-A-2008-81492. In measuring inhibitory activity of the compound, first, the test compound was serially diluted by dimethylsulfoxide (DMSO). Then, to a reaction buffer [50 mM Tris-hydrochloric acid buffer (pH 7.4), 15 mM magnesium acetate, 0.2 mM ethylenediamine-N,N,N',N'-tetraacetic acids (EDTA)], purified human Aurora A protein, FL-Peptide 21 (Caliper Life Sciences, Inc., a final concentration: 100 nM), ATP (a final concentration: 5 uM) and the DMSO solution (a final concentration of DMSO: 5%) of the test compound were added. The mixture was incubated at 25 C. for 50 minutes to perform a kinase reaction. To the mixture, IMAP (registered trade mark) Progressive Binding Reagent diluted 500x with IMAP (registered trade mark) Progressive Binding Buffer A (manufactured by Molecular Devices) was added to terminate the kinase reaction.	B	Cc1cc(Nc2nc(CC3(C(=O)O)CCN(C(=O)c4cccc(Cl)c4Cl)CC3)ccc2F)n[nH]1		CHEMBL3692206	=	IC50	nM	0.4	CHEMBL4722	Homo sapiens	IC50	nM	0.4
298005	17678835	CHEMBL3705704	Inhibitory Assay: An inhibitory activity of the above compound in-vitro against Aurora A kinase activity was measured with reference to a method described in JP-A-2008-81492. In measuring inhibitory activity of the compound, first, the test compound was serially diluted by dimethylsulfoxide (DMSO). Then, to a reaction buffer [50 mM Tris-hydrochloric acid buffer (pH 7.4), 15 mM magnesium acetate, 0.2 mM ethylenediamine-N,N,N',N'-tetraacetic acids (EDTA)], purified human Aurora A protein, FL-Peptide 21 (Caliper Life Sciences, Inc., a final concentration: 100 nM), ATP (a final concentration: 5 uM) and the DMSO solution (a final concentration of DMSO: 5%) of the test compound were added. The mixture was incubated at 25 C. for 50 minutes to perform a kinase reaction. To the mixture, IMAP (registered trade mark) Progressive Binding Reagent diluted 500x with IMAP (registered trade mark) Progressive Binding Buffer A (manufactured by Molecular Devices) was added to terminate the kinase reaction.	B	Cc1cc(Nc2nc(CC3(C(=O)O)CCN(C(=O)c4cccc(C(F)(F)F)c4F)CC3)ccc2F)n[nH]1		CHEMBL3692207	=	IC50	nM	0.5	CHEMBL4722	Homo sapiens	IC50	nM	0.5
298006	17678836	CHEMBL3705704	Inhibitory Assay: An inhibitory activity of the above compound in-vitro against Aurora A kinase activity was measured with reference to a method described in JP-A-2008-81492. In measuring inhibitory activity of the compound, first, the test compound was serially diluted by dimethylsulfoxide (DMSO). Then, to a reaction buffer [50 mM Tris-hydrochloric acid buffer (pH 7.4), 15 mM magnesium acetate, 0.2 mM ethylenediamine-N,N,N',N'-tetraacetic acids (EDTA)], purified human Aurora A protein, FL-Peptide 21 (Caliper Life Sciences, Inc., a final concentration: 100 nM), ATP (a final concentration: 5 uM) and the DMSO solution (a final concentration of DMSO: 5%) of the test compound were added. The mixture was incubated at 25 C. for 50 minutes to perform a kinase reaction. To the mixture, IMAP (registered trade mark) Progressive Binding Reagent diluted 500x with IMAP (registered trade mark) Progressive Binding Buffer A (manufactured by Molecular Devices) was added to terminate the kinase reaction.	B	COc1ccc(CC2(C(=O)O)CCN(C(=O)c3cccc(Cl)c3F)CC2)nc1Nc1cc(C)[nH]n1		CHEMBL3692208	=	IC50	nM	0.6	CHEMBL4722	Homo sapiens	IC50	nM	0.6
298007	17678837	CHEMBL3705704	Inhibitory Assay: An inhibitory activity of the above compound in-vitro against Aurora A kinase activity was measured with reference to a method described in JP-A-2008-81492. In measuring inhibitory activity of the compound, first, the test compound was serially diluted by dimethylsulfoxide (DMSO). Then, to a reaction buffer [50 mM Tris-hydrochloric acid buffer (pH 7.4), 15 mM magnesium acetate, 0.2 mM ethylenediamine-N,N,N',N'-tetraacetic acids (EDTA)], purified human Aurora A protein, FL-Peptide 21 (Caliper Life Sciences, Inc., a final concentration: 100 nM), ATP (a final concentration: 5 uM) and the DMSO solution (a final concentration of DMSO: 5%) of the test compound were added. The mixture was incubated at 25 C. for 50 minutes to perform a kinase reaction. To the mixture, IMAP (registered trade mark) Progressive Binding Reagent diluted 500x with IMAP (registered trade mark) Progressive Binding Buffer A (manufactured by Molecular Devices) was added to terminate the kinase reaction.	B	Cc1cc(Nc2nc(CC3(C(=O)O)CCN(C(=O)c4cccc(Cl)c4F)CC3)ccc2Cl)n[nH]1		CHEMBL3692209	=	IC50	nM	0.4	CHEMBL4722	Homo sapiens	IC50	nM	0.4
298008	17678838	CHEMBL3705704	Inhibitory Assay: An inhibitory activity of the above compound in-vitro against Aurora A kinase activity was measured with reference to a method described in JP-A-2008-81492. In measuring inhibitory activity of the compound, first, the test compound was serially diluted by dimethylsulfoxide (DMSO). Then, to a reaction buffer [50 mM Tris-hydrochloric acid buffer (pH 7.4), 15 mM magnesium acetate, 0.2 mM ethylenediamine-N,N,N',N'-tetraacetic acids (EDTA)], purified human Aurora A protein, FL-Peptide 21 (Caliper Life Sciences, Inc., a final concentration: 100 nM), ATP (a final concentration: 5 uM) and the DMSO solution (a final concentration of DMSO: 5%) of the test compound were added. The mixture was incubated at 25 C. for 50 minutes to perform a kinase reaction. To the mixture, IMAP (registered trade mark) Progressive Binding Reagent diluted 500x with IMAP (registered trade mark) Progressive Binding Buffer A (manufactured by Molecular Devices) was added to terminate the kinase reaction.	B	Cc1cc(Nc2nc(CC3(C(=O)O)CCN(C(=O)c4cccc(Cl)c4F)CC3)ccc2F)n[nH]1		CHEMBL3692210	=	IC50	nM	0.4	CHEMBL4722	Homo sapiens	IC50	nM	0.4
298009	17678839	CHEMBL3705704	Inhibitory Assay: An inhibitory activity of the above compound in-vitro against Aurora A kinase activity was measured with reference to a method described in JP-A-2008-81492. In measuring inhibitory activity of the compound, first, the test compound was serially diluted by dimethylsulfoxide (DMSO). Then, to a reaction buffer [50 mM Tris-hydrochloric acid buffer (pH 7.4), 15 mM magnesium acetate, 0.2 mM ethylenediamine-N,N,N',N'-tetraacetic acids (EDTA)], purified human Aurora A protein, FL-Peptide 21 (Caliper Life Sciences, Inc., a final concentration: 100 nM), ATP (a final concentration: 5 uM) and the DMSO solution (a final concentration of DMSO: 5%) of the test compound were added. The mixture was incubated at 25 C. for 50 minutes to perform a kinase reaction. To the mixture, IMAP (registered trade mark) Progressive Binding Reagent diluted 500x with IMAP (registered trade mark) Progressive Binding Buffer A (manufactured by Molecular Devices) was added to terminate the kinase reaction.	B	CNC(=O)C1(Cc2ccc(F)c(Nc3cc(C)[nH]n3)n2)CCN(C(=O)c2cccc(Cl)c2F)CC1		CHEMBL3692211	=	IC50	nM	0.9	CHEMBL4722	Homo sapiens	IC50	nM	0.9
298010	17678840	CHEMBL3705704	Inhibitory Assay: An inhibitory activity of the above compound in-vitro against Aurora A kinase activity was measured with reference to a method described in JP-A-2008-81492. In measuring inhibitory activity of the compound, first, the test compound was serially diluted by dimethylsulfoxide (DMSO). Then, to a reaction buffer [50 mM Tris-hydrochloric acid buffer (pH 7.4), 15 mM magnesium acetate, 0.2 mM ethylenediamine-N,N,N',N'-tetraacetic acids (EDTA)], purified human Aurora A protein, FL-Peptide 21 (Caliper Life Sciences, Inc., a final concentration: 100 nM), ATP (a final concentration: 5 uM) and the DMSO solution (a final concentration of DMSO: 5%) of the test compound were added. The mixture was incubated at 25 C. for 50 minutes to perform a kinase reaction. To the mixture, IMAP (registered trade mark) Progressive Binding Reagent diluted 500x with IMAP (registered trade mark) Progressive Binding Buffer A (manufactured by Molecular Devices) was added to terminate the kinase reaction.	B	Cc1cc(Nc2nc(CC3(C(=O)NC4CC4)CCN(C(=O)c4cccc(Cl)c4F)CC3)ccc2F)n[nH]1		CHEMBL3692212	=	IC50	nM	0.9	CHEMBL4722	Homo sapiens	IC50	nM	0.9
298011	17678841	CHEMBL3705704	Inhibitory Assay: An inhibitory activity of the above compound in-vitro against Aurora A kinase activity was measured with reference to a method described in JP-A-2008-81492. In measuring inhibitory activity of the compound, first, the test compound was serially diluted by dimethylsulfoxide (DMSO). Then, to a reaction buffer [50 mM Tris-hydrochloric acid buffer (pH 7.4), 15 mM magnesium acetate, 0.2 mM ethylenediamine-N,N,N',N'-tetraacetic acids (EDTA)], purified human Aurora A protein, FL-Peptide 21 (Caliper Life Sciences, Inc., a final concentration: 100 nM), ATP (a final concentration: 5 uM) and the DMSO solution (a final concentration of DMSO: 5%) of the test compound were added. The mixture was incubated at 25 C. for 50 minutes to perform a kinase reaction. To the mixture, IMAP (registered trade mark) Progressive Binding Reagent diluted 500x with IMAP (registered trade mark) Progressive Binding Buffer A (manufactured by Molecular Devices) was added to terminate the kinase reaction.	B	Cc1cc(Nc2nc(CC3(C(=O)N4CCC4)CCN(C(=O)c4cccc(Cl)c4F)CC3)ccc2F)n[nH]1		CHEMBL3692213	=	IC50	nM	1.0	CHEMBL4722	Homo sapiens	IC50	nM	1.0
298012	17678842	CHEMBL3705704	Inhibitory Assay: An inhibitory activity of the above compound in-vitro against Aurora A kinase activity was measured with reference to a method described in JP-A-2008-81492. In measuring inhibitory activity of the compound, first, the test compound was serially diluted by dimethylsulfoxide (DMSO). Then, to a reaction buffer [50 mM Tris-hydrochloric acid buffer (pH 7.4), 15 mM magnesium acetate, 0.2 mM ethylenediamine-N,N,N',N'-tetraacetic acids (EDTA)], purified human Aurora A protein, FL-Peptide 21 (Caliper Life Sciences, Inc., a final concentration: 100 nM), ATP (a final concentration: 5 uM) and the DMSO solution (a final concentration of DMSO: 5%) of the test compound were added. The mixture was incubated at 25 C. for 50 minutes to perform a kinase reaction. To the mixture, IMAP (registered trade mark) Progressive Binding Reagent diluted 500x with IMAP (registered trade mark) Progressive Binding Buffer A (manufactured by Molecular Devices) was added to terminate the kinase reaction.	B	Cc1cc(Nc2nc(CC3(c4noc(C)n4)CCN(C(=O)c4cccc(Cl)c4F)CC3)ccc2F)n[nH]1		CHEMBL3692214	=	IC50	nM	0.7	CHEMBL4722	Homo sapiens	IC50	nM	0.7
298013	17678843	CHEMBL3705704	Inhibitory Assay: An inhibitory activity of the above compound in-vitro against Aurora A kinase activity was measured with reference to a method described in JP-A-2008-81492. In measuring inhibitory activity of the compound, first, the test compound was serially diluted by dimethylsulfoxide (DMSO). Then, to a reaction buffer [50 mM Tris-hydrochloric acid buffer (pH 7.4), 15 mM magnesium acetate, 0.2 mM ethylenediamine-N,N,N',N'-tetraacetic acids (EDTA)], purified human Aurora A protein, FL-Peptide 21 (Caliper Life Sciences, Inc., a final concentration: 100 nM), ATP (a final concentration: 5 uM) and the DMSO solution (a final concentration of DMSO: 5%) of the test compound were added. The mixture was incubated at 25 C. for 50 minutes to perform a kinase reaction. To the mixture, IMAP (registered trade mark) Progressive Binding Reagent diluted 500x with IMAP (registered trade mark) Progressive Binding Buffer A (manufactured by Molecular Devices) was added to terminate the kinase reaction.	B	Cc1cc(Nc2nc(CC3(c4ncon4)CCN(C(=O)c4cccc(Cl)c4F)CC3)ccc2F)n[nH]1		CHEMBL3692215	=	IC50	nM	0.5	CHEMBL4722	Homo sapiens	IC50	nM	0.5
298014	17678844	CHEMBL3705704	Inhibitory Assay: An inhibitory activity of the above compound in-vitro against Aurora A kinase activity was measured with reference to a method described in JP-A-2008-81492. In measuring inhibitory activity of the compound, first, the test compound was serially diluted by dimethylsulfoxide (DMSO). Then, to a reaction buffer [50 mM Tris-hydrochloric acid buffer (pH 7.4), 15 mM magnesium acetate, 0.2 mM ethylenediamine-N,N,N',N'-tetraacetic acids (EDTA)], purified human Aurora A protein, FL-Peptide 21 (Caliper Life Sciences, Inc., a final concentration: 100 nM), ATP (a final concentration: 5 uM) and the DMSO solution (a final concentration of DMSO: 5%) of the test compound were added. The mixture was incubated at 25 C. for 50 minutes to perform a kinase reaction. To the mixture, IMAP (registered trade mark) Progressive Binding Reagent diluted 500x with IMAP (registered trade mark) Progressive Binding Buffer A (manufactured by Molecular Devices) was added to terminate the kinase reaction.	B	Cc1cc(Nc2nc(CC3(c4nnc(C)o4)CCN(C(=O)c4cccc(Cl)c4F)CC3)ccc2F)n[nH]1		CHEMBL3692216	=	IC50	nM	0.7	CHEMBL4722	Homo sapiens	IC50	nM	0.7
298015	17678845	CHEMBL3705704	Inhibitory Assay: An inhibitory activity of the above compound in-vitro against Aurora A kinase activity was measured with reference to a method described in JP-A-2008-81492. In measuring inhibitory activity of the compound, first, the test compound was serially diluted by dimethylsulfoxide (DMSO). Then, to a reaction buffer [50 mM Tris-hydrochloric acid buffer (pH 7.4), 15 mM magnesium acetate, 0.2 mM ethylenediamine-N,N,N',N'-tetraacetic acids (EDTA)], purified human Aurora A protein, FL-Peptide 21 (Caliper Life Sciences, Inc., a final concentration: 100 nM), ATP (a final concentration: 5 uM) and the DMSO solution (a final concentration of DMSO: 5%) of the test compound were added. The mixture was incubated at 25 C. for 50 minutes to perform a kinase reaction. To the mixture, IMAP (registered trade mark) Progressive Binding Reagent diluted 500x with IMAP (registered trade mark) Progressive Binding Buffer A (manufactured by Molecular Devices) was added to terminate the kinase reaction.	B	Cc1noc(C2(Cc3ccc(F)c(Nc4cc(C)[nH]n4)n3)CCN(C(=O)c3cccc(Cl)c3F)CC2)n1		CHEMBL3692217	=	IC50	nM	0.8	CHEMBL4722	Homo sapiens	IC50	nM	0.8
327657	17706383	CHEMBL3887267	Inhibition Assay: Kinase assays were performed at Reaction Biology Corp., Malvern, Pa., USA, using the following general procedure:1) Prepare indicated substrate in freshly prepared Base Reaction Buffer (20 mM Hepes pH 7.5, 10 mM MgCl2, 1 mM EGTA, 0.02% Brij35, 0.02 mg/ml BSA, 0.1 mM Na3VO4, 2 mM DTT, 1% DMSO).2) Deliver cofactors (1.5 mM CaCl2, 16 ug/mL Calmodulin, 2 mM MnCl2) to the substrate solution above.3) Deliver indicated kinase into the substrate solution and gently mix4) Deliver varying concentrations of test compound in DMSO into the kinase reaction mixture.5) Deliver 33P-ATP (specific activity 0.01 uCi/uL final) into the reaction mixture to initiate the reaction.6) Incubate kinase reaction for 120 min at room temperature.7) Reactions are spotted onto P81 ion exchange filter paper (Whatman #3698-915)8) Unbound phosphate is removed by washing filters extensively in 0.75% phosphoric acid.9) 33P signal was determined using Typhoon phosphorimagers (GE Healthcare).	B	CC1(C)CN(c2ccc(-c3oc(-c4c(F)ccc5[nH]ccc45)nc3C(N)=O)cc2)CCN1		CHEMBL3944825	=	IC50	nM	14.62	CHEMBL4722	Homo sapiens	IC50	nM	14.62
327658	17706384	CHEMBL3887267	Inhibition Assay: Kinase assays were performed at Reaction Biology Corp., Malvern, Pa., USA, using the following general procedure:1) Prepare indicated substrate in freshly prepared Base Reaction Buffer (20 mM Hepes pH 7.5, 10 mM MgCl2, 1 mM EGTA, 0.02% Brij35, 0.02 mg/ml BSA, 0.1 mM Na3VO4, 2 mM DTT, 1% DMSO).2) Deliver cofactors (1.5 mM CaCl2, 16 ug/mL Calmodulin, 2 mM MnCl2) to the substrate solution above.3) Deliver indicated kinase into the substrate solution and gently mix4) Deliver varying concentrations of test compound in DMSO into the kinase reaction mixture.5) Deliver 33P-ATP (specific activity 0.01 uCi/uL final) into the reaction mixture to initiate the reaction.6) Incubate kinase reaction for 120 min at room temperature.7) Reactions are spotted onto P81 ion exchange filter paper (Whatman #3698-915)8) Unbound phosphate is removed by washing filters extensively in 0.75% phosphoric acid.9) 33P signal was determined using Typhoon phosphorimagers (GE Healthcare).	B	Cc1ccc2[nH]ccc2c1-c1nc(C(N)=O)c(-c2ccc(N3CCNC(C)(C)C3)cc2)o1		CHEMBL3970921	=	IC50	nM	13.57	CHEMBL4722	Homo sapiens	IC50	nM	13.57
327659	17706385	CHEMBL3887267	Inhibition Assay: Kinase assays were performed at Reaction Biology Corp., Malvern, Pa., USA, using the following general procedure:1) Prepare indicated substrate in freshly prepared Base Reaction Buffer (20 mM Hepes pH 7.5, 10 mM MgCl2, 1 mM EGTA, 0.02% Brij35, 0.02 mg/ml BSA, 0.1 mM Na3VO4, 2 mM DTT, 1% DMSO).2) Deliver cofactors (1.5 mM CaCl2, 16 ug/mL Calmodulin, 2 mM MnCl2) to the substrate solution above.3) Deliver indicated kinase into the substrate solution and gently mix4) Deliver varying concentrations of test compound in DMSO into the kinase reaction mixture.5) Deliver 33P-ATP (specific activity 0.01 uCi/uL final) into the reaction mixture to initiate the reaction.6) Incubate kinase reaction for 120 min at room temperature.7) Reactions are spotted onto P81 ion exchange filter paper (Whatman #3698-915)8) Unbound phosphate is removed by washing filters extensively in 0.75% phosphoric acid.9) 33P signal was determined using Typhoon phosphorimagers (GE Healthcare).	B	CC1(C)CN(c2ccc(-c3oc(-c4ccc(F)c5[nH]ccc45)nc3C(N)=O)cc2)CCN1		CHEMBL3932362	=	IC50	nM	19.36	CHEMBL4722	Homo sapiens	IC50	nM	19.36
327660	17706386	CHEMBL3887267	Inhibition Assay: Kinase assays were performed at Reaction Biology Corp., Malvern, Pa., USA, using the following general procedure:1) Prepare indicated substrate in freshly prepared Base Reaction Buffer (20 mM Hepes pH 7.5, 10 mM MgCl2, 1 mM EGTA, 0.02% Brij35, 0.02 mg/ml BSA, 0.1 mM Na3VO4, 2 mM DTT, 1% DMSO).2) Deliver cofactors (1.5 mM CaCl2, 16 ug/mL Calmodulin, 2 mM MnCl2) to the substrate solution above.3) Deliver indicated kinase into the substrate solution and gently mix4) Deliver varying concentrations of test compound in DMSO into the kinase reaction mixture.5) Deliver 33P-ATP (specific activity 0.01 uCi/uL final) into the reaction mixture to initiate the reaction.6) Incubate kinase reaction for 120 min at room temperature.7) Reactions are spotted onto P81 ion exchange filter paper (Whatman #3698-915)8) Unbound phosphate is removed by washing filters extensively in 0.75% phosphoric acid.9) 33P signal was determined using Typhoon phosphorimagers (GE Healthcare).	B	CC1(C)CN(c2ccc(-c3oc(-c4ccc(Cl)c5[nH]ccc45)nc3C(N)=O)cc2)CCN1		CHEMBL3959866	=	IC50	nM	34.04	CHEMBL4722	Homo sapiens	IC50	nM	34.04
327661	17706387	CHEMBL3887267	Inhibition Assay: Kinase assays were performed at Reaction Biology Corp., Malvern, Pa., USA, using the following general procedure:1) Prepare indicated substrate in freshly prepared Base Reaction Buffer (20 mM Hepes pH 7.5, 10 mM MgCl2, 1 mM EGTA, 0.02% Brij35, 0.02 mg/ml BSA, 0.1 mM Na3VO4, 2 mM DTT, 1% DMSO).2) Deliver cofactors (1.5 mM CaCl2, 16 ug/mL Calmodulin, 2 mM MnCl2) to the substrate solution above.3) Deliver indicated kinase into the substrate solution and gently mix4) Deliver varying concentrations of test compound in DMSO into the kinase reaction mixture.5) Deliver 33P-ATP (specific activity 0.01 uCi/uL final) into the reaction mixture to initiate the reaction.6) Incubate kinase reaction for 120 min at room temperature.7) Reactions are spotted onto P81 ion exchange filter paper (Whatman #3698-915)8) Unbound phosphate is removed by washing filters extensively in 0.75% phosphoric acid.9) 33P signal was determined using Typhoon phosphorimagers (GE Healthcare).	B	COc1ccc(-c2nc(C(N)=O)c(-c3ccc(N4CCNC(C)(C)C4)cc3)o2)c2cc[nH]c12		CHEMBL3923418	=	IC50	nM	20.53	CHEMBL4722	Homo sapiens	IC50	nM	20.53
327662	17706388	CHEMBL3887267	Inhibition Assay: Kinase assays were performed at Reaction Biology Corp., Malvern, Pa., USA, using the following general procedure:1) Prepare indicated substrate in freshly prepared Base Reaction Buffer (20 mM Hepes pH 7.5, 10 mM MgCl2, 1 mM EGTA, 0.02% Brij35, 0.02 mg/ml BSA, 0.1 mM Na3VO4, 2 mM DTT, 1% DMSO).2) Deliver cofactors (1.5 mM CaCl2, 16 ug/mL Calmodulin, 2 mM MnCl2) to the substrate solution above.3) Deliver indicated kinase into the substrate solution and gently mix4) Deliver varying concentrations of test compound in DMSO into the kinase reaction mixture.5) Deliver 33P-ATP (specific activity 0.01 uCi/uL final) into the reaction mixture to initiate the reaction.6) Incubate kinase reaction for 120 min at room temperature.7) Reactions are spotted onto P81 ion exchange filter paper (Whatman #3698-915)8) Unbound phosphate is removed by washing filters extensively in 0.75% phosphoric acid.9) 33P signal was determined using Typhoon phosphorimagers (GE Healthcare).	B	Cc1cc(C)c2[nH]ccc2c1-c1nc(C(N)=O)c(-c2ccc(N3CCNC(C)(C)C3)cc2)o1		CHEMBL3954570	=	IC50	nM	88.4	CHEMBL4722	Homo sapiens	IC50	nM	88.4
327663	17706389	CHEMBL3887267	Inhibition Assay: Kinase assays were performed at Reaction Biology Corp., Malvern, Pa., USA, using the following general procedure:1) Prepare indicated substrate in freshly prepared Base Reaction Buffer (20 mM Hepes pH 7.5, 10 mM MgCl2, 1 mM EGTA, 0.02% Brij35, 0.02 mg/ml BSA, 0.1 mM Na3VO4, 2 mM DTT, 1% DMSO).2) Deliver cofactors (1.5 mM CaCl2, 16 ug/mL Calmodulin, 2 mM MnCl2) to the substrate solution above.3) Deliver indicated kinase into the substrate solution and gently mix4) Deliver varying concentrations of test compound in DMSO into the kinase reaction mixture.5) Deliver 33P-ATP (specific activity 0.01 uCi/uL final) into the reaction mixture to initiate the reaction.6) Incubate kinase reaction for 120 min at room temperature.7) Reactions are spotted onto P81 ion exchange filter paper (Whatman #3698-915)8) Unbound phosphate is removed by washing filters extensively in 0.75% phosphoric acid.9) 33P signal was determined using Typhoon phosphorimagers (GE Healthcare).	B	Cc1cc(F)c2[nH]ccc2c1-c1nc(C(N)=O)c(-c2ccc(N3CCNC(C)(C)C3)cc2)o1		CHEMBL3917983	=	IC50	nM	42.54	CHEMBL4722	Homo sapiens	IC50	nM	42.54
327664	17706390	CHEMBL3887267	Inhibition Assay: Kinase assays were performed at Reaction Biology Corp., Malvern, Pa., USA, using the following general procedure:1) Prepare indicated substrate in freshly prepared Base Reaction Buffer (20 mM Hepes pH 7.5, 10 mM MgCl2, 1 mM EGTA, 0.02% Brij35, 0.02 mg/ml BSA, 0.1 mM Na3VO4, 2 mM DTT, 1% DMSO).2) Deliver cofactors (1.5 mM CaCl2, 16 ug/mL Calmodulin, 2 mM MnCl2) to the substrate solution above.3) Deliver indicated kinase into the substrate solution and gently mix4) Deliver varying concentrations of test compound in DMSO into the kinase reaction mixture.5) Deliver 33P-ATP (specific activity 0.01 uCi/uL final) into the reaction mixture to initiate the reaction.6) Incubate kinase reaction for 120 min at room temperature.7) Reactions are spotted onto P81 ion exchange filter paper (Whatman #3698-915)8) Unbound phosphate is removed by washing filters extensively in 0.75% phosphoric acid.9) 33P signal was determined using Typhoon phosphorimagers (GE Healthcare).	B	Cc1c[nH]c2cccc(-c3nc(C(N)=O)c(-c4ccc(N5CCNC(C)(C)C5)cc4)o3)c12		CHEMBL3945870	=	IC50	nM	271.0	CHEMBL4722	Homo sapiens	IC50	nM	271.0
327665	17706391	CHEMBL3887267	Inhibition Assay: Kinase assays were performed at Reaction Biology Corp., Malvern, Pa., USA, using the following general procedure:1) Prepare indicated substrate in freshly prepared Base Reaction Buffer (20 mM Hepes pH 7.5, 10 mM MgCl2, 1 mM EGTA, 0.02% Brij35, 0.02 mg/ml BSA, 0.1 mM Na3VO4, 2 mM DTT, 1% DMSO).2) Deliver cofactors (1.5 mM CaCl2, 16 ug/mL Calmodulin, 2 mM MnCl2) to the substrate solution above.3) Deliver indicated kinase into the substrate solution and gently mix4) Deliver varying concentrations of test compound in DMSO into the kinase reaction mixture.5) Deliver 33P-ATP (specific activity 0.01 uCi/uL final) into the reaction mixture to initiate the reaction.6) Incubate kinase reaction for 120 min at room temperature.7) Reactions are spotted onto P81 ion exchange filter paper (Whatman #3698-915)8) Unbound phosphate is removed by washing filters extensively in 0.75% phosphoric acid.9) 33P signal was determined using Typhoon phosphorimagers (GE Healthcare).	B	CCc1ccc(-c2nc(C(N)=O)c(-c3ccc(N4CCNC(C)(C)C4)cc3)o2)c2cc[nH]c12		CHEMBL3957869	=	IC50	nM	74.3	CHEMBL4722	Homo sapiens	IC50	nM	74.3
327666	17706392	CHEMBL3887267	Inhibition Assay: Kinase assays were performed at Reaction Biology Corp., Malvern, Pa., USA, using the following general procedure:1) Prepare indicated substrate in freshly prepared Base Reaction Buffer (20 mM Hepes pH 7.5, 10 mM MgCl2, 1 mM EGTA, 0.02% Brij35, 0.02 mg/ml BSA, 0.1 mM Na3VO4, 2 mM DTT, 1% DMSO).2) Deliver cofactors (1.5 mM CaCl2, 16 ug/mL Calmodulin, 2 mM MnCl2) to the substrate solution above.3) Deliver indicated kinase into the substrate solution and gently mix4) Deliver varying concentrations of test compound in DMSO into the kinase reaction mixture.5) Deliver 33P-ATP (specific activity 0.01 uCi/uL final) into the reaction mixture to initiate the reaction.6) Incubate kinase reaction for 120 min at room temperature.7) Reactions are spotted onto P81 ion exchange filter paper (Whatman #3698-915)8) Unbound phosphate is removed by washing filters extensively in 0.75% phosphoric acid.9) 33P signal was determined using Typhoon phosphorimagers (GE Healthcare).	B	CC1(C)CN(c2ccc(-c3oc(-c4cccc5[nH]ccc45)nc3C(N)=O)cc2)CCN1		CHEMBL3956504	=	IC50	nM	46.25	CHEMBL4722	Homo sapiens	IC50	nM	46.25
327667	17706393	CHEMBL3887267	Inhibition Assay: Kinase assays were performed at Reaction Biology Corp., Malvern, Pa., USA, using the following general procedure:1) Prepare indicated substrate in freshly prepared Base Reaction Buffer (20 mM Hepes pH 7.5, 10 mM MgCl2, 1 mM EGTA, 0.02% Brij35, 0.02 mg/ml BSA, 0.1 mM Na3VO4, 2 mM DTT, 1% DMSO).2) Deliver cofactors (1.5 mM CaCl2, 16 ug/mL Calmodulin, 2 mM MnCl2) to the substrate solution above.3) Deliver indicated kinase into the substrate solution and gently mix4) Deliver varying concentrations of test compound in DMSO into the kinase reaction mixture.5) Deliver 33P-ATP (specific activity 0.01 uCi/uL final) into the reaction mixture to initiate the reaction.6) Incubate kinase reaction for 120 min at room temperature.7) Reactions are spotted onto P81 ion exchange filter paper (Whatman #3698-915)8) Unbound phosphate is removed by washing filters extensively in 0.75% phosphoric acid.9) 33P signal was determined using Typhoon phosphorimagers (GE Healthcare).	B	CC1(C)CN(c2ccc(-c3oc(-c4ccc(C(F)(F)F)c5[nH]ccc45)nc3C(N)=O)cc2)CCN1		CHEMBL3928949	=	IC50	nM	16.0	CHEMBL4722	Homo sapiens	IC50	nM	16.0
363848	17739222	CHEMBL3887927	Aurora-2 Kinase Biochemical Assay: The kinase buffer was composed of 50 mM HEPES, pH 7.0, 10 mM MnCl2, 1 mM DTT, 3 microM Na3VO4, and 0.2 mg/mL BSA. The kinase assay was run with an enzyme concentration of 2.5 nM, 10 microM ATP, 1 nM 33P-γ-ATP, and 8 microM substrate, composed of 4 LRRWSLG repeats.	B	CN1CCN(c2ccc(C(=O)Nc3n[nH]c4ccc(Cc5cc(F)cc(F)c5)cc34)c(NC3CCOCC3)c2)CC1		CHEMBL1983268	=	IC50	nM	338.0	CHEMBL4722	Homo sapiens	IC50	nM	338.0
363849	17739223	CHEMBL3887927	Aurora-2 Kinase Biochemical Assay: The kinase buffer was composed of 50 mM HEPES, pH 7.0, 10 mM MnCl2, 1 mM DTT, 3 microM Na3VO4, and 0.2 mg/mL BSA. The kinase assay was run with an enzyme concentration of 2.5 nM, 10 microM ATP, 1 nM 33P-γ-ATP, and 8 microM substrate, composed of 4 LRRWSLG repeats.	B	CN1CCN(c2ccc(C(=O)Nc3n[nH]c4ccc(Cc5cc(F)cc(F)c5)cc34)cc2)CC1		CHEMBL3672894	=	IC50	nM	484.0	CHEMBL4722	Homo sapiens	IC50	nM	484.0
363850	17739224	CHEMBL3887927	Aurora-2 Kinase Biochemical Assay: The kinase buffer was composed of 50 mM HEPES, pH 7.0, 10 mM MnCl2, 1 mM DTT, 3 microM Na3VO4, and 0.2 mg/mL BSA. The kinase assay was run with an enzyme concentration of 2.5 nM, 10 microM ATP, 1 nM 33P-γ-ATP, and 8 microM substrate, composed of 4 LRRWSLG repeats.	B	COCCNc1cc(N2CCN(C)CC2)ccc1C(=O)Nc1n[nH]c2ccc(Cc3cc(F)cc(F)c3)cc12		CHEMBL3672895	=	IC50	nM	568.0	CHEMBL4722	Homo sapiens	IC50	nM	568.0
363851	17739225	CHEMBL3887927	Aurora-2 Kinase Biochemical Assay: The kinase buffer was composed of 50 mM HEPES, pH 7.0, 10 mM MnCl2, 1 mM DTT, 3 microM Na3VO4, and 0.2 mg/mL BSA. The kinase assay was run with an enzyme concentration of 2.5 nM, 10 microM ATP, 1 nM 33P-γ-ATP, and 8 microM substrate, composed of 4 LRRWSLG repeats.	B	CN1CCN(c2ccc(C(=O)Nc3n[nH]c4ccc(Cc5cc(F)cc(F)c5)cc34)c(NC3CCCCC3)c2)CC1		CHEMBL3672896	=	IC50	nM	3234.0	CHEMBL4722	Homo sapiens	IC50	nM	3234.0
371050	17745672	CHEMBL3888080	In Vitro Aurora A Activity Assay (DiscoverX): Reactions were carried out at room temperature in 15 mM HEPES buffer (pH 7.4) containing 20 mM NaCl, 1 mM EGTA, 0.02% Tween 20, 10 mM MgCl2, 5% (v/v) DMSO, and 2.3 nM Aurora A Inhibitor was added to the mixture, and the reaction was initiated by the addition of 75 uM ATP and 2 mM peptide substrate. All kinetic assays were performed in 384-well plates using a Wallac Envision 2102 plate reader (Perkin Elmer).	B	O=C(O)c1ccc(Nc2nccc(Nc3ccccc3C(=O)O)n2)cc1		CHEMBL2170592	=	IC50	nM	6.1	CHEMBL4722	Homo sapiens	IC50	nM	6.1
371051	17745673	CHEMBL3888080	In Vitro Aurora A Activity Assay (DiscoverX): Reactions were carried out at room temperature in 15 mM HEPES buffer (pH 7.4) containing 20 mM NaCl, 1 mM EGTA, 0.02% Tween 20, 10 mM MgCl2, 5% (v/v) DMSO, and 2.3 nM Aurora A Inhibitor was added to the mixture, and the reaction was initiated by the addition of 75 uM ATP and 2 mM peptide substrate. All kinetic assays were performed in 384-well plates using a Wallac Envision 2102 plate reader (Perkin Elmer).	B	NC(=O)c1ccccc1Nc1nccc(Nc2ccccc2C(=O)O)n1		CHEMBL2170593	=	IC50	nM	9000.0	CHEMBL4722	Homo sapiens	IC50	nM	9000.0
371052	17745674	CHEMBL3888080	In Vitro Aurora A Activity Assay (DiscoverX): Reactions were carried out at room temperature in 15 mM HEPES buffer (pH 7.4) containing 20 mM NaCl, 1 mM EGTA, 0.02% Tween 20, 10 mM MgCl2, 5% (v/v) DMSO, and 2.3 nM Aurora A Inhibitor was added to the mixture, and the reaction was initiated by the addition of 75 uM ATP and 2 mM peptide substrate. All kinetic assays were performed in 384-well plates using a Wallac Envision 2102 plate reader (Perkin Elmer).	B	O=C(O)c1ccccc1Nc1ccnc(Nc2ccccc2)n1		CHEMBL244839	=	IC50	nM	79.4	CHEMBL4722	Homo sapiens	IC50	nM	79.4
371053	17745675	CHEMBL3888080	In Vitro Aurora A Activity Assay (DiscoverX): Reactions were carried out at room temperature in 15 mM HEPES buffer (pH 7.4) containing 20 mM NaCl, 1 mM EGTA, 0.02% Tween 20, 10 mM MgCl2, 5% (v/v) DMSO, and 2.3 nM Aurora A Inhibitor was added to the mixture, and the reaction was initiated by the addition of 75 uM ATP and 2 mM peptide substrate. All kinetic assays were performed in 384-well plates using a Wallac Envision 2102 plate reader (Perkin Elmer).	B	O=C(O)c1ccccc1Nc1ccnc(Nc2ccc(N3CCOCC3)cc2)n1		CHEMBL394816	=	IC50	nM	57.6	CHEMBL4722	Homo sapiens	IC50	nM	57.6
371054	17745676	CHEMBL3888080	In Vitro Aurora A Activity Assay (DiscoverX): Reactions were carried out at room temperature in 15 mM HEPES buffer (pH 7.4) containing 20 mM NaCl, 1 mM EGTA, 0.02% Tween 20, 10 mM MgCl2, 5% (v/v) DMSO, and 2.3 nM Aurora A Inhibitor was added to the mixture, and the reaction was initiated by the addition of 75 uM ATP and 2 mM peptide substrate. All kinetic assays were performed in 384-well plates using a Wallac Envision 2102 plate reader (Perkin Elmer).	B	O=C(O)c1ccccc1Nc1ccnc(Nc2ccccc2C(=O)O)n1		CHEMBL2170594	=	IC50	nM	31300.0	CHEMBL4722	Homo sapiens	IC50	nM	31300.0
371055	17745677	CHEMBL3888080	In Vitro Aurora A Activity Assay (DiscoverX): Reactions were carried out at room temperature in 15 mM HEPES buffer (pH 7.4) containing 20 mM NaCl, 1 mM EGTA, 0.02% Tween 20, 10 mM MgCl2, 5% (v/v) DMSO, and 2.3 nM Aurora A Inhibitor was added to the mixture, and the reaction was initiated by the addition of 75 uM ATP and 2 mM peptide substrate. All kinetic assays were performed in 384-well plates using a Wallac Envision 2102 plate reader (Perkin Elmer).	B	COC(=O)c1ccc(Nc2nccc(Nc3ccccc3C(=O)OC)n2)cc1		CHEMBL2170595	=	IC50	nM	24600.0	CHEMBL4722	Homo sapiens	IC50	nM	24600.0
371056	17745678	CHEMBL3888080	In Vitro Aurora A Activity Assay (DiscoverX): Reactions were carried out at room temperature in 15 mM HEPES buffer (pH 7.4) containing 20 mM NaCl, 1 mM EGTA, 0.02% Tween 20, 10 mM MgCl2, 5% (v/v) DMSO, and 2.3 nM Aurora A Inhibitor was added to the mixture, and the reaction was initiated by the addition of 75 uM ATP and 2 mM peptide substrate. All kinetic assays were performed in 384-well plates using a Wallac Envision 2102 plate reader (Perkin Elmer).	B	c1ccc(Nc2ccnc(Nc3ccccc3)n2)cc1		CHEMBL578061	=	IC50	nM	423.0	CHEMBL4722	Homo sapiens	IC50	nM	423.0
371057	17745679	CHEMBL3888080	In Vitro Aurora A Activity Assay (DiscoverX): Reactions were carried out at room temperature in 15 mM HEPES buffer (pH 7.4) containing 20 mM NaCl, 1 mM EGTA, 0.02% Tween 20, 10 mM MgCl2, 5% (v/v) DMSO, and 2.3 nM Aurora A Inhibitor was added to the mixture, and the reaction was initiated by the addition of 75 uM ATP and 2 mM peptide substrate. All kinetic assays were performed in 384-well plates using a Wallac Envision 2102 plate reader (Perkin Elmer).	B	NC(=O)c1ccccc1Nc1nccc(Nc2ccccc2)n1		CHEMBL3962346	=	IC50	nM	38.2	CHEMBL4722	Homo sapiens	IC50	nM	38.2
371058	17745680	CHEMBL3888080	In Vitro Aurora A Activity Assay (DiscoverX): Reactions were carried out at room temperature in 15 mM HEPES buffer (pH 7.4) containing 20 mM NaCl, 1 mM EGTA, 0.02% Tween 20, 10 mM MgCl2, 5% (v/v) DMSO, and 2.3 nM Aurora A Inhibitor was added to the mixture, and the reaction was initiated by the addition of 75 uM ATP and 2 mM peptide substrate. All kinetic assays were performed in 384-well plates using a Wallac Envision 2102 plate reader (Perkin Elmer).	B	O=C(O)c1ccc(Nc2nccc(Nc3ccccc3)n2)cc1		CHEMBL2170597	=	IC50	nM	10.0	CHEMBL4722	Homo sapiens	IC50	nM	10.0
371059	17745681	CHEMBL3888080	In Vitro Aurora A Activity Assay (DiscoverX): Reactions were carried out at room temperature in 15 mM HEPES buffer (pH 7.4) containing 20 mM NaCl, 1 mM EGTA, 0.02% Tween 20, 10 mM MgCl2, 5% (v/v) DMSO, and 2.3 nM Aurora A Inhibitor was added to the mixture, and the reaction was initiated by the addition of 75 uM ATP and 2 mM peptide substrate. All kinetic assays were performed in 384-well plates using a Wallac Envision 2102 plate reader (Perkin Elmer).	B	O=C(O)c1ccc(Nc2ccnc(Nc3ccc(C(=O)O)cc3)n2)cc1		CHEMBL2170598	=	IC50	nM	256.0	CHEMBL4722	Homo sapiens	IC50	nM	256.0
371060	17745682	CHEMBL3888080	In Vitro Aurora A Activity Assay (DiscoverX): Reactions were carried out at room temperature in 15 mM HEPES buffer (pH 7.4) containing 20 mM NaCl, 1 mM EGTA, 0.02% Tween 20, 10 mM MgCl2, 5% (v/v) DMSO, and 2.3 nM Aurora A Inhibitor was added to the mixture, and the reaction was initiated by the addition of 75 uM ATP and 2 mM peptide substrate. All kinetic assays were performed in 384-well plates using a Wallac Envision 2102 plate reader (Perkin Elmer).	B	Cc1cnc(Nc2ccc(C(=O)O)cc2)nc1Nc1ccccc1C(=O)O		CHEMBL2170599	=	IC50	nM	281.0	CHEMBL4722	Homo sapiens	IC50	nM	281.0
371061	17745683	CHEMBL3888080	In Vitro Aurora A Activity Assay (DiscoverX): Reactions were carried out at room temperature in 15 mM HEPES buffer (pH 7.4) containing 20 mM NaCl, 1 mM EGTA, 0.02% Tween 20, 10 mM MgCl2, 5% (v/v) DMSO, and 2.3 nM Aurora A Inhibitor was added to the mixture, and the reaction was initiated by the addition of 75 uM ATP and 2 mM peptide substrate. All kinetic assays were performed in 384-well plates using a Wallac Envision 2102 plate reader (Perkin Elmer).	B	Cc1cc(Nc2ccccc2C(=O)O)nc(Nc2ccc(C(=O)O)cc2)n1		CHEMBL2170600	>	IC50	nM	50000.0	CHEMBL4722	Homo sapiens	IC50	nM	50000.0
371062	17745684	CHEMBL3888080	In Vitro Aurora A Activity Assay (DiscoverX): Reactions were carried out at room temperature in 15 mM HEPES buffer (pH 7.4) containing 20 mM NaCl, 1 mM EGTA, 0.02% Tween 20, 10 mM MgCl2, 5% (v/v) DMSO, and 2.3 nM Aurora A Inhibitor was added to the mixture, and the reaction was initiated by the addition of 75 uM ATP and 2 mM peptide substrate. All kinetic assays were performed in 384-well plates using a Wallac Envision 2102 plate reader (Perkin Elmer).	B	O=C(O)c1ccc(Nc2nccc(Nc3ccccc3Cl)n2)cc1		CHEMBL2170601	=	IC50	nM	2.5	CHEMBL4722	Homo sapiens	IC50	nM	2.5
371063	17745685	CHEMBL3888080	In Vitro Aurora A Activity Assay (DiscoverX): Reactions were carried out at room temperature in 15 mM HEPES buffer (pH 7.4) containing 20 mM NaCl, 1 mM EGTA, 0.02% Tween 20, 10 mM MgCl2, 5% (v/v) DMSO, and 2.3 nM Aurora A Inhibitor was added to the mixture, and the reaction was initiated by the addition of 75 uM ATP and 2 mM peptide substrate. All kinetic assays were performed in 384-well plates using a Wallac Envision 2102 plate reader (Perkin Elmer).	B	O=C(O)c1ccccc1Nc1nc(Nc2ccccc2)ncc1F		CHEMBL244793	=	IC50	nM	11.3	CHEMBL4722	Homo sapiens	IC50	nM	11.3
371064	17745686	CHEMBL3888080	In Vitro Aurora A Activity Assay (DiscoverX): Reactions were carried out at room temperature in 15 mM HEPES buffer (pH 7.4) containing 20 mM NaCl, 1 mM EGTA, 0.02% Tween 20, 10 mM MgCl2, 5% (v/v) DMSO, and 2.3 nM Aurora A Inhibitor was added to the mixture, and the reaction was initiated by the addition of 75 uM ATP and 2 mM peptide substrate. All kinetic assays were performed in 384-well plates using a Wallac Envision 2102 plate reader (Perkin Elmer).	B	O=C(O)c1ccc(Nc2ncc(F)c(Nc3ccccc3C(=O)O)n2)cc1		CHEMBL2170602	=	IC50	nM	3.9	CHEMBL4722	Homo sapiens	IC50	nM	3.9
371065	17745687	CHEMBL3888080	In Vitro Aurora A Activity Assay (DiscoverX): Reactions were carried out at room temperature in 15 mM HEPES buffer (pH 7.4) containing 20 mM NaCl, 1 mM EGTA, 0.02% Tween 20, 10 mM MgCl2, 5% (v/v) DMSO, and 2.3 nM Aurora A Inhibitor was added to the mixture, and the reaction was initiated by the addition of 75 uM ATP and 2 mM peptide substrate. All kinetic assays were performed in 384-well plates using a Wallac Envision 2102 plate reader (Perkin Elmer).	B	O=C(O)c1ccc(Nc2ncc(F)c(Nc3ccccc3Cl)n2)cc1		CHEMBL2170419	=	IC50	nM	0.8	CHEMBL4722	Homo sapiens	IC50	nM	0.8
371066	17745688	CHEMBL3888080	In Vitro Aurora A Activity Assay (DiscoverX): Reactions were carried out at room temperature in 15 mM HEPES buffer (pH 7.4) containing 20 mM NaCl, 1 mM EGTA, 0.02% Tween 20, 10 mM MgCl2, 5% (v/v) DMSO, and 2.3 nM Aurora A Inhibitor was added to the mixture, and the reaction was initiated by the addition of 75 uM ATP and 2 mM peptide substrate. All kinetic assays were performed in 384-well plates using a Wallac Envision 2102 plate reader (Perkin Elmer).	B	Fc1cnc(Nc2ccccc2)nc1Nc1ccccc1Cl		CHEMBL2170420	=	IC50	nM	19.9	CHEMBL4722	Homo sapiens	IC50	nM	19.9
371067	17745689	CHEMBL3888080	In Vitro Aurora A Activity Assay (DiscoverX): Reactions were carried out at room temperature in 15 mM HEPES buffer (pH 7.4) containing 20 mM NaCl, 1 mM EGTA, 0.02% Tween 20, 10 mM MgCl2, 5% (v/v) DMSO, and 2.3 nM Aurora A Inhibitor was added to the mixture, and the reaction was initiated by the addition of 75 uM ATP and 2 mM peptide substrate. All kinetic assays were performed in 384-well plates using a Wallac Envision 2102 plate reader (Perkin Elmer).	B	O=C(O)c1cccc(Nc2nccc(Nc3ccccc3C(=O)O)n2)c1		CHEMBL2170421	=	IC50	nM	18.3	CHEMBL4722	Homo sapiens	IC50	nM	18.3
371068	17745690	CHEMBL3888080	In Vitro Aurora A Activity Assay (DiscoverX): Reactions were carried out at room temperature in 15 mM HEPES buffer (pH 7.4) containing 20 mM NaCl, 1 mM EGTA, 0.02% Tween 20, 10 mM MgCl2, 5% (v/v) DMSO, and 2.3 nM Aurora A Inhibitor was added to the mixture, and the reaction was initiated by the addition of 75 uM ATP and 2 mM peptide substrate. All kinetic assays were performed in 384-well plates using a Wallac Envision 2102 plate reader (Perkin Elmer).	B	O=C(O)c1cccc(Nc2ncc(F)c(Nc3ccccc3C(=O)O)n2)c1		CHEMBL2170422	=	IC50	nM	5.1	CHEMBL4722	Homo sapiens	IC50	nM	5.1
371069	17745691	CHEMBL3888080	In Vitro Aurora A Activity Assay (DiscoverX): Reactions were carried out at room temperature in 15 mM HEPES buffer (pH 7.4) containing 20 mM NaCl, 1 mM EGTA, 0.02% Tween 20, 10 mM MgCl2, 5% (v/v) DMSO, and 2.3 nM Aurora A Inhibitor was added to the mixture, and the reaction was initiated by the addition of 75 uM ATP and 2 mM peptide substrate. All kinetic assays were performed in 384-well plates using a Wallac Envision 2102 plate reader (Perkin Elmer).	B	O=C(O)c1ccc(Nc2nc(Cl)c(Cl)c(Nc3ccccc3C(=O)O)n2)cc1		CHEMBL2170423	=	IC50	nM	1490.0	CHEMBL4722	Homo sapiens	IC50	nM	1490.0
371070	17745692	CHEMBL3888080	In Vitro Aurora A Activity Assay (DiscoverX): Reactions were carried out at room temperature in 15 mM HEPES buffer (pH 7.4) containing 20 mM NaCl, 1 mM EGTA, 0.02% Tween 20, 10 mM MgCl2, 5% (v/v) DMSO, and 2.3 nM Aurora A Inhibitor was added to the mixture, and the reaction was initiated by the addition of 75 uM ATP and 2 mM peptide substrate. All kinetic assays were performed in 384-well plates using a Wallac Envision 2102 plate reader (Perkin Elmer).	B	O=C(O)c1ccc(Nc2ncc(Cl)c(Nc3ccccc3C(=O)O)n2)cc1		CHEMBL2170424	=	IC50	nM	3.17	CHEMBL4722	Homo sapiens	IC50	nM	3.17
371071	17745693	CHEMBL3888080	In Vitro Aurora A Activity Assay (DiscoverX): Reactions were carried out at room temperature in 15 mM HEPES buffer (pH 7.4) containing 20 mM NaCl, 1 mM EGTA, 0.02% Tween 20, 10 mM MgCl2, 5% (v/v) DMSO, and 2.3 nM Aurora A Inhibitor was added to the mixture, and the reaction was initiated by the addition of 75 uM ATP and 2 mM peptide substrate. All kinetic assays were performed in 384-well plates using a Wallac Envision 2102 plate reader (Perkin Elmer).	B	Nc1cnc(Nc2ccc(C(=O)O)cc2)nc1Nc1ccccc1C(=O)O		CHEMBL2170425	=	IC50	nM	376.0	CHEMBL4722	Homo sapiens	IC50	nM	376.0
371072	17745694	CHEMBL3888080	In Vitro Aurora A Activity Assay (DiscoverX): Reactions were carried out at room temperature in 15 mM HEPES buffer (pH 7.4) containing 20 mM NaCl, 1 mM EGTA, 0.02% Tween 20, 10 mM MgCl2, 5% (v/v) DMSO, and 2.3 nM Aurora A Inhibitor was added to the mixture, and the reaction was initiated by the addition of 75 uM ATP and 2 mM peptide substrate. All kinetic assays were performed in 384-well plates using a Wallac Envision 2102 plate reader (Perkin Elmer).	B	Nc1cc(Nc2ccccc2C(=O)O)nc(Nc2ccc(C(=O)O)cc2)n1		CHEMBL2170426	>	IC50	nM	50000.0	CHEMBL4722	Homo sapiens	IC50	nM	50000.0
371073	17745695	CHEMBL3888080	In Vitro Aurora A Activity Assay (DiscoverX): Reactions were carried out at room temperature in 15 mM HEPES buffer (pH 7.4) containing 20 mM NaCl, 1 mM EGTA, 0.02% Tween 20, 10 mM MgCl2, 5% (v/v) DMSO, and 2.3 nM Aurora A Inhibitor was added to the mixture, and the reaction was initiated by the addition of 75 uM ATP and 2 mM peptide substrate. All kinetic assays were performed in 384-well plates using a Wallac Envision 2102 plate reader (Perkin Elmer).	B	O=C(O)c1ccc(Nc2nccc(Nc3ccccc3F)n2)cc1		CHEMBL2170427	=	IC50	nM	3.7	CHEMBL4722	Homo sapiens	IC50	nM	3.7
371074	17745696	CHEMBL3888080	In Vitro Aurora A Activity Assay (DiscoverX): Reactions were carried out at room temperature in 15 mM HEPES buffer (pH 7.4) containing 20 mM NaCl, 1 mM EGTA, 0.02% Tween 20, 10 mM MgCl2, 5% (v/v) DMSO, and 2.3 nM Aurora A Inhibitor was added to the mixture, and the reaction was initiated by the addition of 75 uM ATP and 2 mM peptide substrate. All kinetic assays were performed in 384-well plates using a Wallac Envision 2102 plate reader (Perkin Elmer).	B	FC(F)(F)c1ccccc1Nc1ccnc(Nc2ccccc2)n1		CHEMBL2170428	=	IC50	nM	1773.0	CHEMBL4722	Homo sapiens	IC50	nM	1773.0
371075	17745697	CHEMBL3888080	In Vitro Aurora A Activity Assay (DiscoverX): Reactions were carried out at room temperature in 15 mM HEPES buffer (pH 7.4) containing 20 mM NaCl, 1 mM EGTA, 0.02% Tween 20, 10 mM MgCl2, 5% (v/v) DMSO, and 2.3 nM Aurora A Inhibitor was added to the mixture, and the reaction was initiated by the addition of 75 uM ATP and 2 mM peptide substrate. All kinetic assays were performed in 384-well plates using a Wallac Envision 2102 plate reader (Perkin Elmer).	B	O=C(O)c1ccc(Nc2nccc(Nc3ccc(F)cc3Cl)n2)cc1		CHEMBL2170429	=	IC50	nM	2.0	CHEMBL4722	Homo sapiens	IC50	nM	2.0
371076	17745698	CHEMBL3888080	In Vitro Aurora A Activity Assay (DiscoverX): Reactions were carried out at room temperature in 15 mM HEPES buffer (pH 7.4) containing 20 mM NaCl, 1 mM EGTA, 0.02% Tween 20, 10 mM MgCl2, 5% (v/v) DMSO, and 2.3 nM Aurora A Inhibitor was added to the mixture, and the reaction was initiated by the addition of 75 uM ATP and 2 mM peptide substrate. All kinetic assays were performed in 384-well plates using a Wallac Envision 2102 plate reader (Perkin Elmer).	B	O=C(O)c1ccc(Nc2nccc(Nc3ccc(F)cc3OC(F)(F)F)n2)cc1		CHEMBL3958960	=	IC50	nM	28.0	CHEMBL4722	Homo sapiens	IC50	nM	28.0
371077	17745699	CHEMBL3888080	In Vitro Aurora A Activity Assay (DiscoverX): Reactions were carried out at room temperature in 15 mM HEPES buffer (pH 7.4) containing 20 mM NaCl, 1 mM EGTA, 0.02% Tween 20, 10 mM MgCl2, 5% (v/v) DMSO, and 2.3 nM Aurora A Inhibitor was added to the mixture, and the reaction was initiated by the addition of 75 uM ATP and 2 mM peptide substrate. All kinetic assays were performed in 384-well plates using a Wallac Envision 2102 plate reader (Perkin Elmer).	B	COc1ccccc1Nc1ccnc(Nc2ccc(C(=O)O)cc2)n1		CHEMBL2170431	=	IC50	nM	4.0	CHEMBL4722	Homo sapiens	IC50	nM	4.0
371078	17745700	CHEMBL3888080	In Vitro Aurora A Activity Assay (DiscoverX): Reactions were carried out at room temperature in 15 mM HEPES buffer (pH 7.4) containing 20 mM NaCl, 1 mM EGTA, 0.02% Tween 20, 10 mM MgCl2, 5% (v/v) DMSO, and 2.3 nM Aurora A Inhibitor was added to the mixture, and the reaction was initiated by the addition of 75 uM ATP and 2 mM peptide substrate. All kinetic assays were performed in 384-well plates using a Wallac Envision 2102 plate reader (Perkin Elmer).	B	COc1ccccc1Nc1ccnc(Nc2ccccc2)n1		CHEMBL2170432	=	IC50	nM	46.6	CHEMBL4722	Homo sapiens	IC50	nM	46.6
371079	17745701	CHEMBL3888080	In Vitro Aurora A Activity Assay (DiscoverX): Reactions were carried out at room temperature in 15 mM HEPES buffer (pH 7.4) containing 20 mM NaCl, 1 mM EGTA, 0.02% Tween 20, 10 mM MgCl2, 5% (v/v) DMSO, and 2.3 nM Aurora A Inhibitor was added to the mixture, and the reaction was initiated by the addition of 75 uM ATP and 2 mM peptide substrate. All kinetic assays were performed in 384-well plates using a Wallac Envision 2102 plate reader (Perkin Elmer).	B	N#Cc1ccccc1Nc1ccnc(Nc2ccccc2)n1		CHEMBL2170433	=	IC50	nM	560.0	CHEMBL4722	Homo sapiens	IC50	nM	560.0
371080	17745702	CHEMBL3888080	In Vitro Aurora A Activity Assay (DiscoverX): Reactions were carried out at room temperature in 15 mM HEPES buffer (pH 7.4) containing 20 mM NaCl, 1 mM EGTA, 0.02% Tween 20, 10 mM MgCl2, 5% (v/v) DMSO, and 2.3 nM Aurora A Inhibitor was added to the mixture, and the reaction was initiated by the addition of 75 uM ATP and 2 mM peptide substrate. All kinetic assays were performed in 384-well plates using a Wallac Envision 2102 plate reader (Perkin Elmer).	B	O=C(O)c1ccc(Nc2nccc(Nc3ccccc3C(F)(F)F)n2)cc1		CHEMBL2170434	=	IC50	nM	35.0	CHEMBL4722	Homo sapiens	IC50	nM	35.0
371081	17745703	CHEMBL3888080	In Vitro Aurora A Activity Assay (DiscoverX): Reactions were carried out at room temperature in 15 mM HEPES buffer (pH 7.4) containing 20 mM NaCl, 1 mM EGTA, 0.02% Tween 20, 10 mM MgCl2, 5% (v/v) DMSO, and 2.3 nM Aurora A Inhibitor was added to the mixture, and the reaction was initiated by the addition of 75 uM ATP and 2 mM peptide substrate. All kinetic assays were performed in 384-well plates using a Wallac Envision 2102 plate reader (Perkin Elmer).	B	O=C(O)c1ccc(Nc2nccc(Nc3ccccc3Br)n2)cc1		CHEMBL2170435	=	IC50	nM	2.1	CHEMBL4722	Homo sapiens	IC50	nM	2.1
371082	17745704	CHEMBL3888080	In Vitro Aurora A Activity Assay (DiscoverX): Reactions were carried out at room temperature in 15 mM HEPES buffer (pH 7.4) containing 20 mM NaCl, 1 mM EGTA, 0.02% Tween 20, 10 mM MgCl2, 5% (v/v) DMSO, and 2.3 nM Aurora A Inhibitor was added to the mixture, and the reaction was initiated by the addition of 75 uM ATP and 2 mM peptide substrate. All kinetic assays were performed in 384-well plates using a Wallac Envision 2102 plate reader (Perkin Elmer).	B	O=C(O)Cc1ccc(Nc2nccc(Nc3ccccc3Cl)n2)cc1		CHEMBL2170436	=	IC50	nM	3.3	CHEMBL4722	Homo sapiens	IC50	nM	3.3
371083	17745705	CHEMBL3888080	In Vitro Aurora A Activity Assay (DiscoverX): Reactions were carried out at room temperature in 15 mM HEPES buffer (pH 7.4) containing 20 mM NaCl, 1 mM EGTA, 0.02% Tween 20, 10 mM MgCl2, 5% (v/v) DMSO, and 2.3 nM Aurora A Inhibitor was added to the mixture, and the reaction was initiated by the addition of 75 uM ATP and 2 mM peptide substrate. All kinetic assays were performed in 384-well plates using a Wallac Envision 2102 plate reader (Perkin Elmer).	B	O=C(O)c1ccc(Nc2nccc(Nc3ccccc3Cl)n2)cc1O		CHEMBL2170437	=	IC50	nM	6.6	CHEMBL4722	Homo sapiens	IC50	nM	6.6
371084	17745706	CHEMBL3888080	In Vitro Aurora A Activity Assay (DiscoverX): Reactions were carried out at room temperature in 15 mM HEPES buffer (pH 7.4) containing 20 mM NaCl, 1 mM EGTA, 0.02% Tween 20, 10 mM MgCl2, 5% (v/v) DMSO, and 2.3 nM Aurora A Inhibitor was added to the mixture, and the reaction was initiated by the addition of 75 uM ATP and 2 mM peptide substrate. All kinetic assays were performed in 384-well plates using a Wallac Envision 2102 plate reader (Perkin Elmer).	B	Fc1ccccc1Nc1ccnc(Nc2ccccc2)n1		CHEMBL2170438	=	IC50	nM	284.0	CHEMBL4722	Homo sapiens	IC50	nM	284.0
371085	17745707	CHEMBL3888080	In Vitro Aurora A Activity Assay (DiscoverX): Reactions were carried out at room temperature in 15 mM HEPES buffer (pH 7.4) containing 20 mM NaCl, 1 mM EGTA, 0.02% Tween 20, 10 mM MgCl2, 5% (v/v) DMSO, and 2.3 nM Aurora A Inhibitor was added to the mixture, and the reaction was initiated by the addition of 75 uM ATP and 2 mM peptide substrate. All kinetic assays were performed in 384-well plates using a Wallac Envision 2102 plate reader (Perkin Elmer).	B	O=C(O)c1ccc(Nc2nccc(Nc3ccccc3I)n2)cc1		CHEMBL2170439	=	IC50	nM	35.0	CHEMBL4722	Homo sapiens	IC50	nM	35.0
371086	17745708	CHEMBL3888080	In Vitro Aurora A Activity Assay (DiscoverX): Reactions were carried out at room temperature in 15 mM HEPES buffer (pH 7.4) containing 20 mM NaCl, 1 mM EGTA, 0.02% Tween 20, 10 mM MgCl2, 5% (v/v) DMSO, and 2.3 nM Aurora A Inhibitor was added to the mixture, and the reaction was initiated by the addition of 75 uM ATP and 2 mM peptide substrate. All kinetic assays were performed in 384-well plates using a Wallac Envision 2102 plate reader (Perkin Elmer).	B	N#Cc1ccccc1Nc1ccnc(Nc2ccc(C(=O)O)cc2)n1		CHEMBL2170440	=	IC50	nM	43.0	CHEMBL4722	Homo sapiens	IC50	nM	43.0
371087	17745709	CHEMBL3888080	In Vitro Aurora A Activity Assay (DiscoverX): Reactions were carried out at room temperature in 15 mM HEPES buffer (pH 7.4) containing 20 mM NaCl, 1 mM EGTA, 0.02% Tween 20, 10 mM MgCl2, 5% (v/v) DMSO, and 2.3 nM Aurora A Inhibitor was added to the mixture, and the reaction was initiated by the addition of 75 uM ATP and 2 mM peptide substrate. All kinetic assays were performed in 384-well plates using a Wallac Envision 2102 plate reader (Perkin Elmer).	B	O=C(O)c1cccc(Nc2nccc(Nc3ccccc3Cl)n2)c1		CHEMBL2170441	=	IC50	nM	18.7	CHEMBL4722	Homo sapiens	IC50	nM	18.7
371088	17745710	CHEMBL3888080	In Vitro Aurora A Activity Assay (DiscoverX): Reactions were carried out at room temperature in 15 mM HEPES buffer (pH 7.4) containing 20 mM NaCl, 1 mM EGTA, 0.02% Tween 20, 10 mM MgCl2, 5% (v/v) DMSO, and 2.3 nM Aurora A Inhibitor was added to the mixture, and the reaction was initiated by the addition of 75 uM ATP and 2 mM peptide substrate. All kinetic assays were performed in 384-well plates using a Wallac Envision 2102 plate reader (Perkin Elmer).	B	NC(O)c1ccc(Nc2nccc(Nc3ccccc3Cl)n2)cc1		CHEMBL3971129	=	IC50	nM	30.2	CHEMBL4722	Homo sapiens	IC50	nM	30.2
371089	17745711	CHEMBL3888080	In Vitro Aurora A Activity Assay (DiscoverX): Reactions were carried out at room temperature in 15 mM HEPES buffer (pH 7.4) containing 20 mM NaCl, 1 mM EGTA, 0.02% Tween 20, 10 mM MgCl2, 5% (v/v) DMSO, and 2.3 nM Aurora A Inhibitor was added to the mixture, and the reaction was initiated by the addition of 75 uM ATP and 2 mM peptide substrate. All kinetic assays were performed in 384-well plates using a Wallac Envision 2102 plate reader (Perkin Elmer).	B	O=C(O)c1ccc(Nc2nccc(Nc3ccccc3-c3ccccc3)n2)cc1		CHEMBL2170586	=	IC50	nM	149.0	CHEMBL4722	Homo sapiens	IC50	nM	149.0
371090	17745712	CHEMBL3888080	In Vitro Aurora A Activity Assay (DiscoverX): Reactions were carried out at room temperature in 15 mM HEPES buffer (pH 7.4) containing 20 mM NaCl, 1 mM EGTA, 0.02% Tween 20, 10 mM MgCl2, 5% (v/v) DMSO, and 2.3 nM Aurora A Inhibitor was added to the mixture, and the reaction was initiated by the addition of 75 uM ATP and 2 mM peptide substrate. All kinetic assays were performed in 384-well plates using a Wallac Envision 2102 plate reader (Perkin Elmer).	B	CN(c1ccnc(Nc2ccc(C(=O)O)cc2)n1)c1ccccc1Cl		CHEMBL2170587	=	IC50	nM	8.5	CHEMBL4722	Homo sapiens	IC50	nM	8.5
371091	17745713	CHEMBL3888080	In Vitro Aurora A Activity Assay (DiscoverX): Reactions were carried out at room temperature in 15 mM HEPES buffer (pH 7.4) containing 20 mM NaCl, 1 mM EGTA, 0.02% Tween 20, 10 mM MgCl2, 5% (v/v) DMSO, and 2.3 nM Aurora A Inhibitor was added to the mixture, and the reaction was initiated by the addition of 75 uM ATP and 2 mM peptide substrate. All kinetic assays were performed in 384-well plates using a Wallac Envision 2102 plate reader (Perkin Elmer).	B	CCN(c1ccnc(Nc2ccc(C(=O)O)cc2)n1)c1ccccc1Cl		CHEMBL2170588	=	IC50	nM	50.2	CHEMBL4722	Homo sapiens	IC50	nM	50.2
371092	17745714	CHEMBL3888080	In Vitro Aurora A Activity Assay (DiscoverX): Reactions were carried out at room temperature in 15 mM HEPES buffer (pH 7.4) containing 20 mM NaCl, 1 mM EGTA, 0.02% Tween 20, 10 mM MgCl2, 5% (v/v) DMSO, and 2.3 nM Aurora A Inhibitor was added to the mixture, and the reaction was initiated by the addition of 75 uM ATP and 2 mM peptide substrate. All kinetic assays were performed in 384-well plates using a Wallac Envision 2102 plate reader (Perkin Elmer).	B	O=C(O)c1cccc(Nc2ncc(F)c(Nc3ccccc3Cl)n2)c1		CHEMBL2170589	=	IC50	nM	4.5	CHEMBL4722	Homo sapiens	IC50	nM	4.5
371093	17745715	CHEMBL3888080	In Vitro Aurora A Activity Assay (DiscoverX): Reactions were carried out at room temperature in 15 mM HEPES buffer (pH 7.4) containing 20 mM NaCl, 1 mM EGTA, 0.02% Tween 20, 10 mM MgCl2, 5% (v/v) DMSO, and 2.3 nM Aurora A Inhibitor was added to the mixture, and the reaction was initiated by the addition of 75 uM ATP and 2 mM peptide substrate. All kinetic assays were performed in 384-well plates using a Wallac Envision 2102 plate reader (Perkin Elmer).	B	CN(C)CCNC(=O)c1ccc(Nc2nccc(Nc3ccccc3Cl)n2)cc1		CHEMBL2170591	=	IC50	nM	216.0	CHEMBL4722	Homo sapiens	IC50	nM	216.0
371094	17745716	CHEMBL3888080	In Vitro Aurora A Activity Assay (DiscoverX): Reactions were carried out at room temperature in 15 mM HEPES buffer (pH 7.4) containing 20 mM NaCl, 1 mM EGTA, 0.02% Tween 20, 10 mM MgCl2, 5% (v/v) DMSO, and 2.3 nM Aurora A Inhibitor was added to the mixture, and the reaction was initiated by the addition of 75 uM ATP and 2 mM peptide substrate. All kinetic assays were performed in 384-well plates using a Wallac Envision 2102 plate reader (Perkin Elmer).	B	O=C(NCCN1CCOCC1)c1ccc(Nc2nccc(Nc3ccccc3Cl)n2)cc1		CHEMBL2170590	=	IC50	nM	28.1	CHEMBL4722	Homo sapiens	IC50	nM	28.1
371095	17745717	CHEMBL3888080	In Vitro Aurora A Activity Assay (DiscoverX): Reactions were carried out at room temperature in 15 mM HEPES buffer (pH 7.4) containing 20 mM NaCl, 1 mM EGTA, 0.02% Tween 20, 10 mM MgCl2, 5% (v/v) DMSO, and 2.3 nM Aurora A Inhibitor was added to the mixture, and the reaction was initiated by the addition of 75 uM ATP and 2 mM peptide substrate. All kinetic assays were performed in 384-well plates using a Wallac Envision 2102 plate reader (Perkin Elmer).	B	COCCNC(=O)c1ccc(Nc2nccc(Nc3ccccc3Cl)n2)cc1		CHEMBL2170404	=	IC50	nM	18.0	CHEMBL4722	Homo sapiens	IC50	nM	18.0
371096	17745718	CHEMBL3888080	In Vitro Aurora A Activity Assay (DiscoverX): Reactions were carried out at room temperature in 15 mM HEPES buffer (pH 7.4) containing 20 mM NaCl, 1 mM EGTA, 0.02% Tween 20, 10 mM MgCl2, 5% (v/v) DMSO, and 2.3 nM Aurora A Inhibitor was added to the mixture, and the reaction was initiated by the addition of 75 uM ATP and 2 mM peptide substrate. All kinetic assays were performed in 384-well plates using a Wallac Envision 2102 plate reader (Perkin Elmer).	B	CS(=O)(=O)c1ccc(Nc2nccc(Nc3ccccc3Cl)n2)cc1		CHEMBL2170405	=	IC50	nM	44.9	CHEMBL4722	Homo sapiens	IC50	nM	44.9
371097	17745719	CHEMBL3888080	In Vitro Aurora A Activity Assay (DiscoverX): Reactions were carried out at room temperature in 15 mM HEPES buffer (pH 7.4) containing 20 mM NaCl, 1 mM EGTA, 0.02% Tween 20, 10 mM MgCl2, 5% (v/v) DMSO, and 2.3 nM Aurora A Inhibitor was added to the mixture, and the reaction was initiated by the addition of 75 uM ATP and 2 mM peptide substrate. All kinetic assays were performed in 384-well plates using a Wallac Envision 2102 plate reader (Perkin Elmer).	B	CC(=O)Nc1ccc(Nc2nccc(Nc3ccccc3Cl)n2)cc1		CHEMBL3969926	=	IC50	nM	71.2	CHEMBL4722	Homo sapiens	IC50	nM	71.2
371098	17745720	CHEMBL3888080	In Vitro Aurora A Activity Assay (DiscoverX): Reactions were carried out at room temperature in 15 mM HEPES buffer (pH 7.4) containing 20 mM NaCl, 1 mM EGTA, 0.02% Tween 20, 10 mM MgCl2, 5% (v/v) DMSO, and 2.3 nM Aurora A Inhibitor was added to the mixture, and the reaction was initiated by the addition of 75 uM ATP and 2 mM peptide substrate. All kinetic assays were performed in 384-well plates using a Wallac Envision 2102 plate reader (Perkin Elmer).	B	O=c1[nH]c2ccc(Nc3nccc(Nc4ccccc4Cl)n3)cc2[nH]1		CHEMBL2170407	=	IC50	nM	316.0	CHEMBL4722	Homo sapiens	IC50	nM	316.0
371099	17745721	CHEMBL3888080	In Vitro Aurora A Activity Assay (DiscoverX): Reactions were carried out at room temperature in 15 mM HEPES buffer (pH 7.4) containing 20 mM NaCl, 1 mM EGTA, 0.02% Tween 20, 10 mM MgCl2, 5% (v/v) DMSO, and 2.3 nM Aurora A Inhibitor was added to the mixture, and the reaction was initiated by the addition of 75 uM ATP and 2 mM peptide substrate. All kinetic assays were performed in 384-well plates using a Wallac Envision 2102 plate reader (Perkin Elmer).	B	COc1cc(Nc2nccc(Nc3ccccc3Cl)n2)ccc1C(=O)O		CHEMBL2170408	=	IC50	nM	116.5	CHEMBL4722	Homo sapiens	IC50	nM	116.5
371100	17745722	CHEMBL3888080	In Vitro Aurora A Activity Assay (DiscoverX): Reactions were carried out at room temperature in 15 mM HEPES buffer (pH 7.4) containing 20 mM NaCl, 1 mM EGTA, 0.02% Tween 20, 10 mM MgCl2, 5% (v/v) DMSO, and 2.3 nM Aurora A Inhibitor was added to the mixture, and the reaction was initiated by the addition of 75 uM ATP and 2 mM peptide substrate. All kinetic assays were performed in 384-well plates using a Wallac Envision 2102 plate reader (Perkin Elmer).	B	Clc1ccccc1Nc1ccnc(Nc2ccc(N3CCOCC3)cc2)n1		CHEMBL2170409	=	IC50	nM	27.0	CHEMBL4722	Homo sapiens	IC50	nM	27.0
371101	17745723	CHEMBL3888080	In Vitro Aurora A Activity Assay (DiscoverX): Reactions were carried out at room temperature in 15 mM HEPES buffer (pH 7.4) containing 20 mM NaCl, 1 mM EGTA, 0.02% Tween 20, 10 mM MgCl2, 5% (v/v) DMSO, and 2.3 nM Aurora A Inhibitor was added to the mixture, and the reaction was initiated by the addition of 75 uM ATP and 2 mM peptide substrate. All kinetic assays were performed in 384-well plates using a Wallac Envision 2102 plate reader (Perkin Elmer).	B	NC(=O)c1ccc(Nc2nccc(Nc3ccccc3Cl)n2)cc1		CHEMBL2170442	=	IC50	nM	30.2	CHEMBL4722	Homo sapiens	IC50	nM	30.2
371102	17745724	CHEMBL3888080	In Vitro Aurora A Activity Assay (DiscoverX): Reactions were carried out at room temperature in 15 mM HEPES buffer (pH 7.4) containing 20 mM NaCl, 1 mM EGTA, 0.02% Tween 20, 10 mM MgCl2, 5% (v/v) DMSO, and 2.3 nM Aurora A Inhibitor was added to the mixture, and the reaction was initiated by the addition of 75 uM ATP and 2 mM peptide substrate. All kinetic assays were performed in 384-well plates using a Wallac Envision 2102 plate reader (Perkin Elmer).	B	NS(=O)(=O)c1ccc(Nc2nccc(Nc3ccccc3Cl)n2)cc1		CHEMBL2170410	=	IC50	nM	253.0	CHEMBL4722	Homo sapiens	IC50	nM	253.0
371103	17745725	CHEMBL3888080	In Vitro Aurora A Activity Assay (DiscoverX): Reactions were carried out at room temperature in 15 mM HEPES buffer (pH 7.4) containing 20 mM NaCl, 1 mM EGTA, 0.02% Tween 20, 10 mM MgCl2, 5% (v/v) DMSO, and 2.3 nM Aurora A Inhibitor was added to the mixture, and the reaction was initiated by the addition of 75 uM ATP and 2 mM peptide substrate. All kinetic assays were performed in 384-well plates using a Wallac Envision 2102 plate reader (Perkin Elmer).	B	Fc1cnc(Nc2ccc(N3CCOCC3)cc2)nc1Nc1ccccc1Cl		CHEMBL2170411	=	IC50	nM	21.4	CHEMBL4722	Homo sapiens	IC50	nM	21.4
371104	17745726	CHEMBL3888080	In Vitro Aurora A Activity Assay (DiscoverX): Reactions were carried out at room temperature in 15 mM HEPES buffer (pH 7.4) containing 20 mM NaCl, 1 mM EGTA, 0.02% Tween 20, 10 mM MgCl2, 5% (v/v) DMSO, and 2.3 nM Aurora A Inhibitor was added to the mixture, and the reaction was initiated by the addition of 75 uM ATP and 2 mM peptide substrate. All kinetic assays were performed in 384-well plates using a Wallac Envision 2102 plate reader (Perkin Elmer).	B	Fc1cnc(Nc2ccc(CN3CCOCC3)cc2)nc1Nc1ccccc1Cl		CHEMBL2170412	=	IC50	nM	23.2	CHEMBL4722	Homo sapiens	IC50	nM	23.2
371105	17745727	CHEMBL3888080	In Vitro Aurora A Activity Assay (DiscoverX): Reactions were carried out at room temperature in 15 mM HEPES buffer (pH 7.4) containing 20 mM NaCl, 1 mM EGTA, 0.02% Tween 20, 10 mM MgCl2, 5% (v/v) DMSO, and 2.3 nM Aurora A Inhibitor was added to the mixture, and the reaction was initiated by the addition of 75 uM ATP and 2 mM peptide substrate. All kinetic assays were performed in 384-well plates using a Wallac Envision 2102 plate reader (Perkin Elmer).	B	O=C(NCCO)c1ccc(Nc2nccc(Nc3ccccc3Cl)n2)cc1		CHEMBL2170413	=	IC50	nM	12.3	CHEMBL4722	Homo sapiens	IC50	nM	12.3
371106	17745728	CHEMBL3888080	In Vitro Aurora A Activity Assay (DiscoverX): Reactions were carried out at room temperature in 15 mM HEPES buffer (pH 7.4) containing 20 mM NaCl, 1 mM EGTA, 0.02% Tween 20, 10 mM MgCl2, 5% (v/v) DMSO, and 2.3 nM Aurora A Inhibitor was added to the mixture, and the reaction was initiated by the addition of 75 uM ATP and 2 mM peptide substrate. All kinetic assays were performed in 384-well plates using a Wallac Envision 2102 plate reader (Perkin Elmer).	B	NC(=O)c1ccc(Nc2ncc(F)c(Nc3ccccc3Cl)n2)cc1		CHEMBL2170414	=	IC50	nM	14.4	CHEMBL4722	Homo sapiens	IC50	nM	14.4
371107	17745729	CHEMBL3888080	In Vitro Aurora A Activity Assay (DiscoverX): Reactions were carried out at room temperature in 15 mM HEPES buffer (pH 7.4) containing 20 mM NaCl, 1 mM EGTA, 0.02% Tween 20, 10 mM MgCl2, 5% (v/v) DMSO, and 2.3 nM Aurora A Inhibitor was added to the mixture, and the reaction was initiated by the addition of 75 uM ATP and 2 mM peptide substrate. All kinetic assays were performed in 384-well plates using a Wallac Envision 2102 plate reader (Perkin Elmer).	B	NS(=O)(=O)c1ccc(Nc2ncc(F)c(Nc3ccccc3Cl)n2)cc1		CHEMBL2170415	=	IC50	nM	21.2	CHEMBL4722	Homo sapiens	IC50	nM	21.2
371108	17745730	CHEMBL3888080	In Vitro Aurora A Activity Assay (DiscoverX): Reactions were carried out at room temperature in 15 mM HEPES buffer (pH 7.4) containing 20 mM NaCl, 1 mM EGTA, 0.02% Tween 20, 10 mM MgCl2, 5% (v/v) DMSO, and 2.3 nM Aurora A Inhibitor was added to the mixture, and the reaction was initiated by the addition of 75 uM ATP and 2 mM peptide substrate. All kinetic assays were performed in 384-well plates using a Wallac Envision 2102 plate reader (Perkin Elmer).	B	Clc1ccccc1Nc1ccnc(Nc2ccc(-c3nnn[nH]3)cc2)n1		CHEMBL2170416	=	IC50	nM	3.1	CHEMBL4722	Homo sapiens	IC50	nM	3.1
371109	17745731	CHEMBL3888080	In Vitro Aurora A Activity Assay (DiscoverX): Reactions were carried out at room temperature in 15 mM HEPES buffer (pH 7.4) containing 20 mM NaCl, 1 mM EGTA, 0.02% Tween 20, 10 mM MgCl2, 5% (v/v) DMSO, and 2.3 nM Aurora A Inhibitor was added to the mixture, and the reaction was initiated by the addition of 75 uM ATP and 2 mM peptide substrate. All kinetic assays were performed in 384-well plates using a Wallac Envision 2102 plate reader (Perkin Elmer).	B	Fc1cnc(Nc2ccc(-c3nnn[nH]3)cc2)nc1Nc1ccccc1Cl		CHEMBL2169893	=	IC50	nM	2.9	CHEMBL4722	Homo sapiens	IC50	nM	2.9
371110	17745732	CHEMBL3888080	In Vitro Aurora A Activity Assay (DiscoverX): Reactions were carried out at room temperature in 15 mM HEPES buffer (pH 7.4) containing 20 mM NaCl, 1 mM EGTA, 0.02% Tween 20, 10 mM MgCl2, 5% (v/v) DMSO, and 2.3 nM Aurora A Inhibitor was added to the mixture, and the reaction was initiated by the addition of 75 uM ATP and 2 mM peptide substrate. All kinetic assays were performed in 384-well plates using a Wallac Envision 2102 plate reader (Perkin Elmer).	B	Oc1cc(Nc2ncc(F)c(Nc3ccccc3Cl)n2)ccc1-c1nnn[nH]1		CHEMBL2170417	=	IC50	nM	17.3	CHEMBL4722	Homo sapiens	IC50	nM	17.3
371111	17745733	CHEMBL3888080	In Vitro Aurora A Activity Assay (DiscoverX): Reactions were carried out at room temperature in 15 mM HEPES buffer (pH 7.4) containing 20 mM NaCl, 1 mM EGTA, 0.02% Tween 20, 10 mM MgCl2, 5% (v/v) DMSO, and 2.3 nM Aurora A Inhibitor was added to the mixture, and the reaction was initiated by the addition of 75 uM ATP and 2 mM peptide substrate. All kinetic assays were performed in 384-well plates using a Wallac Envision 2102 plate reader (Perkin Elmer).	B	Clc1ccccc1Nc1nc(Nc2ccc(-c3nnn[nH]3)cc2)ncc1Cl		CHEMBL2170418	=	IC50	nM	3.0	CHEMBL4722	Homo sapiens	IC50	nM	3.0
371112	17745734	CHEMBL3888080	In Vitro Aurora A Activity Assay (DiscoverX): Reactions were carried out at room temperature in 15 mM HEPES buffer (pH 7.4) containing 20 mM NaCl, 1 mM EGTA, 0.02% Tween 20, 10 mM MgCl2, 5% (v/v) DMSO, and 2.3 nM Aurora A Inhibitor was added to the mixture, and the reaction was initiated by the addition of 75 uM ATP and 2 mM peptide substrate. All kinetic assays were performed in 384-well plates using a Wallac Envision 2102 plate reader (Perkin Elmer).	B	O=C(O)c1ccc(Nc2nccc(Nc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL3970534	=	IC50	nM	186.5	CHEMBL4722	Homo sapiens	IC50	nM	186.5
371113	17745735	CHEMBL3888080	In Vitro Aurora A Activity Assay (DiscoverX): Reactions were carried out at room temperature in 15 mM HEPES buffer (pH 7.4) containing 20 mM NaCl, 1 mM EGTA, 0.02% Tween 20, 10 mM MgCl2, 5% (v/v) DMSO, and 2.3 nM Aurora A Inhibitor was added to the mixture, and the reaction was initiated by the addition of 75 uM ATP and 2 mM peptide substrate. All kinetic assays were performed in 384-well plates using a Wallac Envision 2102 plate reader (Perkin Elmer).	B	NC(=O)c1ccc(Nc2nccc(Nc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL3899351	=	IC50	nM	371.5	CHEMBL4722	Homo sapiens	IC50	nM	371.5
371114	17745736	CHEMBL3888080	In Vitro Aurora A Activity Assay (DiscoverX): Reactions were carried out at room temperature in 15 mM HEPES buffer (pH 7.4) containing 20 mM NaCl, 1 mM EGTA, 0.02% Tween 20, 10 mM MgCl2, 5% (v/v) DMSO, and 2.3 nM Aurora A Inhibitor was added to the mixture, and the reaction was initiated by the addition of 75 uM ATP and 2 mM peptide substrate. All kinetic assays were performed in 384-well plates using a Wallac Envision 2102 plate reader (Perkin Elmer).	B	CC(C(N)=O)c1cccc(Nc2nccc(Nc3cccc(C(F)(F)F)c3)n2)c1		CHEMBL3975642	=	IC50	nM	14300.0	CHEMBL4722	Homo sapiens	IC50	nM	14300.0
371115	17745737	CHEMBL3888080	In Vitro Aurora A Activity Assay (DiscoverX): Reactions were carried out at room temperature in 15 mM HEPES buffer (pH 7.4) containing 20 mM NaCl, 1 mM EGTA, 0.02% Tween 20, 10 mM MgCl2, 5% (v/v) DMSO, and 2.3 nM Aurora A Inhibitor was added to the mixture, and the reaction was initiated by the addition of 75 uM ATP and 2 mM peptide substrate. All kinetic assays were performed in 384-well plates using a Wallac Envision 2102 plate reader (Perkin Elmer).	B	FC(F)(F)c1cccc(Nc2ccnc(Nc3cccc(C(F)(F)F)c3)n2)c1		CHEMBL3978679	=	IC50	nM	23700.0	CHEMBL4722	Homo sapiens	IC50	nM	23700.0
371116	17745738	CHEMBL3888080	In Vitro Aurora A Activity Assay (DiscoverX): Reactions were carried out at room temperature in 15 mM HEPES buffer (pH 7.4) containing 20 mM NaCl, 1 mM EGTA, 0.02% Tween 20, 10 mM MgCl2, 5% (v/v) DMSO, and 2.3 nM Aurora A Inhibitor was added to the mixture, and the reaction was initiated by the addition of 75 uM ATP and 2 mM peptide substrate. All kinetic assays were performed in 384-well plates using a Wallac Envision 2102 plate reader (Perkin Elmer).	B	O=C(O)c1ccccc1Nc1nccc(Nc2cccc(C(F)(F)F)c2)n1		CHEMBL3954884	=	IC50	nM	25700.0	CHEMBL4722	Homo sapiens	IC50	nM	25700.0
371117	17745739	CHEMBL3888080	In Vitro Aurora A Activity Assay (DiscoverX): Reactions were carried out at room temperature in 15 mM HEPES buffer (pH 7.4) containing 20 mM NaCl, 1 mM EGTA, 0.02% Tween 20, 10 mM MgCl2, 5% (v/v) DMSO, and 2.3 nM Aurora A Inhibitor was added to the mixture, and the reaction was initiated by the addition of 75 uM ATP and 2 mM peptide substrate. All kinetic assays were performed in 384-well plates using a Wallac Envision 2102 plate reader (Perkin Elmer).	B	NC(=O)c1cccc(Nc2nccc(Nc3cccc(C(F)(F)F)c3)n2)c1		CHEMBL3966220	=	IC50	nM	1260.0	CHEMBL4722	Homo sapiens	IC50	nM	1260.0
371118	17745740	CHEMBL3888080	In Vitro Aurora A Activity Assay (DiscoverX): Reactions were carried out at room temperature in 15 mM HEPES buffer (pH 7.4) containing 20 mM NaCl, 1 mM EGTA, 0.02% Tween 20, 10 mM MgCl2, 5% (v/v) DMSO, and 2.3 nM Aurora A Inhibitor was added to the mixture, and the reaction was initiated by the addition of 75 uM ATP and 2 mM peptide substrate. All kinetic assays were performed in 384-well plates using a Wallac Envision 2102 plate reader (Perkin Elmer).	B	NC(=O)Cc1cccc(Nc2nccc(Nc3cccc(C(F)(F)F)c3)n2)c1		CHEMBL3969341	=	IC50	nM	3600.0	CHEMBL4722	Homo sapiens	IC50	nM	3600.0
371119	17745741	CHEMBL3888080	In Vitro Aurora A Activity Assay (DiscoverX): Reactions were carried out at room temperature in 15 mM HEPES buffer (pH 7.4) containing 20 mM NaCl, 1 mM EGTA, 0.02% Tween 20, 10 mM MgCl2, 5% (v/v) DMSO, and 2.3 nM Aurora A Inhibitor was added to the mixture, and the reaction was initiated by the addition of 75 uM ATP and 2 mM peptide substrate. All kinetic assays were performed in 384-well plates using a Wallac Envision 2102 plate reader (Perkin Elmer).	B	O=C(O)c1cccc(Nc2nccc(Nc3cccc(C(F)(F)F)c3)n2)c1		CHEMBL3929900	=	IC50	nM	16200.0	CHEMBL4722	Homo sapiens	IC50	nM	16200.0
371120	17745742	CHEMBL3888080	In Vitro Aurora A Activity Assay (DiscoverX): Reactions were carried out at room temperature in 15 mM HEPES buffer (pH 7.4) containing 20 mM NaCl, 1 mM EGTA, 0.02% Tween 20, 10 mM MgCl2, 5% (v/v) DMSO, and 2.3 nM Aurora A Inhibitor was added to the mixture, and the reaction was initiated by the addition of 75 uM ATP and 2 mM peptide substrate. All kinetic assays were performed in 384-well plates using a Wallac Envision 2102 plate reader (Perkin Elmer).	B	NC(=O)CCc1cccc(Nc2nccc(Nc3cccc(C(F)(F)F)c3)n2)c1		CHEMBL3960513	=	IC50	nM	15400.0	CHEMBL4722	Homo sapiens	IC50	nM	15400.0
371121	17745743	CHEMBL3888080	In Vitro Aurora A Activity Assay (DiscoverX): Reactions were carried out at room temperature in 15 mM HEPES buffer (pH 7.4) containing 20 mM NaCl, 1 mM EGTA, 0.02% Tween 20, 10 mM MgCl2, 5% (v/v) DMSO, and 2.3 nM Aurora A Inhibitor was added to the mixture, and the reaction was initiated by the addition of 75 uM ATP and 2 mM peptide substrate. All kinetic assays were performed in 384-well plates using a Wallac Envision 2102 plate reader (Perkin Elmer).	B	NC(=O)C1CC1c1cccc(Nc2nccc(Nc3cccc(C(F)(F)F)c3)n2)c1		CHEMBL3908823	>	IC50	nM	50000.0	CHEMBL4722	Homo sapiens	IC50	nM	50000.0
371122	17745744	CHEMBL3888080	In Vitro Aurora A Activity Assay (DiscoverX): Reactions were carried out at room temperature in 15 mM HEPES buffer (pH 7.4) containing 20 mM NaCl, 1 mM EGTA, 0.02% Tween 20, 10 mM MgCl2, 5% (v/v) DMSO, and 2.3 nM Aurora A Inhibitor was added to the mixture, and the reaction was initiated by the addition of 75 uM ATP and 2 mM peptide substrate. All kinetic assays were performed in 384-well plates using a Wallac Envision 2102 plate reader (Perkin Elmer).	B	NC(=O)CCCCc1cccc(Nc2nccc(Nc3cccc(C(F)(F)F)c3)n2)c1		CHEMBL3917769	=	IC50	nM	8870.0	CHEMBL4722	Homo sapiens	IC50	nM	8870.0
371123	17745745	CHEMBL3888080	In Vitro Aurora A Activity Assay (DiscoverX): Reactions were carried out at room temperature in 15 mM HEPES buffer (pH 7.4) containing 20 mM NaCl, 1 mM EGTA, 0.02% Tween 20, 10 mM MgCl2, 5% (v/v) DMSO, and 2.3 nM Aurora A Inhibitor was added to the mixture, and the reaction was initiated by the addition of 75 uM ATP and 2 mM peptide substrate. All kinetic assays were performed in 384-well plates using a Wallac Envision 2102 plate reader (Perkin Elmer).	B	NC(O)C1CCC(c2cccc(Nc3nccc(Nc4cccc(C(F)(F)F)c4)n3)c2)C1		CHEMBL3893288	=	IC50	nM	23000.0	CHEMBL4722	Homo sapiens	IC50	nM	23000.0
371124	17745746	CHEMBL3888080	In Vitro Aurora A Activity Assay (DiscoverX): Reactions were carried out at room temperature in 15 mM HEPES buffer (pH 7.4) containing 20 mM NaCl, 1 mM EGTA, 0.02% Tween 20, 10 mM MgCl2, 5% (v/v) DMSO, and 2.3 nM Aurora A Inhibitor was added to the mixture, and the reaction was initiated by the addition of 75 uM ATP and 2 mM peptide substrate. All kinetic assays were performed in 384-well plates using a Wallac Envision 2102 plate reader (Perkin Elmer).	B	CC(CC(N)=O)c1cccc(Nc2nccc(Nc3cccc(C(F)(F)F)c3)n2)c1		CHEMBL3894354	=	IC50	nM	21600.0	CHEMBL4722	Homo sapiens	IC50	nM	21600.0
371125	17745747	CHEMBL3888080	In Vitro Aurora A Activity Assay (DiscoverX): Reactions were carried out at room temperature in 15 mM HEPES buffer (pH 7.4) containing 20 mM NaCl, 1 mM EGTA, 0.02% Tween 20, 10 mM MgCl2, 5% (v/v) DMSO, and 2.3 nM Aurora A Inhibitor was added to the mixture, and the reaction was initiated by the addition of 75 uM ATP and 2 mM peptide substrate. All kinetic assays were performed in 384-well plates using a Wallac Envision 2102 plate reader (Perkin Elmer).	B	O=C(Nc1ccc(Cl)cc1)c1cccc(Nc2nccc(Nc3cccc(C(F)(F)F)c3)n2)c1		CHEMBL3965790	>	IC50	nM	50000.0	CHEMBL4722	Homo sapiens	IC50	nM	50000.0
371126	17745748	CHEMBL3888080	In Vitro Aurora A Activity Assay (DiscoverX): Reactions were carried out at room temperature in 15 mM HEPES buffer (pH 7.4) containing 20 mM NaCl, 1 mM EGTA, 0.02% Tween 20, 10 mM MgCl2, 5% (v/v) DMSO, and 2.3 nM Aurora A Inhibitor was added to the mixture, and the reaction was initiated by the addition of 75 uM ATP and 2 mM peptide substrate. All kinetic assays were performed in 384-well plates using a Wallac Envision 2102 plate reader (Perkin Elmer).	B	O=C(Nc1ccccc1)c1cccc(Nc2nccc(Nc3cccc(C(F)(F)F)c3)n2)c1		CHEMBL3903320	>	IC50	nM	50000.0	CHEMBL4722	Homo sapiens	IC50	nM	50000.0
371127	17745749	CHEMBL3888080	In Vitro Aurora A Activity Assay (DiscoverX): Reactions were carried out at room temperature in 15 mM HEPES buffer (pH 7.4) containing 20 mM NaCl, 1 mM EGTA, 0.02% Tween 20, 10 mM MgCl2, 5% (v/v) DMSO, and 2.3 nM Aurora A Inhibitor was added to the mixture, and the reaction was initiated by the addition of 75 uM ATP and 2 mM peptide substrate. All kinetic assays were performed in 384-well plates using a Wallac Envision 2102 plate reader (Perkin Elmer).	B	CN(C)c1cc(Nc2ccccc2)nc(Nc2ccccc2)n1		CHEMBL3970937	>	IC50	nM	50000.0	CHEMBL4722	Homo sapiens	IC50	nM	50000.0
371128	17745750	CHEMBL3888080	In Vitro Aurora A Activity Assay (DiscoverX): Reactions were carried out at room temperature in 15 mM HEPES buffer (pH 7.4) containing 20 mM NaCl, 1 mM EGTA, 0.02% Tween 20, 10 mM MgCl2, 5% (v/v) DMSO, and 2.3 nM Aurora A Inhibitor was added to the mixture, and the reaction was initiated by the addition of 75 uM ATP and 2 mM peptide substrate. All kinetic assays were performed in 384-well plates using a Wallac Envision 2102 plate reader (Perkin Elmer).	B	CN(C)c1cc(Nc2ccccc2C(=O)O)nc(Nc2ccccc2)n1		CHEMBL3916557	>	IC50	nM	50000.0	CHEMBL4722	Homo sapiens	IC50	nM	50000.0
371129	17745751	CHEMBL3888080	In Vitro Aurora A Activity Assay (DiscoverX): Reactions were carried out at room temperature in 15 mM HEPES buffer (pH 7.4) containing 20 mM NaCl, 1 mM EGTA, 0.02% Tween 20, 10 mM MgCl2, 5% (v/v) DMSO, and 2.3 nM Aurora A Inhibitor was added to the mixture, and the reaction was initiated by the addition of 75 uM ATP and 2 mM peptide substrate. All kinetic assays were performed in 384-well plates using a Wallac Envision 2102 plate reader (Perkin Elmer).	B	CCOC(=O)c1ccc(Nc2ncc(N)c(Nc3ccccc3C(=O)O)n2)cc1		CHEMBL3986322	=	IC50	nM	1490.0	CHEMBL4722	Homo sapiens	IC50	nM	1490.0
371130	17745752	CHEMBL3888081	"In Vivo Aurora A inhibitory Assay ( MDA-MB-468): Specifically, MDA-MB-468 cells (American Type Culture Collection) were maintained in Dulbecco's modified Eagle's medium (DMEM) plus 10% fetus bovine serum (FBS) (Invitrogen, US) at 37° C., 5% CO2. The cells were plated in 6 cm dishes at a density of 2x105 cells/dish. Cells were then treated with the compounds (0-10 uM); DMSO was used as a negative control and 0.5 uM VX-680 (Tozasertib) (Selleck Chemical LLC) was used as a positive control. Cells were harvested after 2 h of treatment and processed for SDS-PAGE and western blotting as described previously (Gizatullin et al., ""The Aurora kinase inhibitor VX-680 induces endoreduplication and apoptosis preferentially in cells with compromised p53-dependent postmitotic checkpoint function"" Cancer Res. (2006) 66 (15):7668-77). After electro-transfer onto nitrocellulose membranes, the membranes were blocked at room temperature for 1 h with TBS containing 5% (w/v) milk and then washed with a mixture of TBS containing 0.2% Tween 20 (Sigma). The membranes were then gently shaken at 4° C. overnight with anti-phospho histone H3 (Ser 10) antibody (9701, Cell Signaling), and anti-GAPDH monoclonal antibody (E10086CF, Covance) diluted in TBS containing 5% BSA. The membranes were then incubated with HRP conjugated anti-rabbit or anti-mouse IgG antibody (Jackson ImmunoResearch Lab.) at room temperature for 1 h followed by washing with Tween 20-PBS. The membranes were washed again with PBS and developed with the ECL system (PerkinElmer) as described previously (Berndt et al., ""The Akt activation inhibitor TCN-P inhibits Akt phosphorylation by binding to the PH domain of Akt and blocking its recruitment to the plasma membrane."" Cell Death Differ. (2010) 17(11):1795-804)."	B	CN(C)CCNC(=O)c1ccc(Nc2nccc(Nc3ccccc3Cl)n2)cc1		CHEMBL2170591	=	IC50	nM	5500.0	CHEMBL4722	Homo sapiens	IC50	nM	5500.0
371131	17745753	CHEMBL3888081	"In Vivo Aurora A inhibitory Assay ( MDA-MB-468): Specifically, MDA-MB-468 cells (American Type Culture Collection) were maintained in Dulbecco's modified Eagle's medium (DMEM) plus 10% fetus bovine serum (FBS) (Invitrogen, US) at 37° C., 5% CO2. The cells were plated in 6 cm dishes at a density of 2x105 cells/dish. Cells were then treated with the compounds (0-10 uM); DMSO was used as a negative control and 0.5 uM VX-680 (Tozasertib) (Selleck Chemical LLC) was used as a positive control. Cells were harvested after 2 h of treatment and processed for SDS-PAGE and western blotting as described previously (Gizatullin et al., ""The Aurora kinase inhibitor VX-680 induces endoreduplication and apoptosis preferentially in cells with compromised p53-dependent postmitotic checkpoint function"" Cancer Res. (2006) 66 (15):7668-77). After electro-transfer onto nitrocellulose membranes, the membranes were blocked at room temperature for 1 h with TBS containing 5% (w/v) milk and then washed with a mixture of TBS containing 0.2% Tween 20 (Sigma). The membranes were then gently shaken at 4° C. overnight with anti-phospho histone H3 (Ser 10) antibody (9701, Cell Signaling), and anti-GAPDH monoclonal antibody (E10086CF, Covance) diluted in TBS containing 5% BSA. The membranes were then incubated with HRP conjugated anti-rabbit or anti-mouse IgG antibody (Jackson ImmunoResearch Lab.) at room temperature for 1 h followed by washing with Tween 20-PBS. The membranes were washed again with PBS and developed with the ECL system (PerkinElmer) as described previously (Berndt et al., ""The Akt activation inhibitor TCN-P inhibits Akt phosphorylation by binding to the PH domain of Akt and blocking its recruitment to the plasma membrane."" Cell Death Differ. (2010) 17(11):1795-804)."	B	O=C(NCCN1CCOCC1)c1ccc(Nc2nccc(Nc3ccccc3Cl)n2)cc1		CHEMBL2170590	=	IC50	nM	5500.0	CHEMBL4722	Homo sapiens	IC50	nM	5500.0
371132	17745754	CHEMBL3888081	"In Vivo Aurora A inhibitory Assay ( MDA-MB-468): Specifically, MDA-MB-468 cells (American Type Culture Collection) were maintained in Dulbecco's modified Eagle's medium (DMEM) plus 10% fetus bovine serum (FBS) (Invitrogen, US) at 37° C., 5% CO2. The cells were plated in 6 cm dishes at a density of 2x105 cells/dish. Cells were then treated with the compounds (0-10 uM); DMSO was used as a negative control and 0.5 uM VX-680 (Tozasertib) (Selleck Chemical LLC) was used as a positive control. Cells were harvested after 2 h of treatment and processed for SDS-PAGE and western blotting as described previously (Gizatullin et al., ""The Aurora kinase inhibitor VX-680 induces endoreduplication and apoptosis preferentially in cells with compromised p53-dependent postmitotic checkpoint function"" Cancer Res. (2006) 66 (15):7668-77). After electro-transfer onto nitrocellulose membranes, the membranes were blocked at room temperature for 1 h with TBS containing 5% (w/v) milk and then washed with a mixture of TBS containing 0.2% Tween 20 (Sigma). The membranes were then gently shaken at 4° C. overnight with anti-phospho histone H3 (Ser 10) antibody (9701, Cell Signaling), and anti-GAPDH monoclonal antibody (E10086CF, Covance) diluted in TBS containing 5% BSA. The membranes were then incubated with HRP conjugated anti-rabbit or anti-mouse IgG antibody (Jackson ImmunoResearch Lab.) at room temperature for 1 h followed by washing with Tween 20-PBS. The membranes were washed again with PBS and developed with the ECL system (PerkinElmer) as described previously (Berndt et al., ""The Akt activation inhibitor TCN-P inhibits Akt phosphorylation by binding to the PH domain of Akt and blocking its recruitment to the plasma membrane."" Cell Death Differ. (2010) 17(11):1795-804)."	B	COCCNC(=O)c1ccc(Nc2nccc(Nc3ccccc3Cl)n2)cc1		CHEMBL2170404	=	IC50	nM	5500.0	CHEMBL4722	Homo sapiens	IC50	nM	5500.0
371133	17745755	CHEMBL3888081	"In Vivo Aurora A inhibitory Assay ( MDA-MB-468): Specifically, MDA-MB-468 cells (American Type Culture Collection) were maintained in Dulbecco's modified Eagle's medium (DMEM) plus 10% fetus bovine serum (FBS) (Invitrogen, US) at 37° C., 5% CO2. The cells were plated in 6 cm dishes at a density of 2x105 cells/dish. Cells were then treated with the compounds (0-10 uM); DMSO was used as a negative control and 0.5 uM VX-680 (Tozasertib) (Selleck Chemical LLC) was used as a positive control. Cells were harvested after 2 h of treatment and processed for SDS-PAGE and western blotting as described previously (Gizatullin et al., ""The Aurora kinase inhibitor VX-680 induces endoreduplication and apoptosis preferentially in cells with compromised p53-dependent postmitotic checkpoint function"" Cancer Res. (2006) 66 (15):7668-77). After electro-transfer onto nitrocellulose membranes, the membranes were blocked at room temperature for 1 h with TBS containing 5% (w/v) milk and then washed with a mixture of TBS containing 0.2% Tween 20 (Sigma). The membranes were then gently shaken at 4° C. overnight with anti-phospho histone H3 (Ser 10) antibody (9701, Cell Signaling), and anti-GAPDH monoclonal antibody (E10086CF, Covance) diluted in TBS containing 5% BSA. The membranes were then incubated with HRP conjugated anti-rabbit or anti-mouse IgG antibody (Jackson ImmunoResearch Lab.) at room temperature for 1 h followed by washing with Tween 20-PBS. The membranes were washed again with PBS and developed with the ECL system (PerkinElmer) as described previously (Berndt et al., ""The Akt activation inhibitor TCN-P inhibits Akt phosphorylation by binding to the PH domain of Akt and blocking its recruitment to the plasma membrane."" Cell Death Differ. (2010) 17(11):1795-804)."	B	CS(=O)(=O)c1ccc(Nc2nccc(Nc3ccccc3Cl)n2)cc1		CHEMBL2170405	>	IC50	nM	10000.0	CHEMBL4722	Homo sapiens	IC50	nM	10000.0
371134	17745756	CHEMBL3888081	"In Vivo Aurora A inhibitory Assay ( MDA-MB-468): Specifically, MDA-MB-468 cells (American Type Culture Collection) were maintained in Dulbecco's modified Eagle's medium (DMEM) plus 10% fetus bovine serum (FBS) (Invitrogen, US) at 37° C., 5% CO2. The cells were plated in 6 cm dishes at a density of 2x105 cells/dish. Cells were then treated with the compounds (0-10 uM); DMSO was used as a negative control and 0.5 uM VX-680 (Tozasertib) (Selleck Chemical LLC) was used as a positive control. Cells were harvested after 2 h of treatment and processed for SDS-PAGE and western blotting as described previously (Gizatullin et al., ""The Aurora kinase inhibitor VX-680 induces endoreduplication and apoptosis preferentially in cells with compromised p53-dependent postmitotic checkpoint function"" Cancer Res. (2006) 66 (15):7668-77). After electro-transfer onto nitrocellulose membranes, the membranes were blocked at room temperature for 1 h with TBS containing 5% (w/v) milk and then washed with a mixture of TBS containing 0.2% Tween 20 (Sigma). The membranes were then gently shaken at 4° C. overnight with anti-phospho histone H3 (Ser 10) antibody (9701, Cell Signaling), and anti-GAPDH monoclonal antibody (E10086CF, Covance) diluted in TBS containing 5% BSA. The membranes were then incubated with HRP conjugated anti-rabbit or anti-mouse IgG antibody (Jackson ImmunoResearch Lab.) at room temperature for 1 h followed by washing with Tween 20-PBS. The membranes were washed again with PBS and developed with the ECL system (PerkinElmer) as described previously (Berndt et al., ""The Akt activation inhibitor TCN-P inhibits Akt phosphorylation by binding to the PH domain of Akt and blocking its recruitment to the plasma membrane."" Cell Death Differ. (2010) 17(11):1795-804)."	B	CC(=O)Nc1ccc(Nc2nccc(Nc3ccccc3Cl)n2)cc1		CHEMBL3969926	>	IC50	nM	10000.0	CHEMBL4722	Homo sapiens	IC50	nM	10000.0
371135	17745757	CHEMBL3888081	"In Vivo Aurora A inhibitory Assay ( MDA-MB-468): Specifically, MDA-MB-468 cells (American Type Culture Collection) were maintained in Dulbecco's modified Eagle's medium (DMEM) plus 10% fetus bovine serum (FBS) (Invitrogen, US) at 37° C., 5% CO2. The cells were plated in 6 cm dishes at a density of 2x105 cells/dish. Cells were then treated with the compounds (0-10 uM); DMSO was used as a negative control and 0.5 uM VX-680 (Tozasertib) (Selleck Chemical LLC) was used as a positive control. Cells were harvested after 2 h of treatment and processed for SDS-PAGE and western blotting as described previously (Gizatullin et al., ""The Aurora kinase inhibitor VX-680 induces endoreduplication and apoptosis preferentially in cells with compromised p53-dependent postmitotic checkpoint function"" Cancer Res. (2006) 66 (15):7668-77). After electro-transfer onto nitrocellulose membranes, the membranes were blocked at room temperature for 1 h with TBS containing 5% (w/v) milk and then washed with a mixture of TBS containing 0.2% Tween 20 (Sigma). The membranes were then gently shaken at 4° C. overnight with anti-phospho histone H3 (Ser 10) antibody (9701, Cell Signaling), and anti-GAPDH monoclonal antibody (E10086CF, Covance) diluted in TBS containing 5% BSA. The membranes were then incubated with HRP conjugated anti-rabbit or anti-mouse IgG antibody (Jackson ImmunoResearch Lab.) at room temperature for 1 h followed by washing with Tween 20-PBS. The membranes were washed again with PBS and developed with the ECL system (PerkinElmer) as described previously (Berndt et al., ""The Akt activation inhibitor TCN-P inhibits Akt phosphorylation by binding to the PH domain of Akt and blocking its recruitment to the plasma membrane."" Cell Death Differ. (2010) 17(11):1795-804)."	B	O=c1[nH]c2ccc(Nc3nccc(Nc4ccccc4Cl)n3)cc2[nH]1		CHEMBL2170407	=	IC50	nM	5500.0	CHEMBL4722	Homo sapiens	IC50	nM	5500.0
371136	17745758	CHEMBL3888081	"In Vivo Aurora A inhibitory Assay ( MDA-MB-468): Specifically, MDA-MB-468 cells (American Type Culture Collection) were maintained in Dulbecco's modified Eagle's medium (DMEM) plus 10% fetus bovine serum (FBS) (Invitrogen, US) at 37° C., 5% CO2. The cells were plated in 6 cm dishes at a density of 2x105 cells/dish. Cells were then treated with the compounds (0-10 uM); DMSO was used as a negative control and 0.5 uM VX-680 (Tozasertib) (Selleck Chemical LLC) was used as a positive control. Cells were harvested after 2 h of treatment and processed for SDS-PAGE and western blotting as described previously (Gizatullin et al., ""The Aurora kinase inhibitor VX-680 induces endoreduplication and apoptosis preferentially in cells with compromised p53-dependent postmitotic checkpoint function"" Cancer Res. (2006) 66 (15):7668-77). After electro-transfer onto nitrocellulose membranes, the membranes were blocked at room temperature for 1 h with TBS containing 5% (w/v) milk and then washed with a mixture of TBS containing 0.2% Tween 20 (Sigma). The membranes were then gently shaken at 4° C. overnight with anti-phospho histone H3 (Ser 10) antibody (9701, Cell Signaling), and anti-GAPDH monoclonal antibody (E10086CF, Covance) diluted in TBS containing 5% BSA. The membranes were then incubated with HRP conjugated anti-rabbit or anti-mouse IgG antibody (Jackson ImmunoResearch Lab.) at room temperature for 1 h followed by washing with Tween 20-PBS. The membranes were washed again with PBS and developed with the ECL system (PerkinElmer) as described previously (Berndt et al., ""The Akt activation inhibitor TCN-P inhibits Akt phosphorylation by binding to the PH domain of Akt and blocking its recruitment to the plasma membrane."" Cell Death Differ. (2010) 17(11):1795-804)."	B	COc1cc(Nc2nccc(Nc3ccccc3Cl)n2)ccc1C(=O)O		CHEMBL2170408	>	IC50	nM	10000.0	CHEMBL4722	Homo sapiens	IC50	nM	10000.0
371137	17745759	CHEMBL3888081	"In Vivo Aurora A inhibitory Assay ( MDA-MB-468): Specifically, MDA-MB-468 cells (American Type Culture Collection) were maintained in Dulbecco's modified Eagle's medium (DMEM) plus 10% fetus bovine serum (FBS) (Invitrogen, US) at 37° C., 5% CO2. The cells were plated in 6 cm dishes at a density of 2x105 cells/dish. Cells were then treated with the compounds (0-10 uM); DMSO was used as a negative control and 0.5 uM VX-680 (Tozasertib) (Selleck Chemical LLC) was used as a positive control. Cells were harvested after 2 h of treatment and processed for SDS-PAGE and western blotting as described previously (Gizatullin et al., ""The Aurora kinase inhibitor VX-680 induces endoreduplication and apoptosis preferentially in cells with compromised p53-dependent postmitotic checkpoint function"" Cancer Res. (2006) 66 (15):7668-77). After electro-transfer onto nitrocellulose membranes, the membranes were blocked at room temperature for 1 h with TBS containing 5% (w/v) milk and then washed with a mixture of TBS containing 0.2% Tween 20 (Sigma). The membranes were then gently shaken at 4° C. overnight with anti-phospho histone H3 (Ser 10) antibody (9701, Cell Signaling), and anti-GAPDH monoclonal antibody (E10086CF, Covance) diluted in TBS containing 5% BSA. The membranes were then incubated with HRP conjugated anti-rabbit or anti-mouse IgG antibody (Jackson ImmunoResearch Lab.) at room temperature for 1 h followed by washing with Tween 20-PBS. The membranes were washed again with PBS and developed with the ECL system (PerkinElmer) as described previously (Berndt et al., ""The Akt activation inhibitor TCN-P inhibits Akt phosphorylation by binding to the PH domain of Akt and blocking its recruitment to the plasma membrane."" Cell Death Differ. (2010) 17(11):1795-804)."	B	Clc1ccccc1Nc1ccnc(Nc2ccc(N3CCOCC3)cc2)n1		CHEMBL2170409	<	IC50	nM	1.0	CHEMBL4722	Homo sapiens	IC50	nM	1.0
371138	17745760	CHEMBL3888081	"In Vivo Aurora A inhibitory Assay ( MDA-MB-468): Specifically, MDA-MB-468 cells (American Type Culture Collection) were maintained in Dulbecco's modified Eagle's medium (DMEM) plus 10% fetus bovine serum (FBS) (Invitrogen, US) at 37° C., 5% CO2. The cells were plated in 6 cm dishes at a density of 2x105 cells/dish. Cells were then treated with the compounds (0-10 uM); DMSO was used as a negative control and 0.5 uM VX-680 (Tozasertib) (Selleck Chemical LLC) was used as a positive control. Cells were harvested after 2 h of treatment and processed for SDS-PAGE and western blotting as described previously (Gizatullin et al., ""The Aurora kinase inhibitor VX-680 induces endoreduplication and apoptosis preferentially in cells with compromised p53-dependent postmitotic checkpoint function"" Cancer Res. (2006) 66 (15):7668-77). After electro-transfer onto nitrocellulose membranes, the membranes were blocked at room temperature for 1 h with TBS containing 5% (w/v) milk and then washed with a mixture of TBS containing 0.2% Tween 20 (Sigma). The membranes were then gently shaken at 4° C. overnight with anti-phospho histone H3 (Ser 10) antibody (9701, Cell Signaling), and anti-GAPDH monoclonal antibody (E10086CF, Covance) diluted in TBS containing 5% BSA. The membranes were then incubated with HRP conjugated anti-rabbit or anti-mouse IgG antibody (Jackson ImmunoResearch Lab.) at room temperature for 1 h followed by washing with Tween 20-PBS. The membranes were washed again with PBS and developed with the ECL system (PerkinElmer) as described previously (Berndt et al., ""The Akt activation inhibitor TCN-P inhibits Akt phosphorylation by binding to the PH domain of Akt and blocking its recruitment to the plasma membrane."" Cell Death Differ. (2010) 17(11):1795-804)."	B	NC(=O)c1ccc(Nc2nccc(Nc3ccccc3Cl)n2)cc1		CHEMBL2170442	<	IC50	nM	1.0	CHEMBL4722	Homo sapiens	IC50	nM	1.0
371139	17745761	CHEMBL3888081	"In Vivo Aurora A inhibitory Assay ( MDA-MB-468): Specifically, MDA-MB-468 cells (American Type Culture Collection) were maintained in Dulbecco's modified Eagle's medium (DMEM) plus 10% fetus bovine serum (FBS) (Invitrogen, US) at 37° C., 5% CO2. The cells were plated in 6 cm dishes at a density of 2x105 cells/dish. Cells were then treated with the compounds (0-10 uM); DMSO was used as a negative control and 0.5 uM VX-680 (Tozasertib) (Selleck Chemical LLC) was used as a positive control. Cells were harvested after 2 h of treatment and processed for SDS-PAGE and western blotting as described previously (Gizatullin et al., ""The Aurora kinase inhibitor VX-680 induces endoreduplication and apoptosis preferentially in cells with compromised p53-dependent postmitotic checkpoint function"" Cancer Res. (2006) 66 (15):7668-77). After electro-transfer onto nitrocellulose membranes, the membranes were blocked at room temperature for 1 h with TBS containing 5% (w/v) milk and then washed with a mixture of TBS containing 0.2% Tween 20 (Sigma). The membranes were then gently shaken at 4° C. overnight with anti-phospho histone H3 (Ser 10) antibody (9701, Cell Signaling), and anti-GAPDH monoclonal antibody (E10086CF, Covance) diluted in TBS containing 5% BSA. The membranes were then incubated with HRP conjugated anti-rabbit or anti-mouse IgG antibody (Jackson ImmunoResearch Lab.) at room temperature for 1 h followed by washing with Tween 20-PBS. The membranes were washed again with PBS and developed with the ECL system (PerkinElmer) as described previously (Berndt et al., ""The Akt activation inhibitor TCN-P inhibits Akt phosphorylation by binding to the PH domain of Akt and blocking its recruitment to the plasma membrane."" Cell Death Differ. (2010) 17(11):1795-804)."	B	NS(=O)(=O)c1ccc(Nc2nccc(Nc3ccccc3Cl)n2)cc1		CHEMBL2170410	<	IC50	nM	1.0	CHEMBL4722	Homo sapiens	IC50	nM	1.0
371140	17745762	CHEMBL3888081	"In Vivo Aurora A inhibitory Assay ( MDA-MB-468): Specifically, MDA-MB-468 cells (American Type Culture Collection) were maintained in Dulbecco's modified Eagle's medium (DMEM) plus 10% fetus bovine serum (FBS) (Invitrogen, US) at 37° C., 5% CO2. The cells were plated in 6 cm dishes at a density of 2x105 cells/dish. Cells were then treated with the compounds (0-10 uM); DMSO was used as a negative control and 0.5 uM VX-680 (Tozasertib) (Selleck Chemical LLC) was used as a positive control. Cells were harvested after 2 h of treatment and processed for SDS-PAGE and western blotting as described previously (Gizatullin et al., ""The Aurora kinase inhibitor VX-680 induces endoreduplication and apoptosis preferentially in cells with compromised p53-dependent postmitotic checkpoint function"" Cancer Res. (2006) 66 (15):7668-77). After electro-transfer onto nitrocellulose membranes, the membranes were blocked at room temperature for 1 h with TBS containing 5% (w/v) milk and then washed with a mixture of TBS containing 0.2% Tween 20 (Sigma). The membranes were then gently shaken at 4° C. overnight with anti-phospho histone H3 (Ser 10) antibody (9701, Cell Signaling), and anti-GAPDH monoclonal antibody (E10086CF, Covance) diluted in TBS containing 5% BSA. The membranes were then incubated with HRP conjugated anti-rabbit or anti-mouse IgG antibody (Jackson ImmunoResearch Lab.) at room temperature for 1 h followed by washing with Tween 20-PBS. The membranes were washed again with PBS and developed with the ECL system (PerkinElmer) as described previously (Berndt et al., ""The Akt activation inhibitor TCN-P inhibits Akt phosphorylation by binding to the PH domain of Akt and blocking its recruitment to the plasma membrane."" Cell Death Differ. (2010) 17(11):1795-804)."	B	Fc1cnc(Nc2ccc(N3CCOCC3)cc2)nc1Nc1ccccc1Cl		CHEMBL2170411	<	IC50	nM	1.0	CHEMBL4722	Homo sapiens	IC50	nM	1.0
371141	17745763	CHEMBL3888081	"In Vivo Aurora A inhibitory Assay ( MDA-MB-468): Specifically, MDA-MB-468 cells (American Type Culture Collection) were maintained in Dulbecco's modified Eagle's medium (DMEM) plus 10% fetus bovine serum (FBS) (Invitrogen, US) at 37° C., 5% CO2. The cells were plated in 6 cm dishes at a density of 2x105 cells/dish. Cells were then treated with the compounds (0-10 uM); DMSO was used as a negative control and 0.5 uM VX-680 (Tozasertib) (Selleck Chemical LLC) was used as a positive control. Cells were harvested after 2 h of treatment and processed for SDS-PAGE and western blotting as described previously (Gizatullin et al., ""The Aurora kinase inhibitor VX-680 induces endoreduplication and apoptosis preferentially in cells with compromised p53-dependent postmitotic checkpoint function"" Cancer Res. (2006) 66 (15):7668-77). After electro-transfer onto nitrocellulose membranes, the membranes were blocked at room temperature for 1 h with TBS containing 5% (w/v) milk and then washed with a mixture of TBS containing 0.2% Tween 20 (Sigma). The membranes were then gently shaken at 4° C. overnight with anti-phospho histone H3 (Ser 10) antibody (9701, Cell Signaling), and anti-GAPDH monoclonal antibody (E10086CF, Covance) diluted in TBS containing 5% BSA. The membranes were then incubated with HRP conjugated anti-rabbit or anti-mouse IgG antibody (Jackson ImmunoResearch Lab.) at room temperature for 1 h followed by washing with Tween 20-PBS. The membranes were washed again with PBS and developed with the ECL system (PerkinElmer) as described previously (Berndt et al., ""The Akt activation inhibitor TCN-P inhibits Akt phosphorylation by binding to the PH domain of Akt and blocking its recruitment to the plasma membrane."" Cell Death Differ. (2010) 17(11):1795-804)."	B	Fc1cnc(Nc2ccc(CN3CCOCC3)cc2)nc1Nc1ccccc1Cl		CHEMBL2170412	<	IC50	nM	1.0	CHEMBL4722	Homo sapiens	IC50	nM	1.0
371142	17745764	CHEMBL3888081	"In Vivo Aurora A inhibitory Assay ( MDA-MB-468): Specifically, MDA-MB-468 cells (American Type Culture Collection) were maintained in Dulbecco's modified Eagle's medium (DMEM) plus 10% fetus bovine serum (FBS) (Invitrogen, US) at 37° C., 5% CO2. The cells were plated in 6 cm dishes at a density of 2x105 cells/dish. Cells were then treated with the compounds (0-10 uM); DMSO was used as a negative control and 0.5 uM VX-680 (Tozasertib) (Selleck Chemical LLC) was used as a positive control. Cells were harvested after 2 h of treatment and processed for SDS-PAGE and western blotting as described previously (Gizatullin et al., ""The Aurora kinase inhibitor VX-680 induces endoreduplication and apoptosis preferentially in cells with compromised p53-dependent postmitotic checkpoint function"" Cancer Res. (2006) 66 (15):7668-77). After electro-transfer onto nitrocellulose membranes, the membranes were blocked at room temperature for 1 h with TBS containing 5% (w/v) milk and then washed with a mixture of TBS containing 0.2% Tween 20 (Sigma). The membranes were then gently shaken at 4° C. overnight with anti-phospho histone H3 (Ser 10) antibody (9701, Cell Signaling), and anti-GAPDH monoclonal antibody (E10086CF, Covance) diluted in TBS containing 5% BSA. The membranes were then incubated with HRP conjugated anti-rabbit or anti-mouse IgG antibody (Jackson ImmunoResearch Lab.) at room temperature for 1 h followed by washing with Tween 20-PBS. The membranes were washed again with PBS and developed with the ECL system (PerkinElmer) as described previously (Berndt et al., ""The Akt activation inhibitor TCN-P inhibits Akt phosphorylation by binding to the PH domain of Akt and blocking its recruitment to the plasma membrane."" Cell Death Differ. (2010) 17(11):1795-804)."	B	O=C(NCCO)c1ccc(Nc2nccc(Nc3ccccc3Cl)n2)cc1		CHEMBL2170413	<	IC50	nM	1.0	CHEMBL4722	Homo sapiens	IC50	nM	1.0
371143	17745765	CHEMBL3888081	"In Vivo Aurora A inhibitory Assay ( MDA-MB-468): Specifically, MDA-MB-468 cells (American Type Culture Collection) were maintained in Dulbecco's modified Eagle's medium (DMEM) plus 10% fetus bovine serum (FBS) (Invitrogen, US) at 37° C., 5% CO2. The cells were plated in 6 cm dishes at a density of 2x105 cells/dish. Cells were then treated with the compounds (0-10 uM); DMSO was used as a negative control and 0.5 uM VX-680 (Tozasertib) (Selleck Chemical LLC) was used as a positive control. Cells were harvested after 2 h of treatment and processed for SDS-PAGE and western blotting as described previously (Gizatullin et al., ""The Aurora kinase inhibitor VX-680 induces endoreduplication and apoptosis preferentially in cells with compromised p53-dependent postmitotic checkpoint function"" Cancer Res. (2006) 66 (15):7668-77). After electro-transfer onto nitrocellulose membranes, the membranes were blocked at room temperature for 1 h with TBS containing 5% (w/v) milk and then washed with a mixture of TBS containing 0.2% Tween 20 (Sigma). The membranes were then gently shaken at 4° C. overnight with anti-phospho histone H3 (Ser 10) antibody (9701, Cell Signaling), and anti-GAPDH monoclonal antibody (E10086CF, Covance) diluted in TBS containing 5% BSA. The membranes were then incubated with HRP conjugated anti-rabbit or anti-mouse IgG antibody (Jackson ImmunoResearch Lab.) at room temperature for 1 h followed by washing with Tween 20-PBS. The membranes were washed again with PBS and developed with the ECL system (PerkinElmer) as described previously (Berndt et al., ""The Akt activation inhibitor TCN-P inhibits Akt phosphorylation by binding to the PH domain of Akt and blocking its recruitment to the plasma membrane."" Cell Death Differ. (2010) 17(11):1795-804)."	B	NC(=O)c1ccc(Nc2ncc(F)c(Nc3ccccc3Cl)n2)cc1		CHEMBL2170414	<	IC50	nM	1.0	CHEMBL4722	Homo sapiens	IC50	nM	1.0
371144	17745766	CHEMBL3888081	"In Vivo Aurora A inhibitory Assay ( MDA-MB-468): Specifically, MDA-MB-468 cells (American Type Culture Collection) were maintained in Dulbecco's modified Eagle's medium (DMEM) plus 10% fetus bovine serum (FBS) (Invitrogen, US) at 37° C., 5% CO2. The cells were plated in 6 cm dishes at a density of 2x105 cells/dish. Cells were then treated with the compounds (0-10 uM); DMSO was used as a negative control and 0.5 uM VX-680 (Tozasertib) (Selleck Chemical LLC) was used as a positive control. Cells were harvested after 2 h of treatment and processed for SDS-PAGE and western blotting as described previously (Gizatullin et al., ""The Aurora kinase inhibitor VX-680 induces endoreduplication and apoptosis preferentially in cells with compromised p53-dependent postmitotic checkpoint function"" Cancer Res. (2006) 66 (15):7668-77). After electro-transfer onto nitrocellulose membranes, the membranes were blocked at room temperature for 1 h with TBS containing 5% (w/v) milk and then washed with a mixture of TBS containing 0.2% Tween 20 (Sigma). The membranes were then gently shaken at 4° C. overnight with anti-phospho histone H3 (Ser 10) antibody (9701, Cell Signaling), and anti-GAPDH monoclonal antibody (E10086CF, Covance) diluted in TBS containing 5% BSA. The membranes were then incubated with HRP conjugated anti-rabbit or anti-mouse IgG antibody (Jackson ImmunoResearch Lab.) at room temperature for 1 h followed by washing with Tween 20-PBS. The membranes were washed again with PBS and developed with the ECL system (PerkinElmer) as described previously (Berndt et al., ""The Akt activation inhibitor TCN-P inhibits Akt phosphorylation by binding to the PH domain of Akt and blocking its recruitment to the plasma membrane."" Cell Death Differ. (2010) 17(11):1795-804)."	B	NS(=O)(=O)c1ccc(Nc2ncc(F)c(Nc3ccccc3Cl)n2)cc1		CHEMBL2170415	>	IC50	nM	10000.0	CHEMBL4722	Homo sapiens	IC50	nM	10000.0
371145	17745767	CHEMBL3888081	"In Vivo Aurora A inhibitory Assay ( MDA-MB-468): Specifically, MDA-MB-468 cells (American Type Culture Collection) were maintained in Dulbecco's modified Eagle's medium (DMEM) plus 10% fetus bovine serum (FBS) (Invitrogen, US) at 37° C., 5% CO2. The cells were plated in 6 cm dishes at a density of 2x105 cells/dish. Cells were then treated with the compounds (0-10 uM); DMSO was used as a negative control and 0.5 uM VX-680 (Tozasertib) (Selleck Chemical LLC) was used as a positive control. Cells were harvested after 2 h of treatment and processed for SDS-PAGE and western blotting as described previously (Gizatullin et al., ""The Aurora kinase inhibitor VX-680 induces endoreduplication and apoptosis preferentially in cells with compromised p53-dependent postmitotic checkpoint function"" Cancer Res. (2006) 66 (15):7668-77). After electro-transfer onto nitrocellulose membranes, the membranes were blocked at room temperature for 1 h with TBS containing 5% (w/v) milk and then washed with a mixture of TBS containing 0.2% Tween 20 (Sigma). The membranes were then gently shaken at 4° C. overnight with anti-phospho histone H3 (Ser 10) antibody (9701, Cell Signaling), and anti-GAPDH monoclonal antibody (E10086CF, Covance) diluted in TBS containing 5% BSA. The membranes were then incubated with HRP conjugated anti-rabbit or anti-mouse IgG antibody (Jackson ImmunoResearch Lab.) at room temperature for 1 h followed by washing with Tween 20-PBS. The membranes were washed again with PBS and developed with the ECL system (PerkinElmer) as described previously (Berndt et al., ""The Akt activation inhibitor TCN-P inhibits Akt phosphorylation by binding to the PH domain of Akt and blocking its recruitment to the plasma membrane."" Cell Death Differ. (2010) 17(11):1795-804)."	B	Clc1ccccc1Nc1ccnc(Nc2ccc(-c3nnn[nH]3)cc2)n1		CHEMBL2170416	>	IC50	nM	10000.0	CHEMBL4722	Homo sapiens	IC50	nM	10000.0
371146	17745768	CHEMBL3888081	"In Vivo Aurora A inhibitory Assay ( MDA-MB-468): Specifically, MDA-MB-468 cells (American Type Culture Collection) were maintained in Dulbecco's modified Eagle's medium (DMEM) plus 10% fetus bovine serum (FBS) (Invitrogen, US) at 37° C., 5% CO2. The cells were plated in 6 cm dishes at a density of 2x105 cells/dish. Cells were then treated with the compounds (0-10 uM); DMSO was used as a negative control and 0.5 uM VX-680 (Tozasertib) (Selleck Chemical LLC) was used as a positive control. Cells were harvested after 2 h of treatment and processed for SDS-PAGE and western blotting as described previously (Gizatullin et al., ""The Aurora kinase inhibitor VX-680 induces endoreduplication and apoptosis preferentially in cells with compromised p53-dependent postmitotic checkpoint function"" Cancer Res. (2006) 66 (15):7668-77). After electro-transfer onto nitrocellulose membranes, the membranes were blocked at room temperature for 1 h with TBS containing 5% (w/v) milk and then washed with a mixture of TBS containing 0.2% Tween 20 (Sigma). The membranes were then gently shaken at 4° C. overnight with anti-phospho histone H3 (Ser 10) antibody (9701, Cell Signaling), and anti-GAPDH monoclonal antibody (E10086CF, Covance) diluted in TBS containing 5% BSA. The membranes were then incubated with HRP conjugated anti-rabbit or anti-mouse IgG antibody (Jackson ImmunoResearch Lab.) at room temperature for 1 h followed by washing with Tween 20-PBS. The membranes were washed again with PBS and developed with the ECL system (PerkinElmer) as described previously (Berndt et al., ""The Akt activation inhibitor TCN-P inhibits Akt phosphorylation by binding to the PH domain of Akt and blocking its recruitment to the plasma membrane."" Cell Death Differ. (2010) 17(11):1795-804)."	B	Fc1cnc(Nc2ccc(-c3nnn[nH]3)cc2)nc1Nc1ccccc1Cl		CHEMBL2169893	>	IC50	nM	10000.0	CHEMBL4722	Homo sapiens	IC50	nM	10000.0
371147	17745769	CHEMBL3888081	"In Vivo Aurora A inhibitory Assay ( MDA-MB-468): Specifically, MDA-MB-468 cells (American Type Culture Collection) were maintained in Dulbecco's modified Eagle's medium (DMEM) plus 10% fetus bovine serum (FBS) (Invitrogen, US) at 37° C., 5% CO2. The cells were plated in 6 cm dishes at a density of 2x105 cells/dish. Cells were then treated with the compounds (0-10 uM); DMSO was used as a negative control and 0.5 uM VX-680 (Tozasertib) (Selleck Chemical LLC) was used as a positive control. Cells were harvested after 2 h of treatment and processed for SDS-PAGE and western blotting as described previously (Gizatullin et al., ""The Aurora kinase inhibitor VX-680 induces endoreduplication and apoptosis preferentially in cells with compromised p53-dependent postmitotic checkpoint function"" Cancer Res. (2006) 66 (15):7668-77). After electro-transfer onto nitrocellulose membranes, the membranes were blocked at room temperature for 1 h with TBS containing 5% (w/v) milk and then washed with a mixture of TBS containing 0.2% Tween 20 (Sigma). The membranes were then gently shaken at 4° C. overnight with anti-phospho histone H3 (Ser 10) antibody (9701, Cell Signaling), and anti-GAPDH monoclonal antibody (E10086CF, Covance) diluted in TBS containing 5% BSA. The membranes were then incubated with HRP conjugated anti-rabbit or anti-mouse IgG antibody (Jackson ImmunoResearch Lab.) at room temperature for 1 h followed by washing with Tween 20-PBS. The membranes were washed again with PBS and developed with the ECL system (PerkinElmer) as described previously (Berndt et al., ""The Akt activation inhibitor TCN-P inhibits Akt phosphorylation by binding to the PH domain of Akt and blocking its recruitment to the plasma membrane."" Cell Death Differ. (2010) 17(11):1795-804)."	B	Oc1cc(Nc2ncc(F)c(Nc3ccccc3Cl)n2)ccc1-c1nnn[nH]1		CHEMBL2170417	>	IC50	nM	10000.0	CHEMBL4722	Homo sapiens	IC50	nM	10000.0
371148	17745770	CHEMBL3888081	"In Vivo Aurora A inhibitory Assay ( MDA-MB-468): Specifically, MDA-MB-468 cells (American Type Culture Collection) were maintained in Dulbecco's modified Eagle's medium (DMEM) plus 10% fetus bovine serum (FBS) (Invitrogen, US) at 37° C., 5% CO2. The cells were plated in 6 cm dishes at a density of 2x105 cells/dish. Cells were then treated with the compounds (0-10 uM); DMSO was used as a negative control and 0.5 uM VX-680 (Tozasertib) (Selleck Chemical LLC) was used as a positive control. Cells were harvested after 2 h of treatment and processed for SDS-PAGE and western blotting as described previously (Gizatullin et al., ""The Aurora kinase inhibitor VX-680 induces endoreduplication and apoptosis preferentially in cells with compromised p53-dependent postmitotic checkpoint function"" Cancer Res. (2006) 66 (15):7668-77). After electro-transfer onto nitrocellulose membranes, the membranes were blocked at room temperature for 1 h with TBS containing 5% (w/v) milk and then washed with a mixture of TBS containing 0.2% Tween 20 (Sigma). The membranes were then gently shaken at 4° C. overnight with anti-phospho histone H3 (Ser 10) antibody (9701, Cell Signaling), and anti-GAPDH monoclonal antibody (E10086CF, Covance) diluted in TBS containing 5% BSA. The membranes were then incubated with HRP conjugated anti-rabbit or anti-mouse IgG antibody (Jackson ImmunoResearch Lab.) at room temperature for 1 h followed by washing with Tween 20-PBS. The membranes were washed again with PBS and developed with the ECL system (PerkinElmer) as described previously (Berndt et al., ""The Akt activation inhibitor TCN-P inhibits Akt phosphorylation by binding to the PH domain of Akt and blocking its recruitment to the plasma membrane."" Cell Death Differ. (2010) 17(11):1795-804)."	B	Clc1ccccc1Nc1nc(Nc2ccc(-c3nnn[nH]3)cc2)ncc1Cl		CHEMBL2170418	>	IC50	nM	10000.0	CHEMBL4722	Homo sapiens	IC50	nM	10000.0
371149	17745771	CHEMBL3888082	Enzyme Inhibition Assay: The phosphorylation of L-Hse was monitored by coupling the formation of ADP with pyruvate kinase and lactate dehydrogenase (PK/LDH). The resulting oxidation of NADH was monitored at 340 nm by using a SpectraMax plate reader in a 96-well format.	B	O=C(O)c1ccc(Nc2nccc(Nc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL3970534	=	IC50	nM	3940.0	CHEMBL4722	Homo sapiens	IC50	nM	3940.0
371150	17745772	CHEMBL3888082	Enzyme Inhibition Assay: The phosphorylation of L-Hse was monitored by coupling the formation of ADP with pyruvate kinase and lactate dehydrogenase (PK/LDH). The resulting oxidation of NADH was monitored at 340 nm by using a SpectraMax plate reader in a 96-well format.	B	NC(=O)c1ccc(Nc2nccc(Nc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL3899351	=	IC50	nM	226.0	CHEMBL4722	Homo sapiens	IC50	nM	226.0
371151	17745773	CHEMBL3888082	Enzyme Inhibition Assay: The phosphorylation of L-Hse was monitored by coupling the formation of ADP with pyruvate kinase and lactate dehydrogenase (PK/LDH). The resulting oxidation of NADH was monitored at 340 nm by using a SpectraMax plate reader in a 96-well format.	B	CC(C(N)=O)c1cccc(Nc2nccc(Nc3cccc(C(F)(F)F)c3)n2)c1		CHEMBL3975642	=	IC50	nM	1400.0	CHEMBL4722	Homo sapiens	IC50	nM	1400.0
371152	17745774	CHEMBL3888082	Enzyme Inhibition Assay: The phosphorylation of L-Hse was monitored by coupling the formation of ADP with pyruvate kinase and lactate dehydrogenase (PK/LDH). The resulting oxidation of NADH was monitored at 340 nm by using a SpectraMax plate reader in a 96-well format.	B	FC(F)(F)c1cccc(Nc2ccnc(Nc3cccc(C(F)(F)F)c3)n2)c1		CHEMBL3978679	=	IC50	nM	10000.0	CHEMBL4722	Homo sapiens	IC50	nM	10000.0
371153	17745775	CHEMBL3888082	Enzyme Inhibition Assay: The phosphorylation of L-Hse was monitored by coupling the formation of ADP with pyruvate kinase and lactate dehydrogenase (PK/LDH). The resulting oxidation of NADH was monitored at 340 nm by using a SpectraMax plate reader in a 96-well format.	B	O=C(O)c1ccccc1Nc1nccc(Nc2cccc(C(F)(F)F)c2)n1		CHEMBL3954884	=	IC50	nM	64000.0	CHEMBL4722	Homo sapiens	IC50	nM	64000.0
371154	17745776	CHEMBL3888082	Enzyme Inhibition Assay: The phosphorylation of L-Hse was monitored by coupling the formation of ADP with pyruvate kinase and lactate dehydrogenase (PK/LDH). The resulting oxidation of NADH was monitored at 340 nm by using a SpectraMax plate reader in a 96-well format.	B	NC(=O)c1cccc(Nc2nccc(Nc3cccc(C(F)(F)F)c3)n2)c1		CHEMBL3966220	=	IC50	nM	3600.0	CHEMBL4722	Homo sapiens	IC50	nM	3600.0
371155	17745777	CHEMBL3888082	Enzyme Inhibition Assay: The phosphorylation of L-Hse was monitored by coupling the formation of ADP with pyruvate kinase and lactate dehydrogenase (PK/LDH). The resulting oxidation of NADH was monitored at 340 nm by using a SpectraMax plate reader in a 96-well format.	B	NC(=O)Cc1cccc(Nc2nccc(Nc3cccc(C(F)(F)F)c3)n2)c1		CHEMBL3969341	=	IC50	nM	910.0	CHEMBL4722	Homo sapiens	IC50	nM	910.0
371156	17745778	CHEMBL3888082	Enzyme Inhibition Assay: The phosphorylation of L-Hse was monitored by coupling the formation of ADP with pyruvate kinase and lactate dehydrogenase (PK/LDH). The resulting oxidation of NADH was monitored at 340 nm by using a SpectraMax plate reader in a 96-well format.	B	O=C(O)c1cccc(Nc2nccc(Nc3cccc(C(F)(F)F)c3)n2)c1		CHEMBL3929900	=	IC50	nM	9320.0	CHEMBL4722	Homo sapiens	IC50	nM	9320.0
371157	17745779	CHEMBL3888082	Enzyme Inhibition Assay: The phosphorylation of L-Hse was monitored by coupling the formation of ADP with pyruvate kinase and lactate dehydrogenase (PK/LDH). The resulting oxidation of NADH was monitored at 340 nm by using a SpectraMax plate reader in a 96-well format.	B	NCCCCc1cccc(Nc2nccc(Nc3cccc(C(F)(F)F)c3)n2)c1		CHEMBL3933054	>	IC50	nM	15000.0	CHEMBL4722	Homo sapiens	IC50	nM	15000.0
371158	17745780	CHEMBL3888082	Enzyme Inhibition Assay: The phosphorylation of L-Hse was monitored by coupling the formation of ADP with pyruvate kinase and lactate dehydrogenase (PK/LDH). The resulting oxidation of NADH was monitored at 340 nm by using a SpectraMax plate reader in a 96-well format.	B	FC(F)(F)c1cccc(Nc2ccnc(Nc3ccccc3)n2)c1		CHEMBL3979148	=	IC50	nM	14100.0	CHEMBL4722	Homo sapiens	IC50	nM	14100.0
371159	17745781	CHEMBL3888082	Enzyme Inhibition Assay: The phosphorylation of L-Hse was monitored by coupling the formation of ADP with pyruvate kinase and lactate dehydrogenase (PK/LDH). The resulting oxidation of NADH was monitored at 340 nm by using a SpectraMax plate reader in a 96-well format.	B	NC(=O)CCCCc1cccc(Nc2nccc(Nc3cccc(C(F)(F)F)c3)n2)c1		CHEMBL3917769	=	IC50	nM	7460.0	CHEMBL4722	Homo sapiens	IC50	nM	7460.0
371160	17745782	CHEMBL3888082	Enzyme Inhibition Assay: The phosphorylation of L-Hse was monitored by coupling the formation of ADP with pyruvate kinase and lactate dehydrogenase (PK/LDH). The resulting oxidation of NADH was monitored at 340 nm by using a SpectraMax plate reader in a 96-well format.	B	NC(O)C1CCC(c2cccc(Nc3nccc(Nc4cccc(C(F)(F)F)c4)n3)c2)C1		CHEMBL3893288	=	IC50	nM	6250.0	CHEMBL4722	Homo sapiens	IC50	nM	6250.0
371161	17745783	CHEMBL3888082	Enzyme Inhibition Assay: The phosphorylation of L-Hse was monitored by coupling the formation of ADP with pyruvate kinase and lactate dehydrogenase (PK/LDH). The resulting oxidation of NADH was monitored at 340 nm by using a SpectraMax plate reader in a 96-well format.	B	CC(CC(N)=O)c1cccc(Nc2nccc(Nc3cccc(C(F)(F)F)c3)n2)c1	Outside typical range	CHEMBL3894354	>	IC50	nM	150000.0	CHEMBL4722	Homo sapiens	IC50	nM	150000.0
371162	17745784	CHEMBL3888082	Enzyme Inhibition Assay: The phosphorylation of L-Hse was monitored by coupling the formation of ADP with pyruvate kinase and lactate dehydrogenase (PK/LDH). The resulting oxidation of NADH was monitored at 340 nm by using a SpectraMax plate reader in a 96-well format.	B	O=C(Nc1ccc(Cl)cc1)c1cccc(Nc2nccc(Nc3cccc(C(F)(F)F)c3)n2)c1		CHEMBL3965790	=	IC50	nM	10200.0	CHEMBL4722	Homo sapiens	IC50	nM	10200.0
371163	17745785	CHEMBL3888082	Enzyme Inhibition Assay: The phosphorylation of L-Hse was monitored by coupling the formation of ADP with pyruvate kinase and lactate dehydrogenase (PK/LDH). The resulting oxidation of NADH was monitored at 340 nm by using a SpectraMax plate reader in a 96-well format.	B	O=C(Nc1ccccc1)c1cccc(Nc2nccc(Nc3cccc(C(F)(F)F)c3)n2)c1		CHEMBL3903320	=	IC50	nM	8500.0	CHEMBL4722	Homo sapiens	IC50	nM	8500.0
371164	17745786	CHEMBL3888082	Enzyme Inhibition Assay: The phosphorylation of L-Hse was monitored by coupling the formation of ADP with pyruvate kinase and lactate dehydrogenase (PK/LDH). The resulting oxidation of NADH was monitored at 340 nm by using a SpectraMax plate reader in a 96-well format.	B	CN(C)c1cc(Nc2ccccc2)nc(Nc2ccccc2)n1		CHEMBL3970937	>	IC50	nM	15000.0	CHEMBL4722	Homo sapiens	IC50	nM	15000.0
371165	17745787	CHEMBL3888082	Enzyme Inhibition Assay: The phosphorylation of L-Hse was monitored by coupling the formation of ADP with pyruvate kinase and lactate dehydrogenase (PK/LDH). The resulting oxidation of NADH was monitored at 340 nm by using a SpectraMax plate reader in a 96-well format.	B	CN(C)c1cc(Nc2ccccc2C(=O)O)nc(Nc2ccccc2)n1		CHEMBL3916557	>	IC50	nM	15000.0	CHEMBL4722	Homo sapiens	IC50	nM	15000.0
371166	17745788	CHEMBL3888082	Enzyme Inhibition Assay: The phosphorylation of L-Hse was monitored by coupling the formation of ADP with pyruvate kinase and lactate dehydrogenase (PK/LDH). The resulting oxidation of NADH was monitored at 340 nm by using a SpectraMax plate reader in a 96-well format.	B	CCOC(=O)c1ccc(Nc2ncc(N)c(Nc3ccccc3C(=O)O)n2)cc1		CHEMBL3986322	=	IC50	nM	260.0	CHEMBL4722	Homo sapiens	IC50	nM	260.0
371167	17745789	CHEMBL3888082	Enzyme Inhibition Assay: The phosphorylation of L-Hse was monitored by coupling the formation of ADP with pyruvate kinase and lactate dehydrogenase (PK/LDH). The resulting oxidation of NADH was monitored at 340 nm by using a SpectraMax plate reader in a 96-well format.	B	Cc1cnc(Nc2ccc(C(=O)O)cc2)nc1Nc1ccccc1C(=O)O		CHEMBL2170599	=	IC50	nM	145.0	CHEMBL4722	Homo sapiens	IC50	nM	145.0
371168	17745790	CHEMBL3888083	Protein Crystallography Inhibitory Activity Assay: Aurora A was exchanged into 50 mM phosphate buffer (pH 7.4) including 1 mM DTT via PD-10 columns and was concentrated to 20 mg mL-1 using Amicon Ultra-4 10K centrifugal devices (Millipore; Billerica, Mass.). Aurora A crystals were grown using sitting drop vapor diffusion at 18° C. from a 1:1 volume ratio of Aurora A and reservoir solution (200 mM sodium tartrate/20% polyethylene glycol 3350 for the DFG-in inhibitors or 10% Tacsimate/20% polyethylene glycol 3350 for the DFG-out inhibitors) with a final inhibitor concentration of 1 mM. Crystals appeared after two days and were allowed to grow for another 2 days. For data collection, crystals were harvested in a cryoprotectant mixture consisting of the respective reservoir composition including 1 mM inhibitor, 50 mM phosphate pH (7.4) and 25% (v/v) ethylene glycol.	B	O=C(O)c1ccc(Nc2nccc(Nc3ccccc3)n2)cc1		CHEMBL2170597	=	IC50	nM	10.0	CHEMBL4722	Homo sapiens	IC50	nM	10.0
371169	17745791	CHEMBL3888083	Protein Crystallography Inhibitory Activity Assay: Aurora A was exchanged into 50 mM phosphate buffer (pH 7.4) including 1 mM DTT via PD-10 columns and was concentrated to 20 mg mL-1 using Amicon Ultra-4 10K centrifugal devices (Millipore; Billerica, Mass.). Aurora A crystals were grown using sitting drop vapor diffusion at 18° C. from a 1:1 volume ratio of Aurora A and reservoir solution (200 mM sodium tartrate/20% polyethylene glycol 3350 for the DFG-in inhibitors or 10% Tacsimate/20% polyethylene glycol 3350 for the DFG-out inhibitors) with a final inhibitor concentration of 1 mM. Crystals appeared after two days and were allowed to grow for another 2 days. For data collection, crystals were harvested in a cryoprotectant mixture consisting of the respective reservoir composition including 1 mM inhibitor, 50 mM phosphate pH (7.4) and 25% (v/v) ethylene glycol.	B	O=C(O)c1ccc(Nc2nccc(Nc3ccccc3C(=O)O)n2)cc1		CHEMBL2170592	=	IC50	nM	6.1	CHEMBL4722	Homo sapiens	IC50	nM	6.1
371170	17745792	CHEMBL3888083	Protein Crystallography Inhibitory Activity Assay: Aurora A was exchanged into 50 mM phosphate buffer (pH 7.4) including 1 mM DTT via PD-10 columns and was concentrated to 20 mg mL-1 using Amicon Ultra-4 10K centrifugal devices (Millipore; Billerica, Mass.). Aurora A crystals were grown using sitting drop vapor diffusion at 18° C. from a 1:1 volume ratio of Aurora A and reservoir solution (200 mM sodium tartrate/20% polyethylene glycol 3350 for the DFG-in inhibitors or 10% Tacsimate/20% polyethylene glycol 3350 for the DFG-out inhibitors) with a final inhibitor concentration of 1 mM. Crystals appeared after two days and were allowed to grow for another 2 days. For data collection, crystals were harvested in a cryoprotectant mixture consisting of the respective reservoir composition including 1 mM inhibitor, 50 mM phosphate pH (7.4) and 25% (v/v) ethylene glycol.	B	O=C(O)c1ccc(Nc2nccc(Nc3ccccc3-c3ccccc3)n2)cc1		CHEMBL2170586	=	IC50	nM	149.0	CHEMBL4722	Homo sapiens	IC50	nM	149.0
371171	17745793	CHEMBL3888083	Protein Crystallography Inhibitory Activity Assay: Aurora A was exchanged into 50 mM phosphate buffer (pH 7.4) including 1 mM DTT via PD-10 columns and was concentrated to 20 mg mL-1 using Amicon Ultra-4 10K centrifugal devices (Millipore; Billerica, Mass.). Aurora A crystals were grown using sitting drop vapor diffusion at 18° C. from a 1:1 volume ratio of Aurora A and reservoir solution (200 mM sodium tartrate/20% polyethylene glycol 3350 for the DFG-in inhibitors or 10% Tacsimate/20% polyethylene glycol 3350 for the DFG-out inhibitors) with a final inhibitor concentration of 1 mM. Crystals appeared after two days and were allowed to grow for another 2 days. For data collection, crystals were harvested in a cryoprotectant mixture consisting of the respective reservoir composition including 1 mM inhibitor, 50 mM phosphate pH (7.4) and 25% (v/v) ethylene glycol.	B	O=C(O)c1ccc(Nc2nccc(Nc3ccccc3C(F)(F)F)n2)cc1		CHEMBL2170434	=	IC50	nM	35.0	CHEMBL4722	Homo sapiens	IC50	nM	35.0
371172	17745794	CHEMBL3888083	Protein Crystallography Inhibitory Activity Assay: Aurora A was exchanged into 50 mM phosphate buffer (pH 7.4) including 1 mM DTT via PD-10 columns and was concentrated to 20 mg mL-1 using Amicon Ultra-4 10K centrifugal devices (Millipore; Billerica, Mass.). Aurora A crystals were grown using sitting drop vapor diffusion at 18° C. from a 1:1 volume ratio of Aurora A and reservoir solution (200 mM sodium tartrate/20% polyethylene glycol 3350 for the DFG-in inhibitors or 10% Tacsimate/20% polyethylene glycol 3350 for the DFG-out inhibitors) with a final inhibitor concentration of 1 mM. Crystals appeared after two days and were allowed to grow for another 2 days. For data collection, crystals were harvested in a cryoprotectant mixture consisting of the respective reservoir composition including 1 mM inhibitor, 50 mM phosphate pH (7.4) and 25% (v/v) ethylene glycol.	B	O=C(O)c1ccc(Nc2nccc(Nc3ccc(F)cc3OC(F)(F)F)n2)cc1		CHEMBL3958960	=	IC50	nM	28.0	CHEMBL4722	Homo sapiens	IC50	nM	28.0
371173	17745795	CHEMBL3888083	Protein Crystallography Inhibitory Activity Assay: Aurora A was exchanged into 50 mM phosphate buffer (pH 7.4) including 1 mM DTT via PD-10 columns and was concentrated to 20 mg mL-1 using Amicon Ultra-4 10K centrifugal devices (Millipore; Billerica, Mass.). Aurora A crystals were grown using sitting drop vapor diffusion at 18° C. from a 1:1 volume ratio of Aurora A and reservoir solution (200 mM sodium tartrate/20% polyethylene glycol 3350 for the DFG-in inhibitors or 10% Tacsimate/20% polyethylene glycol 3350 for the DFG-out inhibitors) with a final inhibitor concentration of 1 mM. Crystals appeared after two days and were allowed to grow for another 2 days. For data collection, crystals were harvested in a cryoprotectant mixture consisting of the respective reservoir composition including 1 mM inhibitor, 50 mM phosphate pH (7.4) and 25% (v/v) ethylene glycol.	B	O=C(O)c1ccc(Nc2nccc(Nc3ccccc3F)n2)cc1		CHEMBL2170427	=	IC50	nM	3.7	CHEMBL4722	Homo sapiens	IC50	nM	3.7
371174	17745796	CHEMBL3888083	Protein Crystallography Inhibitory Activity Assay: Aurora A was exchanged into 50 mM phosphate buffer (pH 7.4) including 1 mM DTT via PD-10 columns and was concentrated to 20 mg mL-1 using Amicon Ultra-4 10K centrifugal devices (Millipore; Billerica, Mass.). Aurora A crystals were grown using sitting drop vapor diffusion at 18° C. from a 1:1 volume ratio of Aurora A and reservoir solution (200 mM sodium tartrate/20% polyethylene glycol 3350 for the DFG-in inhibitors or 10% Tacsimate/20% polyethylene glycol 3350 for the DFG-out inhibitors) with a final inhibitor concentration of 1 mM. Crystals appeared after two days and were allowed to grow for another 2 days. For data collection, crystals were harvested in a cryoprotectant mixture consisting of the respective reservoir composition including 1 mM inhibitor, 50 mM phosphate pH (7.4) and 25% (v/v) ethylene glycol.	B	O=C(O)c1ccc(Nc2nccc(Nc3ccccc3Cl)n2)cc1		CHEMBL2170601	=	IC50	nM	2.5	CHEMBL4722	Homo sapiens	IC50	nM	2.5
371175	17745797	CHEMBL3888083	Protein Crystallography Inhibitory Activity Assay: Aurora A was exchanged into 50 mM phosphate buffer (pH 7.4) including 1 mM DTT via PD-10 columns and was concentrated to 20 mg mL-1 using Amicon Ultra-4 10K centrifugal devices (Millipore; Billerica, Mass.). Aurora A crystals were grown using sitting drop vapor diffusion at 18° C. from a 1:1 volume ratio of Aurora A and reservoir solution (200 mM sodium tartrate/20% polyethylene glycol 3350 for the DFG-in inhibitors or 10% Tacsimate/20% polyethylene glycol 3350 for the DFG-out inhibitors) with a final inhibitor concentration of 1 mM. Crystals appeared after two days and were allowed to grow for another 2 days. For data collection, crystals were harvested in a cryoprotectant mixture consisting of the respective reservoir composition including 1 mM inhibitor, 50 mM phosphate pH (7.4) and 25% (v/v) ethylene glycol.	B	O=C(O)c1ccc(Nc2nccc(Nc3ccccc3Br)n2)cc1		CHEMBL2170435	=	IC50	nM	2.1	CHEMBL4722	Homo sapiens	IC50	nM	2.1
371176	17745798	CHEMBL3888083	Protein Crystallography Inhibitory Activity Assay: Aurora A was exchanged into 50 mM phosphate buffer (pH 7.4) including 1 mM DTT via PD-10 columns and was concentrated to 20 mg mL-1 using Amicon Ultra-4 10K centrifugal devices (Millipore; Billerica, Mass.). Aurora A crystals were grown using sitting drop vapor diffusion at 18° C. from a 1:1 volume ratio of Aurora A and reservoir solution (200 mM sodium tartrate/20% polyethylene glycol 3350 for the DFG-in inhibitors or 10% Tacsimate/20% polyethylene glycol 3350 for the DFG-out inhibitors) with a final inhibitor concentration of 1 mM. Crystals appeared after two days and were allowed to grow for another 2 days. For data collection, crystals were harvested in a cryoprotectant mixture consisting of the respective reservoir composition including 1 mM inhibitor, 50 mM phosphate pH (7.4) and 25% (v/v) ethylene glycol.	B	N#Cc1ccccc1Nc1ccnc(Nc2ccc(C(=O)O)cc2)n1		CHEMBL2170440	=	IC50	nM	43.0	CHEMBL4722	Homo sapiens	IC50	nM	43.0
371177	17745799	CHEMBL3888083	Protein Crystallography Inhibitory Activity Assay: Aurora A was exchanged into 50 mM phosphate buffer (pH 7.4) including 1 mM DTT via PD-10 columns and was concentrated to 20 mg mL-1 using Amicon Ultra-4 10K centrifugal devices (Millipore; Billerica, Mass.). Aurora A crystals were grown using sitting drop vapor diffusion at 18° C. from a 1:1 volume ratio of Aurora A and reservoir solution (200 mM sodium tartrate/20% polyethylene glycol 3350 for the DFG-in inhibitors or 10% Tacsimate/20% polyethylene glycol 3350 for the DFG-out inhibitors) with a final inhibitor concentration of 1 mM. Crystals appeared after two days and were allowed to grow for another 2 days. For data collection, crystals were harvested in a cryoprotectant mixture consisting of the respective reservoir composition including 1 mM inhibitor, 50 mM phosphate pH (7.4) and 25% (v/v) ethylene glycol.	B	O=C(O)c1ccc(Nc2ncc(F)c(Nc3ccccc3Cl)n2)cc1		CHEMBL2170419	=	IC50	nM	0.8	CHEMBL4722	Homo sapiens	IC50	nM	0.8
371178	17745800	CHEMBL3888083	Protein Crystallography Inhibitory Activity Assay: Aurora A was exchanged into 50 mM phosphate buffer (pH 7.4) including 1 mM DTT via PD-10 columns and was concentrated to 20 mg mL-1 using Amicon Ultra-4 10K centrifugal devices (Millipore; Billerica, Mass.). Aurora A crystals were grown using sitting drop vapor diffusion at 18° C. from a 1:1 volume ratio of Aurora A and reservoir solution (200 mM sodium tartrate/20% polyethylene glycol 3350 for the DFG-in inhibitors or 10% Tacsimate/20% polyethylene glycol 3350 for the DFG-out inhibitors) with a final inhibitor concentration of 1 mM. Crystals appeared after two days and were allowed to grow for another 2 days. For data collection, crystals were harvested in a cryoprotectant mixture consisting of the respective reservoir composition including 1 mM inhibitor, 50 mM phosphate pH (7.4) and 25% (v/v) ethylene glycol.	B	Clc1ccccc1Nc1ccnc(Nc2ccc(-c3nnn[nH]3)cc2)n1		CHEMBL2170416	=	IC50	nM	3.1	CHEMBL4722	Homo sapiens	IC50	nM	3.1
371179	17745801	CHEMBL3888083	Protein Crystallography Inhibitory Activity Assay: Aurora A was exchanged into 50 mM phosphate buffer (pH 7.4) including 1 mM DTT via PD-10 columns and was concentrated to 20 mg mL-1 using Amicon Ultra-4 10K centrifugal devices (Millipore; Billerica, Mass.). Aurora A crystals were grown using sitting drop vapor diffusion at 18° C. from a 1:1 volume ratio of Aurora A and reservoir solution (200 mM sodium tartrate/20% polyethylene glycol 3350 for the DFG-in inhibitors or 10% Tacsimate/20% polyethylene glycol 3350 for the DFG-out inhibitors) with a final inhibitor concentration of 1 mM. Crystals appeared after two days and were allowed to grow for another 2 days. For data collection, crystals were harvested in a cryoprotectant mixture consisting of the respective reservoir composition including 1 mM inhibitor, 50 mM phosphate pH (7.4) and 25% (v/v) ethylene glycol.	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	IC50	nM	2.8	CHEMBL4722	Homo sapiens	IC50	nM	2.8
371180	17745802	CHEMBL3888084	Isothermal titration calorimetry (ITC): The binding of inhibitors to Aurora A kinase was analyzed with a MicroCal iTC200 titration calorimeter (GE Healthcare, Piscataway, N.J.). The protein was exchanged into 100 mM Na/K phosphate (pH 7.4) via PD-10 columns (GE Healthcare Lifesciences; Piscataway, N.J.). A total of 18 aliquots (2.2 uL each) of the protein solution (125 uM) were injected into 200 μL of the inhibitor solution (10 uM) at 25° C. The ITC cell mixture was constantly stirred at 1000 rpm and recorded for 120 seconds between injections. Heat generation due to dilution (blank) was determined in a separate experiment by diluting protein into buffer. The corrected heat values were fitted using a nonlinear least square curve-fitting algorithm (Microcal Origin 7.0) to obtain the stoichiometry (n), binding constant (Ka, Kd).	B	O=C(O)c1ccc(Nc2nccc(Nc3ccccc3)n2)cc1		CHEMBL2170597	=	IC50	nM	10.0	CHEMBL4722	Homo sapiens	IC50	nM	10.0
371180	17745803	CHEMBL3888084	Isothermal titration calorimetry (ITC): The binding of inhibitors to Aurora A kinase was analyzed with a MicroCal iTC200 titration calorimeter (GE Healthcare, Piscataway, N.J.). The protein was exchanged into 100 mM Na/K phosphate (pH 7.4) via PD-10 columns (GE Healthcare Lifesciences; Piscataway, N.J.). A total of 18 aliquots (2.2 uL each) of the protein solution (125 uM) were injected into 200 μL of the inhibitor solution (10 uM) at 25° C. The ITC cell mixture was constantly stirred at 1000 rpm and recorded for 120 seconds between injections. Heat generation due to dilution (blank) was determined in a separate experiment by diluting protein into buffer. The corrected heat values were fitted using a nonlinear least square curve-fitting algorithm (Microcal Origin 7.0) to obtain the stoichiometry (n), binding constant (Ka, Kd).	B	O=C(O)c1ccc(Nc2nccc(Nc3ccccc3)n2)cc1		CHEMBL2170597	=	Kd	nM	39.0	CHEMBL4722	Homo sapiens	Kd	nM	39.0
371181	17745804	CHEMBL3888084	Isothermal titration calorimetry (ITC): The binding of inhibitors to Aurora A kinase was analyzed with a MicroCal iTC200 titration calorimeter (GE Healthcare, Piscataway, N.J.). The protein was exchanged into 100 mM Na/K phosphate (pH 7.4) via PD-10 columns (GE Healthcare Lifesciences; Piscataway, N.J.). A total of 18 aliquots (2.2 uL each) of the protein solution (125 uM) were injected into 200 μL of the inhibitor solution (10 uM) at 25° C. The ITC cell mixture was constantly stirred at 1000 rpm and recorded for 120 seconds between injections. Heat generation due to dilution (blank) was determined in a separate experiment by diluting protein into buffer. The corrected heat values were fitted using a nonlinear least square curve-fitting algorithm (Microcal Origin 7.0) to obtain the stoichiometry (n), binding constant (Ka, Kd).	B	O=C(O)c1ccc(Nc2nccc(Nc3ccccc3C(=O)O)n2)cc1		CHEMBL2170592	=	IC50	nM	6.1	CHEMBL4722	Homo sapiens	IC50	nM	6.1
371181	17745805	CHEMBL3888084	Isothermal titration calorimetry (ITC): The binding of inhibitors to Aurora A kinase was analyzed with a MicroCal iTC200 titration calorimeter (GE Healthcare, Piscataway, N.J.). The protein was exchanged into 100 mM Na/K phosphate (pH 7.4) via PD-10 columns (GE Healthcare Lifesciences; Piscataway, N.J.). A total of 18 aliquots (2.2 uL each) of the protein solution (125 uM) were injected into 200 μL of the inhibitor solution (10 uM) at 25° C. The ITC cell mixture was constantly stirred at 1000 rpm and recorded for 120 seconds between injections. Heat generation due to dilution (blank) was determined in a separate experiment by diluting protein into buffer. The corrected heat values were fitted using a nonlinear least square curve-fitting algorithm (Microcal Origin 7.0) to obtain the stoichiometry (n), binding constant (Ka, Kd).	B	O=C(O)c1ccc(Nc2nccc(Nc3ccccc3C(=O)O)n2)cc1		CHEMBL2170592	=	Kd	nM	34.0	CHEMBL4722	Homo sapiens	Kd	nM	34.0
371182	17745806	CHEMBL3888084	Isothermal titration calorimetry (ITC): The binding of inhibitors to Aurora A kinase was analyzed with a MicroCal iTC200 titration calorimeter (GE Healthcare, Piscataway, N.J.). The protein was exchanged into 100 mM Na/K phosphate (pH 7.4) via PD-10 columns (GE Healthcare Lifesciences; Piscataway, N.J.). A total of 18 aliquots (2.2 uL each) of the protein solution (125 uM) were injected into 200 μL of the inhibitor solution (10 uM) at 25° C. The ITC cell mixture was constantly stirred at 1000 rpm and recorded for 120 seconds between injections. Heat generation due to dilution (blank) was determined in a separate experiment by diluting protein into buffer. The corrected heat values were fitted using a nonlinear least square curve-fitting algorithm (Microcal Origin 7.0) to obtain the stoichiometry (n), binding constant (Ka, Kd).	B	O=C(O)c1ccc(Nc2nccc(Nc3ccccc3-c3ccccc3)n2)cc1		CHEMBL2170586	=	IC50	nM	149.0	CHEMBL4722	Homo sapiens	IC50	nM	149.0
371182	17745807	CHEMBL3888084	Isothermal titration calorimetry (ITC): The binding of inhibitors to Aurora A kinase was analyzed with a MicroCal iTC200 titration calorimeter (GE Healthcare, Piscataway, N.J.). The protein was exchanged into 100 mM Na/K phosphate (pH 7.4) via PD-10 columns (GE Healthcare Lifesciences; Piscataway, N.J.). A total of 18 aliquots (2.2 uL each) of the protein solution (125 uM) were injected into 200 μL of the inhibitor solution (10 uM) at 25° C. The ITC cell mixture was constantly stirred at 1000 rpm and recorded for 120 seconds between injections. Heat generation due to dilution (blank) was determined in a separate experiment by diluting protein into buffer. The corrected heat values were fitted using a nonlinear least square curve-fitting algorithm (Microcal Origin 7.0) to obtain the stoichiometry (n), binding constant (Ka, Kd).	B	O=C(O)c1ccc(Nc2nccc(Nc3ccccc3-c3ccccc3)n2)cc1		CHEMBL2170586	=	Kd	nM	299.0	CHEMBL4722	Homo sapiens	Kd	nM	299.0
371183	17745808	CHEMBL3888084	Isothermal titration calorimetry (ITC): The binding of inhibitors to Aurora A kinase was analyzed with a MicroCal iTC200 titration calorimeter (GE Healthcare, Piscataway, N.J.). The protein was exchanged into 100 mM Na/K phosphate (pH 7.4) via PD-10 columns (GE Healthcare Lifesciences; Piscataway, N.J.). A total of 18 aliquots (2.2 uL each) of the protein solution (125 uM) were injected into 200 μL of the inhibitor solution (10 uM) at 25° C. The ITC cell mixture was constantly stirred at 1000 rpm and recorded for 120 seconds between injections. Heat generation due to dilution (blank) was determined in a separate experiment by diluting protein into buffer. The corrected heat values were fitted using a nonlinear least square curve-fitting algorithm (Microcal Origin 7.0) to obtain the stoichiometry (n), binding constant (Ka, Kd).	B	O=C(O)c1ccc(Nc2nccc(Nc3ccccc3C(F)(F)F)n2)cc1		CHEMBL2170434	=	IC50	nM	35.0	CHEMBL4722	Homo sapiens	IC50	nM	35.0
371183	17745809	CHEMBL3888084	Isothermal titration calorimetry (ITC): The binding of inhibitors to Aurora A kinase was analyzed with a MicroCal iTC200 titration calorimeter (GE Healthcare, Piscataway, N.J.). The protein was exchanged into 100 mM Na/K phosphate (pH 7.4) via PD-10 columns (GE Healthcare Lifesciences; Piscataway, N.J.). A total of 18 aliquots (2.2 uL each) of the protein solution (125 uM) were injected into 200 μL of the inhibitor solution (10 uM) at 25° C. The ITC cell mixture was constantly stirred at 1000 rpm and recorded for 120 seconds between injections. Heat generation due to dilution (blank) was determined in a separate experiment by diluting protein into buffer. The corrected heat values were fitted using a nonlinear least square curve-fitting algorithm (Microcal Origin 7.0) to obtain the stoichiometry (n), binding constant (Ka, Kd).	B	O=C(O)c1ccc(Nc2nccc(Nc3ccccc3C(F)(F)F)n2)cc1		CHEMBL2170434	=	Kd	nM	49.0	CHEMBL4722	Homo sapiens	Kd	nM	49.0
371184	17745810	CHEMBL3888084	Isothermal titration calorimetry (ITC): The binding of inhibitors to Aurora A kinase was analyzed with a MicroCal iTC200 titration calorimeter (GE Healthcare, Piscataway, N.J.). The protein was exchanged into 100 mM Na/K phosphate (pH 7.4) via PD-10 columns (GE Healthcare Lifesciences; Piscataway, N.J.). A total of 18 aliquots (2.2 uL each) of the protein solution (125 uM) were injected into 200 μL of the inhibitor solution (10 uM) at 25° C. The ITC cell mixture was constantly stirred at 1000 rpm and recorded for 120 seconds between injections. Heat generation due to dilution (blank) was determined in a separate experiment by diluting protein into buffer. The corrected heat values were fitted using a nonlinear least square curve-fitting algorithm (Microcal Origin 7.0) to obtain the stoichiometry (n), binding constant (Ka, Kd).	B	O=C(O)c1ccc(Nc2nccc(Nc3ccc(F)cc3OC(F)(F)F)n2)cc1		CHEMBL3958960	=	IC50	nM	28.0	CHEMBL4722	Homo sapiens	IC50	nM	28.0
371184	17745811	CHEMBL3888084	Isothermal titration calorimetry (ITC): The binding of inhibitors to Aurora A kinase was analyzed with a MicroCal iTC200 titration calorimeter (GE Healthcare, Piscataway, N.J.). The protein was exchanged into 100 mM Na/K phosphate (pH 7.4) via PD-10 columns (GE Healthcare Lifesciences; Piscataway, N.J.). A total of 18 aliquots (2.2 uL each) of the protein solution (125 uM) were injected into 200 μL of the inhibitor solution (10 uM) at 25° C. The ITC cell mixture was constantly stirred at 1000 rpm and recorded for 120 seconds between injections. Heat generation due to dilution (blank) was determined in a separate experiment by diluting protein into buffer. The corrected heat values were fitted using a nonlinear least square curve-fitting algorithm (Microcal Origin 7.0) to obtain the stoichiometry (n), binding constant (Ka, Kd).	B	O=C(O)c1ccc(Nc2nccc(Nc3ccc(F)cc3OC(F)(F)F)n2)cc1		CHEMBL3958960	=	Kd	nM	40.0	CHEMBL4722	Homo sapiens	Kd	nM	40.0
371185	17745812	CHEMBL3888084	Isothermal titration calorimetry (ITC): The binding of inhibitors to Aurora A kinase was analyzed with a MicroCal iTC200 titration calorimeter (GE Healthcare, Piscataway, N.J.). The protein was exchanged into 100 mM Na/K phosphate (pH 7.4) via PD-10 columns (GE Healthcare Lifesciences; Piscataway, N.J.). A total of 18 aliquots (2.2 uL each) of the protein solution (125 uM) were injected into 200 μL of the inhibitor solution (10 uM) at 25° C. The ITC cell mixture was constantly stirred at 1000 rpm and recorded for 120 seconds between injections. Heat generation due to dilution (blank) was determined in a separate experiment by diluting protein into buffer. The corrected heat values were fitted using a nonlinear least square curve-fitting algorithm (Microcal Origin 7.0) to obtain the stoichiometry (n), binding constant (Ka, Kd).	B	O=C(O)c1ccc(Nc2nccc(Nc3ccccc3F)n2)cc1		CHEMBL2170427	=	IC50	nM	3.7	CHEMBL4722	Homo sapiens	IC50	nM	3.7
371185	17745813	CHEMBL3888084	Isothermal titration calorimetry (ITC): The binding of inhibitors to Aurora A kinase was analyzed with a MicroCal iTC200 titration calorimeter (GE Healthcare, Piscataway, N.J.). The protein was exchanged into 100 mM Na/K phosphate (pH 7.4) via PD-10 columns (GE Healthcare Lifesciences; Piscataway, N.J.). A total of 18 aliquots (2.2 uL each) of the protein solution (125 uM) were injected into 200 μL of the inhibitor solution (10 uM) at 25° C. The ITC cell mixture was constantly stirred at 1000 rpm and recorded for 120 seconds between injections. Heat generation due to dilution (blank) was determined in a separate experiment by diluting protein into buffer. The corrected heat values were fitted using a nonlinear least square curve-fitting algorithm (Microcal Origin 7.0) to obtain the stoichiometry (n), binding constant (Ka, Kd).	B	O=C(O)c1ccc(Nc2nccc(Nc3ccccc3F)n2)cc1		CHEMBL2170427	=	Kd	nM	16.0	CHEMBL4722	Homo sapiens	Kd	nM	16.0
371186	17745814	CHEMBL3888084	Isothermal titration calorimetry (ITC): The binding of inhibitors to Aurora A kinase was analyzed with a MicroCal iTC200 titration calorimeter (GE Healthcare, Piscataway, N.J.). The protein was exchanged into 100 mM Na/K phosphate (pH 7.4) via PD-10 columns (GE Healthcare Lifesciences; Piscataway, N.J.). A total of 18 aliquots (2.2 uL each) of the protein solution (125 uM) were injected into 200 μL of the inhibitor solution (10 uM) at 25° C. The ITC cell mixture was constantly stirred at 1000 rpm and recorded for 120 seconds between injections. Heat generation due to dilution (blank) was determined in a separate experiment by diluting protein into buffer. The corrected heat values were fitted using a nonlinear least square curve-fitting algorithm (Microcal Origin 7.0) to obtain the stoichiometry (n), binding constant (Ka, Kd).	B	O=C(O)c1ccc(Nc2nccc(Nc3ccccc3Cl)n2)cc1		CHEMBL2170601	=	IC50	nM	2.5	CHEMBL4722	Homo sapiens	IC50	nM	2.5
371186	17745815	CHEMBL3888084	Isothermal titration calorimetry (ITC): The binding of inhibitors to Aurora A kinase was analyzed with a MicroCal iTC200 titration calorimeter (GE Healthcare, Piscataway, N.J.). The protein was exchanged into 100 mM Na/K phosphate (pH 7.4) via PD-10 columns (GE Healthcare Lifesciences; Piscataway, N.J.). A total of 18 aliquots (2.2 uL each) of the protein solution (125 uM) were injected into 200 μL of the inhibitor solution (10 uM) at 25° C. The ITC cell mixture was constantly stirred at 1000 rpm and recorded for 120 seconds between injections. Heat generation due to dilution (blank) was determined in a separate experiment by diluting protein into buffer. The corrected heat values were fitted using a nonlinear least square curve-fitting algorithm (Microcal Origin 7.0) to obtain the stoichiometry (n), binding constant (Ka, Kd).	B	O=C(O)c1ccc(Nc2nccc(Nc3ccccc3Cl)n2)cc1		CHEMBL2170601	=	Kd	nM	15.0	CHEMBL4722	Homo sapiens	Kd	nM	15.0
371187	17745816	CHEMBL3888084	Isothermal titration calorimetry (ITC): The binding of inhibitors to Aurora A kinase was analyzed with a MicroCal iTC200 titration calorimeter (GE Healthcare, Piscataway, N.J.). The protein was exchanged into 100 mM Na/K phosphate (pH 7.4) via PD-10 columns (GE Healthcare Lifesciences; Piscataway, N.J.). A total of 18 aliquots (2.2 uL each) of the protein solution (125 uM) were injected into 200 μL of the inhibitor solution (10 uM) at 25° C. The ITC cell mixture was constantly stirred at 1000 rpm and recorded for 120 seconds between injections. Heat generation due to dilution (blank) was determined in a separate experiment by diluting protein into buffer. The corrected heat values were fitted using a nonlinear least square curve-fitting algorithm (Microcal Origin 7.0) to obtain the stoichiometry (n), binding constant (Ka, Kd).	B	O=C(O)c1ccc(Nc2nccc(Nc3ccccc3Br)n2)cc1		CHEMBL2170435	=	IC50	nM	2.1	CHEMBL4722	Homo sapiens	IC50	nM	2.1
371187	17745817	CHEMBL3888084	Isothermal titration calorimetry (ITC): The binding of inhibitors to Aurora A kinase was analyzed with a MicroCal iTC200 titration calorimeter (GE Healthcare, Piscataway, N.J.). The protein was exchanged into 100 mM Na/K phosphate (pH 7.4) via PD-10 columns (GE Healthcare Lifesciences; Piscataway, N.J.). A total of 18 aliquots (2.2 uL each) of the protein solution (125 uM) were injected into 200 μL of the inhibitor solution (10 uM) at 25° C. The ITC cell mixture was constantly stirred at 1000 rpm and recorded for 120 seconds between injections. Heat generation due to dilution (blank) was determined in a separate experiment by diluting protein into buffer. The corrected heat values were fitted using a nonlinear least square curve-fitting algorithm (Microcal Origin 7.0) to obtain the stoichiometry (n), binding constant (Ka, Kd).	B	O=C(O)c1ccc(Nc2nccc(Nc3ccccc3Br)n2)cc1		CHEMBL2170435	=	Kd	nM	13.0	CHEMBL4722	Homo sapiens	Kd	nM	13.0
371188	17745818	CHEMBL3888084	Isothermal titration calorimetry (ITC): The binding of inhibitors to Aurora A kinase was analyzed with a MicroCal iTC200 titration calorimeter (GE Healthcare, Piscataway, N.J.). The protein was exchanged into 100 mM Na/K phosphate (pH 7.4) via PD-10 columns (GE Healthcare Lifesciences; Piscataway, N.J.). A total of 18 aliquots (2.2 uL each) of the protein solution (125 uM) were injected into 200 μL of the inhibitor solution (10 uM) at 25° C. The ITC cell mixture was constantly stirred at 1000 rpm and recorded for 120 seconds between injections. Heat generation due to dilution (blank) was determined in a separate experiment by diluting protein into buffer. The corrected heat values were fitted using a nonlinear least square curve-fitting algorithm (Microcal Origin 7.0) to obtain the stoichiometry (n), binding constant (Ka, Kd).	B	N#Cc1ccccc1Nc1ccnc(Nc2ccc(C(=O)O)cc2)n1		CHEMBL2170440	=	IC50	nM	43.0	CHEMBL4722	Homo sapiens	IC50	nM	43.0
371188	17745819	CHEMBL3888084	Isothermal titration calorimetry (ITC): The binding of inhibitors to Aurora A kinase was analyzed with a MicroCal iTC200 titration calorimeter (GE Healthcare, Piscataway, N.J.). The protein was exchanged into 100 mM Na/K phosphate (pH 7.4) via PD-10 columns (GE Healthcare Lifesciences; Piscataway, N.J.). A total of 18 aliquots (2.2 uL each) of the protein solution (125 uM) were injected into 200 μL of the inhibitor solution (10 uM) at 25° C. The ITC cell mixture was constantly stirred at 1000 rpm and recorded for 120 seconds between injections. Heat generation due to dilution (blank) was determined in a separate experiment by diluting protein into buffer. The corrected heat values were fitted using a nonlinear least square curve-fitting algorithm (Microcal Origin 7.0) to obtain the stoichiometry (n), binding constant (Ka, Kd).	B	N#Cc1ccccc1Nc1ccnc(Nc2ccc(C(=O)O)cc2)n1		CHEMBL2170440	=	Kd	nM	51.0	CHEMBL4722	Homo sapiens	Kd	nM	51.0
371189	17745820	CHEMBL3888084	Isothermal titration calorimetry (ITC): The binding of inhibitors to Aurora A kinase was analyzed with a MicroCal iTC200 titration calorimeter (GE Healthcare, Piscataway, N.J.). The protein was exchanged into 100 mM Na/K phosphate (pH 7.4) via PD-10 columns (GE Healthcare Lifesciences; Piscataway, N.J.). A total of 18 aliquots (2.2 uL each) of the protein solution (125 uM) were injected into 200 μL of the inhibitor solution (10 uM) at 25° C. The ITC cell mixture was constantly stirred at 1000 rpm and recorded for 120 seconds between injections. Heat generation due to dilution (blank) was determined in a separate experiment by diluting protein into buffer. The corrected heat values were fitted using a nonlinear least square curve-fitting algorithm (Microcal Origin 7.0) to obtain the stoichiometry (n), binding constant (Ka, Kd).	B	Clc1ccccc1Nc1ccnc(Nc2ccc(-c3nnn[nH]3)cc2)n1		CHEMBL2170416	=	IC50	nM	3.1	CHEMBL4722	Homo sapiens	IC50	nM	3.1
371189	17745821	CHEMBL3888084	Isothermal titration calorimetry (ITC): The binding of inhibitors to Aurora A kinase was analyzed with a MicroCal iTC200 titration calorimeter (GE Healthcare, Piscataway, N.J.). The protein was exchanged into 100 mM Na/K phosphate (pH 7.4) via PD-10 columns (GE Healthcare Lifesciences; Piscataway, N.J.). A total of 18 aliquots (2.2 uL each) of the protein solution (125 uM) were injected into 200 μL of the inhibitor solution (10 uM) at 25° C. The ITC cell mixture was constantly stirred at 1000 rpm and recorded for 120 seconds between injections. Heat generation due to dilution (blank) was determined in a separate experiment by diluting protein into buffer. The corrected heat values were fitted using a nonlinear least square curve-fitting algorithm (Microcal Origin 7.0) to obtain the stoichiometry (n), binding constant (Ka, Kd).	B	Clc1ccccc1Nc1ccnc(Nc2ccc(-c3nnn[nH]3)cc2)n1		CHEMBL2170416	=	Kd	nM	18.0	CHEMBL4722	Homo sapiens	Kd	nM	18.0
371190	17745822	CHEMBL3888084	Isothermal titration calorimetry (ITC): The binding of inhibitors to Aurora A kinase was analyzed with a MicroCal iTC200 titration calorimeter (GE Healthcare, Piscataway, N.J.). The protein was exchanged into 100 mM Na/K phosphate (pH 7.4) via PD-10 columns (GE Healthcare Lifesciences; Piscataway, N.J.). A total of 18 aliquots (2.2 uL each) of the protein solution (125 uM) were injected into 200 μL of the inhibitor solution (10 uM) at 25° C. The ITC cell mixture was constantly stirred at 1000 rpm and recorded for 120 seconds between injections. Heat generation due to dilution (blank) was determined in a separate experiment by diluting protein into buffer. The corrected heat values were fitted using a nonlinear least square curve-fitting algorithm (Microcal Origin 7.0) to obtain the stoichiometry (n), binding constant (Ka, Kd).	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	IC50	nM	2.8	CHEMBL4722	Homo sapiens	IC50	nM	2.8
371190	17745823	CHEMBL3888084	Isothermal titration calorimetry (ITC): The binding of inhibitors to Aurora A kinase was analyzed with a MicroCal iTC200 titration calorimeter (GE Healthcare, Piscataway, N.J.). The protein was exchanged into 100 mM Na/K phosphate (pH 7.4) via PD-10 columns (GE Healthcare Lifesciences; Piscataway, N.J.). A total of 18 aliquots (2.2 uL each) of the protein solution (125 uM) were injected into 200 μL of the inhibitor solution (10 uM) at 25° C. The ITC cell mixture was constantly stirred at 1000 rpm and recorded for 120 seconds between injections. Heat generation due to dilution (blank) was determined in a separate experiment by diluting protein into buffer. The corrected heat values were fitted using a nonlinear least square curve-fitting algorithm (Microcal Origin 7.0) to obtain the stoichiometry (n), binding constant (Ka, Kd).	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	Kd	nM	17.0	CHEMBL4722	Homo sapiens	Kd	nM	17.0
403407	17769926	CHEMBL3888486	Kinase Assay: For in vitro method for measuring the inhibitory activity of the aforementioned compounds on the aurora A kinase activity was carried out referring to the method described in JP-A-2008-81492. As the first step of measuring the inhibitory activity of the compound, the test compound was serially diluted with dimethyl sulfoxide (DMSO). Subsequently, purified human aurora A protein, FL-Peptide 21 (Caliper Life Sciences, Inc., a final concentration of 100 nM), ATP (a final concentration of 5 μM), and the solution of the compound of the present invention in DMSO (a final DMSO concentration of 5%) were added to a reaction buffer [50 mM Tris-hydrochloric acid buffer (pH 7.4), 15 mM magnesium acetate, and 0.2 mM ethylenediamine-N,N,N',N'-tetraacetic acid (EDTA)]. Then, the resulting mixture was incubated at 25° C. for 50 minutes to carry out kinase reactions. Then, the IMAP® Progressive Binding Reagent diluted 500-fold with the IMAP® Progressive Binding Buffer A (the product of Molecular Devices, LLC.) was added thereto to terminate the kinase reaction. After leaving the resulting product to stand in the dark at room temperature for 120 minutes, the amount of phosphorylation was determined from the degree of fluorescence polarization as measured by the PHERAstar (BMG LABTECH, excitation wavelength of 485 nm, detection wavelength of 520 nm).	B	Cc1cc(Nc2nc(CC3(C(=O)O)CCN(C(=O)c4cccc(Cl)c4Cl)CC3)ccc2F)n[nH]1		CHEMBL3692206	=	IC50	nM	0.4	CHEMBL4722	Homo sapiens	IC50	nM	0.4
403408	17769927	CHEMBL3888486	Kinase Assay: For in vitro method for measuring the inhibitory activity of the aforementioned compounds on the aurora A kinase activity was carried out referring to the method described in JP-A-2008-81492. As the first step of measuring the inhibitory activity of the compound, the test compound was serially diluted with dimethyl sulfoxide (DMSO). Subsequently, purified human aurora A protein, FL-Peptide 21 (Caliper Life Sciences, Inc., a final concentration of 100 nM), ATP (a final concentration of 5 μM), and the solution of the compound of the present invention in DMSO (a final DMSO concentration of 5%) were added to a reaction buffer [50 mM Tris-hydrochloric acid buffer (pH 7.4), 15 mM magnesium acetate, and 0.2 mM ethylenediamine-N,N,N',N'-tetraacetic acid (EDTA)]. Then, the resulting mixture was incubated at 25° C. for 50 minutes to carry out kinase reactions. Then, the IMAP® Progressive Binding Reagent diluted 500-fold with the IMAP® Progressive Binding Buffer A (the product of Molecular Devices, LLC.) was added thereto to terminate the kinase reaction. After leaving the resulting product to stand in the dark at room temperature for 120 minutes, the amount of phosphorylation was determined from the degree of fluorescence polarization as measured by the PHERAstar (BMG LABTECH, excitation wavelength of 485 nm, detection wavelength of 520 nm).	B	Cc1cc(Nc2nc(CC3(C(=O)O)CCN(C(=O)c4cccc(C(F)(F)F)c4F)CC3)ccc2F)n[nH]1		CHEMBL3692207	=	IC50	nM	0.5	CHEMBL4722	Homo sapiens	IC50	nM	0.5
403409	17769928	CHEMBL3888486	Kinase Assay: For in vitro method for measuring the inhibitory activity of the aforementioned compounds on the aurora A kinase activity was carried out referring to the method described in JP-A-2008-81492. As the first step of measuring the inhibitory activity of the compound, the test compound was serially diluted with dimethyl sulfoxide (DMSO). Subsequently, purified human aurora A protein, FL-Peptide 21 (Caliper Life Sciences, Inc., a final concentration of 100 nM), ATP (a final concentration of 5 μM), and the solution of the compound of the present invention in DMSO (a final DMSO concentration of 5%) were added to a reaction buffer [50 mM Tris-hydrochloric acid buffer (pH 7.4), 15 mM magnesium acetate, and 0.2 mM ethylenediamine-N,N,N',N'-tetraacetic acid (EDTA)]. Then, the resulting mixture was incubated at 25° C. for 50 minutes to carry out kinase reactions. Then, the IMAP® Progressive Binding Reagent diluted 500-fold with the IMAP® Progressive Binding Buffer A (the product of Molecular Devices, LLC.) was added thereto to terminate the kinase reaction. After leaving the resulting product to stand in the dark at room temperature for 120 minutes, the amount of phosphorylation was determined from the degree of fluorescence polarization as measured by the PHERAstar (BMG LABTECH, excitation wavelength of 485 nm, detection wavelength of 520 nm).	B	COc1ccc(CC2(C(=O)O)CCN(C(=O)c3cccc(Cl)c3F)CC2)nc1Nc1cc(C)[nH]n1		CHEMBL3692208	=	IC50	nM	0.6	CHEMBL4722	Homo sapiens	IC50	nM	0.6
403410	17769929	CHEMBL3888486	Kinase Assay: For in vitro method for measuring the inhibitory activity of the aforementioned compounds on the aurora A kinase activity was carried out referring to the method described in JP-A-2008-81492. As the first step of measuring the inhibitory activity of the compound, the test compound was serially diluted with dimethyl sulfoxide (DMSO). Subsequently, purified human aurora A protein, FL-Peptide 21 (Caliper Life Sciences, Inc., a final concentration of 100 nM), ATP (a final concentration of 5 μM), and the solution of the compound of the present invention in DMSO (a final DMSO concentration of 5%) were added to a reaction buffer [50 mM Tris-hydrochloric acid buffer (pH 7.4), 15 mM magnesium acetate, and 0.2 mM ethylenediamine-N,N,N',N'-tetraacetic acid (EDTA)]. Then, the resulting mixture was incubated at 25° C. for 50 minutes to carry out kinase reactions. Then, the IMAP® Progressive Binding Reagent diluted 500-fold with the IMAP® Progressive Binding Buffer A (the product of Molecular Devices, LLC.) was added thereto to terminate the kinase reaction. After leaving the resulting product to stand in the dark at room temperature for 120 minutes, the amount of phosphorylation was determined from the degree of fluorescence polarization as measured by the PHERAstar (BMG LABTECH, excitation wavelength of 485 nm, detection wavelength of 520 nm).	B	Cc1cc(Nc2nc(CC3(C(=O)O)CCN(C(=O)c4cccc(Cl)c4F)CC3)ccc2Cl)n[nH]1		CHEMBL3692209	=	IC50	nM	0.4	CHEMBL4722	Homo sapiens	IC50	nM	0.4
403411	17769930	CHEMBL3888486	Kinase Assay: For in vitro method for measuring the inhibitory activity of the aforementioned compounds on the aurora A kinase activity was carried out referring to the method described in JP-A-2008-81492. As the first step of measuring the inhibitory activity of the compound, the test compound was serially diluted with dimethyl sulfoxide (DMSO). Subsequently, purified human aurora A protein, FL-Peptide 21 (Caliper Life Sciences, Inc., a final concentration of 100 nM), ATP (a final concentration of 5 μM), and the solution of the compound of the present invention in DMSO (a final DMSO concentration of 5%) were added to a reaction buffer [50 mM Tris-hydrochloric acid buffer (pH 7.4), 15 mM magnesium acetate, and 0.2 mM ethylenediamine-N,N,N',N'-tetraacetic acid (EDTA)]. Then, the resulting mixture was incubated at 25° C. for 50 minutes to carry out kinase reactions. Then, the IMAP® Progressive Binding Reagent diluted 500-fold with the IMAP® Progressive Binding Buffer A (the product of Molecular Devices, LLC.) was added thereto to terminate the kinase reaction. After leaving the resulting product to stand in the dark at room temperature for 120 minutes, the amount of phosphorylation was determined from the degree of fluorescence polarization as measured by the PHERAstar (BMG LABTECH, excitation wavelength of 485 nm, detection wavelength of 520 nm).	B	Cc1cc(Nc2nc(CC3(C(=O)O)CCN(C(=O)c4cccc(Cl)c4F)CC3)ccc2F)n[nH]1		CHEMBL3692210	=	IC50	nM	0.4	CHEMBL4722	Homo sapiens	IC50	nM	0.4
403412	17769931	CHEMBL3888486	Kinase Assay: For in vitro method for measuring the inhibitory activity of the aforementioned compounds on the aurora A kinase activity was carried out referring to the method described in JP-A-2008-81492. As the first step of measuring the inhibitory activity of the compound, the test compound was serially diluted with dimethyl sulfoxide (DMSO). Subsequently, purified human aurora A protein, FL-Peptide 21 (Caliper Life Sciences, Inc., a final concentration of 100 nM), ATP (a final concentration of 5 μM), and the solution of the compound of the present invention in DMSO (a final DMSO concentration of 5%) were added to a reaction buffer [50 mM Tris-hydrochloric acid buffer (pH 7.4), 15 mM magnesium acetate, and 0.2 mM ethylenediamine-N,N,N',N'-tetraacetic acid (EDTA)]. Then, the resulting mixture was incubated at 25° C. for 50 minutes to carry out kinase reactions. Then, the IMAP® Progressive Binding Reagent diluted 500-fold with the IMAP® Progressive Binding Buffer A (the product of Molecular Devices, LLC.) was added thereto to terminate the kinase reaction. After leaving the resulting product to stand in the dark at room temperature for 120 minutes, the amount of phosphorylation was determined from the degree of fluorescence polarization as measured by the PHERAstar (BMG LABTECH, excitation wavelength of 485 nm, detection wavelength of 520 nm).	B	CNC(=O)C1(Cc2ccc(F)c(Nc3cc(C)[nH]n3)n2)CCN(C(=O)c2cccc(Cl)c2F)CC1		CHEMBL3692211	=	IC50	nM	0.9	CHEMBL4722	Homo sapiens	IC50	nM	0.9
403413	17769932	CHEMBL3888486	Kinase Assay: For in vitro method for measuring the inhibitory activity of the aforementioned compounds on the aurora A kinase activity was carried out referring to the method described in JP-A-2008-81492. As the first step of measuring the inhibitory activity of the compound, the test compound was serially diluted with dimethyl sulfoxide (DMSO). Subsequently, purified human aurora A protein, FL-Peptide 21 (Caliper Life Sciences, Inc., a final concentration of 100 nM), ATP (a final concentration of 5 μM), and the solution of the compound of the present invention in DMSO (a final DMSO concentration of 5%) were added to a reaction buffer [50 mM Tris-hydrochloric acid buffer (pH 7.4), 15 mM magnesium acetate, and 0.2 mM ethylenediamine-N,N,N',N'-tetraacetic acid (EDTA)]. Then, the resulting mixture was incubated at 25° C. for 50 minutes to carry out kinase reactions. Then, the IMAP® Progressive Binding Reagent diluted 500-fold with the IMAP® Progressive Binding Buffer A (the product of Molecular Devices, LLC.) was added thereto to terminate the kinase reaction. After leaving the resulting product to stand in the dark at room temperature for 120 minutes, the amount of phosphorylation was determined from the degree of fluorescence polarization as measured by the PHERAstar (BMG LABTECH, excitation wavelength of 485 nm, detection wavelength of 520 nm).	B	Cc1cc(Nc2nc(CC3(C(=O)NC4CC4)CCN(C(=O)c4cccc(Cl)c4F)CC3)ccc2F)n[nH]1		CHEMBL3692212	=	IC50	nM	0.9	CHEMBL4722	Homo sapiens	IC50	nM	0.9
403414	17769933	CHEMBL3888486	Kinase Assay: For in vitro method for measuring the inhibitory activity of the aforementioned compounds on the aurora A kinase activity was carried out referring to the method described in JP-A-2008-81492. As the first step of measuring the inhibitory activity of the compound, the test compound was serially diluted with dimethyl sulfoxide (DMSO). Subsequently, purified human aurora A protein, FL-Peptide 21 (Caliper Life Sciences, Inc., a final concentration of 100 nM), ATP (a final concentration of 5 μM), and the solution of the compound of the present invention in DMSO (a final DMSO concentration of 5%) were added to a reaction buffer [50 mM Tris-hydrochloric acid buffer (pH 7.4), 15 mM magnesium acetate, and 0.2 mM ethylenediamine-N,N,N',N'-tetraacetic acid (EDTA)]. Then, the resulting mixture was incubated at 25° C. for 50 minutes to carry out kinase reactions. Then, the IMAP® Progressive Binding Reagent diluted 500-fold with the IMAP® Progressive Binding Buffer A (the product of Molecular Devices, LLC.) was added thereto to terminate the kinase reaction. After leaving the resulting product to stand in the dark at room temperature for 120 minutes, the amount of phosphorylation was determined from the degree of fluorescence polarization as measured by the PHERAstar (BMG LABTECH, excitation wavelength of 485 nm, detection wavelength of 520 nm).	B	Cc1cc(Nc2nc(CC3(C(=O)N4CCC4)CCN(C(=O)c4cccc(Cl)c4F)CC3)ccc2F)n[nH]1		CHEMBL3692213	=	IC50	nM	1.0	CHEMBL4722	Homo sapiens	IC50	nM	1.0
403415	17769934	CHEMBL3888486	Kinase Assay: For in vitro method for measuring the inhibitory activity of the aforementioned compounds on the aurora A kinase activity was carried out referring to the method described in JP-A-2008-81492. As the first step of measuring the inhibitory activity of the compound, the test compound was serially diluted with dimethyl sulfoxide (DMSO). Subsequently, purified human aurora A protein, FL-Peptide 21 (Caliper Life Sciences, Inc., a final concentration of 100 nM), ATP (a final concentration of 5 μM), and the solution of the compound of the present invention in DMSO (a final DMSO concentration of 5%) were added to a reaction buffer [50 mM Tris-hydrochloric acid buffer (pH 7.4), 15 mM magnesium acetate, and 0.2 mM ethylenediamine-N,N,N',N'-tetraacetic acid (EDTA)]. Then, the resulting mixture was incubated at 25° C. for 50 minutes to carry out kinase reactions. Then, the IMAP® Progressive Binding Reagent diluted 500-fold with the IMAP® Progressive Binding Buffer A (the product of Molecular Devices, LLC.) was added thereto to terminate the kinase reaction. After leaving the resulting product to stand in the dark at room temperature for 120 minutes, the amount of phosphorylation was determined from the degree of fluorescence polarization as measured by the PHERAstar (BMG LABTECH, excitation wavelength of 485 nm, detection wavelength of 520 nm).	B	Cc1cc(Nc2nc(CC3(c4noc(C)n4)CCN(C(=O)c4cccc(Cl)c4F)CC3)ccc2F)n[nH]1		CHEMBL3692214	=	IC50	nM	0.7	CHEMBL4722	Homo sapiens	IC50	nM	0.7
403416	17769935	CHEMBL3888486	Kinase Assay: For in vitro method for measuring the inhibitory activity of the aforementioned compounds on the aurora A kinase activity was carried out referring to the method described in JP-A-2008-81492. As the first step of measuring the inhibitory activity of the compound, the test compound was serially diluted with dimethyl sulfoxide (DMSO). Subsequently, purified human aurora A protein, FL-Peptide 21 (Caliper Life Sciences, Inc., a final concentration of 100 nM), ATP (a final concentration of 5 μM), and the solution of the compound of the present invention in DMSO (a final DMSO concentration of 5%) were added to a reaction buffer [50 mM Tris-hydrochloric acid buffer (pH 7.4), 15 mM magnesium acetate, and 0.2 mM ethylenediamine-N,N,N',N'-tetraacetic acid (EDTA)]. Then, the resulting mixture was incubated at 25° C. for 50 minutes to carry out kinase reactions. Then, the IMAP® Progressive Binding Reagent diluted 500-fold with the IMAP® Progressive Binding Buffer A (the product of Molecular Devices, LLC.) was added thereto to terminate the kinase reaction. After leaving the resulting product to stand in the dark at room temperature for 120 minutes, the amount of phosphorylation was determined from the degree of fluorescence polarization as measured by the PHERAstar (BMG LABTECH, excitation wavelength of 485 nm, detection wavelength of 520 nm).	B	Cc1cc(Nc2nc(CC3(c4ncon4)CCN(C(=O)c4cccc(Cl)c4F)CC3)ccc2F)n[nH]1		CHEMBL3692215	=	IC50	nM	0.5	CHEMBL4722	Homo sapiens	IC50	nM	0.5
403417	17769936	CHEMBL3888486	Kinase Assay: For in vitro method for measuring the inhibitory activity of the aforementioned compounds on the aurora A kinase activity was carried out referring to the method described in JP-A-2008-81492. As the first step of measuring the inhibitory activity of the compound, the test compound was serially diluted with dimethyl sulfoxide (DMSO). Subsequently, purified human aurora A protein, FL-Peptide 21 (Caliper Life Sciences, Inc., a final concentration of 100 nM), ATP (a final concentration of 5 μM), and the solution of the compound of the present invention in DMSO (a final DMSO concentration of 5%) were added to a reaction buffer [50 mM Tris-hydrochloric acid buffer (pH 7.4), 15 mM magnesium acetate, and 0.2 mM ethylenediamine-N,N,N',N'-tetraacetic acid (EDTA)]. Then, the resulting mixture was incubated at 25° C. for 50 minutes to carry out kinase reactions. Then, the IMAP® Progressive Binding Reagent diluted 500-fold with the IMAP® Progressive Binding Buffer A (the product of Molecular Devices, LLC.) was added thereto to terminate the kinase reaction. After leaving the resulting product to stand in the dark at room temperature for 120 minutes, the amount of phosphorylation was determined from the degree of fluorescence polarization as measured by the PHERAstar (BMG LABTECH, excitation wavelength of 485 nm, detection wavelength of 520 nm).	B	Cc1cc(Nc2nc(CC3(c4nnc(C)o4)CCN(C(=O)c4cccc(Cl)c4F)CC3)ccc2F)n[nH]1		CHEMBL3692216	=	IC50	nM	0.7	CHEMBL4722	Homo sapiens	IC50	nM	0.7
403418	17769937	CHEMBL3888486	Kinase Assay: For in vitro method for measuring the inhibitory activity of the aforementioned compounds on the aurora A kinase activity was carried out referring to the method described in JP-A-2008-81492. As the first step of measuring the inhibitory activity of the compound, the test compound was serially diluted with dimethyl sulfoxide (DMSO). Subsequently, purified human aurora A protein, FL-Peptide 21 (Caliper Life Sciences, Inc., a final concentration of 100 nM), ATP (a final concentration of 5 μM), and the solution of the compound of the present invention in DMSO (a final DMSO concentration of 5%) were added to a reaction buffer [50 mM Tris-hydrochloric acid buffer (pH 7.4), 15 mM magnesium acetate, and 0.2 mM ethylenediamine-N,N,N',N'-tetraacetic acid (EDTA)]. Then, the resulting mixture was incubated at 25° C. for 50 minutes to carry out kinase reactions. Then, the IMAP® Progressive Binding Reagent diluted 500-fold with the IMAP® Progressive Binding Buffer A (the product of Molecular Devices, LLC.) was added thereto to terminate the kinase reaction. After leaving the resulting product to stand in the dark at room temperature for 120 minutes, the amount of phosphorylation was determined from the degree of fluorescence polarization as measured by the PHERAstar (BMG LABTECH, excitation wavelength of 485 nm, detection wavelength of 520 nm).	B	Cc1noc(C2(Cc3ccc(F)c(Nc4cc(C)[nH]n4)n3)CCN(C(=O)c3cccc(Cl)c3F)CC2)n1		CHEMBL3692217	=	IC50	nM	0.8	CHEMBL4722	Homo sapiens	IC50	nM	0.8
403419	17769938	CHEMBL3888486	Kinase Assay: For in vitro method for measuring the inhibitory activity of the aforementioned compounds on the aurora A kinase activity was carried out referring to the method described in JP-A-2008-81492. As the first step of measuring the inhibitory activity of the compound, the test compound was serially diluted with dimethyl sulfoxide (DMSO). Subsequently, purified human aurora A protein, FL-Peptide 21 (Caliper Life Sciences, Inc., a final concentration of 100 nM), ATP (a final concentration of 5 μM), and the solution of the compound of the present invention in DMSO (a final DMSO concentration of 5%) were added to a reaction buffer [50 mM Tris-hydrochloric acid buffer (pH 7.4), 15 mM magnesium acetate, and 0.2 mM ethylenediamine-N,N,N',N'-tetraacetic acid (EDTA)]. Then, the resulting mixture was incubated at 25° C. for 50 minutes to carry out kinase reactions. Then, the IMAP® Progressive Binding Reagent diluted 500-fold with the IMAP® Progressive Binding Buffer A (the product of Molecular Devices, LLC.) was added thereto to terminate the kinase reaction. After leaving the resulting product to stand in the dark at room temperature for 120 minutes, the amount of phosphorylation was determined from the degree of fluorescence polarization as measured by the PHERAstar (BMG LABTECH, excitation wavelength of 485 nm, detection wavelength of 520 nm).	B	Cc1cc(Nc2nc(CC3(C(=O)O)CCN(C(=O)c4cccc(Cl)c4F)CC3)ccc2C#N)n[nH]1		CHEMBL3953977	=	IC50	nM	220.0	CHEMBL4722	Homo sapiens	IC50	nM	220.0
403420	17769939	CHEMBL3888486	Kinase Assay: For in vitro method for measuring the inhibitory activity of the aforementioned compounds on the aurora A kinase activity was carried out referring to the method described in JP-A-2008-81492. As the first step of measuring the inhibitory activity of the compound, the test compound was serially diluted with dimethyl sulfoxide (DMSO). Subsequently, purified human aurora A protein, FL-Peptide 21 (Caliper Life Sciences, Inc., a final concentration of 100 nM), ATP (a final concentration of 5 μM), and the solution of the compound of the present invention in DMSO (a final DMSO concentration of 5%) were added to a reaction buffer [50 mM Tris-hydrochloric acid buffer (pH 7.4), 15 mM magnesium acetate, and 0.2 mM ethylenediamine-N,N,N',N'-tetraacetic acid (EDTA)]. Then, the resulting mixture was incubated at 25° C. for 50 minutes to carry out kinase reactions. Then, the IMAP® Progressive Binding Reagent diluted 500-fold with the IMAP® Progressive Binding Buffer A (the product of Molecular Devices, LLC.) was added thereto to terminate the kinase reaction. After leaving the resulting product to stand in the dark at room temperature for 120 minutes, the amount of phosphorylation was determined from the degree of fluorescence polarization as measured by the PHERAstar (BMG LABTECH, excitation wavelength of 485 nm, detection wavelength of 520 nm).	B	COc1cc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2OC)=NC3)ccc1C(=O)O		CHEMBL483158	=	IC50	nM	0.6	CHEMBL4722	Homo sapiens	IC50	nM	0.6
412005	17776720	CHEMBL3888649	Mobility Shift Assay: Agents: 1-fold kinase buffer without MnCl2: 50 mM HEPES, pH 7.5, 0.0015% Brij-35, 10 mM MgCl2, 2 mM DTT. 1-fold kinase buffer with MnCl2: 50 mM HEPES, pH 7.5, 0.0015% Brij-35, 10 mM MgCl2, 10 mM MnCl2, 2 mM DTT. Termination solution: 100 mM HEPES, pH 7.5, 0.0015% Brij-35, 0.2% Coating Reagent#3, 50 mM EDTA. 2.5-fold kinase solution: The kinase was added to the 1-fold kinase buffer to form a 2.5-fold kinase solution. 2.5-fold substrate solution: FAM fluorescence-labelled polypeptide and ATP were added to the 1-fold kinase buffer to form a 2.5-fold substrate solution. Compounds: The final test concentration of the compound was 10 μM at maximum. Firstly, a 50-fold concentration (i.e. 500 μM) was prepared with 100% DMSO. The compound was diluted with 100% DMSO by 5 folds at 5 concentrations (successively 500 μM, 100 μM, 20 μM, 4 μM, and 0.8 μM). After diluting with 1-fold kinase buffer by 10 folds, 5 μl of the samples were transferred to a 384-well reaction plate. Two negative control wells and two positive control wells were set at each line respectively. Replication was made in a 96-well plate in five concentrations of 5-fold compound. 10% DMSO was added to the positive control well, and 5 μl of EDTA (250 mM) was added to the negative control well. Procedure: To the 384-well reaction plate was added 5-fold compound dissolved in 10% DMSO at 5 μl/well. To the 384-well reaction plate was added 2.5-fold kinase solution at 10 Î¼l/well. The plate was incubated at room temperature for 10 mins. To the 384-well reaction plate was added 2.5-fold substrate solution at 10 μl/well. The plate was incubated at 28° C. for a certain period. 25 μl termination solution was added to terminate the reaction.	B	Nc1ccc(-c2ccc3ncc4c(=O)[nH]c(=O)n(-c5cccc(C(F)(F)F)c5)c4c3n2)cn1		CHEMBL3903725	>	IC50	nM	10000.0	CHEMBL4722	Homo sapiens	IC50	nM	10000.0
418604	17781847	CHEMBL3888837	Kinase Assay: Aurora-A (h) is incubated with 8 mM MOPS pH 7.0, 0.2 mM EDTA, 200 μM LRRASLG (Kemptide), 10 mM MgAcetate and [γ-33P-ATP](specific activity approx. 500 cpm/pmol, concentration as required). The reaction is initiated by the addition of the MgATP mix. After incubation for 40 minutes at room temperature, the reaction is stopped by the addition of 3% phosphoric acid solution. 10 μL of the reaction is then spotted onto a P30 filtermat and washed three times for 5 minutes in 75 mM phosphoric acid and once in methanol prior to drying and scintillation counting.	B	CC(=O)N1CCC2(CCC(Nc3nc(Nc4cnn(C)c4)ncc3Cl)CC2)CC1		CHEMBL3905686	=	IC50	nM	22.0	CHEMBL4722	Homo sapiens	IC50	nM	22.0
418605	17781848	CHEMBL3888837	Kinase Assay: Aurora-A (h) is incubated with 8 mM MOPS pH 7.0, 0.2 mM EDTA, 200 μM LRRASLG (Kemptide), 10 mM MgAcetate and [γ-33P-ATP](specific activity approx. 500 cpm/pmol, concentration as required). The reaction is initiated by the addition of the MgATP mix. After incubation for 40 minutes at room temperature, the reaction is stopped by the addition of 3% phosphoric acid solution. 10 μL of the reaction is then spotted onto a P30 filtermat and washed three times for 5 minutes in 75 mM phosphoric acid and once in methanol prior to drying and scintillation counting.	B	Cn1cc(Nc2ncc(Cl)c(NC3CC4CN(S(C)(=O)=O)CC4C3)n2)cn1		CHEMBL3917073	=	IC50	nM	4.0	CHEMBL4722	Homo sapiens	IC50	nM	4.0
431586	17791694	CHEMBL3889057	Aurora Kinase Assays: Myc-tagged Aurora A was transfected in Hela cells using Lipofectamine LTX in 24 well plates, and 24 hours after transfection, cells were treated with different concentrations of Example 1 for 2 hours. Cells were then lysed in 2×LDS sample buffer. Proteins from different samples were resolved by 4-12% Bis-Tris NuPage (Invitrogen) gels and analysed by western blotting using P-histone H3 (S10) and P-Aurora A (T288) antibodies.	B	Cn1cc(-c2nc3c(N4CCN(Cc5cccnc5)CC4)c(Br)cnc3[nH]2)cn1		CHEMBL3898132	=	IC50	nM	32.0	CHEMBL4722	Homo sapiens	IC50	nM	32.0
431587	17791695	CHEMBL3889057	Aurora Kinase Assays: Myc-tagged Aurora A was transfected in Hela cells using Lipofectamine LTX in 24 well plates, and 24 hours after transfection, cells were treated with different concentrations of Example 1 for 2 hours. Cells were then lysed in 2×LDS sample buffer. Proteins from different samples were resolved by 4-12% Bis-Tris NuPage (Invitrogen) gels and analysed by western blotting using P-histone H3 (S10) and P-Aurora A (T288) antibodies.	B	Cc1nn(C)c(C)c1-c1nc2c(N3CCN(Cc4cccnc4)CC3)c(Br)cnc2[nH]1		CHEMBL3891461	=	IC50	nM	300.0	CHEMBL4722	Homo sapiens	IC50	nM	300.0
431588	17791696	CHEMBL3889057	Aurora Kinase Assays: Myc-tagged Aurora A was transfected in Hela cells using Lipofectamine LTX in 24 well plates, and 24 hours after transfection, cells were treated with different concentrations of Example 1 for 2 hours. Cells were then lysed in 2×LDS sample buffer. Proteins from different samples were resolved by 4-12% Bis-Tris NuPage (Invitrogen) gels and analysed by western blotting using P-histone H3 (S10) and P-Aurora A (T288) antibodies.	B	Cc1nn(C)cc1-c1nc2c(N3CCN(Cc4ccc(Cl)cc4)CC3)c(Cl)cnc2[nH]1		CHEMBL2207503	=	IC50	nM	38.0	CHEMBL4722	Homo sapiens	IC50	nM	38.0
431589	17791697	CHEMBL3889057	Aurora Kinase Assays: Myc-tagged Aurora A was transfected in Hela cells using Lipofectamine LTX in 24 well plates, and 24 hours after transfection, cells were treated with different concentrations of Example 1 for 2 hours. Cells were then lysed in 2×LDS sample buffer. Proteins from different samples were resolved by 4-12% Bis-Tris NuPage (Invitrogen) gels and analysed by western blotting using P-histone H3 (S10) and P-Aurora A (T288) antibodies.	B	Cc1nn(C)cc1-c1nc2c(N3CCN(Cc4ncon4)CC3)c(Cl)cnc2[nH]1		CHEMBL2207500	=	IC50	nM	40.0	CHEMBL4722	Homo sapiens	IC50	nM	40.0
431590	17791698	CHEMBL3889057	Aurora Kinase Assays: Myc-tagged Aurora A was transfected in Hela cells using Lipofectamine LTX in 24 well plates, and 24 hours after transfection, cells were treated with different concentrations of Example 1 for 2 hours. Cells were then lysed in 2×LDS sample buffer. Proteins from different samples were resolved by 4-12% Bis-Tris NuPage (Invitrogen) gels and analysed by western blotting using P-histone H3 (S10) and P-Aurora A (T288) antibodies.	B	Cc1nc(CN2CCN(c3c(Cl)cnc4[nH]c(-c5cn(C)nc5C)nc34)CC2)no1		CHEMBL2207501	=	IC50	nM	52.0	CHEMBL4722	Homo sapiens	IC50	nM	52.0
431596	17791704	CHEMBL3889059	KINOMEScan Technology Assays: The kinase selectivity was assessed by profiling Example 1 in a 442-kinase panel (386 non-mutant kinases) at a concentration of 1 μM using the KINOMEScan™ technology.28 The S(10) selectivity score that is calculated by dividing the number of non-mutant kinases for which >90% competition was observed in the assay (this is measured as <10% of control) by the total number of non-mutant kinases tested, was determined as 0.057, i.e. 22 hits from the 386 non-mutant kinases tested. Aurora-A, -B, and -C were potently inhibited with % control values determined as 3.4%, 1%, and 16% respectively.	B	Cc1nn(C)cc1-c1nc2c(N3CCN(Cc4ccc(Cl)cc4)CC3)c(Cl)cnc2[nH]1		CHEMBL2207503	=	Kd	nM	7.5	CHEMBL4722	Homo sapiens	Kd	nM	7.5
Inactive	17884022	CHEMBL3991630	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2ccc(F)c(C(F)(F)F)c2)nc1C1CCN(c2ncnc3[nH]ncc23)CC1		CHEMBL3545076	>	Kd	nM	30000.0	CHEMBL4722	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884023	CHEMBL3991630	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	>	Kd	nM	30000.0	CHEMBL4722	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884024	CHEMBL3991630	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1cc(C(F)(F)F)cc(C(F)(F)F)c1)c1cc(Cl)ccc1O		CHEMBL536151	>	Kd	nM	30000.0	CHEMBL4722	Homo sapiens	Kd apparent	nM	30000.0
Active	17884025	CHEMBL3991630	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)NCC(=O)N1C2CCC1c1cc(Nc3ncc(C(F)(F)F)c(NC4CCC4)n3)ccc12		CHEMBL1983111	=	Kd	nM	14.0	CHEMBL4722	Homo sapiens	Kd apparent	nM	14.0
Inactive	17884026	CHEMBL3991630	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(NC(=O)OC[C@@H]2COCCN2)cn2ncnc(Nc3ccc4c(cnn4Cc4cccc(F)c4)c3)c12		CHEMBL1645462	>	Kd	nM	30000.0	CHEMBL4722	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884027	CHEMBL3991630	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Nc1ncnc2c1c(-c1cccc(OCc3ccccc3)c1)cn2[C@H]1C[C@H](N2CCC2)C1		CHEMBL551064	>	Kd	nM	30000.0	CHEMBL4722	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884028	CHEMBL3991630	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2cnc3ccc4ccc(CS(=O)(=O)NCc5ccccn5)cc4c(=O)c3c2)cn1		CHEMBL2323775	>	Kd	nM	30000.0	CHEMBL4722	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884029	CHEMBL3991630	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL475251	>	Kd	nM	30000.0	CHEMBL4722	Homo sapiens	Kd apparent	nM	30000.0
Active	17884030	CHEMBL3991630	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)c1cnc2ccc(-c3cc(Cl)c(O)c(Cl)c3)nc2c1N[C@H]1CC[C@H](CN(C)C)CC1		CHEMBL3688339	=	Kd	nM	194.0	CHEMBL4722	Homo sapiens	Kd apparent	nM	194.0
Inactive	17884031	CHEMBL3991630	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(C2=C(c3cn(C4CCN(Cc5ccccn5)CC4)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL300138	>	Kd	nM	30000.0	CHEMBL4722	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884032	CHEMBL3991630	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F		CHEMBL507361	>	Kd	nM	30000.0	CHEMBL4722	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884033	CHEMBL3991630	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1ncc(Cl)c1-c1cc(C(=O)N[C@H](CN)Cc2ccc(F)c(F)c2)oc1Cl		CHEMBL3137336	>	Kd	nM	30000.0	CHEMBL4722	Homo sapiens	Kd apparent	nM	30000.0
Active	17884034	CHEMBL3991630	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(c1ccc(/C=C/c2n[nH]c3ccccc23)cc1)N1CCNCC1		CHEMBL1908397	=	Kd	nM	470.0	CHEMBL4722	Homo sapiens	Kd apparent	nM	470.0
Active	17884035	CHEMBL3991630	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	=	Kd	nM	514.0	CHEMBL4722	Homo sapiens	Kd apparent	nM	514.0
Active	17884036	CHEMBL3991630	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCS(=O)(=O)c1cccc(-c2cc(C(=O)NC3CCN(C)CC3)c(C)c3[nH]c4ncc(C)cc4c23)c1		CHEMBL3544932	=	Kd	nM	24.0	CHEMBL4722	Homo sapiens	Kd apparent	nM	24.0
Inactive	17884037	CHEMBL3991630	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN1CCCCC1		CHEMBL2110732	>	Kd	nM	30000.0	CHEMBL4722	Homo sapiens	Kd apparent	nM	30000.0
Active	17884038	CHEMBL3991630	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	Kd	nM	6.0	CHEMBL4722	Homo sapiens	Kd apparent	nM	6.0
Inactive	17884039	CHEMBL3991630	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(-c2ccc3ncc4c(c3c2)n(-c2ccc(N3CCNCC3)c(C(F)(F)F)c2)c(=O)n4C)cn1		CHEMBL3218578	>	Kd	nM	30000.0	CHEMBL4722	Homo sapiens	Kd apparent	nM	30000.0
Active	17884040	CHEMBL3991630	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	=	Kd	nM	2.0	CHEMBL4722	Homo sapiens	Kd apparent	nM	2.0
Inactive	17884041	CHEMBL3991630	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	>	Kd	nM	30000.0	CHEMBL4722	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884042	CHEMBL3991630	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	FC(F)(F)c1ccc(/C=C/c2nc(COc3ccc(CCCCn4ccnn4)cc3)co2)cc1		CHEMBL1614707	>	Kd	nM	30000.0	CHEMBL4722	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884043	CHEMBL3991630	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](c1ccc2nccn2c1)n1nnc2ncc(-c3cnn(C)c3)nc21		CHEMBL3334567	>	Kd	nM	30000.0	CHEMBL4722	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884044	CHEMBL3991630	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H]1COC(Nc2ccc3ncnc(Nc4ccc(OCc5nccs5)c(Cl)c4)c3c2)=N1		CHEMBL2103842	>	Kd	nM	30000.0	CHEMBL4722	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884045	CHEMBL3991630	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=c1[nH]c(C2CCCN2)nc2c1oc1ccc(Cl)cc12		CHEMBL3544944	>	Kd	nM	30000.0	CHEMBL4722	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884046	CHEMBL3991630	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(NC(=O)c2ccc(CN3CC[C@H](N(C)C)C3)c(C(F)(F)F)c2)cc1Nc1nccc(-c2cncnc2)n1		CHEMBL206834	>	Kd	nM	30000.0	CHEMBL4722	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884047	CHEMBL3991630	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B			CHEMBL4084193	>	Kd	nM	30000.0	CHEMBL4722	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884048	CHEMBL3991630	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCC(COc2cnc(-c3cccc(Cn4nc(-c5cccc(C#N)c5)ccc4=O)c3)nc2)CC1		CHEMBL3402762	>	Kd	nM	30000.0	CHEMBL4722	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884049	CHEMBL3991630	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NC[C@H](O)CO)c1ccncc1Nc1ccc(I)cc1F		CHEMBL2107832	>	Kd	nM	30000.0	CHEMBL4722	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884050	CHEMBL3991630	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(C(=O)NOCCO)c(Nc2ccc(I)cc2F)n(C)c1=O		CHEMBL3182621	>	Kd	nM	30000.0	CHEMBL4722	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884051	CHEMBL3991630	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cc(Nc2nccc(-c3cn(C)c4ccccc34)n2)c(OC)cc1N(C)CCN(C)C		CHEMBL3353410	>	Kd	nM	30000.0	CHEMBL4722	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884052	CHEMBL3991630	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	c1cc(OCCN2CCCCC2)cc(-c2n[nH]c3ccc(-c4nnc[nH]4)cc23)c1		CHEMBL1614713	>	Kd	nM	30000.0	CHEMBL4722	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884053	CHEMBL3991630	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762	>	Kd	nM	30000.0	CHEMBL4722	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884054	CHEMBL3991630	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)c(F)c2)ccn1		CHEMBL1946170	>	Kd	nM	30000.0	CHEMBL4722	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884055	CHEMBL3991630	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(C)c1nc(-c2cccc(NS(=O)(=O)c3c(F)cccc3F)c2F)c(-c2ccnc(N)n2)s1		CHEMBL2028663	>	Kd	nM	30000.0	CHEMBL4722	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884056	CHEMBL3991630	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)N1CCC(Oc2cc3c(Nc4ccc(Cl)c(Cl)c4F)ncnc3cc2OC)CC1		CHEMBL3545154	>	Kd	nM	30000.0	CHEMBL4722	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884057	CHEMBL3991630	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N[C@@H]1CCCN(c2c(/C=C3\SC(=O)NC3=O)cccc2-c2ccccc2)C1		CHEMBL2048872	>	Kd	nM	30000.0	CHEMBL4722	Homo sapiens	Kd apparent	nM	30000.0
Active	17884058	CHEMBL3991630	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2OC)=NC3)ccc1C(=O)O		CHEMBL483158	=	Kd	nM	5.0	CHEMBL4722	Homo sapiens	Kd apparent	nM	5.0
Inactive	17884059	CHEMBL3991630	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)CN1CCC(Oc2cc3c(Nc4cccc(Cl)c4F)ncnc3cc2OC)CC1		CHEMBL2408045	>	Kd	nM	30000.0	CHEMBL4722	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884060	CHEMBL3991630	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	>	Kd	nM	30000.0	CHEMBL4722	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884061	CHEMBL3991630	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C1NC(=O)[C@@H](c2cn3c4c(cccc24)CCC3)[C@@H]1c1c[nH]c2ccccc12		CHEMBL2103882	>	Kd	nM	30000.0	CHEMBL4722	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884062	CHEMBL3991630	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)N[C@H]4CC[C@H](N5CCN(CC6CC6)CC5)CC4)cc3OC)nc2N1C(C)C		CHEMBL1233528	>	Kd	nM	30000.0	CHEMBL4722	Homo sapiens	Kd apparent	nM	30000.0
Active	17884063	CHEMBL3991630	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1cccc(Cl)c1)Nc1ncc(CCN=c2[nH]cnc3ccsc23)s1		CHEMBL482767	=	Kd	nM	118.0	CHEMBL4722	Homo sapiens	Kd apparent	nM	118.0
Inactive	17884064	CHEMBL3991630	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1ncc(Cl)c1-c1cc(C(=O)N[C@H](CN)Cc2cccc(F)c2)sc1Cl		CHEMBL2219422	>	Kd	nM	30000.0	CHEMBL4722	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884065	CHEMBL3991630	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=c1sn(-c2cccc3ccccc23)c(=O)n1Cc1ccccc1		CHEMBL3545157	>	Kd	nM	30000.0	CHEMBL4722	Homo sapiens	Kd apparent	nM	30000.0
Active	17884066	CHEMBL3991630	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCNC(=O)C#Cc1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(CN(C)C)cc1)c1ccccc1		CHEMBL3699142	=	Kd	nM	59.0	CHEMBL4722	Homo sapiens	Kd apparent	nM	59.0
Inactive	17884067	CHEMBL3991630	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL180022	>	Kd	nM	30000.0	CHEMBL4722	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884068	CHEMBL3991630	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(C(=O)Nc2ccc(Oc3cc4cnn(C)c4cc3-c3cn[nH]c3)c(F)c2)c(=O)n1-c1ccc(F)cc1		CHEMBL3545307	>	Kd	nM	30000.0	CHEMBL4722	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884069	CHEMBL3991630	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCC(CNc2ccc3ncc(-c4cccc(OC(F)(F)F)c4)n3n2)CC1		CHEMBL1952329	>	Kd	nM	30000.0	CHEMBL4722	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884070	CHEMBL3991630	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Nc1nc(N)c2nc(-c3cccc(O)c3)c(-c3cccc(O)c3)nc2n1		CHEMBL230011	>	Kd	nM	30000.0	CHEMBL4722	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884071	CHEMBL3991630	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1c(=O)n(-c2ccc(C(C)(C)C#N)cc2)c2c3cc(-c4cnc5ccccc5c4)ccc3ncc21		CHEMBL1879463	>	Kd	nM	30000.0	CHEMBL4722	Homo sapiens	Kd apparent	nM	30000.0
Active	17884072	CHEMBL3991630	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Kd	nM	477.0	CHEMBL4722	Homo sapiens	Kd apparent	nM	477.0
Inactive	17884073	CHEMBL3991630	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL513909	>	Kd	nM	30000.0	CHEMBL4722	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884074	CHEMBL3991630	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	OCCn1cc(-c2cnc3nnn(Cc4ccc5ncccc5c4)c3n2)cn1		CHEMBL2001019	>	Kd	nM	30000.0	CHEMBL4722	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884075	CHEMBL3991630	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21		CHEMBL1614701	>	Kd	nM	30000.0	CHEMBL4722	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884076	CHEMBL3991630	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ncc(-c2ccc3nccc(-c4ccnnc4)c3c2)cc1NS(=O)(=O)c1ccc(F)cc1F		CHEMBL1236962	>	Kd	nM	30000.0	CHEMBL4722	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884077	CHEMBL3991630	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Oc3cccc(NC(=O)Nc4cc(C(C)(C)C(F)(F)F)on4)c3)c2cc1OC		CHEMBL2029988	>	Kd	nM	30000.0	CHEMBL4722	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884078	CHEMBL3991630	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NOCCO)c1cc(CN2OCCCC2=O)c(F)c(F)c1Nc1ccc(I)cc1F		CHEMBL1614766	>	Kd	nM	30000.0	CHEMBL4722	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884079	CHEMBL3991630	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@H]3CCCNC3)c21		CHEMBL494089	>	Kd	nM	30000.0	CHEMBL4722	Homo sapiens	Kd apparent	nM	30000.0
Active	17884080	CHEMBL3991630	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(C2=Nc3cc(NC(=O)C(N)C4CCCCC4)cc4c3C2=CNNC4=O)cn1		CHEMBL3545137	=	Kd	nM	141.0	CHEMBL4722	Homo sapiens	Kd apparent	nM	141.0
Active	17884081	CHEMBL3991630	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1csc(-c2nnc(Nc3ccc(Oc4ncccc4-c4ccnc(N)n4)cc3)c3ccccc23)c1		CHEMBL2140408	=	Kd	nM	7.0	CHEMBL4722	Homo sapiens	Kd apparent	nM	7.0
Inactive	17884082	CHEMBL3991630	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	>	Kd	nM	30000.0	CHEMBL4722	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884083	CHEMBL3991630	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCOc1ccn(-c2ccc(F)cc2)c(=O)c1C(=O)Nc1ccc(Oc2ccnc(N)c2Cl)c(F)c1		CHEMBL460702	>	Kd	nM	30000.0	CHEMBL4722	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884084	CHEMBL3991630	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc([C@@H]2c3cc4c(cc3[C@H](O)[C@H]3COC(=O)[C@@H]23)OCO4)cc(OC)c1OC		CHEMBL283120	>	Kd	nM	30000.0	CHEMBL4722	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884085	CHEMBL3991630	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc2c(OCc3nnc4ccc(-c5ccccc5)nn34)ccnc2c1		CHEMBL496102	>	Kd	nM	30000.0	CHEMBL4722	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884086	CHEMBL3991630	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncnc(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL3545360	>	Kd	nM	30000.0	CHEMBL4722	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884087	CHEMBL3991630	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N#CCNC(=O)c1ccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)cc1		CHEMBL1078178	>	Kd	nM	30000.0	CHEMBL4722	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884088	CHEMBL3991630	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	>	Kd	nM	30000.0	CHEMBL4722	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884089	CHEMBL3991630	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL288441	>	Kd	nM	30000.0	CHEMBL4722	Homo sapiens	Kd apparent	nM	30000.0
Active	17884090	CHEMBL3991630	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	=	Kd	nM	25.0	CHEMBL4722	Homo sapiens	Kd apparent	nM	25.0
Inactive	17884091	CHEMBL3991630	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1N=C(N)c2cn([C@@H]3O[C@H](COP(=O)(O)O)[C@@H](O)[C@H]3O)c3ncnc1c23		CHEMBL462018	>	Kd	nM	30000.0	CHEMBL4722	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884092	CHEMBL3991630	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(c1ccc(F)c(F)c1Nc1ccc(I)cc1F)N1CC(O)([C@@H]2CCCCN2)C1		CHEMBL2146883	>	Kd	nM	30000.0	CHEMBL4722	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884093	CHEMBL3991630	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Nc1cc(F)cc(F)c1)c1cc(C(=O)N(C)C)cc2c(=O)cc(N3CCOCC3)oc12		CHEMBL3408248	>	Kd	nM	30000.0	CHEMBL4722	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884094	CHEMBL3991630	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCNCC1		CHEMBL2403108	>	Kd	nM	30000.0	CHEMBL4722	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884095	CHEMBL3991630	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC		CHEMBL1289494	>	Kd	nM	30000.0	CHEMBL4722	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884096	CHEMBL3991630	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(S(=O)(=O)N(C(C)=O)c2ccccc2/C=C/c2cc[n+]([O-])cc2)cc1		CHEMBL3991927	>	Kd	nM	30000.0	CHEMBL4722	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884097	CHEMBL3991630	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cccc(-c2nn3c(c2-c2ccnc4ccc(C(N)=O)cc24)CCC3)n1		CHEMBL2364611	>	Kd	nM	30000.0	CHEMBL4722	Homo sapiens	Kd apparent	nM	30000.0
Active	17884098	CHEMBL3991630	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)N(COP(=O)(O)O)C(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL2103830	=	Kd	nM	300.0	CHEMBL4722	Homo sapiens	Kd apparent	nM	300.0
Inactive	17884099	CHEMBL3991630	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCS(=O)(=O)N1CCN(c2ccc(Nc3ncc(C(N)=O)c(NC4CC4)n3)cc2)CC1.Cl		CHEMBL3991929	>	Kd	nM	30000.0	CHEMBL4722	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884100	CHEMBL3991630	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC(=O)c1ccc(N(C(N)=O)c2c(F)cccc2F)nc1-c1ccc(F)cc1F		CHEMBL1090090	>	Kd	nM	30000.0	CHEMBL4722	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884101	CHEMBL3991630	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C1=C/COCc2cc(ccc2OCCN2CCCC2)Nc2nccc(n2)-c2cccc(c2)COC/1		CHEMBL2035187	>	Kd	nM	30000.0	CHEMBL4722	Homo sapiens	Kd apparent	nM	30000.0
Active	17884102	CHEMBL3991630	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(N)sc1-c1ccnc(Nc2ccc(N3CCOCC3)cc2)n1		CHEMBL482967	=	Kd	nM	118.0	CHEMBL4722	Homo sapiens	Kd apparent	nM	118.0
Inactive	17884103	CHEMBL3991630	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cccc(-c2ccc3c(N4CCOC[C@@H]4C)nc(N4CCOC[C@@H]4C)nc3n2)c1		CHEMBL2336325	>	Kd	nM	30000.0	CHEMBL4722	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884104	CHEMBL3991630	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC[C@@](O)(c1ccc(Cl)cc1)c1ccc(-c2cn[nH]c2)cc1		CHEMBL3544960	>	Kd	nM	30000.0	CHEMBL4722	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884105	CHEMBL3991630	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)CC(=O)Nc1n[nH]c2c1CN(C(=O)C1CCN(C)CC1)C2(C)C		CHEMBL1230607	>	Kd	nM	30000.0	CHEMBL4722	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884106	CHEMBL3991630	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)O)c(C)c34)ccc2[nH]1		CHEMBL377300	>	Kd	nM	30000.0	CHEMBL4722	Homo sapiens	Kd apparent	nM	30000.0
Uncertain	17884107	CHEMBL3991630	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCc1nc(C(N)=O)c(Nc2ccc(N3CCC(N4CCN(C)CC4)CC3)c(OC)c2)nc1NC1CCOCC1		CHEMBL3301622	=	Kd	nM	184.0	CHEMBL4722	Homo sapiens	Kd apparent	nM	184.0
Inactive	17884108	CHEMBL3991630	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1		CHEMBL217092	>	Kd	nM	30000.0	CHEMBL4722	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884109	CHEMBL3991630	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC1(C(=O)N[C@@H](CCO)c2ccc(Cl)cc2)CCN(c2ncnc3[nH]ccc23)CC1		CHEMBL2325741	>	Kd	nM	30000.0	CHEMBL4722	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884110	CHEMBL3991630	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CCN(/C=C1/C(=O)O[C@H](COC)[C@@]2(C)C1=C(O)C(=O)C1=C2[C@H](OC(C)=O)C[C@]2(C)C(=O)CC[C@@H]12)CC=C		CHEMBL411907	>	Kd	nM	30000.0	CHEMBL4722	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884111	CHEMBL3991630	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCc1cc2c(cc1N1CCC(N3CCOCC3)CC1)C(C)(C)c1[nH]c3cc(C#N)ccc3c1C2=O		CHEMBL1738797	>	Kd	nM	30000.0	CHEMBL4722	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884112	CHEMBL3991630	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NC1CCNCC1)c1n[nH]cc1NC(=O)c1c(Cl)cccc1Cl		CHEMBL445813	>	Kd	nM	30000.0	CHEMBL4722	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884113	CHEMBL3991630	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CCn1c(=O)c2cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc2n1-c1cccc(C(C)(C)O)n1		CHEMBL1976040	>	Kd	nM	30000.0	CHEMBL4722	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884114	CHEMBL3991630	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(F)c(F)c(Nc2ccc(I)cc2F)c1NS(=O)(=O)C1(C[C@H](O)CO)CC1		CHEMBL1236682	>	Kd	nM	30000.0	CHEMBL4722	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884115	CHEMBL3991630	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(CN2CCN(C(=O)[C@H](C)O)CC2)sc2c(N3CCOCC3)nc(-c3cnc(N)nc3)nc12		CHEMBL1922094	>	Kd	nM	30000.0	CHEMBL4722	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884116	CHEMBL3991630	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCCCCCCCCCCCCCCCCCOP(=O)([O-])OC1CC[N+](C)(C)CC1		CHEMBL372764	>	Kd	nM	30000.0	CHEMBL4722	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884117	CHEMBL3991630	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COC(=O)N[C@@H](C)CNc1nccc(-c2cn(C(C)C)nc2-c2cc(Cl)cc(NS(C)(=O)=O)c2F)n1		CHEMBL3301612	>	Kd	nM	30000.0	CHEMBL4722	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884118	CHEMBL3991630	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1		CHEMBL491473	>	Kd	nM	30000.0	CHEMBL4722	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884119	CHEMBL3991630	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC1(c2ccc(-c3nc4ccn5c(=O)[nH]nc5c4cc3-c3ccccc3)cc2)CCC1		CHEMBL1079175	>	Kd	nM	30000.0	CHEMBL4722	Homo sapiens	Kd apparent	nM	30000.0
Active	17884120	CHEMBL3991630	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@@H](C(=O)N1Cc2n[nH]c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)c2C1)c1ccccc1		CHEMBL402548	=	Kd	nM	11.0	CHEMBL4722	Homo sapiens	Kd apparent	nM	11.0
Active	17884121	CHEMBL3991630	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN(CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1)CCOP(=O)(O)O		CHEMBL415049	=	Kd	nM	49.0	CHEMBL4722	Homo sapiens	Kd apparent	nM	49.0
Inactive	17884122	CHEMBL3991630	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C#Cc1cccc(Nc2ncnc3cc4c(cc23)OCCOCCOCCO4)c1		CHEMBL2087361	>	Kd	nM	30000.0	CHEMBL4722	Homo sapiens	Kd apparent	nM	30000.0
Active	17884123	CHEMBL3991630	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2nc(N[C@@H](C)c3ncc(F)cn3)ncc2Cl)[nH]n1		CHEMBL1231124	=	Kd	nM	306.0	CHEMBL4722	Homo sapiens	Kd apparent	nM	306.0
Inactive	17884124	CHEMBL3991630	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cccc2cc(Oc3ccnc4cc(OCC5(N)CC5)c(OC)cc34)ccc12		CHEMBL2220486	>	Kd	nM	30000.0	CHEMBL4722	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884125	CHEMBL3991630	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3F)ncnc2cc1OC[C@@H]1C[C@@H]2CN(C)C[C@@H]2C1		CHEMBL3544983	>	Kd	nM	30000.0	CHEMBL4722	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884126	CHEMBL3991630	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	>	Kd	nM	30000.0	CHEMBL4722	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884127	CHEMBL3991630	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccc(-c2cnc3ncc(Cc4ccc5ncccc5c4)n3n2)cc1F		CHEMBL3188267	>	Kd	nM	30000.0	CHEMBL4722	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884128	CHEMBL3991630	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC(=O)Nc1cc(-c2cccc(F)c2)sc1C(=O)N[C@H]1CCCNC1		CHEMBL2041933	>	Kd	nM	30000.0	CHEMBL4722	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884129	CHEMBL3991630	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1C#CC(C)(C)N1CCN(C)CC1		CHEMBL2138625	>	Kd	nM	30000.0	CHEMBL4722	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884130	CHEMBL3991630	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	>	Kd	nM	30000.0	CHEMBL4722	Homo sapiens	Kd apparent	nM	30000.0
Active	17884131	CHEMBL3991630	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1cc(-c2ccnc3[nH]c(-c4cccc(CN(C)C)c4)cc23)c(-c2ccc(NC(=O)N(C)C)cc2)n1		CHEMBL1090479	=	Kd	nM	71.0	CHEMBL4722	Homo sapiens	Kd apparent	nM	71.0
Inactive	17884132	CHEMBL3991630	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	30000.0	CHEMBL4722	Homo sapiens	Kd apparent	nM	30000.0
Active	17884133	CHEMBL3991630	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	=	Kd	nM	285.0	CHEMBL4722	Homo sapiens	Kd apparent	nM	285.0
Inactive	17884134	CHEMBL3991630	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=c1[nH]ccc2cc(OC3CCNCC3)ccc12		CHEMBL1667969	>	Kd	nM	30000.0	CHEMBL4722	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884135	CHEMBL3991630	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cnc(NC(=O)Nc2cc(Br)c(C)cc2OC[C@@H]2CNCCO2)cn1		CHEMBL3039517	>	Kd	nM	30000.0	CHEMBL4722	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884136	CHEMBL3991630	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	>	Kd	nM	30000.0	CHEMBL4722	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884137	CHEMBL3991630	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12		CHEMBL2103840	>	Kd	nM	30000.0	CHEMBL4722	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884138	CHEMBL3991630	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(C2CCN(C(=O)Nc3cc(Oc4ccc(NC(=O)C5(C(=O)Nc6ccc(F)cc6)CC5)c(F)c4)ccn3)CC2)CC1		CHEMBL3039525	>	Kd	nM	30000.0	CHEMBL4722	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884139	CHEMBL3991630	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cnc(-c2cc3nccc(Oc4ccc(NC(=S)NC(=O)Cc5ccccc5)cc4F)c3s2)c1		CHEMBL254760	>	Kd	nM	30000.0	CHEMBL4722	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884140	CHEMBL3991630	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN1CCN(Cc2ccc(Nc3ncc(F)c(-c4cc(F)c5nc(C)n(C(C)C)c5c4)n3)nc2)CC1		CHEMBL3301610	>	Kd	nM	30000.0	CHEMBL4722	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884141	CHEMBL3991630	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(C(=O)Nc2cc(Oc3ccc4nc(NC(=O)C5CC5)cn4n3)ccc2C)n(C)n1		CHEMBL2180604	>	Kd	nM	30000.0	CHEMBL4722	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884142	CHEMBL3991630	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@@](C)(Nc1ccnc(-c2c[nH]c3ncccc23)n1)C(=O)NCC(F)(F)F		CHEMBL3039513	>	Kd	nM	30000.0	CHEMBL4722	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884143	CHEMBL3991630	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(c2ccc(C(=O)Nc3n[nH]c4ccc(Cc5cc(F)cc(F)c5)cc34)c(NC3CCOCC3)c2)CC1		CHEMBL1983268	>	Kd	nM	30000.0	CHEMBL4722	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884144	CHEMBL3991630	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(-c4ccc(Cl)cc4)cc23)c1F		CHEMBL1229517	>	Kd	nM	30000.0	CHEMBL4722	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884145	CHEMBL3991630	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413	>	Kd	nM	30000.0	CHEMBL4722	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884146	CHEMBL3991630	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc2ccc(-n3ncc(C(=O)c4cc5ccccc5[nH]4)c3N)cc2[nH]1		CHEMBL3907479	>	Kd	nM	30000.0	CHEMBL4722	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884147	CHEMBL3991630	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(CCc2cc(NC(=O)c3ccc(N4CC(C)NC(C)C4)cc3)n[nH]2)cc(OC)c1		CHEMBL3184679	>	Kd	nM	30000.0	CHEMBL4722	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884148	CHEMBL3991630	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2nccc(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3)c2cc1OC		CHEMBL2105717	>	Kd	nM	30000.0	CHEMBL4722	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884149	CHEMBL3991630	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	30000.0	CHEMBL4722	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884150	CHEMBL3991630	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	>	Kd	nM	30000.0	CHEMBL4722	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884151	CHEMBL3991630	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccc(C)c(-n2c(C)cc(OCc3ccc(F)cc3F)c(Br)c2=O)c1		CHEMBL1088751	>	Kd	nM	30000.0	CHEMBL4722	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884152	CHEMBL3991630	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@H]1CNCCCN1S(=O)(=O)c1cccc2cncc(F)c12		CHEMBL3426621	>	Kd	nM	30000.0	CHEMBL4722	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884153	CHEMBL3991630	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(F)cc(C(=O)NC2CC2)cc1-c1ccc(C(=O)NCC(C)(C)C)cn1		CHEMBL1088752	>	Kd	nM	30000.0	CHEMBL4722	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884154	CHEMBL3991630	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC(=O)c1c(OCc2c(F)cc(Br)cc2F)nsc1NC(=O)NCCCCN1CCCC1		CHEMBL253969	>	Kd	nM	30000.0	CHEMBL4722	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884155	CHEMBL3991630	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2nccc(Oc3ccc(NC(=O)NC4CC4)c(Cl)c3)c2cc1C(N)=O		CHEMBL1289601	>	Kd	nM	30000.0	CHEMBL4722	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884156	CHEMBL3991630	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc([C@@H](C)Nc2ccccc2C(=O)O)c2nc(N3CCOCC3)cc(=O)n2c1		CHEMBL2165191	>	Kd	nM	30000.0	CHEMBL4722	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884157	CHEMBL3991630	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C#Cc1cccc(Nc2ncnc3cc(OC)c(OCCCCCCC(=O)NO)cc23)c1		CHEMBL598797	>	Kd	nM	30000.0	CHEMBL4722	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884158	CHEMBL3991630	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCS(=O)(=O)N1CC(CC#N)(n2cc(-c3ncnc4[nH]ccc34)cn2)C1		CHEMBL2105759	>	Kd	nM	30000.0	CHEMBL4722	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884159	CHEMBL3991630	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(c2nc(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c3ccccc3n2)CC1		CHEMBL565612	>	Kd	nM	30000.0	CHEMBL4722	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884160	CHEMBL3991630	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=S(=O)(c1cccc2c(O)nccc12)N1CCCNCC1		CHEMBL1233300	>	Kd	nM	30000.0	CHEMBL4722	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884161	CHEMBL3991630	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(F)c(F)c1C(=O)c1cnc(NC2CCN(S(C)(=O)=O)CC2)nc1N		CHEMBL384304	>	Kd	nM	30000.0	CHEMBL4722	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884162	CHEMBL3991630	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1C#Cc1cnc2cccnn12		CHEMBL1171837	>	Kd	nM	30000.0	CHEMBL4722	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884163	CHEMBL3991630	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(-c2cc(OC(=O)c3ccccc3)ccc2Cl)cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc12		CHEMBL403989	>	Kd	nM	30000.0	CHEMBL4722	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884164	CHEMBL3991630	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(N4CCN(C(C)=O)CC4)cc3OC)ncc2C(F)(F)F)c1		CHEMBL3545308	>	Kd	nM	30000.0	CHEMBL4722	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884165	CHEMBL3991630	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	>	Kd	nM	30000.0	CHEMBL4722	Homo sapiens	Kd apparent	nM	30000.0
Active	17884166	CHEMBL3991630	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)c1cc(CNc2nc(Nc3cc(C4CC4)[nH]n3)cc(N3CCN(C)CC3)n2)on1		CHEMBL3545085	=	Kd	nM	3.0	CHEMBL4722	Homo sapiens	Kd apparent	nM	3.0
Inactive	17884167	CHEMBL3991630	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3cc(C(C)(C)C)nn3-c3ccc4ncccc4c3)c(F)c2)ccn1		CHEMBL1738757	>	Kd	nM	30000.0	CHEMBL4722	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884168	CHEMBL3991630	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(-c4nc(N5CCOCC5)nc(N5CCOCC5)n4)cc3)cc2)CC1		CHEMBL592445	>	Kd	nM	30000.0	CHEMBL4722	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884169	CHEMBL3991630	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	>	Kd	nM	30000.0	CHEMBL4722	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884170	CHEMBL3991630	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN1CCN(Cc2ccc(-c3cc4c(N[C@H](C)c5ccccc5)ncnc4[nH]3)cc2)CC1		CHEMBL587723	>	Kd	nM	30000.0	CHEMBL4722	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884171	CHEMBL3991630	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	30000.0	CHEMBL4722	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884172	CHEMBL3991630	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Cc1ccc(-c2ccc(OCCN3CCOCC3)cc2)cn1)NCc1ccccc1		CHEMBL571546	>	Kd	nM	30000.0	CHEMBL4722	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884173	CHEMBL3991630	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	>	Kd	nM	30000.0	CHEMBL4722	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884174	CHEMBL3991630	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Nc3ccc(O)cc3)c2cc1OC		CHEMBL405130	>	Kd	nM	30000.0	CHEMBL4722	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884175	CHEMBL3991630	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1		CHEMBL502835	>	Kd	nM	30000.0	CHEMBL4722	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884176	CHEMBL3991630	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	>	Kd	nM	30000.0	CHEMBL4722	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884177	CHEMBL3991630	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)N1CCC[C@H](n2c(=O)n(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1		CHEMBL3991931	>	Kd	nM	30000.0	CHEMBL4722	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884178	CHEMBL3991630	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(-c2cc3c(C)nc(N)nc3n([C@H]3CC[C@H](OCCO)CC3)c2=O)cn1		CHEMBL1234354	>	Kd	nM	30000.0	CHEMBL4722	Homo sapiens	Kd apparent	nM	30000.0
Active	17884179	CHEMBL3991630	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(c1ncccc1CNc1nc(Nc2ccc3c(c2)CC(=O)N3)ncc1C(F)(F)F)S(C)(=O)=O		CHEMBL1084546	=	Kd	nM	627.0	CHEMBL4722	Homo sapiens	Kd apparent	nM	627.0
Inactive	17884180	CHEMBL3991630	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2cnn3c(N)c(Br)c([C@@H]4CCCNC4)nc23)cn1		CHEMBL2386889	>	Kd	nM	30000.0	CHEMBL4722	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884181	CHEMBL3991630	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](N)c1ccc(C(=O)Nc2ccnc3[nH]ccc23)cc1		CHEMBL571948	>	Kd	nM	30000.0	CHEMBL4722	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884182	CHEMBL3991630	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL607707	>	Kd	nM	30000.0	CHEMBL4722	Homo sapiens	Kd apparent	nM	30000.0
Active	17884183	CHEMBL3991630	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(O)C1(Cc2cccc(Nc3nccs3)n2)CCC(Oc2cccc(Cl)c2F)CC1		CHEMBL3182444	=	Kd	nM	0.1	CHEMBL4722	Homo sapiens	Kd apparent	nM	0.1
Inactive	17884184	CHEMBL3991630	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)N[C@H]4O		CHEMBL574737	>	Kd	nM	30000.0	CHEMBL4722	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884185	CHEMBL3991630	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nc(-c2cccnc2)cs1		CHEMBL1908391	>	Kd	nM	30000.0	CHEMBL4722	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884186	CHEMBL3991630	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1nc2cccc(-c3ccc(CN4CCS(=O)(=O)CC4)cc3)n2n1)C1CC1		CHEMBL3301607	>	Kd	nM	30000.0	CHEMBL4722	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884187	CHEMBL3991630	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1c(=O)c(-c2cc[nH]n2)cc2c(C)nc(N)nc21		CHEMBL3545366	>	Kd	nM	30000.0	CHEMBL4722	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884188	CHEMBL3991630	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	>	Kd	nM	30000.0	CHEMBL4722	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884189	CHEMBL3991630	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cccc(Nc2ncnn3ccc(CN4CC[C@@H](N)[C@H](O)C4)c23)c1		CHEMBL3545396	>	Kd	nM	30000.0	CHEMBL4722	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884190	CHEMBL3991630	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CC[C@@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@@H]1CO.Cl		CHEMBL3991935	>	Kd	nM	30000.0	CHEMBL4722	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884191	CHEMBL3991630	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)OC(=O)[C@H](C)N)c(C)c34)ccc2[nH]1		CHEMBL270995	>	Kd	nM	30000.0	CHEMBL4722	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884192	CHEMBL3991630	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1c(C(=O)N(C2CC2)C2CC2)cc2c3c(ncn3C)c(Nc3cc(C)n(C)n3)nc21		CHEMBL3545215	>	Kd	nM	30000.0	CHEMBL4722	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884193	CHEMBL3991630	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1		CHEMBL1173655	>	Kd	nM	30000.0	CHEMBL4722	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884194	CHEMBL3991630	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Oc1cc(-n2cnc3ccc(CN4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1908394	>	Kd	nM	30000.0	CHEMBL4722	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884195	CHEMBL3991630	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OP(C)(C)=O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL2103839	>	Kd	nM	30000.0	CHEMBL4722	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884196	CHEMBL3991630	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	>	Kd	nM	30000.0	CHEMBL4722	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884197	CHEMBL3991630	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O		CHEMBL189963	>	Kd	nM	30000.0	CHEMBL4722	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884198	CHEMBL3991630	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	S=C(NCc1ccc2c(c1)OCO2)N1CCN(c2ncnc3c2oc2ccccc23)CC1		CHEMBL2103851	>	Kd	nM	30000.0	CHEMBL4722	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884199	CHEMBL3991630	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNS(=O)(=O)Nc1nccc(Cc2c(C)c3ccc(Oc4ncccn4)cc3oc2=O)c1F		CHEMBL3264002	>	Kd	nM	30000.0	CHEMBL4722	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884200	CHEMBL3991630	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O[C@H]1CC[C@H](Nc2ncc3nc(Nc4c(F)cc(F)cc4F)n([C@H]4CCOC4)c3n2)CC1		CHEMBL1950289	>	Kd	nM	30000.0	CHEMBL4722	Homo sapiens	Kd apparent	nM	30000.0
Active	17884201	CHEMBL3991630	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(Nc2[nH]nc3c2CN(C(=O)N[C@H](CN(C)C)c2ccccc2)C3(C)C)c2sccc2n1		CHEMBL3128043	=	Kd	nM	981.0	CHEMBL4722	Homo sapiens	Kd apparent	nM	981.0
Inactive	17884202	CHEMBL3991630	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1nn(C)c2c1C(C)(C)Cc1cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc1-2		CHEMBL564829	>	Kd	nM	30000.0	CHEMBL4722	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884203	CHEMBL3991630	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1c(=O)c(F)c(Nc2ccc(I)cc2F)c2c(=O)n(C[C@@H](O)CO)cnc21		CHEMBL1615025	>	Kd	nM	30000.0	CHEMBL4722	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884204	CHEMBL3991630	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	Kd	nM	30000.0	CHEMBL4722	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884205	CHEMBL3991630	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1		CHEMBL255863	>	Kd	nM	30000.0	CHEMBL4722	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884206	CHEMBL3991630	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N#CC1(c2ccc(NC(=O)c3cccnc3NCc3ccncc3)cc2)CCCC1		CHEMBL3186534	>	Kd	nM	30000.0	CHEMBL4722	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884207	CHEMBL3991630	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc3c2cc1OCCCCCN(C)Cc1ccc(Br)cc1N3		CHEMBL3109738	>	Kd	nM	30000.0	CHEMBL4722	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884208	CHEMBL3991630	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(N2CCN(C)CC2)cc1Nc1ncc2c(n1)-c1c(c(C(N)=O)nn1C)CC2		CHEMBL1094408	>	Kd	nM	30000.0	CHEMBL4722	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884209	CHEMBL3991630	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)NCc2cc(F)ccc2Oc2ccc3c(cnn3CCO)c2)cc1		CHEMBL3991932	>	Kd	nM	30000.0	CHEMBL4722	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884210	CHEMBL3991630	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3F)c(C(=O)NOCCO)cc21		CHEMBL3187723	>	Kd	nM	30000.0	CHEMBL4722	Homo sapiens	Kd apparent	nM	30000.0
Active	17884211	CHEMBL3991630	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(/C=C/c3ccccc3)n2)n[nH]1		CHEMBL482968	=	Kd	nM	80.0	CHEMBL4722	Homo sapiens	Kd apparent	nM	80.0
Inactive	17884212	CHEMBL3991630	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cnc(Nc2ccc(OCCN3CCCC3)cc2)nc1Nc1cccc(S(=O)(=O)NC(C)(C)C)c1		CHEMBL1287853	>	Kd	nM	30000.0	CHEMBL4722	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884213	CHEMBL3991630	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Oc1cc(C(=O)Nc2ccc(C(=O)N3CCN(C)CC3)cc2)nnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL2376648	>	Kd	nM	30000.0	CHEMBL4722	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884214	CHEMBL3991630	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	FC(F)(F)c1ccc(CNc2ccc(Cc3c[nH]c4ncc(Cl)cc34)cn2)cn1		CHEMBL3813873	>	Kd	nM	30000.0	CHEMBL4722	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884215	CHEMBL3991630	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@H](Nc1ncnc2[nH]cnc12)c1nc2cccc(F)c2c(=O)n1-c1ccccc1		CHEMBL2216870	>	Kd	nM	30000.0	CHEMBL4722	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884216	CHEMBL3991630	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	>	Kd	nM	30000.0	CHEMBL4722	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884217	CHEMBL3991630	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(S(=O)(=O)Nc2nc3ccccc3nc2Nc2ccc3nsnc3c2)cc1		CHEMBL3218575	>	Kd	nM	30000.0	CHEMBL4722	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884218	CHEMBL3991630	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(NC(=O)N2CCC[C@H]2C(N)=O)sc1-c1ccnc(C(C)(C)C(F)(F)F)c1		CHEMBL2396661	>	Kd	nM	30000.0	CHEMBL4722	Homo sapiens	Kd apparent	nM	30000.0
Active	17884219	CHEMBL3991630	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1		CHEMBL1289926	=	Kd	nM	374.0	CHEMBL4722	Homo sapiens	Kd apparent	nM	374.0
Inactive	17884220	CHEMBL3991630	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC1(COc2ccc3c(c2)ncn3-c2ccc3cccc(N4CCC(N)CC4)c3n2)COC1		CHEMBL2105728	>	Kd	nM	30000.0	CHEMBL4722	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884221	CHEMBL3991630	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2ncnc3ccc(NC4=NC(C)(C)CO4)cc23)ccc1Oc1ccn2ncnc2c1		CHEMBL3989868	>	Kd	nM	30000.0	CHEMBL4722	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884222	CHEMBL3991630	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(-c2ccc3c(N4CCOC[C@@H]4C)nc(N4CCOC[C@@H]4C)nc3n2)cc1CO		CHEMBL1801204	>	Kd	nM	30000.0	CHEMBL4722	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884223	CHEMBL3991630	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COCc1c(-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)c(F)c2)c2c(N)ncnn2c1CN1CCOCC1		CHEMBL3991934	>	Kd	nM	30000.0	CHEMBL4722	Homo sapiens	Kd apparent	nM	30000.0
Active	17884224	CHEMBL3991630	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1c[nH]nc1-c1nc2ccc(CN3CCOCC3)cc2[nH]1)NC1CC1		CHEMBL495727	=	Kd	nM	16.0	CHEMBL4722	Homo sapiens	Kd apparent	nM	16.0
Inactive	17884225	CHEMBL3991630	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL521851	>	Kd	nM	30000.0	CHEMBL4722	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884226	CHEMBL3991630	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OC(=O)C(C)(CO)CO)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL1201182	>	Kd	nM	30000.0	CHEMBL4722	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884227	CHEMBL3991630	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)Nc1cccc(-n2c(=O)n(C3CC3)c(=O)c3c(Nc4ccc(I)cc4F)n(C)c(=O)c(C)c32)c1		CHEMBL2103875	>	Kd	nM	30000.0	CHEMBL4722	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884228	CHEMBL3991630	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(COc2nnc(Nc3ccc(Cl)cc3)c3ccoc23)ccn1		CHEMBL2079588	>	Kd	nM	30000.0	CHEMBL4722	Homo sapiens	Kd apparent	nM	30000.0
Active	17884229	CHEMBL3991630	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccccc32)c(C)c1CCC(=O)O		CHEMBL274654	=	Kd	nM	3254.0	CHEMBL4722	Homo sapiens	Kd apparent	nM	3254.0
Inactive	17884230	CHEMBL3991630	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COCC(=O)NC/C=C/c1ccc2ncnc(Nc3ccc(Oc4ccc(C)nc4)c(C)c3)c2c1		CHEMBL483321	>	Kd	nM	30000.0	CHEMBL4722	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884231	CHEMBL3991630	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(O)c1ccc2c(c1)nc(Nc1cccc(Cl)c1)c1ccncc12		CHEMBL1230165	>	Kd	nM	30000.0	CHEMBL4722	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884232	CHEMBL3991630	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(Cn2c(C)nc3c(C(=O)O)cc(N4CCOCC4)cc32)cccc1C(F)(F)F		CHEMBL3188551	>	Kd	nM	30000.0	CHEMBL4722	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884233	CHEMBL3991630	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)Nc1cc(-c2c[nH]c(C(=O)N[C@H](CO)c3cccc(Cl)c3)c2)c(Cl)cn1		CHEMBL3590106	>	Kd	nM	30000.0	CHEMBL4722	Homo sapiens	Kd apparent	nM	30000.0
Active	17884234	CHEMBL3991630	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL281948	=	Kd	nM	20.0	CHEMBL4722	Homo sapiens	Kd apparent	nM	20.0
Inactive	17884235	CHEMBL3991630	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ncc(-c2ccnc(Nc3ccc(S(C)(=O)=O)cc3)n2)n1C(C)C		CHEMBL488436	>	Kd	nM	30000.0	CHEMBL4722	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884236	CHEMBL3991630	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C[C@@H]1COCCO1)S(=O)(=O)Nc1ccc2ccc3ncc(-c4cnn(C)c4)cc3c(=O)c2c1		CHEMBL1822792	>	Kd	nM	30000.0	CHEMBL4722	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884237	CHEMBL3991630	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	Kd	nM	30000.0	CHEMBL4722	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884238	CHEMBL3991630	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2ccc3nnc(C(F)(F)c4ccc5ncccc5c4)n3n2)cn1		CHEMBL2133806	>	Kd	nM	30000.0	CHEMBL4722	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884239	CHEMBL3991630	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@]1(O)C[C@@H](c2nc(-c3ccc4ccc(-c5ccccc5)nc4c3)c3c(N)nccn32)C1		CHEMBL1091644	>	Kd	nM	30000.0	CHEMBL4722	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884240	CHEMBL3991630	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cccc2cc(-c3nc([C@H]4CC[C@H](C(=O)O)CC4)n4ncnc(N)c34)[nH]c12		CHEMBL3120215	>	Kd	nM	30000.0	CHEMBL4722	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884241	CHEMBL3991630	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1		CHEMBL1230609	>	Kd	nM	30000.0	CHEMBL4722	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884242	CHEMBL3991630	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1ccc(OC(F)(F)F)cc1)c1sccc1NCc1ccnc2ccccc12		CHEMBL1614710	>	Kd	nM	30000.0	CHEMBL4722	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884243	CHEMBL3991630	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C1NC(=O)/C(=C/c2ccc3nccc(-c4ccncc4)c3c2)S1		CHEMBL3544966	>	Kd	nM	30000.0	CHEMBL4722	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884244	CHEMBL3991630	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C(=O)c1cc2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n1C1CCCC1		CHEMBL3545110	>	Kd	nM	30000.0	CHEMBL4722	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884245	CHEMBL3991630	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1		CHEMBL1789941	>	Kd	nM	30000.0	CHEMBL4722	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884246	CHEMBL3991630	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1ccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)cc1)C1CCCN1		CHEMBL3545328	>	Kd	nM	30000.0	CHEMBL4722	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884247	CHEMBL3991630	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@H]1CN(C(=O)c2cc3c(C(=O)C(=O)N(C)C)cn(C)c3cc2Cl)[C@H](C)CN1Cc1ccc(F)cc1		CHEMBL514201	>	Kd	nM	30000.0	CHEMBL4722	Homo sapiens	Kd apparent	nM	30000.0
Active	17884248	CHEMBL3991630	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@]1(C(=O)Nc2ccc(F)nc2)CCCN1c1nc(Nc2cc(C3CC3)n[nH]2)c2cccn2n1		CHEMBL575448	=	Kd	nM	76.0	CHEMBL4722	Homo sapiens	Kd apparent	nM	76.0
Inactive	17884249	CHEMBL3991630	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1c(OCCCN2CCOCC2)ccc2c1N=C(NC(=O)c1cnc(N)nc1)N1CCN=C21		CHEMBL3218576	>	Kd	nM	30000.0	CHEMBL4722	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884250	CHEMBL3991630	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1nccc1Nc1nccc(-c2ccn([C@H](CO)c3ccc(Cl)c(F)c3)c(=O)c2)n1		CHEMBL3544964	>	Kd	nM	30000.0	CHEMBL4722	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884251	CHEMBL3991630	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Nc1cc(C(F)(F)F)c(-c2cc(N3CCOCC3)nc(N3CCOCC3)n2)cn1		CHEMBL2017974	>	Kd	nM	30000.0	CHEMBL4722	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884252	CHEMBL3991630	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(O)CC(=O)NCCn1ccc2ncnc(Nc3ccc(Oc4cccc(C(F)(F)F)c4)c(Cl)c3)c21		CHEMBL1614725	>	Kd	nM	30000.0	CHEMBL4722	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884253	CHEMBL3991630	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(OC)c(/C=C/S(=O)(=O)Cc2ccc(OC)c(NCC(=O)O)c2)c(OC)c1		CHEMBL1241855	>	Kd	nM	30000.0	CHEMBL4722	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884254	CHEMBL3991630	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc2cc(-c3nn(C(C)C)c4ncnc(N)c34)ccc2o1		CHEMBL3991933	>	Kd	nM	30000.0	CHEMBL4722	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884255	CHEMBL3991630	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1		CHEMBL1873475	>	Kd	nM	30000.0	CHEMBL4722	Homo sapiens	Kd apparent	nM	30000.0
Active	17884256	CHEMBL3991630	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccc(Nc2ncc(C(F)(F)F)c(NCc3nccnc3N(C)S(C)(=O)=O)n2)cc1		CHEMBL3137331	=	Kd	nM	622.0	CHEMBL4722	Homo sapiens	Kd apparent	nM	622.0
Inactive	17884257	CHEMBL3991630	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COCCN1CCN(Cc2ccc(-c3n[nH]c4c3C(=O)c3c(NC(=O)NN5CCOCC5)cccc3-4)cc2)CC1		CHEMBL3545083	>	Kd	nM	30000.0	CHEMBL4722	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884258	CHEMBL3991630	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OCCO)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL1908360	>	Kd	nM	30000.0	CHEMBL4722	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884259	CHEMBL3991630	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1C/C=C/CCOc2cccc(c2)-c2ccnc(n2)Nc2cccc(c2)C1		CHEMBL1944698	>	Kd	nM	30000.0	CHEMBL4722	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884260	CHEMBL3991630	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	>	Kd	nM	30000.0	CHEMBL4722	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884261	CHEMBL3991630	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2ccc3nnc(Sc4ccc5ncccc5c4)n3n2)cn1		CHEMBL1236107	>	Kd	nM	30000.0	CHEMBL4722	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884262	CHEMBL3991630	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(-c2cc(O)ccc2Cl)cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc12		CHEMBL400402	>	Kd	nM	30000.0	CHEMBL4722	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884263	CHEMBL3991630	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	>	Kd	nM	30000.0	CHEMBL4722	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17884264	CHEMBL3991630	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](NC(=O)c1ncnc(N)c1Cl)c1ncc(C(=O)Nc2cc(C(F)(F)F)c(Cl)cn2)s1		CHEMBL3348923	>	Kd	nM	30000.0	CHEMBL4722	Homo sapiens	Kd apparent	nM	30000.0
	17964874	CHEMBL3994983	Inhibition of human AURKA (E122 to K401 residues) expressed in mammalian expression system assessed as residual activity at 1 uM by KINOMEscan assay relative to control	B	CNc1cc(Oc2ccc(NC(=O)Nc3cc(C(C)(C)C)on3)c(C)c2)ncn1		CHEMBL4060295	=	Activity	%	100.0	CHEMBL4722	Homo sapiens	Activity	%	100.0
	17979274	CHEMBL3998078	Inhibition of full length recombinant human His-tagged Aurora A expressed in baculovirus expression system at 10 uM by Z'-LYTE assay relative to control	B	CC1=Nc2c(Sc3ccccc3)ncnc2Sc2ccccc21		CHEMBL4061152	=	Inhibition	%	6.0	CHEMBL4722	Homo sapiens	INH	%	6.0
	18007411	CHEMBL4003493	Inhibition of recombinant human AurA/Aur 2 kinase expressed in insect Sf21 cells at 10 uM using Ulight-RRRSLLE substrate after 15 mins by LANCE assay	B	CCc1cc(O)c(F)cc1-c1ccc2c(-c3nc4c([nH]3)CCN(C(=O)c3cnc(N5CCCCC5)cn3)C4)n[nH]c2c1		CHEMBL3644620	>	Inhibition	%	50.0	CHEMBL4722	Homo sapiens	INH	%	50.0
	18008343	CHEMBL4003699	Inhibition of Aurora A (unknown origin)	B	CN(C)CCn1cc(-c2ccn3c(-c4ccc(C(N)=O)c(OCc5ccccc5)c4)cnc3c2)cn1		CHEMBL4063211	=	IC50	nM	5800.0	CHEMBL4722	Homo sapiens	IC50	uM	5.8
	18008344	CHEMBL4003699	Inhibition of Aurora A (unknown origin)	B	CN(C)CCn1cc(-c2ccn3c(-c4ccc(C(N)=O)c(OCc5cccc(C(F)(F)F)c5)c4)cnc3c2)cn1		CHEMBL4091089	>	IC50	nM	10000.0	CHEMBL4722	Homo sapiens	IC50	uM	10.0
	18008345	CHEMBL4003699	Inhibition of Aurora A (unknown origin)	B	CN(C)CCn1cc(-c2ccn3c(-c4ccc(C(N)=O)c(OCc5ccccc5F)c4)cnc3c2)cn1		CHEMBL4087758	>	IC50	nM	10000.0	CHEMBL4722	Homo sapiens	IC50	uM	10.0
	18008346	CHEMBL4003699	Inhibition of Aurora A (unknown origin)	B	CN(C)CCn1cc(-c2ccn3c(-c4ccc(C(N)=O)c(OCc5cccc(F)c5)c4)cnc3c2)cn1		CHEMBL4062453	=	IC50	nM	5300.0	CHEMBL4722	Homo sapiens	IC50	uM	5.3
	18008665	CHEMBL4003778	Inhibition of human Aurora-A using Kemptide as substrate in presence of [gamma-33P]ATP at 1 uM after 40 mins by scintillation counter method	B	CC(C)n1cnc2c(Nc3cccc(Cl)c3)nc(N[C@H]3CCCC[C@@H]3N)nc21		CHEMBL4088144	=	Inhibition	%	4.0	CHEMBL4722	Homo sapiens	INH	%	4.0
	18008666	CHEMBL4003778	Inhibition of human Aurora-A using Kemptide as substrate in presence of [gamma-33P]ATP at 1 uM after 40 mins by scintillation counter method	B	CC(C)n1cnc2c(Nc3cccc(Cl)c3)nc(N[C@@H]3CCCC[C@@H]3N)nc21		CHEMBL4066861	=	Inhibition	%	-5.0	CHEMBL4722	Homo sapiens	INH	%	-5.0
	18008667	CHEMBL4003778	Inhibition of human Aurora-A using Kemptide as substrate in presence of [gamma-33P]ATP at 1 uM after 40 mins by scintillation counter method	B	CC(C)n1cnc2c(Nc3cc(N)cc(Cl)c3)nc(N[C@@H]3CCCC[C@@H]3N)nc21		CHEMBL4078898	=	Inhibition	%	13.0	CHEMBL4722	Homo sapiens	INH	%	13.0
	18012414	CHEMBL4004234	Inhibition of recombinant full length human N-terminal GST-tagged Aurora kinase-A (1 to 403 residues) expressed in baculovirus expression system	B	COc1cc2ncccc2cc1NC(=O)c1csc2cncnc12		CHEMBL3822972	=	IC50	nM	42000.0	CHEMBL4722	Homo sapiens	IC50	uM	42.0
	18031610	CHEMBL4007685	Inhibition of AURKA (unknown origin) after 60 mins by TR-FRET assay	B	CCCNC(=O)c1ccc(Nc2nc(NCC(F)(F)F)c3cc[nH]c3n2)cc1		CHEMBL2006765	=	IC50	nM	472.0	CHEMBL4722	Homo sapiens	IC50	uM	0.472
	18031611	CHEMBL4007685	Inhibition of AURKA (unknown origin) after 60 mins by TR-FRET assay	B	FC(F)(F)CNc1nc(Nc2ccc(N3CCOCC3)c(Cl)c2)nc2ccoc12		CHEMBL4078893	>	IC50	nM	10000.0	CHEMBL4722	Homo sapiens	IC50	uM	10.0
	18031612	CHEMBL4007685	Inhibition of AURKA (unknown origin) after 60 mins by TR-FRET assay	B	FC(F)(F)CNc1nc(Nc2ccc3cn[nH]c3c2)nc2ccoc12		CHEMBL4066664	>	IC50	nM	10000.0	CHEMBL4722	Homo sapiens	IC50	uM	10.0
	18031613	CHEMBL4007685	Inhibition of AURKA (unknown origin) after 60 mins by TR-FRET assay	B	CC1(C)OCC(=O)Nc2cc(Nc3nc(NCC(F)(F)F)c4occc4n3)ccc21		CHEMBL4069365	=	IC50	nM	4050.0	CHEMBL4722	Homo sapiens	IC50	uM	4.05
	18031614	CHEMBL4007685	Inhibition of AURKA (unknown origin) after 60 mins by TR-FRET assay	B	Cc1n[nH]c2cc(Nc3nc(NC4CC4)c4occc4n3)ccc12		CHEMBL4062803	>	IC50	nM	10000.0	CHEMBL4722	Homo sapiens	IC50	uM	10.0
	18033104	CHEMBL4007920	Inhibition of human Aurora A at 0.1 uM relative to control	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1NC(=O)[C@H]1CCCN1.Cl		CHEMBL4093614	=	Inhibition	%	2.0	CHEMBL4722	Homo sapiens	INH	%	2.0
	18053057	CHEMBL4011904	Inhibition of AurA (unknown origin) at 0.1 uM pretreated for 30 mins followed by substrate addition measured after 5 hrs in presence of 1 mM ATP relative to control	B	COC(=O)C1=C(Nc2ccccc2Cl)O/C(=C\c2c[nH]c3ncccc23)C1=O	Outside typical range	CHEMBL4089159	=	Inhibition	%	-19.4	CHEMBL4722	Homo sapiens	INH	%	-19.4
Not Determined	18066699	CHEMBL4014525	Inhibition of human AURORA-A	B	COc1ccc(-c2cnc3scc(NC(=O)C4CCCCC4)c3c2)cc1OC		CHEMBL3334979		IC50			CHEMBL4722	Homo sapiens	IC50		
	18066700	CHEMBL4014525	Inhibition of human AURORA-A	B	CCOc1cc(/C=C2\Oc3ccc(OC)cc3C2=O)ccc1O		CHEMBL4105195	=	IC50	nM	9920.0	CHEMBL4722	Homo sapiens	IC50	uM	9.92
	18066701	CHEMBL4014525	Inhibition of human AURORA-A	B	COc1ccc2c(c1)C(=O)/C(=C/c1ccc(O)c(O)c1)O2		CHEMBL4087337	=	IC50	nM	1050.0	CHEMBL4722	Homo sapiens	IC50	uM	1.05
	18066702	CHEMBL4014525	Inhibition of human AURORA-A	B	O=C1/C(=C/c2ccc(O)c(O)c2)Oc2cc(O)ccc21		CHEMBL490355	=	IC50	nM	850.0	CHEMBL4722	Homo sapiens	IC50	uM	0.85
Active	18078252	CHEMBL4016719	Inhibition of human N-terminal GST/His6-tagged Aurora A (M1 to S403 residues) expressed in baculovirus infected sf9 cells at 1 uM using tetra(LRRLSLG) as substrate by filter binding assay	B	O=C1Nc2ccccc2/C1=C1/Nc2ccccc2/C1=N\OCC(O)CO		CHEMBL1276317		Inhibition	%		CHEMBL4722	Homo sapiens	INH		
Not Active	18078253	CHEMBL4016719	Inhibition of human N-terminal GST/His6-tagged Aurora A (M1 to S403 residues) expressed in baculovirus infected sf9 cells at 1 uM using tetra(LRRLSLG) as substrate by filter binding assay	B	CN1CCN(CCO/N=C2C(=C3/C(=O)Nc4ccccc43)/Nc3ccccc3/2)CC1.Cl		CHEMBL4084775		Inhibition	%		CHEMBL4722	Homo sapiens	INH		
Active	18078254	CHEMBL4016719	Inhibition of human N-terminal GST/His6-tagged Aurora A (M1 to S403 residues) expressed in baculovirus infected sf9 cells at 1 uM using tetra(LRRLSLG) as substrate by filter binding assay	B	O=C1Nc2cc(Br)ccc2/C1=C1/Nc2ccccc2/C1=N\O		CHEMBL409450		Inhibition	%		CHEMBL4722	Homo sapiens	INH		
Active	18078255	CHEMBL4016719	Inhibition of human N-terminal GST/His6-tagged Aurora A (M1 to S403 residues) expressed in baculovirus infected sf9 cells at 1 uM using tetra(LRRLSLG) as substrate by filter binding assay	B	Cc1ccc2c(c1)NC(=O)/C2=C1\Nc2ccccc2\C1=N/O		CHEMBL4067175		Inhibition	%		CHEMBL4722	Homo sapiens	INH		
	18112103	CHEMBL4024296	Inhibition of recombinant human full length C-terminal 6His-tagged Aurora-A expressed in baculovirus infected sf21 cells using kemptide substrate in presence of [gamma33P]ATP after 10 mins by scintillation counting method	B	CN(C)C(=O)c1cc2cnc(Nc3ccc(NC(=O)CCCCCCC(=O)NO)cc3)nc2n1C1CCCC1		CHEMBL4063500	=	IC50	nM	12.0	CHEMBL4722	Homo sapiens	IC50	uM	0.012
	18114476	CHEMBL4025018	Inhibition of wild-type human partial length AURKA (E122 to K401 residues) expressed in mammalian expression system assessed as residual activity at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1cc(Nc2cc(-c3cccc(NC(=O)c4ccc(C(C)(C)C)cc4)c3C)cn(C)c2=O)ccc1C(=O)N1CCOCC1		CHEMBL4077123	=	Activity	%	61.0	CHEMBL4722	Homo sapiens	Activity	%	61.0
	18117601	CHEMBL4025914	Inhibition of N-terminal His6-tagged recombinant full-length human Aurora A expressed in Sf21 insect cells at 3 uM relative to control	B	COc1ccc(-c2nnc(-n3c(-c4ccccc4)nc4cc(Cl)ccc4c3=O)s2)cc1		CHEMBL4103440	=	Inhibition	%	0.0	CHEMBL4722	Homo sapiens	INH	%	0.0
	18121167	CHEMBL4026804	Inhibition of human AURKA (E122 to K401 residues) expressed in mammalian expression system assessed as percent enzyme activity at 1 uM relative to control	B	Cc1ccc(Oc2ccnc3cc(-c4cnn(C5CCNCC5)c4)ccc23)cc1		CHEMBL4091441	=	Activity	%	9.1	CHEMBL4722	Homo sapiens	Activity	%	9.1
	18147062	CHEMBL4032513	Inhibition of aurora A (unknown origin) at 100 nM relative to control	B	Nc1nccc(-c2c[nH]c3ncc(-c4ccc(F)cc4)cc23)n1		CHEMBL4095226	=	Inhibition	%	-5.9	CHEMBL4722	Homo sapiens	INH	%	-5.9
	18147063	CHEMBL4032513	Inhibition of aurora A (unknown origin) at 100 nM relative to control	B	COc1ccnc2[nH]cc(-c3ccnc(N)n3)c12		CHEMBL270686	=	Inhibition	%	10.6	CHEMBL4722	Homo sapiens	INH	%	10.6
	18147098	CHEMBL4032533	Inhibition of aurora A (unknown origin) at 500 nM relative to control	B	Nc1nccc(-c2c[nH]c3ncc(-c4ccc(F)cc4)cc23)n1		CHEMBL4095226	=	Inhibition	%	20.4	CHEMBL4722	Homo sapiens	INH	%	20.4
	18147099	CHEMBL4032533	Inhibition of aurora A (unknown origin) at 500 nM relative to control	B	COc1ccnc2[nH]cc(-c3ccnc(N)n3)c12		CHEMBL270686	=	Inhibition	%	9.5	CHEMBL4722	Homo sapiens	INH	%	9.5
	18153133	CHEMBL4034264	Inhibition of AUR A ATP binding site (unknown origin) at 10 uM	B	c1cc(-c2c[nH]c3cnccc23)ccn1		CHEMBL4084955	=	Inhibition	%	10.3	CHEMBL4722	Homo sapiens	INH	%	10.3
	18153134	CHEMBL4034262	Inhibition of AUR A Lysine 1 labelling site (unknown origin) at 10 uM	B	c1cc(-c2c[nH]c3cnccc23)ccn1		CHEMBL4084955	=	Inhibition	%	10.9	CHEMBL4722	Homo sapiens	INH	%	10.9
	18153347	CHEMBL4034263	Inhibition of AUR A Lysine 2 labelling site (unknown origin) at 10 uM	B	c1cc(-c2c[nH]c3cnccc23)ccn1		CHEMBL4084955	=	Inhibition	%	3.7	CHEMBL4722	Homo sapiens	INH	%	3.7
Not Determined	18163567	CHEMBL4036220	Inhibition of recombinant full length human N-terminal GST-tagged Aurora A expressed in baculovirus infected Sf9 cells at 10 uM using myelin basic protein as substrate after 60 mins by ADP-Glo luminescence assay relative to control	B	O=C(Nc1ccccc1)n1ccc(CNc2nc3ccc(OCCN4CCOCC4)cc3s2)n1		CHEMBL4076349		Inhibition	%		CHEMBL4722	Homo sapiens	INH		
Not Determined	18163568	CHEMBL4036220	Inhibition of recombinant full length human N-terminal GST-tagged Aurora A expressed in baculovirus infected Sf9 cells at 10 uM using myelin basic protein as substrate after 60 mins by ADP-Glo luminescence assay relative to control	B	O=C(Nc1ccc(F)cc1)n1ccc(CNc2nc3ccc(OCCN4CCOCC4)cc3s2)n1		CHEMBL4093507		Inhibition	%		CHEMBL4722	Homo sapiens	INH		
Not Determined	18163569	CHEMBL4036220	Inhibition of recombinant full length human N-terminal GST-tagged Aurora A expressed in baculovirus infected Sf9 cells at 10 uM using myelin basic protein as substrate after 60 mins by ADP-Glo luminescence assay relative to control	B	O=C(Nc1ccc(Cl)cc1)n1ccc(CNc2nc3ccc(OCCN4CCOCC4)cc3s2)n1		CHEMBL4071556		Inhibition	%		CHEMBL4722	Homo sapiens	INH		
Not Determined	18163570	CHEMBL4036220	Inhibition of recombinant full length human N-terminal GST-tagged Aurora A expressed in baculovirus infected Sf9 cells at 10 uM using myelin basic protein as substrate after 60 mins by ADP-Glo luminescence assay relative to control	B	O=C(Nc1ccc(Br)cc1)n1ccc(CNc2nc3ccc(OCCN4CCOCC4)cc3s2)n1		CHEMBL4076200		Inhibition	%		CHEMBL4722	Homo sapiens	INH		
Not Determined	18163571	CHEMBL4036220	Inhibition of recombinant full length human N-terminal GST-tagged Aurora A expressed in baculovirus infected Sf9 cells at 10 uM using myelin basic protein as substrate after 60 mins by ADP-Glo luminescence assay relative to control	B	O=C(Nc1ccc(Cl)c(Cl)c1)n1ccc(CNc2nc3ccc(OCCN4CCOCC4)cc3s2)n1		CHEMBL4078692		Inhibition	%		CHEMBL4722	Homo sapiens	INH		
Not Active	18163572	CHEMBL4036220	Inhibition of recombinant full length human N-terminal GST-tagged Aurora A expressed in baculovirus infected Sf9 cells at 10 uM using myelin basic protein as substrate after 60 mins by ADP-Glo luminescence assay relative to control	B	O=C(Nc1ccccc1CNc1nc2ccc(OCCN3CCOCC3)cc2s1)c1ccccc1		CHEMBL4077517		Inhibition	%		CHEMBL4722	Homo sapiens	INH		
Not Active	18163573	CHEMBL4036220	Inhibition of recombinant full length human N-terminal GST-tagged Aurora A expressed in baculovirus infected Sf9 cells at 10 uM using myelin basic protein as substrate after 60 mins by ADP-Glo luminescence assay relative to control	B	O=C(Nc1cccc(CNc2nc3ccc(OCCN4CCOCC4)cc3s2)c1)c1ccccc1		CHEMBL4075668		Inhibition	%		CHEMBL4722	Homo sapiens	INH		
Not Active	18163574	CHEMBL4036220	Inhibition of recombinant full length human N-terminal GST-tagged Aurora A expressed in baculovirus infected Sf9 cells at 10 uM using myelin basic protein as substrate after 60 mins by ADP-Glo luminescence assay relative to control	B	O=C(Nc1cccc(CNc2nc3ccc(OCCN4CCOCC4)cc3s2)c1)c1ccc(F)cc1		CHEMBL4060436		Inhibition	%		CHEMBL4722	Homo sapiens	INH		
Not Active	18163575	CHEMBL4036220	Inhibition of recombinant full length human N-terminal GST-tagged Aurora A expressed in baculovirus infected Sf9 cells at 10 uM using myelin basic protein as substrate after 60 mins by ADP-Glo luminescence assay relative to control	B	O=C(Nc1cccc(CNc2nc3ccc(OCCN4CCOCC4)cc3s2)c1)c1cccc(Cl)c1		CHEMBL4096830		Inhibition	%		CHEMBL4722	Homo sapiens	INH		
Not Active	18163576	CHEMBL4036220	Inhibition of recombinant full length human N-terminal GST-tagged Aurora A expressed in baculovirus infected Sf9 cells at 10 uM using myelin basic protein as substrate after 60 mins by ADP-Glo luminescence assay relative to control	B	O=C(Nc1cccc(CNc2nc3ccc(OCCN4CCOCC4)cc3s2)c1)c1ccc(Cl)cc1		CHEMBL4069612		Inhibition	%		CHEMBL4722	Homo sapiens	INH		
Not Active	18163577	CHEMBL4036220	Inhibition of recombinant full length human N-terminal GST-tagged Aurora A expressed in baculovirus infected Sf9 cells at 10 uM using myelin basic protein as substrate after 60 mins by ADP-Glo luminescence assay relative to control	B	O=C(Nc1cccc(CNc2nc3ccc(OCCN4CCOCC4)cc3s2)c1)c1ccc([N+](=O)[O-])cc1		CHEMBL4067950		Inhibition	%		CHEMBL4722	Homo sapiens	INH		
Not Active	18163578	CHEMBL4036220	Inhibition of recombinant full length human N-terminal GST-tagged Aurora A expressed in baculovirus infected Sf9 cells at 10 uM using myelin basic protein as substrate after 60 mins by ADP-Glo luminescence assay relative to control	B	O=C(Nc1ccc(CNc2nc3ccc(OCCN4CCOCC4)cc3s2)cc1)c1ccccc1		CHEMBL4085746		Inhibition	%		CHEMBL4722	Homo sapiens	INH		
Not Active	18163579	CHEMBL4036220	Inhibition of recombinant full length human N-terminal GST-tagged Aurora A expressed in baculovirus infected Sf9 cells at 10 uM using myelin basic protein as substrate after 60 mins by ADP-Glo luminescence assay relative to control	B	O=C(Nc1ccc(CNc2nc3ccc(OCCN4CCOCC4)cc3s2)cc1)c1cccc(Cl)c1		CHEMBL4105537		Inhibition	%		CHEMBL4722	Homo sapiens	INH		
Not Active	18163580	CHEMBL4036220	Inhibition of recombinant full length human N-terminal GST-tagged Aurora A expressed in baculovirus infected Sf9 cells at 10 uM using myelin basic protein as substrate after 60 mins by ADP-Glo luminescence assay relative to control	B	O=C(Nc1ccc(CNc2nc3ccc(OCCN4CCOCC4)cc3s2)cc1)c1ccc(Cl)cc1		CHEMBL4087659		Inhibition	%		CHEMBL4722	Homo sapiens	INH		
Not Active	18163581	CHEMBL4036220	Inhibition of recombinant full length human N-terminal GST-tagged Aurora A expressed in baculovirus infected Sf9 cells at 10 uM using myelin basic protein as substrate after 60 mins by ADP-Glo luminescence assay relative to control	B	COc1ccc(C(=O)Nc2ccc(CNc3nc4ccc(OCCN5CCOCC5)cc4s3)cc2)cc1		CHEMBL4097804		Inhibition	%		CHEMBL4722	Homo sapiens	INH		
Not Active	18163582	CHEMBL4036220	Inhibition of recombinant full length human N-terminal GST-tagged Aurora A expressed in baculovirus infected Sf9 cells at 10 uM using myelin basic protein as substrate after 60 mins by ADP-Glo luminescence assay relative to control	B	O=S(=O)(Nc1ccc(CNc2nc3ccc(OCCN4CCOCC4)cc3s2)cc1)c1ccccc1		CHEMBL4079776		Inhibition	%		CHEMBL4722	Homo sapiens	INH		
Not Active	18163583	CHEMBL4036220	Inhibition of recombinant full length human N-terminal GST-tagged Aurora A expressed in baculovirus infected Sf9 cells at 10 uM using myelin basic protein as substrate after 60 mins by ADP-Glo luminescence assay relative to control	B	O=S(=O)(Nc1ccc(CNc2nc3ccc(OCCN4CCOCC4)cc3s2)cc1)c1ccc(F)cc1		CHEMBL4090089		Inhibition	%		CHEMBL4722	Homo sapiens	INH		
Not Active	18163584	CHEMBL4036220	Inhibition of recombinant full length human N-terminal GST-tagged Aurora A expressed in baculovirus infected Sf9 cells at 10 uM using myelin basic protein as substrate after 60 mins by ADP-Glo luminescence assay relative to control	B	O=S(=O)(Nc1ccc(CNc2nc3ccc(OCCN4CCOCC4)cc3s2)cc1)c1ccc(Cl)cc1		CHEMBL4069011		Inhibition	%		CHEMBL4722	Homo sapiens	INH		
Not Active	18163635	CHEMBL4036223	Inhibition of recombinant full length human N-terminal GST-tagged Aurora A expressed in baculovirus infected Sf9 cells at 1 uM using myelin basic protein as substrate after 60 mins by ADP-Glo luminescence assay relative to control	B	O=C(Nc1ccccc1)Nc1cccc(CNc2nc3ccc(OCCN4CCOCC4)cc3s2)c1		CHEMBL4102159		Inhibition	%		CHEMBL4722	Homo sapiens	INH		
Not Active	18163636	CHEMBL4036223	Inhibition of recombinant full length human N-terminal GST-tagged Aurora A expressed in baculovirus infected Sf9 cells at 1 uM using myelin basic protein as substrate after 60 mins by ADP-Glo luminescence assay relative to control	B	O=C(Nc1cccc(Cl)c1)Nc1cccc(CNc2nc3ccc(OCCN4CCOCC4)cc3s2)c1		CHEMBL4084191		Inhibition	%		CHEMBL4722	Homo sapiens	INH		
Not Active	18163637	CHEMBL4036223	Inhibition of recombinant full length human N-terminal GST-tagged Aurora A expressed in baculovirus infected Sf9 cells at 1 uM using myelin basic protein as substrate after 60 mins by ADP-Glo luminescence assay relative to control	B	O=C(Nc1ccc(Cl)cc1)Nc1cccc(CNc2nc3ccc(OCCN4CCOCC4)cc3s2)c1		CHEMBL4061107		Inhibition	%		CHEMBL4722	Homo sapiens	INH		
Not Active	18163638	CHEMBL4036223	Inhibition of recombinant full length human N-terminal GST-tagged Aurora A expressed in baculovirus infected Sf9 cells at 1 uM using myelin basic protein as substrate after 60 mins by ADP-Glo luminescence assay relative to control	B	O=C(Nc1ccccc1)Nc1ccc(CNc2nc3ccc(OCCN4CCOCC4)cc3s2)cc1		CHEMBL4082990		Inhibition	%		CHEMBL4722	Homo sapiens	INH		
Not Active	18163639	CHEMBL4036223	Inhibition of recombinant full length human N-terminal GST-tagged Aurora A expressed in baculovirus infected Sf9 cells at 1 uM using myelin basic protein as substrate after 60 mins by ADP-Glo luminescence assay relative to control	B	O=C(Nc1ccc(F)cc1)Nc1ccc(CNc2nc3ccc(OCCN4CCOCC4)cc3s2)cc1		CHEMBL4099422		Inhibition	%		CHEMBL4722	Homo sapiens	INH		
Not Active	18163640	CHEMBL4036223	Inhibition of recombinant full length human N-terminal GST-tagged Aurora A expressed in baculovirus infected Sf9 cells at 1 uM using myelin basic protein as substrate after 60 mins by ADP-Glo luminescence assay relative to control	B	O=C(Nc1ccc(CNc2nc3ccc(OCCN4CCOCC4)cc3s2)cc1)Nc1cccc(Cl)c1		CHEMBL4072503		Inhibition	%		CHEMBL4722	Homo sapiens	INH		
Not Active	18163641	CHEMBL4036223	Inhibition of recombinant full length human N-terminal GST-tagged Aurora A expressed in baculovirus infected Sf9 cells at 1 uM using myelin basic protein as substrate after 60 mins by ADP-Glo luminescence assay relative to control	B	O=C(Nc1ccc(Cl)cc1)Nc1ccc(CNc2nc3ccc(OCCN4CCOCC4)cc3s2)cc1		CHEMBL4080475		Inhibition	%		CHEMBL4722	Homo sapiens	INH		
Not Active	18163642	CHEMBL4036223	Inhibition of recombinant full length human N-terminal GST-tagged Aurora A expressed in baculovirus infected Sf9 cells at 1 uM using myelin basic protein as substrate after 60 mins by ADP-Glo luminescence assay relative to control	B	CN(C)CCOc1ccc2nc(NCc3ccc(NC(=O)Nc4ccc(Cl)cc4)cc3)sc2c1		CHEMBL4098492		Inhibition	%		CHEMBL4722	Homo sapiens	INH		
Not Active	18163643	CHEMBL4036223	Inhibition of recombinant full length human N-terminal GST-tagged Aurora A expressed in baculovirus infected Sf9 cells at 1 uM using myelin basic protein as substrate after 60 mins by ADP-Glo luminescence assay relative to control	B	O=C(Nc1ccc(Cl)cc1)Nc1ccc(CNc2nc3ccc(OCCC4CCCCN4)cc3s2)cc1		CHEMBL4069775		Inhibition	%		CHEMBL4722	Homo sapiens	INH		
	18163644	CHEMBL4036223	Inhibition of recombinant full length human N-terminal GST-tagged Aurora A expressed in baculovirus infected Sf9 cells at 1 uM using myelin basic protein as substrate after 60 mins by ADP-Glo luminescence assay relative to control	B	O=C(Nc1ccc(CNc2nc3ccc(OCCN4CCOCC4)cc3s2)cc1)Nc1ccc(Cl)c(Cl)c1		CHEMBL4090776	=	Inhibition	%	2.0	CHEMBL4722	Homo sapiens	INH	%	2.0
	18163645	CHEMBL4036223	Inhibition of recombinant full length human N-terminal GST-tagged Aurora A expressed in baculovirus infected Sf9 cells at 1 uM using myelin basic protein as substrate after 60 mins by ADP-Glo luminescence assay relative to control	B	O=C(Nc1ccc(Br)cc1)Nc1ccc(CNc2nc3ccc(OCCN4CCOCC4)cc3s2)cc1		CHEMBL4096062	=	Inhibition	%	9.0	CHEMBL4722	Homo sapiens	INH	%	9.0
Not Active	18163646	CHEMBL4036223	Inhibition of recombinant full length human N-terminal GST-tagged Aurora A expressed in baculovirus infected Sf9 cells at 1 uM using myelin basic protein as substrate after 60 mins by ADP-Glo luminescence assay relative to control	B	COc1ccc(NC(=O)Nc2ccc(CNc3nc4ccc(OCCN5CCOCC5)cc4s3)cc2)cc1		CHEMBL4068755		Inhibition	%		CHEMBL4722	Homo sapiens	INH		
	18163647	CHEMBL4036223	Inhibition of recombinant full length human N-terminal GST-tagged Aurora A expressed in baculovirus infected Sf9 cells at 1 uM using myelin basic protein as substrate after 60 mins by ADP-Glo luminescence assay relative to control	B	S=C(Nc1ccc(Cl)cc1)Nc1ccc(CNc2nc3ccc(OCCN4CCOCC4)cc3s2)cc1		CHEMBL4104452	=	Inhibition	%	3.0	CHEMBL4722	Homo sapiens	INH	%	3.0
Not Active	18163648	CHEMBL4036223	Inhibition of recombinant full length human N-terminal GST-tagged Aurora A expressed in baculovirus infected Sf9 cells at 1 uM using myelin basic protein as substrate after 60 mins by ADP-Glo luminescence assay relative to control	B	COc1ccc(NC(=S)Nc2ccc(CNc3nc4ccc(OCCN5CCOCC5)cc4s3)cc2)cc1		CHEMBL4086553		Inhibition	%		CHEMBL4722	Homo sapiens	INH		
	18185974	CHEMBL4040608	Inhibition of N-terminal His6 tagged recombinant human full length Aurora A expressed in Sf21 cells at 10 uM relative to control	B	N#Cc1c[nH]c2nc(N)nc(-c3ccc(S(N)(=O)=O)cc3)c12		CHEMBL4089551	>	Inhibition	%	80.0	CHEMBL4722	Homo sapiens	INH	%	80.0
	18194695	CHEMBL4042010	Inhibition of recombinant Aurora A (unknown origin) after 120 mins in presence of [33P]ATP	B	CN(CCO/N=C1C(=C2/C(=O)Nc3cc(Br)ccc32)/Nc2ccccc2/1)CC(O)CO		CHEMBL494867	=	IC50	nM	9.7	CHEMBL4722	Homo sapiens	IC50	nM	9.7
	18194696	CHEMBL4042010	Inhibition of recombinant Aurora A (unknown origin) after 120 mins in presence of [33P]ATP	B	CN(CCO/N=C1C(=C2/C(=O)Nc3cc(Br)ccc32)/Nc2ccccc2/1)CC(O)CO.Cl		CHEMBL495306	=	IC50	nM	41.5	CHEMBL4722	Homo sapiens	IC50	nM	41.5
	18194697	CHEMBL4042010	Inhibition of recombinant Aurora A (unknown origin) after 120 mins in presence of [33P]ATP	B	O=C1Nc2cc(Br)ccc2/C1=C1/Nc2ccccc2/C1=N\OCCN1CCCC1		CHEMBL494685	=	IC50	nM	79.0	CHEMBL4722	Homo sapiens	IC50	nM	79.0
	18194698	CHEMBL4042010	Inhibition of recombinant Aurora A (unknown origin) after 120 mins in presence of [33P]ATP	B	Cl.O=C1Nc2cc(Br)ccc2/C1=C1/Nc2ccccc2/C1=N\OCCN1CCCC1		CHEMBL493883	=	IC50	nM	175.0	CHEMBL4722	Homo sapiens	IC50	nM	175.0
	18194699	CHEMBL4042010	Inhibition of recombinant Aurora A (unknown origin) after 120 mins in presence of [33P]ATP	B	Cl.Cl.O=C1Nc2cc(Br)ccc2/C1=C1/Nc2ccccc2/C1=N\OCCN1CCNCC1		CHEMBL3216659	=	IC50	nM	7.1	CHEMBL4722	Homo sapiens	IC50	nM	7.1
	18194700	CHEMBL4042010	Inhibition of recombinant Aurora A (unknown origin) after 120 mins in presence of [33P]ATP	B	COCCN1CCN(CCO/N=C2C(=C3/C(=O)Nc4cc(Br)ccc43)/Nc3ccccc3/2)CC1		CHEMBL493656	=	IC50	nM	330.0	CHEMBL4722	Homo sapiens	IC50	nM	330.0
	18194701	CHEMBL4042010	Inhibition of recombinant Aurora A (unknown origin) after 120 mins in presence of [33P]ATP	B	COCCN1CCN(CCO/N=C2C(=C3/C(=O)Nc4cc(Br)ccc43)/Nc3ccccc3/2)CC1.Cl.Cl		CHEMBL3215571	>	IC50	nM	10000.0	CHEMBL4722	Homo sapiens	IC50	nM	10000.0
	18194702	CHEMBL4042010	Inhibition of recombinant Aurora A (unknown origin) after 120 mins in presence of [33P]ATP	B	O=C1Nc2cc(Br)ccc2/C1=C1/Nc2ccccc2/C1=N\OCCN1CCN(CCOCCO)CC1		CHEMBL493657	=	IC50	nM	14.9	CHEMBL4722	Homo sapiens	IC50	nM	14.9
	18203408	CHEMBL4043829	Inhibition of wild-type human partial length AURKA (E122 to K401 residues) expressed in HEK293 cells assessed as residual activity at 1000 nM after 30 mins by Kinomescan method relative to control	B	COc1cc(OC)c(Cl)c(N2Cc3cnc(Nc4ccc(F)cc4)nc3N(C3CCN(C(=O)/C=C/CN(C)C)CC3)C2=O)c1Cl		CHEMBL4092508	=	Activity	%	100.0	CHEMBL4722	Homo sapiens	Activity	%	100.0
	18212143	CHEMBL4046161	Inhibition of AurA (unknown origin) at 1 uM relative to control	B	Cc1c(-c2ccncc2)c[nH]c1C(N)=O		CHEMBL4100387	<	Inhibition	%	20.0	CHEMBL4722	Homo sapiens	INH	%	20.0
	18218027	CHEMBL4047093	Inhibition of Aurora A (unknown origin) at 10 uM using [33P]-ATP after 20 to 40 mins by scintillation counting method	B	Cc1ccc(NC(=O)c2c(N=Cc3ccc4ccccc4c3)c(C#N)c3n2CCC3)cc1	Outside typical range	CHEMBL4079032	=	Inhibition	%	-18.0	CHEMBL4722	Homo sapiens	INH	%	-18.0
	18218028	CHEMBL4047093	Inhibition of Aurora A (unknown origin) at 10 uM using [33P]-ATP after 20 to 40 mins by scintillation counting method	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1	Outside typical range	CHEMBL941	=	Inhibition	%	-38.0	CHEMBL4722	Homo sapiens	INH	%	-38.0
	18218992	CHEMBL4047247	Inhibition of AURORA (unknown origin) assessed as residual activity relative to control	B	C=CC(=O)Nc1cccc(CNc2cc(Nc3ccccc3)ncc2C(N)=O)c1		CHEMBL4065693	<=	Activity	%	10.0	CHEMBL4722	Homo sapiens	Activity	%	10.0
	18224640	CHEMBL4048563	Inhibition of human recombinant AurKA after 4 hrs by ADP-Glo assay	A	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	IC50	nM	30.0	CHEMBL4722	Homo sapiens	IC50	uM	0.03
	18224641	CHEMBL4048563	Inhibition of human recombinant AurKA after 4 hrs by ADP-Glo assay	A	Cc1cc(Nc2cc(N3CCCCC3)nc(Nc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL4069729	=	IC50	nM	310.0	CHEMBL4722	Homo sapiens	IC50	uM	0.31
	18224642	CHEMBL4048563	Inhibition of human recombinant AurKA after 4 hrs by ADP-Glo assay	A	Cc1cc(Nc2cc(N3CCOCC3)nc(Nc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL4090723	=	IC50	nM	430.0	CHEMBL4722	Homo sapiens	IC50	uM	0.43
	18224643	CHEMBL4048563	Inhibition of human recombinant AurKA after 4 hrs by ADP-Glo assay	A	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Nc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL4105556	=	IC50	nM	293.0	CHEMBL4722	Homo sapiens	IC50	uM	0.293
	18224644	CHEMBL4048563	Inhibition of human recombinant AurKA after 4 hrs by ADP-Glo assay	A	Cc1cc(Nc2nc(Sc3ccc(NC(=O)C4CCCCC4)cc3)nc(N3CCN(C)CC3)n2)n[nH]1		CHEMBL4064515	=	IC50	nM	210.0	CHEMBL4722	Homo sapiens	IC50	uM	0.21
	18224645	CHEMBL4048563	Inhibition of human recombinant AurKA after 4 hrs by ADP-Glo assay	A	CN1C(=O)NC(Cc2c[nH]c3c(Cl)cccc23)C1=O		CHEMBL381230	>	IC50	nM	3000.0	CHEMBL4722	Homo sapiens	IC50	uM	3.0
	18225261	CHEMBL4048655	Inhibition of aurora A (unknown origin) at 1 uM relative to control	B	CC1(c2cccc(Cl)c2)NC(=O)c2c(Cl)cc(Nc3cc(NC(=O)C4CC4)ncn3)c(=O)n21		CHEMBL4064839	=	Inhibition	%	10.0	CHEMBL4722	Homo sapiens	INH	%	10.0
	18232104	CHEMBL4050398	Inhibition of human Aurora A assessed as residual activity at 1 uM in presence of [33P]ATP by filter binding assay relative to control	B	NCCCC[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)CCCCCCCCOc1nc2cc(C(=O)O)ccc2c2cnccc12)C(=O)O		CHEMBL4077554	=	Activity	%	97.0	CHEMBL4722	Homo sapiens	Activity	%	97.0
	18253560	CHEMBL4055064	Inhibition of wild-type human partial length AURA (E122 to K401 residues) expressed in mammalian expression system assessed as residual activity at 50 nM by Kinomescan method relative to control	B	CC1(C)[C@H](Nc2c(C(N)=O)cnn3cc(-c4ccccc4)cc23)CC[C@]1(C)N		CHEMBL4096145	=	Activity	%	88.0	CHEMBL4722	Homo sapiens	Activity	%	88.0
	18253561	CHEMBL4055064	Inhibition of wild-type human partial length AURA (E122 to K401 residues) expressed in mammalian expression system assessed as residual activity at 50 nM by Kinomescan method relative to control	B	COc1ccc(-c2cc3c(N[C@@H]4CC[C@](C)(N)C4(C)C)c(C(N)=O)cnn3c2)cn1		CHEMBL4080797	=	Activity	%	100.0	CHEMBL4722	Homo sapiens	Activity	%	100.0
	18265804	CHEMBL4057254	Inhibition of AurA (unknown origin) at 0.45 uM relative to control	B	Cc1n[nH]c(C)c1-c1ccc2c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)n[nH]c2c1		CHEMBL4095072	=	Inhibition	%	7.0	CHEMBL4722	Homo sapiens	INH	%	7.0
	18266002	CHEMBL4057452	Inhibition of AurA (unknown origin) at 0.49 uM relative to control	B	Cc1[nH]nc(C2CC2)c1-c1ccc2c(NC(=O)C3CC3)noc2c1		CHEMBL4088455	=	Inhibition	%	5.7	CHEMBL4722	Homo sapiens	INH	%	5.7
	18266180	CHEMBL4057630	Inhibition of AurA (unknown origin) at 0.078 uM relative to control	B	COC(=O)Nc1noc2cc(-c3c(-c4ccccn4)n[nH]c3C)ccc12		CHEMBL4066592	=	Inhibition	%	-1.7	CHEMBL4722	Homo sapiens	INH	%	-1.7
	18274755	CHEMBL4118297	Inhibition of AurA in human SKCO1 cells at 1 uM after 4 hrs using biotin labeled FILALKVLFK probe by mass-spectrometric analysis relative to control	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1Cl		CHEMBL3883384	=	Inhibition	%	87.2	CHEMBL4722	Homo sapiens	INH	%	87.2
	18274756	CHEMBL4118297	Inhibition of AurA in human SKCO1 cells at 1 uM after 4 hrs using biotin labeled FILALKVLFK probe by mass-spectrometric analysis relative to control	B	C=CC(=O)Nc1ccccc1Oc1nc(Nc2cnn(CCOC)c2)ncc1Cl		CHEMBL3884839	=	Inhibition	%	52.6	CHEMBL4722	Homo sapiens	INH	%	52.6
	18274757	CHEMBL4118297	Inhibition of AurA in human SKCO1 cells at 1 uM after 4 hrs using biotin labeled FILALKVLFK probe by mass-spectrometric analysis relative to control	B	COc1cc(O)c2c(c1)/C=C/C[C@H](O)[C@H](O)C(=O)/C=C\C[C@H](C)OC2=O		CHEMBL1077979	=	Inhibition	%	59.4	CHEMBL4722	Homo sapiens	INH	%	59.4
Active	18275837	CHEMBL4118797	Binding affinity to AURKA in human NCI-H23 cells at 1 uM by mass spectrometry based pull down assay	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(CCOCCOCCOCCNC(=O)CCCC[C@@H]4SC[C@@H]5NC(=O)N[C@H]45)CC3)cc2)ncc1Cl		CHEMBL4129274		Activity			CHEMBL4722	Homo sapiens	Activity		
Active	18275979	CHEMBL4118939	Binding affinity to AURKA in human NCI-H358 cells at 1 uM by mass spectrometry based pull down assay	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(CCOCCOCCOCCNC(=O)CCCC[C@@H]4SC[C@@H]5NC(=O)N[C@H]45)CC3)cc2)ncc1Cl		CHEMBL4129274		Activity			CHEMBL4722	Homo sapiens	Activity		
	18282048	CHEMBL4120003	Inhibition of recombinant full length His-tagged human Aurora A expressed in baculovirus expression system at 1 uM by FRET assay relative to control	B	CC(C)n1nc(-c2cnc(N)c(OC(F)(F)F)c2)cc1[C@@H]1[C@H]2CN(C3COC3)C[C@H]21		CHEMBL3719135	=	Inhibition	%	16.2	CHEMBL4722	Homo sapiens	INH	%	16.2
	18282367	CHEMBL4120003	Inhibition of recombinant full length His-tagged human Aurora A expressed in baculovirus expression system at 1 uM by FRET assay relative to control	B	Nc1ncc(-c2cc([C@@H]3[C@H]4CN(C5COC5)C[C@H]43)n(CC3CC3)n2)cc1C(F)(F)F		CHEMBL3715238	=	Inhibition	%	27.2	CHEMBL4722	Homo sapiens	INH	%	27.2
	18282636	CHEMBL4120249	Inhibition of AurA (unknown origin) at 0.45 uM relative to control	B	Cc1n[nH]c(C)c1-c1ccc2c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)n[nH]c2c1		CHEMBL4095072	=	Inhibition	%	7.0	CHEMBL4722	Homo sapiens	INH	%	7.0
	18282880	CHEMBL4120465	Inhibition of AurA (unknown origin) at 0.19 uM relative to control	B	Cc1[nH]nc(C2CC2)c1-c1ccc2c(-c3ccc(N4CCN(C)CC4)nc3)n[nH]c2c1		CHEMBL4125807	=	Inhibition	%	3.3	CHEMBL4722	Homo sapiens	INH	%	3.3
	18283094	CHEMBL4120679	Inhibition of AurA (unknown origin) at 0.164 uM relative to control	B	COC(=O)Nc1cc(-c2c(C3CC3)n[nH]c2C)cc2[nH]ncc12		CHEMBL4129737	=	Inhibition	%	6.7	CHEMBL4722	Homo sapiens	INH	%	6.7
	18286284	CHEMBL4121519	Inhibition of recombinant full length His-tagged human Aurora A expressed in baculovirus expression system at 10 uM in presence of ATP relative to control	B	CC(C)(C)NS(=O)(=O)c1ccc(-c2sc(C(=O)N[C@H]3C[C@H](C(=O)O)C3)nc2CC2CCCCC2)c2ccccc12		CHEMBL4128926	=	Inhibition	%	-5.0	CHEMBL4722	Homo sapiens	INH	%	-5.0
	18287445	CHEMBL4121736	Inhibition of aurora A (unknown origin)	B	Cc1ccc(CN2CCOCC2)cc1-c1cc2c(-c3ccc(C#N)cc3)ccnc2[nH]1		CHEMBL4129941	>	IC50	nM	10000.0	CHEMBL4722	Homo sapiens	IC50	uM	10.0
	18287446	CHEMBL4121736	Inhibition of aurora A (unknown origin)	B	Cc1cc(OCCN2CCOCC2)ccc1-c1cc2c(-c3ccc(C#N)cc3)ccnc2[nH]1		CHEMBL4127076	>	IC50	nM	10000.0	CHEMBL4722	Homo sapiens	IC50	uM	10.0
	18287447	CHEMBL4121736	Inhibition of aurora A (unknown origin)	B	Cc1ccc(CN2CCOCC2)cc1-c1cc2c(-c3ccc(C#N)c(C(C)C)c3)ccnc2[nH]1		CHEMBL4128459	>	IC50	nM	10000.0	CHEMBL4722	Homo sapiens	IC50	uM	10.0
	18287448	CHEMBL4121736	Inhibition of aurora A (unknown origin)	B	Cc1cc(OCCN2CCOCC2)ccc1-c1cc2c(-c3ccc(C#N)c(C(C)C)c3)ccnc2[nH]1		CHEMBL4128540	>	IC50	nM	10000.0	CHEMBL4722	Homo sapiens	IC50	uM	10.0
	18300337	CHEMBL4124639	Inhibition of full length recombinant human N-terminal His-tagged aurora A expressed in baculovirus infected Sf9 cells assessed as residual activity at 1 uM relative to control	B	CN(C)CCNc1cncc(-c2ccc3[nH]cc(-c4ccc(N)c(C#N)c4)c3c2)n1		CHEMBL4126750	=	Activity	%	120.0	CHEMBL4722	Homo sapiens	Activity	%	120.0
	18379898	CHEMBL4145800	Inhibition of Aurora A (unknown origin) at 10 uM relative to control	B	COc1cc(NC(=O)Nc2cnc(Nc3ccc(N4CCOCC4)cc3)nc2Oc2ccc(C)cc2OC)cc(OC)c1		CHEMBL4159506	=	Inhibition	%	18.01	CHEMBL4722	Homo sapiens	INH	%	18.01
	18379951	CHEMBL4145852	Inhibition of Aurora A (unknown origin)	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	0.86	CHEMBL4722	Homo sapiens	IC50	nM	0.86
Active	18388003	CHEMBL4147277	Inhibition of AURKA in human MDA-MB-231 cells assessed as abolishment of regular location of protein at 0.5 uM after 48 hrs by DAPI staining based immunofluorescence assay	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Nc3ccc(F)c(Cl)c3)n2)n[nH]1		CHEMBL4168177		Inhibition	%		CHEMBL4722	Homo sapiens	INH		
Active	18388004	CHEMBL4147277	Inhibition of AURKA in human MDA-MB-231 cells assessed as abolishment of regular location of protein at 0.5 uM after 48 hrs by DAPI staining based immunofluorescence assay	B	COc1cc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2OC)=NC3)ccc1C(=O)O		CHEMBL483158		Inhibition	%		CHEMBL4722	Homo sapiens	INH		
	18388039	CHEMBL4147247	Inhibition of AURKA (unknown origin) using FAM-labeled peptide substrate preincubated for 10 mins followed by substrate addition measured after 60 mins by caliper assay	B	COC(=O)c1ccc(Nc2nc(Nc3cc(C)[nH]n3)cc(N3CCN(C)CC3)n2)cc1F		CHEMBL4164736	=	IC50	nM	35.0	CHEMBL4722	Homo sapiens	IC50	nM	35.0
	18388040	CHEMBL4147247	Inhibition of AURKA (unknown origin) using FAM-labeled peptide substrate preincubated for 10 mins followed by substrate addition measured after 60 mins by caliper assay	B	Cc1cc(Nc2cc(N3CCOCC3)nc(Nc3ccc(F)c(Cl)c3)n2)n[nH]1		CHEMBL4175359	=	IC50	nM	6.3	CHEMBL4722	Homo sapiens	IC50	nM	6.3
	18388041	CHEMBL4147247	Inhibition of AURKA (unknown origin) using FAM-labeled peptide substrate preincubated for 10 mins followed by substrate addition measured after 60 mins by caliper assay	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Nc3ccc(F)c(Cl)c3)n2)n[nH]1		CHEMBL4168177	=	IC50	nM	7.1	CHEMBL4722	Homo sapiens	IC50	nM	7.1
	18388042	CHEMBL4147247	Inhibition of AURKA (unknown origin) using FAM-labeled peptide substrate preincubated for 10 mins followed by substrate addition measured after 60 mins by caliper assay	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Nc3ccc(Cl)c(F)c3)n2)n[nH]1		CHEMBL4160260	=	IC50	nM	31.0	CHEMBL4722	Homo sapiens	IC50	nM	31.0
	18388043	CHEMBL4147247	Inhibition of AURKA (unknown origin) using FAM-labeled peptide substrate preincubated for 10 mins followed by substrate addition measured after 60 mins by caliper assay	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Nc3ccc(F)c(F)c3)n2)n[nH]1		CHEMBL4174228	=	IC50	nM	17.0	CHEMBL4722	Homo sapiens	IC50	nM	17.0
	18388044	CHEMBL4147247	Inhibition of AURKA (unknown origin) using FAM-labeled peptide substrate preincubated for 10 mins followed by substrate addition measured after 60 mins by caliper assay	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Nc3ccc(F)cc3)n2)n[nH]1		CHEMBL4163531	=	IC50	nM	23.0	CHEMBL4722	Homo sapiens	IC50	nM	23.0
	18388045	CHEMBL4147247	Inhibition of AURKA (unknown origin) using FAM-labeled peptide substrate preincubated for 10 mins followed by substrate addition measured after 60 mins by caliper assay	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Nc3cccc(F)c3)n2)n[nH]1		CHEMBL4168905	=	IC50	nM	25.0	CHEMBL4722	Homo sapiens	IC50	nM	25.0
	18388046	CHEMBL4147247	Inhibition of AURKA (unknown origin) using FAM-labeled peptide substrate preincubated for 10 mins followed by substrate addition measured after 60 mins by caliper assay	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Nc3ccc(Cl)c(Cl)c3)n2)n[nH]1		CHEMBL4162633	=	IC50	nM	33.0	CHEMBL4722	Homo sapiens	IC50	nM	33.0
	18388047	CHEMBL4147247	Inhibition of AURKA (unknown origin) using FAM-labeled peptide substrate preincubated for 10 mins followed by substrate addition measured after 60 mins by caliper assay	B	COc1ccc(Nc2nc(Nc3cc(C)[nH]n3)cc(N3CCN(C)CC3)n2)c(OC)c1OC		CHEMBL4164598	=	IC50	nM	94.0	CHEMBL4722	Homo sapiens	IC50	nM	94.0
	18388048	CHEMBL4147247	Inhibition of AURKA (unknown origin) using FAM-labeled peptide substrate preincubated for 10 mins followed by substrate addition measured after 60 mins by caliper assay	B	COC(=O)c1ccc(Nc2nc(Nc3cc(C)[nH]n3)cc(N3CCN(C)CC3)n2)cc1OC		CHEMBL4161644	=	IC50	nM	67.0	CHEMBL4722	Homo sapiens	IC50	nM	67.0
	18388049	CHEMBL4147247	Inhibition of AURKA (unknown origin) using FAM-labeled peptide substrate preincubated for 10 mins followed by substrate addition measured after 60 mins by caliper assay	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Nc3ccc4c(c3)OCO4)n2)n[nH]1		CHEMBL4175679	=	IC50	nM	20.0	CHEMBL4722	Homo sapiens	IC50	nM	20.0
	18388050	CHEMBL4147247	Inhibition of AURKA (unknown origin) using FAM-labeled peptide substrate preincubated for 10 mins followed by substrate addition measured after 60 mins by caliper assay	B	COc1ccc(Nc2nc(Nc3cc(C)[nH]n3)cc(N3CCN(C)CC3)n2)cc1OC		CHEMBL4165059	=	IC50	nM	38.0	CHEMBL4722	Homo sapiens	IC50	nM	38.0
	18417129	CHEMBL4153356	Inhibition of GST-tagged human recombinant Aurora A kinase domain (123 to 401 residues) expressed in Sf9 cells after 120 mins by kinase-glo luminescence assay	B	Cc1cccc(NC(=O)Nc2ccc(CCNc3ncnc4oc(-c5ccccc5)c(Cl)c34)cc2)c1		CHEMBL4168861	=	IC50	nM	52.6	CHEMBL4722	Homo sapiens	IC50	nM	52.6
	18417130	CHEMBL4153356	Inhibition of GST-tagged human recombinant Aurora A kinase domain (123 to 401 residues) expressed in Sf9 cells after 120 mins by kinase-glo luminescence assay	B	O=C(Nc1ccc(CCNc2ncnc3oc(-c4ccccc4)c(Cl)c23)cc1)Nc1ccccc1CN1CCC(O)CC1		CHEMBL4176720	=	IC50	nM	228.0	CHEMBL4722	Homo sapiens	IC50	nM	228.0
	18417131	CHEMBL4153356	Inhibition of GST-tagged human recombinant Aurora A kinase domain (123 to 401 residues) expressed in Sf9 cells after 120 mins by kinase-glo luminescence assay	B	O=C(Nc1ccc(CCNc2ncnc3oc(-c4ccccc4)c(Cl)c23)cc1)Nc1ccccc1CN1CCCCC1		CHEMBL4162996	=	IC50	nM	198.0	CHEMBL4722	Homo sapiens	IC50	nM	198.0
	18417132	CHEMBL4153356	Inhibition of GST-tagged human recombinant Aurora A kinase domain (123 to 401 residues) expressed in Sf9 cells after 120 mins by kinase-glo luminescence assay	B	CCN(CC)Cc1ccccc1NC(=O)Nc1ccc(CCNc2ncnc3oc(-c4ccccc4)c(Cl)c23)cc1		CHEMBL4171225	=	IC50	nM	461.9	CHEMBL4722	Homo sapiens	IC50	nM	461.9
	18417133	CHEMBL4153356	Inhibition of GST-tagged human recombinant Aurora A kinase domain (123 to 401 residues) expressed in Sf9 cells after 120 mins by kinase-glo luminescence assay	B	CC(C)Cc1ccccc1NC(=O)Nc1ccc(CCNc2ncnc3oc(-c4ccccc4)c(Cl)c23)cc1		CHEMBL4163577	>	IC50	nM	1000.0	CHEMBL4722	Homo sapiens	IC50	nM	1000.0
	18417134	CHEMBL4153356	Inhibition of GST-tagged human recombinant Aurora A kinase domain (123 to 401 residues) expressed in Sf9 cells after 120 mins by kinase-glo luminescence assay	B	CC(C)c1ccccc1NC(=O)Nc1ccc(CCNc2ncnc3oc(-c4ccccc4)c(Cl)c23)cc1		CHEMBL4174257	=	IC50	nM	525.0	CHEMBL4722	Homo sapiens	IC50	nM	525.0
	18417135	CHEMBL4153356	Inhibition of GST-tagged human recombinant Aurora A kinase domain (123 to 401 residues) expressed in Sf9 cells after 120 mins by kinase-glo luminescence assay	B	CCc1ccccc1NC(=O)Nc1ccc(CCNc2ncnc3oc(-c4ccccc4)c(Cl)c23)cc1		CHEMBL4170043	=	IC50	nM	178.0	CHEMBL4722	Homo sapiens	IC50	nM	178.0
	18417136	CHEMBL4153356	Inhibition of GST-tagged human recombinant Aurora A kinase domain (123 to 401 residues) expressed in Sf9 cells after 120 mins by kinase-glo luminescence assay	B	Cc1ccccc1NC(=O)Nc1ccc(CCNc2ncnc3oc(-c4ccccc4)c(Cl)c23)cc1		CHEMBL4159739	=	IC50	nM	83.2	CHEMBL4722	Homo sapiens	IC50	nM	83.2
	18417137	CHEMBL4153356	Inhibition of GST-tagged human recombinant Aurora A kinase domain (123 to 401 residues) expressed in Sf9 cells after 120 mins by kinase-glo luminescence assay	B	O=C(Nc1ccccc1)Nc1ccc(CCNc2ncnc3oc(-c4ccccc4)c(Cl)c23)cc1		CHEMBL4171920	=	IC50	nM	52.0	CHEMBL4722	Homo sapiens	IC50	nM	52.0
	18417138	CHEMBL4153356	Inhibition of GST-tagged human recombinant Aurora A kinase domain (123 to 401 residues) expressed in Sf9 cells after 120 mins by kinase-glo luminescence assay	B	CN(C)Cc1ccccc1NC(=O)Nc1ccc(CCNc2ncnc3oc(-c4ccccc4)c(Cl)c23)cc1		CHEMBL4162506	=	IC50	nM	124.0	CHEMBL4722	Homo sapiens	IC50	nM	124.0
	18417139	CHEMBL4153356	Inhibition of GST-tagged human recombinant Aurora A kinase domain (123 to 401 residues) expressed in Sf9 cells after 120 mins by kinase-glo luminescence assay	B	CCc1cccc(NC(=O)Nc2ccc(CCNc3ncnc4oc(-c5ccccc5)c(Cl)c34)cc2)c1		CHEMBL4173353	=	IC50	nM	66.3	CHEMBL4722	Homo sapiens	IC50	nM	66.3
	18417140	CHEMBL4153356	Inhibition of GST-tagged human recombinant Aurora A kinase domain (123 to 401 residues) expressed in Sf9 cells after 120 mins by kinase-glo luminescence assay	B	CC(C)c1cccc(NC(=O)Nc2ccc(CCNc3ncnc4oc(-c5ccccc5)c(Cl)c34)cc2)c1		CHEMBL4165437	=	IC50	nM	233.0	CHEMBL4722	Homo sapiens	IC50	nM	233.0
	18417141	CHEMBL4153356	Inhibition of GST-tagged human recombinant Aurora A kinase domain (123 to 401 residues) expressed in Sf9 cells after 120 mins by kinase-glo luminescence assay	B	CC(C)Cc1cccc(NC(=O)Nc2ccc(CCNc3ncnc4oc(-c5ccccc5)c(Cl)c34)cc2)c1		CHEMBL4165021	=	IC50	nM	247.0	CHEMBL4722	Homo sapiens	IC50	nM	247.0
	18417142	CHEMBL4153356	Inhibition of GST-tagged human recombinant Aurora A kinase domain (123 to 401 residues) expressed in Sf9 cells after 120 mins by kinase-glo luminescence assay	B	CN(C)Cc1cccc(NC(=O)Nc2ccc(CCNc3ncnc4oc(-c5ccccc5)c(Cl)c34)cc2)c1		CHEMBL4175638	=	IC50	nM	20.0	CHEMBL4722	Homo sapiens	IC50	nM	20.0
	18417143	CHEMBL4153356	Inhibition of GST-tagged human recombinant Aurora A kinase domain (123 to 401 residues) expressed in Sf9 cells after 120 mins by kinase-glo luminescence assay	B	CCN(C)Cc1cccc(NC(=O)Nc2ccc(CCNc3ncnc4oc(-c5ccccc5)c(Cl)c34)cc2)c1		CHEMBL4161600	=	IC50	nM	9.0	CHEMBL4722	Homo sapiens	IC50	nM	9.0
	18417144	CHEMBL4153356	Inhibition of GST-tagged human recombinant Aurora A kinase domain (123 to 401 residues) expressed in Sf9 cells after 120 mins by kinase-glo luminescence assay	B	CCN(CC)Cc1cccc(NC(=O)Nc2ccc(CCNc3ncnc4oc(-c5ccccc5)c(Cl)c34)cc2)c1		CHEMBL4172214	=	IC50	nM	21.5	CHEMBL4722	Homo sapiens	IC50	nM	21.5
	18417145	CHEMBL4153356	Inhibition of GST-tagged human recombinant Aurora A kinase domain (123 to 401 residues) expressed in Sf9 cells after 120 mins by kinase-glo luminescence assay	B	O=C(Nc1ccc(CCNc2ncnc3oc(-c4ccccc4)c(Cl)c23)cc1)Nc1cccc(CN2CCCCC2)c1		CHEMBL4171792	=	IC50	nM	90.2	CHEMBL4722	Homo sapiens	IC50	nM	90.2
	18417146	CHEMBL4153356	Inhibition of GST-tagged human recombinant Aurora A kinase domain (123 to 401 residues) expressed in Sf9 cells after 120 mins by kinase-glo luminescence assay	B	O=C(Nc1ccc(CCNc2ncnc3oc(-c4ccccc4)c(Cl)c23)cc1)Nc1cccc(CN2CCC(O)CC2)c1		CHEMBL4163926	=	IC50	nM	67.8	CHEMBL4722	Homo sapiens	IC50	nM	67.8
	18417147	CHEMBL4153356	Inhibition of GST-tagged human recombinant Aurora A kinase domain (123 to 401 residues) expressed in Sf9 cells after 120 mins by kinase-glo luminescence assay	B	Cc1ccc(NC(=O)Nc2ccc(CCNc3ncnc4oc(-c5ccccc5)c(Cl)c34)cc2)cc1		CHEMBL4166291	=	IC50	nM	55.5	CHEMBL4722	Homo sapiens	IC50	nM	55.5
	18417148	CHEMBL4153356	Inhibition of GST-tagged human recombinant Aurora A kinase domain (123 to 401 residues) expressed in Sf9 cells after 120 mins by kinase-glo luminescence assay	B	CCc1ccc(NC(=O)Nc2ccc(CCNc3ncnc4oc(-c5ccccc5)c(Cl)c34)cc2)cc1		CHEMBL4177362	=	IC50	nM	139.3	CHEMBL4722	Homo sapiens	IC50	nM	139.3
	18417149	CHEMBL4153356	Inhibition of GST-tagged human recombinant Aurora A kinase domain (123 to 401 residues) expressed in Sf9 cells after 120 mins by kinase-glo luminescence assay	B	CC(C)c1ccc(NC(=O)Nc2ccc(CCNc3ncnc4oc(-c5ccccc5)c(Cl)c34)cc2)cc1		CHEMBL4172897	>	IC50	nM	1000.0	CHEMBL4722	Homo sapiens	IC50	nM	1000.0
	18417150	CHEMBL4153356	Inhibition of GST-tagged human recombinant Aurora A kinase domain (123 to 401 residues) expressed in Sf9 cells after 120 mins by kinase-glo luminescence assay	B	CC(C)Cc1ccc(NC(=O)Nc2ccc(CCNc3ncnc4oc(-c5ccccc5)c(Cl)c34)cc2)cc1		CHEMBL4162227	>	IC50	nM	1000.0	CHEMBL4722	Homo sapiens	IC50	nM	1000.0
	18417151	CHEMBL4153356	Inhibition of GST-tagged human recombinant Aurora A kinase domain (123 to 401 residues) expressed in Sf9 cells after 120 mins by kinase-glo luminescence assay	B	CN(C)Cc1ccc(NC(=O)Nc2ccc(CCNc3ncnc4oc(-c5ccccc5)c(Cl)c34)cc2)cc1		CHEMBL4162635	=	IC50	nM	98.3	CHEMBL4722	Homo sapiens	IC50	nM	98.3
	18417152	CHEMBL4153356	Inhibition of GST-tagged human recombinant Aurora A kinase domain (123 to 401 residues) expressed in Sf9 cells after 120 mins by kinase-glo luminescence assay	B	CCN(CC)Cc1ccc(NC(=O)Nc2ccc(CCNc3ncnc4oc(-c5ccccc5)c(Cl)c34)cc2)cc1		CHEMBL4170570	=	IC50	nM	232.0	CHEMBL4722	Homo sapiens	IC50	nM	232.0
	18417153	CHEMBL4153356	Inhibition of GST-tagged human recombinant Aurora A kinase domain (123 to 401 residues) expressed in Sf9 cells after 120 mins by kinase-glo luminescence assay	B	O=C(Nc1ccc(CCNc2ncnc3oc(-c4ccccc4)c(Cl)c23)cc1)Nc1ccc(CN2CCCCC2)cc1		CHEMBL4166079	=	IC50	nM	451.0	CHEMBL4722	Homo sapiens	IC50	nM	451.0
	18417154	CHEMBL4153356	Inhibition of GST-tagged human recombinant Aurora A kinase domain (123 to 401 residues) expressed in Sf9 cells after 120 mins by kinase-glo luminescence assay	B	O=C(Nc1ccc(CCNc2ncnc3oc(-c4ccccc4)c(Cl)c23)cc1)Nc1ccc(CN2CCC(O)CC2)cc1		CHEMBL4174660	=	IC50	nM	150.0	CHEMBL4722	Homo sapiens	IC50	nM	150.0
	18417181	CHEMBL4153358	Inhibition of Aurora-A autophosphorylation at Thr288 in human HCT116 cells after 1 hr by Western blot analysis	B	CN(C)Cc1ccccc1NC(=O)Nc1ccc(CCNc2ncnc3oc(-c4ccccc4)c(Cl)c23)cc1		CHEMBL4162506	=	IC50	nM	73.4	CHEMBL4722	Homo sapiens	IC50	nM	73.4
	18417182	CHEMBL4153358	Inhibition of Aurora-A autophosphorylation at Thr288 in human HCT116 cells after 1 hr by Western blot analysis	B	O=C(Nc1ccccc1)Nc1ccc(CCNc2ncnc3oc(-c4ccccc4)c(Cl)c23)cc1		CHEMBL4171920	=	IC50	nM	389.6	CHEMBL4722	Homo sapiens	IC50	nM	389.6
	18417183	CHEMBL4153358	Inhibition of Aurora-A autophosphorylation at Thr288 in human HCT116 cells after 1 hr by Western blot analysis	B	O=C(Nc1ccc(CCNc2ncnc3oc(-c4ccccc4)c(Cl)c23)cc1)Nc1ccccc1CN1CCC(O)CC1		CHEMBL4176720	=	IC50	nM	1513.0	CHEMBL4722	Homo sapiens	IC50	nM	1513.0
	18417184	CHEMBL4153358	Inhibition of Aurora-A autophosphorylation at Thr288 in human HCT116 cells after 1 hr by Western blot analysis	B	CN(C)Cc1cccc(NC(=O)Nc2ccc(CCNc3ncnc4oc(-c5ccccc5)c(Cl)c34)cc2)c1		CHEMBL4175638	=	IC50	nM	59.9	CHEMBL4722	Homo sapiens	IC50	nM	59.9
	18417185	CHEMBL4153358	Inhibition of Aurora-A autophosphorylation at Thr288 in human HCT116 cells after 1 hr by Western blot analysis	B	CCN(C)Cc1cccc(NC(=O)Nc2ccc(CCNc3ncnc4oc(-c5ccccc5)c(Cl)c34)cc2)c1		CHEMBL4161600	=	IC50	nM	132.2	CHEMBL4722	Homo sapiens	IC50	nM	132.2
	18440084	CHEMBL4156908	Binding affinity to wild-type human partial length AURKA (E122 to K401 residues) expressed in mammalian expression system assessed as residual binding at 1 uM by Kinomescan method relative to control	B	Cc1cccc(S(=O)(=O)Nc2cc(-c3sc(NC(=O)[C@@H](N)C(C)C)nc3C)cnc2Cl)c1		CHEMBL4174988	=	Activity	%	96.0	CHEMBL4722	Homo sapiens	Activity	%	96.0
	18449821	CHEMBL4178058	Inhibition of human Aurora-A (2 to 403 residues) assessed as residual activity at 500 nM in presence of 33P-ATP by filter binding assay relative to control	B	Cc1cccc(-c2nc(N)sc2-c2ccc3ncccc3n2)c1		CHEMBL4209540	=	Activity	%	120.0	CHEMBL4722	Homo sapiens	Activity	%	120.0
	18450307	CHEMBL4178323	Inhibition of recombinant full length N-terminal GST-tagged AURORA A (unknown origin) expressed in baculovirus infected Sf9 cells assessed as change in enzyme activity at 1 uM in presence of 2 uM ATP relative to control	B	CCN1CCN(Cc2ccc(-c3cc4c(-c5cccc(N6CCOc7cc(C8CC8)cc(F)c7C6=O)c5CO)ccnc4[nH]3)nc2)CC1		CHEMBL3967108	=	Activity	%	-2.0	CHEMBL4722	Homo sapiens	Activity	%	-2.0
	18450357	CHEMBL4178323	Inhibition of recombinant full length N-terminal GST-tagged AURORA A (unknown origin) expressed in baculovirus infected Sf9 cells assessed as change in enzyme activity at 1 uM in presence of 2 uM ATP relative to control	B	O=C1c2c(F)cc(C3CC3)cc2OCCN1c1cccc(-c2ccnc3[nH]c(C4=CCN(C5COC5)CC4)cc23)c1CO		CHEMBL3966346	=	Activity	%	-10.0	CHEMBL4722	Homo sapiens	Activity	%	-10.0
	18463718	CHEMBL4181134	Inhibition of recombinant human full length N-terminal His6-tagged Aurora-A expressed in Sf21 cells at 10 uM by filter binding radioactive ATP transferase assay relative to control	B	C=C(C)n1c(=O)n(C(C)=O)c2cc(Br)cnc21		CHEMBL4212680	=	Inhibition	%	1.0	CHEMBL4722	Homo sapiens	INH	%	1.0
	18464425	CHEMBL4181426	Inhibition of recombinant full length His-tagged human Aurora A expressed in baculovirus expression system at 100 nM relative to control	B	CCOP(=O)(CCCOc1ccc(Nc2ncc([N+](=O)[O-])c(Nc3ccccc3C(=O)NC)n2)cc1)N1CCOCC1		CHEMBL4216755	=	Inhibition	%	48.0	CHEMBL4722	Homo sapiens	INH	%	48.0
	18470572	CHEMBL4182566	Inhibition of human Aurora A at 10 uM by ADP-Glo kinase assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Inhibition	%	84.0	CHEMBL4722	Homo sapiens	INH	%	84.0
	18470735	CHEMBL4182566	Inhibition of human Aurora A at 10 uM by ADP-Glo kinase assay	B	Cc1nc(N)c2ccn(C3CCN(C(=O)c4ccc(S(=O)(=O)F)cc4)CC3)c2n1		CHEMBL4206295	=	Inhibition	%	47.0	CHEMBL4722	Homo sapiens	INH	%	47.0
	18470736	CHEMBL4182566	Inhibition of human Aurora A at 10 uM by ADP-Glo kinase assay	B	Nc1ncnc2c1ccn2C1CCN(C(=O)c2ccc(S(=O)(=O)F)cc2)CC1		CHEMBL4218073	=	Inhibition	%	39.0	CHEMBL4722	Homo sapiens	INH	%	39.0
Not Active	18476724	CHEMBL4183670	Induction of aurora A degradation in human NCI-H3122 cells at 250 nM after 16 hrs in presence of proteasome inhibitor carfilzomib by immunoblot method	B	COc1cc(N2CCN(CCOCCOCCNC(=O)CNc3cccc4c3C(=O)N(C3CCC(=O)NC3=O)C4=O)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL4217325		Activity			CHEMBL4722	Homo sapiens	Activity		
Not Active	18476725	CHEMBL4183670	Induction of aurora A degradation in human NCI-H3122 cells at 250 nM after 16 hrs in presence of proteasome inhibitor carfilzomib by immunoblot method	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCN(CCOCCOCCNC(=O)CNc2cccc3c2C(=O)N(C2CCC(=O)NC2=O)C3=O)CC1		CHEMBL4213986		Activity			CHEMBL4722	Homo sapiens	Activity		
Not Active	18476726	CHEMBL4183671	Induction of aurora A degradation in human KARPAS299 cells at 250 nM after 16 hrs in presence of proteasome inhibitor carfilzomib by immunoblot method	B	COc1cc(N2CCN(CCOCCOCCNC(=O)CNc3cccc4c3C(=O)N(C3CCC(=O)NC3=O)C4=O)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL4217325		Activity			CHEMBL4722	Homo sapiens	Activity		
Not Active	18476727	CHEMBL4183671	Induction of aurora A degradation in human KARPAS299 cells at 250 nM after 16 hrs in presence of proteasome inhibitor carfilzomib by immunoblot method	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCN(CCOCCOCCNC(=O)CNc2cccc3c2C(=O)N(C2CCC(=O)NC2=O)C3=O)CC1		CHEMBL4213986		Activity			CHEMBL4722	Homo sapiens	Activity		
Not Active	18476732	CHEMBL4183674	Induction of aurora A degradation in human NCI-H3122 cells at 250 nM after 16 hrs in presence of cereblon E3 ligase inhibitor MLN4924 by immunoblot method	B	COc1cc(N2CCN(CCOCCOCCNC(=O)CNc3cccc4c3C(=O)N(C3CCC(=O)NC3=O)C4=O)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL4217325		Activity			CHEMBL4722	Homo sapiens	Activity		
Not Active	18476733	CHEMBL4183674	Induction of aurora A degradation in human NCI-H3122 cells at 250 nM after 16 hrs in presence of cereblon E3 ligase inhibitor MLN4924 by immunoblot method	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCN(CCOCCOCCNC(=O)CNc2cccc3c2C(=O)N(C2CCC(=O)NC2=O)C3=O)CC1		CHEMBL4213986		Activity			CHEMBL4722	Homo sapiens	Activity		
Not Active	18476734	CHEMBL4183675	Induction of aurora A degradation in human KARPAS299 cells at 250 nM after 16 hrs in presence of cereblon E3 ligase inhibitor MLN4924 by immunoblot method	B	COc1cc(N2CCN(CCOCCOCCNC(=O)CNc3cccc4c3C(=O)N(C3CCC(=O)NC3=O)C4=O)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL4217325		Activity			CHEMBL4722	Homo sapiens	Activity		
Not Active	18476735	CHEMBL4183675	Induction of aurora A degradation in human KARPAS299 cells at 250 nM after 16 hrs in presence of cereblon E3 ligase inhibitor MLN4924 by immunoblot method	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCN(CCOCCOCCNC(=O)CNc2cccc3c2C(=O)N(C2CCC(=O)NC2=O)C3=O)CC1		CHEMBL4213986		Activity			CHEMBL4722	Homo sapiens	Activity		
Active	18476792	CHEMBL4183693	Induction of aurora A degradation in human Kelly cells at 10 to 160 nM after 16 hrs by immunoblot method	B	COc1cc(N2CCN(CCOCCOCCNC(=O)CNc3cccc4c3C(=O)N(C3CCC(=O)NC3=O)C4=O)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL4217325		Activity			CHEMBL4722	Homo sapiens	Activity		
Active	18476793	CHEMBL4183694	Induction of aurora A degradation in human CHLA20 cells at 10 to 160 nM after 16 hrs by immunoblot method	B	COc1cc(N2CCN(CCOCCOCCNC(=O)CNc3cccc4c3C(=O)N(C3CCC(=O)NC3=O)C4=O)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL4217325		Activity			CHEMBL4722	Homo sapiens	Activity		
Active	18476794	CHEMBL4183695	Induction of aurora A degradation in human NCI-H3122 cells at 0.01 to 1 uM after 16 hrs by immunoblot method	B	COc1cc(N2CCN(CCOCCOCCNC(=O)CNc3cccc4c3C(=O)N(C3CCC(=O)NC3=O)C4=O)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL4217325		Activity			CHEMBL4722	Homo sapiens	Activity		
Active	18476795	CHEMBL4183696	Induction of aurora A degradation in human KARPAS299 cells at 0.01 to 1 uM after 16 hrs by immunoblot method	B	COc1cc(N2CCN(CCOCCOCCNC(=O)CNc3cccc4c3C(=O)N(C3CCC(=O)NC3=O)C4=O)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL4217325		Activity			CHEMBL4722	Homo sapiens	Activity		
Not Active	18476804	CHEMBL4183699	Induction of aurora A degradation in human Kelly cells at 100 nM after 16 hrs in presence of proteasome inhibitor carfilzomib by immunoblot method	B	COc1cc(N2CCN(CCOCCOCCNC(=O)CNc3cccc4c3C(=O)N(C3CCC(=O)NC3=O)C4=O)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL4217325		Activity			CHEMBL4722	Homo sapiens	Activity		
Not Active	18476805	CHEMBL4183699	Induction of aurora A degradation in human Kelly cells at 100 nM after 16 hrs in presence of proteasome inhibitor carfilzomib by immunoblot method	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCN(CCOCCOCCNC(=O)CNc2cccc3c2C(=O)N(C2CCC(=O)NC2=O)C3=O)CC1		CHEMBL4213986		Activity			CHEMBL4722	Homo sapiens	Activity		
Not Active	18476806	CHEMBL4183700	Induction of aurora A degradation in human CHLA20 cells at 100 nM after 16 hrs in presence of proteasome inhibitor carfilzomib and ABCB1 inhibitor tariquidar by immunoblot method	B	COc1cc(N2CCN(CCOCCOCCNC(=O)CNc3cccc4c3C(=O)N(C3CCC(=O)NC3=O)C4=O)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL4217325		Activity			CHEMBL4722	Homo sapiens	Activity		
Not Active	18476807	CHEMBL4183700	Induction of aurora A degradation in human CHLA20 cells at 100 nM after 16 hrs in presence of proteasome inhibitor carfilzomib and ABCB1 inhibitor tariquidar by immunoblot method	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCN(CCOCCOCCNC(=O)CNc2cccc3c2C(=O)N(C2CCC(=O)NC2=O)C3=O)CC1		CHEMBL4213986		Activity			CHEMBL4722	Homo sapiens	Activity		
Not Active	18476808	CHEMBL4183701	Induction of aurora A degradation in human Kelly cells at 100 nM after 16 hrs in presence of cereblon E3 ligase inhibitor MLN4924 by immunoblot method	B	COc1cc(N2CCN(CCOCCOCCNC(=O)CNc3cccc4c3C(=O)N(C3CCC(=O)NC3=O)C4=O)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL4217325		Activity			CHEMBL4722	Homo sapiens	Activity		
Not Active	18476809	CHEMBL4183701	Induction of aurora A degradation in human Kelly cells at 100 nM after 16 hrs in presence of cereblon E3 ligase inhibitor MLN4924 by immunoblot method	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCN(CCOCCOCCNC(=O)CNc2cccc3c2C(=O)N(C2CCC(=O)NC2=O)C3=O)CC1		CHEMBL4213986		Activity			CHEMBL4722	Homo sapiens	Activity		
Not Active	18476810	CHEMBL4183702	Induction of aurora A degradation in human CHLA20 cells at 100 nM after 16 hrs in presence of cereblon E3 ligase inhibitor MLN4924 and ABCB1 inhibitor tariquidar by immunoblot method	B	COc1cc(N2CCN(CCOCCOCCNC(=O)CNc3cccc4c3C(=O)N(C3CCC(=O)NC3=O)C4=O)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL4217325		Activity			CHEMBL4722	Homo sapiens	Activity		
Not Active	18476811	CHEMBL4183702	Induction of aurora A degradation in human CHLA20 cells at 100 nM after 16 hrs in presence of cereblon E3 ligase inhibitor MLN4924 and ABCB1 inhibitor tariquidar by immunoblot method	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCN(CCOCCOCCNC(=O)CNc2cccc3c2C(=O)N(C2CCC(=O)NC2=O)C3=O)CC1		CHEMBL4213986		Activity			CHEMBL4722	Homo sapiens	Activity		
Not Active	18476812	CHEMBL4183703	Induction of aurora A degradation in human Kelly cells at 100 nM after 16 hrs in presence of pomalidomide by immunoblot method	B	COc1cc(N2CCN(CCOCCOCCNC(=O)CNc3cccc4c3C(=O)N(C3CCC(=O)NC3=O)C4=O)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL4217325		Activity			CHEMBL4722	Homo sapiens	Activity		
Not Active	18476813	CHEMBL4183703	Induction of aurora A degradation in human Kelly cells at 100 nM after 16 hrs in presence of pomalidomide by immunoblot method	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCN(CCOCCOCCNC(=O)CNc2cccc3c2C(=O)N(C2CCC(=O)NC2=O)C3=O)CC1		CHEMBL4213986		Activity			CHEMBL4722	Homo sapiens	Activity		
Not Active	18476814	CHEMBL4183704	Induction of aurora A degradation in human CHLA20 cells at 100 nM after 16 hrs in presence of pomalidomide and ABCB1 inhibitor tariquidar by immunoblot method	B	COc1cc(N2CCN(CCOCCOCCNC(=O)CNc3cccc4c3C(=O)N(C3CCC(=O)NC3=O)C4=O)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL4217325		Activity			CHEMBL4722	Homo sapiens	Activity		
Not Active	18476815	CHEMBL4183704	Induction of aurora A degradation in human CHLA20 cells at 100 nM after 16 hrs in presence of pomalidomide and ABCB1 inhibitor tariquidar by immunoblot method	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCN(CCOCCOCCNC(=O)CNc2cccc3c2C(=O)N(C2CCC(=O)NC2=O)C3=O)CC1		CHEMBL4213986		Activity			CHEMBL4722	Homo sapiens	Activity		
Active	18476865	CHEMBL4183730	Induction of aurora A degradation in human NCI-H3122 cells at 250 nM measured over 2 to 16 hrs by immunoblot method	B	COc1cc(N2CCN(CCOCCOCCNC(=O)CNc3cccc4c3C(=O)N(C3CCC(=O)NC3=O)C4=O)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL4217325		Activity			CHEMBL4722	Homo sapiens	Activity		
Active	18476866	CHEMBL4183730	Induction of aurora A degradation in human NCI-H3122 cells at 250 nM measured over 2 to 16 hrs by immunoblot method	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCN(CCOCCOCCNC(=O)CNc2cccc3c2C(=O)N(C2CCC(=O)NC2=O)C3=O)CC1		CHEMBL4213986		Activity			CHEMBL4722	Homo sapiens	Activity		
Active	18476873	CHEMBL4183734	Induction of aurora A degradation in human Kelly cells at 100 nM measured over 2 to 16 hrs by immunoblot method	B	COc1cc(N2CCN(CCOCCOCCNC(=O)CNc3cccc4c3C(=O)N(C3CCC(=O)NC3=O)C4=O)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL4217325		Activity			CHEMBL4722	Homo sapiens	Activity		
Active	18476874	CHEMBL4183734	Induction of aurora A degradation in human Kelly cells at 100 nM measured over 2 to 16 hrs by immunoblot method	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCN(CCOCCOCCNC(=O)CNc2cccc3c2C(=O)N(C2CCC(=O)NC2=O)C3=O)CC1		CHEMBL4213986		Activity			CHEMBL4722	Homo sapiens	Activity		
	18484472	CHEMBL4185634	Inhibition of recombinant full length His-tagged human Aurora A expressed in baculovirus expression system by Z'LYTE assay	B	CCC(=O)Nc1ccc(C(=O)Nc2ccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)cc2)cc1		CHEMBL4206831	=	IC50	nM	52.0	CHEMBL4722	Homo sapiens	IC50	nM	52.0
	18484475	CHEMBL4185637	Inhibition of Aurora A auto-phosphorylation in human HCT116 cells after 4 hrs by Western blot analysis	B	CCC(=O)Nc1ccc(C(=O)Nc2ccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)cc2)cc1		CHEMBL4206831	=	EC50	nM	38.0	CHEMBL4722	Homo sapiens	EC50	nM	38.0
	18484524	CHEMBL4185687	Binding affinity to wild-type human partial length AURKA (E122 to K401 residues) expressed in HEK293 cells at 1 uM by Kinomescan method relative to control	B	CCC(=O)Nc1ccc(C(=O)Nc2ccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)cc2)cc1		CHEMBL4206831	=	Activity	%	0.45	CHEMBL4722	Homo sapiens	Activity	%	0.45
	18484951	CHEMBL4185637	Inhibition of Aurora A auto-phosphorylation in human HCT116 cells after 4 hrs by Western blot analysis	B	CCOC(=O)c1[nH]cc2c1NC1=C(C(=O)CCC1)[C@H]2c1cccc(Oc2nc3ccccc3[nH]2)c1		CHEMBL3393498	=	EC50	nM	106.0	CHEMBL4722	Homo sapiens	EC50	nM	106.0
	18484954	CHEMBL4185634	Inhibition of recombinant full length His-tagged human Aurora A expressed in baculovirus expression system by Z'LYTE assay	B	CCOC(=O)c1[nH]cc2c1NC1=C(C(=O)CCC1)[C@H]2c1cccc(Oc2nc3ccccc3[nH]2)c1		CHEMBL3393498	=	IC50	nM	75.0	CHEMBL4722	Homo sapiens	IC50	nM	75.0
	18485097	CHEMBL4185687	Binding affinity to wild-type human partial length AURKA (E122 to K401 residues) expressed in HEK293 cells at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1ccc(C(=O)Nc2ccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)cc2)cc1		CHEMBL3969370	=	Activity	%	0.0	CHEMBL4722	Homo sapiens	Activity	%	0.0
	18485146	CHEMBL4185637	Inhibition of Aurora A auto-phosphorylation in human HCT116 cells after 4 hrs by Western blot analysis	B	C=CC(=O)Nc1ccc(C(=O)Nc2ccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)cc2)cc1		CHEMBL3969370	=	EC50	nM	5.8	CHEMBL4722	Homo sapiens	EC50	nM	5.8
	18485149	CHEMBL4185634	Inhibition of recombinant full length His-tagged human Aurora A expressed in baculovirus expression system by Z'LYTE assay	B	C=CC(=O)Nc1ccc(C(=O)Nc2ccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)cc2)cc1		CHEMBL3969370	=	IC50	nM	44.0	CHEMBL4722	Homo sapiens	IC50	nM	44.0
	18489489	CHEMBL4187230	Inhibition of wild-type human partial length AURKA (E122 to K401 residues) expressed in mammalian expression system assessed as residual activity at 10 uM by Kinomescan method relative to control	B	Fc1cc(F)cc(-n2cnc3c(NCc4nc5c(F)c(F)ccc5[nH]4)nc(N4CCOCC4)nc32)c1		CHEMBL4207079	=	Activity	%	100.0	CHEMBL4722	Homo sapiens	Activity	%	100.0
	18499331	CHEMBL4188997	Potency index, ratio of BGB324 IC50 to compound IC50 for human partial length Aurora A (E122 to K401 residues) expressed in mammalian expression system	B	CNc1ncc2c(-c3ccc(N4CCN(C)CC4)cc3)nn(CC3CCCC3)c2n1		CHEMBL4218175	=	Ratio IC50		4.0	CHEMBL4722	Homo sapiens	Ratio IC50		4.0
	18499520	CHEMBL4188971	Inhibition of human partial length Aurora A (E122 to K401 residues) expressed in mammalian expression system using poly [Glu, Try] 4:1 as substrate in presence of [gamma-33P]ATP	B	CNc1ncc2c(-c3ccc(N4CCN(C(=O)C(C)(C)C)CC4)nc3)nn(CC3CCCC3)c2n1		CHEMBL4204515	=	IC50	nM	610.0	CHEMBL4722	Homo sapiens	IC50	uM	0.61
	18499521	CHEMBL4188971	Inhibition of human partial length Aurora A (E122 to K401 residues) expressed in mammalian expression system using poly [Glu, Try] 4:1 as substrate in presence of [gamma-33P]ATP	B	CCN1CCN(c2ccc(-c3nn(CC4CCCC4)c4nc(NC)ncc34)cn2)CC1		CHEMBL4213775	=	IC50	nM	280.0	CHEMBL4722	Homo sapiens	IC50	uM	0.28
	18499522	CHEMBL4188971	Inhibition of human partial length Aurora A (E122 to K401 residues) expressed in mammalian expression system using poly [Glu, Try] 4:1 as substrate in presence of [gamma-33P]ATP	B	CNc1ncc2c(-c3ccc(N4CCN(C)CC4)nc3)nn(CC3CCCC3)c2n1		CHEMBL4208852	=	IC50	nM	30.0	CHEMBL4722	Homo sapiens	IC50	uM	0.03
	18499523	CHEMBL4188971	Inhibition of human partial length Aurora A (E122 to K401 residues) expressed in mammalian expression system using poly [Glu, Try] 4:1 as substrate in presence of [gamma-33P]ATP	B	CNc1ncc2c(-c3ccc(N4CCN(C)CC4)cc3)nn(CC3CCCC3)c2n1		CHEMBL4218175	=	IC50	nM	6.0	CHEMBL4722	Homo sapiens	IC50	uM	0.006
	18499524	CHEMBL4188971	Inhibition of human partial length Aurora A (E122 to K401 residues) expressed in mammalian expression system using poly [Glu, Try] 4:1 as substrate in presence of [gamma-33P]ATP	B	Nc1nc(Nc2ccc3c(c2)CC[C@@H](N2CCCC2)CC3)nn1-c1cc2c(nn1)-c1ccccc1CCC2		CHEMBL3809489	=	IC50	nM	26.0	CHEMBL4722	Homo sapiens	IC50	uM	0.026
	18499525	CHEMBL4188971	Inhibition of human partial length Aurora A (E122 to K401 residues) expressed in mammalian expression system using poly [Glu, Try] 4:1 as substrate in presence of [gamma-33P]ATP	B	CNc1ncc2c(-c3ccc(N4CCN(C(=O)C(C)(C)C)CC4)nc3)nn(Cc3cn(Cc4ccccc4)nn3)c2n1		CHEMBL4207004	=	IC50	nM	840.0	CHEMBL4722	Homo sapiens	IC50	uM	0.84
	18499526	CHEMBL4188971	Inhibition of human partial length Aurora A (E122 to K401 residues) expressed in mammalian expression system using poly [Glu, Try] 4:1 as substrate in presence of [gamma-33P]ATP	B	CCN1CCN(c2ccc(-c3nn(Cc4cn(Cc5ccccc5)nn4)c4nc(NC)ncc34)cn2)CC1		CHEMBL4217649	>	IC50	nM	10000.0	CHEMBL4722	Homo sapiens	IC50	uM	10.0
	18499527	CHEMBL4188971	Inhibition of human partial length Aurora A (E122 to K401 residues) expressed in mammalian expression system using poly [Glu, Try] 4:1 as substrate in presence of [gamma-33P]ATP	B	CNc1ncc2c(-c3ccc(N4CCN(C)CC4)nc3)nn(Cc3cn(Cc4ccccc4)nn3)c2n1		CHEMBL4218369	=	IC50	nM	730.0	CHEMBL4722	Homo sapiens	IC50	uM	0.73
	18499528	CHEMBL4188971	Inhibition of human partial length Aurora A (E122 to K401 residues) expressed in mammalian expression system using poly [Glu, Try] 4:1 as substrate in presence of [gamma-33P]ATP	B	CNc1ncc2c(-c3ccc(N4CCNCC4)cc3)nn(Cc3cn(Cc4ccccc4)nn3)c2n1		CHEMBL4211308	>	IC50	nM	10000.0	CHEMBL4722	Homo sapiens	IC50	uM	10.0
	18499529	CHEMBL4188971	Inhibition of human partial length Aurora A (E122 to K401 residues) expressed in mammalian expression system using poly [Glu, Try] 4:1 as substrate in presence of [gamma-33P]ATP	B	CNc1ncc2c(-c3ccc(N4CCNCC4)nc3)nn(Cc3cn(-c4ccsc4C(=O)OC)nn3)c2n1		CHEMBL4205191	=	IC50	nM	790.0	CHEMBL4722	Homo sapiens	IC50	uM	0.79
	18499530	CHEMBL4188971	Inhibition of human partial length Aurora A (E122 to K401 residues) expressed in mammalian expression system using poly [Glu, Try] 4:1 as substrate in presence of [gamma-33P]ATP	B	CNc1ncc2c(-c3ccc(N4CCNCC4)nc3)nn(Cc3cn(Cc4ccccc4)nn3)c2n1		CHEMBL4210084	=	IC50	nM	1800.0	CHEMBL4722	Homo sapiens	IC50	uM	1.8
	18499531	CHEMBL4188971	Inhibition of human partial length Aurora A (E122 to K401 residues) expressed in mammalian expression system using poly [Glu, Try] 4:1 as substrate in presence of [gamma-33P]ATP	B	CNc1ncc2c(-c3ccc(OC)cc3)nn(CC3OCCO3)c2n1		CHEMBL4209569	=	IC50	nM	560.0	CHEMBL4722	Homo sapiens	IC50	uM	0.56
	18499532	CHEMBL4188971	Inhibition of human partial length Aurora A (E122 to K401 residues) expressed in mammalian expression system using poly [Glu, Try] 4:1 as substrate in presence of [gamma-33P]ATP	B	CNc1ncc2c(-c3ccc(N4CCNCC4)nc3)nn(CC3OCCO3)c2n1		CHEMBL4214476	=	IC50	nM	660.0	CHEMBL4722	Homo sapiens	IC50	uM	0.66
	18499533	CHEMBL4188971	Inhibition of human partial length Aurora A (E122 to K401 residues) expressed in mammalian expression system using poly [Glu, Try] 4:1 as substrate in presence of [gamma-33P]ATP	B	CNc1ncc2c(-c3ccc(N4CCNCC4)nc3)nn(CC3CCCC3)c2n1		CHEMBL4213003	=	IC50	nM	160.0	CHEMBL4722	Homo sapiens	IC50	uM	0.16
	18504064	CHEMBL4189904	Binding affinity to DNA-tagged human partial length AURKA expressed in mammalian expression system by qPCR method	A	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	Kd	nM	0.5012	CHEMBL4722	Homo sapiens	pKd		9.3
	18504065	CHEMBL4189904	Binding affinity to DNA-tagged human partial length AURKA expressed in mammalian expression system by qPCR method	A	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccccc3)n2)n[nH]1		CHEMBL4216458	=	Kd	nM	39.81	CHEMBL4722	Homo sapiens	pKd		7.4
	18504066	CHEMBL4189904	Binding affinity to DNA-tagged human partial length AURKA expressed in mammalian expression system by qPCR method	A	CN1CCN(c2cc(Nc3cc(-c4cccc(F)c4)[nH]n3)nc(Sc3ccccc3)n2)CC1		CHEMBL4216563	=	Kd	nM	5011.87	CHEMBL4722	Homo sapiens	pKd		5.3
	18504067	CHEMBL4189904	Binding affinity to DNA-tagged human partial length AURKA expressed in mammalian expression system by qPCR method	A	CN1CCN(c2cc(Nc3cc(C4CCCC4)[nH]n3)nc(Sc3ccccc3)n2)CC1		CHEMBL4204878	=	Kd	nM	100.0	CHEMBL4722	Homo sapiens	pKd		7.0
	18504068	CHEMBL4189904	Binding affinity to DNA-tagged human partial length AURKA expressed in mammalian expression system by qPCR method	A	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(SCc3ccc(F)cc3)n2)n[nH]1		CHEMBL4212119	=	Kd	nM	25.12	CHEMBL4722	Homo sapiens	pKd		7.6
	18504069	CHEMBL4189904	Binding affinity to DNA-tagged human partial length AURKA expressed in mammalian expression system by qPCR method	A	Cc1ccc(CSc2nc(Nc3cc(C)[nH]n3)cc(N3CCN(C)CC3)n2)cc1		CHEMBL4217093	=	Kd	nM	50.12	CHEMBL4722	Homo sapiens	pKd		7.3
Not Active	18504072	CHEMBL4189906	Inhibition of DNA-tagged human partial length AURKA expressed in mammalian expression system at 100 nM by qPCR method	A	CN1CCN(c2cc(Nc3cc(C(C)(C)C)[nH]n3)nc(Sc3ccccc3)n2)CC1		CHEMBL4218060		Inhibition	%		CHEMBL4722	Homo sapiens	INH		
	18507893	CHEMBL4190874	Inhibition of recombinant full-length human Aurora-A at 1 uM using LRRASLG (kemptide) as substrate after 40 mins in presence of [gamma-33P]ATP by scintillation counting method	B	CS(=O)(=O)c1ccc(-n2nc(-c3cnc4[nH]ccc4c3)c3c(N)ncnc32)cc1		CHEMBL4207014	=	Inhibition	%	15.0	CHEMBL4722	Homo sapiens	INH	%	15.0
	18577627	CHEMBL4222213	Inhibition of recombinant human full length His-tagged aurora A expressed in baculovirus expression system at 1 uM using tyrosine04 peptide as substrate after 60 mins in presence of ATP by Z-LYTE assay relative to control	B	C=CC(=O)Nc1cccc(NC(=O)Nc2ccnc(Nc3ccc(N4CCC(N5CCOCC5)CC4)cc3OC)n2)c1		CHEMBL4225781	=	Inhibition	%	10.5	CHEMBL4722	Homo sapiens	INH	%	10.5
	18577651	CHEMBL4222213	Inhibition of recombinant human full length His-tagged aurora A expressed in baculovirus expression system at 1 uM using tyrosine04 peptide as substrate after 60 mins in presence of ATP by Z-LYTE assay relative to control	B	C=CC(=O)Nc1cc(Nc2nccc(-c3cn(C)c4ccccc34)n2)c(OC)cc1N(C)CCN(C)C		CHEMBL3353410	=	Inhibition	%	3.8	CHEMBL4722	Homo sapiens	INH	%	3.8
	18577675	CHEMBL4222213	Inhibition of recombinant human full length His-tagged aurora A expressed in baculovirus expression system at 1 uM using tyrosine04 peptide as substrate after 60 mins in presence of ATP by Z-LYTE assay relative to control	B	C=CC(=O)Nc1cccc(Oc2nc(Nc3ccc(N4CCN(C(C)=O)CC4)cc3OC)ncc2C(F)(F)F)c1		CHEMBL3699588	=	Inhibition	%	19.7	CHEMBL4722	Homo sapiens	INH	%	19.7
	18578638	CHEMBL4222439	Inhibition of Aurora A (unknown origin) using Tamra-PKAtide as substrate by fluorescence polarization assay	B	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2cc(Cc3ccncc3)ns2)n1		CHEMBL4227349	<	IC50	nM	4.0	CHEMBL4722	Homo sapiens	IC50	nM	4.0
	18578639	CHEMBL4222439	Inhibition of Aurora A (unknown origin) using Tamra-PKAtide as substrate by fluorescence polarization assay	B	CCN(CCO)Cc1cc(Nc2nc(C)cn3c(-c4cn[nH]c4)cnc23)sn1		CHEMBL4228240	<	IC50	nM	4.0	CHEMBL4722	Homo sapiens	IC50	nM	4.0
	18578640	CHEMBL4222439	Inhibition of Aurora A (unknown origin) using Tamra-PKAtide as substrate by fluorescence polarization assay	B	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2cc(Cn3cccc3)ns2)n1		CHEMBL4228586	<	IC50	nM	4.0	CHEMBL4722	Homo sapiens	IC50	nM	4.0
	18578641	CHEMBL4222439	Inhibition of Aurora A (unknown origin) using Tamra-PKAtide as substrate by fluorescence polarization assay	B	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2cc(Cn3ccnc3)ns2)n1		CHEMBL4228135	<	IC50	nM	4.0	CHEMBL4722	Homo sapiens	IC50	nM	4.0
	18578642	CHEMBL4222439	Inhibition of Aurora A (unknown origin) using Tamra-PKAtide as substrate by fluorescence polarization assay	B	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2cc(Cn3cccn3)ns2)n1		CHEMBL4228412	<	IC50	nM	4.0	CHEMBL4722	Homo sapiens	IC50	nM	4.0
	18578643	CHEMBL4222439	Inhibition of Aurora A (unknown origin) using Tamra-PKAtide as substrate by fluorescence polarization assay	B	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2cc(Cn3cccc(C)c3=O)ns2)n1		CHEMBL4227844	<	IC50	nM	4.0	CHEMBL4722	Homo sapiens	IC50	nM	4.0
	18578644	CHEMBL4222439	Inhibition of Aurora A (unknown origin) using Tamra-PKAtide as substrate by fluorescence polarization assay	B	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2cc(Cc3nccs3)ns2)n1		CHEMBL4227538	<	IC50	nM	4.0	CHEMBL4722	Homo sapiens	IC50	nM	4.0
	18578645	CHEMBL4222439	Inhibition of Aurora A (unknown origin) using Tamra-PKAtide as substrate by fluorescence polarization assay	B	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2cc(Cc3ncccn3)ns2)n1		CHEMBL4229135	<	IC50	nM	4.0	CHEMBL4722	Homo sapiens	IC50	nM	4.0
	18578646	CHEMBL4222439	Inhibition of Aurora A (unknown origin) using Tamra-PKAtide as substrate by fluorescence polarization assay	B	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2cc(Cc3cnccn3)ns2)n1		CHEMBL4225385	<	IC50	nM	4.0	CHEMBL4722	Homo sapiens	IC50	nM	4.0
	18578647	CHEMBL4222439	Inhibition of Aurora A (unknown origin) using Tamra-PKAtide as substrate by fluorescence polarization assay	B	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2cc(Cc3ccccn3)ns2)n1		CHEMBL4227082	<	IC50	nM	4.0	CHEMBL4722	Homo sapiens	IC50	nM	4.0
	18578648	CHEMBL4222439	Inhibition of Aurora A (unknown origin) using Tamra-PKAtide as substrate by fluorescence polarization assay	B	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2cc(Cc3cccnc3)ns2)n1		CHEMBL4226232	<	IC50	nM	4.0	CHEMBL4722	Homo sapiens	IC50	nM	4.0
	18578689	CHEMBL4222439	Inhibition of Aurora A (unknown origin) using Tamra-PKAtide as substrate by fluorescence polarization assay	B	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2cc(C(NC(C)(C)C)c3ccccn3)ns2)n1		CHEMBL4225923	<=	IC50	nM	4.0	CHEMBL4722	Homo sapiens	IC50	nM	4.0
	18578690	CHEMBL4222439	Inhibition of Aurora A (unknown origin) using Tamra-PKAtide as substrate by fluorescence polarization assay	B	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2cc(C(NC(C)(C)C)c3ccccn3)ns2)n1		CHEMBL4225923	<=	IC50	nM	4.0	CHEMBL4722	Homo sapiens	IC50	nM	4.0
	18578691	CHEMBL4222439	Inhibition of Aurora A (unknown origin) using Tamra-PKAtide as substrate by fluorescence polarization assay	B	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2cc(C(NC(C)(C)C)c3ccccn3)ns2)n1		CHEMBL4225923	<	IC50	nM	4.0	CHEMBL4722	Homo sapiens	IC50	nM	4.0
	18578692	CHEMBL4222439	Inhibition of Aurora A (unknown origin) using Tamra-PKAtide as substrate by fluorescence polarization assay	B	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2cc(C(NC3CCCC3)c3ccccn3)ns2)n1		CHEMBL4227029	<	IC50	nM	4.0	CHEMBL4722	Homo sapiens	IC50	nM	4.0
	18578693	CHEMBL4222439	Inhibition of Aurora A (unknown origin) using Tamra-PKAtide as substrate by fluorescence polarization assay	B	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2cc(C(c3ccccn3)N3CCC(F)CC3)ns2)n1		CHEMBL4226184	<	IC50	nM	4.0	CHEMBL4722	Homo sapiens	IC50	nM	4.0
	18578694	CHEMBL4222439	Inhibition of Aurora A (unknown origin) using Tamra-PKAtide as substrate by fluorescence polarization assay	B	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2cc(C(c3ccccn3)N3CCCCC3)ns2)n1		CHEMBL4227284	<	IC50	nM	4.0	CHEMBL4722	Homo sapiens	IC50	nM	4.0
	18578695	CHEMBL4222439	Inhibition of Aurora A (unknown origin) using Tamra-PKAtide as substrate by fluorescence polarization assay	B	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2cc(C(c3ccccn3)N3CCCC3)ns2)n1		CHEMBL4226438	<	IC50	nM	4.0	CHEMBL4722	Homo sapiens	IC50	nM	4.0
	18578696	CHEMBL4222439	Inhibition of Aurora A (unknown origin) using Tamra-PKAtide as substrate by fluorescence polarization assay	B	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2cc(Cc3cccc(CN4CCCCC4)n3)ns2)n1		CHEMBL4227557	<	IC50	nM	4.0	CHEMBL4722	Homo sapiens	IC50	nM	4.0
	18578697	CHEMBL4222439	Inhibition of Aurora A (unknown origin) using Tamra-PKAtide as substrate by fluorescence polarization assay	B	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2cc(Cc3cccc(C(=O)N4CCCCC4)n3)ns2)n1		CHEMBL4226704	<	IC50	nM	4.0	CHEMBL4722	Homo sapiens	IC50	nM	4.0
	18578698	CHEMBL4222439	Inhibition of Aurora A (unknown origin) using Tamra-PKAtide as substrate by fluorescence polarization assay	B	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2cc(Cc3cccc(CO)n3)ns2)n1		CHEMBL4227818	<	IC50	nM	4.0	CHEMBL4722	Homo sapiens	IC50	nM	4.0
	18578699	CHEMBL4222439	Inhibition of Aurora A (unknown origin) using Tamra-PKAtide as substrate by fluorescence polarization assay	B	COc1cccc(Cc2cc(Nc3nc(C)cn4c(-c5cn[nH]c5)cnc34)sn2)n1		CHEMBL4226969	<	IC50	nM	4.0	CHEMBL4722	Homo sapiens	IC50	nM	4.0
	18578700	CHEMBL4222439	Inhibition of Aurora A (unknown origin) using Tamra-PKAtide as substrate by fluorescence polarization assay	B	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2cc(Cc3cccc(F)n3)ns2)n1		CHEMBL4225181	<	IC50	nM	4.0	CHEMBL4722	Homo sapiens	IC50	nM	4.0
	18578701	CHEMBL4222439	Inhibition of Aurora A (unknown origin) using Tamra-PKAtide as substrate by fluorescence polarization assay	B	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2cc(Cc3ccc(F)cn3)ns2)n1		CHEMBL4226036	<	IC50	nM	4.0	CHEMBL4722	Homo sapiens	IC50	nM	4.0
	18578702	CHEMBL4222439	Inhibition of Aurora A (unknown origin) using Tamra-PKAtide as substrate by fluorescence polarization assay	B	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2cc(Cc3ncccc3F)ns2)n1		CHEMBL4225979	<	IC50	nM	4.0	CHEMBL4722	Homo sapiens	IC50	nM	4.0
	18578703	CHEMBL4222439	Inhibition of Aurora A (unknown origin) using Tamra-PKAtide as substrate by fluorescence polarization assay	B	Cc1cccc(Cc2cc(Nc3nc(C)cn4c(-c5cn[nH]c5)cnc34)sn2)n1		CHEMBL4228308	<	IC50	nM	4.0	CHEMBL4722	Homo sapiens	IC50	nM	4.0
	18578704	CHEMBL4222439	Inhibition of Aurora A (unknown origin) using Tamra-PKAtide as substrate by fluorescence polarization assay	B	Cc1ccc(Cc2cc(Nc3nc(C)cn4c(-c5cn[nH]c5)cnc34)sn2)nc1		CHEMBL4225708	<	IC50	nM	4.0	CHEMBL4722	Homo sapiens	IC50	nM	4.0
	18578705	CHEMBL4222439	Inhibition of Aurora A (unknown origin) using Tamra-PKAtide as substrate by fluorescence polarization assay	B	Cc1ccnc(Cc2cc(Nc3nc(C)cn4c(-c5cn[nH]c5)cnc34)sn2)c1		CHEMBL4226657	<	IC50	nM	4.0	CHEMBL4722	Homo sapiens	IC50	nM	4.0
	18578706	CHEMBL4222439	Inhibition of Aurora A (unknown origin) using Tamra-PKAtide as substrate by fluorescence polarization assay	B	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2cc(Cc3ncccc3C)ns2)n1		CHEMBL4226494	<	IC50	nM	4.0	CHEMBL4722	Homo sapiens	IC50	nM	4.0
	18578764	CHEMBL4222444	Binding affinity to Aurora A (unknown origin) after 45 mins by fluorescence-based thermal stability shift assay	B	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2cc(Cc3ccccn3)ns2)n1		CHEMBL4227082	=	Kd	nM	0.01	CHEMBL4722	Homo sapiens	Kd	nM	0.01
	18578765	CHEMBL4222444	Binding affinity to Aurora A (unknown origin) after 45 mins by fluorescence-based thermal stability shift assay	B	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2cc(C(NC(C)(C)C)c3ccccn3)ns2)n1		CHEMBL4225923	=	Kd	nM	0.01	CHEMBL4722	Homo sapiens	Kd	nM	0.01
	18589526	CHEMBL4224085	Inhibition of Aurora A (unknown origin) using kemptide as substrate after 30 mins by kinase-Glo luminescence method	B	Cn1cc(-c2nn(Cc3ccc(C(=O)NC4CCCC4)cc3)c(=O)c3ccccc23)cn1		CHEMBL4226724	=	IC50	nM	583.0	CHEMBL4722	Homo sapiens	IC50	nM	583.0
	18589527	CHEMBL4224085	Inhibition of Aurora A (unknown origin) using kemptide as substrate after 30 mins by kinase-Glo luminescence method	B	Cn1cc(-c2nn(Cc3ccc(C(=O)NC4CCCCC4)cc3)c(=O)c3ccccc23)cn1		CHEMBL4225880	=	IC50	nM	118.0	CHEMBL4722	Homo sapiens	IC50	nM	118.0
	18589528	CHEMBL4224085	Inhibition of Aurora A (unknown origin) using kemptide as substrate after 30 mins by kinase-Glo luminescence method	B	CN1CCC(NC(=O)c2ccc(Cn3nc(-c4cnn(C)c4)c4ccccc4c3=O)cc2)CC1		CHEMBL4227804	=	IC50	nM	183.0	CHEMBL4722	Homo sapiens	IC50	nM	183.0
	18589529	CHEMBL4224085	Inhibition of Aurora A (unknown origin) using kemptide as substrate after 30 mins by kinase-Glo luminescence method	B	Cn1cc(-c2nn(Cc3ccc(C(=O)NC4CC(C)(C)N([O])C(C)(C)C4)cc3)c(=O)c3ccccc23)cn1		CHEMBL4228646	=	IC50	nM	168.0	CHEMBL4722	Homo sapiens	IC50	nM	168.0
	18589530	CHEMBL4224085	Inhibition of Aurora A (unknown origin) using kemptide as substrate after 30 mins by kinase-Glo luminescence method	B	Cn1cc(Nc2nn(Cc3ccc(C(=O)NC4CCCCC4)cc3)c(=O)c3ccccc23)cn1		CHEMBL4228067	=	IC50	nM	145.0	CHEMBL4722	Homo sapiens	IC50	nM	145.0
	18589531	CHEMBL4224085	Inhibition of Aurora A (unknown origin) using kemptide as substrate after 30 mins by kinase-Glo luminescence method	B	CC(=O)Nc1ccc(Sc2nc(Nc3cc(C)[nH]n3)cc(N3CCN(C)CC3)n2)cc1		CHEMBL4228587	=	IC50	nM	1.0	CHEMBL4722	Homo sapiens	IC50	nM	1.0
Dose-dependent effect	18589538	CHEMBL4224087	Inhibition of Aurora A phosphorylation at Thr288 residue in human HeLa cells after 6 hrs by Western blot method	B	Cn1cc(-c2nn(Cc3ccc(C(=O)NC4CCCCC4)cc3)c(=O)c3ccccc23)cn1		CHEMBL4225880		Inhibition	%		CHEMBL4722	Homo sapiens	INH		
Active	18589540	CHEMBL4224089	Inhibition of Aurora A phosphorylation at Thr288 residue in human HeLa cells at 5 uM after 6 hrs by Western blot method	B	Cn1cc(-c2nn(Cc3ccc(C(=O)NC4CCCCC4)cc3)c(=O)c3ccccc23)cn1		CHEMBL4225880		Inhibition	%		CHEMBL4722	Homo sapiens	INH		
Active	18589541	CHEMBL4224089	Inhibition of Aurora A phosphorylation at Thr288 residue in human HeLa cells at 5 uM after 6 hrs by Western blot method	B	CC(=O)Nc1ccc(Sc2nc(Nc3cc(C)[nH]n3)cc(N3CCN(C)CC3)n2)cc1		CHEMBL4228587		Inhibition	%		CHEMBL4722	Homo sapiens	INH		
	18653763	CHEMBL4230022	Inhibition of AURORA-A (unknown origin) at 1 uM by mobility shift microfluidics platform based assay relative to control	B	CC(C)n1nc(C#Cc2cccc(NC(=O)c3cccc(C(F)(F)F)c3)c2)c2c(N)ncnc21		CHEMBL3736320	=	Inhibition	%	90.0	CHEMBL4722	Homo sapiens	INH	%	90.0
	18653764	CHEMBL4230022	Inhibition of AURORA-A (unknown origin) at 1 uM by mobility shift microfluidics platform based assay relative to control	B	CC(C)n1nc(C#Cc2cccc3cc(-c4cccc(C(F)(F)F)c4)ncc23)c2c(N)ncnc21		CHEMBL4247506	=	Inhibition	%	29.0	CHEMBL4722	Homo sapiens	INH	%	29.0
	18655633	CHEMBL4230587	Binding affinity to wild-type human partial length AURKA (E122 to K401 residues) expressed in mammalian expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	Cc1ccc(NC(=O)c2ccc(CN(CCN(C)C)C(=O)c3cccnc3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL4247298	=	Activity	%	74.0	CHEMBL4722	Homo sapiens	Activity	%	74.0
	18656119	CHEMBL4231151	Inhibition of recombinant human Aurora-A using Ulight-RRRSLLE as substrate measured after 15 mins by LANCE assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	23.0	CHEMBL4722	Homo sapiens	IC50	10'-8M	2.3
	18656125	CHEMBL4231147	Inhibition of recombinant human Aurora-A at 10'-5 M using Ulight-RRRSLLE as substrate measured after 15 mins by LANCE assay relative to control	B	COc1ccc(Nc2ncc3c(n2)-c2ccccc2SC3)cc1OC		CHEMBL4240970	=	Inhibition	%	88.6	CHEMBL4722	Homo sapiens	INH	%	88.6
	18656499	CHEMBL4231207	Inhibition of recombinant human Aurora-A expressed in Sf21 insect cells using Ulight-RRRSLLE as substrate after 15 mins by LANCE method	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	39.0	CHEMBL4722	Homo sapiens	IC50	10'-8M	3.9
Not Active	18659168	CHEMBL4231770	Inhibition of Aurora A (unknown origin)	B	CCCCCc1cc2nn(-c3ccccc3)cc2cn1		CHEMBL4249686		Inhibition	%		CHEMBL4722	Homo sapiens	INH		
	18663900	CHEMBL4232868	Inhibition of human AURKA (E122 to K401 residues) expressed in mammalian expression system assessed as residual activity at 5 uM by KINOMEscan assay relative to control	B	CC(C)CN(C(=O)c1cccnc1)c1c2ccccc2c(=O)n2c1[nH]c1ccccc12		CHEMBL4247704	=	Activity	%	100.0	CHEMBL4722	Homo sapiens	Activity	%	100.0
	18663981	CHEMBL4232965	Binding affinity to human AURKA (E122 to K401 residues) expressed in mammalian expression system by KINOMEscan assay	B	CC(C)CN(C(=O)c1cccnc1)c1c2ccccc2c(=O)n2c1[nH]c1ccccc12		CHEMBL4247704	>=	Kd	nM	5000.0	CHEMBL4722	Homo sapiens	Kd	uM	5.0
	18665493	CHEMBL4233289	Inhibition of AURA (unknown origin)	B	O=C(Cc1cccc(OCCCC2CCNCC2)c1)Nc1nc(-c2ccncc2)cs1		CHEMBL4251324	>	IC50	nM	5000.0	CHEMBL4722	Homo sapiens	IC50	nM	5000.0
	18665563	CHEMBL4233289	Inhibition of AURA (unknown origin)	B	O=C(Cc1cccc(OCCCN2CCNCC2)c1)Nc1nc(-c2ccncc2)cs1		CHEMBL4245507	>	IC50	nM	1000.0	CHEMBL4722	Homo sapiens	IC50	nM	1000.0
	18674541	CHEMBL4235314	Inhibition of AurA (unknown origin)	B	CS(=O)(=O)Nc1cccc(CC(=O)Nc2nc(-c3c[nH]c4ncccc34)cs2)c1		CHEMBL4249925	>	Ki	nM	10000.0	CHEMBL4722	Homo sapiens	Ki	nM	10000.0
	18674542	CHEMBL4235314	Inhibition of AurA (unknown origin)	B	O=C(Cc1cccc(OCCCC2CCNCC2)c1)Nc1nc(-c2c[nH]c3ncccc23)cs1		CHEMBL4245242	>	Ki	nM	1000.0	CHEMBL4722	Homo sapiens	Ki	nM	1000.0
	18674543	CHEMBL4235314	Inhibition of AurA (unknown origin)	B	CN1CCN(CCCOc2cccc(CC(=O)Nc3nc(-c4c[nH]c5ncccc45)cs3)c2)CC1		CHEMBL4248525	>	Ki	nM	1000.0	CHEMBL4722	Homo sapiens	Ki	nM	1000.0
	18693964	CHEMBL4253416	Inhibition of recombinant full length human His-tagged AURKA expressed in baculovirus expression system at 0.1 uM by Z'-Lyte assay relative to control	B	CC1=Nc2c(F)cc(-c3nc(Nc4ccc(C5CCN(C)CC5)cn4)ncc3F)cc2C12CCCC2		CHEMBL4277900	=	Inhibition	%	-2.0	CHEMBL4722	Homo sapiens	INH	%	-2.0
	18694046	CHEMBL4253499	Inhibition of recombinant full length human His-tagged AURKA expressed in baculovirus expression system at 1 uM by Z'-Lyte assay relative to control	B	CC1=Nc2c(F)cc(-c3nc(Nc4ccc(C5CCN(C)CC5)cn4)ncc3F)cc2C12CCCC2		CHEMBL4277900	=	Inhibition	%	6.0	CHEMBL4722	Homo sapiens	INH	%	6.0
	18697610	CHEMBL4254283	Inhibition of wild-type human partial length AURKA (E122 to K401 residues) expressed in mammalian expression system assessed as residual activity at 1 uM by Kinomescan method relative to control	B	CCNc1cc(-c2ccc(NC(=O)Nc3cccc(Cl)c3)cc2C(F)(F)F)ccn1		CHEMBL4281348	=	Activity	%	100.0	CHEMBL4722	Homo sapiens	Activity	%	100.0
	18702506	CHEMBL4255101	Inhibition of recombinant full length human His-tagged AURKA expressed in baculovirus expression system at 1 uM relative to control	B	COc1ccc(S(N)(=O)=O)cc1C(=O)Nc1cccc(-c2nncn2C(C)C)n1		CHEMBL4278211	=	Inhibition	%	-4.0	CHEMBL4722	Homo sapiens	INH	%	-4.0
	18702533	CHEMBL4255101	Inhibition of recombinant full length human His-tagged AURKA expressed in baculovirus expression system at 1 uM relative to control	B	COc1ccc(C(N)=O)cc1C(=O)Nc1cccc(-c2nncn2C(C)C)n1		CHEMBL4282644	=	Inhibition	%	3.0	CHEMBL4722	Homo sapiens	INH	%	3.0
	18702577	CHEMBL4255101	Inhibition of recombinant full length human His-tagged AURKA expressed in baculovirus expression system at 1 uM relative to control	B	COc1ccc(S(C)(=O)=O)cc1C(=O)Nc1cccc(-c2nncn2C(C)C)n1		CHEMBL4287097	=	Inhibition	%	11.0	CHEMBL4722	Homo sapiens	INH	%	11.0
	18702629	CHEMBL4255101	Inhibition of recombinant full length human His-tagged AURKA expressed in baculovirus expression system at 1 uM relative to control	B	COc1cc(C)c(S(N)(=O)=O)cc1C(=O)Nc1cccc(-c2nncn2C(C)C)n1		CHEMBL4283739	=	Inhibition	%	5.0	CHEMBL4722	Homo sapiens	INH	%	5.0
	18702673	CHEMBL4255101	Inhibition of recombinant full length human His-tagged AURKA expressed in baculovirus expression system at 1 uM relative to control	B	COc1cc(C)c(C(N)=O)cc1C(=O)Nc1cccc(-c2nncn2C(C)C)n1		CHEMBL4294318	=	Inhibition	%	2.0	CHEMBL4722	Homo sapiens	INH	%	2.0
	18702716	CHEMBL4255101	Inhibition of recombinant full length human His-tagged AURKA expressed in baculovirus expression system at 1 uM relative to control	B	COc1cc(C)c(S(C)(=O)=O)cc1C(=O)Nc1cccc(-c2nncn2C(C)C)n1		CHEMBL4289040	=	Inhibition	%	-1.0	CHEMBL4722	Homo sapiens	INH	%	-1.0
	18708923	CHEMBL4256642	Inhibition of full length N-terminal His-tagged Aurora A (unknown origin) using fluorescence-labeled FL-Peptide 21 as substrate after 60 mins in presence of ATP by fluorescence assay based Cheng-Prusoff equation analysis	B	Nc1ccc[nH]c1=O		CHEMBL4286709	=	Ki	nM	361000.0	CHEMBL4722	Homo sapiens	Ki	uM	361.0
	18708926	CHEMBL4256646	Inhibition of Aurora A (unknown origin) at 100 uM using peptide as substrate in presence of ATP and MgCl2 by mobility shift assay relative to control	B	Nc1ccc[nH]c1=O		CHEMBL4286709	=	Inhibition	%	58.0	CHEMBL4722	Homo sapiens	INH	%	58.0
	18708952	CHEMBL4256642	Inhibition of full length N-terminal His-tagged Aurora A (unknown origin) using fluorescence-labeled FL-Peptide 21 as substrate after 60 mins in presence of ATP by fluorescence assay based Cheng-Prusoff equation analysis	B	Cn1cc(-c2c[nH]c(=O)c(N)c2)cn1		CHEMBL4288628	=	Ki	nM	7500.0	CHEMBL4722	Homo sapiens	Ki	uM	7.5
	18708955	CHEMBL4256646	Inhibition of Aurora A (unknown origin) at 100 uM using peptide as substrate in presence of ATP and MgCl2 by mobility shift assay relative to control	B	Cn1cc(-c2c[nH]c(=O)c(N)c2)cn1		CHEMBL4288628	=	Inhibition	%	100.0	CHEMBL4722	Homo sapiens	INH	%	100.0
	18708987	CHEMBL4256646	Inhibition of Aurora A (unknown origin) at 100 uM using peptide as substrate in presence of ATP and MgCl2 by mobility shift assay relative to control	B	Nc1cc(-c2ccncc2)c[nH]c1=O		CHEMBL12856	=	Inhibition	%	0.0	CHEMBL4722	Homo sapiens	INH	%	0.0
	18708990	CHEMBL4256642	Inhibition of full length N-terminal His-tagged Aurora A (unknown origin) using fluorescence-labeled FL-Peptide 21 as substrate after 60 mins in presence of ATP by fluorescence assay based Cheng-Prusoff equation analysis	B	Nc1cc(-c2ccncc2)c[nH]c1=O		CHEMBL12856	=	Ki	nM	393900.0	CHEMBL4722	Homo sapiens	Ki	uM	393.9
	18709010	CHEMBL4256642	Inhibition of full length N-terminal His-tagged Aurora A (unknown origin) using fluorescence-labeled FL-Peptide 21 as substrate after 60 mins in presence of ATP by fluorescence assay based Cheng-Prusoff equation analysis	B	Cn1cc(-c2ccncc2)cc(N)c1=O		CHEMBL4282410	=	Ki	nM	99500.0	CHEMBL4722	Homo sapiens	Ki	uM	99.5
	18709013	CHEMBL4256642	Inhibition of full length N-terminal His-tagged Aurora A (unknown origin) using fluorescence-labeled FL-Peptide 21 as substrate after 60 mins in presence of ATP by fluorescence assay based Cheng-Prusoff equation analysis	B	COc1ncc(-c2ccncc2)cc1N		CHEMBL4291350	=	Ki	nM	184700.0	CHEMBL4722	Homo sapiens	Ki	uM	184.7
	18709016	CHEMBL4256646	Inhibition of Aurora A (unknown origin) at 100 uM using peptide as substrate in presence of ATP and MgCl2 by mobility shift assay relative to control	B	COc1ncc(-c2ccncc2)cc1N		CHEMBL4291350	=	Inhibition	%	46.0	CHEMBL4722	Homo sapiens	INH	%	46.0
	18709042	CHEMBL4256642	Inhibition of full length N-terminal His-tagged Aurora A (unknown origin) using fluorescence-labeled FL-Peptide 21 as substrate after 60 mins in presence of ATP by fluorescence assay based Cheng-Prusoff equation analysis	B	Nc1cc(-c2ccnc3ccccc23)c[nH]c1=O		CHEMBL4280308	=	Ki	nM	76300.0	CHEMBL4722	Homo sapiens	Ki	uM	76.3
	18709045	CHEMBL4256646	Inhibition of Aurora A (unknown origin) at 100 uM using peptide as substrate in presence of ATP and MgCl2 by mobility shift assay relative to control	B	Nc1cc(-c2ccnc3ccccc23)c[nH]c1=O		CHEMBL4280308	=	Inhibition	%	62.0	CHEMBL4722	Homo sapiens	INH	%	62.0
	18709071	CHEMBL4256642	Inhibition of full length N-terminal His-tagged Aurora A (unknown origin) using fluorescence-labeled FL-Peptide 21 as substrate after 60 mins in presence of ATP by fluorescence assay based Cheng-Prusoff equation analysis	B	CNc1nccc(-c2c[nH]c(=O)c(N)c2)n1		CHEMBL4292538	=	Ki	nM	21300.0	CHEMBL4722	Homo sapiens	Ki	uM	21.3
	18709074	CHEMBL4256646	Inhibition of Aurora A (unknown origin) at 100 uM using peptide as substrate in presence of ATP and MgCl2 by mobility shift assay relative to control	B	CNc1nccc(-c2c[nH]c(=O)c(N)c2)n1		CHEMBL4292538	=	Inhibition	%	98.0	CHEMBL4722	Homo sapiens	INH	%	98.0
	18709100	CHEMBL4256642	Inhibition of full length N-terminal His-tagged Aurora A (unknown origin) using fluorescence-labeled FL-Peptide 21 as substrate after 60 mins in presence of ATP by fluorescence assay based Cheng-Prusoff equation analysis	B	Nc1cc(-c2ccnc(NC3CC3)n2)c[nH]c1=O		CHEMBL4282263	=	Ki	nM	30200.0	CHEMBL4722	Homo sapiens	Ki	uM	30.2
	18709103	CHEMBL4256646	Inhibition of Aurora A (unknown origin) at 100 uM using peptide as substrate in presence of ATP and MgCl2 by mobility shift assay relative to control	B	Nc1cc(-c2ccnc(NC3CC3)n2)c[nH]c1=O		CHEMBL4282263	=	Inhibition	%	87.0	CHEMBL4722	Homo sapiens	INH	%	87.0
	18709129	CHEMBL4256642	Inhibition of full length N-terminal His-tagged Aurora A (unknown origin) using fluorescence-labeled FL-Peptide 21 as substrate after 60 mins in presence of ATP by fluorescence assay based Cheng-Prusoff equation analysis	B	Nc1cc(-c2ccccc2)cnc1O		CHEMBL1605269	=	Ki	nM	66900.0	CHEMBL4722	Homo sapiens	Ki	uM	66.9
	18709132	CHEMBL4256642	Inhibition of full length N-terminal His-tagged Aurora A (unknown origin) using fluorescence-labeled FL-Peptide 21 as substrate after 60 mins in presence of ATP by fluorescence assay based Cheng-Prusoff equation analysis	B	Nc1cc(-c2cncnc2)c[nH]c1=O		CHEMBL4295011	=	Ki	nM	89600.0	CHEMBL4722	Homo sapiens	Ki	uM	89.6
	18709135	CHEMBL4256642	Inhibition of full length N-terminal His-tagged Aurora A (unknown origin) using fluorescence-labeled FL-Peptide 21 as substrate after 60 mins in presence of ATP by fluorescence assay based Cheng-Prusoff equation analysis	B	Nc1cc(-c2cccnc2)c[nH]c1=O		CHEMBL1201292	=	Ki	nM	125200.0	CHEMBL4722	Homo sapiens	Ki	uM	125.2
	18709138	CHEMBL4256642	Inhibition of full length N-terminal His-tagged Aurora A (unknown origin) using fluorescence-labeled FL-Peptide 21 as substrate after 60 mins in presence of ATP by fluorescence assay based Cheng-Prusoff equation analysis	B	CN(C)Cc1ccc(-c2c[nH]c(=O)c(N)c2)cc1		CHEMBL4280041	>	Ki	nM	100000.0	CHEMBL4722	Homo sapiens	Ki	uM	100.0
	18709141	CHEMBL4256642	Inhibition of full length N-terminal His-tagged Aurora A (unknown origin) using fluorescence-labeled FL-Peptide 21 as substrate after 60 mins in presence of ATP by fluorescence assay based Cheng-Prusoff equation analysis	B	Cc1[nH]c(=O)c(C#N)cc1-c1ccncc1		CHEMBL189	>	Ki	nM	100000.0	CHEMBL4722	Homo sapiens	Ki	uM	100.0
	18709144	CHEMBL4256642	Inhibition of full length N-terminal His-tagged Aurora A (unknown origin) using fluorescence-labeled FL-Peptide 21 as substrate after 60 mins in presence of ATP by fluorescence assay based Cheng-Prusoff equation analysis	B	Cc1[nH]c(=O)c(C(N)=O)cc1-c1ccncc1		CHEMBL4278538	>	Ki	nM	100000.0	CHEMBL4722	Homo sapiens	Ki	uM	100.0
	18709147	CHEMBL4256642	Inhibition of full length N-terminal His-tagged Aurora A (unknown origin) using fluorescence-labeled FL-Peptide 21 as substrate after 60 mins in presence of ATP by fluorescence assay based Cheng-Prusoff equation analysis	B	Cc1nc(O)c(N)cc1-c1ccncc1		CHEMBL302219	>	Ki	nM	100000.0	CHEMBL4722	Homo sapiens	Ki	uM	100.0
	18709150	CHEMBL4256646	Inhibition of Aurora A (unknown origin) at 100 uM using peptide as substrate in presence of ATP and MgCl2 by mobility shift assay relative to control	B	Cc1nc(O)c(N)cc1-c1ccncc1		CHEMBL302219	=	Inhibition	%	49.0	CHEMBL4722	Homo sapiens	INH	%	49.0
	18709176	CHEMBL4256642	Inhibition of full length N-terminal His-tagged Aurora A (unknown origin) using fluorescence-labeled FL-Peptide 21 as substrate after 60 mins in presence of ATP by fluorescence assay based Cheng-Prusoff equation analysis	B	O=C(Nc1cc(-c2ccncc2)c[nH]c1=O)c1ccccc1		CHEMBL1738828	=	Ki	nM	3300.0	CHEMBL4722	Homo sapiens	Ki	uM	3.3
	18709180	CHEMBL4256672	Inhibition of Aurora A (unknown origin) at 30 uM using peptide as substrate in presence of ATP and MgCl2 by mobility shift assay relative to control	B	O=C(Nc1cc(-c2ccncc2)c[nH]c1=O)c1ccccc1		CHEMBL1738828	=	Inhibition	%	59.0	CHEMBL4722	Homo sapiens	INH	%	59.0
	18709206	CHEMBL4256642	Inhibition of full length N-terminal His-tagged Aurora A (unknown origin) using fluorescence-labeled FL-Peptide 21 as substrate after 60 mins in presence of ATP by fluorescence assay based Cheng-Prusoff equation analysis	B	COc1cccc(C(=O)Nc2cc(-c3ccncc3)c[nH]c2=O)c1		CHEMBL4285109	>	Ki	nM	100000.0	CHEMBL4722	Homo sapiens	Ki	uM	100.0
	18709209	CHEMBL4256646	Inhibition of Aurora A (unknown origin) at 100 uM using peptide as substrate in presence of ATP and MgCl2 by mobility shift assay relative to control	B	COc1cccc(C(=O)Nc2cc(-c3ccncc3)c[nH]c2=O)c1		CHEMBL4285109	=	Inhibition	%	89.0	CHEMBL4722	Homo sapiens	INH	%	89.0
	18709235	CHEMBL4256642	Inhibition of full length N-terminal His-tagged Aurora A (unknown origin) using fluorescence-labeled FL-Peptide 21 as substrate after 60 mins in presence of ATP by fluorescence assay based Cheng-Prusoff equation analysis	B	COc1cc(OC)cc(C(=O)Nc2cc(-c3ccncc3)c[nH]c2=O)c1		CHEMBL4292942	>	Ki	nM	100000.0	CHEMBL4722	Homo sapiens	Ki	uM	100.0
	18709238	CHEMBL4256642	Inhibition of full length N-terminal His-tagged Aurora A (unknown origin) using fluorescence-labeled FL-Peptide 21 as substrate after 60 mins in presence of ATP by fluorescence assay based Cheng-Prusoff equation analysis	B	O=C(Nc1cc(-c2ccncc2)c[nH]c1=O)c1cccc(F)c1		CHEMBL4281678	>	Ki	nM	100000.0	CHEMBL4722	Homo sapiens	Ki	uM	100.0
	18709241	CHEMBL4256642	Inhibition of full length N-terminal His-tagged Aurora A (unknown origin) using fluorescence-labeled FL-Peptide 21 as substrate after 60 mins in presence of ATP by fluorescence assay based Cheng-Prusoff equation analysis	B	O=C(Nc1cc(-c2ccncc2)c[nH]c1=O)c1cc(F)cc(F)c1		CHEMBL4279867	>	Ki	nM	100000.0	CHEMBL4722	Homo sapiens	Ki	uM	100.0
	18709244	CHEMBL4256642	Inhibition of full length N-terminal His-tagged Aurora A (unknown origin) using fluorescence-labeled FL-Peptide 21 as substrate after 60 mins in presence of ATP by fluorescence assay based Cheng-Prusoff equation analysis	B	O=c1[nH]cc(-c2ccncc2)cc1NS(=O)(=O)c1ccccc1		CHEMBL4278218	>	Ki	nM	100000.0	CHEMBL4722	Homo sapiens	Ki	uM	100.0
	18709247	CHEMBL4256642	Inhibition of full length N-terminal His-tagged Aurora A (unknown origin) using fluorescence-labeled FL-Peptide 21 as substrate after 60 mins in presence of ATP by fluorescence assay based Cheng-Prusoff equation analysis	B	CN1CCN(c2ccc(C(=O)Nc3cc(-c4ccncc4)c[nH]c3=O)cc2)CC1		CHEMBL4286130	=	Ki	nM	14900.0	CHEMBL4722	Homo sapiens	Ki	uM	14.9
	18709251	CHEMBL4256672	Inhibition of Aurora A (unknown origin) at 30 uM using peptide as substrate in presence of ATP and MgCl2 by mobility shift assay relative to control	B	CN1CCN(c2ccc(C(=O)Nc3cc(-c4ccncc4)c[nH]c3=O)cc2)CC1		CHEMBL4286130	=	Inhibition	%	92.0	CHEMBL4722	Homo sapiens	INH	%	92.0
	18709277	CHEMBL4256642	Inhibition of full length N-terminal His-tagged Aurora A (unknown origin) using fluorescence-labeled FL-Peptide 21 as substrate after 60 mins in presence of ATP by fluorescence assay based Cheng-Prusoff equation analysis	B	O=C(Nc1cc(-c2ccncc2)c[nH]c1=O)c1ccc(N2CCCCC2)cc1		CHEMBL1765097	=	Ki	nM	2600.0	CHEMBL4722	Homo sapiens	Ki	uM	2.6
	18709280	CHEMBL4256642	Inhibition of full length N-terminal His-tagged Aurora A (unknown origin) using fluorescence-labeled FL-Peptide 21 as substrate after 60 mins in presence of ATP by fluorescence assay based Cheng-Prusoff equation analysis	B	O=C(Nc1cc(-c2ccnc(NC3CC3)n2)c[nH]c1=O)c1ccccc1		CHEMBL4291472	=	Ki	nM	17300.0	CHEMBL4722	Homo sapiens	Ki	uM	17.3
	18709284	CHEMBL4256672	Inhibition of Aurora A (unknown origin) at 30 uM using peptide as substrate in presence of ATP and MgCl2 by mobility shift assay relative to control	B	O=C(Nc1cc(-c2ccnc(NC3CC3)n2)c[nH]c1=O)c1ccccc1		CHEMBL4291472	=	Inhibition	%	99.0	CHEMBL4722	Homo sapiens	INH	%	99.0
	18728868	CHEMBL4259698	Inhibition of Aurora A (unknown origin) at 1 uM after 40 mins by scintillation counting method relative to control	B	O=C(N1CCN(c2ncnc3[nH]nc(Cl)c23)CC1)C1(c2ccc(Cl)c(Cl)c2)CCNCC1		CHEMBL4285143	=	Inhibition	%	64.0	CHEMBL4722	Homo sapiens	INH	%	64.0
	18751069	CHEMBL4263736	Inhibition of AURORA-A (unknown origin) at 1 uM relative to control	B	NC1(c2ccc(-c3cnc4c(-c5ccc(S(N)(=O)=O)c6ccccc56)cnn4c3)cc2)CCC1		CHEMBL4278763	=	Inhibition	%	46.0	CHEMBL4722	Homo sapiens	INH	%	46.0
	18751727	CHEMBL4264176	Binding affinity to wild-type human partial length AURKA (E122 to K401 residues) expressed in mammalian expression system assessed as remaining unbound target protein level at 1000 nM by Kinomescan method relative to control	B	COCCN[C@H]1CC[C@H](Nc2cc(-c3csc(NCC4(C#N)CCOCC4)n3)c(Cl)cn2)CC1		CHEMBL4281048	=	Activity	%	100.0	CHEMBL4722	Homo sapiens	Activity	%	100.0
	18753818	CHEMBL4264833	Binding affinity to wild-type human partial length AURKA (E122 to K401 residues) expressed in mammalian expression system assessed as fraction of unbound kinase to substrate at 0.1 uM after 1 hr by KinomeScan assay	B	O=C(Nc1ccc(Oc2c(Br)cnc3[nH]cnc23)c(F)c1)c1cccn(-c2ccc(F)cc2)c1=O		CHEMBL4285809	=	Activity	%	7.0	CHEMBL4722	Homo sapiens	Activity	%	7.0
	18753819	CHEMBL4264833	Binding affinity to wild-type human partial length AURKA (E122 to K401 residues) expressed in mammalian expression system assessed as fraction of unbound kinase to substrate at 0.1 uM after 1 hr by KinomeScan assay	B	O=C(Nc1ccc(Oc2ccnc3[nH]cnc23)c(F)c1)c1cccn(-c2ccc(F)cc2)c1=O		CHEMBL4277499	=	Activity	%	5.0	CHEMBL4722	Homo sapiens	Activity	%	5.0
	18753820	CHEMBL4264833	Binding affinity to wild-type human partial length AURKA (E122 to K401 residues) expressed in mammalian expression system assessed as fraction of unbound kinase to substrate at 0.1 uM after 1 hr by KinomeScan assay	B	CC(C)c1nc2c(Oc3ccc(NC(=O)c4cccn(-c5ccc(F)cc5)c4=O)cc3F)ccnc2[nH]1		CHEMBL4285448	=	Activity	%	1.0	CHEMBL4722	Homo sapiens	Activity	%	1.0
	18753821	CHEMBL4264833	Binding affinity to wild-type human partial length AURKA (E122 to K401 residues) expressed in mammalian expression system assessed as fraction of unbound kinase to substrate at 0.1 uM after 1 hr by KinomeScan assay	B	Cc1cnc2[nH]cnc2c1Oc1ccc(NC(=O)c2cccn(-c3ccc(F)cc3)c2=O)cc1F		CHEMBL4293688	=	Activity	%	1.0	CHEMBL4722	Homo sapiens	Activity	%	1.0
	18753822	CHEMBL4264834	Binding affinity to wild-type human partial length AURKA (E122 to K401 residues) expressed in mammalian expression system assessed as fraction of unbound kinase to substrate at 1 uM after 1 hr by KinomeScan assay	B	O=C(Nc1ccc(Oc2c(Br)cnc3[nH]cnc23)c(F)c1)c1cccn(-c2ccc(F)cc2)c1=O		CHEMBL4285809	=	Activity	%	9.0	CHEMBL4722	Homo sapiens	Activity	%	9.0
	18753823	CHEMBL4264834	Binding affinity to wild-type human partial length AURKA (E122 to K401 residues) expressed in mammalian expression system assessed as fraction of unbound kinase to substrate at 1 uM after 1 hr by KinomeScan assay	B	O=C(Nc1ccc(Oc2ccnc3[nH]cnc23)c(F)c1)c1cccn(-c2ccc(F)cc2)c1=O		CHEMBL4277499	=	Activity	%	2.0	CHEMBL4722	Homo sapiens	Activity	%	2.0
	18753824	CHEMBL4264834	Binding affinity to wild-type human partial length AURKA (E122 to K401 residues) expressed in mammalian expression system assessed as fraction of unbound kinase to substrate at 1 uM after 1 hr by KinomeScan assay	B	CC(C)c1nc2c(Oc3ccc(NC(=O)c4cccn(-c5ccc(F)cc5)c4=O)cc3F)ccnc2[nH]1		CHEMBL4285448	=	Activity	%	2.0	CHEMBL4722	Homo sapiens	Activity	%	2.0
	18753825	CHEMBL4264834	Binding affinity to wild-type human partial length AURKA (E122 to K401 residues) expressed in mammalian expression system assessed as fraction of unbound kinase to substrate at 1 uM after 1 hr by KinomeScan assay	B	Cc1cnc2[nH]cnc2c1Oc1ccc(NC(=O)c2cccn(-c3ccc(F)cc3)c2=O)cc1F		CHEMBL4293688	=	Activity	%	6.0	CHEMBL4722	Homo sapiens	Activity	%	6.0
	18753826	CHEMBL4264835	Binding affinity to wild-type human partial length AURKA (E122 to K401 residues) expressed in mammalian expression system assessed as fraction of unbound kinase to substrate at 10 uM after 1 hr by KinomeScan assay	B	O=C(Nc1ccc(Oc2c(Br)cnc3[nH]cnc23)c(F)c1)c1cccn(-c2ccc(F)cc2)c1=O		CHEMBL4285809	=	Activity	%	45.0	CHEMBL4722	Homo sapiens	Activity	%	45.0
	18753827	CHEMBL4264835	Binding affinity to wild-type human partial length AURKA (E122 to K401 residues) expressed in mammalian expression system assessed as fraction of unbound kinase to substrate at 10 uM after 1 hr by KinomeScan assay	B	O=C(Nc1ccc(Oc2ccnc3[nH]cnc23)c(F)c1)c1cccn(-c2ccc(F)cc2)c1=O		CHEMBL4277499	=	Activity	%	13.0	CHEMBL4722	Homo sapiens	Activity	%	13.0
	18753828	CHEMBL4264835	Binding affinity to wild-type human partial length AURKA (E122 to K401 residues) expressed in mammalian expression system assessed as fraction of unbound kinase to substrate at 10 uM after 1 hr by KinomeScan assay	B	CC(C)c1nc2c(Oc3ccc(NC(=O)c4cccn(-c5ccc(F)cc5)c4=O)cc3F)ccnc2[nH]1		CHEMBL4285448	=	Activity	%	12.0	CHEMBL4722	Homo sapiens	Activity	%	12.0
	18753829	CHEMBL4264835	Binding affinity to wild-type human partial length AURKA (E122 to K401 residues) expressed in mammalian expression system assessed as fraction of unbound kinase to substrate at 10 uM after 1 hr by KinomeScan assay	B	Cc1cnc2[nH]cnc2c1Oc1ccc(NC(=O)c2cccn(-c3ccc(F)cc3)c2=O)cc1F		CHEMBL4293688	=	Activity	%	41.0	CHEMBL4722	Homo sapiens	Activity	%	41.0
	18761178	CHEMBL4266274	Inhibition of Aurora A kinase (unknown origin)	B	Cc1csc(-c2nnc(Nc3ccc(Oc4ncccc4-c4ccnc(N)n4)cc3)c3ccccc23)c1		CHEMBL2140408	=	IC50	nM	5.0	CHEMBL4722	Homo sapiens	IC50	nM	5.0
	18761179	CHEMBL4266273	Competitive inhibition of Aurora A kinase in human cells using varying ATP levels	B	COC(C(=O)N1Cc2[nH]nc(NC(=O)c3ccc(N4CCN(C)CC4)cc3)c2C1)c1ccccc1		CHEMBL1981047	=	IC50	nM	13.0	CHEMBL4722	Homo sapiens	IC50	nM	13.0
	18761180	CHEMBL4266274	Inhibition of Aurora A kinase (unknown origin)	B	O=C1c2[nH]c3cc(-c4ccco4)nn3c(=O)c2CN1Cc1ccccc1		CHEMBL272125	=	IC50	nM	560.0	CHEMBL4722	Homo sapiens	IC50	nM	560.0
	18761181	CHEMBL4266274	Inhibition of Aurora A kinase (unknown origin)	B	O=C(Nc1cccc(Nc2nccc(Nc3cccc(C(F)(F)F)c3)n2)c1)C1CC1		CHEMBL383899	=	IC50	nM	42.0	CHEMBL4722	Homo sapiens	IC50	nM	42.0
	18761182	CHEMBL4266274	Inhibition of Aurora A kinase (unknown origin)	B	COc1cc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2OC)=NC3)ccc1C(=O)O		CHEMBL483158	=	IC50	nM	1.2	CHEMBL4722	Homo sapiens	IC50	nM	1.2
	18761183	CHEMBL4266274	Inhibition of Aurora A kinase (unknown origin)	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	IC50	nM	0.6	CHEMBL4722	Homo sapiens	IC50	nM	0.6
	18761184	CHEMBL4266274	Inhibition of Aurora A kinase (unknown origin)	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	=	IC50	nM	4.0	CHEMBL4722	Homo sapiens	IC50	nM	4.0
	18761185	CHEMBL4266274	Inhibition of Aurora A kinase (unknown origin)	B	CO[C@@H](C(=O)N1Cc2n[nH]c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)c2C1)c1ccccc1		CHEMBL402548	=	IC50	nM	13.0	CHEMBL4722	Homo sapiens	IC50	nM	13.0
	18761186	CHEMBL4266274	Inhibition of Aurora A kinase (unknown origin)	B	O=C(Nc1cccc(Cl)c1)NC1NC=C(CCNc2ncnc3sccc23)S1		CHEMBL4277690	=	IC50	nM	9.0	CHEMBL4722	Homo sapiens	IC50	nM	9.0
	18761187	CHEMBL4266274	Inhibition of Aurora A kinase (unknown origin)	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(/C=C/c3ccccc3)n2)n[nH]1		CHEMBL482968	=	IC50	nM	14.0	CHEMBL4722	Homo sapiens	IC50	nM	14.0
	18761188	CHEMBL4266274	Inhibition of Aurora A kinase (unknown origin)	B	COc1cc2c(Nc3ccc(NC(=O)c4ccccc4)cc3)ncnc2cc1OCCCN1CCOCC1		CHEMBL202721	=	IC50	nM	110.0	CHEMBL4722	Homo sapiens	IC50	nM	110.0
	18761189	CHEMBL4266274	Inhibition of Aurora A kinase (unknown origin)	B	CCN1CCN(C(=O)Cc2ccc(Nc3ncc(F)c(Nc4ccc(C(=O)Nc5ccccc5Cl)cc4)n3)cc2)CC1		CHEMBL502124	=	IC50	nM	3.4	CHEMBL4722	Homo sapiens	IC50	nM	3.4
	18761190	CHEMBL4266275	Inhibition of recombinant aurora 2 (unknown origin) expressed in Sf21 insect cells incubated for 60 mins using [biotin LRRWSLGLRRWSLGLRRWSLGLRRWSLG substrate and [gamma33P]ATP by beta plate counting method	B	COc1cc2c(Nc3ccc(C(=O)Nc4ccccc4)cc3)ncnc2cc1O		CHEMBL4282530	=	IC50	nM	60.0	CHEMBL4722	Homo sapiens	IC50	nM	60.0
	18761202	CHEMBL4266278	Inhibition of NH2-terminal GST-tagged recombinant human Aurora A kinase (118-403 residues) expressed in baculovirus	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	=	IC50	nM	11.0	CHEMBL4722	Homo sapiens	IC50	nM	11.0
	18761243	CHEMBL4266311	Inhibition of recombinant His-tagged human Aurora A kinase expressed in Escherichia coli using Tetra-Kemptide and [gamma-33P]-ATP by liquid scintillation counting method	B	O=C(O)[C@]1(Cc2cccc(Nc3nccs3)n2)CC[C@@H](Oc2cccc(Cl)c2F)CC1		CHEMBL3600873	=	IC50	nM	0.064	CHEMBL4722	Homo sapiens	IC50	nM	0.064
	18761262	CHEMBL4266327	Inhibition of full-length His-tagged recombinant aurora A (unknown origin) expressed in insect cells using biotinylated LRRWSLG substrate by Z'-LYTE assay	B	CC(=O)NCC(=O)N1[C@H]2CC[C@@H]1c1cc(Nc3ncc(C(F)(F)F)c(NC4CCC4)n3)ccc12		CHEMBL4289017	=	IC50	nM	0.8	CHEMBL4722	Homo sapiens	IC50	nM	0.8
	18761264	CHEMBL4266329	Inhibition of aurora A in human MDA-MB-231 cells assessed as reduction in enzyme autophosphorylation incubated for 4 hrs by high-content immunofluorescence imaging	B	CC(=O)NCC(=O)N1[C@H]2CC[C@@H]1c1cc(Nc3ncc(C(F)(F)F)c(NC4CCC4)n3)ccc12		CHEMBL4289017	=	IC50	nM	20.0	CHEMBL4722	Homo sapiens	IC50	nM	20.0
	18761281	CHEMBL4266346	Inhibition of GST-tagged recombinant human Aurora A kinase expressed in High5 cells using LRRWSLGL substrate and [gamma33-ATP] by scintillation proximity assay	B	CCc1cccc(CC)c1NC(=O)N1Cc2[nH]nc(NC(=O)c3ccc(N4CCN(C)CC4)cc3)c2C1		CHEMBL363160	=	IC50	nM	27.0	CHEMBL4722	Homo sapiens	IC50	nM	27.0
	18762881	CHEMBL4266831	Inhibition of recombinant Aurora A (unknown origin) using TAMRA-PKAtide as substrate after 30 mins by fluorescence polarization assay	B	CC(C)c1cc(NS(=O)(=O)c2ccccc2)cc2c(C(N)=O)c(NC(=O)C3CC3)sc12		CHEMBL4292830	=	IC50	nM	827.0	CHEMBL4722	Homo sapiens	IC50	nM	827.0
	18762937	CHEMBL4266831	Inhibition of recombinant Aurora A (unknown origin) using TAMRA-PKAtide as substrate after 30 mins by fluorescence polarization assay	B	CNC(=O)Nc1sc2c(C(C)C)cc(NS(=O)(=O)c3ccccc3)cc2c1C(N)=O		CHEMBL4289877	=	IC50	nM	37.0	CHEMBL4722	Homo sapiens	IC50	nM	37.0
	18762938	CHEMBL4266831	Inhibition of recombinant Aurora A (unknown origin) using TAMRA-PKAtide as substrate after 30 mins by fluorescence polarization assay	B	CNC(=O)Nc1sc2c(C(C)C)cc(NS(=O)(=O)c3cccc(C)c3)cc2c1C(N)=O		CHEMBL4286456	=	IC50	nM	95.0	CHEMBL4722	Homo sapiens	IC50	nM	95.0
	18762939	CHEMBL4266831	Inhibition of recombinant Aurora A (unknown origin) using TAMRA-PKAtide as substrate after 30 mins by fluorescence polarization assay	B	CCS(=O)(=O)Nc1cc(C(C)C)c2sc(NC(=O)NC)c(C(N)=O)c2c1		CHEMBL4284087	=	IC50	nM	24.0	CHEMBL4722	Homo sapiens	IC50	nM	24.0
	18762940	CHEMBL4266831	Inhibition of recombinant Aurora A (unknown origin) using TAMRA-PKAtide as substrate after 30 mins by fluorescence polarization assay	B	CNC(=O)Nc1sc2c(C(C)C)cc(NS(=O)(=O)N(C)C)cc2c1C(N)=O		CHEMBL4290876	=	IC50	nM	9.0	CHEMBL4722	Homo sapiens	IC50	nM	9.0
	18762941	CHEMBL4266831	Inhibition of recombinant Aurora A (unknown origin) using TAMRA-PKAtide as substrate after 30 mins by fluorescence polarization assay	B	CCCNS(=O)(=O)Nc1cc(C(C)C)c2sc(NC(=O)NC)c(C(N)=O)c2c1		CHEMBL4277642	=	IC50	nM	21.0	CHEMBL4722	Homo sapiens	IC50	nM	21.0
	18762942	CHEMBL4266831	Inhibition of recombinant Aurora A (unknown origin) using TAMRA-PKAtide as substrate after 30 mins by fluorescence polarization assay	B	CNC(=O)Nc1sc2c(C(C)C)cc(NS(=O)(=O)c3cccs3)cc2c1C(N)=O		CHEMBL4288081	=	IC50	nM	32.0	CHEMBL4722	Homo sapiens	IC50	nM	32.0
	18762943	CHEMBL4266831	Inhibition of recombinant Aurora A (unknown origin) using TAMRA-PKAtide as substrate after 30 mins by fluorescence polarization assay	B	CNC(=O)Nc1sc2c(C(C)C)cc(NS(=O)(=O)c3cc(C)cs3)cc2c1C(N)=O		CHEMBL4284263	=	IC50	nM	80.0	CHEMBL4722	Homo sapiens	IC50	nM	80.0
	18762944	CHEMBL4266831	Inhibition of recombinant Aurora A (unknown origin) using TAMRA-PKAtide as substrate after 30 mins by fluorescence polarization assay	B	CNC(=O)Nc1sc2c(C(C)C)cc(NS(=O)(=O)c3ccn(C)n3)cc2c1C(N)=O		CHEMBL4279747	=	IC50	nM	5.0	CHEMBL4722	Homo sapiens	IC50	nM	5.0
	18762945	CHEMBL4266831	Inhibition of recombinant Aurora A (unknown origin) using TAMRA-PKAtide as substrate after 30 mins by fluorescence polarization assay	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	IC50	nM	127.0	CHEMBL4722	Homo sapiens	IC50	nM	127.0
Active	18762993	CHEMBL4266838	Inhibition of Aurora A phosphorylation at Thr288 residue in human HCT116 cells up to 1 uM after 3 hrs by Western blot analysis	B	CNC(=O)Nc1sc2c(C(C)C)cc(NS(=O)(=O)c3cccs3)cc2c1C(N)=O		CHEMBL4288081		Inhibition	%		CHEMBL4722	Homo sapiens	INH		
Active	18762994	CHEMBL4266838	Inhibition of Aurora A phosphorylation at Thr288 residue in human HCT116 cells up to 1 uM after 3 hrs by Western blot analysis	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878		Inhibition	%		CHEMBL4722	Homo sapiens	INH		
Active	18762997	CHEMBL4266840	Inhibition of Aurora A phosphorylation at Thr288 residue in human HCT116 cells over 100 nM after 3 hrs by Western blot analysis	B	CNC(=O)Nc1sc2c(C(C)C)cc(NS(=O)(=O)N(C)C)cc2c1C(N)=O		CHEMBL4290876		Inhibition	%		CHEMBL4722	Homo sapiens	INH		
Active	18762998	CHEMBL4266840	Inhibition of Aurora A phosphorylation at Thr288 residue in human HCT116 cells over 100 nM after 3 hrs by Western blot analysis	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084		Inhibition	%		CHEMBL4722	Homo sapiens	INH		
	18764527	CHEMBL4267078	Inhibition of human Aurora A at 100 nM	B	CN1CCC(c2nc(-c3ccc(F)cc3)c(-c3ccnc(Nc4ccc(N5CCNCC5)cc4)n3)s2)CC1		CHEMBL4288103	<	Inhibition	%	70.0	CHEMBL4722	Homo sapiens	INH	%	70.0
	18764528	CHEMBL4267078	Inhibition of human Aurora A at 100 nM	B	CN1CCC(c2nc(-c3cccc(S(C)(=O)=O)c3)c(-c3ccnc(Nc4ccc(N5CCNCC5)cc4)n3)s2)CC1		CHEMBL4286880	<	Inhibition	%	70.0	CHEMBL4722	Homo sapiens	INH	%	70.0
	18764529	CHEMBL4267078	Inhibition of human Aurora A at 100 nM	B	CN1CCC(c2nc(-c3ccc(F)c(NS(C)(=O)=O)c3)c(-c3ccnc(NCC4CC4)n3)s2)CC1		CHEMBL4286841	<	Inhibition	%	70.0	CHEMBL4722	Homo sapiens	INH	%	70.0
	18765645	CHEMBL4267286	Inhibition of human N-terminal GST-tagged AURA (1 to 403 residues) expressed in baculovirus expression system at 1 uM using FAM-labeled peptide as substrate after 10 mins by mobility shift assay relative to control	B	COc1cccc(Nc2cc(Nc3cc(OC)ccc3OC)ncn2)c1		CHEMBL4288300	=	Inhibition	%	52.3	CHEMBL4722	Homo sapiens	INH	%	52.3
	18765646	CHEMBL4267286	Inhibition of human N-terminal GST-tagged AURA (1 to 403 residues) expressed in baculovirus expression system at 1 uM using FAM-labeled peptide as substrate after 10 mins by mobility shift assay relative to control	B	COc1ccc(Nc2cc(NC(=O)c3ccccc3)ncn2)cc1		CHEMBL4283823	=	Inhibition	%	2.6	CHEMBL4722	Homo sapiens	INH	%	2.6
	18765647	CHEMBL4267286	Inhibition of human N-terminal GST-tagged AURA (1 to 403 residues) expressed in baculovirus expression system at 1 uM using FAM-labeled peptide as substrate after 10 mins by mobility shift assay relative to control	B	O=C(O)CCCC(=O)Nc1cc(Nc2cccc(Cl)c2)ncn1		CHEMBL4282460	=	Inhibition	%	8.7	CHEMBL4722	Homo sapiens	INH	%	8.7
	18765648	CHEMBL4267286	Inhibition of human N-terminal GST-tagged AURA (1 to 403 residues) expressed in baculovirus expression system at 1 uM using FAM-labeled peptide as substrate after 10 mins by mobility shift assay relative to control	B	CCOC(=O)c1ccc(Nc2cc(NC(=O)CCCC(=O)O)ncn2)cc1		CHEMBL4290750	=	Inhibition	%	17.3	CHEMBL4722	Homo sapiens	INH	%	17.3
	18765649	CHEMBL4267286	Inhibition of human N-terminal GST-tagged AURA (1 to 403 residues) expressed in baculovirus expression system at 1 uM using FAM-labeled peptide as substrate after 10 mins by mobility shift assay relative to control	B	COc1cccc(Nc2cc(NC(=O)CCCC(=O)O)ncn2)c1		CHEMBL4294156	=	Inhibition	%	19.8	CHEMBL4722	Homo sapiens	INH	%	19.8
	18765650	CHEMBL4267286	Inhibition of human N-terminal GST-tagged AURA (1 to 403 residues) expressed in baculovirus expression system at 1 uM using FAM-labeled peptide as substrate after 10 mins by mobility shift assay relative to control	B	O=C(O)CCCC(=O)Nc1cc(N2CCOCC2)ncn1		CHEMBL4283970	=	Inhibition	%	49.0	CHEMBL4722	Homo sapiens	INH	%	49.0
	18769846	CHEMBL4268022	Inhibition of Aurora A (unknown origin) using STK S2 as substrate after 40 mins by HTRF assay	B	CSc1ncc2c(n1)Nc1n[nH]c(C)c1N=C2c1ccc(Cl)cc1		CHEMBL4290345	=	IC50	nM	182.8	CHEMBL4722	Homo sapiens	IC50	nM	182.8
	18769847	CHEMBL4268022	Inhibition of Aurora A (unknown origin) using STK S2 as substrate after 40 mins by HTRF assay	B	CSc1ncc2c(n1)Nc1n[nH]c(C)c1N=C2c1cccc(Cl)c1		CHEMBL4290758	=	IC50	nM	101.6	CHEMBL4722	Homo sapiens	IC50	nM	101.6
	18769848	CHEMBL4268022	Inhibition of Aurora A (unknown origin) using STK S2 as substrate after 40 mins by HTRF assay	B	CSc1ncc2c(n1)Nc1n[nH]c(C)c1N=C2c1ccccc1Cl		CHEMBL4280119	=	IC50	nM	94.0	CHEMBL4722	Homo sapiens	IC50	nM	94.0
	18769849	CHEMBL4268022	Inhibition of Aurora A (unknown origin) using STK S2 as substrate after 40 mins by HTRF assay	B	CSc1ncc2c(n1)Nc1n[nH]c(C)c1N=C2c1ccccc1		CHEMBL4294161	=	IC50	nM	192.9	CHEMBL4722	Homo sapiens	IC50	nM	192.9
	18769862	CHEMBL4268022	Inhibition of Aurora A (unknown origin) using STK S2 as substrate after 40 mins by HTRF assay	B	Cc1ccc(C2=Nc3c(n[nH]c3C)Nc3nc(N4CCOCC4)ncc32)cc1		CHEMBL4282231	=	IC50	nM	46.2	CHEMBL4722	Homo sapiens	IC50	nM	46.2
	18769863	CHEMBL4268022	Inhibition of Aurora A (unknown origin) using STK S2 as substrate after 40 mins by HTRF assay	B	Cc1ccc(C2=Nc3c(n[nH]c3C)Nc3nc(N4CCN(C)CC4)ncc32)cc1		CHEMBL4289433	=	IC50	nM	108.2	CHEMBL4722	Homo sapiens	IC50	nM	108.2
	18769864	CHEMBL4268022	Inhibition of Aurora A (unknown origin) using STK S2 as substrate after 40 mins by HTRF assay	B	CCN(CC)c1ncc2c(n1)Nc1n[nH]c(C)c1N=C2c1ccc(C)cc1		CHEMBL4278759	=	IC50	nM	268.5	CHEMBL4722	Homo sapiens	IC50	nM	268.5
	18769865	CHEMBL4268022	Inhibition of Aurora A (unknown origin) using STK S2 as substrate after 40 mins by HTRF assay	B	Cc1ccc(C2=Nc3c(n[nH]c3C)Nc3nc(NC(C)(C)C)ncc32)cc1		CHEMBL4286011	=	IC50	nM	356.5	CHEMBL4722	Homo sapiens	IC50	nM	356.5
	18769866	CHEMBL4268022	Inhibition of Aurora A (unknown origin) using STK S2 as substrate after 40 mins by HTRF assay	B	Cc1ccc(C2=Nc3c(n[nH]c3C)Nc3nc(NC(C)C)ncc32)cc1		CHEMBL4293912	=	IC50	nM	63.1	CHEMBL4722	Homo sapiens	IC50	nM	63.1
	18769867	CHEMBL4268022	Inhibition of Aurora A (unknown origin) using STK S2 as substrate after 40 mins by HTRF assay	B	Cc1ccc(C2=Nc3c(n[nH]c3C)Nc3nc(N4CCCCC4)ncc32)cc1		CHEMBL4280932	=	IC50	nM	77.6	CHEMBL4722	Homo sapiens	IC50	nM	77.6
	18769868	CHEMBL4268022	Inhibition of Aurora A (unknown origin) using STK S2 as substrate after 40 mins by HTRF assay	B	CNc1ncc2c(n1)Nc1n[nH]c(C)c1N=C2c1ccc(C)cc1		CHEMBL4291572	=	IC50	nM	396.9	CHEMBL4722	Homo sapiens	IC50	nM	396.9
	18769869	CHEMBL4268022	Inhibition of Aurora A (unknown origin) using STK S2 as substrate after 40 mins by HTRF assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	3.67	CHEMBL4722	Homo sapiens	IC50	nM	3.67
	18769870	CHEMBL4268022	Inhibition of Aurora A (unknown origin) using STK S2 as substrate after 40 mins by HTRF assay	B	CSc1ncc2c(n1)Nc1n[nH]c(C)c1N=C2c1ccc(C(F)(F)F)cc1		CHEMBL4282864	=	IC50	nM	422.9	CHEMBL4722	Homo sapiens	IC50	nM	422.9
	18769871	CHEMBL4268022	Inhibition of Aurora A (unknown origin) using STK S2 as substrate after 40 mins by HTRF assay	B	CSc1ncc2c(n1)Nc1n[nH]c(C)c1N=C2c1ccccc1C(F)(F)F		CHEMBL4293467	=	IC50	nM	128.0	CHEMBL4722	Homo sapiens	IC50	nM	128.0
	18769872	CHEMBL4268022	Inhibition of Aurora A (unknown origin) using STK S2 as substrate after 40 mins by HTRF assay	B	COc1ccc(C2=Nc3c(n[nH]c3C)Nc3nc(SC)ncc32)cc1		CHEMBL4291146	=	IC50	nM	93.0	CHEMBL4722	Homo sapiens	IC50	nM	93.0
	18769873	CHEMBL4268022	Inhibition of Aurora A (unknown origin) using STK S2 as substrate after 40 mins by HTRF assay	B	COc1ccccc1C1=Nc2c(n[nH]c2C)Nc2nc(SC)ncc21		CHEMBL4283293	=	IC50	nM	191.0	CHEMBL4722	Homo sapiens	IC50	nM	191.0
	18769874	CHEMBL4268022	Inhibition of Aurora A (unknown origin) using STK S2 as substrate after 40 mins by HTRF assay	B	CSc1ncc2c(n1)Nc1n[nH]c(C)c1N=C2c1ccc(C)cc1		CHEMBL4294551	=	IC50	nM	70.6	CHEMBL4722	Homo sapiens	IC50	nM	70.6
	18769875	CHEMBL4268022	Inhibition of Aurora A (unknown origin) using STK S2 as substrate after 40 mins by HTRF assay	B	CSc1ncc2c(n1)Nc1n[nH]c(C)c1N=C2c1ccccc1C		CHEMBL4286642	=	IC50	nM	75.0	CHEMBL4722	Homo sapiens	IC50	nM	75.0
	18769876	CHEMBL4268022	Inhibition of Aurora A (unknown origin) using STK S2 as substrate after 40 mins by HTRF assay	B	CSc1ncc2c(n1)Nc1n[nH]c(C)c1N=C2c1cccc(F)c1		CHEMBL4282473	=	IC50	nM	167.0	CHEMBL4722	Homo sapiens	IC50	nM	167.0
	18769956	CHEMBL4268070	Inhibition of recombinant human full length His-tagged Aurora A expressed in baculovirus expression system using peptide substrate after 1 hr by Z'-Lyte assay	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(/C=C/c3ccccc3)n2)n[nH]1		CHEMBL482968	=	IC50	nM	14.0	CHEMBL4722	Homo sapiens	IC50	nM	14.0
	18772827	CHEMBL4268691	Inhibition of Aurora-A (unknown origin)	B	COc1cccc(OCc2cc(C)ccn2)c1-c1ccc2c(c1)CCNCC2		CHEMBL4291402	<	IC50	nM	50118.72	CHEMBL4722	Homo sapiens	pIC50		4.3
Active	18780178	CHEMBL4269922	Binding affinity to human AURKA at 1 uM after 1 hr by KINOMEscan assay	B	CO/C=C/C(=O)c1cc2c3c(c(N)cc(NC(=O)C(C)C)c3n1)N=C2		CHEMBL4293970		Activity			CHEMBL4722	Homo sapiens	Activity		
	18786936	CHEMBL4271850	Inhibition of AurA (unknown origin) at 30 uM relative to control	B	O=c1cc(-c2ccc(-c3ccccc3)cc2)c2ccc(N3CCC(NCCc4ccccc4)CC3)cc2o1		CHEMBL4276817	=	Inhibition	%	6.03	CHEMBL4722	Homo sapiens	INH	%	6.03
	18810308	CHEMBL4275815	Inhibition of Aurora A (unknown origin) using FAM-labelled peptide as substrate pretreated for 10 mins followed by substrate addition and measured after 60 mins by fluorescence assay	B	CN1CCN(c2ccc3c(Nc4cc[nH]n4)nc(-c4ccccc4)nc3c2)CC1		CHEMBL4286550	=	IC50	nM	5951.0	CHEMBL4722	Homo sapiens	IC50	uM	5.951
	18810309	CHEMBL4275815	Inhibition of Aurora A (unknown origin) using FAM-labelled peptide as substrate pretreated for 10 mins followed by substrate addition and measured after 60 mins by fluorescence assay	B	COc1cccc(OC)c1C(=O)c1nc(Nc2cc(C)[nH]n2)c2ccc(N3CCC(C(=O)OC(C)(C)C)CC3)cc2n1		CHEMBL4276766	=	IC50	nM	217.0	CHEMBL4722	Homo sapiens	IC50	uM	0.217
	18810310	CHEMBL4275815	Inhibition of Aurora A (unknown origin) using FAM-labelled peptide as substrate pretreated for 10 mins followed by substrate addition and measured after 60 mins by fluorescence assay	B	Cc1cc(Nc2nc(-c3ccccc3)nc3cc(N4CCC(C(=O)O)CC4)ccc23)n[nH]1		CHEMBL4287422	=	IC50	nM	6.0	CHEMBL4722	Homo sapiens	IC50	uM	0.006
	18810311	CHEMBL4275815	Inhibition of Aurora A (unknown origin) using FAM-labelled peptide as substrate pretreated for 10 mins followed by substrate addition and measured after 60 mins by fluorescence assay	B	CCOC(=O)C1CCN(c2ccc3c(Nc4cc(C)[nH]n4)nc(-c4ccccc4)nc3c2)CC1		CHEMBL4282148	=	IC50	nM	38.0	CHEMBL4722	Homo sapiens	IC50	uM	0.038
	18810312	CHEMBL4275815	Inhibition of Aurora A (unknown origin) using FAM-labelled peptide as substrate pretreated for 10 mins followed by substrate addition and measured after 60 mins by fluorescence assay	B	Cc1cc(Nc2nc(-c3ccccc3)nc3cc(N4CCN(C)CC4)ccc23)n[nH]1		CHEMBL4292755	=	IC50	nM	10.0	CHEMBL4722	Homo sapiens	IC50	uM	0.01
	18810313	CHEMBL4275815	Inhibition of Aurora A (unknown origin) using FAM-labelled peptide as substrate pretreated for 10 mins followed by substrate addition and measured after 60 mins by fluorescence assay	B	COc1ccc2c(Nc3cc(C)[nH]n3)nc(-c3ccccc3)nc2c1		CHEMBL4278681	=	IC50	nM	34.0	CHEMBL4722	Homo sapiens	IC50	uM	0.034
	18810314	CHEMBL4275815	Inhibition of Aurora A (unknown origin) using FAM-labelled peptide as substrate pretreated for 10 mins followed by substrate addition and measured after 60 mins by fluorescence assay	B	Cc1cc(Nc2nc(-c3ccccc3)nc3cc([N+](=O)[O-])ccc23)n[nH]1		CHEMBL4289343	=	IC50	nM	325.0	CHEMBL4722	Homo sapiens	IC50	uM	0.325
	18810315	CHEMBL4275815	Inhibition of Aurora A (unknown origin) using FAM-labelled peptide as substrate pretreated for 10 mins followed by substrate addition and measured after 60 mins by fluorescence assay	B	Cc1cc(Nc2nc(-c3ccccc3)nc3cc(F)ccc23)n[nH]1		CHEMBL4293828	=	IC50	nM	72.0	CHEMBL4722	Homo sapiens	IC50	uM	0.072
	18810316	CHEMBL4275815	Inhibition of Aurora A (unknown origin) using FAM-labelled peptide as substrate pretreated for 10 mins followed by substrate addition and measured after 60 mins by fluorescence assay	B	Cc1ccc(C(=O)c2nc(Nc3cc(C)[nH]n3)c3ccc(Cl)cc3n2)cc1		CHEMBL4285937	=	IC50	nM	1300.0	CHEMBL4722	Homo sapiens	IC50	uM	1.3
	18810317	CHEMBL4275815	Inhibition of Aurora A (unknown origin) using FAM-labelled peptide as substrate pretreated for 10 mins followed by substrate addition and measured after 60 mins by fluorescence assay	B	COc1ccc(C(=O)c2nc(Nc3cc(C)[nH]n3)c3ccc(Cl)cc3n2)cc1		CHEMBL4290414	=	IC50	nM	744.0	CHEMBL4722	Homo sapiens	IC50	uM	0.744
	18810318	CHEMBL4275815	Inhibition of Aurora A (unknown origin) using FAM-labelled peptide as substrate pretreated for 10 mins followed by substrate addition and measured after 60 mins by fluorescence assay	B	Cc1cc(Nc2nc(-c3ccccc3)nc3cc(Cl)ccc23)n[nH]1		CHEMBL4282545	=	IC50	nM	132.0	CHEMBL4722	Homo sapiens	IC50	uM	0.132
	18810319	CHEMBL4275815	Inhibition of Aurora A (unknown origin) using FAM-labelled peptide as substrate pretreated for 10 mins followed by substrate addition and measured after 60 mins by fluorescence assay	B	Cc1cc(Nc2nc(-c3ccccc3)nc3c([N+](=O)[O-])cccc23)n[nH]1		CHEMBL4282268	=	IC50	nM	174.0	CHEMBL4722	Homo sapiens	IC50	uM	0.174
	18810320	CHEMBL4275815	Inhibition of Aurora A (unknown origin) using FAM-labelled peptide as substrate pretreated for 10 mins followed by substrate addition and measured after 60 mins by fluorescence assay	B	COc1cccc2c(Nc3cc(C)[nH]n3)nc(Cc3ccccc3)nc12		CHEMBL4290132	=	IC50	nM	41.0	CHEMBL4722	Homo sapiens	IC50	uM	0.041
	18810321	CHEMBL4275815	Inhibition of Aurora A (unknown origin) using FAM-labelled peptide as substrate pretreated for 10 mins followed by substrate addition and measured after 60 mins by fluorescence assay	B	COc1cccc2c(Nc3cc(C)[nH]n3)nc(-c3ccccc3)nc12		CHEMBL4292474	=	IC50	nM	25.0	CHEMBL4722	Homo sapiens	IC50	uM	0.025
	18810322	CHEMBL4275815	Inhibition of Aurora A (unknown origin) using FAM-labelled peptide as substrate pretreated for 10 mins followed by substrate addition and measured after 60 mins by fluorescence assay	B	Cc1cc(Nc2nc(C(=O)c3ccccc3)nc3ccccc23)n[nH]1		CHEMBL4281846	=	IC50	nM	188.0	CHEMBL4722	Homo sapiens	IC50	uM	0.188
	18810323	CHEMBL4275815	Inhibition of Aurora A (unknown origin) using FAM-labelled peptide as substrate pretreated for 10 mins followed by substrate addition and measured after 60 mins by fluorescence assay	B	Cc1cc(Nc2nc(C(C)C)nc3ccccc23)n[nH]1		CHEMBL4289062	=	IC50	nM	103.0	CHEMBL4722	Homo sapiens	IC50	uM	0.103
	18810324	CHEMBL4275815	Inhibition of Aurora A (unknown origin) using FAM-labelled peptide as substrate pretreated for 10 mins followed by substrate addition and measured after 60 mins by fluorescence assay	B	Cc1cc(Nc2nc(-c3ccc4ccccc4c3)nc3ccccc23)n[nH]1		CHEMBL4278387	=	IC50	nM	128.0	CHEMBL4722	Homo sapiens	IC50	uM	0.128
	18810325	CHEMBL4275815	Inhibition of Aurora A (unknown origin) using FAM-labelled peptide as substrate pretreated for 10 mins followed by substrate addition and measured after 60 mins by fluorescence assay	B	Cc1cc(Nc2nc(Cc3ccccc3)nc3ccccc23)n[nH]1		CHEMBL4280722	=	IC50	nM	69.0	CHEMBL4722	Homo sapiens	IC50	uM	0.069
	18810326	CHEMBL4275815	Inhibition of Aurora A (unknown origin) using FAM-labelled peptide as substrate pretreated for 10 mins followed by substrate addition and measured after 60 mins by fluorescence assay	B	Cc1cc(Nc2nc(-c3ccccc3)nc3ccccc23)n[nH]1		CHEMBL359482	=	IC50	nM	28.0	CHEMBL4722	Homo sapiens	IC50	uM	0.028
Active	18810460	CHEMBL4275825	Inhibition of Aurora A phosphorylation at Thr288 residue in human 293T cells at 1 to 2 uM after 24 hrs by western blot analysis	B	CCOC(=O)C1CCN(c2ccc3c(Nc4cc(C)[nH]n4)nc(-c4ccccc4)nc3c2)CC1		CHEMBL4282148		Inhibition	%		CHEMBL4722	Homo sapiens	INH		
Active	18810462	CHEMBL4275827	Inhibition of Aurora A phosphorylation at Thr288 residue in human 293T cells at 1 uM after 24 hrs by western blot analysis	B	CCOC(=O)C1CCN(c2ccc3c(Nc4cc(C)[nH]n4)nc(-c4ccccc4)nc3c2)CC1		CHEMBL4282148		Inhibition	%		CHEMBL4722	Homo sapiens	INH		
Not Active	18847343	CHEMBL4304877	Inhibition of wild-type human partial length AURKA (E122 to K401 residues) expressed in mammalian expression system at 1 uM by Kinomescan method	B	O=C(Nc1ccc2[nH]nc(-c3ccc4[nH]ccc4c3)c2c1)c1c(Cl)cccc1Cl		CHEMBL4517719		Inhibition	%		CHEMBL4722	Homo sapiens	INH		
	18851333	CHEMBL4305825	Inhibition of AURA (unknown origin)	B	Cc1nc2c(F)cc(-c3nc(Nc4ccc5c(n4)CCN(CCN(C)C)C5)ncc3F)cc2n1C(C)C		CHEMBL4448494	>	IC50	nM	30000.0	CHEMBL4722	Homo sapiens	IC50	nM	30000.0
	18857847	CHEMBL4307693	Binding affinity to wild-type human partial length AURKA (E122 to K401 residues) expressed in mammalian expression system assessed as residual binding level at 10 uM by Kinomescan method relative to control	B	CC(C)N1C(=O)C(NCCCN(C)C)=C(c2cn(C)c3ccccc23)C1=O.Cl		CHEMBL4533018	=	Activity	%	90.0	CHEMBL4722	Homo sapiens	Activity	%	90.0
	18864255	CHEMBL4309578	Inhibition of human Aurora A at 10 uM using H-LRRASLG as substrate after 40 mins in presence of [gamma33P]ATP by scintillation counting method relative to control	B	COc1cc(Cl)cc(-c2nn(-c3cccc(NC(=O)Nc4cc(C(F)(F)F)cc(C(F)(F)F)c4)c3)cc2-c2ccncc2)c1	Outside typical range	CHEMBL4436746	=	Inhibition	%	-15.1	CHEMBL4722	Homo sapiens	INH	%	-15.1
	18871002	CHEMBL4309981	Inhibition of GST-tagged AURORA A (unknown origin) expressed in baculovirus infected Sf9 cells using MBP as substrate	B	O=C1N=C(NCc2cccs2)S/C1=C\c1ccc2ncccc2c1		CHEMBL393929	=	IC50	nM	1300.0	CHEMBL4722	Homo sapiens	IC50	uM	1.3
	18871003	CHEMBL4309981	Inhibition of GST-tagged AURORA A (unknown origin) expressed in baculovirus infected Sf9 cells using MBP as substrate	B	O=C1Nc2ccccc2/C1=C\c1c(Cl)[nH]c2ccccc12		CHEMBL261425	>	IC50	nM	20000.0	CHEMBL4722	Homo sapiens	IC50	uM	20.0
	18871004	CHEMBL4309981	Inhibition of GST-tagged AURORA A (unknown origin) expressed in baculovirus infected Sf9 cells using MBP as substrate	B	CCN(CC)C(=O)c1ccc(Nc2nc(OCC3CCCCC3)c3nc[nH]c3n2)cc1		CHEMBL1802728	=	IC50	nM	67.0	CHEMBL4722	Homo sapiens	IC50	uM	0.067
	18871005	CHEMBL4309981	Inhibition of GST-tagged AURORA A (unknown origin) expressed in baculovirus infected Sf9 cells using MBP as substrate	B	NS(=O)(=O)c1ccc(Nc2ncn(C(=O)c3c(F)cccc3F)n2)cc1		CHEMBL4474459	=	IC50	nM	18.0	CHEMBL4722	Homo sapiens	IC50	uM	0.018
	18871006	CHEMBL4309981	Inhibition of GST-tagged AURORA A (unknown origin) expressed in baculovirus infected Sf9 cells using MBP as substrate	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	IC50	nM	23.0	CHEMBL4722	Homo sapiens	IC50	uM	0.023
	18878160	CHEMBL4311508	Inhibition of Aurora A (unknown origin) using kemptide acetate salt as substrate after 30 mins by kinase-Glo luminescence method	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	IC50	nM	0.95	CHEMBL4722	Homo sapiens	IC50	nM	0.95
	18878161	CHEMBL4311508	Inhibition of Aurora A (unknown origin) using kemptide acetate salt as substrate after 30 mins by kinase-Glo luminescence method	B	CC1(C)CC(NC(=O)c2ccc(Nc3ncc(F)c(Nc4ccccc4Cl)n3)cc2)CC(C)(C)N1[O]		CHEMBL4451940	=	IC50	nM	0.18	CHEMBL4722	Homo sapiens	IC50	nM	0.18
	18878162	CHEMBL4311508	Inhibition of Aurora A (unknown origin) using kemptide acetate salt as substrate after 30 mins by kinase-Glo luminescence method	B	CC1(C)CC(NC(=O)c2ccc(Nc3ncc(Cl)c(Nc4ccccc4Cl)n3)cc2)CC(C)(C)N1[O]		CHEMBL4455202	=	IC50	nM	0.19	CHEMBL4722	Homo sapiens	IC50	nM	0.19
	18878163	CHEMBL4311508	Inhibition of Aurora A (unknown origin) using kemptide acetate salt as substrate after 30 mins by kinase-Glo luminescence method	B	CC1(C)CC(NC(=O)c2ccc(Nc3ncc(Br)c(Nc4ccccc4Cl)n3)cc2)CC(C)(C)N1[O]		CHEMBL4471448	=	IC50	nM	0.46	CHEMBL4722	Homo sapiens	IC50	nM	0.46
	18878164	CHEMBL4311508	Inhibition of Aurora A (unknown origin) using kemptide acetate salt as substrate after 30 mins by kinase-Glo luminescence method	B	CC1(C)CC(NC(=O)c2ccc(Nc3ncc([N+](=O)[O-])c(Nc4ccccc4Cl)n3)cc2)CC(C)(C)N1[O]		CHEMBL4520619	=	IC50	nM	1.86	CHEMBL4722	Homo sapiens	IC50	nM	1.86
	18878165	CHEMBL4311508	Inhibition of Aurora A (unknown origin) using kemptide acetate salt as substrate after 30 mins by kinase-Glo luminescence method	B	CC1(C)CC(NC(=O)c2ccc(Nc3ncc([N+](=O)[O-])c(Nc4cccc(Cl)c4)n3)cc2)CC(C)(C)N1[O]		CHEMBL4457980	=	IC50	nM	0.62	CHEMBL4722	Homo sapiens	IC50	nM	0.62
	18878166	CHEMBL4311508	Inhibition of Aurora A (unknown origin) using kemptide acetate salt as substrate after 30 mins by kinase-Glo luminescence method	B	CC1(C)CC(NC(=O)c2ccc(Nc3ncc([N+](=O)[O-])c(Nc4ccc(Cl)cc4)n3)cc2)CC(C)(C)N1[O]		CHEMBL4443125	=	IC50	nM	1.61	CHEMBL4722	Homo sapiens	IC50	nM	1.61
	18878167	CHEMBL4311508	Inhibition of Aurora A (unknown origin) using kemptide acetate salt as substrate after 30 mins by kinase-Glo luminescence method	B	CC1(C)CC(NC(=O)c2ccc(Nc3ncc([N+](=O)[O-])c(Nc4ccccc4O)n3)cc2)CC(C)(C)N1[O]		CHEMBL4525614	=	IC50	nM	8.5	CHEMBL4722	Homo sapiens	IC50	nM	8.5
	18878168	CHEMBL4311508	Inhibition of Aurora A (unknown origin) using kemptide acetate salt as substrate after 30 mins by kinase-Glo luminescence method	B	CC1(C)CC(NC(=O)c2ccc(Nc3ncc([N+](=O)[O-])c(Nc4cccc(O)c4)n3)cc2)CC(C)(C)N1[O]		CHEMBL4440617	=	IC50	nM	0.14	CHEMBL4722	Homo sapiens	IC50	nM	0.14
	18878169	CHEMBL4311508	Inhibition of Aurora A (unknown origin) using kemptide acetate salt as substrate after 30 mins by kinase-Glo luminescence method	B	CC1(C)CC(NC(=O)c2ccc(Nc3ncc([N+](=O)[O-])c(Nc4ccc(O)cc4)n3)cc2)CC(C)(C)N1[O]		CHEMBL4447241	=	IC50	nM	0.59	CHEMBL4722	Homo sapiens	IC50	nM	0.59
	18878170	CHEMBL4311508	Inhibition of Aurora A (unknown origin) using kemptide acetate salt as substrate after 30 mins by kinase-Glo luminescence method	B	CC1(C)CC(NC(=O)c2ccc(Nc3ncc(F)c(Nc4ccc(C(=O)Nc5ccccc5Cl)cc4)n3)cc2)CC(C)(C)N1[O]		CHEMBL4563026	=	IC50	nM	0.06	CHEMBL4722	Homo sapiens	IC50	nM	0.06
	18878171	CHEMBL4311508	Inhibition of Aurora A (unknown origin) using kemptide acetate salt as substrate after 30 mins by kinase-Glo luminescence method	B	CC1(C)CC(NC(=O)c2ccc(Nc3ncc([N+](=O)[O-])c(Nc4ccc(C(=O)Nc5ccccc5Cl)cc4)n3)cc2)CC(C)(C)N1[O]		CHEMBL4442043	=	IC50	nM	5.48	CHEMBL4722	Homo sapiens	IC50	nM	5.48
	18878172	CHEMBL4311508	Inhibition of Aurora A (unknown origin) using kemptide acetate salt as substrate after 30 mins by kinase-Glo luminescence method	B	CC1(C)CC(NC(=O)c2ccc(Nc3ncc([N+](=O)[O-])c(Nc4ccc(C(=O)Nc5cccc(Cl)c5)cc4)n3)cc2)CC(C)(C)N1[O]		CHEMBL4460717	=	IC50	nM	0.11	CHEMBL4722	Homo sapiens	IC50	nM	0.11
	18878173	CHEMBL4311508	Inhibition of Aurora A (unknown origin) using kemptide acetate salt as substrate after 30 mins by kinase-Glo luminescence method	B	CC1(C)CC(NC(=O)c2ccc(Nc3ncc([N+](=O)[O-])c(Nc4ccc(C(=O)Nc5ccc(Cl)cc5)cc4)n3)cc2)CC(C)(C)N1[O]		CHEMBL4516770	=	IC50	nM	20.0	CHEMBL4722	Homo sapiens	IC50	nM	20.0
	18878174	CHEMBL4311508	Inhibition of Aurora A (unknown origin) using kemptide acetate salt as substrate after 30 mins by kinase-Glo luminescence method	B	CN1CCC(NC(=O)c2ccc(Nc3ncc(F)c(Nc4ccc(C(=O)Nc5ccccc5Cl)cc4)n3)cc2)CC1		CHEMBL4528809	=	IC50	nM	2.28	CHEMBL4722	Homo sapiens	IC50	nM	2.28
Dose-dependent effect	18878190	CHEMBL4311510	Inhibition of Aurora A phosphorylation at Thr288 residue in human HeLa cells after 12 hrs by Western blot analysis	B	CC1(C)CC(NC(=O)c2ccc(Nc3ncc(F)c(Nc4ccc(C(=O)Nc5ccccc5Cl)cc4)n3)cc2)CC(C)(C)N1[O]		CHEMBL4563026		Inhibition	%		CHEMBL4722	Homo sapiens	INH		
Active	18878192	CHEMBL4311512	Inhibition of Aurora A phosphorylation at Thr288 residue in human HeLa cells at 5 uM after 12 hrs by Western blot analysis	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878		Inhibition	%		CHEMBL4722	Homo sapiens	INH		
Not Active	18878194	CHEMBL4311514	Inhibition of Aurora A phosphorylation at Thr288 residue in human HeLa cells at <10 nM after 12 hrs by ELISA	B	CC1(C)CC(NC(=O)c2ccc(Nc3ncc(F)c(Nc4ccc(C(=O)Nc5ccccc5Cl)cc4)n3)cc2)CC(C)(C)N1[O]		CHEMBL4563026		Inhibition	%		CHEMBL4722	Homo sapiens	INH		
	18878196	CHEMBL4311516	Inhibition of Aurora A phosphorylation at Thr288 residue in human HeLa cells after 12 hrs by ELISA	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	IC50	nM	13.0	CHEMBL4722	Homo sapiens	IC50	uM	0.013
	18878197	CHEMBL4311516	Inhibition of Aurora A phosphorylation at Thr288 residue in human HeLa cells after 12 hrs by ELISA	B	CC1(C)CC(NC(=O)c2ccc(Nc3ncc(F)c(Nc4ccc(C(=O)Nc5ccccc5Cl)cc4)n3)cc2)CC(C)(C)N1[O]		CHEMBL4563026	=	IC50	nM	8.0	CHEMBL4722	Homo sapiens	IC50	uM	0.008
	18878203	CHEMBL4311520	Inhibition of recombinant N-terminal His6-tagged Aurora A (62 to 344 residues) (unknown origin) expressed in baculovirus expression system	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	Ki	nM	0.6	CHEMBL4722	Homo sapiens	Ki	nM	0.6
	18878207	CHEMBL4311524	Inhibition of recombinant human Aurora A	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(/C=C/c3ccccc3)n2)n[nH]1		CHEMBL482968	=	IC50	nM	14.0	CHEMBL4722	Homo sapiens	IC50	nM	14.0
	18878209	CHEMBL4311526	Inhibition of recombinant full-length His-tagged Aurora A (unknown origin) expressed in insect cells using biotinylated LRRWSLG as substrate in presence of [gamma33]P-ATP by scintillation proximity assay	B	CC(=O)NCC(=O)N1[C@H]2CC[C@@H]1c1cc(Nc3ncc(C(F)(F)F)c(NC4CCC4)n3)ccc12		CHEMBL4289017	=	IC50	nM	0.8	CHEMBL4722	Homo sapiens	IC50	nM	0.8
	18878211	CHEMBL4311528	Inhibition of Aurora A (unknown origin)	B	COc1cc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2OC)=NC3)ccc1C(=O)O		CHEMBL483158	=	IC50	nM	1.2	CHEMBL4722	Homo sapiens	IC50	nM	1.2
	18886116	CHEMBL4313436	Inhibition of human Aurora A at 10 uM using [H-LRRASLG] as substrate by [gamma-33P]-ATP assay relative to control	B	COc1ccc(-c2nn(-c3cccc(NC(=O)c4cccc(C(F)(F)F)c4)c3)cc2-c2ccncc2)cc1Cl		CHEMBL4553144	=	Inhibition	%	3.1	CHEMBL4722	Homo sapiens	INH	%	3.1
	18886201	CHEMBL4313436	Inhibition of human Aurora A at 10 uM using [H-LRRASLG] as substrate by [gamma-33P]-ATP assay relative to control	B	COc1ccc(-c2nn(-c3cccc(NC(=O)Nc4cc(C(F)(F)F)cc(C(F)(F)F)c4)c3)cc2-c2ccncc2)cc1Cl		CHEMBL4559825	=	Inhibition	%	-3.14	CHEMBL4722	Homo sapiens	INH	%	-3.14
	18893326	CHEMBL4315085	Inhibition of recombinant full length His-tagged human aurora A using peptide substrate in presence of ATP at its Km concentration by Z-lyte kinase assay	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(/C=C/c3ccccc3)n2)n[nH]1		CHEMBL482968	=	IC50	nM	14.0	CHEMBL4722	Homo sapiens	IC50	nM	14.0
	18895024	CHEMBL4315506	Inhibition of recombinant human N-terminal GST-tagged full length Aurora A expressed in baculovirus infected Sf9 insect cells assessed as enzyme activity incubated for 15 mins by [gamma-33]ATP based scintillation counting method relative to control	B	CC(C)C/C=N/c1c(C#N)c2n(c1C(=O)Nc1ccc(Br)cc1)CCC2		CHEMBL4592358	=	Activity	%	1.0	CHEMBL4722	Homo sapiens	Activity	%	1.0
	18895043	CHEMBL4315506	Inhibition of recombinant human N-terminal GST-tagged full length Aurora A expressed in baculovirus infected Sf9 insect cells assessed as enzyme activity incubated for 15 mins by [gamma-33]ATP based scintillation counting method relative to control	B	CC/C=N/c1c(C#N)c2n(c1C(=O)Nc1ccccc1)CCC2		CHEMBL4527978	=	Activity	%	-8.0	CHEMBL4722	Homo sapiens	Activity	%	-8.0
	18895062	CHEMBL4315506	Inhibition of recombinant human N-terminal GST-tagged full length Aurora A expressed in baculovirus infected Sf9 insect cells assessed as enzyme activity incubated for 15 mins by [gamma-33]ATP based scintillation counting method relative to control	B	CCC1SCC(=O)N1c1c(C#N)c2n(c1C(=O)Nc1ccccc1)CCC2		CHEMBL4471323	=	Activity	%	11.0	CHEMBL4722	Homo sapiens	Activity	%	11.0
	18895081	CHEMBL4315506	Inhibition of recombinant human N-terminal GST-tagged full length Aurora A expressed in baculovirus infected Sf9 insect cells assessed as enzyme activity incubated for 15 mins by [gamma-33]ATP based scintillation counting method relative to control	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	=	Activity	%	-38.0	CHEMBL4722	Homo sapiens	Activity	%	-38.0
	18919464	CHEMBL4322820	Binding affinity to recombinant full-length N-terminal His-FLAG-GST-tagged AURKA (unknown origin) expressed in baculovirus infected Sf9 insect cells incubated for 1 hr by TR-FRET assay	B	CO[C@@H]1[C@H](NCCOCCOCCOCCNC(=O)CCC2=[N+]3C(=Cc4c(C)cc(C)n4[B-]3(F)F)C=C2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL4465866	=	Kd	nM	45.0	CHEMBL4722	Homo sapiens	Kd	nM	45.0
	18919652	CHEMBL4322820	Binding affinity to recombinant full-length N-terminal His-FLAG-GST-tagged AURKA (unknown origin) expressed in baculovirus infected Sf9 insect cells incubated for 1 hr by TR-FRET assay	B	CO[C@@H]1[C@H](N(C)CCOCCOCCOCCNC(=O)CCC2=[N+]3C(=Cc4c(C)cc(C)n4[B-]3(F)F)C=C2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL4576489	=	Kd	nM	51.0	CHEMBL4722	Homo sapiens	Kd	nM	51.0
	18934069	CHEMBL4326601	Inhibition of human AuroraA at 10 uM using [H-LRRASLG] as substrate by [gamma-33P]-ATP assay relative to control	B	CC(=O)N1CCN(c2ccc(Nc3ncc(C(F)(F)F)c(N4Cc5cccc(N(C)S(C)(=O)=O)c5C4)n3)cc2)CC1		CHEMBL4476226	=	Inhibition	%	95.3	CHEMBL4722	Homo sapiens	INH	%	95.3
	18934115	CHEMBL4326647	Inhibition of human AuroraA using [H-LRRASLG] as substrate by [gamma-33P]-ATP assay	B	CC(=O)N1CCN(c2ccc(Nc3ncc(C(F)(F)F)c(N4Cc5cccc(N(C)S(C)(=O)=O)c5C4)n3)cc2)CC1		CHEMBL4476226	=	IC50	nM	3.0	CHEMBL4722	Homo sapiens	IC50	uM	0.003
	18934903	CHEMBL4326802	Inhibition of Aurora A (unknown origin)	B	O=C(Cc1ccc(-c2ccccc2)cc1)Nc1cc(C2CCC2)[nH]n1		CHEMBL4439395	>	IC50	nM	10000.0	CHEMBL4722	Homo sapiens	IC50	nM	10000.0
	18937717	CHEMBL4327588	Inhibition of human Aurora A assessed as residual activity at 1 uM using [H-LRRASLG] as substrate by [gamma-33P]-ATP assay relative to control	B	ClC/C=C/C[N+]12CN3CN(CN(C3)C1)C2.[Cl-]		CHEMBL4438024	=	Activity	%	102.06	CHEMBL4722	Homo sapiens	Activity	%	102.06
	18937718	CHEMBL4327588	Inhibition of human Aurora A assessed as residual activity at 1 uM using [H-LRRASLG] as substrate by [gamma-33P]-ATP assay relative to control	B	C(=C/c1ccccc1)\C[N+]12CN3CN(CN(C3)C1)C2.[Cl-]		CHEMBL4446405	=	Activity	%	101.47	CHEMBL4722	Homo sapiens	Activity	%	101.47
	18938429	CHEMBL4327949	Inhibition of human Aurora A assessed as residual activity at 100 uM using [H-LRRASLG] as substrate by [gamma-33P]-ATP assay relative to control	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	<	Activity	%	65.0	CHEMBL4722	Homo sapiens	Activity	%	65.0
	18938801	CHEMBL4328313	Inhibition of human Aurora A using [H-LRRASLG] as substrate by [gamma-33P]-ATP assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	1.38	CHEMBL4722	Homo sapiens	IC50	10'-9M	1.38
	18950209	CHEMBL4331061	Inhibition of human Aurora A assessed as residual activity at 10 uM using [H-LRRASLG] as substrate preincubated for 20 mins followed by [gamma-33P]-ATP addition and measured after 120 mins by Hotspot assay relative to control	B	CN1CCC(Nc2ccc(C(=O)Nc3cc(-c4cc(C#N)cs4)n[nH]3)cc2)CC1		CHEMBL4473820	=	Activity	%	58.36	CHEMBL4722	Homo sapiens	Activity	%	58.36
	18958678	CHEMBL4333285	Binding affinity to wild-type human partial length AURKA (E122 to K401 residues) expressed in mammalian expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	CC(C)Nc1sc(C(=O)c2ccc(Cl)s2)c(N)c1C#N		CHEMBL4563315	=	Activity	%	100.0	CHEMBL4722	Homo sapiens	Activity	%	100.0
	18976040	CHEMBL4338198	Inhibition of Aurora A (unknown origin) by [33P]-ATP filter binding kinase assay	B	COc1cc(Br)cc2[nH]cc(-c3oc(-c4ccc[nH]4)nc3I)c12		CHEMBL4555884	>	IC50	nM	10000.0	CHEMBL4722	Homo sapiens	IC50	uM	10.0
	18976041	CHEMBL4338198	Inhibition of Aurora A (unknown origin) by [33P]-ATP filter binding kinase assay	B	COc1cc(Br)cc2[nH]cc(-c3cnc(-c4ccc(Br)[nH]4)o3)c12		CHEMBL4475097	>	IC50	nM	10000.0	CHEMBL4722	Homo sapiens	IC50	uM	10.0
	18976042	CHEMBL4338198	Inhibition of Aurora A (unknown origin) by [33P]-ATP filter binding kinase assay	B	COc1cc2c(-c3cnc(-c4ccc[nH]4)o3)c[nH]c2cc1Br		CHEMBL4564337	=	IC50	nM	22000.0	CHEMBL4722	Homo sapiens	IC50	uM	22.0
	18976043	CHEMBL4338198	Inhibition of Aurora A (unknown origin) by [33P]-ATP filter binding kinase assay	B	COc1cc(Br)cc2[nH]cc(-c3cnc(-c4ccc[nH]4)o3)c12		CHEMBL4446434	>	IC50	nM	10000.0	CHEMBL4722	Homo sapiens	IC50	uM	10.0
	18976044	CHEMBL4338198	Inhibition of Aurora A (unknown origin) by [33P]-ATP filter binding kinase assay	B	COc1cc(Br)cc2[nH]cc(-c3cnc(-c4cc(Br)c[nH]4)o3)c12		CHEMBL4476426	>	IC50	nM	10000.0	CHEMBL4722	Homo sapiens	IC50	uM	10.0
	18976045	CHEMBL4338198	Inhibition of Aurora A (unknown origin) by [33P]-ATP filter binding kinase assay	B	COc1cc(Br)cc2[nH]c(I)c(-c3cnc(-c4ccc[nH]4)o3)c12		CHEMBL4548361	>	IC50	nM	10000.0	CHEMBL4722	Homo sapiens	IC50	uM	10.0
	18976088	CHEMBL4338235	Binding affinity to wild-type human partial length AURKA (E122 to K401 residues) expressed in mammalian expression system assessed as residual binding level at 10 uM by active-site directed competition binding assay based Kinomescan method relative to control	B	COc1cc2c(-c3cnc(-c4ccc[nH]4)o3)c[nH]c2cc1Br		CHEMBL4564337	=	Activity	%	80.0	CHEMBL4722	Homo sapiens	Activity	%	80.0
	18985977	CHEMBL4340085	Inhibition of recombinant human aurora A at 10 uM using Ulight-RRRSLLE substrate incubated for 15 mins by LANCE assay relative to untreated control	B	COc1ccc(Nc2ncc3c(n2)-c2cccnc2SC3)cc1		CHEMBL4582099	=	Inhibition	%	100.0	CHEMBL4722	Homo sapiens	INH	%	100.0
	18985978	CHEMBL4340085	Inhibition of recombinant human aurora A at 10 uM using Ulight-RRRSLLE substrate incubated for 15 mins by LANCE assay relative to untreated control	B	COc1ccc(Nc2ncc3c(n2)-c2cccnc2SC3)cc1OC		CHEMBL4463108	=	Inhibition	%	98.0	CHEMBL4722	Homo sapiens	INH	%	98.0
	18985979	CHEMBL4340085	Inhibition of recombinant human aurora A at 10 uM using Ulight-RRRSLLE substrate incubated for 15 mins by LANCE assay relative to untreated control	B	COc1cc(Nc2ncc3c(n2)-c2cccnc2SC3)cc(OC)c1OC		CHEMBL4584918	=	Inhibition	%	91.0	CHEMBL4722	Homo sapiens	INH	%	91.0
	18997589	CHEMBL4342897	Inhibition of human recombinant His6-tagged Aurora A expressed in baculovirus using Biotinyl-Ahx-tetra (LRRWSLG) as substrate incubated for 60 mins by beta scintillation counter	B	COc1cc2c(Nc3ccc(NC(=O)c4ccccc4)cc3)ncnc2cc1OCCCN1CCOCC1		CHEMBL202721	=	IC50	nM	110.0	CHEMBL4722	Homo sapiens	IC50	nM	110.0
	18997615	CHEMBL4342913	Inhibition of Aurora A in human MCF7 cells	B	COc1cc2c(Nc3ccc(C(=O)Nc4ccccc4)cc3)ncnc2cc1O		CHEMBL4282530	=	IC50	nM	60.0	CHEMBL4722	Homo sapiens	IC50	nM	60.0
	18997617	CHEMBL4342915	Inhibition of Aurora A in human MCF7 cells relative to control	B	COc1cc2c(Nc3ccc(C(=O)Nc4ccccc4)cc3)ncnc2cc1O		CHEMBL4282530	=	Inhibition	%	60.0	CHEMBL4722	Homo sapiens	INH	%	60.0
	19021604	CHEMBL4347780	Inhibition of recombinant human AurA at 20 nM using Ulight-RRRSLLE peptide as substrate measured after 15 mins by LANCE assay relative to control	B	O=C(CCCCCn1cc(Nc2ncc(Cl)c(Nc3ccc(Cl)cc3)n2)cn1)NO		CHEMBL4526274	=	Inhibition	%	37.0	CHEMBL4722	Homo sapiens	INH	%	37.0
	19021605	CHEMBL4347747	Inhibition of recombinant human AurA at 200 nM using Ulight-RRRSLLE peptide as substrate measured after 15 mins by LANCE assay relative to control	B	O=C(CCCCCn1cc(Nc2ncc(Cl)c(Nc3ccc(Cl)cc3)n2)cn1)NO		CHEMBL4526274	=	Inhibition	%	89.0	CHEMBL4722	Homo sapiens	INH	%	89.0
	19031496	CHEMBL4349441	Inhibition of aurora A (unknown origin)	B	Cc1cn(-c2cc(C(=O)Nc3cccc(Nc4ccc5c(c4)NC(=O)/C5=C\c4ccc[nH]4)c3)cc(C(F)(F)F)c2)cn1		CHEMBL2037209	=	IC50	nM	15.0	CHEMBL4722	Homo sapiens	IC50	nM	15.0
	19032177	CHEMBL4349770	Inhibition of recombinant human full length N-terminal GST/His6-tagged Aurora-A (M1 to S403) expressed in Sf9 insect cells at 20 nM using phosphatidylserine as substrate incubated for 60 mins in presence of [33P]-ATP by scintillation counting method	B	Cn1cc(-c2n[nH]c3ccc(NCc4cc(F)ccc4S(C)(=O)=O)cc23)cn1		CHEMBL4555442	=	Inhibition	%	-7.0	CHEMBL4722	Homo sapiens	INH	%	-7.0
	19035287	CHEMBL4350383	Inhibition of human Aurora A assessed as residual activity at 10 uM using [H-LRRASLG] as substrate by [gamma-33P]-ATP assay	B	O=C1NC2(CCCCC2)n2c1c(Cl)cc(Nc1ccncn1)c2=O		CHEMBL4439094	=	Activity	%	100.0	CHEMBL4722	Homo sapiens	Activity	%	100.0
Active	19041014	CHEMBL4352275	Inhibition of human Aurora A at 10 uM using [H-LRRASLG] as substrate in presence of [gamma-33P]-ATP	B	CC(C)(C)C(=O)N1N=CC[C@H]1c1ccccc1		CHEMBL4521353		Inhibition	%		CHEMBL4722	Homo sapiens	INH		
	19043737	CHEMBL4353206	Inhibition of human Aurora A using H-LRRASLG as substrate at 0.1 uM in presence of 33P-gamma ATP by hotspot kinase assay relative to control	B	CN1CCC(Nc2ccc(C(=O)Nc3cc(-c4ccc5c(c4)OCO5)n[nH]3)cc2)CC1		CHEMBL4456471	=	Inhibition	%	76.55	CHEMBL4722	Homo sapiens	INH	%	76.55
	19052187	CHEMBL4355254	Inhibition of Aurora A (unknown origin)	B	Cc1ccc2c(c1)nc(CCN1C(=O)c3cccc4cccc(c34)C1=O)n2-c1ccncc1		CHEMBL4558162	>	IC50	nM	10000.0	CHEMBL4722	Homo sapiens	IC50	uM	10.0
	19052947	CHEMBL4355654	Inhibition of C-terminal His4-tagged Aurora A (unknown origin) using PKB-GSK2 biotinylated peptide as substrate incubated for 90 mins by ELISA	B	Cc1cc(Nc2nn(C(C)C)c(=O)c3cc(OCCN4CCOCC4)ccc23)n[nH]1		CHEMBL4475847	=	IC50	nM	420.0	CHEMBL4722	Homo sapiens	IC50	uM	0.42
	19059464	CHEMBL4357765	Binding affinity to wild-type human partial length AURKA (E122 to K401 residues) expressed in mammalian expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1C(=O)Nc1c(C)cccc1Cl		CHEMBL4515441	=	Activity	%	100.0	CHEMBL4722	Homo sapiens	Activity	%	100.0
	19088874	CHEMBL4365307	Inhibition of Aurora A (unknown origin)	B	Cc1cnc(Nc2ccc(-c3nnn[nH]3)cc2)nc1OC(C)C		CHEMBL4516559	=	IC50	nM	0.438	CHEMBL4722	Homo sapiens	IC50	nM	0.438
	19088875	CHEMBL4365307	Inhibition of Aurora A (unknown origin)	B	COc1ccc(Oc2nc(Nc3ccc(-c4nnn[nH]4)cc3)ncc2Cl)cc1		CHEMBL4462759	=	IC50	nM	0.012	CHEMBL4722	Homo sapiens	IC50	nM	0.012
	19088876	CHEMBL4365307	Inhibition of Aurora A (unknown origin)	B	Fc1ccc(Oc2nc(Nc3ccc(-c4nnn[nH]4)cc3)ncc2Cl)cc1		CHEMBL4476212	=	IC50	nM	0.012	CHEMBL4722	Homo sapiens	IC50	nM	0.012
	19088877	CHEMBL4365307	Inhibition of Aurora A (unknown origin)	B	Fc1ccccc1Oc1nc(Nc2ccc(-c3nnn[nH]3)cc2)ncc1Cl		CHEMBL4443279	=	IC50	nM	0.012	CHEMBL4722	Homo sapiens	IC50	nM	0.012
	19090037	CHEMBL4365611	Inhibition of wild-type human partial length AURKA (E122 to K401 residues) expressed in mammalian expression system assessed as residual activity at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cccnc1)c1cc(C(=O)c2c(F)cccc2Br)c[nH]1		CHEMBL4436895	=	Activity	%	83.0	CHEMBL4722	Homo sapiens	Activity	%	83.0
	19091817	CHEMBL4366291	Inhibition of human Aurora A at 100 nM using [H-LRRASLG] as substrate by [gamma-33P]-ATP assay	B	COc1ccc(N2C(=O)COc3ccc(-c4cnc(OC)c(NS(=O)(=O)c5ccc(F)cc5)c4)cc32)cc1		CHEMBL4528675	=	Inhibition	%	3.17	CHEMBL4722	Homo sapiens	INH	%	3.17
	19111742	CHEMBL4370589	Inhibition of aurora A (unknown origin) using Kemptide as substrate at 1 uM after 60 mins by ADP-Glo luminescence assay relative to control	B	Cc1cc(Nc2nc(Nc3ccc(C(=O)NC4CC(C)(C)N([O])C(C)(C)C4)cc3)ncc2F)no1		CHEMBL4522901	=	Inhibition	%	69.0	CHEMBL4722	Homo sapiens	INH	%	69.0
	19111743	CHEMBL4370589	Inhibition of aurora A (unknown origin) using Kemptide as substrate at 1 uM after 60 mins by ADP-Glo luminescence assay relative to control	B	CCCCOC(=O)Cc1cc(Nc2nc(Nc3ccc(C(=O)NC4CC(C)(C)N([O])C(C)(C)C4)cc3)ncc2F)n[nH]1		CHEMBL4443086	=	Inhibition	%	84.5	CHEMBL4722	Homo sapiens	INH	%	84.5
	19111754	CHEMBL4370595	Inhibition of aurora A (unknown origin) using Kemptide as substrate after 60 mins by ADP-Glo luminescence assay	B	Cc1cc(Nc2nc(Nc3ccc(C(=O)NC4CC(C)(C)N([O])C(C)(C)C4)cc3)ncc2F)no1		CHEMBL4522901	=	IC50	nM	20.1	CHEMBL4722	Homo sapiens	IC50	nM	20.1
	19111755	CHEMBL4370595	Inhibition of aurora A (unknown origin) using Kemptide as substrate after 60 mins by ADP-Glo luminescence assay	B	CCCCOC(=O)Cc1cc(Nc2nc(Nc3ccc(C(=O)NC4CC(C)(C)N([O])C(C)(C)C4)cc3)ncc2F)n[nH]1		CHEMBL4443086	=	IC50	nM	9.3	CHEMBL4722	Homo sapiens	IC50	nM	9.3
	19111756	CHEMBL4370595	Inhibition of aurora A (unknown origin) using Kemptide as substrate after 60 mins by ADP-Glo luminescence assay	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	IC50	nM	0.95	CHEMBL4722	Homo sapiens	IC50	nM	0.95
Dose-dependent effect	19111760	CHEMBL4370597	Inhibition of aurora A phosphorylation at Thr288 residues in human HeLa cells after 24 hrs by immunofluorescence assay	B	CCCCOC(=O)Cc1cc(Nc2nc(Nc3ccc(C(=O)NC4CC(C)(C)N([O])C(C)(C)C4)cc3)ncc2F)n[nH]1		CHEMBL4443086		Inhibition	%		CHEMBL4722	Homo sapiens	INH		
Dose-dependent effect	19111763	CHEMBL4370600	Inhibition of aurora A in human HeLa cells assessed as decrease in Eg5 level after 24 hrs by Western blot analysis	B	CCCCOC(=O)Cc1cc(Nc2nc(Nc3ccc(C(=O)NC4CC(C)(C)N([O])C(C)(C)C4)cc3)ncc2F)n[nH]1		CHEMBL4443086		Inhibition	%		CHEMBL4722	Homo sapiens	INH		
Dose-dependent effect	19111764	CHEMBL4370601	Inhibition of aurora A in human HeLa cells assessed as decrease in Bora level after 24 hrs by Western blot analysis	B	CCCCOC(=O)Cc1cc(Nc2nc(Nc3ccc(C(=O)NC4CC(C)(C)N([O])C(C)(C)C4)cc3)ncc2F)n[nH]1		CHEMBL4443086		Inhibition	%		CHEMBL4722	Homo sapiens	INH		
Dose-dependent effect	19111765	CHEMBL4370602	Inhibition of aurora A in human HeLa cells assessed as decrease in TPX2 level after 24 hrs by Western blot analysis	B	CCCCOC(=O)Cc1cc(Nc2nc(Nc3ccc(C(=O)NC4CC(C)(C)N([O])C(C)(C)C4)cc3)ncc2F)n[nH]1		CHEMBL4443086		Inhibition	%		CHEMBL4722	Homo sapiens	INH		
	19113896	CHEMBL4371112	Binding affinity to His6 tagged MBP fused human aurora A (123 to 390 residues) expressed in Escherichia coli Tuner (DE3) cells by isothermal titration calorimetric method	B	O=C(O)c1ccc(Nc2nccc(Nc3ccccc3F)n2)cc1		CHEMBL2170427	=	Kd	nM	16.0	CHEMBL4722	Homo sapiens	Kd	nM	16.0
	19113897	CHEMBL4371112	Binding affinity to His6 tagged MBP fused human aurora A (123 to 390 residues) expressed in Escherichia coli Tuner (DE3) cells by isothermal titration calorimetric method	B	O=C(O)c1ccc(Nc2nccc(Nc3ccccc3)n2)cc1		CHEMBL2170597	=	Kd	nM	39.0	CHEMBL4722	Homo sapiens	Kd	nM	39.0
	19113898	CHEMBL4371111	Inhibition of His6 tagged MBP fused human aurora A (123 to 390 residues) expressed in Escherichia coli Tuner (DE3) cells	B	O=C(O)c1ccc(Nc2ncc(F)c(Nc3ccccc3F)n2)cc1		CHEMBL4434792	=	IC50	nM	0.8	CHEMBL4722	Homo sapiens	IC50	nM	0.8
	19113899	CHEMBL4371111	Inhibition of His6 tagged MBP fused human aurora A (123 to 390 residues) expressed in Escherichia coli Tuner (DE3) cells	B	O=C(O)c1ccc(Nc2nccc(Nc3ccccc3F)n2)cc1		CHEMBL2170427	=	IC50	nM	3.7	CHEMBL4722	Homo sapiens	IC50	nM	3.7
	19113900	CHEMBL4371111	Inhibition of His6 tagged MBP fused human aurora A (123 to 390 residues) expressed in Escherichia coli Tuner (DE3) cells	B	O=C(O)c1ccc(Nc2nccc(Nc3ccccc3)n2)cc1		CHEMBL2170597	=	IC50	nM	10.0	CHEMBL4722	Homo sapiens	IC50	nM	10.0
	19114495	CHEMBL4371426	Binding affinity to AURKA in SILAC-labeled human MDA-MB-231 cells lysate by mass spectrometry based kinAffinity assay	B	COc1cc2c(Oc3ccc(NS(=O)(=O)c4cc(F)ccc4F)cc3F)ccnc2cc1OCCCN1CCN(C)CC1		CHEMBL4443828	=	Kd	nM	847.0	CHEMBL4722	Homo sapiens	Kd(free)	uM	0.847
	19114519	CHEMBL4371365	Inhibition of AurA (unknown origin) using biotinylated peptide as substrate at 10 uM by TR-FRET assay relative to control	B	COc1cc2c(Oc3ccc(NS(=O)(=O)c4cc(F)ccc4F)cc3F)ccnc2cc1OCCCN1CCN(C)CC1		CHEMBL4443828	=	Efficacy	%	83.0	CHEMBL4722	Homo sapiens	Efficacy	%	83.0
	19114520	CHEMBL4371364	Inhibition of AurA (unknown origin) using fluorescence labeled peptide as substrate at 10 uM by IMAP assay relative to control	B	COc1cc2c(Oc3ccc(NS(=O)(=O)c4cc(F)ccc4F)cc3F)ccnc2cc1OCCCN1CCN(C)CC1		CHEMBL4443828	=	Efficacy	%	83.0	CHEMBL4722	Homo sapiens	Efficacy	%	83.0
	19114583	CHEMBL4371365	Inhibition of AurA (unknown origin) using biotinylated peptide as substrate at 10 uM by TR-FRET assay relative to control	B	COc1cc2c(Oc3ccc(NS(=O)(=O)c4ccccc4C(F)(F)F)cc3F)ccnc2cc1OCCCN1CCN(C)CC1		CHEMBL4587811	=	Efficacy	%	83.0	CHEMBL4722	Homo sapiens	Efficacy	%	83.0
	19114584	CHEMBL4371364	Inhibition of AurA (unknown origin) using fluorescence labeled peptide as substrate at 10 uM by IMAP assay relative to control	B	COc1cc2c(Oc3ccc(NS(=O)(=O)c4ccccc4C(F)(F)F)cc3F)ccnc2cc1OCCCN1CCN(C)CC1		CHEMBL4587811	=	Efficacy	%	83.0	CHEMBL4722	Homo sapiens	Efficacy	%	83.0
	19114673	CHEMBL4371364	Inhibition of AurA (unknown origin) using fluorescence labeled peptide as substrate at 10 uM by IMAP assay relative to control	B	COc1cc2c(Oc3ccc(NS(=O)(=O)c4c(F)cccc4F)cc3F)ccnc2cc1OCCCN1CCN(C)CC1		CHEMBL4462318	=	Efficacy	%	83.0	CHEMBL4722	Homo sapiens	Efficacy	%	83.0
	19114674	CHEMBL4371365	Inhibition of AurA (unknown origin) using biotinylated peptide as substrate at 10 uM by TR-FRET assay relative to control	B	COc1cc2c(Oc3ccc(NS(=O)(=O)c4c(F)cccc4F)cc3F)ccnc2cc1OCCCN1CCN(C)CC1		CHEMBL4462318	=	Efficacy	%	83.0	CHEMBL4722	Homo sapiens	Efficacy	%	83.0
	19114697	CHEMBL4371426	Binding affinity to AURKA in SILAC-labeled human MDA-MB-231 cells lysate by mass spectrometry based kinAffinity assay	B	COc1cc2c(Oc3ccc(NS(=O)(=O)c4c(F)cccc4F)cc3F)ccnc2cc1OCCCN1CCN(C)CC1		CHEMBL4462318	=	Kd	nM	146.0	CHEMBL4722	Homo sapiens	Kd(free)	uM	0.146
	19114824	CHEMBL4371364	Inhibition of AurA (unknown origin) using fluorescence labeled peptide as substrate at 10 uM by IMAP assay relative to control	B	COc1cc2c(Oc3ccc(NS(=O)(=O)c4cc(F)ccc4F)cc3F)ccnc2cc1OCCCN1CCCC(C)C1		CHEMBL4457733	=	Efficacy	%	83.0	CHEMBL4722	Homo sapiens	Efficacy	%	83.0
	19114825	CHEMBL4371365	Inhibition of AurA (unknown origin) using biotinylated peptide as substrate at 10 uM by TR-FRET assay relative to control	B	COc1cc2c(Oc3ccc(NS(=O)(=O)c4cc(F)ccc4F)cc3F)ccnc2cc1OCCCN1CCCC(C)C1		CHEMBL4457733	=	Efficacy	%	83.0	CHEMBL4722	Homo sapiens	Efficacy	%	83.0
	19120473	CHEMBL4372744	Inhibition of AURKA (unknown origin) at 1 uM relative to control	B	O=C1Nc2ccc(C(=O)c3ccco3)cc2/C1=C/c1cc(Cl)c(O)c(Cl)c1		CHEMBL73157	=	Inhibition	%	67.0	CHEMBL4722	Homo sapiens	INH	%	67.0
Active	19133303	CHEMBL4375307	Inhibition of AURKA phosphorylation in human HCT116 cells measured after 24 to 48 hrs by Western blot analysis	B	O=C(Nc1ccc2cc(C(=O)Nc3nccs3)ccc2c1)c1ccc(Cl)c(Cl)c1		CHEMBL4445812		Inhibition	%		CHEMBL4722	Homo sapiens	INH		
Active	19133304	CHEMBL4375307	Inhibition of AURKA phosphorylation in human HCT116 cells measured after 24 to 48 hrs by Western blot analysis	B	COc1cc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2OC)=NC3)ccc1C(=O)O		CHEMBL483158		Inhibition	%		CHEMBL4722	Homo sapiens	INH		
Active	19133305	CHEMBL4375306	Inhibition of AURKA in human HCT116 cells assessed as reduction in PLK1 phosphorylation measured after 24 to 48 hrs by Western blot analysis	B	COc1cc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2OC)=NC3)ccc1C(=O)O		CHEMBL483158		Inhibition	%		CHEMBL4722	Homo sapiens	INH		
	19133364	CHEMBL4375351	Binding affinity to wild-type human partial length AURKA (E122 to K401 residues) expressed in mammalian expression system measured after 1 hr by Kinomescan method	B	O=C(Nc1ccc2cc(C(=O)Nc3nccs3)ccc2c1)c1ccc(Cl)c(Cl)c1		CHEMBL4445812	=	Kd	nM	23.0	CHEMBL4722	Homo sapiens	Kd	nM	23.0
	19140804	CHEMBL4376568	Inhibition of recombinant full length human His-tagged Aurora A expressed in baculovirus expression system at 1 uM using biotin as substrate preincubated for 5 mins followed by substrate addition and measured after 30 to 60 mins in presence of ATP by HTRF assay relative to control	B	Cn1cc(-c2ccc(F)cc2)c(=O)c2c(Nc3ccc(Oc4ccnc(NC(=O)C5CC5)c4)c(F)c3)nccc21		CHEMBL4584949	<	Inhibition	%	50.0	CHEMBL4722	Homo sapiens	INH	%	50.0
	19159292	CHEMBL4382396	Binding affinity to wild-type human partial length AURKA (E122 to K401 residues) expressed in mammalian expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC)cc1N(C)CCN(C)C		CHEMBL4473365	=	Activity	%	4.2	CHEMBL4722	Homo sapiens	Activity	%	4.2
	19180689	CHEMBL4387125	Inhibition of Aurora A (unknown origin) at 2 uM pre-incubated for 10 mins before FAM-labeled peptide substrate addition by mobility shift assay relative to control	B	COc1cc2nccc(Oc3ccc(NC(=O)c4c[nH]c(=O)cc4Nc4ccccc4)cc3)c2cc1OC		CHEMBL4448864	=	Inhibition	%	29.9	CHEMBL4722	Homo sapiens	INH	%	29.9
	19180690	CHEMBL4387125	Inhibition of Aurora A (unknown origin) at 2 uM pre-incubated for 10 mins before FAM-labeled peptide substrate addition by mobility shift assay relative to control	B	COc1cc2nccc(Oc3ccc(NC(=O)c4cn(C)c(=O)cc4Nc4ccccc4)cc3)c2cc1OC		CHEMBL4452889	=	Inhibition	%	40.9	CHEMBL4722	Homo sapiens	INH	%	40.9
	19180691	CHEMBL4387125	Inhibition of Aurora A (unknown origin) at 2 uM pre-incubated for 10 mins before FAM-labeled peptide substrate addition by mobility shift assay relative to control	B	COc1cc2nccc(Oc3ccc(NC(=O)c4cnc(Cl)cc4Nc4ccccc4)cc3)c2cc1OC		CHEMBL4443473	=	Inhibition	%	48.2	CHEMBL4722	Homo sapiens	INH	%	48.2
	19180692	CHEMBL4387125	Inhibition of Aurora A (unknown origin) at 2 uM pre-incubated for 10 mins before FAM-labeled peptide substrate addition by mobility shift assay relative to control	B	COc1cc2nccc(Oc3ccc(NC(=O)c4cnc(Cl)cc4Nc4cccc(F)c4)cc3)c2cc1OC		CHEMBL4538251	=	Inhibition	%	48.6	CHEMBL4722	Homo sapiens	INH	%	48.6
	19180693	CHEMBL4387125	Inhibition of Aurora A (unknown origin) at 2 uM pre-incubated for 10 mins before FAM-labeled peptide substrate addition by mobility shift assay relative to control	B	COc1cc2nccc(Oc3ccc(NC(=O)c4cnc(Cl)cc4Nc4ccc(F)cc4)cc3)c2cc1OC		CHEMBL4457034	=	Inhibition	%	47.1	CHEMBL4722	Homo sapiens	INH	%	47.1
	19180694	CHEMBL4387125	Inhibition of Aurora A (unknown origin) at 2 uM pre-incubated for 10 mins before FAM-labeled peptide substrate addition by mobility shift assay relative to control	B	COc1cc2nccc(Oc3ccc(NC(=O)c4cnc(Cl)cc4Nc4ccccc4F)cc3)c2cc1OC		CHEMBL4434827	=	Inhibition	%	51.5	CHEMBL4722	Homo sapiens	INH	%	51.5
	19180695	CHEMBL4387125	Inhibition of Aurora A (unknown origin) at 2 uM pre-incubated for 10 mins before FAM-labeled peptide substrate addition by mobility shift assay relative to control	B	COc1cc2nccc(Oc3ccc(NC(=O)c4cnc(Cl)cc4Nc4ccccc4Cl)cc3)c2cc1OC		CHEMBL4470480	=	Inhibition	%	68.3	CHEMBL4722	Homo sapiens	INH	%	68.3
	19180696	CHEMBL4387125	Inhibition of Aurora A (unknown origin) at 2 uM pre-incubated for 10 mins before FAM-labeled peptide substrate addition by mobility shift assay relative to control	B	COc1cc2nccc(Oc3ccc(NC(=O)c4cnc(Cl)cc4Nc4cccc(Cl)c4)cc3)c2cc1OC		CHEMBL4439851	=	Inhibition	%	55.1	CHEMBL4722	Homo sapiens	INH	%	55.1
	19180697	CHEMBL4387125	Inhibition of Aurora A (unknown origin) at 2 uM pre-incubated for 10 mins before FAM-labeled peptide substrate addition by mobility shift assay relative to control	B	COc1cc2nccc(Oc3ccc(NC(=O)c4cnc(Cl)cc4Nc4ccc(Cl)cc4)cc3)c2cc1OC		CHEMBL4436133	=	Inhibition	%	51.9	CHEMBL4722	Homo sapiens	INH	%	51.9
	19180698	CHEMBL4387125	Inhibition of Aurora A (unknown origin) at 2 uM pre-incubated for 10 mins before FAM-labeled peptide substrate addition by mobility shift assay relative to control	B	COc1cc2nccc(Oc3ccc(NC(=O)c4cnc(Cl)cc4Nc4ccccc4Br)cc3)c2cc1OC		CHEMBL4585471	=	Inhibition	%	78.2	CHEMBL4722	Homo sapiens	INH	%	78.2
	19180699	CHEMBL4387125	Inhibition of Aurora A (unknown origin) at 2 uM pre-incubated for 10 mins before FAM-labeled peptide substrate addition by mobility shift assay relative to control	B	COc1cc2nccc(Oc3ccc(NC(=O)c4cnc(Cl)cc4Nc4ccc(F)c(Br)c4)cc3)c2cc1OC		CHEMBL4559686	=	Inhibition	%	81.3	CHEMBL4722	Homo sapiens	INH	%	81.3
	19180700	CHEMBL4387125	Inhibition of Aurora A (unknown origin) at 2 uM pre-incubated for 10 mins before FAM-labeled peptide substrate addition by mobility shift assay relative to control	B	COc1cc2nccc(Oc3ccc(NC(=O)c4cnc(Cl)cc4Nc4ccc(Br)cc4F)cc3)c2cc1OC		CHEMBL4449328	=	Inhibition	%	70.0	CHEMBL4722	Homo sapiens	INH	%	70.0
	19180701	CHEMBL4387125	Inhibition of Aurora A (unknown origin) at 2 uM pre-incubated for 10 mins before FAM-labeled peptide substrate addition by mobility shift assay relative to control	B	COc1cc2nccc(Oc3ccc(NC(=O)c4cnc(Cl)cc4Nc4cccc5ccccc45)cc3)c2cc1OC		CHEMBL4459876	=	Inhibition	%	59.9	CHEMBL4722	Homo sapiens	INH	%	59.9
	19180702	CHEMBL4387125	Inhibition of Aurora A (unknown origin) at 2 uM pre-incubated for 10 mins before FAM-labeled peptide substrate addition by mobility shift assay relative to control	B	COc1cc2nccc(Oc3ccc(NC(=O)c4cnc(Cl)cc4Nc4ccc(F)c(Br)c4)cc3F)c2cc1OC		CHEMBL4592677	=	Inhibition	%	82.9	CHEMBL4722	Homo sapiens	INH	%	82.9
	19180703	CHEMBL4387125	Inhibition of Aurora A (unknown origin) at 2 uM pre-incubated for 10 mins before FAM-labeled peptide substrate addition by mobility shift assay relative to control	B	COc1cc2nccc(Oc3ccc(NC(=O)c4cnc5ccc(Br)cc5c4Nc4ccc(F)c(Br)c4)cc3F)c2cc1OC		CHEMBL4582046	=	Inhibition	%	6.6	CHEMBL4722	Homo sapiens	INH	%	6.6
	19180704	CHEMBL4387125	Inhibition of Aurora A (unknown origin) at 2 uM pre-incubated for 10 mins before FAM-labeled peptide substrate addition by mobility shift assay relative to control	B	COc1cc2nccc(Oc3ccc(NC(=O)c4cccnc4Nc4ccc(F)c(Br)c4)cc3F)c2cc1OC		CHEMBL4581386	=	Inhibition	%	48.4	CHEMBL4722	Homo sapiens	INH	%	48.4
	19180705	CHEMBL4387125	Inhibition of Aurora A (unknown origin) at 2 uM pre-incubated for 10 mins before FAM-labeled peptide substrate addition by mobility shift assay relative to control	B	COc1cc2nccc(Oc3ccc(NC(=O)c4c(Nc5ccc(F)c(Br)c5)cc(C)nc4Cl)cc3F)c2cc1OC		CHEMBL4468608	=	Inhibition	%	0.6	CHEMBL4722	Homo sapiens	INH	%	0.6
	19180706	CHEMBL4387125	Inhibition of Aurora A (unknown origin) at 2 uM pre-incubated for 10 mins before FAM-labeled peptide substrate addition by mobility shift assay relative to control	B	COc1cc2nccc(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3)c2cc1OC		CHEMBL2105717	=	Inhibition	%	0.4	CHEMBL4722	Homo sapiens	INH	%	0.4
	19180962	CHEMBL4387172	Inhibition of recombinant full length human His-tagged Aurora A expressed in baculovirus expression system at 0.1 uM using serine/threonine-1 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control	B	CCN1CCN(Cc2ccc(Nc3ncc(F)c(-c4cc(F)c5nc(C)n(C(C)C)c5c4)n3)nc2)CC1		CHEMBL3301610	=	Inhibition	%	9.5	CHEMBL4722	Homo sapiens	INH	%	9.5
	19181188	CHEMBL4387172	Inhibition of recombinant full length human His-tagged Aurora A expressed in baculovirus expression system at 0.1 uM using serine/threonine-1 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control	B	CCN1CC2(C1)CN(c1ccc(Nc3ncc(F)c(-c4cnn5c4[C@H](C)CCCC5)n3)nc1)C2		CHEMBL4545456	=	Inhibition	%	12.0	CHEMBL4722	Homo sapiens	INH	%	12.0
	19191233	CHEMBL4389592	Inhibition of wild-type human partial length AURKA (E122 to K401 residues) expressed in mammalian expression system at 1 uM by Kinomescan method relative to control	B	O=C(Nc1cccc([C@@H]2CN(c3ncnc4[nH]ccc34)CCN2CCO)c1)Nc1c(F)cccc1N1CCCC1		CHEMBL4564973	=	Inhibition	%	3.6	CHEMBL4722	Homo sapiens	INH	%	3.6
	19191715	CHEMBL4389115	Inhibition of wild-type human partial length AURKA (E122 to K401 residues) expressed in mammalian expression system at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cccc([C@H]2CCCN(c3ncnc4[nH]ccc34)C2)c1)Nc1ccccc1N1CCCC1		CHEMBL4555459	=	Inhibition	%	0.8	CHEMBL4722	Homo sapiens	INH	%	0.8
	19200004	CHEMBL4391218	Binding affinity to wild-type human partial length AURKA (E122 to K401 residues) expressed in mammalian expression system assessed as residual binding level at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cc(-c2cn(CCNc3c4c(nc5ccccc35)CCCC4)nn2)ccn1)Nc1cccc2c1C1CCCCN1C2=O		CHEMBL4559936	=	Activity	%	9.5	CHEMBL4722	Homo sapiens	Activity	%	9.5
	19225451	CHEMBL4395871	Inhibition of recombinant human Aurora A at 10 uM using Ulight-RRRSLLE substrate incubated for 15 mins in presence of ATP by LANCE assay relative to control	B	CCc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(=O)C3CC3)c2)[nH]1		CHEMBL4536012	=	Inhibition	%	2.76	CHEMBL4722	Homo sapiens	INH	%	2.76
	19266314	CHEMBL4405264	Inhibition of wild-type human partial length AURKA (E122 to K401 residues) expressed in mammalian expression system at 1 uM by Kinomescan method relative to control	B	CC[C@H](Nc1nc(N)nc(C)c1C#N)c1nc2cccc(NCc3ccc(C(=O)NO)cc3)c2c(=O)n1-c1ccccc1		CHEMBL4455923	<	Inhibition	%	50.0	CHEMBL4722	Homo sapiens	INH	%	50.0
	19274892	CHEMBL4407579	Inhibition of recombinant human full-length His-tagged AURKA expressed in baculovirus expression system at 25 uM using FRET-labeled Ser/Thr 01 peptide as substrate measured after 1 hr by Z'-lyte assay relative to control	A	Nc1ncc2cc(-c3c(Br)cccc3Br)c(N)nc2n1		CHEMBL57531	=	Inhibition	%	20.0	CHEMBL4722	Homo sapiens	INH	%	20.0
	19274893	CHEMBL4407579	Inhibition of recombinant human full-length His-tagged AURKA expressed in baculovirus expression system at 25 uM using FRET-labeled Ser/Thr 01 peptide as substrate measured after 1 hr by Z'-lyte assay relative to control	A	Nc1ncc2cc(-c3c(Cl)cccc3-c3cccnc3)c(N3C[C@H]4[C@H](N)[C@H]4C3)nc2n1		CHEMBL4453148	=	Inhibition	%	9.0	CHEMBL4722	Homo sapiens	INH	%	9.0
	19274894	CHEMBL4407579	Inhibition of recombinant human full-length His-tagged AURKA expressed in baculovirus expression system at 25 uM using FRET-labeled Ser/Thr 01 peptide as substrate measured after 1 hr by Z'-lyte assay relative to control	A	CC(C)COc1cccc(Cl)c1-c1cc2cnc(N)nc2nc1N1C[C@H]2[C@H](N)[C@H]2C1		CHEMBL4546703	=	Inhibition	%	8.0	CHEMBL4722	Homo sapiens	INH	%	8.0
	19275933	CHEMBL4407936	Inhibition of recombinant full length human Aurora A at 1 uM using LRRASLG as substrate incubated for 40 mins in presence of [gamma-33P]-ATP by scintillation counting method relative to control	B	Cc1ccc(NC(=O)C2(C(=O)Nc3ccc(Nc4ncc(F)c(-c5cc(F)c6nc(C)n(C(C)C)c6c5)n4)cc3)CC2)cc1		CHEMBL4445335	=	Inhibition	%	79.0	CHEMBL4722	Homo sapiens	INH	%	79.0
	19292313	CHEMBL4411564	Inhibition of N-terminal GST tagged full length human AurA (1 to 403 end residues) expressed in baculovirus expression system at 1 uM in presence of ATP at its Km level relative to control	B	Cn1cc(Nc2nccc(N3C[C@H]4CC[C@H](C3)N4C(=O)[C@@H]3CC3(F)F)n2)cn1		CHEMBL4458435	=	Inhibition	%	62.0	CHEMBL4722	Homo sapiens	INH	%	62.0
	19312939	CHEMBL4416494	Inhibition of recombinant human N-terminal His6-tagged full length Aurora A expressed by baculovirus infected Sf21 insect cells at 10 uM using Kemptide as substrate relative to control	B	N#CC[C@H]1CC[C@H](n2c(=O)[nH]c3cnc(Nc4ccc[nH]c4=O)nc32)CC1		CHEMBL4463007	>	Inhibition	%	75.0	CHEMBL4722	Homo sapiens	INH	%	75.0
	19371115	CHEMBL4424872	Inhibition of recombinant full-length human N-terminal His6-tagged AuroraA expressed in baculovirus infected Sf21 insect cells using Kemptide as substrate	A	COc1cc(C2CN(C(=O)c3cc(COC[C@@H](O)CO)ccn3)C2)ccc1OCc1ccc(C2CC2)cc1		CHEMBL4474690	>	IC50	nM	1000.0	CHEMBL4722	Homo sapiens	IC50	nM	1000.0
	19400701	CHEMBL4425338	Inhibition of aurora A kinase (unknown origin)	B	COc1ccc(Nc2nc(Nc3ccc4ncccc4c3)nc(NC(Cc3c[nH]c4ncccc34)C(N)=O)n2)cc1OC		CHEMBL1213152	=	IC50	nM	270.0	CHEMBL4722	Homo sapiens	IC50	nM	270.0
	19407720	CHEMBL4426897	Inhibition of aurora A (unknown origin)	B	CCc1ccc2c(c1)c(=O)c(C(=O)Nc1ccc(Oc3ncnc4cc(OC)c(OC)cc34)c(F)c1)c(C)n2C		CHEMBL4571241	=	IC50	nM	192.4	CHEMBL4722	Homo sapiens	IC50	nM	192.4
	19411485	CHEMBL4427680	Inhibition of Aurora A (unknown origin)	B	Cc1cnc(-c2cc(Cl)ccc2F)cc1-n1c(=O)n(CC(N)=O)c2cnccc21		CHEMBL4564126	>=	IC50	nM	5000.0	CHEMBL4722	Homo sapiens	IC50	uM	5.0
	19411541	CHEMBL4427624	Inhibition of Aurora A (unknown origin) at 1 uM relative to control	B	Cc1cnc(-c2cc(Cl)ccc2F)cc1-n1c(=O)n(CC(N)=O)c2cnccc21		CHEMBL4564126	<=	Inhibition	%	16.0	CHEMBL4722	Homo sapiens	INH	%	16.0
Tde	19411836	CHEMBL4427795	Inhibition of aurora A in human HCT116 cells assessed as decrease in histone H3 phosphorylation at Ser-10 at 20 uM by Western blot analysis	B	COc1ccc(C2CC(c3ccc4ccccc4c3O)=NN2C(=S)Nc2cccc(OC)c2)cc1		CHEMBL4514298		Inhibition	%		CHEMBL4722	Homo sapiens	INH		
Tde	19411839	CHEMBL4427793	Inhibition of aurora A phosphorylation at Thr-288 in human HCT116 cells at 20 uM by Western blot analysis	B	COc1ccc(C2CC(c3ccc4ccccc4c3O)=NN2C(=S)Nc2cccc(OC)c2)cc1		CHEMBL4514298		Inhibition	%		CHEMBL4722	Homo sapiens	INH		
	19411841	CHEMBL4427790	Inhibition of human recombinant N-terminal His6-tagged full-length aurora A expressed in Sf21 insect cells using ER-alpha as substrate after 25 mins by immunoblot analysis	B	COc1ccc(C2CC(c3ccc4ccccc4c3O)=NN2C(=S)Nc2cccc(OC)c2)cc1	Outside typical range	CHEMBL4514298	=	IC50	nM	105030.0	CHEMBL4722	Homo sapiens	IC50	uM	105.03
	19435655	CHEMBL4430368	Inhibition of AURKA (unknown origin)	B	COc1ccc2c(c1)C(=Cc1ccc3c(-c4ccc(N5CCN(C)CC5)nc4)n[nH]c3c1)C(=O)N2		CHEMBL4434704	=	IC50	nM	700.0	CHEMBL4722	Homo sapiens	IC50	uM	0.7
	19435656	CHEMBL4430368	Inhibition of AURKA (unknown origin)	B	COc1ccc2c(c1)[C@]1(C[C@H]1c1ccc3c(-c4ccc(N5CCN(C)CC5)nc4)n[nH]c3c1)C(=O)N2		CHEMBL4516793	>	IC50	nM	1000.0	CHEMBL4722	Homo sapiens	IC50	uM	1.0
	19435657	CHEMBL4430368	Inhibition of AURKA (unknown origin)	B	COc1ccc2c(c1)[C@]1(C[C@H]1c1ccc3c(-c4ccc(N5CCN(C)CC5)cc4)n[nH]c3c1)C(=O)N2		CHEMBL4448596	>	IC50	nM	1000.0	CHEMBL4722	Homo sapiens	IC50	uM	1.0
	19435658	CHEMBL4430368	Inhibition of AURKA (unknown origin)	B	COc1ccc2c(c1)[C@]1(C[C@H]1c1ccc3c(-c4ccc(N5CCNCC5)cc4)n[nH]c3c1)C(=O)N2		CHEMBL4553351	>	IC50	nM	1000.0	CHEMBL4722	Homo sapiens	IC50	uM	1.0
	19435659	CHEMBL4430368	Inhibition of AURKA (unknown origin)	B	COc1ccc2c(c1)[C@]1(C[C@H]1c1ccc3c(-c4ccc(N5C[C@H](C)N[C@H](C)C5)cc4)n[nH]c3c1)C(=O)N2		CHEMBL4440053	>	IC50	nM	1000.0	CHEMBL4722	Homo sapiens	IC50	uM	1.0
Not Determined	19435660	CHEMBL4430368	Inhibition of AURKA (unknown origin)	B	COc1ccc2c(c1)[C@]1(C[C@H]1c1ccc3c(-c4ccc(C5(F)CCN(C)CC5)cc4)n[nH]c3c1)C(=O)N2		CHEMBL4437913		IC50			CHEMBL4722	Homo sapiens	IC50		
	19435661	CHEMBL4430368	Inhibition of AURKA (unknown origin)	B	CCN1CCN(c2ccc(-c3n[nH]c4cc([C@@H]5C[C@@]56C(=O)Nc5ccc(OC)cc56)ccc34)cc2)CC1		CHEMBL4440812	>	IC50	nM	1000.0	CHEMBL4722	Homo sapiens	IC50	uM	1.0
	19435662	CHEMBL4430368	Inhibition of AURKA (unknown origin)	B	COc1ccc2c(c1)[C@]1(C[C@H]1c1ccc3c(-c4ccc(N5CCN(CCO)CC5)cc4)n[nH]c3c1)C(=O)N2		CHEMBL4470693	>	IC50	nM	1000.0	CHEMBL4722	Homo sapiens	IC50	uM	1.0
	19435663	CHEMBL4430368	Inhibition of AURKA (unknown origin)	B	COc1ccc2c(c1)[C@@]1(C[C@@H]1c1ccc3c(-c4ccc(N5CCN(C)CC5)nc4)n[nH]c3c1)C(=O)N2		CHEMBL4467348	>	IC50	nM	1000.0	CHEMBL4722	Homo sapiens	IC50	uM	1.0
	19435812	CHEMBL4430386	Inhibition of human Aurora-A at 0.1 uM	B	COc1ccc2c(c1)[C@]1(C[C@H]1c1ccc3c(-c4ccc(N5CCN(C)CC5)nc4)n[nH]c3c1)C(=O)N2		CHEMBL4516793	=	Inhibition	%	71.0	CHEMBL4722	Homo sapiens	INH	%	71.0
	19435813	CHEMBL4430386	Inhibition of human Aurora-A at 0.1 uM	B	COc1ccc2c(c1)[C@]1(C[C@H]1c1ccc3c(-c4ccc(N5CCN(C)CC5)cc4)n[nH]c3c1)C(=O)N2		CHEMBL4448596	=	Inhibition	%	70.0	CHEMBL4722	Homo sapiens	INH	%	70.0
	19435814	CHEMBL4430386	Inhibition of human Aurora-A at 0.1 uM	B	COc1ccc2c(c1)[C@]1(C[C@H]1c1ccc3c(/C=C/c4ccc(N5CCN(C)CC5)nc4)n[nH]c3c1)C(=O)N2		CHEMBL3353341	=	Inhibition	%	96.0	CHEMBL4722	Homo sapiens	INH	%	96.0
	19448413	CHEMBL4433047	Inhibition of Aurora A (unknown origin)	B	Cc1ccc(-c2cc3nccnc3c(NCCCCN)n2)cc1		CHEMBL4436576	=	IC50	nM	1258.93	CHEMBL4722	Homo sapiens	pIC50		5.9
	19474675	CHEMBL4479364	Inhibition of Aurora A (unknown origin)	B	COc1ncc(-c2cc3c(c(NC(=O)CN4CCOCC4)c2)COC3)cc1NS(C)(=O)=O		CHEMBL4561692	<	IC50	nM	10000.0	CHEMBL4722	Homo sapiens	pIC50		5.0
	19478944	CHEMBL4480176	Inhibition of Aurora A (unknown origin)	B	Cc1ccc(-c2nn(-c3ccccc3)cc2C(=O)NOCc2ccccc2F)cc1		CHEMBL4575118	=	IC50	nM	8300.0	CHEMBL4722	Homo sapiens	IC50	uM	8.3
	20600434	CHEMBL4603315	Inhibition of recombinant human full length AURKA expressed in baculovirus expression system using Ser/Thr-01 peptide as substrate after 1 hr in presence of ATP by Z'LYTE assay	B	C[C@@H]1C[C@H]1C(=O)N1CCN(c2cnc(C#N)c(-c3cnn(C)c3)n2)C[C@H]1C		CHEMBL4634634	=	IC50	nM	15970.0	CHEMBL4722	Homo sapiens	IC50	uM	15.97
	20629074	CHEMBL4610388	Inhibition of wild-type human partial length AURKA (E122 to K401 residues) expressed in mammalian expression system assessed as residual activity at 500 nM by Kinomescan method relative to control	B	CCOC(=O)c1cnc2ccc(-c3ccncc3)nc2c1N[C@H]1CC[C@H](CN(C)C)CC1		CHEMBL4646793	=	Activity	%	97.0	CHEMBL4722	Homo sapiens	Activity	%	97.0
	20629082	CHEMBL4610396	Inhibition of wild-type human partial length AURKA (E122 to K401 residues) expressed in mammalian expression system assessed as residual activity at 100 nM by Kinomescan method relative to control	B	CC(=O)c1cnc2ccc(-c3cc(Cl)c(O)c(Cl)c3)nc2c1N[C@H]1CC[C@H](CN(C)C)CC1		CHEMBL3688339	=	Activity	%	6.6	CHEMBL4722	Homo sapiens	Activity	%	6.6
	20631967	CHEMBL4610921	Inhibition of Aurora A (unknown origin) at 1 uM after 1 hr in presence of ATP by Kinase-Glo reagent-based luminescence assay relative to control	B	O=C(Nc1ccc(Nc2nccc(NC3CCCC3)n2)cc1)NC1CCCCC1		CHEMBL4643443	=	Inhibition	%	36.1	CHEMBL4722	Homo sapiens	INH	%	36.1
	20631968	CHEMBL4610921	Inhibition of Aurora A (unknown origin) at 1 uM after 1 hr in presence of ATP by Kinase-Glo reagent-based luminescence assay relative to control	B	O=C(Cc1ccc(Nc2nccc(NC3CCCC3)n2)cc1)NC1CCCCC1		CHEMBL4646386	=	Inhibition	%	79.4	CHEMBL4722	Homo sapiens	INH	%	79.4
	20631969	CHEMBL4610921	Inhibition of Aurora A (unknown origin) at 1 uM after 1 hr in presence of ATP by Kinase-Glo reagent-based luminescence assay relative to control	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	Inhibition	%	97.4	CHEMBL4722	Homo sapiens	INH	%	97.4
	20631976	CHEMBL4610922	Inhibition of Aurora A (unknown origin) after 1 hr in presence of ATP by Kinase-Glo reagent-based luminescence assay	B	O=C(Cc1ccc(Nc2nccc(NC3CCCC3)n2)cc1)NC1CCCCC1		CHEMBL4646386	=	IC50	nM	309.0	CHEMBL4722	Homo sapiens	IC50	nM	309.0
	20631977	CHEMBL4610922	Inhibition of Aurora A (unknown origin) after 1 hr in presence of ATP by Kinase-Glo reagent-based luminescence assay	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	IC50	nM	0.95	CHEMBL4722	Homo sapiens	IC50	nM	0.95
Active	20631984	CHEMBL4610928	Inhibition of Aurora A in human HCT116 cells assessed as reduction in phosphorylation at Thr288 residue at 0.5 to 5 uM after 12 hrs by Western blot analysis	B	O=C(Cc1ccc(Nc2nccc(NC3CCCC3)n2)cc1)NC1CCCCC1		CHEMBL4646386		Inhibition	%		CHEMBL4722	Homo sapiens	INH		
	20632002	CHEMBL4610946	Inhibition of Aurora A (unknown origin)	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	Ki	nM	0.37	CHEMBL4722	Homo sapiens	Ki	nM	0.37
	20632005	CHEMBL4610949	Inhibition of recombinant full-length His-tagged human Aurora A expressed in baculovirus expression system	B	c1nc2c(NC3CCCCC3)nc(Nc3ccc(N4CCOCC4)cc3)nc2[nH]1		CHEMBL188343	=	IC50	nM	400.0	CHEMBL4722	Homo sapiens	IC50	nM	400.0
	20680922	CHEMBL4623061	Inhibition of Aurora kinase A (unknown origin) incubated for 30 mins by Kinase Glo luminescent assay	B	Cc1noc(C)c1-c1cnc(N)c(Oc2ccc(C(=O)NC3CCCCC3)cc2)n1		CHEMBL4635731	=	IC50	nM	230.0	CHEMBL4722	Homo sapiens	IC50	nM	230.0
	20680923	CHEMBL4623061	Inhibition of Aurora kinase A (unknown origin) incubated for 30 mins by Kinase Glo luminescent assay	B	Cc1noc(C)c1-c1cnc(N)c(Oc2ccc(C(=O)N3CCOCC3)cc2)n1		CHEMBL4647800	=	IC50	nM	172.0	CHEMBL4722	Homo sapiens	IC50	nM	172.0
	20680924	CHEMBL4623061	Inhibition of Aurora kinase A (unknown origin) incubated for 30 mins by Kinase Glo luminescent assay	B	Cc1noc(C)c1-c1cnc(N)c(Oc2ccc(C(=O)N3CCN(C)CC3)cc2)n1		CHEMBL4633273	=	IC50	nM	143.0	CHEMBL4722	Homo sapiens	IC50	nM	143.0
	20680925	CHEMBL4623061	Inhibition of Aurora kinase A (unknown origin) incubated for 30 mins by Kinase Glo luminescent assay	B	Cc1noc(C)c1-c1cnc(N)c(Oc2ccc(C(=O)Nc3ccccc3)cc2)n1		CHEMBL4640055	=	IC50	nM	220.0	CHEMBL4722	Homo sapiens	IC50	nM	220.0
	20680926	CHEMBL4623061	Inhibition of Aurora kinase A (unknown origin) incubated for 30 mins by Kinase Glo luminescent assay	B	Cc1noc(C)c1-c1cnc(N)c(Oc2ccc(C(=O)Nc3ccc(Cl)cc3)cc2)n1		CHEMBL4636044	=	IC50	nM	458.0	CHEMBL4722	Homo sapiens	IC50	nM	458.0
	20680927	CHEMBL4623061	Inhibition of Aurora kinase A (unknown origin) incubated for 30 mins by Kinase Glo luminescent assay	B	Cc1noc(C)c1-c1cnc(N)c(Oc2ccc(C(=O)Nc3cccc(Cl)c3)cc2)n1		CHEMBL4647086	=	IC50	nM	90.0	CHEMBL4722	Homo sapiens	IC50	nM	90.0
	20680928	CHEMBL4623061	Inhibition of Aurora kinase A (unknown origin) incubated for 30 mins by Kinase Glo luminescent assay	B	Cn1cc(-c2cnc(N)c(Oc3ccc(C(=O)Nc4ccccc4)cc3)n2)cn1		CHEMBL4646357	=	IC50	nM	220.0	CHEMBL4722	Homo sapiens	IC50	nM	220.0
	20680929	CHEMBL4623061	Inhibition of Aurora kinase A (unknown origin) incubated for 30 mins by Kinase Glo luminescent assay	B	Cn1cc(-c2cnc(N)c(Oc3ccc(C(=O)Nc4ccc(Cl)cc4)cc3)n2)cn1		CHEMBL4642258	=	IC50	nM	190.0	CHEMBL4722	Homo sapiens	IC50	nM	190.0
	20680930	CHEMBL4623061	Inhibition of Aurora kinase A (unknown origin) incubated for 30 mins by Kinase Glo luminescent assay	B	Cn1cc(-c2cnc(N)c(Oc3ccc(C(=O)Nc4cccc(Cl)c4)cc3)n2)cn1		CHEMBL4644226	=	IC50	nM	658.0	CHEMBL4722	Homo sapiens	IC50	nM	658.0
	20680931	CHEMBL4623061	Inhibition of Aurora kinase A (unknown origin) incubated for 30 mins by Kinase Glo luminescent assay	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	IC50	nM	1.05	CHEMBL4722	Homo sapiens	IC50	nM	1.05
Dose-dependent effect	20680942	CHEMBL4623059	Inhibition of Aurora kinase A in human HeLa cells assessed as reduction in phosphorylation at Thr288 residue incubated for 24 hrs by western blot analysis	B	Cc1noc(C)c1-c1cnc(N)c(Oc2ccc(C(=O)Nc3cccc(Cl)c3)cc2)n1		CHEMBL4647086		Inhibition	%		CHEMBL4722	Homo sapiens	INH		
	20680951	CHEMBL4623073	Inhibition of recombinant Aurora A (unknown origin) by radioactive flashplate assay	B	COc1cc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2OC)=NC3)ccc1C(=O)O		CHEMBL483158	=	IC50	nM	1.2	CHEMBL4722	Homo sapiens	IC50	nM	1.2
	20680952	CHEMBL4623072	Inhibition of recombinant human Aurora A using peptide substrate in presence of ATP at its Km concentration by Z-lyte kinase assay	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(/C=C/c3ccccc3)n2)n[nH]1		CHEMBL482968	=	IC50	nM	14.0	CHEMBL4722	Homo sapiens	IC50	nM	14.0
	20680955	CHEMBL4623057	Inhibition of recombinant human N-terminal His6-tagged Aurora A expressed in baculovirus expression system by enzyme coupled assay	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	IC50	nM	0.6	CHEMBL4722	Homo sapiens	IC50	nM	0.6
	20680957	CHEMBL4623076	Inhibition of Aurora A (unknown origin) by biochemical kinase assay	B	CO[C@@H](C(=O)N1Cc2n[nH]c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)c2C1)c1ccccc1		CHEMBL402548	=	IC50	nM	13.0	CHEMBL4722	Homo sapiens	IC50	nM	13.0
	20683669	CHEMBL4623649	Inhibition of human Aurora A using [H-LRRASLG] as substrate at 20 uM in presence of [gamma-33P]-ATP incubated for 2 hrs by hotspot kinase assay relative to control	B	CCOC(=O)c1cnc2ccccc2c1Nc1cccc(S(N)(=O)=O)c1		CHEMBL4645551	=	Inhibition	%	64.32	CHEMBL4722	Homo sapiens	INH	%	64.32
	20683670	CHEMBL4623649	Inhibition of human Aurora A using [H-LRRASLG] as substrate at 20 uM in presence of [gamma-33P]-ATP incubated for 2 hrs by hotspot kinase assay relative to control	B	CCOC(=O)c1cnc2ccc(Br)cc2c1Nc1cccc(S(N)(=O)=O)c1		CHEMBL4648901	=	Inhibition	%	26.9	CHEMBL4722	Homo sapiens	INH	%	26.9
	20683671	CHEMBL4623649	Inhibition of human Aurora A using [H-LRRASLG] as substrate at 20 uM in presence of [gamma-33P]-ATP incubated for 2 hrs by hotspot kinase assay relative to control	B	CCOC(=O)c1cnc2ccc(C)cc2c1Nc1cccc(S(N)(=O)=O)c1		CHEMBL4644959	=	Inhibition	%	14.93	CHEMBL4722	Homo sapiens	INH	%	14.93
	20683672	CHEMBL4623649	Inhibition of human Aurora A using [H-LRRASLG] as substrate at 20 uM in presence of [gamma-33P]-ATP incubated for 2 hrs by hotspot kinase assay relative to control	B	CCOC(=O)c1cnc2cc(Cl)cc(Cl)c2c1Nc1cccc(S(N)(=O)=O)c1		CHEMBL4635411	=	Inhibition	%	61.3	CHEMBL4722	Homo sapiens	INH	%	61.3
	20683673	CHEMBL4623649	Inhibition of human Aurora A using [H-LRRASLG] as substrate at 20 uM in presence of [gamma-33P]-ATP incubated for 2 hrs by hotspot kinase assay relative to control	B	CCOC(=O)c1cnc2ccccc2c1Nc1cccc(S(=O)(=O)NC)c1		CHEMBL4632919	=	Inhibition	%	6.15	CHEMBL4722	Homo sapiens	INH	%	6.15
	20683674	CHEMBL4623649	Inhibition of human Aurora A using [H-LRRASLG] as substrate at 20 uM in presence of [gamma-33P]-ATP incubated for 2 hrs by hotspot kinase assay relative to control	B	CCOC(=O)c1cnc2ccc(Br)cc2c1Nc1cccc(S(=O)(=O)NC)c1		CHEMBL4638407	=	Inhibition	%	10.68	CHEMBL4722	Homo sapiens	INH	%	10.68
	20683675	CHEMBL4623649	Inhibition of human Aurora A using [H-LRRASLG] as substrate at 20 uM in presence of [gamma-33P]-ATP incubated for 2 hrs by hotspot kinase assay relative to control	B	CCOC(=O)c1cnc2ccc(C)cc2c1Nc1cccc(S(=O)(=O)NC)c1		CHEMBL4642062	=	Inhibition	%	6.43	CHEMBL4722	Homo sapiens	INH	%	6.43
	20683676	CHEMBL4623649	Inhibition of human Aurora A using [H-LRRASLG] as substrate at 20 uM in presence of [gamma-33P]-ATP incubated for 2 hrs by hotspot kinase assay relative to control	B	CCOC(=O)c1cnc2cc(Cl)cc(Cl)c2c1Nc1cccc(S(=O)(=O)NC)c1		CHEMBL4637300	=	Inhibition	%	58.65	CHEMBL4722	Homo sapiens	INH	%	58.65
	20683677	CHEMBL4623649	Inhibition of human Aurora A using [H-LRRASLG] as substrate at 20 uM in presence of [gamma-33P]-ATP incubated for 2 hrs by hotspot kinase assay relative to control	B	CCOC(=O)c1cnc2ccccc2c1Nc1cccc(NS(C)(=O)=O)c1		CHEMBL4641064	=	Inhibition	%	71.89	CHEMBL4722	Homo sapiens	INH	%	71.89
	20683678	CHEMBL4623649	Inhibition of human Aurora A using [H-LRRASLG] as substrate at 20 uM in presence of [gamma-33P]-ATP incubated for 2 hrs by hotspot kinase assay relative to control	B	CCOC(=O)c1cnc2ccc(Br)cc2c1Nc1cccc(NS(C)(=O)=O)c1		CHEMBL4640153	=	Inhibition	%	66.0	CHEMBL4722	Homo sapiens	INH	%	66.0
	20683679	CHEMBL4623649	Inhibition of human Aurora A using [H-LRRASLG] as substrate at 20 uM in presence of [gamma-33P]-ATP incubated for 2 hrs by hotspot kinase assay relative to control	B	CCOC(=O)c1cnc2ccc(C)cc2c1Nc1cccc(NS(C)(=O)=O)c1		CHEMBL4645713	=	Inhibition	%	64.4	CHEMBL4722	Homo sapiens	INH	%	64.4
	20683680	CHEMBL4623649	Inhibition of human Aurora A using [H-LRRASLG] as substrate at 20 uM in presence of [gamma-33P]-ATP incubated for 2 hrs by hotspot kinase assay relative to control	B	CCOC(=O)c1cnc2c(Cl)ccc(Cl)c2c1Nc1cccc(NS(C)(=O)=O)c1		CHEMBL4639147	=	Inhibition	%	37.65	CHEMBL4722	Homo sapiens	INH	%	37.65
	20683693	CHEMBL4623651	Inhibition of human Aurora A using [H-LRRASLG] as substrate in presence of [gamma-33P]-ATP incubated for 2 hrs by hotspot kinase assay	B	CCOC(=O)c1cnc2ccccc2c1Nc1cccc(S(N)(=O)=O)c1		CHEMBL4645551	=	IC50	nM	16600.0	CHEMBL4722	Homo sapiens	IC50	uM	16.6
Not Determined	20683694	CHEMBL4623651	Inhibition of human Aurora A using [H-LRRASLG] as substrate in presence of [gamma-33P]-ATP incubated for 2 hrs by hotspot kinase assay	B	CCOC(=O)c1cnc2ccc(Br)cc2c1Nc1cccc(S(N)(=O)=O)c1		CHEMBL4648901		IC50			CHEMBL4722	Homo sapiens	IC50		
Not Determined	20683695	CHEMBL4623651	Inhibition of human Aurora A using [H-LRRASLG] as substrate in presence of [gamma-33P]-ATP incubated for 2 hrs by hotspot kinase assay	B	CCOC(=O)c1cnc2ccc(C)cc2c1Nc1cccc(S(N)(=O)=O)c1		CHEMBL4644959		IC50			CHEMBL4722	Homo sapiens	IC50		
	20683696	CHEMBL4623651	Inhibition of human Aurora A using [H-LRRASLG] as substrate in presence of [gamma-33P]-ATP incubated for 2 hrs by hotspot kinase assay	B	CCOC(=O)c1cnc2cc(Cl)cc(Cl)c2c1Nc1cccc(S(N)(=O)=O)c1		CHEMBL4635411	=	IC50	nM	7640.0	CHEMBL4722	Homo sapiens	IC50	uM	7.64
	20683697	CHEMBL4623651	Inhibition of human Aurora A using [H-LRRASLG] as substrate in presence of [gamma-33P]-ATP incubated for 2 hrs by hotspot kinase assay	B	CCOC(=O)c1cnc2cc(Cl)cc(Cl)c2c1Nc1cccc(S(=O)(=O)NC)c1		CHEMBL4637300	=	IC50	nM	930.0	CHEMBL4722	Homo sapiens	IC50	uM	0.93
	20683698	CHEMBL4623651	Inhibition of human Aurora A using [H-LRRASLG] as substrate in presence of [gamma-33P]-ATP incubated for 2 hrs by hotspot kinase assay	B	CCOC(=O)c1cnc2ccccc2c1Nc1cccc(NS(C)(=O)=O)c1		CHEMBL4641064	=	IC50	nM	13400.0	CHEMBL4722	Homo sapiens	IC50	uM	13.4
	20683699	CHEMBL4623651	Inhibition of human Aurora A using [H-LRRASLG] as substrate in presence of [gamma-33P]-ATP incubated for 2 hrs by hotspot kinase assay	B	CCOC(=O)c1cnc2ccc(Br)cc2c1Nc1cccc(NS(C)(=O)=O)c1		CHEMBL4640153	=	IC50	nM	1770.0	CHEMBL4722	Homo sapiens	IC50	uM	1.77
	20683700	CHEMBL4623651	Inhibition of human Aurora A using [H-LRRASLG] as substrate in presence of [gamma-33P]-ATP incubated for 2 hrs by hotspot kinase assay	B	CCOC(=O)c1cnc2ccc(C)cc2c1Nc1cccc(NS(C)(=O)=O)c1		CHEMBL4645713	=	IC50	nM	980.0	CHEMBL4722	Homo sapiens	IC50	uM	0.98
Not Determined	20683701	CHEMBL4623651	Inhibition of human Aurora A using [H-LRRASLG] as substrate in presence of [gamma-33P]-ATP incubated for 2 hrs by hotspot kinase assay	B	CCOC(=O)c1cnc2c(Cl)ccc(Cl)c2c1Nc1cccc(NS(C)(=O)=O)c1		CHEMBL4639147		IC50			CHEMBL4722	Homo sapiens	IC50		
	20683703	CHEMBL4623651	Inhibition of human Aurora A using [H-LRRASLG] as substrate in presence of [gamma-33P]-ATP incubated for 2 hrs by hotspot kinase assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	3.0	CHEMBL4722	Homo sapiens	IC50	uM	0.003
	20683788	CHEMBL4623693	Inhibition of AURKA (unknown origin)	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Nc3ccc(S(N)(=O)=O)cc3)n2)n[nH]1		CHEMBL3237167	=	IC50	nM	5.0	CHEMBL4722	Homo sapiens	IC50	uM	0.005
	20683789	CHEMBL4623693	Inhibition of AURKA (unknown origin)	B	COc1cc2c(Nc3ccc(NC(=O)c4ccccc4)cc3)ncnc2cc1OCCCN1CCOCC1		CHEMBL202721	=	IC50	nM	110.0	CHEMBL4722	Homo sapiens	IC50	uM	0.11
	22391647	CHEMBL4666955	Inhibition of recombinant human His-tagged full length Aurora A expressed in baculovirus expression system using Ser/Thr 01 as substrate at 0.1 uM incubated for 60 mins by Z'-Lyte assay relative to control	B	O=C(Nc1c[nH]nc1-c1cc(Cl)ccc1OC(F)F)c1cnn2cccnc12		CHEMBL4744172	=	Inhibition	%	20.0	CHEMBL4722	Homo sapiens	INH	%	20.0
	22391648	CHEMBL4666955	Inhibition of recombinant human His-tagged full length Aurora A expressed in baculovirus expression system using Ser/Thr 01 as substrate at 0.1 uM incubated for 60 mins by Z'-Lyte assay relative to control	B	Cn1cc(NC(=O)c2cnn3cccnc23)c(-c2cc(Cl)ccc2OC(F)F)n1		CHEMBL4777342	=	Inhibition	%	13.0	CHEMBL4722	Homo sapiens	INH	%	13.0
	22391649	CHEMBL4666955	Inhibition of recombinant human His-tagged full length Aurora A expressed in baculovirus expression system using Ser/Thr 01 as substrate at 0.1 uM incubated for 60 mins by Z'-Lyte assay relative to control	B	O=C(Nc1c[nH]nc1-c1cc2ccccc2cc1OC(F)F)c1cnn2cccnc12		CHEMBL4745474	=	Inhibition	%	24.0	CHEMBL4722	Homo sapiens	INH	%	24.0
	22391931	CHEMBL4667082	Inhibition of recombinant human His-tagged full length Aurora A expressed in baculovirus expression system using Ser/Thr 01 as substrate at 10 uM incubated for 60 mins by Z'-Lyte assay relative to control	B	CN1C(=O)[C@@H](NC(=O)c2n[nH]c3ncc(C(F)(F)C(F)(F)F)cc23)COc2ccccc21		CHEMBL4785812	=	Inhibition	%	0.0	CHEMBL4722	Homo sapiens	INH	%	0.0
Dose-dependent effect	22393930	CHEMBL4667735	Inhibition of recombinant human N-terminal His-tagged Aurora A expressed in Sf21 cells using peptide substrate by TR-FRET assay	B	Cl.NCCO/N=C1C(=C2/C(=O)Nc3ccc([N+](=O)[O-])cc32)/Nc2ccc(O)cc2/1		CHEMBL4763626		Inhibition	%		CHEMBL4722	Homo sapiens	INH		
	22393931	CHEMBL4667735	Inhibition of recombinant human N-terminal His-tagged Aurora A expressed in Sf21 cells using peptide substrate by TR-FRET assay	B	Cl.NCCO/N=C1C(=C2/C(=O)Nc3ccc([N+](=O)[O-])cc32)/Nc2ccc(O)cc2/1		CHEMBL4763626	=	IC50	nM	222.0	CHEMBL4722	Homo sapiens	IC50	nM	222.0
	22393933	CHEMBL4667737	Inhibition of recombinant human N-terminal His-tagged Aurora A expressed in Sf21 cells using peptide substrate at 1 uM by TR-FRET assay relative to control	B	Cl.NCCO/N=C1C(=C2/C(=O)Nc3ccc([N+](=O)[O-])cc32)/Nc2ccc(O)cc2/1		CHEMBL4763626	=	Inhibition	%	47.7	CHEMBL4722	Homo sapiens	INH	%	47.7
	22395787	CHEMBL4668325	Inhibition of Aurora A (unknown origin)	B	COc1cc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2OC)=NC3)ccc1C(=O)O		CHEMBL483158	=	IC50	nM	1.2	CHEMBL4722	Homo sapiens	IC50	nM	1.2
	22408900	CHEMBL4671024	Inhibition of AuroraA (unknown origin) at 1 uM by Kinase-Glo luminescent kinase assay relative to control	B	Cn1cc(-c2nn(-c3ccc(NC(=O)Nc4ccc(Cl)c(C(F)(F)F)c4)cc3)c(=O)c3ccccc23)cn1		CHEMBL4785054	=	Inhibition	%	32.3	CHEMBL4722	Homo sapiens	INH	%	32.3
	22408901	CHEMBL4671024	Inhibition of AuroraA (unknown origin) at 1 uM by Kinase-Glo luminescent kinase assay relative to control	B	Cn1cc(-c2nn(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)c(=O)c3ccccc23)cn1		CHEMBL4751001	=	Inhibition	%	9.5	CHEMBL4722	Homo sapiens	INH	%	9.5
	22408902	CHEMBL4671024	Inhibition of AuroraA (unknown origin) at 1 uM by Kinase-Glo luminescent kinase assay relative to control	B	Cn1cc(-c2nn(-c3ccc(NC(=O)Nc4ccc(Cl)cc4)cc3)c(=O)c3ccccc23)cn1		CHEMBL4757792	=	Inhibition	%	9.2	CHEMBL4722	Homo sapiens	INH	%	9.2
	22408903	CHEMBL4671024	Inhibition of AuroraA (unknown origin) at 1 uM by Kinase-Glo luminescent kinase assay relative to control	B	Cn1cc(-c2nn(-c3ccc(NC(=O)Nc4ccc(F)cc4F)cc3)c(=O)c3ccccc23)cn1		CHEMBL4757774	<	Inhibition	%	1.0	CHEMBL4722	Homo sapiens	INH	%	1.0
	22408904	CHEMBL4671024	Inhibition of AuroraA (unknown origin) at 1 uM by Kinase-Glo luminescent kinase assay relative to control	B	O=C(Nc1ccc(Nc2n[nH]c(=O)c3ccccc23)cc1)Nc1ccc(Cl)c(C(F)(F)F)c1		CHEMBL4794671	=	Inhibition	%	10.4	CHEMBL4722	Homo sapiens	INH	%	10.4
	22408905	CHEMBL4671024	Inhibition of AuroraA (unknown origin) at 1 uM by Kinase-Glo luminescent kinase assay relative to control	B	O=C(Nc1ccc(Nc2n[nH]c(=O)c3ccccc23)cc1)Nc1cccc(C(F)(F)F)c1		CHEMBL4795345	=	Inhibition	%	16.9	CHEMBL4722	Homo sapiens	INH	%	16.9
	22408906	CHEMBL4671024	Inhibition of AuroraA (unknown origin) at 1 uM by Kinase-Glo luminescent kinase assay relative to control	B	O=C(Nc1ccc(CNc2n[nH]c(=O)c3ccccc23)cc1)Nc1ccc(Cl)c(C(F)(F)F)c1		CHEMBL4785603	=	Inhibition	%	4.2	CHEMBL4722	Homo sapiens	INH	%	4.2
	22408907	CHEMBL4671024	Inhibition of AuroraA (unknown origin) at 1 uM by Kinase-Glo luminescent kinase assay relative to control	B	O=C(Nc1ccc(CNc2n[nH]c(=O)c3ccccc23)cc1)Nc1cccc(C(F)(F)F)c1		CHEMBL4754133	=	Inhibition	%	6.1	CHEMBL4722	Homo sapiens	INH	%	6.1
	22408908	CHEMBL4671024	Inhibition of AuroraA (unknown origin) at 1 uM by Kinase-Glo luminescent kinase assay relative to control	B	O=C(Nc1ccc(CCNc2n[nH]c(=O)c3ccccc23)cc1)Nc1ccc(Cl)c(C(F)(F)F)c1		CHEMBL4758452	=	Inhibition	%	6.2	CHEMBL4722	Homo sapiens	INH	%	6.2
	22408909	CHEMBL4671024	Inhibition of AuroraA (unknown origin) at 1 uM by Kinase-Glo luminescent kinase assay relative to control	B	O=C(Nc1ccc(CCNc2n[nH]c(=O)c3ccccc23)cc1)Nc1cccc(C(F)(F)F)c1		CHEMBL4755343	=	Inhibition	%	16.3	CHEMBL4722	Homo sapiens	INH	%	16.3
	22408910	CHEMBL4671024	Inhibition of AuroraA (unknown origin) at 1 uM by Kinase-Glo luminescent kinase assay relative to control	B	O=C(Nc1ccc(Cl)cc1)Nc1ccc(CCNc2n[nH]c(=O)c3ccccc23)cc1		CHEMBL4763465	=	Inhibition	%	16.6	CHEMBL4722	Homo sapiens	INH	%	16.6
	22408911	CHEMBL4671024	Inhibition of AuroraA (unknown origin) at 1 uM by Kinase-Glo luminescent kinase assay relative to control	B	O=C(Nc1ccc(CCNc2n[nH]c(=O)c3ccccc23)cc1)NC1CCCCC1		CHEMBL4761521	=	Inhibition	%	28.8	CHEMBL4722	Homo sapiens	INH	%	28.8
	22408912	CHEMBL4671024	Inhibition of AuroraA (unknown origin) at 1 uM by Kinase-Glo luminescent kinase assay relative to control	B	O=C(Nc1ccc(CCNc2n[nH]c(=O)c3ccccc23)cc1)c1ccc(Cl)c(C(F)(F)F)c1		CHEMBL4745882	=	Inhibition	%	2.4	CHEMBL4722	Homo sapiens	INH	%	2.4
	22408913	CHEMBL4671024	Inhibition of AuroraA (unknown origin) at 1 uM by Kinase-Glo luminescent kinase assay relative to control	B	O=C(Nc1ccc(CCNc2n[nH]c(=O)c3ccccc23)cc1)c1cccc(C(F)(F)F)c1		CHEMBL4761439	=	Inhibition	%	6.8	CHEMBL4722	Homo sapiens	INH	%	6.8
	22408914	CHEMBL4671024	Inhibition of AuroraA (unknown origin) at 1 uM by Kinase-Glo luminescent kinase assay relative to control	B	O=C(Cc1cccc(C(F)(F)F)c1)Nc1ccc(CCNc2n[nH]c(=O)c3ccccc23)cc1		CHEMBL4784626	=	Inhibition	%	3.1	CHEMBL4722	Homo sapiens	INH	%	3.1
	22408915	CHEMBL4671024	Inhibition of AuroraA (unknown origin) at 1 uM by Kinase-Glo luminescent kinase assay relative to control	B	O=C(CC1CCCCC1)Nc1ccc(CCNc2n[nH]c(=O)c3ccccc23)cc1		CHEMBL4790560	=	Inhibition	%	17.3	CHEMBL4722	Homo sapiens	INH	%	17.3
	22408916	CHEMBL4671024	Inhibition of AuroraA (unknown origin) at 1 uM by Kinase-Glo luminescent kinase assay relative to control	B	O=C(Nc1ccc(CCNc2n[nH]c(=O)c3ccccc23)cc1)C1CCCCC1		CHEMBL4744828	=	Inhibition	%	5.9	CHEMBL4722	Homo sapiens	INH	%	5.9
	22408917	CHEMBL4671024	Inhibition of AuroraA (unknown origin) at 1 uM by Kinase-Glo luminescent kinase assay relative to control	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	Inhibition	%	97.4	CHEMBL4722	Homo sapiens	INH	%	97.4
	22408936	CHEMBL4671026	Inhibition of AuroraA (unknown origin)	B	Nc1ncc(-c2cnn(CCO)c2)c2scc(-c3ccc(NC(=O)Nc4cccc(F)c4)cc3)c12		CHEMBL1980297	=	IC50	nM	120.0	CHEMBL4722	Homo sapiens	IC50	nM	120.0
	22419405	CHEMBL4673019	Inhibition of AURA (unknown origin) at 0.1 uM in presence of ATP at Km concentration by TR-FRET assay relative to control	B	Cc1cc(-c2nc(C(=O)Nc3cc4oc(N5CCOCC5)nc4nc3N3CCC(O)CC3)co2)ccn1		CHEMBL4750630	=	Inhibition	%	3.0	CHEMBL4722	Homo sapiens	INH	%	3.0
	22419406	CHEMBL4673019	Inhibition of AURA (unknown origin) at 0.1 uM in presence of ATP at Km concentration by TR-FRET assay relative to control	B	Cc1cc(-c2nc(C(=O)Nc3cc4oc(N5CCOCC5)nc4nc3N3CCC(F)CC3)co2)ccn1		CHEMBL4784665	=	Inhibition	%	0.0	CHEMBL4722	Homo sapiens	INH	%	0.0
	22419407	CHEMBL4673019	Inhibition of AURA (unknown origin) at 0.1 uM in presence of ATP at Km concentration by TR-FRET assay relative to control	B	Cc1cc(-c2nc(C(=O)Nc3cc4oc(N5CCOCC5)nc4nc3N3CC[C@@H](O)C3)co2)ccn1		CHEMBL4783351	=	Inhibition	%	0.0	CHEMBL4722	Homo sapiens	INH	%	0.0
	22419408	CHEMBL4673019	Inhibition of AURA (unknown origin) at 0.1 uM in presence of ATP at Km concentration by TR-FRET assay relative to control	B	Cc1cc(-c2nc(C(=O)Nc3cc4oc(N5CCOCC5)nc4nc3N3CC[C@H](O)C3)co2)ccn1		CHEMBL4741488	=	Inhibition	%	6.0	CHEMBL4722	Homo sapiens	INH	%	6.0
	22419417	CHEMBL4673022	Inhibition of AURA (unknown origin) at 1 uM in presence of ATP at Km concentration by TR-FRET assay relative to control	B	Cc1cc(-c2nc(C(=O)Nc3cc4oc(N5CCOCC5)nc4nc3N3CCC(O)CC3)co2)ccn1		CHEMBL4750630	=	Inhibition	%	19.0	CHEMBL4722	Homo sapiens	INH	%	19.0
	22419418	CHEMBL4673022	Inhibition of AURA (unknown origin) at 1 uM in presence of ATP at Km concentration by TR-FRET assay relative to control	B	Cc1cc(-c2nc(C(=O)Nc3cc4oc(N5CCOCC5)nc4nc3N3CCC(F)CC3)co2)ccn1		CHEMBL4784665	=	Inhibition	%	13.0	CHEMBL4722	Homo sapiens	INH	%	13.0
	22419419	CHEMBL4673022	Inhibition of AURA (unknown origin) at 1 uM in presence of ATP at Km concentration by TR-FRET assay relative to control	B	Cc1cc(-c2nc(C(=O)Nc3cc4oc(N5CCOCC5)nc4nc3N3CC[C@@H](O)C3)co2)ccn1		CHEMBL4783351	=	Inhibition	%	0.0	CHEMBL4722	Homo sapiens	INH	%	0.0
	22419420	CHEMBL4673022	Inhibition of AURA (unknown origin) at 1 uM in presence of ATP at Km concentration by TR-FRET assay relative to control	B	Cc1cc(-c2nc(C(=O)Nc3cc4oc(N5CCOCC5)nc4nc3N3CC[C@H](O)C3)co2)ccn1		CHEMBL4741488	=	Inhibition	%	5.0	CHEMBL4722	Homo sapiens	INH	%	5.0
	22423123	CHEMBL4674136	Inhibition of human Aurora A using [H-LRRASLG] as substrate at 0.5 uM by [gamma-33P]-ATP assay relative to control	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	>	Inhibition	%	80.0	CHEMBL4722	Homo sapiens	INH	%	80.0
	22423821	CHEMBL4674486	Inhibition of human Aurora A using [H-LRRASLG] as substrate assessed as residual activity at 1 uM by [gamma-33P]-ATP assay relative to control	B	Nc1ncc(-c2cnc(C3CCNCC3)s2)cc1OC1CCCCC1		CHEMBL4785602	=	Activity	%	62.44	CHEMBL4722	Homo sapiens	Activity	%	62.44
	22423822	CHEMBL4674486	Inhibition of human Aurora A using [H-LRRASLG] as substrate assessed as residual activity at 1 uM by [gamma-33P]-ATP assay relative to control	B	Nc1ncc(-c2cnc(C3CCNCC3)s2)cc1OCc1ccncc1		CHEMBL4749141	=	Activity	%	46.75	CHEMBL4722	Homo sapiens	Activity	%	46.75
	22455886	CHEMBL4682016	Inhibition of Aurora A (unknown origin)	B	Nc1ncc(-c2ccc(C(=O)O)cc2)cc1-c1ccc(Cl)cc1		CHEMBL4757082	>	IC50	nM	30000.0	CHEMBL4722	Homo sapiens	IC50	uM	30.0
	22752650	CHEMBL4700129	Inhibition of Aurora A (unknown origin) preincubated with enzyme for 15 mins followed by substrate/ATP challenge for 90 mins by ProfilerPro plate based lab-chip EZ reader analysis	B	C#Cc1nc(Nc2cccc(CC(N)=O)c2)nc2[nH]cnc12		CHEMBL4786783	=	IC50	nM	80.0	CHEMBL4722	Homo sapiens	IC50	uM	0.08
Not Determined	22752705	CHEMBL4700175	Inhibition of human Aurora A by kinase-profiling analysis	B	C#Cc1nc(Nc2ccc(S(N)(=O)=O)cc2)nc2[nH]cnc12		CHEMBL4074015		IC50			CHEMBL4722	Homo sapiens	IC50		
	22752706	CHEMBL4700175	Inhibition of human Aurora A by kinase-profiling analysis	B	C#Cc1nc(Nc2ccccc2)nc2[nH]cnc12		CHEMBL4094562	=	IC50	nM	1300.0	CHEMBL4722	Homo sapiens	IC50	uM	1.3
	22766114	CHEMBL4703211	Inhibition of recombinant Aurora A (unknown origin) using myelin basic protein as substrate incubated for 30 mins in presence or absence of DTT by [gamma-33P]-ATP based radioactive filter binding assay	B	CCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COC(=O)CC(=O)OC[C@@H]1O[C@H](n2cnc3c(N)ncnc32)[C@@H](O)[C@H]1O	Outside typical range	CHEMBL4756152	=	IC50	nM	1300000.0	CHEMBL4722	Homo sapiens	IC50	uM	1300.0
	22766115	CHEMBL4703211	Inhibition of recombinant Aurora A (unknown origin) using myelin basic protein as substrate incubated for 30 mins in presence or absence of DTT by [gamma-33P]-ATP based radioactive filter binding assay	B	Nc1ncnc2c1ncn2[C@H]1O[C@@H](COC(=O)CC(=O)O)[C@H](O)[C@@H]1O	Outside typical range	CHEMBL4794430	=	IC50	nM	420000.0	CHEMBL4722	Homo sapiens	IC50	uM	420.0
	22766116	CHEMBL4703211	Inhibition of recombinant Aurora A (unknown origin) using myelin basic protein as substrate incubated for 30 mins in presence or absence of DTT by [gamma-33P]-ATP based radioactive filter binding assay	B	CCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COC(=O)CC(=O)NC[C@@H]1O[C@H](n2cnc3c(N)ncnc32)[C@@H](O)[C@H]1O	Outside typical range	CHEMBL4792773	=	IC50	nM	1100000.0	CHEMBL4722	Homo sapiens	IC50	uM	1100.0
	22766117	CHEMBL4703211	Inhibition of recombinant Aurora A (unknown origin) using myelin basic protein as substrate incubated for 30 mins in presence or absence of DTT by [gamma-33P]-ATP based radioactive filter binding assay	B	Nc1ncnc2c1ncn2[C@H]1O[C@@H](CNC(=O)CC(=O)O)[C@H](O)[C@@H]1O	Outside typical range	CHEMBL4754114	=	IC50	nM	910000.0	CHEMBL4722	Homo sapiens	IC50	uM	910.0
	22766118	CHEMBL4703211	Inhibition of recombinant Aurora A (unknown origin) using myelin basic protein as substrate incubated for 30 mins in presence or absence of DTT by [gamma-33P]-ATP based radioactive filter binding assay	B	CCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COC(=O)CCC(=O)OC[C@@H]1O[C@H](n2cnc3c(N)ncnc32)[C@@H](O)[C@H]1O	Outside typical range	CHEMBL4745854	=	IC50	nM	497000.0	CHEMBL4722	Homo sapiens	IC50	uM	497.0
	22766119	CHEMBL4703211	Inhibition of recombinant Aurora A (unknown origin) using myelin basic protein as substrate incubated for 30 mins in presence or absence of DTT by [gamma-33P]-ATP based radioactive filter binding assay	B	CCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COC(=O)CCCC(=O)OC[C@@H]1O[C@H](n2cnc3c(N)ncnc32)[C@@H](O)[C@H]1O	Outside typical range	CHEMBL4742648	=	IC50	nM	542000.0	CHEMBL4722	Homo sapiens	IC50	uM	542.0
	22766120	CHEMBL4703211	Inhibition of recombinant Aurora A (unknown origin) using myelin basic protein as substrate incubated for 30 mins in presence or absence of DTT by [gamma-33P]-ATP based radioactive filter binding assay	B	CC(C)(C)COC(=O)CCC(=O)OC[C@@H]1O[C@H](n2cnc3c(N)ncnc32)[C@@H](O)[C@H]1O	Outside typical range	CHEMBL4783213	=	IC50	nM	430000.0	CHEMBL4722	Homo sapiens	IC50	uM	430.0
	22766121	CHEMBL4703211	Inhibition of recombinant Aurora A (unknown origin) using myelin basic protein as substrate incubated for 30 mins in presence or absence of DTT by [gamma-33P]-ATP based radioactive filter binding assay	B	CNC(=O)[C@H](O)C(C)(C)COC(=O)CCC(=O)OC[C@@H]1O[C@H](n2cnc3c(N)ncnc32)[C@@H](O)[C@H]1O	Outside typical range	CHEMBL4748202	=	IC50	nM	1300000.0	CHEMBL4722	Homo sapiens	IC50	uM	1300.0
	22766122	CHEMBL4703211	Inhibition of recombinant Aurora A (unknown origin) using myelin basic protein as substrate incubated for 30 mins in presence or absence of DTT by [gamma-33P]-ATP based radioactive filter binding assay	B	CNC(=O)CCNC(=O)[C@H](O)C(C)(C)COC(=O)CCC(=O)OC[C@@H]1O[C@H](n2cnc3c(N)ncnc32)[C@@H](O)[C@H]1O	Outside typical range	CHEMBL4754844	=	IC50	nM	1400000.0	CHEMBL4722	Homo sapiens	IC50	uM	1400.0
	22766123	CHEMBL4703211	Inhibition of recombinant Aurora A (unknown origin) using myelin basic protein as substrate incubated for 30 mins in presence or absence of DTT by [gamma-33P]-ATP based radioactive filter binding assay	B	CC(C)(COC(=O)CCC(=O)OC[C@@H]1O[C@H](n2cnc3c(N)ncnc32)[C@@H](O)[C@H]1O)[C@@H](O)C(=O)NCCC(=O)NCCS		CHEMBL4777408	=	IC50	nM	83000.0	CHEMBL4722	Homo sapiens	IC50	uM	83.0
	22766124	CHEMBL4703211	Inhibition of recombinant Aurora A (unknown origin) using myelin basic protein as substrate incubated for 30 mins in presence or absence of DTT by [gamma-33P]-ATP based radioactive filter binding assay	B	CC(C)(COP(=O)(O)OP(=O)(O)OC[C@@H]1O[C@H](n2cnc3c(N)ncnc32)[C@@H](O)[C@H]1OP(=O)(O)O)[C@H](O)C(=O)NCCC(=O)NCCS		CHEMBL4756598	=	IC50	nM	5000.0	CHEMBL4722	Homo sapiens	IC50	uM	5.0
	22766125	CHEMBL4703211	Inhibition of recombinant Aurora A (unknown origin) using myelin basic protein as substrate incubated for 30 mins in presence or absence of DTT by [gamma-33P]-ATP based radioactive filter binding assay	B	CC(C)(COP(=O)(O)OP(=O)(O)OC[C@@H]1O[C@H](n2cnc3c(N)ncnc32)[C@@H](O)[C@H]1O)[C@H](O)C(=O)NCCC(=O)NCCS		CHEMBL4750759	=	IC50	nM	17000.0	CHEMBL4722	Homo sapiens	IC50	uM	17.0
	22766126	CHEMBL4703211	Inhibition of recombinant Aurora A (unknown origin) using myelin basic protein as substrate incubated for 30 mins in presence or absence of DTT by [gamma-33P]-ATP based radioactive filter binding assay	B	CCNC(=O)CCNC(=O)[C@@H](O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@@H]1O[C@H](n2cnc3c(N)ncnc32)[C@@H](O)[C@H]1OP(=O)(O)O	Outside typical range	CHEMBL4752126	=	IC50	nM	160000.0	CHEMBL4722	Homo sapiens	IC50	uM	160.0
	22766127	CHEMBL4703212	Inhibition of recombinant Aurora A (unknown origin) using myelin basic protein as substrate incubated for 30 mins in presence of DTT by [gamma-33P]-ATP based radioactive filter binding assay	B	CC(C)(COC(=O)CCC(=O)OC[C@@H]1O[C@H](n2cnc3c(N)ncnc32)[C@@H](O)[C@H]1O)[C@@H](O)C(=O)NCCC(=O)NCCS	Outside typical range	CHEMBL4777408	=	IC50	nM	731000.0	CHEMBL4722	Homo sapiens	IC50	uM	731.0
	22766128	CHEMBL4703213	Inhibition of recombinant Aurora A (unknown origin) using myelin basic protein as substrate incubated for 30 mins in absence of DTT by [gamma-33P]-ATP based radioactive filter binding assay	B	CC(C)(COC(=O)CCC(=O)OC[C@@H]1O[C@H](n2cnc3c(N)ncnc32)[C@@H](O)[C@H]1O)[C@@H](O)C(=O)NCCC(=O)NCCS	Outside typical range	CHEMBL4777408	=	IC50	nM	117000.0	CHEMBL4722	Homo sapiens	IC50	uM	117.0
	22768266	CHEMBL4703626	Inhibition of human Aurora A	B	COc1cccc(Cn2cnc3ccc(-c4cn[nH]c4)cc3c2=O)c1		CHEMBL4742990	=	IC50	nM	11.0	CHEMBL4722	Homo sapiens	IC50	nM	11.0
	22768267	CHEMBL4703626	Inhibition of human Aurora A	B	COc1cccc(Cn2ncc3ccc(-c4cn[nH]c4)cc3c2=O)c1		CHEMBL4744858	=	IC50	nM	137.0	CHEMBL4722	Homo sapiens	IC50	nM	137.0
	22790970	CHEMBL4709475	Inhibition of AuroraA (unknown origin) assessed as residual activity at 0.1 uM preincubated for 20 min followed by [gamma33P]ATP addition and measured after 120 mins by Hotspot assay relative to control	B	Cc1cccn(-c2ccc(-c3ccc4c(C(=O)NCc5ccncc5)n[nH]c4c3)c(Cl)c2)c1=O		CHEMBL4758500	=	Activity	%	87.8	CHEMBL4722	Homo sapiens	Activity	%	87.8
Not Determined	22803253	CHEMBL4711872	Inhibition of Aurora A (unknown origin) incubated for 40 mins in presence of ATP by Kinase-glo luminescence assay	B	O=C(Nc1c[nH]nc1-c1nc(-c2ccc(CN3CCOCC3)cc2)c[nH]1)c1ccccc1		CHEMBL4778011		IC50			CHEMBL4722	Homo sapiens	IC50		
	22803254	CHEMBL4711872	Inhibition of Aurora A (unknown origin) incubated for 40 mins in presence of ATP by Kinase-glo luminescence assay	B	COc1ccc(C(=O)Nc2c[nH]nc2-c2nc(-c3ccc(CN4CCOCC4)cc3)c[nH]2)cc1		CHEMBL4782433	=	IC50	nM	359.0	CHEMBL4722	Homo sapiens	IC50	uM	0.359
	22803255	CHEMBL4711872	Inhibition of Aurora A (unknown origin) incubated for 40 mins in presence of ATP by Kinase-glo luminescence assay	B	O=C(Nc1c[nH]nc1-c1nc(-c2ccc(CN3CCOCC3)cc2)c[nH]1)c1ccc([N+](=O)[O-])cc1		CHEMBL4744513	=	IC50	nM	466.0	CHEMBL4722	Homo sapiens	IC50	uM	0.466
	22803256	CHEMBL4711872	Inhibition of Aurora A (unknown origin) incubated for 40 mins in presence of ATP by Kinase-glo luminescence assay	B	O=C(Nc1c[nH]nc1-c1nc(-c2ccc(CN3CCOCC3)cc2)c[nH]1)c1ccc(Cl)cc1		CHEMBL4763483	=	IC50	nM	2514.0	CHEMBL4722	Homo sapiens	IC50	uM	2.5140000000000002
	22803257	CHEMBL4711872	Inhibition of Aurora A (unknown origin) incubated for 40 mins in presence of ATP by Kinase-glo luminescence assay	B	O=C(Nc1c[nH]nc1-c1nc(-c2ccc(CN3CCOCC3)cc2)c[nH]1)c1cccc(Cl)c1		CHEMBL4758261	=	IC50	nM	939.0	CHEMBL4722	Homo sapiens	IC50	uM	0.9390000000000001
Not Determined	22803258	CHEMBL4711872	Inhibition of Aurora A (unknown origin) incubated for 40 mins in presence of ATP by Kinase-glo luminescence assay	B	O=C(Nc1c[nH]nc1-c1nc(-c2ccc(CN3CCCC3)cc2)c[nH]1)c1ccc([N+](=O)[O-])cc1		CHEMBL4761780		IC50			CHEMBL4722	Homo sapiens	IC50		
	22803259	CHEMBL4711872	Inhibition of Aurora A (unknown origin) incubated for 40 mins in presence of ATP by Kinase-glo luminescence assay	B	COc1ccc(C(=O)Nc2c[nH]nc2-c2nc(-c3ccc(CN4CCCCC4)cc3)c[nH]2)cc1		CHEMBL4750823	=	IC50	nM	1523.0	CHEMBL4722	Homo sapiens	IC50	uM	1.5230000000000001
	22803260	CHEMBL4711872	Inhibition of Aurora A (unknown origin) incubated for 40 mins in presence of ATP by Kinase-glo luminescence assay	B	O=C(Nc1c[nH]nc1-c1nc(-c2ccc(CN3CCCCC3)cc2)c[nH]1)c1ccc(Cl)cc1		CHEMBL4797744	=	IC50	nM	2055.0	CHEMBL4722	Homo sapiens	IC50	uM	2.055
	22803261	CHEMBL4711872	Inhibition of Aurora A (unknown origin) incubated for 40 mins in presence of ATP by Kinase-glo luminescence assay	B	O=C(Nc1c[nH]nc1-c1nc(-c2ccc(CN3CCCCC3)cc2)c[nH]1)c1cccc(Cl)c1		CHEMBL4795804	=	IC50	nM	1132.0	CHEMBL4722	Homo sapiens	IC50	uM	1.1320000000000001
	22803262	CHEMBL4711872	Inhibition of Aurora A (unknown origin) incubated for 40 mins in presence of ATP by Kinase-glo luminescence assay	B	Cc1nc(Cl)cc(Nc2c[nH]nc2-c2nc(-c3ccc(CN4CCOCC4)cc3)c[nH]2)n1		CHEMBL4794655	=	IC50	nM	145.0	CHEMBL4722	Homo sapiens	IC50	uM	0.145
	22803263	CHEMBL4711872	Inhibition of Aurora A (unknown origin) incubated for 40 mins in presence of ATP by Kinase-glo luminescence assay	B	O=C(Nc1c[nH]nc1-c1nc2ccc(CN3CCOCC3)cc2[nH]1)NC1CC1		CHEMBL495727	=	IC50	nM	26.0	CHEMBL4722	Homo sapiens	IC50	uM	0.026000000000000002
Not Determined	22803264	CHEMBL4711872	Inhibition of Aurora A (unknown origin) incubated for 40 mins in presence of ATP by Kinase-glo luminescence assay	B	CSc1nc(Cl)c(C)c(Nc2c[nH]nc2-c2ncc(-c3ccc(OCCCN4CCOCC4)cc3)[nH]2)n1		CHEMBL4789251		IC50			CHEMBL4722	Homo sapiens	IC50		
Dose-dependent effect	22803309	CHEMBL4711882	Inhibition of Aurora A phosphorylation in human K562 cells incubated for 48 hrs by Western blot analysis	B	O=C(Nc1c[nH]nc1-c1nc(-c2ccc(CN3CCOCC3)cc2)c[nH]1)c1cccc(Cl)c1		CHEMBL4758261		Inhibition	%		CHEMBL4722	Homo sapiens	INH		
Dose-dependent effect	22803311	CHEMBL4711884	Inhibition of Aurora A phosphorylation in human HCT116 cells incubated for 48 hrs by Western blot analysis	B	O=C(Nc1c[nH]nc1-c1nc(-c2ccc(CN3CCOCC3)cc2)c[nH]1)c1cccc(Cl)c1		CHEMBL4758261		Inhibition	%		CHEMBL4722	Homo sapiens	INH		
	22809757	CHEMBL4713292	Inhibition of recombinant full length human Aurora-A assessed as residual activity at 1 uM using LRRASLG as substrate incubated for 40 mins in presence of Km ATP by radiometric scintillation counting analysis relative to control	B	CNC(=O)c1cnc2[nH]ccc2c1N[C@@H]1CCN(Cc2ccc(Cl)cc2)[C@H](C)C1		CHEMBL4761365	=	Activity	%	10.0	CHEMBL4722	Homo sapiens	Activity	%	10.0
	22820430	CHEMBL4716217	Inhibition of human recombinant Aurora A assessed as residual activity at 1 uM relative to control	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCNCC1		CHEMBL2403108	=	Activity	%	82.0	CHEMBL4722	Homo sapiens	Activity	%	82.0
	22820431	CHEMBL4716217	Inhibition of human recombinant Aurora A assessed as residual activity at 1 uM relative to control	B	COc1cc2c(cc1Nc1ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n1)CCNC2		CHEMBL4782674	=	Activity	%	4.0	CHEMBL4722	Homo sapiens	Activity	%	4.0
	22826313	CHEMBL4717498	Inhibition of human recombinant Aurora A assessed as residual activity at 10 uM relative to control	B	CN1CCN(CCCOc2cccc3nc(Nc4ccc(Cl)c(C(F)(F)F)c4)ccc23)CC1		CHEMBL4797203	<	Activity	%	60.0	CHEMBL4722	Homo sapiens	Activity	%	60.0
	22836132	CHEMBL4718844	Inhibition of recombinant human full length His-tagged AURKA expressed in baculovirus expression system at 500 nM using Ser/Thr 01 as substrate incubated for 1 hr in presence of ATP at its Km concentration by Z'-LYTE assay relative to control	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	=	Inhibition	%	20.0	CHEMBL4722	Homo sapiens	INH	%	20.0
	22836133	CHEMBL4718844	Inhibition of recombinant human full length His-tagged AURKA expressed in baculovirus expression system at 500 nM using Ser/Thr 01 as substrate incubated for 1 hr in presence of ATP at its Km concentration by Z'-LYTE assay relative to control	B	OCC[C@@H](Nc1ncnc2[nH]c(-c3ccccc3)cc12)c1ccccc1		CHEMBL4786776	=	Inhibition	%	-3.0	CHEMBL4722	Homo sapiens	INH	%	-3.0
	22836134	CHEMBL4718844	Inhibition of recombinant human full length His-tagged AURKA expressed in baculovirus expression system at 500 nM using Ser/Thr 01 as substrate incubated for 1 hr in presence of ATP at its Km concentration by Z'-LYTE assay relative to control	B	CN(C)CCNCc1ccc(-c2cc3c(N[C@H](CO)c4ccccc4)ncnc3[nH]2)cc1F		CHEMBL4748367	=	Inhibition	%	3.0	CHEMBL4722	Homo sapiens	INH	%	3.0
	22836135	CHEMBL4718844	Inhibition of recombinant human full length His-tagged AURKA expressed in baculovirus expression system at 500 nM using Ser/Thr 01 as substrate incubated for 1 hr in presence of ATP at its Km concentration by Z'-LYTE assay relative to control	B	OC[C@@H](Nc1ncnc2[nH]c(-c3ccccc3)cc12)c1ccccc1		CHEMBL4780286	=	Inhibition	%	19.0	CHEMBL4722	Homo sapiens	INH	%	19.0
	22836136	CHEMBL4718844	Inhibition of recombinant human full length His-tagged AURKA expressed in baculovirus expression system at 500 nM using Ser/Thr 01 as substrate incubated for 1 hr in presence of ATP at its Km concentration by Z'-LYTE assay relative to control	B	COc1ccccc1-c1cc2c(N[C@H](CO)c3ccccc3)ncnc2[nH]1		CHEMBL4783569	=	Inhibition	%	9.0	CHEMBL4722	Homo sapiens	INH	%	9.0
	22836137	CHEMBL4718844	Inhibition of recombinant human full length His-tagged AURKA expressed in baculovirus expression system at 500 nM using Ser/Thr 01 as substrate incubated for 1 hr in presence of ATP at its Km concentration by Z'-LYTE assay relative to control	B	CCOc1ccccc1-c1cc2c(N[C@H](CO)c3ccccc3)ncnc2[nH]1		CHEMBL4776396	=	Inhibition	%	-2.0	CHEMBL4722	Homo sapiens	INH	%	-2.0
	22843497	CHEMBL4720494	Inhibition of human Aurora A assessed as residual activity using [H-LRRASLG] as substrate at 1 uM by [gamma-33P]-ATP assay relative to control	B	O=C(Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1)c1cc([N+](=O)[O-])ccc1F		CHEMBL4750196	=	Activity	%	85.68	CHEMBL4722	Homo sapiens	Activity	%	85.68
	22843844	CHEMBL4720830	Inhibition of human Aurora A using [H-LRRASLG] as substrate by [gamma-33P]-ATP assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	0.936	CHEMBL4722	Homo sapiens	IC50	10^-10M	9.36
	22844623	CHEMBL4721298	Inhibition of wild-type human partial length AURKA (E122 to K401 residues) expressed in mammalian expression system assessed as residual activity at 1 uM by Kinomescan method relative to control	B	CCOc1nc(Nc2ccc(C(=O)N3CCOCC3)cc2OC)nc2[nH]ccc12		CHEMBL4794578	=	Activity	%	94.81	CHEMBL4722	Homo sapiens	Activity	%	94.81
	22849862	CHEMBL4723264	Inhibition of Aurora A (unknown origin) by biochemical assay	B	COCCOc1cc(NC(=O)N2CCCc3cc(CN4CCN(C)CC4=O)c(C=O)nc32)ncc1C#N		CHEMBL3973674	=	IC50	nM	5600.0	CHEMBL4722	Homo sapiens	IC50	nM	5600.0
	22887460	CHEMBL4728480	Inhibition AuroraA (unknown origin) at 1 uM relative to control	B	CC(C)N1c2cc(Nc3nccc(-c4ccccc4)n3)ccc2N(C)C(=O)[C@H]1C		CHEMBL4748851	=	Inhibition	%	67.4	CHEMBL4722	Homo sapiens	INH	%	67.4
	22887461	CHEMBL4728480	Inhibition AuroraA (unknown origin) at 1 uM relative to control	B	CC(C)N1c2cc(Nc3nccc(-c4ccncc4)n3)ccc2N(C)C(=O)[C@H]1C		CHEMBL4747650	=	Inhibition	%	43.7	CHEMBL4722	Homo sapiens	INH	%	43.7
	22887462	CHEMBL4728480	Inhibition AuroraA (unknown origin) at 1 uM relative to control	B	COc1ccccc1-c1ccnc(Nc2ccc3c(c2)N(C(C)C)[C@H](C)C(=O)N3C)n1		CHEMBL4790090	=	Inhibition	%	86.8	CHEMBL4722	Homo sapiens	INH	%	86.8
	22887463	CHEMBL4728480	Inhibition AuroraA (unknown origin) at 1 uM relative to control	B	CC(C)N1c2cc(Nc3nccc(-c4cccc(C#N)c4)n3)ccc2N(C)C(=O)[C@H]1C		CHEMBL4759451	=	Inhibition	%	54.4	CHEMBL4722	Homo sapiens	INH	%	54.4
	22887464	CHEMBL4728480	Inhibition AuroraA (unknown origin) at 1 uM relative to control	B	CC(C)N1c2cc(Nc3cccc(-c4ccccc4)c3)ccc2N(C)C(=O)[C@H]1C		CHEMBL4780212	=	Inhibition	%	-1.5	CHEMBL4722	Homo sapiens	INH	%	-1.5
	22887465	CHEMBL4728480	Inhibition AuroraA (unknown origin) at 1 uM relative to control	B	CC(C)N1c2cc(Nc3cccc(-c4ccncc4)c3)ccc2N(C)C(=O)[C@H]1C		CHEMBL4779338	=	Inhibition	%	14.2	CHEMBL4722	Homo sapiens	INH	%	14.2
	22887466	CHEMBL4728480	Inhibition AuroraA (unknown origin) at 1 uM relative to control	B	COc1ccccc1-c1cccc(Nc2ccc3c(c2)N(C(C)C)[C@H](C)C(=O)N3C)c1		CHEMBL4754662	=	Inhibition	%	-0.8	CHEMBL4722	Homo sapiens	INH	%	-0.8
	22887467	CHEMBL4728480	Inhibition AuroraA (unknown origin) at 1 uM relative to control	B	CC(C)N1c2cc(Nc3cccc(-c4cccc(C#N)c4)c3)ccc2N(C)C(=O)[C@H]1C		CHEMBL4756378	=	Inhibition	%	-1.8	CHEMBL4722	Homo sapiens	INH	%	-1.8
	22887468	CHEMBL4728481	Inhibition AuroraA (unknown origin) at 100 nM relative to control	B	CC(C)N1c2cc(Nc3nccc(-c4ccccc4)n3)ccc2N(C)C(=O)[C@H]1C		CHEMBL4748851	=	Inhibition	%	10.6	CHEMBL4722	Homo sapiens	INH	%	10.6
	22887469	CHEMBL4728481	Inhibition AuroraA (unknown origin) at 100 nM relative to control	B	CC(C)N1c2cc(Nc3nccc(-c4ccncc4)n3)ccc2N(C)C(=O)[C@H]1C		CHEMBL4747650	=	Inhibition	%	4.0	CHEMBL4722	Homo sapiens	INH	%	4.0
	22887470	CHEMBL4728481	Inhibition AuroraA (unknown origin) at 100 nM relative to control	B	COc1ccccc1-c1ccnc(Nc2ccc3c(c2)N(C(C)C)[C@H](C)C(=O)N3C)n1		CHEMBL4790090	=	Inhibition	%	37.4	CHEMBL4722	Homo sapiens	INH	%	37.4
	22887471	CHEMBL4728481	Inhibition AuroraA (unknown origin) at 100 nM relative to control	B	CC(C)N1c2cc(Nc3nccc(-c4cccc(C#N)c4)n3)ccc2N(C)C(=O)[C@H]1C		CHEMBL4759451	=	Inhibition	%	8.7	CHEMBL4722	Homo sapiens	INH	%	8.7
	22887472	CHEMBL4728481	Inhibition AuroraA (unknown origin) at 100 nM relative to control	B	CC(C)N1c2cc(Nc3cccc(-c4ccccc4)c3)ccc2N(C)C(=O)[C@H]1C		CHEMBL4780212	=	Inhibition	%	-3.4	CHEMBL4722	Homo sapiens	INH	%	-3.4
	22887473	CHEMBL4728481	Inhibition AuroraA (unknown origin) at 100 nM relative to control	B	CC(C)N1c2cc(Nc3cccc(-c4ccncc4)c3)ccc2N(C)C(=O)[C@H]1C		CHEMBL4779338	=	Inhibition	%	-6.1	CHEMBL4722	Homo sapiens	INH	%	-6.1
	22887474	CHEMBL4728481	Inhibition AuroraA (unknown origin) at 100 nM relative to control	B	COc1ccccc1-c1cccc(Nc2ccc3c(c2)N(C(C)C)[C@H](C)C(=O)N3C)c1		CHEMBL4754662	=	Inhibition	%	1.1	CHEMBL4722	Homo sapiens	INH	%	1.1
	22887475	CHEMBL4728481	Inhibition AuroraA (unknown origin) at 100 nM relative to control	B	CC(C)N1c2cc(Nc3cccc(-c4cccc(C#N)c4)c3)ccc2N(C)C(=O)[C@H]1C		CHEMBL4756378	=	Inhibition	%	-3.0	CHEMBL4722	Homo sapiens	INH	%	-3.0
Not Active	22889485	CHEMBL4729004	Inhibition of wild-type human partial length AURKA (E122 to K401 residues) expressed in mammalian expression system at 1 uM by Kinomescan method	B	COc1cc(OCc2ccnc(Nc3cnn(C)c3)n2)cc2sc(N[C@H]3CCCC[C@@H]3O)nc12		CHEMBL4748740		Inhibition	%		CHEMBL4722	Homo sapiens	INH		
Not Active	22909793	CHEMBL4734039	Inhibition of recombinant human full length AURKA expressed in baculovirus expression system using Ser/Thr-01 peptide as substrate at 10 uM after 1 hr in presence of ATP by Z'LYTE assay	B	c1ccc(CSc2ncnc3[nH]cnc23)cc1		CHEMBL397434		Inhibition	%		CHEMBL4722	Homo sapiens	INH		
Not Active	22909794	CHEMBL4734039	Inhibition of recombinant human full length AURKA expressed in baculovirus expression system using Ser/Thr-01 peptide as substrate at 10 uM after 1 hr in presence of ATP by Z'LYTE assay	B	Clc1cccc(CSc2ncnc3[nH]cnc23)c1		CHEMBL4754930		Inhibition	%		CHEMBL4722	Homo sapiens	INH		
Not Active	22909795	CHEMBL4734039	Inhibition of recombinant human full length AURKA expressed in baculovirus expression system using Ser/Thr-01 peptide as substrate at 10 uM after 1 hr in presence of ATP by Z'LYTE assay	B	Brc1ccccc1CSc1ncnc2[nH]cnc12		CHEMBL4776788		Inhibition	%		CHEMBL4722	Homo sapiens	INH		
	22913255	CHEMBL4734886	Inhibition of AURKA (unknown origin)	B	O=C1C=CC2(C=C1)OCC(=O)N2c1nc(-c2cccc3ccccc23)nn1-c1ccccc1		CHEMBL4756015	>	IC50	nM	100000.0	CHEMBL4722	Homo sapiens	IC50	uM	100.0
Not Active	22936026	CHEMBL4739723	Inhibition of human Aurora A at 1 uM using substrate peptide by off-chip mobility shift assay	B	CC(=O)c1ccc(C(N)=O)cc1Oc1ccc(OCCOC2CCOCC2)cc1		CHEMBL4749965		Inhibition	%		CHEMBL4722	Homo sapiens	INH		
	22952757	CHEMBL4766694	Inhibition of recombinant full length human Aurora A assessed as residual activity at 10 uM using LRRASLG as substrate incubated for 40 mins in presence of [gamma-33ATP] by scintillation counting based radiometry assay relative to control	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Nc3ncnc4c3OCCCN4)cc2)no1		CHEMBL4793380	=	Activity	%	47.0	CHEMBL4722	Homo sapiens	Activity	%	47.0
	22957739	CHEMBL4768048	Inhibition of Aurora A (unknown origin)	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(/C=C/c3ccccc3)n2)n[nH]1		CHEMBL482968	=	IC50	nM	14.0	CHEMBL4722	Homo sapiens	IC50	nM	14.0
	22957815	CHEMBL4768060	Inhibition of Aurora A (unknown origin) incubated for 1 hrs by HTRF assay	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(/C=C/c3ccccc3)n2)n[nH]1		CHEMBL482968	=	IC50	nM	15.28	CHEMBL4722	Homo sapiens	IC50	nM	15.28
	22957816	CHEMBL4768060	Inhibition of Aurora A (unknown origin) incubated for 1 hrs by HTRF assay	B	CCC(=O)Nc1nc2ccc(-c3ccc4ncn(CCN5CCOCC5)c(=O)c4c3)cc2[nH]1		CHEMBL4785479	=	IC50	nM	21.94	CHEMBL4722	Homo sapiens	IC50	nM	21.94
	22957817	CHEMBL4768060	Inhibition of Aurora A (unknown origin) incubated for 1 hrs by HTRF assay	B	CCC(=O)Nc1nc2ccc(-c3ccc4ncn(CCc5c[nH]c6ccccc56)c(=O)c4c3)cc2[nH]1		CHEMBL4794556	=	IC50	nM	27.12	CHEMBL4722	Homo sapiens	IC50	nM	27.12
	22957818	CHEMBL4768060	Inhibition of Aurora A (unknown origin) incubated for 1 hrs by HTRF assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	18.09	CHEMBL4722	Homo sapiens	IC50	nM	18.09
Dose-dependent effect	22957823	CHEMBL4768062	Inhibition of Aurora A in human MDA-MB-231 cells assessed as reduction in Aurora Thr288 residue phosphorylation incubated for 24 hrs by Western blot analysis	B	CCC(=O)Nc1nc2ccc(-c3ccc4ncn(CCN5CCOCC5)c(=O)c4c3)cc2[nH]1		CHEMBL4785479		Inhibition	%		CHEMBL4722	Homo sapiens	INH		
Dose-dependent effect	22957824	CHEMBL4768063	Inhibition of Aurora A in human MDA-MB-231 cells assessed as reduction in Histone H3 phosphorylation incubated for 24 hrs by Western blot analysis	B	CCC(=O)Nc1nc2ccc(-c3ccc4ncn(CCN5CCOCC5)c(=O)c4c3)cc2[nH]1		CHEMBL4785479		Inhibition	%		CHEMBL4722	Homo sapiens	INH		
	22981502	CHEMBL4773006	Inhibition of Aurora A (unknown origin)	B	Cn1cc(-c2ccc3c(Nc4cccc(NC(=O)Nc5cccc(F)c5)c4)ncnc3c2)cn1		CHEMBL4799738	=	IC50	nM	18.98	CHEMBL4722	Homo sapiens	IC50	nM	18.975
	22981503	CHEMBL4773006	Inhibition of Aurora A (unknown origin)	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	=	IC50	nM	1386.0	CHEMBL4722	Homo sapiens	IC50	nM	1386.0
	22981504	CHEMBL4773006	Inhibition of Aurora A (unknown origin)	B	CCNC(=O)C#Cc1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(CN(C)C)cc1)c1ccccc1		CHEMBL3699142	=	IC50	nM	25.0	CHEMBL4722	Homo sapiens	IC50	nM	25.0
	22981505	CHEMBL4773006	Inhibition of Aurora A (unknown origin)	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	IC50	nM	0.6	CHEMBL4722	Homo sapiens	IC50	nM	0.6
	22986117	CHEMBL4774184	Inhibition of Aurora A (unknown origin)	B	CC(C)(C)c1cc(NC(=O)Cc2ccc(Nc3ncnc4[nH]c(-c5ccc(S(C)(=O)=O)cc5)cc34)cc2)no1		CHEMBL4791960	=	IC50	nM	242.0	CHEMBL4722	Homo sapiens	IC50	uM	0.242
	22989353	CHEMBL4774933	Inhibition of Aurora A (unknown origin) at 1 uM relative to control	B	Nc1n[nH]c2cccc(C#Cc3cccc(NC(=O)c4ccc(N5CCOCC5)c(C(F)(F)F)c4)c3)c12		CHEMBL4793906	=	Inhibition	%	43.36	CHEMBL4722	Homo sapiens	INH	%	43.36
	23120187	CHEMBL4804345	Inhibition of AURA in human NCI-H929 cells by mass spectroscopic analysis	B	Nc1ncc(-c2cccc3ncsc23)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4855542	=	IC50	nM	14700.0	CHEMBL4722	Homo sapiens	IC50	uM	14.7
	23120188	CHEMBL4804345	Inhibition of AURA in human NCI-H929 cells by mass spectroscopic analysis	B	CN(C1CC1)S(=O)(=O)c1ccc(-c2cnc(N)c(-c3ccc4c(c3)CCNC4=O)c2)c(F)c1		CHEMBL4860979	=	IC50	nM	21400.0	CHEMBL4722	Homo sapiens	IC50	uM	21.4
	23120189	CHEMBL4804345	Inhibition of AURA in human NCI-H929 cells by mass spectroscopic analysis	B	COc1cc(NS(=O)(=O)C2CC2)ccc1-c1cnc(N)c(-c2ccc3c(c2)CCNC3=O)c1		CHEMBL4867931	=	IC50	nM	11900.0	CHEMBL4722	Homo sapiens	IC50	uM	11.9
	23120190	CHEMBL4804345	Inhibition of AURA in human NCI-H929 cells by mass spectroscopic analysis	B	Nc1ncc(-c2ccc(NS(=O)(=O)C3CC3)cc2F)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4855730	=	IC50	nM	43200.0	CHEMBL4722	Homo sapiens	IC50	uM	43.2
	23120191	CHEMBL4804345	Inhibition of AURA in human NCI-H929 cells by mass spectroscopic analysis	B	Nc1ncc(-c2ccc(NS(=O)(=O)C3CC3)cc2OC2CCCCC2)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4868141	=	IC50	nM	40200.0	CHEMBL4722	Homo sapiens	IC50	uM	40.2
	23120192	CHEMBL4804345	Inhibition of AURA in human NCI-H929 cells by mass spectroscopic analysis	B	Nc1ncc(-c2cccc([N+](=O)[O-])c2F)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4859660	=	IC50	nM	66200.0	CHEMBL4722	Homo sapiens	IC50	uM	66.2
	23121231	CHEMBL4804527	Inhibition of AURA in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	Nc1ncc(-c2cccc3ncsc23)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4855542	=	Inhibition	%	0.0	CHEMBL4722	Homo sapiens	INH	%	0.0
	23121232	CHEMBL4804527	Inhibition of AURA in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	CN(C1CC1)S(=O)(=O)c1ccc(-c2cnc(N)c(-c3ccc4c(c3)CCNC4=O)c2)c(F)c1		CHEMBL4860979	=	Inhibition	%	0.0	CHEMBL4722	Homo sapiens	INH	%	0.0
	23121233	CHEMBL4804527	Inhibition of AURA in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	COc1cc(NS(=O)(=O)C2CC2)ccc1-c1cnc(N)c(-c2ccc3c(c2)CCNC3=O)c1		CHEMBL4867931	=	Inhibition	%	0.0	CHEMBL4722	Homo sapiens	INH	%	0.0
	23121234	CHEMBL4804527	Inhibition of AURA in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	Nc1ncc(-c2ccc(NS(=O)(=O)C3CC3)cc2F)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4855730	<=	Inhibition	%	75.0	CHEMBL4722	Homo sapiens	INH	%	75.0
	23121235	CHEMBL4804527	Inhibition of AURA in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	Nc1ncc(-c2ccc(NS(=O)(=O)C3CC3)cc2OC2CCCCC2)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4868141	=	Inhibition	%	35.0	CHEMBL4722	Homo sapiens	INH	%	35.0
	23121236	CHEMBL4804527	Inhibition of AURA in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	Nc1ncc(-c2cccc([N+](=O)[O-])c2F)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4859660	<=	Inhibition	%	90.0	CHEMBL4722	Homo sapiens	INH	%	90.0
	23122450	CHEMBL4804801	Inhibition of human AURKA assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN1CCN(C(=O)c2ccc3cc(CCNc4ccnc5ccc(C#N)cc45)ccc3c2)CC1		CHEMBL4878072	=	Activity	%	88.0	CHEMBL4722	Homo sapiens	Activity	%	88.0
	23123145	CHEMBL4805389	Inhibition of human AURKA assessed as percent of control at 1000 nM by KINOMEscan assay relative to control	B	COc1cc2nc(NC3CC3)nc(NC3CCN(C(C)C)CC3)c2cc1OC.O=C(O)C(F)(F)F		CHEMBL4870304	=	Activity	%	56.0	CHEMBL4722	Homo sapiens	Activity	%	56.0
	23123742	CHEMBL4805986	Inhibition of DNA-tagged human AURKA assessed as percent of control at 50000 nM by qPCR analysis relative to control	B	CN1C(=O)/C(=C2/C(=O)Nc3ccccc32)c2ccccc21		CHEMBL607535	=	Activity	%	100.0	CHEMBL4722	Homo sapiens	Activity	%	100.0
	23124380	CHEMBL4806406	Inhibition of human AURKA assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN(C)C(=O)c1ccc(N2CCCN(c3ccnc4sc(C(N)=O)c(N)c34)CC2)cc1		CHEMBL2348350	=	Activity	%	98.0	CHEMBL4722	Homo sapiens	Activity	%	98.0
	23124381	CHEMBL4806406	Inhibition of human AURKA assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN(C)C(=O)c1ccc(N2CCCN(c3ccnc4sc(C(N)=O)c(N)c34)CC2)cc1		CHEMBL2348350	=	Activity	%	99.0	CHEMBL4722	Homo sapiens	Activity	%	99.0
	23127461	CHEMBL4807619	Inhibition of Aurora A (unknown origin) assessed as residual activity at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)csc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL4867844	=	Activity	%	37.0	CHEMBL4722	Homo sapiens	Activity	%	37.0
	23127462	CHEMBL4807619	Inhibition of Aurora A (unknown origin) assessed as residual activity at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	=	Activity	%	67.0	CHEMBL4722	Homo sapiens	Activity	%	67.0
	23127822	CHEMBL4807749	Inhibition of AuroraA (unknown origin) assessed as residual activity measured at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)csc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL4867844	=	Activity	%	25.0	CHEMBL4722	Homo sapiens	Activity	%	25.0
	23127823	CHEMBL4807749	Inhibition of AuroraA (unknown origin) assessed as residual activity measured at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(Cl)ccnc3C)s2)cc(NN2CCN(CCO)CC2)n1		CHEMBL4855726	>	Activity	%	75.0	CHEMBL4722	Homo sapiens	Activity	%	75.0
	23127824	CHEMBL4807749	Inhibition of AuroraA (unknown origin) assessed as residual activity measured at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	=	Activity	%	50.0	CHEMBL4722	Homo sapiens	Activity	%	50.0
	23150906	CHEMBL4810423	Inhibition of recombinant full length human Aurora A using LRRASLG as substrate incubated for 40 mins in presence of [gamma-33ATP] by radiometric scintillation counting method	B	CCc1cc(Nc2nc(N[C@@H](C)c3ccc(F)cc3)nc3ccccc23)n[nH]1		CHEMBL4848826	=	IC50	nM	11.0	CHEMBL4722	Homo sapiens	IC50	nM	11.0
	23150907	CHEMBL4810423	Inhibition of recombinant full length human Aurora A using LRRASLG as substrate incubated for 40 mins in presence of [gamma-33ATP] by radiometric scintillation counting method	B	CCc1cc(Nc2nc(NCCc3ccc(F)cc3)nc3ccccc23)n[nH]1		CHEMBL4858397	=	IC50	nM	41.0	CHEMBL4722	Homo sapiens	IC50	nM	41.0
	23150908	CHEMBL4810423	Inhibition of recombinant full length human Aurora A using LRRASLG as substrate incubated for 40 mins in presence of [gamma-33ATP] by radiometric scintillation counting method	B	CCc1cc(Nc2nc(NCCc3ccc(F)cc3)nc3cccc(F)c23)n[nH]1		CHEMBL4876138	=	IC50	nM	180.0	CHEMBL4722	Homo sapiens	IC50	nM	180.0
	23150909	CHEMBL4810423	Inhibition of recombinant full length human Aurora A using LRRASLG as substrate incubated for 40 mins in presence of [gamma-33ATP] by radiometric scintillation counting method	B	CCc1cc(Nc2nc(NCCc3ccccc3)nc3cccc(OC)c23)n[nH]1		CHEMBL4855000	>	IC50	nM	10000.0	CHEMBL4722	Homo sapiens	IC50	nM	10000.0
	23150910	CHEMBL4810423	Inhibition of recombinant full length human Aurora A using LRRASLG as substrate incubated for 40 mins in presence of [gamma-33ATP] by radiometric scintillation counting method	B	CCc1cc(Nc2nc(N[C@@H](C)c3ccc(F)cc3)nc3cccc(F)c23)n[nH]1		CHEMBL4847311	=	IC50	nM	51.0	CHEMBL4722	Homo sapiens	IC50	nM	51.0
	23150911	CHEMBL4810423	Inhibition of recombinant full length human Aurora A using LRRASLG as substrate incubated for 40 mins in presence of [gamma-33ATP] by radiometric scintillation counting method	B	CCc1cc(Nc2nc(N[C@@H](C)c3ccc(C)cc3)nc3cccc(F)c23)n[nH]1		CHEMBL4871944	=	IC50	nM	75.0	CHEMBL4722	Homo sapiens	IC50	nM	75.0
	23150912	CHEMBL4810423	Inhibition of recombinant full length human Aurora A using LRRASLG as substrate incubated for 40 mins in presence of [gamma-33ATP] by radiometric scintillation counting method	B	CCc1cc(Nc2nc(N[C@@H](C)c3ccc(F)cn3)nc3cccc(F)c23)n[nH]1		CHEMBL4870615	=	IC50	nM	25.0	CHEMBL4722	Homo sapiens	IC50	nM	25.0
	23150913	CHEMBL4810423	Inhibition of recombinant full length human Aurora A using LRRASLG as substrate incubated for 40 mins in presence of [gamma-33ATP] by radiometric scintillation counting method	B	CCc1cc(Nc2nc(N[C@@H](C)c3ccc(C#N)cn3)nc3cccc(F)c23)n[nH]1		CHEMBL4849245	=	IC50	nM	220.0	CHEMBL4722	Homo sapiens	IC50	nM	220.0
	23150914	CHEMBL4810423	Inhibition of recombinant full length human Aurora A using LRRASLG as substrate incubated for 40 mins in presence of [gamma-33ATP] by radiometric scintillation counting method	B	CCc1cc(Nc2nc(N[C@@H](C)c3ncc(F)cn3)nc3cccc(F)c23)n[nH]1		CHEMBL4875743	=	IC50	nM	80.0	CHEMBL4722	Homo sapiens	IC50	nM	80.0
	23150915	CHEMBL4810423	Inhibition of recombinant full length human Aurora A using LRRASLG as substrate incubated for 40 mins in presence of [gamma-33ATP] by radiometric scintillation counting method	B	CCc1cc(Nc2nc(N[C@@H](C)c3ccc(F)cn3)nc3cccc(OC)c23)n[nH]1		CHEMBL4854871	=	IC50	nM	860.0	CHEMBL4722	Homo sapiens	IC50	nM	860.0
	23150916	CHEMBL4810423	Inhibition of recombinant full length human Aurora A using LRRASLG as substrate incubated for 40 mins in presence of [gamma-33ATP] by radiometric scintillation counting method	B	CCc1cc(Nc2nc(NCc3ccc(F)cn3)nc3cccc(OC)c23)n[nH]1		CHEMBL4847703	=	IC50	nM	4600.0	CHEMBL4722	Homo sapiens	IC50	nM	4600.0
	23150917	CHEMBL4810423	Inhibition of recombinant full length human Aurora A using LRRASLG as substrate incubated for 40 mins in presence of [gamma-33ATP] by radiometric scintillation counting method	B	CCc1cc(Nc2nc(NCc3ccc(Cl)cc3)nc3cccc(OC)c23)n[nH]1		CHEMBL4874424	>	IC50	nM	10000.0	CHEMBL4722	Homo sapiens	IC50	nM	10000.0
	23150918	CHEMBL4810423	Inhibition of recombinant full length human Aurora A using LRRASLG as substrate incubated for 40 mins in presence of [gamma-33ATP] by radiometric scintillation counting method	B	CCc1cc(Nc2nc(NCc3ccc(Cl)cc3OC)nc3cccc(OC)c23)n[nH]1		CHEMBL4877302	=	IC50	nM	8900.0	CHEMBL4722	Homo sapiens	IC50	nM	8900.0
	23150919	CHEMBL4810423	Inhibition of recombinant full length human Aurora A using LRRASLG as substrate incubated for 40 mins in presence of [gamma-33ATP] by radiometric scintillation counting method	B	CCc1cc(Nc2nc(N[C@@H](C)c3ccc(Cl)cn3)nc3cccc(OC)c23)n[nH]1		CHEMBL4852125	=	IC50	nM	22000.0	CHEMBL4722	Homo sapiens	IC50	nM	22000.0
	23150920	CHEMBL4810423	Inhibition of recombinant full length human Aurora A using LRRASLG as substrate incubated for 40 mins in presence of [gamma-33ATP] by radiometric scintillation counting method	B	CCc1cc(Nc2nc(N[C@@H](C)c3ccc(F)cn3)nc3cccc(C)c23)n[nH]1		CHEMBL4875929	=	IC50	nM	330.0	CHEMBL4722	Homo sapiens	IC50	nM	330.0
	23150921	CHEMBL4810423	Inhibition of recombinant full length human Aurora A using LRRASLG as substrate incubated for 40 mins in presence of [gamma-33ATP] by radiometric scintillation counting method	B	CCc1cc(Nc2nc(NCc3ccc(Cl)cc3)nc3cccc(C)c23)n[nH]1		CHEMBL4872426	=	IC50	nM	1200.0	CHEMBL4722	Homo sapiens	IC50	nM	1200.0
	23150922	CHEMBL4810423	Inhibition of recombinant full length human Aurora A using LRRASLG as substrate incubated for 40 mins in presence of [gamma-33ATP] by radiometric scintillation counting method	B	CCc1cc(Nc2nc(NCc3ccc(Cl)cc3OC)nc3cccc(C)c23)n[nH]1		CHEMBL4860332	=	IC50	nM	1200.0	CHEMBL4722	Homo sapiens	IC50	nM	1200.0
	23154595	CHEMBL4811101	Inhibition of human Aurora A at 1 uM measured after 30 mins by [gamma-33P]-ATP assay	A	CN1CCN(c2ccc(Nc3nccc(Nc4ccc5nc[nH]c5c4)n3)cc2)CC1		CHEMBL4858727	=	Inhibition	%	20.6	CHEMBL4722	Homo sapiens	INH	%	20.6
	23154596	CHEMBL4811101	Inhibition of human Aurora A at 1 uM measured after 30 mins by [gamma-33P]-ATP assay	A	Cc1cc(Nc2nccc(Nc3ccc4nc[nH]c4c3)n2)ccc1N1CCN(C)CC1		CHEMBL4850121	=	Inhibition	%	15.7	CHEMBL4722	Homo sapiens	INH	%	15.7
	23154597	CHEMBL4811101	Inhibition of human Aurora A at 1 uM measured after 30 mins by [gamma-33P]-ATP assay	A	Cc1cccc(Nc2ncc([N+](=O)[O-])c(Nc3ccc4nc[nH]c4c3)n2)c1		CHEMBL4855763	=	Inhibition	%	15.6	CHEMBL4722	Homo sapiens	INH	%	15.6
	23178055	CHEMBL4815837	Inhibition of Aurora A (unknown origin)	B	Cn1cc(-c2cc3ncnc(Nc4ccc(CC(=O)Nc5cc(C(C)(C)C)nn5C)cc4)c3s2)cn1		CHEMBL4868797	=	IC50	nM	893.0	CHEMBL4722	Homo sapiens	IC50	uM	0.893
Active	23200640	CHEMBL4820733	Inhibition of recombinant human full length Aurora-A I31F mutant using LRRASLG as substrate incubated for 40 mins by scintillation counting method	B	CNc1nc(C)c(-c2nc(Nc3cccc(N4CCN5CCC4CC5)c3)ncc2C)s1		CHEMBL4860925		Inhibition	%		CHEMBL4722	Homo sapiens	INH		
	23209860	CHEMBL4822469	Inhibition of human Aurora-A at 1 uM	B	Cc1nn(C(C)C)c(C)c1-c1nc2c(-c3ccc4c(c3)CCCC[C@H]4NC(=O)c3nc(C(C)(C)C)no3)ccnc2[nH]1		CHEMBL4877846	>	Inhibition	%	80.0	CHEMBL4722	Homo sapiens	INH	%	80.0
	23209895	CHEMBL4822492	Inhibition of human Aurora-A	B	Cc1nn(C(C)C)c(C)c1-c1nc2c(-c3ccc4c(c3)CCCC[C@H]4NC(=O)c3nc(C(C)(C)C)no3)ccnc2[nH]1		CHEMBL4877846	=	IC50	nM	60.08	CHEMBL4722	Homo sapiens	IC50	nM	60.08
	23234033	CHEMBL4827612	Inhibition of wild-type human partial length AURKA (E122 to K401 residues) expressed in mammalian expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	O=C(O)c1ccc(-c2ccnc3[nH]c(-c4ccccc4)nc23)cc1C1CCCC1		CHEMBL4870467	<	Activity	%	10.0	CHEMBL4722	Homo sapiens	Activity	%	10.0
	23246360	CHEMBL4830052	Inhibition of Aurora A (unknown origin)	B	Cl.Cn1nccc1-c1ccc(C(=O)N[C@@H]2CNCC[C@H]2c2ccc(F)c(F)c2)c(F)c1		CHEMBL4556790	>	IC50	nM	10000.0	CHEMBL4722	Homo sapiens	IC50	nM	10000.0
	23250052	CHEMBL4830974	Inhibition of His-tagged human full length recombinant AURKA expressed in baculovirus expression system at 1 uM by Z'-LYTE assay	B	COc1cc(N2CCN(C(C)=O)CC2)ccc1Nc1ncc(Cl)c(Nc2ccc(NCc3ccc(S(=O)(=O)F)cc3)cc2)n1		CHEMBL4866162	=	Inhibition	%	100.0	CHEMBL4722	Homo sapiens	INH	%	100.0
Not Active	23250053	CHEMBL4830974	Inhibition of His-tagged human full length recombinant AURKA expressed in baculovirus expression system at 1 uM by Z'-LYTE assay	B	COc1cc(N2CCN(C(C)=O)CC2)ccc1Nc1ncc(Cl)c(Nc2cccc(NC(C)=O)c2)n1		CHEMBL4856343		Inhibition	%		CHEMBL4722	Homo sapiens	INH		
Active	23250106	CHEMBL4831001	Inhibition of His-tagged human full length recombinant AURKA expressed in baculovirus expression system at 100 nM by Z'-LYTE assay	B	C#CCNC(=O)c1cc(Nc2cc(C3CC3)[nH]n2)nc(N2CCN(Cc3ccc(S(=O)(=O)F)cc3)CC2)n1		CHEMBL4855850		Inhibition	%		CHEMBL4722	Homo sapiens	INH		
	23250107	CHEMBL4831001	Inhibition of His-tagged human full length recombinant AURKA expressed in baculovirus expression system at 100 nM by Z'-LYTE assay	B	COc1cc(N2CCN(C(C)=O)CC2)ccc1Nc1ncc(Cl)c(Nc2ccc(NCc3ccc(S(=O)(=O)F)cc3)cc2)n1		CHEMBL4866162	=	Inhibition	%	30.0	CHEMBL4722	Homo sapiens	INH	%	30.0
	23250206	CHEMBL4831026	Inhibition of Aurora A (unknown origin) using 5' FAM-LRRASLG-CONH2 peptide as a substrate in the presence of ATP incubated for 60 mins by microfluidics assay	B	Cn1cc(-c2ccn3c(-c4ccc(-c5cccc(Cl)c5)s4)cnc3c2)cn1		CHEMBL4847680	=	IC50	nM	1300.0	CHEMBL4722	Homo sapiens	IC50	uM	1.3
	23250207	CHEMBL4831026	Inhibition of Aurora A (unknown origin) using 5' FAM-LRRASLG-CONH2 peptide as a substrate in the presence of ATP incubated for 60 mins by microfluidics assay	B	COc1cccc(OC)c1-c1ccc(-c2cnc3cc(-c4cnn(C)c4)ccn23)s1		CHEMBL4852822	=	IC50	nM	970.0	CHEMBL4722	Homo sapiens	IC50	uM	0.97
Not Active	23257279	CHEMBL4832370	Inhibition of AURKA (unknown origin)	A	FC(F)(F)c1cccc(CN2CCN(c3nnc(Nc4ccc(N5CCOCC5)cc4)c4ccccc34)CC2)c1		CHEMBL4873715		Inhibition	%		CHEMBL4722	Homo sapiens	INH		
Not Active	23257280	CHEMBL4832370	Inhibition of AURKA (unknown origin)	A	CN1CCN(c2ccc(Nc3nnc(N4CCN(Cc5cccc(C(F)(F)F)c5)CC4)c4ccccc34)cc2)CC1		CHEMBL4860840		Inhibition	%		CHEMBL4722	Homo sapiens	INH		
Not Active	23257281	CHEMBL4832370	Inhibition of AURKA (unknown origin)	A	CC1COCCN1c1ccc(Nc2nnc(N3CCN(Cc4cccc(C(F)(F)F)c4)CC3)c3ccccc23)cc1		CHEMBL4874645		Inhibition	%		CHEMBL4722	Homo sapiens	INH		
	23295512	CHEMBL4840524	Inhibition of recombinant His-tagged full length human Aurora A expressed in baculovirus expression system at 1 uM measured by select screen assay relative to control	B	CN1CCN(c2ccc(C(=O)Nc3n[nH]c4c3CN(Cc3cc(F)cc(F)c3)C4(C)C)cc2)CC1		CHEMBL4849505	=	Inhibition	%	11.0	CHEMBL4722	Homo sapiens	INH	%	11.0
Active	23297332	CHEMBL4841148	Inhibition of AURKA (unknown origin) in HRPE cells overexpressing MYC/Bcl2 assessed as inhibition of autophosphorylation of threonine 288 at 20 uM measured for 6 hrs by immunostaining based fluorescence microscopic analysis	B	COc1cc2c(cc1O)[C@@H]1Cc3ccc(OC)c(O)c3CN1CC2		CHEMBL1235966		Inhibition	%		CHEMBL4722	Homo sapiens	INH		
	23297809	CHEMBL4841289	Inhibition of AURKA (unknown origin)	B	Cc1n[nH]c2ccc(-c3cc(N[C@@H](CO)c4ccccc4)cnc3Cl)cc12		CHEMBL4876497	>	IC50	nM	1000.0	CHEMBL4722	Homo sapiens	IC50	nM	1000.0
	23299276	CHEMBL4841738	Inhibition of AURORA-A (unknown origin) at 1000 nM relative to control	B	Nc1c(-c2nc3cc(N4CCN(C(=O)CCCCCNc5cccc6c5C(=O)N(C5CCC(=O)NC5=O)C6=O)CC4)ccc3[nH]2)c(=O)[nH]c2cccc(F)c12		CHEMBL4860038	=	Inhibition	%	17.0	CHEMBL4722	Homo sapiens	INH	%	17.0
	23299277	CHEMBL4841738	Inhibition of AURORA-A (unknown origin) at 1000 nM relative to control	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	=	Inhibition	%	38.0	CHEMBL4722	Homo sapiens	INH	%	38.0
	23309947	CHEMBL4843874	Inhibition of Aurora A (unknown origin) at 100 uM relative to control	B	COc1cc(NC(=O)Nc2ccc(O)c3ccccc23)cc(OC)c1OC		CHEMBL4855557	=	Inhibition	%	30.0	CHEMBL4722	Homo sapiens	INH	%	30.0
	23314893	CHEMBL4845009	Inhibition of recombinant GST-AURKA (residues Ser123 to Ser401) (unknown origin) expressed in Sf9 insect cells using tetra(-LRRASLG) peptide as substrate at 1 uM incubated for 90 mins by ATP Kinase Glo assay	B	CN(C)c1ccc2c(Oc3ccc(NC(=O)Nc4ccccc4)cc3)ncnc2c1		CHEMBL4877247	=	Inhibition	%	40.0	CHEMBL4722	Homo sapiens	INH	%	40.0
	23314894	CHEMBL4845009	Inhibition of recombinant GST-AURKA (residues Ser123 to Ser401) (unknown origin) expressed in Sf9 insect cells using tetra(-LRRASLG) peptide as substrate at 1 uM incubated for 90 mins by ATP Kinase Glo assay	B	CN(C)c1ccc2c(Oc3ccc(NC(=O)NCc4ccc(F)cc4)cc3)ncnc2c1		CHEMBL4851635	=	Inhibition	%	5.0	CHEMBL4722	Homo sapiens	INH	%	5.0
Not Determined	23314895	CHEMBL4845009	Inhibition of recombinant GST-AURKA (residues Ser123 to Ser401) (unknown origin) expressed in Sf9 insect cells using tetra(-LRRASLG) peptide as substrate at 1 uM incubated for 90 mins by ATP Kinase Glo assay	B	O=C(Nc1cccc(Cl)c1)Nc1ncc(CCNc2ncnc3cc(F)ccc23)s1		CHEMBL4867079		Inhibition	%		CHEMBL4722	Homo sapiens	INH		
Not Determined	23314896	CHEMBL4845009	Inhibition of recombinant GST-AURKA (residues Ser123 to Ser401) (unknown origin) expressed in Sf9 insect cells using tetra(-LRRASLG) peptide as substrate at 1 uM incubated for 90 mins by ATP Kinase Glo assay	B	COc1ccc2c(NCCc3cnc(NC(=O)Nc4cccc(Cl)c4)s3)ncnc2c1		CHEMBL4861838		Inhibition	%		CHEMBL4722	Homo sapiens	INH		
	23314897	CHEMBL4845009	Inhibition of recombinant GST-AURKA (residues Ser123 to Ser401) (unknown origin) expressed in Sf9 insect cells using tetra(-LRRASLG) peptide as substrate at 1 uM incubated for 90 mins by ATP Kinase Glo assay	B	COc1ccc2c(Nc3ccc(NC(=O)Nc4ccccc4)cc3)ncnc2c1		CHEMBL4877038	=	Inhibition	%	56.0	CHEMBL4722	Homo sapiens	INH	%	56.0
	23314898	CHEMBL4845009	Inhibition of recombinant GST-AURKA (residues Ser123 to Ser401) (unknown origin) expressed in Sf9 insect cells using tetra(-LRRASLG) peptide as substrate at 1 uM incubated for 90 mins by ATP Kinase Glo assay	B	COc1ccc2c(Oc3ccc(NC(=O)Nc4ccccc4)cc3)ncnc2c1		CHEMBL4872597	=	Inhibition	%	36.0	CHEMBL4722	Homo sapiens	INH	%	36.0
	23314899	CHEMBL4845009	Inhibition of recombinant GST-AURKA (residues Ser123 to Ser401) (unknown origin) expressed in Sf9 insect cells using tetra(-LRRASLG) peptide as substrate at 1 uM incubated for 90 mins by ATP Kinase Glo assay	B	O=C(Nc1ccccc1)Nc1ccc(Oc2ncnc3cc(F)ccc23)cc1		CHEMBL4871510	=	Inhibition	%	13.0	CHEMBL4722	Homo sapiens	INH	%	13.0
	23314900	CHEMBL4845009	Inhibition of recombinant GST-AURKA (residues Ser123 to Ser401) (unknown origin) expressed in Sf9 insect cells using tetra(-LRRASLG) peptide as substrate at 1 uM incubated for 90 mins by ATP Kinase Glo assay	B	Nc1ccc2c(Oc3ccc(NC(=O)Nc4ccccc4)cc3)ncnc2c1		CHEMBL4851294	=	Inhibition	%	47.0	CHEMBL4722	Homo sapiens	INH	%	47.0
	23314901	CHEMBL4845009	Inhibition of recombinant GST-AURKA (residues Ser123 to Ser401) (unknown origin) expressed in Sf9 insect cells using tetra(-LRRASLG) peptide as substrate at 1 uM incubated for 90 mins by ATP Kinase Glo assay	B	CNc1ccc2c(Oc3ccc(NC(=O)Nc4ccccc4)cc3)ncnc2c1		CHEMBL4877828	=	Inhibition	%	57.0	CHEMBL4722	Homo sapiens	INH	%	57.0
	23314902	CHEMBL4845009	Inhibition of recombinant GST-AURKA (residues Ser123 to Ser401) (unknown origin) expressed in Sf9 insect cells using tetra(-LRRASLG) peptide as substrate at 1 uM incubated for 90 mins by ATP Kinase Glo assay	B	CN(C)c1ccc2c(Nc3ccc(NC(=O)Nc4ccccc4)cc3)ncnc2c1		CHEMBL4871756	=	Inhibition	%	33.0	CHEMBL4722	Homo sapiens	INH	%	33.0
	23314903	CHEMBL4845009	Inhibition of recombinant GST-AURKA (residues Ser123 to Ser401) (unknown origin) expressed in Sf9 insect cells using tetra(-LRRASLG) peptide as substrate at 1 uM incubated for 90 mins by ATP Kinase Glo assay	B	O=C(Nc1ccccc1)Nc1ccc(Oc2ncnc3cc(N4CCCC4)ccc23)cc1		CHEMBL4871989	=	Inhibition	%	43.0	CHEMBL4722	Homo sapiens	INH	%	43.0
	23314904	CHEMBL4845009	Inhibition of recombinant GST-AURKA (residues Ser123 to Ser401) (unknown origin) expressed in Sf9 insect cells using tetra(-LRRASLG) peptide as substrate at 1 uM incubated for 90 mins by ATP Kinase Glo assay	B	COc1cc2ncnc(Oc3ccc(NC(=O)Nc4ccccc4)cc3)c2cc1OC		CHEMBL1277162	=	Inhibition	%	46.0	CHEMBL4722	Homo sapiens	INH	%	46.0
	23314905	CHEMBL4845009	Inhibition of recombinant GST-AURKA (residues Ser123 to Ser401) (unknown origin) expressed in Sf9 insect cells using tetra(-LRRASLG) peptide as substrate at 1 uM incubated for 90 mins by ATP Kinase Glo assay	B	CN(C)c1ccc2ncnc(Oc3ccc(NC(=O)Nc4ccccc4)cc3)c2c1		CHEMBL4876562	=	Inhibition	%	29.0	CHEMBL4722	Homo sapiens	INH	%	29.0
	23314906	CHEMBL4845009	Inhibition of recombinant GST-AURKA (residues Ser123 to Ser401) (unknown origin) expressed in Sf9 insect cells using tetra(-LRRASLG) peptide as substrate at 1 uM incubated for 90 mins by ATP Kinase Glo assay	B	O=C(Nc1ccccc1)Nc1ccc(Oc2ncnc3ccc(N4CCCC4)cc23)cc1		CHEMBL4850463	=	Inhibition	%	11.0	CHEMBL4722	Homo sapiens	INH	%	11.0
	23314907	CHEMBL4845009	Inhibition of recombinant GST-AURKA (residues Ser123 to Ser401) (unknown origin) expressed in Sf9 insect cells using tetra(-LRRASLG) peptide as substrate at 1 uM incubated for 90 mins by ATP Kinase Glo assay	B	CN(C)c1ccc2c(Oc3ccc(NC(=O)Nc4ccccc4Cl)cc3)ncnc2c1		CHEMBL4864248	=	Inhibition	%	43.0	CHEMBL4722	Homo sapiens	INH	%	43.0
	23314908	CHEMBL4845009	Inhibition of recombinant GST-AURKA (residues Ser123 to Ser401) (unknown origin) expressed in Sf9 insect cells using tetra(-LRRASLG) peptide as substrate at 1 uM incubated for 90 mins by ATP Kinase Glo assay	B	CN(C)c1ccc2c(Oc3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)ncnc2c1		CHEMBL4860468	=	Inhibition	%	71.0	CHEMBL4722	Homo sapiens	INH	%	71.0
	23314909	CHEMBL4845009	Inhibition of recombinant GST-AURKA (residues Ser123 to Ser401) (unknown origin) expressed in Sf9 insect cells using tetra(-LRRASLG) peptide as substrate at 1 uM incubated for 90 mins by ATP Kinase Glo assay	B	CN(C)c1ccc2c(Oc3ccc(NC(=O)Nc4ccc(Cl)cc4)cc3)ncnc2c1		CHEMBL4846414	=	Inhibition	%	70.0	CHEMBL4722	Homo sapiens	INH	%	70.0
	23314910	CHEMBL4845009	Inhibition of recombinant GST-AURKA (residues Ser123 to Ser401) (unknown origin) expressed in Sf9 insect cells using tetra(-LRRASLG) peptide as substrate at 1 uM incubated for 90 mins by ATP Kinase Glo assay	B	COc1ccccc1NC(=O)Nc1ccc(Oc2ncnc3cc(N(C)C)ccc23)cc1		CHEMBL4857617	=	Inhibition	%	24.0	CHEMBL4722	Homo sapiens	INH	%	24.0
	23314911	CHEMBL4845009	Inhibition of recombinant GST-AURKA (residues Ser123 to Ser401) (unknown origin) expressed in Sf9 insect cells using tetra(-LRRASLG) peptide as substrate at 1 uM incubated for 90 mins by ATP Kinase Glo assay	B	COc1cccc(NC(=O)Nc2ccc(Oc3ncnc4cc(N(C)C)ccc34)cc2)c1		CHEMBL4857271	=	Inhibition	%	46.0	CHEMBL4722	Homo sapiens	INH	%	46.0
	23314912	CHEMBL4845009	Inhibition of recombinant GST-AURKA (residues Ser123 to Ser401) (unknown origin) expressed in Sf9 insect cells using tetra(-LRRASLG) peptide as substrate at 1 uM incubated for 90 mins by ATP Kinase Glo assay	B	COc1ccc(NC(=O)Nc2ccc(Oc3ncnc4cc(N(C)C)ccc34)cc2)cc1		CHEMBL4877440	=	Inhibition	%	23.0	CHEMBL4722	Homo sapiens	INH	%	23.0
	23314913	CHEMBL4845009	Inhibition of recombinant GST-AURKA (residues Ser123 to Ser401) (unknown origin) expressed in Sf9 insect cells using tetra(-LRRASLG) peptide as substrate at 1 uM incubated for 90 mins by ATP Kinase Glo assay	B	CN(C)c1ccc2c(Oc3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)ncnc2c1		CHEMBL4878431	=	Inhibition	%	35.0	CHEMBL4722	Homo sapiens	INH	%	35.0
	23314914	CHEMBL4845009	Inhibition of recombinant GST-AURKA (residues Ser123 to Ser401) (unknown origin) expressed in Sf9 insect cells using tetra(-LRRASLG) peptide as substrate at 1 uM incubated for 90 mins by ATP Kinase Glo assay	B	CN(C)c1ccc2c(Oc3ccc(NC(=O)Nc4ccc(C(F)(F)F)cc4)cc3)ncnc2c1		CHEMBL4874053	=	Inhibition	%	46.0	CHEMBL4722	Homo sapiens	INH	%	46.0
	23314915	CHEMBL4845009	Inhibition of recombinant GST-AURKA (residues Ser123 to Ser401) (unknown origin) expressed in Sf9 insect cells using tetra(-LRRASLG) peptide as substrate at 1 uM incubated for 90 mins by ATP Kinase Glo assay	B	COc1ccc(NC(=O)Nc2ccc(Oc3ncnc4cc(N(C)C)ccc34)cc2)cc1Cl		CHEMBL4877148	=	Inhibition	%	53.0	CHEMBL4722	Homo sapiens	INH	%	53.0
	23314916	CHEMBL4845009	Inhibition of recombinant GST-AURKA (residues Ser123 to Ser401) (unknown origin) expressed in Sf9 insect cells using tetra(-LRRASLG) peptide as substrate at 1 uM incubated for 90 mins by ATP Kinase Glo assay	B	COc1ccc(Cl)cc1NC(=O)Nc1ccc(Oc2ncnc3cc(N(C)C)ccc23)cc1		CHEMBL4859405	=	Inhibition	%	70.0	CHEMBL4722	Homo sapiens	INH	%	70.0
	23314917	CHEMBL4845009	Inhibition of recombinant GST-AURKA (residues Ser123 to Ser401) (unknown origin) expressed in Sf9 insect cells using tetra(-LRRASLG) peptide as substrate at 1 uM incubated for 90 mins by ATP Kinase Glo assay	B	CN(C)c1ccc2c(Oc3ccc(NC(=O)NCc4ccccc4)cc3)ncnc2c1		CHEMBL4873828	=	Inhibition	%	7.0	CHEMBL4722	Homo sapiens	INH	%	7.0
	23314918	CHEMBL4845009	Inhibition of recombinant GST-AURKA (residues Ser123 to Ser401) (unknown origin) expressed in Sf9 insect cells using tetra(-LRRASLG) peptide as substrate at 1 uM incubated for 90 mins by ATP Kinase Glo assay	B	CN(C)c1ccc2c(Oc3ccc(NC(=O)NCCc4ccccc4)cc3)ncnc2c1		CHEMBL4849425	=	Inhibition	%	35.0	CHEMBL4722	Homo sapiens	INH	%	35.0
	23314919	CHEMBL4845009	Inhibition of recombinant GST-AURKA (residues Ser123 to Ser401) (unknown origin) expressed in Sf9 insect cells using tetra(-LRRASLG) peptide as substrate at 1 uM incubated for 90 mins by ATP Kinase Glo assay	B	CN(C)c1ccc2c(Oc3ccc(NC(=O)NCc4ccc(S(N)(=O)=O)cc4)cc3)ncnc2c1		CHEMBL4857690	=	Inhibition	%	2.0	CHEMBL4722	Homo sapiens	INH	%	2.0
	23314920	CHEMBL4845009	Inhibition of recombinant GST-AURKA (residues Ser123 to Ser401) (unknown origin) expressed in Sf9 insect cells using tetra(-LRRASLG) peptide as substrate at 1 uM incubated for 90 mins by ATP Kinase Glo assay	B	CN(C)c1ccc2c(Oc3ccc(NC(=O)NCc4ccc(C#N)cc4)cc3)ncnc2c1		CHEMBL4846051	=	Inhibition	%	5.0	CHEMBL4722	Homo sapiens	INH	%	5.0
	23314921	CHEMBL4845009	Inhibition of recombinant GST-AURKA (residues Ser123 to Ser401) (unknown origin) expressed in Sf9 insect cells using tetra(-LRRASLG) peptide as substrate at 1 uM incubated for 90 mins by ATP Kinase Glo assay	B	CN(C)c1ccc2c(Oc3ccc(NC(=O)NCc4ccc(C(F)(F)F)cc4)cc3)ncnc2c1		CHEMBL4854210	=	Inhibition	%	16.0	CHEMBL4722	Homo sapiens	INH	%	16.0
	23314922	CHEMBL4845009	Inhibition of recombinant GST-AURKA (residues Ser123 to Ser401) (unknown origin) expressed in Sf9 insect cells using tetra(-LRRASLG) peptide as substrate at 1 uM incubated for 90 mins by ATP Kinase Glo assay	B	COc1ccc(CNC(=O)Nc2ccc(Oc3ncnc4cc(N(C)C)ccc34)cc2)cc1		CHEMBL4870448	=	Inhibition	%	6.0	CHEMBL4722	Homo sapiens	INH	%	6.0
	23314923	CHEMBL4845009	Inhibition of recombinant GST-AURKA (residues Ser123 to Ser401) (unknown origin) expressed in Sf9 insect cells using tetra(-LRRASLG) peptide as substrate at 1 uM incubated for 90 mins by ATP Kinase Glo assay	B	COc1ccc(CNC(=O)Nc2ccc(Oc3ncnc4cc(N(C)C)ccc34)cc2)cc1OC		CHEMBL4876396	=	Inhibition	%	4.0	CHEMBL4722	Homo sapiens	INH	%	4.0
	23314924	CHEMBL4845009	Inhibition of recombinant GST-AURKA (residues Ser123 to Ser401) (unknown origin) expressed in Sf9 insect cells using tetra(-LRRASLG) peptide as substrate at 1 uM incubated for 90 mins by ATP Kinase Glo assay	B	CN(C)c1ccc2c(Oc3ccc(NC(=O)NCc4c(F)c(F)c(F)c(F)c4F)cc3)ncnc2c1		CHEMBL4866196	=	Inhibition	%	3.0	CHEMBL4722	Homo sapiens	INH	%	3.0
	23314925	CHEMBL4845009	Inhibition of recombinant GST-AURKA (residues Ser123 to Ser401) (unknown origin) expressed in Sf9 insect cells using tetra(-LRRASLG) peptide as substrate at 1 uM incubated for 90 mins by ATP Kinase Glo assay	B	CN(C)c1ccc2c(Oc3ccc(NC(=O)NCc4cccnc4)cc3)ncnc2c1		CHEMBL4878471	=	Inhibition	%	1.0	CHEMBL4722	Homo sapiens	INH	%	1.0
	23314926	CHEMBL4845009	Inhibition of recombinant GST-AURKA (residues Ser123 to Ser401) (unknown origin) expressed in Sf9 insect cells using tetra(-LRRASLG) peptide as substrate at 1 uM incubated for 90 mins by ATP Kinase Glo assay	B	Cc1ccc(CNC(=O)Nc2ccc(Oc3ncnc4cc(N(C)C)ccc34)cc2)cn1		CHEMBL4846384	=	Inhibition	%	4.0	CHEMBL4722	Homo sapiens	INH	%	4.0
	23314927	CHEMBL4845009	Inhibition of recombinant GST-AURKA (residues Ser123 to Ser401) (unknown origin) expressed in Sf9 insect cells using tetra(-LRRASLG) peptide as substrate at 1 uM incubated for 90 mins by ATP Kinase Glo assay	B	COc1ccc(CNC(=O)Nc2ccc(Oc3ncnc4cc(N(C)C)ccc34)cc2)cn1		CHEMBL4870360	=	Inhibition	%	2.0	CHEMBL4722	Homo sapiens	INH	%	2.0
	23314928	CHEMBL4845009	Inhibition of recombinant GST-AURKA (residues Ser123 to Ser401) (unknown origin) expressed in Sf9 insect cells using tetra(-LRRASLG) peptide as substrate at 1 uM incubated for 90 mins by ATP Kinase Glo assay	B	CC(NC(=O)Nc1ccc(Oc2ncnc3cc(N(C)C)ccc23)cc1)c1nccs1		CHEMBL4851545	=	Inhibition	%	6.0	CHEMBL4722	Homo sapiens	INH	%	6.0
	23314929	CHEMBL4845009	Inhibition of recombinant GST-AURKA (residues Ser123 to Ser401) (unknown origin) expressed in Sf9 insect cells using tetra(-LRRASLG) peptide as substrate at 1 uM incubated for 90 mins by ATP Kinase Glo assay	B	CN(C)c1ccc2c(Oc3ccc(NC(=O)NCc4nccs4)cc3)ncnc2c1		CHEMBL4863584	=	Inhibition	%	2.0	CHEMBL4722	Homo sapiens	INH	%	2.0
	23314930	CHEMBL4845009	Inhibition of recombinant GST-AURKA (residues Ser123 to Ser401) (unknown origin) expressed in Sf9 insect cells using tetra(-LRRASLG) peptide as substrate at 1 uM incubated for 90 mins by ATP Kinase Glo assay	B	CN(C)c1ccc2c(Oc3ccc(NC(=O)NCc4ccn(C)n4)cc3)ncnc2c1		CHEMBL4878293	=	Inhibition	%	58.0	CHEMBL4722	Homo sapiens	INH	%	58.0
	23314931	CHEMBL4845009	Inhibition of recombinant GST-AURKA (residues Ser123 to Ser401) (unknown origin) expressed in Sf9 insect cells using tetra(-LRRASLG) peptide as substrate at 1 uM incubated for 90 mins by ATP Kinase Glo assay	B	CN(C)c1ccc2c(Oc3ccc(NC(=O)NCc4ccc(C(F)(F)F)nc4)cc3)ncnc2c1		CHEMBL4847875	=	Inhibition	%	7.0	CHEMBL4722	Homo sapiens	INH	%	7.0
Not Determined	23314932	CHEMBL4845009	Inhibition of recombinant GST-AURKA (residues Ser123 to Ser401) (unknown origin) expressed in Sf9 insect cells using tetra(-LRRASLG) peptide as substrate at 1 uM incubated for 90 mins by ATP Kinase Glo assay	B	CN(C)CCCOc1ccc2c(NCCc3cnc(NC(=O)Nc4cccc(Cl)c4)s3)ncnc2c1		CHEMBL4864729		Inhibition	%		CHEMBL4722	Homo sapiens	INH		
	23314933	CHEMBL4845009	Inhibition of recombinant GST-AURKA (residues Ser123 to Ser401) (unknown origin) expressed in Sf9 insect cells using tetra(-LRRASLG) peptide as substrate at 1 uM incubated for 90 mins by ATP Kinase Glo assay	B	COc1cc(Oc2ccnc3cc(OC)c(OC)cc23)ccc1NC(=O)NC(C)c1nccs1		CHEMBL1908396	=	Inhibition	%	42.0	CHEMBL4722	Homo sapiens	INH	%	42.0
	23314934	CHEMBL4845009	Inhibition of recombinant GST-AURKA (residues Ser123 to Ser401) (unknown origin) expressed in Sf9 insect cells using tetra(-LRRASLG) peptide as substrate at 1 uM incubated for 90 mins by ATP Kinase Glo assay	B	FC(F)(F)c1ccc(CNc2ccc(Cc3c[nH]c4ncc(Cl)cc34)cn2)cn1		CHEMBL3813873	=	Inhibition	%	63.0	CHEMBL4722	Homo sapiens	INH	%	63.0
Not Determined	23314976	CHEMBL4845011	Inhibition of recombinant GST-AURKA (residues Ser123 to Ser401) (unknown origin) expressed in Sf9 insect cells using tetra(-LRRASLG) peptide as substrate incubated for 90 mins by ATP Kinase Glo assay	B	FC(F)(F)c1ccc(CNc2ccc(Cc3c[nH]c4ncc(Cl)cc34)cn2)cn1		CHEMBL3813873		IC50			CHEMBL4722	Homo sapiens	IC50		
Not Determined	23314977	CHEMBL4845011	Inhibition of recombinant GST-AURKA (residues Ser123 to Ser401) (unknown origin) expressed in Sf9 insect cells using tetra(-LRRASLG) peptide as substrate incubated for 90 mins by ATP Kinase Glo assay	B	CN(C)c1ccc2c(Oc3ccc(NC(=O)Nc4ccccc4)cc3)ncnc2c1		CHEMBL4877247		IC50			CHEMBL4722	Homo sapiens	IC50		
	23314978	CHEMBL4845011	Inhibition of recombinant GST-AURKA (residues Ser123 to Ser401) (unknown origin) expressed in Sf9 insect cells using tetra(-LRRASLG) peptide as substrate incubated for 90 mins by ATP Kinase Glo assay	B	CN(C)c1ccc2c(Oc3ccc(NC(=O)NCc4ccc(F)cc4)cc3)ncnc2c1		CHEMBL4851635	>	IC50	nM	10000.0	CHEMBL4722	Homo sapiens	IC50	uM	10.0
	23314979	CHEMBL4845011	Inhibition of recombinant GST-AURKA (residues Ser123 to Ser401) (unknown origin) expressed in Sf9 insect cells using tetra(-LRRASLG) peptide as substrate incubated for 90 mins by ATP Kinase Glo assay	B	O=C(Nc1cccc(Cl)c1)Nc1ncc(CCNc2ncnc3cc(F)ccc23)s1		CHEMBL4867079	=	IC50	nM	9.0	CHEMBL4722	Homo sapiens	IC50	nM	9.0
	23314980	CHEMBL4845011	Inhibition of recombinant GST-AURKA (residues Ser123 to Ser401) (unknown origin) expressed in Sf9 insect cells using tetra(-LRRASLG) peptide as substrate incubated for 90 mins by ATP Kinase Glo assay	B	COc1ccc2c(NCCc3cnc(NC(=O)Nc4cccc(Cl)c4)s3)ncnc2c1		CHEMBL4861838	=	IC50	nM	9.0	CHEMBL4722	Homo sapiens	IC50	nM	9.0
	23314981	CHEMBL4845011	Inhibition of recombinant GST-AURKA (residues Ser123 to Ser401) (unknown origin) expressed in Sf9 insect cells using tetra(-LRRASLG) peptide as substrate incubated for 90 mins by ATP Kinase Glo assay	B	COc1ccc(NC(=O)Nc2ccc(Oc3ncnc4cc(N(C)C)ccc34)cc2)cc1		CHEMBL4877440	>	IC50	nM	10000.0	CHEMBL4722	Homo sapiens	IC50	uM	10.0
	23314982	CHEMBL4845011	Inhibition of recombinant GST-AURKA (residues Ser123 to Ser401) (unknown origin) expressed in Sf9 insect cells using tetra(-LRRASLG) peptide as substrate incubated for 90 mins by ATP Kinase Glo assay	B	CN(C)c1ccc2c(Oc3ccc(NC(=O)NCc4ccc(C(F)(F)F)nc4)cc3)ncnc2c1		CHEMBL4847875	>	IC50	nM	10000.0	CHEMBL4722	Homo sapiens	IC50	uM	10.0
	23314983	CHEMBL4845011	Inhibition of recombinant GST-AURKA (residues Ser123 to Ser401) (unknown origin) expressed in Sf9 insect cells using tetra(-LRRASLG) peptide as substrate incubated for 90 mins by ATP Kinase Glo assay	B	CN(C)CCCOc1ccc2c(NCCc3cnc(NC(=O)Nc4cccc(Cl)c4)s3)ncnc2c1		CHEMBL4864729	=	IC50	nM	22.0	CHEMBL4722	Homo sapiens	IC50	nM	22.0
Not Active	23317285	CHEMBL4879591	KinomeScan assay: inhibition of AURKA	B	CCC(=N\O)/C(C)=C/c1ccc(F)cc1		CHEMBL3697701		% Control	%	100.0	CHEMBL4722	Homo sapiens	% Control	%	100.0
Not Active	23317753	CHEMBL4879591	KinomeScan assay: inhibition of AURKA	B	CCC(=N\O)/C(C)=C/c1ccc(F)c(C)c1		CHEMBL3701197		% Control	%	82.0	CHEMBL4722	Homo sapiens	% Control	%	82.0
Not Active	23318427	CHEMBL4879591	KinomeScan assay: inhibition of AURKA	B	Cn1cncc1[C@](O)(COc1ccc(C#N)cc1-c1ccc(OC(F)(F)F)cc1)c1ccc(C#N)cc1		CHEMBL4586794		% Control	%	95.0	CHEMBL4722	Homo sapiens	% Control	%	95.0
Not Active	23318903	CHEMBL4879591	KinomeScan assay: inhibition of AURKA	B	Cn1cncc1[C@@](O)(COc1ccc(C#N)cc1-c1ccc(OC(F)(F)F)cc1)c1ccc(C#N)cc1		CHEMBL4526341		% Control	%	76.0	CHEMBL4722	Homo sapiens	% Control	%	76.0
Not Active	23319543	CHEMBL4879591	KinomeScan assay: inhibition of AURKA	B	CCCCN(CCCC)C(=O)CN1C[C@H](c2cc(OC)c3c(c2)OCO3)[C@@H](C(=O)O)[C@@H]1CC(C)(C)CCC		CHEMBL111612		% Control	%	90.3	CHEMBL4722	Homo sapiens	% Control	%	90.3
Not Active	23320015	CHEMBL4879591	KinomeScan assay: inhibition of AURKA	B	CCCCN(CCCC)C(=O)CN1C[C@@H](c2cc(OC)c3c(c2)OCO3)[C@H](C(=O)O)[C@H]1CC(C)(C)CCC		CHEMBL4513786		% Control	%	90.2	CHEMBL4722	Homo sapiens	% Control	%	90.2
Not Active	23320693	CHEMBL4879591	KinomeScan assay: inhibition of AURKA	B	c1ccc(N2CCN(Cc3nc4ccccc4[nH]3)CC2)nc1		CHEMBL440687		% Control	%	89.0	CHEMBL4722	Homo sapiens	% Control	%	89.0
Not Active	23321161	CHEMBL4879591	KinomeScan assay: inhibition of AURKA	B	CSc1cccnc1N1CCN(Cc2nc3ccccc3[nH]2)CC1		CHEMBL4630641		% Control	%	74.0	CHEMBL4722	Homo sapiens	% Control	%	74.0
Not Active	23321791	CHEMBL4879591	KinomeScan assay: inhibition of AURKA	B	CCCOc1ccc([C@H]2[C@H](C(=O)O)[C@@H](c3ccc4c(c3)OCO4)CN2CC(=O)Nc2c(CC)cccc2CC)cc1		CHEMBL332794		% Control	%	93.0	CHEMBL4722	Homo sapiens	% Control	%	93.0
Not Active	23322259	CHEMBL4879591	KinomeScan assay: inhibition of AURKA	B	CCCOc1ccc([C@@H]2[C@@H](C(=O)O)[C@H](c3ccc4c(c3)OCO4)CN2CC(=O)Nc2c(CC)cccc2CC)cc1		CHEMBL4533479		% Control	%	94.0	CHEMBL4722	Homo sapiens	% Control	%	94.0
Not Active	23322948	CHEMBL4879591	KinomeScan assay: inhibition of AURKA	B	COc1ccc2c(c1)O[C@@H](c1ccc(OC)c(OC)c1)C[C@H]2NC(=O)C1(c2ccc3c(c2)OC(F)(F)O3)CC1		CHEMBL4093612		% Control	%	92.0	CHEMBL4722	Homo sapiens	% Control	%	92.0
Not Active	23323416	CHEMBL4879591	KinomeScan assay: inhibition of AURKA	B	COc1ccc2c(c1)O[C@H](c1ccc(OC)c(OC)c1)C[C@@H]2NC(=O)C1(c2ccc3c(c2)OC(F)(F)O3)CC1		CHEMBL4066040		% Control	%	100.0	CHEMBL4722	Homo sapiens	% Control	%	100.0
Not Active	23323953	CHEMBL4880572	Aurora-A( h) Millipore kinase activity assay	B	CC1=C(C#N)C(c2ccc3[nH]nc(C)c3c2)C(C#N)=C(C)N1		CHEMBL4593677		Inhibition	%	40.0	CHEMBL4722	Homo sapiens	% inhibition	%	40.0
Not Active	23324270	CHEMBL4879591	KinomeScan assay: inhibition of AURKA	B	CC1=C(C#N)[C@@H](c2ccc3[nH]nc(C)c3c2)C(C#N)=C(c2ccc(Cl)cc2)N1		CHEMBL4522773		% Control	%	100.0	CHEMBL4722	Homo sapiens	% Control	%	100.0
Not Active	23324905	CHEMBL4879591	KinomeScan assay: inhibition of AURKA	B	O=C(c1ccc(OCCC2CCOCC2)cc1)[C@H]1CC[C@@H](Cn2nnc3ccccc3c2=O)[C@@H]1C(=O)O		CHEMBL4585243		% Control	%	97.0	CHEMBL4722	Homo sapiens	% Control	%	97.0
Not Active	23325373	CHEMBL4879591	KinomeScan assay: inhibition of AURKA	B	O=C(c1ccc(OCCC2CCOCC2)cc1)[C@@H]1CC[C@H](Cn2nnc3ccccc3c2=O)[C@H]1C(=O)O		CHEMBL4539943		% Control	%	100.0	CHEMBL4722	Homo sapiens	% Control	%	100.0
Not Active	23326020	CHEMBL4879591	KinomeScan assay: inhibition of AURKA	B	NS(=O)(=O)c1cc(NC(=O)Cc2ccccc2)ccc1Oc1cccc(Cl)c1		CHEMBL4521594		% Control	%	69.0	CHEMBL4722	Homo sapiens	% Control	%	69.0
Not Active	23326488	CHEMBL4879591	KinomeScan assay: inhibition of AURKA	B	NS(=O)(=O)c1cc(NC(=O)C2(c3ccccc3Cl)CC2)ccc1Oc1cccc(Cl)c1		CHEMBL4516843		% Control	%	100.0	CHEMBL4722	Homo sapiens	% Control	%	100.0
Not Active	23327188	CHEMBL4879591	KinomeScan assay: inhibition of AURKA	B	O=C(NCc1ncc(C(F)(F)F)cc1Cl)c1ccc2c(c1)C1(CCS(=O)(=O)CC1)[C@H](C1CC1)N2S(=O)(=O)c1ccc(F)cc1		CHEMBL4537788		% Control	%	97.0	CHEMBL4722	Homo sapiens	% Control	%	97.0
Not Active	23327656	CHEMBL4879591	KinomeScan assay: inhibition of AURKA	B	O=C(NCc1ncc(C(F)(F)F)cc1Cl)c1ccc2c(c1)C1(CCS(=O)(=O)CC1)[C@@H](C1CC1)N2S(=O)(=O)c1ccc(F)cc1		CHEMBL4564312		% Control	%	81.0	CHEMBL4722	Homo sapiens	% Control	%	81.0
Not Active	23328243	CHEMBL4879591	KinomeScan assay: inhibition of AURKA	B	Cc1c(NC(=O)c2cc(C(N)=O)nc3cc(F)ccc23)c(C(F)(F)F)nn1Cc1ccc(C#N)cc1		CHEMBL4448899		% Control	%	89.0	CHEMBL4722	Homo sapiens	% Control	%	89.0
Not Active	23328711	CHEMBL4879591	KinomeScan assay: inhibition of AURKA	B	Cc1c(NC(=O)c2cc(C(N)=O)nc3cc(F)ccc23)c(C(F)(F)F)nn1Cc1ccc(C(C)(C)C)cc1		CHEMBL4552180		% Control	%	100.0	CHEMBL4722	Homo sapiens	% Control	%	100.0
Not Active	23329251	CHEMBL4880958	Aurora-A(h) Eurofins Kinase panel	B	CN1CCN(c2cnc3c(C4CCN(C(=O)c5ccc(OC(F)(F)F)cc5N)CC4)ncnc3c2)CC1		CHEMBL4445670		% residual kinase activity	%	109.0	CHEMBL4722	Homo sapiens	% residual kinase activity	%	109.0
Not Active	23329657	CHEMBL4879591	KinomeScan assay: inhibition of AURKA	B	CN1CCN(c2cnc3c(C4CCN(C(=O)c5ccc(OC(F)(F)F)cc5N)CC4)ncnc3c2)CC1		CHEMBL4445670		% Control	%	100.0	CHEMBL4722	Homo sapiens	% Control	%	100.0
Not Active	23330125	CHEMBL4879591	KinomeScan assay: inhibition of AURKA	B	Cc1nc(C2CCN(C(=O)c3ccc(OC(F)(F)F)cc3N)CC2)c2ncc(N3CCN(C)CC3)cc2n1		CHEMBL4455582		% Control	%	99.0	CHEMBL4722	Homo sapiens	% Control	%	99.0
Not Active	23330881	CHEMBL4879591	KinomeScan assay: inhibition of AURKA	B	O=C(N1CCS(=O)(=O)CC1)N1C[C@H](c2ccc(OC(F)(F)F)cc2)C[C@H](c2nc(C3CC3)no2)C1		CHEMBL4630644		% Control	%	100.0	CHEMBL4722	Homo sapiens	% Control	%	100.0
Not Active	23331349	CHEMBL4879591	KinomeScan assay: inhibition of AURKA	B	Cc1noc([C@H]2C[C@@H](c3ccc(C(F)(F)F)cc3)CN(C(=O)N3CCS(=O)(=O)C3)C2)n1		CHEMBL4630643		% Control	%	85.0	CHEMBL4722	Homo sapiens	% Control	%	85.0
Not Active	23331936	CHEMBL4879591	KinomeScan assay: inhibition of AURKA	B	Cc1cc(C)c(-n2ccn3nc(-c4cccnc4)cc23)cc1NC(=O)c1cc(C#N)cc(S(F)(F)(F)(F)F)c1		CHEMBL3907057		% Control	%	75.9	CHEMBL4722	Homo sapiens	% Control	%	75.9
Not Active	23332404	CHEMBL4879591	KinomeScan assay: inhibition of AURKA	B	Cc1cc(NC(=O)c2cccc(S(F)(F)(F)(F)F)c2)cc(-n2ccn3nc(-c4cccnc4)cc23)c1		CHEMBL4526351		% Control	%	84.9	CHEMBL4722	Homo sapiens	% Control	%	84.9
Not Active	23333120	CHEMBL4879591	KinomeScan assay: inhibition of AURKA	B	CC(=O)C1=C(C)N(c2cccc(C(F)(F)F)c2)C(=O)N[C@@H]1c1ccc(C#N)nc1		CHEMBL3617968		% Control	%	83.9	CHEMBL4722	Homo sapiens	% Control	%	83.9
Not Active	23333759	CHEMBL4879591	KinomeScan assay: inhibition of AURKA	B	CNCc1ccccc1-c1csc([C@@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1		CHEMBL4535474		% Control	%	73.0	CHEMBL4722	Homo sapiens	% Control	%	73.0
Not Active	23334227	CHEMBL4879591	KinomeScan assay: inhibition of AURKA	B	CNCc1ccccc1-c1csc([C@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1		CHEMBL4520788		% Control	%	73.0	CHEMBL4722	Homo sapiens	% Control	%	73.0
Not Active	23334866	CHEMBL4881490	Aurora A (h) Upstate kinase activity assay	B	Cc1c[nH]c2nccc(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)c12		CHEMBL1971943		Inhibition	%	77.0	CHEMBL4722	Homo sapiens	% inhibition	%	77.0
Not Active	23335206	CHEMBL4879591	KinomeScan assay: inhibition of AURKA	B	Cc1c[nH]c2nccc(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)c12		CHEMBL1971943		% Control	%	94.0	CHEMBL4722	Homo sapiens	% Control	%	94.0
Not Active	23335674	CHEMBL4879591	KinomeScan assay: inhibition of AURKA	B	Cn1cc(Cl)c2c(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)ccnc21		CHEMBL4546802		% Control	%	100.0	CHEMBL4722	Homo sapiens	% Control	%	100.0
Not Active	23336301	CHEMBL4879591	KinomeScan assay: inhibition of AURKA	B	O=C(NC[C@H]1[C@@H]2CN(C(=O)OCc3cc(C(F)(F)F)cc(C(F)(F)F)c3)C[C@H]12)c1ccc2[nH]nnc2c1		CHEMBL4165749		% Control	%	93.0	CHEMBL4722	Homo sapiens	% Control	%	93.0
Not Active	23336769	CHEMBL4879591	KinomeScan assay: inhibition of AURKA	B	Cc1nccc(COC(=O)N2C[C@H]3[C@H](CNC(=O)c4ccc5[nH]nnc5c4)[C@H]3C2)n1		CHEMBL4552354		% Control	%	91.0	CHEMBL4722	Homo sapiens	% Control	%	91.0
Not Active	23337791	CHEMBL4882162	STK6 Invitrogen selectivity data (BI)	B	CN(C)C(=O)Cn1cc(-c2nc([C@@](C)(c3ccc(-c4cnc(N)nc4)cc3)C3CC3)no2)cn1		CHEMBL3417525		% Ctrl	%	75.5	CHEMBL4722	Homo sapiens	% Ctrl	%	75.5
Not Active	23337850	CHEMBL4879591	KinomeScan assay: inhibition of AURKA	B	CN(C)C(=O)Cn1cc(-c2nc([C@@](C)(c3ccc(-c4cnc(N)nc4)cc3)C3CC3)no2)cn1		CHEMBL3417525		% Control	%	73.0	CHEMBL4722	Homo sapiens	% Control	%	73.0
Not Active	23338318	CHEMBL4879591	KinomeScan assay: inhibition of AURKA	B	CN(C)C(=O)Cn1cc(-c2nc(C3(c4ccc(-c5cnc(N)nc5)cc4)CC3)no2)cn1		CHEMBL4560241		% Control	%	82.0	CHEMBL4722	Homo sapiens	% Control	%	82.0
Not Active	23338930	CHEMBL4879591	KinomeScan assay: inhibition of AURKA	B	CCS(=O)(=O)c1cc2cc(C[C@](O)(CC(C)(C)c3ccc(F)cc3C(N)=O)C(F)(F)F)[nH]c2cn1		CHEMBL3358954		% Control	%	88.0	CHEMBL4722	Homo sapiens	% Control	%	88.0
Not Active	23339398	CHEMBL4879591	KinomeScan assay: inhibition of AURKA	B	CCS(=O)(=O)c1cc2cc(C[C@@](O)(CC(C)(C)c3ccc(F)cc3C(N)=O)C(F)(F)F)[nH]c2cn1		CHEMBL4531220		% Control	%	88.0	CHEMBL4722	Homo sapiens	% Control	%	88.0
Not Active	23340035	CHEMBL4879591	KinomeScan assay: inhibition of AURKA	B	CS(=O)(=O)c1cc(C2(NC(=O)c3cncc4c3cnn4-c3ccc(F)cc3)CC2)ccn1		CHEMBL4456123		% Control	%	89.0	CHEMBL4722	Homo sapiens	% Control	%	89.0
Not Active	23340503	CHEMBL4879591	KinomeScan assay: inhibition of AURKA	B	CS(=O)(=O)NCC[C@H](NC(=O)c1cncc2c1cnn2-c1ccc(F)cc1)c1ccnc(S(C)(=O)=O)c1		CHEMBL4539555		% Control	%	100.0	CHEMBL4722	Homo sapiens	% Control	%	100.0
Not Active	23341160	CHEMBL4879591	KinomeScan assay: inhibition of AURKA	B	CC(=O)N1CCC(c2ccc(C(=O)NC(=N)N)cc2C(F)(F)F)CC1		CHEMBL2170610		% Control	%	87.0	CHEMBL4722	Homo sapiens	% Control	%	87.0
Not Active	23341628	CHEMBL4879591	KinomeScan assay: inhibition of AURKA	B	CC(=O)N1CCC(c2ccc(C(=O)NC3=NCCN3)cc2C(F)(F)F)CC1		CHEMBL4540759		% Control	%	100.0	CHEMBL4722	Homo sapiens	% Control	%	100.0
Slightly Active	23342244	CHEMBL4879591	KinomeScan assay: inhibition of AURKA	B	CCC(=O)N[C@H]1CC[C@@H](C(=O)N(C)c2ccc(-c3nc4ccccc4o3)cc2)C1		CHEMBL1834184		% Control	%	43.0	CHEMBL4722	Homo sapiens	% Control	%	43.0
Not Active	23342712	CHEMBL4879591	KinomeScan assay: inhibition of AURKA	B	CCC(=O)N[C@@H]1CC[C@H](C(=O)N(C)c2ccc(-c3nc4ccccc4o3)cc2)C1		CHEMBL1834199		% Control	%	100.0	CHEMBL4722	Homo sapiens	% Control	%	100.0
Active	23343290	CHEMBL4882475	STK6 Invitrogen selectivity data (BI)	B	CCOC(=O)c1cc2cc(-c3cc(C(=O)NCc4ccc(C(=O)O)cc4)nn3C)ccc2[nH]1		CHEMBL1939876		% Ctrl	%	-1.0	CHEMBL4722	Homo sapiens	% Ctrl	%	-1.0
Not Active	23343342	CHEMBL4879591	KinomeScan assay: inhibition of AURKA	B	CCOC(=O)c1cc2cc(-c3cc(C(=O)NCc4ccc(C(=O)O)cc4)nn3C)ccc2[nH]1		CHEMBL1939876		% Control	%	90.0	CHEMBL4722	Homo sapiens	% Control	%	90.0
Not Active	23343810	CHEMBL4879591	KinomeScan assay: inhibition of AURKA	B	Cn1nc(C(=O)NCc2ccc(C(=O)O)cc2)cc1-c1ccc2[nH]ccc2c1		CHEMBL1939880		% Control	%	100.0	CHEMBL4722	Homo sapiens	% Control	%	100.0
Not Active	23344448	CHEMBL4879591	KinomeScan assay: inhibition of AURKA	B	CCOCCn1cc(C(=O)Nc2ccc(-n3nc(-c4cccnc4)cc3C(F)(F)F)cn2)ccc1=O		CHEMBL4516982		% Control	%	85.0	CHEMBL4722	Homo sapiens	% Control	%	85.0
Not Active	23345021	CHEMBL4879591	KinomeScan assay: inhibition of AURKA	B	COc1ccc2c(O[C@@H]3C[C@H]4C(=O)N[C@]5(C(=O)O)CC5/C=C\CCCCC[C@H](NC(=O)OC5CCCC5)C(=O)N4C3)cc(-c3csc(NC(=O)C(C)C)n3)nc2c1C		CHEMBL4588900		% Control	%	69.0	CHEMBL4722	Homo sapiens	% Control	%	69.0
Not Active	23345489	CHEMBL4879591	KinomeScan assay: inhibition of AURKA	B	O=C(N[C@H]1CCCCC/C=C\C2C[C@@]2(C(=O)O)NC(=O)[C@@H]2C[C@@H](Oc3ccncc3)CN2C1=O)OC1CCCC1		CHEMBL4516471		% Control	%	92.0	CHEMBL4722	Homo sapiens	% Control	%	92.0
Not Active	23346066	CHEMBL4879591	KinomeScan assay: inhibition of AURKA	B	Cc1cc(Nc2nccc(C)n2)cc(-c2cnc([C@@]3(O)CC[C@H](C(=O)O)C(C)(C)C3)s2)c1		CHEMBL3685796		% Control	%	100.0	CHEMBL4722	Homo sapiens	% Control	%	100.0
Not Active	23346535	CHEMBL4879591	KinomeScan assay: inhibition of AURKA	B	Cc1ccc(-c2cnc([C@@]3(O)CC[C@H](C(=O)O)C(C)(C)C3)s2)cc1Nc1cccc(C(F)(F)F)n1		CHEMBL4530401		% Control	%	60.2	CHEMBL4722	Homo sapiens	% Control	%	60.2
Not Active	23347145	CHEMBL4879591	KinomeScan assay: inhibition of AURKA	B	C[C@@H](NC(=O)Nc1cc2[nH]ncc2c(CO)n1)c1ccccc1		CHEMBL4538174		% Control	%	82.0	CHEMBL4722	Homo sapiens	% Control	%	82.0
Not Active	23347626	CHEMBL4879591	KinomeScan assay: inhibition of AURKA	B	C[C@H](NC(=O)Nc1cc2[nH]ncc2c(CO)n1)c1ccccn1		CHEMBL4557026		% Control	%	100.0	CHEMBL4722	Homo sapiens	% Control	%	100.0
Not Active	23348205	CHEMBL4879591	KinomeScan assay: inhibition of AURKA	B	CC(=O)Nc1c(C(C)=O)c(=O)n(C)c2nc(-c3ccc(Cl)cc3Cl)c(-c3ccc(Cl)cc3)cc12		CHEMBL204232		% Control	%	100.0	CHEMBL4722	Homo sapiens	% Control	%	100.0
Not Active	23348673	CHEMBL4879591	KinomeScan assay: inhibition of AURKA	B	CC(=O)c1c(NS(C)(=O)=O)c2cc(-c3ccc(Cl)cc3)c(-c3ccc(Cl)cc3Cl)nc2n(C)c1=O		CHEMBL4578164		% Control	%	87.0	CHEMBL4722	Homo sapiens	% Control	%	87.0
Not Active	23349260	CHEMBL4879591	KinomeScan assay: inhibition of AURKA	B	O=S(=O)(NC1CCC(c2cc(F)ccc2F)(S(=O)(=O)c2ccc(Cl)cc2)CC1)C(F)(F)F		CHEMBL1091513		% Control	%	100.0	CHEMBL4722	Homo sapiens	% Control	%	100.0
Not Active	23349878	CHEMBL4879591	KinomeScan assay: inhibition of AURKA	B	COc1cc(-c2cn(C3CCc4c(F)cccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1cnc(C)c1		CHEMBL3609637		% Control	%	100.0	CHEMBL4722	Homo sapiens	% Control	%	100.0
Not Active	23350346	CHEMBL4879591	KinomeScan assay: inhibition of AURKA	B	COc1cc(-c2cn(C3CCc4ccccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1ccc(C)n1		CHEMBL4534005		% Control	%	58.0	CHEMBL4722	Homo sapiens	% Control	%	58.0
Not Active	23350951	CHEMBL4879591	KinomeScan assay: inhibition of AURKA	B	CN([C@@H]1CCc2c(CC(=O)O)c3ccccc3n2C1)S(=O)(=O)c1ccc(F)cc1		CHEMBL561132		% Control	%	100.0	CHEMBL4722	Homo sapiens	% Control	%	100.0
Not Active	23351419	CHEMBL4879591	KinomeScan assay: inhibition of AURKA	B	CN([C@@H]1CCc2c(CC(=O)O)c3cc(S(C)(=O)=O)ccc3n2C1)S(=O)(=O)c1ccc(F)cc1		CHEMBL1643772		% Control	%	100.0	CHEMBL4722	Homo sapiens	% Control	%	100.0
Not Active	23351965	CHEMBL4882658	AURKA (Aurora A) Kinase screen	B	C[C@H]1CN(c2cc(-c3n[nH]c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4098877		Inhibition	%	-0.2108	CHEMBL4722	Homo sapiens	% Inhibition	%	-0.2108
Not Active	23352443	CHEMBL4879591	KinomeScan assay: inhibition of AURKA	B	C[C@H]1CN(c2cc(-c3n[nH]c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4098877		% Control	%	94.0	CHEMBL4722	Homo sapiens	% Control	%	94.0
Not Active	23352911	CHEMBL4879591	KinomeScan assay: inhibition of AURKA	B	C[C@H]1CN(c2cc(-c3nn(C)c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4560589		% Control	%	100.0	CHEMBL4722	Homo sapiens	% Control	%	100.0
Not Active	23353793	CHEMBL4879591	KinomeScan assay: inhibition of AURKA	B	O=C(O)c1cc(-c2ccc(C3CCNCC3)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc2c1		CHEMBL1800685		% Control	%	100.0	CHEMBL4722	Homo sapiens	% Control	%	100.0
Not Active	23354261	CHEMBL4879591	KinomeScan assay: inhibition of AURKA	B	Cc1c(C(=O)O)cc(-c2ccc(C3CCNCC3)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc12		CHEMBL4566600		% Control	%	100.0	CHEMBL4722	Homo sapiens	% Control	%	100.0
Not Active	23354993	CHEMBL4879591	KinomeScan assay: inhibition of AURKA	B	COCCOc1nc(-c2ccc(Cl)nc2)nc2c1CN(C(=O)c1ncn3ccccc13)CC2		CHEMBL2204538		% Control	%	81.0	CHEMBL4722	Homo sapiens	% Control	%	81.0
Not Active	23355461	CHEMBL4879591	KinomeScan assay: inhibition of AURKA	B	CC(C)CC(=O)N1CCc2nc(-c3ccc(Br)cc3)nc(N(C)Cc3ccccc3)c2C1		CHEMBL4518342		% Control	%	72.0	CHEMBL4722	Homo sapiens	% Control	%	72.0
Not Active	23356097	CHEMBL4879591	KinomeScan assay: inhibition of AURKA	B	CC(C)(O)c1cncc(-c2nc3ccc(F)cc3n2C2CC2)c1		CHEMBL3582478		% Control	%	94.0	CHEMBL4722	Homo sapiens	% Control	%	94.0
Not Active	23356565	CHEMBL4879591	KinomeScan assay: inhibition of AURKA	B	FC(F)(F)c1ccc2c(c1)nc(-c1cccnc1)n2C1CC1		CHEMBL3582461		% Control	%	98.0	CHEMBL4722	Homo sapiens	% Control	%	98.0
Not Active	23357174	CHEMBL4879591	KinomeScan assay: inhibition of AURKA	B	C[C@H](c1ccc(F)cc1)N(Cc1cccc(C(=O)O)c1)C(=O)c1cnc2ccccc2c1		CHEMBL3577885		% Control	%	100.0	CHEMBL4722	Homo sapiens	% Control	%	100.0
Not Active	23357821	CHEMBL4879591	KinomeScan assay: inhibition of AURKA	B	O=C(Nc1cccnn1)N1CCC(=Cc2cccc(Oc3ccc(C(F)(F)F)cn3)c2)CC1		CHEMBL1651534		% Control	%	100.0	CHEMBL4722	Homo sapiens	% Control	%	100.0
Not Active	23358289	CHEMBL4879591	KinomeScan assay: inhibition of AURKA	B	O=C(Nc1cccnn1)N1CC(C/C=C/c2cncc(Oc3ccc(C(F)(F)F)cn3)n2)C1		CHEMBL4780458		% Control	%	100.0	CHEMBL4722	Homo sapiens	% Control	%	100.0
Not Active	23358875	CHEMBL4879591	KinomeScan assay: inhibition of AURKA	B	COc1cccc(CNC(=O)c2nc3scc(COCc4ccc(C(=O)O)cc4)c3c(=O)[nH]2)c1		CHEMBL3337894		% Control	%	80.9	CHEMBL4722	Homo sapiens	% Control	%	80.9
Not Active	23359473	CHEMBL4879591	KinomeScan assay: inhibition of AURKA	B	C[C@H](c1cccc(C#N)c1)n1cc(Cl)cc(C(N)=O)c1=N		CHEMBL3799292		% Control	%	97.0	CHEMBL4722	Homo sapiens	% Control	%	97.0
Not Active	23359941	CHEMBL4879591	KinomeScan assay: inhibition of AURKA	B	C[C@@H](c1cccc(C#N)c1)n1cc(Cl)cc(C(N)=O)c1=N		CHEMBL3797887		% Control	%	96.0	CHEMBL4722	Homo sapiens	% Control	%	96.0
Not Active	23360526	CHEMBL4879591	KinomeScan assay: inhibition of AURKA	B	Cn1nc(C(F)(F)F)cc1-c1cnc(N2CCc3cc(S(=O)(=O)Nc4c(F)cc(Cl)cc4F)cc(N4CCCC4=O)c32)nc1		CHEMBL4455357		% Control	%	88.0	CHEMBL4722	Homo sapiens	% Control	%	88.0
Not Active	23360994	CHEMBL4879591	KinomeScan assay: inhibition of AURKA	B	Nc1cnc(N2CCc3cc(S(=O)(=O)Nc4c(F)cc(Cl)cc4F)cc(N4CCCC4=O)c32)nc1		CHEMBL4585920		% Control	%	100.0	CHEMBL4722	Homo sapiens	% Control	%	100.0
Not Active	23361567	CHEMBL4879591	KinomeScan assay: inhibition of AURKA	B	Cc1nc(N2CC[C@@H](O)C2)ncc1-c1cc(C(F)(F)F)cc2[nH]ncc12		CHEMBL3799512		% Control	%	87.0	CHEMBL4722	Homo sapiens	% Control	%	87.0
Not Active	23362103	CHEMBL4879591	KinomeScan assay: inhibition of AURKA	B	Cc1cc(-n2nc(Cc3cc(F)cc(C(F)(F)F)c3)nc2C)ccc1C(N)=O		CHEMBL4082756		% Control	%	99.0	CHEMBL4722	Homo sapiens	% Control	%	99.0
Not Active	23362571	CHEMBL4879591	KinomeScan assay: inhibition of AURKA	B	Cc1nc(Cc2cccc(C(F)(F)F)c2)sc1-c1ccc(C(N)=O)nc1		CHEMBL4100408		% Control	%	100.0	CHEMBL4722	Homo sapiens	% Control	%	100.0
Not Active	23363212	CHEMBL4883222	AURKA (Aurora A) Kinase activity screen	B	CN1CCN(C(=O)C(C)(C)c2ccc(C(=O)Nc3cn4cc(-c5ccncc5)ccc4n3)cc2)CC1		CHEMBL4531334		Inhibition	%	8.554	CHEMBL4722	Homo sapiens	% inhibition	%	8.5544
Not Active	23363213	CHEMBL4883222	AURKA (Aurora A) Kinase activity screen	B	CN1CCN(C(=O)C(C)(C)c2ccc(C(=O)Nc3cn4cc(-c5ccncc5)ccc4n3)cc2)CC1		CHEMBL4531334		Inhibition	%	4.511	CHEMBL4722	Homo sapiens	% inhibition	%	4.5114
Not Active	23364213	CHEMBL4879591	KinomeScan assay: inhibition of AURKA	B	CO[C@H]1CC[C@H](CNc2ccc(S(=O)(=O)NC(=O)c3ccc(N4CCN(CC5=C(c6ccc(Cl)cc6)CC(C)(C)CC5)CC4)cc3Oc3cnc4[nH]ccc4c3)cc2[N+](=O)[O-])CC1		CHEMBL4228713		% Control	%	100.0	CHEMBL4722	Homo sapiens	% Control	%	100.0
Not Active	23364681	CHEMBL4879591	KinomeScan assay: inhibition of AURKA	B	O=C(NS(=O)(=O)c1ccc(NCC2CCOCC2)c([N+](=O)[O-])c1)c1ccc(N2CCN(Cc3ccc(C(F)(F)F)cc3-c3ccc(Cl)cc3)CC2)cc1Oc1cnc2[nH]ccc2c1		CHEMBL4551344		% Control	%	96.0	CHEMBL4722	Homo sapiens	% Control	%	96.0
Not Active	23365420	CHEMBL4879591	KinomeScan assay: inhibition of AURKA	B	CN(C)CC#Cc1ccc(OCCCc2sc(N3CCc4cccc(C(=O)Nc5nc6ccccc6s5)c4C3)nc2C(=O)O)c(F)c1		CHEMBL3342332		% Control	%	92.0	CHEMBL4722	Homo sapiens	% Control	%	92.0
Not Active	23365963	CHEMBL4879591	KinomeScan assay: inhibition of AURKA	B	Cc1c(Oc2c(F)cccc2F)c(OC(C)C)nn1-c1ncc(C2CC2)cc1F		CHEMBL3589752		% Control	%	84.0	CHEMBL4722	Homo sapiens	% Control	%	84.0
Not Active	23366553	CHEMBL4879591	KinomeScan assay: inhibition of AURKA	B	Nc1c(C(=O)NCc2ccc(C(=O)NCCCC3CCCCC3)cc2)cnn1-c1ccccc1		CHEMBL4436748		% Control	%	100.0	CHEMBL4722	Homo sapiens	% Control	%	100.0
Not Active	23367021	CHEMBL4879591	KinomeScan assay: inhibition of AURKA	B	O=C(NCCCC1CCCCC1)c1ccc(CNC(=O)c2cnn(-c3ccccc3)c2C(F)(F)F)cc1		CHEMBL4531775		% Control	%	100.0	CHEMBL4722	Homo sapiens	% Control	%	100.0
Not Active	23367474	CHEMBL4883827	Aurora-A ProQinase selectivity panel	B	O=C1c2ccc(Nc3ccc(F)cc3F)cc2CCc2ccc(OC[C@H](O)CO)cc21		CHEMBL2152944		% Residual activity with Skepinone-L	%	99.0	CHEMBL4722	Homo sapiens	% Residual activity with Skepinone-L	%	99.0
Not Active	23367899	CHEMBL4879591	KinomeScan assay: inhibition of AURKA	B	O=C(Nc1cnc(Oc2ccc(F)cc2)nc1)N1CCc2ncccc2[C@@H]1c1ccc(F)cc1		CHEMBL4458424		% Control	%	100.0	CHEMBL4722	Homo sapiens	% Control	%	100.0
Not Active	23368367	CHEMBL4879591	KinomeScan assay: inhibition of AURKA	B	O=C(Nc1ccc(Oc2ccc(F)cc2)cc1)N1CCc2ncccc2[C@H]1c1ccc(F)cc1		CHEMBL4592872		% Control	%	100.0	CHEMBL4722	Homo sapiens	% Control	%	100.0
Not Active	23368966	CHEMBL4879591	KinomeScan assay: inhibition of AURKA	B	C[C@H](c1ccnc(Nc2nc3ccc(-c4cc(N(C)C)ncn4)cc3[nH]2)c1)N1CCN(C(=O)CC(F)(F)F)CC1		CHEMBL4537673		% Control	%	100.0	CHEMBL4722	Homo sapiens	% Control	%	100.0
Not Active	23369434	CHEMBL4879591	KinomeScan assay: inhibition of AURKA	B	CN(C)c1ncnc(-c2ccc3nc(Nc4cc(CN5CCN(C(=O)CC(F)(F)F)CC5)ccn4)[nH]c3c2)c1Cl		CHEMBL4538591		% Control	%	84.0	CHEMBL4722	Homo sapiens	% Control	%	84.0
Not Active	23369978	CHEMBL4884223	Aurora-A(h) Eurofins kinase panel	B	CCc1ccccc1C(=O)Nc1n[nH]c2c(C)c(F)c(C3C(C#N)=C(C)N(C)C(C)=C3C#N)cc12		CHEMBL4580220		% residual kinase activity	%	34.0	CHEMBL4722	Homo sapiens	% residual kinase activity	%	34.0
	23369979	CHEMBL4884223	Aurora-A(h) Eurofins kinase panel	B	CCc1ccccc1C(=O)Nc1n[nH]c2c(C)c(F)c(C3C(C#N)=C(C)N(C)C(C)=C3C#N)cc12		CHEMBL4580220		IC50	nM	480.0	CHEMBL4722	Homo sapiens	IC50	nM	480.0
Not Active	23370402	CHEMBL4879591	KinomeScan assay: inhibition of AURKA	B	CCc1ccccc1C(=O)Nc1n[nH]c2c(C)c(F)c(C3C(C#N)=C(C)N(C)C(C)=C3C#N)cc12		CHEMBL4580220		% Control	%	51.0	CHEMBL4722	Homo sapiens	% Control	%	51.0
Not Active	23370870	CHEMBL4879591	KinomeScan assay: inhibition of AURKA	B	CC1=C(C#N)C(c2ccc3c(c2)c(NC(=O)c2ccccc2C)nn3C)C(C#N)=C(C)N1		CHEMBL4630642		% Control	%	61.0	CHEMBL4722	Homo sapiens	% Control	%	61.0
Not Active	23371679	CHEMBL4879591	KinomeScan assay: inhibition of AURKA	B	CS(=O)(=O)N1CCCC(NC(=O)[C@H](CCC2CCCCC2)NC(=O)c2ccc(CNC(=O)c3cnc4ccccn34)cc2)C1		CHEMBL4591082		% Control	%	100.0	CHEMBL4722	Homo sapiens	% Control	%	100.0
Not Active	23372147	CHEMBL4879591	KinomeScan assay: inhibition of AURKA	B	CS(=O)(=O)N1CCCC(NC(=O)[C@H](CCC2CCCCC2)NC(=O)c2ccc(CNc3ncnc4c3nnn4-c3ccccc3)cc2)C1		CHEMBL4568183		% Control	%	100.0	CHEMBL4722	Homo sapiens	% Control	%	100.0
	23372661	CHEMBL4884626	AurA [Aur2(AURALGF1)] Takeda global kinase panel	B	CN1C(=O)[C@@H](N2CCc3cn(Cc4ccccc4)nc3C2=O)COc2ccccc21		CHEMBL4088216		IC50	nM	1000.0	CHEMBL4722	Homo sapiens	pIC50		6.0
	23373070	CHEMBL4884917	AurA [Aur2(AURALGF1)] Takeda global kinase panel	B	CN1C(=O)[C@@H](N2CCc3c(nn(Cc4ccccc4)c3Br)C2=O)COc2ccccc21		CHEMBL4549667		IC50	nM	1000.0	CHEMBL4722	Homo sapiens	pIC50		6.0
	23373431	CHEMBL4885208	AurA [Aur2(AURALGF1)] Takeda global kinase panel	B	CN1C(=O)[C@@H](N2CCc3cn(CC4CCS(=O)(=O)CC4)nc3C2=O)COc2ccccc21		CHEMBL4097778		IC50	nM	1000.0	CHEMBL4722	Homo sapiens	pIC50		6.0
Not Active	23374918	CHEMBL4885912	Aurora_A Kinase panel	B	CC(C)(O)[C@H](F)CN1Cc2cc(NC(=O)c3cnn4cccnc34)c(N3CCOCC3)cc2C1=O		CHEMBL4475494		Inhibition	%	20.5	CHEMBL4722	Homo sapiens	% Inhibition	%	20.5
Not Active	23375574	CHEMBL4879591	KinomeScan assay: inhibition of AURKA	B	O=C1CCc2cc(Nc3cc(OC4CCOCC4)c([N+](=O)[O-])cc3Cl)ccc2N1		CHEMBL4075278		% Control	%	87.0	CHEMBL4722	Homo sapiens	% Control	%	87.0
Not Active	23376042	CHEMBL4879591	KinomeScan assay: inhibition of AURKA	B	N#Cc1ccc(Nc2ccc3[nH]c(=O)[nH]c3c2)c(Cl)c1		CHEMBL4063249		% Control	%	87.0	CHEMBL4722	Homo sapiens	% Control	%	87.0
Not Active	23376620	CHEMBL4879591	KinomeScan assay: inhibition of AURKA	B	O=c1nc(-c2ccccn2)sc2ccccc12		CHEMBL4516611		% Control	%	87.0	CHEMBL4722	Homo sapiens	% Control	%	87.0
Not Active	23377089	CHEMBL4879591	KinomeScan assay: inhibition of AURKA	B	O=C1NC(c2ccccn2)Sc2ccccc21		CHEMBL4561806		% Control	%	93.0	CHEMBL4722	Homo sapiens	% Control	%	93.0
Not Active	23377947	CHEMBL4879591	KinomeScan assay: inhibition of AURKA	B	CNC(=O)Nc1ccc2c(c1)CC[C@@]21OC(=O)N(CC(=O)N(Cc2ccc(F)cc2)[C@@H](C)C(F)(F)F)C1=O		CHEMBL4282264		% Control	%	80.0	CHEMBL4722	Homo sapiens	% Control	%	80.0
Not Active	23378415	CHEMBL4879591	KinomeScan assay: inhibition of AURKA	B	CNC(=O)Nc1ccc2c(c1)[C@@]1(CC2)OC(=O)N(CC(=O)N(Cc2ccc(F)cc2)[C@@H](C)C(F)(F)F)C1=O		CHEMBL4536197		% Control	%	79.0	CHEMBL4722	Homo sapiens	% Control	%	79.0
Not Active	23379582	CHEMBL4879591	KinomeScan assay: inhibition of AURKA	B	N#CC1(c2ccccn2)CCN(Cc2cc(C(=O)O)c(=O)n3ccccc23)CC1		CHEMBL1800285		% Control	%	100.0	CHEMBL4722	Homo sapiens	% Control	%	100.0
Not Active	23380050	CHEMBL4879591	KinomeScan assay: inhibition of AURKA	B	N#CC1(c2ccccn2)CCN(Cc2cc(C(=O)N3CCCC3)c(=O)n3ccccc23)CC1		CHEMBL2204283		% Control	%	90.0	CHEMBL4722	Homo sapiens	% Control	%	90.0
Not Active	23380744	CHEMBL4879591	KinomeScan assay: inhibition of AURKA	B	COc1ccc2cc(OCC3(C(=O)O)CN(C(=O)c4ccc(F)cc4)C3)ccc2c1		CHEMBL3286797		% Control	%	100.0	CHEMBL4722	Homo sapiens	% Control	%	100.0
Not Active	23381392	CHEMBL4879591	KinomeScan assay: inhibition of AURKA	B	C[C@H](NC(=O)c1cnc2n1[C@](C)(Cc1ccc(C#N)cc1)C(=O)N2c1cc(Cl)c(F)c(Cl)c1)C(=O)NC1(c2ccccn2)CC1		CHEMBL4530740		% Control	%	100.0	CHEMBL4722	Homo sapiens	% Control	%	100.0
Not Active	23381860	CHEMBL4879591	KinomeScan assay: inhibition of AURKA	B	C[C@@]1(Cc2ccc(C#N)cc2)C(=O)N(c2cc(Cl)cc(Cl)c2)c2ncc(C(=O)NC3(c4nc(C5CCC5)no4)CC3)n21		CHEMBL4577237		% Control	%	92.0	CHEMBL4722	Homo sapiens	% Control	%	92.0
Not Active	23382387	CHEMBL4887109	Aurora-A Invitrogen kinase activity assay	B	CNC(=O)c1ccc(Nc2ncc(C(F)(F)F)c(NCc3nccnc3N(C)S(C)(=O)=O)n2)cc1		CHEMBL3137331		Inhibition	%	87.0	CHEMBL4722	Homo sapiens	% inhibition	%	87.0
	23382388	CHEMBL4887109	Aurora-A Invitrogen kinase activity assay	B	CNC(=O)c1ccc(Nc2ncc(C(F)(F)F)c(NCc3nccnc3N(C)S(C)(=O)=O)n2)cc1		CHEMBL3137331		IC50	nM	135.0	CHEMBL4722	Homo sapiens	IC50	nM	135.0
Not Active	23382484	CHEMBL4879591	KinomeScan assay: inhibition of AURKA	B	CNC(=O)c1ccc(Nc2ncc(C(F)(F)F)c(NCc3nccnc3N(C)S(C)(=O)=O)n2)cc1		CHEMBL3137331		% Control	%	50.0	CHEMBL4722	Homo sapiens	% Control	%	50.0
Active	23382952	CHEMBL4879591	KinomeScan assay: inhibition of AURKA	B	CN(c1ccnc(CNc2nc(Nc3ccc4c(c3)CC(=O)N4)ncc2C(F)(F)F)n1)S(C)(=O)=O		CHEMBL4518706		% Control	%	14.0	CHEMBL4722	Homo sapiens	% Control	%	14.0
Not Active	23384006	CHEMBL4887607	STK6 Invitrogen Lab (UK) kinase screen (BI)	B	CCC(F)(F)c1cc(N2CCC(S(C)(=O)=O)CC2)nc2sc(C(N)=O)c(N)c12		CHEMBL4522930		% Ctrl	%	93.0	CHEMBL4722	Homo sapiens	% Ctrl	%	93.0
Slightly Active	23384007	CHEMBL4887607	STK6 Invitrogen Lab (UK) kinase screen (BI)	B	CCC(F)(F)c1cc(N2CCC(S(C)(=O)=O)CC2)nc2sc(C(N)=O)c(N)c12		CHEMBL4522930		% Ctrl	%	38.0	CHEMBL4722	Homo sapiens	% Ctrl	%	38.0
Not Active	23384185	CHEMBL4887780	Aurora_A(h) Millipore kinase panel	B	CC[C@@H](Nc1c(C#N)c(-c2ccc(-c3cccc(C)c3F)cc2)nc2cnccc12)C(=O)O		CHEMBL4802045		Inhibition	%	13.76	CHEMBL4722	Homo sapiens	% inhibition	%	13.76
Not Active	23384633	CHEMBL4888159	AURKA (Aurora A) SelectScreen Kinase panel (LifeTechnologies)	B	C=CC(=O)Nc1ccc2[nH]c(=O)n(C3CCN(Cc4ccc(-c5nc6cc[nH]c(=O)c6cc5-c5ccccc5)cc4)CC3)c2c1		CHEMBL4795065		Inhibition	%	15.0	CHEMBL4722	Homo sapiens	% Inhibition	%	15.0
Not Active	23384867	CHEMBL4879591	KinomeScan assay: inhibition of AURKA	B	CO[C@@H](C)c1c(Nc2ccc([C@H](N(C)C(=O)C3CCS(=O)(=O)CC3)C(F)(F)F)cc2)cnc2cc(Cl)nn12		CHEMBL4568735		% Control	%	100.0	CHEMBL4722	Homo sapiens	% Control	%	100.0
Not Active	23385334	CHEMBL4879591	KinomeScan assay: inhibition of AURKA	B	CO[C@@H](C)c1c(Nc2ccc([C@@H](N(C)C(=O)C3CCS(=O)(=O)CC3)C(F)(F)F)cc2)cnc2cc(Cl)nn12		CHEMBL4584981		% Control	%	100.0	CHEMBL4722	Homo sapiens	% Control	%	100.0
Not Active	23385862	CHEMBL4888335	Aurora_A Invitrogen kinase panel	B	COc1nc2ccc([C@@](O)(c3ccccc3)C3CCN(C(C)=O)CC3)cc2c(Cl)c1Cc1ccc(-n2cccn2)cc1		CHEMBL4802042		Inhibition	%	9.0	CHEMBL4722	Homo sapiens	% inhibition	%	9.0
